PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mathews, PM; Guerra, CB; Jiang, Y; Grbovic, OM; Kao, BH; Schmidt, SD; Dinakar, R; Mercken, M; Hille-Rehfeld, A; Rohrer, J; Mehta, P; Cataldo, AM; Nixon, RA				Mathews, PM; Guerra, CB; Jiang, Y; Grbovic, OM; Kao, BH; Schmidt, SD; Dinakar, R; Mercken, M; Hille-Rehfeld, A; Rohrer, J; Mehta, P; Cataldo, AM; Nixon, RA			Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases A beta secretion - Role for altered lysosomal hydrolase distribution in beta-amyloidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CATHEPSIN-D; ENDOCYTIC PATHWAY; DEFICIENT FIBROBLASTS; CEREBROSPINAL-FLUID; MEMBRANE-PROTEIN; CYTOPLASMIC TAIL; GOLGI-APPARATUS; EXPRESSION; TRANSMEMBRANE	Prominent endosomal and lysosomal changes are an invariant feature of neurons in sporadic Alzheimer's disease (AD). These changes include increased levels of lysosomal hydrolases in early endosomes and increased expression of the cation-dependent mannose 6-phosphate receptor (CD-MPR), which is partially localized to early endosomes. To determine whether AD-associated redistribution of lysosomal hydrolases resulting from changes in CD-MPR expression affects amyloid precursor protein (APP) processing, we stably transfected APP-overexpressing murine L cells with human CD-MPR. As controls for these cells, we also expressed CD-MPR trafficking mutants that either localize to the plasma membrane (CD-MPRpm) or to early endosomes (CD-MPRendo). Expression of CD-MPR resulted in a partial redistribution of a representative lysosomal hydrolase, cathepsin D, to early endosomal compartments. Turnover of APP and secretion of sAPPalpha and sAPPbeta were not altered by overexpression of any of the CD-MPR constructs. However, secretion of both human Abeta40 and Abeta42 into the growth media nearly tripled in CD-MPR- and CD-MPRendo-expressing cells when compared with parental or CD-MPRpm-expressing cells. Comparable increases were confirmed for endogenous mouse Abeta40 in L cells expressing these CD-MPR constructs but not overexpressing human APP. These data suggest that redistribution of lysosomal hydrolases to early endocytic compartments mediated by increased expression of the CD-MPR may represent a potentially pathogenic mechanism for accelerating Abeta generation in sporadic AD, where the mechanism of amyloidogenesis is unknown.	Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; NYU, Sch Med, Orangeburg, NY 10962 USA; Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02478 USA; Janssen Res Fdn, B-2340 Beerse, Belgium; Univ Gottingen, Ctr Biochem & Mol Cell Biol, D-37073 Gottingen, Germany; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	Nathan Kline Institute for Psychiatric Research; New York University; Harvard University; McLean Hospital; Johnson & Johnson; University of Gottingen; Friedrich Miescher Institute for Biomedical Research; Institute for Basic Research in Developmental Disabilities	Mathews, PM (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.	mathews@nki.rfmh.org	Schmidt, Stephen/AAC-6967-2019; Schmidt, Stephen/B-5398-2012	Rohrer, Jack/0000-0002-2058-490X	NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER; NIA NIH HHS [AG14762, AG17617] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Bertram L, 2001, ANN NEUROL, V49, P114, DOI 10.1002/1531-8249(200101)49:1<114::AID-ANA18>3.0.CO;2-M; Bertram L, 2000, EXP GERONTOL, V35, P1353, DOI 10.1016/S0531-5565(00)00193-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; CATALDO AM, 1994, BRAIN RES, V640, P68, DOI 10.1016/0006-8993(94)91858-9; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cataldo AM, 1996, J NEUROSCI, V16, P186; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Chevallier N, 1997, BRAIN RES, V750, P11, DOI 10.1016/S0006-8993(96)01330-3; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DELBRUCK R, 1994, EUR J CELL BIOL, V64, P7; DREYER RN, 1994, EUR J BIOCHEM, V224, P265, DOI 10.1111/j.1432-1033.1994.00265.x; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Gruninger-Leitch F, 2000, NAT BIOTECHNOL, V18, P66, DOI 10.1038/71944; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; KIT SAUL, 1967, J VIROL, V1, P238; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KOO EH, 1994, J BIOL CHEM, V269, P17386; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; MATHEWS PM, 1992, J CELL BIOL, V118, P1027, DOI 10.1083/jcb.118.5.1027; Matsui T, 2001, ANN NEUROL, V49, P544, DOI 10.1002/ana.110; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Menzer G, 2001, AM J MED GENET, V105, P179, DOI 10.1002/ajmg.1204; MESSNER DJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P391, DOI 10.1006/abbi.1993.1528; MIRRA SS, 1993, ARCH PATHOL LAB MED, V117, P132; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; MunierLehmann H, 1996, J BIOL CHEM, V271, P15166, DOI 10.1074/jbc.271.25.15166; Papassotiropoulos A, 2000, ANN NEUROL, V47, P399, DOI 10.1002/1531-8249(200003)47:3<399::AID-ANA22>3.0.CO;2-5; Papassotiropoulos A, 1999, NEUROSCI LETT, V262, P171, DOI 10.1016/S0304-3940(99)00071-3; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Petanceska SS, 2000, J NEUROCHEM, V74, P1878, DOI 10.1046/j.1471-4159.2000.0741878.x; Petanceska SS, 1999, J NEUROCHEM, V73, P2316, DOI 10.1046/j.1471-4159.1999.0732316.x; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Ponnambalam S, 1996, J CELL SCI, V109, P675; Potempska A, 1999, AMYLOID, V6, P14, DOI 10.3109/13506129908993283; ROHRER J, 1995, J CELL BIOL, V130, P1297, DOI 10.1083/jcb.130.6.1297; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; Saftig P, 1996, J BIOL CHEM, V271, P27241, DOI 10.1074/jbc.271.44.27241; SCHWAGERL AL, 1995, J NEUROCHEM, V64, P443; Schweizer A, 1997, P NATL ACAD SCI USA, V94, P14471, DOI 10.1073/pnas.94.26.14471; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; STEIN M, 1987, BIOL CHEM H-S, V368, P937, DOI 10.1515/bchm3.1987.368.2.937; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; VANNOSTRAND WE, 1989, NATURE, V341, P546; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200	64	84	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5299	5307		10.1074/jbc.M108161200	http://dx.doi.org/10.1074/jbc.M108161200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11551970	hybrid			2022-12-27	WOS:000173962900096
J	Gori, F; Divieti, P; Demay, MB				Gori, F; Divieti, P; Demay, MB			Cloning and characterization of a novel WD-40 repeat protein that dramatically accelerates osteoblastic differentiation.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; WD-REPEAT; FAMILY-MEMBERS; BETA-SUBUNITS; BONE; GENE; EXPRESSION; RECEPTOR; IDENTIFICATION; OSF2/CBFA1	The bone morphogenetic proteins (BMPs) play a pivotal role in endochondral bone formation. Using differential display polymerase chain reaction, we have identified a novel gene, named BIG-3 (BMP-2-induced gene 3 kb), that is induced as a murine prechondroblastic cell line, MLB13MYC clone 17, acquires osteoblastic features in response to BMP-2 treatment. The 3-kilobase mRNA encodes a 34-kDa protein containing seven WD-40 repeats. Northern and Western analyses demonstrated that BIG-3 mRNA and protein were induced after 24 h of BMP-2 treatment. BIG-3 mRNA was expressed in conditionally immortalized murine bone marrow stromal cells, osteoblasts, osteocytes, and growth plate chondrocytes, as well as in primary calvarial osteoblasts. Immunohistochemistry demonstrated that BIG-3 was expressed in the osteoblasts of calvariae isolated from mouse embryos. To identify a role for BIG-3 in osteoblast differentiation, MC3T3-E1 cells were stably transfected with the full-length coding region of BIG-3 (MC3T3E1-BIG-3) cloned downstream of a cytomegalovirus promoter in pcDNA3.1. Pooled MC3T3E1-BlG-3 clones expressed alkaline phosphatase activity earlier and achieved a peak level of activity 10-fold higher than cells transfected with the empty vector (MC3T3E1-EV) at 14 days. Cyclic AMP production in response to parathyroid hormone was increased 10- and 14-fold at 7 and 14 days, respectively, in MC3T3E1-BlG-3 clones, relative to MC3T3E1-EV clones. This increase in cAMP production was associated with an increase in PTH binding. Expression of BIG-3 increased mRNA levels encoding Cbfa1, type I collagen, and osteocalcin and accelerated formation of mineralized nodules. In conclusion, we have identified a novel WD-40 protein, induced by BMP-2 treatment, that dramatically accelerates the program of osteoblastic differentiation in stably transfected MC3T3E1 cells.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Demay, MB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu	Gori, Francesca/S-9422-2019	Divieti Pajevic, Paola/0000-0001-9853-9837	NIDCR NIH HHS [1 F32 DE-05754] Funding Source: Medline; NIDDK NIH HHS [DK36597, 1 KO8 DK02889] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE005754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036597, K08DK002889] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; BANROQUES J, 1989, MOL CELL BIOL, V9, P3710, DOI 10.1128/MCB.9.9.3710; Bos MP, 1996, CALCIFIED TISSUE INT, V58, P95, DOI 10.1007/s002239900017; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; DALRYMPLE MA, 1989, CELL, V58, P811, DOI 10.1016/0092-8674(89)90930-6; Divieti P, 1998, J BONE MINER RES, V13, P1835, DOI 10.1359/jbmr.1998.13.12.1835; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; DUCY P, 1996, PRINCIPLES BONE BIOL; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; GARDELLA TJ, 1995, J BIOL CHEM, V270, P6584, DOI 10.1074/jbc.270.12.6584; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; HANEVOLD CD, 1993, J BONE MINER RES, V8, P1191; Harris Stephen E., 1995, Molecular and Cellular Differentiation, V3, P137; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; LEE K, 1993, BONE, V14, P341, DOI 10.1016/8756-3282(93)90162-4; Liu BY, 1998, ENDOCRINOLOGY, V139, P1952, DOI 10.1210/en.139.4.1952; MacLean HE, 1999, J BONE MINER RES, V14, pS219; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neer EJ, 2000, P NATL ACAD SCI USA, V97, P960, DOI 10.1073/pnas.97.3.960; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; QUARLES LD, 1991, ENDOCRINOLOGY, V128, P3144, DOI 10.1210/endo-128-6-3144; ROSEN V, 1994, J BONE MINER RES, V9, P1759; RUGGIERI R, 1989, P NATL ACAD SCI USA, V86, P8778, DOI 10.1073/pnas.86.22.8778; SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; STEIN GS, 1996, PRINCIPLES BONE BIOL; STENBECK G, 1993, EMBO J, V12, P2841, DOI 10.1002/j.1460-2075.1993.tb05945.x; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; YOCHEM J, 1987, J MOL BIOL, V195, P233, DOI 10.1016/0022-2836(87)90646-2; ZHANG M, 1991, GENE, V97, P153, DOI 10.1016/0378-1119(91)90047-F	47	74	78	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46515	46522		10.1074/jbc.M105757200	http://dx.doi.org/10.1074/jbc.M105757200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551928	hybrid			2022-12-27	WOS:000172573100137
J	Weixel, KM; Bradbury, NA				Weixel, KM; Bradbury, NA			mu 2 binding directs the cystic fibrosis transmembrane conductance regulator to the clathrin-mediated endocytic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; GROWTH-FACTOR RECEPTORS; EPITOPE-TAGGED CFTR; SORTING SIGNALS; COATED VESICLES; INTERNALIZATION MOTIF; TRANSFERRIN RECEPTOR; CHLORIDE CHANNELS; CARBOXYL-TERMINUS; AP-2 COMPLEXES	The cystic fibrosis transmembrane conductance regulator (CFTR) contains a conserved tyrosine-based internalization motif, (DSI)-D-1424y, which interacts with the endocytic clathrin adaptor complex, AP-2, and is required for its efficient endocytosis. Although direct interactions between several endocytic sequences and the medium chain and endocytic clathrin adaptor complexes have been shown by protein-protein interaction assays, whether all these interactions occur in vivo or are physiologically important has not always been addressed. Here we show, using both in vitro and in vivo assays, a physiologically relevant interaction between CFTR and the tt subunit of AP-2. Cross-linking experiments were performed using photoreactive peptides containing the YDSI motif and purified adaptor complexes. CFTR peptides cross-linked a 50-kDa subunit of purified AP-2 complexes, the apparent molecular mass of mu2. Furthermore, isolated mu2 bound to the sorting motif, YDSI, both in cross-linking experiments and glutathione S-transferase pull-down experiments, confirming that mu2 mediates the interaction between CFTR and A-P-2 complexes. Inducible overexpression of dominant-negative mu2 in HeLa cells results in AP-2 complexes that fail to interact with CFTR. Moreover, internalization of CFTR in mutant cells is greatly reduced compared with wild type HeLa cells. These results indicate that the AP-2 endocytic complex selectively interacts with the conserved tyrosine-based internalization signal in the carboxyl terminus of CFTR, YDSI. Furthermore, this interaction is mediated by the mu2 subunit of AP-2 and mutations in mu2 that block its interaction with YDSI inhibit the incorporation of CFTR into the clathrin-mediated endocytic pathway.	Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Cyst Fibrosis Res Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bradbury, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Cyst Fibrosis Res Ctr, 3500 Terrace St, Pittsburgh, PA 15261 USA.				NIDDK NIH HHS [1P50DK56490] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK056490] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BELTZER JP, 1991, EMBO J, V10, P3735, DOI 10.1002/j.1460-2075.1991.tb04942.x; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; Bradbury NA, 1999, AM J PHYSIOL-LUNG C, V276, pL659, DOI 10.1152/ajplung.1999.276.4.L659; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COHN JA, 1994, CYSTIC FIBROSIS CURR, V2; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Garippa RJ, 1996, J BIOL CHEM, V271, P20660, DOI 10.1074/jbc.271.34.20660; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Howard M, 1996, KIDNEY INT, V49, P1642, DOI 10.1038/ki.1996.239; Hu W, 2001, BIOCHEM J, V354, P561, DOI 10.1042/0264-6021:3540561; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; Lukacs GL, 1997, BIOCHEM J, V328, P353; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; PRINCE LS, 1993, AM J PHYSIOL, V264, pC491, DOI 10.1152/ajpcell.1993.264.2.C491; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Takahashi A, 1996, AM J PHYSIOL-CELL PH, V271, pC1887, DOI 10.1152/ajpcell.1996.271.6.C1887; Tousson A, 1996, J CELL SCI, V109, P1325; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WEBSTER P, 1994, AM J PHYSIOL, V267, P340; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; WEIXEL KM, 2001, IN PRESS METHODS MOL	53	39	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46251	46259		10.1074/jbc.M104545200	http://dx.doi.org/10.1074/jbc.M104545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11560923	hybrid			2022-12-27	WOS:000172573100104
J	Lelievre, V; Pineau, N; Hu, ZT; Ioffe, Y; Byun, JY; Muller, JM; Waschek, JA				Lelievre, V; Pineau, N; Hu, ZT; Ioffe, Y; Byun, JY; Muller, JM; Waschek, JA			Proliferative actions of natriuretic peptides on neuroblastoma cells - Involvement of guanylyl cyclase and non-guanylyl cyclase pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE CELLS; CLEARANCE RECEPTOR; SELECTIVE INHIBITOR; MESANGIAL CELLS; POTENTIAL ROLE; GROWTH-FACTOR; RAT-BRAIN; IN-VITRO	To identify neural tumor cell lines that could be used as models to study growth-related natriuretic peptide actions, we determined the effects of these peptides on the proliferation of human and rodent neuroblastoma cell lines. Subnanomolar concentrations of atrial natriuretic peptide (ANP) and type C natriuretic peptide (CNP) stimulated proliferation in all four cell lines. These actions were associated with cGMP elevation and were blocked by a protein kinase G inhibitor. These data imply the involvement of guanylyl cyclase (GC)-coupled natriuretic receptors. However, higher concentrations of ANP and CNP, and low concentrations of des-[Gln(18), Ser(19), Gly(20), Leu(21) , Gly(22)]-ANP(4-23)-NH2 (desANP(4-23)) (analog for NPR-C receptor) exerted antiproliferative actions in three of the cell lines. These effects were insensitive to a protein kinase G inhibitor and to HS-142-1, suggesting that growth-inhibitory actions involved a non-GC receptor. They did not appear to involve cAMP, protein kinase X protein kinase C, or calcium mobilization but were abolished when constitutive mitogen-activated protein kinase activity was inhibited. Radioligand binding experiments revealed the presence of a uniform class of binding sites in NG108 cells and multiple binding sites in Neuro2a cells. Northern and reverse transcriptase-polymerase chain reaction analyses revealed differential gene expression for NPRA/B/C in NG108 and Neuro2a cells. The results indicate that natriuretic peptides stimulate neuroblastoma cell proliferation through type NPRA/B (GC) receptors. Higher concentrations of ANP and CNP exerted a mitogen-activated protein kinase-dependent antiproliferative action mediated by a non-GC receptor that interacts with desANP(4-23) with relatively high affinity.	Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Univ Poitiers, UFR Sci, Lab Biol Interact Cellulaires, CNRS,UMR 6558, F-86022 Poitiers, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Waschek, JA (corresponding author), Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat, 68-225 NPI,760 Westwood Plaza, Los Angeles, CA 90024 USA.			Lelievre, Vincent/0000-0003-4150-8233; Muller, Jean-Marc/0000-0001-6009-7471	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034475] Funding Source: NIH RePORTER; NICHD NIH HHS [HD04612, HD34475, HD06576] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKIHO H, 1995, GASTROENTEROLOGY, V109, P1105, DOI 10.1016/0016-5085(95)90568-5; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; APPEL RG, 1990, AM J PHYSIOL, V259, pE312, DOI 10.1152/ajpendo.1990.259.3.E312; Awazu M, 1997, KIDNEY INT, V52, P356, DOI 10.1038/ki.1997.341; BROWN J, 1995, AM J PHYSIOL-REG I, V269, pR261, DOI 10.1152/ajpregu.1995.269.2.R261; BROWN J, 1994, AM J PHYSIOL, V266, pR1383, DOI 10.1152/ajpregu.1994.266.4.R1383; CAHILL PA, 1991, BIOCHEM BIOPH RES CO, V179, P1606, DOI 10.1016/0006-291X(91)91758-5; Cameron VA, 1996, ENDOCRINOLOGY, V137, P817, DOI 10.1210/en.137.3.817; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELPORTE C, 1991, EUR J PHARM-MOLEC PH, V207, P81, DOI 10.1016/S0922-4106(05)80041-0; DELPORTE C, 1992, EUR J PHARM-MOLEC PH, V227, P247, DOI 10.1016/0922-4106(92)90002-D; ESPINER EA, 1995, ENDOCRIN METAB CLIN, V24, P481, DOI 10.1016/S0889-8529(18)30028-8; FULLER F, 1988, J BIOL CHEM, V263, P9395; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; HANEDA M, 1993, BIOCHEM BIOPH RES CO, V192, P642, DOI 10.1006/bbrc.1993.1463; Henning RJ, 2001, CARDIOVASC RES, V49, P27, DOI 10.1016/S0008-6363(00)00229-7; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; KASHIWAGI M, 1995, EUR J BIOCHEM, V233, P102, DOI 10.1111/j.1432-1033.1995.102_1.x; Koide M, 1996, DIFFERENTIATION, V61, P1, DOI 10.1046/j.1432-0436.1996.6110001.x; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Lelievre V, 1998, J BIOL CHEM, V273, P19685, DOI 10.1074/jbc.273.31.19685; Lelievre V, 1998, EUR J PHARMACOL, V341, P299, DOI 10.1016/S0014-2999(97)01463-5; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Matsuda Yuzuru, 1997, P289; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Murthy KS, 1998, AM J PHYSIOL-CELL PH, V275, pC1409, DOI 10.1152/ajpcell.1998.275.6.C1409; NAKAO K, 1992, J HYPERTENS, V10, P1111, DOI 10.1097/00004872-199210000-00002; NEEDLEMAN P, 1989, ANNU REV PHARMACOL, V29, P23, DOI 10.1146/annurev.pa.29.040189.000323; NIIMURA S, 1989, RES COMMUN CHEM PATH, V63, P189; NUSSENZVEIG DR, 1990, J BIOL CHEM, V265, P20952; ODORISIO MS, 1992, REGUL PEPTIDES, V37, P213; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; PINCUS DW, 1990, BRAIN RES, V514, P355, DOI 10.1016/0006-8993(90)91433-H; Prins BA, 1996, J BIOL CHEM, V271, P14156, DOI 10.1074/jbc.271.24.14156; RASHED HM, 1993, HEPATOLOGY, V17, P677, DOI 10.1002/hep.1840170423; Rozen S, 2000, Methods Mol Biol, V132, P365; Segawa K, 1998, N-S ARCH PHARMACOL, V357, P70; Sellitti DF, 2001, REGUL PEPTIDES, V97, P103, DOI 10.1016/S0167-0115(00)00184-1; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; Sugimoto T, 1996, J BIOL CHEM, V271, P544, DOI 10.1074/jbc.271.1.544; TONG Y, 1990, NEUROPEPTIDES, V16, P63, DOI 10.1016/0143-4179(90)90113-D; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0; ZORAD S, 1993, EUR J PHARMACOL, V241, P195, DOI 10.1016/0014-2999(93)90203-T	49	34	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43668	43676		10.1074/jbc.M107341200	http://dx.doi.org/10.1074/jbc.M107341200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11553633	hybrid			2022-12-27	WOS:000172297700026
J	Abadjieva, A; Pauwels, K; Hilven, P; Crabeel, M				Abadjieva, A; Pauwels, K; Hilven, P; Crabeel, M			A new yeast metabolon involving at least the two first enzymes of arginine biosynthesis - Acetylglutamate synthase activity requires complex formation with acetylglutamate kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; GENE; CLONING; LOCALIZATION; DISRUPTION; EXPRESSION; SEQUENCES; PRECURSOR; PRODUCTS	Open reading frame YJL071W of Saccharomyces cer. evisiae was shown to be ARG2 and identified as the structural gene for acetylglutamate synthase, first step in arginine biosynthesis. The three Ascomycete acetylglutamate synthases characterized to date appear homologous, but unlike the other enzymes of the yeast arginine biosynthesis pathway, they showed no significant similarity to their prokaryotic equivalents. The measured synthase activity did not increase with the number of ARG2 gene copies unless the number of ARG5,6 gene copies was increased similarly. ARG5,6 encodes a precursor that is maturated in the mitochondria into acetylglutamate kinase and acetylglutamyl-phosphate reductase, catalyzing the second and third steps in the pathway. The results imply that the synthase must interact stoichiometrically in vivo with the kinase, the reductase, or both to be active. Results obtained with synthetic ARG5 and ARG6 genes suggested that both the kinase and the reductase could be needed. This situation, which has completely escaped notice in yeast until now, is reminiscent of the observation in Neurospora crassa that nonsense arg-6 kinase/reductase mutants lack synthase activity (Hinde, R. W., Jacobson, J. A., Weiss, R. L., and Davis, R. H. (1986) J. Biol. Chem. 261, 5848-5852). In immunoprecipitation experiments, hemagglutinin-tagged synthase coprecipitated with a protein proven by microsequencing to be the kinase. Western blot analyses showed that the synthase has reduced stability in the absence of the kinase/reductase. Our data demonstrate the existence of a new yeast arginine metabolon involving at least the first two, and possibly the first three, enzymes of the pathway. Hypotheses regarding the biological significance of this interaction are discussed.	Free Univ Brussels VIB, Dept Microbiol, COOVI, CERIA, B-1070 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Crabeel, M (corresponding author), Free Univ Brussels VIB, Dept Microbiol, COOVI, CERIA, E Grysonlaan 1, B-1070 Brussels, Belgium.	merabeel@vub.ac.be						BOONCHIRD C, 1991, EUR J BIOCHEM, V199, P325, DOI 10.1111/j.1432-1033.1991.tb16128.x; Crabeel M, 1997, EUR J BIOCHEM, V250, P232, DOI 10.1111/j.1432-1033.1997.0232a.x; Crabeel M, 1996, J BIOL CHEM, V271, P25011, DOI 10.1074/jbc.271.40.25011; CUNIN R, 1986, MICROBIOL REV, V50, P193; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; DEDEKEN RH, 1962, BIOCHEM BIOPH RES CO, V8, P462, DOI 10.1016/0006-291X(62)90297-8; DUBOIS E, 1991, MOL CELL BIOL, V11, P2162, DOI 10.1128/MCB.11.4.2162; GESSERT SF, 1994, J BIOL CHEM, V269, P8189; GRISOLIA S, 1953, J BIOL CHEM, V204, P753; HILGER F, 1973, J GEN MICROBIOL, V75, P33, DOI 10.1099/00221287-75-1-33; HINDE RW, 1986, J BIOL CHEM, V261, P5848; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; JAUNIAUX JC, 1987, THESIS U LIBRE BRUXE; KIM JH, 1995, MOL CELLS, V5, P461; MESSENGUY F, 1976, J BACTERIOL, V22, P277; MINET M, 1971, THESIS U LIBRE BRUXE; MOUNTAIN A, 1986, J BACTERIOL, V165, P1026, DOI 10.1128/jb.165.3.1026-1028.1986; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; SHIGESADA K, 1978, EUR J BIOCHEM, V84, P285, DOI 10.1111/j.1432-1033.1978.tb12167.x; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; Vandenbol M, 1999, YEAST, V15, P1411, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1411::AID-YEA463>3.0.CO;2-M; VANHUFFEL C, 1992, EUR J BIOCHEM, V205, P33; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wattiez R, 2000, ELECTROPHORESIS, V21, P2703, DOI 10.1002/1522-2683(20000701)21:13<2703::AID-ELPS2703>3.3.CO;2-N; WIPF B, 1979, J BACTERIOL, V140, P874, DOI 10.1128/JB.140.3.874-880.1979; WOLF EC, 1980, J BIOL CHEM, V255, P9189; Yu YG, 1996, MOL MICROBIOL, V22, P545, DOI 10.1046/j.1365-2958.1996.1321494.x	28	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42869	42880		10.1074/jbc.M103732200	http://dx.doi.org/10.1074/jbc.M103732200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553611	hybrid			2022-12-27	WOS:000172169300033
J	Kampfer, S; Windegger, M; Hochholdinger, F; Schwaiger, W; Pestell, RG; Baier, G; Grunicke, HH; Uberall, F				Kampfer, S; Windegger, M; Hochholdinger, F; Schwaiger, W; Pestell, RG; Baier, G; Grunicke, HH; Uberall, F			Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; SMOOTH-MUSCLE-CELLS; RHO FAMILY PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; INDEPENDENT ACTIVATION; BINDING PROTEIN; T-LYMPHOCYTES; PKC-EPSILON; MAP KINASE; GROWTH	Transcriptional activation of the cyclin D1 by oncogenic Ras appears to be mediated by several pathways leading to the activation of multiple transcription factors which interact with distinct elements of the cyclin D1 promoter. The present investigations revealed that cyclin D1 induction by transforming Ha-Ras is MEK and Rac-dependent and requires the PKC isotypes epsilon, lambda, and zeta, but not cPKC-alpha. This conclusion is based on observations indicating that cyclin D1 induction by transforming Ha-Ras was depressed in a dose-dependent manner by PD98059, a selective inhibitor of the mitogen-activated kinase kinase MEK-1, demonstrating that Ha-Ras employs extracellular signal-regulated kinases (ERKs) for signal transmission to the cyclin D1 promoter. Evidence is presented that PKC isotypes epsilon and zeta, but not lambda are required for the Ras-mediated activation of ERKs. Expression of kinase-defective, dominant negative (DN) mutants of nPKC-epsilon or aPKC-zeta inhibit ERK activation by constitutively active Raf-1. Phosphorylation within the TEY motif and subsequent activation of ERKs by constitutively active MEK-1 was significantly inhibited by DN aPKC-zeta, indicating that aPKC-zeta functions downstream of MEK-1 in the pathway leading to cyclin D1 induction. In contrast, TEY phosphorylation induced by constitutively active MEK-1 was not effected by nPKC-epsilon, suggesting another position for this kinase within the cascade investigated. Transformation by oncogenic Ras requires activation of several Ras effector pathways which may be PKC-dependent and converge on the cyclin D1 promoter. Therefore, we investigated a role for PKC isotypes in the Ras-Rac-mediated transcriptional regulation of cyclin D1. We have been able to reveal that cyclin D1 induction by oncogenic Ha-Ras is Rac-dependent and requires the PKC isotypes epsilon, lambda, and zeta, but not cPKC-alpha. Evidence is presented that aPKC-lambda acts upstream of Rac, between Ras and Rac, whereas the PKC isotypes epsilon and zeta act downstream of Rac and are required for the activation of ERKs.	Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria; Albert Einstein Coll Med, Bronx, NY 10461 USA; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria	University of Innsbruck; Yeshiva University; Albert Einstein College of Medicine; University of Innsbruck	Uberall, F (corresponding author), Univ Innsbruck, Inst Med Chem & Biochem, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	Florian.Ueberall@uibk.ac.at	Baier, Gottfried/E-8755-2012	Baier, Gottfried/0000-0002-2085-8325				Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Chiloeches A, 2001, MOL CELL BIOL, V21, P2423, DOI 10.1128/MCB.21.7.2423-2434.2001; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Genot E, 1998, ONCOGENE, V17, P1731, DOI 10.1038/sj.onc.1202101; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hazzalin CA, 1996, CURR BIOL, V6, P1028, DOI 10.1016/S0960-9822(02)00649-8; HERBER B, 1994, ONCOGENE, V9, P1295; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hochholdinger F, 1999, MOL CELL BIOL, V19, P8052; Huang CS, 2000, MOL CARCINOGEN, V27, P65, DOI 10.1002/(SICI)1098-2744(200002)27:2<65::AID-MC2>3.0.CO;2-E; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; MARQUARDT B, 1994, ONCOGENE, V9, P3213; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MITEV V, 1995, BIOCHEM BIOPH RES CO, V208, P245, DOI 10.1006/bbrc.1995.1330; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sajan MP, 1999, J BIOL CHEM, V274, P30495, DOI 10.1074/jbc.274.43.30495; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Skaletz-Rorowski A, 1999, ARTERIOSCL THROM VAS, V19, P1608, DOI 10.1161/01.ATV.19.7.1608; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; WON KA, 1992, P NATL ACAD SCI USA, V89, P9910, DOI 10.1073/pnas.89.20.9910; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	52	65	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42834	42842		10.1074/jbc.M102047200	http://dx.doi.org/10.1074/jbc.M102047200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551901	hybrid			2022-12-27	WOS:000172169300028
J	Kim, M; Chen, B; Hussey, RE; Chishti, Y; Montefiori, D; Hoxie, JA; Byron, O; Campbell, G; Harrison, SC; Reinherz, EL				Kim, M; Chen, B; Hussey, RE; Chishti, Y; Montefiori, D; Hoxie, JA; Byron, O; Campbell, G; Harrison, SC; Reinherz, EL			The stoichiometry of trimeric SIV glycoprotein interaction with CD4 differs from that of anti-envelope antibody Fab fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; SOLUBLE CD4; SYNERGISTIC NEUTRALIZATION; ATOMIC-STRUCTURE; HTLV-III/LAV; HIV-1 GP41; RECEPTOR-BINDING; CD4-BINDING SITE; GP120 MOLECULES	Human and simian immunodeficiency viruses infect host lymphoid cells by binding CD4 molecules via their gp160 envelope glycoproteins. Biochemical studies on recombinant SIVmac32H (pJ5) envelope ectodomain gp140 precursor protein show that the envelope is a trimer. Using size exclusion chromatography, quantitative amino acid analysis, analytical ultracentrifugation, and CD4-based competition assay, we demonstrate that the stoichiometry of CD4 receptor-oligomeric envelope interaction is 1:1. By contrast, Fab fragments of both neutralizing and non-neutralizing monoclonal antibodies bind at a 3:1 ratio. Thus, despite displaying equivalent CD4 binding sites on each of the three gp140 protomers within an uncleaved trimer, only one site binds the soluble 4-domain human CD4 extracellular segment. The anti-cooperativity and the faster k(off) of gp140 trimer:CD4 versus gp120 monomer:CD4 interaction suggest that CD4-induced conformational change is impeded in the intact envelope. The implications of these findings for immunity against human immunodeficiency virus and simian immunodeficiency virus are discussed.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Mol Med Lab, Boston, MA 02115 USA; Duke Univ, Sch Med, Dept Surg, Durham, NC 27710 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Duke University; University of Pennsylvania; University of Glasgow	Reinherz, EL (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu		Byron, Olwyn/0000-0001-7857-4520	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI143649, P01AI043649, N01AI085343] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43649, AI85343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BENVENISTE RE, 1988, J VIROL, V62, P2091, DOI 10.1128/JVI.62.6.2091-2101.1988; Burton DR, 2000, VIROLOGY, V270, P1, DOI 10.1006/viro.2000.0239; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2000, J BIOL CHEM, V275, P34946, DOI 10.1074/jbc.M004905200; CHOI WS, 1994, J VIROL, V68, P5395, DOI 10.1128/JVI.68.9.5395-5402.1994; COHN EJ, 1943, AM CHEM SOC MONOGRAP; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DESROSIERS RC, 1988, ANNU REV MICROBIOL, V42, P607, DOI 10.1146/annurev.mi.42.100188.003135; DSOUZA MP, 1993, AIDS RES HUM RETROV, V9, P415, DOI 10.1089/aid.1993.9.415; EARL PL, 1992, J VIROL, V66, P5610, DOI 10.1128/JVI.66.9.5610-5614.1992; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Edinger AL, 2000, J VIROL, V74, P7922, DOI 10.1128/JVI.74.17.7922-7935.2000; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fouts TR, 1998, AIDS RES HUM RETROV, V14, P591, DOI 10.1089/aid.1998.14.591; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; JAVAHERIAN K, 1994, J VIROL, V68, P2624, DOI 10.1128/JVI.68.4.2624-2631.1994; JONES DH, 1994, VACCINE, V12, P250, DOI 10.1016/0264-410X(94)90202-X; KENT KA, 1992, AIDS RES HUM RETROV, V8, P1147, DOI 10.1089/aid.1992.8.1147; KENT KA, 1991, AIDS, V5, P829, DOI 10.1097/00002030-199107000-00006; KIM H, 1977, CHEM REV, V77, P659, DOI 10.1021/cr60309a002; KLATZMANN D, 1984, SCIENCE, V225, P59, DOI 10.1126/science.6328660; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAAL S, 1994, J VIROL, V68, P4001, DOI 10.1128/JVI.68.6.4001-4008.1994; Langlois AJ, 1998, J VIROL, V72, P6950, DOI 10.1128/JVI.72.8.6950-6955.1998; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; MCKEATING JA, 1991, J VIROL, V65, P852, DOI 10.1128/JVI.65.2.852-860.1991; MCKEATING JA, 1992, VIROLOGY, V191, P732, DOI 10.1016/0042-6822(92)90249-O; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; MOORE JP, 1991, J VIROL, V65, P1133, DOI 10.1128/JVI.65.3.1133-1140.1991; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; MULLIGAN MJ, 1992, VIROLOGY, V187, P233, DOI 10.1016/0042-6822(92)90311-C; MURPHEYCORB M, 1986, NATURE, V321, P435, DOI 10.1038/321435a0; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nyambi PN, 1998, J VIROL, V72, P9384, DOI 10.1128/JVI.72.11.9384-9391.1998; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; POLZIEN F, 1992, AIDS RES HUM RETROV, V8, P1171, DOI 10.1089/aid.1992.8.1171; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Salzwedel K, 2000, P NATL ACAD SCI USA, V97, P12794, DOI 10.1073/pnas.230438497; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Stamatatos L, 1997, VIROLOGY, V229, P360, DOI 10.1006/viro.1997.8443; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; TILLEY SA, 1992, AIDS RES HUM RETROV, V8, P461, DOI 10.1089/aid.1992.8.461; VANCOTT TC, 1994, J IMMUNOL, V153, P449; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000	70	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42667	42676		10.1074/jbc.M104166200	http://dx.doi.org/10.1074/jbc.M104166200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544255	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000172169300006
J	Madril, AC; Johnson, RE; Washington, MT; Prakash, L; Prakash, S				Madril, AC; Johnson, RE; Washington, MT; Prakash, L; Prakash, S			Fidelity and damage bypass ability of Schizosaccharomyces pombe Eso1 protein, comprised of DNA polymerase eta and sister chromatid cohesion protein Ctf7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM VARIANT CELLS; THYMINE-THYMINE DIMER; XERODERMA-PIGMENTOSUM; POSTREPLICATION REPAIR; REPLICATION; YEAST; HYPERMUTABILITY; PHOTOPRODUCTS; PROCESSIVITY; REQUIREMENT	DNA polymerase eta (Pol eta) functions in error-free bypass of ultraviolet light-induced DNA lesions, and mutational inactivation of Pol eta in humans causes the cancer prone syndrome, the variant form of xeroderma pigmentosum (XPV). Both Saccharomyces cerevisiae and human Pol eta efficiently insert two adenines opposite the two thymines of a cyclobutane pyrimidine dimer. Interestingly, in the fission yeast Schizosaccharomyces pombe, the eso1(+) encoded protein is comprised of two domains, wherein the NH2 terminus is highly homologous to Pol eta, and the COOH terminus is highly homologous to the S. cerevisiae Ctf`7 protein which is essential for the establishment of sister chromatid cohesion during S phase. Here we characterize the DNA polymerase activity of S. pombe GST-Eso1 fusion protein and a truncated version containing only the Pol eta domain. Both proteins exhibit a similar DNA polymerase activity with a low processivity, and steady-state kinetic analyses show that on undamaged DNA, both proteins misincorporate nucleotides with frequencies of similar to 10(-2) to 10(-3). We also examine the two proteins for their ability to replicate a cyclobutane pyrimidine dimer-containing DNA template and find that both proteins replicate through the lesion equally well. Thus, fusion with Ctf`7 has no significant effect on the DNA replication or damage bypass properties of Pol eta. The possible role of Ctf`7 fusion with Pol eta in the replication of Cohesin-bound DNA sequences is discussed.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Blocker Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.		Prakash, Satya/C-6420-2013	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261; Washington, Todd/0000-0001-8680-2992				BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; BOYER JC, 1990, CANCER RES, V50, P2593; CLEAVER JE, 1981, CYTOGENET CELL GENET, V31, P188, DOI 10.1159/000131646; Creighton S, 1995, METHOD ENZYMOL, V262, P232; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McDonald JP, 1997, GENETICS, V147, P1557; MODRICH P, 1975, J BIOL CHEM, V250, P5508; Pavlov YI, 2001, MUTAT RES-FUND MOL M, V478, P129, DOI 10.1016/S0027-5107(01)00131-2; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WATERS HL, 1993, J INVEST DERMATOL, V101, P744, DOI 10.1111/1523-1747.ep12371686; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001	31	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42857	42862		10.1074/jbc.M106917200	http://dx.doi.org/10.1074/jbc.M106917200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551952	hybrid			2022-12-27	WOS:000172169300031
J	Yamamoto, Y; Wada, O; Suzawa, N; Yogiashi, Y; Yano, T; Kato, S; Yanagisawa, J				Yamamoto, Y; Wada, O; Suzawa, N; Yogiashi, Y; Yano, T; Kato, S; Yanagisawa, J			The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; STEROID-HORMONE RECEPTORS; RESISTANT BREAST-CANCER; RETINOID-X-RECEPTOR; GROWTH-FACTOR-BETA; NUCLEAR RECEPTOR; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; N-COR	The effects of estrogen and anti-estrogen are mediated through the estrogen receptors ER alpha and beta, which function as ligand-induced transcriptional factors. The nonsteroidal anti-estrogen tamoxifen is the most commonly used endocrine in the treatment of all stages of breast cancer in both pre- and postmenopausal women. Several lines of evidence have indicated that tamoxifen promotes association between ER alpha and corepressors N-Cor or silencing mediator for retinoid and thyroid hormone receptor (SMRT). Our results indicate that N-CoR/SMRT recognize and interact with helices H3 and H5 of the ER alpha ligand-binding domain in a 4-hydroxy tamoxifen-dependent manner. The mutant ER alpha (D351Y), derived from a tamoxifen-stimulated tumor and containing an amino acid substitution at position 351 within H3, showed reduced interaction with N-CoR/SMRT and high tamoxifen-induced activation function-1 (AF-1) activity. While the estradiol-dependent transcriptional activity of ER alpha (D351Y) was almost equal to that of wild-type ER alpha, the mutant exhibited higher levels of transcriptional activity in the presence of both E2 and 4-hydroxy tamoxifen compared with wild-type ER alpha. These results may explain the observation that the growth of tumor cells expressing ER alpha (D351Y) can be stimulated by tamoxifen, E2, or both.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130034, Japan; Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; Taiho Pharmaceut Co Ltd, Canc Res Lab, Hanno Res Ctr, Hanno, Saitama 3578527, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Taiho Pharmaceutical	Yanagisawa, J (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130034, Japan.	junny-tky@umin.ac.jp						Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Anghel SI, 2000, J BIOL CHEM, V275, P20867, DOI 10.1074/jbc.M002098200; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen SC, 2000, J BIOL CHEM, V275, P15039, DOI 10.1074/jbc.275.20.15039; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Endoh H, 1999, MOL CELL BIOL, V19, P5363; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Glass CK, 2000, GENE DEV, V14, P121; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huang EY, 2000, GENE DEV, V14, P45; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jordan VC, 1998, SCI AM, V279, P60, DOI 10.1038/scientificamerican1098-60; JORDAN VC, 1982, MOL CELL ENDOCRINOL, V27, P291, DOI 10.1016/0303-7207(82)90095-8; KARNIK PS, 1994, CANCER RES, V54, P349; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEDNICER D, 1967, J MED CHEM, V10, P78, DOI 10.1021/jm00313a016; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LEES JA, 1989, J STEROID BIOCHEM, V34, P33, DOI 10.1016/0022-4731(89)90063-0; Levenson AS, 1998, CANCER RES, V58, P1872; Levenson AS, 1997, J STEROID BIOCHEM, V60, P261, DOI 10.1016/S0960-0760(96)00184-7; Levenson AS, 1999, EUR J CANCER, V35, P1628, DOI 10.1016/S0959-8049(99)00183-5; Levenson AS, 2001, J STEROID BIOCHEM, V76, P61, DOI 10.1016/S0960-0760(00)00143-6; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Liu H, 2001, CANCER RES, V61, P3632; Lopez GN, 1999, MOL ENDOCRINOL, V13, P897, DOI 10.1210/me.13.6.897; MCDONNELL DP, 1995, ANN NY ACAD SCI, V761, P121, DOI 10.1111/j.1749-6632.1995.tb31374.x; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; MORROW M, 1993, ARCH SURG-CHICAGO, V128, P1187; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; ONATE SA, 1995, SCIENCE, V270, P1354; Parker MG, 1998, BIOCHEM SOC SYMP, P45; Pritchard Kathleen I., 2000, Cancer, V88, P3065, DOI 10.1002/1097-0142(20000615)88:12+<3065::AID-CNCR25>3.0.CO;2-P; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; ROBERTSON DW, 1982, J MED CHEM, V25, P167, DOI 10.1021/jm00344a015; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; TONETTI DA, 1995, ANTI-CANCER DRUG, V6, P498, DOI 10.1097/00001813-199508000-00002; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; VANLEEUWEN FE, 1994, LANCET, V343, P448, DOI 10.1016/S0140-6736(94)92692-1; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Webb P, 2000, J BIOL CHEM, V275, P37552, DOI 10.1074/jbc.M007435200; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; WOLF DM, 1994, BREAST CANCER RES TR, V31, P129, DOI 10.1007/BF00689683; WOLF DM, 1994, BREAST CANCER RES TR, V31, P117, DOI 10.1007/BF00689682; WOLF DM, 1993, BREAST CANCER RES TR, V27, P27, DOI 10.1007/BF00683191; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	89	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42684	42691		10.1074/jbc.M107844200	http://dx.doi.org/10.1074/jbc.M107844200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553641	hybrid			2022-12-27	WOS:000172169300008
J	English, WR; Holtz, B; Vogt, G; Knauper, V; Murphy, G				English, WR; Holtz, B; Vogt, G; Knauper, V; Murphy, G			Characterization of the role of the "MT-loop" - An eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT LINEAR PLOT; GELATINASE-A; TISSUE INHIBITORS; DOMAIN; IDENTIFICATION; STROMELYSIN-3; PROTEOLYSIS; EXPRESSION; SUBSTRATE; COMPLEX	Progelatinase A (proGLA) activation is thought to be initiated almost exclusively by the type I transmembrane members of the membrane type matrix metalloproteinase family (MT-MMP): MT1, -2, -3, and -5-MMP (MMP14, -15, -16, and -24). One difference between these enzymes and the other MMP family members is the insertion of eight amino acids between strands beta II and III in the catalytic domain. In MT1-MMP, the best characterized of these enzymes to date, these residues consist of (163)PYAYIREG(170). To investigate the role of this region of MT1-MMP on its catalytic activities, we have made a variety of mutations and deletions in both soluble and membrane-bound forms of the enzyme. Characterization of the activity of the soluble forms toward peptides and fibrinogen revealed that neither mutation nor deletion of residues 163-170 significantly impaired catalytic function, suggesting these residues have little influence on conformation of the active site cleft. Equally none of the mutants showed significant differences in K-l(app) for the N-terminal inhibitory domain of TIMP2, again indicating that mutation or deletion of resides 163-170 has no major effect on the overall topology of the active site of MT1-MMP. However, characterization of the kinetics of activation of proGLA with and without its gelatin binding region by the mutants generated have shown that efficient activation of proGLA is, at least in part, through an interaction with residues 163-170 of MT1-MMP. The expression, localization, and processing from the 63- to the 60/45-kDa forms of wild-type and key mutant forms of MT1-MMP were also examined by transient transfection in Chinese hamster ovary cells, but no differences were observed. Processing and activation of proGLA was also examined in transiently transfected cells. All the mutants examined were able process proGLA but, as found with the soluble forms, were kinetically impaired when compared with wild-type MT1-MMP.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; CEA, Dept Ingn & Etud Prot, F-91191 Gif Sur Yvette, France; Univ York, Dept Bion Bone & Joint Res, York YO10 5YW, N Yorkshire, England	University of East Anglia; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of York - UK	English, WR (corresponding author), Univ E Anglia, Sch Biol Sci, Univ Plain, Norwich NR4 7TJ, Norfolk, England.	w.english@uea.ac.uk		Knauper, Vera/0000-0002-3965-9924; English, William/0000-0003-3024-2441				Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; CORNISHB.A, 1974, BIOCHEM J, V139, P721, DOI 10.1042/bj1390721; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.3.CO;2-A; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Ha HY, 2001, CANCER RES, V61, P984; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holtz B, 1999, BIOCHEMISTRY-US, V38, P12174, DOI 10.1021/bi990876m; Imper V, 1998, BIOL EXTRAC, P219; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Llano E, 1999, CANCER RES, V59, P2570; Miyamori H, 2000, BIOCHEM BIOPH RES CO, V267, P796, DOI 10.1006/bbrc.1999.2050; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Mucha A, 1998, J BIOL CHEM, V273, P2763, DOI 10.1074/jbc.273.5.2763; Murphy G, 2000, FIBRINOLYSIS PROTEOL, V14, P165, DOI 10.1054/fipr.2000.0068; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; Nagase H, 1998, Cell Res, V8, P179; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200; Sang Q X, 1998, Cell Res, V8, P171; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shofuda K, 1997, J BIOL CHEM, V272, P9749; Stanton H, 1998, J CELL SCI, V111, P2789; Terp GE, 2000, J BIOMOL STRUCT DYN, V17, P933, DOI 10.1080/07391102.2000.10506582; Velasco G, 2000, CANCER RES, V60, P877; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLIAMS JW, 1979, BIOCHEMISTRY-US, V18, P2567, DOI 10.1021/bi00579a021; Woessner J.F., 2000, PROTEIN PROFILE SER; Zhang YN, 1996, J BIOL CHEM, V271, P8015, DOI 10.1074/jbc.271.14.8015; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	44	60	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42018	42026		10.1074/jbc.M107783200	http://dx.doi.org/10.1074/jbc.M107783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11555661	hybrid			2022-12-27	WOS:000172450400065
J	Kishore, R; McMullen, MR; Nagy, LE				Kishore, R; McMullen, MR; Nagy, LE			Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol - Role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ALCOHOLIC LIVER-INJURY; AU-RICH ELEMENTS; SIGNAL-TRANSDUCTION; POSTTRANSCRIPTIONAL STABILIZATION; UNTRANSLATED REGION; SMOOTH-MUSCLE; P38; STABILITY; TRANSCRIPTION	Increased expression of tumor necrosis factor a (TNF alpha) in response to chronic ethanol has been implicated in the pathogenesis of alcoholic liver disease. However, the molecular mechanisms by which ethanol increases the levels of TNF alpha are not well characterized. Utilizing Kupffer cells isolated from rats fed an ethanol containing diet and a murine macrophage cell line, RAW264.7, exposed to ethanol in culture, we have demonstrated that exposure to chronic ethanol results in an enhanced expression of lipopolysaccharide (LPS)-induced TNFa. While chronic ethanol had no effect on the rate of LPS-induced TNF alpha transcription as measured by nuclear run-on experiments, TNF alpha mRNA half-life was increased by chronic ethanol. Chronic ethanol also potentiated the activation of LPS-induced p38 mitogen-activated protein (MAP) kinase in Kupffer cells, as well as in RAW264.7 cells. Specific inhibition of p38 MAP kinase activation by SB203580 in Kupffer cells or by overexpression of dominant negative p38 MAP kinase in RAW264.7 cells blocked ethanol-mediated TNF alpha mRNA stabilization. Furthermore, using chimeric reporter constructs, we have shown that A + U-rich elements in the W-untranslated region of TNFa mRNA are not sufficient to impart ethanol-mediated stabilization on TNF alpha mRNA.	Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University	Nagy, LE (corresponding author), Case Western Reserve Univ, Dept Nutr, 2123 Abington Rd,Rm201, Cleveland, OH 44106 USA.	len2@po.cwru.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R56AA011975, R01AA011975] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 11975] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Aldred A, 1999, AM J PHYSIOL-GASTR L, V276, pG98, DOI 10.1152/ajpgi.1999.276.1.G98; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEUTLER B, 1995, J INVEST MED, V43, P227; BICKEL M, 1990, J IMMUNOL, V145, P840; BJARNASON I, 1984, LANCET, V1, P179; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chen JP, 1998, BIOCHEM J, V334, P669, DOI 10.1042/bj3340669; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; FUKUI H, 1991, J HEPATOL, V12, P162, DOI 10.1016/0168-8278(91)90933-3; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Hanford DS, 1996, MOL ENDOCRINOL, V10, P1719, DOI 10.1210/me.10.12.1719; Hel Z, 1996, MOL CELL BIOL, V16, P5579; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; HONCHEL R, 1990, PROG LEUC B, V10, P171; Huang JS, 1999, ARCH BIOCHEM BIOPHYS, V366, P131, DOI 10.1006/abbi.1999.1203; Jacob CO, 1996, J IMMUNOL, V156, P3043; JACOB CO, 1992, IMMUNOL TODAY, V13, P122, DOI 10.1016/0167-5699(92)90107-I; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Lee NH, 1998, J BIOL CHEM, V273, P22317, DOI 10.1074/jbc.273.35.22317; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Mathurin P, 2000, HEPATOLOGY, V32, P1008, DOI 10.1053/jhep.2000.19621; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Nanbu R, 1997, EUR J BIOCHEM, V247, P169, DOI 10.1111/j.1432-1033.1997.00169.x; Pauli Urs, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P323; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Ridley SH, 1998, FEBS LETT, V439, P75, DOI 10.1016/S0014-5793(98)01342-8; ROIVAINEN R, 1995, P NATL ACAD SCI USA, V92, P1891, DOI 10.1073/pnas.92.6.1891; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Rovin BH, 1999, CYTOKINE, V11, P118, DOI 10.1006/cyto.1998.0409; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Saklatvala J, 1999, BIOCHEM SOC SYMP, P63; SHALABY MR, 1989, TRANSPLANTATION, V47, P1057, DOI 10.1097/00007890-198906000-00028; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Short S, 2000, J BIOL CHEM, V275, P12963, DOI 10.1074/jbc.275.17.12963; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Wang YZ, 2000, J BIOL CHEM, V275, P22550, DOI 10.1074/jbc.M909785199; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777; Xu KM, 2000, J BIOL CHEM, V275, P7604, DOI 10.1074/jbc.275.11.7604; Xu KM, 2000, J BIOL CHEM, V275, P23012, DOI 10.1074/jbc.M001611200; Zeldin G, 1996, ALCOHOL CLIN EXP RES, V20, P1639, DOI 10.1111/j.1530-0277.1996.tb01710.x	62	82	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41930	41937		10.1074/jbc.M107181200	http://dx.doi.org/10.1074/jbc.M107181200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551956	hybrid			2022-12-27	WOS:000172450400052
J	Roseman, S				Roseman, S			Reflections on glycobiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; SIALIC ACIDS; ENZYMATIC-SYNTHESIS; CHICKEN HEPATOCYTES; CELL-SURFACE; NUCLEOSIDE POLYPHOSPHATES; GLUCOSAMINE METABOLISM; CAENORHABDITIS-ELEGANS; STRUCTURAL-ANALYSIS		Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, McCollum Pratt Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Roseman, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.				NIGMS NIH HHS [GM51215] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANESE J, 1982, J BIOL CHEM, V257, P3165; Baeg GH, 2001, DEVELOPMENT, V128, P87; BARTHOLOMEW BA, 1973, J BIOL CHEM, V248, P5751; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; CABIB E, 1958, J BIOL CHEM, V231, P259; CANTOR CR, 1980, BIOPHYSICAL CHEM CON; CAPUTTO R, 1950, J BIOL CHEM, V184, P333; CARLSON DM, 1966, J BIOL CHEM, V241, P2984; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; COMB DG, 1960, J BIOL CHEM, V235, P2529; COMB DG, 1966, J BIOL CHEM, V241, P5637; COMB DG, 1958, J BIOL CHEM, V232, P807; CONANT JB, 1952, PASTEURS STUDY FERME; DEN H, 1975, J BIOL CHEM, V250, P739; Ebnet K, 1999, HISTOCHEM CELL BIOL, V112, P1, DOI 10.1007/s004180050387; Fruton J. S., 1953, GEN BIOCH; GABRIEL O, 1982, METHOD ENZYMOL, V83, P332; GHALAMBOR MA, 1963, BIOCHEM BIOPH RES CO, V10, P346, DOI 10.1016/0006-291X(63)90536-9; GHOSH S, 1960, J BIOL CHEM, V235, P1265; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gottschalk A., 1972, GLYCOPROTEINS THEIR; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; HARDMAN JG, 1971, ANNU REV PHYSIOL, V33, P311, DOI 10.1146/annurev.ph.33.030171.001523; HASCALL VG, 2000, GLYCOCONJ J, V17, P599; HEATH EC, 1958, J BIOL CHEM, V230, P511; HUMPHREYS T, 1967, CELL SURFACE SPECIFI, P195; Jacob F, 1979, Curr Top Dev Biol, V13 Pt 1, P117; Jarchow J, 2000, J STRUCT BIOL, V132, P95, DOI 10.1006/jsbi.2000.4309; JARNEFELT J, 1978, J BIOL CHEM, V253, P8006; Kabat EA, 1956, BLOOD GROUP SUBSTANC; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; KEAN EL, 1966, J BIOL CHEM, V241, P5643; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Laine R A, 1988, Adv Exp Med Biol, V228, P331; LAINE RA, 1994, GLYCOBIOLOGY, V4, P759, DOI 10.1093/glycob/4.6.759; LELOIR LF, 1959, ARCH BIOCHEM BIOPHYS, V81, P508, DOI 10.1016/0003-9861(59)90232-2; Lesley J, 2000, J BIOL CHEM, V275, P26967; Meyer K, 1934, J BIOL CHEM, V107, P629; MISEVIC GN, 1990, J BIOL CHEM, V265, P20577; MOFFATT JG, 1958, J AM CHEM SOC, V80, P3756, DOI 10.1021/ja01547a073; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MORELL AG, 1968, J BIOL CHEM, V243, P155; NAKATO H, 1995, DEVELOPMENT, V121, P3687; OBRINK B, 1977, P NATL ACAD SCI USA, V74, P1077, DOI 10.1073/pnas.74.3.1077; ORR CW, 1969, J MEMBRANE BIOL, V1, P109, DOI 10.1007/BF01869777; OSBORN MJ, 1969, ANNU REV BIOCHEM, V38, P501, DOI 10.1146/annurev.bi.38.070169.002441; PARK JT, 1952, J BIOL CHEM, V194, P877; PARK LS, 1983, FED PROC, V42, P2129; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; RALL TW, 1962, J BIOL CHEM, V237, P1228; Renkonen O, 2000, CELL MOL LIFE SCI, V57, P1423, DOI 10.1007/PL00000627; ROBBINS PW, 1957, J BIOL CHEM, V229, P837; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; ROSEMAN S, 1989, FEMS MICROBIOL LETT, V63, P3, DOI 10.1016/0168-6445(89)90003-X; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; ROSEMAN S, 1959, ANNU REV BIOCHEM, V28, P545, DOI 10.1146/annurev.bi.28.070159.002553; ROSEMAN S, 1961, J AM CHEM SOC, V83, P659, DOI 10.1021/ja01464a035; ROSEMAN S, 1962, P NATL ACAD SCI USA, V48, P437, DOI 10.1073/pnas.48.3.437; ROSEMAN S, 1974, NEUROSCIENCES 3RD ST, P795; ROTH S, 1971, J CELL BIOL, V51, P536, DOI 10.1083/jcb.51.2.536; SCHACHTE.H, 1970, J BIOL CHEM, V245, P1090; SCHNAAR RL, 1978, J BIOL CHEM, V253, P7940; SCHWARTZ NB, 1975, J BIOL CHEM, V250, P5200; SPARROW JR, 1988, J NEUROSCI RES, V21, P398, DOI 10.1002/jnr.490210231; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; UMBREIT J, 1975, J BIOL CHEM, V250, P9360; van Meer G, 2001, P NATL ACAD SCI USA, V98, P1321, DOI 10.1073/pnas.98.4.1321; Varki Ajit, 1995, Seminars in Developmental Biology, V6, P127, DOI 10.1016/S1044-5781(06)80022-8; WAECHTER CJ, 1976, ANNU REV BIOCHEM, V45, P95, DOI 10.1146/annurev.bi.45.070176.000523; WEIGEL PH, 1979, J BIOL CHEM, V254, P830; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476; [No title captured]; [No title captured]	82	213	218	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41527	41542		10.1074/jbc.R100053200	http://dx.doi.org/10.1074/jbc.R100053200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553646	hybrid			2022-12-27	WOS:000172450400001
J	Wang, JF; Zhang, XF; Groopman, JE				Wang, JF; Zhang, XF; Groopman, JE			Stimulation of beta(1) integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-RECEPTOR; ALPHA(V)BETA(3) INTEGRIN; HEREDITARY LYMPHEDEMA; LYMPHATIC ENDOTHELIUM; FOCAL ADHESIONS; VEGF RECEPTOR-3; KINASE; ANGIOGENESIS; ACTIVATION; LIGAND	Interactions between integrins and tyrosine kinase receptors can modulate a variety of cell functions. We observed a cooperative interaction between the beta(1) integrin and vascular endothelial growth factor receptor-3 (VEGFR-3 or Flt4) that appeared to be required for cell migration. By using VEGFR-3-transfected 293 cells (293/VEGFR-3) or primary dermal microvascular endothelial cells (DMEC), we found that stimulation with either soluble or immobilized extracellular matrix (ECM) proteins, collagen or fibronectin (FN), resulted in the increased tyrosine phosphorylation of VEGFR-3 in the absence of a cognate ligand. This increased tyrosine phosphorylation of VEGFR-3 was diminished by pretreatment with a blocking antibody against the beta(1) integrin. Cross-linking with anti-beta(1) integrin antibody induced a similar degree of tyrosine phosphorylation of VEGFR-3. Stimulation with collagen or FN induced an association between beta(1) integrin and VEGFR-3 in both 293/VEGFR-3 and primary DMEC cells. Collagen or FN-induced tyrosine phosphorylation of VEGFR-3 was inhibited by treatment with cytochalasin D, an inhibitor of actin polymerization. Collagen or FN was able to induce the migration of 293/VEGFR-3 or DMEC cells to a limited extent. However, migration was dramatically enhanced when a gradient of the cognate ligand, VEGF-D, was added. VEGF-D failed to induce cell migration in the absence of ECM proteins. Introducing a mutation at the kinase domain of VEGFR-3 or treatment with blocking antibody against either VEGFR-3 or beta(1) integrin inhibited cell migration induced by ECM and VEGF-D, indicating that signals from both beta(1) integrin and VEGFR-3 are required for this cell function.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Inst Med,Div Expt Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Groopman, JE (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Inst Med,Div Expt Med, 4 Blackfan Circle, Boston, MA 02115 USA.	jgroopma@caregroup.harvard.edu			NHLBI NIH HHS [HL 61940, HL 53745] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053745, R01HL061940] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Aplin AE, 1999, J CELL SCI, V112, P695; APRELIKOVA O, 1992, CANCER RES, V52, P746; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brugge JS, 1998, NAT GENET, V19, P309, DOI 10.1038/1189; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; DIAKONOVA M, 1995, J CELL SCI, V108, P2499; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GALLAND F, 1993, ONCOGENE, V8, P1233; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guilherme A, 1998, J BIOL CHEM, V273, P22899, DOI 10.1074/jbc.273.36.22899; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Hewett PW, 1996, BIOCHEM BIOPH RES CO, V221, P697, DOI 10.1006/bbrc.1996.0659; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Joukov V, 1996, EMBO J, V15, P290; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karpanen T, 2001, CANCER RES, V61, P1786; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Kukk E, 1996, DEVELOPMENT, V122, P3829; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; Lymboussaki A, 1998, AM J PATHOL, V153, P395, DOI 10.1016/S0002-9440(10)65583-6; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; POLVERINI PJ, 1995, CRIT REV ORAL BIOL M, V6, P230, DOI 10.1177/10454411950060030501; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sastry SK, 1996, DEV BIOL, V180, P455, DOI 10.1006/dbio.1996.0319; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Varner J A, 1997, EXS, V79, P361; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Woodard AS, 1998, J CELL SCI, V111, P469; Yu X, 2000, J CELL SCI, V113, P2139	58	97	102	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41950	41957		10.1074/jbc.M101370200	http://dx.doi.org/10.1074/jbc.M101370200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553610	hybrid			2022-12-27	WOS:000172450400055
J	Zhang, YG; Liu, GM; Dong, ZG				Zhang, YG; Liu, GM; Dong, ZG			MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; SERINE PHOSPHORYLATION; MAP KINASE; SIGNAL-TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TYROSINE PHOSPHORYLATION; IFN-GAMMA; DEPENDENT ACTIVATION; AP-1 TRANSACTIVATION	Phosphorylation of Tyr(705) and Ser(727) of signal transducer and activator of transcription 3 (STAT3) are known to be required for maximal activation by diverse stimuli. Tyr(705) phosphorylation is generally accepted to be mediated by the Janus kinase family. But the mechanism for STAT3 (Ser(727)) phosphorylation is not well understood. Here, we provide evidence that LTVA-induced phosphorylation of STAT3 at Ser(727) is inhibited by pretreatment of JB6 cells with PD98059 or SB202190. Phosphorylation of STAT3 (Ser(727)) is also markedly prevented by a dominant negative mutant of ERK2, c-Jun N-terminal kinase 1 (JNK1), or p38 kinase and in knockout Jnk1(-/-) or Jnk2(-/-) cells. Furthermore, STAT3 (Ser(727)) phosphorylation is suppressed by C- or N-terminal "kinase-dead" mutants of mitogen- and stress-activated protein kinase 1 (MSK1), a downstream kinase of ERKs and p38 kinase, and H89, a potential MSK1 inhibitor. In vitro experiments showed that active MSK1 and JNKs, but not ERKs or p38 kinase, phosphorylate STAT3 (Ser(727)). Additionally, the role of MAPKs in mediating UVA-stimulated DNA binding activity of STAT3 was investigated. Overall, these results suggest that UVA-induced Ser(727) phosphorylation of STAT3 may occur through MSK1 and JNKs.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.			Zhang, Yiguo/0000-0003-3910-2779	NCI NIH HHS [CA77646, CA74916, CA81064] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA074916, R01CA081064, R01CA077646, R37CA081064] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Aragane Y, 1997, P NATL ACAD SCI USA, V94, P11490, DOI 10.1073/pnas.94.21.11490; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bode JG, 1999, J BIOL CHEM, V274, P30222, DOI 10.1074/jbc.274.42.30222; Bos M, 1997, CLIN CANCER RES, V3, P2099; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Chen NY, 2001, CANCER RES, V61, P3908; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Danial NN, 2000, ONCOGENE, V19, P2523, DOI 10.1038/sj.onc.1203484; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; EILERS A, 1994, MOL CELL BIOL, V14, P1364, DOI 10.1128/MCB.14.2.1364; Frank DA, 1999, MOL MED, V5, P432; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gatsios P, 1998, J BIOL CHEM, V273, P22962, DOI 10.1074/jbc.273.36.22962; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Griffiths HR, 1998, CRIT REV CL LAB SCI, V35, P189, DOI 10.1080/10408369891234192; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Janknecht R, 1999, SCIENCE, V284, P443, DOI 10.1126/science.284.5413.443; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lim CP, 2001, J BIOL CHEM, V276, P21004, DOI 10.1074/jbc.M007592200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maziere C, 2000, FREE RADICAL BIO MED, V28, P1430, DOI 10.1016/S0891-5849(00)00264-1; Moan J, 1999, PHOTOCHEM PHOTOBIOL, V70, P243, DOI 10.1111/j.1751-1097.1999.tb07995.x; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Ng J, 1997, J BIOL CHEM, V272, P24542, DOI 10.1074/jbc.272.39.24542; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Novak U, 1998, BIOCHEM BIOPH RES CO, V247, P558, DOI 10.1006/bbrc.1998.8829; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Ryder JW, 2000, J BIOL CHEM, V275, P1457, DOI 10.1074/jbc.275.2.1457; Sartor CI, 1997, CANCER RES, V57, P978; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schindler C, 2000, ADV PHARMACOL, V47, P113; Schuringa JJ, 2000, BIOCHEM J, V347, P89, DOI 10.1042/0264-6021:3470089; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Uddin S, 2000, J BIOL CHEM, V275, P27634; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Williams JG, 2000, CURR OPIN GENET DEV, V10, P503, DOI 10.1016/S0959-437X(00)00119-2; Woodhead A D, 1999, J Epidemiol, V9, pS102; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200; Zhang YG, 2001, J BIOL CHEM, V276, P14572, DOI 10.1074/jbc.M004615200; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618	79	65	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42534	42542		10.1074/jbc.M106044200	http://dx.doi.org/10.1074/jbc.M106044200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553624	hybrid			2022-12-27	WOS:000172450400128
J	Cheng, JZ; Sharma, R; Yang, YS; Singhal, SS; Sharma, A; Saini, MK; Singh, SV; Zimniak, P; Awasthi, S; Awasthi, YC				Cheng, JZ; Sharma, R; Yang, YS; Singhal, SS; Sharma, A; Saini, MK; Singh, SV; Zimniak, P; Awasthi, S; Awasthi, YC			Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; N-TERMINAL KINASE; LIPID-PEROXIDATION PRODUCT; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; ATP-DEPENDENT TRANSPORT; HUMAN LEUKEMIA-CELLS; INDUCED APOPTOSIS; CONJUGATE TRANSPORTER; CASPASE ACTIVATION; SHOCK-PROTEIN	To explore the role of lipid peroxidation (LPG) products in the initial phase of stress mediated signaling, we studied the effect of mild, transient oxidative or heat stress on parameters that regulate the cellular concentration of 4-hydroxynonenal (4-HNE). When K562 cells were exposed to mild heat shock (42 degreesC, 30 min) or oxidative stress (50 mum H2O2,20 min) and allowed to recover for 2 h, there was a severalfold induction of hGST5.8, which catalyzes the formation of glutathione-4-HNE conjugate (GS-HNE), and RLIP76, which mediates the transport of GS-HNE from cells (Awasthi, S., Cheng, J., Singhal, S. S., Saini, M. K., Pandya, U., Pikula, S., Bandorowicz-Pikula, J., Singh, S. V., Zimniak, P., and Awasthi, Y. C. (2000) Biochemistry 39, 9327-9334). Enhanced LPO was observed in stressed cells, but the major antioxidant enzymes and HSP70 remained unaffected. The stressed cells showed higher GS-HNE-conjugating activity and increased efflux of GS-FINE. Stress-pre-conditioned cells with induced hGST5.8 and RLIP76 acquired resistance to 4-HNE and H2O2-mediated apoptosis by suppressing a sustained activation of c-Jun N-terminal kinase and caspase 3. The protective effect of stress pre-conditioning against apoptosis was abrogated by coating the cells with anti-RLIP76 IgG, which inhibited the efflux of GS-HNE from cells, indicating that the cells acquired resistance to apoptosis by metabolizing and excluding 4-HNE at a higher rate. Induction of hGST5.8 and RLIP76 by mild, transient stress and the resulting resistance of stress-pre-conditioned cells to apoptosis appears to be a general phenomenon since it was not limited to K562 cells but was also evident in lung cancer cells, H-69, H-226, human leukemia cells, HL-60, and human retinal pigmented epithelial cells. These results strongly suggest a role of LPO products, particularly 4-HNE, in the initial phase of stress mediated signaling.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Arlington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Awasthi, YC (corresponding author), Univ Texas, Med Branch, Dept Human Biol Biochem & Genet, 7-138 Med Res Bldg, Galveston, TX 77555 USA.		Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717	NCI NIH HHS [CA 76348, CA 27967, CA 77495] Funding Source: Medline; NEI NIH HHS [EY 04396] Funding Source: Medline; NIEHS NIH HHS [ES 07804] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076348, R01CA077495, R01CA027967] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R55EY004396, R01EY004396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007804] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; AWASTHI S, 1994, J CLIN INVEST, V93, P958, DOI 10.1172/JCI117102; Awasthi S, 1998, BIOCHEMISTRY-US, V37, P5239, DOI 10.1021/bi972131r; Awasthi S, 1998, BIOCHEMISTRY-US, V37, P5231, DOI 10.1021/bi972130z; Awasthi S, 2001, BIOCHEMISTRY-US, V40, P4159, DOI 10.1021/bi002182f; AWASTHI YC, 1975, J BIOL CHEM, V250, P5144; BEERS RF, 1952, J BIOL CHEM, V195, P133; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Boon PJM, 1999, TOXICOL APPL PHARM, V159, P214, DOI 10.1006/taap.1999.8742; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camandola S, 2000, J NEUROCHEM, V74, P159, DOI 10.1046/j.1471-4159.2000.0740159.x; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chen Y, 2001, J BIOL CHEM, V276, P8350, DOI 10.1074/jbc.M008431200; Chen YR, 2000, INT J ONCOL, V16, P651; Cheng JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P29, DOI 10.1006/abbi.1999.1479; Cheng JZ, 2001, BIOCHEM BIOPH RES CO, V282, P1268, DOI 10.1006/bbrc.2001.4707; Desmots F, 2001, CHEM-BIOL INTERACT, V133, P315; Dianzani MU, 1999, ACTA BIOCHIM POL, V46, P61, DOI 10.18388/abp.1999_4184; Gabai VL, 2000, MOL CELL BIOL, V20, P6826, DOI 10.1128/MCB.20.18.6826-6836.2000; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hammer A, 1997, FREE RADICAL BIO MED, V23, P26, DOI 10.1016/S0891-5849(96)00630-2; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; KERENDIAN J, 1992, CURR EYE RES, V11, P385, DOI 10.3109/02713689209001792; KONDO T, 1993, J BIOL CHEM, V268, P20366; Kruman I, 1997, J NEUROSCI, V17, P5089; Kwak HJ, 1998, CELL IMMUNOL, V187, P1, DOI 10.1006/cimm.1998.1309; LABELLE EF, 1986, BIOCHEM J, V238, P443, DOI 10.1042/bj2380443; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; LEE YP, 1966, ANAL BIOCHEM, V14, P71, DOI 10.1016/0003-2697(66)90057-1; Liu SX, 1998, ARCH BIOCHEM BIOPHYS, V352, P306, DOI 10.1006/abbi.1998.0608; Liu W, 2000, J CELL SCI, V113, P635; MacFarlane M, 2000, BIOCHEM J, V348, P93, DOI 10.1042/0264-6021:3480093; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209; PARADISI L, 1985, CHEM-BIOL INTERACT, V53, P209, DOI 10.1016/S0009-2797(85)80097-1; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Rinaldi M, 2000, BIOCHEM BIOPH RES CO, V272, P75, DOI 10.1006/bbrc.2000.2691; ROSSI MA, 1990, BIOCHEM PHARMACOL, V39, P1715, DOI 10.1016/0006-2952(90)90116-3; Ruef J, 1998, CIRCULATION, V97, P1071, DOI 10.1161/01.CIR.97.11.1071; Sharma R, 2001, ARCH BIOCHEM BIOPHYS, V391, P171, DOI 10.1006/abbi.2001.2395; Singhal SS, 1999, INVEST OPHTH VIS SCI, V40, P2652; SINGHAL SS, 1994, ARCH BIOCHEM BIOPHYS, V311, P242, DOI 10.1006/abbi.1994.1233; SINGHAL SS, 1994, BBA-PROTEIN STRUCT M, V1204, P279, DOI 10.1016/0167-4838(94)90019-1; Singhal SS, 1999, TOXICOL LETT, V109, P87, DOI 10.1016/S0378-4274(99)00124-1; Soh YJ, 2000, MOL PHARMACOL, V58, P535, DOI 10.1124/mol.58.3.535; Song BJ, 2001, CHEM-BIOL INTERACT, V130, P943, DOI 10.1016/S0009-2797(00)00247-7; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Thomas A, 2000, ONCOGENE, V19, P5259, DOI 10.1038/sj.onc.1203895; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Ullrich O, 1996, BIOCHEM J, V315, P705, DOI 10.1042/bj3150705; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Wagner BA, 2000, J BIOL CHEM, V275, P22461, DOI 10.1074/jbc.M001434200; Xiao B, 1999, BIOCHEMISTRY-US, V38, P11887, DOI 10.1021/bi990468i; Yang Y, 2001, J BIOL CHEM, V276, P19220, DOI 10.1074/jbc.M100551200; ZIMNIAK P, 1994, J BIOL CHEM, V269, P992	70	133	138	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41213	41223		10.1074/jbc.M106838200	http://dx.doi.org/10.1074/jbc.M106838200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522795	hybrid			2022-12-27	WOS:000171925600112
J	Glassford, J; Holman, M; Banerji, L; Clayton, E; Klaus, GGB; Turner, M; Lam, EWF				Glassford, J; Holman, M; Banerji, L; Clayton, E; Klaus, GGB; Turner, M; Lam, EWF			Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR VAV; T-CELL RECEPTOR; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; DEFICIENT MICE; GUANOSINE TRIPHOSPHATASES; RETINOBLASTOMA PROTEIN; MEDIATED PROLIFERATION; D1 EXPRESSION	B lymphocytes from mice null for the Rho-family guanine-nucleotide exchange factor, Vav, are defective in their ability to proliferate in response to BCR crosslinking, but are able to proliferate normally in response to LPS. In addition, they have a depletion of CD5(+) (B1) lymphocytes and defective IgG class switching. This phenotype is reminiscent of that observed in mice null for the cell cycle regulatory protein, cyclin D2. We demonstrate here that the inability of vav(-/-) B cells to proliferate in response to BCR ligation is due to an inability to induce cyclin D2. In addition, we show that the proliferative defect of these cells occurs after the cells have entered early Gl phase. Analyses of potential downstream signaling intermediates revealed differential activation of the stress-activated MAP kinases in the absence of Vav, normal activation of the ERK, MAPK, and phosphatidylinositol 3-kinase pathways, and defective intracellular calcium mobilization. We further demonstrate that intracellular calcium homeostasis is required for cyclin D2 induction, implicating a possible link with the defective calcium response of vav(-/-) B cells and their inability to induce cyclin D2.	Hammersmith Hosp, Imperial Coll, Sch Med, CRC Labs, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Sch Med, Sect Canc Cell Biol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, Sect Virol & Cell Biol, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, Ludwig Inst Canc Res, London W2 1PG, England; Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England; Babraham Inst, Lab Lymphocyte Signalling & Dev, Mol Immunol Programme, Cambridge CB2 4AT, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Ludwig Institute for Cancer Research; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Lam, EWF (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, CRC Labs, Du Cane Rd, London W12 0NN, England.		Lam, Eric W-F/AAW-8566-2020; Turner, Martin/N-9976-2014	Lam, Eric W-F/0000-0003-1274-3576; Turner, Martin/0000-0002-3801-9896				Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200; Bachmann MF, 1999, J IMMUNOL, V163, P137; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; CHOI MSK, 1995, EUR J IMMUNOL, V25, P1352, DOI 10.1002/eji.1830250533; Collins TL, 1997, IMMUNOL TODAY, V18, P221; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Dey A, 2000, MOL BIOL CELL, V11, P3835, DOI 10.1091/mbc.11.11.3835; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Graves JD, 1996, P NATL ACAD SCI USA, V93, P13814, DOI 10.1073/pnas.93.24.13814; Gulbranson-Judge A, 1999, EUR J IMMUNOL, V29, P477, DOI 10.1002/(SICI)1521-4141(199902)29:02&lt;477::AID-IMMU477&gt;3.0.CO;2-V; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Johnson-Leger C, 1998, J IMMUNOL, V161, P4618; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lam EWF, 1999, EUR J IMMUNOL, V29, P3380, DOI 10.1002/(SICI)1521-4141(199910)29:10<3380::AID-IMMU3380>3.0.CO;2-C; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee CH, 1999, IUBMB LIFE, V48, P585, DOI 10.1080/152165499306450; MATSUGUCHI T, 1995, EMBO J, V14, P257, DOI 10.1002/j.1460-2075.1995.tb06999.x; Nunes JA, 1996, J BIOL CHEM, V271, P1591, DOI 10.1074/jbc.271.3.1591; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Page K, 2001, AM J PHYSIOL-LUNG C, V280, pL955, DOI 10.1152/ajplung.2001.280.5.L955; Parada Y, 2001, J BIOL CHEM, V276, P23572, DOI 10.1074/jbc.M101885200; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Ramakrishnan M, 1998, AM J RESP CELL MOL, V18, P736, DOI 10.1165/ajrcmb.18.6.3152; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sakata N, 2000, CELL IMMUNOL, V201, P109, DOI 10.1006/cimm.2000.1645; Salmon RA, 1997, J IMMUNOL, V159, P5309; Salojin KV, 1999, J IMMUNOL, V163, P844; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simon VR, 2001, CELL PROLIFERAT, V34, P15, DOI 10.1046/j.1365-2184.2001.00192.x; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Swart JM, 2000, BIOCHEM BIOPH RES CO, V276, P417, DOI 10.1006/bbrc.2000.3489; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Terada Y, 1999, KIDNEY INT, V56, P1258, DOI 10.1046/j.1523-1755.1999.00704.x; TOODY GM, 2001, NAT IMMUNOL, V2, P542; Turchi L, 2000, EXP CELL RES, V261, P220, DOI 10.1006/excr.2000.5060; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Williams CD, 1997, BLOOD, V90, P194; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	61	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41040	41048		10.1074/jbc.M105305200	http://dx.doi.org/10.1074/jbc.M105305200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546804	hybrid			2022-12-27	WOS:000171925600090
J	Guaiquil, VH; Vera, JC; Golde, DW				Guaiquil, VH; Vera, JC; Golde, DW			Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER ISOFORMS; MYELOID-LEUKEMIA CELLS; ASCORBIC-ACID; HYDROGEN-PEROXIDE; DEHYDROASCORBIC ACID; ENDOTHELIAL-CELLS; FACTORS SIGNAL; DNA-DAMAGE; APOPTOSIS; EXPRESSION	Vitamin C is a well known antioxidant whose precise role in protecting cells from oxidative challenge is uncertain. In vitro results have been confounded by prooxidant effects of ascorbic acid and an overlapping role of glutathione. We used HL-60 cells as a model to determine the precise and independent role of vitamin C in cellular protection against cell death induced by oxidative stress. HL-60 cells do not depend on glutathione to transport or reduce dehydroascorbic acid. Depletion of glutathione rendered the HL-60 cells highly sensitive to cell death induced by H2O2, an effect that was not mediated by changes in the activities of glutathione reductase, glutathione peroxidase, catalase, or superoxide dismutase. The increased sensitivity to oxidative stress was largely reversed when glutathione-depleted cells were preloaded with ascorbic acid by exposure to dehydroascorbic acid. Resistance to H2O2 treatment in cells loaded with vitamin C was accompanied by intracellular consumption of ascorbic acid, generation of dehydroascorbic acid, and a decrease in the cellular content of reactive oxygen species. Some of the dehydroascorbic acid generated was exported out of the cells via the glucose transporters. Our data indicate that vitamin C is an important independent antioxidant in protecting cells against death from oxidative stress.	Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Therapeut, New York, NY 10021 USA; Univ Concepcion, Dept Fisiopatol, Concepcion, Chile	Memorial Sloan Kettering Cancer Center; Universidad de Concepcion	Golde, DW (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Therapeut, 1275 York Ave, New York, NY 10021 USA.	d-golde@ski.mskcc.org			NCI NIH HHS [CA30388, CA08748] Funding Source: Medline; NHLBI NIH HHS [HL42107] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA030388, R37CA030388, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042107] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agus DB, 1999, CANCER RES, V59, P4555; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BASS DA, 1983, J IMMUNOL, V130, P1910; Binder C, 1997, ANTICANCER RES, V17, P4299; BRUNK UT, 1995, FREE RADICAL BIO MED, V19, P813, DOI 10.1016/0891-5849(95)02001-Q; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; EK A, 1995, BIOCHEM PHARMACOL, V50, P1339; FARBER JL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432207; FERNANDES RS, 1994, BIOCHEM PHARMACOL, V48, P675, DOI 10.1016/0006-2952(94)90044-2; Fujibayashi Y, 1997, RADIAT RES, V147, P729, DOI 10.2307/3579487; GerardMonnier D, 1996, PATHOL BIOL, V44, P77; Guaiquil VH, 1997, J BIOL CHEM, V272, P9915; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; HIRAISHI H, 1993, GASTROENTEROL JPN, V28, P132, DOI 10.1007/BF02989224; Kawamura T, 2001, CANCER-AM CANCER SOC, V92, P634, DOI 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X; Kurata T, 1999, JPN J CANCER RES, V90, P1238, DOI 10.1111/j.1349-7006.1999.tb00702.x; Li X, 2001, ARCH BIOCHEM BIOPHYS, V387, P143, DOI 10.1006/abbi.2000.2245; MAKINO N, 1994, J BIOL CHEM, V269, P1020; MALINS DC, 1993, CANCER-AM CANCER SOC, V71, P3036, DOI 10.1002/1097-0142(19930515)71:10<3036::AID-CNCR2820711025>3.0.CO;2-P; MEISTER A, 1994, J BIOL CHEM, V269, P9397; MEISTER A, 1994, CANCER RES, V54, pS1969; Mendiratta S, 1998, FREE RADICAL BIO MED, V24, P789, DOI 10.1016/S0891-5849(97)00351-1; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Sattler M, 1999, BLOOD, V93, P2928; Schnelldorfer T, 2000, CANCER-AM CANCER SOC, V89, P1440, DOI 10.1002/1097-0142(20001001)89:7<1440::AID-CNCR5>3.3.CO;2-S; Sweetman SF, 1997, NUTR CANCER, V27, P122, DOI 10.1080/01635589709514513; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Vera JC, 1998, BLOOD, V91, P2536, DOI 10.1182/blood.V91.7.2536.2536_2536_2546; VERA JC, 1995, J BIOL CHEM, V270, P23706, DOI 10.1074/jbc.270.40.23706; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Vethanayagam JGG, 1999, FREE RADICAL BIO MED, V26, P1591, DOI 10.1016/S0891-5849(99)00031-3; Wang YH, 1997, P NATL ACAD SCI USA, V94, P13816, DOI 10.1073/pnas.94.25.13816; Witenberg B, 1999, BIOCHEM PHARMACOL, V57, P823, DOI 10.1016/S0006-2952(98)00351-7; Witenberg B, 1999, RADIAT RES, V152, P468, DOI 10.2307/3580142	41	105	108	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40955	40961		10.1074/jbc.M106878200	http://dx.doi.org/10.1074/jbc.M106878200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533037	hybrid			2022-12-27	WOS:000171925600078
J	Huang, S; Chen, LY; Zuraw, BL; Ye, RD; Pan, ZXK				Huang, S; Chen, LY; Zuraw, BL; Ye, RD; Pan, ZXK			Chemoattractant-stimulated NF-kappa B activation is dependent on the low molecular weight GTPase RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; PERIPHERAL-BLOOD MONOCYTES; FMET-LEU-PHE; PHOSPHATIDYLINOSITOL 3-KINASE; ADP-RIBOSYLATION; GENE-EXPRESSION; PEPTIDE RECEPTOR; CELLS; TRANSCRIPTION; PATHWAY	Chemoattractants bind to seven transmembrane-spanning, G-protein-coupled receptors on monocytes and neutrophils and induce a variety of functional responses, including activation of the transcription factor NF-kappaB. The signaling mechanisms utilized by chemoattractants to activate NF-kappaB in human peripheral blood monocytes are poorly defined. We previously demonstrated that fMet-Leu-Phe (fMLP) stimulates NF-kappaB activation, and this function of fMLP requires phosphatidylinositol 3-kinase (PI3K). Here we present evidence that fMLP activates RhoA and that fMLP-induced NF-kappaB activation requires this small GTPase. Stimulation of monocytes with fMLP rapidly activated RhoA as well as NF-kappaB, and their activation was markedly reduced by pertussis toxin treatment. Pretreatment of monocyte with a RhoA inhibitor, C3 transferase from Clostridium botulinum, effectively blocked fMLP-induced NF-kappaB activation as well as interleukin-1 beta gene expression. A dominant negative form of RhoA (T19N) also inhibited fMLP-stimulated reporter gene expression in a KB-dependent manner. Cotransfection of the monocytic THP1 cells with a constitutively active form of RhoA (Q63L) with the promoter reporter plasmid results in a marked increase in NF-kappaB-mediated reporter gene expression. Furthermore, the PI3K inhibitors wortmannin and LY294002 block RhoA activation induced by fMLP. These results demonstrate that low molecular weight GTPase RhoA is a novel signal transducer for fMLP-induced NF-kappaB activation and G alpha (i) or G alpha (o) class of heterotrimeric G proteins likely mediate RhoA activation via PI3K in human peripheral blood monocytes.	Scripps Res Inst, Dept Mol & Expt Med, Dept Immunol, La Jolla, CA 92037 USA; Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	Scripps Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Pan, ZXK (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zkpan@scripps.edu	Ye, Richard/ABF-2413-2020; Ye, Richard/O-5223-2016	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Zuraw, Bruce/0000-0003-0640-6768	NCRR NIH HHS [M01RR00833] Funding Source: Medline; NIAID NIH HHS [T32 AI 07469, AI43524] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043524, T32AI007469, R56AI043524] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aktories K, 1997, J CLIN INVEST, V99, P827, DOI 10.1172/JCI119245; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Arbour N, 1996, CYTOKINE, V8, P468, DOI 10.1006/cyto.1996.0063; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; BOMMAKANTI RK, 1992, J BIOL CHEM, V267, P7576; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; BURNETTE WN, 1994, STRUCTURE, V2, P151, DOI 10.1016/S0969-2126(00)00017-4; Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Gomez J, 1997, J IMMUNOL, V158, P1516; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hippenstiel S, 2000, BLOOD, V95, P3044; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; KUMAGAI N, 1993, J BIOL CHEM, V268, P24535; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MARI B, 1994, J BIOL CHEM, V269, P8517; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; NAKAJIMA T, 1994, BIOCHEM BIOPH RES CO, V204, P950, DOI 10.1006/bbrc.1994.2552; NAKANISHI S, 1995, CELL SIGNAL, V7, P545, DOI 10.1016/0898-6568(95)00033-L; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; PAN ZX, 1995, J BIOL CHEM, V270, P7787, DOI 10.1074/jbc.270.14.7787; Pan ZXK, 2000, J IMMUNOL, V164, P404, DOI 10.4049/jimmunol.164.1.404; Pan ZXK, 1998, BBA-GENE STRUCT EXPR, V1443, P90, DOI 10.1016/S0167-4781(98)00198-5; Pan ZXK, 1998, J IMMUNOL, V160, P3038; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 1998, CURR OPIN GENET DEV, V8, P63, DOI 10.1016/S0959-437X(98)80063-4; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SNYDERMAN R, 1986, J LEUKOCYTE BIOL, V40, P785, DOI 10.1002/jlb.40.6.785; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	43	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40977	40981		10.1074/jbc.M105242200	http://dx.doi.org/10.1074/jbc.M105242200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533055	hybrid			2022-12-27	WOS:000171925600081
J	Kavakli, IH; Park, JS; Slattery, CJ; Salamone, PR; Frohlick, J; Okita, TW				Kavakli, IH; Park, JS; Slattery, CJ; Salamone, PR; Frohlick, J; Okita, TW			Analysis of allosteric effector binding sites of potato ADP-glucose pyrophosphorylase through reverse genetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAF ADPGLUCOSE PYROPHOSPHORYLASE; STARCH-DEFICIENT MUTANT; ARABIDOPSIS-THALIANA; CATALYTIC-PROPERTIES; SMALL-SUBUNIT; MUTAGENESIS; SEQUENCES; ENDOSPERM; TUBER; 3-PHOSPHOGLYCERATE	ADP-glucose pyrophosphorylase (AGPase) is a key regulatory enzyme of bacterial glycogen and plant starch synthesis as it controls carbon flux via its allosteric regulatory behavior. Unlike the bacterial enzyme that is composed of a single subunit type, the plant AGPase is a heterotetrameric enzyme (alpha (2)beta (2)) with distinct roles for each subunit type. The large subunit (LS) is involved mainly in allosteric regulation through its interaction with the catalytic small subunit (SS). The LS modulates the catalytic activity of the SS by increasing the allosteric regulatory response of the hetero-oligomeric enzyme. To identify regions of the LS involved in binding of effector molecules, a reverse genetics approach was employed. A potato (Solanum tuberosum L.) AGPase LS down-regulatory mutant (E38A) was subjected to random mutagenesis using error-prone polymerise chain reaction and screened for the capacity to form an enzyme capable of restoring glycogen production in glgC(-) Escherichia coli. Dominant mutations were identified by their capacity to restore glycogen production when the LS containing only the second site mutations was co-expressed with the wild-type SS. Sequence analysis showed that most of the mutations were decidedly nonrandom and were clustered at conserved N- and C-terminal regions. Kinetic analysis of the dominant mutant enzymes indicated that the K-m values for cofactor and substrates were comparable with the wildtype AGPase, whereas the affinities for activator and inhibitor were altered appreciably. These AGPase variants displayed increased resistance to P-i inhibition and/or greater sensitivity toward 3-phosphoglyceric acid activation. Further studies of Lys-197, Pro-261, and Lys-420, residues conserved in AGPase sequences, by site-directed mutagenesis suggested that the effectors 3-phosphoglyceric acid and PI interact at two closely located binding sites.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Okita, TW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	okita@wsu.edu	Kavakli, Ibrahim/AAF-5468-2020	Kavakli, Ibrahim/0000-0001-6624-3505; Okita, Tom/0000-0002-2246-0599				BALL K, 1994, J BIOL CHEM, V269, P24706; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; BALLICORA MA, 1996, 5 NIAR COE INT S REG, P5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Fu YB, 1998, PLANT PHYSIOL, V117, P989, DOI 10.1104/pp.117.3.989; Giroux MJ, 1996, P NATL ACAD SCI USA, V93, P5824, DOI 10.1073/pnas.93.12.5824; GOVONS S, 1969, J BACTERIOL, V97, P970, DOI 10.1128/JB.97.2.970-972.1969; Greene TW, 1996, PLANT PHYSIOL, V112, P1315, DOI 10.1104/pp.112.3.1315; Greene TW, 1998, P NATL ACAD SCI USA, V95, P10322, DOI 10.1073/pnas.95.17.10322; Greene TW, 1996, P NATL ACAD SCI USA, V93, P1509, DOI 10.1073/pnas.93.4.1509; Kavakli IH, 2001, BIOCHEM BIOPH RES CO, V281, P783, DOI 10.1006/bbrc.2001.4416; Kavakli IH, 2000, AUST J PLANT PHYSIOL, V27, P561, DOI 10.1071/PP99176; KLECZKOWSKI LA, 1993, PLANT PHYSIOL, V101, P179, DOI 10.1104/pp.101.1.179; Laughlin MJ, 1998, PHYTOCHEMISTRY, V47, P621, DOI 10.1016/S0031-9422(97)00578-5; Laughlin MJ, 1998, PLANT J, V14, P159, DOI 10.1046/j.1365-313X.1998.00102.x; LI L, 1992, CARBOHYD RES, V227, P227, DOI 10.1016/0008-6215(92)85074-A; LIN TP, 1988, PLANT PHYSIOL, V88, P1175, DOI 10.1104/pp.88.4.1175; MORELL M, 1988, J BIOL CHEM, V263, P633; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; NAKATA PA, 1991, PLANT MOL BIOL, V17, P1089, DOI 10.1007/BF00037149; OKITA TW, 1992, PLANT PHYSIOL, V100, P560, DOI 10.1104/pp.100.2.560; Okita TW, 1998, PORTL PR P, V14, P99; OLIVE MR, 1989, PLANT MOL BIOL, V12, P525, DOI 10.1007/BF00036967; PLAXTON WC, 1987, PLANT PHYSIOL, V83, P105, DOI 10.1104/pp.83.1.105; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; PREISS J, 1991, BIOCHEM SOC T, V19, P539, DOI 10.1042/bst0190539; Preiss J., 1996, PHOTOASSIMILATE DIST, P63; PREISS J, 1994, P IMPR CER QUAL GEN, P115; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; Salamone PR, 2000, FEBS LETT, V482, P113, DOI 10.1016/S0014-5793(00)01985-2; Slattery CJ, 2000, TRENDS PLANT SCI, V5, P291, DOI 10.1016/S1360-1385(00)01657-5; SMITHWHITE BJ, 1992, J MOL EVOL, V34, P449, DOI 10.1007/BF00162999; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; WEBER H, 1995, PLANTA, V195, P352, DOI 10.1007/BF00202592	35	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40834	40840		10.1074/jbc.M106310200	http://dx.doi.org/10.1074/jbc.M106310200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524424	hybrid			2022-12-27	WOS:000171925600062
J	Verhees, CH; Huynen, MA; Ward, DE; Schiltz, E; de Vos, WM; van der Oost, J				Verhees, CH; Huynen, MA; Ward, DE; Schiltz, E; de Vos, WM; van der Oost, J			The phosphoglucose isomerase from the hyperthermophilic archaeon Pyrococcus furiosus is a unique glycolytic enzyme that belongs to the cupin superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBDEN-MEYERHOF PATHWAY; DEPENDENT PHOSPHOFRUCTOKINASE; SUGAR FERMENTATION; PURIFICATION; EVOLUTION; GLYCERALDEHYDE-3-PHOSPHATE; ALIGNMENT; OPERATION; SEQUENCE; KINASES	Pyrococcus furiosus uses a variant of the Embden-Meyerhof pathway during growth on sugars. All but one of the genes that encode the glycolytic enzymes of P. furiosus have previously been identified, either by homology searching of its genome or by reversed genetics. We here report the isolation of the missing link of the pyrococcal glycolysis, the phosphoglucose isomerase (PGI), which was purified to homogeneity from P. furiosus and biochemically characterized. The P. furiosus PGI, a dimer of identical 23.5-kDa subunits, catalyzes the reversible isomerization of glucose 6-phosphate to fructose 6-phosphate, with K, values of 1.99 and 0.63 mm, respectively. An optimum pH of 7.0 has been determined in both directions, and at its optimum temperature of 90 degreesC the enzyme has a half-life of 2.4 h. The N-terminal sequence was used for the identification of the pgiA gene in the P. furiosus genome. The pgiA transcription start site has been determined, and a monocistronic messenger was detected in P. furiosus during growth on maltose and pyruvate. The pgiA gene was functionally expressed in Escherichia coli BL21(DE3). The deduced amino acid sequence of this first archaeal PGI revealed that it is not related to its bacterial and eukaryal counterparts. In contrast, this archaeal PGI shares similarity with the cupin superfamily that consists of a variety of proteins that are generally involved in sugar metabolism in both prokaryotes and eukaryotes. As for the P. furiosus PGI, distinct phylogenetic origins have previously been reported for other enzymes from the pyrococcal glycolytic pathway. Apparently, convergent evolution by recruitment of several unique enzymes has resulted in the unique Pyrococcus glycolysis.	Univ Wageningen & Res Ctr, Microbiol Lab, NL-6703 CT Wageningen, Netherlands; European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Freiburg, D-79104 Freiburg, Germany	Wageningen University & Research; European Molecular Biology Laboratory (EMBL); University of Freiburg	Verhees, CH (corresponding author), Univ Wageningen & Res Ctr, Microbiol Lab, Hesselink Van Suchtelenweg 4, NL-6703 CT Wageningen, Netherlands.		van+der+Oost, John/Y-2548-2019; Huynen, Martijn A/A-1530-2014; Huijnen, M.A./H-8051-2014	Huynen, Martijn A/0000-0001-6189-5491; 				Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Bell SD, 1999, P NATL ACAD SCI USA, V96, P13662, DOI 10.1073/pnas.96.24.13662; BORK P, 1993, PROTEIN SCI, V2, P31; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Galperin MY, 2000, FEMS MICROBIOL LETT, V183, P259, DOI 10.1016/S0378-1097(99)00612-6; Hansen T, 2001, J BACTERIOL, V183, P3428, DOI 10.1128/JB.183.11.3428-3435.2001; Huynen MA, 1999, TRENDS MICROBIOL, V7, P281, DOI 10.1016/S0966-842X(99)01539-5; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; KENGEN SWM, 1993, EUR J BIOCHEM, V213, P305, DOI 10.1111/j.1432-1033.1993.tb17763.x; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Ko TP, 2000, ACTA CRYSTALLOGR D, V56, P411, DOI 10.1107/S0907444900002237; Li XC, 2000, BBA-PROTEIN STRUCT M, V1476, P363, DOI 10.1016/S0167-4838(99)00258-7; LOWE SL, 1975, J BIOL CHEM, V250, P94; MARCHAND M, 1989, EUR J BIOCHEM, V184, P455, DOI 10.1111/j.1432-1033.1989.tb15038.x; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; NATAKE M, 1964, AGR BIOL CHEM TOKYO, V28, P510; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ROBINSON KA, 1994, GENE, V151, P173, DOI 10.1016/0378-1119(94)90651-3; Rost B, 1996, METHOD ENZYMOL, V266, P525; Ruijter GJG, 1999, BIOCHIMIE, V81, P267, DOI 10.1016/S0300-9084(99)80061-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAFER T, 1992, ARCH MICROBIOL, V158, P188, DOI 10.1007/BF00290815; SCHAFER T, 1993, ARCH MICROBIOL, V159, P354, DOI 10.1007/BF00290918; SCHREYER R, 1980, ARCH MICROBIOL, V127, P289, DOI 10.1007/BF00427206; Siebers B, 1998, J BACTERIOL, V180, P2137, DOI 10.1128/JB.180.8.2137-2143.1998; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; TAKAMA M, 1980, J BIOCHEM, V87, P1821, DOI 10.1093/oxfordjournals.jbchem.a132927; THOMAS DA, 1981, J GEN MICROBIOL, V124, P403; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000	36	48	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40926	40932		10.1074/jbc.M104603200	http://dx.doi.org/10.1074/jbc.M104603200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533028	hybrid, Green Published			2022-12-27	WOS:000171925600074
J	Jodo, S; Xiao, S; Hohlbaum, A; Strehlow, D; Marshak-Rothstein, A; Ju, ST				Jodo, S; Xiao, S; Hohlbaum, A; Strehlow, D; Marshak-Rothstein, A; Ju, ST			Apoptosis-inducing membrane vesicles - A novel agent with unique properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MEDIATED CYTOTOXICITY; FAS LIGAND EXPRESSION; T-CELLS; MONOCLONAL-ANTIBODY; RETROVIRAL VECTORS; DOWN-REGULATION; GENE-TRANSFER; CD95 LIGAND; B-CELLS; ANTIGEN	The CD95 ligand (FasL) transmembrane protein is found on activated T cells and cells outside the immune system. A well-known turnover process of membrane FasL is mediated by matrix metalloproteinase, which generates soluble FasL (sFasL). Here, we demonstrate that membrane FasL turnover occurs effectively through the release of membrane vesicles. Quantitative analysis indicates that this process is as effective as sFasL release for FasL-3T3 cells but somewhat less effective for FasL-expressing T cells. The apoptosis-inducing membrane vesicles display unique properties not found in FasL-expressing cells and sFasL. Unlike sFasL, vesicle-associated FasL remained bioactive, killing the same panel of targets that are susceptible to FasL-expressing cells. In contrast to FasL-expressing T cells, FasL-mediated killing by vesicles do not involve LFA-1/ICAM interaction and do not depend on de novo protein synthesis. These observations indicate that the release of FasL-bearing vesicles contributes to the turnover of cell-associated FasL, but the impact of the bioactive FasL-expressing vesicles on the function of cell-associated FasL is different from that of sFasL.	Boston Univ, Ctr Arthrit, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Ctr Arthrit, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University; Boston University	Ju, ST (corresponding author), Boston Univ, Ctr Arthrit, Sch Med, Dept Med, 715 Albany St,Med Campus K508, Boston, MA 02118 USA.				NATIONAL CANCER INSTITUTE [R01CA090691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES010244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM058724] Funding Source: NIH RePORTER; NCI NIH HHS [CA 90691] Funding Source: Medline; NIAID NIH HHS [AI 36938] Funding Source: Medline; NIEHS NIH HHS [ES 10244] Funding Source: Medline; NIGMS NIH HHS [GM 58724] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albanese J, 1998, BLOOD, V91, P3862; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Bennett MW, 1998, J IMMUNOL, V160, P5669; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; ETTINGER R, 1995, J IMMUNOL, V154, P4302; French LE, 1996, J CELL BIOL, V133, P335, DOI 10.1083/jcb.133.2.335; French LE, 1997, J IMMUNOL, V159, P2196; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Jodo S, 2000, J IMMUNOL, V165, P5487, DOI 10.4049/jimmunol.165.10.5487; Jodo S, 2000, J IMMUNOL, V164, P5062, DOI 10.4049/jimmunol.164.10.5062; JONES B, 1986, J IMMUNOL, V136, P348; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; JU ST, 1990, J IMMUNOL, V144, P23; JU ST, 1994, P NATL ACAD SCI USA, V91, P4185, DOI 10.1073/pnas.91.10.4185; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kojima H, 1997, J IMMUNOL, V159, P2728; Lu LN, 1997, J IMMUNOL, V158, P5676; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Moller P, 1996, AM J PATHOL, V149, P9; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OZDEMIRLI M, 1992, J IMMUNOL, V149, P1889; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; STALDER T, 1994, J IMMUNOL, V152, P1127; Strand S, 1998, NAT MED, V4, P588, DOI 10.1038/nm0598-588; Strehlow D, 2000, P NATL ACAD SCI USA, V97, P4209, DOI 10.1073/pnas.070049197; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Wang J, 1997, J EXP MED, V186, P1171, DOI 10.1084/jem.186.7.1171; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Widom RL, 1997, GENE, V198, P407, DOI 10.1016/S0378-1119(97)00360-0; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	54	50	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39938	39944		10.1074/jbc.M107005200	http://dx.doi.org/10.1074/jbc.M107005200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546786	hybrid			2022-12-27	WOS:000171789200059
J	Brusselmans, K; Bono, F; Maxwell, P; Dor, Y; Dewerchin, M; Collen, D; Herbert, JM; Carmeliet, P				Brusselmans, K; Bono, F; Maxwell, P; Dor, Y; Dewerchin, M; Collen, D; Herbert, JM; Carmeliet, P			Hypoxia-inducible factor-2 alpha (HIF-2 alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS DOMAIN PROTEIN-1; TRANSCRIPTION FACTOR; NEONATAL HYPOGLYCEMIA; O-2 HOMEOSTASIS; FACTOR 1-ALPHA; MICE LACKING; SOLID TUMORS; FACTOR-I; FACTOR-1-ALPHA; ANGIOGENESIS	Deprivation of oxygen (hypoxia) and/or glucose (hypoglycemia) represents a serious stress that affects cellular survival. The hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha), which has been implicated in the cellular response to hypoxia (Semenza, G. L. (1999) Annu. Rev. Cell Dev. Biol. 15, 551-578), mediates apoptosis during hypoxia (Halterman, M. W., Miller, C. C., and Federoff, H. J. (1999) J. Neurosci. 19,6818-6824 and Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Ahramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., and Keshet, E. (1998) Nature 394, 485-490), but the function of its homologue HIF-2 alpha remains unknown. Therefore, the role of HIF-2 alpha in cellular survival was studied by targeted inactivation of the HIF-2 alpha gene (HIF-2 alpha (-/-)) in murine embryonic stem (ES) cells. In contrast to HIF-1 alpha deficiency, loss of HIF-2 alpha did not protect ES cells against apoptosis during hypoxia. Both HIF-1 alpha (-/-) and HIF-2 alpha (-/-) ES cells were, however, resistant to apoptosis in response to hypoglycemia. When co-cultured with wild type ES cells, HIF-2 alpha (-/-) ES cells became rapidly and progressively enriched in hypoglycemia but not in hypoxia. Thus, HIF-1 alpha and HIF-2 alpha may have distinct roles in responses to environmental stress, and despite its name, HIF-2 alpha may be more important in the survival response to environmental variables other than the level of oxygen.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Sanofi Synthelabo Rech, Cardiovasc Thrombosis Res Dept, F-31036 Toulouse, France; Wellcome Trust Ctr Human Genet, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 7BN, England; Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel	Flanders Institute for Biotechnology (VIB); KU Leuven; Sanofi-Aventis; Sanofi France; University of Oxford; Wellcome Centre for Human Genetics; Hebrew University of Jerusalem	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Carmeliet, Peter/AAQ-5140-2020; Maxwell, Patrick H/C-5557-2008; Dor, Yuval/C-2405-2011	Carmeliet, Peter/0000-0001-7961-1821; Maxwell, Patrick H/0000-0002-0338-2679; 				AKAZAWA S, 1987, DIABETOLOGIA, V30, P791; Akeno N, 2001, ENDOCRINOLOGY, V142, P959, DOI 10.1210/en.142.2.959; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Favier J, 1999, FEBS LETT, V462, P19, DOI 10.1016/S0014-5793(99)01476-3; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Smoak IW, 1997, REPROD TOXICOL, V11, P495, DOI 10.1016/S0890-6238(97)00016-6; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tkacs NC, 2000, DIABETES, V49, P820, DOI 10.2337/diabetes.49.5.820; Traill Z, 1998, ARCH DIS CHILD-FETAL, V79, pF145, DOI 10.1136/fn.79.2.F145; Vincent KA, 2000, CIRCULATION, V102, P2255; Wenger RH, 1997, BIOL CHEM, V378, P609; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Williams AF, 1997, B WORLD HEALTH ORGAN, V75, P261	33	88	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 19	2001	276	42					39192	39196		10.1074/jbc.C100428200	http://dx.doi.org/10.1074/jbc.C100428200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	484CT	11546756	hybrid			2022-12-27	WOS:000171673200113
J	Gratacap, MP; Payrastre, B; Nieswandt, B; Offermanns, S				Gratacap, MP; Payrastre, B; Nieswandt, B; Offermanns, S			Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; STRESS FIBER FORMATION; PLATELET SHAPE CHANGE; BETA-GAMMA-SUBUNITS; SMALL GTPASE RHO; THROMBOXANE A(2); MYOSIN PHOSPHORYLATION; RECEPTOR LIGATION; G(12) FAMILY; ACTIVATION	Platelets were used to study the activation of Rho and Rac through G-protein-coupled receptors and its regulation by cyclic nucleotides. The thromboxane A(2) (TXA(2)) mimetic U46619 rapidly activated both small GTPases independently of integrin alpha (IIb)beta (3) activation. U46619, which leads to the activation of G(12)/G(13) and G(q) did not induce Rac activation in G alpha (q)-deficient platelets but was able to activate Rho, to stimulate actin polymerization and phosphatidylinositol 4,5-bisphosphate formation, and to induce shape change. Rac activation by U46619 in wild-type platelets could be blocked by chelation of intracellular Ca2+ and was partially sensitive to apyrase and AR-C69931MX an antagonist of the Gi-coupled ADP receptor. Cyclic AMP, which completely blocks platelet function, inhibited the U46619-induced activation of Gq and G(12)/G(13) as well as of Rac and Rho. In contrast, cGMP, which has no effect on platelet shape change blocked only activation of G(q) and Rac. These data demonstrate that Rho and Rac are differentially regulated through heterotrimeric G-proteins. The G(12)/G(13)-mediated Rho activation is involved in the shape change response, whereas Rac is activated through Gq and is not required for shape change. Cyclic AMP and cGMP differentially interfere with U46619-induced Rho and Rac activation at least in part by selective effects on the regulation of individual G-proteins through the TXA2 receptor.	Heidelberg Univ, Inst Pharmakol, D-69120 Heidelberg, Germany; Hop Purpan, INSERM Unite 326, F-31059 Toulouse, France; Univ Witten Herdecke, Dept Mol Oncol, D-42117 Wuppertal, Germany	Ruprecht Karls University Heidelberg; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Witten Herdecke University	Offermanns, S (corresponding author), Heidelberg Univ, Inst Pharmakol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@urz.uni-heidelberg.de	; Offermanns, Stefan/L-3313-2017	, Bernard/0000-0002-8693-0190; Gratacap, Marie-Pierre/0000-0003-4362-6401; Offermanns, Stefan/0000-0001-8676-6805				Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Belisle B, 2000, J BIOL CHEM, V275, P26225, DOI 10.1074/jbc.M002743200; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chatah NEH, 2001, J BIOL CHEM, V276, P34059, DOI 10.1074/jbc.M104917200; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Clerk A, 2001, MOL CELL BIOL, V21, P1173, DOI 10.1128/MCB.21.4.1173-1184.2001; DANIEL JL, 1984, J BIOL CHEM, V259, P9826; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; FOX JEB, 1993, THROMB HAEMOSTASIS, V70, P884; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; GEIGER J, 1994, AM J PHYSIOL, V267, pC236, DOI 10.1152/ajpcell.1994.267.1.C236; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Habib A, 1999, J BIOL CHEM, V274, P2645, DOI 10.1074/jbc.274.5.2645; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Herault JP, 1998, THROMB HAEMOSTASIS, V79, P383, DOI 10.1055/s-0037-1614996; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hofmann F, 2000, J CELL SCI, V113, P1671; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; KINSELLA BT, 1994, J BIOL CHEM, V269, P29914; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LAUGWITZ KL, 1994, METHOD ENZYMOL, V237, P283; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; MALMSTEN C, 1975, P NATL ACAD SCI USA, V72, P1446, DOI 10.1073/pnas.72.4.1446; Manganello JM, 1999, J BIOL CHEM, V274, P28003, DOI 10.1074/jbc.274.39.28003; MATSUOKA I, 1989, Japanese Journal of Pharmacology, V49, p142P; MENSHIKOV MY, 1993, EUR J PHARM-MOLEC PH, V245, P281, DOI 10.1016/0922-4106(93)90108-L; MORII N, 1992, J BIOL CHEM, V267, P20921; MORINELLI TA, 1983, BLOOD, V61, P41; Nieswandt B, 2000, BLOOD, V96, P2520; Nishioka H, 2001, BIOCHEM BIOPH RES CO, V280, P970, DOI 10.1006/bbrc.2001.4237; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; OFFERMANNS S, 1991, METHOD ENZYMOL, V195, P286; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Pulcinelli FM, 1998, FEBS LETT, V435, P115, DOI 10.1016/S0014-5793(98)01049-7; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Ueda H, 2000, J BIOL CHEM, V275, P2098, DOI 10.1074/jbc.275.3.2098; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; WURZINGER LJ, 1990, ADV ANAT EMBRYOL CEL, V120, P1	70	83	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2001	276	51					47906	47913		10.1074/jbc.M104442200	http://dx.doi.org/10.1074/jbc.M104442200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505QL	11560922	hybrid			2022-12-27	WOS:000172927000026
J	Tanoue, S; Nishioka, T				Tanoue, S; Nishioka, T			A receptor-type guanylyl cyclase expression is regulated under circadian clock in peripheral tissues of the silk moth - Light-induced shifting of the expression rhythm and correlation with eclosion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE RECEPTOR; DROSOPHILA-MELANOGASTER; NITRIC-OXIDE; CYCLIC-GMP; MALPIGHIAN TUBULES; BEHAVIORAL RHYTHMS; SKELETAL-MUSCLE; TIMELESS; TRANSCRIPTION; PERIOD	The mechanisms by which the circadian clock controls behavior through regulating gene expression in peripheral tissues are largely unknown. Here we demonstrate that the expression of a receptor-type guanylyl cyclase (BmGC-I) from the silk moth Bombyx mori is regulated in the flight muscles in a circadian fashion. BmGC-I mRNA was expressed from the end of the light period through the middle of the dark period. BmGC-I protein expression and cGMP levels were high around the initiation of eclosion events at the beginning of the photoperiod. The rhythm of the BmGC-I and cGMP levels free-ran in constant light and synchronized to the environmental photoperiodic cycle. The circadian regulation of BmGC-I expression was also observed in the legs but not in other tissues examined. BmGC-I therefore represents a circadian output gene that regulates eclosion behavior.	Kyoto Univ, Lab Insect Physiol, Grad Sch Agr Sci, Kyoto 6068502, Japan	Kyoto University	Nishioka, T (corresponding author), Kyoto Univ, Lab Insect Physiol, Grad Sch Agr Sci, Kyoto 6068502, Japan.							Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Ball EE, 1998, J COMP NEUROL, V394, P1, DOI 10.1002/(SICI)1096-9861(19980427)394:1<1::AID-CNE1>3.0.CO;2-4; Benavides A, 1998, AM J PHYSIOL-REG I, V275, pR811, DOI 10.1152/ajpregu.1998.275.3.R811; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Giebultowicz JM, 1997, NATURE, V386, P664, DOI 10.1038/386664a0; GIGLIOTTI S, 1993, DEV BIOL, V159, P450, DOI 10.1006/dbio.1993.1255; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee C, 1999, MOL CELL BIOL, V19, P5316; LIU WC, 1995, J BIOL CHEM, V270, P12418, DOI 10.1074/jbc.270.21.12418; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; MCNEIL L, 1995, J BIOL CHEM, V270, P7189, DOI 10.1074/jbc.270.13.7189; NICOLE M, 1987, NUCLEIC ACIDS RES, V15, P2781; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; PIECE J, 1977, ANAL BIOCHEM, V81, P478; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; QUILAN MC, 1997, J EXP BIOL, V200, P2363; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SAEZ L, 1996, NEURON, V17, P979; SAMBROOK J, 1989, MOL CLONING, V1, P7; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SHIBANAKA Y, 1991, BIOCHEM BIOPH RES CO, V180, P881, DOI 10.1016/S0006-291X(05)81147-7; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Tanoue S, 2001, INSECT BIOCHEM MOLEC, V31, P971, DOI 10.1016/S0965-1748(01)00045-5; TRUMAN JW, 1971, P NATL ACAD SCI USA, V68, P595, DOI 10.1073/pnas.68.3.595; Young ME, 1998, FEBS LETT, V424, P79, DOI 10.1016/S0014-5793(98)00143-4; Young ME, 1997, BIOCHEM J, V322, P223, DOI 10.1042/bj3220223; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217	41	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 14	2001	276	50					46765	46769		10.1074/jbc.M106980200	http://dx.doi.org/10.1074/jbc.M106980200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	502XR	11557767	hybrid			2022-12-27	WOS:000172768500014
J	Escobar-Henriques, M; Balguerie, A; Monribot, C; Boucherie, H; Daignan-Fornier, B				Escobar-Henriques, M; Balguerie, A; Monribot, C; Boucherie, H; Daignan-Fornier, B			Proteome analysis and morphological studies reveal multiple effects of the immunosuppressive drug mycophenolic acid specifically resulting from guanylic nucleotide depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; CDC37; PROGRESSION; MECHANISM; CHAPERONE; MUTANTS; COMPLEX; GENES	Mycophenolic acid (NMA), one of the most promising immunosuppressive drugs recently developed, is a potent inhibitor of IMP dehydrogenase, the first committed step toward GMP synthesis. We found that all the drug effects on yeast cells were prevented by bypassing GMP synthesis, thus confirming the high specificity of MPA. Although the primary target of MPA is clearly identified, we aimed to further understand how GTP depletion leads to growth arrest and developed a new approach based on proteome analysis combined with overexpression studies. Essential proteins down-expressed in the presence of NMA were identified by protein two-dimensional gel analysis and subsequently overexpressed in yeast. Two such proteins, Cdc37p and Sup45p, when overexpressed allowed partial relief of MPA toxicity, strongly suggesting that their lower amount after MPA treatment significantly contributed to the MPA effect. These conserved proteins involved in cell cycle progression and translation are therefore important secondary targets for MPA. Our data establish that NEPA effects occur through inhibition of a unique primary target resulting in guanine nucleotides depletion, thereby affecting multiple cellular processes.	CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Daignan-Fornier, B (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	B.Daigman-Fornier@ibgc.u-bordeaux2.fr		Escobar-Henriques, Mafalda/0000-0002-0879-3119				Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Balguerie A, 1999, J CELL SCI, V112, P2529; BOUCHERIE H, 1995, YEAST, V11, P601, DOI 10.1002/yea.320110702; BoyMarcotte E, 1996, MICROBIOL-UK, V142, P459, DOI 10.1099/13500872-142-3-459; Denis V, 1998, MOL MICROBIOL, V30, P557, DOI 10.1046/j.1365-2958.1998.01087.x; Escobar-Henriques M, 2001, J BIOL CHEM, V276, P1523, DOI 10.1074/jbc.M007926200; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Guetsova ML, 1997, GENETICS, V147, P383; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Perrot M, 1999, ELECTROPHORESIS, V20, P2280, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2280::AID-ELPS2280>3.3.CO;2-H; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Pruyne D, 2000, J CELL SCI, V113, P365; Qiu Y, 2000, TRANSPLANTATION, V69, P890; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000	24	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46237	46242		10.1074/jbc.M103416200	http://dx.doi.org/10.1074/jbc.M103416200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11535588	hybrid			2022-12-27	WOS:000172573100102
J	Folcher, M; Gaillard, H; Nguyen, LT; Nguyen, KT; Lacroix, P; Bamas-Jacques, N; Rinkel, M; Thompson, CJ				Folcher, M; Gaillard, H; Nguyen, LT; Nguyen, KT; Lacroix, P; Bamas-Jacques, N; Rinkel, M; Thompson, CJ			Pleiotropic functions of a Streptomyces pristinaespiralis autoregulator receptor in development, antibiotic biosynthesis, and expression of a superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-FACTOR RECEPTOR; COELICOLOR A3(2); TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; GRISEUS; BUTYROLACTONE; GENE; PROTEIN; DNA; DIFFERENTIATION	In Streptomyces, a family of related butyrolactones and their corresponding receptor proteins serve as quorum-sensing systems that can activate morphological development and antibiotic biosynthesis. Streptomyces pristinaespiralis contains a gene cluster encoding enzymes and regulatory proteins for the biosynthesis of pristinamycin, a clinically important streptogramin antibiotic complex. One of these proteins, PapR1, belongs to a well known family of Streptomyces antibiotic regulatory proteins. Gel shift assays using crude cytoplasmic extracts detected SpbR, a developmentally regulated protein that bound to the papR1 promoter. SpbR was purified, and its gene was cloned using reverse genetics. spbR encoded a 25-kDa protein similar to Streptomyces autoregulatory proteins of the butyrolactone receptor family, including scbR from Streptomyces coelicolor. In Escherichia coli, purified SpbR and ScbR produced bound sequences immediately upstream of papR1, spbR, and scbR. SpbR DNA-binding activity was inhibited by an extracellular metabolite with chromatographic properties similar to those of the well known gamma -butyrolactone signaling compounds. DNase I protection assays mapped the SpbR-binding site in the papR1 promoter to a sequence homologous to other known butyrolactone autoregulatory elements. A nucleotide data base search showed that these binding motifs were primarily located upstream of genes encoding Streptomyces antibiotic regulatory proteins and butyrolactone receptors in various Streptomyces species. Disruption of the spbR gene in S. pristinaespiralis resulted in severe defects in growth, morphological differentiation, pristinamycin biosynthesis, and expression of a secreted superoxide dismutase.	Univ Basel, Bioctr, Dept Mol Microbiol, CH-4056 Basel, Switzerland	University of Basel	Thompson, CJ (corresponding author), Univ Basel, Bioctr, Dept Mol Microbiol, 70 Klingelbergstr, CH-4056 Basel, Switzerland.		Nguyen, Kien/F-9234-2019; Gaillard, Helene/M-2914-2014	Nguyen, Kien/0000-0003-2685-3928; Gaillard, Helene/0000-0002-5740-0641				Bate N, 1999, CHEM BIOL, V6, P617, DOI 10.1016/S1074-5521(99)80113-6; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bibb M, 1996, MICROBIOL-SGM, V142, P1335, DOI 10.1099/13500872-142-6-1335; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; BRAUN D, 1995, FEMS MICROBIOL LETT, V126, P37, DOI 10.1111/j.1574-6968.1995.tb07387.x; Cho YH, 2000, MOL MICROBIOL, V35, P150, DOI 10.1046/j.1365-2958.2000.01685.x; Folcher M, 2001, J BIOL CHEM, V276, P1479, DOI 10.1074/jbc.M007690200; Fuqua C, 1998, CURR OPIN MICROBIOL, V1, P183, DOI 10.1016/S1369-5274(98)80009-X; GRANOZZI C, 1990, J GEN MICROBIOL, V136, P713, DOI 10.1099/00221287-136-4-713; Harth G, 1999, J BIOL CHEM, V274, P4281, DOI 10.1074/jbc.274.7.4281; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Henderson IR, 2000, TRENDS MICROBIOL, V8, P529, DOI 10.1016/S0966-842X(00)01853-9; Hopwood D.A., 1985, GENETIC MANIPULATION; HORINOUCHI S, 1994, MOL MICROBIOL, V12, P859, DOI 10.1111/j.1365-2958.1994.tb01073.x; KHOKHLOV AS, 1973, Z ALLG MIKROBIOL, V13, P647, DOI 10.1002/jobm.3630130803; KHOKHLOV AS, 1967, DOKL AKAD NAUK SSSR+, V177, P232; Kim EJ, 1996, EUR J BIOCHEM, V241, P178, DOI 10.1111/j.1432-1033.1996.0178t.x; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kinoshita H, 1999, J BACTERIOL, V181, P5075, DOI 10.1128/JB.181.16.5075-5080.1999; Kitani S, 1999, J BACTERIOL, V181, P5081, DOI 10.1128/JB.181.16.5081-5084.1999; MANIATIS T, 1989, MOL CLONING LAB MANU, P74; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Nakano H, 1998, J BACTERIOL, V180, P3317, DOI 10.1128/JB.180.13.3317-3322.1998; Neumann T, 1996, MICROBIOL-UK, V142, P1953, DOI 10.1099/13500872-142-8-1953; Oh SH, 1997, J BACTERIOL, V179, P122, DOI 10.1128/jb.179.1.122-127.1997; Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x; Onaka H, 1997, J BACTERIOL, V179, P2748, DOI 10.1128/jb.179.8.2748-2752.1997; ONAKA H, 1995, J BACTERIOL, V177, P6083, DOI 10.1128/jb.177.21.6083-6092.1995; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; PREUDHOM.J, 1968, B SOC CHIM FR, P585; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; SCHNELL S, 1995, J BACTERIOL, V177, P5924, DOI 10.1128/jb.177.20.5924-5929.1995; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; Waki M, 1997, J BACTERIOL, V179, P5131, DOI 10.1128/jb.179.16.5131-5137.1997; YAMADA Y, 1987, J ANTIBIOT, V40, P496, DOI 10.7164/antibiotics.40.496	39	107	114	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44297	44306		10.1074/jbc.M101109200	http://dx.doi.org/10.1074/jbc.M101109200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557748	hybrid			2022-12-27	WOS:000172297700102
J	Foster, LJ; Li, DL; Randhawa, VK; Klip, A				Foster, LJ; Li, DL; Randhawa, VK; Klip, A			Insulin accelerates inter-endosomal GLUT4 traffic via phosphatidylinositol 3-kinase and protein kinase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; GLUCOSE-TRANSPORTER TRANSLOCATION; AMINO-ACID-TRANSPORT; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; BREFELDIN-A; SUBCELLULAR TRAFFICKING; SENSITIVE TRAFFICKING; COMPARTMENT-ABLATION; PLASMA-MEMBRANE	Insulin enhances plasmalemmal-directed traffic of glucose transporter-4 (GLUT4), but it is unknown whether insulin regulates GLUT4 traffic through endosomal compartments. In L6 myoblasts expressing Myc-tagged GLUT4, insulin markedly stimulated the rate of GLUT4myc recycling. In myoblasts stimulated with insulin to maximize surface GLUT4myc levels, we followed the rates of surface-labeled GLUT4myc endocytosis and chased its intracellular distribution in space and time using confocal immunofluorescence microscopy. Surface-labeled GLUT4myc internalized rapidly (t(1/2) 3 min), reaching the early endosome by 2 min and the transferrin receptor-rich, perinuclear recycling endosome by 20 min. Upon re-addition of insulin, the t(1/2) of GLUT4 disappearance from the plasma membrane was unchanged (3 min), but strikingly, GLUT4myc reached the recycling endosome by 10 and left by 20 min. This effect of insulin was blocked by the phosphatidylinositol 3-kinase inhibitor LY294002 or by transiently transfected dominant-negative phosphatidylinositol 3-kinase and protein kinase B mutants. In contrast, insulin did not alter the rate of arrival of rhodamine-labeled transferrin at the recycling endosome. These results reveal a heretofore unknown effect of insulin to accelerate interendosomal travel rates of GLUT4 and identify the recycling endosome as an obligatory stage in insulin-dependent GLUT4 recycling.	Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							BAO SC, 1995, J BIOL CHEM, V270, P30199; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CLARK AE, 1991, BIOCHEM J, V278, P235, DOI 10.1042/bj2780235; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; CZECH MP, 1993, J BIOL CHEM, V268, P9187; FOSTER LJ, 1999, DIABET ANN, V12, P111; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gillingham AK, 1999, J CELL SCI, V112, P4793; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Hill MM, 1999, MOL CELL BIOL, V19, P7771; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; HUNDAL HS, 1994, BIOCHEM J, V297, P289, DOI 10.1042/bj2970289; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KANAI F, 1993, J BIOL CHEM, V268, P14523; Kawanaka K, 2001, J BIOL CHEM, V276, P20101, DOI 10.1074/jbc.M010599200; Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, pC1487, DOI 10.1152/ajpcell.1998.275.6.C1487; Khayat ZA, 2000, J CELL SCI, V113, P279; KING PA, 1992, J CLIN INVEST, V90, P1568, DOI 10.1172/JCI116025; KonoSugita E, 1996, EUR J BIOCHEM, V236, P1033, DOI 10.1111/j.1432-1033.1996.01033.x; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; LACHAAL M, 1994, J BIOL CHEM, V269, P23689; Lee W, 2000, BIOCHEMISTRY-US, V39, P9358, DOI 10.1021/bi0007021; Lee W, 1999, J BIOL CHEM, V274, P37755, DOI 10.1074/jbc.274.53.37755; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martin S, 2000, TRAFFIC, V1, P652, DOI 10.1034/j.1600-0854.2000.010809.x; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Millar CA, 1997, BIOCHEM SOC T, V25, P974, DOI 10.1042/bst0250974; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; OKADA T, 1994, J BIOL CHEM, V269, P3568; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SATOH S, 1993, J BIOL CHEM, V268, P17820; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang QH, 1999, MOL CELL BIOL, V19, P4008; WITT DP, 1978, BIOCHEMISTRY-US, V17, P3913, DOI 10.1021/bi00612a004; YANG J, 1993, J BIOL CHEM, V268, P4600; YEH JI, 1995, J BIOL CHEM, V270, P2107, DOI 10.1074/jbc.270.5.2107; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	53	86	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44212	44221		10.1074/jbc.M102964200	http://dx.doi.org/10.1074/jbc.M102964200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11560920	hybrid			2022-12-27	WOS:000172297700093
J	Ghiso, JA; Holton, J; Miravalle, L; Calero, M; Lashley, T; Vidal, R; Houlden, H; Wood, N; Neubert, TA; Rostagno, A; Plant, G; Revesz, T; Frangione, B				Ghiso, JA; Holton, J; Miravalle, L; Calero, M; Lashley, T; Vidal, R; Houlden, H; Wood, N; Neubert, TA; Rostagno, A; Plant, G; Revesz, T; Frangione, B			Systemic amyloid deposits in familial British dementia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; ALZHEIMERS-DISEASE; BETA-PROTEIN; CYTOSKELETAL PATHOLOGY; PYROGLUTAMYL-PEPTIDES; PLAQUE-FORMATION; BLOOD-BRAIN; CYSTATIN-C; ANGIOPATHY; CLEARANCE	Familial British dementia (FBD) is an early onset inherited disorder that, like familial Alzheimer's disease (FAD), is characterized by progressive dementia, amyloid deposition in the brain, and neurofibrillary degeneration of limbic neurons. The primary structure of the amyloid subunit (ABri) extracted from FBD brain tissues (Vidal, R., Frangione, B., Rostagno, A., Mead, S., Revesz, T., Plant, G., and Ghiso, J. (1999) Nature 399, 776-781) is entirely different and unrelated to any previously known amyloid protein. Patients with FBD have a single nucleotide substitution at codon 267 in the BRI2 gene, resulting in an arginine replacing the stop codon and a longer open reading frame of 277 amino acids instead of 266. The ABri peptide comprises the 34 C-terminal residues of the mutated precursor ABriPP-277 and is generated via furin-like proteolytic processing. Here we report that carriers of the Stop-to-Arg mutation have a soluble form of the amyloid peptide (sABri) in the circulation with an estimated concentration in the range of 20 ng/ml, several fold higher than that of soluble A beta. In addition, ABri species identical to those identified in the brain were also found as fibrillar components of amyloid deposits predominantly in the blood vessels of several peripheral tissues, including pancreas and myocardium. We hypothesize that the high concentration of the soluble de novo created amyloidogenic peptide and/or the insufficient tissue clearance are the main causative factors for the formation of amyloid deposits outside the brain. Thus, FBD constitutes the first documented cerebral amyloidosis associated with neurodegeneration and dementia in which the amyloid deposition is also systemic.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; Inst Neurol, Div Neuropathol, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Pathogenesis, London WC1N 3BG, England	New York University; New York University; New York University; New York University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Ghiso, JA (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave,TH-432, New York, NY 10016 USA.	ghisoj01@popmail.med.nyu.edu	Wood, Nicholas W/C-2505-2009; Houlden, Henry J/C-1532-2008; Calero, Miguel/H-5691-2015; Rostagno, Agueda/A-5801-2008; Lashley, Tammaryn/D-2583-2009; Revesz, Tamas/A-8732-2010; Holton, Janice L/F-6831-2011	Wood, Nicholas W/0000-0002-9500-3348; Houlden, Henry J/0000-0002-2866-7777; Calero, Miguel/0000-0001-5366-3324; Revesz, Tamas/0000-0003-2501-0259; Holton, Janice L/0000-0002-3882-5249; Lashley, Tammaryn/0000-0001-7389-0348; Rostagno, Agueda/0000-0002-6817-2074	NCRR NIH HHS [RR14662, RR13077] Funding Source: Medline; NIA NIH HHS [AG08721, AG05891] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014662, S10RR013077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005891, R37AG005891, R01AG008721] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIKAWA H, 1985, ANN NEUROL, V17, P297, DOI 10.1002/ana.410170313; BARAISTER M, 1990, GENETICS NEUROLOGICA, P93; BATEMAN A, 1990, J BIOL CHEM, V265, P22130; BENEDIKZ E, 1990, VIRCHOWS ARCH A, V417, P325, DOI 10.1007/BF01605784; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; CASTANO EM, 1995, CURR OPIN NEUROL, V8, P279, DOI 10.1097/00019052-199508000-00006; COURTENMYERS G, 1987, NEUROLOGY, V37, P269; Dickson DW, 1997, ANN NEUROL, V42, P541, DOI 10.1002/ana.410420403; Garden RW, 1999, J NEUROCHEM, V72, P676, DOI 10.1046/j.1471-4159.1999.0720676.x; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; Ghiso J, 2000, ANN NY ACAD SCI, V920, P84; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; GOLOLOBOV MY, 1994, ARCH BIOCHEM BIOPHYS, V309, P300, DOI 10.1006/abbi.1994.1117; GRIFFITHS RA, 1982, J NEUROL NEUROSUR PS, V45, P396, DOI 10.1136/jnnp.45.5.396; GUDMUNDSSON G, 1972, BRAIN, V95, P387, DOI 10.1093/brain/95.2.387; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; LOVE S, 1982, J NEUROL NEUROSUR PS, V45, P271, DOI 10.1136/jnnp.45.3.271; MASTERS CL, 1981, BRAIN, V104, P535, DOI 10.1093/brain/104.3.535; MCDONALD JK, 1998, HDB PROTEOLYTIC ENZY, P408; Mead S, 2000, BRAIN, V123, P975, DOI 10.1093/brain/123.5.975; Messer M, 1965, C R Trav Lab Carlsberg, V35, P1; MISUMI Y, 1998, HDB PROTEOLYTIC ENZY, P378; MORI H, 1992, J BIOL CHEM, V267, P17082; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Revesz T, 1999, ACTA NEUROPATHOL, V97, P170, DOI 10.1007/s004010050970; SAIDO T, 1996, NEUROSCI LETT, V13, P173; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SKODRAS G, 1993, ANN CLIN LAB SCI, V23, P275; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Tekirian TL, 1998, J NEUROPATH EXP NEUR, V57, P76, DOI 10.1097/00005072-199801000-00009; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WEN GY, 1994, ACTA NEUROPATHOL, V88, P201; Worster-Drought C, 1933, J NEUROL PSYCHOPATHO, V14, P27; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	40	61	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43909	43914		10.1074/jbc.M105956200	http://dx.doi.org/10.1074/jbc.M105956200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557758	hybrid			2022-12-27	WOS:000172297700057
J	Otipoby, KL; Draves, KE; Clark, EA				Otipoby, KL; Draves, KE; Clark, EA			CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYN-DEFICIENT MICE; ACTIVATED PROTEIN-KINASE; TYROSINE-PHOSPHATASE SHP-1; ANTIGEN RECEPTOR; NEGATIVE REGULATOR; PHOSPHOLIPASE C-GAMMA-1; CD22-DEFICIENT MICE; AUTOIMMUNE-DISEASE; ADHESION MOLECULE; PATHWAYS	Recognition of antigen by the B cell antigen receptor (BCR) determines the subsequent fate of a B cell and is regulated in part by the involvement of other surface molecules, termed coreceptors. CD22 is a B cell-restricted coreceptor that gets rapidly tyrosyl-phosphorylated and recruits various signaling molecules to the membrane following BCR ligation. Although CD22 contains three immunoreceptor tyrosine-based inhibitory motifs (ITIMs), only the two carboxyl-terminal ITIM tyrosines are required for efficient recruitment of the SHP-1 phosphatase after BCR ligation. Furthermore, Grb2 is inducibly recruited to CD22 in human and mu- rine B cells. Unlike SHP-1, Grb2 recruitment to CD22 is not inhibited by specific doses of the Src family kinase-specific inhibitor PP1. The tyrosine residue in CD22 required for Grb2 recruitment (Tyr-828) is distinct and independent from the two ITIM tyrosines required for efficient SHP-1 recruitment (Tyr-843 and Tyr-863). Individually both Lyn and Syk are required for maximal phosphorylation of CD22 following ligation of the BCR, and together Lyn and Syk are required for all of the constitutive and induced tyrosine phosphorylation of CD22. We propose that the cytoplasmic tail of CD22 contains two domains that regulate signal transduction pathways initiated by the BCR and B cell fate.	Univ Washington, Reg Primate Res Ctr, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Otipoby, KL (corresponding author), Univ Washington, Reg Primate Res Ctr, Dept Immunol, Box 357330, Seattle, WA 98195 USA.		Clark, Edward/K-3462-2012	Clark, Edward A/0000-0001-8061-5475	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044250] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NIAID NIH HHS [AI44250] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; Carroll M C, 2000, Adv Immunol, V74, P61; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Craxton A, 1999, ADV IMMUNOL, V73, P79, DOI 10.1016/S0065-2776(08)60786-5; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Graves JD, 1996, P NATL ACAD SCI USA, V93, P13814, DOI 10.1073/pnas.93.24.13814; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HARDY RR, 1986, HDB EXPT IMMUNOLOGY, V1, P1; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LANKESTER AC, 1995, J BIOL CHEM, V270, P20305, DOI 10.1074/jbc.270.35.20305; LAW CL, 1993, J IMMUNOL, V151, P175; LAW CL, 1994, IMMUNOL TODAY, V15, P442, DOI 10.1016/0167-5699(94)90275-5; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; PEZZUTTO A, 1988, J IMMUNOL, V140, P1791; PEZZUTTO A, 1987, J IMMUNOL, V138, P98; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; STAMENKOVIC I, 1990, NATURE, V345, P74, DOI 10.1038/345074a0; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; TORRES RM, 1992, J IMMUNOL, V149, P2641; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Tuscano JM, 1999, BLOOD, V94, P1382, DOI 10.1182/blood.V94.4.1382.416k14_1382_1392; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yohannan J, 1999, J BIOL CHEM, V274, P18769, DOI 10.1074/jbc.274.26.18769; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	56	89	94	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44315	44322		10.1074/jbc.M105446200	http://dx.doi.org/10.1074/jbc.M105446200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551923	hybrid			2022-12-27	WOS:000172297700104
J	Schramek, N; Bracher, A; Bacher, A				Schramek, N; Bracher, A; Bacher, A			Biosynthesis of riboflavin - Single turnover kinetic analysis of GTP cyclohydrolase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHYDROBIOPTERIN; TRIPHOSPHATE; COFACTOR	GTP cyclohydrolase II catalyzes the conversion of GTP into a mixture of 2,5-diamino-6-ribosylamino-4(3H)- Pyrimidinone 5'-phosphate (Compound 2), formate, and pyrophosphate. Moreover, GMP was recently shown to be formed as a minor product. The major product (Compound 2) serves as the first committed intermediate in the biosynthesis of the vitamin, riboflavin. Numerous pathogenic microorganisms are absolutely dependent on endogenous synthesis of riboflavin. The enzymes of this pathway are therefore potential drug targets, and mechanistic studies appear relevant for development of bactericidal inhibitors. Pre-steady state quenched flow analysis of GTP cyclohydrolase II shows the rate-determining step to be located at the beginning of the reaction sequence catalyzed by the enzyme. Thus, GTP is consumed at a rate constant of 0.064 s(-1), and the reaction product, Compound 2, is formed at an apparent rate constant of 0.062 s(-1). Stopped flow experiments monitored by multiwavelength photometry are well in line with these data. 2-Amino-5-formylamino-6-ribosylamino-4(3H)-pyrimidinone triphosphate can serve as substrate for GTP cyclohydrolase II but does not fulfill the criteria for a kinetically competent intermediate. A hypothetical reaction mechanism involves the slow formation of a phosphoguanosyl derivative of the enzyme under release of pyrophosphate. The covalently bound phosphoguanosyl moiety is proposed to undergo rapid hydrolytic release of formate from the imidazole ring and/or hydrolytic cleavage of the phosphodiester bond.	Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, D-85747 Garching, Germany	Technical University of Munich	Bacher, A (corresponding author), Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.							Bacher A, 1997, METHOD ENZYMOL, V280, P382; BLAU N, 1982, BIOCH CLIN ASPECTS P, V1, P103; Bracher A, 2001, BIOCHEMISTRY-US, V40, P7896, DOI 10.1021/bi010322v; Bracher A, 1999, J BIOL CHEM, V274, P16727, DOI 10.1074/jbc.274.24.16727; Brown G. M., 1987, ESCHERICHIA COLI SAL, V1, P521; DAWSON RCM, 1986, DATA BIOCH RES, P109; DIETRICH R, 1979, J AM CHEM SOC, V101, P6144, DOI 10.1021/ja00514a059; FOOR F, 1975, J BIOL CHEM, V250, P3545; KWON NS, 1989, J BIOL CHEM, V264, P20496; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729; Ritz H, 2001, J BIOL CHEM, V276, P22273, DOI 10.1074/jbc.M100752200; Schramek N, 2001, J BIOL CHEM, V276, P2622, DOI 10.1074/jbc.M004912200; TAYEH MA, 1989, J BIOL CHEM, V264, P19654	13	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44157	44162		10.1074/jbc.M107306200	http://dx.doi.org/10.1074/jbc.M107306200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11553632	hybrid			2022-12-27	WOS:000172297700086
J	Lopez-Corcuera, B; Nunez, E; Martinez-Maza, R; Geerlings, A; Aragon, C				Lopez-Corcuera, B; Nunez, E; Martinez-Maza, R; Geerlings, A; Aragon, C			Substrate-induced conformational changes of extracellular loop 1 in the glycine transporter GLYT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN TRANSPORTER; TRANSMEMBRANE DOMAIN; GABA TRANSPORTER; ION-BINDING; RAT-BRAIN; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; ACID TRANSPORTERS; RECOMBINANT GLYT1; COCAINE BINDING	The neurotransmitter glycine is removed from the synaptic cleft by two Na+-and Cl--dependent transporters, the glial (GLYT1) and neuronal (GLYT2) glycine transporters. GLYT2 lacks a conserved cysteine in the first hydrophilic loop (EL1) that is reactive to [2-(trimethylammonium)ethyl] methanethiosulfonate (MTSET) in related transporters. A chimeric GLYT2 (GLYT2a-EL1) that contains GLYT1 sequences in this region, including the relevant cysteine, was sensitive to the reagent, and its sensitivity was decreased by co-substrates. We combined cysteine-specific biotinylation to detect transporter-reagent interactions with MTSET inactivation assays and temperature dependence analysis to study the mechanism by which Cl-, Na+, and glycine reduce methanethiosulfonate reagent inhibition. We demonstrate a Na+ protective effect rather than an increased susceptibility to the reagent exerted by Li+, as reported for the serotonin transporter. The different inhibition, protection, and reactivation properties between GLYT2a-EL1 and serotonin transporter suggest that EL1 is a source of structural heterogeneity involved in the specific effect of lithium on serotonin transport. The protection by Na+ or Cl- on GLYT2a-EL1 was clearly dependent on temperature, suggesting that EL1 is not involved in ion binding but is subjected to ion-induced conformational changes. Na+ and Cl- were required for glycine protection, indicating the necessity of prior ion interaction with the transporter for the binding of glycine. We conclude that EL1 acts as a fluctuating hinge undergoing sequential conformational changes during the transport cycle.	Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Aragon, C (corresponding author), Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Maza, Rodrigo Martínez/ABH-3989-2020; Corcuera, Beatriz López/D-5188-2009; Aragon, Carmen/K-9783-2014	Maza, Rodrigo Martínez/0000-0002-7249-9205; Corcuera, Beatriz López/0000-0002-0383-4241; Aragon, Carmen/0000-0001-8287-9386				AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Barker EL, 1999, J NEUROSCI, V19, P4705; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borowsky B, 1998, J BIOL CHEM, V273, P29077, DOI 10.1074/jbc.273.44.29077; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; Hanley JG, 2000, J BIOL CHEM, V275, P840, DOI 10.1074/jbc.275.2.840; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Kamdar G, 2001, J BIOL CHEM, V276, P4038, DOI 10.1074/jbc.M008483200; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KESHET GI, 1995, FEBS LETT, V371, P39, DOI 10.1016/0014-5793(95)00859-8; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; LIU QR, 1993, J BIOL CHEM, V268, P22802; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Lopez-Corcuera B, 2001, MOL MEMBR BIOL, V18, P13, DOI 10.1080/09687680120521; Lopez-Corcuera B, 1998, J NEUROCHEM, V71, P2211; Mager S, 1996, J NEUROSCI, V16, P5405; Malandro MS, 1996, ANNU REV BIOCHEM, V65, P305; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Nelson N, 1998, J NEUROCHEM, V71, P1785; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; NUNEZ E, 1994, J BIOL CHEM, V269, P16920; Nunez E, 2000, BRIT J PHARMACOL, V129, P200, DOI 10.1038/sj.bjp.0703049; Nunez E, 2000, BRIT J PHARMACOL, V129, P802, DOI 10.1038/sj.bjp.0703100; OLIVARES L, 1995, J BIOL CHEM, V270, P9437, DOI 10.1074/jbc.270.16.9437; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Ponce J, 2000, J BIOL CHEM, V275, P13856, DOI 10.1074/jbc.275.18.13856; Ponce J, 1998, NEUROSCI LETT, V242, P25, DOI 10.1016/S0304-3940(98)00037-8; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Roux MJ, 2001, J BIOL CHEM, V276, P17699, DOI 10.1074/jbc.M009196200; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Simpson RK, 1995, NEUROCHEM RES, V20, P1203, DOI 10.1007/BF00995384; Sloan JL, 1999, J BIOL CHEM, V274, P23740, DOI 10.1074/jbc.274.34.23740; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; TAMURA S, 1995, J BIOL CHEM, V270, P28712, DOI 10.1074/jbc.270.48.28712; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; UHL GR, 1992, TRENDS PHARMACOL SCI, V13, P421, DOI 10.1016/0165-6147(92)90133-Q; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WERMAN R, 1967, NATURE, V214, P681, DOI 10.1038/214681a0; Yu N, 1998, FEBS LETT, V426, P174, DOI 10.1016/S0014-5793(98)00333-0; ZAFRA F, 1995, J NEUROSCI, V15, P3952	55	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43463	43470		10.1074/jbc.M107438200	http://dx.doi.org/10.1074/jbc.M107438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551961	hybrid			2022-12-27	WOS:000172169300107
J	Maurice, D; Pierreux, CE; Howell, M; Wilentz, RE; Owen, MJ; Hill, CS				Maurice, D; Pierreux, CE; Howell, M; Wilentz, RE; Owen, MJ; Hill, CS			Loss of Smad4 function in pancreatic tumors - C-terminal truncation leads to decreased stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; TRANSCRIPTIONAL ACTIVATION; MUTATIONAL INACTIVATION; SUPPRESSORS SMAD2; CRYSTAL-STRUCTURE; MAD PROTEINS; DPC4; GENE; DOMAIN	At early stages of tumorigenesis, the transforming growth factor-beta (TGF-beta) signaling pathway is thought to have tumor suppressor activity as a result of its ability to arrest the growth of epithelial cells. Smad4 plays a pivotal role in the TGF-beta signaling pathway and has been identified as a tumor suppressor, being mutated or deleted in similar to 50% of pancreatic carcinomas and 15% of colorectal cancers. A nonsense mutation generating a C-terminal truncation of 38 amino acids in the Smad4 protein has been identified in a pancreatic adenocarcinoma (Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. (1996) Science 271, 350-353), and here we investigate the functional consequences of this mutation. We demonstrate that the C-terminal truncation prevents Smad4 homomeric complex formation and heteromeric complex formation with activated Smad2. Furthermore, the mutant protein is unable to be recruited to DNA by transcription factors and hence cannot form transcriptionally active DNA-binding complexes. These observations are supported by molecular modeling, which indicates that the truncation removes residues critical for homomeric and heteromeric Smad complex formation. We go on to show that the mutant Smad4 is highly unstable compared with wild type Smad4 and is rapidly degraded through the ubiquitin-proteasome pathway. Consistent with this, we demonstrate that the pancreatic adenocarcinoma harboring this mutated allele, in conjunction with loss of the other allele, expresses no Smad4 protein. Thus we conclude that these tumors completely lack Smad4 activity.	Imperial Canc Res Fund, Lab Lymphocyte Mol Biol, London WC2A 3PX, England; Imperial Canc Res Fund, Lab Dev Signalling, London WC2A 3PX, England; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA	Cancer Research UK; Cancer Research UK; Johns Hopkins University; Johns Hopkins Medicine	Hill, CS (corresponding author), Imperial Canc Res Fund, Lab Lymphocyte Mol Biol, 44 Lincolns Inn Fields, London WC2A 3PX, England.	c.hill@icrf.icnet.uk	Maurice, Donald/AAE-9332-2019; Wilentz, Robb/AAJ-3857-2020	Howell, Michael/0000-0003-0912-0079; Hill, Caroline/0000-0002-8632-0480				Akhurst RJ, 1999, J PATHOL, V187, P82, DOI 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Duff EK, 1998, BRIT J CANCER, V78, P1615, DOI 10.1038/bjc.1998.731; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Germain S, 2000, GENE DEV, V14, P435; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Grady WM, 1999, CANCER RES, V59, P320; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hill CS, 2001, CURR OPIN GENET DEV, V11, P533, DOI 10.1016/S0959-437X(00)00229-X; Houlston R, 1998, HUM MOL GENET, V7, P1907, DOI 10.1093/hmg/7.12.1907; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howell M, 1999, DEV BIOL, V214, P354, DOI 10.1006/dbio.1999.9430; Howell M, 1997, EMBO J, V16, P7411, DOI 10.1093/emboj/16.24.7411; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Jonson T, 1999, GENE CHROMOSOME CANC, V24, P62, DOI 10.1002/(SICI)1098-2264(199901)24:1<62::AID-GCC9>3.0.CO;2-4; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Qin B, 1999, STRUCTURE, V7, P1493, DOI 10.1016/S0969-2126(00)88340-9; Reiss M, 1997, ONCOL RES, V9, P447; Riggins GJ, 1997, CANCER RES, V57, P2578; Schutte M, 1996, CANCER RES, V56, P2527; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shi YG, 2001, BIOESSAYS, V23, P223, DOI 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.3.CO;2-L; SMITH JC, 1993, EMBO J, V12, P4463, DOI 10.1002/j.1460-2075.1993.tb06135.x; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilentz RE, 2000, AM J PATHOL, V156, P37, DOI 10.1016/S0002-9440(10)64703-7; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Wong C, 1999, MOL CELL BIOL, V19, P1821; Woodford-Richens K, 2000, CANCER RES, V60, P2477; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0	51	71	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43175	43181		10.1074/jbc.M105895200	http://dx.doi.org/10.1074/jbc.M105895200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553622	hybrid			2022-12-27	WOS:000172169300071
J	Schaefer, LK; Wang, SG; Schaefer, TS				Schaefer, LK; Wang, SG; Schaefer, TS			Functional interaction of Jun and homeodomain proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SPECIFICITY; C-JUN; LEUCINE-ZIPPER; TRANSCRIPTION FACTORS; FOS JUN; NEGATIVE REGULATOR; CRYSTAL-STRUCTURE; RESPONSIVE GENES; NUCLEAR FACTOR; GROWTH-FACTORS	We have used the yeast two-hybrid system to identify proteins that interact with the N-terminal region of c-Jun, which is known to be involved in regulatory interactions. One of the proteins identified is the homeodomain-containing protein Hex. The Hex homeodomain is sufficient for interaction; moreover, the homeodomains of several other transcription factors also interact. Mutations within helix III of the Hex homeodomain greatly reduce the interaction. In vitro, c-Jun/c-Fos, JunB/c-Fos, and JunD/c-Fos all interact with the Hex homeodomain more strongly than the respective Jun proteins (or c-Fos) alone, suggesting that heterodimerization exposes reactive regions in the N termini of the Jun proteins. In transfected cells, Hex expression inhibits Jun- or Jun/cFos-dependent transcription of a reporter gene; the presence of Hex-binding sites in the promoter enhances the inhibitory effect. Jun-dependent activation of transcription from the basic fibroblast growth factor gene, previously shown to be regulated by both Jun and homeodomain proteins, was also dramatically reduced by Hex expression. Furthermore, in contrast to the reduction of Jun-mediated transcription by Hex, we found that expression of the Drosophila ultrabithorax gene enhanced c-Jun-dependent transcription. We conclude that the functional interaction between members of the Jun and homeodomain families of transcription factors could play a critical role in regulating developmental and differentiation programs.	Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schaefer, TS (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd,Box 064, Houston, TX 77030 USA.							AHEARN JM, 1987, J BIOL CHEM, V262, P10695; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; BEDFORD FK, 1993, NUCLEIC ACIDS RES, V21, P1245, DOI 10.1093/nar/21.5.1245; BENBROOK DM, 1990, ONCOGENE, V5, P295; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BREIER G, 1988, EMBO J, V7, P1329, DOI 10.1002/j.1460-2075.1988.tb02948.x; Care A, 1996, MOL CELL BIOL, V16, P4842; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; CURRAN T, 1992, TRANSCRIPTIONAL REGU, P797; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; ERDOS G, 1995, J CELL PHYSIOL, V164, P404, DOI 10.1002/jcp.1041640221; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; HROMAS R, 1993, BIOCHEM BIOPH RES CO, V195, P976, DOI 10.1006/bbrc.1993.2140; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; JONES DH, 1992, BIOTECHNIQUES, V12, P528; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200; KERPPOLA TK, 1994, ONCOGENE, V9, P675; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KORNFELD K, 1989, GENE DEV, V3, P243, DOI 10.1101/gad.3.2.243; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; LEMOUELLIC H, 1988, GENE DEV, V2, P125, DOI 10.1101/gad.2.1.125; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Miller H., 1972, EXPT MOL GENETICS; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; MOFFETT J, 1996, P NATL ACAD SCI USA, V93, P2770; MONTECLARO FS, 1993, P NATL ACAD SCI USA, V90, P6726, DOI 10.1073/pnas.90.14.6726; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RASONE L, 1993, GENE EXPRESSION, V3, P37; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1991, ONCOGENE, V6, P533; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P24; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; van der Eb A J, 1980, Methods Enzymol, V65, P826; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	66	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43074	43082		10.1074/jbc.M102552200	http://dx.doi.org/10.1074/jbc.M102552200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551904	hybrid			2022-12-27	WOS:000172169300059
J	Shakkottai, VG; Regaya, I; Wulff, H; Fajloun, Z; Tomita, H; Fathallah, M; Cahalan, MD; Gargus, JJ; Sabatier, JM; Chandy, KG				Shakkottai, VG; Regaya, I; Wulff, H; Fajloun, Z; Tomita, H; Fathallah, M; Cahalan, MD; Gargus, JJ; Sabatier, JM; Chandy, KG			Design and characterization of a highly selective peptide inhibitor of the small conductance calcium-activated K+ channel, SkCa2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-LYMPHOCYTES; POTASSIUM CHANNELS; SCORPION TOXIN; STRUCTURAL CONSERVATION; LEIUROTOXIN-I; APAMIN; CELLS; PHARMACOLOGY; AFFINITY; BRAIN	Apamin-sensitive small conductance calcium-activated potassium channels (SKCa1-3) mediate the slow afterhyperpolarization in neurons, but the molecular identity of the channel has not been defined because of the lack of specific inhibitors. Here we describe the structure-based design of a selective inhibitor of SKCa2. Leiurotoxin I (Lei) and PO5, peptide toxins that share the RXCQ motif, potently blocked human SKCa2 and SKCa3 but not SKCa1, whereas maurotoxin, Pi1, Tsk, and PO1 were ineffective. Lei blocked these channels more potently than PO5 because of the presence of Ala(1), Phe(2), and Met(7). By replacing Met(7) in the RXCQ motif of Lei with the shorter, unnatural, positively charged diaminobutanoic acid (Dab), we generated Lei-Dab(7), a selective SKCa2 inhibitor (K-d = 3.8 nM) that interacts with residues in the external vestibule of the channel. SKCa3 was rendered sensitive to Lei-Dab(7) by replacing His(521) with the corresponding SKCa2 residue (Asn(367)). Intracerebroventricular injection of Lei-Dab(7) into mice resulted in no gross central nervous system toxicity at concentrations that specifically blocked SKCa2 homotetramers. Lei-Dab(7) will be a useful tool to investigate the functional role of SKCa2 in mammalian tissues.	Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; Fac Med Nord, CNRS, Unite Mixte Rech 6560, F-13014 Marseille, France; Hop St Marguerite, INSERM, Assistance Publ Hop Marseille, CIC 9502, F-13009 Marseille, France	University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Shakkottai, VG (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Rm 291,Joan Irvine Smith Hall, Irvine, CA 92697 USA.	vshakkot@uci.edu	Fajloun, Ziad/AAO-8595-2021; wulff, Heike/Z-2056-2019; Regaya, Imed/L-7899-2018	Tomita, Hiroaki/0000-0003-2628-880X; SABATIER, Jean-Marc/0000-0002-9040-5647; Regaya, Imed/0000-0001-8671-5186	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059222] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59222] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Aiyar J, 1996, J BIOL CHEM, V271, P31013, DOI 10.1074/jbc.271.49.31013; Barfod ET, 2001, AM J PHYSIOL-CELL PH, V280, pC836, DOI 10.1152/ajpcell.2001.280.4.C836; Behrens B., 1934, ARCH EXP PATHOL PH, V177, P379; Chandy KG, 1998, MOL PSYCHIATR, V3, P32, DOI 10.1038/sj.mp.4000353; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; Desai R, 2000, J BIOL CHEM, V275, P39954, DOI 10.1074/jbc.M001562200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Empson RM, 2001, NEUROSCIENCE, V102, P297, DOI 10.1016/S0306-4522(00)00494-2; Fajloun Z, 2000, EUR J BIOCHEM, V267, P5149, DOI 10.1046/j.1432-1327.2000.01577.x; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Ghanshani S, 1998, GENOMICS, V51, P160, DOI 10.1006/geno.1998.5333; GRISSMER S, 1992, J GEN PHYSIOL, V99, P63, DOI 10.1085/jgp.99.1.63; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hanselmann C, 1996, J PHYSIOL-LONDON, V496, P627, DOI 10.1113/jphysiol.1996.sp021714; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jager H, 2000, FEBS LETT, V469, P196, DOI 10.1016/S0014-5793(00)01236-9; JENKINSON DH, 1983, CELL CALCIUM, V4, P429, DOI 10.1016/0143-4160(83)90019-2; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kimura T, 2000, NEUROSCI LETT, V295, P93, DOI 10.1016/S0304-3940(00)01598-6; Klocker N, 2001, MOL CELL NEUROSCI, V17, P514, DOI 10.1006/mcne.2000.0956; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Koschak A, 1998, J BIOL CHEM, V273, P2639, DOI 10.1074/jbc.273.5.2639; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MCCOWN TJ, 1990, EUR J PHARMACOL, V187, P49, DOI 10.1016/0014-2999(90)90339-8; MERRIFIELD B, 1986, SCIENCE, V232, P341, DOI 10.1126/science.3961484; Mourre C, 1997, BRAIN RES, V778, P405, DOI 10.1016/S0006-8993(97)01165-7; Nagayama T, 2000, AM J PHYSIOL-REG I, V279, pR1731, DOI 10.1152/ajpregu.2000.279.5.R1731; Paolocci N, 2001, CIRCULATION, V103, P119; Pribnow D, 1999, MUSCLE NERVE, V22, P742, DOI 10.1002/(SICI)1097-4598(199906)22:6<742::AID-MUS11>3.0.CO;2-1; Rajamohan F, 1996, P NATL ACAD SCI USA, V93, P14338, DOI 10.1073/pnas.93.25.14338; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Rimini R, 2000, MOL BRAIN RES, V85, P218, DOI 10.1016/S0169-328X(00)00255-2; SABATIER JM, 1994, INT J PEPT PROT RES, V43, P486; SABATIER JM, 1993, BIOCHEMISTRY-US, V32, P2763, DOI 10.1021/bi00062a005; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; Shah M, 2000, BRIT J PHARMACOL, V129, P627, DOI 10.1038/sj.bjp.0703111; Smith LA, 1997, BIOCHEMISTRY-US, V36, P7690, DOI 10.1021/bi963105g; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	50	95	109	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43145	43151		10.1074/jbc.M106981200	http://dx.doi.org/10.1074/jbc.M106981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11527975	hybrid			2022-12-27	WOS:000172169300067
J	Sokal, I; Li, N; Klug, CS; Filipek, S; Hubbell, WL; Baehr, W; Palczewski, K				Sokal, I; Li, N; Klug, CS; Filipek, S; Hubbell, WL; Baehr, W; Palczewski, K			Calcium-sensitive regions of GCAP1 as observed by chemical modifications, fluorescence, and EPR spectroscopies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING PROTEIN; PHOTORECEPTOR GUANYLATE-CYCLASE; OXIDASE SUBUNIT P47(PHOX); DOMINANT CONE DYSTROPHY; CENTRAL-NERVOUS-SYSTEM; RABBIT PSOAS MUSCLE; LOOP-GAP RESONATOR; BINDING PROTEIN; CONFORMATIONAL-CHANGES; ACETYLCHOLINE-RECEPTOR	Guanylyl cyclase-activating proteins are EF-hand Ca2+-binding proteins that belong to the calmodulin superfamily. They are involved in the regulation of photoreceptor membrane-associated guanylyl cyclases that produce cGMP, a second messenger of vertebrate vision. Here, we investigated changes in GCAP1 structure using mutagenesis, chemical modifications, and spectroscopic methods. Two Cys residues of GCAP1 situated in spatially distinct regions of the N-terminal domain (positions 18 and 29) and two Cys residues located within the C-terminal lobe (positions 106 and 125) were employed to detect conformational changes upon Ca2+ binding. GCAP1 mutants with only a single Cys residue at each of these positions, modified with N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine, an environmentally sensitive fluorophore, and with (1-oxy-2,2,5,5-tetramethylpyrroline-3-methyl)methanethiosulfonate, a spin label reagent, were studied using fluorescence and EPR spectroscopy, respectively. Only minor structural changes around Cys(18), Cys(29), Cys(106), and Cys(125) were observed as a function of Ca2+ concentration. No Ca2+-dependent oligomerization of GCAP1 was observed at physiologically relevant Ca2+ concentrations, in contrast to the observation reported by others for GCAP2. Based on these results and previous studies, we propose a photoreceptor activation model that assumes changes within the flexible central helix upon Ca2+ dissociation, causing relative reorientation of two structural domains containing a pair of EF-hand motifs and thus switching its partner, guanylyl cyclase, from an inactive (or low activity) to an active conformation.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Utah, Hlth Sci Ctr, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84112 USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Warsaw	Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.		Filipek, Slawomir/A-2985-2008	Filipek, Slawomir/0000-0003-3147-3858	NATIONAL EYE INSTITUTE [R01EY008123, R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY008123, R01 EY008061, EY08061, EY08123] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AJTAI K, 1989, BIOCHEMISTRY-US, V28, P2204, DOI 10.1021/bi00431a035; ALLEN DJ, 1989, BIOCHEMISTRY-US, V28, P9586, DOI 10.1021/bi00451a006; ALTENBACH C, 1989, BIOCHEMISTRY-US, V28, P7806, DOI 10.1021/bi00445a042; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; ANDLEY UP, 1985, CURR EYE RES, V4, P831, DOI 10.3109/02713688509095249; Bobkova EA, 1999, BIOPHYS J, V76, P1001, DOI 10.1016/S0006-3495(99)77264-4; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner B, 1999, BIOPHYS J, V77, P2677, DOI 10.1016/S0006-3495(99)77102-X; Brenner B, 1999, BIOPHYS J, V77, P2692, DOI 10.1016/S0006-3495(99)77103-1; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Dizhoor AM, 2000, CELL SIGNAL, V12, P711, DOI 10.1016/S0898-6568(00)00134-0; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; DUNN SMJ, 1993, BIOCHEMISTRY-US, V32, P8608, DOI 10.1021/bi00084a031; DUNN SMJ, 1983, BIOCHEMISTRY-US, V22, P2512, DOI 10.1021/bi00279a031; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; GETHER U, 1995, J BIOL CHEM, V270, P28268; GILARDI G, 1994, ANAL CHEM, V66, P3840, DOI 10.1021/ac00093a047; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Gordon AM, 1997, J MUSCLE RES CELL M, V18, P643, DOI 10.1023/A:1018631806182; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; GREENE LE, 1986, J BIOL CHEM, V261, P1279; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; HATAKENAKA S, 1985, BRAIN RES, V331, P209, DOI 10.1016/0006-8993(85)91546-X; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HIDAKA H, 1993, NEUROSCI RES, V16, P73, DOI 10.1016/0168-0102(93)90074-Z; HUANG MJ, 1994, J AM CHEM SOC, V116, P2515; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; KATAOKA M, 1993, J BIOCHEM-TOKYO, V114, P535, DOI 10.1093/oxfordjournals.jbchem.a124212; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; Kawamura S, 1996, J BIOL CHEM, V271, P21359, DOI 10.1074/jbc.271.35.21359; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; KOBAYASHI M, 1993, BIOCHEM BIOPH RES CO, V196, P1017, DOI 10.1006/bbrc.1993.2351; KOBAYASHI M, 1992, BIOCHEM BIOPH RES CO, V189, P511, DOI 10.1016/0006-291X(92)91587-G; Kojima K, 2001, J BIOL CHEM, V276, P2115, DOI 10.1074/jbc.M003111200; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li N, 1998, EUR J BIOCHEM, V252, P591, DOI 10.1046/j.1432-1327.1998.2520591.x; LI N, 2001, IN PRESS BIOL CHEM; LIANG JN, 1987, EXP EYE RES, V45, P197, DOI 10.1016/S0014-4835(87)80143-4; LIANG JN, 1987, CURR EYE RES, V6, P351, DOI 10.3109/02713688709025187; Lucas KA, 2000, PHARMACOL REV, V52, P375; MAPLE JR, 1994, J COMPUT CHEM, V15, P162, DOI 10.1002/jcc.540150207; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MIKI M, 1984, BIOCHIM BIOPHYS ACTA, V790, P275, DOI 10.1016/0167-4838(84)90032-3; Moon C, 1998, J NEUROSCI, V18, P3195; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park HS, 1999, BIOCHEM BIOPH RES CO, V259, P38, DOI 10.1006/bbrc.1999.0721; Park HS, 1998, ARCH BIOCHEM BIOPHYS, V360, P165, DOI 10.1006/abbi.1998.0938; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Phan BC, 1996, BIOPHYS CHEM, V59, P341, DOI 10.1016/0301-4622(95)00127-1; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; POLANS AS, 1995, P NATL ACAD SCI USA, V92, P9176, DOI 10.1073/pnas.92.20.9176; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SempleRowland SL, 1996, FEBS LETT, V385, P47, DOI 10.1016/0014-5793(96)00345-6; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Sokal I, 2000, BBA-MOL CELL RES, V1498, P233, DOI 10.1016/S0167-4889(00)00099-9; Sokal I, 1999, J BIOL CHEM, V274, P19829, DOI 10.1074/jbc.274.28.19829; Surguchov A, 1997, GENOMICS, V39, P312, DOI 10.1006/geno.1996.4513; TAKAMATSU K, 1993, NEUROSCI RES, V17, P291, DOI 10.1016/0168-0102(93)90112-4; TAKAMI K, 1985, NEUROSCIENCE, V15, P667, DOI 10.1016/0306-4522(85)90068-5; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TERASAWA M, 1992, J BIOL CHEM, V267, P19596; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y	87	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43361	43373		10.1074/jbc.M103614200	http://dx.doi.org/10.1074/jbc.M103614200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11524415	Green Accepted, hybrid			2022-12-27	WOS:000172169300095
J	Stephens, LR; Anderson, KE; Hawkins, PT				Stephens, LR; Anderson, KE; Hawkins, PT			Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVATION; SYK; PROTEIN; EXPRESSION; PRODUCTS; INSULIN; PATHWAY; DOMAINS	DAPP-1 ((d) under bar ual-(a) under bar daptor for (p) under bar hosphotyrosine and 3-(p) under bar hosphoinositides-(1) under bar) is a broadly distributed pleckstrin homology (PH) and Src homology 2 domain containing protein that can bind phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) and can be phosphorylated on tyrosine 139 and internalised in response to activation of type I phosphoinositide 3-kinases (PI3K). Tyrosine phosphorylation of DAPP-1 appears important for appropriate intracellular targeting and creates a potential binding site for Src homology 2 domain-containing proteins. In endothelial cells overexpressing wild-type platelet-derived growth factor beta (PDGF beta) receptors, which express Bmx and Src as their major Btk ((B) under bar ruton's (t) under bar yrosine (k) under bar inase) family and Src family tyrosine kinases, respectively, PDGF can stimulate PI3K-dependent tyrosine phosphorylation of DAPP-1. Transient overexpression of Src most effectively, compared with Bmx and Syk, augments basal and PDGF-stimulated tyrosine phosphorylation of DAPP-1, whereas overexpression of dominant-negative Src, but not dominant-negative Bmx, inhibits PDGF-stimulated phosphorylation of DAPP-1. Cells expressing mutant PDGF beta (Y579F/Y581F) receptors (which fail to bind and activate Src-type kinases) fail to tyrosine phosphorylate DAPP-1 in response to PDGF. We show that in DT40 chicken B cell lines, antibody stimulation leads to PI3K-dependent tyrosine phosphorylation of DAPP-1 that is lost in Lyn- or Syk-deficient cell lines but not Btk-deficient cell lines. PI3K-dependent activation of PKB is only lost in Syk-deficient lines. Finally, in vitro we find lipid-modified Src to be the most effective DAPP-1 tyrosine kinase (versus Syk, Lyn, Btk, and Bmx); phosphorylation of DAPP-1 but not Src autophosphorylation is stimulated similar to 10-fold by PtdIns(3,4,5)P-3 (IC50 = 150 nM) and phosphatidylinositol 3,4-bisphosphate but not by their nonbiological diastereoisomers and depends on PH domain mediated binding of DAPP-1 to PtdIns(3,4,5)P-3-containing membranes. We conclude that Src family kinases are responsible for tyrosine phosphorylation of DAPP-1 in vivo and that PI3K regulation is at the level of PH domain-mediated translocation of DAPP-1 to PI3K products in the membrane.	Babraham Inst, Signalling Program, Inositide Lab, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stephens, LR (corresponding author), Babraham Inst, Signalling Program, Inositide Lab, Cambridge CB2 4AT, England.			Hawkins, Phillip/0000-0002-6979-0464; Anderson, Karen/0000-0002-7394-6660; stephens, len/0000-0002-2771-3487				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson KE, 2000, CURR BIOL, V10, P1403, DOI 10.1016/S0960-9822(00)00794-6; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Dowler S, 2000, BIOCHEM J, V349, P605, DOI 10.1042/0264-6021:3490605; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Gold MR, 1999, J IMMUNOL, V163, P1894; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; KHARLUND JK, 1998, J BIOL CHEM, V273, P1859; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Marshall AJ, 2000, J EXP MED, V191, P1319, DOI 10.1084/jem.191.8.1319; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Painter GF, 1999, J CHEM SOC PERK T 1, P923, DOI 10.1039/a900278b; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rao VR, 1999, J BIOL CHEM, V274, P37893, DOI 10.1074/jbc.274.53.37893; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X	29	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42767	42773		10.1074/jbc.M107194200	http://dx.doi.org/10.1074/jbc.M107194200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11524430	hybrid			2022-12-27	WOS:000172169300019
J	Engers, R; Springer, E; Michiels, F; Collard, JG; Gabbert, HE				Engers, R; Springer, E; Michiels, F; Collard, JG; Gabbert, HE			Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; MATRIX-METALLOPROTEINASE; EPITHELIAL-CELLS; I COLLAGEN; RHO; ADHESION; KINASE; GENE; INVASIVENESS; METASTASIS	Rho-like GTPases, including Cdc42, Rac1, and RhoA, regulate distinct actin cytoskeleton changes required for adhesion, migration, and invasion of cells. Tiam1 specifically activates Rac, and earlier studies have demonstrated that Tiam1-Rac signaling affects migration and invasion in a cell type- and cell substrate-specific manner. In the present study, we examined the role of Tiam1-Rac signaling in migration and invasion of human renal cell carcinomas. Stable overexpression of Tiam1 or constitutively active V12-Rac1 in a human renal cell carcinoma cell line (clearCa-28) strongly inhibited cell migration by promoting E-cadherin-mediated cell-cell adhesion. Blocking E-cadherin-mediated adhesion by E-cadherin-specific HAV peptides allowed cells to migrate, but was not sufficient to antagonize Tiam1- and V12-Rac1-induced inhibition of Matrigel invasion, suggesting that Rac may influence invasion also through other mechanisms. Indeed, Tiam1-mediated Rac activation induced transcriptional up-regulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) and post-transcriptional up-regulation of TIMP-2, whereas secretion and activity levels of their counterparts, matrix metalloproteinase-9 and matrix metalloproteinase-2, respectively, were not affected. Application of recombinant TIMP-1 and TIMP-2 proteins significantly inhibited invasion of mock-transfected clearCa-28 cells, supporting a role of TIMPs in Rac-mediated inhibition of invasion. To our knowledge, this is the first evidence that increased Rac signaling may inhibit invasion of epithelial tumor cells by up-regulation of TIMP-1 and TIMP-2.	Univ Dusseldorf, Inst Pathol, D-40225 Dusseldorf, Germany; Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Heinrich Heine University Dusseldorf; Netherlands Cancer Institute	Engers, R (corresponding author), Univ Dusseldorf, Inst Pathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	engers@med.uni-duesseldorf.de						Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Bigg HF, 1997, J BIOL CHEM, V272, P15496, DOI 10.1074/jbc.272.24.15496; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; Cockett MI, 1998, BIOCHEM SOC SYMP, P295; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Engers R, 2000, J CANCER RES CLIN, V126, P682, DOI 10.1007/s004320000148; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Engers R, 1999, INT J CANCER, V80, P406, DOI 10.1002/(SICI)1097-0215(19990129)80:3<406::AID-IJC12>3.0.CO;2-L; Engers R, 1996, BRIT J CANCER, V73, P491, DOI 10.1038/bjc.1996.86; Evers EE, 2000, METHOD ENZYMOL, V325, P403; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gjoerup O, 1998, J BIOL CHEM, V273, P18812, DOI 10.1074/jbc.273.30.18812; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hammani K, 1996, J BIOL CHEM, V271, P25498, DOI 10.1074/jbc.271.41.25498; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; Li YY, 1999, CARDIOVASC RES, V42, P162, DOI 10.1016/S0008-6363(98)00297-1; MAREEL MM, 1993, CRIT REV ONCOGENESIS, V4, P559; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Quirin N, 1999, J CELL PHYSIOL, V180, P372, DOI 10.1002/(SICI)1097-4652(199909)180:3<372::AID-JCP8>3.0.CO;2-G; RAY JM, 1994, EUR RESPIR J, V7, P2062; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Wang MS, 1997, ONCOGENE, V14, P2767, DOI 10.1038/sj.onc.1201245; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	51	88	101	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41889	41897		10.1074/jbc.M105049200	http://dx.doi.org/10.1074/jbc.M105049200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551917	hybrid			2022-12-27	WOS:000172450400047
J	Gumbiowski, K; Cherepanov, D; Muller, M; Panke, O; Promto, P; Winkler, S; Junge, W; Engelbrecht, S				Gumbiowski, K; Cherepanov, D; Muller, M; Panke, O; Promto, P; Winkler, S; Junge, W; Engelbrecht, S			F-ATPase: Forced full rotation of the rotor despite covalent cross-link with the stator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; C-SUBUNIT OLIGOMER; COUPLING FACTOR-I; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; GAMMA-SUBUNIT; EPSILON-SUBUNIT; SYNTHASE; F-1-ATPASE; F1-ATPASE	In ATP synthase (F0F1-ATPase) ion flow through the membrane-intrinsic portion, Fo, drives the central "rotor", subunits c(10)epsilon gamma, relative to the "stator" ab(2)delta(alpha beta)(3). This converts ADP and P-i into ATP. Vice versa, ATP hydrolysis drives the rotation backwards. Covalent cross-links between rotor and stator subunits have been shown to inhibit these activities. Aiming at the rotary compliance of subunit gamma we introduced disulfide bridges between gamma (rotor) and a or beta (stator). We engineered cysteine residues into positions located roughly at the "top," "center," and "bottom" parts of the coiled-coil portion of gamma and suitable residues on alpha or beta. This part of gamma is located at the center of the (alpha beta)(3) domain with its C-terminal part at the top of F-1 and the bottom part close to the F-0 complex. Disulfide bridge formation under oxidizing conditions was quantitative as shown by SDS-polyacrylamide gel electrophoresis and immunoblotting. As expected both the ATPase activities and the yield of rotating subunits gamma dropped to zero when the cross-link was formed at the center (gamma L262C <----> alpha A334C) and bottom (,gamma Cys(87) <----> beta D380C) positions. But much to our surprise disulfide bridging impaired neither ATP hydrolysis activity nor the full rotation of gamma and the enzyme-generated torque of oxidized F-1, which had been engineered at the top position (gamma A285C <----> alpha P280C). Apparently the high torque of this rotary engine uncoiled the a-helix and forced amino acids at the C-terminal portion of gamma into full rotation around their dihedral (Ramachandran) angles. This conclusion was supported by molecular dynamics simulations: If gamma Cys(285)-Val(286) are attached covalently to (alpha beta )3 and gamma Ala(1)-Ser(281) is forced to rotate, gamma GlY(282)-Ala(284) can serve as cardan shaft.	Univ Osnabruck, FB Biol, Abt Biophys, D-49069 Osnabruck, Germany	University Osnabruck	Engelbrecht, S (corresponding author), Univ Osnabruck, FB Biol, Abt Biophys, Barbarastr 11, D-49069 Osnabruck, Germany.		Cherepanov, Dmitry A./R-8391-2016	Cherepanov, Dmitry A./0000-0001-6286-4638				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1992, X PLOR VERSION 3 1; Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Dalke A, 1997, Pac Symp Biocomput, P85; DARAGAN VA, 1993, BIOCHEMISTRY-US, V32, P11488, DOI 10.1021/bi00094a004; DOWNER NW, 1976, BIOCHEMISTRY-US, V15, P2930, DOI 10.1021/bi00658a036; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Engelbrecht S, 1997, FEBS LETT, V414, P485, DOI 10.1016/S0014-5793(97)00997-6; Fillingame RH, 2000, NAT STRUCT BIOL, V7, P1002, DOI 10.1038/80902; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KRAUSE I, 1987, 5 MINUTE SILVER STAI; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; MORONEY JV, 1984, J BIOL CHEM, V259, P7281; MUSIER KM, 1987, BIOCHEMISTRY-US, V26, P5982, DOI 10.1021/bi00393a006; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; RANKIN W, 2001, IN PRESS I EL EL ENG; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SCHREIBER H, 1992, BIOCHEMISTRY-US, V31, P5856, DOI 10.1021/bi00140a022; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WISE JG, 1990, J BIOL CHEM, V265, P10403; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zhou YT, 1996, BBA-BIOENERGETICS, V1275, P96, DOI 10.1016/0005-2728(96)00056-4	42	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42287	42292		10.1074/jbc.M106884200	http://dx.doi.org/10.1074/jbc.M106884200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533065	hybrid			2022-12-27	WOS:000172450400099
J	Kanzaki, M; Pessin, JE				Kanzaki, M; Pessin, JE			Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOSE-TRANSPORTER; SUBCELLULAR TRAFFICKING; 3T3-L1 ADIPOCYTES; RHO-PROTEINS; KINASE; FILAMENTS; MEMBRANE; RAC	Rhodamine-labeled phalloidin staining of morphologically differentiated 3T3L1 adipocytes demonstrated that F-actin predominantly exists juxtaposed to and lining the inner face of the plasma membrane (cortical actin) with a smaller amount of stress fiber and/or ruffling actin confined to the cell bottom in contact with the substratum. The extent of cortical actin disruption with various doses of either latrunculin B or Clostridium difficile toxin B (a Rho family small GTP-binding protein toxin) directly correlated with the inhibition of insulin-stimulated glucose uptake and GLUT4 translocation. The dissolution of the cortical actin network had no significant effect on proximal insulin receptor signaling events including insulin receptor autophosphorylation, tyrosine phosphorylation of insulin receptor substrate and Cb1, or serine/threonine phosphorylation of Akt. Surprisingly, however, stabilization of F-actin with jasplakinolide also resulted in a dose-dependent inhibition of insulin-stimulated glucose uptake and GLUT4 translocation. In vivo time-lapse confocal fluorescent microscopy of actin-yellow fluorescent protein demonstrated that insulin stimulation initially results in cortical actin remodeling followed by an increase in polymerized actin in the peri-nuclear region. Importantly, the insulin stimulation of cortical actin rearrangements was completely blocked by treatment of the cells with latrunculin B, C. difficile toxin B, and jasplakinolide. Furthermore, expression of the dominant-interfering TC10/T31N mutant completely disrupted cortical actin and prevents any insulin-stimulated actin remodeling. Together, these data demonstrate that cortical actin, but not stress fibers, lamellipodia, or filopodia, plays an important regulatory role in insulin-stimulated GLUT4 translocation. In addition, cortical F-actin does not function in a static manner (e.g. barrier or scaffold), but insulin-stimulated dynamic cortical actin remodeling is necessary for the GLUT4 translocation process.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Pessin, JE (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	Jeffrey-Pessin@uiowa.edu	Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955	NIDDK NIH HHS [DK33823, DK25295, DK59291] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033823, P30DK025295, R01DK033823, R01DK059291] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANG Q, 1999, MOL CELL BIOL, V19, P4008; Ballestrem C, 1998, J CELL SCI, V111, P1649; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Carbajal ME, 1997, ENDOCRINOLOGY, V138, P5374, DOI 10.1210/en.138.12.5374; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; CZECH MP, 1993, J BIOL CHEM, V268, P9187; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Dorrestijn J, 1996, DIABETOLOGIA, V39, P558, DOI 10.1007/s001250050478; Dorrestijn J, 1997, EXP CLIN ENDOCR DIAB, V105, P254, DOI 10.1055/s-0029-1211762; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; JHUN BH, 1992, J BIOL CHEM, V267, P17710; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KADOWAKI T, 1986, J BIOL CHEM, V261, P6141; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kandror KV, 1996, AM J PHYSIOL-ENDOC M, V271, pE1, DOI 10.1152/ajpendo.1996.271.1.E1; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052, DOI 10.1128/MCB.13.10.6052; Khayat ZA, 2000, J CELL SCI, V113, P279; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V208, P985, DOI 10.1006/bbrc.1995.1431; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; LELKES PI, 1986, FEBS LETT, V208, P357, DOI 10.1016/0014-5793(86)81049-3; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Machesky LM, 1999, NAT CELL BIOL, V1, pE29, DOI 10.1038/10020; MARCUSOHN J, 1995, CURR BIOL, V5, P1296, DOI 10.1016/S0960-9822(95)00256-9; Martin MAE, 1999, CELL MOL LIFE SCI, V56, P200, DOI 10.1007/s000180050422; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; MATTER K, 1989, J NEUROCHEM, V52, P370, DOI 10.1111/j.1471-4159.1989.tb09131.x; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; MORITA K, 1988, BIOCHEM PHARMACOL, V37, P3357; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; OKONSKI MS, 1990, J CLIN INVEST, V86, P1649, DOI 10.1172/JCI114887; OKONSKI MS, 1993, PANCREAS, V8, P638, DOI 10.1097/00006676-199309000-00018; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Peyrollier K, 2000, BIOCHEM J, V352, P617, DOI 10.1042/0264-6021:3520617; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schroer T A, 1992, Curr Opin Neurobiol, V2, P618, DOI 10.1016/0959-4388(92)90028-J; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Simpson F, 2001, TRAFFIC, V2, P2, DOI 10.1034/j.1600-0854.2001.020102.x; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Terada S, 2000, CURR OPIN NEUROBIOL, V10, P566, DOI 10.1016/S0959-4388(00)00129-X; TSAKIRIDIS T, 1995, BIOCHEM J, V309, P1; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Tsakiridis T, 1998, J BIOL CHEM, V273, P28322, DOI 10.1074/jbc.273.43.28322; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Vollenweider P, 1999, MOL CELL BIOL, V19, P1081; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; YANG J, 1993, J BIOL CHEM, V268, P4600	82	232	242	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42436	42444		10.1074/jbc.M108297200	http://dx.doi.org/10.1074/jbc.M108297200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546823	hybrid			2022-12-27	WOS:000172450400115
J	Liberati, C; Cera, MR; Secco, P; Santoro, C; Mantovani, R; Ottolenghi, S; Ronchi, A				Liberati, C; Cera, MR; Secco, P; Santoro, C; Mantovani, R; Ottolenghi, S; Ronchi, A			Cooperation and competition between the binding of COUP-TFII and NF-Y on human epsilon- and gamma-globin gene promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTAL CCAAT BOX; GREEK HEREDITARY PERSISTENCE; NUCLEAR FACTOR-Y; MHC CLASS-II; FETAL HEMOGLOBIN; TRANSCRIPTIONAL ACTIVATION; TRANSGENIC MICE; ACTIVE REPRESSION; ERYTHROID-CELLS; POINT MUTATION	The nuclear receptor COUP-TFII was recently shown to bind to the promoter of the epsilon- and gamma -globin genes and was identified as the nuclear factor NF-E3. Transgenic experiments and genetic evidence from humans affected with hereditary persistence of fetal hemoglobin suggest that NF-E3 may be a repressor of adult epsilon and gamma expression. We show that, on the epsilon -promoter, recombinant COUP-TFII binds to two sites, the more downstream of which overlaps with an NF-Y binding CCAAT box. Binding occurs efficiently to either the 5' or the 3' COUP-TFII site but not to both sites simultaneously. However, adding recombinant NF-Y induces the formation of a stable COUP-(TFIINF)-N-.-Y-promoter complex at concentrations of COUP-TFII that would not give significant binding in the absence of NF-Y. Mutations of the promoter indicate that COUP-TFII cooperates with NF-Y when bound to the 5' site, whereas binding at the 3' site is mutually exclusive. Likewise, in the gamma -promoter, COUP-TFII binds to a site overlapping the distal member of a duplicated CCAAT box, competing with NF-Y binding. Transfections in K562 cells show that both the mutation of the 5' COUP-TFII or of the NF-Y site on the epsilon -promoter decrease the activity of a luciferase reporter; the mutation of the 3' COUP-TFII site has little effect. These results, together with transgenic experiments suggesting a repressive activity of COUP-TFII on the epsilon -promoter and the observation that, on the 3' site, COUP-TFII and NF-Y binding is mutually exclusive, suggest that COUP-TFII may exert different effects on epsilon transcription depending on whether it binds to the 5' or to the 3' site. At the 5' site, COUP-TFII might cooperate with NF-Y, forming a stable complex, and stimulate transcription; at the 3' site, COUP-TFII might compete for binding with NF-Y and, directly or indirectly, decrease gene activity.	Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy; Univ Piemonte Orientale A Avogadro, Dipartimento Sci Med, I-28100 Novara, Italy; Univ Modena, Dipartimento Biol Anim, I-41100 Modena, Italy	University of Milano-Bicocca; University of Eastern Piedmont Amedeo Avogadro; Universita di Modena e Reggio Emilia	Ronchi, A (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy.		santoro, claudio/G-6819-2012		Telethon [E.0596] Funding Source: Medline	Telethon(Fondazione Telethon)		Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Bailey PJ, 1997, J STEROID BIOCHEM, V63, P165, DOI 10.1016/S0960-0760(97)00079-4; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Caretti G, 2000, J MOL BIOL, V302, P539, DOI 10.1006/jmbi.2000.4028; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Falck J, 1999, J BIOL CHEM, V274, P18753, DOI 10.1074/jbc.274.26.18753; Filipe A, 1999, EMBO J, V18, P687, DOI 10.1093/emboj/18.3.687; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; FUCHAROEN S, 1990, NUCLEIC ACIDS RES, V18, P5245, DOI 10.1093/nar/18.17.5245; GE RW, 1994, J BIOL CHEM, V269, P13185; GELINAS R, 1985, NATURE, V313, P323, DOI 10.1038/313323a0; GILMAN JG, 1988, NUCLEIC ACIDS RES, V16, P10635, DOI 10.1093/nar/16.22.10635; Glass CK, 2000, GENE DEV, V14, P121; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; INDRAK K, 1991, ANN HEMATOL, V63, P1; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Jackson SM, 1998, J LIPID RES, V39, P767; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kelly D, 1998, J BIOL CHEM, V273, P21115, DOI 10.1074/jbc.273.33.21115; Leng X, 1996, MOL CELL BIOL, V16, P2332; Liberati C, 1998, J BIOL CHEM, V273, P16880, DOI 10.1074/jbc.273.27.16880; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1992, EMBO J, V11, P3315, DOI 10.1002/j.1460-2075.1992.tb05410.x; MANTOVANI R, 1989, NUCLEIC ACIDS RES, V17, P6681, DOI 10.1093/nar/17.16.6681; MILOS PM, 1992, GENE DEV, V6, P991, DOI 10.1101/gad.6.6.991; MOTUM PI, 1994, BRIT J HAEMATOL, V86, P219, DOI 10.1111/j.1365-2141.1994.tb03284.x; NEY P, 1990, GENE DEV, V4, P93; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; OTTOLENGHI S, 1989, HEMOGLOBIN, V13, P523, DOI 10.3109/03630268908993104; PAULWEBER B, 1993, MOL CELL BIOL, V13, P1534, DOI 10.1128/MCB.13.3.1534; PERKINS AC, 1995, NATURE, V375, P318; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Power SC, 1996, MOL CELL BIOL, V16, P778; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Ronchi A, 1996, EMBO J, V15, P143, DOI 10.1002/j.1460-2075.1996.tb00342.x; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934; Smirnov DA, 2000, VIROLOGY, V268, P319, DOI 10.1006/viro.1999.0181; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; Tanimoto K, 2000, GENE DEV, V14, P2778, DOI 10.1101/gad.822500; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Villard J, 2000, MOL CELL BIOL, V20, P3364, DOI 10.1128/MCB.20.10.3364-3376.2000; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Weatherall DJ, 1981, THALASSEMIA SYNDROME; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zertal-Zidani S, 1999, HEMOGLOBIN, V23, P159, DOI 10.3109/03630269908996160	58	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41700	41709		10.1074/jbc.M102987200	http://dx.doi.org/10.1074/jbc.M102987200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11544252	hybrid, Green Published			2022-12-27	WOS:000172450400023
J	Senoo-Matsuda, N; Yasuda, K; Tsuda, M; Ohkubo, T; Yoshimura, S; Nakazawa, H; Hartman, PS; Ishii, N				Senoo-Matsuda, N; Yasuda, K; Tsuda, M; Ohkubo, T; Yoshimura, S; Nakazawa, H; Hartman, PS; Ishii, N			A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; ONSET OPTIC ATROPHY; OXIDATIVE STRESS; SUCCINATE-DEHYDROGENASE; SENSITIVE MUTANT; DEFICIENCY; OXYGEN; MUTATION; GENE; PARAGANGLIOMA	A mev-1(kn1) mutant of the nematode Caenorhabditis elegans is defective in the cytochrome b large subunit (Cyt-1/ceSDHC) in complex II of the mitochondrial electron transport chain. We have previously shown that a mutation in mev-1 causes shortened life span and rapid accumulation of aging markers such as fluorescent materials and protein carbonyls in an oxygen-dependent fashion. However, it remains unclear as to whether this hypersensitivity is caused by direct toxicity of the exogenous oxygen or by the damage of endogenous reactive oxygen species derived from mitochondria. Here we report important biochemical changes in mev-1 animals that serve to explain their abnormalities under normoxic conditions: (i) an overproduction of superoxide anion from mitochondria; and (ii) a reciprocal reduction in glutathione content even under atmospheric oxygen. In addition, unlike wild type, the levels of superoxide anion production from mev-1 mitochondria were significantly elevated under hyperoxia. Under normal circumstances, it is well known that superoxide anion is produced at complexes I and III in the electron transport system. Our data suggest that the mev-1(kn1) mutation increases superoxide anion production at complex II itself rather than at complexes I and III. The mev-1 mutant also had a lactate level 2-fold higher than wild type, indicative of lactic acidosis, a hallmark of human mitochondrial diseases. These data indicate that Cyt-1/ceSDHC plays an important role not only in energy metabolism but also in superoxide anion production that is critically involved in sensitivity to atmospheric oxygen.	Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591193, Japan; Tokai Univ, Sch Med, Dept Physiol, Kanagawa 2591193, Japan; Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA	Tokai University; Tokai University; Texas Christian University	Ishii, N (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591193, Japan.		Yasuda, Kayo/ABA-5867-2021	Yasuda, Kayo/0000-0002-6205-9249				Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; ANDERSON AE, 1985, HDB METHODS OXYGEN R, P317; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BOURGEOIS M, 1992, BRAIN DEV-JPN, V14, P404, DOI 10.1016/S0387-7604(12)80349-4; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3; FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7, DOI 10.1152/ajpgi.1997.273.1.G7; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; Howell N, 1999, INT REV CYTOL, V186, P49; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; MARTIN JJ, 1988, J NEUROL SCI, V84, P189, DOI 10.1016/0022-510X(88)90124-4; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; RIGGS JE, 1984, NEUROLOGY, V34, P48, DOI 10.1212/WNL.34.1.48; RIVNER MH, 1989, NEUROLOGY, V39, P693, DOI 10.1212/WNL.39.5.693; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Taylor RW, 1996, ANN NEUROL, V39, P224, DOI 10.1002/ana.410390212; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916	31	209	219	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41553	41558		10.1074/jbc.M104718200	http://dx.doi.org/10.1074/jbc.M104718200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527963	hybrid			2022-12-27	WOS:000172450400004
J	Stromhaug, PE; Bevan, A; Dunn, WA				Stromhaug, PE; Bevan, A; Dunn, WA			GSA11 encodes a unique 208-kDa protein required for pexophagy and autophagy in Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST HANSENULA-POLYMORPHA; PEROXISOME-DEFICIENT MUTANTS; VACUOLE TARGETING PATHWAY; ISOLATED RAT HEPATOCYTES; SACCHAROMYCES-CEREVISIAE; SELECTIVE INACTIVATION; CONJUGATION SYSTEM; VESICLE FORMATION; CVT PATHWAY; DEGRADATION	Cells are capable of adapting to changes in their environment by synthesizing needed proteins and degrading superfluous ones. Pichia pastoris synthesizes peroxisomal enzymes to grow in methanol medium. Upon adapting from methanol medium to one containing glucose, this yeast rapidly and selectively degrades peroxisomes by an autophagic process referred to as pexophagy. In this study, we have utilized a novel approach to identify genes required for this degradative pathway. Our approach involves the random integration of a vector containing the Zeocin resistance gene into the yeast genome by restriction enzyme-mediated integration. Cells unable to degrade peroxisomes during glucose adaptation were isolated, and the genes that were disrupted by the insertion of the vector were determined by sequencing. By using this approach, we have identified a number of genes required for glucose-induced selective autophagy of peroxisomes (GSA genes). We report here the characterization of Gsa11, a unique 208-kDa protein. We found that this protein is required for glucose-induced pexophagy and starvation-induced autophagy. Gsa11 is a cytosolic protein that becomes associated with one or more structures situated near the vacuole during glucose adaptation. The punctate localization of Gsa11 was not observed in gsa10, gsa12, gsa14, and gsa19 mutants. We have previously shown that Gsa9 appears to relocate from a compartment at the vacuole surface to regions between the vacuole and the peroxisomes being sequestered. In the gsa11 mutants, the vacuole only partially surrounded the peroxisomes, but Gsa9 was still distributed around the peroxisome cluster. This suggests that Gsa9 binds to the peroxisomes independent of the vacuole. The data also indicate that Gsa11 is not necessary for Gsa9 to interact with peroxisomes but acts at an intermediate event required for the vacuole to engulf the peroxisomes.	Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Norwegian Radium Hosp, Dept Cell Biol, Inst Canc Res, N-0310 Oslo, Norway	State University System of Florida; University of Florida; University of Oslo	Bevan, A (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.							Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; Holtzman E, 1989, LYSOSOMES; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Hutchins MU, 1999, J CELL SCI, V112, P4079; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kiel JAKW, 1999, YEAST, V15, P741, DOI 10.1002/(SICI)1097-0061(19990630)15:9<741::AID-YEA416>3.0.CO;2-O; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 1997, J MEMBRANE BIOL, V157, P105, DOI 10.1007/s002329900220; Klionsky DJ, 1998, J BIOL CHEM, V273, P10807, DOI 10.1074/jbc.273.18.10807; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; LARDEUX BR, 1987, J BIOL CHEM, V262, P14514; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LUIKEN JJFP, 1992, FEBS LETT, V304, P93, DOI 10.1016/0014-5793(92)80596-9; Marzella L, 1987, LYSOSOMES THEIR ROLE, P319; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; MORTIMORE GE, 1983, P NATL ACAD SCI-BIOL, V80, P2179, DOI 10.1073/pnas.80.8.2179; MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Planta RJ, 1999, YEAST, V15, P329, DOI 10.1002/(SICI)1097-0061(19990315)15:4<329::AID-YEA360>3.0.CO;2-C; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Saiz JE, 1999, YEAST, V15, P155, DOI 10.1002/(SICI)1097-0061(19990130)15:2<155::AID-YEA342>3.0.CO;2-U; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Sattler T, 2000, J CELL BIOL, V151, P529, DOI 10.1083/jcb.151.3.529; Schlumpberger M, 1997, J BACTERIOL, V179, P1068, DOI 10.1128/jb.179.4.1068-1076.1997; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Seglen PO, 1996, ADV EXP MED BIOL, V389, P103; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Snyder WB, 1999, MOL BIOL CELL, V10, P4005, DOI 10.1091/mbc.10.12.4005; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stasyk OV, 1999, CURR GENET, V36, P262, DOI 10.1007/s002940050499; Straub M, 1997, J BACTERIOL, V179, P3875, DOI 10.1128/jb.179.12.3875-3883.1997; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; TUTTLE DL, 1995, J CELL SCI, V108, P25; VANDERKLEI IJ, 1991, YEAST, V7, P813, DOI 10.1002/yea.320070806; Veenhuis M, 1996, FEBS LETT, V383, P114, DOI 10.1016/0014-5793(96)00220-7; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; Veenhuis M, 2000, MICROSC RES TECHNIQ, V51, P584, DOI 10.1002/1097-0029(20001215)51:6<584::AID-JEMT8>3.0.CO;2-W; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Yuan WP, 1997, J CELL SCI, V110, P1935; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353	71	52	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42422	42435		10.1074/jbc.M104087200	http://dx.doi.org/10.1074/jbc.M104087200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533052	hybrid			2022-12-27	WOS:000172450400114
J	Takeda, M; Dohmae, N; Takio, K; Arai, K; Watanabe, S				Takeda, M; Dohmae, N; Takio, K; Arai, K; Watanabe, S			Cell cycle-dependent interaction of Mad2 with conserved box1/2 region of human granulocyte-macrophage colony-stimulating factor receptor common beta c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN MAD2; CYCLOSOME/ANAPHASE-PROMOTING COMPLEX; GROWTH SIGNAL-TRANSDUCTION; SPINDLE CHECKPOINT; BUDDING YEAST; TYROSINE PHOSPHORYLATION; INSULIN-RECEPTOR; MITOTIC ARREST; GM-CSF; ACTIVATION	Box1 and 2 (box1/2) are conserved cytoplasmic motifs located in the membrane proximal region of cytokine receptors, including the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor common betac. Deletion of box1/2 abrogated all the examined activities of GM-CSF, and this phenomenon is explained by the loss of binding by Jak2. To test if a molecule other than Jak2 interacting with the box1/2 region plays a role in GM-CSF receptor signal transduction, we screened for molecules interacting with the box1/2 region by a pull-down assay using recombinant purified protein of GST fused with the betac box1/2 region and a Ba/F3 cell lysate. The mouse homologue of Mad2 protein, which plays an important role in the M phase of the cell cycle, was revealed to associate with the box1/2 region specifically. Peptides corresponding to the box1 sequence also bound to Mad2, and mutation of the box1 decreased the Mad2 interaction. Deletion analysis indicated that interaction with box1/2 occurred through the C-terminal portion of Mad2. Mad2 is known to change affinity for binding partners cell cycle dependently. Binding affinity of Mad2 to box1/2 increased in the late M phase, suggesting the possibility that GM-CSF participates in regulation of the M phase check point through interaction with Mad2.	Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Japan Sci & Technol Corp, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Biomol Characterizat Div, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; RIKEN	Watanabe, S (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410				ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; AVALOS BR, 1995, BLOOD, V85, P3117, DOI 10.1182/blood.V85.11.3117.bloodjournal85113117; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; DINERSTEIN H, 1995, MOL ENDOCRINOL, V9, P1701, DOI 10.1210/me.9.12.1701; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Elledge SJ, 1998, SCIENCE, V279, P999, DOI 10.1126/science.279.5353.999; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Gual P, 1998, ENDOCRINOLOGY, V139, P884, DOI 10.1210/en.139.3.884; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; MIYAJIMA A, 1993, BLOOD, V82, P1960; MIYAJIMA A, 1987, GENE, V58, P273, DOI 10.1016/0378-1119(87)90382-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Okuda K, 1997, BLOOD, V90, P4759, DOI 10.1182/blood.V90.12.4759.4759_4759_4766; ONEAL KD, 1995, MOL CELL BIOL, V15, P4657; ONeal KD, 1995, ANN NY ACAD SCI, V766, P282, DOI 10.1111/j.1749-6632.1995.tb26677.x; ONeill TJ, 1997, J BIOL CHEM, V272, P10035; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pennisi E, 1998, SCIENCE, V279, P477, DOI 10.1126/science.279.5350.477; Poelzl G, 2000, P NATL ACAD SCI USA, V97, P2836, DOI 10.1073/pnas.050580997; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; WANG YD, 1995, MOL ENDOCRINOL, V9, P303, DOI 10.1210/me.9.3.303; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681	42	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41803	41809		10.1074/jbc.M101488200	http://dx.doi.org/10.1074/jbc.M101488200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551900	hybrid			2022-12-27	WOS:000172450400036
J	Hickox, JR; Bi, M; Hardy, DM				Hickox, JR; Bi, M; Hardy, DM			Heterogeneous processing and zona pellucida binding activity of pig zonadhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE SUBMAXILLARY MUCIN; SPERM MEMBRANE-PROTEIN; VONWILLEBRAND-FACTOR; MULTIPLE FORMS; EXTRACELLULAR-MATRIX; POLYACRYLAMIDE GELS; D-DOMAINS; HYALURONIDASE; RAM; MULTIMERIZATION	Zonadhesin is a mosaic protein in sperm membrane fractions that binds directly and in a species-specific manner to the extracellular matrix (zona pellucida) of the oocyte. The active form of pig zonadhesin from capacitated, epididymal spermatozoa comprises two covalently associated polypeptide chains of M-r 105,000 (p105) and M-r 45,000 (p45). Here we report detection and characterization of multiple zonadhesin isoforms in freshly ejaculated cells. Antibodies to the predicted von Willebrand D0-D1, D1, and D3 domains of pig zonadhesin recognized p105, p45, and additional M-r 60,000-90,000 polypeptides in particulate fractions of uncapacitated cells. Although the p105/45 form constituted a minority of all zonadhesin forms in sperm membrane fractions, it was the predominant form capable of binding to the pig zona pellucida. Zonadhesin-binding sites were distributed over the entire zona pellucida. Anion exchange chromatography resolved active, p105/45 zonadhesin from the p60-90 inactive forms. Without disulfide bond reduction some zonadhesin was M-r greater than or equal to 300,000, including M-r 300,000 and 900,000 proteins comprising in part multimers of p105/45. The multimeric forms did not bind the zona pellucida as avidly as did the p105/45 monomer. Expressed Dl and D3 domain fragments containing the CG(L/V)CG sequence motif spontaneously formed multimers at -246 mV E-h in vitro. Double Cys --> Ser mutants of the D1 fragment formed multimers with the same apparent kinetics as the wild type protein. Zonadhesin localized to the apical head of pig spermatozoa. We conclude that a heterogeneous combination of specific proteolysis and intermolecular disulfide bond formation in the sperm head generates multiple forms of zonadhesin with differing avidities for the zona pellucida.	Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Hardy, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.		Hardy, Daniel/AAP-5823-2020	Hardy, Daniel/0000-0002-7297-3093	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD035166] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-35166] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; BI M, 2002, IN PRESS FERTILIZATI; DUNBAR BS, 1980, BIOCHEMISTRY-US, V19, P356, DOI 10.1021/bi00543a017; Gao Z, 1998, J BIOL CHEM, V273, P3415, DOI 10.1074/jbc.273.6.3415; Haden NP, 2000, BIOL REPROD, V63, P1839, DOI 10.1095/biolreprod63.6.1839; HARDY DM, 1987, BIOL REPROD, V37, P189, DOI 10.1095/biolreprod37.1.189; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HARDY DM, 1994, J BIOL CHEM, V269, P19000; HARRISON RAP, 1988, BIOCHEM J, V252, P865, DOI 10.1042/bj2520865; HARRISON RAP, 1988, J REPROD FERTIL, V82, P777, DOI 10.1530/jrf.0.0820777; HARRISON RAP, 1988, BIOCHEM J, V252, P875, DOI 10.1042/bj2520875; Hunnicutt GR, 1996, BIOL REPROD, V54, P1343, DOI 10.1095/biolreprod54.6.1343; JAISWAL BS, 2002, FERTILIZATION; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Perez-Vilar J, 1998, J BIOL CHEM, V273, P34527, DOI 10.1074/jbc.273.51.34527; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; Perez-Vilar J, 1998, J BIOL CHEM, V273, P6982, DOI 10.1074/jbc.273.12.6982; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Wilson MD, 2001, NUCLEIC ACIDS RES, V29, P1352, DOI 10.1093/nar/29.6.1352; Yanagimachi R., 1994, P189	29	33	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41502	41509		10.1074/jbc.M106795200	http://dx.doi.org/10.1074/jbc.M106795200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526117	hybrid			2022-12-27	WOS:000171925600148
J	Rui, LY; Fisher, TL; Thomas, J; White, MF				Rui, LY; Fisher, TL; Thomas, J; White, MF			Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; MAMMALIAN TARGET; KAPPA-B; 3T3-L1 ADIPOCYTES; MICE LACKING; IN-VITRO; RESISTANCE; PATHWAY; RAPAMYCIN; ALPHA	Insulin and insulin-like growth factor-1 (IGF-1) regulate metabolism and body growth through homologous receptor tyrosine kinases that phosphorylate the insulin receptor substrate (IRS) proteins. IRS-2 is an important IRS protein, as it mediates peripheral insulin action and beta -cell survival. In this study, we show that insulin, IGF-1, or osmotic stress promoted ubiquitin/proteasome-mediated degradation of IRS-2 in 3T3-L1 cells, Fao hepatoma, cells and mouse embryo fibroblasts; however, insulin/IGF-1 did not promote degradation of IRS-1 in 3T3-L1 preadipocytes or mouse embryo fibroblasts. MG132 or lactacystin, specific inhibitors of 26S proteasome, blocked insulin/IGF-1-induced degradation of IRS-2 and enhanced the detection of ubiquitinated IRS-2. Insulin/IGF1-induced ubiquitination and degradation of IRS-2 was blocked by inhibitors of phosphatidylinositol 3-kinase (wortmannin or LY294002) or mTOR (rapamycin). Chronic insulin or IGF-1 treatment of IRS-1-deficient mouse embryo fibroblasts inhibited IRS-2-mediated activation of Akt and ERK1/2, which was reversed by lactacystin pretreatment. By contrast, IRS-I activation of Akt and ERK1/2 was not inhibited by chronic insulin/IGF-1 stimulation in IRS-2-deficient mouse embryo fibroblasts. Thus, we identified a novel negative feedback mechanism by which the ubiquitin/proteasome-mediated degradation of IRS-2 limits the magnitude and duration of the response to insulin or IGF-1.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	White, MF (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, 1 Joslin Pl, Boston, MA 02215 USA.	morris.white@joslin.harvard.edu			NIDDK NIH HHS [DK 43808] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043808] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; DeFronzo RA, 1997, DIABETES REV, V5, P177; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Egawa K, 2000, ENDOCRINOLOGY, V141, P1930, DOI 10.1210/en.141.6.1930; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Goldberg AL, 2001, SCI AM, V284, P68, DOI 10.1038/scientificamerican0101-68; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Merforth S, 1999, MOL BIOL REP, V26, P83, DOI 10.1023/A:1006966005662; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wojcik C, 1999, DRUG DISCOV TODAY, V4, P188; Yenush L, 1997, BIOESSAYS, V19, P491, DOI 10.1002/bies.950190608	41	163	174	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40362	40367		10.1074/jbc.M105332200	http://dx.doi.org/10.1074/jbc.M105332200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546773	hybrid			2022-12-27	WOS:000171789200114
J	Koc, EC; Burkhart, W; Blackburn, K; Moyer, MB; Schlatzer, DM; Moseley, A; Spremulli, LL				Koc, EC; Burkhart, W; Blackburn, K; Moyer, MB; Schlatzer, DM; Moseley, A; Spremulli, LL			The large subunit of the mammalian mitochondrial ribosome - Analysis of the complement of ribosomal proteins present	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRESPONDING GENE-SEQUENCES; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; IDENTIFICATION; RNA; TRANSCRIPTION; YEAST; CELLS; MRPS	Identification of all the protein components of the large subunit (39 S) of the mammalian mitochondrial ribosome has been achieved by carrying out proteolytic digestions of whole 39 S subunits followed by analysis of the resultant peptides by liquid chromatography and mass spectrometry. Peptide sequence information was used to search the human EST data bases and complete coding sequences were assembled. The human mitochondrial 39 S subunit has 48 distinct proteins. Twenty eight of these are homologs of the Escherichia coli 50 S ribosomal proteins L1, L2, L3, L4, L7/L12, L9, L10, L11, L13, L14, L15, L16, L17, L18, L19, L20, L21, L22, L23, L24, L27, L28, L30, L32, L33, L34, L35, and L36. Almost all of these proteins have homologs in Drosophila melanogaster, Caenorhabditis elegans, and Saccharomyces cerevisiae mitochondrial ribosomes. No mitochondrial homologs to prokaryotic ribosomal proteins L5, L6, L25, L29, and L31 could be found either in the peptides obtained or by analysis of the available data bases. The remaining 20 proteins present in the 39 S subunits are specific to mitochondrial ribosomes. Proteins in this group have no apparent homologs in bacterial, chloroplast, archaebacterial, or cytosolic ribosomes. All but two of the proteins has a clear homolog in D. melanogaster while all can be found in the genome of C. elegans. Ten of the 20 mitochondrial specific 39 S proteins have homologs in S. cerevisiae. Homologs of 2 of these new classes of ribosomal proteins could be identified in the Arabidopsis thaliana genome.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; GlaxoSmithKline Res & Dev, Dept Pathway Genom, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline	Spremulli, LL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32734] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BEHAL RH, 1994, J BIOL CHEM, V269, P31372; Bogdanov AA, 1995, BIOCHEM CELL BIOL, V73, P869, DOI 10.1139/o95-094; BURKHART W, 1992, TECHNIQUES PROTEIN C, V4, P399; CAHILL A, 1995, ANAL BIOCHEM, V232, P47, DOI 10.1006/abio.1995.9962; CLAROS MG, 1996, EUR J BIOCHEM, V241, P770, DOI DOI 10.1111/J.1432-1033.1996.00779.X; EICK D, 1994, TRENDS GENET, V10, P292, DOI 10.1016/0168-9525(90)90013-V; Furumoto H, 2000, FEBS LETT, V486, P195, DOI 10.1016/S0014-5793(00)02293-6; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463; JOSEFSSON LG, 1981, CELL, V25, P151, DOI 10.1016/0092-8674(81)90239-7; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Lu M, 2000, P NATL ACAD SCI USA, V97, P2023, DOI 10.1073/pnas.97.5.2023; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Mariottini P, 1999, J BIOL CHEM, V274, P31853, DOI 10.1074/jbc.274.45.31853; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; Patel VB, 2001, J BIOL CHEM, V276, P6739, DOI 10.1074/jbc.M005781200; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spahr CS, 2000, ELECTROPHORESIS, V21, P1635, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1635::AID-ELPS1635>3.0.CO;2-1; Spirina O, 2000, GENE, V261, P229, DOI 10.1016/S0378-1119(00)00504-7; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046; WITTMANNLIEBOLD B, 1985, RIBOSOMAL PROTEINS S; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	47	188	228	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43958	43969		10.1074/jbc.M106510200	http://dx.doi.org/10.1074/jbc.M106510200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551941	hybrid			2022-12-27	WOS:000172297700063
J	Shin, DM; Luo, X; Wilkie, TM; Miller, LJ; Peck, AB; Humphreys-Beher, MG; Muallem, S				Shin, DM; Luo, X; Wilkie, TM; Miller, LJ; Peck, AB; Humphreys-Beher, MG; Muallem, S			Polarized expression of G protein-coupled receptors and an all-or-none discharge of Ca2+ pools at initiation sites of [Ca2+]i waves in polarized exocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; SALIVARY-GLAND CELLS; CALCIUM-RELEASE; INTRACELLULAR STORES; SIGNALING COMPLEXES; OSCILLATIONS; TRISPHOSPHATE; ACETYLCHOLINE; PROPAGATION	In the present work we examined localization and behavior of G protein-coupled receptors (GPCR) in polarized exocrine cells to address the questions of how luminal to basal Ca2+ waves can be generated in a receptor-specific manner and whether quantal Ca2+ release reflects partial release from a continuous pool or an all-or-none release from a compartmentalized pool. Immunolocalization revealed that expression of GPCRs in polarized cells is not uniform, with high levels of GPCR expression at or near the tight junctions. Measurement of phospholipase C beta activity and receptor-dependent recruitment and trapping of the box domain of RGS4 in GPCRs complexes indicated autonomous functioning of G(q)-coupled receptors in acinar cells. These findings explain the generation of receptor-specific Ca2+ waves and why the waves are always initiated at the apical pole. The initiation site of Ca2+ wave at the apical pole and the pattern of wave propagation were independent of inositol 1,4,5-trisphosphate concentration. Furthermore, a second Ca2+ wave with the same initiation site and pattern was launched by inhibition of sarco/endoplasmic reticulum Ca2+-ATPase pumps of cells continuously stimulated with sub-maximal agonist concentration. By contrast, rapid sequential application of sub-maximal and maximal agonist concentrations to the same cell triggered C2+ waves with different initiation sites. These findings indicate that signaling specificity in pancreatic acinar cells is aided by polarized expression and autonomous functioning of GPCRs and that quantal C2+ release is not due to a partial Ca2+ release from a continuous pool, but rather, it is due to an all-or-none Ca2+ release from a compartmentalized Ca2+ pool.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Mayo Clin & Mayo Fdn, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; Univ Florida, Dept Pathol & Lab Med, Gainesville, FL 32610 USA; Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; Univ Florida, Dept Therapeut & Pharmacol, Gainesville, FL 32610 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Muallem, S (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Shin, Dong Min/0000-0001-6042-0435				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOOTMAN MD, 1992, J PHYSIOL-LONDON, V450, P163, DOI 10.1113/jphysiol.1992.sp019121; Callamaras N, 2000, EMBO J, V19, P3608, DOI 10.1093/emboj/19.14.3608; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; DeToledo CF, 1997, AM J PHYSIOL-GASTR L, V272, pG488, DOI 10.1152/ajpgi.1997.272.3.G488; Fogarty KE, 2000, J PHYSIOL-LONDON, V526, P515, DOI 10.1111/j.1469-7793.2000.t01-1-00515.x; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ito K, 1999, J CELL BIOL, V146, P405, DOI 10.1083/jcb.146.2.405; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Koizumi S, 1999, J BIOL CHEM, V274, P33327, DOI 10.1074/jbc.274.47.33327; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MISSIAEN L, 1994, MOL CELL ENDOCRINOL, V98, P147, DOI 10.1016/0303-7207(94)90133-3; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MUALLEM S, 1987, BIOCHEM BIOPH RES CO, V149, P213, DOI 10.1016/0006-291X(87)91626-3; MUALLEM S, 1989, J BIOL CHEM, V264, P205; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Nguyen KHT, 2000, ARTHRITIS RHEUM-US, V43, P2297, DOI 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rios JD, 1999, INVEST OPHTH VIS SCI, V40, P1102; ROETTGER BF, 1995, J CELL BIOL, V130, P579, DOI 10.1083/jcb.130.3.579; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Takemura H, 1999, BIOCHEM BIOPH RES CO, V259, P656, DOI 10.1006/bbrc.1999.0818; Taylor Colin W., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P109; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TOTORICI G, 1994, J BIOL CHEM, V269, P29621; Williams JA, 1997, DIGESTION, V58, P42, DOI 10.1159/000201524; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Xu X, 1997, CELL CALCIUM, V22, P217, DOI 10.1016/S0143-4160(97)90015-4; Xu X, 1996, J BIOL CHEM, V271, P24684, DOI 10.1074/jbc.271.40.24684; Yule DI, 1997, J BIOL CHEM, V272, P9093; YULE DI, 1991, CELL CALCIUM, V12, P145, DOI 10.1016/0143-4160(91)90016-8; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zeng WZ, 1996, J BIOL CHEM, V271, P18520, DOI 10.1074/jbc.271.31.18520; ZHANG BX, 1994, J BIOL CHEM, V269, P17132; Zhao XS, 2001, EMBO J, V20, P2680, DOI 10.1093/emboj/20.11.2680	42	52	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44146	44156		10.1074/jbc.M105203200	http://dx.doi.org/10.1074/jbc.M105203200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11553617	hybrid			2022-12-27	WOS:000172297700085
J	Zhang, LH; Youn, HD; Liu, JO				Zhang, LH; Youn, HD; Liu, JO			Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NF kappa B-dependent activation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES SP A92-308110; CYTOSOLIC BINDING-PROTEIN; PEPTIDYL-PROLYL ISOMERASE; CYCLOSPORINE-A; GENE-EXPRESSION; IMMUNOSUPPRESSANT FK506; SIGNAL TRANSMISSION; MAMMALIAN PROTEIN; MACROLIDES FK-506; NUCLEAR-FACTOR	Sanglifehrin A belongs to a novel family of immunophilin-binding ligands. Sanglifehrin A is similar to cyclosporin A in that it binds to cyclophilins. Unlike cyclosporin A, however, the cyclophilin-sanglifehrin A complex has no effect on the calcium-dependent protein phosphatase calcineurin. It has been previously shown that sanglifehrin A specifically blocks T cell proliferation in response to interleukin 2 by inhibiting the appearance of cell cycle kinase activity cyclinE-Cdk2. How sanglifehrin A treatment leads to the cell cycle blockade has remained unknown. We report that sanglifehrin A is capable of activating the tumor suppressor gene p53 at the transcription level, leading to up-regulation of p21 that then binds and inhibits the cylcinE-Cdk2 complex. Further analysis of different elements in the p53 promoter showed that sanglifehrin A activates p53 transcription primarily through the activation of the transcription factor NF kappaB by activating I kappaB kinase in a manner that is similar to several genotoxic agents. Unlike other genotoxic drugs, sanglifehrin A does not cause DNA damage, making it a unique natural product that is capable of activating the NF kappaB signaling pathway without affecting DNA.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; MIT, Canc Res Ctr, Dept Chem, Cambridge, MA 02139 USA; MIT, Canc Res Ctr, Dept Biol, Cambridge, MA 02139 USA	Johns Hopkins University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, JO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.		Youn, Hong-Duk/J-2774-2012					Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cardenas ME, 1999, CLIN MICROBIOL REV, V12, P583, DOI 10.1128/CMR.12.4.583; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; DUMONT FJ, 1990, J IMMUNOL, V144, P1418; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Fehr T, 1999, J ANTIBIOT, V52, P474, DOI 10.7164/antibiotics.52.474; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hellin AC, 1998, ONCOGENE, V16, P1187, DOI 10.1038/sj.onc.1201638; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Pei XH, 1999, J BIOL CHEM, V274, P35240, DOI 10.1074/jbc.274.49.35240; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sanglier JJ, 1999, J ANTIBIOT, V52, P466, DOI 10.7164/antibiotics.52.466; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SUN XG, 1995, MOL CELL BIOL, V15, P4489; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; WU HY, 1994, J BIOL CHEM, V269, P20067; Yeh JRJ, 2000, P NATL ACAD SCI USA, V97, P12782, DOI 10.1073/pnas.97.23.12782; Zenke G, 2001, J IMMUNOL, V166, P7165, DOI 10.4049/jimmunol.166.12.7165; Zhang LH, 2001, J IMMUNOL, V166, P5611, DOI 10.4049/jimmunol.166.9.5611; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427	39	44	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43534	43540		10.1074/jbc.M104257200	http://dx.doi.org/10.1074/jbc.M104257200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557753	hybrid			2022-12-27	WOS:000172297700009
J	Gonzalez-Baro, MR; Granger, DA; Coleman, RA				Gonzalez-Baro, MR; Granger, DA; Coleman, RA			Mitochondrial glycerol phosphate acyltransferase contains two transmembrane domains with the active site in the N-terminal domain facing the cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; OUTER-MEMBRANE; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; ACYL-COA; DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; GLYCEROPHOSPHATE ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; TRANSVERSE-PLANE; TOPOGRAPHY	The topography of mitochondrial glycerol-3-phosphate acyltransferase (GPAT) was determined using rat liver mitochondria and mutagenized recombinant rat GPAT (828 aa (amino acids)) expressed in CHO cells. Hydrophobicity analysis of GPAT predicts two transmembrane domains (TMDs), residues 472-493 and 576-592. Residues 224-323 correspond to the active site of the enzyme, which is believed to lie on the cytosolic face of the outer mitochondrial membrane. Protease treatment of rat liver mitochondria revealed that GPAT has a membrane-protected segment of 14 kDa that could correspond to the mass of the two predicted TMDs plus a loop between aa 494 and 575. Recombinant GPAT constructs containing tagged epitopes were transiently expressed in Chinese hamster ovary cells and immunolocalized. Both the C and N termini epitope tags could be detected after selective permeabilization of only the plasma membrane, indicating that both termini face the cytosol. A 6-8-fold increase in GPAT-specific activity in the transfected cells confirmed correct protein folding and orientation. When the C terminus and loop-tagged GPAT construct was immunoassayed, the epitope at the C terminus could be detected when the plasma membrane was permeabilized, but loop-epitope accessibility required disruption of the outer mitochondrial membrane. Similar results were observed when GPAT was truncated before the second TMD, again consistent with an orientation in which the loop faces the mitochondrial intermembrane space. Although protease digestion of the HA-tagged loop resulted in preservation of a 14-kDa fragment, consistent with a membrane protected loop domain, neither the truncated nor loop-tagged enzymes conferred GPAT activity when overexpressed, suggesting that the loop plays a critical structural or regulatory role for GPAT function. Based on these data, we propose a GPAT topography model with two transmembrane domains in which both the N (aa 1-471) and C (aa 593-end) termini face the cytosol and a single loop (aa 494-575) faces the intermembrane space.	Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Coleman, RA (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Nutr, CB 7400, Chapel Hill, NC 27599 USA.				NIDDK NIH HHS [DK56598] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balija VS, 2000, J BIOL CHEM, V275, P31668, DOI 10.1074/jbc.M002963200; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Bhat BG, 1999, BBA-MOL CELL BIOL L, V1439, P415, DOI 10.1016/S1388-1981(99)00103-1; Chakraborty TR, 1999, J BIOL CHEM, V274, P29786, DOI 10.1074/jbc.274.42.29786; CHANG YY, 1967, J LIPID RES, V8, P447; COLEMAN RA, 1980, BIOCHIM BIOPHYS ACTA, V595, P184, DOI 10.1016/0005-2736(80)90082-6; COLEMAN RA, 1983, J BIOL CHEM, V258, P450; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; COLEMAN RA, 1983, ENZYMES, V16, P605; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dircks LK, 1999, J BIOL CHEM, V274, P34728, DOI 10.1074/jbc.274.49.34728; Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9; Fleischer S, 1979, Methods Enzymol, V55, P32; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Heath RJ, 1999, J BACTERIOL, V181, P1944, DOI 10.1128/JB.181.6.1944-1946.1999; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; HESLER CB, 1985, J BIOL CHEM, V260, P7452; HESLER CB, 1990, J BIOL CHEM, V265, P6600; HUBBARD SJ, 2001, PROTEOLYTIC ENZYMES, P233; IGAL RA, 2001, J BIOL CHEM     0823; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P8829, DOI 10.1021/bi00152a020; Kast C, 1996, J BIOL CHEM, V271, P9240, DOI 10.1074/jbc.271.16.9240; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; NIKONOV AV, 1998, RRD LIP RES 2, V2, P207; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Saeki K, 2000, J BIOL CHEM, V275, P31996, DOI 10.1074/jbc.M004794200; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sun J, 1997, J BIOL CHEM, V272, P21793, DOI 10.1074/jbc.272.35.21793; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; [No title captured]	42	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43182	43188		10.1074/jbc.M107885200	http://dx.doi.org/10.1074/jbc.M107885200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11557771	hybrid			2022-12-27	WOS:000172169300072
J	Kitzing, K; Macheroux, P; Amrhein, N				Kitzing, K; Macheroux, P; Amrhein, N			Spectroscopic and kinetic characterization of the bifunctional chorismate synthase from Neurospora crassa - Evidence for a common binding site for 5-enolpyruvylshikimate 3-phosphate and NADPH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANALOGS PROVIDE EVIDENCE; SACCHAROMYCES-CEREVISIAE; FLAVIN REDUCTASE; RAPID REACTION; INTERMEDIATE; PURIFICATION; SUBSTRATE; MECHANISM; HYDROXYLASE; PROTEINS	Chorismate synthase catalyzes the anti-1,4-elimination of the phosphate group and the C-(6proR) hydrogen from 5-enolpyruvylshikimate 3-phosphate to yield chorismate, a central building block in aromatic amino acid biosynthesis. The enzyme has an absolute requirement for reduced FMN, which in the case of the fungal chorismate synthases is supplied by an intrinsic FMN: NADPH oxidoreductase activity, i.e. these enzymes have an additional catalytic activity. Therefore, these fungal enzymes have been termed "bifunctional." We have cloned chorismate synthase from the common bread mold Neurospora crassa, expressed it heterologously in Escherichia coli, and purified it in a three-step purification procedure to homogeneity. Recombinant IV. crassa chorismate synthase has a diaphorase activity, i.e. it catalyzes the reduction of oxidized FMN at the expense of NADPH. Using NADPH as a reductant, a reduced Ravin intermediate was observed under single and multiple turnover conditions with spectral features similar to those reported for monofunctional chorismate synthases, thus demonstrating that the intermediate is common to the chorismate synthase-catalyzed reaction. Furthermore, multiple turnover experiments in the presence of oxygen have provided evidence that NADPH binds in or near the substrate (5-enolpyruvylshikimate 3-phosphate) binding site, suggesting that NADPH binding to bifunctional chorismate synthases is embedded in the general protein structure and a special NADPH binding domain is not required to generate the intrinsic oxidoreductase activity.	Swiss Fed Inst Technol, Inst Pflanzenwissensch, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Amrhein, N (corresponding author), Swiss Fed Inst Technol, Inst Pflanzenwissensch, Univ Str 2, CH-8092 Zurich, Switzerland.	nikolaus.amrhein@ipw.biol.ethz.ch	Macheroux, Peter/AAB-5157-2019	Macheroux, Peter/0000-0002-0242-454X				Bornemann S, 1996, BIOCHEMISTRY-US, V35, P9907, DOI 10.1021/bi952958q; Fitzpatrick TB, 2001, J BIOL CHEM, V276, P18052, DOI 10.1074/jbc.M100867200; FLOSS HG, 1972, J BIOL CHEM, V247, P736; GAERTNER FH, 1973, J BIOL CHEM, V248, P4602; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; HENSTRAND JM, 1995, J BIOL CHEM, V270, P20447, DOI 10.1074/jbc.270.35.20447; Henstrand JM, 1996, MOL MICROBIOL, V22, P859, DOI 10.1046/j.1365-2958.1996.01534.x; HESSING HGM, 1987, MOL GEN GENET, V210, P256, DOI 10.1007/BF00325691; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; ITO J, 1969, J BACTERIOL, V97, P725, DOI 10.1128/JB.97.2.725-733.1969; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Macheroux P, 1996, BIOCHEMISTRY-US, V35, P1643, DOI 10.1021/bi951705u; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Macheroux P, 1996, J BIOL CHEM, V271, P25850, DOI 10.1074/jbc.271.42.25850; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; Maniatis T., 1982, MOL CLONING; MORELL H, 1967, J BIOL CHEM, V242, P82; NEGRI A, 1988, J BIOL CHEM, V263, P13557; Osborne A, 2000, J BIOL CHEM, V275, P35825, DOI 10.1074/jbc.M005796200; POWLOWSKI J, 1989, J BIOL CHEM, V264, P16008; RAMJEE MN, 1991, J AM CHEM SOC, V113, P8566, DOI 10.1021/ja00022a078; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHALLER A, 1990, ARCH BIOCHEM BIOPHYS, V282, P437, DOI 10.1016/0003-9861(90)90141-K; STOTT K, 1993, J BIOL CHEM, V268, P6097; WELCH GR, 1974, ARCH BIOCHEM BIOPHYS, V165, P505, DOI 10.1016/0003-9861(74)90276-8; WHITE PJ, 1988, BIOCHEM J, V251, P313, DOI 10.1042/bj2510313	28	15	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42658	42666		10.1074/jbc.M107249200	http://dx.doi.org/10.1074/jbc.M107249200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11526120	hybrid			2022-12-27	WOS:000172169300005
J	He, JQ; Lau, AG; Yaffe, MB; Hall, RA				He, JQ; Lau, AG; Yaffe, MB; Hall, RA			Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PEPTIDYL-PROLYL ISOMERASE; CAMP-MEDIATED INHIBITION; NHE-RF; BETA(2)-ADRENERGIC RECEPTOR; SUBSTRATE RECOGNITION; NA/H EXCHANGER; PROTEIN; ASSOCIATION; BINDING	Na+/H+ exchanger regulatory factor (NHERF)-1 is a PDZ domain-containing adaptor protein known to bind to various receptors, channels, cytoskeletal elements, and cytoplasmic signaling proteins. We report here that the phosphorylation state of NHERF-1 is profoundly regulated by the cell cycle: NHERF-1 in HeLa cells is hyperphosphorylated in mitosis phase and much less phosphorylated at other points of the cell cycle. This mitosis phase-dependent phosphorylation of NHERF-1 could be blocked by roscovitine, consistent with phosphorylation by cyclin-dependent kinases. In vitro studies with purified NHERF-1 fusion proteins and purified kinases revealed that NHERF-1 was robustly phosphorylated by the cyclin-dependent kinase Cdc2. In contrast, the NHERF-1 relative NHERF-2 was not phosphorylated at all by Cdc2. NHERF-1 possesses two serines (Ser(279) and Ser(301)) that conform to the SPX(K/R) motif preferred for phosphorylation by Cdc2. Mutation of either of these serines reduced Cdc2-mediated phosphorylation of NHERF-1 in vitro, and mutation of both residues together completely abolished Cdc2-mediated phosphorylation. When the S279A/S301A NHERF-1 mutant was expressed in cells, it failed to exhibit the mitosis phase-dependent phosphorylation observed with wild-type NHERF-1. Mutation of both Ser(279) and Ser(301) to aspartate, to mimic Cdc2 phosphorylation of NHERF-1, resulted in a NHERF-1 mutant with a markedly impaired ability to oligomerize in vitro. Similarly, endogenous NHERF-1 from lysates of mitosis phase HeLa cells exhibited a markedly reduced ability to oligomerize relative to endogenous NHERF-1 from lysates of interphase HeLa cells. Mitosis phase NHERF-1 furthermore exhibited the ability to associate with Pint, a WW domain-containing peptidylprolyl isomerase that does not detectably bind to NHERF-1 in interphase lysates. The association of NHERF-1 with Pint facilitated dephosphorylation of NHERF-1, as shown in experiments in which cellular Pin1 activity was blocked by the selective inhibitor juglone. These data reveal that cellular NHERF-1 is phosphorylated during mitosis phase by Cdc2 at Ser(279) and Ser(301) and that this phosphorylation regulates NHERF-1 oligomerization and association with Pin1.	Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr 5113, Atlanta, GA 30322 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Emory University; Massachusetts Institute of Technology (MIT)	Hall, RA (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr 5113, 1510 Clifton Rd, Atlanta, GA 30322 USA.			Hall, Randy/0000-0002-8318-8728	NHLBI NIH HHS [R01-HL64713] Funding Source: Medline; NIGMS NIH HHS [R01-GM60594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernardo AA, 1999, J CLIN INVEST, V104, P195, DOI 10.1172/JCI5344; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; CHAKRABORTY M, 1994, P NATL ACAD SCI USA, V91, P2115, DOI 10.1073/pnas.91.6.2115; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Gerez L, 2000, MOL BIOL CELL, V11, P2201, DOI 10.1091/mbc.11.7.2201; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Lu K P, 2000, Prog Cell Cycle Res, V4, P83; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	51	62	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41559	41565		10.1074/jbc.M106859200	http://dx.doi.org/10.1074/jbc.M106859200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533036	hybrid			2022-12-27	WOS:000172450400005
J	Kumar, MB; Ramadoss, P; Reen, RK; Perdew, GH				Kumar, MB; Ramadoss, P; Reen, RK; Perdew, GH			The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; DNA-BINDING FORM; NUCLEAR TRANSLOCATOR; ACTIVATION DOMAINS; MICE LACKING; CORE COMPLEX; GAGA FACTOR; IN-VIVO; PROTEIN; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	The aryl hydrocarbon receptor (AhR), a basic helix-loop-helix/Per-Arnt-Sim transcription factor, mediates many of the toxic and biological effects of the environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin, which include the transcriptional activation of dioxin-responsive genes such as CYP1A1. Many aspects of this process are known; however, the mechanism of transcriptional activation and the proteins that are key to this process remain to be determined. The hAhR has a complex transactivation domain, composed of three potentially distinct subdomains. Deletional analysis of the hAhR transactivation domain indicates that removal of the P/S/T-rich subdomain enhances transcriptional activity, whereas the Q-rich subdomain is critical for hAhR transactivation potential, and the acidic subdomain by itself fails to activate a dioxin response element-driven reporter gene. Deletional analysis of the Q-rich subdomain identified a critical stretch of 23 amino acids between residues 666 and 688 of the hAhR, which are required for transactivation potential. Alanine scanning mutagenesis of this region identified a leucine residue (Leu-678), which is required for hAhR activity. Functional analysis of this point mutant revealed that it is capable of binding ligand, heterodimerization, and subsequent binding to dioxin response elements. Further, when bAhR/L678A and hAhR containing only the acidic subdomain were overexpressed they acted as dominant negative receptors and repressed wild-type hAhR activity. In addition, the hAhR/L678A failed to activate CYP1A1 gene transcription in transfected BP-8 cells and exhibited reduced binding to RIP140 in vitro. Thus, Leu-678 appears to be critical for efficient transactivation activity of the hAhR and appears to disrupt recruitment of co-regulators.	Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Penn State Univ, Grad Program Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004869, R29ES004869] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04869] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Agianian B, 1999, J MOL BIOL, V285, P527, DOI 10.1006/jmbi.1998.2355; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Dong LQ, 1997, J BIOL CHEM, V272, P29614, DOI 10.1074/jbc.272.47.29614; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; HENRY EC, 1993, BIOCHEM J, V294, P95, DOI 10.1042/bj2940095; HORD NG, 1994, MOL PHARMACOL, V46, P618; JAIN S, 1994, J BIOL CHEM, V269, P31518; Ko HP, 1997, MOL CELL BIOL, V17, P3497, DOI 10.1128/MCB.17.7.3497; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Korkalainen M, 2000, BIOCHEM BIOPH RES CO, V273, P272, DOI 10.1006/bbrc.2000.2931; Kress S, 1998, EUR J BIOCHEM, V258, P803, DOI 10.1046/j.1432-1327.1998.2580803.x; Kumar MB, 1999, GENE EXPRESSION, V8, P273; Kumar MB, 1999, J BIOL CHEM, V274, P22155, DOI 10.1074/jbc.274.32.22155; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Nguyen TA, 1999, ARCH BIOCHEM BIOPHYS, V367, P250, DOI 10.1006/abbi.1999.1282; OKINO ST, 1995, MOL CELL BIOL, V15, P3714; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Pollenz RS, 1996, J BIOL CHEM, V271, P30886, DOI 10.1074/jbc.271.48.30886; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Rojo-Niersbach E, 1999, J BIOL CHEM, V274, P33778, DOI 10.1074/jbc.274.47.33778; Rowlands JC, 1996, MOL PHARMACOL, V50, P538; SAFE SH, 1986, ANNU REV PHARMACOL, V26, P371, DOI 10.1146/annurev.pa.26.040186.002103; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; Serra E, 1998, NUCLEIC ACIDS RES, V26, P3800, DOI 10.1093/nar/26.16.3800; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; SOGAWA K, 1995, J CANCER RES CLIN, V121, P612, DOI 10.1007/BF01197779; Swanson HI, 1998, MOL PHARMACOL, V54, P671; TUKEY RH, 1984, BIOCHEMISTRY-US, V23, P6003, DOI 10.1021/bi00320a016; VANDENHEUVEL JP, 1998, PCR PROTOCOLS MOL TO, P41; Vaquero A, 2000, J BIOL CHEM, V275, P19461, DOI 10.1074/jbc.M000967200; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; Wilkins RC, 1999, J MOL BIOL, V285, P515, DOI 10.1006/jmbi.1998.2356; Zhou H, 1997, J IMMUNOL, V158, P4741	47	62	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42302	42310		10.1074/jbc.M104798200	http://dx.doi.org/10.1074/jbc.M104798200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551916	hybrid			2022-12-27	WOS:000172450400101
J	McGuire, J; Okamoto, K; Whitelaw, ML; Tanaka, H; Poellinger, L				McGuire, J; Okamoto, K; Whitelaw, ML; Tanaka, H; Poellinger, L			Definition of a dioxin receptor mutant that is a constitutive activator of transcription - Delineation of overlapping repression and ligand binding functions within the PAS domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; HEAT-SHOCK PROTEIN; HELIX-LOOP-HELIX; AH-RECEPTOR; SIGNAL-TRANSDUCTION; MICE LACKING; IN-VIVO; HSP90; SPECIFICITY; COMPLEX	The intracellular dioxin (aryl hydrocarbon) receptor is a ligand-activated transcription factor that mediates the adaptive and toxic responses to environmental pollutants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and structurally related congeners. Whereas the ligand-free receptor is characterized by its association with the molecular chaperone hsp90, exposure to ligand initiates a multistep activation process involving nuclear translocation, dissociation from the hsp90 complex, an dimerization with its partner protein Arnt. In this study, we have characterized a dioxin receptor deletion mutant lacking the minimal ligand-binding domain of the receptor. This mutant did not bind ligand and localized constitutively to the nucleus. However, this protein was functionally inert since it failed to dimerize with Arnt and to bind DNA. In contrast, a dioxin receptor deletion mutant lacking the minimal PAS B motif but maintaining the N-terminal half of the ligand-binding domain showed constitutive dimerization with Arnt, bound DNA, and activated transcription in a ligand-independent manner. Interestingly, this mutant showed a more potent functional activity than the dioxin-activated wild-type receptor in several different cell lines. In conclusion, the constitutively active dioxin receptor may provide an important mechanistic tool to investigate receptor-mediated regulatory pathways in closer detail.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Univ Adelaide, Dept Biochem, Adelaide, SA 5005, Australia; Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan	Karolinska Institutet; University of Adelaide; University of Tokyo	Poellinger, L (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.							ANTONSSON C, 1995, MOL CELL BIOL, V15, P756; BERGHARD A, 1993, MOL CELL BIOL, V13, P677, DOI 10.1128/MCB.13.1.677; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CARVER LA, 1994, J BIOL CHEM, V269, P30109; Carver LA, 1997, J BIOL CHEM, V272, P11452; CHEN HS, 1994, J BIOL CHEM, V269, P27554; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; CUTHILL S, 1991, MOL CELL BIOL, V11, P401, DOI 10.1128/MCB.11.1.401; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRADIN K, 1994, J BIOL CHEM, V269, P23800; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; JAIN S, 1994, J BIOL CHEM, V269, P31518; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; MA Q, 1995, J BIOL CHEM, V270, P12697, DOI 10.1074/jbc.270.21.12697; Ma Q, 1997, J BIOL CHEM, V272, P8878; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MASON GGF, 1994, J BIOL CHEM, V269, P4438; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; PERDEW GH, 1992, BIOCHEM BIOPH RES CO, V182, P55, DOI 10.1016/S0006-291X(05)80111-1; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pongratz I, 1998, MOL CELL BIOL, V18, P4079, DOI 10.1128/MCB.18.7.4079; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; WHITELAW ML, 1994, MOL CELL BIOL, V14, P8343, DOI 10.1128/MCB.14.12.8343; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; YAMAMOTO KR, 1988, COLD SPRING HARB SYM, V53, P803, DOI 10.1101/SQB.1988.053.01.091; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079	39	81	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41841	41849		10.1074/jbc.M105607200	http://dx.doi.org/10.1074/jbc.M105607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551926	hybrid			2022-12-27	WOS:000172450400041
J	Weinman, EJ; Evangelista, CM; Steplock, D; Liu, MZ; Shenolikar, S; Bernardo, A				Weinman, EJ; Evangelista, CM; Steplock, D; Liu, MZ; Shenolikar, S; Bernardo, A			Essential role for NHERF in cAMP-mediated inhibition of the Na+-HCO3- co-transporter in BSC-1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; PROTEIN-KINASE-A; PARATHYROID-HORMONE; PROXIMAL TUBULE; PHOSPHORYLATION; EXPRESSION; CLONING; NHE-3	Prior studies have indicated a requirement for the PDZ domain-containing protein, Na+/H+ Exchanger Regulatory Factor (NHERF), for protein kinase A (PKA)mediated inhibition of the renal basolateral Na+-HCO3- co-transporter (NBC). The present studies explore the potential mechanisms by which NHERF transduces cAMP signals to inhibit NBC. In BSC-1 cells, cells that express NBC but lack NHERF, 8-bromo-cAMP (100 mum for 15 min) failed to inhibit transport until wild-type mNHERF-(1-355) was expressed. mNHERF-(116-355) containing PDZ II and C-terminal ezrin-binding sequences or a mutant unphosphorylated form of rabbit NHERF effectively transduced the cAMP signals that inhibited NBC. By contrast, mNHERF-(1-126) encompassing N-terminal PDZ I and mNDERF-(1-325), which lacks ezrin-binding, failed to support cAMP inhibition of NBC activity. NBC and NHERF did not associate with each other in yeast two-hybrid or co-immunoprecipitation assays, and confocal microscopy indicated distinct subcellular localization of the two proteins. NBC was phosphorylated in BSC-1 cells, but its phosphorylation was not increased by cAMP nor was immunoprecipitated NBC phosphorylated by PKA in vitro. Acute exposure of mNHERF-(1-355)-expressing BSC-1 cells to cAMP did not change cell surface expression of NBC. Although these results established an essential role for NHERF in cAMP-mediated inhibition of NBC in BSC-1 cells, they also suggest a novel mechanism for NHERF-mediated signal transduction distinct from that previously characterized from studies of other NHERF targets.	Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; Chicago Vet Affairs Hlth Care Syst, W Side Div, Chicago, IL 60612 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Duke University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Weinman, EJ (corresponding author), Univ Maryland, Sch Med, Dept Med, 22 S Greene St,Rm N3W143, Baltimore, MD 21201 USA.	eweinman@medicine.umaryland.edu			NIDDK NIH HHS [DK 55881] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIBA T, 1986, J CLIN INVEST, V78, P1472, DOI 10.1172/JCI112738; Bernardo AA, 1999, J CLIN INVEST, V104, P195, DOI 10.1172/JCI5344; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; GEIBEL J, 1990, P NATL ACAD SCI USA, V87, P7917, DOI 10.1073/pnas.87.20.7917; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; HARPER JF, 1984, COMPUT BIOL MED, V14, P437, DOI 10.1016/0010-4825(84)90044-1; JENTSCH TJ, 1986, J BIOL CHEM, V261, P2120; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; PASTORIZAMUNOZ E, 1992, J CLIN INVEST, V89, P1485, DOI 10.1172/JCI115739; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; RUIZ OS, 1989, AM J PHYSIOL, V256, pF414, DOI 10.1152/ajprenal.1989.256.3.F414; RUIZ OS, 1992, AM J PHYSIOL, V262, pF560, DOI 10.1152/ajprenal.1992.262.4.F560; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	23	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42339	42346		10.1074/jbc.M106153200	http://dx.doi.org/10.1074/jbc.M106153200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535598	hybrid			2022-12-27	WOS:000172450400105
J	Ballou, LM; Tian, PY; Lin, HY; Jiang, YP; Lin, RZ				Ballou, LM; Tian, PY; Lin, HY; Jiang, YP; Lin, RZ			Dual regulation of glycogen synthase kinase-3 beta by the alpha(1A)-adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-FATE SPECIFICATION; P70 S6 KINASE; DIFFERENTIAL REGULATION; GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; ALPHA-1-ADRENERGIC RECEPTORS; SIGNALING PATHWAY; COUPLED RECEPTORS; POTENTIAL ROLE	Catecholamines, acting through adrenergic receptors, play an important role in modulating the effects of insulin on glucose metabolism. Insulin activation of glycogen synthesis is mediated in part by the inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3). In this study, catecholamine regulation of GSK-3 beta was investigated in Rat-1 fibroblasts stably expressing the alpha (1A)-adrenergic receptor. Treatment of these cells with either insulin or phenylephrine (PE), an al-adrenergic receptor agonist, induced Ser-9 phosphorylation of GSK-3 beta and inhibited GSK-3 beta activity. Insulin-induced GSK-3 beta phosphorylation is mediated by the phosphatidylinositol 3-kinase/Akt signaling pathway. PE treatment does not activate phosphatidylinositol 3-kinase or Akt (Ballou, L. M., Cross, M. E., Huang, S., McReynolds, E. M., Zhang, B. X., and Lin, R. Z. (2000) J. Biol. Chem. 275, 4803-4809), but instead inhibits insulin-induced Akt activation and GSK-3 beta phosphorylation. Experiments using protein kinase C (PKC) inhibitors suggest that phorbol ester-sensitive novel PKC and Go 6983-sensitive atypical PKC isoforms are involved in the PE-induced phosphorylation of GSK-3 beta. Indeed, PE treatment of Rat-1 cells increased the activity of atypical PKC zeta, and expression of PKC zeta in COS-7 cells stimulated GSK-3 beta Ser-9 phosphorylation. In addition, PE-induced GSK-3 beta phosphorylation was reduced in Rat-1 cells treated with a cell-permeable PKC zeta pseudosubstrate peptide inhibitor. These results suggest that the alpha (1A)-adrenergic receptor regulates GSK-3 beta through two signaling pathways. One pathway inhibits insulin-induced GSK-3 beta phosphorylation by blocking insulin activation of Akt. The second pathway stimulates Ser-9 phosphorylation of GSK3 beta, probably via PKC.	Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; Audie L Murphy Vet Affairs Med Ctr, Res Serv, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Lin, RZ (corresponding author), SUNY Stony Brook, Dept Med, Div Hematol, Stony Brook, NY 11794 USA.		Lin, Richard/J-1754-2014	Lin, Richard/0000-0002-3473-7276				Ballou LM, 2000, J BIOL CHEM, V275, P4803, DOI 10.1074/jbc.275.7.4803; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; BOUSCAREL B, 1986, BIOCHIM BIOPHYS ACTA, V888, P126, DOI 10.1016/0167-4889(86)90078-9; BOUSCAREL B, 1988, BIOCHEM J, V251, P47, DOI 10.1042/bj2510047; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; del Pulgar T, 2000, BIOCHEM J, V347, P369, DOI 10.1042/bj3470369; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Exton J H, 1975, Adv Cyclic Nucleotide Res, V5, P519; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; HUTSON NJ, 1976, J BIOL CHEM, V251, P5200; Isagawa T, 2000, BIOCHEM BIOPH RES CO, V273, P209, DOI 10.1006/bbrc.2000.2926; Kenny BA, 1996, BRIT J PHARMACOL, V118, P871, DOI 10.1111/j.1476-5381.1996.tb15480.x; Kim L, 1999, CELL, V99, P399, DOI 10.1016/S0092-8674(00)81526-3; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Lin RZ, 1998, J BIOL CHEM, V273, P30033, DOI 10.1074/jbc.273.45.30033; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Murray NR, 1999, J CELL BIOL, V145, P699, DOI 10.1083/jcb.145.4.699; PEREZ DM, 1993, MOL PHARMACOL, V44, P784; Ruel L, 1999, J BIOL CHEM, V274, P21790, DOI 10.1074/jbc.274.31.21790; Rybkin II, 2000, J BIOL CHEM, V275, P5460, DOI 10.1074/jbc.275.8.5460; SCHWINN DA, 1995, J PHARMACOL EXP THER, V272, P134; Shaw M, 1999, FEBS LETT, V461, P120, DOI 10.1016/S0014-5793(99)01434-9; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Weeks G, 2000, CURR OPIN MICROBIOL, V3, P625, DOI 10.1016/S1369-5274(00)00151-X; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; WU DQ, 1992, J BIOL CHEM, V267, P25798; YAMAMOTOHONDA R, 1995, J BIOL CHEM, V270, P2729, DOI 10.1074/jbc.270.6.2729; YANG SD, 1994, J CELL BIOCHEM, V56, P550, DOI 10.1002/jcb.240560416	50	65	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40910	40916		10.1074/jbc.M103480200	http://dx.doi.org/10.1074/jbc.M103480200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533051	hybrid			2022-12-27	WOS:000171925600072
J	Conti, LR; Radeke, CM; Shyng, SL; Vandenberg, CA				Conti, LR; Radeke, CM; Shyng, SL; Vandenberg, CA			Transmembrane topology of the sulfonylurea receptor SUR1.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; RESISTANCE-ASSOCIATED PROTEIN; MEMBRANE TOPOLOGY; EPITOPE INSERTION; P-GLYCOPROTEIN; INSULIN-SECRETION; SUBUNIT; GLYCOSYLATION; REGULATOR; OPENERS	Sulfonylurea receptors (SURx) are multi-spanning transmembrane proteins of the ATP-binding cassette (ABC) family, which associate with Kir6.x to form ATP-sensitive potassium channels. Two models, with 13-17 transmembrane segments, have been proposed for SURx topologies. Recently, we demonstrated that the aminoterminal region of SUR1 contains 5 transmembrane segments, supporting the 17-transmembrane model. To investigate the topology of the complete full-length SUR1, two strategies were employed. Topology was probed by accessibility of introduced cysteines to a membrane-impermeable biotinylating reagent, biotin maleimide. Amino acid positions 6/26, 99, 159, 337, 567, 1051, and 1274 were accessible, therefore extracellular, whereas many endogenous and some introduced cysteines were inaccessible, thus likely cytoplasmic or intramembrane. These sites correspond to extracellular loops 1-3, 5-6, and 8 and the NH2 terminus, and intracellular loops 3-8 and COOH terminus in the 17-transmembrane model. Immunofluorescence was used to determine accessibility of epitope-tagged SUR1 in intact and permeabilized cells. Epitopes at positions 337 and 1050 (putative external loops 3 and 6) were labeled in intact cells, therefore external, whereas positions 485 and 1119 (putative internal loops 5 and 7) only were accessible after permeabilization and therefore internal. These results are compatible with the 17-transmembrane model with two pairs of transmembrane segments as possible reentrant loops.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Oregon Health & Science University	Vandenberg, CA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.				NHLBI NIH HHS [HL 41656] Funding Source: Medline; NIDDK NIH HHS [R01 DK057699, DK 57699] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL041656, R01HL041656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft SJH, 2000, J MEMBRANE BIOL, V176, P187, DOI 10.1007/s002320001095; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; CHANG XB, 1994, J BIOL CHEM, V269, P18572; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Fujita A, 2000, PHARMACOL THERAPEUT, V85, P39, DOI 10.1016/S0163-7258(99)00050-9; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; KAST C, 1995, BIOCHEMISTRY-US, V34, P4402, DOI 10.1021/bi00013a032; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; Kast C, 1996, J BIOL CHEM, V271, P9240, DOI 10.1074/jbc.271.16.9240; Lehrman MA, 2001, J BIOL CHEM, V276, P8623, DOI 10.1074/jbc.R100002200; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Nasonkin I, 1999, J BIOL CHEM, V274, P29420, DOI 10.1074/jbc.274.41.29420; Nelson DA, 1996, BIOCHEMISTRY-US, V35, P14793, DOI 10.1021/bi960777y; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	32	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41270	41278		10.1074/jbc.M106555200	http://dx.doi.org/10.1074/jbc.M106555200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546780	hybrid			2022-12-27	WOS:000171925600119
J	de la Serna, IL; Roy, K; Carlson, KA; Imbalzano, AN				de la Serna, IL; Roy, K; Carlson, KA; Imbalzano, AN			MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; SKELETAL-MUSCLE; GENE-EXPRESSION; MYOGENIC DIFFERENTIATION; GLUCOCORTICOID RECEPTOR; TRANSCRIPTIONAL ACTIVATION; TERMINAL DIFFERENTIATION; DEPENDENT KINASES; DNA-BINDING; MICE LEADS	Cell cycle arrest is critical for muscle differentiation, and the two processes are closely coordinated but temporally separable. SWI/SNF complexes are ATP-dependent chromatin-remodeling enzymes that have been shown to be required for muscle differentiation in cell culture and have also been reported to be required for Rb-mediated cell cycle arrest. We therefore looked more closely at how SWI/SNF enzymes affect the events that occur during MyoD-induced myogenesis, namely, cell cycle regulation and muscle-specific gene expression, in cells that inducibly express dominant negative versions of Brahma (BRM) and Brahma-related gene 1 (BRG1), the ATPase subunits of two distinct SWI/SNF complexes. Although dominant negative BRM and BRG1 inhibited expression of every muscle-specific regulator and structural gene assayed, there was no effect on MyoD-induced activation of cell cycle regulatory proteins, and thus, cells arrested normally. In particular, in the presence or absence of dominant negative BRM or BRG1, MyoD was able to activate expression of p21, cyclin D3, and Rb, all of which are critical for cell cycle withdrawal in the G(1)/G(0) phase of the cell cycle. These findings suggest that at least one basis for the distinct mechanisms that regulate cessation of cell proliferation and muscle-specific gene expression during muscle differentiation is that SWI/SNF-mediated chromatin-remodeling enzymes are required only for the latter.	Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Dept Cell Biol, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020371, R01GM056244] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056244, F32GM20371, GM56244] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1995, EMBO J, V14, P1176, DOI 10.1002/j.1460-2075.1995.tb07101.x; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gao CY, 1997, BIOESSAYS, V19, P307, DOI 10.1002/bies.950190408; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; JAHN L, 1994, EXP CELL RES, V212, P297, DOI 10.1006/excr.1994.1147; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; Mal A, 2000, J CELL BIOL, V149, P281, DOI 10.1083/jcb.149.2.281; MARTELLI F, 1994, ONCOGENE, V9, P3579; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; MONTARRAS D, 1991, NEW BIOL, V3, P592; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; O'Neill D, 1999, P NATL ACAD SCI USA, V96, P349, DOI 10.1073/pnas.96.2.349; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Strober BE, 1996, MOL CELL BIOL, V16, P1576; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Valdez MR, 2000, DEV BIOL, V219, P287, DOI 10.1006/dbio.2000.9621; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Zabludoff SD, 1998, CELL GROWTH DIFFER, V9, P1; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	65	89	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41486	41491		10.1074/jbc.M107281200	http://dx.doi.org/10.1074/jbc.M107281200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522799	hybrid			2022-12-27	WOS:000171925600146
J	Lawson, TG; Sweep, ME; Schlax, PE; Bohnsack, RN; Haas, AL				Lawson, TG; Sweep, ME; Schlax, PE; Bohnsack, RN; Haas, AL			Kinetic analysis of the conjugation of ubiquitin to picornavirus 3C proteases catalyzed by the mammalian ubiquitin-protein ligase E3 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; HEPATITIS-A VIRUS; MEDIATED PROTEOLYTIC SYSTEM; BINDING-SITES; AFFINITY PURIFICATION; MULTIUBIQUITIN CHAIN; CARRIER PROTEIN; G-ALPHA; DEGRADATION; PATHWAY	The 3C proteases of the encephalomyocarditis virus and the hepatitis A virus are both type III substrates for the mammalian ubiquitin-protein ligase E3 alpha. The conjugation of ubiquitin to these proteins requires internal ten-amino acid-long protein destruction signal sequences. To evaluate how these destruction signals modulate interactions that must occur between E3a and the 3C proteases, we have kinetically analyzed the formation of ubiquitin-3C protease conjugates in a reconstituted system of purified E1, HsUbc2b/E2(14Kb), and human E3a. Our measurements show that the encephalomyocarditis virus 3C protease is ubiquitinated in this system with K-m = 42 +/- 11 muM and V-max = 0.051 +/- 0.01 pmol/min whereas the parameters for the ubiquitination of the hepatitis A virus 3C protease are K-m = 20 +/- 5 muM and V-max = 0.018 +/- 0.003 pmol/min. Mutations in the destruction signal sequences resulted in changes in the rate at which E3a conjugates ubiquitin to the altered 3C protease proteins. The K-m and V-max values for these reactions change proportionally in the same direction. These results suggest differences in rates of conjugation of ubiquitin to 3C proteases are primarily a k(cat) effect. Replacing specific encephalomyocarditis virus 3C protease lysine residues with arginine residues was found to increase, rather than decrease, the rate of ubiquitin conjugation, and the K,, and V.. values for these reactions are both higher than for the wild type protein. The ability of E3a to catalyze the conjugation of ubiquitin to both 3C proteases was found to be inhibited by lysylalanine and phenylalanylalanine, demonstrating that the same sites on E3a that bind destabilizing N-terminal amino acids in type I and 11 substrates also interact with the 3C proteases.	Bates Coll, Dept Chem, Lewiston, ME 04240 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lawson, TG (corresponding author), Bates Coll, Dept Chem, Lewiston, ME 04240 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34009] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANCHORDOGUY TJ, 1995, J EXP BIOL, V198, P1299; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; Bergmann EM, 1997, J VIROL, V71, P2436, DOI 10.1128/JVI.71.3.2436-2448.1997; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gladding RL, 1997, BIOCHEM BIOPH RES CO, V238, P119, DOI 10.1006/bbrc.1997.7251; GONDA DK, 1989, J BIOL CHEM, V264, P16700; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; HAAS AL, 1991, J BIOL CHEM, V266, P5104; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; LAWSON TG, 1994, J BIOL CHEM, V269, P28429; Lawson TG, 1999, J BIOL CHEM, V274, P9871, DOI 10.1074/jbc.274.14.9871; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; PALMENBERG AC, 1984, NUCLEIC ACIDS RES, V12, P2969, DOI 10.1093/nar/12.6.2969; PAUL AV, 1987, VIRUS RES, V8, P153, DOI 10.1016/0168-1702(87)90026-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; REISS Y, 1989, J BIOL CHEM, V264, P10378; REISS Y, 1988, J BIOL CHEM, V263, P2693; REISS Y, 1990, J BIOL CHEM, V265, P3685; Schauber C, 1998, GENES CELLS, V3, P307, DOI 10.1046/j.1365-2443.1998.00192.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WING SS, 1992, J BIOL CHEM, V267, P6494; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832	35	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39629	39637		10.1074/jbc.M102659200	http://dx.doi.org/10.1074/jbc.M102659200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11526102	hybrid			2022-12-27	WOS:000171789200018
J	Webb, HM; Ruddock, LW; Marchant, RJ; Jonas, K; Klappa, P				Webb, HM; Ruddock, LW; Marchant, RJ; Jonas, K; Klappa, P			Interaction of the periplasmic peptidylprolyl cis-trans isomerase SurA with model peptides - The N-terminal region of SurA is essential and sufficient for peptide binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; PROLYL CIS/TRANS ISOMERASES; ESCHERICHIA-COLI SURA; TRIGGER FACTOR; CIS,TRANS-ISOMERASE FKPA; PRESECRETORY PROTEINS; MISFOLDED PROTEINS; STATIONARY-PHASE; CATALYSIS; RECOGNITION	One of the rate-limiting steps in protein folding has been shown to be the cis-trans isomerization of proline residues, which is catalyzed by a range of peptidylprolyl cis-trans isomerases. To characterize the interaction between model peptides and the periplasmic peptidylprolyl cis-trans isomerase SurA from E. coli, we employed a chemical cross-linking strategy that has been used previously to elucidate the interaction of substrates with other folding catalysts. The interaction between purified SurA and model peptides was significant in that it showed saturation and was abolished by denaturation of SurA; however the interaction was independent of the presence of proline residues in the model peptides. From results obtained by limited proteolysis we conclude that an N-terminal fragment of SurA, comprising 150 amino acids that do not contain the active sites involved in the peptidylprolyl cis-trans isomerization, is essential for the binding of peptides by SurA. This was confirmed by probing the interaction of the model peptide with the recombinant N-terminal fragment, expressed in Escherichia coli. Hence we propose that, similar to protein disulfide isomerase and other folding catalysts, SurA exhibits a modular architecture composed of a substrate binding domain and distinct catalytically active domains.	Univ Kent, Canterbury CT2 7NJ, Kent, England; Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland	University of Kent; Finland National Institute for Health & Welfare; University of Oulu	Klappa, P (corresponding author), Univ Kent, Canterbury CT2 7NJ, Kent, England.			Ruddock, Lloyd/0000-0002-6247-686X; Jonas, Kim/0000-0003-1891-2617				Bang N, 2000, EUR J BIOCHEM, V267, P3270, DOI 10.1046/j.1432-1327.2000.01355.x; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; FREEDMAN RB, 1995, METHOD ENZYMOL, V251, P397, DOI 10.1016/0076-6879(95)51143-1; FREEDMAN RB, 1999, MOL CHAPERONES PROTE, P437; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1996, EUR J BIOCHEM, V239, P509, DOI 10.1111/j.1432-1033.1996.0509u.x; Klappa P, 2000, J BIOL CHEM, V275, P13213, DOI 10.1074/jbc.275.18.13213; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KLAPPA P, 1991, EMBO J, V10, P2795, DOI 10.1002/j.1460-2075.1991.tb07828.x; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Lazar SW, 1998, J BACTERIOL, V180, P5704, DOI 10.1128/JB.180.21.5704-5711.1998; Maruyama T, 2000, FRONT BIOSCI-LANDMRK, V5, pD821, DOI 10.2741/maruyama; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Ramm K, 2000, J BIOL CHEM, V275, P17106, DOI 10.1074/jbc.M910234199; Ruddock LW, 2000, PROTEIN SCI, V9, P758; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Scholz C, 1998, J MOL BIOL, V277, P723, DOI 10.1006/jmbi.1997.1604; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; TORMO A, 1990, J BACTERIOL, V172, P4339, DOI 10.1128/jb.172.8.4339-4347.1990; YURA T, 1992, NUCLEIC ACIDS RES, V20, P3305, DOI 10.1093/nar/20.13.3305; Zarnt T, 1997, J MOL BIOL, V271, P827, DOI 10.1006/jmbi.1997.1206	26	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45622	45627		10.1074/jbc.M107508200	http://dx.doi.org/10.1074/jbc.M107508200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11546789	Green Accepted, hybrid			2022-12-27	WOS:000172573100019
J	Ho, YY; Deckelbaum, RJ; Chen, YH; Vogel, T; Talmage, DA				Ho, YY; Deckelbaum, RJ; Chen, YH; Vogel, T; Talmage, DA			Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; APOPROTEIN-E; SIGNAL-TRANSDUCTION; EXPRESSION; MACROPHAGES; BINDING; GROWTH; RAT; ACTIVATION	Independently of its role in lipid homeostasis, apolipoprotein E (apoE) inhibits cell proliferation. We compared the effects of apoE added to media (exogenous apoE) with the effects of stably expressed apoE (endogenous apoE) on cell proliferation. Exogenous and endogenous apoE increased population doubling times by 30-50% over a period of 14 days by prolonging the G(1) phase of the cell cycle. Exogenous and endogenous apoE also decreased serum-stimulated DNA synthesis by 30-50%. However, apoE did not cause cell cycle arrest; both apoE-treated and control cells achieved equivalent saturation densities at 14 days. Further analyses demonstrated that exogenous and endogenous apoE prevented activation of MAPK but not induction of c-fos expression in response to serum growth factors. Endogenous (but not exogenous) apoE altered serum concentration-dependent effects on proliferation. Whereas control (non-apoE-expressing) cell numbers increased with increasing serum concentrations (1.6-fold for every 2-fold increase in serum), apoE-expressing cell numbers did not differ as serum levels were raised from 2.5 to 10%. In addition, in low serum (0.1%), apoE-expressing cells had elevated DNA synthesis levels compared with control cells. We conclude that apoE does not simply inhibit cell proliferation; rather, the presence of apoE alters the response to and requirement for serum mitogens.	Columbia Univ, Inst Human Nutr, HHSC 5 503, New York, NY 10032 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA; Biotechnol Gen Ltd, IL-76326 Rehovot, Israel	Columbia University; Columbia University	Talmage, DA (corresponding author), Columbia Univ, Inst Human Nutr, HHSC 5 503, 701 W 168th St, New York, NY 10032 USA.	dat1@columbia.edu		Talmage, David/0000-0003-4627-3007	NATIONAL CANCER INSTITUTE [R01CA079737] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040404] Funding Source: NIH RePORTER; NCI NIH HHS [CA79737] Funding Source: Medline; NHLBI NIH HHS [HL40404] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; BROWNING PJ, 1994, J EXP MED, V180, P1949, DOI 10.1084/jem.180.5.1949; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chen SC, 1998, J CLIN INVEST, V102, P653, DOI 10.1172/JCI3483; Chen YC, 1999, ONCOGENE, V18, P139, DOI 10.1038/sj.onc.1202272; CRESPO P, 1993, LEUKEMIA RES, V17, P771, DOI 10.1016/0145-2126(93)90111-W; DAHAN S, 1994, J CELL BIOL, V127, P1859, DOI 10.1083/jcb.127.6.1859; DEVIVO M, 1994, J BIOL CHEM, V269, P19671; DORY L, 1991, J LIPID RES, V32, P783; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Garcia JH, 1996, NEUROIMAG CLIN N AM, V6, P801; GRANOT E, 1995, ATHEROSCLEROSIS, V114, P115, DOI 10.1016/0021-9150(94)05475-X; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Ho YY, 2000, BIOCHEMISTRY-US, V39, P4746, DOI 10.1021/bi992294a; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Khuri FR, 1996, CELL GROWTH DIFFER, V7, P595; Lin CY, 1998, J LIPID RES, V39, P293; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAJACK RA, 1988, J CELL BIOL, V107, P1207, DOI 10.1083/jcb.107.3.1207; Mamdouh Z, 2000, CIRCULATION, V102, P87; MAZZONE T, 1992, J BIOL CHEM, V267, P1081; MAZZONE T, 1994, J LIPID RES, V35, P1345; OSEIFRIMPONG J, 1994, MOL CARCINOGEN, V10, P72, DOI 10.1002/mc.2940100204; Paka L, 1999, J BIOL CHEM, V274, P36403, DOI 10.1074/jbc.274.51.36403; RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514; REYLAND ME, 1991, J BIOL CHEM, V266, P21099; REYLAND ME, 1992, J BIOL CHEM, V267, P17933; RIFAI N, 1987, CLIN CHIM ACTA, V163, P207, DOI 10.1016/0009-8981(87)90024-6; ROSENFELD ME, 1993, ARTERIOSCLER THROMB, V13, P1382, DOI 10.1161/01.ATV.13.9.1382; ROSES AD, 1995, ARZNEIMITTEL-FORSCH, V45-1, P413; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; SEITZ WR, 1984, CLIN BIOCHEM, V17, P120; Swertfeger DK, 2001, J BIOL CHEM, V276, P25043, DOI 10.1074/jbc.M102357200; TALMAGE DA, 1991, CELL GROWTH DIFFER, V2, P51; TALMAGE DA, 1992, ONCOGENE, V7, P1837; Thommes KB, 1996, EXP CELL RES, V226, P59, DOI 10.1006/excr.1996.0202; VOGEL T, 1994, J CELL BIOCHEM, V54, P299, DOI 10.1002/jcb.240540306; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068	41	22	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43455	43462		10.1074/jbc.M105325200	http://dx.doi.org/10.1074/jbc.M105325200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551921	hybrid			2022-12-27	WOS:000172169300106
J	Nakajima, H; Kiyokawa, N; Katagiri, YU; Taguchi, T; Suzuki, T; Sekino, T; Mimori, K; Ebata, T; Saito, M; Nakao, H; Takeda, T; Fujimoto, J				Nakajima, H; Kiyokawa, N; Katagiri, YU; Taguchi, T; Suzuki, T; Sekino, T; Mimori, K; Ebata, T; Saito, M; Nakao, H; Takeda, T; Fujimoto, J			Kinetic analysis of binding between shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O157-H7; HEMOLYTIC UREMIC SYNDROMES; N-GLYCOSIDASE ACTIVITY; MELANOMA B16 CELLS; GLOBOTRIAOSYL CERAMIDE; CHOLERA-TOXIN; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; SHIGELLA-DYSENTERIAE; CRYSTAL-STRUCTURE	Shiga toxin (Stx) binds to the receptor glycolipid Gb3Cer on the cell surface and is responsible for hemolytic uremic syndrome. Stx has two isoforms, Stx1 and Stx2, and in clinical settings Stx2 is known to cause more severe symptoms, although the differences between the mechanisms of action of Stx1 and Stx2 are as yet unknown. In this study, the binding modes of these two isoforms to the receptor were investigated with a surface plasmon resonance analyzer to compare differences by real time receptor binding analysis. A sensor chip having a lipophilically modified dextran matrix or quasicrystalline hydrophobic layer was used to immobilize an amphipathic lipid layer that mimics the plasma membrane surface. Dose responsiveness was observed with both isoforms when either the toxin concentration or the Gb3Cer concentration was increased. In addition, this assay was shown to be specific, because neither Stx1 nor Stx2 bound to GM3, but both bound weakly to Gb4Cer. It was also shown that a number of fitting models can be used to analyze the sensorgrams obtained with different concentrations of the toxins, and the "bivalent analyte" model was found to best fit the interaction between Stxs and Gb3Cer. This shows that,the interaction between Stxs and Gb3Cer in the lipid bilayer has a multivalent effect. The presence of cholesterol in the lipid bilayer significantly enhanced the binding of Stxs to Gb3Cer, although kinetics were unaffected. The association and dissociation rate constants of Stx1 were larger than those of Stx2: Stx2 binds to the receptor more slowly than Stx1 but, once bound, is difficult to dissociate. The data described herein clearly demonstrate differences between the binding properties of Stx1 and Stx2 and may facilitate understanding of the differences in clinical manifestations caused by these toxins.	Natl Childrens Med Res Ctr, Dept Pathol, Setagaya Ku, Tokyo 1548509, Japan; Natl Childrens Med Res Ctr, Dept Infect Dis, Setagaya Ku, Tokyo 1548509, Japan; Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST)	Fujimoto, J (corresponding author), Natl Childrens Med Res Ctr, Dept Pathol, Setagaya Ku, 3-35-31 Taishido, Tokyo 1548509, Japan.							Arab S, 1996, GLYCOCONJUGATE J, V13, P159, DOI 10.1007/BF00731490; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brigotti M, 1997, TOXICON, V35, P1431, DOI 10.1016/S0041-0101(96)00225-5; BRULET P, 1977, BIOCHEMISTRY-US, V16, P1209, DOI 10.1021/bi00625a028; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Erb EM, 2000, ANAL BIOCHEM, V280, P29, DOI 10.1006/abio.1999.4469; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Hakomori SI, 1998, ANN NY ACAD SCI, V845, P1, DOI 10.1111/j.1749-6632.1998.tb09657.x; HAMALAINEN M, 1998, BIA J, V5, P12; HEAD SC, 1991, J BIOL CHEM, V266, P3617; IUPAC-IUB Commission on Biochemical Nomenclature, 1977, LIPIDS, V12, P455; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Iwabuchi K, 2000, J BIOL CHEM, V275, P15174, DOI 10.1074/jbc.275.20.15174; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; JACKSON MP, 1987, MICROB PATHOGENESIS, V2, P147, DOI 10.1016/0882-4010(87)90106-9; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; KAYE SA, 1993, INFECT IMMUN, V61, P3886, DOI 10.1128/IAI.61.9.3886-3891.1993; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; KHINE AA, 1994, J CELL PHYSIOL, V161, P319, DOI 10.1002/jcp.1041610217; KLEANTHOUS H, 1990, ARCH DIS CHILD, V65, P722, DOI 10.1136/adc.65.7.722; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lange S, 1997, J BIOL CHEM, V272, P20884, DOI 10.1074/jbc.272.33.20884; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Lingwood CA, 2000, METHOD ENZYMOL, V312, P459; LOUISE CB, 1995, INFECT IMMUN, V63, P2766, DOI 10.1128/IAI.63.7.2766-2769.1995; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; MacKenzie CR, 2000, METHOD ENZYMOL, V312, P205; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; MASSERINI M, 1992, BIOCHEMISTRY-US, V31, P2422, DOI 10.1021/bi00123a030; MERRITT EA, 1994, PROTEIN SCI, V3, P166; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; MILFORD DV, 1990, ARCH DIS CHILD, V65, P716, DOI 10.1136/adc.65.7.716; Mori T, 2000, EXP HEMATOL, V28, P1260, DOI 10.1016/S0301-472X(00)00538-5; Mylvaganam M, 2000, METHOD ENZYMOL, V312, P473; Nakajima H, 2001, PROTEIN EXPRES PURIF, V22, P267, DOI 10.1006/prep.2001.1449; NYHOLM PG, 1995, INT J BIOL MACROMOL, V17, P199, DOI 10.1016/0141-8130(95)92686-K; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; OGASAWARA T, 1988, MICROB PATHOGENESIS, V4, P127, DOI 10.1016/0882-4010(88)90054-X; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Peter MG, 2000, BBA-MOL BASIS DIS, V1501, P116, DOI 10.1016/S0925-4439(00)00011-9; Picking WD, 1999, BIOCHEMISTRY-US, V38, P7177, DOI 10.1021/bi982335n; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; SAXENA SK, 1989, J BIOL CHEM, V264, P596; SCOTLAND SM, 1987, EPIDEMIOL INFECT, V99, P613, DOI 10.1017/S0950268800066462; SPECTOR AA, 1985, J LIPID RES, V26, P1015; STEFFNER P, 1997, BIA J, V4, P10; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Yuan CB, 2000, BIOPHYS J, V79, P2768, DOI 10.1016/S0006-3495(00)76516-7	53	106	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42915	42922		10.1074/jbc.M106015200	http://dx.doi.org/10.1074/jbc.M106015200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11557760	hybrid			2022-12-27	WOS:000172169300039
J	Heeren, J; Grewal, T; Jackle, S; Beisiegel, U				Heeren, J; Grewal, T; Jackle, S; Beisiegel, U			Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PERITONEAL-MACROPHAGES; LOW-DENSITY-LIPOPROTEIN; TRIGLYCERIDE-RICH LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; RECEPTOR-RELATED PROTEIN; LDL-RECEPTOR; RAT-LIVER; BETA-VLDL; DEGRADATION; FRACTIONS	We have recently described a novel recycling pathway of triglyceride-rich lipoprotein (TRL)-associated apolipoprotein (apo) E in human hepatoma cells. We now demonstrate that not only TRL-derived apoE but also lipoprotein lipase (LPL) is efficiently recycled in vitro and in vivo. Similar recycling kinetics of apoE and LPL in normal and low density lipoprotein receptor-negative human fibroblasts also indicate that the low density lipoprotein receptor-related protein seems to be involved. Intracellular sorting mechanisms are responsible for reduced lysosomal degradation of both ligands after receptor-mediated internalization. Immediately after internalization in rat liver, TRLs are disintegrated, and apoE and LPL are found in endosomal compartments, whereas TRL-derived phospholipids accumulate in the perinuclear region of hepatocytes. Subsequently, substantial amounts of both proteins can be found in purified recycling endosomes, indicating a potential resecretion of these TRL components. Pulse-chase experiments of perfused rat livers with radiolabeled TRLs demonstrated a serum-induced release of internalized apoE and LPL into the perfusate. Analysis of the secreted proteins identified similar to 80% of the recycled TRL-derived proteins in the high density lipoprotein fractions. These results provide the first evidence that recycling of TRL-derived apoE and LPL could play an important role in the modulation of lipoproteins in vivo.	Univ Hamburg, Hosp Eppendorf, Dept Med Biochem & Mol Biol, D-20246 Hamburg, Germany	University of Hamburg	Heeren, J (corresponding author), Univ Hamburg, Hosp Eppendorf, Dept Internal Med, Martinistr 52, D-20249 Hamburg, Germany.		Eckhardt, Erik/G-1567-2010	Grewal, Thomas/0000-0002-7937-8887				BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Beisiegel U, 1997, P NUTR SOC, V56, P731, DOI 10.1079/PNS19970073; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; BRADLEY WA, 1986, J LIPID RES, V27, P40; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Enrich C, 1999, HEPATOLOGY, V30, P1115, DOI 10.1002/hep.510300505; Fazio S, 1999, J BIOL CHEM, V274, P8247, DOI 10.1074/jbc.274.12.8247; FELTS JM, 1975, BIOCHEM BIOPH RES CO, V66, P1467, DOI 10.1016/0006-291X(75)90524-0; Goldberg IJ, 1996, J LIPID RES, V37, P693; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Havel R J, 1986, Methods Enzymol, V129, P591; Heeren J, 1999, J CELL SCI, V112, P349; Heeren J, 2001, CURR OPIN LIPIDOL, V12, P255, DOI 10.1097/00041433-200106000-00003; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; JACKLE S, 1991, J LIPID RES, V32, P485; Ji ZS, 1998, J BIOL CHEM, V273, P13452, DOI 10.1074/jbc.273.22.13452; JONES AL, 1984, J LIPID RES, V25, P1151; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; LOMBARDI P, 1993, J BIOL CHEM, V268, P26113; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Mahley RW, 1999, J LIPID RES, V40, P1; MYERS JN, 1993, J CELL BIOL, V123, P1389, DOI 10.1083/jcb.123.6.1389; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Pol A, 1997, BIOCHEM J, V323, P435, DOI 10.1042/bj3230435; Pol A, 1997, ELECTROPHORESIS, V18, P2548, DOI 10.1002/elps.1150181410; Rensen PCN, 2000, J BIOL CHEM, V275, P8564, DOI 10.1074/jbc.275.12.8564; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Zambon A, 1996, J LIPID RES, V37, P2394	33	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42333	42338		10.1074/jbc.M107461200	http://dx.doi.org/10.1074/jbc.M107461200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546820	hybrid			2022-12-27	WOS:000172450400104
J	Hong, ERL; Shinohara, A; Bishop, DK				Hong, ERL; Shinohara, A; Bishop, DK			Saccharomyces cerevisiae Dmc1 protein promotes renaturation of single-strand DNA (ssDNA) and assimilation of ssDNA into homologous super-coiled duplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECA; HUMAN RAD51 PROTEIN; FORMS RING STRUCTURES; MEIOTIC RECOMBINATION; NUCLEOPROTEIN FILAMENT; ATP HYDROLYSIS; BREAK REPAIR; EXCHANGE; COMPLEXES; SYNAPSIS	Dmc1 and Rad51 are eukaryotic RecA homologues that are involved in meiotic recombination. The expression of Dmc1 is limited to meiosis, whereas Rad51 is expressed in mitosis and meiosis. Dmc1 and Ptad51 have unique and overlapping functions during meiotic recombination. Here we report the purification of the Dmc1 protein from the budding yeast Saccharomyces cerevisiae and present basic characterization of its biochemical activity. The protein has a weak DNA-dependent ATPase activity and binds both single-strand DNA (ssDNA) and double-strand DNA. Electrophoretic mobility shift assays suggest that DNA binding by Dmc1 is cooperative. Dmc1 renatures linearized plasmid DNA with first order reaction kinetics and without requiring added nucleotide cofactor. In addition, Dmc1 catalyzes strand assimilation of ssDNA oligonucleotides into homologous supercoiled duplex DNA in a reaction promoted by ATP or the non-hydrolyzable ATP analogue AMP-PNP.	Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	University of Chicago; University of Chicago; Osaka University	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.				NIGMS NIH HHS [GM50936] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BRYANT FR, 1989, BIOCHEMISTRY-US, V28, P1062, DOI 10.1021/bi00429a021; BRYANT FR, 1985, P NATL ACAD SCI USA, V82, P297, DOI 10.1073/pnas.82.2.297; De Zutter SK, 1999, J MOL BIOL, V293, P769, DOI 10.1006/jmbi.1999.3200; Dresser ME, 1997, GENETICS, V147, P533; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Huang H V, 1988, Biotechnology, V10, P269; Ivanov EL, 1996, GENETICS, V142, P693; KOLODNER R, 1980, P NATL ACAD SCI-BIOL, V77, P4847, DOI 10.1073/pnas.77.8.4847; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; LAUDER SD, 1991, J BIOL CHEM, V266, P5450; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MCENTEE K, 1985, BIOCHEMISTRY-US, V24, P4345, DOI 10.1021/bi00337a014; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Namsaraev EA, 1998, J BIOL CHEM, V273, P6177, DOI 10.1074/jbc.273.11.6177; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; RADDING CM, 1991, J BIOL CHEM, V266, P5355; RATTRAY AJ, 1994, GENETICS, V138, P587; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; Shinohara A, 1999, MUTAT RES-DNA REPAIR, V435, P13, DOI 10.1016/S0921-8777(99)00033-6; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; SIKORSKI RS, 1989, GENETICS, V122, P19; SILVER MS, 1982, BIOCHEMISTRY-US, V21, P6066, DOI 10.1021/bi00267a007; STASIAK A, 1992, MOL MICROBIOL, V6, P3267, DOI 10.1111/j.1365-2958.1992.tb02194.x; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; TERASAWA M, 1995, GENE DEV, V9, P925, DOI 10.1101/gad.9.8.925; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126	65	108	109	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41906	41912		10.1074/jbc.M105563200	http://dx.doi.org/10.1074/jbc.M105563200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551925	hybrid			2022-12-27	WOS:000172450400049
J	Nilsson, IM; Ohvo-Rekila, H; Slotte, JP; Johnson, AE; von Heijne, G				Nilsson, IM; Ohvo-Rekila, H; Slotte, JP; Johnson, AE; von Heijne, G			Inhibition of protein translocation across the endoplasmic reticulum membrane by sterols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE ANISOTROPY DECAY; HIGHER-ORDER ANALYSIS; PLASMA-MEMBRANE; CHOLESTEROL ACYLTRANSFERASE; INTRACELLULAR CHOLESTEROL; HUMAN-FIBROBLASTS; SIGNAL SEQUENCE; RAT-LIVER; ACYL-COA; CULTURED FIBROBLASTS	Cholesterol and related sterols are known to modulate the physical properties of biological membranes and can affect the activities of membrane-bound protein complexes. Here, we report that an early step in protein translocation across the endoplasmic reticulum (ER) membrane is reversibly inhibited by cholesterol levels significantly lower than those found in the plasma membrane. By UV-induced chemical cross-linking we further show that high cholesterol levels prevent cross-linking between ribosome-nascent chain complexes and components of the Sec61 translocon, but have no effect on cross-linking to the signal recognition particle. The inhibiting effect on translocation is different between different sterols. Our data suggest that the protein translocation machinery may be sensitive to changes in cholesterol levels in the ER membrane.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Abo Akad Univ, Dept Biochem & Pharm, FIN-20521 Turku, Finland; Texas A&M Univ, Syst Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA	Stockholm University; Abo Akademi University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.		Johnson, Arthur E/G-3457-2012; von Heijne, Gunnar/AAH-9389-2019; Nilsson, IngMarie/H-2887-2012; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 26494] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENYASHAR V, 1989, BIOCHIM BIOPHYS ACTA, V985, P271, DOI 10.1016/0005-2736(89)90412-4; BILLHEIMER JT, 1985, METHOD ENZYMOL, V111, P286; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brown MS, 1998, NUTR REV, V56, pS1; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Christian AE, 1997, J LIPID RES, V38, P2264; CLEJAN S, 1981, BIOCHEMISTRY-US, V20, P2200, DOI 10.1021/bi00511a019; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Field FJ, 1998, J LIPID RES, V39, P333; Fielding CJ, 1997, J LIPID RES, V38, P1503; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; Finegold L., 1993, CHOLESTEROL MEMBRANE; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; Greenfield JJA, 1999, J CELL SCI, V112, P1477; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; KUDCHODKAR BJ, 1983, ATHEROSCLEROSIS, V46, P353, DOI 10.1016/0021-9150(83)90184-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lange Y, 1997, J BIOL CHEM, V272, P17018, DOI 10.1074/jbc.272.27.17018; LANGE Y, 1984, J BIOL CHEM, V259, P4624; LANGE Y, 1993, J BIOL CHEM, V268, P13838; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Lange Y, 1998, CURR OPIN STRUC BIOL, V8, P435, DOI 10.1016/S0959-440X(98)80119-X; LANGE Y, 1994, J BIOL CHEM, V269, P29371; LANGE Y, 1991, J LIPID RES, V32, P329; Lange Y, 1999, J LIPID RES, V40, P2264; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LAU WF, 1995, EXPERIENTIA, V51, P731, DOI 10.1007/BF01941271; Leppimaki P, 2000, EUR J BIOCHEM, V267, P6385, DOI 10.1046/j.1432-1327.2000.01726.x; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LILJESTROM P, 1991, J VIROL, V65, P147; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MITCHELL DC, 1990, BIOCHEMISTRY-US, V29, P9143, DOI 10.1021/bi00491a007; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; OKWU AK, 1994, J LIPID RES, V35, P644; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RANADIVE GN, 1987, BIOCHEMISTRY-US, V26, P2426, DOI 10.1021/bi00383a005; REINHART MP, 1987, J BIOL CHEM, V262, P9649; ROTHBLAT GH, 1971, J LIPID RES, V12, P647; RUJANAVECH C, 1986, J BIOL CHEM, V261, P7196; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Skiba PJ, 1996, J BIOL CHEM, V271, P13392, DOI 10.1074/jbc.271.23.13392; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; STRAUME M, 1988, BIOCHEMISTRY-US, V27, P7723, DOI 10.1021/bi00420a022; STRAUME M, 1987, BIOCHEMISTRY-US, V26, P5121, DOI 10.1021/bi00390a034; TAVANI DM, 1982, J LIPID RES, V23, P774; Urich, 1994, COMP ANIMAL BIOCH, P624, DOI DOI 10.1007/978-3-662-06303-3_16; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; van Meer G, 1998, TRENDS CELL BIOL, V8, P29, DOI 10.1016/S0962-8924(97)01196-3; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; XU XX, 1991, J BIOL CHEM, V266, P17040; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; YEAGLE PL, 1988, BIOL CHOLESTEROL, P121; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	71	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41748	41754		10.1074/jbc.M105823200	http://dx.doi.org/10.1074/jbc.M105823200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535595	hybrid			2022-12-27	WOS:000172450400029
J	Saelens, X; Kalai, M; Vandenabeele, P				Saelens, X; Kalai, M; Vandenabeele, P			Translation inhibition in apoptosis - Caspase-dependent PKR activation and eIF2-alpha phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; TUMOR-NECROSIS-FACTOR; INITIATION-FACTOR 4G; INTERFERON-GAMMA; BINDING DOMAINS; TNF-ALPHA; CLEAVAGE; DIMERIZATION; CELLS	The protein kinase PKR is a major player in the cellular antiviral response, acting mainly by phosphorylation of the alpha -subunit of the eukaryotic translation initiation factor 2 (eIF2-alpha) to block de novo protein synthesis. PKR activation requires binding of double-stranded RNA or PACT/RAX proteins to its regulatory domain. Since several reports have demonstrated that translation is inhibited in apoptosis, we investigated whether PKR and eIF2-alpha phosphorylation contribute to this process. We show that PKR is proteolysed and that eIF2-alpha is phosphorylated at the early stages of apoptosis induced by various stimuli. Both events coincide with the onset of caspase activity and are prevented by caspase inhibitors. Using site-directed mutagenesis we show that PKR is specifically proteolysed at Asp(251) during cellular apoptosis. This site is cleaved in vitro by recombinant caspase-3, caspase-7, and caspase-8 and not by the proinflammatory caspase-1 and caspase-11. The released kinase domain efficiently phosphorylates eIF2-alpha at the cognate Ser(51) residue, and its overexpression in mammalian cells impairs the translation of its own mRNA and of reporter mRNAs. Our results demonstrate a new and caspase-dependent activation mode for PKR, leading to eIF2-alpha phosphorylation and translation inhibition in apoptosis.	Flanders Interuniv Inst Biotechnol, Dept Mol Biol, Unit Mol Signaling & Cell Death, B-9000 Ghent, Belgium; Univ Ghent, B-9000 Ghent, Belgium	Ghent University	Vandenabeele, P (corresponding author), Flanders Interuniv Inst Biotechnol, Dept Mol Biol, Unit Mol Signaling & Cell Death, KL Ledaganckstr 35, B-9000 Ghent, Belgium.	peter.vandenabeele@dmb.rug.ac.be	Vandenabeele, Peter/AAD-5793-2022; Saelens, Xavier/N-5728-2015; Vandenabeele, Peter/C-8597-2009	Vandenabeele, Peter/0000-0002-6669-8822; , Xavier/0000-0002-3861-6965				Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; de la Vega CM, 1999, CELL SIGNAL, V11, P399, DOI 10.1016/S0898-6568(99)00009-1; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; FRANSEN L, 1986, EUR J CANCER CLIN ON, V22, P419, DOI 10.1016/0277-5379(86)90107-0; Fulda S, 2000, CANCER RES, V60, P3947; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; McCarthy JEG, 2000, CURR BIOL, V10, pR715, DOI 10.1016/S0960-9822(00)00706-5; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MIN JW, 1980, CELL, V19, P683; Morley SJ, 1998, FEBS LETT, V438, P41, DOI 10.1016/S0014-5793(98)01269-1; Nadano D, 2000, J BIOL CHEM, V275, P13967, DOI 10.1074/jbc.275.18.13967; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; OLDFIELD S, 1994, EUR J BIOCHEM, V221, P399, DOI 10.1111/j.1432-1033.1994.tb18752.x; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296; SAFER B, 1983, CELL, V33, P7, DOI 10.1016/0092-8674(83)90326-4; Satoh S, 1999, BIOCHEM J, V342, P65, DOI 10.1042/0264-6021:3420065; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; Tang NM, 1999, MOL CELL BIOL, V19, P4757; TSUJIMOTO M, 1986, J IMMUNOL, V136, P2441; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Utz PJ, 2000, CELL DEATH DIFFER, V7, P589, DOI 10.1038/sj.cdd.4400696; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yeung MC, 1996, P NATL ACAD SCI USA, V93, P12451, DOI 10.1073/pnas.93.22.12451; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434	54	150	155	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41620	41628		10.1074/jbc.M103674200	http://dx.doi.org/10.1074/jbc.M103674200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11555640	hybrid			2022-12-27	WOS:000172450400013
J	Shima, T; Okumura, N; Takao, T; Satomi, Y; Yagi, T; Okada, M; Nagai, K				Shima, T; Okumura, N; Takao, T; Satomi, Y; Yagi, T; Okada, M; Nagai, K			Interaction of the SH2 domain of Fyn with a cytoskeletal protein beta-adducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-DEFICIENT MICE; TYROSINE-PHOSPHORYLATED PROTEINS; FOCAL ADHESION KINASE; SRC-FAMILY KINASES; INCREASED FEARFULNESS; MEMBRANE SKELETON; PLASMA-MEMBRANE; BINDING-PROTEIN; RHO-KINASE; ASSOCIATION	Fyn is a Src family tyrosine kinase expressed abundantly in neurons and believed to have specific functions in the brain. To understand the function of Fyn tyrosine kinase, we attempted to identify Fyn Src homology 2 (SH2) domain-binding proteins from a Nonidet P-40-insoluble fraction of the mouse brain. beta -Adducin, an actin filament-associated cytoskeletal protein, was isolated by two-dimensional gel electrophoresis and identified by tandem mass spectrometry. beta -Adducin was tyrosine phosphorylated by coexpression with wild type but not with a kinase-negative form of Fyn in COS-7 cells. Cell staining analysis showed that coexpression of beta -adducin with Fyn induced translocation of beta -adducin from the cytoplasm to the periphery of the cells where it was colocalized with actin filaments and Fyn. These findings suggest that tyrosine-phosphorylated beta -adducin associates with the SH2 domain of Fyn and colocalizes under plasma membranes.	Osaka Univ, Inst Prot Res, Div Prot Metab, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Div Organ Chem, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Mol & Cellular Biol, Div Mol Genet, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Okumura, N (corresponding author), Osaka Univ, Inst Prot Res, Div Prot Metab, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	taisha@protein.osaka-u.ac.jp		Satomi, Yoshinori/0000-0002-8991-1040				ALLAND L, 1994, J BIOL CHEM, V269, P16701; BARE DJ, 1993, ONCOGENE, V8, P1429; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; BENNETT V, 1988, J BIOL CHEM, V263, P5860; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; BIXBY JL, 1993, J NEUROSCI, V13, P3421; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; DONG LQ, 1995, J BIOL CHEM, V270, P25534, DOI 10.1074/jbc.270.43.25534; Fernandez-de-Cossio J, 2000, ELECTROPHORESIS, V21, P1694, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1694::AID-ELPS1694>3.0.CO;2-W; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GARDNER K, 1986, J BIOL CHEM, V261, P1339; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; ICHIHARA Y, 2000, NATURE, V408, P448; JOSHI R, 1991, J CELL BIOL, V115, P665, DOI 10.1083/jcb.115.3.665; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; KIPROV D, 1980, COR VASA, V22, P116; Kobayashi S, 1997, J BIOL CHEM, V272, P16262, DOI 10.1074/jbc.272.26.16262; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LING E, 1986, J BIOL CHEM, V261, P13875; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Miyakawa T, 1996, MOL BRAIN RES, V37, P145; MIYAKAWA T, 1994, MOL BRAIN RES, V27, P179, DOI 10.1016/0169-328X(94)90201-1; MIYAKAWA T, 1995, MOL BRAIN RES, V28, P349, DOI 10.1016/0169-328X(94)00251-9; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; NADA S, 1994, ONCOGENE, V9, P3571; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; PALFREY HC, 1985, J BIOL CHEM, V260, P6021; PARSONS JT, 1989, CURR TOP MICROBIOL, V147, P79; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Shima T, 2000, BRAIN RES, V870, P36, DOI 10.1016/S0006-8993(00)02399-4; TAKEUCHI M, 1993, J BIOL CHEM, V268, P27413; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; WASEEM A, 1988, EUR J BIOCHEM, V178, P563, DOI 10.1111/j.1432-1033.1988.tb14483.x; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; YAGI T, 1993, ONCOGENE, V8, P3343	46	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42233	42240		10.1074/jbc.M102699200	http://dx.doi.org/10.1074/jbc.M102699200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11526103	hybrid			2022-12-27	WOS:000172450400093
J	Hanada, T; Yoshida, T; Kinjyo, I; Minoguchi, S; Yasukawa, H; Kato, S; Mimata, H; Nomura, Y; Seki, Y; Kubo, M; Yoshimura, A				Hanada, T; Yoshida, T; Kinjyo, I; Minoguchi, S; Yasukawa, H; Kato, S; Mimata, H; Nomura, Y; Seki, Y; Kubo, M; Yoshimura, A			A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING SUPPRESSOR; STAT3 ACTIVATION; T-CELLS; LIVER; APOPTOSIS; BINDING; GAMMA; DIFFERENTIATION; ELONGATION; REGULATOR	Cytokines exert biological functions by activating Janus tyrosine kinases (JAKs), and JAR inhibitors JAB (also referred to as SOCS1 and SSI1) and CIS3 (SOCS3) play an essential role in the negative regulation of cytokine signaling. We have found that transgenic (Tg) mice expressing a mutant JAB (F59D-JAB) exhibited a more potent STAT3 activation and a more severe colitis than did wild-type littermates after treatment with dextran sulfate sodium. We now find that there is a prolonged activation of JAKs and STATs in response to a number of cytokines in T cells from Tg mice with lek promoter-driven F59D-JAB. Overexpression of F59D-JAB also sustained activation of JAK2 in Ba/F3 cells. These data suggested that F59D-JAB up-regulated STAT activity by sustaining JAK activation. To elucidate molecular mechanisms related to F59D-JAB, we analyzed the effects of F59D-JAB on the JAK/STAT pathway using the 293 cell transient expression system. We found that the C-terminal SOCS-box played an essential role in augmenting cytokine signaling by F59D-JAB. The SOCS-box interacted with the Elongin BC complex, and this interaction stabilized JAB. F59D-JAB induced destabilization of wild-type JAB, whereas overexpression of Elongin BC canceled this effect. Levels of endogenous JAB and CIS3 in T cells from F59D-JAB Tg-mouse were lower than in wild-type mice. We propose that F59D-JAB destabilizes wild-type, endogenous JAB and CIS3 by chelating the Elongin BC complex, thereby sustaining JAK activation.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Oita Med Univ, Dept Urol, Oita 8795593, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan; Kurume Univ, Dept Pathol, Kurume, Fukuoka 8300011, Japan; Tokyo Univ Sci, Res Inst Biol Sci, Div Immunobiol, Noda, Chiba 2780022, Japan	Kyushu University; Oita University; Kurume University; Kurume University; Tokyo University of Science	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013	Kinjyo, Ichiko/0000-0001-7051-3790				Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Attar RM, 1998, MOL CELL BIOL, V18, P477, DOI 10.1128/MCB.18.1.477; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Suzuki R, 1998, ONCOGENE, V17, P2271, DOI 10.1038/sj.onc.1202143; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	35	63	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40746	40754		10.1074/jbc.M106139200	http://dx.doi.org/10.1074/jbc.M106139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522790	hybrid			2022-12-27	WOS:000171925600051
J	Hoffmann, J; Haendeler, J; Zeiher, AM; Dimmeler, S				Hoffmann, J; Haendeler, J; Zeiher, AM; Dimmeler, S			TNF alpha and oxLDL reduce protein S-nitrosylation in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; APOPTOSIS; NO; NITROSOGLUTATHIONE; NITROSATION; SUPPRESSION; GLUTATHIONE; ACTIVATION; CASPASE-3; ENZYME	Nitric oxide (NO) plays an important role in the regulation of the functional integrity of the endothelium. The intracellular reaction of NO with reactive cysteine groups leads to the formation of S-nitrosothiols. To investigate the regulation of S-nitrosothiols in endothelial cells, we first analyzed the composition of the S-nitrosylated molecules in endothelial cells. Gel filtration revealed that more than 95% of the detected S-nitrosothiols had a molecular mass of more than 5000 Da. Moreover, inhibition of de novo synthesis of glutathione using N-butyl-sulfoximine did not diminish the overall cellular S-NO content suggesting that S-nitrosylated glutathione quantitatively plays only a minor role in endothelial cells. Having demonstrated that most of the S-nitrosothiols are proteins, we determined the regulation of the S-nitrosylation by pro-inflammatory and proatherogenic factors, such as TNF alpha and mildly oxidized low density lipoprotein (oxLDL). TNF alpha and oxLDL induced denitrosylation of various proteins as assessed by Saville-Griess assay, by immunostaining with an anti-S-nitrosocysteine antibody, and by a Western blot approach. Furthermore, the caspase-3 p17 subunit, which has previously been shown to be S-nitrosylated and thereby inhibited, was denitrosylated by TNFa treatment suggesting that S-nitrosylation and denitrosylation are important regulatory mechanisms in endothelial cells contributing to the integrity of the endothelial cell monolayer.	Goethe Univ Frankfurt, Dept Internal Med 4, D-6000 Frankfurt, Germany	Goethe University Frankfurt	Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 4, Theodor Stern Kai 7, D-6000 Frankfurt, Germany.	Dimmeler@em.uni-frankfurt.de		Dimmeler, Stefanie/0000-0002-1045-2436; Haendeler, Judith/0000-0001-8507-4540				Agnoletti L, 1999, CIRCULATION, V100, P1983, DOI 10.1161/01.CIR.100.19.1983; Alonso J, 1997, MOL CELL BIOL, V17, P5719, DOI 10.1128/MCB.17.10.5719; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; De Frutos T, 1999, AM J PHYSIOL-HEART C, V277, pH1317, DOI 10.1152/ajpheart.1999.277.4.H1317; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; Dimmeler S, 1997, CIRCULATION, V95, P1760; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Haendeler J, 1997, NITRIC OXIDE-BIOL CH, V1, P282, DOI 10.1006/niox.1997.0134; HARRISON DG, 1994, BASIC RES CARDIOL, V89, P87; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Peterson TE, 1999, CIRC RES, V85, P29; Rossig L, 2000, J BIOL CHEM, V275, P25502, DOI 10.1074/jbc.M002283200; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; Tsao PS, 1998, J CARDIOVASC PHARM, V32, pS48; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731	33	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41383	41387		10.1074/jbc.M107566200	http://dx.doi.org/10.1074/jbc.M107566200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524431	hybrid			2022-12-27	WOS:000171925600133
J	Mao, Y; Desai, SD; Ting, CY; Hwang, JL; Liu, LF				Mao, Y; Desai, SD; Ting, CY; Hwang, JL; Liu, LF			26 S proteasome-mediated degradation of topoisomerase II cleavable complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING ANTITUMOR DRUGS; ACUTE MYELOID-LEUKEMIA; KAPPA-B ACTIVATION; DNA TOPOISOMERASE; SECONDARY LEUKEMIAS; SUMO-1 CONJUGATION; CELLS; BETA; ALPHA; GENE	DNA topoisomerase II (TOP2) cleavable complexes represent an unusual type of DNA damage characterized by reversible TOP2-DNA cross-links and DNA double strand breaks. Many antitumor drugs and physiological stresses are known to induce TOP2 cleavable complexes leading to apoptotic cell death and genomic instability. However, the molecular mechanism(s) for repair of TOP2 cleavable complexes remains unclear. In the current studies, we show that TOP2 cleavable complexes induced by the prototypic TOP2 poison VM-26 are proteolytically degraded by the ubiquitin/26 S proteasome pathway. Surprisingly the TOP2 beta isozyme is preferentially degraded over TOP2 alpha isozyme. In addition, transcription inhibitors such as 5,6-dichlorobenzimidazole riboside and camptothecin can substantially block VM-26-induced TOP2 beta degradation. These results are consistent with a model in which the repair of TOP2 beta cleavable complexes may involve transcription-dependent proteolysis of TOP2 beta to reveal the protein-concealed double strand breaks.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Academia Sinica - Taiwan	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.		Ting, chun-yuan/F-6448-2013	Ting, chun-yuan/0000-0002-2302-4203; Liu, Leroy/0000-0001-9396-763X	NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027731] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39662] Funding Source: Medline; NIGMS NIH HHS [GM27731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauman ME, 1997, MODERN PATHOL, V10, P168; BODLEY AL, 1993, MOL CELL BIOL, V13, P6190, DOI 10.1128/MCB.13.10.6190; Boland MP, 2000, J BIOL CHEM, V275, P25231, DOI 10.1074/jbc.275.33.25231; Broeker PLS, 1996, BLOOD, V87, P1912, DOI 10.1182/blood.V87.5.1912.bloodjournal8751912; CHAMPOUX JJ, 1972, P NATL ACAD SCI USA, V69, P143, DOI 10.1073/pnas.69.1.143; CHARCOSSET JY, 1993, B CANCER, V80, P923; CHUNG TDY, 1989, P NATL ACAD SCI USA, V86, P9431, DOI 10.1073/pnas.86.23.9431; D'Arpa P, 1994, Adv Pharmacol, V29B, P127; DARPA P, 1990, CANCER RES, V50, P6919; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Elli R, 1996, CANCER GENET CYTOGEN, V87, P112, DOI 10.1016/0165-4608(95)00294-4; Errington F, 1999, MOL PHARMACOL, V56, P1309, DOI 10.1124/mol.56.6.1309; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; GOVONI M, 1995, BIOCHEM BIOPH RES CO, V213, P282, DOI 10.1006/bbrc.1995.2127; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Hiom K, 1999, CURR BIOL, V9, pR446, DOI 10.1016/S0960-9822(99)80278-4; Hsu CT, 2000, CANCER RES, V60, P3701; HUNGER SP, 1993, BLOOD, V81, P3197; HWANG JL, 1989, CANCER RES, V49, P958; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; KUMAR A, 1973, J MOL BIOL, V80, P265, DOI 10.1016/0022-2836(73)90172-1; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Liu LF, 1996, ANN NY ACAD SCI, V803, P44, DOI 10.1111/j.1749-6632.1996.tb26375.x; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Long B H, 1992, Semin Oncol, V19, P3; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Moreland N, 1997, EUR J CANCER, V33, P1668, DOI 10.1016/S0959-8049(97)00165-2; Nakajima T, 1996, J BIOL CHEM, V271, P24842, DOI 10.1074/jbc.271.40.24842; NAMBI P, 1989, BIOCHEM J, V262, P485, DOI 10.1042/bj2620485; Ng SW, 1999, NUCLEIC ACIDS RES, V27, P993, DOI 10.1093/nar/27.4.993; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; NITISS JL, 1992, CANCER RES, V52, P4467; POMMIER Y, 1988, CANCER RES, V48, P512; RATAIN MJ, 1992, ANN ONCOL, V3, P107, DOI 10.1093/oxfordjournals.annonc.a058121; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; SANDER M, 1983, J BIOL CHEM, V258, P8421; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; SMITH PJ, 1994, BRIT J CANCER, V70, P914, DOI 10.1038/bjc.1994.420; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Sumner AT, 1996, CHROMOSOME RES, V4, P5, DOI 10.1007/BF02254938; Tabata M, 2001, J BIOL CHEM, V276, P8029, DOI 10.1074/jbc.M009831200; TAN KB, 1992, CANCER RES, V52, P231; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Watanabe K, 2000, BIOCHEM PHARMACOL, V60, P823, DOI 10.1016/S0006-2952(00)00387-7; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014	58	157	159	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40652	40658		10.1074/jbc.M104009200	http://dx.doi.org/10.1074/jbc.M104009200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546768	hybrid			2022-12-27	WOS:000171925600038
J	Farazi, TA; Waksman, G; Gordon, JI				Farazi, TA; Waksman, G; Gordon, JI			The biology and enzymology of protein N-myristoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYPTOCOCCUS-NEOFORMANS; VIRUS-REPLICATION; CRYSTAL-STRUCTURE; MYRISTIC ACID; FATTY-ACIDS; MYRISTOYLTRANSFERASE; COA; INHIBITORS; PALMITOYLATION; ANALOGS		Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.				NIAID NIH HHS [AI 38200] Funding Source: Medline; NIGMS NIH HHS [GM 07200] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038200] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Bhatnagar RS, 1998, NAT STRUCT BIOL, V5, P1091, DOI 10.1038/4202; Bhatnagar RS, 1997, BIOCHEMISTRY-US, V36, P6700, DOI 10.1021/bi970311v; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; Cordo SM, 1999, MICROBES INFECT, V1, P609, DOI 10.1016/S1286-4579(99)80060-4; Devadas B, 1998, J MED CHEM, V41, P996, DOI 10.1021/jm980001q; DEVADAS B, 1992, J BIOL CHEM, V267, P7224; DEVADAS B, 1995, J MED CHEM, V38, P1837, DOI 10.1021/jm00011a001; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P9177, DOI 10.1021/bi0107997; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P6335, DOI 10.1021/bi0101401; Farazi TA, 2000, BIOCHEMISTRY-US, V39, P15807, DOI 10.1021/bi002074t; Furuishi K, 1997, BIOCHEM BIOPH RES CO, V237, P504, DOI 10.1006/bbrc.1997.7178; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; HARPER DR, 1993, J GEN VIROL, V74, P1181, DOI 10.1099/0022-1317-74-6-1181; Hermida-Matsumoto L, 1999, J VIROL, V73, P1902, DOI 10.1128/JVI.73.3.1902-1908.1999; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; LINDER ME, 2000, ENZYMES PROTEIN LIPI, V21, P215; LODGE JK, 1994, P NATL ACAD SCI USA, V91, P12008, DOI 10.1073/pnas.91.25.12008; Lodge JK, 1997, MICROBIOL-UK, V143, P357, DOI 10.1099/00221287-143-2-357; Lodge JK, 1998, J BIOL CHEM, V273, P12482, DOI 10.1074/jbc.273.20.12482; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; Ntwasa M, 2001, EXP CELL RES, V262, P134, DOI 10.1006/excr.2000.5086; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; PAIGE LA, 1990, BIOCHEMISTRY-US, V29, P10566, DOI 10.1021/bi00498a021; PAIGE LA, 1989, J MED CHEM, V32, P1665, DOI 10.1021/jm00128a001; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Qi QG, 2000, J BIOL CHEM, V275, P9673, DOI 10.1074/jbc.275.13.9673; Raju RVS, 1998, BIOCHEMISTRY-US, V37, P14928, DOI 10.1021/bi980891b; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RUDNICK DA, 1991, J BIOL CHEM, V266, P9732; SAERMARK T, 1991, AIDS, V5, P951, DOI 10.1097/00002030-199108000-00005; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEINBURG RA, 1995, MOL MICROBIOL, V16, P241, DOI 10.1111/j.1365-2958.1995.tb02296.x; Weston SA, 1998, NAT STRUCT BIOL, V5, P213, DOI 10.1038/nsb0398-213; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	51	415	431	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39501	39504		10.1074/jbc.R100042200	http://dx.doi.org/10.1074/jbc.R100042200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11527981	hybrid			2022-12-27	WOS:000171789200001
J	Wang, Y; Shao, L; Shi, SL; Harris, RJ; Spellman, MW; Stanley, P; Haltiwanger, RS				Wang, Y; Shao, L; Shi, SL; Harris, RJ; Spellman, MW; Stanley, P; Haltiwanger, RS			Modification of epidermal growth factor-like repeats with O-fucose - Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; LINKED FUCOSE; GLYCOSYLATION PATHWAY; STRUCTURAL-ANALYSIS; NOTCH; FRINGE; GLYCOSYLTRANSFERASES; IDENTIFICATION; TRANSFERASE; UROKINASE	The O-fucose modification is found on epidermal growth factor-like repeats of a number of cell surface and secreted proteins. O-Fucose glycans play important roles in ligand-induced receptor signaling. For example, elongation of O-fucose on Notch by the beta1,3-N-acetylglucosaminyltransferase Fringe modulates the ability of Notch to respond to its ligands. The enzyme that adds O-fucose to epidermal growth factor-like repeats, GDP-fucose protein O-fucosyltransferase (O-FucT-1), was purified previously from Chinese hamster ovary (CHO) cells. Here we report the isolation of a cDNA that encodes human O-FucT-1. A probe deduced from N-terminal sequence analysis of purified CHO O-FucT-1 was used to screen a human heart cDNA library and expressed sequence tag and genomic data bases. The cDNA contains an open reading frame encoding a protein of 388 amino acids with a predicted N-terminal transmembrane sequence typical of a type H membrane orientation. Likewise, the mouse homolog obtained from an expressed sequence tag and 5'-rapid amplification of cDNA ends of a mouse liver cDNA library encodes a type H transmembrane protein of 393 amino acids with 90.4% identity to human O-FucT-1. Homologs were also found in Drosophila and Caenorhabditis elegans with 41.2 and 29.4% identity to human O-FucT-1, respectively. The human gene (POFUT1) is on chromosome 20 between PLAGL2 and KIF3B, near the centromere at 20p11. The mouse gene (Pofut1) maps near Plagl2 on a homologous region of mouse chromosome 2. POFUT1 gene transcripts were expressed in all tissues examined, consistent with the widespread localization of the modification. Expression of a soluble form of human O-FucT-1 in insect cells yielded a protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic properties similar to those of O-FucT-1 purified from CHO cells. The identification of the gene encoding protein O-fucosyltransferase I now makes possible mutational strategies to examine the functions of the unusual O-fucose post-translational modification.	SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; Genentech Inc, Dept Metab & Pharmacokinet, S San Francisco, CA 94080 USA; Genentech Inc, Dept Analyt Chem, S San Francisco, CA 94080 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Roche Holding; Genentech; Roche Holding; Genentech; Yeshiva University; Albert Einstein College of Medicine; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.			Stanley, Pamela/0000-0001-5704-3747	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061126, GM 61126] Funding Source: Medline; PHS HHS [NC 30645] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams JC, 2000, DEV DYNAM, V218, P280; APPELLA E, 1987, J BIOL CHEM, V262, P4437; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Becker DJ, 1999, BBA-MOL BASIS DIS, V1455, P193, DOI 10.1016/S0925-4439(99)00071-X; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; HALLGREN P, 1975, J BIOL CHEM, V250, P5312; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Kao YH, 1999, BIOCHEMISTRY-US, V38, P7097, DOI 10.1021/bi990234z; KENTZER EJ, 1990, BIOCHEM BIOPH RES CO, V171, P401, DOI 10.1016/0006-291X(90)91407-J; Kikuno R, 2000, NUCLEIC ACIDS RES, V28, P331, DOI 10.1093/nar/28.1.331; KLEENE R, 1993, BIOCHIM BIOPHYS ACTA, V1154, P283, DOI 10.1016/0304-4157(93)90003-7; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; McEver RP, 1997, GLYCOCONJUGATE J, V14, P585, DOI 10.1023/A:1018584425879; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 1996, GLYCOBIOLOGY, V6, P837, DOI 10.1093/glycob/6.8.837; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	34	196	208	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40338	40345		10.1074/jbc.M107849200	http://dx.doi.org/10.1074/jbc.M107849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11524432	hybrid			2022-12-27	WOS:000171789200111
J	Pal, GP; Elce, JS; Jia, ZC				Pal, GP; Elce, JS; Jia, ZC			Dissociation and aggregation of calpain in the presence of calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBUNITS; HETERODIMER; PROTEASE; REVEALS	Calpain is a heterodimeric Ca2+-dependent cysteine protease consisting of a large (80 kDa) catalytic subunit and a small (28 kDa) regulatory subunit. The effects of Ca2+ on the enzyme include activation, aggregation, and autolysis. They may also include subunit dissociation, which has been the subject of some debate. Using the inactive C105S-80k/21k form of calpain to eliminate autolysis, we have studied its disassociation and aggregation in the presence of Ca2+ and the inhibition of its aggregation by means of crystallization, light scattering, and sedimentation. Aggregation, as assessed by light scattering, depended on the ionic strength and pH of the buffer, on the Ca2+ concentration, and on the presence or absence of calpastatin. At low ionic strength, calpain aggregated rapidly in the presence of Ca2+, but this was fully reversible by EDTA. With Ca2+ in 0.2 M NaCl, no aggregation was visible but ultracentrifugation showed that a mixture of soluble high molecular weight complexes was present. Calpastatin prevented aggregation, leading instead to the formation of a calpastatin-calpain complex. Crystallization in the presence of Ca2+ gave rise to crystals mixed with an amorphous precipitate. The crystals contained only the small subunit, thereby demonstrating subunit dissociation, and the precipitate was highly enriched in the large subunit. Reversible dissociation in the presence of Ca2+ was also unequivocally demonstrated by the exchange of slightly different small subunits between mu -calpain and m-calpain. We conclude that subunit dissociation is a dynamic process and is not complete in most buffer conditions unless driven by factors such as crystal formation or autolysis of active enzymes. Exposure of the hydrophobic dimerization surface following subunit dissociation may be the main factor responsible for Ca2+-induced aggregation of calpain. It is likely that dissociation serves as an early step in calpain activation by releasing the constraints upon protease domain I.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Stuart St, Kingston, ON K7L 3N6, Canada.	jia@post.queensu.ca						Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Dourdin N, 1999, EXP CELL RES, V246, P433, DOI 10.1006/excr.1998.4325; Dutt P, 1998, FEBS LETT, V436, P367, DOI 10.1016/S0014-5793(98)01167-3; Elce JS, 1997, BIOCHEM J, V326, P31, DOI 10.1042/bj3260031; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; GOLL DE, 1990, INTRACELLULAR CALCIU, P103; Harada K, 1999, J NEUROCHEM, V72, P2556, DOI 10.1046/j.1471-4159.1999.0722556.x; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hosfield CM, 2001, J BIOL CHEM, V276, P7404, DOI 10.1074/jbc.M007352200; KAPPRELL HP, 1989, J BIOL CHEM, V264, P17888; Kitagaki H, 2000, BIOSCI BIOTECH BIOCH, V64, P689, DOI 10.1271/bbb.64.689; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Maki M, 2000, METH MOL B, V144, P85; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SORIMACHI H, 1994, FEBS LETT, V343, P1, DOI 10.1016/0014-5793(94)80595-4; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; YOSHIZAWA T, 1995, BIOCHEM BIOPH RES CO, V208, P376, DOI 10.1006/bbrc.1995.1348; YOSHIZAWA T, 1995, FEBS LETT, V358, P101, DOI 10.1016/0014-5793(94)01401-L; Zhang WL, 1996, BIOCHEM BIOPH RES CO, V227, P890, DOI 10.1006/bbrc.1996.1601	28	69	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2001	276	50					47233	47238		10.1074/jbc.M105149200	http://dx.doi.org/10.1074/jbc.M105149200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	502XR	11551918	hybrid			2022-12-27	WOS:000172768500076
J	Martelli, MP; Boomer, J; Bu, M; Bierer, BE				Martelli, MP; Boomer, J; Bu, M; Bierer, BE			T cell regulation of p62(dok) (Dok1) association with Crk-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; ANTIGEN-RECEPTOR; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; ZETA-CHAIN; BCR-ABL; DOCKING PROTEIN; FAMILY KINASES; LIGAND AVIDITY; CD2 ANTIGEN	In addition to engagement of the T cell receptor-CD3 complex, T lymphocytes can be activated by a variety of cell surface molecules including the similar to 50-kDa surface receptor CD2. While the majority of biochemical signaling elements are triggered by either CD2 or TcR-CD3 receptors, a small number of proteins are engaged by only one receptor. Recently, p62(dok) (Dok1), a member of the Dok family of adapter molecules, has been reported to be activated by CD2 and not by C133 engagement. Here we have examined the role of p62(dok) in CD2-dependent signaling in Jurkat T cells. As previously reported, we find that ligation of the CD2 molecule by mitogenic pairs of anti-CD2 mAbs led to phosphorylation of p62(dok). While CD2-induced p62(dok) tyrosine phosphorylation was independent of both the p36/38 membrane adapter protein linker of activated T cells (LAT) and the ZAP70/Syk family of kinases, it was dependent upon the Src family of kinases including Lck and Fyn. We find further that CD2 engagement induced the association of tyrosine-phosphorylated p62(dok) to Crk-L. The CD2-dependent association of p62(dok) to Crk-L was independent of expression of the ZAP70/Syk family of kinases. Of note, while T cell receptor-CD3 engagement did not induce either p62(dok) phosphorylation or Crk-L association in Jurkat T cells, it did inhibit CD2-dependent p62 (dok)-Crk-L complexes; this TcR-CD3-mediated regulation was dependent upon ZAP70 kinase activity. Our data suggest that phosphorylation of p62(dok) and its interaction with other signaling proteins may depend upon integrated signals emanating from the CD2 receptor, utilizing a ZAP70/LAT-independent pathway, and the TcR-CD3 receptor, which is ZAP70/Syk-dependent.	NHLBI, Lab Lymphocyte Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bierer, BE (corresponding author), NHLBI, Lab Lymphocyte Biol, NIH, Bldg 10,Rm 6C208,10 Ctr Dr, Bethesda, MD 20892 USA.	biererb@nih.gov	Martelli, Maria Paola/ABH-3300-2021; Martelli, Maria Paola/I-5618-2012	Martelli, Maria Paola/0000-0001-9139-1729; Bierer, Barbara/0000-0001-6448-8170				ARULANANDAM ARN, 1994, J EXP MED, V180, P1861, DOI 10.1084/jem.180.5.1861; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bell GM, 1996, J EXP MED, V183, P169, DOI 10.1084/jem.183.1.169; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Bhat A, 1998, J BIOL CHEM, V273, P32360, DOI 10.1074/jbc.273.48.32360; Bierer B E, 1993, Semin Immunol, V5, P249, DOI 10.1006/smim.1993.1029; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; BOUTON AH, 1991, MOL CELL BIOL, V11, P945, DOI 10.1128/MCB.11.2.945; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chopra R, 1999, BLOOD REV, V13, P211, DOI 10.1054/blre.1999.0119; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fukai I, 2000, EUR J IMMUNOL, V30, P3507, DOI 10.1002/1521-4141(2000012)30:12<3507::AID-IMMU3507>3.0.CO;2-O; GASSMANN M, 1994, EUR J IMMUNOL, V24, P139, DOI 10.1002/eji.1830240121; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Green JM, 2000, J IMMUNOL, V164, P3591, DOI 10.4049/jimmunol.164.7.3591; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; HAHN WC, 1993, J EXP MED, V178, P1831, DOI 10.1084/jem.178.5.1831; HAHN WC, 1992, P NATL ACAD SCI USA, V89, P7179, DOI 10.1073/pnas.89.15.7179; HAHN WC, 1993, J IMMUNOL, V150, P2607; Harriague J, 2000, EUR J IMMUNOL, V30, P3319, DOI 10.1002/1521-4141(200011)30:11<3319::AID-IMMU3319>3.0.CO;2-1; HUBERT P, 1993, J EXP MED, V178, P1587, DOI 10.1084/jem.178.5.1587; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kashige N, 2000, P NATL ACAD SCI USA, V97, P2093, DOI 10.1073/pnas.040547997; King PD, 1996, INT IMMUNOL, V8, P1707, DOI 10.1093/intimm/8.11.1707; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; KIYOKAWA E, 1997, CRIT REV ONCOL, P329; Lee SJ, 2000, BRIT J HAEMATOL, V111, P993, DOI 10.1046/j.1365-2141.2000.02216.x; LEY SC, 1991, EUR J IMMUNOL, V21, P2203, DOI 10.1002/eji.1830210931; Lin HM, 1998, J BIOL CHEM, V273, P19914, DOI 10.1074/jbc.273.31.19914; Lin HM, 2001, INT IMMUNOL, V13, P13, DOI 10.1093/intimm/13.1.13; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MarieCardine A, 1996, J BIOL CHEM, V271, P20734, DOI 10.1074/jbc.271.34.20734; Martelli MP, 2000, BLOOD, V96, P2181; Maru Y, 2001, INT J HEMATOL, V73, P308, DOI 10.1007/BF02981955; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Meinl E, 2000, J IMMUNOL, V165, P3578, DOI 10.4049/jimmunol.165.7.3578; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; MOINGEON P, 1992, P NATL ACAD SCI USA, V89, P1492, DOI 10.1073/pnas.89.4.1492; MONOSTORI E, 1990, J IMMUNOL, V144, P1010; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; MORLEY P, 2001, ADV IMMUNOL, V77, P1; Nelms K, 1998, IMMUNITY, V9, P13, DOI 10.1016/S1074-7613(00)80584-1; Nemorin JG, 2000, J BIOL CHEM, V275, P14590, DOI 10.1074/jbc.275.19.14590; Nemorin JG, 2001, J IMMUNOL, V166, P4408, DOI 10.4049/jimmunol.166.7.4408; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; ODA T, 1995, LEUKEMIA, V9, P295; OHNO H, 1991, J IMMUNOL, V146, P3742; PANTALEO G, 1987, EUR J IMMUNOL, V17, P55, DOI 10.1002/eji.1830170110; Sakkab D, 2000, J BIOL CHEM, V275, P10772, DOI 10.1074/jbc.275.15.10772; SAMELSON LE, 1990, J IMMUNOL, V145, P2448; Sattler M, 2001, J BIOL CHEM, V276, P2451, DOI 10.1074/jbc.M006250200; Sattler M, 2001, INT J HEMATOL, V73, P278, DOI 10.1007/BF02981952; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Songyang Z, 2001, J BIOL CHEM, V276, P2459, DOI 10.1074/jbc.M005504200; SPRUYT LL, 1991, J EXP MED, V174, P1407, DOI 10.1084/jem.174.6.1407; Steeg C, 1997, EUR J IMMUNOL, V27, P2233, DOI 10.1002/eji.1830270917; Sunder-Plassmann R, 1998, J BIOL CHEM, V273, P24249, DOI 10.1074/jbc.273.37.24249; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Uemura N, 1999, J BIOL CHEM, V274, P37525, DOI 10.1074/jbc.274.53.37525; Ueno H, 2000, EUR J IMMUNOL, V30, P78; van Dijk TB, 2000, BLOOD, V96, P3406; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Verhagen AM, 1996, EUR J IMMUNOL, V26, P2841, DOI 10.1002/eji.1830261207; Von Bonin A, 1998, IMMUNOLOGY, V93, P376; Vuica M, 1997, J EXP MED, V186, P259, DOI 10.1084/jem.186.2.259; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; WISNIEWSKI D, 1994, LEUKEMIA, V8, P688; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yoshida K, 2000, J BIOL CHEM, V275, P24945, DOI 10.1074/jbc.M909012199; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943	85	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45654	45661		10.1074/jbc.M105777200	http://dx.doi.org/10.1074/jbc.M105777200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11553620	hybrid			2022-12-27	WOS:000172573100023
J	Imamura, T; Huang, J; Dalle, S; Ugi, S; Usui, I; Luttrell, LM; Miller, WE; Lefkowitz, RJ; Olefsky, JM				Imamura, T; Huang, J; Dalle, S; Ugi, S; Usui, I; Luttrell, LM; Miller, WE; Lefkowitz, RJ; Olefsky, JM			beta-arrestin-mediated recruitment of the Src family kinase yes mediates endothelin-1-stimulated glucose transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; STIMULATED GLUT4 TRANSLOCATION; INSULIN-RECEPTOR; 3T3-L1 ADIPOCYTES; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAY; ALPHA-SUBUNIT; C-SRC; ACTIVATION; CELLS	The insulin and the endothelin type A (ETA) receptor both can couple into the heterotrimeric G protein alpha (q/11) (G alpha (q/11)), leading to G alpha (q/11) tyrosine phosphorylation, phosphatidylinositol 3-kinase activation, and subsequent stimulation of glucose transport. In this study, we assessed the potential role of Src kinase in ET-1 signaling to glucose transport in 3T3-L1 adipocytes. Src kinase inhibitor PP2 blocked ET-1-induced Src kinase activity, G alpha (q/11) tyrosine phosphorylation, and glucose transport stimulation. To determine which Src family kinase member was involved, we microinjected anti-c-Src, -c-Fyn, or -c-Yes antibody into these cells and found that only anti-e-Yes antibody blocked GLUT4 translocation (70% decreased). Overexpression or microinjection of a dominant negative mutant (K298M) of Src kinase also inhibited ET-1-induced Ga,,,, tyrosine phosphorylation and GLUT4 translocation. In co-immunoprecipitation experiments, we found that beta -arrestin 1 associated with the ETA receptor in an agonist-dependent manner and that beta -arrestin 1 recruited Src kinase to a molecular complex that included the ETA receptor. Microinjection of beta -arrestin 1 antibody inhibited ET-1- but not insulin-stimulated GLUT4 translocation. In conclusion, 1) the Src kinase Yes can induce tyrosine phosphorylation of G alpha (q/11) in response to ET-1 stimulation, and 2) beta -arrestin I and Src kinase form a molecular complex with the ETA receptor to mediate ET-1 signaling to G alpha (q/11) with subsequent glucose transport stimulation.	Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Durham Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Lefkowitz, Robert/AAW-2649-2021	Luttrell, Louis/0000-0003-2805-6949; Miller, William/0000-0001-6900-4884	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-33651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; HARUTA T, 1995, J BIOL CHEM, V270, P27991; HOLMAN GD, 1994, BIOESSAYS, V16, P753, DOI 10.1002/bies.950161010; Imamura T, 1999, J BIOL CHEM, V274, P33691, DOI 10.1074/jbc.274.47.33691; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Ishibashi K, 2001, J CLIN INVEST, V107, P1193, DOI 10.1172/JCI11753; Ishibashi KI, 2000, ENDOCRINOLOGY, V141, P4623, DOI 10.1210/en.141.12.4623; JAMES DE, 1994, J CELL BIOL, V126, P1123, DOI 10.1083/jcb.126.5.1123; Kandror KV, 1996, AM J PHYSIOL-ENDOC M, V271, pE1, DOI 10.1152/ajpendo.1996.271.1.E1; Kanzaki M, 2000, J BIOL CHEM, V275, P7167, DOI 10.1074/jbc.275.10.7167; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KEFALAS P, 1995, INT J BIOCHEM CELL B, V27, P551, DOI 10.1016/1357-2725(95)00024-J; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MEYERSON G, 1993, FEBS LETT, V332, P27, DOI 10.1016/0014-5793(93)80475-A; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; QUON MJ, 1994, J BIOL CHEM, V269, P27920; ROTH RA, 1983, SCIENCE, V219, P299, DOI 10.1126/science.6849137; SHIA MA, 1983, J BIOL CHEM, V258, P4450; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Umemori H, 1997, SCIENCE, V276, P1878, DOI 10.1126/science.276.5320.1878; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VANOBBERGHEN E, 1983, P NATL ACAD SCI-BIOL, V80, P945; Vollenweider P, 1997, ENDOCRINOLOGY, V138, P4941, DOI 10.1210/en.138.11.4941; Williams JC, 1998, TRENDS BIOCHEM SCI, V23, P179, DOI 10.1016/S0968-0004(98)01202-X; Wu-Wong JSR, 1999, J BIOL CHEM, V274, P8103, DOI 10.1074/jbc.274.12.8103	32	105	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43663	43667		10.1074/jbc.M105364200	http://dx.doi.org/10.1074/jbc.M105364200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546805	hybrid			2022-12-27	WOS:000172297700025
J	Yu, JW; Lemmon, MA				Yu, JW; Lemmon, MA			All phox homology (PX) domains from Saccharomyces cerevisiae specifically recognize phosphatidylinositol 3-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL INHERITANCE; MEMBRANE-PROTEINS; LATE-GOLGI; BINDING; YEAST; NUCLEAR; COMPLEX	Phox homology (PX) domains are named for a 130-amino acid region of homology shared with part of two components of the phagocyte NADPH oxidase (phox) complex. They are found in proteins involved in vesicular trafficking, protein sorting, and lipid modification. It was recently reported that certain PX domains specifically recognize phosphatidylinositol 3-phosphate (PtdIns-3-P) and drive recruitment of their host proteins to the cytoplasmic leaflet of endosomal and/or vacuolar membranes where this phosphoinositide is enriched. We have analyzed phosphoinositide binding by all 15 PX domains encoded by the Saccharomyces cerevisiae genome. All yeast PX domains specifically recognize PtdIns-3-P in protein-lipid overlay experiments, with just one exception (a significant sequence outlier). In surface plasmon resonance studies, four of the yeast PX domains bind PtdIns-3-P with high (micromolar range) affinity. Although the remaining PX domains specifically recognize PtdIns-3-P, they bind this lipid with only low affinity. Interestingly, many proteins with "low affinity" PX domains are known to form large multimeric complexes, which may increase the overall avidity for membranes. Our results establish that PtdIns-3-P, and not other phosphoinositides, is the target of all PX domains in S. cerevisiae and suggest a role for PX domains in assembly of multiprotein complexes at specific membrane surfaces.	Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Grad Grp Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809, 422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu		Lemmon, Mark/0000-0002-3379-5319	NIGMS NIH HHS [R01-GM56846, R01 GM056846] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056846] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Fisk HA, 1997, J CELL BIOL, V138, P485, DOI 10.1083/jcb.138.3.485; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kurten RC, 2001, J CELL SCI, V114, P1743; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; MCCONNELL SJ, 1992, J CELL BIOL, V118, P385, DOI 10.1083/jcb.118.2.385; Nothwehr SF, 1997, J CELL SCI, V110, P1063; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Phillips SA, 2001, J BIOL CHEM, V276, P5074, DOI 10.1074/jbc.M004671200; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Prehoda KE, 2001, NAT STRUCT BIOL, V8, P570, DOI 10.1038/89586; RON D, 1992, BIOTECHNIQUES, V13, P866; Sankaran VG, 2001, BIOCHEMISTRY-US, V40, P8581, DOI 10.1021/bi010425d; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051	35	162	166	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44179	44184		10.1074/jbc.M108811200	http://dx.doi.org/10.1074/jbc.M108811200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557775	hybrid			2022-12-27	WOS:000172297700089
J	Dunphy, JT; Greentree, WK; Linder, ME				Dunphy, JT; Greentree, WK; Linder, ME			Enrichment of G-protein palmitoyltransferase activity in low density membranes - In vitro reconstitution of G(alpha i) to these domains requires palmitoyltransferase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; G-BETA-GAMMA; PLASMA-MEMBRANE; CAVEOLAE MEMBRANE; ALPHA-SUBUNITS; EPITHELIAL-CELLS; LIPID RAFTS; PALMITOYLATION; LOCALIZATION; ACTIVATION	Many signaling proteins are targeted to low density, sphingomyelin- and cholesterol-enriched membranes, also called lipid rafts. These domains organize receptor-mediated signaling events at the plasma membrane. Fatty acylation is one mechanism for targeting proteins to rafts. It was therefore of interest to determine if protein palmitoyltransferase activity is also present in these domains. In this study, protein palmitoyltransferase activity, assayed using G-protein alpha subunits as a substrate, was found to be highly enriched in low density membranes derived from cells that express caveolin as well as those that do not. Depletion of cellular cholesterol with the drug methyl-beta -cyclodextrin resulted in inhibition of palmitoyltransferase activity and a redistribution of the remaining activity to membranes of higher density. This effect was reversed by adding cholesterol to cyclodextrin-treated cells. When reconstituted into cell membranes, the population of purified recombinant G(alphai) that was palmitoylated was highly enriched in the low density membrane fractions, whereas the bulk unmodified G(alphai)-protein was largely excluded. This effect required palmitoyltransferase activity and was abolished if the palmitoylated cysteine was mutated. Thus, palmitoyltransferase facilitates the enrichment of fatty acylated signaling molecules in plasma membrane subdomains.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Linder, ME (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 So Euclid Ave, St Louis, MO 63110 USA.	mlinder@cellbio.wustl.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	NIGMS NIH HHS [GM51466] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; ARREAZA G, 1995, J BIOL CHEM, V270, P23641, DOI 10.1074/jbc.270.40.23641; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Dunphy JT, 2000, BBA-MOL CELL BIOL L, V1485, P185, DOI 10.1016/S1388-1981(00)00060-3; FIEDLER K, 1993, BIOCHEMISTRY-US, V32, P6365, DOI 10.1021/bi00076a009; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Holowka D, 2001, SEMIN IMMUNOL, V13, P99, DOI 10.1006/smim.2000.0301; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; Jones TLZ, 1997, BIOCHEMISTRY-US, V36, P7185, DOI 10.1021/bi9628376; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; MAKI RG, 1990, P NATL ACAD SCI USA, V87, P5658, DOI 10.1073/pnas.87.15.5658; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SARASTE J, 1987, J CELL BIOL, V105, P2021, DOI 10.1083/jcb.105.5.2021; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	48	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43300	43304		10.1074/jbc.M104275200	http://dx.doi.org/10.1074/jbc.M104275200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11557754	hybrid			2022-12-27	WOS:000172169300087
J	Niu, SL; Mitchell, DC; Litman, BJ				Niu, SL; Mitchell, DC; Litman, BJ			Optimization of receptor-G protein coupling by bilayer lipid composition II - Formation of metarhodopsin II-transducin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID DEFICIENCY; GTP-BINDING PROTEIN; DOCOSAHEXAENOIC ACID; CYTOPLASMIC LOOP; GAMMA-SUBUNITS; GUINEA-PIG; RHODOPSIN; MEMBRANES; CHOLESTEROL; EQUILIBRIUM	The visual transduction system was used as a model to investigate the effects of membrane lipid composition on receptor-G protein coupling. Rhodopsin was reconstituted into large, unilamellar phospholipid vesicles with varying acyl chain unsaturation, with and without cholesterol. The association constant (K-alpha) for metarhodopsin II (MII) and transducin (G(t)) binding was determined by monitoring MII-G(t) complex formation spectrophotometrically. At 20 degreesC, in pH 7.5 isotonic buffer, the strongest MII-G(t) binding was observed in 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine (18:0,22:6PC), whereas the weakest binding was in 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (18:0,18:1PC) with 30 mol% cholesterol. Increasing acyl chain unsaturation from 18:0,18:1PC to 18:0,22:6PC resulted in a 3-fold increase in K-alpha. The inclusion of 30 mol% cholesterol in the membrane reduced K-alpha in both 18:0,22:6PC and 18:0,18:1PC. These findings demonstrate that membrane compositions can alter the signaling cascade by changing protein-protein interactions occurring predominantly in the hydrophilic region of the proteins, external to the lipid bilayer. These findings, if extended to other members of the superfamily of G protein-coupled receptors, suggest that a loss in efficiency of receptor-G protein binding is a contributing factor to the loss of cognitive skills, odor and spatial discrimination, and visual function associated with n-3 fatty acid deficiency.	NIAAA, Sect Fluorescence Studies, Lab Membrane Biochem & Biophys, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Litman, BJ (corresponding author), NIAAA, Sect Fluorescence Studies, Lab Membrane Biochem & Biophys, Pk 5,Rm 158,12420 Parklawn Dr, Rockville, MD 20852 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000072, Z01AA000105, Z01AA000080, ZIAAA000080] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], [No title captured]; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; HOFMANN KP, 1985, BIOCHIM BIOPHYS ACTA, V810, P278, DOI 10.1016/0005-2728(85)90143-4; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUHN H, 1981, P NATL ACAD SCI-BIOL, V78, P6873, DOI 10.1073/pnas.78.11.6873; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LITMAN BJ, 1996, LIPIDS S, V31, P193; LITMAN BJ, 1996, BIOMEMBRANE, P1; MATHEWS RG, 1963, J GEN PHYSIOL, V47, P215; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MITCHELL DC, 1992, BIOCHEMISTRY-US, V31, P662, DOI 10.1021/bi00118a005; MITCHELL DC, 1990, BIOCHEMISTRY-US, V29, P9143, DOI 10.1021/bi00491a007; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; OBRIEN DF, 1977, BIOCHEMISTRY-US, V16, P1295, DOI 10.1021/bi00626a009; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parkes JH, 1999, BIOCHEMISTRY-US, V38, P6862, DOI 10.1021/bi9827666; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SanGiovanni JP, 2000, PEDIATRICS, V105, P1292, DOI 10.1542/peds.105.6.1292; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; STINSON AM, 1991, EXP EYE RES, V52, P213, DOI 10.1016/0014-4835(91)90261-C; STRAUME M, 1990, BIOCHEMISTRY-US, V29, P9135, DOI 10.1021/bi00491a006; Weisinger HS, 1996, LIPIDS, V31, P65, DOI 10.1007/BF02522413; Weisinger HS, 1999, INVEST OPHTH VIS SCI, V40, P327	38	91	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42807	42811		10.1074/jbc.M105778200	http://dx.doi.org/10.1074/jbc.M105778200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544259	hybrid			2022-12-27	WOS:000172169300024
J	Hilaire, S; Belanger, C; Bertrand, J; Laperriere, A; Foord, SM; Bouvier, M				Hilaire, S; Belanger, C; Bertrand, J; Laperriere, A; Foord, SM; Bouvier, M			Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; HORMONE RECEPTOR; COUPLED RECEPTORS; ADRENOMEDULLIN RECEPTORS; TERMINAL TAIL; DESENSITIZATION; ENDOCYTOSIS; BINDING; CELLS; LOCALIZATION	The calcitonin receptor-like receptor (CRLR) is a seven-transmembrane domain (7TM) protein that requires the receptor activity-modifying protein 1 (RAMP1) to be expressed at the cell surface as a functional calcitonin gene-related peptide (CGRP) receptor. Although dimerization between the two molecules is well established, very little is known concerning the trafficking of this heterodimer upon receptor activation. Also, the subcellular localization and biochemical state of this ubiquitously expressed protein, in the absence of CRLR, remains poorly characterized. Here we report that when expressed alone RAMP1 is retained inside the cells where it is found in the endoplasmic reticulum and the Golgi predominantly as a disulfide-linked homodimer. In contrast, when expressed with CRLR, it is targeted to the cell surface as a 1:1 heterodimer with the 7TM protein. Although heterodimer formation does not involve intermolecular disulfide bonds, RAMP-CRLR association promotes the formation of intramolecular disulfide bonds within RAMP1. CGRP binding and receptor activation lead to the phosphorylation of CRLR and the internalization of the receptor as a stable complex. The internalization was found to be both dynamin- and beta -arrestin-dependent, indicating that the formation of a ternary complex between CRLR, RAMP1, and beta -arrestin leads to clathrin-coated pit-mediated endocytosis. These results therefore indicate that although atypical by its heterodimeric composition and its targeting to the plasma membrane, the CGRP receptor shares endocytotic mechanisms that are common to most classical 7TM receptors.	Univ Montreal, Fac Med, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Glaxo Wellcome Med Res Ctr, Receptor Syst Unit, Stevenage SG1 2NY, Herts, England	Universite de Montreal; GlaxoSmithKline	Bouvier, M (corresponding author), Univ Montreal, Fac Med, Dept Biochim, POB 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Bouvier@bcm.umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100				Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Aldecoa A, 2000, FEBS LETT, V471, P156, DOI 10.1016/S0014-5793(00)01387-9; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Drake WM, 1999, ENDOCRINOLOGY, V140, P533, DOI 10.1210/en.140.1.533; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; FLUHMANN B, 1995, BIOCHEM BIOPH RES CO, V206, P341, DOI 10.1006/bbrc.1995.1047; Foord SM, 1999, TRENDS PHARMACOL SCI, V20, P184, DOI 10.1016/S0165-6147(99)01347-4; Fraser NJ, 1999, MOL PHARMACOL, V55, P1054, DOI 10.1124/mol.55.6.1054; Fullekrug J, 1999, J CELL SCI, V112, P2813; Gines S, 2001, MOL PHARMACOL, V59, P1314, DOI 10.1124/mol.59.5.1314; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Groarke DA, 2001, MOL PHARMACOL, V59, P375, DOI 10.1124/mol.59.2.375; Haasemann M, 1998, J CELL SCI, V111, P917; Hauri HP, 2000, J CELL SCI, V113, P587; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Hilairet S, 2001, J BIOL CHEM, V276, P29575, DOI 10.1074/jbc.M102722200; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kuwasako K, 2000, J BIOL CHEM, V275, P29602, DOI 10.1074/jbc.M004534200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leuthauser K, 2000, BIOCHEM J, V351, P347, DOI 10.1042/0264-6021:3510347; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; Mentlein R, 2001, CELL TISSUE RES, V303, P27, DOI 10.1007/s004410000302; NJUKI F, 1993, CLIN SCI, V85, P385, DOI 10.1042/cs0850385; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; Poyner DR, 1997, BIOCHEM SOC T, V25, P1032, DOI 10.1042/bst0251032; Sexton PM, 2001, CELL SIGNAL, V13, P73, DOI 10.1016/S0898-6568(00)00143-1; Troispoux C, 1999, MOL ENDOCRINOL, V13, P1599, DOI 10.1210/me.13.9.1599; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; WADA I, 1991, J BIOL CHEM, V266, P19599; Walker JKL, 1999, J BIOL CHEM, V274, P31515, DOI 10.1074/jbc.274.44.31515; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	47	113	123	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42182	42190		10.1074/jbc.M107323200	http://dx.doi.org/10.1074/jbc.M107323200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535606	hybrid			2022-12-27	WOS:000172450400086
J	Seifert, R; Wenzel-Seifert, K				Seifert, R; Wenzel-Seifert, K			Defective G(i) protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-FORMYLPEPTIDE RECEPTOR; NEUTROPHIL FUNCTION; LIGAND-BINDING; CELLS; GLYCOSYLATION; ACTIVATION; RECONSTITUTION; EXPRESSION; LEUKOCYTES; MEMBRANES	The formyl peptide receptor (FPR) is a prototypical chemoattractant receptor expressed in neutrophils. It is well known that the FPR couples to G(i) proteins to activate phospholipase C, chemotaxis, and cytotoxic cell functions, but the in vivo role of the FPR in man has remained elusive. Recently, F110S and C126W mutations of the FPR have been associated with localized juvenile periodontitis. We studied FPR-F110S and FPR-C126W in comparison with wild-type FPR (FPR-WT) by coexpressing epitope-tagged versions of these receptors with the G protein G alpha (i2)beta (1)gamma (2) in Sf9 insect cells. FPRs were efficiently expressed in Sf9 membranes as assessed by immunoblotting using the beta (2)-adrenoreceptor as a standard. FPR-C126W differed from FPR-WT and FPR-F110S in migration on SDS-polyacrylamide gels and tunicamycin-sensitive glycosylation. FPR-WT efficiently reconstituted high-affinity agonist binding and agonist- and inverse agonist-regulated guanosine 5'-O-(3-thiotriphosphate) (GTP gammaS) binding to G alpha (i2)beta (1)gamma (2). In contrast, FPR-F110S only weakly reconstituted agonist-stimulated GTP gammaS binding, and FPR-C126W was completely inefficient. Collectively, our data show almost complete and complete loss of G(i) protein coupling in FPR-F110S and FPR-C126W, respectively. The severe functional defects in FPR-F110S and FPR-C126W contrast with the discrete clinical symptoms associated with these mutations, indicating that loss of FPR function in host defense is, for the most part, readily compensated.	Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	University of Kansas	Wenzel-Seifert, K (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 5003 Malott Hall, Lawrence, KS 66045 USA.		Seifert, Roland/G-3189-2013					Benya RV, 2000, MOL PHARMACOL, V58, P1490, DOI 10.1124/mol.58.6.1490; Boer U, 2000, BIOCHEM J, V350, P839, DOI 10.1042/0264-6021:3500839; BOMMAKANTI RK, 1995, BIOCHEMISTRY-US, V34, P6720, DOI 10.1021/bi00020a017; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; COWEN DS, 1990, J BIOL CHEM, V265, P16181; CUPO JF, 1989, BIOCHIM BIOPHYS ACTA, V982, P31, DOI 10.1016/0005-2736(89)90170-3; DANIEL MA, 1993, J PERIODONTOL, V64, P617, DOI 10.1902/jop.1993.64.7.617; Dennison DK, 1997, PERIODONTOL 2000, V14, P54, DOI 10.1111/j.1600-0757.1997.tb00192.x; DILLON SB, 1988, VIRCHOWS ARCH B, V55, P65; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; GIERSCHIK P, 1991, EUR J BIOCHEM, V197, P725, DOI 10.1111/j.1432-1033.1991.tb15964.x; GOLDMAN DW, 1985, J EXP MED, V162, P145, DOI 10.1084/jem.162.1.145; Grunewald S, 1996, BIOCHEMISTRY-US, V35, P15149, DOI 10.1021/bi9607564; Gwinn MR, 1999, J PERIODONTOL, V70, P1194, DOI 10.1902/jop.1999.70.10.1194; JACOBS AA, 1995, J LEUKOCYTE BIOL, V57, P679, DOI 10.1002/jlb.57.4.679; Klinker JF, 1996, GEN PHARMACOL, V27, P33, DOI 10.1016/0306-3623(95)00107-7; Le YY, 2000, IMMUNOL REV, V177, P185, DOI 10.1034/j.1600-065X.2000.17704.x; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Miettinen HM, 1999, J BIOL CHEM, V274, P27934, DOI 10.1074/jbc.274.39.27934; Miettinen HM, 1997, J IMMUNOL, V159, P4045; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; PEREZ HD, 1991, J CLIN INVEST, V87, P971, DOI 10.1172/JCI115105; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; QUEHENBERGER O, 1992, J BIOL CHEM, V267, P19757; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Seifert R, 1998, EUR J BIOCHEM, V255, P369, DOI 10.1046/j.1432-1327.1998.2550369.x; Seifert R, 2001, RECEPTOR CHANNEL, V7, P357; SEIFERT R, 1991, REV PHYSIOL BIOCH P, V117, P1; VANDYKE TE, 1986, J PERIODONTOL, V57, P703, DOI 10.1902/jop.1986.57.11.703; VANDYKE TE, 1981, BIOCHEM BIOPH RES CO, V100, P1278, DOI 10.1016/0006-291X(81)91962-8; Wara-aswapati N, 1999, J DENT CHILD, V66, P167; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wenzel-Seifert K, 1999, J BIOL CHEM, V274, P33259, DOI 10.1074/jbc.274.47.33259; Wenzel-Seifert K, 1998, J BIOL CHEM, V273, P24181, DOI 10.1074/jbc.273.37.24181; Wenzel-Seifert K., 2001, PHYSL INFLAMMATION, P146; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; Wise A, 1999, BIOCHEMISTRY-US, V38, P2272, DOI 10.1021/bi982054f	41	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42043	42049		10.1074/jbc.M106621200	http://dx.doi.org/10.1074/jbc.M106621200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11559706	hybrid			2022-12-27	WOS:000172450400068
J	Jacobs, AR; LeRoith, D; Taylor, SI				Jacobs, AR; LeRoith, D; Taylor, SI			Insulin receptor substrate-1 pleckstrin homology and phosphotyrosine-binding domains are both involved in plasma membrane targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT4 TRANSLOCATION; PROTEIN; DOWNSTREAM; ACTIVATION; IRS-1; COMPARTMENTALIZATION; PHOSPHORYLATION; LOCALIZATION; ASSOCIATION; DYNAMICS	The localization of insulin receptor substrate (IRS) molecules may be responsible for the differential biological activities of insulin and other peptides such as platelet-derived growth factor. The subcellular localization of IRS-1 is controversial, with some reports suggesting association with the cytoskeleton and other studies reporting membrane localization. In this study, we used immunofluorescence microscopy to define the localization of IRS-1. In the basal state, recombinant IRS-1 was localized predominantly in the cytoplasm. In response to insulin, recombinant IRS-1 translocated to the plasma membrane. We have also studied the localization of green fluorescent protein (GFP) fusion proteins. Unlike native IRS-1, a fusion protein containing GFP plus full-length IRS-1 appeared to localize in inclusion bodies. In contrast, when GFP was fused to the N terminus of IRS-1 (i.e. the pleckstrin homology and phosphotyrosine-binding domains), this fusion protein was targeted to the plasma membrane. Mutations of phosphoinositide-binding sites in both the pleckstrin homology and phosphotyrosine-binding domains significantly reduced the ability of Myc-tagged IRS-1 to translocate to the plasma membrane following insulin stimulation. However, these mutations did not cause a statistically significant impairment of tyrosine phosphorylation in response to insulin. This raises the possibility that IRS-1 tyrosine phosphorylation may occur prior to plasma membrane translocation.	NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; George Washington Univ, Grad Program Genet, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); George Washington University	LeRoith, D (corresponding author), NIDDK, Clin Endocrinol Branch, NIH, Rm 8D12,Bldg 10, Bethesda, MD 20892 USA.	Derek@helix.nih.gov						Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Burks DJ, 1997, J BIOL CHEM, V272, P27716, DOI 10.1074/jbc.272.44.27716; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Clark SF, 2000, J BIOL CHEM, V275, P3819, DOI 10.1074/jbc.275.6.3819; Dhe-Paganon S, 1999, P NATL ACAD SCI USA, V96, P8378, DOI 10.1073/pnas.96.15.8378; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Goalstone ML, 2001, J BIOL CHEM, V276, P12805, DOI 10.1074/jbc.M009443200; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Kriauciunas KM, 2000, MOL CELL BIOL, V20, P6849, DOI 10.1128/MCB.20.18.6849-6859.2000; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; QUON MJ, 1994, J BIOL CHEM, V269, P27920; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Razzini G, 2000, MOL ENDOCRINOL, V14, P823, DOI 10.1210/me.14.6.823; Sable CL, 1998, J BIOL CHEM, V273, P29600, DOI 10.1074/jbc.273.45.29600; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Takeuchi H, 1998, BIOCHEM J, V334, P211, DOI 10.1042/bj3340211; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; Vainshtein I, 2001, J BIOL CHEM, V276, P8073, DOI 10.1074/jbc.M008436200; VanRenterghem B, 1998, J BIOL CHEM, V273, P29942, DOI 10.1074/jbc.273.45.29942; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Xu P, 1999, J BIOL CHEM, V274, P15262, DOI 10.1074/jbc.274.21.15262	32	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40795	40802		10.1074/jbc.M105194200	http://dx.doi.org/10.1074/jbc.M105194200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526109	hybrid			2022-12-27	WOS:000171925600057
J	Krasotkina, J; Walters, T; Maruya, KA; Ragsdale, SW				Krasotkina, J; Walters, T; Maruya, KA; Ragsdale, SW			Characterization of the B-12- and iron-sulfur-containing reductive dehalogenase from Desulfitobacterium chlororespirans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE; SP-NOV; HALOALKANE DEHALOGENASE; DESULFOMONILE-TIEDJEI; COENZYME-A; PURIFICATION; TETRACHLOROETHENE; DECHLORINATION; PROTEIN; ENZYME	The United Nations and the U.S. Environmental Protection Agency have identified a variety of chlorinated aromatics that constitute a significant health and environmental risk as "priority organic pollutants," the so-called "dirty dozen." Microbes have evolved the ability to utilize chlorinated aromatics as terminal electron acceptors in an energy-generating process called dehalorespiration. In this process, a reductive dehalogenase (CprA), couples the oxidation of an electron donor to the reductive elimination of chloride. We have characterized the B-12 and iron-sulfur cluster-containing 3-chloro-4-hydroxybenzoate reductive dehalogenase from Desulfitobacterium chlororespirans. By defining the substrate and inhibitor specificity for the dehalogenase, the enzyme was found to require an hydroxyl group ortho to the halide. Inhibition studies indicate that the hydroxyl group is required for substrate binding. The carboxyl group can be replaced by other functionalities, e.g. acetyl or halide groups, ortho or meta to the chloride to be eliminated. The purified D. chlororespirans enzyme could dechlorinate an hydroxylated PCB (3,3',5,5'-tetra-chloro-4,4'-biphenyldiol) at a rate about 1% of that with 3-chloro-4-hydroxybenzoate. Solvent deuterium isotope effect studies indicate that transfer of a single proton is partially rate-limiting in the dehalogenation reaction.	Univ Nebraska, Dept Biochem, Beadle Ctr, Lincoln, NE 68588 USA; Skidaway Inst Oceanog, Savannah, GA 31411 USA	University of Nebraska System; University of Nebraska Lincoln; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Ragsdale, SW (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr, Lincoln, NE 68588 USA.	sragsdale1@unl.edu						Alber BE, 1999, BIOCHEMISTRY-US, V38, P13119, DOI 10.1021/bi9828876; Anandarajah K, 2000, BIOCHEMISTRY-US, V39, P5303, DOI 10.1021/bi9923813; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bouchard B, 1996, INT J SYST BACTERIOL, V46, P1010, DOI 10.1099/00207713-46-4-1010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christiansen N, 1998, FEBS LETT, V436, P159, DOI 10.1016/S0014-5793(98)01114-4; Christiansen N, 1996, INT J SYST BACTERIOL, V46, P442, DOI 10.1099/00207713-46-2-442; Copley SD, 1998, CURR OPIN CHEM BIOL, V2, P613, DOI 10.1016/S1367-5931(98)80092-6; DOLFING J, 1987, ARCH MICROBIOL, V149, P102, DOI 10.1007/BF00425073; DRUMMOND JT, 1994, BIOCHEMISTRY-US, V33, P3732, DOI 10.1021/bi00178a033; GRIFFITH GD, 1992, APPL ENVIRON MICROB, V58, P409, DOI 10.1128/AEM.58.1.409-411.1992; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Hurt JD, 1997, J BIOL CHEM, V272, P13512, DOI 10.1074/jbc.272.21.13512; JABLONSKI PE, 1993, J BIOL CHEM, V268, P325; JOHANSSON IM, 1994, EUR J BIOCHEM, V224, P901, DOI 10.1111/j.1432-1033.1994.00901.x; KRAUTLER B, 1999, CHEM BIOCH B12, V1, P315; Krooshof GH, 1998, BIOCHEMISTRY-US, V37, P15013, DOI 10.1021/bi9815187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROCHE SD, 1990, J BACTERIOL, V172, P164, DOI 10.1128/JB.172.1.164-171.1990; Li YF, 1998, J BIOL CHEM, V273, P15035, DOI 10.1074/jbc.273.24.15035; LJUNGDAH.LG, 1973, BIOCHEMISTRY-US, V12, P1802, DOI 10.1021/bi00733a022; Loffler FE, 1996, APPL ENVIRON MICROB, V62, P3809, DOI 10.1128/AEM.62.10.3809-3813.1996; McCarthy DL, 1996, BIOCHEMISTRY-US, V35, P14634, DOI 10.1021/bi961730f; Messmer M, 1996, ARCH MICROBIOL, V165, P18, DOI 10.1007/s002030050291; Miller E, 1998, ARCH MICROBIOL, V169, P497, DOI 10.1007/s002030050602; Miller E, 1996, ARCH MICROBIOL, V166, P379, DOI 10.1007/BF01682983; MOHN WW, 1991, ARCH MICROBIOL, V157, P1; MORRIS PJ, 1992, APPL ENVIRON MICROB, V58, P3088, DOI 10.1128/AEM.58.9.3088-3094.1992; Neumann A, 1996, J BIOL CHEM, V271, P16515, DOI 10.1074/jbc.271.28.16515; NI SS, 1995, J BACTERIOL, V177, P5135, DOI 10.1128/jb.177.17.5135-5139.1995; QUENSEN JF, 1990, APPL ENVIRON MICROB, V56, P2360, DOI 10.1128/AEM.56.8.2360-2369.1990; Rabinowitz J C, 1978, Methods Enzymol, V53, P275; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; RAGSDALE SW, 1999, CHEM BIOCH B12, V1, P633; Sanford RA, 1996, APPL ENVIRON MICROB, V62, P3800, DOI 10.1128/AEM.62.10.3800-3808.1996; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P5624, DOI 10.1021/bi952904g; Schumacher W, 1997, FEBS LETT, V409, P421, DOI 10.1016/S0014-5793(97)00520-6; Schumacher W, 1996, J BACTERIOL, V178, P2328, DOI 10.1128/jb.178.8.2328-2333.1996; Simianu M, 1998, BIOCHEMISTRY-US, V37, P10027, DOI 10.1021/bi9726483; Smidt H, 2000, J BACTERIOL, V182, P5683, DOI 10.1128/JB.182.20.5683-5691.2000; Smith KS, 2000, J BACTERIOL, V182, P6605, DOI 10.1128/JB.182.23.6605-6613.2000; STEINER H, 1975, EUR J BIOCHEM, V59, P253, DOI 10.1111/j.1432-1033.1975.tb02449.x; van de Pas BA, 1999, J BIOL CHEM, V274, P20287, DOI 10.1074/jbc.274.29.20287; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; Wiegel J, 1999, APPL ENVIRON MICROB, V65, P2217; Wohlfarth G, 1997, CURR OPIN BIOTECH, V8, P290, DOI 10.1016/S0958-1669(97)80006-7	47	59	60	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40991	40997		10.1074/jbc.M106217200	http://dx.doi.org/10.1074/jbc.M106217200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533062	hybrid			2022-12-27	WOS:000171925600083
J	Blobe, GC; Liu, XD; Fang, SJJ; How, T; Lodish, HF				Blobe, GC; Liu, XD; Fang, SJJ; How, T; Lodish, HF			A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling - Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; DEPENDENT DEGRADATION; C-TERMINUS; KINASE; PATHWAY; CLONING; CELLS; BINDS; RESPONSIVENESS; ARREST	Transforming growth factor beta (TGF-beta) mediates its biological effects through three high-affinity cell surface receptors, the TGF-beta type I, type II, and type III receptors, and the Smad family of transcription factors. Although the functions of the type II and type I receptors are well established, the precise role of the type III receptor in TGF-beta signaling remains to be established. While expression cloning signaling molecules downstream of TGF-beta, we cloned GIPC (GAIP-interacting protein, C terminus), a PDZ domain-containing protein. GIPC binds a Class I PDZ binding motif in the cytoplasmic domain of the type III receptor resulting in regulation of expression of the type III receptor at the cell surface. Increased expression of the type III receptor mediated by GIPC enhanced cellular responsiveness to TGF-beta both in terms of inhibition of proliferation and in plasminogen-activating inhibitor (PAD-based promoter gene induction assays. In all cases, deletion of the Class I PDZ binding motif of the type III receptor prevented the type III receptor from binding to GIPC and abrogated the effects of GIPC on type III receptor expressing cells. These results establish, for the first time, a protein that interacts with the cytoplasmic domain of the type III receptor, determine that expression of the type III receptor is regulated at the protein level and that increased expression of the type III receptor is sufficient to enhance TGF-beta signaling. These results further support an essential, non-redundant role for the type I receptor in TGF-beta signaling.	Duke Univ, Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Duke University; Duke University; University of Colorado System; University of Colorado Boulder; Massachusetts Institute of Technology (MIT); Whitehead Institute	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA.	blobe001@mc.duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; LIU, XUEDONG/0000-0001-7209-4964	NATIONAL CANCER INSTITUTE [R01CA063260] Funding Source: NIH RePORTER; NCI NIH HHS [CA 63260] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blain SW, 2000, J BIOL CHEM, V275, P32066, DOI 10.1074/jbc.M006496200; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Cai HB, 1999, J NEUROSCI, V19, P6519; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Fink SP, 2001, CANCER RES, V61, P256; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; James P, 1996, GENETICS, V144, P1425; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Onishi M, 1996, EXP HEMATOL, V24, P324; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; SANKAR S, 1995, J BIOL CHEM, V270, P13567, DOI 10.1074/jbc.270.22.13567; Sun LZ, 1997, J BIOL CHEM, V272, P25367, DOI 10.1074/jbc.272.40.25367; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tani TT, 2001, J BIOL CHEM, V276, P36535, DOI 10.1074/jbc.M105785200; Venkatasubbarao K, 2000, ANTICANCER RES, V20, P43; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9	34	165	171	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39608	39617		10.1074/jbc.M106831200	http://dx.doi.org/10.1074/jbc.M106831200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546783	hybrid			2022-12-27	WOS:000171789200016
J	Okamura, Y; Takeyama, H; Matsunaga, T				Okamura, Y; Takeyama, H; Matsunaga, T			A magnetosome-specific GTPase from the magnetic bacterium Magnetospirillum magneticum AMB-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; SP STRAIN AMB-1; SIGNAL RECOGNITION PARTICLE; BINDING PROTEIN OBG; ESCHERICHIA-COLI; SUCCESSIVE COMPARTMENTS; NUCLEOTIDE BINDING; BACILLUS-SUBTILIS; GOLGI MEMBRANES; COATED VESICLES	Magnetic bacteria produce intracellular vesicles that envelope single domain magnetite crystals. Although many proteins are present in this intracellular vesicle membrane, five are specific to this membrane. A 16-kDa protein, designated Mms16, is the most abundant of the magnetosome-specific proteins, and to establish its function we cloned and sequenced its gene from Magnetospirillum magneticum AMB-1. This was achieved by determination of the N-terminal amino acid sequence of the protein following two dimensional polyacrylamide gel electrophoresis, and sequencing of the gene was performed by gene walking using anchored polymerase chain reaction. Mms16 contains a putative ATP/GTP binding motif (P-loop). Recombinant Mms16 with a hemagglutinin tag, was expressed in Escherichia coli and purified. Recombinant Mms16 protein could bind GTP and showed GTPase activity. GTP was the preferred substrate for Mms16-catalyzed nucleotide triphosphate hydrolysis. These results suggest that a novel protein specifically localized on the magnetic particle membrane, Mms16, is a GTPase. Mms16 protein showed similar characteristics to small GTPases involved in the formation of intracellular vesicles. Furthermore, addition of the GTPase inhibitor AlF4- also inhibited magnetic particle synthesis, suggesting that GTPase is required for magnetic particles synthesis.	Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan	Tokyo University of Agriculture & Technology	Matsunaga, T (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol, 2-24-16 Naka Cho, Tokyo 1848588, Japan.	tmatsuna@cc.tuat.ac.jp	Matsunaga, Tadashi/A-6293-2015; Okamura, Yoshiko/M-4019-2019; Okamura, Yoshiko/W-2677-2017	Matsunaga, Tadashi/0000-0002-6216-3687; Okamura, Yoshiko/0000-0001-8333-7722; Okamura, Yoshiko/0000-0001-8333-7722				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Anthony C., 1982, BIOCH METHYLOTROPHS; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Britton RA, 1998, MOL MICROBIOL, V27, P739, DOI 10.1046/j.1365-2958.1998.00719.x; Britton RA, 1997, J BACTERIOL, V179, P4575, DOI 10.1128/jb.179.14.4575-4582.1997; CARLIER MF, 1988, BIOCHEMISTRY-US, V27, P3555, DOI 10.1021/bi00410a005; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; FRANKEL RB, 1983, BIOCHIM BIOPHYS ACTA, V763, P147, DOI 10.1016/0167-4889(83)90038-1; GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988; HELMS JB, 1993, J CELL BIOL, V119, P139; HOOPER AB, 1984, EUR J BIOCHEM, V141, P565, DOI 10.1111/j.1432-1033.1984.tb08230.x; HUREK T, 1995, MOL MICROBIOL, V18, P225, DOI 10.1111/j.1365-2958.1995.mmi_18020225.x; INADA T, 1989, J BACTERIOL, V171, P5017, DOI 10.1128/jb.171.9.5017-5024.1989; ISEGAWA Y, 1992, MOL CELL PROBE, V6, P467, DOI 10.1016/0890-8508(92)90043-W; KAHN RA, 1988, J BIOL CHEM, V263, P8282; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Kondratieva E.N., 1992, PROKARYOTES, VVolume 1, P312; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPETINA EG, 1987, P NATL ACAD SCI USA, V84, P2261, DOI 10.1073/pnas.84.8.2261; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LUNARDI J, 1988, P NATL ACAD SCI USA, V85, P8958, DOI 10.1073/pnas.85.23.8958; LUTKENHAUS J, 1993, MOL MICROBIOL, V9, P403, DOI 10.1111/j.1365-2958.1993.tb01701.x; MARCH PE, 1988, ONCOGENE, V2, P539; MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651; Matsunaga T, 2000, BIOCHEM BIOPH RES CO, V268, P932, DOI 10.1006/bbrc.2000.2236; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; NAKAMURA C, 1995, J BIOCHEM-TOKYO, V118, P23, DOI 10.1093/oxfordjournals.jbchem.a124884; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; NOKIHARA K, 1992, ELECTROPHORESIS, V13, P701, DOI 10.1002/elps.11501301149; Okamura Y, 2000, APPL BIOCHEM BIOTECH, V84-6, P441, DOI 10.1385/ABAB:84-86:1-9:441; Okuda Y, 1996, GENE, V171, P99, DOI 10.1016/0378-1119(95)00008-9; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rothman JE, 1996, PROTEIN SCI, V5, P185; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMID SL, 1995, FASEB J, V9, P1445, DOI 10.1096/fasebj.9.14.7589986; Schuler D, 1999, APPL MICROBIOL BIOT, V52, P464, DOI 10.1007/s002530051547; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; TAKIFF HE, 1989, J BACTERIOL, V171, P2581, DOI 10.1128/jb.171.5.2581-2590.1989; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIDWANS SJ, 1995, J BACTERIOL, V177, P3308, DOI 10.1128/jb.177.11.3308-3311.1995; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATSON WS, 1989, BERGEYS MANUAL SYSTE, V3, P1808; WEISS O, 1989, J BIOL CHEM, V264, P21066; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118	58	65	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2001	276	51					48183	48188		10.1074/jbc.M106408200	http://dx.doi.org/10.1074/jbc.M106408200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505QL	11557762	hybrid			2022-12-27	WOS:000172927000060
J	Hatae, T; Wada, M; Yokoyama, C; Shimonishi, M; Tanabe, T				Hatae, T; Wada, M; Yokoyama, C; Shimonishi, M; Tanabe, T			Prostacyclin-dependent apoptosis mediated by PPAR delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; PEROXISOME PROLIFERATOR; PROSTANOID RECEPTORS; PROTEIN-KINASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); DIFFERENTIAL EXPRESSION; ENDOTHELIAL-CELLS; MOLECULAR-BIOLOGY; INDUCE APOPTOSIS; RETINOIC ACID	Prostacyclin (PGI(2)) plays important roles in hemostasis both as a vasodilator and an endogenous inhibitor of platelet aggregation. PGI(2) functions in these roles through a specific IP receptor, a G protein-coupled receptor linked to G. and increases in cAMP. Here, we report that intracellular prostacyclin formed by expressing prostacyclin synthase in human embryonic kidney 293 cells promotes apoptosis by activating endogenous peroxisome proliferator-activated receptor delta (PPAR delta). In contrast, treatment of cells with extracellular prostacyclin or dibutyryl cAMP actually reduced apoptosis. On the contrary, treatment of the cells with RpcAMP (adenosine 3',5'-cyclic monophosphothioate, Rp-isomer), an antagonist of cAMP, enhanced prostacyclin-mediated apoptosis. The expression of an L431A/G434A mutant of PPAR delta completely blocked prostacyclin-mediated PPAR delta activation and apoptosis. These observations indicate that prostacyclin can act through endogenous PPAR delta as a second signaling pathway that controls cell fate.	Natl Cardiovasc Ctr, Res Inst, Dept Pharmacol, Suita, Osaka 5658565, Japan	National Cerebral & Cardiovascular Center - Japan	Tanabe, T (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Pharmacol, Suita, Osaka 5658565, Japan.							Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Beauchamp MH, 2001, J APPL PHYSIOL, V90, P2279, DOI 10.1152/jappl.2001.90.6.2279; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; DOHLMAN HG, 1993, NATURE, V366, P307, DOI 10.1038/366307b0; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; HARA S, 1994, J BIOL CHEM, V269, P19897; HATAE T, 1996, FEBS LETT, V289, P268; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Heneka MT, 1999, J NEUROIMMUNOL, V100, P156, DOI 10.1016/S0165-5728(99)00192-7; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kedzie KM, 1998, MOL PHARMACOL, V54, P584, DOI 10.1124/mol.54.3.584; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kinoshita T, 1999, BBA-MOL CELL BIOL L, V1438, P120, DOI 10.1016/S1388-1981(99)00034-7; Lazar MA, 2001, NAT MED, V7, P23, DOI 10.1038/83301; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Narko K, 1997, J BIOL CHEM, V272, P21455, DOI 10.1074/jbc.272.34.21455; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Ono-Saito N, 1999, PHARMACOL THERAPEUT, V82, P123, DOI 10.1016/S0163-7258(98)00070-9; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Prescott SM, 1996, CELL, V87, P783, DOI 10.1016/S0092-8674(00)81983-2; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Robinson SW, 1996, J NEUROCHEM, V67, P212; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; SMITH EM, 1996, J BIOL CHEM, V271, P33698; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; TANABE T, 1995, J LIPID MEDIAT CELL, V12, P243, DOI 10.1016/0929-7855(95)00031-K; Todaka T, 1999, STROKE, V30, P419, DOI 10.1161/01.STR.30.2.419; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; USHIKUBI F, 1995, J LIPID MEDIAT CELL, V12, P343, DOI 10.1016/0929-7855(95)00022-I; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4; WATABE A, 1993, J BIOL CHEM, V268, P20175; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zou MH, 1997, BIOL CHEM, V378, P707, DOI 10.1515/bchm.1997.378.7.707	53	112	113	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46260	46267		10.1074/jbc.M107180200	http://dx.doi.org/10.1074/jbc.M107180200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551955	hybrid			2022-12-27	WOS:000172573100105
J	Hirono, M; Sugiyama, T; Kishimoto, Y; Sakai, I; Miyazawa, T; Kishio, M; Inoue, H; Nakao, K; Ikeda, M; Kawahara, S; Kirino, Y; Katsuki, M; Horie, H; Ishikawa, Y; Yoshioka, T				Hirono, M; Sugiyama, T; Kishimoto, Y; Sakai, I; Miyazawa, T; Kishio, M; Inoue, H; Nakao, K; Ikeda, M; Kawahara, S; Kirino, Y; Katsuki, M; Horie, H; Ishikawa, Y; Yoshioka, T			Phospholipase C beta 4 and protein kinase C alpha and/or protein kinase C beta I are involved in the induction of long term depression in cerebellar Purkinje cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLIMBING FIBER INNERVATION; MICE LACKING MGLUR1; GAMMA MUTANT MICE; MOTOR COORDINATION; DIFFERENTIAL REGULATION; GLUTAMATE SENSITIVITY; SYNAPTIC DEPRESSION; RAT-BRAIN; TRANSLOCATION; POTENTIATION	Activation of the type-1 metabotropic glutamate receptor (mG1uR1) signaling pathway in the cerebellum involves activation of phospholipase C (PLC) and protein kinase C (PKC) for the induction of cerebellar long term depression (LTD). The PLC and PKC isoforms that are involved in LTD remain unclear, however. One previous study found no change in LTD in PKC gamma -deficient mice, thus, in the present study, we examined cerebellar LTD in PLC beta4-deficient mice. Immunohistochemical and Western blot analyses of cerebellum from wild-type mice revealed that PLC beta1 was expressed weakly and uniformly, PLC beta2 was not detected, PLC beta3 was expressed predominantly in caudal cerebellum (lobes 7-10), and PLC beta4 was expressed uniformly throughout. In PLC beta4-deficient mice, expression of total PLC beta, the mGluR1-mediated Ca2+ response, and LTD induction were greatly reduced in rostral cerebellum (lobes 1-6). Furthermore, we used immunohistochemistry to localize PKC alpha, -betaI, -beta II, and -gamma in mouse cerebellar Purkinje cells during LTD induction. Both PKC alpha and PKC betaI were found to be translocated to the plasmamembrane under these conditions. Taken together, these results suggest that mG1uR1-mediated activation of PLC beta4 in rostral cerebellar Purkinje cells induced LTD via PKC alpha and/or PKC betaI.	Waseda Univ, Adv Res Inst Sci & Engn, Dept Mol Neurobiol, Shinjuku Ku, Tokyo 1698555, Japan; Waseda Univ, Sch Human Sci, Dept Mol Neurobiol, Tokorozawa, Saitama 3591192, Japan; Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Bunkyo Ku, Tokyo 1130033, Japan; Yokohama City Univ, Sch Med, Dept Physiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; Univ Tokyo, Inst Med Sci, Res Ctr Anim Models Human Dis, Dept DNA Biol & Embryo Engn,Minato Ku, Tokyo 1088639, Japan	Waseda University; Waseda University; University of Tokyo; Yokohama City University; National Defense Medical College - Japan; University of Tokyo	Yoshioka, T (corresponding author), Waseda Univ, Adv Res Inst Sci & Engn, Dept Mol Neurobiol, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.			Sugiyama, Takashi/0000-0002-7872-1540; Kishimoto, Yasushi/0000-0002-4828-1249; Hirono, Moritoshi/0000-0001-6068-1045				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Angenstein F, 1999, NEUROSCIENCE, V93, P1289, DOI 10.1016/S0306-4522(99)00315-2; Buchner K, 1999, MOL BRAIN RES, V64, P222, DOI 10.1016/S0169-328X(98)00324-6; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CHEN S, 1993, NEUROSCIENCE, V56, P177, DOI 10.1016/0306-4522(93)90572-W; COCKCROFT S, 1992, BIOCHEM J, V288, P1; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; Garcia MM, 1997, J COMP NEUROL, V385, P26; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; HIRANO T, 1990, NEUROSCI LETT, V119, P145, DOI 10.1016/0304-3940(90)90819-U; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KIM MJ, 1993, BIOCHEM BIOPH RES CO, V194, P706, DOI 10.1006/bbrc.1993.1879; KISHIMOTO Y, 2001, IN PRESS NEUROREPORT; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MIN DS, 1993, J BIOL CHEM, V268, P12207; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; Nakao K, 1998, EXP ANIM TOKYO, V47, P167, DOI 10.1538/expanim.47.167; NAKAZAWA K, 1995, NEURON, V15, P697, DOI 10.1016/0896-6273(95)90157-4; Netzeband JG, 1997, J NEUROPHYSIOL, V78, P63, DOI 10.1152/jn.1997.78.1.63; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROUSTAN P, 1995, NEUROREPORT, V6, P1837, DOI 10.1097/00001756-199510020-00004; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; Sena CM, 1996, J NEUROCHEM, V66, P1086; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Son H, 1996, BRAIN RES, V739, P282, DOI 10.1016/S0006-8993(96)00836-0; STAAK S, 1995, BRAIN RES, V682, P55, DOI 10.1016/0006-8993(95)00319-L; TANAKA O, 1994, NEUROSCI LETT, V182, P17, DOI 10.1016/0304-3940(94)90194-5; VanderZee EA, 1997, PROG NEURO-PSYCHOPH, V21, P531, DOI 10.1016/S0278-5846(97)00017-1; WARNKE R, 1980, J HISTOCHEM CYTOCHEM, V28, P771, DOI 10.1177/28.8.7003003; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V98, P657, DOI 10.1093/oxfordjournals.jbchem.a135322	47	52	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45236	45242		10.1074/jbc.M105413200	http://dx.doi.org/10.1074/jbc.M105413200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11551922	hybrid, Green Published			2022-12-27	WOS:000172406700117
J	Martin, MC; Dransfield, I; Haslett, C; Rossi, AG				Martin, MC; Dransfield, I; Haslett, C; Rossi, AG			Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; GRANULOCYTE APOPTOSIS; AGING NEUTROPHILS; BINDING PROTEINS; ACTIVATION; INHIBITOR; PHAGOCYTOSIS; MITOCHONDRIA; 3-KINASE; RELEASE	The second messenger molecule cyclic AMP dramatically modulates the apoptotic program in a wide variety of cells, accelerating apoptosis in some and delaying the rate of apoptosis in others. Human neutrophil apoptosis, a process that regulates the fate and numbers of these potentially histotoxic cells in inflammatory sites, is profoundly delayed by the cell-permeable analog of cyclic AMP, dibutyryl-cAMP. We have investigated the mechanisms underlying cyclic AMP-mediated delay of neutrophil apoptosis, and we show that cyclic AMP inhibits loss of mitochondrial potential occurring during constitutive neutrophil apoptosis. Furthermore, we demonstrate that cyclic AMP also suppresses caspase activation in these inflammatory cells. Despite increasing protein kinase A activity, this kinase is unlikely to mediate the effect of cyclic AMP on apoptosis because blockade of protein kinase A activation did not influence the survival effects of cyclic AMP. Further investigation of the signaling mechanism demonstrated that the delay of apoptosis is independent of phosphoinositide 3-kinase and MAPK activation. Our results suggest cyclic AMP delays neutrophil apoptosis via a novel, reversible, and transcriptionally independent mechanism. We show that proteasome activity in the neutrophil is vitally involved in this process, and we suggest that a balance of pro-apoptotic and anti-apoptotic proteins plays a key role in the powerful ability of cyclic AMP to delay neutrophil death.	Univ Edinburgh, Sch Med, Resp Med Unit, MRC,Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Martin, MC (corresponding author), Univ Edinburgh, Sch Med, Resp Med Unit, MRC,Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland.	moragmartin@hotmail.com		Martin, Morag/0000-0002-8667-6057; Dransfield, Ian/0000-0001-5848-7059				AHMED MU, 1996, BIOCHEM J, V318, P965; Akgul C, 2001, FEBS LETT, V487, P318, DOI 10.1016/S0014-5793(00)02324-3; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cox G, 1997, J LEUKOCYTE BIOL, V61, P224, DOI 10.1002/jlb.61.2.224; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; ERHARDT P, 1995, MOL CELL BIOL, V15, P5524; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HANNAH S, 1995, FEBS LETT, V372, P233, DOI 10.1016/0014-5793(95)00986-J; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; HASLETT C, 1985, AM J PATHOL, V119, P101; HASLETT C, 1989, CURR OPIN IMMUNOL, V2, P10, DOI 10.1016/0952-7915(89)90091-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KIEFER J, 1995, J IMMUNOL, V155, P4525; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 1999, BIOCHEM SOC SYMP, V66, P1; LANOTTE M, 1991, J CELL PHYSIOL, V146, P73, DOI 10.1002/jcp.1041460110; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Liu YQ, 1999, J IMMUNOL, V162, P3639; MCCONKEY DJ, 1990, J IMMUNOL, V145, P1227; MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ottonello L, 1998, EXP HEMATOL, V26, P895; Parvathenani LK, 1998, J BIOL CHEM, V273, P6736, DOI 10.1074/jbc.273.12.6736; Plevin R, 1997, CELL SIGNAL, V9, P323, DOI 10.1016/S0898-6568(96)00193-3; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Pryde JG, 2000, J BIOL CHEM, V275, P33574, DOI 10.1074/jbc.M001008200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rossi AG, 1995, BIOCHEM BIOPH RES CO, V217, P892, DOI 10.1006/bbrc.1995.2855; ROSSI AG, 1998, LUNG BIOL HEALTH DIS, V112, P9; ROSSI AG, 1994, IMMUNOPHARMACOLOGY N, P223; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Simon HU, 2001, IMMUNOL REV, V179, P156, DOI 10.1034/j.1600-065X.2001.790115.x; Staples KJ, 2001, J IMMUNOL, V167, P2074, DOI 10.4049/jimmunol.167.4.2074; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; VANHOOIJDONK CAEM, 1994, CYTOMETRY, V17, P185, DOI 10.1002/cyto.990170212; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Ward C, 1999, TRENDS PHARMACOL SCI, V20, P503, DOI 10.1016/S0165-6147(99)01391-7; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Whyte MKB, 1997, J LEUKOCYTE BIOL, V62, P195, DOI 10.1002/jlb.62.2.195; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	55	90	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45041	45050		10.1074/jbc.M105197200	http://dx.doi.org/10.1074/jbc.M105197200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11560927	hybrid			2022-12-27	WOS:000172406700094
J	Nomizu, M; Pietrzynski, G; Kato, T; Lachance, P; Menard, R; Ziomek, E				Nomizu, M; Pietrzynski, G; Kato, T; Lachance, P; Menard, R; Ziomek, E			Substrate specificity of the streptococcal cysteine protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC INACTIVATION; PROTEINASE PRECURSOR; CATHEPSIN-B; PYOGENES; MECHANISM; CLEAVAGE; TOXIN; INFECTIONS; RESISTANCE; SURFACE	The streptococcal pyrogenic exotoxin B (SpeB) is an important factor in mediating Streptococcus pyogenes infections. SpeB is the zymogen of the streptococcal cysteine protease (SCP), of which relatively little is known regarding substrate specificity. To investigate this aspect of SCP function, a series of internally quenched fluorescent substrates was designed based on the cleavage sites identified in the autocatalytic processing of Spell to mature SCP. The best substrates for SCP contain three amino acids in the nonprimed position (i.e. AIK in P-3-P-2-P-1). Varying the length of the substrate on the primed side of the scissile bond has a relatively lower effect on activity. The highest activity (k(cat)/K-M = 2.8 +/- 0.6 (10(5) x M-1 s(-1)) is observed for the pentamer 3-aminobenzoic acid-AIKAG-3-nitrotyrosine, which spans subsites S-3 to S-2' on the enzyme. High pressure liquid chromatography and mass spectrometry analyses show that the substrates are cleaved at the site predicted from the autoprocessing experiments. These results show that SCP can display an important level of endopeptidase activity. Substitutions at position P-2 of the substrate clearly indicate that the S-2 subsite of SCP can readily accommodate substrates containing a hydrophobic residue at that position and that some topological preference exists for that subsite. Substitutions in positions P-3, P-1, and P-1' had little or no effect on SCP activity. The substrate specificity outlined in this work further supports the similarity between SCP and the cysteine proteases of the papain family. From the data regarding the identified or proposed natural substrates for SCP, it appears that this substrate specificity profile may also apply to the processing of mammalian and streptococcal protein targets by SCP.	Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Ziomek, E (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.							BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Burns EH, 1998, MICROB PATHOGENESIS, V24, P333, DOI 10.1006/mpat.1998.0204; BUSTIN M, 1970, J BIOL CHEM, V245, P846; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; GERLACH D, 1983, ZBL BAKT-INT J MED M, V255, P221, DOI 10.1016/S0174-3031(83)80161-9; GERWIN BI, 1966, J BIOL CHEM, V241, P3331; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; KORTT AA, 1973, BIOCHEMISTRY-US, V12, P338, DOI 10.1021/bi00726a025; LIU TY, 1971, ENZYMES, V8, P609; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; MENARD R, 1993, FEBS LETT, V328, P107, DOI 10.1016/0014-5793(93)80975-Z; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; NOMIZU M, 1993, INT J PEPT PROT RES, V42, P216; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; PINKNEY M, 1995, INFECT IMMUN, V63, P2776, DOI 10.1128/IAI.63.7.2776-2779.1995; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Storer AC, 1996, PERSPECT DRUG DISCOV, V6, P33, DOI 10.1007/BF02174044; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; WOLF BB, 1994, J BIOL CHEM, V269, P30682	30	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44551	44556		10.1074/jbc.M106306200	http://dx.doi.org/10.1074/jbc.M106306200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11553627	hybrid			2022-12-27	WOS:000172406700029
J	Szczesna-Skorupa, E; Kemper, B				Szczesna-Skorupa, E; Kemper, B			The juxtamembrane sequence of cytochrome P-4502C1 contains an endoplasmic reticulum retention signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAINS; TRANSPORT VESICLES; VIRUS GLYCOPROTEIN; PLASMA-MEMBRANE; PROTEIN; GOLGI; YEAST; ER; DETERMINANTS; LOCALIZATION	The N-terminal signal anchor of cytochrome P-450 2C1 mediates retention in the endoplasmic reticulum (ER) membrane of several reporter proteins. The same sequence fused to the C terminus of the extracellular domain of the epidermal growth factor receptor permits transport of the chimeric protein to the plasma membrane. In the N-terminal position, the ER retention function of this signal depends on the polarity of the hydrophobic domain and the sequence KQS in the short hydrophilic linker immediately following the transmembrane domain. To determine what properties are required for the ER retention function of the signal anchor in a position other than the N terminus, the effect of mutations in the linker and hydrophobic domains on subcellular localization in COST cells of chimeric proteins with the P-450 signal anchor in an internal or C-terminal position was analyzed. For the C-terminal position, the signal anchor was fused to the end of the luminal domain of epidermal growth factor receptor, and green fluorescent protein was additionally fused at the C terminus of the signal anchor for the internal position. In these chimeras, the ER retention function of the signal anchor was rescued by deletion of three leucines at the C-terminal side of its hydrophobic domain; however, deletion of three valines from the N-terminal side did not affect transport to the cell surface. ER retention of the C-terminal deletion mutants was eliminated by substitution of alanines for glutamine and serine in the linker sequence. These data are consistent with a model in which the position of the linker sequence at the membrane surface, which is critical for ER retention, is dependent on the transmembrane domain.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kemper, B (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.				NIGMS NIH HHS [GM35897] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Hoppe HC, 2000, CELL MICROBIOL, V2, P569, DOI 10.1046/j.1462-5822.2000.00081.x; IVESSA NE, 1992, J CELL BIOL, V117, P949, DOI 10.1083/jcb.117.5.949; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; KUROKI K, 1989, MOL CELL BIOL, V9, P4459, DOI 10.1128/MCB.9.10.4459; Letourneur F, 1998, J BIOL CHEM, V273, P33273, DOI 10.1074/jbc.273.50.33273; Li Y, 1998, J BIOL CHEM, V273, P29830, DOI 10.1074/jbc.273.45.29830; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MASAKI R, 1994, J CELL BIOL, V126, P1407, DOI 10.1083/jcb.126.6.1407; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Milland J, 2001, J BIOL CHEM, V276, P12012, DOI 10.1074/jbc.M010018200; Misumi Y, 2001, J BIOL CHEM, V276, P6867, DOI 10.1074/jbc.M010121200; Mottola G, 2000, J BIOL CHEM, V275, P24070, DOI 10.1074/jbc.M910400199; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MURAKAMI K, 1994, J BIOCHEM, V116, P164, DOI 10.1093/oxfordjournals.jbchem.a124489; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; Puertollano R, 1998, J BIOL CHEM, V273, P12740, DOI 10.1074/jbc.273.21.12740; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; Satoh J, 1996, Mult Scler, V1, P279; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Szczesna-Skorupa E, 2000, ARCH BIOCHEM BIOPHYS, V374, P128, DOI 10.1006/abbi.1999.1628; Szczesna-Skorupa E, 2000, J BIOL CHEM, V275, P19409, DOI 10.1074/jbc.M002394200; Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; SZEZESNASKORUPA E, 1993, J BIOL CHEM, V268, P1757; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	40	22	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45009	45014		10.1074/jbc.M104676200	http://dx.doi.org/10.1074/jbc.M104676200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11557755	hybrid			2022-12-27	WOS:000172406700090
J	Kaplan, DD; Meigs, TE; Casey, PJ				Kaplan, DD; Meigs, TE; Casey, PJ			Distinct regions of the cadherin cytoplasmic domain are essential for functional interaction with G alpha(12) and beta-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; CELL-ADHESION; COMPLEX-FORMATION; ACTIVATION; RHO; INHIBITION; EXCHANGE; BINDING; KINASE; PHOSPHORYLATION	Heterotrimeric G proteins of the G(12) subfamily mediate cellular signals leading to events such as cytoskeletal rearrangements, cell proliferation, and oncogenic transformation. Several recent studies have revealed direct effector proteins through which G(12) subfamily members may transmit signals leading to various cellular responses. Our laboratory recently demonstrated that G alpha (12) and G alpha (13) specifically interact with the cytoplasmic domains of several members of the cadherin family of cell adhesion molecules (Meigs, T. E., Fields, T. A., McKee, D. D., and Casey, P. J. (2001) Proc. Natl. Acad. Sei. U. S. A. 98, 519-524). This interaction causes beta -catenin to release from cadherin and relocalize to the cytoplasm and nucleus, where it participates in transcriptional activation. Here we report that two distinct regions of the epithelial cadherin (E-cadherin) tail are required for interaction with beta -catenin and G alpha (12), respectively. Deletion of an acidic, 19-amino acid region of E-cadherin abolishes its ability to bind beta -catenin in vitro, to inhibit beta -catenin-mediated transactivation, or to stabilize beta -catenin; causes subcellular mislocalization of beta -catenin; and disrupts cadherin-mediated cell adhesion. On the other hand, deletion of a distinct 11-amino acid region of E-cadherin dramatically attenuates interaction with G alpha (12); furthermore, G alpha (12) is ineffective in stimulating beta -catenin release from an E-cadherin cytoplasmic domain lacking this putative G alpha (12)-binding region. These findings indicate that G alpha (12) and beta -catenin do not compete for the same binding site on cadherin and provide molecular targets for selectively disrupting the interaction of these proteins with cadherin.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	casey006@mc.duke.edu		Kaplan, Daniel/0000-0001-8297-560X; Casey, Patrick/0000-0002-7366-9309	NATIONAL CANCER INSTITUTE [R21CA091159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055717, R55GM055717] Funding Source: NIH RePORTER; NCI NIH HHS [CA91159] Funding Source: Medline; NIGMS NIH HHS [GM55717] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Finnemann S, 1997, J BIOL CHEM, V272, P11856, DOI 10.1074/jbc.272.18.11856; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hooley R, 1996, J BIOL CHEM, V271, P6152, DOI 10.1074/jbc.271.11.6152; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; Jones TLZ, 1998, BIOCHEMISTRY-US, V37, P3196, DOI 10.1021/bi972253j; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Papkoff J, 1997, J BIOL CHEM, V272, P4536; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; Plonk SG, 1998, J BIOL CHEM, V273, P4823, DOI 10.1074/jbc.273.9.4823; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; Postma FR, 2001, CURR BIOL, V11, P121, DOI 10.1016/S0960-9822(01)00030-6; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655, DOI 10.1074/jbc.270.31.18655; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; SIMEHA I, 2001, MOL BIOL CELL, V12, P1177; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200	47	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44037	44043		10.1074/jbc.M106121200	http://dx.doi.org/10.1074/jbc.M106121200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546809	hybrid			2022-12-27	WOS:000172297700072
J	Martinelli, R; Sabroe, I; LaRosa, G; Williams, TJ; Pease, JE				Martinelli, R; Sabroe, I; LaRosa, G; Williams, TJ; Pease, JE			The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-3; TERNARY COMPLEX MODEL; GUINEA-PIG MODEL; MCP-1 RECEPTOR; CHEMOTACTIC PROTEIN-1; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; IN-VIVO; EXPRESSION; CELLS	Despite sharing considerable homology with the members of the monocyte chemoattractant protein (MCP) family, the CC chemokine eotaxin (CCL11) has previously been reported to signal exclusively via the receptor CC chemokine receptor 3 (CCR3) Using the monocyte cell line THP-1, we investigated the relative abilities of eotaxin and MCPs 1-4 to induce CCR2 signaling, employing assays of directed cell migration and intracellular calcium flux. Surprisingly, 1 muM concentrations of eotaxin were able to recruit THP-1 cells in chemotaxis assays, and this migration was sensitive to antagonism of CCR2 but not CCR3. Radiolabeled eotaxin binding assays performed on transfectants bearing CCR2b or CCR3 confirmed eotaxin binding to CCR2 with a K-d of 7.50 +/- 3.30 nm, compared with a K-d of 1.68 +/- 0.91 nM at CCR3. In addition, whereas 1 muM concentrations of eotaxin were able to recruit CCR2b transfectants, substimulatory concentrations of eotaxin inhibited MCP-1-induced chemotaxis of CCR2b transfectants and also inhibited MCP-1-induced intracellular calcium flux of THP-1 cells. Collectively, these findings suggest that eotaxin is a partial agonist of the CCR2b receptor. A greater understanding of the interaction of CCR2 with all of its ligands, both full and partial agonists, may aid the rational design of specific antagonists that hold great promise as future therapeutic treatments for a variety of inflammatory disorders.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, Leukocyte Biol Sect, London SW7 2AZ, England; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Imperial College London; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Pease, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, Leukocyte Biol Sect, Sir Alexander Fleming Bldg, London SW7 2AZ, England.		Sabroe, Ian/AAE-5858-2019; Pease, James/X-4521-2018; Sabroe, Ian/I-5981-2013	Pease, James/0000-0003-3749-0341; Sabroe, Ian/0000-0001-9750-8975; Martinelli, Roberta/0000-0003-0784-5973				Berkhout TA, 1997, J BIOL CHEM, V272, P16404, DOI 10.1074/jbc.272.26.16404; Blease K, 2000, J IMMUNOL, V165, P2603, DOI 10.4049/jimmunol.165.5.2603; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Crump MP, 1998, J BIOL CHEM, V273, P22471, DOI 10.1074/jbc.273.35.22471; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; DELEAN A, 1980, J BIOL CHEM, V255, P7108; FRANCI C, 1995, J IMMUNOL, V154, P6511; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Han KH, 1999, J BIOL CHEM, V274, P32055, DOI 10.1074/jbc.274.45.32055; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; Heinemann A, 2000, J IMMUNOL, V165, P7224, DOI 10.4049/jimmunol.165.12.7224; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Humbles AA, 1997, J EXP MED, V186, P601, DOI 10.1084/jem.186.4.601; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Kim Y, 2001, J IMMUNOL, V166, P5183, DOI 10.4049/jimmunol.166.8.5183; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murphy PM, 2000, PHARMACOL REV, V52, P145; MYERS SJ, 1995, J BIOL CHEM, V270, P5786, DOI 10.1074/jbc.270.11.5786; Nakamura H, 1999, AM J RESP CRIT CARE, V160, P1952, DOI 10.1164/ajrccm.160.6.9811089; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Polentarutti N, 1997, J IMMUNOL, V158, P2689; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Ruffing N, 1998, CELL IMMUNOL, V189, P160, DOI 10.1006/cimm.1998.1379; Sabroe I, 2000, J BIOL CHEM, V275, P25985, DOI 10.1074/jbc.M908864199; Sabroe I, 1998, J IMMUNOL, V161, P6139; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Strange PG, 1999, BIOCHEM PHARMACOL, V58, P1081; Struyf S, 1999, J IMMUNOL, V162, P4903; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Yamagami S, 1997, FEBS LETT, V400, P329, DOI 10.1016/S0014-5793(96)01411-1; Ying S, 1999, J IMMUNOL, V163, P6321; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	49	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42957	42964		10.1074/jbc.M103933200	http://dx.doi.org/10.1074/jbc.M103933200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11559700	hybrid			2022-12-27	WOS:000172169300044
J	Jamali, M; Rogerson, PJ; Wilton, S; Skerjanc, IS				Jamali, M; Rogerson, PJ; Wilton, S; Skerjanc, IS			Nkx2-5 activity is essential for cardiomyogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; BONE MORPHOGENETIC PROTEINS; CARDIAC GENE-EXPRESSION; TINMAN-RELATED GENES; DNA-BINDING TARGETS; ENHANCER FACTOR 2C; HEART DEVELOPMENT; SKELETAL-MUSCLE; P19 CELLS; TRANSCRIPTION FACTORS	The homeobox transcription factor tinman is essential for heart vessel formation in Drosophila. In contrast, mice lacking the murine homologue Nkx2-5 are defective in cardiac looping but not in cardiac myocyte development. The lack of an essential role for Nkx2-5 in cardiomyogenesis in mammalian systems is most likely the result of genetic redundancy with family members. In this study, we used a dominant negative mutant of Nkx2-5, created by fusing the repressor domain of engrailed 2 to the Nkx2-5 homeodomain, termed Nkx/EnR. Expression of Nkx/EnR inhibited Me2SO-induced cardiomyogenesis in P19 cells but not skeletal myogenesis. Nkx/EnR inhibited expression of cardiomyoblast markers, such as GATA-4 and MEF2C, but not of mesoderm markers, such as Brachyury T and Wnt5b, or of skeletal lineage markers, such as MyoD and Mox1. To identify the minimal region of Nkx2-5 that can trigger cardiomyogenesis, we analyzed the activity of various Nkx2-5 deletion mutants. The C-terminal domain was not necessary for the ability of Nkx2-5 to induce cardiomyogenesis and loss of this domain did not enhance myogenesis. Therefore, Nkx2-5 function is essential for commitment of mesoderm into the cardiac muscle lineage, and the N-terminal region, together with the homeodomain, is sufficient for cardiomyogenesis in P19 cells.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Skerjanc, IS (corresponding author), Univ Western Ontario, Dept Biochem, Med Sci Bldg, London, ON N6A 5C1, Canada.		Skerjanc, Ilona/AAN-3318-2020					Andree B, 1998, MECH DEVELOP, V70, P119, DOI 10.1016/S0925-4773(97)00186-X; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BADIANI P, 1994, GENE DEV, V8, P770, DOI 10.1101/gad.8.7.770; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; BODMER R, 1993, DEVELOPMENT, V118, P719; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; Davis DL, 2000, DEV BIOL, V217, P310, DOI 10.1006/dbio.1999.9561; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; Fu YC, 1998, DEVELOPMENT, V125, P4439; Gajewski K, 1997, EMBO J, V16, P515, DOI 10.1093/emboj/16.3.515; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Gofflot F, 1997, DEV DYNAM, V210, P431, DOI 10.1002/(SICI)1097-0177(199712)210:4<431::AID-AJA7>3.0.CO;2-H; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Grow MW, 1998, DEV BIOL, V204, P187, DOI 10.1006/dbio.1998.9080; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Lien CL, 1999, DEVELOPMENT, V126, P75; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MCBURNEY MW, 1994, SOMAT CELL MOLEC GEN, V20, P515, DOI 10.1007/BF02255842; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Montross WT, 2000, J CELL SCI, V113, P1759; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Newman CS, 1998, DEV GENET, V22, P230; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; RUDNICKI MA, 1990, DEV BIOL, V138, P348, DOI 10.1016/0012-1606(90)90202-T; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; SKERJANC IS, 1994, MOL CELL BIOL, V1464, P8451; Tanaka M, 1999, DEVELOPMENT, V126, P1269; VIDRICAIRE G, 1994, DEVELOPMENT, V120, P115; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Wilton S, 1999, IN VITRO CELL DEV-AN, V35, P175; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	63	69	83	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42252	42258		10.1074/jbc.M107814200	http://dx.doi.org/10.1074/jbc.M107814200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11526122	hybrid			2022-12-27	WOS:000172450400095
J	Li, ZY; Xi, XD; Du, XP				Li, ZY; Xi, XD; Du, XP			A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IB; VON-WILLEBRAND-FACTOR; RECEPTOR GAMMA-CHAIN; IX-V COMPLEX; VONWILLEBRAND-FACTOR; MONOCLONAL-ANTIBODY; CYTOPLASMIC DOMAIN; FIBRINOGEN BINDING; ADHESION RECEPTOR; IIB/IIIA COMPLEX	We have recently shown that the platelet integrin alpha (IIb)beta (3) is activated by von Willebrand factor (vWF) binding to its platelet receptor, glycoprotein Ib-IX (GPIb-IX, via the protein kinase G (PKG) signaling pathway. Here we show that GPIb-IX-mediated activation of integrin alpha (IIb)beta (3) is inhibited by dominant negative mutants of Raf-1 and MEK1 in a reconstituted integrin activation model in Chinese hamster ovary (CHO) cells and that the integrin-dependent platelet aggregation induced by either vWF or low dose thrombin is inhibited by MEK inhibitors PD98059 and U0126. Thus, mitogen-activated protein kinase MAPK) pathway is important in GPIb-IX-dependent activation of platelet integrin alpha (IIb)beta (3). Furthermore, vWF binding to GPIb-IX induces phosphorylation of Thr-202/Tyr-204 of extracellular signal-regulated kinase 2 (ERK2). GPIb-IX-induced ERK2 phosphorylation is inhibited by PKG inhibitors and enhanced by overexpression of recombinant PKG. PKG activators also induce ERK phosphorylation, indicating that activation of MAPK pathway is downstream from PKG. Thus, our data delineate a novel integrin activation pathway in which ligand binding to GPIb-IX activates PKG that stimulates MAPK pathway, leading to integrin activation.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	xdu@uic.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062350, R29HL052547] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL068819, HL62350, R01 HL062350, HL52547] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrews RK, 2001, BLOOD, V98, P681, DOI 10.1182/blood.V98.3.681; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P28766, DOI 10.1074/jbc.273.44.28766; BorschHaubold AG, 1996, BIOCHEM J, V318, P207; Bugaud F, 1999, BLOOD, V94, P3800, DOI 10.1182/blood.V94.11.3800.423k25_3800_3805; Canobbio I, 2001, J BIOL CHEM, V276, P26022, DOI 10.1074/jbc.M102639200; CHEN QM, 1994, J BIOL CHEM, V269, P26602; DEMARCO L, 1985, P NATL ACAD SCI USA, V82, P7424; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; DEMARCO L, 1985, J CLIN INVEST, V75, P1198, DOI 10.1172/JCI111816; DU XP, 1994, J BIOL CHEM, V269, P18287; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Du XP, 1996, J BIOL CHEM, V271, P7362, DOI 10.1074/jbc.271.13.7362; Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; GINSBERG MH, 1995, THROMB HAEMOSTASIS, V74, P352; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Hood J, 1998, J BIOL CHEM, V273, P23504, DOI 10.1074/jbc.273.36.23504; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; JAMIESON GA, 1978, J CLIN INVEST, V61, P861, DOI 10.1172/JCI109000; KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; KROLL MH, 1991, J CLIN INVEST, V88, P1568, DOI 10.1172/JCI115468; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Mazzucato M, 1998, J BIOL CHEM, V273, P1880, DOI 10.1074/jbc.273.4.1880; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Munday AD, 2000, BLOOD, V96, P577; Nadal F, 1997, J BIOL CHEM, V272, P22381, DOI 10.1074/jbc.272.36.22381; OKUMURA T, 1976, THROMB RES, V8, P701, DOI 10.1016/0049-3848(76)90250-4; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; QURESHI SA, 1991, J BIOL CHEM, V266, P20594; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; RUAN CG, 1987, BLOOD, V69, P570; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; SAKARIASSEN KS, 1986, BRIT J HAEMATOL, V63, P681, DOI 10.1111/j.1365-2141.1986.tb07552.x; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Suhasini M, 1998, MOL CELL BIOL, V18, P6983, DOI 10.1128/MCB.18.12.6983; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; WEISS HJ, 1978, J LAB CLIN MED, V92, P750; Wu Y, 2001, BLOOD, V97, P3836, DOI 10.1182/blood.V97.12.3836; YAMAMOTO N, 1985, THROMB RES, V39, P751, DOI 10.1016/0049-3848(85)90259-2; Zaffran Y, 2000, J BIOL CHEM, V275, P16779, DOI 10.1074/jbc.275.22.16779; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	49	112	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42226	42232		10.1074/jbc.M106129200	http://dx.doi.org/10.1074/jbc.M106129200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11522789	hybrid			2022-12-27	WOS:000172450400092
J	Perrin, RJ; Woods, WS; Clayton, DF; George, JM				Perrin, RJ; Woods, WS; Clayton, DF; George, JM			Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SYSTEM ATROPHY; LEWY BODY DISEASE; FAMILIAL PARKINSONS-DISEASE; HUMAN ALPHA-SYNUCLEIN; GLIAL CYTOPLASMIC INCLUSIONS; BRAIN IRON ACCUMULATION; ALZHEIMERS-DISEASE; IN-VITRO; NACP/ALPHA-SYNUCLEIN; SPORADIC PARKINSONS	Detergent-stable multimers of alpha -synuclein have been found specifically in the brains of patients with Parkinson's disease and other neurodegenerative diseases. Here we show that recombinant alpha -synuclein forms multimers in vitro upon exposure to vesicles containing certain Polyunsaturated fatty acid (PUFA) acyl groups, including arachidonoyl and docosahexaenoyl. This process occurs at physiological concentrations and much faster than in aqueous solution. PUFA-induced aggregation involves physical association with the vesicle surface via the large apolipoprotein-like lipid-binding domain that constitutes the majority of the protein. beta- and gamma -synucleins, as well as the Parkinson's disease-associated alpha -synuclein variants A30P and A53T, show similar tendencies to multimerize in the presence of PUFAs. Multimerization does not require the presence of any tyrosine residues in the sequence. The membrane-based interaction of the synucleins with specific long chain polyunsaturated phospholipids may be relevant to the protein family's physiological functions and may also contribute to the aggregation of alpha -synuclein observed in neurodegenerative disease.	Univ Illinois, Dept Cell & Struct Biol, Chem & Life Sci Lab B107, Urbana, IL 61801 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	George, JM (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Chem & Life Sci Lab B107, 601 S Goodwin, Urbana, IL 61801 USA.		George, Julia M/B-2169-2008; Woods, Wendy/B-6602-2008; Clayton, David/B-2190-2008	George, Julia M/0000-0001-6194-6914; Clayton, David/0000-0002-6395-3488	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013762] Funding Source: NIH RePORTER; NIA NIH HHS [1R01 AG13762] Funding Source: Medline; NIGMS NIH HHS [5T32GM07143-20] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Baba M, 1998, AM J PATHOL, V152, P879; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Celis A, 1999, ELECTROPHORESIS, V20, P355, DOI 10.1002/(SICI)1522-2683(19990201)20:2<355::AID-ELPS355>3.0.CO;2-N; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Culvenor JG, 1999, AM J PATHOL, V155, P1173, DOI 10.1016/S0002-9440(10)65220-0; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; El-Agnaf OMA, 1998, NEUROREPORT, V9, P3925, DOI 10.1097/00001756-199812010-00029; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Farrer M, 1998, ANN NEUROL, V43, P394, DOI 10.1002/ana.410430320; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Hartman VN, 2001, NEUROREPORT, V12, P943, DOI 10.1097/00001756-200104170-00016; Harvey S, 2001, PHYSIOL GENOMICS, V5, P129, DOI 10.1152/physiolgenomics.2001.5.3.129; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Jin H, 1997, NEUROBIOL LEARN MEM, V68, P271, DOI 10.1006/nlme.1997.3795; KIKUGAWA K, 1991, MEMBRANE LIPID OXIDA, V2, P171; Kim JH, 1999, FEBS LETT, V454, P42, DOI 10.1016/S0014-5793(99)00745-0; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kruger R, 2000, J NEURAL TRANSM, V107, P31, DOI 10.1007/s007020050002; Langston JW, 1998, EXP NEUROL, V154, P684, DOI 10.1006/exnr.1998.6975; Leaf A, 1999, J MEMBRANE BIOL, V172, P1, DOI 10.1007/s002329900578; Lin JJ, 1999, EUR NEUROL, V42, P217, DOI 10.1159/000008110; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Liu JW, 2000, BREAST CANCER RES TR, V62, P99, DOI 10.1023/A:1006418219012; McKeith IG, 2000, ANN NY ACAD SCI, V920, P1; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nagar S, 2001, ACTA NEUROL SCAND, V103, P120, DOI 10.1034/j.1600-0404.2001.103002120.x; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Neumann M, 2000, ACTA NEUROPATHOL, V100, P568, DOI 10.1007/s004010000224; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shoji M, 2000, J NEUROL NEUROSUR PS, V68, P605, DOI 10.1136/jnnp.68.5.605; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Vaughan J, 1998, ANN NEUROL, V44, P270, DOI 10.1002/ana.410440221; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Warner TT, 1998, J NEUROL NEUROSUR PS, V65, P378, DOI 10.1136/jnnp.65.3.378; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	71	223	226	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41958	41962		10.1074/jbc.M105022200	http://dx.doi.org/10.1074/jbc.M105022200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553616	hybrid			2022-12-27	WOS:000172450400056
J	Sargent, TG; Lloyd, JA				Sargent, TG; Lloyd, JA			The human gamma-globin TATA and CACCC elements have key, distinct roles in suppressing beta-globin gene expression in embryonic/fetal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; LOCUS-CONTROL REGION; KRUPPEL-LIKE FACTOR; TRANSGENIC MICE; CHROMATIN STRUCTURE; HEREDITARY PERSISTENCE; FETAL HEMOGLOBIN; TRANSCRIPTION; ACTIVATION; PROMOTER	The competition model of globin gene regulation states that the gamma -globin gene precludes expression of the beta -globin gene in early development by competing for the enhancing activity of the locus control region. The gamma -globin gene with a - 161 promoter is sufficient for suppressing beta -globin gene expression, and the gamma -globin TATA and CACCC elements are necessary for this effect. In this work, stable transfection and transgenic mouse assays have been performed with constructs containing HS3 and HS2 from the locus control region, the gamma -globin gene with promoter mutation(s), and the beta -globin gene. The data indicate that the gamma -globin TATA and CACCC elements together have at least an additive effect on the beta/gamma -globin mRNA ratio in early erythroid cells, suggesting that the elements work coordinately to suppress beta -globin gene expression. The TATA and CACCC are the major gamma -globin promoter elements responsible for this effect. Transgenic mouse experiments indicate that the gamma -globin TATA element plays a role in gamma -globin expression and beta -globin suppression in the embryo and fetus; in contrast, the CACCC element has a stage-specific effect in the fetus. The results suggest that, as is true for the erythroid Kruppel-like factor (EKLF) and the beta -globin promoter CACCC, a protein(s) binds to the gamma -globin CACCC element to coordinate stage-specific gene expression.	Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23298 USA	Virginia Commonwealth University	Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Dept Human Genet, Med Coll Virginia Campus,POB 980033, Richmond, VA 23298 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK062154] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 60080, R01 HL060080] Funding Source: Medline; NIDDK NIH HHS [R21 DK062154] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON KP, 1993, MOL BIOL CELL, V4, P1077, DOI 10.1091/mbc.4.10.1077; Asano H, 1999, MOL CELL BIOL, V19, P3571; Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Bagga R, 2000, NUCLEIC ACIDS RES, V28, P2541, DOI 10.1093/nar/28.13.2541; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P4894, DOI 10.1073/pnas.81.15.4894; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Elnitski L, 2001, J BIOL CHEM, V276, P6289, DOI 10.1074/jbc.M009624200; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; LLOYD JA, 1992, MOL CELL BIOL, V12, P1561, DOI 10.1128/MCB.12.4.1561; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Ronchi A, 1996, EMBO J, V15, P143, DOI 10.1002/j.1460-2075.1996.tb00342.x; Ryan TM, 2000, NUCLEIC ACIDS RES, V28, P2736, DOI 10.1093/nar/28.14.2736; Sabatino DE, 1998, MOL CELL BIOL, V18, P6634, DOI 10.1128/MCB.18.11.6634; Sargent TG, 1999, J BIOL CHEM, V274, P11229, DOI 10.1074/jbc.274.16.11229; Sargent TG, 1999, DNA CELL BIOL, V18, P293, DOI 10.1089/104454999315358; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	36	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41817	41824		10.1074/jbc.M103073200	http://dx.doi.org/10.1074/jbc.M103073200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551906	hybrid			2022-12-27	WOS:000172450400038
J	Yamauchi, T; Kamon, J; Waki, H; Murakami, K; Motojima, K; Komeda, K; Ide, T; Kubota, N; Terauchi, Y; Tobe, K; Miki, H; Tsuchida, A; Akanuma, Y; Nagai, R; Kimura, S; Kadowaki, T				Yamauchi, T; Kamon, J; Waki, H; Murakami, K; Motojima, K; Komeda, K; Ide, T; Kubota, N; Terauchi, Y; Tobe, K; Miki, H; Tsuchida, A; Akanuma, Y; Nagai, R; Kimura, S; Kadowaki, T			Mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma) deficiency and PPAR gamma agonist improve insulin resistance.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE ADIPOSE-TISSUE; GENE-EXPRESSION; PRO12ALA POLYMORPHISM; ALPHA; OBESITY; THIAZOLIDINEDIONES; RATS; MICE; ADIPOGENESIS; SENSITIVITY	Peroxisome proliferator-activated receptor (PPAR) gamma is a ligand-activated transcription factor and a member of the nuclear hormone receptor superfamily that is thought to be the master regulator of fat storage; however, the relationship between PPAR gamma and insulin sensitivity is highly controversial. We show here that supraphysiological activation of PPAR gamma by PPAR gamma agonist thiazolidinediones (TZD) markedly increases triglyceride (TG) content of white adipose tissue (WAT), thereby decreasing TG content of liver and muscle, leading to amelioration of insulin resistance at the expense of obesity. Moderate reduction of PPAR gamma activity by heterozygous PPAR gamma deficiency decreases TG content of WAT, skeletal muscle, and liver due to increased leptin expression and increase in fatty acid combustion and decrease in lipogenesis, thereby ameliorating high fat diet-induced obesity and insulin resistance. Moreover, although heterozygous PPAR gamma deficiency and TZD have opposite effects on total WAT mass, heterozygous PPAR gamma deficiency decreases lipogenesis in WAT, whereas TZD stimulate adipocyte differentiation and apoptosis, thereby both preventing adipocyte hypertrophy, which is associated with alleviation of insulin resistance presumably due to decreases in free fatty acids, and tumor necrosis factor a, and up-regulation of adiponectin, at least in part. We conclude that, although by different mechanisms, both heterozygous PPAR gamma deficiency and PPAR gamma agonist improve insulin resistance, which is associated with decreased TG content of muscle/liver and prevention of adipocyte hypertrophy.	Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan; Tokyo Med Univ, Div Lab Anim Sci, Anim Res Ctr, Tokyo 1608402, Japan; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 1000005, Japan	University of Tokyo; Meiji Pharmaceutical University; Tokyo Medical University; Asahi Life Foundation	Kadowaki, T (corresponding author), Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Kubota, Naoto/N-7892-2015; Waki, Hironori/AAE-3942-2020; Terauchi, Yasuo/AAO-4347-2020	Waki, Hironori/0000-0002-5302-9793; 				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; ASKEW EW, 1975, J CLIN INVEST, V56, P521, DOI 10.1172/JCI108120; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Bakopanos E, 2000, DIABETES, V49, P2108, DOI 10.2337/diabetes.49.12.2108; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gonzalez FJ, 1997, BIOCHIMIE, V79, P139, DOI 10.1016/S0300-9084(97)81506-4; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Kahn CR, 2000, J CLIN INVEST, V106, P1305, DOI 10.1172/JCI11705; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	34	524	549	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41245	41254		10.1074/jbc.M103241200	http://dx.doi.org/10.1074/jbc.M103241200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533050	hybrid			2022-12-27	WOS:000171925600116
J	Chellappa, R; Kandasamy, P; Oh, CS; Jiang, Y; Vemula, M; Martin, CE				Chellappa, R; Kandasamy, P; Oh, CS; Jiang, Y; Vemula, M; Martin, CE			The membrane proteins, Spt23p and Mga2p, play distinct roles in the activation of Saccharomyces cerevisiae OLE1 gene expression - Fatty acid-mediated regulation of Mga2p activity is independent of its proteolytic processing into a soluble transcription activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESATURASE GENE; ENCODES; YEAST; CHAIN; ATF6	The Saccharomyces OLE1 gene encodes the Delta -9 fatty acid desaturase, an enzyme that converts saturated fatty acyl-CoAs into cis-Delta -9 unsaturated fatty acids. OLE1 gene expression is regulated by unsaturated fatty acids, which repress transcription and destabilize the OLE1 mRNA. Expression of OLE1 is activated by N-terminal proteolytic fragments of two homologous endoplasmic reticulum membrane proteins, Spt23p and Mga2p. Disruption of either gene does not significantly affect cell growth or fatty acid metabolism; cells that contain null alleles of both genes, however, are unsaturated fatty acid auxotrophs. An analysis of spt23 Delta and mga2 Delta strains shows that Spt23p and Mga2p differentially activate and regulate OLE1 transcription. In glucose-grown cells, both genes activate transcription to similar levels of activity. Expressed alone, Mga2p induces high levels of OLE1 transcription in cells exposed to cobalt or grown in glycerol-containing medium. Spt23p expressed alone activates OLE1 transcription to levels similar to those in wild type cells. OLE1 expression is strongly repressed by unsaturated fatty acids in spt23 Delta or mga2 Delta cells, under all growth conditions. To test if OLE1 expression is controlled by fatty acids at the level of membrane proteolysis, soluble N-terminal fragments of Spt23p and Mga2p that lack their membrane-spanning regions (Atm) were expressed under the control of their native promoters in spt23 Delta ;mga2 Delta cells. Under those conditions, Mga2p Delta tm acts as a powerful transcription activator that is strongly repressed by unsaturated fatty acids. By comparison, the Spt23p Delta tm polypeptide weakly activates transcription and shows little regulation by unsaturated fatty acids. Co-expression of the two soluble fragments results in activation to levels observed with the Mga2p Delta tm protein alone. The fatty acid repression of transcription under those conditions is attenuated by Spt23 Delta tm, however, suggesting that the two proteins may interact to modulate OLE1 gene expression.	Rutgers State Univ, Nelson Labs, Div Life Sci, Piscataway, NJ 08854 USA; Rutgers State Univ, Bur Biol Res, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Genzyme Corp, Boston, MA 01701 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Sanofi-Aventis; Genzyme Corporation	Martin, CE (corresponding author), Rutgers State Univ, Nelson Labs, Div Life Sci, 604 Allison Rd, Piscataway, NJ 08854 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045768] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45768] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Choi JY, 1996, J BIOL CHEM, V271, P3581; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; Nakagawa Y, 2001, J BACTERIOL, V183, P745, DOI 10.1128/JB.183.2.745-751.2001; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Vasconcelles MJ, 2001, J BIOL CHEM, V276, P14374, DOI 10.1074/jbc.M009546200; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang SR, 1999, GENETICS, V151, P473; Zhang SR, 1997, MOL CELL BIOL, V17, P4718, DOI 10.1128/MCB.17.8.4718	20	80	83	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43548	43556		10.1074/jbc.M107845200	http://dx.doi.org/10.1074/jbc.M107845200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557770	hybrid			2022-12-27	WOS:000172297700011
J	Singer, E; Landgraf, R; Horan, T; Slamon, D; Eisenberg, D				Singer, E; Landgraf, R; Horan, T; Slamon, D; Eisenberg, D			Identification of a heregulin binding site in HER3 extracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR EGF RECEPTOR; INSULIN-RECEPTOR; HUMAN-BREAST; DIFFERENTIATION FACTOR; ERBB3; AFFINITY; ACTIVATION; GENE; SUBSTITUTION	HER3 (also known as c-Erb-b3) is a type I receptor tyrosine kinase similar in sequence to the epidermal growth factor (EGF) receptor. The extracellular segment of this transmembrane receptor contains four domains. Domains I and II are similar in sequence to domains III and IV, respectively, and domains II and IV are cysteine-rich. We show that the EGF-like domain of heregulin (hrg) binds to domains I and II of HER3, in contrast to the EGF receptor, for which prior studies have shown that a construct consisting of domains III and portions of domain IV binds EGF. Next, we identified a putative hrg binding site by limited proteolysis of the recombinant extracellular domains of HER3 (HER3-ECDI-IV) in both the presence and absence of hrg. In the absence of hrg, HER3-ECDI-IV is cleaved after position Tyr(50), near the beginning of domain I. Binding of hrg to HER3-ECDI-IV fully protects position Tyr(50) from proteolysis. To confirm that domain I contains a hrg binding site, we expressed domains I and II (HERS-ECDI-II) and find that it binds hrg with 68 nm affinity. These data suggest that domains I and II of HER3-ECDI-IV act as a functional unit in folding and binding of hrg. Thus, our biochemical findings reinforce the structural hypothesis of others that HER3-ECDI-IV is similar to the insulinlike growth factor-1 receptor (IGF-IR), as follows: 1) The protected cleavage site in HER3-ECDI-IV corresponds to a binding footprint in domain I of IGF-1R; 2) HER3-ECDI-II binds hrg with a 68 nm dissociation constant, supporting the hypothesis that domain I is involved in ligand binding;, and 3) the large accessible surface area (1749 Angstrom) of domain L1 of IGF-1R that is buried by domain S1, as well as the presence of conserved contacts in this interface of type 1 RTKs, suggests that domains L1 and S1 of IGF-1R function as a unit as observed for HER3-ECDI-II. Our results are consistent with the propos that HER3 has a structure similar to IGF-1R and binds ligand at a site in corresponding domains.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Energy Lab Struct Biol & Mol Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Amgen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Dept Energy Lab Struct Biol & Mol Med, Inst Mol Biol, Box 951750, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu			NCI NIH HHS [CA 16042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; ALIMANDI M, 1995, ONCOGENE, V10, P1813; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; COHEN SA, 1988, ANAL BIOCHEM, V174, P1, DOI 10.1016/0003-2697(88)90512-X; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Dougall WC, 1996, DNA CELL BIOL, V15, P31, DOI 10.1089/dna.1996.15.31; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; HURWITZ DR, 1991, J BIOL CHEM, V266, P22035; Jorissen RN, 2000, PROTEIN SCI, V9, P310; Kita Y, 1996, BIOCHEM BIOPH RES CO, V226, P59, DOI 10.1006/bbrc.1996.1311; KOHDA D, 1993, J BIOL CHEM, V268, P1976; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Landgraf R, 1998, BIOCHEMISTRY-US, V37, P3220, DOI 10.1021/bi972326z; Landgraf R, 2000, BIOCHEMISTRY-US, V39, P8503, DOI 10.1021/bi000953+; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAX I, 1988, MOL CELL BIOL, V8, P1970, DOI 10.1128/MCB.8.5.1970; LAX I, 1991, CELL REGUL, V2, P337, DOI 10.1091/mbc.2.5.337; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; NAKAE J, 1995, J BIOL CHEM, V270, P22017, DOI 10.1074/jbc.270.37.22017; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Summerfield AE, 1996, J BIOL CHEM, V271, P19656, DOI 10.1074/jbc.271.33.19656; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERVORM ER, 1992, J BIOL CHEM, V267, P66; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; WOLTJER RL, 1992, P NATL ACAD SCI USA, V89, P7801, DOI 10.1073/pnas.89.16.7801; WU DG, 1989, J BIOL CHEM, V264, P17469; WU DG, 1990, P NATL ACAD SCI USA, V87, P3151, DOI 10.1073/pnas.87.8.3151; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	46	33	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44266	44274		10.1074/jbc.M105428200	http://dx.doi.org/10.1074/jbc.M105428200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11555649	hybrid			2022-12-27	WOS:000172297700099
J	Mao, YW; Xiang, H; Wang, J; Korsmeyer, S; Reddan, J; Li, DWC				Mao, YW; Xiang, H; Wang, J; Korsmeyer, S; Reddan, J; Li, DWC			Human bcl-2 gene attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis through down-regulation of the alpha B-crystallin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CAMPTOTHECIN-INDUCED APOPTOSIS; A-CRYSTALLIN; FIBER DIFFERENTIATION; NUCLEOTIDE-SEQUENCE; OXIDATIVE DAMAGE; DEATH; EXPRESSION; PROTEIN; INHIBITION	It is well established that the proto-oncogene, bcl-2, can prevent apoptosis induced by a variety of factors. Regarding the mechanism by which BCL-2 prevents cell death, one theory suggests that it acts by protecting cells from oxidative stress. In the lens system, oxidative stress-induced apoptosis is implicated in cataractogenesis. To explore the possibility of anti-apoptotic gene therapy development for cataract prevention and also to further test the anti-oxidative stress theory of BCL-2 action, we have introduced the human bcl-2 gene into an immortalized rabbit lens epithelial cell line, N/N1003A. The stable expression clones of both vector- and bcl-2-transfected cells have been established. Treatment of the two cell lines With H2O2 revealed that bcl-2-transfected cells were less capable of detoxifying H2O2 than the control cells. Moreover, bcl-2-transfected cells are more susceptible to H2O2-induced apoptosis. To explore why bcl-2-transfected cells have reduced resistance to H2O2-induced apoptosis, we examined the expression patterns of several relevant genes and found that expression of the alphaB-crystallin gene was distinctly downregulated in bcl-2-transfected cells compared with that in vector-transfected cells. This down-regulation was specific because a substantial inhibition of BCL-2 expression through antisense bcl-2 RNA significantly restored the level of alphaB-crystallin and, moreover, enhanced the ability of the bcl-2-transfected cells against H2O2-induced apoptosis. Introduction of a mouse alphaB-crystallin gene into bcl-2-transfected cells also counteracted the BCL-2 effects. Down-regulation of alphaB-crystallin gene was largely derived from changed lens epithelial cell-derived growth factor activity. Besides, alphaB-crystallin prevents apoptosis through interaction with procaspase-3 and partially processed procaspase-3 to prevent caspase-3 activation. Together, our results reveal that BCL-2 can regulate gene expression in rabbit lens epithelial cells. Through down-regulation of the alphaB-crystallin gene, BCL-2 attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis.	Univ Med & Dent New Jersey, Sch Osteopath Med, Ctr Sci, Dept Mol Biol, Stratford, NJ 08084 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Oakland University	Li, DWC (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Ctr Sci, Dept Mol Biol, Rm 347,2 Med Ctr Dr, Stratford, NJ 08084 USA.			Mao, Yingwei/0000-0001-7339-1565; xiang, hua/0000-0003-0369-1225	NATIONAL EYE INSTITUTE [R29EY011372] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT H, 1994, FEBS LETT, V351, P45, DOI 10.1016/0014-5793(94)00817-5; Andersson M, 2000, INVEST OPHTH VIS SCI, V41, P2623; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; de Moissac D, 1998, J BIOL CHEM, V273, P23946, DOI 10.1074/jbc.273.37.23946; DUBIN RA, 1991, MOL CELL BIOL, V9, P4340; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Feng LX, 1999, J CELL BIOCHEM, V74, P576, DOI 10.1002/(SICI)1097-4644(19990915)74:4<576::AID-JCB7>3.0.CO;2-N; Froesch BA, 1999, J BIOL CHEM, V274, P6469, DOI 10.1074/jbc.274.10.6469; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; FURUTA S, 1986, P NATL ACAD SCI USA, V83, P313, DOI 10.1073/pnas.83.2.313; Furuya Y, 1996, CLIN CANCER RES, V2, P389; GIBLIN FJ, 1987, EXP EYE RES, V45, P77, DOI 10.1016/S0014-4835(87)80080-5; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HO YS, 1988, NUCLEIC ACIDS RES, V16, P5207, DOI 10.1093/nar/16.11.5207; Hochman A, 2000, CELL MOL BIOL, V46, P41; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KANTOROW M, 1995, J BIOL CHEM, V270, P17215, DOI 10.1074/jbc.270.29.17215; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; KING CR, 1983, CELL, V32, P707, DOI 10.1016/0092-8674(83)90056-9; KORSMEYER SJ, 1992, BLOOD, V80, P879; Krausz E, 1996, INVEST OPHTH VIS SCI, V37, P2120; Lee YJ, 1997, BLOOD, V89, P4480, DOI 10.1182/blood.V89.12.4480; Li DWC, 1998, EUR J BIOCHEM, V257, P351, DOI 10.1046/j.1432-1327.1998.2570351.x; Li DWC, 2001, EXP CELL RES, V266, P279, DOI 10.1006/excr.2001.5223; LI DWC, 1995, J CELL BIOL, V130, P169; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Li WC, 1996, FREE RADICAL BIO MED, V20, P301, DOI 10.1016/0891-5849(96)02050-3; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MIYASHITA T, 1995, J BIOL CHEM, V270, P26049, DOI 10.1074/jbc.270.44.26049; MIYASHITA T, 1992, CANCER RES, V52, P5407; NIESON DA, 1983, P NATL ACAD SCI USA, V80, P5198; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; REDDAN JR, 1986, DIFFERENTIATION, V33, P168, DOI 10.1111/j.1432-0436.1986.tb00422.x; REED JC, 1992, LAB INVEST, V67, P443; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Ricca A, 2000, INT J CANCER, V86, P188, DOI 10.1002/(SICI)1097-0215(20000415)86:2<188::AID-IJC7>3.3.CO;2-N; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; SARAFIAN TA, 1994, TOXICOL LETT, V74, P149, DOI 10.1016/0378-4274(94)90093-0; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; SLATER AFG, 1995, BIOCHEM J, V306, P771, DOI 10.1042/bj3060771; Smith J.A., 2000, CURRENT PROTOCOLS MO; Spector A, 1996, EXP EYE RES, V62, P521, DOI 10.1006/exer.1996.0063; SPECTOR A, 1981, EXP EYE RES, V33, P673, DOI 10.1016/S0014-4835(81)80107-8; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VERHAEGEN S, 1995, BIOCHEM PHARMACOL, V50, P1021, DOI 10.1016/0006-2952(95)00233-P; Verma S, 2001, J BIOL CHEM, V276, P4671, DOI 10.1074/jbc.M008983200; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; WALTON MI, 1993, CANCER RES, V53, P1853; WOLFE JT, 1994, FEBS LETT, V352, P58, DOI 10.1016/0014-5793(94)00920-1; Wride MA, 1999, DEV BIOL, V213, P142, DOI 10.1006/dbio.1999.9375; Xiang H, 2000, BIOCHEM BIOPH RES CO, V278, P503, DOI 10.1006/bbrc.2000.3834; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhan QM, 1999, ONCOGENE, V18, P297, DOI 10.1038/sj.onc.1202310; ZIGLER JS, 1989, FREE RADICAL BIO MED, V7, P499	72	95	99	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43435	43445		10.1074/jbc.M102195200	http://dx.doi.org/10.1074/jbc.M102195200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11546795	hybrid			2022-12-27	WOS:000172169300104
J	Abbott, DW; Ivanova, VS; Wang, XY; Bonner, WM; Ausio, J				Abbott, DW; Ivanova, VS; Wang, XY; Bonner, WM; Ausio, J			Characterization of the stability and folding of H2A.Z chromatin particles - Implications for transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME CORE PARTICLE; TETRAHYMENA-THERMOPHILA; HISTONE H2A.Z; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; IONIC STRENGTHS; VARIANT; DNA	H2A.Z and H2A.1 nucleosome core particles and oligonucleosome arrays were obtained using recombinant versions of these histones and a native histone H2B/H3/H4 complement reconstituted onto appropriate DNA templates. Analysis of the reconstituted nucleosome core particles using native polyacrylamide gel electrophoresis and DNase I footprinting showed that H2A.Z nucleosome core particles were almost structurally indistinguishable from its H2A.1 or native chicken erythrocyte counterparts. While this result is in good agreement with the recently published crystallographic structure of the H2A.Z nucleosome core particle (Suto, R. K., Clarkson, M J., Tremethick, D. J., and Luger, YL (2000) Nat. Struct. Biol. 7,1121-1124), the ionic strength dependence of the sedimentation coefficient of these particles exhibits a substantial destabilization, which is most likely the result of the histone H2A.Z-H213 dimer binding less tightly to the nucleosome. Analytical ultracentrifuge analysis of the H2A.Z 208-12, a DNA template consisting of 12 tandem repeats of a 208-base pair sequence derived from the sea urchin Lytechinus variegatus 5 S rRNA gene, reconstituted oligonucleosome complexes in the absence of histone HI shows that their NaCl-dependent folding ability is significantly reduced. These results support the notion that the histone H2A.Z variant may play a chromatin-destabilizing role, which may be important for transcriptional activation.	Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA	University of Victoria; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055,Petch Bldg,220, Victoria, BC V8W 3P6, Canada.	jausio@uvic.ca						Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; ALLIS CD, 1982, CELL, V31, P131, DOI 10.1016/0092-8674(82)90412-3; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; AUSIO J, 1984, J MOL BIOL, V176, P77, DOI 10.1016/0022-2836(84)90383-8; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; Ausio J, 2000, BIOPHYS CHEM, V86, P141, DOI 10.1016/S0301-4622(00)00144-7; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; BONNER WM, 1980, EUR J BIOCHEM, V109, P17, DOI 10.1111/j.1432-1033.1980.tb04762.x; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; COTTON RW, 1981, NUCLEIC ACIDS RES, V9, P445, DOI 10.1093/nar/9.2.445; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; DONG F, 1990, BIOCHEMISTRY-US, V29, P10710, DOI 10.1021/bi00499a020; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0; EICKBUSH TH, 1988, J BIOL CHEM, V263, P18972; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GREULICH KO, 1985, J MOL BIOL, V186, P167, DOI 10.1016/0022-2836(85)90266-9; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HATCH CL, 1988, NUCLEIC ACIDS RES, V16, P1113, DOI 10.1093/nar/16.3.1113; Hayes JJ, 2001, CURR OPIN GENET DEV, V11, P124, DOI 10.1016/S0959-437X(00)00168-4; HURLEY CK, 1977, ANAL BIOCHEM, V80, P624, DOI 10.1016/0003-2697(77)90687-X; Jackson JD, 1996, TRENDS BIOCHEM SCI, V21, P466, DOI 10.1016/S0968-0004(96)20028-3; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; PEHRSON JR, 1992, SCIENCE, V257, P1398; READ CM, 1985, BIOCHEMISTRY-US, V24, P4435, DOI 10.1021/bi00337a027; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; STARGELL LA, 1993, GENE DEV, V7, P2641, DOI 10.1101/gad.7.12b.2641; STEIN A, 1979, J MOL BIOL, V130, P103, DOI 10.1016/0022-2836(79)90421-2; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; VANDAAL A, 1988, NUCLEIC ACIDS RES, V16, P7487, DOI 10.1093/nar/16.15.7487; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; WENKERT D, 1984, J CELL BIOL, V98, P2107, DOI 10.1083/jcb.98.6.2107; Widom J, 1999, METH MOL B, V119, P61; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; YAGER TD, 1984, J BIOL CHEM, V259, P4212	57	119	123	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41945	41949		10.1074/jbc.M108217200	http://dx.doi.org/10.1074/jbc.M108217200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551971	hybrid			2022-12-27	WOS:000172450400054
J	Abbott, JJ; Pei, JM; Ford, JL; Qi, Y; Grishin, VN; Phillips, MA; Grishin, NV				Abbott, JJ; Pei, JM; Ford, JL; Qi, Y; Grishin, VN; Phillips, MA; Grishin, NV			Structure prediction and active site analysis of the metal binding determinants gamma-glutamyleysteine synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COLI GLUTAMINE-SYNTHETASE; HIDDEN MARKOV-MODELS; GLUTAMYLCYSTEINE SYNTHETASE; ESCHERICHIA-COLI; PHOSPHORYL TRANSFER; PROTEINS; ENZYMES; GLUTATHIONE; MECHANISM	gamma -Glultamylcysteine synthetase (gamma -GCS) catalyzes the first step in the de novo biosynthesis of glutathione. In trypanosomes, glutathione is conjugated to spermidine to form a unique cofactor termed trypanothione, an essential cofactor for the maintenance of redox balance in the cell. Using extensive similarity searches and sequence motif analysis we detected homology between gamma -GCS and glutamine synthetase (GS), allowing these proteins to be unified into a superfamily of carboxylate-amine/ammonia ligases. The structure of gamma -GCS, which was previously poorly understood, was modeled using the known structure of GS. Two metal-binding sites, each ligated. by three conserved active site residues (nl: Glu-55, Glu-93, Glu-100; and n2: Glu-53, Gln-321, and Glu-489), are predicted to form the catalytic center of the active site, where the nl site is expected to bind free metal and the n2 site to interact with MgATP. To elucidate the roles of the metals and their ligands in catalysis, these six residues were mutated to alanine in the Trypanosoma brucei enzyme. All mutations caused a substantial loss of activity. Most notably, E93A was able to catalyze the L-Glu-dependent ATP hydrolysis but not the peptide bond ligation, suggesting that the nl metal plays an important role in positioning L-Glu for the reaction chemistry. The apparent K-m values for ATP were increased for both the E489A and Q321A mutant enzymes, consistent with a role for the n2 metal in ATP binding and phosphoryl transfer. Furthermore, the apparent K-d values for activation of E489A and Q321A by free Mg2+ increased. Finally, substitution of Mn2+ for Mg2+ in the reaction rescued the catalytic deficits caused by both mutations, demonstrating that the nature of the metal ligands plays an important role in metal specificity.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Phillips, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI34432] Funding Source: Medline; NIGMS NIH HHS [T32-GM08014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abell LM, 1995, BIOCHEMISTRY-US, V34, P16695, DOI 10.1021/bi00051a018; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; Fairlamb Alan H., 1997, P149; Francis SH, 2000, BIOCHEMISTRY-US, V39, P9591, DOI 10.1021/bi000392m; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Ginsburg A., 1972, ADV PROTEIN CHEM, V26, P1; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Grondin K, 1997, EMBO J, V16, P3057, DOI 10.1093/emboj/16.11.3057; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Henikoff JG, 1996, COMPUT APPL BIOSCI, V12, P135; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P5172, DOI 10.1021/bi00473a025; HUNT JB, 1975, ARCH BIOCHEM BIOPHYS, V166, P102, DOI 10.1016/0003-9861(75)90370-7; HUNT JB, 1980, J BIOL CHEM, V255, P590; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; LIU HJ, 1995, J AOAC INT, V78, P736; Lueder DV, 1996, J BIOL CHEM, V271, P17485, DOI 10.1074/jbc.271.29.17485; MAURIZI MR, 1987, BIOCHEMISTRY-US, V26, P5023, DOI 10.1021/bi00390a021; MAY MJ, 1994, P NATL ACAD SCI USA, V91, P10059, DOI 10.1073/pnas.91.21.10059; Meister A., 1989, METABOLISM FUNCTIONS, P367; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ORLOWSKI M, 1971, BIOCHEMISTRY-US, V10, P372, DOI 10.1021/bi00779a003; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; SHAPIRO BM, 1968, BIOCHEMISTRY-US, V7, P2153, DOI 10.1021/bi00846a018; WALKER DR, 1997, INTELL SYST MOL BIOL, V5, P333; WANG CC, 1995, ANNU REV PHARMACOL, V35, P93, DOI 10.1146/annurev.pa.35.040195.000521; WATANABE K, 1986, NUCLEIC ACIDS RES, V14, P4393, DOI 10.1093/nar/14.11.4393; WITMER MR, 1994, PROTEIN SCI, V3, P1746, DOI 10.1002/pro.5560031015; WOTTON JC, 1996, METHOD ENZYMOL, V266, P554	43	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42099	42107		10.1074/jbc.M104672200	http://dx.doi.org/10.1074/jbc.M104672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527962	hybrid			2022-12-27	WOS:000172450400076
J	Casula, S; Shmukler, BE; Wilhelm, S; Stuart-Tilley, AK; Su, WF; Chernova, MN; Brugnara, C; Alper, SL				Casula, S; Shmukler, BE; Wilhelm, S; Stuart-Tilley, AK; Su, WF; Chernova, MN; Brugnara, C; Alper, SL			A dominant negative mutant of the KCC1K-Cl cotransporter - Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SICKLE-CELL DISEASE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; ERYTHROCYTE DEHYDRATION; NA-K-2CL COTRANSPORTER; CARBOXY-TERMINUS; XENOPUS OOCYTES; CLONING; EXPRESSION; ISOFORMS	K-Cl cotransport regulates cell volume and chloride equilibrium potential. Inhibition of erythroid K-Cl cotransport has emerged as an important adjunct strategy for the treatment of sickle cell anemia. However, structure-function relationships among the polypeptide products of the four K-Cl cotransporter (KCC) genes are little understood. We have investigated the importance of the N- and C-terminal cytoplasmic domains of mouse KCC1 to its K-Cl cotransport function expressed in Xenopus oocytes. Truncation of as few as eight C-terminal amino acids (aa) abolished function despite continued polypeptide accumulation and surface expression. These C-terminal loss-of-function mutants lacked a dominant negative phenotype. Truncation of the N-terminal 46 aa diminished function. Removal of 89 or 117 aa (Delta (N)117) abolished function despite continued polypeptide accumulation and surface expression and exhibited dominant negative phenotypes that required the presence of the C-terminal cytoplasmic domain. The dominant negative loss-of-function mutant Delta (N)117 was co-immunoprecipitated with wild type KCC1 polypeptide, and its co-expression did not reduce wild type KCC1 at the oocyte surface. Delta (N)117 also exhibited dominant negative inhibition of human KCC1 and KCC3 and, with lower potency, mouse KCC4 and rat KCC2.	Beth Israel Deaconess Med Ctr, Mol Med Unit, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Alper, SL (corresponding author), Beth Israel Deaconess Med Ctr, Mol Med Unit, RW763 East Campus,330 Brookline Ave, Boston, MA 02215 USA.	salper@caregroup.harvard.edu	Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713; Casula, Sabina/0000-0003-2817-9295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009853, P60HL015157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050422] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL15157, F32-HL09853] Funding Source: Medline; NIDDK NIH HHS [R01-DK50422, DK35854] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bianchi L, 2000, AM J PHYSIOL-HEART C, V279, pH3003, DOI 10.1152/ajpheart.2000.279.6.H3003; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Brugnara C, 1995, Ann N Y Acad Sci, V763, P262, DOI 10.1111/j.1749-6632.1995.tb32411.x; Chernova MN, 1997, BBA-BIOMEMBRANES, V1329, P111, DOI 10.1016/S0005-2736(97)00090-4; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DeFranceschi L, 1997, J CLIN INVEST, V100, P1847, DOI 10.1172/JCI119713; Gard DL, 1999, MICROSC RES TECHNIQ, V44, P388; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Holtzman EJ, 1998, AM J PHYSIOL-RENAL, V275, pF550, DOI 10.1152/ajprenal.1998.275.4.F550; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lauf PK, 2001, CELL PHYSIOL BIOCHEM, V11, P143, DOI 10.1159/000047802; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mercado A, 2001, AM J PHYSIOL-CELL PH, V281, pC670, DOI 10.1152/ajpcell.2001.281.2.C670; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Monroy A, 2000, AM J PHYSIOL-RENAL, V279, pF161, DOI 10.1152/ajprenal.2000.279.1.F161; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Mount DB, 1999, AM J PHYSIOL-RENAL, V276, pF347, DOI 10.1152/ajprenal.1999.276.3.F347; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Pellegrino CM, 1998, BLOOD CELL MOL DIS, V24, P31, DOI 10.1006/bcmd.1998.0168; Plata C, 1999, AM J PHYSIOL-RENAL, V276, pF359, DOI 10.1152/ajprenal.1999.276.3.F359; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sangan P, 2000, J BIOL CHEM, V275, P30813, DOI 10.1074/jbc.M003931200; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; Shmukler BE, 2000, BBA-GENE STRUCT EXPR, V1492, P353, DOI 10.1016/S0167-4781(00)00118-4; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Su WF, 1999, AM J PHYSIOL-CELL PH, V277, pC899, DOI 10.1152/ajpcell.1999.277.5.C899	36	89	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41870	41878		10.1074/jbc.M107155200	http://dx.doi.org/10.1074/jbc.M107155200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551954	hybrid, Green Published			2022-12-27	WOS:000172450400045
J	Iancu, CV; Borza, T; Choe, JY; Fromm, HJ; Honzatko, RB				Iancu, CV; Borza, T; Choe, JY; Fromm, HJ; Honzatko, RB			Recombinant mouse muscle adenylosuccinate synthetase - Overexpression, kinetics, and crystal structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; BINDING; PURIFICATION; HYDANTOCIDIN; RESIDUES; TARGET; GDP	Vertebrates possess two isozymes of adenylosuccinate synthetase. The acidic isozyme is similar to the synthetase from bacteria and plants, being involved in the de novo biosynthesis of AMP, whereas the basic isozyme participates in the purine nucleotide cycle. Reported here is the first instance of overexpression and crystal structure determination of a basic isozyme of adenylosuccinate synthetase. The recombinant mouse muscle enzyme purified to homogeneity in milligram quantities exhibits a specific activity comparable with that of the rat muscle enzyme isolated from tissue and K-m parameters for GTP, IMP, and L-aspartate (12, 45, and 140 mum, respectively) similar to those of the enzyme from Escherichia coli. The mouse muscle and E. coli enzymes have similar polypeptide folds, differing primarily in the conformation of loops, involved in substrate recognition and stabilization of the transition state. Residues 65-68 of the muscle isozyme adopt a conformation not observed in any previous synthetase structure. In its new conformation, segment 65-68 forms intramolecular hydrogen bonds with residues essential for the recognition of IMP and, in fact, sterically excludes IMP from the active site. Observed differences in ligand recognition among adenylosuccinate synthetases may be due in part to conformational variations in the IMP pocket of the ligand-free enzymes.	Iowa State Univ, DEpt Biochem Biophys & Molec Biol, Ames, IA 50011 USA	Iowa State University	Honzatko, RB (corresponding author), Iowa State Univ, DEpt Biochem Biophys & Molec Biol, Molec Biol Bldg, Ames, IA 50011 USA.	honzatko@iastate.edu	Borza, Tudor/A-8510-2012; Borza, Tudor/M-4937-2019	Borza, Tudor/0000-0002-2527-6551; Borza, Tudor/0000-0002-2527-6551	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS010546, R56NS010546] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 10546] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASS MB, 1984, J BIOL CHEM, V259, P2330; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe JY, 1999, BIOCHEMISTRY-US, V38, P6953, DOI 10.1021/bi990159s; CLARK SW, 1977, COMP BIOCHEM PHYS B, V58, P63, DOI 10.1016/0305-0491(77)90128-6; COOPER BF, 1986, BIOCHEMISTRY-US, V25, P7323, DOI 10.1021/bi00371a013; DONG Q, 1990, J BIOL CHEM, V265, P6235; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fischer H E, 1978, Methods Enzymol, V51, P207; FonnePfister R, 1996, P NATL ACAD SCI USA, V93, P9431, DOI 10.1073/pnas.93.18.9431; GOODMAN MN, 1977, J BIOL CHEM, V252, P5054; GUICHERIT OM, 1991, J BIOL CHEM, V266, P22582; HARADA S, 1979, J MOL BIOL, V132, P729, DOI 10.1016/0022-2836(79)90385-1; Honzatko RB, 1999, ADV ENZYMOL RAMB, V73, P57, DOI 10.1002/9780470123195.ch3; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; KANG C, 1997, BIOL CHEM, V272, P11881; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEATHERBARROW RJ, 1977, ENZFITTER; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LOWENSTEIN JM, 1972, PHYSIOL REV, V52, P382, DOI 10.1152/physrev.1972.52.2.382; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MANFREDI JP, 1989, AM J PHYSIOL, V257, pC29, DOI 10.1152/ajpcell.1989.257.1.C29; MATSUDA Y, 1977, BIOCHEM BIOPH RES CO, V78, P766, DOI 10.1016/0006-291X(77)90245-5; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MUIRHEAD KM, 1974, J BIOL CHEM, V249, P459; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OGAWA H, 1977, J BIOCHEM, V81, P859, DOI 10.1093/oxfordjournals.jbchem.a131550; OGAWA H, 1978, EUR J BIOCHEM, V85, P331, DOI 10.1111/j.1432-1033.1978.tb12243.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poland BW, 1996, J MOL BIOL, V264, P1013, DOI 10.1006/jmbi.1996.0693; POLAND BW, 1993, J BIOL CHEM, V268, P25334; Poland BW, 1996, J BIOL CHEM, V271, P15407, DOI 10.1074/jbc.271.26.15407; Poland BW, 1997, J BIOL CHEM, V272, P15200, DOI 10.1074/jbc.272.24.15200; Poland BW, 1996, BIOCHEMISTRY-US, V35, P15753, DOI 10.1021/bi961758r; Prade L, 2000, J MOL BIOL, V296, P569, DOI 10.1006/jmbi.1999.3473; RUDOLPH FB, 1969, J BIOL CHEM, V244, P3832; SILVA MM, 1995, J MOL BIOL, V254, P431, DOI 10.1006/jmbi.1995.0629; SPECTOR T, 1984, BIOCHEM PHARMACOL, V33, P1611, DOI 10.1016/0006-2952(84)90282-X; SPECTOR T, 1976, BIOCHIM BIOPHYS ACTA, V445, P509, DOI 10.1016/0005-2744(76)90104-2; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; Wang WY, 1997, J BIOL CHEM, V272, P7078, DOI 10.1074/jbc.272.11.7078; Wang WY, 1997, J BIOL CHEM, V272, P16911, DOI 10.1074/jbc.272.27.16911; Wang WY, 1998, J BIOL CHEM, V273, P16000, DOI 10.1074/jbc.273.26.16000; ZALKIN H, 1992, PROG NUCLEIC ACID RE, V42, P259, DOI 10.1016/S0079-6603(08)60578-4	47	15	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42146	42152		10.1074/jbc.M106294200	http://dx.doi.org/10.1074/jbc.M106294200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11560929	hybrid			2022-12-27	WOS:000172450400082
J	Yu, ST; Cao, WQ; Kashireddy, P; Meyer, K; Jia, YZ; Hughes, DE; Tan, YJ; Feng, JC; Yeldandi, AV; Rao, MS; Costa, RH; Gonzalez, FJ; Reddy, JK				Yu, ST; Cao, WQ; Kashireddy, P; Meyer, K; Jia, YZ; Hughes, DE; Tan, YJ; Feng, JC; Yeldandi, AV; Rao, MS; Costa, RH; Gonzalez, FJ; Reddy, JK			Human peroxisome proliferator-activated receptor alpha (PPAR alpha) supports the induction of peroxisome proliferation in PPAR alpha-deficient mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA OXIDASE; ACID BETA-OXIDATION; FUNCTIONAL-CHARACTERIZATION; TISSUE DISTRIBUTION; MICE LACKING; CDNA CLONING; GENE; EXPRESSION; RAT; IDENTIFICATION	Peroxisome proliferators, which function as peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, induce peroxisomal, microsomal, and mitochondrial fatty acid oxidation enzymes, in conjunction with peroxisome proliferation, in liver cells. Sustained activation of PPAR alpha leads to the development of liver tumors in rats and mice. The assertion that synthetic PPAR alpha ligands pose negligible carcinogenic risk to humans is attributable, in part, to the failure to observe peroxisome proliferation in human hepatocytes. To explore the mechanism(s) of species-specific differences in response to PPAR alpha ligands, we determined the functional competency of human PPAR alpha in vivo and compared its potency with that of mouse PPAR alpha. Recombinant adenovirus that expresses human or mouse PPAR alpha was produced and administered intravenously to PPAR alpha -deficient mice. Human as well as mouse PPAR alpha fully restored the development of peroxisome proliferator-induced immediate pleiotropic responses, including peroxisome proliferation and enhanced expression of genes involved in lipid metabolism as well as nonperoxisomal genes, such as CD36, Ly-6D, Rbp7, monoglyceride lipase, pyruvate dehydrogenase kinase-4, and CV, that have been identified recently to be up-regulated in livers with peroxisome proliferation. These studies establish that human PPAR alpha is functionally competent and is equally as dose-sensitive as mouse PPAR alpha in inducing peroxisome proliferation within the context of mouse liver environment and that it can heterodimerize with mouse retinoid X receptor, and this human PPAR alpha -mouse retinoid X receptor chimeric heterodimer transcriptionally activates mouse PPAR alpha target genes in a manner qualitatively similar to that of mouse PPAR alpha.	Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA; NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Reddy, JK (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu			NATIONAL CANCER INSTITUTE [R01CA084472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER; NCI NIH HHS [CA84472] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansari-Lari MA, 1998, GENOME RES, V8, P29; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; ASHBY J, 1994, HUM EXP TOXICOL, V13, pS1, DOI 10.1177/096032719401300201; Cherkaoui-Malki M, 2001, GENE EXPRESSION, V9, P291, DOI 10.3727/000000001783992533; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Cook WS, 2000, BIOCHEM BIOPH RES CO, V278, P250, DOI 10.1006/bbrc.2000.3739; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Elcombe CR, 1996, ANN NY ACAD SCI, V804, P628, DOI 10.1111/j.1749-6632.1996.tb18649.x; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Gervois P, 1999, MOL ENDOCRINOL, V13, P1535, DOI 10.1210/me.13.9.1535; Glass CK, 2000, GENE DEV, V14, P121; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Johnson EF, 1996, FASEB J, V10, P1241, DOI 10.1096/fasebj.10.11.8836037; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; MOODY DE, 1985, TOXICOL APPL PHARM, V78, P351, DOI 10.1016/0041-008X(85)90240-6; MUKHERJEE R, 1994, J STEROID BIOCHEM, V51, P157, DOI 10.1016/0960-0760(94)90089-2; NEMALI MR, 1988, CANCER RES, V48, P5316; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; QI C, 1999, CELL BIOCH BIOPHYS, V31, P1; RAO MS, 1987, CARCINOGENESIS, V8, P631; Reddy JK, 1996, ANN NY ACAD SCI, V804, P176, DOI 10.1111/j.1749-6632.1996.tb18616.x; REDDY JK, 1979, CANCER RES, V39, P152; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Sapone A, 2000, PHARMACOGENETICS, V10, P321, DOI 10.1097/00008571-200006000-00006; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Witz IP, 2000, J CELL BIOCHEM, P61; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1	49	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42485	42491		10.1074/jbc.M106480200	http://dx.doi.org/10.1074/jbc.M106480200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551940	hybrid			2022-12-27	WOS:000172450400121
J	Bittner, F; Oreb, M; Mendel, RR				Bittner, F; Oreb, M; Mendel, RR			ABA3 is a molybdenum cofactor sulfurase required for activation of aldehyde oxidase and xanthine dehydrogenase in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID BIOSYNTHESIS; MUTANTS; GENES; MUTATION; NIFS	The xanthine oxidase class of molybdenum enyzmes requires a terminal sulfur ligand at the active site. It has been proposed that a special sulfurase catalyzes the insertion of this ligand thereby activating the enzymes. Previous analyses of mutants in plants indicated that the genetic locus aba3 is involved in this step leading to activation of the molybdenum enzymes aldehyde oxidase and xanthine dehydrogenase. Here we report the cloning of the aba3 gene from Arabidopsis thaliana and the biochemical characterization of the purified protein. ABA3 is a two-domain protein with a N-terminal NifS-like sulfurase domain and a C-terminal domain that might be involved in recognizing the target enzymes. Molecular analysis of three aba3 mutants identified mutations in both domains. ABA3 contains highly conserved binding motifs for pyridoxal phosphate and for a persulfide. The purified recombinant protein possesses a cysteine desulfurase activity, is yellow in color, and shows a NifS-like change in absorbance in the presence of L-cysteine. Pretreatment of ABA3 with a thiol-specific alkylating reagent inhibited its desulfurase activity. These data indicate a transsulfuration reaction similar to bacterial NifS. In a fully defined in vitro system, the purified protein was able to activate aldehyde oxidase by using L-cysteine as sulfur donor. Finally, we show that the expression of the aba3 gene is inducible by drought-stress.	Tech Univ Braunschweig, Bot Inst, D-38023 Braunschweig, Germany	Braunschweig University of Technology	Mendel, RR (corresponding author), Tech Univ Braunschweig, Bot Inst, D-38023 Braunschweig, Germany.	R.Mendel@tu-bs.de		Oreb, Mislav/0000-0002-6118-1517				Akaba S, 1999, J BIOCHEM-TOKYO, V126, P395, DOI 10.1093/oxfordjournals.jbchem.a022463; Amrani L, 2000, MOL MICROBIOL, V38, P114, DOI 10.1046/j.1365-2958.2000.02119.x; FINNERTY V, 1976, GENET BIOL DROSOPHIL, P721; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; LEYDECKER MT, 1995, PLANT PHYSIOL, V107, P1427, DOI 10.1104/pp.107.4.1427; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Marin E, 1997, PLANT PHYSIOL BIOCH, V35, P369; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scheible WR, 1997, PLANTA, V203, P304, DOI 10.1007/s004250050196; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Sekimoto H, 1998, PLANT CELL PHYSIOL, V39, P433, DOI 10.1093/oxfordjournals.pcp.a029387; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Seo M, 2000, PLANT J, V23, P481, DOI 10.1046/j.1365-313x.2000.00812.x; WAHL RC, 1982, J BIOL CHEM, V257, P3958; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200; Zeevaart JAD, 1999, N COMP BIOC, V33, P189; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	22	228	244	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40381	40384		10.1074/jbc.C100472200	http://dx.doi.org/10.1074/jbc.C100472200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11553608	hybrid			2022-12-27	WOS:000171925600004
J	Itoh, T; Kondo, M; Tanaka, Y; Kobayashi, M; Sasada, R; Igarashi, K; Suenaga, M; Koyama, N; Nishimura, O; Fujino, M				Itoh, T; Kondo, M; Tanaka, Y; Kobayashi, M; Sasada, R; Igarashi, K; Suenaga, M; Koyama, N; Nishimura, O; Fujino, M			Novel betacellulin derivatives - Separation of the differentiation activity from the mitogenic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; RECOMBINANT HUMAN BETACELLULIN; SITE-DIRECTED MUTAGENESIS; SIGNAL-TRANSDUCTION; FACTOR-ALPHA; EGF FAMILY; IN-VITRO; EXPRESSION; CELLS; RECEPTOR	Betacellulin (BTC) is a member of the epidermal growth factor family. It has two biological activities: mitogenic activity in fibroblasts and vascular smooth muscle cells, and differentiation activity for the differentiation of pancreatic acinar AR42J cells into insulin-secreting cells. The previous finding that recombinant BTC promotes the neogenesis of beta -cells in a mouse model supports the possibility that BTC is a therapeutic protein. However, the mitogenic activity of BTC may not be needed for differentiation into beta -cells and may cause a side effect in clinical use. We prepared several derivatives of BTC to segregate the two activities, to decrease the mitogenic activity, and to maintain the differentiation activity. We succeeded in obtaining BTC derivatives segregated by the two biological activities by preparing truncated-type derivatives. A derivative of BTC, BTC24-76, with a truncated N-terminal 23 amino acids and C-terminal 4 amino acids, was 2.5-fold more active in differentiation and had one-tenth of the mitogenic activity. The derivatives described in the present study should be helpful in future applications as therapeutic proteins and in basic research for discovery of a BTC-specific receptor.	Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan	Takeda Chemical Industries	Itoh, T (corresponding author), Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.	Ito1_Takashi@takeda.co.jp						Alimandi M, 1997, EMBO J, V16, P5608, DOI 10.1093/emboj/16.18.5608; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BURGESS AW, 1988, BIOCHEMISTRY-US, V27, P4977, DOI 10.1021/bi00414a005; CHAN SJ, 1979, P NATL ACAD SCI USA, V76, P5036, DOI 10.1073/pnas.76.10.5036; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DUDGEON TJ, 1990, FEBS LETT, V261, P392, DOI 10.1016/0014-5793(90)80600-N; Dunbar AJ, 1999, BIOCHEM J, V344, P713, DOI 10.1042/0264-6021:3440713; Dunbar AJ, 2000, INT J BIOCHEM CELL B, V32, P805, DOI 10.1016/S1357-2725(00)00028-5; ENGLER DA, 1988, J BIOL CHEM, V263, P12384; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; FEILD JA, 1992, BIOCHEM J, V283, P91, DOI 10.1042/bj2830091; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Huotari MA, 1998, ENDOCRINOLOGY, V139, P1494, DOI 10.1210/en.139.4.1494; Ishiyama N, 1998, DIABETOLOGIA, V41, P623, DOI 10.1007/s001250050959; Kallincos NC, 2000, GROWTH FACTORS, V18, P203, DOI 10.3109/08977190009003245; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAR E, 1988, MOL CELL BIOL, V8, P1247, DOI 10.1128/MCB.8.3.1247; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; MASSAGUE J, 1983, J BIOL CHEM, V258, P3606; MATSUNAMI RK, 1991, J CELL BIOCHEM, P46242; Miyagawa J, 1999, ENDOCR J, V46, P755, DOI 10.1507/endocrj.46.755; Nishimura O, 1998, CHEM COMMUN, P1135, DOI 10.1039/a801297k; Pinkas-Kramarski R, 1998, ONCOGENE, V16, P1249, DOI 10.1038/sj.onc.1201642; RAY P, 1988, BIOCHEMISTRY-US, V27, P7289, DOI 10.1021/bi00419a017; Riese DJ, 1996, ONCOGENE, V12, P345; SASADA R, 1988, MOL CELL BIOL, V8, P588, DOI 10.1128/MCB.8.2.588; SASADA R, 1993, BIOCHEM BIOPH RES CO, V190, P1173, DOI 10.1006/bbrc.1993.1173; Seno M, 1996, GROWTH FACTORS, V13, P181, DOI 10.3109/08977199609003220; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; SIMPSON RJ, 1985, EUR J BIOCHEM, V153, P629, DOI 10.1111/j.1432-1033.1985.tb09346.x; Tada H, 1999, J CELL BIOCHEM, V72, P423, DOI 10.1002/(SICI)1097-4644(19990301)72:3<423::AID-JCB11>3.3.CO;2-G; Thompson SA, 1996, J BIOL CHEM, V271, P17927, DOI 10.1074/jbc.271.30.17927; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Wang LM, 1998, P NATL ACAD SCI USA, V95, P6809, DOI 10.1073/pnas.95.12.6809; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; WATANABE T, 1994, J BIOL CHEM, V269, P9966; WINKLER ME, 1989, BIOCHEMISTRY-US, V28, P6373, DOI 10.1021/bi00441a033; YAMAGATA H, 1989, P NATL ACAD SCI USA, V86, P3589, DOI 10.1073/pnas.86.10.3589; YAMAMOTO A, 1989, J BIOCHEM-TOKYO, V106, P552, DOI 10.1093/oxfordjournals.jbchem.a122892; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021	45	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40698	40703		10.1074/jbc.M106603200	http://dx.doi.org/10.1074/jbc.M106603200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522793	hybrid			2022-12-27	WOS:000171925600044
J	Kurihara, N; Menaa, C; Maeda, H; Haile, DJ; Reddy, SV				Kurihara, N; Menaa, C; Maeda, H; Haile, DJ; Reddy, SV			Osteoclast-stimulating factor interacts with the spinal muscular atrophy gene product to stimulate osteoclast formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL MOTOR-NEURON; BONE; PROTEIN; SMN; IDENTIFICATION; DIFFERENTIATION; MOUSE; OSTEOPETROSIS; EXPRESSION; HOMOLOGY	We have recently identified and cloned an intracellular peptide termed osteoclast-stimulating factor (OSF) that increases osteoclast (OCL) formation and bone resorption through a cellular signal transduction cascade, possibly through its interaction with c-Src or related family members. To further identify participants in the OSF signaling cascade, we used yeast two-hybrid screening with Saccharomyces cerevisiae, and we found that the 40-kDa spinal muscular atrophy disease-determining gene product, survival motor neuron (SMN), interacts with the OSF-Src homology 3 domain. Reverse transcription-polymerase chain reaction analysis of SMN mRNA expression in cells of the OCL lineage demonstrates that expression of the exon 7 splice variant of SMN is restricted to mature OCLs, whereas the unspliced transcript was expressed in OCL precursors as well as mature OCLs. Treatment of murine bone marrow cultures with conditioned media (5% (v/v)) from 293 cells transiently expressing the SMN cDNA significantly increased OCL formation, compared with treatment with conditioned media from mock-transfected cells. Furthermore, OCL-stimulatory activity by OSF or SMN was abolished by antisense constructs to SMN or OSF, respectively. These data confirm the participation of SMN in the OSF-enhanced expression of an OCL stimulator. OSF-SMN interaction may provide more insights into novel cellular signaling mechanisms that may play an important role in congenital bone fractures associated with type I spinal muscular atrophy disease.	Univ Texas, Hlth Sci Ctr, Dept Med Hematol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Reddy, SV (corresponding author), Univ Pittsburgh, Div Hematol Oncol, 3500 5th Ave,Suite 206, Pittsburgh, PA 15213 USA.	reddysv@msx.upmc.edu			NIDCR NIH HHS [DE 12603] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012603] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bergin A, 1997, GENE, V204, P47, DOI 10.1016/S0378-1119(97)00510-6; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Choi SJ, 1998, J CLIN INVEST, V102, P1360, DOI 10.1172/JCI2667; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HORTON MA, 1985, CANCER RES, V45, P5663; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Iwahashi H, 1997, NATURE, V390, P413, DOI 10.1038/37144; Kelly TE, 1999, AM J MED GENET, V87, P65, DOI 10.1002/(SICI)1096-8628(19991105)87:1<65::AID-AJMG13>3.0.CO;2-5; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; KURIHARA N, 1990, ENDOCRINOLOGY, V127, P3215, DOI 10.1210/endo-127-6-3215; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Reddy S, 1998, J CELL PHYSIOL, V177, P636, DOI 10.1002/(SICI)1097-4652(199812)177:4<636::AID-JCP14>3.3.CO;2-8; Reddy SV, 1998, CRIT REV EUKAR GENE, V8, P1; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Schaub R, 2000, CYTOGENET CELL GENET, V88, P87, DOI 10.1159/000015492; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Strasswimmer J, 1999, HUM MOL GENET, V8, P1219, DOI 10.1093/hmg/8.7.1219; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Williams BY, 2000, FEBS LETT, V470, P207, DOI 10.1016/S0014-5793(00)01320-X	33	37	41	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41035	41039		10.1074/jbc.M100233200	http://dx.doi.org/10.1074/jbc.M100233200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11551898	hybrid			2022-12-27	WOS:000171925600089
J	Rommelaere, H; De Neve, M; Neirynck, K; Peelaers, D; Waterschoot, D; Goethals, M; Fraeyman, N; Vandekerckhove, J; Ampe, A				Rommelaere, H; De Neve, M; Neirynck, K; Peelaers, D; Waterschoot, D; Goethals, M; Fraeyman, N; Vandekerckhove, J; Ampe, A			Prefoldin recognition motifs in the nonhomologous proteins of the actin and tubulin families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CHAPERONIN; UNFOLDED PROTEINS; GAMMA-TUBULIN; BINDING-SITES; YEAST ACTIN; BETA-ACTIN; COMPLEX; SUBUNITS; POLYPEPTIDE; MODEL	Nascent actin and tubulin molecules undergo a series of complex interactions with chaperones and are thereby guided to their native conformation. These cytoskeletal proteins have the initial part of the pathway in common: both interact with prefoldin and with the cytosolic chaperonin containing tailless complex polypeptide 1. Little is understood with regard to how these chaperones and, in particular, prefoldin recognize the non-native forms of these target proteins. Using mutagenesis, we provide evidence that beta -actin and alpha -tubulin each have two prefoldin interaction sites. The most amino-terminally located site of both proteins shows striking sequence similarity, although these proteins are nonhomologous. Very similar motifs are present in beta- and gamma -tubulin and in the newly identified prefoldin target protein actin-related protein 1. Actin-related proteins 2 and 3 have related motifs, but these have altered charge properties. The latter two proteins do not bind prefoldin, although we identify them here as target proteins for the cytosolic chaperonin. Actin fragments containing the two prefoldin interaction regions compete efficiently with actin for prefoldin binding. In addition, they also compete with tubulins, suggesting that these target proteins contact similar prefoldin subunits.	State Univ Ghent VIB, B-9000 Ghent, Belgium; State Univ Ghent VIB, B-9000 Ghent, Belgium; Univ Ghent, Fac Med, Dept Biochem, B-9000 Ghent, Belgium; Univ Ghent, Fac Med, Dept Pharmacol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	Rommelaere, H (corresponding author), State Univ Ghent VIB, K L Ledeganckstr 35, B-9000 Ghent, Belgium.	Heidi.Rommelaere@rug.ac.be						Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Dobrzynski JK, 1996, BIOCHEMISTRY-US, V35, P15870, DOI 10.1021/bi961114j; Dobrzynski JK, 2000, BIOCHEMISTRY-US, V39, P3988, DOI 10.1021/bi992110s; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; TIAN GL, 1995, NATURE, V375, P250, DOI 10.1038/375250a0; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443	28	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41023	41028		10.1074/jbc.M106591200	http://dx.doi.org/10.1074/jbc.M106591200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11535601	hybrid			2022-12-27	WOS:000171925600087
J	Takabe, W; Kodama, T; Hamakubo, T; Tanaka, K; Suzuki, T; Aburatani, H; Matsukawa, N; Noguchi, N				Takabe, W; Kodama, T; Hamakubo, T; Tanaka, K; Suzuki, T; Aburatani, H; Matsukawa, N; Noguchi, N			Anti-atherogenic antioxidants regulate the expression and function of proteasome alpha-type subunits in human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERITABLE HYPERLIPIDEMIC RABBIT; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; CORONARY ANGIOPLASTY; PROBUCOL TREATMENT; ATHEROSCLEROSIS; ADHESION; VCAM-1; PROGRESSION; RESTENOSIS	It has been proposed that phenolic antioxidants such as probucol exert their anti-atherogenic effects through scavenging lipid-derived radicals. In this study the potential for genomics to reveal unanticipated pharmacological properties of phenolic antioxidants is explored. It was found that two anti-atherogenic compounds, BO-653 and probucol, inhibited the expression of three alpha -type proteasome subunits, PMSA2, PMSA3, and PMSA4 in human umbilical vein endothelial cells. Here we report that both BO-653 and probucol caused not only inhibition of the mRNA levels of these three subunits but also inhibition of both the gene expression and protein synthesis of the alpha -type subunit, PMSA1. Other subunit components of the proteasome such as the beta -type subunits (PMSB1, PMSB7), the ATPase subunit of 19 S (PMSC6), the non-ATPase subunit of 19 S (PMSD1), and PA28 (PMSE2) were not significantly affected by treatment with these compounds. The specific inhibition of alpha -type subunit expression in response to these antioxidants resulted in functional alterations of the proteasome with suppression of degradation of multi-ubiquitinated proteins and I kappaB alpha. These results suggest that certain compounds previously classified solely as antioxidants are able to exert potentially important modulatory effects on proteasome function.	Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 1538904, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo 1138613, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1138613, Japan	University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Noguchi, N (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, 4-6-1 Komaba, Tokyo 1538904, Japan.			Suzuki, Toshiaki/0000-0002-0650-6251				Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cominacini L, 1997, FREE RADICAL BIO MED, V22, P117, DOI 10.1016/S0891-5849(96)00271-7; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cynshi O, 1998, P NATL ACAD SCI USA, V95, P10123, DOI 10.1073/pnas.95.17.10123; Daida H, 2000, AM J CARDIOL, V86, P550, DOI 10.1016/S0002-9149(00)01013-4; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Fruebis J, 1997, ARTERIOSCL THROM VAS, V17, P1289, DOI 10.1161/01.ATV.17.7.1289; Fruebis J, 1999, J LIPID RES, V40, P1958; FUJIWARA T, 1989, BIOCHEMISTRY-US, V28, P7332, DOI 10.1021/bi00444a028; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOTOH N, 1992, BIOCHIM BIOPHYS ACTA, V1128, P147, DOI 10.1016/0005-2760(92)90300-K; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOCHSTRASSER M, 1996, ANNU REV GENET, V30, P415; Kalogeris TJ, 1999, AM J PHYSIOL-CELL PH, V276, pC856, DOI 10.1152/ajpcell.1999.276.4.C856; Kalogeris TJ, 1999, AM J PHYSIOL-LUNG C, V276, pL9, DOI 10.1152/ajplung.1999.276.1.L9; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; KUMATORI A, 1990, P NATL ACAD SCI USA, V87, P7071, DOI 10.1073/pnas.87.18.7071; KUZUYA M, 1993, FREE RADICAL BIO MED, V14, P67, DOI 10.1016/0891-5849(93)90510-2; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAO SJT, 1994, METHOD ENZYMOL, V234, P505; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Noguchi N, 1997, ARCH BIOCHEM BIOPHYS, V347, P141, DOI 10.1006/abbi.1997.0331; Noguchi N, 1997, ARCH BIOCHEM BIOPHYS, V342, P236, DOI 10.1006/abbi.1997.9994; Parola M, 1999, ANTIOXID REDOX SIGN, V1, P255, DOI 10.1089/ars.1999.1.3-255; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; TAKABE W, 2001, J ATHEROSCLER THROMB, V7, P223; Tardif JC, 1997, NEW ENGL J MED, V337, P365, DOI 10.1056/NEJM199708073370601; Thurberg BL, 1998, CURR OPIN LIPIDOL, V9, P387, DOI 10.1097/00041433-199810000-00002; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Umetani M, 2000, BIOCHEM BIOPH RES CO, V272, P370, DOI 10.1006/bbrc.2000.2784; Witting PK, 2000, ARTERIOSCL THROM VAS, V20, pE26, DOI 10.1161/01.ATV.20.8.e26; Zapolska-Downar D, 2001, ATHEROSCLEROSIS, V155, P123, DOI 10.1016/S0021-9150(00)00553-0; Zhang SH, 1997, J CLIN INVEST, V99, P2858, DOI 10.1172/JCI119479	37	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40497	40501		10.1074/jbc.M104882200	http://dx.doi.org/10.1074/jbc.M104882200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533053	hybrid			2022-12-27	WOS:000171925600019
J	Hodge, DR; Xiao, WH; Clausen, PA; Heidecker, G; Szyf, M; Farrar, WL				Hodge, DR; Xiao, WH; Clausen, PA; Heidecker, G; Szyf, M; Farrar, WL			Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; BINDING PROTEIN; METHYLATED DNA; EXPRESSION; PROMOTER; IL-6; 5-METHYLCYTOSINE; DIFFERENTIATION; INDUCTION; TISSUES	Methylation of mammalian DNA by the DNA methyltransferase enzyme (dnmt-1) at CpG dinucleotide sequences has been recognized as an important epigenetic control mechanism in regulating the expression of cellular genes (Yen, R. W., Vertino, P. M., Nelkin, B. D., Yu, J. J., el-Deiry, W., Cumaraswamy, A., Lennon, G. G., Trask, B. J., Celano, P., and Baylin, S. B. (1992) Nucleic Acids Res. 20, 2287-2291; Ramehandani, S., Bigey, P., and Szyf, M. (1998) Biol. Chem. 379, 535-5401). Here we show that interleukin (IL)-6 regulates the methyltransferase promoter and resulting enzyme activity, which requires transcriptional activation by the Fli-1 transcription factor (Spyropoulos, D. D., Pharr, P. N., Lavenburg, K. R., Jackers, P., Papas, T. S., Ogawa, M., and Watson, D. K. (1998) Mol. Cell. Biol. 15, 5643-5652). The data suggest that inflammatory cytokines such as IL-6 may exert many epigenetic changes in cells via the regulation of the methyltransferase gene. Furthermore, IL-6 regulation of transcription factors like Fli-1, which can help to direct cells along opposing differentiation pathways, may in fact be reflected in part by their ability to regulate the methylation of cellular genes.	NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, SAIC Frederick,NIH, Frederick, MD 21702 USA; NCI, Frederick Canc Res & Dev Ctr, Cytokine Mol Mechanisms Sect, NIH, Frederick, MD 21702 USA; NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, NIH, Frederick, MD 21702 USA; Invitrogen Corp, Gaithersburg, MD 20852 USA; NCI, Frederick Canc Res & Dev Ctr, Lab Leukocyte Biol, NIH, Frederick, MD 21702 USA; McGill Univ, Dept Pharmacol, Montreal, PQ H3G 1Y6, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Thermo Fisher Scientific; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; McGill University	Hodge, DR (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, SAIC Frederick,NIH, Frederick, MD 21702 USA.		Xiao, Weihua/N-2775-2013	Xiao, Weihua/0000-0001-9102-6326	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Bastian LS, 1999, BLOOD, V93, P2637, DOI 10.1182/blood.V93.8.2637.408k20_2637_2644; Belinsky SA, 1995, TOXICOL LETT, V82-3, P335, DOI 10.1016/0378-4274(95)03486-2; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Chung TDK, 1999, PROSTATE, V38, P199; De Marzo AM, 1999, CANCER RES, V59, P3855; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Ferry AE, 1997, J BIOL CHEM, V272, P20030, DOI 10.1074/jbc.272.32.20030; GOLDBERG DM, 1993, CLIN CHEM, V39, P2360; Hsu DW, 1999, P NATL ACAD SCI USA, V96, P9751, DOI 10.1073/pnas.96.17.9751; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Malik K, 2000, BRIT J CANCER, V83, P1583, DOI 10.1054/bjoc.2000.1549; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NAVARRO S, 1991, EXP HEMATOL, V19, P11; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; PETRANGELI E, 1995, BRIT J CANCER, V72, P973, DOI 10.1038/bjc.1995.444; Ramchandani S, 1998, BIOL CHEM, V379, P535; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; SPYROPOULOS DD, 1998, MOL CELL BIOL, V15, P5643; Stirzaker C, 1997, CANCER RES, V57, P2229; STORB U, 1983, P NATL ACAD SCI-BIOL, V80, P6642, DOI 10.1073/pnas.80.21.6642; TILG H, 1994, BLOOD, V83, P113; TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354; VOGEL MC, 1988, FEBS LETT, V236, P9, DOI 10.1016/0014-5793(88)80275-8; Wierzbowska A, 1999, BRIT J HAEMATOL, V105, P412, DOI 10.1046/j.1365-2141.1999.01350.x; YEBRA MJ, 1995, BIOCHEMISTRY-US, V34, P14752, DOI 10.1021/bi00045a016; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287	33	132	143	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39508	39511		10.1074/jbc.C100343200	http://dx.doi.org/10.1074/jbc.C100343200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11551897	hybrid			2022-12-27	WOS:000171789200003
J	Xiao, B; Shi, GB; Gao, JH; Blaszczyk, J; Liu, Q; Ji, XH; Yan, HG				Xiao, B; Shi, GB; Gao, JH; Blaszczyk, J; Liu, Q; Ji, XH; Yan, HG			Unusual conformational changes in 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as revealed by X-ray crystallography and NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 RESONANCE ASSIGNMENTS; ESCHERICHIA-COLI; PROTEIN; BINDING; REFINEMENT; PROGRAM; COMPLEX; H-1	The crystal structure of Escherichia coli 6-hydroxy-methyl-7,8-dihydropterin pyrophosphokinase (HPPK) in complex with MgADP has been determined at 1.5-Angstrom resolution with a crystallographic R factor of 0.191. The solution structure of HPPK in complex with Mg2+ and beta,gamma -methyleneadenosine 5'-triphosphate (MgAMPPCP) has been determined using a simulated annealing pro. tocol with 3,523 experimental NMR restraints. The root mean square deviation of the ensemble of 20 refined conformers that represent the solution structure from the mean coordinate set derived from them is 0.74 +/- 0.26 A for all backbone atoms and 0.49 +/- 0.22 Angstrom when residues Pro(14), Pro(44)-Gln(50), and Arg(84)-Pro(91) are excluded. Binding of MgADP causes significant changes in the conformation and dynamical property of three loops of HPPK that are involved in catalysis. A dramatic, unusual conformational change is that loop 3 moves away from the active center significantly with some residues moving by > 17 Angstrom. The binding of MgADP also stabilizes loop 1 and loop 3 but makes loop 2 more mobile. Very similar conformational and dynamical changes are observed in the NAM solution structure of HPPK(.)MgAMPPCP. The conformational and dynamical changes may play important roles in both substrate binding and product release in the catalytic cycle.	NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Michigan State University	Ji, XH (corresponding author), NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA.		Ji, Xinhua/C-9664-2012	Ji, Xinhua/0000-0001-6942-1514	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051901] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 51901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Bermingham A, 2000, J BIOL CHEM, V275, P17962, DOI 10.1074/jbc.M000331200; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Brunger AT, 1997, METHOD ENZYMOL, V277, P243, DOI 10.1016/S0076-6879(97)77015-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hennig M, 1999, J MOL BIOL, V287, P211, DOI 10.1006/jmbi.1999.2623; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shi GB, 2000, BBA-PROTEIN STRUCT M, V1478, P289, DOI 10.1016/S0167-4838(00)00043-1; Shi GB, 1999, J BIOMOL NMR, V14, P189, DOI 10.1023/A:1008309801414; Stammers DK, 1999, FEBS LETT, V456, P49, DOI 10.1016/S0014-5793(99)00860-1; SWITZER RL, 1974, ENZYMES, V10, P607; Wang LC, 1998, BIOCHEMISTRY-US, V37, P12727, DOI 10.1021/bi9808924; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Xiao B, 1999, STRUCTURE, V7, P489, DOI 10.1016/S0969-2126(99)80065-3; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	24	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40274	40281		10.1074/jbc.M103837200	http://dx.doi.org/10.1074/jbc.M103837200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546767	hybrid			2022-12-27	WOS:000171789200102
J	Tian, XJ; Feig, LA				Tian, XJ; Feig, LA			Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-RAS; INTEGRIN ACTIVATION; CATALYTIC DOMAIN; PROTEIN; IDENTIFICATION; RESIDUES; RAS-GRF1/CDC25(MM); PHOSPHORYLATION; P21RAS; M-RAS/R-RAS3	Sos and Ras-GRF are two families of guanine nucleotide exchange factors that activate Ras proteins in cells. Sos proteins are ubiquitously expressed and are activated in response to cell-surface tyrosine kinase stimulation. In contrast, Ras-GRF proteins are expressed primarily in central nervous system neurons and are activated by calcium/calmodulin binding and by phosphorylation. Although both Sos1 and Ras-GRF1 activate the Ras proteins Ha-Ras, N-Ras, and Ki-Ras, only Ras-GRF1 also activates the functionally distinct R-Ras GTPase. In this study, we determined which amino acid sequences in these exchange factors and their target GTPases are responsible for this signaling specificity difference. Analysis of chimeras and individual amino acid exchanges between Sos1 and Ras-GRF1 revealed that the critical amino acids reside within an 11-amino acid segment of their catalytic domains between the second and third structurally conserved regions (amino acids (aa) 828-838 in Sos1 and 1057-1067 in Ras-GRF1) of Ras guanine nucleotide exchange factors. In Sos1, this segment is in helix B, which is known to interact with the switch 2 region of Ha-Ras. Interestingly, a similar analysis of Ha-Ras and R-Ras chimeras did not identify the switch 2 region of Ha-Ras as encoding specificity. Instead, we found a more distal protein segment, helix 3 (aa 91-103 in Ha-Ras and 117-129 in R-Ras), which interacts instead primarily with helix K (aa 1002-1016) of Sos1. These findings suggest that specificity derives from the fact that R-Ras-specific amino acids in the region analogous to Ha-Ras helix 3 prevent a functional interaction with Sos1 indirectly, possibly by preventing an appropriate association of its switch 2 region with helix B of Sos1. Although previous studies have shown that helix B of Sos1 and helix 3 of Ha-Ras are involved in promoting nucleotide exchange on Ras proteins, this study highlights the importance of these regions in establishing signaling specificity.	Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts University	Feig, LA (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.							BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; CEN H, 1992, EMBO J, V11, P4007, DOI 10.1002/j.1460-2075.1992.tb05494.x; CHEN LP, 1993, DEV GENET, V14, P339, DOI 10.1002/dvg.1020140503; COX AD, 1994, ONCOGENE, V9, P3281; Day GJ, 1998, MOL CELL BIOL, V18, P7444, DOI 10.1128/MCB.18.12.7444; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; Fan WT, 1998, CURR BIOL, V8, P935, DOI 10.1016/S0960-9822(07)00376-4; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FASANO O, 1988, EMBO J, V7, P3375, DOI 10.1002/j.1460-2075.1988.tb03210.x; FEIG LA, 1994, CURR OPIN CELL BIOL, V6, P204, DOI 10.1016/0955-0674(94)90137-6; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; Gotoh T, 2001, J BIOL CHEM, V276, P38029; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HOWE LR, 1993, ONCOGENE, V8, P2583; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; Kiyono M, 2000, J BIOL CHEM, V275, P29788, DOI 10.1074/jbc.M001378200; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Leonardsen L, 1996, ONCOGENE, V13, P2177; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; MITSOU MY, 1992, EMBO J, V11, P2391; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; Nielsen KH, 2001, ONCOGENE, V20, P2091, DOI 10.1038/sj.onc.1204306; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; QUILLIAM LA, 1994, MOL CELL BIOL, V14, P1113, DOI 10.1128/MCB.14.2.1113; Quilliam LA, 1996, J BIOL CHEM, V271, P11076, DOI 10.1074/jbc.271.19.11076; SEGAL M, 1993, P NATL ACAD SCI USA, V90, P5564, DOI 10.1073/pnas.90.12.5564; Self AJ, 2001, J CELL SCI, V114, P1357; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; van den Berghe N, 1999, J BIOL CHEM, V274, P11078, DOI 10.1074/jbc.274.16.11078; VERROTTI AC, 1992, EMBO J, V11, P2855, DOI 10.1002/j.1460-2075.1992.tb05353.x; Wang BC, 2000, J BIOL CHEM, V275, P5222, DOI 10.1074/jbc.275.7.5222; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	45	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 14	2001	276	50					47248	47256		10.1074/jbc.M107407200	http://dx.doi.org/10.1074/jbc.M107407200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	502XR	11560935	hybrid			2022-12-27	WOS:000172768500078
J	Talavera, K; Staes, M; Janssens, A; Klugbauer, N; Droogmans, G; Hofmann, F; Nilius, B				Talavera, K; Staes, M; Janssens, A; Klugbauer, N; Droogmans, G; Hofmann, F; Nilius, B			Aspartate residues of the Glu-Glu-Asp-Asp (EEDD) pore locus control selectivity and permeation of the T-type Ca2+ channel alpha(1G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM CHANNELS; ION PERMEATION; MOLECULAR-BASIS; VOLTAGE; NEURONS; BLOCK; CONDUCTANCE; CURRENTS; CLONING; SUBUNIT	The structural determinant of the permeation and selectivity properties of high voltage-activated (HVA) Ca2+ channels is a locus formed by four glutamate residues (EEEE), one in each P-region of the domains I-IV of the a, subunit. We tested whether the divergent aspartate residues of the EEDD locus of low voltage-activated (LVA or T-type) Ca2+ channels account for the distinctive permeation and selectivity features of these channels. Using the whole-cell patch-clamp technique in the HEK293 expression system, we studied the properties of the alpha (1G) T-type, the alpha (1C) L-type Ca2+ channel subunits, and alpha (1G) pore mutants, containing aspartate-to-glutamate conversions in domain III, domain IV, or both. Three characteristic features of HVA Ca2+ channel permeation, (a) Ba2+ over Ca2+ permeability, (b) Ca2+/ Ba2+ anomalous mole fraction effect (AMFE), and (c) high Cd2+ sensitivity, were conferred on the domain III mutant (EEED) of alpha (1G). In contrast, the relative Ca2+/ Ba2+ permeability and the lack of AMFE of the alpha (1G) wild type channel were retained in the domain IV mutant (EEDE). The double mutant (EEEE) displayed AMFE and a Cd2+ sensitivity similar to that of alpha (1C), but currents were larger in Ca2+ than in Ba2+-containing solutions. The mutation in domain III, but not that in domain IV, consistently displayed outward fluxes of monovalent cations. H+ blocked Ca2+ currents in all mutants more efficiently than in alpha (1G). In addition, activation curves of all mutants were displaced to more positive voltages and had a larger slope factor than in a,c, wild type. We conclude that the aspartate residues of the EEDD locus of the alpha (1G) Ca2+ channel subunit not only control its permeation properties, but also affect its activation curve. The mutation of both divergent aspartates only partially confers HVA channel permeation properties to the alpha (1G) Ca2+ channel subunit.	Katholieke Univ Leuven, Fysiol Lab, B-3000 Louvain, Belgium; Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany	KU Leuven; Technical University of Munich	Nilius, B (corresponding author), Katholieke Univ Leuven, Fysiol Lab, Campus Gasthuisberg Herestr 49, B-3000 Louvain, Belgium.		Talavera, Karel/K-7990-2014	Talavera, Karel/0000-0002-3124-138X; Janssens, Annelies/0000-0002-6735-8248				ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; BYERLY L, 1985, J GEN PHYSIOL, V85, P491, DOI 10.1085/jgp.85.4.491; CAMPBELL DL, 1988, BIOPHYS J, V54, P945, DOI 10.1016/S0006-3495(88)83030-3; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P571, DOI 10.1113/jphysiol.1987.sp016552; Chen XH, 1997, J BIOL CHEM, V272, P30002, DOI 10.1074/jbc.272.48.30002; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Delisle BP, 2000, BIOPHYS J, V78, P1895, DOI 10.1016/S0006-3495(00)76738-5; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Feng ZP, 2001, J BIOL CHEM, V276, P5726, DOI 10.1074/jbc.C000791200; FRIEL DD, 1989, P NATL ACAD SCI USA, V86, P5207, DOI 10.1073/pnas.86.13.5207; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Klockner U, 1996, J BIOL CHEM, V271, P22293; Klugbauer N, 1999, PFLUG ARCH EUR J PHY, V437, P710, DOI 10.1007/s004240050836; Lee JH, 1999, J NEUROSCI, V19, P1912; Mangoni ME, 1997, RECEPTOR CHANNEL, V5, P1; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Serrano JR, 2000, BIOPHYS J, V79, P3052, DOI 10.1016/S0006-3495(00)76540-4; Talavera K, 1998, BIOPHYS J, V74, pA108; Varadi G, 1999, CRIT REV BIOCHEM MOL, V34, P181, DOI 10.1080/10409239991209264; VASSORT G, 1994, J CARDIOVASC ELECTR, V5, P376, DOI 10.1111/j.1540-8167.1994.tb01175.x; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yang N, 1999, BIOPHYS J, V76, pA259; YUE DT, 1990, J GEN PHYSIOL, V95, P911, DOI 10.1085/jgp.95.5.911	37	57	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45628	45635		10.1074/jbc.M103047200	http://dx.doi.org/10.1074/jbc.M103047200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11526105	hybrid			2022-12-27	WOS:000172573100020
J	Bijnens, AP; Gils, A; Stassen, JM; Komissarov, AA; Knockaert, I; Brouwers, E; Shore, JD; Declerck, PJ				Bijnens, AP; Gils, A; Stassen, JM; Komissarov, AA; Knockaert, I; Brouwers, E; Shore, JD; Declerck, PJ			The distal hinge of the reactive site loop and its proximity - A target to modulate plasminogen activator inhibitor-1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST-ACTING INHIBITOR; TISSUE-TYPE; MONOCLONAL-ANTIBODIES; ANTITHROMBIN-III; SERPIN; IDENTIFICATION; TYPE-1; EPITOPE; SUBSTRATE; MECHANISM	The serpin plasminogen activator inhibitor type 1 (PAI-1) plays a regulatory role in various physiological processes (e.g. fibrinolysis and pericellular proteolysis) and forms a potential target for therapeutic interventions. In this study we identified the epitopes of three PAI-1 inhibitory monoclonal antibodies (MA-44E4, MA-42A2F6, and MA-56A7C10). Differential cross-reactivities of these monoclonals with PAI-1 from different species and sequence alignments between these PAI-1s, combined with the three-dimensional structure, revealed several charged residues as possible candidates to contribute to the respective epitopes. The production, characterization, and subsequent evaluation of a variety of alanine mutants using surface plasmon resonance revealed that the residues His(185), Arg(186), and Arg(187) formed the major sites of interaction for MA-44E4. In contrast, the epitopes of MA-42A2F6 and MA-56A7C10 were found to be conformational. The epitope of MA-42A2F6 comprises residues Lys(243) and Glu(350), whereas the epitope of MA-56A7C10 comprises residues Glu(242), Lys(243), Glu(244), Glu(350) Asp(355) and Arg(356). The participation of Glu(350), Asp(355), and Arg(356) provides a molecular explanation for the differential exposure of this epitope in the different conformations of PAI-1 and for the effect of these antibodies on the kinetics of the formation of the initial PAI-1-proteinase complexes. The localization of the epitopes of MA-44E4, MA42A2F6, and MA-56A7C10 elucidates two previously unidentified molecular mechanisms to modulate PAI-1 activity and opens new perspectives for the rational development of PAI-1 neutralizing compounds.	Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium; Boehringer Ingelheim Pharma KG, Cardiovasc Pharmacol, D-88397 Biberach, Germany; Henry Ford Hlth Ctr, Div Biochem Res, Detroit, MI 48202 USA	KU Leuven; Boehringer Ingelheim; Henry Ford Health System	Declerck, PJ (corresponding author), Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, Van Evenstr 4, B-3000 Louvain, Belgium.	Paul.declerek@farm.kuleuven.ac.be	Declerck, Paul J/A-2330-2017	Declerck, Paul J/0000-0003-1259-9105	NHLBI NIH HHS [HL 54930] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AERTGEERTS K, 1995, NAT STRUCT BIOL, V2, P891, DOI 10.1038/nsb1095-891; ANDREASEN PA, 1986, FEBS LETT, V209, P213, DOI 10.1016/0014-5793(86)81113-9; ASAKURA S, 1990, J BIOL CHEM, V265, P5135; ASAKURA S, 1989, J BIOL CHEM, V264, P13736; AUDENAERT AM, 1994, J BIOL CHEM, V269, P19559; Bijnens AP, 2000, J BIOL CHEM, V275, P6375, DOI 10.1074/jbc.275.9.6375; Bijnens AP, 1997, THROMB HAEMOSTASIS, V77, P350; Bijnens AP, 2001, THROMB HAEMOSTASIS, V85, P866; Bjorquist P, 1997, BBA-PROTEIN STRUCT M, V1341, P87, DOI 10.1016/S0167-4838(97)00065-4; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; Debrock S, 1997, BBA-PROTEIN STRUCT M, V1337, P257, DOI 10.1016/S0167-4838(96)00173-2; Debrock S, 1998, THROMB HAEMOSTASIS, V79, P597; DECLERCK PJ, 1988, BLOOD, V71, P220; DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693; Egelund R, 1998, BIOCHEMISTRY-US, V37, P6375, DOI 10.1021/bi973043+; EVANS SA, 1982, J BIOL CHEM, V257, P3014; Fa M, 2000, STRUCT FOLD DES, V8, P397, DOI 10.1016/S0969-2126(00)00121-0; Gils A, 1998, THROMB HAEMOSTASIS, V80, P531; Gils A, 1997, FEBS LETT, V415, P192, DOI 10.1016/S0014-5793(97)01122-8; Gils A, 1996, BIOCHEMISTRY-US, V35, P7474, DOI 10.1021/bi960079d; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; Greenspan NS, 1999, NAT BIOTECHNOL, V17, P936, DOI 10.1038/13590; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HOESS RH, 1994, J IMMUNOL, V153, P724; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jonsson U., 1992, ADV BIOSENSOR, P291; JUHANVAGUE I, 1995, BAILLIERE CLIN HAEM, V8, P329, DOI 10.1016/S0950-3536(05)80271-9; KEIJER J, 1991, BLOOD, V78, P401; KRUITHOF EKO, 1984, BLOOD, V64, P907; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; Lijnen HR, 1999, THROMB HAEMOSTASIS, V82, P837; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Muehlenweg B, 2000, THROMB RES, V98, P73, DOI 10.1016/S0049-3848(99)00238-8; MUNCH M, 1993, BIOCHIM BIOPHYS ACTA, V1202, P29, DOI 10.1016/0167-4838(93)90059-Z; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Ngo TH, 1997, FIBRINOLYSIS PROTEOL, V11, P37, DOI 10.1016/S0268-9499(97)80007-0; Ngo TH, 2001, J BIOL CHEM, V276, P26243, DOI 10.1074/jbc.M008241200; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; OLSON ST, 1982, J BIOL CHEM, V257, P4891; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; PERRIE AM, 1993, FIBRINOLYSIS, V7, P257, DOI 10.1016/0268-9499(93)90134-H; PRINS MH, 1991, ARCH INTERN MED, V151, P1721, DOI 10.1001/archinte.151.9.1721; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Stoop AA, 2000, J MOL BIOL, V301, P1135, DOI 10.1006/jmbi.2000.4035; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; TUCKER HM, 1995, NAT STRUCT BIOL, V2, P442, DOI 10.1038/nsb0695-442; URANO T, 1992, EUR J BIOCHEM, V209, P985, DOI 10.1111/j.1432-1033.1992.tb17372.x; VAGUE IJ, 1987, THROMB HAEMOSTASIS, V58, P1096; VERHEIJEN JH, 1984, THROMB HAEMOSTASIS, V51, P392; Vleugels N, 2000, THROMB HAEMOSTASIS, V84, P871, DOI 10.1055/s-0037-1614130; Vleugels N, 1998, FIBRINOLYSIS PROTEOL, V12, P277, DOI 10.1016/S0268-9499(98)80020-9; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652; Wiman B, 1999, SCAND J CLIN LAB INV, V59, P23; Wind T, 2001, EUR J BIOCHEM, V268, P1095, DOI 10.1046/j.1432-1327.2001.2680041095.x	57	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44912	44918		10.1074/jbc.M103077200	http://dx.doi.org/10.1074/jbc.M103077200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11559698	hybrid			2022-12-27	WOS:000172406700078
J	Di Fulvio, M; Lauf, PK; Adragna, NC				Di Fulvio, M; Lauf, PK; Adragna, NC			Nitric oxide signaling pathway regulates potassium chloride cotransporter-1 mRNA expression in vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SOLUBLE GUANYLATE-CYCLASE; K-CL COTRANSPORTER; MESSENGER-RNA; CYCLIC-GMP; GENE-TRANSCRIPTION; MOLECULAR-CLONING; I-ALPHA; ACTIVATION; TRANSLATION	Rat vascular smooth muscle cells (VSMCs) express at least two mRNAs for K-Cl cotransporters (KCC): KCC1 and KCC3. cGMP-dependent protein kinase I regulates KCC3 mRNA expression in these cells. Here, we show evidence implicating the nitric oxide (NO)/cGMP signaling pathway in the expression of KCC1 mRNA, considered to be the major cell volume regulator. VSMCs, expressing soluble guanylyl cyclase (sGC) and PKG-I isoforms showed a time- and concentration-dependent increase in KCC1 mRNA levels after treatment with sodium nitroprusside as demonstrated by semiquantitative RT-PCR. sGC-dependent regulation of KCC1 mRNA expression was confirmed using YC-1, a NO-independent sGC stimulator. The sGC inhibitor LY83583 blocked the effects of sodium nitroprusside and YC-1. Moreover, 8-Br-cGMP increased KCC1 mRNA expression in a concentration- and time-dependent fashion. The 8-Br-cGMP effect was partially blocked by KT5823 but not by actinomycin D. However, actinomycin D and cycloheximide increased basal KCC1 mRNA in an additive manner, suggesting different mechanisms of action for both drugs. These findings suggest that in VSMCs, the NO/cGMP-signaling pathway participates in KCC1 mRNA regulation at the post-transcriptional level.	Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; Wright State Univ, Sch Med, Dept Physiol & Biophys, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Adragna, NC (corresponding author), Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Biol Sci Bldg,Rm 152-6,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.							Adragna NC, 1998, J MEMBRANE BIOL, V166, P157, DOI 10.1007/s002329900457; Adragna NC, 2000, AM J PHYSIOL-CELL PH, V278, pC381, DOI 10.1152/ajpcell.2000.278.2.C381; Adragna NC, 2001, FASEB J, V15, pA114; Andreopoulos S, 2000, GEN PHARMACOL-VASC S, V34, P147, DOI 10.1016/S0306-3623(00)00062-8; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Bouton C, 2000, J BIOL CHEM, V275, P32688, DOI 10.1074/jbc.275.42.32688; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Collins SP, 1999, J BIOL CHEM, V274, P8391, DOI 10.1074/jbc.274.13.8391; Di Fulvio M, 2001, J BIOL CHEM, V276, P21046, DOI 10.1074/jbc.M100901200; Di Fulvio M, 2001, FASEB J, V15, pA114; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Gudi T, 1996, J BIOL CHEM, V271, P4597; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Hofmann F, 2000, J CELL SCI, V113, P1671; Holtzman EJ, 1998, AM J PHYSIOL-RENAL, V275, pF550, DOI 10.1152/ajprenal.1998.275.4.F550; Idriss SD, 1999, J BIOL CHEM, V274, P9489, DOI 10.1074/jbc.274.14.9489; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; Kim SO, 2000, BBA-MOL CELL RES, V1496, P277, DOI 10.1016/S0167-4889(00)00026-4; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Lincoln T M, 1995, Adv Pharmacol, V34, P305; Lincoln TM, 1998, ACTA PHYSIOL SCAND, V164, P507, DOI 10.1111/j.1365-201X.1998.tb10700.x; Lincoln TM, 1996, METHOD ENZYMOL, V269, P149; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mancini L, 2000, BIOCHEM BIOPH RES CO, V274, P477, DOI 10.1006/bbrc.2000.3164; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nakielny S, 1997, CURR OPIN CELL BIOL, V9, P420, DOI 10.1016/S0955-0674(97)80016-6; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; PAPAPETROPOULOS A, 1995, HYPERTENSION, V26, P696, DOI 10.1161/01.HYP.26.4.696; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PILZ RB, 1995, FASEB J, V9, P552, DOI 10.1096/fasebj.9.7.7737465; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Scott WS, 1998, J SURG RES, V79, P66, DOI 10.1006/jsre.1998.5382; Shen MR, 2000, PFLUG ARCH EUR J PHY, V440, P751, DOI 10.1007/s004240000338; Soff GA, 1997, J CLIN INVEST, V100, P2580, DOI 10.1172/JCI119801; Su WF, 1999, AM J PHYSIOL-CELL PH, V277, pC899, DOI 10.1152/ajpcell.1999.277.5.C899; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	49	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44534	44540		10.1074/jbc.M104899200	http://dx.doi.org/10.1074/jbc.M104899200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11553613	hybrid			2022-12-27	WOS:000172406700027
J	Gagliardi, D; Perrin, R; Marechal-Drouard, L; Grienenberger, JM; Leaver, CJ				Gagliardi, D; Perrin, R; Marechal-Drouard, L; Grienenberger, JM; Leaver, CJ			Plant mitochondrial polyadenylated mRNAs are degraded by a 3 '- to 5 '-exoribonuclease activity, which proceeds unimpeded by stable secondary structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST MESSENGER-RNA; CYTOPLASMIC MALE-STERILITY; PROTEIN COMPLEX; DEGRADATION; SITES; ENDONUCLEASE; SUBUNIT-9; SEQUENCE; PATHWAYS	Recently, we and others have reported that mRNAs may be polyadenylated in plant mitochondria, and that polyadenylation accelerates the degradation rate of mRNAs. To further characterize the molecular mechanisms involved in plant mitochondrial mRNA degradation, we have analyzed the polyadenylation and degradation processes of potato atp9 mRNAs. The overall majority of polyadenylation sites of potato atp9 mRNAs is located at or in the vicinity of their mature 3'-extremities. We show that a 3'- to 5'-exoribonuclease activity is responsible for the preferential degradation of polyadenylated mRNAs as compared with non-polyadenylated mRNAs, and that 20-30 adenosine residues constitute the optimal poly(A) tail size for inducing degradation of RNA substrates in vitro. The addition of as few as seven non-adenosine nucleotides 3' to the poly(A) tail is sufficient to aim st completely inhibit the in vitro degradation of the RNA substrate. Interestingly, the exoribonuclease activity proceeds unimpeded by stable secondary structures present in RNA substrates. From these results, we propose that in plant mitochondria, poly(A) tails added at the 3' ends of mRNAs promote an efficient 3'- to 5'-degradation process.	CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford	Gagliardi, D (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.		Gagliardi, Dominique/P-2834-2016; Gagliardi, Dominique/AAS-1783-2021; Drouard, Laurence/D-2385-2010	Gagliardi, Dominique/0000-0002-5871-7544; Gagliardi, Dominique/0000-0002-5871-7544; Drouard, Laurence/0000-0001-6537-524X				Bellaoui M, 1997, EMBO J, V16, P5057, DOI 10.1093/emboj/16.16.5057; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; DELLORTO P, 1993, PLANT SCI, V88, P45, DOI 10.1016/0168-9452(93)90108-C; Dombrowski S, 1997, EMBO J, V16, P5069, DOI 10.1093/emboj/16.16.5069; Drager RG, 1999, PLANT J, V19, P521, DOI 10.1046/j.1365-313X.1999.00546.x; Fey J, 1999, FEBS LETT, V458, P124, DOI 10.1016/S0014-5793(99)01140-0; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; Giege P, 2001, CR ACAD SCI III-VIE, V324, P209, DOI 10.1016/S0764-4469(00)01293-2; Hayes R, 1999, TRENDS BIOCHEM SCI, V24, P199, DOI 10.1016/S0968-0004(99)01388-2; Hayes R, 1996, EMBO J, V15, P1132, DOI 10.1002/j.1460-2075.1996.tb00451.x; KALEIKAU EK, 1992, CURR GENET, V22, P463, DOI 10.1007/BF00326411; Kudla J, 1996, EMBO J, V15, P7137, DOI 10.1002/j.1460-2075.1996.tb01105.x; KUNH J, 2001, MOL CELL BIOL, V21, P731; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; LIZAMA L, 1994, FEBS LETT, V349, P243, DOI 10.1016/0014-5793(94)00677-6; Lupold DS, 1999, PLANT CELL, V11, P1565, DOI 10.1105/tpc.11.8.1565; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Militello KT, 2000, MOL CELL BIOL, V20, P2308, DOI 10.1128/MCB.20.7.2308-2316.2000; MIN JJ, 1993, MOL CELL BIOL, V13, P4167, DOI 10.1128/MCB.13.7.4167; Regnier P, 2000, BIOESSAYS, V22, P235; Schuster G, 1999, PLANT PHYSIOL, V120, P937, DOI 10.1104/pp.120.4.937; SCHUSTER W, 1986, NUCLEIC ACIDS RES, V14, P5943, DOI 10.1093/nar/14.15.5943; Williams MA, 2000, NUCLEIC ACIDS RES, V28, P4444, DOI 10.1093/nar/28.22.4444	24	33	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43541	43547		10.1074/jbc.M106601200	http://dx.doi.org/10.1074/jbc.M106601200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557765	hybrid			2022-12-27	WOS:000172297700010
J	Louro, RO; Bento, I; Matias, PM; Catarino, T; Baptista, AM; Soares, CM; Carrondo, MA; Turner, DL; Xavier, AV				Louro, RO; Bento, I; Matias, PM; Catarino, T; Baptista, AM; Soares, CM; Carrondo, MA; Turner, DL; Xavier, AV			Conformational component in the coupled transfer of multiple electrons and protons in a monomeric tetraheme cytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; X-RAY-DIFFRACTION; DESULFURICANS ATCC-27774; ENERGY TRANSDUCTION; ANGSTROM RESOLUTION; STRUCTURAL BASIS; C-OXIDASE; C(3); REDOX; TRANSLOCATION	Cell metabolism relies on energy transduction usually performed by complex membrane-spanning proteins that couple different chemical processes, e.g. electron and proton transfer in proton-pumps. There is great interest in determining at the molecular level the structural details that control these energy transduction events, particularly those involving multiple electrons and protons, because tight control is required to avoid the production of dangerous reactive intermediates. Tetraheme cytochrome c(3) is a small soluble and monomeric protein that performs a central step in the bioenergetic, metabolism of sulfate reducing bacteria, termed "proton-thrusting," linking the oxidation of molecular hydrogen with the reduction of sulfate. The mechanochemical coupling involved in the transfer of multiple electrons and protons in cytochrome c. from Desulfovibrio desulfuricans ATCC 27774 is described using results derived from the microscopic thermodynamic characterization of the redox and acid-base centers involved, crystallographic studies in the oxidized and reduced states of the cytochrome, and theoretical studies of the redox and acid-base transitions. This proton-assisted two-electron step involves very small, localized structural changes that are sufficient to generate the complex network of functional cooperativities leading to energy transduction, while using molecular mechanisms distinct from those established for other Desulfovibrio sp. cytochromes from the same structural family.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, P-2825114 Monte De Caparica, Portugal; Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Southampton	Xavier, AV (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Rua Quinta Grande,6,Apt 127, P-2780156 Oeiras, Portugal.		Soares, Claudio M/E-2675-2012; Baptista, Antonio M./C-7246-2012; Turner, David/B-8267-2009; Bento, Isabel/A-5436-2011; Turner, David L/B-9061-2011; Louro, Ricardo O./AAB-4601-2020; Matias, Pedro M/B-7180-2008; Catarino, Teresa/A-9267-2012	Soares, Claudio M/0000-0003-1154-556X; Baptista, Antonio M./0000-0002-7044-1210; Turner, David L/0000-0002-3754-6459; Louro, Ricardo O./0000-0002-2392-6450; Matias, Pedro M/0000-0001-6170-451X; Catarino, Teresa/0000-0003-3782-4014; Carrondo, Maria Armenia/0000-0002-1261-1162; Bento, Isabel/0000-0003-3801-4929				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baptista AM, 1999, BIOPHYS J, V76, P2978, DOI 10.1016/S0006-3495(99)77452-7; BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; BLAIR DF, 1986, BIOPHYS J, V50, P713, DOI 10.1016/S0006-3495(86)83511-1; Brennan L, 2000, J MOL BIOL, V298, P61, DOI 10.1006/jmbi.2000.3652; BRUNGER AT, 1992, XPLORA SYSTEM CRYSTA; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; GILSON MK, 1987, J COMPUT CHEM, V9, P327; HIGUCHI Y, 1984, J MOL BIOL, V172, P109, DOI 10.1016/0022-2836(84)90417-0; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Iverson TM, 2001, J BIOL INORG CHEM, V6, P390, DOI 10.1007/s007750100213; KRAB K, 1987, BIOCHIM BIOPHYS ACTA, V895, P25, DOI 10.1016/S0304-4173(87)80015-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Louro RO, 1998, BIOCHEMISTRY-US, V37, P15808, DOI 10.1021/bi981505t; Louro RO, 1997, J BIOL INORG CHEM, V2, P488, DOI 10.1007/s007750050160; Louro RO, 1996, J BIOL INORG CHEM, V1, P34, DOI 10.1007/s007750050020; LOURO RO, 2001, IN PRESS CHEMBIOCHEM; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Martel PJ, 1999, J BIOL INORG CHEM, V4, P73, DOI 10.1007/s007750050291; Matias PM, 1996, PROTEIN SCI, V5, P1342, DOI 10.1002/pro.5560050713; MATIAS PM, 1993, J MOL BIOL, V234, P680, DOI 10.1006/jmbi.1993.1620; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Messias AC, 1998, J MOL BIOL, V281, P719, DOI 10.1006/jmbi.1998.1974; MOORE GR, 1980, BIOCHIM BIOPHYS ACTA, V590, P261, DOI 10.1016/0005-2728(80)90030-4; MORAIS J, 1995, BIOCHEMISTRY-US, V34, P12830, DOI 10.1021/bi00039a044; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAPA S, 1976, BIOCHIM BIOPHYS ACTA, V456, P39, DOI 10.1016/0304-4173(76)90008-2; Pereira MM, 1999, BBA-BIOENERGETICS, V1413, P1, DOI 10.1016/S0005-2728(99)00073-0; PERUTZ MF, 1980, J MOL BIOL, V138, P649, DOI 10.1016/S0022-2836(80)80022-2; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROUSSEL A, 1989, TURBO FRODO SILICON, P77; Salgueiro CA, 2001, BIOCHEMISTRY-US, V40, P9709, DOI 10.1021/bi010330b; Salgueiro CA, 1997, J BIOL INORG CHEM, V2, P343, DOI 10.1007/s007750050141; Santana M, 2001, J BACTERIOL, V183, P687, DOI 10.1128/JB.183.2.687-699.2001; Simoes P, 1998, INORG CHIM ACTA, V273, P213, DOI 10.1016/S0020-1693(97)06018-0; Soares CM, 1997, J BIOL INORG CHEM, V2, P714, DOI 10.1007/s007750050188; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Turner DL, 1996, EUR J BIOCHEM, V241, P723, DOI 10.1111/j.1432-1033.1996.00723.x; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Williams RJP, 1999, J SOLID STATE CHEM, V145, P488, DOI 10.1006/jssc.1999.8192; Wyman J, 1968, Q Rev Biophys, V1, P35; XAVIER AV, 2001, EUR J BIOCH S1, V268, pR2	46	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44044	44051		10.1074/jbc.M107136200	http://dx.doi.org/10.1074/jbc.M107136200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551953	hybrid			2022-12-27	WOS:000172297700073
J	Reese, J; Das, SK; Paria, BC; Lim, H; Song, H; Matsumoto, H; Knudtson, KL; DuBois, RN; Dey, SK				Reese, J; Das, SK; Paria, BC; Lim, H; Song, H; Matsumoto, H; Knudtson, KL; DuBois, RN; Dey, SK			Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIIMPLANTATION MOUSE UTERUS; BLASTOCYST IMPLANTATION; LUMINAL EPITHELIUM; OVARIAN-STEROIDS; MESSENGER-RNA; CELLS; MICE; RECEPTOR; DIFFERENTIATION; PROGESTERONE	Infertility and spontaneous pregnancy losses are an enduring problem to women's health. The establishment of pregnancy depends on successful implantation, where a complex series of interactions occurs between the heterogeneous cell types of the uterus and blastocyst. Although a number of genes are implicated in embryo-uterine interactions during implantation, genetic evidence suggests that only a small number of them are critical to this process. To obtain a global view and identify novel pathways of implantation, we used a dual screening strategy to analyze the expression of nearly 10,000 mouse genes by microarray analysis. Comparison of implantation and interimplantation sites by a conservative statistical approach revealed 36 up-regulated genes and 27 down-regulated genes at the implantation site. We also compared the uterine gene expression profile of progesterone-treated, delayed implanting mice to that of mice in which delayed implantation was terminated by estrogen. The results show up-regulation of 128 genes and down-regulation of 101 genes after termination of the delayed implantation. A combined analysis of these experiments showed specific up-regulation of 27 genes both at the implantation site and during uterine activation, representing a broad diversity of molecular functions. In contrast, the majority of genes that were decreased in the combined analysis were related to host immunity or the immune response, suggesting the importance of these genes in regulating the uterine environment for the implanting blastocyst. Collectively, we identified genes with recognized roles in implantation, genes with potential roles in this process, and genes whose functions have yet to be defined in this event. The identification of unique genetic markers for the onset of implantation signifies that genome-wide analysis coupled with functional assays is a promising approach to resolve the molecular pathways required for successful implantation.	Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Kansas City, KS 66160 USA; Univ Iowa, Dept Internal Med, Diabet & Endocrinol Res Ctr, Iowa City, IA 52242 USA; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Gastroenterol, Nashville, TN 37232 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Iowa; Vanderbilt University; Vanderbilt University	Dey, SK (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, MRRC 3017,3901 Rainbow Blvd, Kansas City, KS 66160 USA.		Lim, Hyunjung J/D-5343-2011; DuBois, Raymond N./AAX-8869-2020	Lim, Hyunjung J/0000-0003-2191-666X; Reese, Jeff/0000-0001-8751-6146; Song, Haengseok/0000-0002-5027-7310	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037394, R01HD012304, U01HD029968, R37HD012304, R03HD037677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047297, R01DK047297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007814] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29968, HD33994, HD37677, HD37394, HD02528, HD12304] Funding Source: Medline; NIDDK NIH HHS [DK47297] Funding Source: Medline; NIEHS NIH HHS [ES07814] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Benson GV, 1996, DEVELOPMENT, V122, P2687; BILLINGTON WD, 1992, BAILLIERE CLIN OB GY, V6, P417, DOI 10.1016/S0950-3552(05)80004-5; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Choe YS, 1997, MOL REPROD DEV, V48, P261, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;261::AID-MRD14&gt;3.0.CO;2-0; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Das SK, 1997, DEV BIOL, V190, P178, DOI 10.1006/dbio.1997.8694; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; DAS SK, 1995, MOL ENDOCRINOL, V9, P691, DOI 10.1210/me.9.6.691; DAS SK, 1994, DEVELOPMENT, V120, P1071; DAYA S, 1986, NEW ENGL J MED, V315, P1551; DEY SK, 1981, J REPROD IMMUNOL, V3, P141, DOI 10.1016/0165-0378(81)90055-3; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; GRUMMER R, 1994, BIOL REPROD, V51, P1109, DOI 10.1095/biolreprod51.6.1109; Head JR, 1996, NAT IMMUN, V15, P7; Jin H, 2001, CIRCULATION, V103, P736; Kim NK, 2001, THROMB RES, V103, P135, DOI 10.1016/S0049-3848(01)00288-2; Kimber SJ, 2000, SEMIN CELL DEV BIOL, V11, P61, DOI 10.1006/scdb.2000.0152; Kumar S, 1998, J CLIN ENDOCR METAB, V83, P4443, DOI 10.1210/jc.83.12.4443; Lim H, 1997, ENDOCRINOLOGY, V138, P4599, DOI 10.1210/en.138.11.4599; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; LIM H, 2001, IN PRESS VITAM HORM; MCMASTER MT, 1992, J IMMUNOL, V148, P1699; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Paria BC, 1999, DEV BIOL, V208, P488, DOI 10.1006/dbio.1999.9206; Paria BC, 2000, SEMIN CELL DEV BIOL, V11, P67, DOI 10.1006/scdb.2000.0153; Paria BC, 1998, ENDOCRINOLOGY, V139, P5235, DOI 10.1210/en.139.12.5235; Paria BC, 1998, ENDOCRINOLOGY, V139, P3958, DOI 10.1210/en.139.9.3958; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; PSYCHOYOS A, 1973, HDB PHYSL, P187; Reese J, 1998, BIOL REPROD, V58, P719, DOI 10.1095/biolreprod58.3.719; SAKOFF JA, 1994, J REPROD FERTIL, V101, P97; Salamonsen LA, 1996, REPROD FERT DEVELOP, V8, P1157, DOI 10.1071/RD9961157; Salamonsen LA, 1999, REV REPROD, V4, P11; Shim C, 1997, MOL REPROD DEV, V48, P176, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;176::AID-MRD5&gt;3.0.CO;2-P; Smith SE, 1997, DEV BIOL, V184, P38, DOI 10.1006/dbio.1997.8521; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Suzuki N, 2000, ENDOCRINOLOGY, V141, P4247, DOI 10.1210/en.141.11.4247; Tatsumi K, 1999, MOL HUM REPROD, V5, P153, DOI 10.1093/molehr/5.2.153; Tinel H, 2000, MOL HUM REPROD, V6, P1119, DOI 10.1093/molehr/6.12.1119; WEITLAUF HM, 1994, BIOL IMPLANTATION, P391; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368; YOSHINAG.K, 1966, J REPROD FERTIL, V12, P593, DOI 10.1530/jrf.0.0120593; Yoshioka K, 2000, BIOCHEM BIOPH RES CO, V272, P531, DOI 10.1006/bbrc.2000.2818	48	173	189	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44137	44145		10.1074/jbc.M107563200	http://dx.doi.org/10.1074/jbc.M107563200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551965	hybrid			2022-12-27	WOS:000172297700084
J	Yasuda, S; Kitagawa, H; Ueno, M; Ishitani, H; Fukasawa, M; Nishijima, M; Kobayashi, S; Hanada, K				Yasuda, S; Kitagawa, H; Ueno, M; Ishitani, H; Fukasawa, M; Nishijima, M; Kobayashi, S; Hanada, K			A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; SERINE PALMITOYLTRANSFERASE; GOLGI-APPARATUS; SPHINGOID BASE; RAT-LIVER; CYTOSOLIC SURFACE; GLUCOSYLCERAMIDE; SPHINGOLIPIDS; BIOSYNTHESIS; MEMBRANES	Ceramide produced at the endoplasmic reticulum. (ER) is transported to the lumen of the Golgi apparatus for conversion to sphingomyelin (SM). N-(3-Hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide (HPA-12) is a novel analog of ceramide. Metabolic labeling experiments showed that HPA-12 inhibits conversion of ceramide to SM, but not to glucosylceramide, in Chinese hamster ovary cells. Cultivation of cells with HPA-12 significantly reduced the content of SM. HPA-12 did not inhibit the activity of SM synthase. The inhibition of SM formation by HPA-12 was abrogated when the Golgi apparatus was made to merge with the ER by brefeldin A. Moreover, HPA-12 inhibited redistribution of a fluorescent analog of ceramide, N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-D-erythro-sphin-gosine (C-5-DWE-Cer), from intracellular membranes to the Golgi region. Among four stereoisomers of the drug, (1R,3R)-HPA-12, which resembles natural ceramide stereochemically, was found to be the most active, although (1R,3R)-HPA-12 did not affect ER-to-Golgi trafficking of protein. Interestingly, (1R,3R)-HPA-12 inhibited conversion of ceramide to SM little in mutant cells defective in an ATP- and cytosol-dependent pathway of ceramide transport. These results indicated that (1R,3R)-HPA-12 inhibits ceramide trafficking from the ER to the site of SM synthesis, possibly due to an antagonistic interaction with a ceramide-recognizing factor(s) involved in the ATP- and cytosol-dependent pathway.	Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Infectious Diseases (NIID); Japan Science & Technology Agency (JST); University of Tokyo	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1,Toyama, Tokyo 1628640, Japan.		UENO, Masaharu/M-1609-2013; Kobayashi, Shu/E-9214-2012	UENO, Masaharu/0000-0001-5253-0968; Hanada, Kentaro/0000-0003-1383-2781; YASUDA, Satoshi/0000-0002-1011-0815				Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 2000, BIOCHEM J, V346, P671, DOI 10.1042/0264-6021:3460671; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; HANADA K, 1991, BIOCHIM BIOPHYS ACTA, V1086, P151, DOI 10.1016/0005-2760(91)90002-Y; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; HANADA K, 1990, J BIOL CHEM, V265, P22137; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; INOKUCHI JI, 1987, J LIPID RES, V28, P565; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; MANDON EC, 1992, J BIOL CHEM, V267, P11144; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Wang E, 2000, METHOD ENZYMOL, V311, P15; ZWEERINK MM, 1992, J BIOL CHEM, V267, P25032	34	115	117	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43994	44002		10.1074/jbc.M104884200	http://dx.doi.org/10.1074/jbc.M104884200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546801	hybrid, Green Published			2022-12-27	WOS:000172297700067
J	Castro, DS; Hermanson, E; Joseph, B; Wallen, A; Aarnisalo, P; Heller, A; Perlmann, T				Castro, DS; Hermanson, E; Joseph, B; Wallen, A; Aarnisalo, P; Heller, A; Perlmann, T			Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTORS; NGFI-B; X-RECEPTOR; FUNCTIONAL DOMAINS; HORMONE RECEPTORS; RESPONSE PATHWAYS; PROGENITOR CELLS; ACID RESPONSE; GENE; EXPRESSION	Dopamine cells are generated in the ventral midbrain during embryonic development. The progressive degeneration of these cells in patients with Parkinson's disease, and the potential therapeutic benefit by transplantation of in vitro generated dopamine cells, has triggered intense interest in understanding the process whereby these cells develop. Nurr1 is an orphan nuclear receptor essential for the development of midbrain dopaminergic neurons. However, the mechanism by which Nurr1 promotes dopamine cell differentiation has remained unknown. In this study we have used a dopamine-synthesizing cell line (MN9D) with immature characteristics to analyze the function of Nurr1 in dopamine cell development. The results demonstrate that Nurr1 can induce cell cycle arrest and a highly differentiated cell morphology in these cells. These two functions were both mediated through a DNA binding-dependent mechanism that did not require Nurr1 interaction with the heterodimerization partner retinoid X receptor. However, retinoids can promote the differentiation of MN9D cells independently of Nurr1. Importantly, the closely related orphan receptors NGFI-B and Nor1 were also able to induce cell cycle arrest and differentiation. Thus, the growth inhibitory activities of the NGFI-B/Nurr1/ Nor1 orphan receptors, along with their widespread expression patterns both during development and in the adult, suggest a more general role in control of cell proliferation in the developing embryo and in adult tissues.	Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Ludwig Institute for Cancer Research; Karolinska Institutet; University of Chicago	Perlmann, T (corresponding author), Ludwig Inst Canc Res, Box 240, S-17177 Stockholm, Sweden.	Thomas.Perlmann@licr.ki.se	Castro, Diogo S/I-6217-2016; Wallén-Mackenzie, Åsa/B-9105-2017	Castro, Diogo S/0000-0001-8178-9565; Wallén-Mackenzie, Åsa/0000-0002-8713-070X; Joseph, Bertrand/0000-0001-5655-9979				BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Botling J, 1997, J BIOL CHEM, V272, P9443; CASTELLANO F, 1994, INT J DEV NEUROSCI, V12, P77, DOI 10.1016/0736-5748(94)90098-1; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Crispino M, 1998, MOL BRAIN RES, V59, P178, DOI 10.1016/S0169-328X(98)00143-0; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Heller A, 1996, BRAIN RES, V725, P132, DOI 10.1016/S0006-8993(96)00345-9; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Honkaniemi J, 2000, BRAIN RES, V877, P203, DOI 10.1016/S0006-8993(00)02673-1; Horn V, 1996, FASEB J, V10, P1071, DOI 10.1096/fasebj.10.9.8801169; Iwawaki T, 2000, BIOCHEM BIOPH RES CO, V274, P590, DOI 10.1006/bbrc.2000.3204; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; JOHN A, 1995, DEVELOPMENT, V121, P1801; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; Maira M, 1999, MOL CELL BIOL, V19, P7549; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Maruyama K, 1998, INT J ONCOL, V12, P1237; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Minucci S, 1997, MOL CELL BIOL, V17, P644, DOI 10.1128/MCB.17.2.644; Murphy EP, 2001, ARTHRITIS RHEUM-US, V44, P782, DOI 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.3.CO;2-8; Ogura T, 1996, DEVELOPMENT, V122, P537; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; SPORN MB, 1994, RETINOIDS, P319; Tetradis S, 2001, BIOCHEM BIOPH RES CO, V281, P913, DOI 10.1006/bbrc.2001.4459; Tetradis S, 2001, ENDOCRINOLOGY, V142, P663, DOI 10.1210/en.142.2.663; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vivat V, 1997, EMBO J, V16, P5697, DOI 10.1093/emboj/16.18.5697; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Xing GQ, 1997, MOL BRAIN RES, V47, P251, DOI 10.1016/S0169-328X(97)00056-9; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462	60	111	122	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43277	43284		10.1074/jbc.M107013200	http://dx.doi.org/10.1074/jbc.M107013200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553630	hybrid			2022-12-27	WOS:000172169300084
J	Chandel, NS; Schumacker, PT; Arch, RH				Chandel, NS; Schumacker, PT; Arch, RH			Reactive oxygen species are downstream products of TRAF-mediated signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-RECEPTOR; ACTIVATED PROTEIN-KINASE; CELL-DEATH; TRANSCRIPTION FACTOR; INTERACTING PROTEIN; NEGATIVE SELECTION; GENE-TRANSCRIPTION; CONTAINS 2; T-CELLS	Members of the TNFR (tumor necrosis factor receptor) superfamily are involved in regulating activation and differentiation of cells as well as cell survival and programmed cell death/apoptosis. Multimerization of TNFRs can lead to recruitment of TRAFs (TNFR-associated factors) by the receptors resulting in activation of kinases and transcription factors, such as c-Jun N-terminal kinase and nuclear factor kappaB (NF-kappaB). Signal transduction triggered by TNF-alpha also induces an increase in intracellular reactive oxygen species (ROS). ROS have been suggested to play a role in NF-kappaB activation, which is thought to promote cell survival. However, oxidation of proteins and lipids by ROS can also result in apoptosis. The processes generating intracellular ROS and the mechanism(s) regulating the cellular redox status have not been fully elucidated. We investigated whether TRAFs play a role in controlling intracellular ROS levels. Our results indicate that recruitment of TRAFs to the plasma membrane of human embryonic kidney (HEK) 293 cells is crucial for activation of signaling pathways, which regulate ROS production in mitochondria. TRAF-mediated changes in ROS levels enhanced NF-kappaB activation but were not dependent on NF-kappaB-inducing kinase. Consistent with its anti-apoptotic function, Bcl-x(L) interfered with TRAF-mediated ROS generation but not NF-kappaB activation. Taken together, our results suggest a novel role of TRAFs in signal transduction pathways triggered by TNFR-related proteins, which balance cell survival and apoptosis by regulating the electron transport in mitochondria.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Washington University (WUSTL); Washington University (WUSTL); University of Chicago	Arch, RH (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Campus Box 8052, St Louis, MO 63110 USA.			Schumacker, Paul T/0000-0001-9591-2034				Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Arch RH, 1999, ANNU REV CELL DEV BI, V15, P113, DOI 10.1146/annurev.cellbio.15.1.113; Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Baichwal V. R., 1997, CURR BIOL, V7, P94; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Brodersen J, 1999, EUR J BIOCHEM, V259, P218, DOI 10.1046/j.1432-1327.1999.00017.x; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chiarle R, 1999, J IMMUNOL, V163, P194; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; FUKAMI JI, 1967, SCIENCE, V155, P713, DOI 10.1126/science.155.3763.713; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; Ginn-Pease ME, 1998, FREE RADICAL BIO MED, V25, P346, DOI 10.1016/S0891-5849(98)00067-7; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 1998, CANCER J SCI AM, V4, pS92; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Natoli G, 1997, J BIOL CHEM, V272, P26079, DOI 10.1074/jbc.272.42.26079; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; PENNICA D, 1992, J BIOL CHEM, V267, P21172; Piette J, 1997, BIOL CHEM, V378, P1237; RAO KMK, 1992, J LEUKOCYTE BIOL, V51, P496; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; van der Eb A J, 1980, Methods Enzymol, V65, P826; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453	54	155	164	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42728	42736		10.1074/jbc.M103074200	http://dx.doi.org/10.1074/jbc.M103074200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11559697	hybrid			2022-12-27	WOS:000172169300014
J	Mottley, C; Mason, RP				Mottley, C; Mason, RP			Sulfur-centered radical formation from the antioxidant dihydrolipoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LIPOIC ACID; MICROSOMAL LIPID-PEROXIDATION; ELECTRON-SPIN-RESONANCE; PULSE-RADIOLYSIS; DEPENDENT GENERATION; PHENOXYL RADICALS; HYPOCHLOROUS ACID; AQUEOUS-SOLUTIONS; INDUCED OXIDATION; HL-60 CELLS	Lipoic acid and its reduced form, dihydrolipoic acid, are thought to be strong antioxidants. There are also reports of dihydrolipoic acid acting as a pro-oxidant under certain circumstances. This article reports the direct observation by ESR spectrometry of the disulfide radical anion and the spin trapping of the primary thiyl radical formed from the oxidation of dihydrolipoic acid through thiol pumping with phenol and horseradish peroxidase. The disulfide radical anion reacts rapidly with oxygen to form the reactive radical superoxide, which is also trapped. The radical species formed show a potential for pro-oxidant activity of this compound. Although antioxidants, in general, have been shown to have pro-oxidant potential, the pro-oxidant chemistry of dihydrolipoic acid has not been well characterized.	NIEHS, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA; Luther Coll, Dept Chem, Decorah, IA 52101 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mason, RP (corresponding author), NIEHS, Lab Pharmacol & Chem, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050139, ZIAES050139] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKHLAQ MS, 1987, Z NATURFORSCH C, V42, P134; ALTENKIRCH H, 1990, NEUROTOXICOL TERATOL, V12, P619, DOI 10.1016/0892-0362(90)90073-L; BAST A, 1988, BIOCHIM BIOPHYS ACTA, V963, P558, DOI 10.1016/0005-2760(88)90326-8; BONOMI F, 1989, BIOCHIM BIOPHYS ACTA, V994, P180, DOI 10.1016/0167-4838(89)90158-1; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; CHAN PC, 1973, J AM CHEM SOC, V95, P5504, DOI 10.1021/ja00798a012; Coombes JS, 2000, AM J PHYSIOL-REG I, V279, pR2149, DOI 10.1152/ajpregu.2000.279.6.R2149; CREMONINI MA, 1993, J ORG CHEM, V58, P3805, DOI 10.1021/jo00067a011; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; ELLIOT AJ, 1982, RADIAT PHYS CHEM, V19, P417; Galati G, 1999, CHEM RES TOXICOL, V12, P521, DOI 10.1021/tx980271b; GILBERT BC, 1975, J CHEM SOC PERK T 2, P892, DOI 10.1039/p29750000892; Goldman R, 1999, FREE RADICAL BIO MED, V27, P1050, DOI 10.1016/S0891-5849(99)00140-9; GOLDMAN R, 1995, BIOCHEMISTRY-US, V34, P4765, DOI 10.1021/bi00014a034; GRIERSON L, 1992, INT J RADIAT BIOL, V62, P265, DOI 10.1080/09553009214552111; HAENEN GRMM, 1991, BIOCHEM PHARMACOL, V42, P2244, DOI 10.1016/0006-2952(91)90363-A; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; KAGAN VE, 1992, J LIPID RES, V33, P385; LAL M, 1994, RADIAT PHYS CHEM, V43, P595, DOI 10.1016/0969-806X(94)90174-0; Lal M, 1997, J AM CHEM SOC, V119, P5735, DOI 10.1021/ja970744l; MATSUGO S, 1995, BIOCHEM BIOPH RES CO, V208, P161, DOI 10.1006/bbrc.1995.1318; MOTTLEY C, 1986, BIOCHEM BIOPH RES CO, V141, P622, DOI 10.1016/S0006-291X(86)80218-2; MOTTLEY C, 1987, MOL PHARMACOL, V31, P417; MURPHY ME, 1992, EUR J BIOCHEM, V210, P139, DOI 10.1111/j.1432-1033.1992.tb17401.x; NETA P, 1974, J PHYS CHEM-US, V78, P523, DOI 10.1021/j100598a013; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 1998, DRUG METAB REV, V30, P245, DOI 10.3109/03602539808996311; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; PIERING WF, 1990, CLIN CHEM, V36, P571; PREHN JHM, 1992, J CEREBR BLOOD F MET, V12, P78, DOI 10.1038/jcbfm.1992.10; RAO DNR, 1990, J BIOL CHEM, V265, P844; REDPATH JL, 1973, RADIAT RES, V54, P364, DOI 10.2307/3573731; ROMERO FJ, 1992, J BIOL CHEM, V267, P1680; SCHEER B, 1993, ARCH BIOCHEM BIOPHYS, V302, P385, DOI 10.1006/abbi.1993.1228; SCHOLICH H, 1989, BIOCHIM BIOPHYS ACTA, V1001, P256, DOI 10.1016/0005-2760(89)90108-2; SCHREIBER J, 1989, J BIOL CHEM, V264, P7936; SCOTT BC, 1994, FREE RADICAL RES, V20, P119, DOI 10.3109/10715769409147509; STARY FE, 1975, J ORG CHEM, V40, P58, DOI 10.1021/jo00889a013; STEVENS B, 1974, PHOTOCHEM PHOTOBIOL, V19, P315, DOI 10.1111/j.1751-1097.1974.tb06517.x; Stoyanovsky DA, 1996, ARCH BIOCHEM BIOPHYS, V330, P3, DOI 10.1006/abbi.1996.0219; STOYANOVSKY DA, 1995, ARCH BIOCHEM BIOPHYS, V317, P315, DOI 10.1006/abbi.1995.1169; SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221; WEINER SA, 1972, J AM CHEM SOC, V94, P581, DOI 10.1021/ja00757a043; WERTZ JE, 1972, ELECT SPIN RESONANCE, P464; Yan LJ, 1996, ARCH BIOCHEM BIOPHYS, V327, P330, DOI 10.1006/abbi.1996.0130	45	35	35	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42677	42683		10.1074/jbc.M104889200	http://dx.doi.org/10.1074/jbc.M104889200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11546802	hybrid			2022-12-27	WOS:000172169300007
J	Rimoldi, D; Muehlethaler, K; Salvi, S; Valmori, D; Romero, P; Cerottini, JC; Levy, F				Rimoldi, D; Muehlethaler, K; Salvi, S; Valmori, D; Romero, P; Cerottini, JC; Levy, F			Subcellular localization of the melanoma-associated protein Melan-A(MART-1) influences the processing of its HLA-A2-restricted epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELAN-A/MART-1 ANTIGENIC PEPTIDE; NEWLY SYNTHESIZED PROTEINS; TUMOR-ASSOCIATED ANTIGEN; ENDOPLASMIC-RETICULUM; IN-VIVO; MONOCLONAL-ANTIBODIES; CTL RESPONSES; DEGRADATION; MEMBRANE; CELLS	The peptide derived from the melanoma-associated protein Melan-A (Melan-A(26-35)/HLA-A2) is an attractive candidate for tumor immunotherapy but little is known about the intracellular processing of this antigen. Here we show that Melan-A is a single-pass membrane protein with an NH2 terminus exposed to the lumen of the exocytic compartment. In transfected melanoma cells, Melan-A accumulates in the Golgi region. Inversion of the membrane topology leads to the retention of Melan-A in the endoplasmic reticulum. Most strikingly, melanoma cells expressing this form of Melan-A are more effectively recognized by specific CTL than those expressing either Melan-A in its native membrane orientation or Melan-A artificially localized in the cytosol. Our data are compatible with the notion that proteins retained in the endoplasmic reticulum are more efficiently degraded and produce more antigenic peptides.	Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Univ Hosp, Ludwig Inst Canc Res, Div Clin Oncoimmunol, CH-1011 Lausanne, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Rimoldi, D (corresponding author), Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, Ch Boveresses 155, CH-1066 Epalinges, Switzerland.		Romero, Pedro/S-6015-2017; Valmori, Danila/K-2439-2015; Valmori, Danila/AAL-9766-2021	Romero, Pedro/0000-0002-9688-2882; 				AMARCOSTESEC A, 1994, BIOCHEM BIOPH RES CO, V204, P710, DOI 10.1006/bbrc.1994.2517; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hauri HP, 2000, J CELL SCI, V113, P587; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kawakami Y, 1997, J IMMUNOL METHODS, V202, P13, DOI 10.1016/S0022-1759(96)00211-6; KOCHER T, 1995, CANCER RES, V55, P2236; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; Noppen C, 2000, INT J CANCER, V87, P241, DOI 10.1002/1097-0215(20000715)87:2<241::AID-IJC15>3.0.CO;2-L; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rimoldi D, 1999, INT J CANCER, V82, P901, DOI 10.1002/(SICI)1097-0215(19990909)82:6<901::AID-IJC21>3.0.CO;2-X; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Romero P, 1997, J IMMUNOL, V159, P2366; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schultz-Thater E, 2000, BRIT J CANCER, V83, P204; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Valmori D, 1999, J EXP MED, V189, P895, DOI 10.1084/jem.189.6.895; Valmori D, 2000, J IMMUNOL, V164, P1125, DOI 10.4049/jimmunol.164.2.1125; Valmori D, 1998, J IMMUNOL, V161, P6956; Valmori D, 1998, J IMMUNOL, V160, P1750; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Wang Y, 1999, IMMUNOL REV, V172, P67, DOI 10.1111/j.1600-065X.1999.tb01356.x; Yewdell JW, 1996, J IMMUNOL, V157, P1823	37	24	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43189	43196		10.1074/jbc.M103221200	http://dx.doi.org/10.1074/jbc.M103221200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551907	hybrid			2022-12-27	WOS:000172169300073
J	Wallace, AD; Cidlowski, JA				Wallace, AD; Cidlowski, JA			Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; DOWN-REGULATION; ESTROGEN-RECEPTOR; GENE-EXPRESSION; 26S PROTEASOME; PHOSPHORYLATED SITES; MULTIPLE MECHANISMS; HORMONE RECEPTORS; PROTEIN STABILITY; UBIQUITIN SYSTEM	Ligand-dependent down-regulation of the glucocorticoid receptor (GR) has been shown to limit hormone responsiveness, but the mechanisms involved in this process are poorly understood. The glucocorticoid receptor is a phosphoprotein that upon ligand binding becomes hyperphosphorylated, and recent evidence indicates that phosphorylation status of the glucocorticoid receptor plays a prominent role in receptor protein turnover. Because phosphorylation is a key signal for ubiquitination and proteasomal catabolism of many proteins, we evaluated whether the ubiquitin-proteasomal pathway had a role in glucocorticoid receptor down-regulation and the subsequent transcriptional response to glucocorticoids. Pretreatment of COS-1 cells expressing mouse glucocorticoid receptor with the proteasome inhibitor MG-132 effectively blocks glucocorticoid receptor protein down-regulation by the glucocorticoid dexamethasone. Interestingly, both MG-132 and a second proteasome inhibitor beta -lactone significantly enhanced hormone response of transfected mouse glucocorticoid receptor toward transcriptional activation of glucocorticoid receptor-mediated reporter gene expression. The transcriptional activity of the endogenous human glucocorticoid receptor in HeLa cells was also enhanced by MG-132. Direct evidence for ubiquitination of the glucocorticoid receptor was obtained by immunoprecipitation of cellular extracts from proteasome-impaired cells. Examination of the primary sequence of mouse, hu man, and rat glucocorticoid receptor has identified a candidate PEST degradation motif. Mutation of Lys-426 within this PEST element both abrogated ligand-dependent down-regulation of glucocorticoid receptor protein and simultaneously enhanced glucocorticoid receptor-induced transcriptional activation of gene expression. Unlike wild type GR, proteasomal inhibition failed to enhance significantly transcriptional activity of K426A mutant GR. Together these findings suggest a major role of the ubiquitin-proteasome pathway in regulating glucocorticoid receptor protein turnover, thereby providing a mechanism to terminate glucocorticoid responses.	NIEHS, Mol Endocrinol Grp, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Mol Endocrinol Grp, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	cidlowski@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516				Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; ALLGOOD VE, 1993, J BIOL CHEM, V268, P20870; ALLGOOD VE, 1990, J BIOL CHEM, V265, P12424; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BELLINGHAM DL, 1992, MOL ENDOCRINOL, V6, P2090, DOI 10.1210/me.6.12.2090; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; BODWELL JE, 1995, J STEROID BIOCHEM, V52, P135, DOI 10.1016/0960-0760(94)00157-H; Bodwell JE, 1998, J STEROID BIOCHEM, V65, P91, DOI 10.1016/S0960-0760(97)00185-4; BURNSTEIN KL, 1994, MOL ENDOCRINOL, V8, P1764, DOI 10.1210/me.8.12.1764; BURNSTEIN KL, 1991, STEROIDS, V56, P52, DOI 10.1016/0039-128X(91)90124-E; BURNSTEIN KL, 1990, J BIOL CHEM, V265, P7284; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; CIDLOWSKI JA, 1981, ENDOCRINOLOGY, V109, P1975; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; DANIELSEN M, 1989, CANCER RES, V49, pS2286; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; ERNST MK, 1995, MOL CELL BIOL, V15, P872; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOECK W, 1989, J BIOL CHEM, V264, P14396; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCINTYRE WR, 1985, J BIOL CHEM, V260, P418; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; McKinsey TA, 1997, J BIOL CHEM, V272, P22377, DOI 10.1074/jbc.272.36.22377; MENDEL DB, 1986, NATURE, V324, P478, DOI 10.1038/324478a0; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nawaz Z, 1999, CANCER RES, V59, P372; NIRMALA PB, 1995, BIOCHEM BIOPH RES CO, V213, P24, DOI 10.1006/bbrc.1995.2093; Oakley Robert H., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P63; OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Roberts BJ, 1999, J BIOL CHEM, V274, P36351, DOI 10.1074/jbc.274.51.36351; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHEIBLE PP, 1987, J STEROID BIOCHEM, V26, P181, DOI 10.1016/0022-4731(87)90069-0; SCHMIDT TJ, 1994, RECEPTOR, V4, P229; Shao DL, 1999, J CLIN INVEST, V103, P1617, DOI 10.1172/JCI7421; SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; SVEC F, 1981, J BIOL CHEM, V256, P5984; Syvala H, 1998, LIFE SCI, V63, P1505, DOI 10.1016/S0024-3205(98)00417-2; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; VanAntwerp DJ, 1996, MOL CELL BIOL, V16, P6037; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Webster JC, 1999, TRENDS ENDOCRIN MET, V10, P396, DOI 10.1016/S1043-2760(99)00186-1; Webster JC, 1997, J BIOL CHEM, V272, P9287; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; YAGLOM J, 1995, MOL CELL BIOL, V15, P731	68	297	313	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42714	42721		10.1074/jbc.M106033200	http://dx.doi.org/10.1074/jbc.M106033200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555652	hybrid			2022-12-27	WOS:000172169300012
J	Caran, N; Johnson, LD; Jenkins, KJ; Tombes, RM				Caran, N; Johnson, LD; Jenkins, KJ; Tombes, RM			Cytosolic targeting domains of gamma and delta calmodulin-dependent protein kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; PROMOTES NEURITE OUTGROWTH; CAM KINASE; RECEPTOR STIMULATION; AXON GUIDANCE; IN-VIVO; EXPRESSION; ISOFORMS; CELLS; PHOSPHORYLATION	Ca2+/calmodulin-dependent protein kinase II (CaMK-II) isozyme variability is the result of alternative usage of variable domain sequences. Isozyme expression is cell type-specific to transduce the appropriate Ca2+ signals. We have determined the subcellular targeting domain of delta (E) CaMK-II, an isozyme that induces neurite outgrowth, and of a structurally similar isozyme, gamma (C) CaMK-II, which does not induce neurite outgrowth. BE CaMK-II co-localizes with filamentous actin in the perinuclear region and in cellular extensions. In contrast, gamma (C) CaMK-II is uniformly cytosolic. Constitutively active BE CaMK-II induces F-actin-rich extensions, thereby supporting a functional role for its localization. C-terminal constructs, which lack central variable domain sequences, can oligomerize and localize like full-length delta (E) and gamma (C) CaMK-II. Central variable domains themselves are monomeric and have no targeting capability. The C-terminal 95 residues of delta CaMK-II also has no targeting capability but can efficiently oligomerize. These findings define a targeting domain for gamma and delta CaMK-IIs that is in between the central variable and association domains. This domain is responsible for the subcellular targeting differences between gamma and delta CaMK-IIs.	Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University	Tombes, RM (corresponding author), Virginia Commonwealth Univ, Dept Biol, POB 842012, Richmond, VA 23284 USA.	rtombes@hsc.vcu.edu	Tombes, Robert M/B-5224-2011; Tombes, Robert M/A-7780-2008					Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BROCKE L, 1995, J NEUROSCI, V15, P6797; Donai H, 2000, MOL BRAIN RES, V85, P189, DOI 10.1016/S0169-328X(00)00221-7; Dosemeci A, 1999, BIOCHEM BIOPH RES CO, V263, P657, DOI 10.1006/bbrc.1999.1433; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; GOSHIMA Y, 1993, J NEUROSCI, V13, P559; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hoch B, 2000, J CELL BIOCHEM, V79, P293, DOI 10.1002/1097-4644(20001101)79:2<293::AID-JCB120>3.3.CO;2-H; Hoch B, 1998, J CELL BIOCHEM, V68, P259, DOI 10.1002/(SICI)1097-4644(19980201)68:2<259::AID-JCB12>3.0.CO;2-A; Johnson LD, 2000, J NEUROCHEM, V75, P2380, DOI 10.1046/j.1471-4159.2000.0752380.x; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Lau PM, 1999, J CELL BIOL, V145, P1265, DOI 10.1083/jcb.145.6.1265; Masse T, 1997, J NEUROSCI, V17, P924; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; Nomura T, 1997, BRAIN RES, V766, P129, DOI 10.1016/S0006-8993(97)00535-0; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; SCOPES RK, 1987, PROTEIN PURIFICATION, P188; Shen K, 1998, J NEUROCHEM, V70, P96; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Singer HA, 1997, J BIOL CHEM, V272, P9393; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; SOLEM M, 1995, J NEUROSCI, V15, P5966; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Tombes RM, 1999, BBA-MOL CELL RES, V1452, P1, DOI 10.1016/S0167-4889(99)00113-5; Tombes RM, 1997, BBA-MOL CELL RES, V1355, P281, DOI 10.1016/S0167-4889(96)00141-3; URQUIDI V, 1995, FEBS LETT, V358, P23, DOI 10.1016/0014-5793(94)01381-A; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; Wang HY, 1997, J BIOL CHEM, V272, P1817, DOI 10.1074/jbc.272.3.1817; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	41	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42514	42519		10.1074/jbc.M103013200	http://dx.doi.org/10.1074/jbc.M103013200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535587	hybrid			2022-12-27	WOS:000172450400125
J	Ghosh, SS; Sappal, BS; Kalpana, GV; Lee, SW; Chowdhury, JR; Chowdhury, NR				Ghosh, SS; Sappal, BS; Kalpana, GV; Lee, SW; Chowdhury, JR; Chowdhury, NR			Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INACTIVATION ANALYSIS; PROTEIN-PROTEIN INTERACTIONS; UDP-GLUCURONOSYLTRANSFERASE; CRIGLER-NAJJAR; ISOZYMES; REGION; PHENOL; SITE	Genetic lesions of bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) completely or partially abolish hepatic bilirubin glucuronidation, causing Crigler-Najjar syndrome type I or 2, respectively. Clinical observations indicate that some mutant forms of human UGT1A1 (hUGT1A1) may be dominant-negative, suggesting their interaction with the wildtype enzyme. To evaluate intermolecular interaction of hUGT1A1, Gunn rat fibroblasts were stably transduced with hUGT1A1 cDNA. Gel permeation chromatography of solubilized microsomes suggested dimerization of hUGT1A1 in solution. Nearest-neighbor cross-linking analysis indicated that, within microsomal membranes, hUGT1A1 dimerized more efficiently at pH 7.4 than at pH 9. Two-hybrid analysis in yeast and mammalian systems demonstrated positive interaction of hUGT1A1 with itself, but not with another UGT isoform, human UGT1A6, which differs only in the N-terminal domain. Dimerization was abolished by deletion of the membrane-embedded helix from the N-terminal domain of hUGT1A1, but not by substitution of several individual amino acid residues or partial deletion of the C-terminal domain. A C127Y substitution abolished UGT1A1 activity, but not its dimerization. Coexpression of mutagenized and wild-type hUGT1A1 in COS-7 cells showed that the mutant form markedly suppressed the catalytic activity of wild-type hUGT1A1. Homodimerization of hUGT1A1 may explain the dominant-negative effect of some mutant forms of the enzyme.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chowdhury, NR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	chowdhur@aecom.yu.edu		Kalpana, Ganjam/0000-0003-4111-0604	NIDDK NIH HHS [P30-DK 41296, DK 46057, DK 39137] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046057, P30DK041296, R01DK039137] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BRIGGS MM, 1977, BIOCHEMISTRY-US, V16, P73, DOI 10.1021/bi00620a012; Chowdhury J, 2001, METABOLIC MOL BASES, V2, P3063; CHOWDHURY J R, 1981, Hepatology, V1, P622; CHOWDHURY JR, 1985, P NATL ACAD SCI USA, V82, P2990, DOI 10.1073/pnas.82.9.2990; Ciotti M, 1998, BIOCHEMISTRY-US, V37, P11018, DOI 10.1021/bi980747q; CRIGLER JF, 1952, PEDIATRICS, V10, P169; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gantla S, 1998, AM J HUM GENET, V62, P585, DOI 10.1086/301756; GANTLA S, 1995, EP FOR, V2, P3; GSCHAIDMEIER H, 1994, BIOCHEM PHARMACOL, V48, P1545, DOI 10.1016/0006-2952(94)90198-8; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kadakol A, 2001, J MED GENET, V38, P244, DOI 10.1136/jmg.38.4.244; Koiwai O, 1996, HUM MOL GENET, V5, P645, DOI 10.1093/hmg/5.5.645; MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MATERN H, 1982, J BIOL CHEM, V257, P7422; MATSUI M, 1980, ANAL BIOCHEM, V105, P141, DOI 10.1016/0003-2697(80)90435-2; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; PETERS WHM, 1984, J BIOL CHEM, V259, P1701; RITTER JK, 1992, J BIOL CHEM, V267, P3257; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Seppen J, 1996, BIOCHEM J, V314, P477, DOI 10.1042/bj3140477; SEPPEN J, 1995, PROTEIN EXPRES PURIF, V6, P149, DOI 10.1006/prep.1995.1018; VANES HHG, 1993, CYTOGENET CELL GENET, V63, P114, DOI 10.1159/000133513	28	84	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42108	42115		10.1074/jbc.M106742200	http://dx.doi.org/10.1074/jbc.M106742200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546782	hybrid			2022-12-27	WOS:000172450400077
J	Janknecht, R				Janknecht, R			Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; HEAT-SHOCK PROTEINS; MAPKAP KINASE-2; NUCLEAR EXPORT; TNF-ALPHA; IN-VIVO; PHOSPHORYLATION; STRESS; EXPRESSION; SUBSTRATE	Mitogen-activated protein kinase-activated protein kinase 2 (MK2) is an important intracellular mediator of stress signals. In this report, a novel target of MK2 has been identified, the ETS transcription factor family member ER81, whose dysregulation contributes to tumorigenesis and whose normal function is required during development. MK2 phosphorylates ER81 in vitro within its central inhibitory domain, and overexpression of MK2 leads to increased in vivo phosphorylation of ER81. Two serine residues, ER81 amino acids 191 and 216, were identified as MK2 phosphorylation sites. MK2 suppresses basal ER81-dependent transcription, and this suppressive effect is alleviated upon mutation of the NM phosphorylation sites in a cell type-specific manner. However, NM can also interfere with ER81-mediated transcription independently of serine 191 and serine 216 phosphorylation. Furthermore, MM overexpression counteracts the stimulation of ER81 activity by p38 mitogen-activated protein kinase. Altogether, AM may regulate ER81 transcriptional activity in a cell type-specific manner and thereby modulate various physiological processes beyond stress responses.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Janknecht, R (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.			Janknecht, Ralf/0000-0003-1741-1562	NCI NIH HHS [CA85257, R01 CA085257] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085257] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baert JL, 1997, INT J CANCER, V70, P590, DOI 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; BredemeierErnst I, 1997, FEBS LETT, V408, P47, DOI 10.1016/S0014-5793(97)00387-6; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; ENGEL K, 1995, J CELL BIOCHEM, V57, P321, DOI 10.1002/jcb.240570216; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Fluck M, 2000, BIOCHEM BIOPH RES CO, V270, P488, DOI 10.1006/bbrc.2000.2457; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; JEON IS, 1995, ONCOGENE, V10, P1229; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MONTE D, 1995, ONCOGENE, V11, P771; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Stein B, 1997, J BIOL CHEM, V272, P19509, DOI 10.1074/jbc.272.31.19509; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; VANDERGEER P, 1994, ELECTROPHORESIS, V15, P544, DOI 10.1002/elps.1150150173; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946	37	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41856	41861		10.1074/jbc.M106630200	http://dx.doi.org/10.1074/jbc.M106630200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551945	hybrid			2022-12-27	WOS:000172450400043
J	Renner, DB; Yamaguchi, Y; Wada, T; Handa, H; Price, DH				Renner, DB; Yamaguchi, Y; Wada, T; Handa, H; Price, DH			A highly purified RNA polymerase II elongation control system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPT RELEASE FACTOR; COLI NUSG PROTEIN; P-TEFB KINASE; IN-VITRO; MESSENGER-RNA; HIV-1 TAT; TERMINAL DOMAIN; DROSOPHILA; SPT5; COMPLEX	Studying the sensitivity of transcription to the nucleotide analog 5,6-dichloro-1-beta -D-ribofuranosylbenzimidazole has led to the discovery of a number of proteins involved in the regulation of transcription elongation by RNA polymerase II. We have developed a highly purified elongation control system composed of three purified proteins added back to isolated RNA polymerase II elongation complexes. Two of the proteins, 5,6-dichloro-1-13D-ribofuranosylbenzimidazole sensitivity-inducing factor (DSIF) and negative elongation factor (NELF), act as negative transcription elongation factors by increasing the time the polymerase spent at pause sites. reverses the negative effect of DSIF and NELF through a mechanism dependent on its kinase activity. TFIIF is a general initiation factor that positively affects elongation by decreasing pausing. We show that TFIIF functionally competes with DSIF and NELF, and this competition is dependent on the relative concentrations of TFIIF and NELF.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Tokyo Inst Technol, Fac Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268501, Japan	University of Iowa; Tokyo Institute of Technology; Tokyo Institute of Technology	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.		Yamaguchi, Yuki/B-9390-2015; Price, David H/F-6173-2010	Yamaguchi, Yuki/0000-0002-0197-614X; Price, David/0000-0002-5597-385X	NIGMS NIH HHS [GM35500] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; ASO T, 1995, FASEB J, V9, P1419, DOI 10.1096/fasebj.9.14.7589983; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Clement JQ, 2000, J MOL BIOL, V299, P1179, DOI 10.1006/jmbi.2000.3745; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Halle JP, 1996, TRENDS GENET, V12, P161, DOI 10.1016/0168-9525(96)30035-8; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hirose Y, 2000, GENE DEV, V14, P1415; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; LI J, 1992, J BIOL CHEM, V267, P6012; Lis JT, 2000, GENE DEV, V14, P792; Liu MY, 1998, J BIOL CHEM, V273, P25541, DOI 10.1074/jbc.273.40.25541; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Peng J, 1998, COLD SPRING HARB SYM, V63, P365, DOI 10.1101/sqb.1998.63.365; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; PRICE DH, 1987, J BIOL CHEM, V262, P3244; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; Shilatifard A, 1998, FASEB J, V12, P1437, DOI 10.1096/fasebj.12.14.1437; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Xie Z, 1997, J BIOL CHEM, V272, P31902, DOI 10.1074/jbc.272.50.31902; Xie Z, 1996, J BIOL CHEM, V271, P11043, DOI 10.1074/jbc.271.19.11043; Xie Z, 1998, J BIOL CHEM, V273, P3771, DOI 10.1074/jbc.273.6.3771; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; Zorio DAR, 2001, CURR BIOL, V11, pR144, DOI 10.1016/S0960-9822(01)00063-X	55	142	146	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42601	42609		10.1074/jbc.M104967200	http://dx.doi.org/10.1074/jbc.M104967200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553615	hybrid			2022-12-27	WOS:000172450400136
J	Welford, SM; Hebert, SP; Deneen, B; Arvand, A; Denny, CT				Welford, SM; Hebert, SP; Deneen, B; Arvand, A; Denny, CT			DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN; INTERACTS; EWS/FLI; FLI-1; EWS; GENES	Specific chromosomal translocations involving the ews gene and one of five members of the ets family of transcription factors create ews/ets fusion genes that are found in similar to 85% of Ewing's family of tumors. ews/ets fusion genes consistently maintain an intact and functional ets DNA binding domain (DBD) in all of these cases. We demonstrate here, however, that EWS/FLI1, the most prevalent EWS/ETS fusion, activates oncogenic pathways independent of its DBD. In in vivo tumor assays, EWS/FLI1 molecules with either point mutations or a large deletion in the ets DBD retain the ability to accelerate tumors in NIH 3T3 cells, whereas they lose the ability to bind DNA in vitro. Additionally, whereas inhibition of DBD functions of EWS/FLI1 with a dominant negative form of FLI1 is sufficient to inhibit anchorage-independent growth in NIH 3T3 cells, it is ineffective in inhibiting tumor growth in SCID mice. Usage of this dominant negative construct in a Ewing's tumor cell line, however, does reduce the rate of tumor formation, supporting the need for a functional DBD in this context. Together, these results suggest that EWS/FLI1 induces both DBD-dependent and DBD-independent oncogenic pathways.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat, Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Expt Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Denny, CT (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	cdenny@ucla.edu		Deneen, Benjmain/0000-0002-6335-1081	NCI NIH HHS [CA32737, CA87771] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087771, P01CA032737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arvand A, 2001, CANCER RES, V61, P5311; ARVAND A, 2001, IN PRESS ONCOGENE; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Chansky HA, 2001, CANCER RES, V61, P3586; Jaishankar S, 1999, ONCOGENE, V18, P5592, DOI 10.1038/sj.onc.1202940; Kim J, 1999, PHYSIOL GENOMICS, V1, P127, DOI 10.1152/physiolgenomics.1999.1.3.127; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; Knoop LL, 2001, J BIOL CHEM, V276, P22317, DOI 10.1074/jbc.M008950200; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; MAO XH, 1994, J BIOL CHEM, V269, P18216; May WA, 1997, NAT GENET, V17, P495, DOI 10.1038/ng1297-495; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; Teitell MA, 1999, LAB INVEST, V79, P1535; Thompson AD, 1999, ONCOGENE, V18, P5506, DOI 10.1038/sj.onc.1202928; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086; Zwerner JP, 2001, ONCOGENE, V20, P626, DOI 10.1038/sj.onc.1204133	25	51	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41977	41984		10.1074/jbc.M106757200	http://dx.doi.org/10.1074/jbc.M106757200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553628	hybrid			2022-12-27	WOS:000172450400059
J	Liang, CP; Tall, AR				Liang, CP; Tall, AR			Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETICALLY-OBESE MICE; GENE-EXPRESSION; HEPATIC EXPRESSION; DIABETES-MELLITUS; MESSENGER-RNA; BODY-WEIGHT; CHOLESTEROL; ALPHA; PATTERNS; HEPATOCYTES	Leptin, a hormone secreted by adipose tissue, has been shown to have a major influence on hepatic lipid and lipoprotein metabolism. To characterize changes in lipid and lipoprotein gene expression in mouse liver, suppression subtractive hybridization and cDNA microarray analysis were used to identify mRNAs differentially expressed after leptin treatment of ob/ob mice. Ob/ob mice showed a profound decrease in mRNAs encoding genes controlling bile acid synthesis and transport as well as a variety of apolipoprotein genes and hepatic lipase with reversal upon leptin administration, suggesting that leptin coordinately regulates high density lipoprotein and bile salt metabolism. Leptin administration also resulted in decreased expression of genes involved in fatty acid and cholesterol synthesis, glycolysis, gluconeogenesis, and urea synthesis, and increased expression of genes mediating fatty acid oxidation, ATP synthesis, and oxidant defenses. The changes in mRNA expression are consistent with a switch in energy metabolism from glucose utilization and fatty acid synthesis to fatty acid oxidation and increased respiration. The latter changes may produce oxidant stress, explaining the unexpected finding that leptin induces a battery of genes involved in antioxidant defenses. Expression cluster analysis revealed responses of several sets of genes that were kinetically linked. Thus, the mRNA levels of genes involved in fatty acid and cholesterol synthesis are rapidly (<1 h) repressed by leptin administration, in association with an acute decrease in plasma insulin levels and decreased sterol regulator element-binding protein-1 expression. In contrast, genes participating in fatty acid oxidation and ketogenesis were induced more slowly (24 h), following an increase in expression of their common regulatory factor, peroxisome proliferator-activated receptor a. However, the regulation of genes involved in high density lipoprotein and bile salt metabolism shows complex kinetics and is likely to be mediated by novel transcription factors.	Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA	Columbia University	Liang, CP (corresponding author), Columbia Univ, Dept Med, Div Mol Med, 630 W 168th St, New York, NY 10032 USA.	CL534@columbia.edu	Tall, Alan/AAT-8528-2021					Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; BRAY GA, 1971, PHYSIOL REV, V51, P598, DOI 10.1152/physrev.1971.51.3.598; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Choy L, 1998, J BIOL CHEM, V273, P31455, DOI 10.1074/jbc.273.47.31455; Crosson SM, 1997, DIABETOLOGIA, V40, P1117, DOI 10.1007/s001250050796; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Enriquez A, 1999, BIOCHEM BIOPH RES CO, V255, P300, DOI 10.1006/bbrc.1999.0202; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fruhbeck G, 2000, DIABETOLOGIA, V43, P3, DOI 10.1007/s001250050002; GE RW, 1994, J BIOL CHEM, V269, P13185; Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kimura T, 1998, J BIOL CHEM, V273, P27505, DOI 10.1074/jbc.273.42.27505; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Minc E, 1999, J BIOL CHEM, V274, P503, DOI 10.1074/jbc.274.1.503; Murphy JE, 1997, P NATL ACAD SCI USA, V94, P13921, DOI 10.1073/pnas.94.25.13921; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; NISHINA PM, 1994, METABOLISM, V43, P549, DOI 10.1016/0026-0495(94)90194-5; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pessayre D, 1999, CELL BIOL TOXICOL, V15, P367, DOI 10.1023/A:1007649815992; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reidy SP, 2000, COMP BIOCHEM PHYS A, V125, P285, DOI 10.1016/S1095-6433(00)00159-8; Renz M, 2000, J BIOL CHEM, V275, P10429, DOI 10.1074/jbc.275.14.10429; Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Silver DL, 2000, J CLIN INVEST, V105, P151, DOI 10.1172/JCI8087; Silver DL, 1999, J BIOL CHEM, V274, P4140, DOI 10.1074/jbc.274.7.4140; Soukas A, 2000, GENE DEV, V14, P963; Stroup D, 2000, J LIPID RES, V41, P1; Tall AR, 2000, NAT MED, V6, P1104, DOI 10.1038/80433; TALL AR, 2001, METABOLIC MOL BASES, P2915; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vicent D, 1998, DIABETES, V47, P1451, DOI 10.2337/diabetes.47.9.1451; Watson AM, 1999, DRUG METAB DISPOS, V27, P695; White DW, 2000, DIABETES, V49, P1443, DOI 10.2337/diabetes.49.9.1443; Wiesenthal SR, 1999, DIABETES, V48, P766, DOI 10.2337/diabetes.48.4.766; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Zaiou M, 1998, J CLIN INVEST, V101, P1699, DOI 10.1172/JCI2166; Zhou YT, 1998, P NATL ACAD SCI USA, V95, P8898, DOI 10.1073/pnas.95.15.8898	56	116	125	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2001	276	52					49066	49076		10.1074/jbc.M107250200	http://dx.doi.org/10.1074/jbc.M107250200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522XK	11551957	hybrid			2022-12-27	WOS:000173922100060
J	Watson, PA; Nesterova, A; Burant, CF; Klemm, DJ; Reusch, JEB				Watson, PA; Nesterova, A; Burant, CF; Klemm, DJ; Reusch, JEB			Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH GLUCOSE; CARDIOVASCULAR-DISEASE; KINASE PATHWAY; CYCLIC-AMP; VITAMIN-E; TRANSCRIPTION; ACTIVATION; GROWTH; CREB; CBP	We hypothesized that diabetes and glucose-induced reactive oxygen species lead to depletion of cAMP response element-binding protein (CREB) content in the vasculature. In primary cultures of smooth muscle cells (SMC) high medium glucose decreased CREB function but increased SMC chemokinesis and entry into the cell cycle. These effects were blocked by pretreatment with the antioxidants. High glucose increased intracellular reactive oxygen species detected by CM-H(2)DCFA. SMC exposed to oxidative stress (H2O2) demonstrated a 3.5-fold increase in chemokinesis (p < 0.05) and accelerated entry into cell cycle, accompanied by a significant decrease in CREB content. Chronic oxidative challenge similar to the microenvironment in diabetes (glucose oxidase treatment) decreases CREB content (40-50%). Adenoviral-mediated expression of constitutively active CREB abolished the increase in chemokinesis and cell cycle progression induced by either high glucose or oxidative stress. Analysis of vessels from insulin resistant or diabetic animals indicates that CREB content is decreased in the vascular stroma. Treatment of insulin-resistant animals with the insulin sensitizer rosiglitazone restores vessel wall CREB content toward that observed in normal animals. In summary, high glucose and oxidative stress decrease SMC CREB content increase chemokinesis and entry into the cell cycle, which is blocked by antioxidants or restoration of CREB content. Thus, decreased vascular CREB content could be one of the molecular mechanisms leading to increased atherosclerosis in diabetes.	Denver Vet Affairs Med Ctr, Denver Res Inst, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Cardiovasc Pulm Res Sect, Denver, CO 80220 USA; Pfizer Inc, Ann Arbor, MI 48105 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Pfizer	Reusch, JEB (corresponding author), Denver Vet Affairs Med Ctr, Denver Res Inst, Rm 9C-120,1055 Clermont St, Denver, CO 80220 USA.		Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Reusch, Jane/0000-0001-8620-1003	NIDDK NIH HHS [R01 DK53969, K08 DK02351] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002351, R01DK053969] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham E, 2000, CRIT CARE MED, V28, pN100, DOI 10.1097/00003246-200004001-00012; Absher PM, 1999, ATHEROSCLEROSIS, V143, P245, DOI 10.1016/S0021-9150(98)00295-0; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; Bornfeldt KE, 1996, TRENDS CARDIOVAS MED, V6, P143, DOI 10.1016/1050-1738(96)00038-2; Carter AM, 1997, DIABETIC MED, V14, P423, DOI 10.1002/(SICI)1096-9136(199706)14:6<423::AID-DIA421>3.0.CO;2-F; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Costa M, 1996, EUR J BIOCHEM, V237, P532, DOI 10.1111/j.1432-1033.1996.00532.x; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Etienne P, 1998, DIFFERENTIATION, V63, P225, DOI 10.1111/j.1432-0436.1998.00225.x; Gerstein HC, 1996, DIABETES CARE, V19, P1225, DOI 10.2337/diacare.19.11.1225; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Goalstone ML, 1999, DIABETOLOGIA, V42, P310, DOI 10.1007/s001250051156; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GROUP ND, 1995, NIH PUBLICATION; Haffner SM, 1998, ENDOCR REV, V19, P583, DOI 10.1210/er.19.5.583; HEASLEY LE, 1991, CELL REGUL, V2, P479, DOI 10.1091/mbc.2.6.479; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; INOGUCHI T, 1994, AM J PHYSIOL, V267, pE369, DOI 10.1152/ajpendo.1994.267.3.E369; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Karasu C, 1997, METABOLISM, V46, P872, DOI 10.1016/S0026-0495(97)90072-X; Karasu C, 2000, EUR J PHARMACOL, V392, P163, DOI 10.1016/S0014-2999(00)00140-0; Kimura I, 1998, IMMUNOPHARMACOLOGY, V40, P105, DOI 10.1016/S0162-3109(98)00024-1; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917; Kreisberg JI, 1996, KIDNEY INT, V50, P805, DOI 10.1038/ki.1996.379; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; LopesVirella MF, 1996, DIABETES, V45, pS40, DOI 10.2337/diab.45.3.S40; Mompeo B, 1999, ANN VASC SURG, V13, P294, DOI 10.1007/s100169900260; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; NATARAJAN R, 1992, BIOCHEM BIOPH RES CO, V187, P552, DOI 10.1016/S0006-291X(05)81529-3; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Osanai H, 1998, AM J CARDIOL, V81, P698, DOI 10.1016/S0002-9149(97)01021-7; Owens GK, 1996, J HYPERTENS, V14, pS55; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; Shimomura A, 1998, J NEUROCHEM, V70, P1029; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Wang R, 1998, Nihon Ika Daigaku Zasshi, V65, P284; Yasunari K, 1997, CIRC RES, V81, P953; Yasunari K, 1999, CIRCULATION, V99, P1370, DOI 10.1161/01.CIR.99.10.1370; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; YOUNG JK, 1994, NEUROSCI LETT, V165, P13, DOI 10.1016/0304-3940(94)90698-X	55	67	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46142	46150		10.1074/jbc.M104770200	http://dx.doi.org/10.1074/jbc.M104770200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11560925	hybrid			2022-12-27	WOS:000172573100089
J	Jana, M; Liu, XJ; Koka, S; Ghosh, S; Petro, TM; Pahan, K				Jana, M; Liu, XJ; Koka, S; Ghosh, S; Petro, TM; Pahan, K			Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RAT PRIMARY ASTROCYTES; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; C-6 GLIAL-CELLS; MULTIPLE-SCLEROSIS; C/EBP-BETA; AUTOIMMUNE ENCEPHALOMYELITIS; INHIBITS INDUCTION; GENE-EXPRESSION; MESSENGER-RNA	The present study was undertaken to investigate the role of CD40 ligation in the expression of inducible nitric-oxide synthase (iNOS) in mouse BV-2 microglial cells and primary microglia. Ligation of CD40 alone by either cross-linking antibodies against CD40 or a recombinant CD40 ligand (CD154) was unable to induce the production of NO in BV-2 microglial cells. The absence of induction of NO production by CD40 ligation alone even in CD40-overexpressed BV-2 microglial cells suggests that a signal transduced by the ligation of CD40 alone is not sufficient to induce NO production. However, CD40 ligation markedly stimulated interferon-gamma (IFN-gamma)-mediated NO production. Ligation of CD40 in CD40-overexpressed cells further stimulated IFN-gamma -induced production of NO. This stimulation of NO production was accompanied by stimulation of the iNOS protein and mRNA In addition to BV-2 glial cells, CD40 ligation also stimulated IFN-gamma -mediated NO production in mouse primary microglia and peritoneal macrophages. To understand the mechanism of induction/stimulation of iNOS, we investigated the roles of nuclear factor kappaB (NF-kappaB) and CCAAT/enhancer-binding protein beta (C/EBP beta), transcription factors responsible for the induction of iNOS. IFN-gamma alone was able to induce the activation of NF-kappaB as well as C/EBP beta. However, CD40 ligation alone induced the activation of only NF-kappaB but not of C/EBP beta, suggesting that the activation of NF-kappaB alone by CD40 ligation is not sufficient to induce the expression of iNOS and that the activation of C/EBP beta is also necessary for the expression of iNOS. Consistently, dominant-negative mutants of p65 (Delta p65) and C/EBP beta (DeltaC/EBP beta) inhibited the expression of iNOS in BV-2 microglial cells that were stimulated with the combination of IFN-gamma and CD40 ligand. Stimulation of IFN-gamma -mediated activation of NF-kappaB but not of C/EBP beta by CD40 ligation suggests that CD40 ligation stimulates the expression of iNOS in IFN-gamma -treated BV-2 microglial cells through the stimulation of NF-kappaB activation. This study illustrates a novel role for CD40 ligation in stimulating the expression of iNOS in microglial cells, which may participate in the pathogenesis of neuroinflammatory diseases.	Univ Nebraska, Med Ctr, Dept Oral Biol, Lincoln, NE 68583 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Yale University	Pahan, K (corresponding author), Univ Nebraska, Med Ctr, Dept Oral Biol, 40th & Holdrege, Lincoln, NE 68583 USA.				NINDS NIH HHS [R01 NS039940-02, R01 NS039940-01A1, R01 NS039940, NS39940] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039940] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner T, 1997, J IMMUNOL, V158, P2940; BROSNAN CF, 1994, DEV NEUROSCI-BASEL, V16, P152, DOI 10.1159/000112102; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Eberhardt W, 1998, J IMMUNOL, V160, P4961; FEINSTEIN DL, 1994, J NEUROCHEM, V62, P315; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; GALEA E, 1992, P NATL ACAD SCI USA, V89, P10945, DOI 10.1073/pnas.89.22.10945; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Goldring CEP, 1996, NUCLEIC ACIDS RES, V24, P1682, DOI 10.1093/nar/24.9.1682; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; Gupta AK, 1999, AM J PHYSIOL-RENAL, V276, pF599, DOI 10.1152/ajprenal.1999.276.4.F599; Hecker M, 1997, BRIT J PHARMACOL, V120, P1067, DOI 10.1038/sj.bjp.0701026; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Hu SX, 1995, GLIA, V15, P491, DOI 10.1002/glia.440150412; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; JOHNSON AW, 1995, J NEUROL NEUROSUR PS, V58, P107, DOI 10.1136/jnnp.58.1.107; KOLB H, 1992, IMMUNOL TODAY, V13, P157, DOI 10.1016/0167-5699(92)90118-Q; KOPROWSKI H, 1993, P NATL ACAD SCI USA, V90, P3024, DOI 10.1073/pnas.90.7.3024; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MITROVIC B, 1994, NEUROSCIENCE, V61, P575, DOI 10.1016/0306-4522(94)90435-9; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 1997, J BIOL CHEM, V272, P7786, DOI 10.1074/jbc.272.12.7786; Pahan K, 2000, FEBS LETT, V472, P203, DOI 10.1016/S0014-5793(00)01465-4; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; Pahan K, 1998, FREE RADICAL BIO MED, V24, P39, DOI 10.1016/S0891-5849(97)00137-8; Pahan K, 1998, J BIOL CHEM, V273, P12219, DOI 10.1074/jbc.273.20.12219; Pahan K, 2001, J BIOL CHEM, V276, P7899, DOI 10.1074/jbc.M008262200; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Salkowski CA, 1997, J IMMUNOL, V158, P905; Samoilova EB, 1997, J MOL MED, V75, P603, DOI 10.1007/s001090050145; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; STEIN B, 1995, MOL CELL BIOL, V15, P4971; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tan J, 1999, J NEUROIMMUNOL, V97, P77, DOI 10.1016/S0165-5728(99)00053-3; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	52	88	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44527	44533		10.1074/jbc.M106771200	http://dx.doi.org/10.1074/jbc.M106771200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11551948	hybrid, Green Accepted			2022-12-27	WOS:000172406700026
J	Morillas, M; Gomez-Puertas, P; Roca, R; Serra, D; Asins, G; Valencia, A; Hegardt, FG				Morillas, M; Gomez-Puertas, P; Roca, R; Serra, D; Asins, G; Valencia, A; Hegardt, FG			Structural model of the catalytic core of carnitine palmitoyltransferase I and carnitine octanoyltransferase (COT) - Mutation of CPT I histidine 473 and alanine 381 and COT alanine 238 impairs the catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RAT-LIVER; SEQUENCE ALIGNMENT; PROTEIN STRUCTURES; MALONYL-COA; SWISS-MODEL; RESIDUES; CDNA; CLASSIFICATION; INHIBITION	Carnitine palmitoyltransferase I (CPT I) and carnitine octanoyltransferase (COT) catalyze the conversion of long- and medium-chain acyl-CoA to acylcarnitines in the presence of carnitine. We propose a common three-dimensional structural model for the catalytic domain of both, based on fold identification for 200 amino acids surrounding the active site through a threading approach. The model is based on the three-dimensional structure of the rat enoyl-CoA hydratase, established by x-ray diffraction analysis. The study shows that the structural model of 200 amino acids of the catalytic site is practically identical in CPT I and COT with identical distribution of 4 beta -sheets and 6 alpha -helices. Functional analysis of the model was done by site-directed mutagenesis. When the critical histidine residue 473 in CPT I (327 in COT), localized in the acyl-CoA pocket in the model, was mutated to alanine, the catalytic activity was abolished. Mutation of the conserved alanine residue to aspartic acid, A381D (in CPT I) and A238D (in COT), which are 92/89 amino acids far from the catalytic histidine, respectively (but very close to the acyl-CoA pocket in the structural model), decreased the activity by 86 and 80%, respectively. The K-m for acyl-CoA increased 6-8-fold, whereas the K-m for carnitine hardly changed. The inhibition of the mutant CPT I by malonyl-CoA was not altered. The structural model explains the loss of activity reported for the CPT I mutations R451A, W452A, D454G, W391A, del 8395, P479L, and L484P, all of which occur in or near the modeled catalytic domain.	Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; CSIC, Natl Biotechnol Ctr, Prot Design Grp, E-28049 Madrid, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC)	Hegardt, FG (corresponding author), Sch Pharm, Dept Biochem, Avda Diagonal 643, E-08028 Barcelona, Spain.	hegardt@farmacia.far.ub.es	Valencia, Alfonso/I-3127-2015; Serra, Dolors/L-3657-2014; Gomez-Puertas, Paulino/G-8821-2014	Valencia, Alfonso/0000-0002-8937-6789; Serra, Dolors/0000-0002-4936-4206; Gomez-Puertas, Paulino/0000-0003-3131-729X; Morillas, Montserrat/0000-0001-7068-3167				a'Bhaird NN, 1998, BIOCHEM J, V330, P1029, DOI 10.1042/bj3301029; ABHAIRD NN, 1992, BIOCHEM J, V286, P637, DOI 10.1042/bj2860637; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRITTON CH, 1995, P NATL ACAD SCI USA, V92, P1984, DOI 10.1073/pnas.92.6.1984; BROWN NF, 1994, J BIOL CHEM, V269, P19157; Brown NF, 2001, J LIPID RES, V42, P1134; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Cronin CN, 1998, J BIOL CHEM, V273, P24465, DOI 10.1074/jbc.273.38.24465; Cronin CN, 1997, BIOCHEM BIOPH RES CO, V238, P784, DOI 10.1006/bbrc.1997.7390; Cronin CN, 1997, EUR J BIOCHEM, V247, P1029, DOI 10.1111/j.1432-1033.1997.01029.x; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Dai J, 2000, J BIOL CHEM, V275, P22020, DOI 10.1074/jbc.M002118200; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; ESSER V, 1993, J BIOL CHEM, V268, P5817; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holm L, 1996, NUCLEIC ACIDS RES, V24, P206, DOI 10.1093/nar/24.1.206; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ijlst L, 1998, J CLIN INVEST, V102, P527, DOI 10.1172/JCI2927; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; JONES DT, 1995, PROTEINS, V23, P387, DOI 10.1002/prot.340230312; Jones DT, 1999, PROTEINS, P104; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Morillas M, 2000, BIOCHEM J, V351, P495, DOI 10.1042/0264-6021:3510495; Morillas M, 2000, FEBS LETT, V466, P183, DOI 10.1016/S0014-5793(99)01788-3; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pazos F., 1997, BIOCOMPUTING EMERGEN, P132; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Rost B, 1996, METHOD ENZYMOL, V266, P525; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Sherman F, 1986, LAB COURSE MANUAL ME; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; Yamazaki N, 1996, BBA-GENE STRUCT EXPR, V1307, P157, DOI 10.1016/0167-4781(96)00069-3	47	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45001	45008		10.1074/jbc.M106920200	http://dx.doi.org/10.1074/jbc.M106920200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11553629	hybrid			2022-12-27	WOS:000172406700089
J	Abe, Y; Matsumoto, S; Wei, SM; Nezu, K; Miyoshi, A; Kito, K; Ueda, N; Shigemoto, K; Hitsumoto, Y; Nikawa, J				Abe, Y; Matsumoto, S; Wei, SM; Nezu, K; Miyoshi, A; Kito, K; Ueda, N; Shigemoto, K; Hitsumoto, Y; Nikawa, J			Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED KILLER-CELLS; SACCHAROMYCES-CEREVISIAE; KILLING ACTIVITY; TYROSINE KINASE; NUCLEAR IMPORT; DNA-DAMAGE; LAK CELLS; LYMPHOTOXIN; GENE; P53	A human protein kinase, p53-related protein kinase (PRPK), was cloned from an interleukin-2-activated cytotoxic T-cell subtraction library. PRPK appears to be a homologue of a growth-related yeast serine/threonine protein kinase, YGR262c. However, a complementation assay using YGR262c-disrupted yeast indicated that PRPK is not functionally identical to the yeast enzyme. PRPK expression was observed in interleukin-2-activated cytotoxic T-cells, some human epithelial tumor cell lines, and the testes. The intrinsic transcriptional activity of p53 was up-regulated by a transient transfection of PRPK to COS-7 cells. PRPK was shown to bind to p53 and to phosphorylate p53 at Ser-15. These results indicate that PRPK may play an important role in the cell cycle and cell apoptosis through phosphorylation of p53.	Ehime Univ, Sch Med, Dept Pathol & Hyg 1, Shigenobu, Ehime 7910295, Japan; Okayama Univ, Fac Sci, Dept Biol Chem, Div Clin Immunol, Okayama 7000005, Japan; Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Dept Biochem Engn & Sci, Kawazu, Fukuoka 8208502, Japan	Ehime University; Okayama University; Kyushu Institute of Technology	Abe, Y (corresponding author), Ehime Univ, Sch Med, Dept Pathol & Hyg 1, Shigenobu, Ehime 7910295, Japan.							ABE Y, 1993, LYMPHOKINE CYTOK RES, V12, P279; ABE Y, 1991, JPN J CANCER RES, V82, P23, DOI 10.1111/j.1349-7006.1991.tb01740.x; ABE Y, 1992, LYMPHOKINE CYTOK RES, V11, P115; Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; AIELLO L, 1979, VIROLOGY, V94, P460, DOI 10.1016/0042-6822(79)90476-8; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Becker W, 1996, BBA-MOL CELL RES, V1312, P63, DOI 10.1016/0167-4889(96)00036-5; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Clemente ML, 1997, YEAST, V13, P287, DOI 10.1002/(SICI)1097-0061(19970315)13:3<287::AID-YEA75>3.0.CO;2-5; HOLLINGS PE, 1997, HUM GENET, V93, P609; HORIUCHI A, 1994, CLIN EXP IMMUNOL, V96, P152; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kueng P, 1997, J CELL BIOL, V139, P1851, DOI 10.1083/jcb.139.7.1851; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MIYAKE M, 1992, EUR J IMMUNOL, V22, P2147, DOI 10.1002/eji.1830220828; Nikawa J, 1998, NUCLEIC ACIDS RES, V26, P860, DOI 10.1093/nar/26.3.860; Park SH, 1997, CYTOGENET CELL GENET, V77, P271, DOI 10.1159/000134595; QINGBAI S, 2000, J BIOL CHEM, V275, P20444; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; Stocchetto S, 1997, FEBS LETT, V414, P171, DOI 10.1016/S0014-5793(97)00980-0; TANGUAY DA, 1994, MOL IMMUNOL, V31, P643, DOI 10.1016/0161-5890(94)90173-2; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toshima J, 1998, BIOCHEM BIOPH RES CO, V249, P107, DOI 10.1006/bbrc.1998.9099; Toshima J, 1995, J BIOL CHEM, V270, P31331, DOI 10.1074/jbc.270.52.31331	27	57	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44003	44011		10.1074/jbc.M105669200	http://dx.doi.org/10.1074/jbc.M105669200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546806	hybrid			2022-12-27	WOS:000172297700068
J	Diviani, D; Soderling, J; Scott, JD				Diviani, D; Soderling, J; Scott, JD			AKAP-Lbc anchors protein kinase A and nucleates G alpha(12)-selective Rho-mediated stress fiber formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SIGNALING ENZYMES; SCAFFOLD PROTEIN; FAMILY GTPASES; CELL-POLARITY; P115 RHOGEF; DBL FAMILY; CG-NAP; G-ALPHA(13); ONCOGENE	Guanine nucleotide exchange factors of the Dbl family relay signals from membrane receptors to Rho family GTPases. We now demonstrate that a longer transcript of the Lbc gene encodes a chimeric molecule, which we have called AKAP-Lbc, that functions as an A-kinase-anchoring protein (AKAP) and a Rho-selective guanine nucleotide exchange factor. Expression of AKAP-Lbc in fibroblasts favors the formation of stress fibers in a Rho-dependent manner. Application of lysophosphatidic acid or selective expression of G alpha (12) enhances cellular AKAP-Lbc activation. Furthermore, biochemical studies indicate that AKAP-Lbc functions as an adaptor protein to selectively couple G alpha (12) to Rho. Thus, AKAP-Lbc anchors PKA and nucleates the assembly of a Rho-mediated signaling pathway.	Oregon Hlth Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.			Diviani, Dario/0000-0003-4375-3718	NIDDK NIH HHS [DK44239] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044239] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Corbin J D, 1974, Methods Enzymol, V38, P287; Diviani D, 2001, J CELL SCI, V114, P1431; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Scott JN, 2000, SCI AM, V282, P72, DOI 10.1038/scientificamerican0600-72; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Takenawa T, 2001, J CELL SCI, V114, P1801; Togashi H, 2000, J BIOL CHEM, V275, P29570, DOI 10.1074/jbc.M003726200; TOKSOZ D, 1994, ONCOGENE, V9, P621; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	48	189	199	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44247	44257		10.1074/jbc.M106629200	http://dx.doi.org/10.1074/jbc.M106629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546812	hybrid			2022-12-27	WOS:000172297700097
J	Wang, NS; Unkila, MT; Reineks, EZ; Distelhorst, CW				Wang, NS; Unkila, MT; Reineks, EZ; Distelhorst, CW			Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CHROMOSOMAL BREAKPOINT; SUBCELLULAR LOCATION; OUTER-MEMBRANE; BCL-X(L); PROTEIN; FAMILY; LOCALIZATION; DIMERIZATION; ACTIVATION	Bcl-2 protein family members function either to promote or inhibit programmed cell death. Bcl-2, typically an inhibitor of apoptosis, has also been demonstrated to have pro-apoptotic activity (Cheng, E. H., Kirsch, D. G., Clem, R. J., et al. (1997) Science 278, 1966-1968). The pro-apoptotic activity has been attributed to the cleavage of Bcl-2 by caspase-3, which converts Bcl-2 to a proapoptotic molecule. Bcl-2 is a membrane protein that is localized in the endoplasmic reticulum (ER) membrane, the outer mitochondrial membrane, and the nuclear envelope. Here, we demonstrate that transient expression of Bcl-2 at levels comparable to those found in stably transfected cells induces apoptosis in human embryonic kidney 293 cells and in the human breast cell line MDA-MB-468 cells. Furthermore, we have targeted Bcl-2 specifically to either the ER or the outer mitochondrial membrane to test whether induction of apoptosis by Bcl-2 is dependent upon its localization within either of these membranes. Our findings indicate that Bcl-2 specifically targeted to the mitochondria induces cell death, whereas Bcl-2 that is targeted to the ER does not. The expression of Bcl-2 does result in its cleavage to a 20-kDa protein; however, mutation of the caspase-3 cleavage site (D34A) does not inhibit its ability to induce cell death. Additionally, we find that transiently expressed ER-targeted Bcl-2 inhibits cell death induced by Bax overexpression. In conclusion, the ability of Bcl-2 to promote apoptosis is associated with its localization at the mitochondria. Furthermore, the ability of ER-targeted Bcl-2 to protect against Bax-induced apoptosis suggests that the ER localization of Bcl-2 may play an important role in its protective function.	Case Western Reserve Univ, Dept Med, Ctr Comprehens Canc, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pharmacol, Ctr Comprehens Canc, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Dept Med, Ctr Comprehens Canc, 329 Biomed Res Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.				NCI NIH HHS [R01 CA85804, T32 CA59366] Funding Source: Medline; NIGMS NIH HHS [T32GM07250] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085804, T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAO Y, 1994, CANCER RES, V54, P2468; Annis MG, 2001, ONCOGENE, V20, P1939, DOI 10.1038/sj.onc.1204288; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dragowska WH, 2000, CYTOMETRY, V40, P346, DOI 10.1002/1097-0320(20000801)40:4<346::AID-CYTO10>3.0.CO;2-W; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; JANIAK F, 1994, J BIOL CHEM, V269, P9842; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lee ST, 1999, ONCOGENE, V18, P3520, DOI 10.1038/sj.onc.1202716; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MITOMA J, 1992, J BIOCHEM-TOKYO, V111, P20, DOI 10.1093/oxfordjournals.jbchem.a123712; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; SHERWOOD SW, 1995, METHOD CELL BIOL, V46, P77; Shinoura N, 1999, CANCER RES, V59, P4119; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Uhlmann EJ, 1998, J BIOL CHEM, V273, P17926, DOI 10.1074/jbc.273.28.17926; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wei MC, 2000, GENE DEV, V14, P2060; Wolf CM, 1999, BIOCHEM BIOPH RES CO, V254, P821, DOI 10.1006/bbrc.1998.0132; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	46	148	154	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44117	44128		10.1074/jbc.M101958200	http://dx.doi.org/10.1074/jbc.M101958200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546793	hybrid			2022-12-27	WOS:000172297700082
J	Beck, CG; Studer, C; Zuber, JF; Demange, BJ; Manning, U; Urfer, R				Beck, CG; Studer, C; Zuber, JF; Demange, BJ; Manning, U; Urfer, R			The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIRECTED MUTAGENESIS; T1/35KDA FAMILY; VACCINIA VIRUS; MCP-1 RECEPTOR; GROWTH-FACTOR; COWPOX VIRUS; RESIDUES; COMPLEX; DOMAIN	Monocyte chemoattractant protein-1 (MCP-1) is a chemotactic cytokine mainly acting on monocytes and T cells that elicits its biological effects by interacting with the seven-transmembrane helix receptor CCR2B. The vaccinia virus strain Lister and many other poxviruses express soluble proteins (vCCI) that bind MCP-1 and other CC chemokines and inhibit their function. In order to define the interaction site of MCP-1 with vCCI from vaccinia, surface exposed residues of MCP-1 were identified and mutated to alanine. The MCP-1 variants were expressed, purified, and their interaction with vCCI was characterized. The site on MCP-1 for vCCI binding is dominated by arginine 18 with important additional contributions from tyrosine 13 and arginine 24. These residues define a binding site that largely overlaps with the CCR2B receptor interaction site. The viral chemokine-binding protein vCCI thus inhibits the biological function of MCP-1 by directly masking its CCR2B receptor-binding site.	Novartis Pharma AG, Dept Arthrit Biol, CH-4002 Basel, Switzerland	Novartis	Urfer, R (corresponding author), AGY Therapeut, 290 Utah Ave, San Francisco, CA 94080 USA.	roman@agyinc.com						Alcami A, 1998, J IMMUNOL, V160, P624; Beall CJ, 1996, BIOCHEM J, V313, P633, DOI 10.1042/bj3130633; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Chakravarty L, 1998, J BIOL CHEM, V273, P29641, DOI 10.1074/jbc.273.45.29641; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Davis-Smyth T, 1998, J BIOL CHEM, V273, P3216, DOI 10.1074/jbc.273.6.3216; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Lalani AS, 1997, J LEUKOCYTE BIOL, V62, P570, DOI 10.1002/jlb.62.5.570; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MARTINEZPOMARES L, 1995, VIROLOGY, V206, P591, DOI 10.1016/S0042-6822(95)80076-X; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; PATEL AH, 1990, J GEN VIROL, V71, P2013, DOI 10.1099/0022-1317-71-9-2013; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Steitz SA, 1998, FEBS LETT, V430, P158, DOI 10.1016/S0014-5793(98)00637-1; URFER R, 1994, EMBO J, V13, P5896, DOI 10.1002/j.1460-2075.1994.tb06935.x; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	39	44	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43270	43276		10.1074/jbc.M106305200	http://dx.doi.org/10.1074/jbc.M106305200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551937	hybrid			2022-12-27	WOS:000172169300083
J	Murphy, OJ; Yi, XH; Weis, RM; Thompson, LK				Murphy, OJ; Yi, XH; Weis, RM; Thompson, LK			Hydrogen exchange reveals a stable and expandable core within the aspartate receptor cytoplasmic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; DISULFIDE CROSS-LINKING; LIGAND-BINDING DOMAIN; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; SIGNAL-TRANSDUCTION; CONFORMATIONAL-CHANGES; COVALENT MODIFICATION; SERINE CHEMORECEPTOR; F-19 NMR	Intensive study of bacterial chemoreceptors has not yet revealed how receptor methylation and ligand binding alter the interactions between the receptor cytoplasmic domain and the CheA kinase to control kinase activity. Both monomeric and dimeric forms of an Asp receptor cytoplasmic fragment have been shown to be highly dynamic, with a small core of slowly exchanging amide hydrogens (Seeley, S. K., Weis, R. M., and Thompson, L. K. (1996) Biochemistry 35, 5199-5206). Hydrogen exchange studies of the wildtype cytoplasmic fragment and an S461L mutant thought to mimic the kinase-inactivating state are used to investigate the relationship between the stable core and dimer dissociation. Our results establish that (i) decreasing pH stabilizes the dimeric state, (ii) the stable core is present also in the transition state for dissociation, and (iii) this core is expanded significantly by small changes in electrostatic and hydrophobic interactions. These kinase-inactivating changes stabilize both the monomeric and the dimeric states of the protein, which has interesting implications for the mechanism of kinase activation. We conclude that the cytoplasmic domain is a flexible region poised for stabilization by small changes in electrostatic and hydrophobic interactions such as those caused by methylation of glutamate residues and by ligand-induced conformational changes during signaling.	Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Weis, RM (corresponding author), Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047601, R01GM053210, R29GM047601] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047601, GM47601, GM53210] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES P, 1988, CELL, V55, P817, DOI 10.1016/0092-8674(88)90137-7; Ames P, 1996, MOL MICROBIOL, V19, P737, DOI 10.1046/j.1365-2958.1996.408930.x; Amsler CD., 1995, 2 COMPONENT SIGNAL T, P89; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1994, PROTEINS, V20, P4, DOI 10.1002/prot.340200103; Bass RB, 1999, BIOCHEMISTRY-US, V38, P9317, DOI 10.1021/bi9908179; Bass RB, 1999, STRUCT FOLD DES, V7, P829, DOI 10.1016/S0969-2126(99)80106-3; Biemann HP, 1996, J BIOL CHEM, V271, P27927, DOI 10.1074/jbc.271.44.27927; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Bornhorst JA, 2000, BIOCHEMISTRY-US, V39, P9486, DOI 10.1021/bi0002737; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Clarke J, 1998, CURR OPIN STRUC BIOL, V8, P112, DOI 10.1016/S0959-440X(98)80018-3; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; DANIELSON MA, 1994, BIOCHEMISTRY-US, V33, P6100, DOI 10.1021/bi00186a009; Danielson MA, 1997, J BIOL CHEM, V272, P32878, DOI 10.1074/jbc.272.52.32878; Danielson MA, 1996, ANNU REV BIOPH BIOM, V25, P163, DOI 10.1146/annurev.bb.25.060196.001115; DUNTEN P, 1991, J BIOL CHEM, V266, P1491; Englander S W, 1978, Methods Enzymol, V49, P24; Englander S W, 1972, Methods Enzymol, V26, P406; ENGLANDER SW, 1963, BIOCHEMISTRY-US, V2, P798, DOI 10.1021/bi00904a030; ENGLANDER SW, 1969, BIOPOLYMERS, V7, P379, DOI 10.1002/bip.1969.360070309; ENGLANDER SW, 1984, Q REV BIOPHYS, V16, P521; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Hazelbauer GL, 1992, CURR OPIN STRUC BIOL, V2, P505; Hughson AG, 1996, P NATL ACAD SCI USA, V93, P11546, DOI 10.1073/pnas.93.21.11546; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jurica MS, 1998, STRUCT FOLD DES, V6, P809, DOI 10.1016/S0969-2126(98)00082-3; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; KRIKOS A, 1985, P NATL ACAD SCI USA, V82, P1326, DOI 10.1073/pnas.82.5.1326; KUWAJIMA K, 1976, J MOL BIOL, V106, P359, DOI 10.1016/0022-2836(76)90091-7; LeMoual H, 1997, BIOCHEMISTRY-US, V36, P13441, DOI 10.1021/bi9713207; Levit MN, 1998, MOL MICROBIOL, V30, P459, DOI 10.1046/j.1365-2958.1998.01066.x; Levit MN, 1999, BIOCHEMISTRY-US, V38, P6651, DOI 10.1021/bi982839l; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; LONG DG, 1992, BIOCHEMISTRY-US, V31, P9904, DOI 10.1021/bi00156a007; Manson MD, 1998, J BACTERIOL, V180, P1009, DOI 10.1128/JB.180.5.1009-1022.1998; MARUYAMA IN, 1995, J MOL BIOL, V253, P530, DOI 10.1006/jmbi.1995.0571; MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609; MILLIGAN DL, 1988, J BIOL CHEM, V263, P6268; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Murphy OJ, 2001, BIOCHEMISTRY-US, V40, P1358, DOI 10.1021/bi0015109; MUSKAVITCH MA, 1978, SCIENCE, V201, P63, DOI 10.1126/science.351803; MUTOH N, 1986, J BACTERIOL, V167, P992, DOI 10.1128/jb.167.3.992-998.1986; OOSAWA K, 1988, J BACTERIOL, V170, P2521, DOI 10.1128/jb.170.6.2521-2526.1988; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; Seeley SK, 1996, BIOCHEMISTRY-US, V35, P5199, DOI 10.1021/bi9524979; Seeley SK, 1996, BIOCHEMISTRY-US, V35, P16336, DOI 10.1021/bi961749i; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Stock J, 2000, CURR BIOL, V10, pR11, DOI 10.1016/S0960-9822(99)00248-1; Stock JB, 1996, ESCHERICHIA COLI SAL, P1103; Surette MG, 1996, J BIOL CHEM, V271, P17966, DOI 10.1074/jbc.271.30.17966; SwintKruse L, 1996, BIOCHEMISTRY-US, V35, P171, DOI 10.1021/bi9517603; Tatsuno I, 1996, SCIENCE, V274, P423, DOI 10.1126/science.274.5286.423; Trammell MA, 1999, BIOCHEMISTRY-US, V38, P329, DOI 10.1021/bi981964u; WOODWARD C, 1982, MOL CELL BIOCHEM, V48, P135, DOI 10.1007/BF00421225; WOODWARD CK, 1980, BIOPHYS J, V32, P561, DOI 10.1016/S0006-3495(80)84990-3; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; WU JR, 1995, BIOCHEMISTRY-US, V34, P3056, DOI 10.1021/bi00009a037; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507	66	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43262	43269		10.1074/jbc.M105585200	http://dx.doi.org/10.1074/jbc.M105585200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553619	hybrid			2022-12-27	WOS:000172169300082
J	Cai, YF; Singh, BB; Aslanukov, A; Zhao, HY; Ferreira, PA				Cai, YF; Singh, BB; Aslanukov, A; Zhao, HY; Ferreira, PA			The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; BOVINE BRAIN KINESIN; NUCLEAR-PORE COMPLEX; AXONAL-TRANSPORT; GTP HYDROLYSIS; EXPORT; IMPORT; MOTOR; EXPRESSION; REGULATOR	The Ran-binding protein 2 (RanBP2) is a vertebrate mosaic protein composed of four interspersed RanGTPase binding domains (RBDs), a variable and species-specific zinc finger cluster domain, leucine-rich, cyclophilin, and cyclophilin-like (CLD) domains. Functional mapping of RanBP2 showed that the domains, zinc finger and CLD, between RBD1 and RBD2, and RBD3 and RBD4, respectively, associate specifically with the nuclear export receptor, CRM1/exportin-1, and components of the 19 S regulatory particle of the 26 S proteasome. Now, we report the mapping of a novel RanBP2 domain located between RBD2 and RBD3, which is also conserved in the partially duplicated isoform RanBP2L1. Yet, this domain leads to the neuronal association of only RanBP2 with two kinesin microtubule-based motor proteins, KIF5B and KIF5C. These kinesins associate directly in vitro and in vivo with RanBP2. Moreover, the kinesin light chain and RanGTPase are part of this RanBP2 macroassembly complex. These data provide evidence of a specific docking site in RanBP2 for KIF5B and KIF5C. A model emerges whereby RanBP2 acts as a selective signal integrator of nuclear and cytoplasmic trafficking pathways in neurons.	Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Ferreira, PA (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ferreira@mcw.edu	Ferreira, Paulo/A-3893-2008; Ferreira, Paulo A/S-4209-2016	Ferreira, Paulo A/0000-0003-4585-1717; Singh, Brij/0000-0003-0535-5997	NATIONAL EYE INSTITUTE [R01EY011993, R01EY012665] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011993, EY11993, EY012665] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Adler R., 1986, RETINA MODEL CELL BI, P297; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; AMARATUNGA A, 1993, J BIOL CHEM, V268, P17427; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BostUsinger L, 1997, EXP EYE RES, V64, P781, DOI 10.1006/exer.1996.0271; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; BUTLER G, 1994, BBA-GENE STRUCT EXPR, V1219, P711, DOI 10.1016/0167-4781(94)90233-X; CHENG Y, 1995, SCIENCE, V267, P1807, DOI 10.1126/science.7534442; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; ELLURU RG, 1995, MOL BIOL CELL, V6, P21, DOI 10.1091/mbc.6.1.21; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Fauser S, 2001, MAMM GENOME, V12, P406, DOI 10.1007/s003350010291; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; Ferreira PA, 2000, METHOD ENZYMOL, V315, P455; Floer M, 1999, J BIOL CHEM, V274, P16279, DOI 10.1074/jbc.274.23.16279; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P4318, DOI 10.1073/pnas.92.10.4318; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nakielny S, 1998, CURR BIOL, V8, P89, DOI 10.1016/S0960-9822(98)70039-9; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; Nothwang HG, 1998, GENOMICS, V47, P383, DOI 10.1006/geno.1997.5119; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; REN MD, 1995, MOL CELL BIOL, V15, P2117; Ribbeck K, 1999, CURR BIOL, V9, P47, DOI 10.1016/S0960-9822(99)80046-3; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schwoebel ED, 1998, J BIOL CHEM, V273, P35170, DOI 10.1074/jbc.273.52.35170; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	77	76	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41594	41602		10.1074/jbc.M104514200	http://dx.doi.org/10.1074/jbc.M104514200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553612	hybrid			2022-12-27	WOS:000172450400010
J	Lowen, M; Scott, G; Zwollo, P				Lowen, M; Scott, G; Zwollo, P			Functional analyses of two alternative isoforms of the transcription factor Pax-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DIFFERENTIATION; DNA-BINDING ACTIVITY; NF-KAPPA-B; PAIRED DOMAIN; FACTOR BSAP; NUCLEAR TRANSLOCATION; DIRECT ASSOCIATION; ACTIVATOR PROTEIN; 3'ALPHA ENHANCER; REDOX REGULATION	The Pax-5 gene plays a central role in B cell development, activation, and differentiation. At least four different isoforms have been identified, of which isoform Pax-5a has been extensively studied, while functions for alternative isoforms were previously unknown. Here, using a transient transfection system, we provide evidence that alternative isoform Pax-5d acts as a dominant-negative regulator by suppressing activity of Pax-5a in a dose-dependent manner. In contrast, co-expression in the presence of alternative isoform Pax-5e causes an increase in Pax-5a activity. Protein studies on Pax-5e using Western blot analysis revealed that this 19-kDa isoform migrates as a 27-kDa species on SDS-polyacrylamide electrophoresis gels, while a mutant Pax-5e form in which a C-terminal cysteine residue has been mutated, runs at the expected 19 kDa. Using both Western blot and immunoprecipitation assays, we further provide evidence that this size discrepancy may be caused by a tight association between Pax-5e and a thioredoxin-like factor. Comparison of various B cell lines as well as resting and lipopolysaccharide-activated mature B lymphocytes shows that increased B cell proliferation correlates with increased levels of Pax-5e/thioredoxin, whereas increased Pax-5d amounts correlate with inhibition of cell growth. Together, our results suggest that during activation and differentiation of B lymphocytes, Pax-5a function is modulated by two alternative spliced isoforms: the dominant negative Pax-5d isoform may mediate inhibition of Pax-5a activity in resting B cells, while alternative isoform Pax-5e associated with thioredoxin may increase Pax-5a activity through an unknown (redox) mechanism.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	William & Mary	Zwollo, P (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.							Albracht SPJ, 2000, FEBS LETT, V485, P1, DOI 10.1016/S0014-5793(00)02172-4; Anspach J, 2001, J IMMUNOL, V166, P2617, DOI 10.4049/jimmunol.166.4.2617; ASANO M, 1992, MECH DEVELOP, V39, P29, DOI 10.1016/0925-4773(92)90023-D; BABERIS A, 1990, GENE DEV, V22, P37; COLIGAN JE, 1998, CURRENT PROTOCOLS IM, V2; Crow MK, 2001, BIOTECHNIQUES, V30, P311, DOI 10.2144/01302st04; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; ERICSON ML, 1992, LYMPHOKINE CYTOK RES, V11, P201; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; Hagman J, 2000, CURR TOP MICROBIOL, V245, P169; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; KAMBE F, 1996, MOL ENDOCRINOL, V10, P810; Khayat M, 2001, J IMMUNOL, V166, P2937, DOI 10.4049/jimmunol.166.5.2937; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Liberg D, 1999, CRIT REV IMMUNOL, V19, P127; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; NEURATH MF, 1994, J IMMUNOL, V153, P730; Nilsson J, 2000, BLOOD, V95, P1420, DOI 10.1182/blood.V95.4.1420.004k12_1420_1426; ORR MD, 1966, BIOCHEM BIOPH RES CO, V25, P109, DOI 10.1016/0006-291X(66)90647-4; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Reya T, 1998, CURR OPIN IMMUNOL, V10, P158, DOI 10.1016/S0952-7915(98)80244-6; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Tavassoli K, 1997, HUM GENET, V101, P371, DOI 10.1007/s004390050644; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Tell G, 1998, J BIOL CHEM, V273, P25062, DOI 10.1074/jbc.273.39.25062; TRANBETCKE A, 1990, J BACTERIOL, V172, P2920, DOI 10.1128/jb.172.6.2920-2929.1990; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vogan KJ, 1996, MOL CELL BIOL, V16, P6677; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; WAKATSUKI Y, 1994, J EXP MED, V179, P1099, DOI 10.1084/jem.179.4.1099; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; Wallin JJ, 1999, J BIOL CHEM, V274, P15959, DOI 10.1074/jbc.274.22.15959; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; Wei SJ, 2000, CANCER RES, V60, P6688; ZWOLLO P, 1994, J BIOL CHEM, V269, P15310; Zwollo P, 1998, J BIOL CHEM, V273, P18647, DOI 10.1074/jbc.273.29.18647; Zwollo P, 1997, J BIOL CHEM, V272, P10160, DOI 10.1074/jbc.272.15.10160	49	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42565	42574		10.1074/jbc.M106536200	http://dx.doi.org/10.1074/jbc.M106536200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535600	hybrid			2022-12-27	WOS:000172450400132
J	Sweet, DH; Miller, DS; Pritchard, JB				Sweet, DH; Miller, DS; Pritchard, JB			Ventricular choline transport - A role for organic cation transporter 2 expressed in choroid plexus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOLATERAL MEMBRANE-VESICLES; TISSUE DISTRIBUTION PATTERN; FUNCTIONAL-CHARACTERISTICS; RAT-KIDNEY; ANION TRANSPORTER; PROXIMAL TUBULES; APICAL MEMBRANE; BRAIN; CLONING; LOCALIZATION	To determine whether organic cation transporter (OCT) family members might mediate choline transport in choroid plexus (CP), the handling of choline by cloned transporters and by intact CP isolated from the adult rat was investigated. Expression of OCT1 and OCT2 in Xenopus oocytes increased hemicholinium-3-sensitive choline uptake. In contrast, OCT3 did not mediate choline transport. Estimated K-m values for choline in rOCT1-, rOCT2-, and hOCT2-expressing oocytes were 346 +/- 50, 441 +/- 67, and 102 +/- 80 mum, respectively. Membrane potential was the major driving force for choline uptake in rat and human OCT2-expressing oocytes and in intact CP in vitro. Lowering of medium pH (6 versus 7.4) was equally effective at inhibiting choline uptake in CP, suggesting that there might be a non-OCT component of choline uptake that is responsive to an H+ gradient. However, choline efflux from CP was not stimulated by a trans-applied H+ gradient. Choline uptake by CP was Na+-independent with an estimated K-m of 183 mum. Reverse transcriptase-polymerase chain reaction detected OCT2 and OCT3, but not OCT1, mRNA expression in CP. Transfection of intact CP with a rOCT2/green fluorescent protein fusion construct resulted in strong apical membrane fluorescence with no detectable signal in the basal and lateral plasma membranes. These data indicate that OCT2 mediates choline transport across the ventricular membrane of CP.	NIEHS, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sweet, DH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Sweet, Douglas H/H-7914-2013	Sweet, Douglas H/0000-0002-8911-9184	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080048, ZIAES080048, Z01ES048014, Z01ES080054] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AQUILONIUS SM, 1972, ACTA PHYSIOL SCAND, V85, P78, DOI 10.1111/j.1748-1716.1972.tb05237.x; Arndt P, 2001, AM J PHYSIOL-RENAL, V281, pF454, DOI 10.1152/ajprenal.2001.281.3.F454; BRODIE BB, 1960, J PHARMACOL EXP THER, V130, P20; Budiman T, 2000, J BIOL CHEM, V275, P29413, DOI 10.1074/jbc.M004645200; Busch AE, 1996, J BIOL CHEM, V271, P32599, DOI 10.1074/jbc.271.51.32599; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; CORNFORD EM, 1978, J NEUROCHEM, V30, P299, DOI 10.1111/j.1471-4159.1978.tb06530.x; CREWS FT, 1980, J NEUROCHEM, V34, P1491, DOI 10.1111/j.1471-4159.1980.tb11229.x; Dudley AJ, 2000, BRIT J PHARMACOL, V131, P71, DOI 10.1038/sj.bjp.0703518; EHRLICH BE, 1982, BRAIN RES, V250, P245, DOI 10.1016/0006-8993(82)90418-8; Erb C, 1999, BIOCHEM PHARMACOL, V57, P681, DOI 10.1016/S0006-2952(98)00338-4; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Grundemann D, 1997, J BIOL CHEM, V272, P10408; Grundemann D, 1999, MOL PHARMACOL, V56, P1, DOI 10.1124/mol.56.1.1; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; HAMEL E, 1990, BRAIN RES, V516, P301, DOI 10.1016/0006-8993(90)90931-Z; HAPPE HK, 1993, J NEUROCHEM, V60, P1191, DOI 10.1111/j.1471-4159.1993.tb03277.x; HEDIGER MA, 1995, J PHYSL, V482, P7; Jenden D J, 1990, Adv Neurol, V51, P131; JOPE RS, 1979, BRAIN RES REV, V1, P313, DOI 10.1016/0165-0173(79)90009-2; Karbach U, 2000, AM J PHYSIOL-RENAL, V279, pF679, DOI 10.1152/ajprenal.2000.279.4.F679; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; KLEIN J, 1993, NEUROCHEM INT, V22, P293, DOI 10.1016/0197-0186(93)90058-D; Koepsell H, 1999, J MEMBRANE BIOL, V167, P103, DOI 10.1007/s002329900475; KOPPEN A, 1993, J PHARMACOL EXP THER, V266, P720; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; LANMAN RC, 1980, J PHARMACOL EXP THER, V215, P563; LINDVALLAXELSSON M, 1989, EXP BRAIN RES, V77, P605; MALSTROM K, 1987, BIOCHIM BIOPHYS ACTA, V902, P269, DOI 10.1016/0005-2736(87)90305-1; Murakami H, 2000, PHARMACEUT RES, V17, P1526, DOI 10.1023/A:1007613326759; Okuda M, 1996, BIOCHEM BIOPH RES CO, V224, P500, DOI 10.1006/bbrc.1996.1056; Pritchard JB, 1999, J BIOL CHEM, V274, P33382, DOI 10.1074/jbc.274.47.33382; PRITCHARD JB, 1988, AM J PHYSIOL, V255, pF597, DOI 10.1152/ajprenal.1988.255.4.F597; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; Rapoport SI, 1976, BLOOD BRAIN BARRIER; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Sawada N, 1999, J PHARM PHARMACOL, V51, P847, DOI 10.1211/0022357991773050; Schweifer N, 1996, MAMM GENOME, V7, P735, DOI 10.1007/s003359900223; Segal M., 1998, INTRO BLOOD BRAIN BA, P251; SHIMADA H, 1987, AM J PHYSIOL, V253, pF795, DOI 10.1152/ajprenal.1987.253.5.F795; SPECTOR R, 1979, J NEUROCHEM, V33, P291, DOI 10.1111/j.1471-4159.1979.tb11731.x; SPECTOR R, 1979, J NEUROCHEM, V33, P895, DOI 10.1111/j.1471-4159.1979.tb09919.x; Sweet D. H., 1997, FASEB Journal, V11, pA278; Sweet DH, 1999, AM J PHYSIOL-RENAL, V277, pF890, DOI 10.1152/ajprenal.1999.277.6.F890; Sweet DH, 2000, AM J PHYSIOL-RENAL, V279, pF826, DOI 10.1152/ajprenal.2000.279.5.F826; Sweet DH, 1999, AM J PHYSIOL-RENAL, V276, pF864, DOI 10.1152/ajprenal.1999.276.6.F864; Sweet DH, 1999, CELL BIOCHEM BIOPHYS, V31, P89, DOI 10.1007/BF02738157; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Terashita S, 1998, BBA-BIOMEMBRANES, V1369, P1, DOI 10.1016/S0005-2736(97)00207-1; Urakami Y, 1998, J PHARMACOL EXP THER, V287, P800; Uwai Y, 2000, EUR J PHARMACOL, V409, P31, DOI 10.1016/S0014-2999(00)00837-2; Vargas HM, 1996, LIFE SCI, V58, P1995, DOI 10.1016/0024-3205(96)00190-7; Villalobos AR, 1999, AM J PHYSIOL-CELL PH, V276, pC1288, DOI 10.1152/ajpcell.1999.276.6.C1288; Walsh R. C., 1996, FASEB Journal, V10, pA127; Wu X, 2000, BBA-BIOMEMBRANES, V1466, P315, DOI 10.1016/S0005-2736(00)00189-9; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Wu X, 1998, FASEB J, V12, pA1042; Wu X, 1998, J BIOL CHEM, V273, P32776, DOI 10.1074/jbc.273.49.32776; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482; Wu XA, 2000, AM J PHYSIOL-RENAL, V279, pF449, DOI 10.1152/ajprenal.2000.279.3.F449; Yabuuchi H, 1999, J PHARMACOL EXP THER, V289, P768; YAMAMURA HI, 1973, J NEUROCHEM, V21, P1355, DOI 10.1111/j.1471-4159.1973.tb06022.x; Zhang L, 1997, MOL PHARMACOL, V51, P913, DOI 10.1124/mol.51.6.913; Zhang L, 1998, ANNU REV PHARMACOL, V38, P431, DOI 10.1146/annurev.pharmtox.38.1.431	67	118	120	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41611	41619		10.1074/jbc.M108472200	http://dx.doi.org/10.1074/jbc.M108472200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553644	hybrid			2022-12-27	WOS:000172450400012
J	Youn, H; Kerby, RL; Thorsteinsson, MV; Conrad, M; Staples, CR; Serate, J; Beack, J; Roberts, GP				Youn, H; Kerby, RL; Thorsteinsson, MV; Conrad, M; Staples, CR; Serate, J; Beack, J; Roberts, GP			The heme pocket afforded by Gly(117) is crucial for proper heme ligation and activity of CooA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING TRANSCRIPTIONAL ACTIVATOR; ELECTRON-PARAMAGNETIC-RESONANCE; CAMP RECEPTOR PROTEIN; NITRIC-OXIDE SYNTHASE; RHODOSPIRILLUM-RUBRUM; BINDING; LIGAND; DNA; SPECTROSCOPY; HEMOPROTEIN	CooA, a CO-sensing homodimeric transcription activator from Rhodospirillum rubrum, undergoes a conformational change in response to CO binding to its heme prosthetic group that allows it to bind specific DNA sequences. In a recent structural study (Lanzilotta, W. N., Schuller, D. J., Thorsteinsson, M. V., Kerby, R. L., Roberts, G. P., and Poulos, T. L. (2000) Nat. Struct. Biol. 7, 876-880), it was suggested that CO binding to CooA results in a modest repositioning of the C-helices that serve as the dimer interface. Gly(117) is one of the residues on the C-helix within 7 Angstrom of the heme iron on the Pro(2) side of the heme in CooA. Analysis of a series of Gly(117) variants revealed altered CO-sensing function and heme ligation states dependent on the size of the substituted amino acid at this position; bulky substitutions perturbed CooA both spectrally and functionally. A combination of spectroscopic and mutagenic studies showed that a representative Gly(117) variant, G117I CooA, was specifically perturbed in its Pro(2) ligation in both Fe(III) and Fe(II) forms, but comparison with other CooA variants indicated that perturbation of Pro(2) ligation is not the basis for the lack of CO response in G117I CooA. These results have led to the hypothesis that (i) the heme and the C-helix region move toward each other following CO binding and the interaction of the heme with the C-helix is crucial for CooA activation, and (ii) this event occurs only when a properly sized heme pocket is afforded.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Roberts, GP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.				NIGMS NIH HHS [GM53228] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053228] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Ausubel F. M., 1995, SHORT PROTOCOLS MOL, P21; Baichoo N, 1997, BIOCHEMISTRY-US, V36, P10830, DOI 10.1021/bi970714v; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; DEDUVE C, 1948, ACTA CHEM SCAND, V2, P264, DOI 10.3891/acta.chem.scand.02-0264; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; He YP, 1999, J BIOL CHEM, V274, P10840, DOI 10.1074/jbc.274.16.10840; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; IGNARRO LJ, 1991, BIOCHEM PHARMACOL, V41, P485, DOI 10.1016/0006-2952(91)90618-F; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Lukat-Rodgers GS, 1998, BIOCHEMISTRY-US, V37, P13543, DOI 10.1021/bi981439v; LukatRodgers GS, 1997, BIOCHEMISTRY-US, V36, P4178, DOI 10.1021/bi9628230; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Nakajima H, 2001, J BIOL CHEM, V276, P7055, DOI 10.1074/jbc.M003972200; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Reynolds MF, 1998, J AM CHEM SOC, V120, P9080, DOI 10.1021/ja981146p; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Stone JR, 1996, BIOCHEMISTRY-US, V35, P3258, DOI 10.1021/bi952386+; TANG SC, 1976, J AM CHEM SOC, V98, P2414, DOI 10.1021/ja00425a008; Thorsteinsson MV, 2000, BIOCHEMISTRY-US, V39, P8284, DOI 10.1021/bi000327c; Thorsteinsson MV, 2001, J BIOL CHEM, V276, P26807, DOI 10.1074/jbc.M102758200; Thorsteinsson MV, 2000, J BIOL CHEM, V275, P39332, DOI 10.1074/jbc.M007691200; Tsai AL, 1996, J BIOL CHEM, V271, P32563, DOI 10.1074/jbc.271.51.32563; Won HS, 2000, BIOCHEMISTRY-US, V39, P13953, DOI 10.1021/bi000012x; Yamamoto K, 2001, J BIOL CHEM, V276, P11473, DOI 10.1074/jbc.C100047200; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	35	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41603	41610		10.1074/jbc.M106165200	http://dx.doi.org/10.1074/jbc.M106165200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551932	hybrid			2022-12-27	WOS:000172450400011
J	Fagioli, C; Mezghrani, A; Sitia, R				Fagioli, C; Mezghrani, A; Sitia, R			Reduction of interchain disulfide bonds precedes the dislocation of Ig-mu chains from the endoplasmic reticulum to the cytosol for proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-MEDIATED RETENTION; ER QUALITY-CONTROL; PROTEIN TRANSLOCATION; LIGHT-CHAINS; B-CELLS; RAPID DEGRADATION; SECRETORY PATHWAY; IMMUNOGLOBULIN; MEMBRANE; RETROTRANSLOCATION	Proteins that fail to fold or assemble in the endoplasmic reticulum (ER) are generally dislocated across the membrane to be degraded by cytosolic proteasomes. To investigate how the quality control machinery handles individual subunits that are part of covalent oligomers, we have analyzed the fate of transport-competent Ig light (L) chains that form disulfide bonds with short-lived a heavy chains. When expressed alone, L chains are secreted. In cells producing excess mu, most L chains are retained in the ER as covalent mu .L or mu (2).L-2 complexes. While ft chains present in these complexes are degraded by proteasomes, L chains are stable. Few L chains are secreted; most reassociate with newly synthesized mu chains. Therefore, interchain disulfide bonds are reduced in the ER lumen before the dislocation of fl chains in a site from which freed L chains can be rapidly reinserted in the assembly line. The ER can thus sustain the simultaneous formation and reduction of disulfide bonds.	San Raffaele Sci Inst, Dept Mol Pathol Med, I-21032 Milan, Italy; Univ Vita Salute San Raffaele, I-21032 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Sitia, R (corresponding author), San Raffaele Sci Inst, Dept Mol Pathol Med, I-21032 Milan, Italy.		Fagioli, Claudio/AAN-4147-2020; Sitia, Roberto/AAB-5005-2019	Fagioli, Claudio/0000-0001-9889-4695; Sitia, Roberto/0000-0001-7086-4152				Bader M, 1999, NAT CELL BIOL, V1, pE57, DOI 10.1038/11025; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; Brewer JW, 1997, MOL IMMUNOL, V34, P323, DOI 10.1016/S0161-5890(97)00029-1; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Carelli S, 1997, EUR J IMMUNOL, V27, P1283, DOI 10.1002/eji.1830270533; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; FRA AM, 1993, EMBO J, V12, P4755, DOI 10.1002/j.1460-2075.1993.tb06164.x; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; GARDNER AM, 1993, J BIOL CHEM, V268, P25940; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; GUENZI S, 1994, EUR J IMMUNOL, V24, P2477, DOI 10.1002/eji.1830241033; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; Ho SC, 2000, J IMMUNOL, V164, P4713, DOI 10.4049/jimmunol.164.9.4713; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Johnson AE, 2000, CELL, V102, P709, DOI 10.1016/S0092-8674(00)00059-3; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; KEHRY M, 1980, CELL, V21, P393, DOI 10.1016/0092-8674(80)90476-6; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Mancini R, 2000, FASEB J, V14, P769, DOI 10.1096/fasebj.14.5.769; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; NEUBERGER MS, 1993, IMMUNOL REV, V132, P147, DOI 10.1111/j.1600-065X.1993.tb00841.x; O'Hare T, 1999, J IMMUNOL, V163, P11; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; RABINOVICH E, 1993, J BIOL CHEM, V268, P24145; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; Reddy PS, 1999, IMMUNOL TODAY, V20, P582, DOI 10.1016/S0167-5699(99)01542-X; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Romisch K, 1999, J CELL SCI, V112, P4185; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SIDMAN C, 1981, CELL, V23, P379, DOI 10.1016/0092-8674(81)90133-1; SITIA R, 1987, EMBO J, V6, P3969, DOI 10.1002/j.1460-2075.1987.tb02739.x; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; VALETTI C, 1994, MOL BIOL CELL, V5, P1311, DOI 10.1091/mbc.5.12.1311; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; Winitz D, 1996, J BIOL CHEM, V271, P27645, DOI 10.1074/jbc.271.44.27645	45	67	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40962	40967		10.1074/jbc.M107456200	http://dx.doi.org/10.1074/jbc.M107456200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533039	hybrid			2022-12-27	WOS:000171925600079
J	Xu, JG; Paquet, M; Lau, AG; Wood, JD; Ross, CA; Hall, RA				Xu, JG; Paquet, M; Lau, AG; Wood, JD; Ross, CA; Hall, RA			beta(1)-Adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2) - Differential regulation of receptor internalization by MAGI-2 and PSD-95.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; D-ASPARTATE RECEPTORS; LONG-TERM POTENTIATION; HIPPOCAMPAL CA1 REGION; BETA(2)-ADRENERGIC RECEPTOR; PDZ-DOMAIN; POSTSYNAPTIC DENSITY; BETA-2-ADRENERGIC RECEPTORS; BETA-1-ADRENERGIC RECEPTOR; TUMOR-SUPPRESSOR	The beta (1)-adrenergic receptor (beta (1)AR) is known to be localized to synapses and to modulate synaptic plasticity in many brain regions, but the molecular mechanisms determining beta (1)AR subcellular localization are not fully understood. Using overlay and pull-down techniques, we found that the beta (1)AR carboxyl terminus associates with MAGI-2 (membrane-associated guanylate kinase inverted-2), a protein also known as S-SCAM (synaptic scaffolding molecule). MAGI-2 is a multidomain scaffolding protein that contains nine potential protein-protein interaction modules, including 6 PDZ domains, 2 WW domains, and a guanylate kinase-like domain. The beta (1)AR carboxyl terminus binds with high affinity to the first PDZ domain of MAGI-2, with the last few amino acids of the beta (1)AR carboxyl terminus being the key determinants of the interaction. In cells, the association of full-length beta (1)AR with MAGI-2 occurs constitutively and is enhanced by agonist stimulation of the receptor, as assessed by both co-immunoprecipitation experiments and immunofluorescence co-localization studies. Agonist-induced internalization of the beta (1)AR is markedly increased by co-expression with MAGI-2. Strikingly, this result is the opposite of the effect of co-expression with PSD-95, a previously reported binding partner of the beta (1)AR. Further cellular experiments revealed that MAGI-2 has no effect on beta (1)AR oligomerization but does promote association of beta (1)AR with the cytoplasmic signaling protein beta -catenin, a known MAGI-2 binding partner. These data reveal that MAGI-2 is a specific beta (1)AR binding partner that modulates beta (1)AR function and facilitates the physical association of the beta (1)AR with intracellular proteins involved in signal transduction and synaptic regulation.	Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr 5113, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA	Emory University; Johns Hopkins University	Hall, RA (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr 5113, 1510 Clifton Rd, Atlanta, GA 30322 USA.		Wood, Jonathan D/A-5060-2009	Hall, Randy/0000-0002-8318-8728	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034172] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM60982] Funding Source: Medline; NINDS NIH HHS [R01-NS34172] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; AOKI C, 1987, BRAIN RES, V437, P264, DOI 10.1016/0006-8993(87)91642-8; Bramham CR, 1997, NEUROREPORT, V8, P719, DOI 10.1097/00001756-199702100-00028; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; CASH R, 1986, BRAIN RES, V370, P127, DOI 10.1016/0006-8993(86)91112-1; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen AS, 1999, J NEUROPHYSIOL, V82, P3139, DOI 10.1152/jn.1999.82.6.3139; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2001, BIOCHEM BIOPH RES CO, V283, P969, DOI 10.1006/bbrc.2001.4880; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; FLEXNER JB, 1985, P NATL ACAD SCI USA, V82, P7458, DOI 10.1073/pnas.82.21.7458; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Fukaya M, 1999, NEUROSCI RES, V33, P111, DOI 10.1016/S0168-0102(98)00120-5; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GREEN SA, 1994, J BIOL CHEM, V269, P26215; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hebert TE, 1998, BIOCHEM J, V330, P287; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Ikegaya Y, 1997, NEUROREPORT, V8, P3143, DOI 10.1097/00001756-199709290-00027; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; MANTYH PW, 1995, J NEUROSCI, V15, P152; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mino A, 2000, GENES CELLS, V5, P1009, DOI 10.1046/j.1365-2443.2000.00385.x; Moody TD, 1998, BRAIN RES, V794, P75, DOI 10.1016/S0006-8993(98)00217-0; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; Nicholas AP, 1996, TRENDS PHARMACOL SCI, V17, P245, DOI 10.1016/S0165-6147(96)10022-5; NIELSON KA, 1994, BEHAV NEURAL BIOL, V62, P190, DOI 10.1016/S0163-1047(05)80017-2; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Patrie KM, 2001, J AM SOC NEPHROL, V12, P667, DOI 10.1681/ASN.V124667; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V247, P597, DOI 10.1006/bbrc.1998.8603; Steinberg SF, 1999, CIRC RES, V85, P1101; Steinberg SF, 2000, CIRC RES, V87, P1079, DOI 10.1161/01.RES.87.12.1079; STRADER CD, 1983, P NATL ACAD SCI-BIOL, V80, P1840, DOI 10.1073/pnas.80.7.1840; SUZUKI T, 1992, MOL PHARMACOL, V41, P542; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; van Stegeren AH, 1998, PSYCHOPHARMACOLOGY, V138, P305, DOI 10.1007/s002130050675; WAEBER C, 1991, SYNAPSE, V8, P270, DOI 10.1002/syn.890080405; Wang SJ, 1999, J NEUROSCI, V19, P570; Watanabe Y, 1996, NEUROSCIENCE, V71, P1031, DOI 10.1016/0306-4522(95)00498-X; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Xiao RP, 1999, CIRC RES, V85, P1092; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Zitzer H, 1999, J BIOL CHEM, V274, P18153, DOI 10.1074/jbc.274.26.18153	77	102	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41310	41317		10.1074/jbc.M107480200	http://dx.doi.org/10.1074/jbc.M107480200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526121	hybrid			2022-12-27	WOS:000171925600124
J	Zhong, XT; Malhotra, R; Woodruff, R; Guidotti, G				Zhong, XT; Malhotra, R; Woodruff, R; Guidotti, G			Mammalian plasma membrane ecto-nucleoside triphosphate diphosphohydrolase 1, CD39, is not active intracellularly - The N-glycosylation state of CD39 correlates with surface activity and localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ATP-DIPHOSPHOHYDROLASE; YEAST ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; PROTEIN TRANSLOCATION; QUATERNARY STRUCTURE; PLATELET-FUNCTION; GOLGI; APYRASE; GENE	CD39 is a member of the membrane-bound ecto-nucleoside triphosphate diphosphohydrolase family. The active site for native CD39 is located on the outer surface of the cellular plasma membrane; however, it is not yet known at what stage this enzyme becomes active along the secretory pathway to the plasma membrane. In this study, sucrose density fractionations performed on CD39-transfected COS-7 cell membranes suggest that CD39 activity resides primarily in the plasma membrane. Furthermore, we have created recombinant, soluble versions of CD39, one that is secreted and others that are retained in the endoplasmic reticulum, to demonstrate that CD39 is not active until it reaches the plasma membrane both in yeast and COS-7 cells. Moreover, the secreted active soluble CD39 in COS-7 cells is found to receive a higher degree of N-glycan addition than the inactive form retained intracellularly. When COS-7 cells were treated with tunicamycin to prevent N-glycosylation, soluble CD39 was not detected in the extracellular medium and remained inactive intracellularly. Surface biotinylation analysis also revealed that surface-expressed wild type CD39 receives a higher degree of N-glycosylation than intracellular forms and that inhibition of N-glycosylation prevents its plasma membrane localization. In addition, both intact and digitonin-permeablized COS-7 cells transfected with CD39 possess similar ecto-ATPase activities, further supporting the conclusion that only surface-expressed CD39 is enzymatically active. All of these data suggest that intracellular CD39 is inactive and that only a fully glycosylated CD39 has apyrase activity and is localized at the cell surface.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Guidotti, G (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.			Malhotra, Rajeev/0000-0003-0120-4630	NHLBI NIH HHS [HL08893] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; Ballensiefen W, 1997, EUR J BIOCHEM, V247, P142, DOI 10.1111/j.1432-1033.1997.00142.x; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; Brake AJ, 1996, ANNU REV CELL DEV BI, V12, P519, DOI 10.1146/annurev.cellbio.12.1.519; Coppi MV, 1997, ARCH BIOCHEM BIOPHYS, V346, P312, DOI 10.1006/abbi.1997.0332; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Esch JSA, 1999, BIOCHEMISTRY-US, V38, P2248, DOI 10.1021/bi982426k; Feraille E, 2000, MOL BIOL CELL, V11, P39, DOI 10.1091/mbc.11.1.39; Gao XD, 1999, J BIOL CHEM, V274, P21450, DOI 10.1074/jbc.274.30.21450; Gayle RB, 1998, J CLIN INVEST, V101, P1851, DOI 10.1172/JCI1753; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Grinthal A, 2000, BIOCHEMISTRY-US, V39, P9, DOI 10.1021/bi991751k; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hicks-Berger CA, 2000, J BIOL CHEM, V275, P34041, DOI 10.1074/jbc.M004723200; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Koziak K, 2000, J BIOL CHEM, V275, P2057, DOI 10.1074/jbc.275.3.2057; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Mateo J, 1999, BRIT J PHARMACOL, V128, P396, DOI 10.1038/sj.bjp.0702805; MAYINGER P, 1993, EMBO J, V12, P659, DOI 10.1002/j.1460-2075.1993.tb05699.x; MAYINGER P, 1995, J CELL BIOL, V131, P1377, DOI 10.1083/jcb.131.6.1377; MILLER JH, 1992, SHORT COURSE BACTERI, P439; Mulero JJ, 1999, J BIOL CHEM, V274, P20064, DOI 10.1074/jbc.274.29.20064; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PLESNER L, 1995, INT REV CYTOL, V158, P141; Puglielli L, 1999, J BIOL CHEM, V274, P12665, DOI 10.1074/jbc.274.18.12665; QUEMENEUR E, 1994, J BIOL CHEM, V269, P5485; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; Robson SC, 1997, BLOOD COAGUL FIBRIN, V8, P21, DOI 10.1097/00001721-199701000-00005; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sambrook J., 2002, MOL CLONING LAB MANU; SAROKIN L, 1984, MOL CELL BIOL, V4, P2750, DOI 10.1128/MCB.4.12.2750; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SHERMAN F, 1986, METHODS YEAST GENETI, P160; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Smith TM, 1999, BIOCHEMISTRY-US, V38, P1509, DOI 10.1021/bi9821768; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Wang TF, 1997, MOL BRAIN RES, V47, P295, DOI 10.1016/S0169-328X(97)00066-1; Wang TF, 1998, J BIOL CHEM, V273, P11392, DOI 10.1074/jbc.273.18.11392; Wang TF, 1998, J BIOL CHEM, V273, P24814, DOI 10.1074/jbc.273.38.24814; Wang TF, 1996, J BIOL CHEM, V271, P9898, DOI 10.1074/jbc.271.17.9898; Yeung G, 2000, BIOCHEMISTRY-US, V39, P12916, DOI 10.1021/bi000959z; Zhong XT, 1999, J BIOL CHEM, V274, P32704, DOI 10.1074/jbc.274.46.32704; Zhong XT, 2000, J BIOL CHEM, V275, P35592, DOI 10.1074/jbc.M006932200; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7; [No title captured]	58	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41518	41525		10.1074/jbc.M104415200	http://dx.doi.org/10.1074/jbc.M104415200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546800	hybrid, Green Published			2022-12-27	WOS:000171925600150
J	Zhu, K; Baudhuin, LM; Hong, GY; Williams, FS; Cristina, KL; Kabarowski, JHS; Witte, ON; Xu, Y				Zhu, K; Baudhuin, LM; Hong, GY; Williams, FS; Cristina, KL; Kabarowski, JHS; Witte, ON; Xu, Y			RETRACTED: Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. (Retracted Article. See vol 280, pg 43280, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							LOW-DENSITY-LIPOPROTEIN; SPHINGOSINE 1-PHOSPHATE; ACID; IDENTIFICATION; ACTIVATION; CELLS; LYSOPHOSPHOLIPIDS; ATHEROSCLEROSIS; TRANSDUCTION; FIBROBLASTS	Sphingosylphosphorylcholine (SPC) and lysophosphatidylcholine (LPC) are bioactive lipid molecules involved in numerous biological processes. We have recently identified ovarian cancer G protein-coupled receptor 1 (OGR1) as a specific and high affinity receptor for SPC, and G2A as a receptor with high affinity for LPC, but low affinity for SPC. Among G protein-coupled receptors, GPR4 shares highest sequence homology with OGR1 (51%). In this work, we have identified GPR4 as not only another high affinity receptor for SPC, but also a receptor for LPC, albeit of lower affinity. Both SPC and LPC induce increases in intracellular calcium concentration in GPR4-, but not vector-transfected MCF10A cells. These effects are insensitive to treatment with BN52021, WEB-2170, and WEB-2086 (specific platelet activating factor (PAF) receptor antagonists), suggesting that they are not mediated through an endogenous PAF receptor. SPC and LPC bind to GPR4 in GPR4-transfected CHO cells with K-d/SPC = 36 nM, and K-d/LPC = 159 nM, respectively. Competitive binding is elicited only by SPC and LPC. Both SPC and LPC activate GPR4-dependent activation of serum response element reporter and receptor internalization. Swiss 3T3 cells expressing GPR4 respond to both SPC and LPC, but not sphingosine 1-phosphate (SIP), PAF, psychosine (Psy), glucosyl-beta1'1-sphingosine (Glu-Sph), galactosyl-beta1'1-ceramide (GalCer), or lactosyl-beta1'1-ceramide (Lac-Cer) to activate extracellular signal-regulated kinase mitogen-activated protein kinase in a concentration- and time-dependent manner. SPC and LPC stimulate DNA synthesis in GPR4-expressing Swiss 3T3 cells. Both extracellular signal-regulated kinase activation and DNA synthesis stimulated by SPC and LPC are pertussis toxin-sensitive, suggesting the involvement of a G(i)-heterotrimeric G protein. In addition, GPR4 expression confers chemotactic responses to both SPC and LPC in Swiss 3T3 cells. Taken together, our data indicate that GPR4 is a receptor with high affinity to SPC and low affinity to LPC, and that multiple cellular functions can be transduced via this receptor.	Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Obstet & Gynecol, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Xu, Y (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	xuy@ccf.org			NATIONAL CANCER INSTITUTE [R01CA076204, R21CA084038] Funding Source: NIH RePORTER; NCI NIH HHS [CA76204, R21 CA84038-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AN SZ, 1995, FEBS LETT, V375, P121, DOI 10.1016/0014-5793(95)01196-L; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1999, MOL PHARMACOL, V55, P787; Bohm SK, 1997, BIOCHEM J, V322, P1; Carson MJ, 2001, SCIENCE, V293, P618, DOI 10.1126/science.1063516; CHISOLM G, 1996, OXIDIZED LIPOPROTEIN; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1697, DOI 10.1016/S0891-5849(00)00227-6; Choi JW, 1996, CELL IMMUNOL, V168, P78, DOI 10.1006/cimm.1996.0051; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; DESAI NN, 1993, J CELL BIOL, V121, P1385, DOI 10.1083/jcb.121.6.1385; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Gomez-Munoz A, 1999, J LIPID RES, V40, P988; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Hirayama T, 1998, HYPERTENS RES-CLIN E, V21, P137, DOI 10.1291/hypres.21.137; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Im DS, 2001, J CELL BIOL, V153, P429, DOI 10.1083/jcb.153.2.429; JALINK K, 1990, J BIOL CHEM, V265, P12232; Kabarowski JHS, 2000, P NATL ACAD SCI USA, V97, P12109, DOI 10.1073/pnas.97.22.12109; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kohno M, 1998, CIRCULATION, V98, P353, DOI 10.1161/01.CIR.98.4.353; Kyaw H, 1998, DNA CELL BIOL, V17, P493, DOI 10.1089/dna.1998.17.493; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAHADEVAN MS, 1995, GENOMICS, V30, P84, DOI 10.1006/geno.1995.0013; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; MOCHIZUKI M, 1983, CURR EYE RES, V2, P621, DOI 10.3109/02713688208996363; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy AA, 1998, J CLIN ENDOCR METAB, V83, P2110, DOI 10.1210/jc.83.6.2110; Murugesan G, 1996, J CLIN INVEST, V97, P2736, DOI 10.1172/JCI118728; Ogita T, 1997, AM J PHYSIOL-HEART C, V272, pH17, DOI 10.1152/ajpheart.1997.272.1.H17; Okajima F, 1998, BIOCHEM J, V336, P491, DOI 10.1042/bj3360491; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; Prokazova NV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P31; Sasagawa T, 1998, J NUTR SCI VITAMINOL, V44, P809, DOI 10.3177/jnsv.44.809; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; Xu Y, 1996, GENOMICS, V35, P397, DOI 10.1006/geno.1996.0377; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Yokota T, 1995, J INTERN MED, V238, P479, DOI 10.1111/j.1365-2796.1995.tb01229.x	41	196	217	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41325	41335		10.1074/jbc.M008057200	http://dx.doi.org/10.1074/jbc.M008057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11535583	hybrid			2022-12-27	WOS:000171925600126
J	Levine, A; Belenghi, B; Damari-Weisler, H; Granot, D				Levine, A; Belenghi, B; Damari-Weisler, H; Granot, D			Vesicle-associated membrane protein of Arabidopsis suppresses Bax-induced apoptosis in yeast downstream of oxidative burst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DISEASE RESISTANCE RESPONSE; VESICULAR TRANSPORT; SUSPENSION-CULTURES; MEDIATED APOPTOSIS; THALIANA CDNAS; PLANTS; FUSION; TRANSCRIPTION; INVOLVEMENT	Programmed cell death (PCD) in many systems is controlled by relative amounts of the apoptosis-regulating proteins Bax and Bcl-2 through homo- or heterodimerization. Here we show that Bax-induced PCD of yeast was suppressed by transformation with a vesicle-associated membrane protein from Arabidopsis (AtVAMP), which was isolated by screening a cDNA expression library against sugar-induced cell death in yeast. AtVAMP expression blocked Bax-induced PCD downstream of oxidative burst. AtVAMP also prevented H2O2-induced apoptosis in yeast and in Arabidopsis cells. Reduced oxidation of lipids and plasma membrane proteins was detected in the AtVAMP-transformed yeast, suggesting improved membrane repair. Inhibition of intracellular vesicle trafficking by brefeldin A induced apoptosis from a sublethal concentration of H2O2. No protection occurred by overexpression of the yeast homolog SCN2. However, efficient suppression of yeast PCD occurred by expression of a chimeric gene, composed of the conserved domains from yeast, fused to the variable N-terminal domain from Arabidopsis, resulting in exchange of the proline-rich N-terminal domain of SCN2 with a proline-poor Arabidopsis sequence. Our results suggest that intracellular vesicle traffic can regulate execution of apoptosis by affecting the rate of membrane recycling and that the proline-rich N-terminal domain of VAMP inhibited this process.	Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel; Agr Res Org, Volcani Ctr, Inst Field & Garden Crops, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Levine, A (corresponding author), Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel.							Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Amor Y, 1998, FEBS LETT, V440, P1, DOI 10.1016/S0014-5793(98)01408-2; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Clement MV, 1999, FREE RADICAL RES, V30, P247, DOI 10.1080/10715769900300271; Coco S, 1999, J NEUROSCI, V19, P9803; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Cosulich SC, 1997, EMBO J, V16, P6182, DOI 10.1093/emboj/16.20.6182; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Frohlich KU, 2000, FEBS LETT, V473, P6, DOI 10.1016/S0014-5793(00)01474-5; Gerst JE, 1997, J BIOL CHEM, V272, P16591, DOI 10.1074/jbc.272.26.16591; Granot D, 1997, CELL DEATH DIFFER, V4, P555, DOI 10.1038/sj.cdd.4400280; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; HUG H, 1994, FEBS LETT, V351, P311, DOI 10.1016/0014-5793(94)00852-3; Jayadev S, 1999, J BIOL CHEM, V274, P8261, DOI 10.1074/jbc.274.12.8261; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; Krausgrill S, 1998, PLANT J, V13, P275, DOI 10.1046/j.1365-313X.1998.00026.x; KUSHNIR S, 1995, P NATL ACAD SCI USA, V92, P10580, DOI 10.1073/pnas.92.23.10580; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Long AR, 1998, MECH DEVELOP, V76, P33, DOI 10.1016/S0925-4773(98)00110-5; Machleidt T, 1998, FEBS LETT, V436, P51, DOI 10.1016/S0014-5793(98)01095-3; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; MAY MJ, 1993, PLANT PHYSIOL, V103, P621, DOI 10.1104/pp.103.2.621; MINET M, 1992, PLANT J, V2, P417; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Ryerson DE, 1996, TRENDS PLANT SCI, V1, P212; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Swanton E, 1999, J BIOL CHEM, V274, P37583, DOI 10.1074/jbc.274.53.37583; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559	49	66	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46284	46289		10.1074/jbc.M107375200	http://dx.doi.org/10.1074/jbc.M107375200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551960	hybrid			2022-12-27	WOS:000172573100108
J	Kamata, T; Tieu, KK; Irie, A; Springer, TA; Takada, Y				Kamata, T; Tieu, KK; Irie, A; Springer, TA; Takada, Y			Amino acid residues in the alpha(IIb) subunit that are critical for ligand binding to integrin alpha(IIb)beta(3) are clustered in the beta-propeller model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET GLYCOPROTEIN-IIB; GPIIB-IIIA; MONOCLONAL-ANTIBODY; GLANZMANN THROMBASTHENIA; FIBRINOGEN BINDING; IIB/IIIA COMPLEX; DOMAIN; SITE; SEQUENCE; RECEPTOR	Several distinct regions of the integrin am, subunit have been implicated in ligand binding. To localize the ligand binding sites in alpha (IIb), we swapped all 27 predicted loops with the corresponding sequences of alpha (4) or alpha (5). 19 of the 27 swapping mutations had no effect on binding to both fibrinogen and ligand-mimetic antibodies (e.g. LJ-CP3), suggesting that these regions do not contain major ligand binding sites. In contrast, swapping the remaining 8 predicted loops completely blocked ligand binding. Ala scanning mutagenesis of these critical predicted loops identified more than 30 discontinuous residues in repeats 2-4 and at the boundary between repeats 4 and 5 as critical for ligand binding. Interestingly, these residues are clustered in the predicted beta -propeller model consistent with this model. Most of the critical residues are located at the edge of the upper face of the propeller, and several critical residues are located on the side of the propeller domain. None of the predicted loops in repeats 1, 6, and 7, and none of the four putative Ca2+ binding predicted loops on the lower surface of the beta -propeller were important for ligand binding. The results map an important ligand binding interface at the edge of the top and on the side of the beta -propeller toroid, centering on repeat 3.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA	Scripps Research Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Kamata, T (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kamata@sc.itc.keio.ac.jp; takada@scripps.edu		takada, yoshikazu/0000-0001-5481-9589	NHLBI NIH HHS [HL48675] Funding Source: Medline; NIGMS NIH HHS [GM49899] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baneres JL, 1998, J BIOL CHEM, V273, P24744, DOI 10.1074/jbc.273.38.24744; Baneres JL, 2000, J BIOL CHEM, V275, P5888, DOI 10.1074/jbc.275.8.5888; Basani RB, 2000, BLOOD, V95, P180, DOI 10.1182/blood.V95.1.180.001k16_180_188; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; BRANDON C, 1991, INTRO PROTEIN STRUCT; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gidwitz S, 2000, J BIOL CHEM, V275, P6680, DOI 10.1074/jbc.275.9.6680; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; Grimaldi CM, 1998, BLOOD, V91, P1562, DOI 10.1182/blood.V91.5.1562.1562_1562_1571; GULINO D, 1992, J BIOL CHEM, V267, P1001; Honda S, 1998, J CLIN INVEST, V102, P1183, DOI 10.1172/JCI3206; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Irie A, 1997, P NATL ACAD SCI USA, V94, P7198, DOI 10.1073/pnas.94.14.7198; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; KLOCZEWIAK M, 1982, BIOCHEM BIOPH RES CO, V107, P181, DOI 10.1016/0006-291X(82)91686-2; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Loftus JC, 1996, J BIOL CHEM, V271, P2033, DOI 10.1074/jbc.271.4.2033; LOMBARDO VT, 1985, J CLIN INVEST, V76, P1950, DOI 10.1172/JCI112193; McKay BS, 1996, J BIOL CHEM, V271, P30544, DOI 10.1074/jbc.271.48.30544; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; Niewiarowska J, 1997, THROMB HAEMOSTASIS, V78, P1510; NIIYA K, 1987, BLOOD, V70, P475; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; Oxvig C, 1998, P NATL ACAD SCI USA, V95, P4870, DOI 10.1073/pnas.95.9.4870; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; PHILLIPS DR, 1988, BLOOD, V71, P831; PIDARD D, 1983, J BIOL CHEM, V258, P2582; PONCZ M, 1987, J BIOL CHEM, V262, P8476; PONCZ M, 1990, BLOOD, V75, P1282; PRAMMER KV, 1994, RECEPTOR, V4, P93; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; Russell RB, 1998, J MOL BIOL, V282, P903, DOI 10.1006/jmbi.1998.2043; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHIFFER SG, 1995, J BIOL CHEM, V270, P14270, DOI 10.1074/jbc.270.24.14270; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Springer TA, 2000, CELL, V102, P275, DOI 10.1016/S0092-8674(00)00033-7; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; STANLEY P, 1994, EMBO J, V13, P1790, DOI 10.1002/j.1460-2075.1994.tb06447.x; TAUB R, 1989, J BIOL CHEM, V264, P259; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Thornton MA, 1999, BLOOD, V94, P3947, DOI 10.1182/blood.V94.11.3947.423k41_3947_3950; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; TOMIYAMA Y, 1992, J BIOL CHEM, V267, P18085; TOMIYAMA Y, 1992, BLOOD, V79, P2303; Tozer EC, 1999, BLOOD, V93, P918, DOI 10.1182/blood.V93.3.918.403k26_918_924; WOODS VL, 1984, BLOOD, V63, P368; Xia Z, 1996, BRIT J HAEMATOL, V93, P204, DOI 10.1046/j.1365-2141.1996.445980.x; YLANNE J, 1988, BLOOD, V72, P1478; Zhang XP, 1999, BIOCHEMISTRY-US, V38, P14424, DOI 10.1021/bi990323b	58	71	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44275	44283		10.1074/jbc.M107021200	http://dx.doi.org/10.1074/jbc.M107021200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557768	hybrid			2022-12-27	WOS:000172297700100
J	Vosper, H; Patel, L; Graham, TL; Khoudoli, GA; Hill, A; Macphee, CH; Pinto, I; Smith, SA; Suckling, KE; Wolf, CR; Palmer, CNA				Vosper, H; Patel, L; Graham, TL; Khoudoli, GA; Hill, A; Macphee, CH; Pinto, I; Smith, SA; Suckling, KE; Wolf, CR; Palmer, CNA			The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; INSULIN ACTION ENHANCER; PPAR-GAMMA; STEROL 27-HYDROXYLASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); GENE-EXPRESSION; CHOLESTEROL; TROGLITAZONE; ATHEROSCLEROSIS; EFFLUX	The peroxisome Proliferator-activated receptors (PPARs) are a family of fatty acid-activated transcription factors which control lipid homeostasis and cellular differentiation. PPAR alpha (NR1C1) controls lipid oxidation and clearance in hepatocytes and PPAR gamma (NR1C3) promotes preadipocyte differentiation and lipogenesis. Drugs that activate PPAR alpha are effective in lowering plasma levels of lipids and have been used in the management of hyperlipidemia. PPAR gamma agonists increase insulin sensitivity and are used in the management of type 2 diabetes. In contrast, there are no marketed drugs that selectively target PPAR delta (NR1C2) and the physiological roles of PPAR delta are unclear. In this report we demonstrate that the expression of PPAR5 is increased during the differentiation of human macrophages in vitro. In addition, a highly selective agonist of PPAR delta (compound F) promotes lipid accumulation in primary human macrophages and in macrophages derived from the human monocytic cell line, THP-1. Compound F increases the expression of genes involved in lipid uptake and storage such as the class A and B scavenger receptors (SRA, CD36) and adipophilin. PPAR delta activation also represses key genes involved in lipid metabolism and efflux, ie. cholesterol 27-hydroxylase and apolipoprotein E. We have generated THP-1 sublines that overexpress PPAR delta and have confirmed that PPAR delta is a powerful promoter of macrophage lipid accumulation. These data suggest that PPAR5 may play a role in the pathology of diseases associated with lipid-filled macrophages, such as atherosclerosis, arthritis, and neurodegeneration.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Imperial Canc Res Fund, Mol Pharmacol Unit, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland; GlaxoSmithKline, Harlow CM19 5AW, Essex, England	University of Dundee; University of Dundee; University of Dundee; GlaxoSmithKline	Palmer, CNA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.	palmerc@icrf.icnet.uk	Eckhardt, Erik/G-1567-2010; Palmer, Colin NA/C-7053-2008	Palmer, Colin NA/0000-0002-6415-6560; Vosper, Helen/0000-0001-7796-5183; Wolf, Charles Roland/0000-0002-6969-0113				Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718; BJORKHEM I, 1994, P NATL ACAD SCI USA, V91, P8592, DOI 10.1073/pnas.91.18.8592; BRIGHTY DW, 1991, P NATL ACAD SCI USA, V88, P7802, DOI 10.1073/pnas.88.17.7802; Buechler C, 2001, BBA-MOL CELL BIOL L, V1532, P97, DOI 10.1016/S1388-1981(01)00121-4; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kang AK, 1997, MUTAT RES-GENOMICS, V382, P57, DOI 10.1016/S1383-5726(97)00009-5; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Koshiyama H, 2001, J CLIN ENDOCR METAB, V86, P3452, DOI 10.1210/jc.86.7.3452; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; Kumar S, 1996, DIABETOLOGIA, V39, P701; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lim H, 2000, TRENDS ENDOCRIN MET, V11, P137, DOI 10.1016/S1043-2760(00)00243-5; Mano H, 2000, J BIOL CHEM, V275, P8126, DOI 10.1074/jbc.275.11.8126; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Seed B, 1998, NAT MED, V4, P1004, DOI 10.1038/1990; Shanahan CM, 2001, ATHEROSCLEROSIS, V154, P269, DOI 10.1016/S0021-9150(00)00473-1; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Shinohara E, 1998, ATHEROSCLEROSIS, V136, P275, DOI 10.1016/S0021-9150(97)00220-7; Shiomi M, 1999, ATHEROSCLEROSIS, V142, P345, DOI 10.1016/S0021-9150(98)00259-7; Shu H, 2000, BIOCHEM BIOPH RES CO, V267, P345, DOI 10.1006/bbrc.1999.1968; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Thieringer R, 2000, J IMMUNOL, V164, P1046, DOI 10.4049/jimmunol.164.2.1046; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; Wang CG, 2001, MOL CELL BIOL, V21, P3057, DOI 10.1128/MCB.21.9.3057-3070.2001; Westman J, 1998, ARTERIOSCL THROM VAS, V18, P554, DOI 10.1161/01.ATV.18.4.554; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585; 1997, Patent No. 9728149	52	219	237	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44258	44265		10.1074/jbc.M108482200	http://dx.doi.org/10.1074/jbc.M108482200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557774	hybrid			2022-12-27	WOS:000172297700098
J	Blaine, SA; Wick, M; Dessev, C; Nemenoff, RA				Blaine, SA; Wick, M; Dessev, C; Nemenoff, RA			Induction of cPLA(2) in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-jun	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; CYTOSOLIC PHOSPHOLIPASE A(2); INDUCED GENE-EXPRESSION; TRANSCRIPTION FACTORS; HUMAN 12-LIPOXYGENASE; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; A431 CELLS; SP-FAMILY; PROMOTER	Activating mutations in ras genes are frequently associated with non-small cell lung cancer cells (NSCLC) and contribute to transformed growth in these cells. Expression of oncogenic forms of Ras in these cells is associated with increased expression and activity of cytosolic phospholipase A(2) (cPLA(2)) and cyclooxygenase-2 (COX-2), leading to constitutively elevated levels of prostaglandin production. Expression of oncogenic Ras is sufficient to induce these enzymes in normal lung epithelial cells. We have previously reported that the JNK and ERK pathways are necessary for induction of cPLA(2) and have defined a minimal region of the cPLA(2) promoter from -58 to -12 that is required for Ha-Ras-mediated induction. To further characterize the cis-regulatory elements within this region involved in this response, site-directed mutagenesis was used to make mutations at various sites. Three cis-regulatory elements were identified: regions -21/-18, -37/-30, and -55/-53. Mutations in any of these elements decreased basal and Ha-Ras-induced cPLA(2) promoter activity in both normal lung epithelial cells, as well as steady state promoter activity in A549 cells, with a mutation in element -21/-18 completely eliminating all promoter activity. Overexpression studies and gel shift assays indicated that Spl may serve as a transcription factor functionally regulating promoter activity by directly interacting with two of the cis-regulatory elements, -21/-18 and -37/-30. Expression of Ha-Ras led to induction of e-Jun protein, which showed functional cooperation with Sp1 in driving promoter activity. Additional unidentified transcription factors bound to the regions from -55/-53 and -37/-34.	Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Nemenoff, RA (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Dept Pharmacol, Box C-281,4200 E 9th Ave, Denver, CO 80262 USA.				NATIONAL CANCER INSTITUTE [P50CA058187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039902, P01DK019928] Funding Source: NIH RePORTER; NCI NIH HHS [CA 58187] Funding Source: Medline; NIDDK NIH HHS [DK 39902, DK 19928] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Avis IM, 1996, J CLIN INVEST, V97, P806, DOI 10.1172/JCI118480; BONVENTRE JV, 1992, J AM SOC NEPHROL, V3, P128; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chen BK, 1997, BBA-LIPID LIPID MET, V1344, P270, DOI 10.1016/S0005-2760(96)00151-8; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Chen BK, 2000, MOL PHARMACOL, V57, P153; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; DEBRAVO MG, 1991, LIPIDS, V26, P866, DOI 10.1007/BF02535969; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; DeWitt D L, 1993, Am J Med, V95, p40S, DOI 10.1016/0002-9343(93)90396-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Giaccone G, 1996, CHEST, V109, pS130, DOI 10.1378/chest.109.5_Supplement.130S; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hida T, 1998, ANTICANCER RES, V18, P775; HUBBARD WC, 1989, CANCER RES, V49, P826; HUBBARD WC, 1988, CANCER RES, V48, P4770; Huber R, 1998, GENE, V214, P35, DOI 10.1016/S0378-1119(98)00233-9; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Liu YW, 1997, BIOCHEM J, V324, P133, DOI 10.1042/bj3240133; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; MIYASHITA A, 1995, NUCLEIC ACIDS RES, V23, P293, DOI 10.1093/nar/23.2.293; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Pena P, 1999, MOL ENDOCRINOL, V13, P1402, DOI 10.1210/me.13.8.1402; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; ROBERTS PE, 1990, AM J PHYSIOL, V259, pL415, DOI 10.1152/ajplung.1990.259.6.L415; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; TAY A, 1994, BBA-GENE STRUCT EXPR, V1217, P345, DOI 10.1016/0167-4781(94)90299-2; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Van Putten V, 2001, J BIOL CHEM, V276, P1226, DOI 10.1074/jbc.M003581200; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; WU T, 1994, NUCLEIC ACIDS RES, V22, P5093, DOI 10.1093/nar/22.23.5093; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917	41	68	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42737	42743		10.1074/jbc.M107773200	http://dx.doi.org/10.1074/jbc.M107773200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11559711	hybrid			2022-12-27	WOS:000172169300015
J	Kuo, HJ; Tran, NT; Clary, SA; Morris, NP; Glanville, RW				Kuo, HJ; Tran, NT; Clary, SA; Morris, NP; Glanville, RW			Characterization of EHD4, an EH domain-containing protein expressed in the extracellular matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VI COLLAGEN; SECRETORY PATHWAY; GLOBULAR DOMAINS; SIGNAL SEQUENCE; ALPHA-3 CHAIN; BINDING-SITES; EPS15; CARTILAGE; SPECIFICITY; NETWORK	To identify proteins that promote assembly of type VI collagen tetramers or stabilize type VI collagen filaments, a two-hybrid screen of a human placenta library was used and a new extracellular protein discovered. The cDNA sequence of the new protein encodes 541 amino acid residues. This cDNA sequence is identical to EHD4, a recently described member of the EH domain family of proteins. Two mRNAs of 4.4 and 3.0 kilobases were present in human skin fibroblasts and most tissues tested but were most prevalent in the heart. The chromosomal localization of the gene for this new protein was determined to be at 15q14-q15. Three polyclonal peptide antibodies were made against synthetic EHD4 peptides. The affinity-purified antibodies were used in immunofluorescent staining of developing limbs and matrices produced by human skin fibroblasts and mouse NIH3T3 fibroblasts in culture. Embryonic rat limb cartilage was strongly stained throughout development, and cultured fibroblasts deposited an extracellular filamentous network containing EHD4. In non-denaturing extracts of fetal bovine cartilage and in human skin fibroblast culture media, two components of similar to 220 and 158 kDa were observed, which, after reduction, migrated as a 56-kDa component on SDS-polyacrylamide gel electrophoresis. EHD4 is the first extracellular matrix protein described that contains an EH domain.	Shriners Hosp Children, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Congenital Heart Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Glanville, RW (corresponding author), Oregon Med Laser Ctr, 9205 SW Barnes Rd, Portland, OR 97225 USA.							ARNOUX B, 1995, J MOL BIOL, V246, P609, DOI 10.1006/jmbi.1994.0112; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Enmon JL, 2000, BIOCHEMISTRY-US, V39, P4309, DOI 10.1021/bi9927383; GREGORY KE, 2001, IN PRESS J BONE MIN; Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67; Jowett T., 1997, TISSUE IN SITU HYBRI, P128; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; KIELTY CM, 1992, J CELL BIOL, V118, P979, DOI 10.1083/jcb.118.4.979; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KUO HJ, 1995, EUR J BIOCHEM, V232, P364, DOI 10.1111/j.1432-1033.1995.364zz.x; Lunstrum GP, 1999, J HISTOCHEM CYTOCHEM, V47, P1, DOI 10.1177/002215549904700101; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Morris NP, 2000, J HISTOCHEM CYTOCHEM, V48, P725, DOI 10.1177/002215540004800601; Murphy JM, 1999, MATRIX BIOL, V18, P487, DOI 10.1016/S0945-053X(99)00042-6; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; PERRIS R, 1993, EXP CELL RES, V209, P103, DOI 10.1006/excr.1993.1290; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; SATO S, 1993, EXP CELL RES, V207, P8, DOI 10.1006/excr.1993.1157; Suzuki Y, 1998, J DENT RES, V77, P1799, DOI 10.1177/00220345980770100701; Tebar F, 1997, J BIOL CHEM, V272, P15413, DOI 10.1074/jbc.272.24.15413; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530	35	16	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43103	43110		10.1074/jbc.M106128200	http://dx.doi.org/10.1074/jbc.M106128200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11533061	hybrid			2022-12-27	WOS:000172169300063
J	Lin, JL; Liang, ZM; Zhang, Z; Li, GP				Lin, JL; Liang, ZM; Zhang, Z; Li, GP			Membrane topography and topogenesis of prenylated rab acceptor (PRA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-ANCHOR PROTEINS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE SEGMENTS; MESSENGER-RNA; STOP-TRANSFER; TRANSLOCATION; ORIENTATION; TRANSLATION; INTEGRATION; SEQUENCE	The mouse prenylated Rab acceptor (mPRA1) is associated with the Golgi membrane at steady state and interacts with Rab proteins. It contains two internal hydrophobic domains (34 residues each) that have enough residues to form four transmembrane (TM) segments. In this study, we have determined the membrane topography of mPRA1 in both intact cells and isolated microsomes. The putative TM segments of mPRA1 were used to substitute for a known TM segment of a model membrane protein to determine whether the mPRA1 segments integrate into the membrane. Furthermore, N-linked glycosylation scanning methods were used to distinguish luminal domains from cytoplasmic domains of mPRA1. The data demonstrate that mPRA1 is a polytopic membrane protein containing four TM segments. These TM segments act cooperatively during the translocation and integration at the endoplasmic reticulum membrane. All hydrophilic domains are in the cytoplasm, including the N-terminal domain, the linker domain between the two hydrophobic domains, and the C-terminal domain. As a result, the bulk of mPRA1 is located in the cytoplasm, supporting its postulated role in regulating Rab membrane targeting and intracellular trafficking.	Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Lin, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 940 SL Young Blvd,BMSB 853, Oklahoma City, OK 73104 USA.	jialing-lin@ouhsc.edu	Li, Guangpu/GRS-5397-2022		NIGMS NIH HHS [R01 GM062964] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062964] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bucci C, 1999, BIOCHEM BIOPH RES CO, V258, P657, DOI 10.1006/bbrc.1999.0651; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; FALCONE D, 1991, MOL CELL BIOL, V11, P2656, DOI 10.1128/MCB.11.5.2656; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang ZM, 2000, BIOCHEM BIOPH RES CO, V275, P509, DOI 10.1006/bbrc.2000.3316; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LIN JL, 1995, J BIOL CHEM, V270, P6935, DOI 10.1074/jbc.270.12.6935; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; MIHARA K, 1980, P NATL ACAD SCI-BIOL, V77, P4160, DOI 10.1073/pnas.77.7.4160; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; SKACH WR, 1993, J BIOL CHEM, V268, P23552; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; WALTER P, 1983, METHOD ENZYMOL, V96, P682; WESSELS HP, 1991, METHOD CELL BIOL, V34, P287; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590	32	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41733	41741		10.1074/jbc.M103475200	http://dx.doi.org/10.1074/jbc.M103475200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535589	hybrid, Green Accepted			2022-12-27	WOS:000172450400027
J	Li, YH; Martin, LD; Spizz, G; Adler, KB				Li, YH; Martin, LD; Spizz, G; Adler, KB			MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYRISTOYL-ELECTROSTATIC SWITCH; KINASE-C; SIGNAL-TRANSDUCTION; GOBLET CELLS; CGMP ANALOGS; IN-VITRO; ACTIVATION; RELEASE; ALPHA	Hypersecretion of airway mucin characterizes numerous respiratory diseases. Although diverse pathological stimuli can provoke exocytotic release of mucin from secretory cells of the airway epithelium, mechanisms involved remain obscure. This report describes a new paradigm for the intracellular signaling mechanism regulating airway mucin secretion. Direct evidence is provided that the myristoylated alanine-rich C kinase substrate (MARCKS) is a central regulatory molecule linking secretagogue stimulation at the cell surface to mucin granule release by differentiated normal human bronchial epithelial cells in vitro. Down-regulation of MARCKS expression or disruption of MARCKS function in these cells inhibits the secretory response to subsequent stimulation. The intracellular mechanism controlling this secretory process involves cooperative action of two separate protein kinases, protein kinase C and cGMP-dependent protein kinase. Upon stimulation, activated protein kinase C phosphorylates MARCKS, causing translocation of MARCKS from the plasma membrane to the cytoplasm, where it is then dephosphorylated by a protein phosphatase 2A that is activated by cGMP-dependent protein kinase, and associates with both actin and myosin. Dephosphorylated cytoplasmic MARCKS would also be free to interact with mucin granule membranes and thus could link granules to the contractile cytoskeleton, mediating their movement to the cell periphery and subsequent exocytosis. These findings suggest several novel intracellular targets for pharmacological intervention in disorders involving aberrant secretion of respiratory mucin and may relate to other lesions involving exocytosis of membrane-bound granules in various cells and tissues.	N Carolina State Univ, Coll Vet Med, Dept Anat Physiol Sci & Radiol, Raleigh, NC 27606 USA; NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Adler, KB (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Anat Physiol Sci & Radiol, 4700 Hillsborough St, Raleigh, NC 27606 USA.				NHLBI NIH HHS [R01 HL39862] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Abdullah LH, 1996, BIOCHEM J, V316, P943, DOI 10.1042/bj3160943; ADEREM A, 1992, TRENDS BIOCHEM SCI, V17, P438, DOI 10.1016/0968-0004(92)90016-3; Adler K. B., 1998, Research in Immunology, V149, P245, DOI 10.1016/S0923-2494(98)80093-X; ADLER KB, 1990, AM J RESP CELL MOL, V2, P145, DOI 10.1165/ajrcmb/2.2.145; COHN LA, 1992, EXP LUNG RES, V18, P299, DOI 10.3109/01902149209031687; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; Harlow E., 1988, ANTIBODIES LAB MANUA, P570; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Huang XC, 1996, ADV EXP MED BIOL, V396, P209; KAARTINEN L, 1993, IN VITRO CELL DEV-AN, V29A, P481, DOI 10.1007/BF02639383; Ko KH, 1997, AM J RESP CELL MOL, V16, P194, DOI 10.1165/ajrcmb.16.2.9032127; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; LARIVEE P, 1994, AM J RESP CELL MOL, V11, P199, DOI 10.1165/ajrcmb.11.2.8049080; LETHEM MI, 1993, AM J RESP CELL MOL, V9, P315, DOI 10.1165/ajrcmb/9.3.315; LIN H, 1989, AM J RESP CELL MOL, V1, P41, DOI 10.1165/ajrcmb/1.1.41; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; SEKHAR KR, 1992, MOL PHARMACOL, V42, P103; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Spizz G, 1996, J BIOL CHEM, V271, P553, DOI 10.1074/jbc.271.1.553; Swierczynski SL, 1996, J BIOL CHEM, V271, P23424, DOI 10.1074/jbc.271.38.23424; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wei JY, 1998, J MOL NEUROSCI, V10, P53, DOI 10.1007/BF02737085; Wright DT, 1996, AM J PHYSIOL-LUNG C, V271, pL854, DOI 10.1152/ajplung.1996.271.5.L854; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219	28	127	141	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40982	40990		10.1074/jbc.M105614200	http://dx.doi.org/10.1074/jbc.M105614200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533058	hybrid			2022-12-27	WOS:000171925600082
J	Sanz, C; Marquez, M; Peralvarez, A; Elouatik, S; Sepulcre, F; Querol, E; Lazarova, T; Padros, E				Sanz, C; Marquez, M; Peralvarez, A; Elouatik, S; Sepulcre, F; Querol, E; Lazarova, T; Padros, E			Contribution of extracellular Glu residues to the structure and function of bacteriorhodopsin - Presence of specific cation-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-BLUE TRANSITION; ELECTRON-SPIN RESONANCE; PURPLE MEMBRANE; PROTON-RELEASE; ANGSTROM RESOLUTION; THERMAL-DENATURATION; ABSORPTION-SPECTRUM; PHASE-TRANSITIONS; ACID PH; PROTEIN	Single and multiple mutants of extracellular Glu side chains of bacteriorhodopsin were analyzed by acid and calcium titration, differential scanning calorimetry, and thermal difference spectrophotometry. Acid titration spectra show that the second group protonating with Asps' is revealed in E204Q in the absence of Cl- but is not observed in the triple mutant E9Q/E194Q/E204Q or in the quadruple mutant E9Q/E74Q/E194Q/E204Q. The results point to Glue as the second group protonating cooperatively with Asp(85). Comparison of the apparent pK(u) of Asp(85) protonation in water and in the deionized forms and results of calcium titration suggest that cation-binding sites are of low affinity in the multiple Glu mutants. Like for deionized wild type bacteriorhodopsin, differential scanning calorimetry reveals a lack of the pretransition in the multiple mutants, whereas in E9Q it appears at lower temperature and with lower cooperativity. Additionally, at neutral pH the band at 630 nm arising from cation release upon temperature increase is absent for the multiple mutants. Based on these results, we propose the presence of two cation-binding sites in the extracellular region of bacteriorhodopsin having as ligands Glu(9), Glu(194), Glu(204), and water molecules.	Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Spain; Univ Politecn Catalunya, Escola Univ Engn Tecn Ind, Dept Engn Quim, Barcelona 08036, Spain; Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; Universitat Politecnica de Catalunya; Autonomous University of Barcelona	Padros, E (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Spain.		Peralvarez-Marin, Alex/AAH-4305-2020; sanz, carolina/D-7868-2016; Peralvarez-Marin, Alex/A-8958-2017	Peralvarez-Marin, Alex/0000-0002-3457-0875; Sepulcre, Francesc/0000-0002-1425-8323				ARIKI M, 1986, J BIOL CHEM, V261, P8167; Azuaga AI, 1996, BIOCHEMISTRY-US, V35, P16328, DOI 10.1021/bi961845j; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; BALASHOV SP, 1995, BIOCHEMISTRY-US, V34, P8820, DOI 10.1021/bi00027a034; Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; Balashov SP, 1999, BIOCHEMISTRY-US, V38, P2026, DOI 10.1021/bi981926a; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bressler S, 1999, BIOCHEMISTRY-US, V38, P2018, DOI 10.1021/bi981901b; CHANG CH, 1986, BIOPHYS J, V49, P731, DOI 10.1016/S0006-3495(86)83699-2; CHANG CH, 1985, P NATL ACAD SCI USA, V82, P396, DOI 10.1073/pnas.82.2.396; CLADERA J, 1988, BIOCHIM BIOPHYS ACTA, V943, P148, DOI 10.1016/0005-2736(88)90546-9; Dencher NA, 2000, BBA-BIOENERGETICS, V1460, P192, DOI 10.1016/S0005-2728(00)00139-0; DUNACH M, 1988, J BIOL CHEM, V263, P17378; DUNACH M, 1989, BIOCHEMISTRY-US, V28, P8940, DOI 10.1021/bi00448a038; DUNACH M, 1986, BIOSCIENCE REP, V6, P961, DOI 10.1007/BF01114972; DUNACH M, 1987, BIOCHEMISTRY-US, V26, P1179, DOI 10.1021/bi00378a028; DUNACH M, 1988, J BIOL CHEM, V263, P7555; EHRENBERG B, 1983, FEBS LETT, V164, P63, DOI 10.1016/0014-5793(83)80019-2; Eliash T, 2001, BIOPHYS J, V81, P1155, DOI 10.1016/S0006-3495(01)75772-4; ENGELHARD M, 1990, EUR BIOPHYS J, V19, P11; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; FISHER U, 1979, BIOPHYS J, V28, P211; Fu X, 1997, FEBS LETT, V416, P167, DOI 10.1016/S0014-5793(97)01194-0; Gat Y, 1997, BIOCHEMISTRY-US, V36, P4135, DOI 10.1021/bi962322e; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; HIRAKI K, 1981, BIOCHIM BIOPHYS ACTA, V647, P18, DOI 10.1016/0005-2736(81)90291-1; JACKSON MB, 1978, BIOCHEMISTRY-US, V17, P911, DOI 10.1021/bi00598a026; JEFFREY GA, 1994, HYDROGEN BONDING BIO, P459; JONAS R, 1991, P NATL ACAD SCI USA, V88, P149, DOI 10.1073/pnas.88.1.149; KIMURA Y, 1984, PHOTOCHEM PHOTOBIOL, V40, P641, DOI 10.1111/j.1751-1097.1984.tb05353.x; Kusnetzow A, 1999, BIOPHYS J, V76, P2370, DOI 10.1016/S0006-3495(99)77394-7; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lazarova T, 2000, BIOPHYS J, V78, P2022, DOI 10.1016/S0006-3495(00)76749-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; METZ G, 1992, FEBS LETT, V303, P237, DOI 10.1016/0014-5793(92)80528-O; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; MOWERY PC, 1979, BIOCHEMISTRY-US, V18, P4100, DOI 10.1021/bi00586a007; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Pardo L, 1998, BIOPHYS J, V75, P777, DOI 10.1016/S0006-3495(98)77567-8; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; RIVIERE ME, 1991, ARCH BIOCHEM BIOPHYS, V284, P1, DOI 10.1016/0003-9861(91)90253-F; Sanz C, 1999, FEBS LETT, V456, P191, DOI 10.1016/S0014-5793(99)00950-3; Sepulcre F, 1996, BIOPHYS J, V70, P852, DOI 10.1016/S0006-3495(96)79627-3; STUART JA, 1995, BIOSPECTROSCOPY, V1, P9, DOI 10.1002/bspy.350010104; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; SZUNDI I, 1987, P NATL ACAD SCI USA, V84, P3681, DOI 10.1073/pnas.84.11.3681; SZUNDI I, 1989, BIOPHYS J, V56, P369, DOI 10.1016/S0006-3495(89)82683-9; SZUNDI I, 1988, BIOPHYS J, V54, P227, DOI 10.1016/S0006-3495(88)82951-5; TAKAHASHI K, 1981, BIOCHEMISTRY-US, V20, P6185, DOI 10.1021/bi00524a042; TSUJI K, 1990, EUR BIOPHYS J, V18, P63, DOI 10.1007/BF00185421; Tuzi S, 1999, BIOPHYS J, V76, P1523, DOI 10.1016/S0006-3495(99)77311-X; VARO G, 1989, BIOPHYS J, V56, P1143, DOI 10.1016/S0006-3495(89)82761-4; Varo G, 1999, BIOPHYS J, V76, P3219, DOI 10.1016/S0006-3495(99)77473-4; Wang JP, 1999, BIOPHYS J, V76, P2777, DOI 10.1016/S0006-3495(99)77431-X; ZHANG YN, 1992, BIOPHYS J, V61, P1201, DOI 10.1016/S0006-3495(92)81929-X; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	60	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40788	40794		10.1074/jbc.M104836200	http://dx.doi.org/10.1074/jbc.M104836200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524418	hybrid			2022-12-27	WOS:000171925600056
J	Jordan, BWM; Dinev, D; LeMellay, V; Troppmair, J; Gotz, R; Wixler, L; Sendtner, M; Ludwig, S; Rapp, UR				Jordan, BWM; Dinev, D; LeMellay, V; Troppmair, J; Gotz, R; Wixler, L; Sendtner, M; Ludwig, S; Rapp, UR			Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PROTEINS; IAP; GROWTH; GENE; ACTIVATION; HILP; RAF; ITA	The inhibitor of apoptosis proteins (IAPs) have been shown to interact with a growing number of intracellular proteins and pathways to fulfil their anti-apoptotic role. In the search for novel IAP-interacting proteins we identified the neurotrophin receptor-interacting MAGE homologue (NRAGE) as being able to bind to the avian LAP homologue ITA. This interaction requires the RING domain of ITA. NRAGE additionally coimmunoprecipitates with XLAP. When overexpressed in 32D cells NRAGE augments interleukin-3 withdrawal induced apoptosis, possibly through binding endogenous XIAP. Moreover, NRAGE is able to overcome the anti-apoptotic effect of Bcl-2.	Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Univ Wurzburg, Inst Neurobiol, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, Versbacher Str 5, D-97078 Wurzburg, Germany.		Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Ludwig, Stephan/0000-0003-4490-3052; Troppmair, Jakob/0000-0002-0611-3837				Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; CLEVELAND JL, 1994, ONCOGENE, V9, P2217; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Digby MR, 1996, DNA CELL BIOL, V15, P981, DOI 10.1089/dna.1996.15.981; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Gotz R, 2000, HUM MOL GENET, V9, P2479, DOI 10.1093/hmg/9.17.2479; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Johnson DE, 2000, CANCER RES, V60, P1818; Kalmes A, 1998, CANCER RES, V58, P2986; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; PFISTERER P, 1995, J BIOL CHEM, V270, P29870, DOI 10.1074/jbc.270.50.29870; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	32	73	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39985	39989		10.1074/jbc.C100171200	http://dx.doi.org/10.1074/jbc.C100171200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546791	hybrid			2022-12-27	WOS:000171789200066
J	Tabares, L; Ales, E; Lindau, M; de Toledo, GA				Tabares, L; Ales, E; Lindau, M; de Toledo, GA			Exocytosis of catecholamine (CA)-containing and CA-free granules in chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE CYCLE; TORPEDO ELECTRIC ORGAN; FUSION PORE; CAPACITANCE MEASUREMENTS; NEUROMUSCULAR-JUNCTION; CHOLINERGIC SYNAPSES; TRANSMITTER RELEASE; SECRETORY PRODUCTS; ENDOCRINE-CELLS; MAST-CELLS	Recent evidence suggests that endocytosis in neuroendocrine cells and neurons can be tightly coupled to exocytosis, allowing rapid retrieval from the plasma membrane of fused vesicles for future use. This can be a much faster mechanism for membrane recycling than classical clathrin-mediated endocytosis. During a fast exo-endocytotic cycle, the vesicle membrane does not fully collapse into the plasma membrane; nevertheless, it releases the vesicular contents through the fusion pore. Once the vesicle is depleted of transmitter, its membrane is recovered without renouncing its identity. In this report, we show that chromaffin cells contain catecholamine-free granules that retain their ability to fuse with the plasma membrane. These catecholamine-free granules represent 7% of the total population of fused vesicles, but they contributed to 47% of the fusion events when the cells were treated with reserpine for several hours. We propose that rat chromaffin granules that transiently fuse with the plasma membrane preserve their exocytotic machinery, allowing another round of exocytosis.	Univ Seville, Sch Med, Dept Physiol & Biophys, Seville 41009, Spain; Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	University of Sevilla; Cornell University	de Toledo, GA (corresponding author), Univ Seville, Sch Med, Dept Physiol & Biophys, Avenida Sanchez Pizjuan 4, Seville 41009, Spain.		Lindau, Manfred/ABD-3449-2021; Alvarez de Toledo, Guillermo/I-2888-2015; Ales, Eva/E-6315-2010; Tabares, Lucia/K-8768-2015	Lindau, Manfred/0000-0002-5722-9557; Alvarez de Toledo, Guillermo/0000-0001-7193-2663; Ales, Eva/0000-0002-5536-4616; Tabares, Lucia/0000-0002-4027-4044				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Chow Robert H., 1995, P245; Clift-O'Grady L, 1998, METHODS, V16, P150, DOI 10.1006/meth.1998.0662; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DETOLEDO GA, 1988, J GEN PHYSL S, V43, P333; DIXON WR, 1975, J PHYSIOL-LONDON, V244, P805, DOI 10.1113/jphysiol.1975.sp010827; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; HARTMANN J, 1995, FEBS LETT, V363, P217, DOI 10.1016/0014-5793(95)00318-4; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; Henkel AW, 2000, EMBO J, V19, P84, DOI 10.1093/emboj/19.1.84; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HILLE B, 1992, IONIC CHANNELS EXCIT, P296; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; MONCK JR, 1991, BIOPHYS J, V59, P39, DOI 10.1016/S0006-3495(91)82196-8; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Oberhauser AF, 1996, BIOPHYS J, V71, P1131, DOI 10.1016/S0006-3495(96)79315-3; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184; SEARL T, 1991, J PHYSIOL-LONDON, V444, P99, DOI 10.1113/jphysiol.1991.sp018868; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Williams J, 1997, NEURON, V18, P683, DOI 10.1016/S0896-6273(00)80308-6; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; ZIMMERMANN H, 1977, NEUROSCIENCE, V2, P715, DOI 10.1016/0306-4522(77)90025-2; ZIMMERMANN H, 1977, NEUROSCIENCE, V2, P695, DOI 10.1016/0306-4522(77)90024-0	41	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39974	39979		10.1074/jbc.M106498200	http://dx.doi.org/10.1074/jbc.M106498200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11524425	hybrid, Green Published			2022-12-27	WOS:000171789200064
J	Forwood, JK; Harley, V; Jans, DA				Forwood, JK; Harley, V; Jans, DA			The C-terminal nuclear localization signal of the sex determining region Y (SRY) high mobility group domain mediates nuclear import through beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-TARGETING COMPLEX; RNA-BINDING-PROTEIN; T-ANTIGEN NLS; DNA-BINDING; HMG-BOX; ENHANCES RECOGNITION; RIBOSOMAL-PROTEINS; TRANSPORT FACTORS; MOLECULAR-BASIS; HIGH-AFFINITY	The sex-determining factor SRY is a DNA-binding protein that diverts primordial gonads from the ovarian pathway toward male differentiation to form testes. It gains access to the nucleus through two distinct nuclear localization signals (NLSs) that flank the high mobility group (HMG) DNA-binding domain, but the mechanisms through which these NLSs operate have not been studied. In this study, we reconstitute the nuclear import of SRY in vitro, demonstrating a lack of requirement for exogenous factors for nuclear accumulation and a significant reduction in nuclear transport in the presence of antibodies to importin beta but not importin alpha. Using a range of quantitative binding assays including enzyme-linked immunosorbent assay, fluorescence polarization, and native gel mobility electrophoresis, we assess the binding of importins to SRY, demonstrating a high affinity recognition (in the low nm range) by Imp beta independent of Imp alpha. In assessing the contribution of each NLS, we found that the N-terminal NLS was recognized poorly by importins, whereas the C-terminal NLS was bound by importin beta with similar affinity to SRY. We also found that RanGTP, but not RanGDP, could dissociate the SRY-importin beta complex in solution using FP. We describe a novel double-fluorescent label DNA binding assay to demonstrate mutual exclusivity between importin beta recognition and DNA binding on the part of SRY, which may represent an alternative release mechanism upon nuclear entry. This study represents the first characterization of the nuclear import pathway for a HMG domain-containing protein. Importantly, it demonstrates for the first time that recognition of SRY by Imp beta is of comparable affinity to that with which Imp alpha/beta recognizes conventional NLS-containing substrates.	Australian Natl Univ, Nucl Signaling Lab, Div Biochem & Mol Biol, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; Prince Henry Hosp, Monash Med Ctr, Clayton, Vic 3168, Australia; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3152, Australia	Australian National University; John Curtin School of Medical Research; Monash University; Monash University	Jans, DA (corresponding author), Australian Natl Univ, Nucl Signaling Lab, Div Biochem & Mol Biol, John Curtin Sch Med Res, POB 334, Canberra, ACT 0200, Australia.		Harley, Vincent/B-8092-2018; Forwood, Jade K/K-4123-2014	Harley, Vincent/0000-0002-2405-1262; Forwood, Jade K/0000-0003-3267-9997; Jans, David/0000-0001-5115-4745				Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Albertini M, 1998, J CELL BIOL, V143, P1447, DOI 10.1083/jcb.143.6.1447; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Briggs LJ, 1998, J BIOL CHEM, V273, P22745, DOI 10.1074/jbc.273.35.22745; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Dasso M, 1998, AM J HUM GENET, V63, P311, DOI 10.1086/301990; Efthymiadis A, 1997, J BIOL CHEM, V272, P22134, DOI 10.1074/jbc.272.35.22134; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GRASSER KD, 1991, NUCLEIC ACIDS RES, V19, P2573, DOI 10.1093/nar/19.10.2573; GUSTAFSON ML, 1994, ANNU REV MED, V45, P505, DOI 10.1146/annurev.med.45.1.505; HAQQ CM, 1993, P NATL ACAD SCI USA, V90, P1097, DOI 10.1073/pnas.90.3.1097; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; Hood JK, 1999, CURR OPIN CELL BIOL, V11, P241, DOI 10.1016/S0955-0674(99)80032-5; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Hubner S, 1999, J BIOL CHEM, V274, P22610, DOI 10.1074/jbc.274.32.22610; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Imamoto N, 1998, EUR J HISTOCHEM, V42, P9; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; Izaurralde E, 1998, RNA, V4, P351; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; JANS DA, 1995, BIOCHEM J, V311, P705, DOI 10.1042/bj3110705; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; MCELREAVEY K, 1993, EUR J BIOCHEM, V218, P769, DOI 10.1111/j.1432-1033.1993.tb18432.x; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Truant R, 1999, MOL CELL BIOL, V19, P1210; WAGNER CR, 1992, MOL CELL BIOL, V12, P1915, DOI 10.1128/MCB.12.5.1915; WEBER G, 1953, ADV PROTEIN CHEM, V8, P415, DOI 10.1016/S0065-3233(08)60096-0; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wozniak RW, 1998, TRENDS CELL BIOL, V8, P184, DOI 10.1016/S0962-8924(98)01248-3; Xiao CY, 1998, FEBS LETT, V440, P297, DOI 10.1016/S0014-5793(98)01478-1; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191	62	94	102	5	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46575	46582		10.1074/jbc.M101668200	http://dx.doi.org/10.1074/jbc.M101668200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11535586	hybrid			2022-12-27	WOS:000172573100144
J	Ibrahim, HR; Thomas, U; Pellegrini, A				Ibrahim, HR; Thomas, U; Pellegrini, A			A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIALLY UNFOLDED LYSOZYME; EGG-WHITE LYSOZYME; SOLID-STATE NMR; ESCHERICHIA-COLI; BACTERICIDAL ACTIVITY; DAMAGE MECHANISM; MODEL SYSTEM; BILAYERS; CHANNEL; PROTEINS	Recently, we have found that partially unfolded lysozyme exerts broad spectrum antimicrobial action in vitro against Gram-negative and Gram-positive bacteria independent of its catalytic activity. In parallel, an internal peptide (residues 98-112) of hen egg white lysozyme, obtained after digestion with clostripain, possessed broad spectrum antimicrobial action in vitro. This internal peptide is part of a helix-loop-helix domain (87-114 sequence of hen lysozyme) located at the upper lip of the active site cleft of lysozyme. The helix-loop-helix (HLH) structures are known motifs commonly found in membrane-active and DNA-binding proteins. To evaluate the contribution of the HLH peptide to the antimicrobial properties of lysozyme, the HLH sequence and its secondary structure derivatives of chicken and human lysozyme were synthesized and tested for antimicrobial activity against several bacterial strains. We found that the full HLH peptide of both chicken and human lysozymes was potently microbicidal against both Gram-positive and Gram-negative bacteria and the fungus Candida albicans. The N-terminal helix of HLH was specifically bactericidal to Gram-positive bacteria, whereas the C-terminal helix was bactericidal to all tested strains. Outer and inner membrane permeabilization studies, as well as measurements of transmembrane electrochemical potentials, provided evidence that HLH peptide and its C-terminal helix domain kill Gram-negative bacteria by crossing the outer membrane via self-promoted uptake and causing damage to the inner membrane through channel formation. The results are discussed in terms of proposed mechanisms for the catalytically independent antimicrobial activity of lysozyme that offer a new strategy for the design of potential antimicrobial drugs in the treatment of infectious diseases.	Kagoshima Univ, Fac Agr, Dept Biochem & Biotechnol, Kagoshima 8900065, Japan; Univ Zurich, Inst Vet Physiol, Dept Appl Vet Physiol, CH-8057 Zurich, Switzerland	Kagoshima University; University of Zurich	Ibrahim, HR (corresponding author), Kagoshima Univ, Fac Agr, Dept Biochem & Biotechnol, 1-21-24 Korimoto, Kagoshima 8900065, Japan.		Ibrahim, Hisham/AAB-3945-2021	Ibrahim, Hisham/0000-0002-7809-900X				ANDREU D, 1985, BIOCHEMISTRY-US, V24, P1683, DOI 10.1021/bi00328a017; BANKS J G, 1986, Biotechnology and Applied Biochemistry, V8, P103; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; BUKHARIN OV, 1976, ANTIBIOT MED BIOTEK, V21, P805; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHEN HC, 1988, FEBS LETT, V236, P462, DOI 10.1016/0014-5793(88)80077-2; Coonrod J D, 1986, Semin Respir Infect, V1, P118; Cross TA, 1999, NAT STRUCT BIOL, V6, P610, DOI 10.1038/10650; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; HASSELBERGER FX, 1978, USES ENZYMES IMMOBIL, P128; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; HUGHEY VL, 1987, APPL ENVIRON MICROB, V53, P2165, DOI 10.1128/AEM.53.9.2165-2170.1987; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Hung SC, 1999, BIOPHYS J, V77, P3120, DOI 10.1016/S0006-3495(99)77142-0; Ibrahim HR, 2000, BBA-GEN SUBJECTS, V1523, P196, DOI 10.1016/S0304-4165(00)00122-7; Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P3799, DOI 10.1021/jf960133x; Ibrahim HR, 1998, NAHRUNG, V42, P187, DOI 10.1002/(SICI)1521-3803(199808)42:03/04<187::AID-FOOD187>3.3.CO;2-6; Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P1416, DOI 10.1021/jf9507147; IBRAHIM HR, 1994, J BIOL CHEM, V269, P5059; Ibrahim HR, 1997, J AGR FOOD CHEM, V45, P89, DOI 10.1021/jf9604899; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kim Y, 1998, PROTEIN SCI, V7, P342; Kovacs F, 1999, P NATL ACAD SCI USA, V96, P7910, DOI 10.1073/pnas.96.14.7910; KUDINOVA TI, 1976, ANTIBIOT MED BIOTEK, V21, P441; LAIBLE NJ, 1985, INFECT IMMUN, V48, P720, DOI 10.1128/IAI.48.3.720-728.1985; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x; LEMARBRE P, 1981, BLOOD, V58, P994, DOI 10.1182/blood.V58.5.994.994; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; OHNO N, 1989, J BIOL CHEM, V264, P4434; Osserman E.F., 1974, LYSOZYME; Pellegrini A, 1997, J APPL MICROBIOL, V82, P372, DOI 10.1046/j.1365-2672.1997.00372.x; POSSE E, 1994, BBA-BIOMEMBRANES, V1193, P101, DOI 10.1016/0005-2736(94)90338-7; POST CB, 1986, J MOL BIOL, V190, P455, DOI 10.1016/0022-2836(86)90015-X; Ridder ANJA, 2000, BIOCHEMISTRY-US, V39, P6521, DOI 10.1021/bi000073v; SAVA G, 1988, EUR J CANCER CLIN ON, V24, P1737, DOI 10.1016/0277-5379(88)90075-2; SCHINDLER M, 1977, BIOCHEMISTRY-US, V16, P423, DOI 10.1021/bi00622a013; SHAI Y, 1995, TRENDS BIOCHEM SCI, V20, P460, DOI 10.1016/S0968-0004(00)89101-X; SONG HW, 1994, J MOL BIOL, V244, P522, DOI 10.1006/jmbi.1994.1750; SONG HY, 1991, J BACTERIOL, V173, P2927, DOI 10.1128/JB.173.9.2927-2934.1991; SRISAILAM S, 2000, BIOCHIM BIOPHYS ACTA, V15, P1; THACORE H, 1966, AM REV RESPIR DIS, V93, P786; TOMIZAWA H, 1994, BIOCHEMISTRY-US, V33, P8770, DOI 10.1021/bi00195a019; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; Wang W, 1999, BBA-GEN SUBJECTS, V1473, P418, DOI 10.1016/S0304-4165(99)00200-7; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902	51	231	250	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43767	43774		10.1074/jbc.M106317200	http://dx.doi.org/10.1074/jbc.M106317200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11560930	hybrid			2022-12-27	WOS:000172297700039
J	Arora, M; Munoz, E; Tenner, AJ				Arora, M; Munoz, E; Tenner, AJ			Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C1Q RECEPTOR; MOLECULAR CHARACTERIZATION; BACTERICIDAL FACTOR; COMPLEMENT; PROTEIN; ACTIVATION; EXPRESSION; DEFENSE; C1QR(P); CELLS	Mannan-binding lectin (MBL) constitutes an important part of the human innate immune defense system. It has been shown to mediate the activation of complement upon binding to specific microbial carbohydrate motifs, to directly opsonize organisms, and to enhance the phagocytosis of targets suboptimally opsonized with IgG or complement components C3b or C4b. This enhancement of phagocytic activity induced by MBL and other molecules that contain a collagen-like region contiguous with a pattern recognition domain is mediated by a 126,000 M-r surface glycoprotein, designated C1qRp. Although it has been known that the collagen-like domain of these "defense collagens" contains the interaction site(s) that triggers this enhancement of uptake, the specific interaction site has not been identified. To address this issue, wild type and mutant MBL constructs were generated, inserted into baculovirus, expressed in Sf9 cells, and the recombinant MBL (rMBL) proteins purified by mannan affinity chromatography. The effect of wild type and mutant rMBL on the phagocytosis of targets suboptimally opsonized with IgG or with IgM and C4b by human peripheral blood monocytes. was then assessed. Two mutants, one of which has five GXY triplets deleted below the kin region of MBL and the other one having only two of the GXY triplets deleted below the kink, failed to enhance phagocytosis, suggesting the importance of the specific sequence GEKGEP in stimulating phagocytic activity. Similar sequences were detected in other defense collagens, implicating the consensus motif GE(K/Q/R)GEP as critical in mediating the enhancement of phagocytosis through C1qRp. Clarification of specific ligand-C1qRp interactions should facilitate the investigation of the signal transduction processes involved in the cell activation, as well as provide the basis for the design of specific modulators of the functions mediated by this receptor.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 Biol Sci II, Irvine, CA 92697 USA.	atenner@uci.edu			NCRR NIH HHS [M01 RR00827] Funding Source: Medline; NIAID NIH HHS [AI41090] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041090] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BOBAK DA, 1988, EUR J IMMUNOL, V18, P2001, DOI 10.1002/eji.1830181220; BOBAK DA, 1986, J IMMUNOL, V136, P4604; BOBAK DA, 1987, J IMMUNOL, V138, P1150; BOHNSACK JF, 1985, J EXP MED, V161, P912, DOI 10.1084/jem.161.5.912; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Dean YD, 2000, J BIOL CHEM, V275, P34382, DOI 10.1074/jbc.M006229200; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; FONSECA MI, 2001, IN PRESS J LEUKOCYTE; GUAN E, 1994, J IMMUNOL, V152, P4005; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; JI YH, 1993, J IMMUNOL, V150, P571; JI YH, 1988, J IMMUNOL, V141, P4271; KAWASAKI N, 1983, J BIOCHEM, V94, P937, DOI 10.1093/oxfordjournals.jbchem.a134437; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lionetti F. J., 1980, METHODS CELL SEPARAT, P141; Lovik G, 2000, EUR J IMMUNOL, V30, P3355, DOI 10.1002/1521-4141(2000012)30:12<3355::AID-IMMU3355>3.0.CO;2-1; Ma Y, 1997, J BIOCHEM-TOKYO, V122, P810; MASUSHITA M, 1992, J EXP MED, V176, P1497; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Nepomuceno RR, 1998, J IMMUNOL, V160, P1929; Nepomuceno RR, 1999, J IMMUNOL, V162, P3583; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Ruiz S, 1995, J BIOL CHEM, V270, P30627, DOI 10.1074/jbc.270.51.30627; Ruiz S, 1999, J LEUKOCYTE BIOL, V66, P416, DOI 10.1002/jlb.66.3.416; SATO T, 1994, INT IMMUNOL, V6, P665, DOI 10.1093/intimm/6.4.665; TAKADA F, 1993, BIOCHEM BIOPH RES CO, V196, P1003, DOI 10.1006/bbrc.1993.2349; TENNER A, 1989, BEHRING I MITT, V84, P220; TENNER AJ, 1980, J IMMUNOL, V125, P1658; Tenner AJ, 1998, IMMUNOBIOLOGY, V199, P250, DOI 10.1016/S0171-2985(98)80031-4; TENNER AJ, 1981, J IMMUNOL, V127, P648; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; Tenner AJ, 1999, CURR OPIN IMMUNOL, V11, P34, DOI 10.1016/S0952-7915(99)80007-7; TENNER AJ, 1995, IMMUNITY, V3, P485, DOI 10.1016/1074-7613(95)90177-9; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Webster SD, 2000, J LEUKOCYTE BIOL, V67, P109, DOI 10.1002/jlb.67.1.109; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; YOUNG KR, 1991, J IMMUNOL, V146, P3356; Zhao H, 2000, FASEB J, V14, pA689	42	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43087	43094		10.1074/jbc.M105455200	http://dx.doi.org/10.1074/jbc.M105455200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11533031	hybrid			2022-12-27	WOS:000172169300061
J	Kalbfuss, B; Mabon, SA; Misteli, T				Kalbfuss, B; Mabon, SA; Misteli, T			Correction of alternative splicing of tau in frontotemporal dementia and Parkinsonism linked to chromosome 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; NEURODEGENERATIVE DISORDERS; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; NEURONAL CELLS; SR PROTEINS; MUTATIONS; GENE	Mutations in the human tau gene cause frontotemporal dementia and Parkinsonism associated with chromosome 17 (FTDP-17). One of the major disease mechanisms in FTDP-17 is the increased inclusion of tau exon 10 during pre-mRNA splicing. Here we show that modified oligonucleotides directed against the tau exon 10 splice junctions suppress inclusion of tau exon 10. The effect is mediated by the formation of a stable pre-mRNA-oligonucleotide hybrid, which blocks access of the splicing machinery to the pre-mRNA. Correction of tau splicing occurs in a tau minigene system and in endogenous tau RNA in neuronal pheochromocytoma cells and is specific to exon 10 of the tau gene. Antisense oligonucleotide-mediated exclusion of exon 10 has a physiological effect by increasing the ratio of protein lacking the microtubule-binding domain encoded by exon 10. As a consequence, the microtubule cytoskeleton becomes destabilized and cell morphology is altered. Our results demonstrate that alternative splicing defects of tau as found in FTDP-17 patients can be corrected by application of antisense oligonucleotides. These findings provide a tool to study specific tau isoforms in vivo and might lead to a novel therapeutic strategy for FTDP-17.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, 41 Lib Dr,Bldg 41, Bethesda, MD 20892 USA.							Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; D'Souza I, 2000, J BIOL CHEM, V275, P17700, DOI 10.1074/jbc.M909470199; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193; Gao QS, 2000, J NEUROCHEM, V74, P490, DOI 10.1046/j.1471-4159.2000.740490.x; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Higgins JJ, 1998, NEUROLOGY, V50, P270, DOI 10.1212/WNL.50.1.270; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishizawa K, 2000, ACTA NEUROPATHOL, V100, P235, DOI 10.1007/s004019900177; Janke C, 2000, BRAIN RES PROTOC, V5, P231, DOI 10.1016/S1385-299X(00)00018-0; Jay P, 2000, EUR J BIOCHEM, V267, P2921, DOI 10.1046/j.1432-1327.2000.01306.x; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591; LAMOND AI, 1989, CELL, V58, P383, DOI 10.1016/0092-8674(89)90852-0; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Sierakowska H, 1996, P NATL ACAD SCI USA, V93, P12840, DOI 10.1073/pnas.93.23.12840; SMITH CJ, 1995, FEBS LETT, V375, P243, DOI 10.1016/0014-5793(95)01221-Y; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Vanier MT, 1998, J CELL SCI, V111, P1419; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; Wilhelmsen KC, 1999, P NATL ACAD SCI USA, V96, P7120, DOI 10.1073/pnas.96.13.7120; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3	49	86	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42986	42993		10.1074/jbc.M105113200	http://dx.doi.org/10.1074/jbc.M105113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11560926	hybrid			2022-12-27	WOS:000172169300048
J	Mathupala, SP; Rempel, A; Pedersen, PL				Mathupala, SP; Rempel, A; Pedersen, PL			Glucose catabolism in cancer cells - Identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-1; EXPRESSION; TUMOR; TRANSCRIPTION; ELEMENTS; LINE; MITOCHONDRIA; PURIFICATION; METABOLISM; ENHANCER	One of the most common signatures of highly malignant tumors is their capacity to metabolize more glucose to lactic acid than their tissues of origin. Hepatomas exhibiting this phenotype are dependent on the high expression of type Il hexokinase, which supplies such tumors with abundant amounts of glucose 6-phosphate, a significant carbon and energy source especially under hypoxic conditions. Here we report that the distal region of the hepatoma. type Il hexokinase promoter displays consensus motifs for hypoxia-inducible factor (HIF-1) that overlap E-box sequences known to be related in other gene promoters to glucose response. Moreover, we show that subjecting transfected hepatoma cells to hypoxic conditions activates the type II hexokinase promoter almost 3-fold, a value that approaches 7-fold in the presence of glucose. Consistent with these findings is the induction under hypoxic conditions of the HIF-1 protein. Reporter gene analyses with a series of nested deletion mutants of the hepatoma type II hexokinase promoter show that a significant fraction of the total activation observed under hypoxic conditions localizes to the distal region where the overlapping HIF-1/E-box sequences are located. Finally, DNase I footprint analysis with a segment of the promoter containing these elements reveals the binding of several nuclear proteins. In summary, these novel studies identify and characterize a marked glucose-modulated activation response of the type II hexokinase gene to hypoxic conditions within highly glycolytic hepatoma cells, a property that may help assure that such cells exhibit a growth and survival advantage over their parental cells of origin.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Pedersen, PL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.				NCI NIH HHS [T32 CA 67751, CA 80118] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080118, T32CA067751] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Aisenberg AC, 1961, GLYCOLYSIS RESP TUMO; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BURK D, 1967, JNCI-J NATL CANCER I, V38, P839; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; KINGSTON RE, 1994, CURRENT PROTOCOLS MO; Kinzler KW, 1996, NATURE, V379, P19, DOI 10.1038/379019a0; Mathupala S. P., 1996, FASEB Journal, V10, pA1514; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; MATHUPALA SP, 1995, J BIOL CHEM, V270, P16918, DOI 10.1074/jbc.270.28.16918; NAKASHIMA RA, 1988, CANCER RES, V48, P913; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Rempel A, 1996, CANCER RES, V56, P2468; REMPEL A, 1996, FEBS LETT, V385, P223; Riddle SR, 2000, AM J PHYSIOL-LUNG C, V278, pL407, DOI 10.1152/ajplung.2000.278.2.L407; Sambrook J., 2002, MOL CLONING LAB MANU; Semenza G L, 2000, Respir Res, V1, P159, DOI 10.1186/rr27; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; SHINOHARA Y, 1991, FEBS LETT, V291, P55, DOI 10.1016/0014-5793(91)81102-E; SHOWE MK, 1992, NUCLEIC ACIDS RES, V20, P3153, DOI 10.1093/nar/20.12.3153; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WEINHOUSE S, 1972, CANCER RES, V23, P987	32	280	304	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43407	43412		10.1074/jbc.M108181200	http://dx.doi.org/10.1074/jbc.M108181200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11557773	hybrid			2022-12-27	WOS:000172169300100
J	Pombo, I; Martin-Verdeaux, S; Iannascoli, B; Le Mao, J; Deriano, L; Rivera, J; Blank, U				Pombo, I; Martin-Verdeaux, S; Iannascoli, B; Le Mao, J; Deriano, L; Rivera, J; Blank, U			IgE receptor type 1-dependent regulation of a Rab3D-associated kinase - A possible link in the calcium-dependent assembly of snare complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC-VESICLE FUSION; MAST-CELL SECRETION; SMALL G-PROTEINS; FC-EPSILON-RI; MEMBRANE-PROTEIN; TARGET MEMBRANE; RAB3 SUBFAMILY; EXOCYTOSIS; PHOSPHORYLATION; SYNTAXIN-4	Following activation through high affinity IgE receptors (Fc epsilon RI), mast cells release, within a few minutes, their granule content of inflammatory and allergic mediators. Fc epsilon RI-induced degranulation is a SNARE (soluble N-ethylmaleimide attachment protein receptors)-dependent fusion process. It is regulated by Rab3D, a subfamily member of Rab GTPases. Evidence exists showing that Rab3 action is calcium-regulated although the molecular mechanisms remain unclear. To obtain an understanding of Rab3D function we have searched for Rab3D-associated effectors that respond to allergic triggering through Fc epsilon RI. Using the RBL-2H3 mast cell line we detected a Ser/Thr kinase activity, termed here Rak3D (from Rab3D-associated kinase), because it was specifically co-immunoprecipitated with anti-Rab3D antibody. Rak3D activity, as measured by its auto- or transphosphorylation, was maximal in resting cells and decreased upon stimulation. The down-regulation of the observed activity was blocked with EGTA, but not with other degranulation inhibitors, suggesting that its activity functions downstream of calcium influx. We found that Rak3D phosphorylates the NH2-terminal regulatory domain of the t-SNARE syntaxin 4, but not syntaxin 2 or 3. The phosphorylation of syntaxin 4 decreased its binding to its partner SNAP23. Thus, we propose a novel phosphorylation-dependent mechanism by which Rab3D controls SNARE assembly in a calcium-dependent manner.	Inst Pasteur, Unite Immunoallergie, F-75724 Paris 15, France; NIAMS, Mol Inflammat Sect, NIH, Bethesda, MD 20892 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Blank, U (corresponding author), Inst Pasteur, Unite Immunoallergie, 25-28 Rue Dr Roux, F-75724 Paris 15, France.		Deriano, Ludovic/D-2048-2019	Deriano, Ludovic/0000-0002-9673-9525; Blank, Ulrich/0000-0002-2661-2983	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041101, Z01AR041101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMCZEWSKI M, 1992, J BIOL CHEM, V267, P18126; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Doussau F, 1998, J NEUROSCI, V18, P3147; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Duprez V, 1998, J BIOL CHEM, V273, P33985, DOI 10.1074/jbc.273.51.33985; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Galli S., 1998, FUNDAMENTAL IMMUNOLO, P1127; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hackam DJ, 1996, J IMMUNOL, V156, P4377; Haynes LP, 2001, J BIOL CHEM, V276, P9726, DOI 10.1074/jbc.M006959200; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Johannes L, 1998, J NEUROCHEM, V71, P1127; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kim TD, 1997, J BIOL CHEM, V272, P31225, DOI 10.1074/jbc.272.50.31225; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; LEY SC, 1991, EUR J IMMUNOL, V21, P2203, DOI 10.1002/eji.1830210931; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Ludowyke RI, 2000, J BIOL CHEM, V275, P6144, DOI 10.1074/jbc.275.9.6144; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; OBERHAUSER AF, 1994, FEBS LETT, V339, P171, DOI 10.1016/0014-5793(94)80409-5; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Ren MD, 1996, P NATL ACAD SCI USA, V93, P5151, DOI 10.1073/pnas.93.10.5151; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Roa M, 1997, J IMMUNOL, V159, P2815; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; Tuvim MJ, 1999, AM J RESP CELL MOL, V20, P79, DOI 10.1165/ajrcmb.20.1.3279; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Williams RM, 2000, J CELL SCI, V113, P3839; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; YANO H, 1993, J BIOL CHEM, V268, P25846; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	62	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42893	42900		10.1074/jbc.M103527200	http://dx.doi.org/10.1074/jbc.M103527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555639	hybrid			2022-12-27	WOS:000172169300036
J	Zhang, Q; Fan, JS; Zhang, MJ				Zhang, Q; Fan, JS; Zhang, MJ			Interdomain chaperoning between PSD-95, Dlg, and Zo-1 (PDZ) domains of glutamate receptor-interacting proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; AMPA RECEPTORS; POSTSYNAPTIC DENSITY; CRYSTAL-STRUCTURE; C-TERMINUS; BINDING; GLUR2; REQUIRES; COMPLEX; PHOSPHORYLATION	The multiple PSD-95, Dlg, and Zo-1 (PDZ) domain protein, glutamate receptor-interacting protein (GRIP), is involved in the clustering and trafficking of the alpha -amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor by directly binding to the cytoplasmic tail of the receptor's GluR2 subunit. Both the forth and fifth PDZ domains (PDZ4 and PDZ5) of GRIP are required for effective binding to the receptor. Using NAM and circular dichroism spectroscopic techniques, we show that PDZ5 is completely unstructured in solution. Freshly prepared PDZ4 is largely folded, but the domain can spontaneously unfold. Neither PDZ4 nor PDZ5 binds to GluR2 in solution. Unexpectedly, when PDZ4 and PDZ5 are covalently connected (i.e. PDZ45), both PDZ domains become well folded and stable in solution. The covalent linkage of the two PDZ domains is essential for proper folding of the tandem PDZ domains and its effective binding to GluR2. The interdomain chaperoning effect observed in the PDZ domains of GRIP represents a previously uncharacterized function of PDZ domains.	Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk		Zhang, Mingjie/0000-0001-9404-0190				Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Chung HJ, 2000, J NEUROSCI, V20, P7258; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	34	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43216	43220		10.1074/jbc.M105996200	http://dx.doi.org/10.1074/jbc.M105996200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553623	hybrid			2022-12-27	WOS:000172169300076
J	Ahuja, D; Karow, DS; Kilpatrick, JE; Imperiale, MJ				Ahuja, D; Karow, DS; Kilpatrick, JE; Imperiale, MJ			RNA polymerase II-dependent positional effects on mRNA 3 ' end processing in the adenovirus major late transcription unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; POLY(A) SITE SELECTION; POLYADENYLATION SPECIFICITY FACTOR; GENE-EXPRESSION; SPLICE SITE; CLEAVAGE; SEQUENCES; PROTEIN; 3'-END; RECOGNITION	During the early phase of adenovirus infection, the promoter-proximal L1 poly(A) site in the major late transcription unit is used preferentially despite the fact that the distal L3 poly(A) site is stronger (i.e. it competes better for processing factors and is cleaved at a faster rate, in vitro). Previous work had established that this was due at least in part to the stable binding of the processing factor, cleavage and polyadenylation specificity factor, to the L1 poly(A) site as mediated by specific regulatory sequences. It is now demonstrated that in addition, the L1 poly(A) site has a positional advantage because of its 5' location in the transcription unit. We also show that preferential processing of a particular poly(A) site in a complex transcription unit is dependent on RNA polymerase II. Our results are consistent with recent reports demonstrating that the processing factors cleavage and polyadenylation specificity factor and cleavage stimulatory factor are associated with the RNA polymerase II holoenzyme; thus, processing at a weak poly(A) site like L1 can be enhanced by virtue of its being the first site to be transcribed.	Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Imperiale, MJ (corresponding author), 6310 Canc Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.							AKUSJARVI G, 1981, NATURE, V292, P420, DOI 10.1038/292420a0; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; BAHRING S, 1994, BIOTECHNIQUES, V16, P807; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Cooke C, 1996, MOL CELL BIOL, V16, P2579; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; DEMERCOYROL L, 1989, BIOCHEM J, V258, P165, DOI 10.1042/bj2580165; DENOME RM, 1988, MOL CELL BIOL, V8, P4829, DOI 10.1128/MCB.8.11.4829; DEZAZZO JD, 1989, MOL CELL BIOL, V9, P4951, DOI 10.1128/MCB.9.11.4951; DEZAZZO JD, 1991, MOL CELL BIOL, V11, P5977, DOI 10.1128/MCB.11.12.5977; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; FALCKPEDERSEN E, 1989, J VIROL, V63, P532, DOI 10.1128/JVI.63.2.532-541.1989; GILMARTIN GM, 1991, MOL CELL BIOL, V11, P2432, DOI 10.1128/MCB.11.5.2432; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; GILMARTIN GM, 1988, GENE DEV, V2, P578, DOI 10.1101/gad.2.5.578; Gilmartin GM, 1996, J VIROL, V70, P1775, DOI 10.1128/JVI.70.3.1775-1783.1996; Graveley BR, 1996, MOL CELL BIOL, V16, P4942; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; Imperiale M J, 1995, Curr Top Microbiol Immunol, V199 ( Pt 2), P139; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; KOBRIN BJ, 1986, MOL CELL BIOL, V6, P1687, DOI 10.1128/MCB.6.5.1687; LASSMAN CR, 1992, J IMMUNOL, V148, P2578; LASSMAN CR, 1992, J IMMUNOL, V148, P1251; MANLEY JL, 1982, J MOL BIOL, V159, P581, DOI 10.1016/0022-2836(82)90102-4; MANN KP, 1993, MOL CELL BIOL, V13, P2411, DOI 10.1128/MCB.13.4.2411; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; Nevins J R, 1981, Adv Virus Res, V26, P1, DOI 10.1016/S0065-3527(08)60419-4; NEVINS JR, 1978, CELL, V15, P1477, DOI 10.1016/0092-8674(78)90071-5; NEVINS JR, 1981, NATURE, V290, P113, DOI 10.1038/290113a0; PRESCOTT JC, 1992, J BIOL CHEM, V267, P8175; Prescott JC, 1997, MOL CELL BIOL, V17, P2207, DOI 10.1128/MCB.17.4.2207; SANDIG V, 1993, GENE, V131, P255, DOI 10.1016/0378-1119(93)90302-J; Schul W, 1996, EMBO J, V15, P2883, DOI 10.1002/j.1460-2075.1996.tb00649.x; SHAW AR, 1980, CELL, V22, P905, DOI 10.1016/0092-8674(80)90568-1; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, BBA-GENE STRUCT EXPR, V1261, P183, DOI 10.1016/0167-4781(94)00248-2; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; WILSONGUNN SI, 1992, J VIROL, V66, P5418, DOI 10.1128/JVI.66.9.5418-5424.1992; WILUSZ J, 1990, MOL CELL BIOL, V10, P6397, DOI 10.1128/MCB.10.12.6397	59	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41825	41831		10.1074/jbc.M104709200	http://dx.doi.org/10.1074/jbc.M104709200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551915	hybrid			2022-12-27	WOS:000172450400039
J	Azpiazu, I; Gautam, N				Azpiazu, I; Gautam, N			G protein gamma subunit interaction with a receptor regulates receptor-stimulated nucleotide exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GTP-BINDING; RHODOPSIN; PURIFICATION; COMPLEX; SWITCH; G(Q)	The surfaces of heterotrimeric G proteins (alpha beta gamma) in contact with receptors and the molecular events at these sites, which lead to G protein activation, are largely unknown. We show here that a peptide from the C terminus of a G protein gamma subunit blocks muscarinic receptor-stimulated G protein activation in a sequence-dependent fashion. A G protein mutated at the same site on the gamma subunit shows enhanced receptor stimulated nucleotide exchange without affecting G protein hetero-trimerization. Ineffective contact between the gamma subunit and receptor increases the rate of receptor-stimulated nucleotide exchange. Specific interaction of the G protein gamma subunit with the receptor thus helps the beta gamma complex to act at a distance and control guanine nucleotide exchange in the a subunit.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gautam, N (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Box 8054, St Louis, MO 63110 USA.				NIGMS NIH HHS [GM46963, R01 GM046963] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azpiazu I, 1999, J BIOL CHEM, V274, P35305, DOI 10.1074/jbc.274.50.35305; AZPIAZU L, 2001, IN PRESS METHODS ENZ; BENNETT N, 1985, J BIOL CHEM, V260, P4156; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hayashi MK, 1996, J BIOCHEM, V120, P1232; Hou YM, 2000, J BIOL CHEM, V275, P38961, DOI 10.1074/jbc.C000604200; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LINDER ME, 1995, METHOD ENZYMOL, V250, P314; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	20	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41742	41747		10.1074/jbc.M104034200	http://dx.doi.org/10.1074/jbc.M104034200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546799	hybrid			2022-12-27	WOS:000172450400028
J	Niccolai, N; Ciutti, A; Spiga, O; Scarselli, M; Bernini, A; Bracci, L; Di Maro, D; Dalvit, C; Molinari, H; Esposito, G; Temussi, PA				Niccolai, N; Ciutti, A; Spiga, O; Scarselli, M; Bernini, A; Bracci, L; Di Maro, D; Dalvit, C; Molinari, H; Esposito, G; Temussi, PA			NMR studies of protein surface accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; NUCLEAR-MAGNETIC-RESONANCE; WATER-MOLECULES; ORGANIC-SOLVENTS; AQUEOUS-SOLUTION; BINDING-SITES; HYDRATION; SPECTROSCOPY; SUPPRESSION; REFINEMENT	Characterization of protein surface accessibility represents a new frontier of structural biology. A surface accessibility investigation for two structurally well-defined proteins, tendamistat and bovine pancreatic trypsin inhibitor, is performed here by a combined analysis of water-protein Overhauser effects and paramagnetic perturbation profiles induced by the soluble spin-label 4-hydroxy-2,2,6,6-tetramethyl-piperidine-1-oxyI on NMR spectra. This approach seems to be reliable not only for distinguishing between buried and exposed residues but also for finding molecular locations where a network of more ordered waters covers the protein surface. From the presented set of data, an overall picture of the surface accessibility of the two proteins can be inferred. Detailed knowledge of protein accessibility can form the basis for successful design of mutants with increased activity and/or greater specificity.	Univ Siena, Biomol Struct Res Ctr, I-53100 Siena, Italy; Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; BIOMODEN perl, I-53100 Siena, Italy; Pharmacia Dept Chem, I-20014 Nerviano, Milan, Italy; Univ Verona, Ist Policattedra, I-37100 Verona, Italy; Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy; Univ Naples, Dept Chem, I-80100 Naples, Italy	University of Siena; University of Siena; Pfizer; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine; University of Naples Federico II	Niccolai, N (corresponding author), Univ Siena, Biomol Struct Res Ctr, Via Fiorentina 1, I-53100 Siena, Italy.		molinari, henriette/ABE-9775-2021; Molinari, Henriette/A-1695-2008; Bracci, Luisa/V-9913-2018; Temussi, Piero A/N-5830-2017; Bernini, Andrea/H-9412-2012	Molinari, Henriette/0000-0002-3678-130X; Bracci, Luisa/0000-0002-0738-5746; Temussi, Piero A/0000-0001-6032-4291; Bernini, Andrea/0000-0002-7528-2749				AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BERNDT KD, 1992, J MOL BIOL, V227, P757, DOI 10.1016/0022-2836(92)90222-6; BILLETER M, 1990, BIOPOLYMERS, V29, P695, DOI 10.1002/bip.360290404; BRUNNE RM, 1993, J MOL BIOL, V231, P1040, DOI 10.1006/jmbi.1993.1350; Dalvit C, 1996, J MAGN RESON SER B, V112, P282, DOI 10.1006/jmrb.1996.0143; Dalvit C, 1999, J BIOMOL NMR, V14, P23, DOI 10.1023/A:1008378929578; Dalvit C, 1998, J BIOMOL NMR, V11, P437, DOI 10.1023/A:1008272928075; DENISOV VP, 1995, J MOL BIOL, V245, P682, DOI 10.1006/jmbi.1994.0055; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krantz A, 1998, TRENDS BIOTECHNOL, V16, P198, DOI 10.1016/S0167-7799(98)01177-9; Liepinsh E, 1997, NAT BIOTECHNOL, V15, P264, DOI 10.1038/nbt0397-264; Mattos C, 1996, NAT BIOTECHNOL, V14, P595, DOI 10.1038/nbt0596-595; Melacini G, 1999, J MAGN RESON, V136, P214, DOI 10.1006/jmre.1998.1646; Melacini G, 1999, J BIOMOL NMR, V15, P189, DOI 10.1023/A:1008316612907; Molinari H, 1997, BIOPHYS J, V73, P382, DOI 10.1016/S0006-3495(97)78078-0; Nakasako M, 1999, J MOL BIOL, V289, P547, DOI 10.1006/jmbi.1999.2795; Niccolai N, 2001, PROTEIN SCI, V10, P1498, DOI 10.1110/ps.30101; OTTING G, 1991, J AM CHEM SOC, V113, P4363, DOI 10.1021/ja00011a068; OTTING G, 1989, J AM CHEM SOC, V111, P1871, DOI 10.1021/ja00187a050; Otting G, 1997, PROG NUCL MAG RES SP, V31, P259, DOI 10.1016/S0079-6565(97)00012-5; PFLUGRATH JW, 1986, J MOL BIOL, V189, P383, DOI 10.1016/0022-2836(86)90520-6; Ringe D, 1995, CURR OPIN STRUC BIOL, V5, P825, DOI 10.1016/0959-440X(95)80017-4; Savvides SN, 1996, J BIOL CHEM, V271, P8101, DOI 10.1074/jbc.271.14.8101; Scarselli M, 1999, J BIOMOL NMR, V15, P125, DOI 10.1023/A:1008319507565; WLODAWER A, 1987, J MOL BIOL, V198, P469, DOI 10.1016/0022-2836(87)90294-4; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130	30	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42455	42461		10.1074/jbc.M107387200	http://dx.doi.org/10.1074/jbc.M107387200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546818	Green Published, hybrid			2022-12-27	WOS:000172450400117
J	Jia, YF; Ransom, RF; Shibanuma, M; Liu, CH; Welsh, MJ; Smoyer, WE				Jia, YF; Ransom, RF; Shibanuma, M; Liu, CH; Welsh, MJ; Smoyer, WE			Identification and characterization of hic-5/ARA55 as an hsp27 binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-B-CRYSTALLIN; FOCAL ADHESION PROTEIN; TUMOR-NECROSIS-FACTOR; EMBRYONIC STEM-CELLS; SMALL STRESS PROTEIN; ACTIN POLYMERIZATION; MOLECULAR-WEIGHT; OXIDATIVE STRESS; RECEPTOR COACTIVATOR	hsp27 has been reported to participate in a wide variety of activities, including resistance to thermal and metabolic stress, regulation of growth and differentiation, and acting as a molecular chaperone or a regulator of actin polymerization. We hypothesized that these diverse functions are regulated in a cell- or tissue-specific manner via interaction with various binding proteins. To investigate this hypothesis, we used hsp27 as a "bait" to screen a yeast two-hybrid cDNA library from rat kidney glomeruli and identified a novel hsp27 binding protein, hic-5 (also known as ARA55), a focal adhesion protein and steroid receptor co-activator. Biochemical interaction between hsp27 and hic-5 was confirmed by co-immunoprecipitation, and critical protein-protein interaction regions were mapped to the hic-5 LIM domains and the hsp27 C-terminal domain. Initial analysis of the functional role of hsp27(.)hic-5 interaction revealed that hic-5 significantly inhibited the protection against heat-induced cell death conferred by hsp27 overexpression in co-transfected 293T cells. In contrast, when a non-hsp27-interacting hic-5 truncation mutant (hic-5/Delta LIM4) was co-expressed with hsp27, the hic-5 inhibition of hsp27 protection was absent. We conclude that hic-5 is a true hsp27 binding protein and inhibits the ability of hsp27 to provide protection against heat shock in an interaction-dependent manner.	Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Showa Univ, Sch Pharmaceut Sci, Dept Microbiol, Tokyo 142, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Showa University	Welsh, MJ (corresponding author), Univ Michigan, Med Ctr, Dept Cell & Dev Biol, 4728 MSII,Box 0616, Ann Arbor, MI 48109 USA.	welsh@umich.edu	Welsh, Michael/B-1968-2008		NIDDK NIH HHS [K08 DK02455-01] Funding Source: Medline; NIEHS NIH HHS [ES06265] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006265] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arata S, 1997, J CELL PHYSIOL, V170, P19, DOI 10.1002/(SICI)1097-4652(199701)170:1<19::AID-JCP3>3.0.CO;2-O; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BITAR KN, 1991, BIOCHEM BIOPH RES CO, V181, P1192, DOI 10.1016/0006-291X(91)92065-R; CIOCCA DR, 1983, CANCER RES, V43, P1204; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; FUQUA SAW, 1994, BREAST CANCER RES TR, V32, P177, DOI 10.1007/BF00665768; Hagmann J, 1998, J CELL SCI, V111, P2181; Hoch B, 1996, MOL CELL BIOCHEM, V161, P231, DOI 10.1007/BF00240054; Horman S, 1997, CELL PROLIFERAT, V30, P21, DOI 10.1111/j.1365-2184.1997.tb00913.x; Hu YH, 1999, P NATL ACAD SCI USA, V96, P10218, DOI 10.1073/pnas.96.18.10218; Huot J, 1996, CANCER RES, V56, P273; Ishino K, 2000, J CELL BIOCHEM, V76, P411, DOI 10.1002/(SICI)1097-4644(20000301)76:3<411::AID-JCB9>3.0.CO;2-J; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Joanisse DR, 1998, BIOCHEM BIOPH RES CO, V244, P102, DOI 10.1006/bbrc.1998.8214; KAMPINGA HH, 1994, BIOCHEM BIOPH RES CO, V204, P1170, DOI 10.1006/bbrc.1994.2586; KATO K, 1994, J BIOL CHEM, V269, P11274; KNAUF U, 1992, FEBS LETT, V309, P297, DOI 10.1016/0014-5793(92)80793-G; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; KREISBERG JI, 1978, KIDNEY INT, V14, P21, DOI 10.1038/ki.1978.86; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Landry J, 1999, BIOCHEM SOC SYMP, P79; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Liu CH, 2000, J BIOL CHEM, V275, P18724, DOI 10.1074/jbc.M001981200; Liu CH, 1999, BIOCHEM BIOPH RES CO, V255, P256, DOI 10.1006/bbrc.1999.0174; Lutsch G, 1997, CIRCULATION, V96, P3466; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; MEHLEN P, 1995, J IMMUNOL, V154, P363; Mehlen P, 1997, J BIOL CHEM, V272, P31657, DOI 10.1074/jbc.272.50.31657; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Nishiya N, 1998, NUCLEIC ACIDS RES, V26, P4267, DOI 10.1093/nar/26.18.4267; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; PIOTROWICZ RS, 1995, FASEB J, V9, P1079, DOI 10.1096/fasebj.9.11.7649407; ROBERTS KP, 1995, BIOL REPROD, V53, P1446, DOI 10.1095/biolreprod53.6.1446; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schneider GB, 1998, J CELL PHYSIOL, V177, P575, DOI 10.1002/(SICI)1097-4652(199812)177:4<575::AID-JCP8>3.0.CO;2-1; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Thomas SA, 1996, BRIT J UROL, V77, P367, DOI 10.1046/j.1464-410X.1996.09058.x; Thomas SM, 1999, J CELL SCI, V112, P181; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Welsh MJ, 1996, BIOL REPROD, V55, P141, DOI 10.1095/biolreprod55.1.141; Wu W, 1996, TOXICOL APPL PHARM, V141, P330; Yang L, 2000, MOL BIOL CELL, V11, P2007, DOI 10.1091/mbc.11.6.2007; ZHU Y, 1994, J BIOL CHEM, V269, P22379	56	49	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39911	39918		10.1074/jbc.M103510200	http://dx.doi.org/10.1074/jbc.M103510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546764	hybrid			2022-12-27	WOS:000171789200056
J	Murray, D; McLaughlin, S; Honig, B				Murray, D; McLaughlin, S; Honig, B			The role of electrostatic interactions in the regulation of the membrane association of G protein beta gamma heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; SMALL BASIC PEPTIDES; CRYSTAL-STRUCTURE; LIPID MODIFICATIONS; ACIDIC LIPIDS; BINDING; SUBUNITS; RESIDUES; INSIGHTS; SRC	In this paper we report calculations of electrostatic interactions between the transducin (G(t)) beta gamma heterodimer (G(t)beta gamma) and phospholipid membranes. Although membrane association of G(t)beta gamma is due primarily to the hydrophobic penetration into the membrane interior of a farnesyl chain attached to the gamma subunit, structural studies have revealed that there is a prominent patch of basic residues on the surface of the beta subunit surrounding the site of farnesylation that is exposed upon dissociation from the G(t)alpha subunit. Moreover, phosducin, which produces dissociation of G(t)beta gamma from membranes, interacts directly with G(t)beta gamma and introduces a cluster of acidic residues into this region. The calculations, which are based on the finite difference Poisson-Boltzmann method, account for a number of experimental observations and suggest that charged residues play a role in mediating protein-membrane interactions. Specifically, the calculations predict the following. 1) Favorable electrostatic interactions enhance the membrane partitioning due to the farnesyl group by an order of magnitude although G(t)beta gamma has a large net negative charge (-12). 2) This electrostatic attraction positions G(t)beta gamma so that residues implicated in mediating the interaction of G(t)beta gamma with its membrane-bound effectors are close to the membrane surface. 3) The binding of phosducin to G(t)beta gamma diminishes the membrane partitioning of G(t)beta gamma by an order of magnitude. 4) Lowering the ionic strength of the solution converts the electrostatic attraction into a repulsion. Sequence analysis and homology model building suggest that our conclusions may be generalized to other G beta gamma and phosducin isoforms as well.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Columbia University; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Honig, B (corresponding author), Weill Cornell Med Sch, Dept Microbiol & Immunol, 1300 York Ave,Box 62, New York, NY 10021 USA.	bh6@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024971, R37GM024971] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24971] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Balcueva EA, 2000, EXP CELL RES, V257, P310, DOI 10.1006/excr.2000.4893; BenTal N, 1997, BIOPHYS J, V73, P1717, DOI 10.1016/S0006-3495(97)78203-1; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bhatnagar RS, 1997, TRENDS CELL BIOL, V7, P14, DOI 10.1016/S0962-8924(97)10044-7; BIGAY J, 1994, METHOD ENZYMOL, V237, P449; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burden LM, 1999, BIOCHEMISTRY-US, V38, P15141, DOI 10.1021/bi991571a; BUSER CA, 1994, BIOCHEMISTRY-US, V33, P13093, DOI 10.1021/bi00248a019; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; Danner S, 1996, P NATL ACAD SCI USA, V93, P10145, DOI 10.1073/pnas.93.19.10145; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hessel E, 2001, J BIOL CHEM, V276, P2538, DOI 10.1074/jbc.M009061200; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; Kleinschmidt JH, 1997, BIOPHYS J, V73, P2546, DOI 10.1016/S0006-3495(97)78283-3; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEE RH, 1988, EXP EYE RES, V46, P829, DOI 10.1016/S0014-4835(88)80035-6; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Magee T, 1999, CELL, V98, P9, DOI 10.1016/S0092-8674(00)80601-7; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; MILES MF, 1993, P NATL ACAD SCI USA, V90, P10831, DOI 10.1073/pnas.90.22.10831; MONTICH G, 1993, BIOCHIM BIOPHYS ACTA, V1146, P17, DOI 10.1016/0005-2736(93)90333-U; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PEITZSCH RM, 1995, BIOPHYS J, V68, P729, DOI 10.1016/S0006-3495(95)80253-5; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schroder S, 1996, P NATL ACAD SCI USA, V93, P2100, DOI 10.1073/pnas.93.5.2100; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; SHARP KA, 1990, J PHYS CHEM-US, V94, P7684, DOI 10.1021/j100382a068; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Tanaka H, 1996, BIOCHEM BIOPH RES CO, V223, P587, DOI 10.1006/bbrc.1996.0939; Thibault C, 1997, J BIOL CHEM, V272, P12253, DOI 10.1074/jbc.272.19.12253; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WU G, 1993, BIOCHEMISTRY-US, V32, P879, DOI 10.1021/bi00054a020; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Yang AS, 1999, PROTEINS, P66	59	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45153	45159		10.1074/jbc.M101784200	http://dx.doi.org/10.1074/jbc.M101784200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11557749	hybrid			2022-12-27	WOS:000172406700107
J	Tieman, BC; Johnston, MF; Fisher, MT				Tieman, BC; Johnston, MF; Fisher, MT			A comparison of the GroE chaperonin requirements for sequentially and structurally homologous malate dehydrogenases - The importance of folding kinetics and solution environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DODECAMERIC GLUTAMINE-SYNTHETASE; NATIVE ESCHERICHIA-COLI; IN-VITRO; AGGREGATION; MECHANISM; PROTEINS; STABILIZATION; RENATURATION; COMMITMENT; CATALYZE	Escherichia coli malate dehydrogenase (EcMDH) and its eukaryotic counterpart, porcine mitochondrial malate dehydrogenase (PmMDH), are highly homologous proteins with significant sequence identity (60%) and virtually identical native structural folds. Despite this homology, EcMDH folds rapidly and efficiently in vitro and does not seem to interact with GroE chaperonins at physiological temperatures (37 degrees C), whereas PmMDH folds much slower than EcMDH and requires these chaperonins to fold to the native state at 37 degrees C. Double jump experiments indicate that the slow folding behavior of PmMDH is not limited by proline isomerization. Although the folding enhancer glycerol (<5 M) does not alter the renaturation kinetics of EcMDH, it dramatically accelerates the spontaneous renaturation of PmMDH at all temperatures tested. Kinetic analysis of PmMDH renaturation with increasing glycerol concentrations suggests that this osmolyte increases the on-pathway kinetics of the monomer folding to assembly-competent forms. Other osmolytes such as trimethylamine N-oxide, sucrose, and betaine also reactivate PmMDH at nonpermissive temperatures (37 <degrees>C). Glycerol jump experiments with preformed GroEL.PmMDH complexes indicate that the shift between stringent (requires ATP and GroES) and relaxed (only requires ATP) complex conformations is rapid (<3-5 s). The similarity in irreversible misfolding kinetics of PmMDH measured with glycerol or the activated chaperonin complex (GroEL.GroES.ATP) suggests that these folding aids may influence the same step in the PmMDH folding reaction. Moreover, the interactions between glycerol-induced PmMDH folding intermediates and GroEL.GroES.ATP are diminished. Our results support the notion that the protein folding kinetics of sequentially and structurally homologous proteins, rather than the structural fold, dictates the GroE chaperonin requirement.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Fisher, MT (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	mfisher1@kumc.edu			NIGMS NIH HHS [GM49309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049309] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Clark AC, 1999, J MOL BIOL, V285, P1765, DOI 10.1006/jmbi.1998.2402; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; Clark AC, 1997, J MOL BIOL, V268, P512, DOI 10.1006/jmbi.1997.0969; Clark AC, 1999, J MOL BIOL, V285, P1777, DOI 10.1006/jmbi.1998.2403; COURTENAY ES, 2000, BIOCHEMISTRY-US, V39, P959; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Eisenstein E, 1998, METHOD ENZYMOL, V290, P119, DOI 10.1016/S0076-6879(98)90011-8; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Fenton WA, 1997, PROTEIN SCI, V6, P743; FISHER MT, 1994, J BIOL CHEM, V269, P13629; FISHER MT, 1992, BIOCHEMISTRY-US, V31, P3955, DOI 10.1021/bi00131a010; FISHER MT, 1994, J BIOL CHEM, V269, P29598; Frieden C, 1997, P NATL ACAD SCI USA, V94, P5535, DOI 10.1073/pnas.94.11.5535; Frye KJ, 1997, PROTEIN SCI, V6, P789; HALL MD, 1992, J MOL BIOL, V226, P867, DOI 10.1016/0022-2836(92)90637-Y; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jacob M, 1999, BIOCHEMISTRY-US, V38, P13773, DOI 10.1021/bi991503o; JAENICKE R, 1979, BIOCHEMISTRY-US, V18, P1217, DOI 10.1021/bi00574a016; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kendrick BS, 1998, P NATL ACAD SCI USA, V95, P14142, DOI 10.1073/pnas.95.24.14142; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladurner AG, 1999, NAT STRUCT BIOL, V6, P28; LIU YF, 1995, BIOCHEMISTRY-US, V34, P12884, DOI 10.1021/bi00039a051; MATTINGLY JR, 1993, J BIOL CHEM, V268, P26320; MILLER AD, 1993, BIOCHEM J, V291, P139, DOI 10.1042/bj2910139; Netzer WJ, 1998, TRENDS BIOCHEM SCI, V23, P68, DOI 10.1016/S0968-0004(97)01171-7; Panda M, 2000, J BIOL CHEM, V275, P63, DOI 10.1074/jbc.275.1.63; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; RODERICK SL, 1986, J BIOL CHEM, V261, P9461; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Schmid F X, 1986, Methods Enzymol, V131, P70; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Voziyan PA, 2000, J PHARM SCI-US, V89, P1036, DOI 10.1002/1520-6017(200008)89:8<1036::AID-JPS8>3.0.CO;2-5; Voziyan PA, 1998, J BIOL CHEM, V273, P25073, DOI 10.1074/jbc.273.39.25073; Voziyan PA, 2000, PROTEIN SCI, V9, P2405, DOI 10.1110/ps.9.12.2405; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; Weatherly GT, 2001, PROTEIN SCI, V10, P12, DOI 10.1110/ps.29301; Widmann M, 2000, J BIOL CHEM, V275, P18619, DOI 10.1074/jbc.C000156200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	50	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44541	44550		10.1074/jbc.M106693200	http://dx.doi.org/10.1074/jbc.M106693200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11551947	hybrid			2022-12-27	WOS:000172406700028
J	Baltrusch, S; Lenzen, S; Okar, DA; Lange, AJ; Tiedge, M				Baltrusch, S; Lenzen, S; Okar, DA; Lange, AJ; Tiedge, M			Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library - Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TISSUE-SPECIFIC EXPRESSION; GLUCOSE SENSOR PARADIGM; INSULIN-SECRETING CELLS; REGULATORY PROTEIN; FRUCTOSE 6-PHOSPHATE; RAT-BRAIN; B-CELLS; SUBCELLULAR-LOCALIZATION; INTRACELLULAR BINDING	The low affinity glucose-phosphorylating enzyme glucokinase shows the phenomenon of intracellular translocation in beta cells of the pancreas and the liver. To identify potential binding partners of glucokinase by a systematic strategy, human beta cell glucokinase was screened by a 12-mer random peptide library displayed by the M13 phage. This panning procedure revealed two consensus motifs with a high binding affinity for glucokinase. The first consensus motif, LSAXXVAG, corresponded to the glucokinase regulatory protein of the liver. The second consensus motif, SLKVWT, showed a complete homology to the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2), which acts as a key regulator of glucose metabolism. Through yeast two-hybrid analysis it became evident that the binding of glucokinase to PFK-2/FBPase-2 is conferred by the bisphosphatase domain, whereas the kinase domain is responsible for dimerization. 5'-Rapid amplification of cDNA ends analysis and Northern blot analysis revealed that rat pancreatic islets express the brain isoform of PFK-2/FBPase-2. A minor portion of the islet PFK-2/FBPase-2 cDNA clones comprised a novel splice variant with 8 additional amino acids in the kinase domain. The binding of the islet/brain PFK-2/ FBPase-2 isoform. to glucokinase was comparable with that of the liver isoform. The interaction between glucokinase and PFK-2/FBPase-2 may provide the rationale for recent observations of a fructose-2,6-bisphosphate level-dependent partial channeling of glycolytic intermediates between glucokinase and glycolytic enzymes. In pancreatic beta cells this interaction may have a regulatory function for the metabolic stimulus-secretion coupling. Changes in fructose-2,6-bisphosphate levels and modulation of PFK-2/FBPase-2 activities may participate in the physiological regulation of glucokinase-mediated glucose-induced insulin secretion.	Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany; Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Hannover Medical School; University of Minnesota System; University of Minnesota Twin Cities	Tiedge, M (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany.				NIDDK NIH HHS [DK-38354] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK038354, R01DK038354] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agius L, 1997, BIOCHEM SOC T, V25, P145, DOI 10.1042/bst0250145; AGIUS L, 1995, BIOCHEM J, V309, P711, DOI 10.1042/bj3090711; AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Ausubel FM, 1998, CURRENT PROTOCOLS MO; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Batra RS, 1996, FEBS LETT, V393, P167, DOI 10.1016/0014-5793(96)00878-2; BURCH PT, 1981, DIABETES, V30, P923, DOI 10.2337/diabetes.30.11.923; BURCH PT, 1985, DIABETES, V34, P1014, DOI 10.2337/diabetes.34.10.1014; Cascante M, 2000, BIOCHEM J, V352, P899, DOI 10.1042/0264-6021:3520899; CHEN C, 1994, DIABETES, V43, P684, DOI 10.2337/diabetes.43.5.684; CHEN C, 1994, J CLIN INVEST, V94, P1616, DOI 10.1172/JCI117503; CHIKRI M, 1995, BIOCHEMISTRY-US, V34, P8876, DOI 10.1021/bi00027a040; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIRIACY M, 1979, J BACTERIOL, V139, P152, DOI 10.1128/JB.139.1.152-160.1979; DACUNHA MV, 1996, J BIOL CHEM, V271, P6292; DARVILLE MI, 1987, FEBS LETT, V224, P317, DOI 10.1016/0014-5793(87)80476-3; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; DETHEUX M, 1993, FEBS LETT, V321, P111, DOI 10.1016/0014-5793(93)80089-D; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Jorns A, 1999, VIRCHOWS ARCH, V434, P75, DOI 10.1007/s004280050308; Lenzen S, 2000, BBA-GEN SUBJECTS, V1523, P65, DOI 10.1016/S0304-4165(00)00100-8; LENZEN S, 1988, BIOCHEM PHARMACOL, V37, P371, DOI 10.1016/0006-2952(88)90201-8; LENZEN S, 1987, ACTA ENDOCRINOL-COP, V115, P21, DOI 10.1530/acta.0.1150021; LIANG Y, 1994, DIABETES, V43, P1138, DOI 10.2337/diabetes.43.9.1138; LIANG Y, 1990, J BIOL CHEM, V265, P16863; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; Magnuson Mark A., 1994, P155; MALAISSE WJ, 1982, DIABETES, V31, P90, DOI 10.2337/diabetes.31.1.90; MALAISSE WJ, 1991, INT J BIOCHEM, V23, P1471, DOI 10.1016/0020-711X(91)90290-4; MATSCHINSKY F, 1993, J CLIN INVEST, V92, P2092, DOI 10.1172/JCI116809; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MATSCHINSKY FM, 1993, DIABETOLOGIA, V36, P1215, DOI 10.1007/BF00401072; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; MEGLASSON MD, 1984, AM J PHYSIOL, V246, pE1, DOI 10.1152/ajpendo.1984.246.1.E1; NIEMEYER H, 1988, ARCH BIOCHEM BIOPHYS, V265, P91, DOI 10.1016/0003-9861(88)90374-8; Noma Y, 1996, ENDOCRINOLOGY, V137, P1485, DOI 10.1210/en.137.4.1485; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; PERMUTT MA, 1992, DIABETES, V41, P1367, DOI 10.2337/diabetes.41.11.1367; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Sakurai T, 1996, BIOCHEM BIOPH RES CO, V218, P159, DOI 10.1006/bbrc.1996.0028; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENER A, 1984, BIOCHEM J, V221, P759, DOI 10.1042/bj2210759; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Stubbs M, 2000, DIABETES, V49, P2048, DOI 10.2337/diabetes.49.12.2048; TAULER A, 1989, P NATL ACAD SCI USA, V86, P7316, DOI 10.1073/pnas.86.19.7316; Tiedge M, 1999, DIABETES, V48, P514, DOI 10.2337/diabetes.48.3.514; Tiedge M, 1997, BBA-PROTEIN STRUCT M, V1337, P175, DOI 10.1016/S0167-4838(96)00162-8; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; WARNER JP, 1995, MAMM GENOME, V6, P532, DOI 10.1007/BF00356171; Watanabe F, 1999, FEBS LETT, V458, P304, DOI 10.1016/S0014-5793(99)01174-6; WATANABE F, 1994, BIOCHEM BIOPH RES CO, V198, P335, DOI 10.1006/bbrc.1994.1047; Watanabe F, 1997, J NEUROCHEM, V69, P1; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103	62	69	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43915	43923		10.1074/jbc.M105470200	http://dx.doi.org/10.1074/jbc.M105470200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11522786	hybrid			2022-12-27	WOS:000172297700058
J	Choy, JS; Tobe, BTD; Huh, JH; Kron, SJ				Choy, JS; Tobe, BTD; Huh, JH; Kron, SJ			Yng2p-dependent NuA4 histone H4 acetylation activity is required for mitotic and meiotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TUMOR-SUPPRESSOR P33(ING1); B-TYPE CYCLINS; CELL-CYCLE; ACETYLTRANSFERASE COMPLEXES; GENE ACTIVATION; IN-VIVO; TRANSCRIPTION; GROWTH; CHROMATIN	In all eukaryotes, multisubunit histone acetyltransferase (HAT) complexes acetylate the highly conserved lysine residues in the amino-terminal tails of core histones to regulate chromatin structure and gene expression. One such complex in yeast, NuA4, specifically acetylates nucleosome-associated histone H4. Recent studies have revealed that NuA4 comprises at least 11 subunits, including Yng2p, a yeast homolog of the candidate human tumor suppressor gene, ING1. Consistent with prior data, we find that cells lacking Yng2p are deficient for NnA4 activity and are temperature-sensitive. Furthermore, we show that the NuA4 complex is present in the absence of Yng2p, suggesting that Yng2p functions to maintain or activate NuA4 HAT activity. Sporulation of diploid yng2 mutant cells reveals a defect in meiotic progression, whereas synchronized yng2 mutant cells display a mitotic delay. Surprisingly, genome-wide expression analysis revealed little change from wild type. Nocodazole arrest and release relieves the mitotic defects, suggesting that Yng2p may have a critical function prior to or during metaphase. Rather than a uniform decrease in acetylated forms of histone H4, we find striking cell-to-cell heterogeneity in the loss of acetylated histone H4 in yng2 mutant cells. Treating yng2 mutants with the histone deacetylase inhibitor trichostatin A suppressed the mitotic delay and restored global histone H4 acetylation, arguing that reduced H4 acetylation may underlie the cell cycle delay.	Univ Chicago, Ctr Mol Oncol, Donnelley Biol Sci Learning Ctr, Chicago, IL 60637 USA; Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Kron, SJ (corresponding author), Univ Chicago, Ctr Mol Oncol, Donnelley Biol Sci Learning Ctr, 924 E 57th St,Rm R320, Chicago, IL 60637 USA.			Choy, John/0000-0001-9196-3280; Kron, Stephen/0000-0003-1518-2436	NIGMS NIH HHS [R01 GM60443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SH, 1999, MOL BIOL CELL, V10, P3301, DOI 10.1091/mbc.10.10.3301; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; DAHMANN C, 1995, GENETICS, V140, P957; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Ikeda K, 1999, MOL CELL BIOL, V19, P855; John S, 2000, GENE DEV, V14, P1196; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Liu L, 1999, MOL CELL BIOL, V19, P1202; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Morales V, 2000, MOL CELL BIOL, V20, P7230, DOI 10.1128/MCB.20.19.7230-7237.2000; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zeremski M, 1999, J BIOL CHEM, V274, P32172, DOI 10.1074/jbc.274.45.32172; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	46	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43653	43662		10.1074/jbc.M102531200	http://dx.doi.org/10.1074/jbc.M102531200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11544250	hybrid			2022-12-27	WOS:000172297700024
J	Jacobs, RL; Stead, LM; Brosnan, ME; Brosnan, JT				Jacobs, RL; Stead, LM; Brosnan, ME; Brosnan, JT			Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; TYPE-1 DIABETES-MELLITUS; AMINO-ACID-TRANSPORT; HIGH-PROTEIN-DIET; METABOLISM; GLUCAGON; HYPERHOMOCYSTEINEMIA; CELLS; METHYLTRANSFERASE	An elevated plasma level of homocysteine is a risk factor for the development of cardiovascular disease. The purpose of this study was to investigate the effect of glucagon on homocysteine metabolism in the rat. Male Sprague-Dawley rats were treated with 4 mg/kg/day (3 injections per day) glucagon for 2 days while control rats received vehicle injections. Glucagon treatment resulted in a 30% decrease in total plasma homocysteine and increased hepatic activities of glycine N-methyltransferase, cystathionine beta -synthase, and cystathionine gamma -lyase. Enzyme activities of the remethylation pathway were unaffected. The 90% elevation in activity of cystathionine beta -synthase was accompanied by a 2-fold increase in its mRNA level. Hepatocytes prepared from glucagon-injected rats exported less homocysteine, when incubated with methionine, than did hepatocytes of saline-treated rats. Flux through cystathionine beta -synthase was increased 5-fold in hepatocytes isolated from glucagon-treated rats as determined by production of (CO2)-C-14 and alpha-[1-C-14]ketobutyrate from L-[1-C-14]methionine. Methionine transport was elevated 2-fold in hepatocytes isolated from glueagon-treated rats resulting in increased hepatic methionine levels. Hepatic concentrations of S-adenosylmethionine and S-adenosylhomocysteine, allosteric activators of cystathionine beta -synthase, were also increased following glucagon treatment. These results indicate that glucagon can regulate plasma homocysteine through its effects on the hepatic transsulfuration pathway.	Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada	Memorial University Newfoundland	Brosnan, JT (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada.	jbrosnan@mun.ca		Jacobs, Rene/0000-0002-5525-1355				Barazzoni R, 1999, DIABETOLOGIA, V42, P326, DOI 10.1007/s001250051158; BERGMEYER HU, 1981, METHODS ENZYMATIC AN, V3; Berry MN, 1991, LAB TECHNIQUES BIOCH, V21, P44; BRATTSTROM L, 1989, J INHERIT METAB DIS, V12, P475, DOI 10.1007/BF01802045; CARR FPA, 1981, BIOCHEM J, V198, P655, DOI 10.1042/bj1980655; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELAHABA G, 1959, J BIOL CHEM, V234, P603; EASSERMAN DH, 1989, AM J PHYSIOL, V257, pE108; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; FOREMAN JW, 1982, METABOLISM, V31, P613, DOI 10.1016/0026-0495(82)90101-9; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GOSS SJ, 1986, J CELL SCI, V82, P309; HANDLOGTEN ME, 1984, J BIOL CHEM, V259, P3519; HULTBERG B, 1991, SCAND J CLIN LAB INV, V51, P277, DOI 10.3109/00365519109091615; Hussein WI, 1999, ANN INTERN MED, V131, P348, DOI 10.7326/0003-4819-131-5-199909070-00005; JACOBS EE, 1956, J BIOL CHEM, V223, P147; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; KOLBIN DD, 1981, ANESTHESIOLOGY, V54, P318; Lakritz J, 1997, ANAL BIOCHEM, V247, P63, DOI 10.1006/abio.1997.2032; Mabrouk GM, 1998, BIOCHEM J, V330, P759; Martinov MV, 2000, J THEOR BIOL, V204, P521, DOI 10.1006/jtbi.2000.2035; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; MUDD SH, 1965, J BIOL CHEM, V240, P4382; Nedrebo BG, 1998, METABOLISM, V47, P89, DOI 10.1016/S0026-0495(98)90198-6; OSULLIVAN D, 2000, AM J PHYSIOL, V278, pE576; PERET J, 1981, J NUTR, V111, P1173, DOI 10.1093/jn/111.7.1173; QIAN D, 1998, BIOCHEM J, V313, P479; ROBILLON JF, 1994, DIABETES METAB, V20, P494; SALTER M, 1986, BIOCHEM J, V233, P499, DOI 10.1042/bj2330499; SNODGRASS PJ, 1978, J BIOL CHEM, V253, P2748; Squires SA, 1997, DIABETES, V46, P1945, DOI 10.2337/diabetes.46.12.1945; Stead LM, 2000, BIOCHEM J, V350, P685, DOI 10.1042/0264-6021:3500685; STIPANUK MH, 1979, J NUTR, V109, P2126, DOI 10.1093/jn/109.12.2126; UBBINK JB, 1993, AM J CLIN NUTR, V57, P47, DOI 10.1093/ajcn/57.1.47; UNGER RH, 1976, DIABETES, V25, P136, DOI 10.2337/diab.25.2.136; Van Baal WM, 1999, OBSTET GYNECOL, V94, P485, DOI 10.1016/S0029-7844(99)00412-3; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; VESTER B, 1991, EUR J CLIN CHEM CLIN, V29, P549; WAGNER C, 1989, J BIOL CHEM, V264, P9638; WANG J, 1991, CLIN CHIM ACTA, V204, P239, DOI 10.1016/0009-8981(91)90235-5; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WHITE MF, 1985, BIOCHIM BIOPHYS ACTA, V822, P355, DOI 10.1016/0304-4157(85)90015-2; WYSS M, 1994, MOL CELL BIOCHEM, V133, P51, DOI 10.1007/BF01267947; Yamamoto N, 1996, J NUTR SCI VITAMINOL, V42, P589, DOI 10.3177/jnsv.42.589	51	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43740	43747		10.1074/jbc.M107553200	http://dx.doi.org/10.1074/jbc.M107553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559709				2022-12-27	WOS:000172297700035
J	Andersson, U; Levander, F; Radstrom, P				Andersson, U; Levander, F; Radstrom, P			Trehalose-6-phosphate phosphorylase is part of a novel metabolic pathway for trehalose utilization in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; SUBSP LACTIS; TREA GENE; PURIFICATION; PHOSPHOGLUCOMUTASE; EXPRESSION; CLEAVAGE; PROTEINS; CLONING	Lactococcus lactis splits phosphorylated trehalose by the action of inorganic phosphate-dependent trehalose-6-phosphate phosphorylase (TrePP) in a novel catabolic pathway. TrePP was found to catalyze the reversible conversion of trehalose 6-phosphate into beta -glucose 1-phosphate and glucose 6-phosphate by measuring intermediate sugar phosphates in cell extracts from trehalose-cultivated lactococci. According to native PAGE and SDS-PAGE, TrePP was shown to be a monomeric enzyme with a molecular mass of 94 kDa. Reaction kinetics suggested that the enzyme follows a ternary complex mechanism with optimal phosphorolysis at 35 degreesC and pH 6.3. The equilibrium constants were found to be 0.026 and 0.032 at pH 6.3 and 7.0, respectively, favoring the formation of trehalose 6-phosphate. The Michaelis-Menten constants of TrePP for trehalose 6-phosphate, inorganic phosphate, beta -glucose 1-phosphate, and glucose 6-phosphate were determined to be 6, 32, 0.9, and 4 mm, respectively. The TrePP-encoding gene, designated trePP, was localized in a putative trehalose operon of L. lactis. This operon includes the gene encoding beta -phosphoglucomutase in addition to three open reading frames believed to encode a transcriptional regulator and two trehalose-specific phosphotransferase system components. The identity of trePP was confirmed by determining the N-terminal amino acid sequence of TrePP and by its overexpression in Escherichia coli and L. lactis, as well as the construction of a lactococcal trePP knockout mutant. Furthermore, both TrePP and P-phosphoglucomutase activity were detected in Enterococcus faecalis cell extract, indicating that this bacterium exhibits the same trehalose assimilation route as L. lactis.	Lund Inst Technol, Ctr Chem & Chem Engn, SE-22100 Lund, Sweden	Lund University	Radstrom, P (corresponding author), Lund Inst Technol, Ctr Chem & Chem Engn, POB 124, SE-22100 Lund, Sweden.			Levander, Fredrik/0000-0002-0710-9792				Aisaka K, 1998, BIOSCI BIOTECH BIOCH, V62, P782, DOI 10.1271/bbb.62.782; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; BHUMIRATANA A, 1974, J BACTERIOL, V119, P484, DOI 10.1128/JB.119.2.484-493.1974; BOLOTIN A, 1999, 6 S LACT AC BACT GEN, P27; BOOS W, 1990, J BACTERIOL, V172, P3450, DOI 10.1128/jb.172.6.3450-3461.1990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; Dahl MK, 1997, FEMS MICROBIOL LETT, V148, P233, DOI 10.1016/S0378-1097(97)00039-6; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; Eis C, 2001, BIOCHEM J, V356, P757, DOI 10.1042/0264-6021:3560757; Eis C, 1999, BIOCHEM J, V341, P385, DOI 10.1042/0264-6021:3410385; GOTSCHE S, 1995, J BACTERIOL, V177, P2721, DOI 10.1128/jb.177.10.2721-2726.1995; HELFERT C, 1995, MOL MICROBIOL, V16, P111, DOI 10.1111/j.1365-2958.1995.tb02396.x; KAASEN I, 1994, GENE, V145, P9, DOI 10.1016/0378-1119(94)90316-6; KLEIN W, 1995, J BACTERIOL, V177, P4043, DOI 10.1128/jb.177.14.4043-4052.1995; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levander F, 2001, APPL ENVIRON MICROB, V67, P4546, DOI 10.1128/AEM.67.10.4546-4553.2001; MARECHAL LR, 1972, J BIOL CHEM, V247, P3223; Nilsson U, 2001, MICROBIOL-SGM, V147, P1565, DOI 10.1099/00221287-147-6-1565; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; POY F, 1990, INFECT IMMUN, V58, P1479, DOI 10.1128/IAI.58.5.1479-1480.1990; Qian N, 1997, MICROBIOL-SGM, V143, P855, DOI 10.1099/00221287-143-3-855; QIAN N, 1994, J BACTERIOL, V176, P5304, DOI 10.1128/JB.176.17.5304-5311.1994; RIMMELE M, 1994, J BACTERIOL, V176, P5654, DOI 10.1128/JB.176.18.5654-5664.1994; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; Schlosser A, 2000, FEMS MICROBIOL LETT, V184, P187, DOI 10.1016/S0378-1097(00)00045-8; Schock F, 1996, GENE, V175, P59, DOI 10.1016/0378-1119(96)00120-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uhland K, 2000, J BIOL CHEM, V275, P23439, DOI 10.1074/jbc.M002793200; VANDEGUCHTE M, 1989, APPL ENVIRON MICROB, V55, P224, DOI 10.1128/AEM.55.1.224-228.1989; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WHITE JW, 1961, ANAL BIOCHEM, V2, P380, DOI 10.1016/0003-2697(61)90011-2; [No title captured]	35	56	66	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42707	42713		10.1074/jbc.M108279200	http://dx.doi.org/10.1074/jbc.M108279200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553642	hybrid			2022-12-27	WOS:000172169300011
J	Ando, T; Kawabe, T; Ohara, H; Ducommun, B; Itoh, M; Okamoto, T				Ando, T; Kawabe, T; Ohara, H; Ducommun, B; Itoh, M; Okamoto, T			Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G(2)/M arrest after DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CDC25 MITOTIC INDUCER; FISSION YEAST; POLYMERASE-DELTA; PROTEIN-KINASE; CHECKPOINT PATHWAY; AUXILIARY PROTEIN; 14-3-3 BINDING; MULTIPLE ROLES; INHIBITOR P21	Although a major effect of p21, a cyclin-dependent kinase inhibitor, is considered to be exerted during G(1) phase of the cell cycle, p21 gene knock-out studies suggested its involvement in G(2)/M checkpoint as well. Here we demonstrate evidence that p21 is required for the cell cycle arrest at G(2) upon DNA damage. We found that expression of wild-type p21 (p21(WT)), not mutant p21 (p21(PCNA-)) lacking the interaction with proliferating cell nuclear antigen (PCNA), caused G2 cell cycle arrest in p53-deficient DLD1 colon cancer cell line after the DNA damage by treatment with cis-diamminedichloroplatinum (II). We also found that p21(WT) was associated with Cdc2/cyclin B1 together with PCNA. Furthermore, coimmunoprecipitation experiments revealed that PCNA interacted with Cdc25C at the G(2)/M transition, and this interaction was abolished when p21(WT) was expressed presumably due to the competition between p21(WT) and Cdc25C in the binding to PCNA. These findings suggest that p21 plays a regulatory role in the maintenance of cell cycle arrest at G(2) by blocking the interaction of Cdc25C with PCNA.	Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Internal Med 1, Mizuho Ku, Aichi 4678601, Japan; Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat Cel, CNRS, UMR 5088, F-31062 Toulouse, France	Nagoya City University; Nagoya City University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Okamoto, T (corresponding author), Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp	DUCOMMUN, Bernard/B-3208-2008	DUCOMMUN, Bernard/0000-0002-7126-8368				ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Baldin V, 1997, ONCOGENE, V14, P2485, DOI 10.1038/sj.onc.1201063; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chan TA, 2000, GENE DEV, V14, P1584; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gabrielli BG, 1996, J CELL SCI, V109, P1081; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; GOUBIN F, 1995, ONCOGENE, V10, P2281; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hindges R, 1997, BIOL CHEM, V378, P345; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kobayashi K, 2000, CANCER RES, V60, P3978; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI Y, 1994, ONCOGENE, V9, P2261; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morris MC, 2000, J BIOL CHEM, V275, P28849, DOI 10.1074/jbc.M002942200; NAGATA A, 1991, NEW BIOL, V3, P959; Nurse P, 1997, CELL, V91, P865, DOI 10.1016/S0092-8674(00)80476-6; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Prosperi E, 1997, Prog Cell Cycle Res, V3, P193; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139; Saha P, 1997, MOL CELL BIOL, V17, P4338, DOI 10.1128/MCB.17.8.4338; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SEKI T, 1992, MOL BIOL CELL, V3, P1373, DOI 10.1091/mbc.3.12.1373; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Suganuma M, 1999, CANCER RES, V59, P5887; SZEPESI A, 1994, BLOOD, V84, P3413; TAN CK, 1986, J BIOL CHEM, V261, P2310; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	76	147	152	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42971	42977		10.1074/jbc.M106460200	http://dx.doi.org/10.1074/jbc.M106460200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11559705	hybrid			2022-12-27	WOS:000172169300046
J	Ishii, T; Satoh, E; Nishimura, M				Ishii, T; Satoh, E; Nishimura, M			Integrin-linked kinase controls neurite outgrowth in N1E-115 neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; RHO-FAMILY GTPASES; MAP KINASE; PC12 CELLS; FACTOR RECEPTOR; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; DEPENDENT GROWTH; ADAPTER PROTEIN	Mouse N1E-115 cells grown on a laminin matrix exhibit neurite outgrowth in response to serum deprivation. Treatment of cells with an antibody against beta (1) integrin inhibits neurite outgrowth. Thus, beta (1) integrin is involved in the neuritogenesis of N1E-115 cells on a laminin matrix. Integrin-linked kinase (ILK), a recently identified cytoplasmic serine/threonine protein kinase that binds to the cytoplasmic domain of beta (1) integrin, has an important role in transmembrane signal transduction via integrins. We report that ILK is expressed in N1E-115 cells, the expression levels of which are constant under both normal and differentiating conditions. A stable transfection of a kinase-deficient mutant of ILK (DN-ILK) results in inhibition of neurite outgrowth in serum-starved N1E-115 cells grown on laminin. On the other hand, a transient expression of wild type ILK stimulated neurite outgrowth. The ILK activity in the parental cells was transiently activated after seeding on the laminin matrix, whereas that in the DN-ILK-transfected cells was not. These results suggest that transient activation of ILK is required for neurite outgrowth in serum-starved N1E-115 cells on laminin. Under the same conditions, p38 mitogen-activated protein (MAP) kinase, but neither MAP kinase/extracellular signal-regulated kinase kinase (MEK) nor extracellular signal-regulated kinases (ERK), was transiently activated after N1E-115 cell attachment to laminin, but not in the DN-ILK-expressed cells. The time course of p38 MAP kinase activation was very similar to that of ILK activation. Furthermore, a p38 MAP kinase inhibitor, SB203580, significantly blocked neurite outgrowth. Thus' activation of p38 MAP kinase is involved in ILK-mediated signal transduction leading to integrin-dependent neurite outgrowth in N1E-115 cells.	Univ Obihiro, Sch Vet Med, Dept Pharmacol, Obihiro, Hokkaido 0808555, Japan	Obihiro University of Agriculture & Veterinary Medicine	Nishimura, M (corresponding author), Univ Obihiro, Sch Vet Med, Dept Pharmacol, Obihiro, Hokkaido 0808555, Japan.							CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Huang Y, 1999, INT J MOL MED, V3, P563; Huang Y, 2000, J CELL BIOL, V150, P861, DOI 10.1083/jcb.150.4.861; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Li FG, 1999, J CELL SCI, V112, P4589; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; ROSSINO P, 1990, EXP CELL RES, V189, P100, DOI 10.1016/0014-4827(90)90262-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P6463; Sarner S, 2000, MOL CELL BIOL, V20, P158, DOI 10.1128/MCB.20.1.158-172.2000; Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; TURNER DC, 1989, J NEUROSCI, V9, P3287; TURNER DC, 1989, DEV NEUROSCI-BASEL, V11, P300, DOI 10.1159/000111908; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wu CY, 1999, J CELL SCI, V112, P4485; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; ZHANG ZY, 1993, J BIOL CHEM, V268, P5557; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	43	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42994	43003		10.1074/jbc.M105198200	http://dx.doi.org/10.1074/jbc.M105198200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11560928	hybrid			2022-12-27	WOS:000172169300049
J	Shen, W; Scearce, LM; Brestelli, JE; Sund, NJ; Kaestner, KH				Shen, W; Scearce, LM; Brestelli, JE; Sund, NJ; Kaestner, KH			Foxa3 (hepatocyte nuclear factor 3 gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE AMINOTRANSFERASE GENE; ENRICHED TRANSCRIPTION FACTORS; GLUCOCORTICOID RESPONSE UNIT; PHOSPHOENOLPYRUVATE CARBOXYKINASE; DEFINITIVE ENDODERM; FACTOR-BINDING; MOUSE EMBRYO; IN-VIVO; LIVER; DIFFERENTIATION	The winged helix transcription factors, hepatocyte nuclear factors 3 alpha, -beta, and -gamma (HN-F-3, encoded by the Foxa1, -a2, and -a3 genes, respectively), are expressed early in embryonic endoderm and play important roles in the regulation of gene expression in liver and pancreas. Foxa1 has been shown to be required for glucagon secretion in the pancreas, whereas Foxa2 is critical for the regulation of insulin secretion in pancreatic beta -cells. Here we address the role of Foxa3 in the maintenance of glucose homeostasis. Mice homozygous for a null mutation in Foxa3 appear normal under fed conditions. However, when fasted, Foxa3(-/-) mice have a significantly lower blood glucose compared with control mice. The fasting hypoglycemia in Foxa3(-/-) mice could not be attributed to defects in pancreatic hormone secretion, ketone production, or hepatic glycogen breakdown. Surprisingly, mRNA levels for several gluconeogenic enzymes were up-regulated appropriately in fasted Foxa3(-/-) mice, despite the fact that the corresponding genes had been shown to be activated by FOXA proteins in vitro. However, the mRNA for the plasma membrane glucose transporter GLUT2 was decreased by 64% in the fasted and 93% in the fed state, suggesting that efflux of newly synthesized glucose is limiting in Foxa3(-/-) hepatocytes. Thus, Foxa3 is the dominating transcriptional regulator of GLUT2 expression in hepatocytes in vivo. In addition, we investigated the hepatic transcription factor network in Foxa3(-/-) mice and found that the normal activation of HNF-4 alpha, HNF-1 alpha, and PGC-1 induced by fasting is attenuated in mice lacking Foxa3.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, 560 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.				NIDDK NIH HHS [P30-DK50306, P30-DK19525, R01 DK55342, P01 DK49210] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK055342, P01DK049210, P30DK050306] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; BURCHELL A, 1990, FASEB J, V4, P2978, DOI 10.1096/fasebj.4.12.2168325; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Cha JY, 2000, J BIOL CHEM, V275, P18358, DOI 10.1074/jbc.M909536199; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Duncan SA, 1997, DEVELOPMENT, V124, P279; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kaestner KH, 2000, GENE DEV, V14, P142; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; NITSCH D, 1993, P NATL ACAD SCI USA, V90, P5479, DOI 10.1073/pnas.90.12.5479; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; Scott DK, 1998, MOL ENDOCRINOL, V12, P482, DOI 10.1210/me.12.4.482; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; THORENS B, 1990, AM J PHYSIOL, V259, P279; Wang GF, 1996, MICROW OPT TECHN LET, V11, P10, DOI 10.1002/(SICI)1098-2760(199601)11:1<10::AID-MOP3>3.0.CO;2-S; Wang JC, 2000, J BIOL CHEM, V275, P14717, DOI 10.1074/jbc.275.19.14717; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Zaret KS, 1996, ANNU REV PHYSIOL, V58, P231, DOI 10.1146/annurev.physiol.58.1.231; Zimmermann PL, 1997, DNA CELL BIOL, V16, P713, DOI 10.1089/dna.1997.16.713	31	86	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42812	42817		10.1074/jbc.M106344200	http://dx.doi.org/10.1074/jbc.M106344200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11546810	hybrid			2022-12-27	WOS:000172169300025
J	Xu, XH; Hamhouyia, F; Thomas, SD; Burke, TJ; Girvan, AC; McGregor, WG; Trent, JO; Miller, DM; Bates, PJ				Xu, XH; Hamhouyia, F; Thomas, SD; Burke, TJ; Girvan, AC; McGregor, WG; Trent, JO; Miller, DM; Bates, PJ			Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-ANTIGEN HELICASE; LARGE-TUMOR-ANTIGEN; ATPASE ACTIVITIES; ANTIPROLIFERATIVE ACTIVITY; INTERACTING LIGANDS; BINDING PROTEIN; NUCLEOLIN; COMPLEX; AGENTS; SITE	The discovery of G-rich oligonucleotides (GROs) that have non-antisense antiproliferative activity against a number of cancer cell lines has been recently described. This biological activity of GROs was found to be associated with their ability to form stable G-quartet-containing structures and their binding to a specific cellular protein, most likely nucleolin (Bates, P. J., Kahlon, J. B., Thomas, S. D., Trent, J. O., and Miller, D. M. (1999) J. Biol Chem. 274, 26369-26377). In this report, we further investigate the novel mechanism of GRO activity by examining their effects on cell cycle progression and on nucleic, acid and protein biosynthesis. Cell cycle analysis of several tumor cell lines showed that cells accumulate in S phase in response to treatment with an active GRO. Analysis of 5-bromodeoxyuridine incorporation by these cells indicated the absence of de novo DNA synthesis, suggesting an arrest of the cell cycle predominantly in S phase. At the same time point, RNA and protein synthesis were found to be ongoing, indicating that arrest of DNA replication is a primary event in GRO-mediated inhibition of proliferation. This specific blockade of DNA replication eventually resulted in altered cell morphology and induction of apoptosis. To characterize further GRO-mediated inhibition of DNA replication, we used an in vitro assay based on replication of SV40 DNA. GROs were found to be capable of inhibiting DNA replication in the in vitro assay, and this activity was correlated to their antiproliferative effects. Furthermore, the effect of GROs on DNA replication in this assay was related to their inhibition of SV40 large T antigen helicase activity. The data presented suggest that the antiproliferative activity of GROs is a direct result of their inhibition of DNA replication, which may result from modulation of a replicative helicase activity.	Univ Louisville, James Graham Brown Canc Ctr, Human Mol Biol Grp, Dept Med, Louisville, KY 40202 USA; Univ Louisville, James Graham Brown Canc Ctr, Human Mol Biol Grp, Dept Pharmacol Toxicol, Louisville, KY 40202 USA; Univ Louisville, James Graham Brown Canc Ctr, Human Mol Biol Grp, Dept Biochem Mol Biol, Louisville, KY 40202 USA; Univ Louisville, James Graham Brown Canc Ctr, Human Mol Biol Grp, Dept Chem, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Bates, PJ (corresponding author), 204B Baxter Bldg,570 S Preston St, Louisville, KY 40202 USA.	paula.bates@louisville.edu		Bates, Paula/0000-0002-4622-4152; trent, John/0000-0002-7346-4231				Bachur NR, 1998, BIOCHEM PHARMACOL, V55, P1025, DOI 10.1016/S0006-2952(97)00617-5; BACHUR NR, 1992, MOL PHARMACOL, V41, P993; Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Benimetskaya L, 1997, NUCLEIC ACIDS RES, V25, P2648, DOI 10.1093/nar/25.13.2648; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; BURGESS TL, 1995, P NATL ACAD SCI USA, V92, P4051, DOI 10.1073/pnas.92.9.4051; Callebaut C, 1998, J BIOL CHEM, V273, P21988, DOI 10.1074/jbc.273.34.21988; Chino M, 1998, J ANTIBIOT, V51, P480, DOI 10.7164/antibiotics.51.480; Crooke ST, 2000, METHOD ENZYMOL, V313, P3; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; DERENZINI M, 1995, LAB INVEST, V73, P497; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; GEORGE JW, 1992, J BIOL CHEM, V267, P10683; Gewirtz AM, 1998, BLOOD, V92, P712, DOI 10.1182/blood.V92.3.712.415a32_712_736; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Ginisty H, 1999, J CELL SCI, V112, P761; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gotzmann J, 1997, ELECTROPHORESIS, V18, P2645, DOI 10.1002/elps.1150181421; Haider SR, 1997, EXP CELL RES, V234, P498, DOI 10.1006/excr.1997.3644; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; JENSEN PO, 1993, CYTOMETRY, V14, P455; KIBBEY MC, 1995, J NEUROSCI RES, V42, P314, DOI 10.1002/jnr.490420305; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; Lee CH, 1998, J BIOL CHEM, V273, P7650, DOI 10.1074/jbc.273.13.7650; LegerSilvestre I, 1997, CHROMOSOMA, V105, P542, DOI 10.1007/BF02510491; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LI JJ, 1984, P NATL ACAD SCI USA, V81, P4249; MAINE IP, 1992, BIOCHEMISTRY-US, V31, P3968, DOI 10.1021/bi00131a012; Malkas LH, 1998, J CELL BIOCHEM, P18; Mann MJ, 2000, J CLIN INVEST, V106, P1071, DOI 10.1172/JCI11459; McGregor WG, 1999, MOL CELL BIOL, V19, P147; Morgan D M, 1998, Methods Mol Biol, V79, P179; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; ROBERTS JD, 1988, P NATL ACAD SCI USA, V85, P7064, DOI 10.1073/pnas.85.19.7064; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Sirri V, 2000, MICRON, V31, P121, DOI 10.1016/S0968-4328(99)00068-2; Sorokina EA, 1999, J BIOL CHEM, V274, P27491, DOI 10.1074/jbc.274.39.27491; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; STAHL H, 1985, J VIROL, V54, P473, DOI 10.1128/JVI.54.2.473-482.1985; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; THOMAS DC, 1993, P NATL ACAD SCI USA, V90, P7744, DOI 10.1073/pnas.90.16.7744; Tuteja N, 1998, BIOCHEM BIOPH RES CO, V244, P861, DOI 10.1006/bbrc.1998.8363; Tuteja N, 1997, BIOCHEM BIOPH RES CO, V236, P636, DOI 10.1006/bbrc.1997.7021; TUTEJA N, 1995, GENE, V160, P143, DOI 10.1016/0378-1119(95)00207-M; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Veaute X, 2000, MUTAT RES-DNA REPAIR, V459, P19, DOI 10.1016/S0921-8777(99)00052-X; WAGA S, 1994, J BIOL CHEM, V269, P10923; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; Zhu KC, 1999, BIOCHEM BIOPH RES CO, V266, P361, DOI 10.1006/bbrc.1999.1815	63	137	156	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43221	43230		10.1074/jbc.M104446200	http://dx.doi.org/10.1074/jbc.M104446200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555643	hybrid			2022-12-27	WOS:000172169300077
J	Lin, Y; Rajala, MW; Berger, JP; Moller, DE; Barzilai, N; Scherer, PE				Lin, Y; Rajala, MW; Berger, JP; Moller, DE; Barzilai, N; Scherer, PE			Hyperglycemia-induced production of acute phase reactants in adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE LUMINAL FLUID; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; HEART-DISEASE; 24P3 GENE; EXPRESSION; PROTEIN; ASSOCIATION; ADIPOCYTES; COMPLEMENT	Chronic elevation of systemic levels of acute phase reactants and inflammatory cytokines found in patients with diabetes and the often-associated metabolic syndrome X (hypertriglyceridemia, low serum high density lipoprotein cholesterol, hypertension, and accelerated atherosclerosis) may be responsible for the increased incidence of cardiovascular problems in this population. Here we examine the contribution of adipose tissue to the systemic elevation of acute phase reactants associated with chronic hyperglycemia. We demonstrate that adipose tissue expresses a number of acute phase reactants at high levels, including serum amyloid A3 (SAA3), alpha1-acid glycoprotein, the lipocalin 24p3 as well as plasminogen activator inhibitor-1 (PAI-1). Additionally, we show SAA3 is expressed at low levels under normal conditions but in the diabetic state is dramatically up-regulated in adipose tissue while down-regulated in liver. Furthermore, pro-inflammatory stimuli and high glucose can lead to the induction of SAA3 in adipose tissue in vivo as well as in the 3T3-L1 adipocyte cell line. Adipose tissue may therefore play a major role in the pathogenic sequelae of Type II diabetes, in particular the cardiovascular problems associated with prolonged hyperglycemia.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA; Merck Res Labs, Dept Mol Endocrinol, Rahway, NJ 07065 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Merck & Company	Scherer, PE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392	NIA NIH HHS [R01 AG18381] Funding Source: Medline; NIDDK NIH HHS [1R01-DK55758] Funding Source: Medline; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018381] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Boncela J, 2001, J BIOL CHEM, V276, P35305, DOI 10.1074/jbc.M104028200; Burgess-Beusse BL, 1998, MOL CELL BIOL, V18, P7269, DOI 10.1128/MCB.18.12.7269; CABANA VG, 1989, J LIPID RES, V30, P39; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Chu ST, 1996, BIOCHEM J, V316, P545, DOI 10.1042/bj3160545; Chu ST, 1998, J PEPT RES, V52, P390; Chu ST, 2000, MOL REPROD DEV, V57, P26, DOI 10.1002/1098-2795(200009)57:1&lt;26::AID-MRD5&gt;3.0.CO;2-4; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; FIGUEREDO A, 1993, DIABETES CARE, V16, P445, DOI 10.2337/diacare.16.2.445; FLOWER DR, 1991, BIOCHEM BIOPH RES CO, V180, P69, DOI 10.1016/S0006-291X(05)81256-2; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GANDA OP, 1992, DIABETES CARE, V15, P1245, DOI 10.2337/diacare.15.10.1245; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; KANNEL WB, 1990, AM HEART J, V120, P672, DOI 10.1016/0002-8703(90)90026-T; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Loskutoff DJ, 1998, ARTERIOSCL THROM VAS, V18, P1, DOI 10.1161/01.ATV.18.1.1; Mattacks CA, 1999, CYTOKINE, V11, P334, DOI 10.1006/cyto.1998.0442; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Orabona C, 2001, EUR CYTOKINE NETW, V12, P154; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pickup JC, 2000, CLIN ENDOCRINOL, V52, P107, DOI 10.1046/j.1365-2265.2000.00921.x; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; RIDKER PM, 1999, BLOOD COAGUL FIBRIN, V10, P9; RODBELL M, 1964, J BIOL CHEM, V239, P375; Scherer PE, 1998, NAT BIOTECHNOL, V16, P581, DOI 10.1038/nbt0698-581; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Soukas A, 2000, GENE DEV, V14, P963; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; WHITE RT, 1992, J BIOL CHEM, V267, P9210; YOKOYAMA H, 1995, J INTERN MED, V237, P519, DOI 10.1111/j.1365-2796.1995.tb00878.x; YUDKIN JS, 1995, J INTERN MED, V238, P21, DOI 10.1111/j.1365-2796.1995.tb00895.x; Zerega B, 2000, EUR J CELL BIOL, V79, P165, DOI 10.1078/S0171-9335(04)70019-9	39	201	214	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42077	42083		10.1074/jbc.M107101200	http://dx.doi.org/10.1074/jbc.M107101200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546817	hybrid			2022-12-27	WOS:000172450400073
J	Oh, SM; Hahm, DH; Kim, IH; Choi, SY				Oh, SM; Hahm, DH; Kim, IH; Choi, SY			Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE KINASE; TRANSDUCTION PATHWAY; MAMMALIAN-CELLS; IN-VIVO; BINDING; EXPRESSION; INHIBITOR; DNA; IDENTIFICATION; COLLAGENASE	It has been proposed that human neutrophil lactoferrin (Lf) could be involved in gene expression as a DNA-binding protein after its translocation. into the nucleus. However, the molecular basis of Lf action has not been defined, and Lf-regulated target genes have not been identified. We report here that overexpressed Lf functions as a specific trans-activator of matrix metalloproteinase 1 (MMP1) gene, and that induction of this AP-1-responsive gene is mediated via the stress-activated MAPK signaling modules. Transactivation of the MMP1 promoter by overexpressed Lf requires the presence of an AP-1 binding site. In gel shift experiments, Lf did not interact directly with AP-1-containing fragments of the MMP1 promoter. However, nuclear extracts from Lf-expressing cells contained increased levels of proteins that bound to AP-1 elements. This Lf-induced AP-1 DNA binding activity was reduced by a p38 MAPK inhibitor. Inhibitors of the MEK kinases had little effect on Lf-induced AP-1. However, expression of dominant-negative MKK4 or JNK1 inhibited Lf-induced gene expression. The JNK activity stimulated by Lf correlates with the enhanced AP-I binding ability. These findings demonstrate that the Lf-induced activation of AP-1 is mediated via JNK and p38 NLAPK pathways.	Korea Univ, Grad Sch Biotechnol, Div Life Sci, SUngbuk Gu, Seoul 136701, South Korea	Korea University	Choi, SY (corresponding author), Korea Univ, Grad Sch Biotechnol, Div Life Sci, SUngbuk Gu, 5-1 Anamdong, Seoul 136701, South Korea.							ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Baveye S, 2000, FEBS LETT, V469, P5, DOI 10.1016/S0014-5793(00)01243-6; BAYNES RD, 1986, SCAND J HAEMATOL, V36, P79; BEZAULT J, 1994, CANCER RES, V54, P2310; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Damiens E, 1999, J CELL BIOCHEM, V74, P486, DOI 10.1002/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.3.CO;2-Y; Damiens E, 1998, BBA-MOL CELL RES, V1402, P277, DOI 10.1016/S0167-4889(98)00013-5; DAVIDSON LA, 1989, AM J PHYSIOL, V257, pG930, DOI 10.1152/ajpgi.1989.257.6.G930; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FAUCHEUX BA, 1995, P NATL ACAD SCI USA, V92, P9603, DOI 10.1073/pnas.92.21.9603; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GARRE C, 1992, J CELL PHYSIOL, V153, P477, DOI 10.1002/jcp.1041530306; GRAVES DT, 1989, SCIENCE, V245, P1490, DOI 10.1126/science.2781291; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HE JL, 1995, NATURE, V373, P721, DOI 10.1038/373721a0; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MACHNICKI M, 1993, INT J EXP PATHOL, V74, P433; NOVAK TJ, 1990, NUCLEIC ACIDS RES, V18, P4523, DOI 10.1093/nar/18.15.4523; Ping PP, 2000, CIRC RES, V86, P921, DOI 10.1161/01.RES.86.9.921; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; TIMMERS HT, 1990, NUCLEIC ACIDS RES, V18, P23, DOI 10.1093/nar/18.1.23; WATANABE H, 1993, J CELL SCI, V104, P991; WENG HQ, 1995, J BIOL CHEM, V270, P13637, DOI 10.1074/jbc.270.23.13637; WILSON LD, 1987, MOL CELL BIOL, V7, P2406, DOI 10.1128/MCB.7.7.2406	31	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42575	42579		10.1074/jbc.M107724200	http://dx.doi.org/10.1074/jbc.M107724200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535608	hybrid			2022-12-27	WOS:000172450400133
J	Reeves, DC; Goren, EN; Akabas, MH; Lummis, SCR				Reeves, DC; Goren, EN; Akabas, MH; Lummis, SCR			Structural and electrostatic properties of the 5-HT3 receptor pore revealed by substituted cysteine accessibility mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MEMBRANE-SPANNING SEGMENT; CHANNEL-LINING RESIDUES; ALPHA-SUBUNIT; M2 SEGMENT; XENOPUS-OOCYTES; DOMAIN; MUTATIONS; PERMEABILITY; BINDING	5-HT3 receptors are members of the Cys loop family of ligand-gated ion channels. We used the substituted cysteine accessibility method to identify amino acid residues in the channel forming domain, M2 that face the water-accessible surface and to locate their position in the ion conduction pathway. Cysteine was substituted for each residue, one at a time, in the M2 segment (Asp(274)-Asp(298)). 5-Hydroxytryptamine EC50 values for functional mutants did not vary from wild type (1.4 +/- 0.2 mum) by more than 10-fold, and five mutants were nonfunctional. Covalent modification of the mutant receptors with sulfydryl reagents revealed 11 residues to be water-accessible, with a pattern consistent with an a-helix except at Leu(285) and Leu(293). The data suggest that charge selectivity begins at a more cytoplasmic level than Val(291). Modification at some positions (Val(291) Leu(293), Ile(294), Leu(287), and Ser(280)) resulted in channels that were locked open. Reaction rates with accessible cysteines were voltage-dependent at some residues, suggesting that access occurs via the ion channel. Overall the data observed are similar but not identical to that reported for other members of the family and confirms the high degree of structural and functional homology between receptors in the Cys loop receptor family.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	University of Cambridge; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine		s.lummis@mole.bio.cam.ac.uk		Akabas, Myles/0000-0001-8781-7846				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; COHEN BN, 1992, J GEN PHYSIOL, V99, P545, DOI 10.1085/jgp.99.4.545; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cruz H, 2001, BIOPHYS J, V80, p336A; Dalziel JE, 2000, MOL PHARMACOL, V57, P875; Dang H, 2000, MOL PHARMACOL, V57, P1114; Danielson MA, 1997, J BIOL CHEM, V272, P32878, DOI 10.1074/jbc.272.52.32878; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Gunthorpe MJ, 1999, J PHYSIOL-LONDON, V519, P713, DOI 10.1111/j.1469-7793.1999.0713n.x; HARGREAVES AC, 1994, MOL PHARMACOL, V46, P1120; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Pan ZH, 1997, P NATL ACAD SCI USA, V94, P6490, DOI 10.1073/pnas.94.12.6490; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Pashkov VS, 1999, FEBS LETT, V457, P117, DOI 10.1016/S0014-5793(99)01023-6; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Spier AD, 1999, MOL BRAIN RES, V67, P221; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Ueno S, 2000, BRIT J PHARMACOL, V131, P296, DOI 10.1038/sj.bjp.0703504; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m; Zhang L, 1997, BRIT J PHARMACOL, V120, P353, DOI 10.1038/sj.bjp.0700934	46	70	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42035	42042		10.1074/jbc.M106066200	http://dx.doi.org/10.1074/jbc.M106066200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11557761	hybrid			2022-12-27	WOS:000172450400067
J	Seet, LF; Hong, WJ				Seet, LF; Hong, WJ			Endofin, an endosomal FYVE domain protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; RAB5 EFFECTOR EEA1; ZINC-FINGER DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MEMBRANE TRAFFICKING; AUTOANTIGEN EEA1; LOCALIZATION; FUSION; HRS; BINDING	KIAA0305 is an uncharacterized member of the FYVE domain protein family. It is closely related to SARA, with about 50% identity in the carboxyl-terminal 800-amino acid region. Indirect immunofluorescence microscopy using polyclonal antibodies raised against KLAA0305 revealed that it is enriched in early endosomes. The Myc-tagged version is also faithfully targeted to the early endosome. We have tentatively called KLAA0305 endofin (for endosome-associated FYVE-domain protein). The association of endofin with endosomes is mediated by its FYVE domain because deletion mutants lacking the central FYVE finger motif are distributed in the cytoplasm. In addition, a single point mutation in the FYVW finger motif at cysteine, residue 753 (C753S) is sufficient to abolish its endosomal association. Its endosomal localization is also sensitive to the phosphatidylinositol 3-kinase inhibitor, wortmannin. Using in vitro liposome binding assays, we demonstrate that Myc-tagged endofin associates preferentially with phosphatidylinositol 3-phosphate, whereas the C753S point mutant was unable to do so. We also show that endofin co-localizes with SARA but that they are not associated in a common complex because they failed to co-immunoprecipitate in co-expressing cells. Endofin also does not associate with Smad2 nor behave like SARA in affecting transforming growth factor-beta signaling. At high levels of expression, both endofin and SARA can cause an endosome aggregation/fusion effect. In COS7 cells, which can support high levels of exogenous protein expression, both proteins can also cause other structural anomalies in the endocytic pathway, as represented by enlarged vesicular structures. These endosomal aggregates/fusions accumulated endocytosed epidermal growth factor. Taken together, this report provides evidence to suggest that endofin and the highly related SARA are endosomal proteins with potential roles in regulating membrane traffic.	Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hong, WJ (corresponding author), Inst Mol & Cell Biol, Membrane Biol Lab, 30 Med Dr, Singapore 117609, Singapore.		HONG, Wanjin/E-9927-2010					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Derubeis AR, 2000, GENE, V255, P195, DOI 10.1016/S0378-1119(00)00303-6; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hayakawa A, 2000, J BIOL CHEM, V275, P29636, DOI 10.1074/jbc.M002696200; Herrgard S, 2000, FEBS LETT, V486, P107, DOI 10.1016/S0014-5793(00)02201-8; Ito K, 1999, BIOCHEM BIOPH RES CO, V257, P206, DOI 10.1006/bbrc.1999.0430; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; OKADA T, 1994, J BIOL CHEM, V269, P3563; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	39	59	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42445	42454		10.1074/jbc.M105917200	http://dx.doi.org/10.1074/jbc.M105917200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546807	hybrid			2022-12-27	WOS:000172450400116
J	Stasiv, Y; Regulski, M; Kuzin, B; Tully, T; Enikolopov, G				Stasiv, Y; Regulski, M; Kuzin, B; Tully, T; Enikolopov, G			The Drosophila nitric-oxide synthase gene (dNOS) encodes a family of proteins that can modulate NOS activity by acting as dominant negative regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EXPRESSION; DIVERSITY; PATHWAY; HEME	Nitric oxide (NO) is involved in organ development, synaptogenesis, and response to hypoxia in Drosophila. We cloned and analyzed the only gene in the fly genome that encodes Drosophila nitric-oxide synthase (dNOS). It consists of 19 exons and is dispersed over 34 kilobases of genomic DNA. Alternative transcription start sites and alternative splice sites are used to generate a remarkable variety of mRNAs from the dNOS gene. We identified eight new transcripts that are widely expressed throughout Drosophila development and encode a family of DNOS-related proteins. Alternative splicing affects both the 5'-untranslated region and the coding region of the dNOS primary transcript. Most of the splicing alterations in the coding region of the gene lead to premature termination of the open reading frame. As a result, none of the alternative transcripts encode an enzymatically active protein. However, some of these shorter DNOS protein products can effectively inhibit enzymatic activity of the full-length DNOS1 protein when co-expressed in mammalian cells, thus acting as dominant negative regulators of NO synthesis. Using immunoprecipitation, we demonstrate that these short DNOS protein isoforms can form heterodimers with DNOS1, pointing to a physical basis for the dominant negative effect. Our results suggest a novel regulatory function for the family of proteins encoded by the Drosophila NOS gene.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Enikolopov, G (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Enikolopov, Grigori N/B-7771-2009; Enikolopov, Grigori/P-5731-2019	Enikolopov, Grigori N/0000-0001-8178-8917; Enikolopov, Grigori/0000-0001-8178-8917; Kuzin, Boris/0000-0001-9951-1553	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036413] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36413] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; DiGregorio PJ, 2001, J BIOL CHEM, V276, P1930, DOI 10.1074/jbc.M003911200; DOW JAT, 1994, AM J PHYSIOL, V266, pR1716, DOI 10.1152/ajpregu.1994.266.5.R1716; Enikolopov G, 1999, CELL DEATH DIFFER, V6, P956, DOI 10.1038/sj.cdd.4400577; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Forstermann U, 1998, FASEB J, V12, P773; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; FUJISAWA H, 1994, J NEUROCHEM, V63, P140; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; HALL AV, 1994, J BIOL CHEM, V269, P33082; HARLOW E, 1988, ANTIBODIES LABORATOR, P488; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P2627, DOI 10.1093/nar/21.11.2627; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Kuzin B, 2000, CURR BIOL, V10, P459, DOI 10.1016/S0960-9822(00)00443-7; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; Larsson B, 1998, BIOCHEM BIOPH RES CO, V251, P898, DOI 10.1006/bbrc.1998.9578; LEE CM, 1995, J BIOL CHEM, V270, P27403, DOI 10.1074/jbc.270.46.27403; Luckhart S, 1999, GENE, V232, P25, DOI 10.1016/S0378-1119(99)00121-3; Luckhart S, 2001, INSECT BIOCHEM MOLEC, V31, P249, DOI 10.1016/S0965-1748(00)00144-2; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; RAMAN CS, 2000, PORPHYRIN HDB, V4, P293; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Sambrook J., 2002, MOL CLONING LAB MANU; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Truman JW, 1996, DEVELOPMENT, V122, P3949; Wang Y, 1999, CRIT REV NEUROBIOL, V13, P21, DOI 10.1615/CritRevNeurobiol.v13.i1.20; Wang Y, 1999, P NATL ACAD SCI USA, V96, P12150, DOI 10.1073/pnas.96.21.12150; Wildemann B, 1999, J NEUROBIOL, V38, P1, DOI 10.1002/(SICI)1097-4695(199901)38:1<1::AID-NEU1>3.0.CO;2-L; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	38	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42241	42251		10.1074/jbc.M105066200	http://dx.doi.org/10.1074/jbc.M105066200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11526108	hybrid			2022-12-27	WOS:000172450400094
J	Ueda, H; Morishita, R; Itoh, H; Narumiya, S; Mikoshiba, K; Kato, K; Asano, T				Ueda, H; Morishita, R; Itoh, H; Narumiya, S; Mikoshiba, K; Kato, K; Asano, T			G alpha(11) induces caspase-mediated proteolytic activation of Rho-associated kinase, ROCK-I, in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; STRESS FIBER FORMATION; BETA-GAMMA-SUBUNITS; G-ALPHA-Q; SERINE/THREONINE KINASE; SIGNALING PATHWAYS; FOCAL ADHESIONS; PHOSPHORYLATION; APOPTOSIS; MYOSIN	Expression of the constitutively active mutant of G(alpha 11) (G alpha (11)QL) induces the formation of vinculin-containing focal adhesion-like structures in HeLa cells. This was found to be inhibited by Y-27632, a specific inhibitor of Rho-associated kinases (ROCK), but not by co-expression with a dominant negative mutant of RhoA, suggesting Rho-independent activation of ROCK by G alpha (11)QL. Investigation of trypan blue exclusion and immunocytochemistry with an antibody against cleaved caspase revealed the cellular phenotype of G alpha (11)QL-expressing cells to be identical to that displayed by cells undergoing apoptosis, and the caspase inhibitor zVAD-fmk blocked all morphological changes induced by G alpha (11)QL. Transfection of G alpha (11)QL induced cleavage of ROCK-I, and this proteolysis was also prevented by zVAD-fmk. ROCK-I C-terminally truncated at its authentic caspase sites also induced the formation of vinculin-containing focal adhesion-like structures. In addition, cleavage of ROCK-I was observed when cells overexpressing ml muscarinic acetylcholine receptors were stimulated with carbachol. These results suggest that Gall induces proteolytic activation of ROCK-I by caspase and thereby regulates the actin cytoskeleton during apoptosis.	Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Kasugai, Aichi 4800392, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068315, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan	University of Tokyo; Kyoto University; University of Tokyo	Asano, T (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Kamiyacho, Kasugai, Aichi 4800392, Japan.		Mikoshiba, Katsuhiko/N-7943-2015					Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Azuma T, 2000, J BIOL CHEM, V275, P3761, DOI 10.1074/jbc.275.6.3761; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Luthin GR, 1997, LIFE SCI, V60, P963, DOI 10.1016/S0024-3205(97)00035-0; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mejillano M, 2001, J BIOL CHEM, V276, P1865, DOI 10.1074/jbc.M007271200; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; MORISHITA R, 1995, J BIOL CHEM, V270, P29469, DOI 10.1074/jbc.270.49.29469; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Ueda H, 1999, J BIOL CHEM, V274, P12124, DOI 10.1074/jbc.274.17.12124; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Ueda H, 2000, J BIOL CHEM, V275, P2098, DOI 10.1074/jbc.275.3.2098; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Zhang JD, 1999, J CELL BIOL, V145, P99, DOI 10.1083/jcb.145.1.99	37	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42527	42533		10.1074/jbc.M102529200	http://dx.doi.org/10.1074/jbc.M102529200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546796	hybrid			2022-12-27	WOS:000172450400127
J	Tsukada, Y; Miyazawa, K; Kitamura, N				Tsukada, Y; Miyazawa, K; Kitamura, N			High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; TUMOR CYTOTOXIC FACTOR; C-MET RECEPTOR; TRANSCRIPTION FACTOR E2F; PROTEIN-KINASE KINASE; EPITHELIAL-CELLS; RETINOBLASTOMA PROTEIN; CYCLIN-E; MOLECULAR-CLONING; HUMAN FIBROBLASTS	Hepatocyte growth factor (HGF) induces growth stimulation of a variety of cell types, but it also induces growth inhibition of several types of tumor cell lines. The molecular mechanism of the HGF-induced growth inhibition of tumor cells remains obscure. We have investigated the intracellular signaling pathway involved in the antiproliferative effect of HGF on the human hepatocellular carcinoma cell line HepG2. HGF induced strong activation of ERK in HepG2 cells. Although the serum-dependent proliferation of HepG2 cells was inhibited by the MEK inhibitor PD98059 in a dose-dependent manner, 10 muM PD98059 reduced the HGF-induced strong activation of ERK to a weak activation; and as a result, the proliferation inhibited by HGF was completely restored. Above or below this specific concentration, the restoration was incomplete. Expression of constitutively activated Ha-Ras, which induces strong activation of ERK, led to the proliferation inhibition of HepG2 cells, as was observed in HGF-treated HepG2 cells. This inhibition was suppressed by the MEK inhibitor. Furthermore, HGF treatment and expression of constitutively activated Ha-Ras changed the hyperphosphorylated form of the retinoblastoma tumor suppressor gene product pRb to the hypophosphorylated form. This change was inhibited by the same concentration of MEK inhibitor needed to suppress the proliferation inhibition. These results suggest that ERK activity is required for both the stimulation and inhibition of proliferation of HepG2 cells; that the level of ERK activity determines the opposing proliferation responses; and that HGF-induced proliferation inhibition is caused by cell cycle arrest, which results from pRb being maintained in its active hypophosphorylated form via a high-intensity ERK signal in HepG2 cells.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomed Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Kitamura, N (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomed Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.		MIYAZAWA, KEIJI/I-9713-2014					ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arakaki N, 1998, BIOCHEM BIOPH RES CO, V245, P211, DOI 10.1006/bbrc.1998.8397; Arakaki N, 1999, J BIOL CHEM, V274, P13541, DOI 10.1074/jbc.274.19.13541; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Conner EA, 1997, BIOCHEM BIOPH RES CO, V236, P396, DOI 10.1006/bbrc.1997.6938; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAGNASS AU, 1994, BIOCHEM BIOPH RES CO, V202, P701; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; DOWDY SF, 1997, HUMAN GENOME METHODS, P121; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Edamatsu H, 1998, FEBS LETT, V440, P231, DOI 10.1016/S0014-5793(98)01457-4; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Fafeur V, 1997, CELL GROWTH DIFFER, V8, P655; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Gius DR, 1999, CANCER RES, V59, P2577; Gohda E, 1998, BIOCHEM BIOPH RES CO, V245, P278, DOI 10.1006/bbrc.1998.8416; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; HALABAN R, 1992, ONCOGENE, V7, P2195; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HIGASHIO K, 1990, BIOCHEM BIOPH RES CO, V170, P397, DOI 10.1016/0006-291X(90)91287-3; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KAN M, 1991, BIOCHEM BIOPH RES CO, V174, P331, DOI 10.1016/0006-291X(91)90524-B; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; KOMADA M, 1993, ONCOGENE, V8, P2381; KOMADA M, 1994, J BIOL CHEM, V269, P16131; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; LEES EM, 1993, MOL CELL BIOL, V13, P1194, DOI 10.1128/MCB.13.2.1194; Lissy NA, 1998, IMMUNITY, V8, P57, DOI 10.1016/S1074-7613(00)80458-6; LIU ML, 1995, CARCINOGENESIS, V16, P841, DOI 10.1093/carcin/16.4.841; LONGATI P, 1994, ONCOGENE, V9, P49; Matsumoto K, 1993, HEPATOCYTE GROWTH FA, P225; MIYAZAKI M, 1992, CELL BIOL INT REP, V16, P145, DOI 10.1016/S0309-1651(06)80108-6; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; MORITA M, 1994, HEPATOLOGY, V19, P426; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nagahara H, 1999, P NATL ACAD SCI USA, V96, P14961, DOI 10.1073/pnas.96.26.14961; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rahimi N, 1996, J BIOL CHEM, V271, P24850, DOI 10.1074/jbc.271.40.24850; Ravi RK, 1998, J CLIN INVEST, V101, P153, DOI 10.1172/JCI831; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SantoniRugiu E, 1996, P NATL ACAD SCI USA, V93, P9577, DOI 10.1073/pnas.93.18.9577; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SHIBAMOTO S, 1992, CELL STRUCT FUNCT, V17, P185, DOI 10.1247/csf.17.185; Shima N, 1998, J CELL PHYSIOL, V177, P130, DOI 10.1002/(SICI)1097-4652(199810)177:1<130::AID-JCP14>3.3.CO;2-O; SHIMA N, 1991, CELL BIOL INT REP, V15, P397, DOI 10.1016/0309-1651(91)90128-6; SHIMA N, 1991, BIOCHEM BIOPH RES CO, V180, P1151, DOI 10.1016/S0006-291X(05)81187-8; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; STOKER M, 1989, J CELL PHYSIOL, V139, P565, DOI 10.1002/jcp.1041390316; STOKER M, 1985, J CELL SCI, V77, P209; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; TAJIMA H, 1991, FEBS LETT, V291, P229, DOI 10.1016/0014-5793(91)81291-F; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yanagawa K, 1998, ONCOL REP, V5, P185; ZARNEGAR R, 1989, CANCER RES, V49, P3314; ZHU H, 1994, J BIOL CHEM, V269, P29943	85	79	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40968	40976		10.1074/jbc.M010890200	http://dx.doi.org/10.1074/jbc.M010890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533045	hybrid			2022-12-27	WOS:000171925600080
J	Zhai, JB; Lin, H; Shamim, M; Schlaepfer, WW; Canete-Soler, R				Zhai, JB; Lin, H; Shamim, M; Schlaepfer, WW; Canete-Soler, R			Identification of a novel interaction of 14-3-3 with p190RhoGEF.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; MOLECULAR-CLONING; EXCHANGE FACTOR; NEURONAL EXPRESSION; MESSENGER-RNAS; NERVOUS-SYSTEM; P115 RHOGEF; RAT CDNAS; KINASE; FAMILY	Activation of Rho GTPases by guanine nucleotide exchange factors (GEFs) mediates a broad range of cytoskeletal alterations that determine cell shape. In the nervous system, Rho GTPases are essential for establishing highly asymmetrical neuronal forms and may fine-tune the shape of dendrites in differentiated neurons. p190RhoGEF is a brain-enriched, RhoA-specific GEF whose highly interactive C-terminal domain provides potential linkage to multiple pathways in the cell. In the present study, a yeast two-hybrid screen was used to identify 14-3-3 eta and 14-3-3 epsilon as additional binding partners of p190RhoGEF. Interactions between p190RhoGEF and 14-3-3 eta were confirmed biochemically and by colocalization of the respective proteins when fused to fluorescent markers and transfected in neuronal cells. We also mapped a unique phosphorylation-independent binding site (I(1370)QAIQNL) in p190RhoGEF. Deletion of the binding site abolished interactions in vitro as well as the ability of 14-3-3 eta to alter the cytoplasmic aggregation of p190RhoGEF in cotransfected cells. The findings suggest a potential role for 14-3-3 in modulating p190RhoGEF activity or in linking p190RhoGEF to the activities of other pathways in the neuron.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Schlaepfer, WW (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 609 Stellar Chance Labs, Philadelphia, PA 19104 USA.							Cacace AM, 1999, MOL CELL BIOL, V19, P229; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dorner C, 1999, J BIOL CHEM, V274, P33654, DOI 10.1074/jbc.274.47.33654; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Kawai T, 1999, GENE, V227, P249, DOI 10.1016/S0378-1119(98)00605-2; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; WATANABE M, 1993, DEV BRAIN RES, V73, P225, DOI 10.1016/0165-3806(93)90142-W; WATANABE M, 1991, MOL BRAIN RES, V10, P151, DOI 10.1016/0169-328X(91)90105-7; WATANABE M, 1993, MOL BRAIN RES, V17, P135, DOI 10.1016/0169-328X(93)90082-Z; WATANABE M, 1994, MOL BRAIN RES, V25, P113, DOI 10.1016/0169-328X(94)90285-2; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7	29	83	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41318	41324		10.1074/jbc.M107709200	http://dx.doi.org/10.1074/jbc.M107709200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533041	hybrid			2022-12-27	WOS:000171925600125
J	Miura, K; Miyazawa, S; Furuta, S; Mitsushita, J; Kamijo, K; Ishida, H; Miki, T; Suzukawa, K; Resau, J; Copeland, TD; Kamata, T				Miura, K; Miyazawa, S; Furuta, S; Mitsushita, J; Kamijo, K; Ishida, H; Miki, T; Suzukawa, K; Resau, J; Copeland, TD; Kamata, T			The Sos1-Rac1 signaling - Possible involvement of a vacuolar H+ -ATPase E subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PROTON ATPASE; RECEPTOR; GENE; DBL; DOMAIN; CDC42; MSOS1; RAC1; GRB2	We have purified and identified a 32-kDa protein interacting with the Dbl oncogene homology domain of mSos1(Sos-DH) from rat brains by glutathione S-transferase-Sos-DH affinity chromatography. Peptide sequencing revealed that the protein is identical to a positive regulatory E subunit (V-ATPase E) of a vacuolar H+-ATPase, which is responsible for acidification of endosome and alkalinization of intracellular pH. The interaction between V-ATPase E and Sos-DH was confirmed by yeast two-hybrid assay. A coimmunoprecipitation assay demonstrated that a V-ATPase E protein physiologically bound to mSos1, and the protein was colocalized with mSos1 in the cytoplasm, as determined by immunohistochemistry. mSos1 was found in the early endosome fraction together with V-ATPase E and Rac1, suggesting the functional involvement of mSos1/V-ATPase E complexes in the Rac1 activity at endosomes. Overexpression of V-ATPase E in COS cells enhanced the ability of mSos1 to promote the guanine nucleotide exchange activity for Rac1 and stimulated the kinase activity of Jun kinase, a downstream target of Rac1. Thus, the data indicate that V-ATPase E may participate in the regulation of the mSos1-dependent Rac1 signaling pathway involved in growth factor receptor-mediated cell growth control.	Shinshu Univ, Sch Med, Dept Mol Biol & Biochem, Matsumoto, Nagano 3908621, Japan; Sci Applicat Int Corp, SAIC Frederick, Frederick, MD 21702 USA; NCI, Frederick Canc Res & Dev Ctr, Adv BioSci Labs, NIH, Frederick, MD 21702 USA; NCI, Basic Res Lab, NIH, Bethesda, MD 20892 USA	Shinshu University; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kamata, T (corresponding author), Shinshu Univ, Sch Med, Dept Mol Biol & Biochem, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	kamatat@sch.md.shinshu-u.ac.jp	Mitsushita, Junji/D-7688-2016	Mitsushita, Junji/0000-0001-9402-4318; Suzukawa, Kazumi/0000-0001-9904-3905				ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Downward J, 1996, CANCER SURV, V27, P87; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HART MJ, 1994, J BIOL CHEM, V269, P62; HEMKEN P, 1992, J BIOL CHEM, V267, P9948; HIGUCHI R, 1990, PCR TECHNOLOGY; Kamata T, 1998, MOL BRAIN RES, V54, P219, DOI 10.1016/S0169-328X(97)00332-X; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KARLOVICH CA, 1995, SCIENCE, V268, P576, DOI 10.1126/science.7725106; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LaitalaLeinonen T, 1996, MOL BIOL CELL, V7, P129, DOI 10.1091/mbc.7.1.129; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Li BQ, 1996, P NATL ACAD SCI USA, V93, P1001, DOI 10.1073/pnas.93.3.1001; LI BQ, 1992, SCIENCE, V256, P1456, DOI 10.1126/science.1604323; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Niessen H, 1997, BLOOD, V90, P4598; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; Qian XL, 1998, MOL CELL BIOL, V18, P771, DOI 10.1128/MCB.18.2.771; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WANG W, 1995, NAT GENET, V10, P294, DOI 10.1038/ng0795-294; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; XIE XS, 1988, J BIOL CHEM, V263, P9859; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470	35	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46276	46283		10.1074/jbc.M102387200	http://dx.doi.org/10.1074/jbc.M102387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11560919	hybrid			2022-12-27	WOS:000172573100107
J	Vaux, EC; Wood, SM; Cockman, ME; Nicholls, LG; Yeates, KM; Pugh, CW; Maxwell, PH; Ratcliffe, PJ				Vaux, EC; Wood, SM; Cockman, ME; Nicholls, LG; Yeates, KM; Pugh, CW; Maxwell, PH; Ratcliffe, PJ			Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; ALPHA-SUBUNIT; RENAL-CARCINOMA; GENE-EXPRESSION; FACTOR-I; HYPOXIA; PROTEIN; FACTOR-1-ALPHA; HIF-1-ALPHA; BINDING	Hypoxia-inducible factor (HIF) mediates a widespread transcriptional response to hypoxia through binding to cis-acting DNA sequences termed hypoxia response elements (HREs). Activity of the transcriptional complex is suppressed in the presence of oxygen by processes that include the targeting of HIF-alpha subunits for ubiquitin-mediated proteolysis. To provide further insights into these processes we constructed Chinese hamster ovary (CHO) cells bearing stably integrated plasmids that expressed HRE-linked surface antigens and used these cells in genetic screens for mutants that demonstrated constitutive up-regulation of HRE activity. From mutagenized cultures, clones were isolated that demonstrated up-regulation of HRE activity and increased HIF-1 alpha protein levels in normoxic culture. Transfection and cell fusion studies suggested that these cells possess recessive defects that affect one or more pathways involved in HIF-alpha proteolysis. Two lines were demonstrated to harbor truncating mutations in the von Hippel-Lindau VHL) tumor suppressor gene. In these cells, defects in ubiquitylation of exogenous human HIF-1 alpha in vitro could be complemented by wild type pVHL, and re-expression of a wild type VHL gene restored a normal pattern of HIF/ HRE activity, demonstrating the critical dependence of HIF regulation on pVHL in CHO cells. In contrast, other mutant cells had no demonstrable mutation in the VHL gene, and ubiquitylated exogenous HIEF-1 alpha normally, suggesting that they contain defects at other points in the oxygen-regulated processing of HIF-alpha subunits.	Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Ratcliffe, PJ (corresponding author), Wellcome Trust Ctr Human Genet, Henry Wellcome Bldg Genomic Med,Roosevelt Dr, Oxford OX3 7BN, England.	peter.ratcliffe@imm.ox.ac.uk	Maxwell, Patrick H/C-5557-2008; Cockman, Matthew/V-9619-2019	Maxwell, Patrick H/0000-0002-0338-2679; Cockman, Matthew/0000-0002-3310-4821; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X				Berra E, 2001, FEBS LETT, V491, P85, DOI 10.1016/S0014-5793(01)02159-7; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Ebert BL, 1999, BLOOD, V94, P1864; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Gorospe M, 1999, MOL CELL BIOL, V19, P1289; HASEGAWA K, 1990, BIOCHIM BIOPHYS ACTA, V1051, P221, DOI 10.1016/0167-4889(90)90126-X; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; ONEILL JP, 1978, CANCER RES, V38, P506; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Ravi R, 2000, GENE DEV, V14, P34; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schoenfeld AR, 2000, ONCOGENE, V19, P5851, DOI 10.1038/sj.onc.1203985; Semenza GL, 2000, GENE DEV, V14, P1983; TAFT SA, 1994, ENVIRON MOL MUTAGEN, V23, P96, DOI 10.1002/em.2850230204; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Woodward ER, 2000, GENOMICS, V65, P253, DOI 10.1006/geno.2000.6144; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	44	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44323	44330		10.1074/jbc.M104678200	http://dx.doi.org/10.1074/jbc.M104678200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11555645	hybrid			2022-12-27	WOS:000172297700105
J	Saunders, DN; Jankova, L; Harrop, SJ; Curmi, PMG; Gould, AR; Ranson, M; Baker, MS				Saunders, DN; Jankova, L; Harrop, SJ; Curmi, PMG; Gould, AR; Ranson, M; Baker, MS			Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CONFORMATIONAL CHANGE; HINGE REGION; DATA-BANK; SERPIN; SUBSTRATE; OVALBUMIN; ANTITHROMBIN; RESOLUTION; TRANSITION	The molecular interactions driving reactive center loop (RCL) insertion are of considerable interest in gaining a better understanding of the serpin inhibitory mechanism. Previous studies have suggested that interactions in the proximal hinge/breach region may be critical determinants of RCL insertion in serpins. In this study, conformational and functional changes in plasminogen activator inhibitor-2 (PAI-2) following incubation with a panel of synthetic RCL peptides indicated that the P14 residue is critical for RCL insertion, and hence inhibitory activity, in PAI-2. Only RCL peptides with a P14 threonine were able to induce the stressed to relaxed transition and abolish inhibitory activity in PAI-2, indicating that RCL insertion into beta -sheet A of PAI-2 is dependent upon this residue. The recently solved crystal structure of relaxed PAI-2 (PAI-2-RCL peptide complex) allowed detailed analysis of molecular interactions involving P14 related to RCL insertion. Of most interest is the rearrangement of hydrogen bonding around the breach region that accompanies the stressed to relaxed transition, in particular the formation of a side chain hydrogen bond between the threonine at P14 and an adjacent tyrosine on strand 2 of beta -sheet B in relaxed PAI-2. Structural alignment of known serpin sequences showed that this pairing (or the equivalent serine/threonine pairing) is highly conserved (similar to 87%) in inhibitory serpins and may represent a general structural basis for serpin inhibitory activity.	St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; Univ Wollongong, Dept Biol Sci, Wollongong, NSW 2522, Australia; Univ New S Wales, Sch Phys, Initiat Biomol Struct, Kensington, NSW 2052, Australia; Biotech Australia Pty Ltd, Roseville, NSW 2069, Australia; Royal Womens Hosp, Gynaecol Canc Res Ctr, Carlton, Vic 3053, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Wollongong; University of New South Wales Sydney	Saunders, DN (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.		Ranson, Marie/A-6324-2008; Saunders, Darren/B-7677-2008; Ranson, Marie/AAC-4468-2019; Ranson, Marie/GRO-5792-2022; Curmi, Paul/G-7185-2011	Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Curmi, Paul/0000-0001-5762-7638; Saunders, Darren/0000-0003-0924-0513; Baker, Mark/0000-0001-5858-4035				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; BAUMANN U, 1992, J MOL BIOL, V226, P1207, DOI 10.1016/0022-2836(92)91062-T; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORK I, 1992, J BIOL CHEM, V267, P1976; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; Gils A, 1996, BIOCHEMISTRY-US, V35, P7474, DOI 10.1021/bi960079d; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jankova L, 2001, J BIOL CHEM, V276, P43374, DOI 10.1074/jbc.M103021200; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Saunders DN, 1998, J BIOL CHEM, V273, P10965, DOI 10.1074/jbc.273.18.10965; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; Skinner R, 1998, J MOL BIOL, V283, P9, DOI 10.1006/jmbi.1998.2083; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; TUCKER HM, 1995, NAT STRUCT BIOL, V2, P442, DOI 10.1038/nsb0695-442; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303; WRIGHT HT, 1990, J MOL BIOL, V213, P513; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1	27	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43383	43389		10.1074/jbc.M103123200	http://dx.doi.org/10.1074/jbc.M103123200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555638	hybrid			2022-12-27	WOS:000172169300097
J	Xie, SQ; Wu, HY; Wang, Q; Cogswell, JP; Husain, I; Conn, C; Stambrook, P; Jhanwar-Uniyal, M; Dai, W				Xie, SQ; Wu, HY; Wang, Q; Cogswell, JP; Husain, I; Conn, C; Stambrook, P; Jhanwar-Uniyal, M; Dai, W			Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT; KINASE; ATM; PHOSPHORYLATION; PROTEIN; CHK2; EXPRESSION; CARCINOMAS; CANCER; SITES	Polo-like kinase 3 (Plk3, previously termed Prk) contributes to regulation of M phase of the cell cycle (Ouyang, B., Pan, H., Lu, L., Li, J., Stambrook, P., Li, B., and Dai, W. (1997) J. Biol. Chem. 272, 28646-28651). Plk3 physically interacts with Cdc25C and phosphorylates this protein phosphatase predominantly on serine 216 (Ouyang, B., Li, W., Pan, H., Meadows, J., Hoffmann, L, and Dai, W. (1999) Oncogene 18, 6029-6036), suggesting that the role of Plk3 in mitosis is mediated, at least in part, through direct regulation of Cdc25C. Here we show that ectopic expression of a kinase-active Plk3 (Plk3-A) induced apoptosis. In response to DNA damage, the kinase activity of Plk3 was rapidly increased in an ATM-dependent manner, whereas that of Plk1 was markedly inhibited. Recombinant Plk3 phosphorylated in vitro a glutathione S-transferase fusion protein containing p53, but not glutathione S-transferase alone. Recombinant Plk1 also phosphorylated p53 but on residues that differed from those targeted by Plk3. Co-immunoprecipitation and pull-down assays demonstrated that Plk3 physically interacted with p53 and that this interaction was enhanced upon DNA damage. An vitro kinase assays followed by immunoblotting showed that serine 20 of p53 was a target of Plk3. Furthermore, expression of a kinase-defective Plk3 mutant (Plk3(K52R)) resulted in significant reduction of p53 phosphorylation on serine 20, which was correlated with a decrease in the expression of p21 and with a concomitant increase in cell proliferation. These results strongly suggest that PIk3 functionally links DNA damage to cell cycle arrest and apoptosis via the p53 pathway.	Amer Hlth Fdn, Valhalla, NY 10595 USA; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; Univ Cincinnati, Dept Cell Biol, Cincinnati, OH 45267 USA	American Health Foundation; GlaxoSmithKline; University System of Ohio; University of Cincinnati	Dai, W (corresponding author), Amer Hlth Fdn, 1 Dana Rd, Valhalla, NY 10595 USA.	wei-dai_nyu@yahoo.com			PHS HHS [R01-74229] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Chehab NH, 2000, GENE DEV, V14, P278; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Conn CW, 2000, CANCER RES, V60, P6826; Dai W, 2000, GENE CHROMOSOME CANC, V27, P332, DOI 10.1002/(SICI)1098-2264(200003)27:3<332::AID-GCC15>3.0.CO;2-K; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Haggman MJ, 1997, UROLOGY, V50, P643, DOI 10.1016/S0090-4295(97)00304-X; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HUSSAIN RF, 1993, J IMMUNOL METHODS, V160, P89, DOI 10.1016/0022-1759(93)90012-V; KAGAN J, 1995, ONCOGENE, V11, P2121; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Knecht R, 1999, CANCER RES, V59, P2794; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Nakamura Y, 1998, NAT MED, V4, P1231, DOI 10.1038/3207; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shieh SY, 2000, GENE DEV, V14, P289; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tominaga K, 1999, J BIOL CHEM, V274, P31463, DOI 10.1074/jbc.274.44.31463; Westphal CH, 1997, CURR BIOL, V7, pR789, DOI 10.1016/S0960-9822(06)00406-4; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	33	172	184	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43305	43312		10.1074/jbc.M106050200	http://dx.doi.org/10.1074/jbc.M106050200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551930	hybrid			2022-12-27	WOS:000172169300088
J	Carr, A; Sledjeski, DD; Podbielski, A; Boyle, MDP; Kreikemeyer, B				Carr, A; Sledjeski, DD; Podbielski, A; Boyle, MDP; Kreikemeyer, B			Similarities between complement-mediated and streptolysin S-mediated hemolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE HEMOLYSIS; TERMINAL STAGES; IDENTIFICATION; STREPTOCOCCUS; CHANNEL; VIRULENCE; PROTEINS; TOXIN; LOCUS; C9	The oxygen-stable hemolysin streptolysin S (SLS) of Streptococcus pyogenes is encoded in part by the pel/sagA gene product. Antibodies to a synthetic peptide from the C terminus of the Pel/SagA open reading frame inhibited hemolysis mediated by both culture supernatants from multiple M serotypes of S. pyogenes isolates or a commercially available SLS preparation. Analysis of the SLS-mediated hemolytic reaction demonstrated that it was temperature- and concentration-dependent. Like complement-mediated hemolysis it conforms to the prediction of a one-hit mechanism of hemolysis. A number of intermediates in the SLS-mediated hemolysis of sheep erythrocytes could be distinguished. SLS could bind to erythrocytes below 17 degreesC; however, lysis could only occur at temperatures > 23 degreesC. Following binding of SLS and washing, a papain-sensitive intermediate could be distinguished prior to insertion of the SLS complex into the erythrocyte membrane, which resulted in formation of a transmembrane pore and led to irreversible osmotic lysis of the cell. These intermediates were similar to those described previously during complement-mediated hemolysis.	Med Coll Ohio, Dept Microbiol & Immunol, Toledo, OH 43614 USA; Univ Hosp Rostock, Dept Med Microbiol & Hyg, D-18055 Rostock, Germany	University of Rostock	Boyle, MDP (corresponding author), Med Coll Ohio, Dept Microbiol & Immunol, 3055 Arlington Ave, Toledo, OH 43614 USA.	mboyle@mco.edu		Kreikemeyer, Bernd/0000-0001-9527-5098; Sledjeski, Darren/0000-0001-9882-6625	NIAID NIH HHS [AI43474] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; BHAKDI S, 1985, BIOCHEM SOC SYMP, P221; BHAKDI S, 1984, PHILOS T R SOC B, V306, P311, DOI 10.1098/rstb.1984.0092; BHAKDI S, 1982, MOL IMMUNOL, V19, P1167, DOI 10.1016/0161-5890(82)90327-3; BHAKDI S, 1978, J IMMUNOL, V121, P2526; BOYLE MDP, 1979, J IMMUNOL, V123, P71; BOYLE MDP, 1978, J IMMUNOL, V120, P1721; BOYLE MDP, 1979, J IMMUNOL, V123, P77; Boyle MDP, 2001, J MICROBIOL METH, V46, P87, DOI 10.1016/S0167-7012(01)00279-2; BOYLE MDP, 1980, MOL IMMUNOL, V17, P425, DOI 10.1016/0161-5890(80)90064-4; BOYLE MDP, 1981, IMMUNOL IMMUNOPATHOL, V20, P287; DELISI C, 1980, J IMMUNOL, V125, P2055; DELISI C, 1980, J IMMUNOL, V125, P2334; DISCIPIO RG, 1991, J IMMUNOL, V147, P4239; DOURMASHKIN RR, 1966, AM J MED, V41, P699, DOI 10.1016/0002-9343(66)90031-3; DROBNIEWSKI FA, 1989, J BACTERIOL, V171, P3060, DOI 10.1128/jb.171.6.3060-3067.1989; DUNCAN JL, 1976, INFECT IMMUN, V14, P77, DOI 10.1128/IAI.14.1.77-82.1976; EBERHARD TH, 2000, 100 GEN M AM SOC MIC; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Ginsburg I, 1999, APMIS, V107, P1051, DOI 10.1111/j.1699-0463.1999.tb01509.x; GINSBURG I, 1963, J EXP MED, V118, P919, DOI 10.1084/jem.118.6.919; GINSBURG I, 1965, J EXP MED, V121, P633, DOI 10.1084/jem.121.4.633; GINSBURG I, 1972, MICROBIAL TOXINS BAC, V3, P100; HONDA T, 1992, CAN J MICROBIOL, V38, P1175, DOI 10.1139/m92-192; KOYAMA J, 1963, J BIOCHEM-TOKYO, V53, P147, DOI 10.1093/oxfordjournals.jbchem.a127670; KOYAMA J, 1963, J BIOCHEM-TOKYO, V54, P146; LAI CY, 1978, ARCH BIOCHEM BIOPHYS, V191, P804, DOI 10.1016/0003-9861(78)90423-X; LEE PK, 1991, J INFECT DIS, V164, P711, DOI 10.1093/infdis/164.4.711; Li ZQ, 1999, J BACTERIOL, V181, P6019, DOI 10.1128/JB.181.19.6019-6027.1999; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OKADA M, 1980, BIOCHEM BIOPH RES CO, V94, P406, DOI 10.1016/S0006-291X(80)80235-X; PODLACK ER, 1984, MOL IMMUNOL, V21, P589; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; RAPP HJ, 1970, MOL BASIS COMPLEMENT; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999	37	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41790	41796		10.1074/jbc.M107401200	http://dx.doi.org/10.1074/jbc.M107401200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546819	hybrid			2022-12-27	WOS:000172450400034
J	Choi, IR; Ostrovsky, M; Zhang, GC; White, KA				Choi, IR; Ostrovsky, M; Zhang, GC; White, KA			Regulatory activity of distal and core RNA elements in tombusvirus subgenomic mRNA2 transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUSHY-STUNT VIRUS; CUCUMBER-NECROSIS VIRUS; FLOCK HOUSE VIRUS; COAT PROTEIN GENE; MESSENGER-RNA; VIRAL-RNA; POSITIVE-STRAND; EXPRESSION; SEQUENCE; ACCUMULATION	Positive-strand RNA viruses that encode multiple cistrons often mediate expression of T-encoded open reading frames via RNA-templated transcription of subgenomic (sg) mRNAs. Tomato bushy stunt virus (TBSV) is a positive-strand RNA virus that transcribes two such sg mRNAs during infections. We have previously identified a distal element (DE), located similar to 1100 nucleotides upstream from the initiation site of sg mRNA2 transcription, part of which must base pair with a portion of a core element (CE), located just 5' to the initiation site, for efficient transcription to occur (Zhang, G., Slowinski, V., and White, K. A (1999) RNA 5, 550-561). Here we have analyzed further this long distance RNA-RNA interaction and have investigated the regulatory roles of other subelements within the DE and CE. Our results indicate that M the functional base-pairing interaction between these elements occurs in the positive strand and that the interaction likely acts to properly position other subelements, (ii) two previously undefined subelements within the DE and CE are important and essential, respectively, for efficient sg mRNA2 accumulation, and (iii) the production of (-)-strand sg mRNA2 can be uncoupled from the synthesis of its (+)-strand complement. These data provide important insight into the mechanism of sg mRNA2 transcription.	York Univ, Dept Biol, N York, ON M3J 1P3, Canada	York University - Canada	White, KA (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	kawhite@yorku.ca						CHAPMAN S, 1992, VIROLOGY, V191, P223, DOI 10.1016/0042-6822(92)90183-P; HEARNE PQ, 1990, VIROLOGY, V177, P141, DOI 10.1016/0042-6822(90)90468-7; HILLMAN BI, 1989, VIROLOGY, V169, P42, DOI 10.1016/0042-6822(89)90039-1; JOHNSTON JC, 1995, VIROLOGY, V214, P100, DOI 10.1006/viro.1995.9950; Kim KH, 1997, VIROLOGY, V232, P187, DOI 10.1006/viro.1997.8565; Kim KH, 1999, RNA, V5, P636, DOI 10.1017/S1355838299982006; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; Limmer S, 1997, PROG NUCLEIC ACID RE, V57, P1, DOI 10.1016/S0079-6603(08)60276-7; Maia IG, 1996, PLANT MOL BIOL, V32, P367, DOI 10.1007/BF00039391; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miller WA, 2000, VIROLOGY, V273, P1, DOI 10.1006/viro.2000.0421; Miller WA, 1997, SEMIN VIROL, V8, P3, DOI 10.1006/smvy.1997.0101; MILLER WA, 1985, NATURE, V313, P68, DOI 10.1038/313068a0; Nagy PD, 2000, VIROLOGY, V276, P279, DOI 10.1006/viro.2000.0577; Oster SK, 1998, J VIROL, V72, P5845, DOI 10.1128/JVI.72.7.5845-5851.1998; Pasternak AO, 2000, J VIROL, V74, P11642, DOI 10.1128/JVI.74.24.11642-11653.2000; Price BD, 2000, J VIROL, V74, P11724, DOI 10.1128/JVI.74.24.11724-11733.2000; Sambrook J., 2002, MOL CLONING LAB MANU; SCHOLTHOF HB, 1995, VIROLOGY, V213, P425, DOI 10.1006/viro.1995.0015; Siegel RW, 1997, P NATL ACAD SCI USA, V94, P11238, DOI 10.1073/pnas.94.21.11238; Sit TL, 1998, SCIENCE, V281, P829, DOI 10.1126/science.281.5378.829; TAVAZZA M, 1994, J GEN VIROL, V75, P1515, DOI 10.1099/0022-1317-75-7-1515; van Marle G, 1999, P NATL ACAD SCI USA, V96, P12056, DOI 10.1073/pnas.96.21.12056; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; WHITE KA, 1994, J VIROL, V68, P14, DOI 10.1128/JVI.68.1.14-24.1994; Zhang GC, 1999, RNA, V5, P550, DOI 10.1017/S1355838299982080; ZHONG WD, 1993, J VIROL, V67, P2716, DOI 10.1128/JVI.67.5.2716-2722.1993; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	28	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41761	41768		10.1074/jbc.M106727200	http://dx.doi.org/10.1074/jbc.M106727200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546813	hybrid			2022-12-27	WOS:000172450400031
J	Claing, A; Chen, W; Miller, WE; Vitale, N; Moss, J; Premont, RT; Lefkowitz, RJ				Claing, A; Chen, W; Miller, WE; Vitale, N; Moss, J; Premont, RT; Lefkowitz, RJ			beta-arrestin-mediated ADP-ribosylation factor 6 activation and beta(2)-adrenergic receptor endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PROTEIN-COUPLED RECEPTORS; PLASMA-MEMBRANE; CLATHRIN ADAPTER; GOLGI-COMPLEX; ARF6; GTPASE; CELLS; DOMAINS; BINDING	beta -Arrestins are multifunctional adaptor proteins known to regulate internalization of agonist-stimulated G protein-coupled receptors by linking them to endocytic proteins such as clathrin and AP-2. Here we describe a previously unappreciated mechanism by which beta -arrestin orchestrates the process of receptor endocytosis through the activation of ADP-ribosylation factor 6 (ARF6), a small GTP-binding protein. Involvement of ARF6 in the endocytic process is demonstrated by the ability of GTP-binding defective and GTP hydrolysis-deficient mutants to inhibit internalization of the beta (2)-adrenergic receptor. The importance of regulation of ARF6 function is shown by the ability of the ARF GTPase-activating protein GIT1 to inhibit and of the ARF nucleotide exchange factor, ARNO, to enhance receptor endocytosis. Endogenous beta -arrestin is found in complex with ARNO. Upon agonist stimulation of the receptor, beta -arrestin also interacts with the GDP-liganded form of ARF6, thereby facilitating ARNO-promoted GTP loading and activation of the G protein. Thus, the agonist-driven formation of a complex including beta -arrestin, ARNO, and ARF6 provides a molecular mechanism that explains how the agonist-stimulated receptor recruits a small G protein necessary for the endocytic process and controls its activation.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; CNRS, Ctr Neurochim, UPR2356, F-67084 Strasbourg, France; NHLBI, Pulm Crit Care Med Branch, Nihon Univ, Bethesda, MD 20892 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021; Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907; Premont, Richard/0000-0002-8053-5026; Miller, William/0000-0001-6900-4884; Chen, Wei/0000-0002-9934-4000	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HONG JX, 1994, J BIOL CHEM, V269, P9743; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lawrence JTR, 2001, MOL CELL BIOL, V21, P5276, DOI 10.1128/MCB.21.15.5276-5285.2001; Liang JO, 1997, J BIOL CHEM, V272, P33001, DOI 10.1074/jbc.272.52.33001; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rothman JE, 1996, PROTEIN SCI, V5, P185; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Song J, 1998, J CELL SCI, V111, P2257; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; VON ZM, 1992, J BIOL CHEM, V267, P3530; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	44	172	185	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42509	42513		10.1074/jbc.M108399200	http://dx.doi.org/10.1074/jbc.M108399200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533043	hybrid			2022-12-27	WOS:000172450400124
J	Dick, RA; Kwak, MK; Sutter, TR; Kensler, TW				Dick, RA; Kwak, MK; Sutter, TR; Kensler, TW			Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase - A new role for leukotriene B-4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDO-KETO REDUCTASE; LIPID-PEROXIDATION; RAT-LIVER; ALDEHYDE DEHYDROGENASES; ALCOHOL-DEHYDROGENASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; SOS CHROMOTEST; CDNA CLONING; PRODUCTS	There are several known routes for the metabolic detoxication of alpha,beta -unsaturated aldehydes and ketones, including conjugation to glutathione and reduction and oxidation of the aldehyde to an alcohol and a carboxylic acid, respectively. In this study, we describe a fourth class of detoxication that involves the reduction of the alpha,beta -carbon = carbon double bond to a single bond. This reaction is catalyzed by NAD(P)H-dependent alkenal/one oxidoreductase (AO), an enzyme heretofore known as leukotriene B-4 12-hydroxydehydrogenase, 15-oxoprostagiandin 13-reductase, and dithiolethione-inducible gene-1. AO is shown to effectively reduce cytotoxic lipid peroxidation products such as 4-hydroxy-2-nonenal (HNE) (k(cat) = 4.0 x 10(3) min(-1); k(cat)/K-m = 3.3 x 10(7) min(-1) M-1) and acrolein (k(cat) = 2.2 x 10(2) min(-1); k(cat)/K-m = 1.5 x 10(6) min(-1) m(-1)) and common industrial compounds such as ethyl vinyl ketone (k(cat) = 9.6 x 10(3) min(-1); k(cat)/K-m = 8.8 x 10(7) min(-1) M-1) and 15-oxoprostaglandin E-1 (k(cat) = 2.4 x 10(3) min(-1); k(cat)/K-m = 2.4 x 10(9) min(-1) M-1). Furthermore, transfection of human embryonic kidney cells with a rat liver AO expression vector protected these cells from challenge with HNE. The concentration of HNE at which 50% of the cells were killed after 24 h increased from similar to 15 mum in control cells to similar to 70 muM in AO-transfected cells. Overexpression of AO also completely abolished protein alkylation by HNE at all concentrations tested (up to 30 muM). Thus, we describe a novel antioxidative activity of a previously characterized bioactive lipid-metabolizing enzyme that could prove to be therapeutically or prophylactically useful due to its high catalytic rate and inducibility.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA; Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Memphis	Kensler, TW (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Rm 7032,615 N Wolfe, Baltimore, MD 21205 USA.	tkensler@jhsph.edu	Kensler, Thomas W/D-8686-2014	Kensler, Thomas W/0000-0002-6676-261X	NCI NIH HHS [CA39416, T32CA09243] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039416, T32CA009243] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allali-Hassani A, 1998, FEBS LETT, V426, P362, DOI 10.1016/S0014-5793(98)00374-3; Aviram M, 2000, FREE RADICAL RES, V33, pS85; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; CARMICHAEL J, 1987, CANCER RES, V47, P936; Carvalho VM, 2000, CHEM RES TOXICOL, V13, P397, DOI 10.1021/tx9901682; Chen HJC, 1996, CHEM RES TOXICOL, V9, P306, DOI 10.1021/tx9501389; Cheng JZ, 2001, BIOCHEM BIOPH RES CO, V282, P1268, DOI 10.1006/bbrc.2001.4707; Clapper ML, 1998, PHARMACOL THERAPEUT, V78, P17, DOI 10.1016/S0163-7258(97)00164-2; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; DIANZANI MU, 1993, CRIT REV ONCOL HEMAT, V15, P125, DOI 10.1016/1040-8428(93)90052-6; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Eder E, 2000, MUTAT RES-GEN TOX EN, V470, P29, DOI 10.1016/S1383-5718(00)00078-4; EDER E, 1991, CHEM RES TOXICOL, V4, P50, DOI 10.1021/tx00019a007; Ensor CM, 1998, BIOCHEM J, V330, P103, DOI 10.1042/bj3300103; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Esterbauer H., 1982, FREE RADICAL LIPID P, P101; ESTERBAUER H, 1990, MEMBRANE LIPID OXIDA, V1, P239; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Hayes JD, 1998, CHEM-BIOL INTERACT, V112, P51, DOI 10.1016/S0009-2797(97)00151-8; Haynes RL, 2000, MOL PHARMACOL, V58, P788, DOI 10.1124/mol.58.4.788; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; JURGENS G, 1993, ARTERIOSCLER THROMB, V13, P1689, DOI 10.1161/01.ATV.13.11.1689; Kensler T W, 2000, Drug Metabol Drug Interact, V17, P3; Kensler TW, 1999, CHEM RES TOXICOL, V12, P113, DOI 10.1021/tx980185b; KITAMURA S, 1993, BIOCHEM MOL BIOL INT, V30, P839; Kitson TM, 2001, CHEM-BIOL INTERACT, V130, P57, DOI 10.1016/S0009-2797(00)00222-2; KNAPP DR, 1979, HDB ANAL DERIVATIZAT, P340; Knight LP, 1999, CARCINOGENESIS, V20, P1215, DOI 10.1093/carcin/20.7.1215; Koster J F, 1986, Free Radic Res Commun, V1, P273, DOI 10.3109/10715768609051637; Laurent A, 2000, TOXICOL LETT, V114, P203, DOI 10.1016/S0378-4274(99)00301-X; LINDAHL R, 1991, BIOCHEM PHARMACOL, V41, P1583, DOI 10.1016/0006-2952(91)90157-Z; Loureiro APM, 2000, CHEM RES TOXICOL, V13, P601, DOI 10.1021/tx000004h; Luckey SW, 1999, ADV EXP MED BIOL, V463, P71; Mano J, 2000, EUR J BIOCHEM, V267, P3661, DOI 10.1046/j.1432-1327.2000.01398.x; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MITCHELL DY, 1987, TOXICOL APPL PHARM, V87, P403, DOI 10.1016/0041-008X(87)90245-6; MITCHELL DY, 1991, HEPATOLOGY, V13, P728, DOI 10.1016/0270-9139(91)92572-P; MITCHELL DY, 1989, ARCH BIOCHEM BIOPHYS, V269, P11, DOI 10.1016/0003-9861(89)90081-7; Montine KS, 1997, AM J PATHOL, V150, P437; Moran LK, 2001, CURR MED CHEM, V8, P763, DOI 10.2174/0929867013372904; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; PRESTERA T, 1993, P NATL ACAD SCI USA, V90, P2965, DOI 10.1073/pnas.90.7.2965; Primiano T, 1998, CARCINOGENESIS, V19, P999, DOI 10.1093/carcin/19.6.999; Primiano T, 1996, CARCINOGENESIS, V17, P2297, DOI 10.1093/carcin/17.11.2297; *QIAGEN INC, 2001, QIAEXPR; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; SELLIN S, 1991, BIOCHEMISTRY-US, V30, P2514, DOI 10.1021/bi00223a031; Srivastava S, 1998, BIOCHEMISTRY-US, V37, P12909, DOI 10.1021/bi9804333; Srivastava S, 2000, FREE RADICAL BIO MED, V29, P642, DOI 10.1016/S0891-5849(00)00351-8; Srivastava S, 2001, CHEM-BIOL INTERACT, V130, P563, DOI 10.1016/S0009-2797(00)00299-4; TAKEHIKO Y, 1993, J BIOL CHEM, V268, P18128; TAKEHIKO Y, 1996, J BIOL CHEM, V271, P2844; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Vermeiren GLJ, 2000, RESUSCITATION, V45, P35, DOI 10.1016/S0300-9572(00)00168-4	57	111	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40803	40810		10.1074/jbc.M105487200	http://dx.doi.org/10.1074/jbc.M105487200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524419	hybrid			2022-12-27	WOS:000171925600058
J	Rojnuckarin, P; Miyakawa, Y; Fox, NE; Deou, J; Daum, G; Kaushansky, K				Rojnuckarin, P; Miyakawa, Y; Fox, NE; Deou, J; Daum, G; Kaushansky, K			The roles of phosphatidylinositol 3-kinase and protein kinase C zeta for thrombopoietin-induced mitogen-activated protein kinase activation in primary murine megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; PI 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; TYROSINE-PHOSPHATASE; GLUCOSE-TRANSPORT; RECEPTOR; RAS; PATHWAY; SHP2; GAB1	Thrombopoietin (TPO) stimulates a network of intracellular signaling pathways that displays extensive cross-talk. We have demonstrated previously that the ERK/mitogen-activated protein kinase pathway is important for TPO-induced endomitosis in primary megakaryocytes (MKs). One known pathway by which TPO induces ERR activation is through the association of Shc with the penultimate phosphotyrosine within the TPO receptor, Mpl. However, several investigators found that the membrane-proximal half of the cytoplasmic domain of Mpl is sufficient to activate ERK in vitro and support base-line megakaryopoiesis an vivo. Using BaF3 cells expressing a truncated Mpl (T69Mp1) as a tool to identify non-Shc/Ras-dependent signaling pathways, we describe here novel mechanisms of TPO-induced ERK activation mediated, in part, by phosphoinositide 3-kinase PI3K). Similar to cells expressing full-length receptor, PI3K was activated by its incorporation into a complex with IRS2 or Gab2. Furthermore, the MEK-phosphorylating activity of protein kinase C zeta (PKC zeta) was also enhanced after TPO stimulation of T69Mp1, contributing to ERK activity. PKC zeta and PI3K also contribute to TPO-induced ERK activation in MKs, confirming their physiological relevance. Like in BaF3 cells, a TPO-induced signaling complex containing p85PI3K is detectable in MKs expressing T61Mpl and is probably responsible for PI3K activation. These data demonstrate a novel role of PI3K and PKC zeta in steady-state megakaryopoiesis.	Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaushansky, K (corresponding author), Univ Washington, Sch Med, Div Hematol, Box 357710,1959 NE Pacific St, Seattle, WA 98195 USA.	kkaushan@u.washington.edu						BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Bouscary D, 2001, ONCOGENE, V20, P2197, DOI 10.1038/sj.onc.1204317; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; Geddis AE, 2001, J BIOL CHEM, V276, P34473, DOI 10.1074/jbc.M105178200; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; King TS, 1997, ALIMENT PHARM THER, V11, P17, DOI 10.1046/j.1365-2036.1997.90262000.x; Kirito K, 2000, BLOOD, V96, p538A; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kunitama M, 1997, BIOCHEM BIOPH RES CO, V231, P290, DOI 10.1006/bbrc.1996.5969; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luoh SM, 2000, MOL CELL BIOL, V20, P507, DOI 10.1128/MCB.20.2.507-515.2000; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; MARRA F, 1995, FEBS LETT, V376, P141, DOI 10.1016/0014-5793(95)01261-0; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Monick MM, 2000, J IMMUNOL, V165, P4632, DOI 10.4049/jimmunol.165.8.4632; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Rojnuckarin P, 1999, BLOOD, V94, P1273, DOI 10.1182/blood.V94.4.1273.416k04_1273_1282; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Sajan MP, 1999, J BIOL CHEM, V274, P30495, DOI 10.1074/jbc.274.43.30495; Sarbassov DD, 1998, MOL ENDOCRINOL, V12, P1870, DOI 10.1210/me.12.12.1870; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; vanDijk MCM, 1997, BIOCHEM J, V325, P303, DOI 10.1042/bj3250303; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; XIAO S, 1994, J BIOL CHEM, V269, P21244; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200	45	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41014	41022		10.1074/jbc.M106508200	http://dx.doi.org/10.1074/jbc.M106508200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11535599	hybrid			2022-12-27	WOS:000171925600086
J	Woolhead, CA; Thompson, SJ; Moore, M; Tissier, C; Mant, A; Rodger, A; Henry, R; Robinson, C				Woolhead, CA; Thompson, SJ; Moore, M; Tissier, C; Mant, A; Rodger, A; Henry, R; Robinson, C			Distinct albino3-dependent and -independent pathways for thylakoid membrane protein insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; SEC-INDEPENDENT INSERTION; ESCHERICHIA-COLI; POSTTRANSLATIONAL INTEGRATION; INNER MEMBRANE; MITOCHONDRIAL; BACTERIAL; HOMOLOG; BINDING; OXA1P	The homologous proteins Oxa1, YidC, and Alb3 mediate the insertion of membrane proteins in mitochondria, bacteria, and chloroplast thylakoids, respectively. Depletion of YidC in Escherichia coli affects the integration of every membrane protein studied, and Alb3 has been shown previously to be required for the insertion of a signal recognition particle (SRP)-dependent protein, Lhcb1, in thylakoids. In this study we have analyzed the "global" role of Alb3 in the insertion of thylakoid membrane proteins. We show that insertion of two chlorophyll-binding proteins, Lhcb4.1 and Lhcb5, is almost totally blocked by preincubation of thylakoids with anti-Alb3 antibodies, indicating a requirement for Alb3 in the insertion pathway. Insertion of the related PsbS protein, on the other hand, is unaffected by Alb3 antibodies, and insertion of a group of SRP-independent, signal peptide-bearing proteins, PsbX, PsbW, and PsbY, is likewise completely unaffected. Proteinase K is furthermore able to completely degrade Alb3, but this treatment does not affect the insertion of these proteins. Among the thylakoid proteins studied here, Alb3 requirement correlates strictly with a requirement for stromal factors and nucleoside triphosphates. However, the majority of proteins tested do not require Alb3 or any other known form of translocation apparatus.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Warwick; University of Warwick; University of Arkansas System; University of Arkansas Fayetteville	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	Crobinson@bio.warwick.ac.uk	Rodger, Alison/A-1063-2009	Rodger, Alison/0000-0002-7111-3024; Thompson, Simon/0000-0003-0769-8555; Mant, Alexandra/0000-0001-7169-209X				BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; BREYTON C, 1994, J BIOL CHEM, V269, P7597; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; DOUCE R, 1996, ADV PHOTOSYNTH, V4, P69; Gau AE, 1998, MOL GEN GENET, V260, P56, DOI 10.1007/s004380050870; GEBERT JF, 1988, J BIOL CHEM, V263, P16652; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Kim SJ, 1999, J BIOL CHEM, V274, P4715, DOI 10.1074/jbc.274.8.4715; Kim SJ, 1998, FEBS LETT, V424, P105, DOI 10.1016/S0014-5793(98)00148-3; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; Mant A, 1998, FEBS LETT, V423, P183, DOI 10.1016/S0014-5793(98)00089-1; Mant A, 2001, J BIOL CHEM, V276, P36200, DOI 10.1074/jbc.M102914200; MICHL D, 1994, EMBO J, V13, P1310, DOI 10.1002/j.1460-2075.1994.tb06383.x; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; Robinson D, 1996, PLANT J, V10, P149, DOI 10.1046/j.1365-313X.1996.10010149.x; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Thompson SJ, 1998, J BIOL CHEM, V273, P18979, DOI 10.1074/jbc.273.30.18979; Thompson SJ, 1999, J BIOL CHEM, V274, P4059, DOI 10.1074/jbc.274.7.4059; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Zhu YX, 1998, GENE, V208, P1, DOI 10.1016/S0378-1119(97)00613-6	38	72	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40841	40846		10.1074/jbc.M106523200	http://dx.doi.org/10.1074/jbc.M106523200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524428	hybrid, Green Submitted			2022-12-27	WOS:000171925600063
J	Kang, YK; Koo, DB; Park, JS; Choi, YH; Kim, HN; Chang, WK; Lee, KK; Han, YM				Kang, YK; Koo, DB; Park, JS; Choi, YH; Kim, HN; Chang, WK; Lee, KK; Han, YM			Typical demethylation events in cloned pig embryos - Clues on species-specific differences in epigenetic reprogramming of a cloned donor genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSFER; IN-VITRO; PREIMPLANTATION DEVELOPMENT; PATERNAL GENOME; SOMATIC-CELLS; CLONING; MOUSE; FETAL	We investigated whether a genomic demethylation process occurs in pig preimplantation embryos produced by either normal fertilization or somatic cell nuclear transfer. The methylation status of the centromeric satellite and the PRE-1 short interspersed element (SINE) sequences was characterized using bisulfite-sequencing technology. Typical demethylation processes were identified in these repetitive sequences of the cloned donor genome during cleavage, the patterns of which were similar to the ones detected in fertilized counterparts. These findings are different from previous observations with cloned bovine embryos where various repeated regions of the donor genome exhibited aberrant methylation patterns. Our results indicate that species-specific differences exist in modifying the epigenetic status of cloned donor genomes.	KRIBB, Anim Dev Biotechnol Lab, Taejon 305600, South Korea; Natl Livestock Res Inst, Suwon 441350, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Han, YM (corresponding author), KRIBB, Anim Dev Biotechnol Lab, POB 115, Taejon 305600, South Korea.		Han, Yong-Mahn/C-1652-2011					Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Han YM, 1999, BIOL REPROD, V60, P1110, DOI 10.1095/biolreprod60.5.1110; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Koo DB, 2000, BIOL REPROD, V63, P986, DOI 10.1095/biolreprod63.4.986; Koo DB, 2001, MOL REPROD DEV, V58, P15, DOI 10.1002/1098-2795(200101)58:1&lt;15::AID-MRD3&gt;3.0.CO;2-Y; Latham KE, 1999, INT REV CYTOL, V193, P71; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MONK M, 1991, DEVELOPMENT, V112, P189; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 1998, THERIOGENOLOGY, V49, P23, DOI 10.1016/S0093-691X(97)00399-3; Prather RS, 2000, SCIENCE, V289, P1886, DOI 10.1126/science.289.5486.1886; REIK W, 1997, GENOMIC IMPRINTING F, P1; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; SINGER DS, 1987, NUCLEIC ACIDS RES, V15, P2780, DOI 10.1093/nar/15.6.2780; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	23	137	149	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39980	39984		10.1074/jbc.M106516200	http://dx.doi.org/10.1074/jbc.M106516200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11524426	hybrid			2022-12-27	WOS:000171789200065
J	Bouchier-Hayes, L; Conroy, H; Egan, H; Adrain, C; Creagh, EM; MacFarlane, M; Martin, SJ				Bouchier-Hayes, L; Conroy, H; Egan, H; Adrain, C; Creagh, EM; MacFarlane, M; Martin, SJ			CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED-PROXIMITY MODEL; KINASE COMPLEX; CELL-DEATH; IKK-GAMMA; APOPTOSIS; OLIGOMERIZATION; RIP; RECEPTOR; NEMO	Proteins possessing the caspase recruitment domain (CARD) motif have been implicated in pathways leading to activation of caspases or NF-kappaB in the context of apoptosis or inflammation, respectively. Here we report the identification of a novel protein, CARDINAL, that contains a CARD motif and also exhibits a high degree of homology to the C terminus of DEFCAP/NAC, a recently described member of the Apaf-1/Nod-1 family. In contrast with the majority of CARD proteins described to date, CARDINAL failed to promote apoptosis or NF-kappaB activation. Rather, CARDINAL potently suppressed NF-kappaB activation associated with overexpression of TRAIL-R1, TRAIL-R2, RIP, RICK, Bcl10, and TRADD, or through ligand-induced stimulation of the interleukin-1 or tumor necrosis factor receptors. Co-immunoprecipitation experiments revealed that CARDINAL interacts with the regulatory subunit of the I kappaB kinase (IKK) complex, IKK gamma (NEMO), providing a molecular basis for CARDINAL function. Thus, CARDINAL is a novel regulator of NF-kappaB activation in the context of pro-inflammatory signals.	Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland; Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	Trinity College Dublin; University of Leicester	Martin, SJ (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.		Creagh, Emma/AAX-1064-2021; Bouchier-Hayes, Lisa/T-9491-2019; Adrain, Colin/I-6259-2013	Creagh, Emma/0000-0001-7631-4370; Bouchier-Hayes, Lisa/0000-0003-3886-5977; Adrain, Colin/0000-0001-7597-4393; Conroy, Helen/0000-0002-5857-2760; Martin, Seamus/0000-0002-8539-3143				Adrain C, 1999, J BIOL CHEM, V274, P20855, DOI 10.1074/jbc.274.30.20855; Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Kumar S, 1999, TRENDS BIOCHEM SCI, V24, P1, DOI 10.1016/S0968-0004(98)01332-2; Martin Seamus J., 2001, Trends in Cell Biology, V11, P188, DOI 10.1016/S0962-8924(01)01971-7; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Poyet JL, 2001, J BIOL CHEM, V276, P3183, DOI 10.1074/jbc.C000792200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	34	90	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44069	44077		10.1074/jbc.M107373200	http://dx.doi.org/10.1074/jbc.M107373200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551959	hybrid			2022-12-27	WOS:000172297700076
J	Le Guiner, C; Plet, A; Galiana, D; Gesnel, MC; Del Gatto-Konczak, F; Breathnach, R				Le Guiner, C; Plet, A; Galiana, D; Gesnel, MC; Del Gatto-Konczak, F; Breathnach, R			Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; 3'-SPLICE-SITE SELECTION; INTRON SEQUENCES; IN-VIVO; ENHANCER; COMPLEX; SITES; FGFR2; 5'-SPLICE-SITE; DETERMINANTS	The fibroblast growth factor receptor (FGFR)-2 gene contains two mutually exclusive exons, K-SAM and BEK. We made a cell line designed to become drug-resistant on repression of BEK exon splicing. One drug-resistant derivative of this line carried an insertion within the BEK exon of a sequence containing at least two independent splicing silencers. One silencer was a pyrimidine-rich sequence, which markedly increased binding of polypyrimidine tract-binding protein to the BEK exon. The BEK exon binds to polypyrimidine tract-binding protein even in the silencer's absence. Several exonic pyrimidine runs are required for this binding, and they are also required for overexpression of polypyrimidine tract-binding protein to repress BEK exon splicing. These results show that binding of polypyrimidine tract-binding protein to exon sequences can repress splicing. In epithelial cells, the K-SAM exon is spliced in preference to the BEK exon, whose splicing is repressed. Mutation of the BEK exon pyrimidine runs decreases this repression. If this mutation is combined with the deletion of a sequence in the intron upstream from the BEK exon, a complete switch from K-SAM to BEK exon splicing ensues. Binding of polypyrimidine tract binding protein to the BEK exon thus participates in the K-SAM/BEK alternative splicing choice.	CHR, Inst Biol, INSERM, CHR, F-44093 Nantes 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Breathnach, R (corresponding author), CHR, Inst Biol, INSERM, CHR, 9 Quai Moncousu, F-44093 Nantes 1, France.		Breathnach, Richard/K-7599-2015; Del Gatto-Konczak, Fabienne/L-1506-2015					Ashiya M, 1997, RNA, V3, P996; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Carstens RP, 1997, ONCOGENE, V15, P3059, DOI 10.1038/sj.onc.1201498; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Chabot B, 1996, TRENDS GENET, V12, P472, DOI 10.1016/0168-9525(96)10037-8; CHAMPIONARNAUD P, 1991, ONCOGENE, V6, P979; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Chou MY, 1999, MOL CELL BIOL, V19, P69; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DelGatto F, 1996, NUCLEIC ACIDS RES, V24, P2017, DOI 10.1093/nar/24.11.2017; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; DelGatto F, 1997, MOL CELL BIOL, V17, P5106, DOI 10.1128/MCB.17.9.5106; DELGATTO F, 1995, GENOMICS, V27, P558, DOI 10.1006/geno.1995.1095; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Grabowski PJ, 1998, CELL, V92, P709, DOI 10.1016/S0092-8674(00)81399-9; Hajihosseini MK, 2001, P NATL ACAD SCI USA, V98, P3855, DOI 10.1073/pnas.071586898; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Jones RB, 2001, J BIOL CHEM, V276, P4158, DOI 10.1074/jbc.M006151200; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; LIN CH, 1995, RNA, V1, P234; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; Perez I, 1997, RNA, V3, P764; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Roberts GC, 1996, EMBO J, V15, P6301, DOI 10.1002/j.1460-2075.1996.tb01020.x; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Southby J, 1999, MOL CELL BIOL, V19, P2699; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; VALCARCEL J, 1997, CURR BIOL, V7, P705; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088	47	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43677	43687		10.1074/jbc.M107381200	http://dx.doi.org/10.1074/jbc.M107381200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557769	hybrid			2022-12-27	WOS:000172297700027
J	Plemper, RK; Hammond, AL; Cattaneo, R				Plemper, RK; Hammond, AL; Cattaneo, R			Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN; HEMAGGLUTININ-NEURAMINIDASE; CELL-FUSION; SURFACE EXPRESSION; EDMONSTON STRAIN; MESSENGER-RNA; F-PROTEIN; RETENTION; IDENTIFICATION; RECEPTOR	The endoplasmic reticulum (ER) was investigated as the initial oligomerization site for the envelope glycoproteins H and F of measles virus (MV), a clinically relevant member of the Paramyxoviridae family, and consequences of this interaction for viral replication were studied. Both proteins were tagged at their cytosolic tails with RRR and KKXX motifs, respectively, resulting in their efficient retention in the ER. Cotransfection of the retained constructs with transport competent ATV glycoproteins revealed a dominant negative effect on their biological activity indicating intracellular complex formation and thus retention. Pulse-chase analysis and co-immunoprecipitation experiments demonstrated that this effect is based on both homo- and hetero-oligomerization in the ER. Recombinant viruses additionally expressing ER-retained F showed an altered cytopathic phenotype accompanied by greatly reduced particle release. Similar mutant viruses additionally expressing ER-retained H could not be rescued indicating an even greater negative effect of this protein on virus viability. Our study suggests that both homo- and hetero-oligomerization of AIV glycoproteins occur in the ER and that these events are of significance for early steps of particle assembly.	Mayo Fdn, Program Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Plemper, RK (corresponding author), Mayo Fdn, Program Mol Med, 200 1st St SW, Rochester, MN 55905 USA.							Bolt G, 1998, VIROLOGY, V252, P387, DOI 10.1006/viro.1998.9464; Browne H, 1996, J VIROL, V70, P4311, DOI 10.1128/JVI.70.7.4311-4316.1996; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; CATTANEO R, 1987, EMBO J, V6, P681, DOI 10.1002/j.1460-2075.1987.tb04808.x; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; HORVATH CM, 1992, J VIROL, V66, P4564, DOI 10.1128/JVI.66.7.4564-4569.1992; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; HU AZ, 1995, J GEN VIROL, V76, P705, DOI 10.1099/0022-1317-76-3-705; HU XL, 1992, J VIROL, V66, P1528, DOI 10.1128/JVI.66.3.1528-1534.1992; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Johannes L, 1998, TRENDS CELL BIOL, V8, P158, DOI 10.1016/S0962-8924(97)01209-9; Kado G, 1976, Dev Biol Stand, V37, P261; Maltese WA, 2001, J BIOL CHEM, V276, P20267, DOI 10.1074/jbc.M007238200; MALVOISIN E, 1993, J GEN VIROL, V74, P2365, DOI 10.1099/0022-1317-74-11-2365; MARKWELL MAK, 1980, P NATL ACAD SCI-BIOL, V77, P5693, DOI 10.1073/pnas.77.10.5693; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; OGURA H, 1991, J GEN VIROL, V72, P2679, DOI 10.1099/0022-1317-72-11-2679; Paterson RG, 1997, VIROLOGY, V237, P1, DOI 10.1006/viro.1997.8759; Plemper RK, 2000, J VIROL, V74, P6485, DOI 10.1128/JVI.74.14.6485-6493.2000; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; RICHARDSON C, 1986, VIROLOGY, V155, P508, DOI 10.1016/0042-6822(86)90212-6; Salzwedel K, 1998, J VIROL, V72, P7523, DOI 10.1128/JVI.72.9.7523-7531.1998; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Suzuki T, 2001, J VIROL, V75, P4604, DOI 10.1128/JVI.75.10.4604-4613.2001; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Tanaka Y, 1996, J VIROL, V70, P5005, DOI 10.1128/JVI.70.8.5005-5015.1996; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tong SX, 1999, J GEN VIROL, V80, P107, DOI 10.1099/0022-1317-80-1-107; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Wang Z, 2001, VACCINE, V19, P2329, DOI 10.1016/S0264-410X(00)00523-5; Yao QZ, 1997, J VIROL, V71, P650, DOI 10.1128/JVI.71.1.650-656.1997	38	88	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44239	44246		10.1074/jbc.M105967200	http://dx.doi.org/10.1074/jbc.M105967200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11535597	hybrid			2022-12-27	WOS:000172297700096
J	Beresford, PJ; Zhang, D; Oh, DY; Fan, ZS; Greer, EL; Russo, ML; Jaju, M; Lieberman, J				Beresford, PJ; Zhang, D; Oh, DY; Fan, ZS; Greer, EL; Russo, ML; Jaju, M; Lieberman, J			Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CHROMATIN-LIKE STRUCTURE; FACTOR-I; CELL-DEATH; GRANULE-EXOCYTOSIS; MEDIATED APOPTOSIS; ADENOVIRUS GENOME; INHIBITOR; LEUKEMIA; TEMPLATE	The cytotoxic T lymphocyte protease granzyme A (GzmA) initiates a novel caspase-independent cell death pathway characterized by single-stranded DNA nicking. The previously identified GzmA substrate SET is in a multimeric 270-420-kDa endoplasmic reticulum-associated complex that also contains the tumor suppressor protein pp32. GzmA cleaved the nucleosome assembly protein SET after Lys(176) and disrupted its nucleosome assembly activity. The purified SET complex required only GzmA to reconstitute single-stranded DNA nicking in isolated nuclei. DNA nicking occurred independently of caspase activation. The SET complex contains a 25-kDa Mg2+-dependent nuclease that degrades calf thymus DNA and plasmid DNA. Thus, GzmA activates a DNase (GzmA-activated DNase) within the SET complex to produce a novel form of DNA damage during cytotoxic T lymphocyte-mediated death.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 800 Huntington Ave, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015	Greer, Eric/0000-0002-7501-7371; ZHANG, DONG/0000-0002-1068-8334	NIAID NIH HHS [AI45587] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; Beresford PJ, 1998, J IMMUNOL, V161, P161; Blink EJ, 1999, IMMUNOL CELL BIOL, V77, P206, DOI 10.1046/j.1440-1711.1999.00817.x; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; MATSUMOTO K, 1995, J BIOL CHEM, V270, P9645, DOI 10.1074/jbc.270.16.9645; Matsumoto K, 1999, FEBS LETT, V463, P285, DOI 10.1016/S0014-5793(99)01632-4; Mills JC, 1998, J CELL SCI, V111, P625; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; SELLINS KS, 1991, J IMMUNOL, V147, P795; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shi LF, 1996, P NATL ACAD SCI USA, V93, P11002, DOI 10.1073/pnas.93.20.11002; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; SUIDAN HS, 1994, P NATL ACAD SCI USA, V91, P8112, DOI 10.1073/pnas.91.17.8112; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	47	132	140	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43285	43293		10.1074/jbc.M108137200	http://dx.doi.org/10.1074/jbc.M108137200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555662	hybrid, Green Published			2022-12-27	WOS:000172169300085
J	Sekimata, M; Takahashi, A; Murakami-Sekimata, A; Homma, Y				Sekimata, M; Takahashi, A; Murakami-Sekimata, A; Homma, Y			Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; DNA METHYLATION; GENE; METHYLTRANSFERASE; INHIBITION; CHROMATIN; FAMILY; YEAST; MECP2; IDENTIFICATION	MBD2, a methyl-CpG-binding protein, is a component of the MeCP1 histone deacetylase (HDAC) complex and plays a critical role in DNA methylation-mediated transcriptional repression. To understand the molecular basis of the methylation-associated repression, we attempted to identify MBD2-interacting proteins by a yeast two-hybrid system. Using MBD2 as bait, we isolated a novel zinc finger protein, referred to as MIZF. A direct interaction between MBD2 and MIZF was confirmed by in vitro binding assays and immunoprecipitation experiments. Four of seven zinc fingers present in the C-terminal region of MIZF are required for binding with MBD2. The MIZF mRNA is expressed in all human tissues and cell lines examined. The subcellular localization of MIZF is distinct from that of MBD2, although both proteins co-localize in some areas of the nuclei; MIZF localizes diffusely in the nucleoplasmic region, whereas MBD2 preferentially localizes in major satellites. A reporter assay demonstrated that MIZF significantly abrogates transcriptional activities. This repression is attenuated by an HDAC inhibitor, trichostatin A, and is completely dependent on the interaction with MBD2. These results suggest that MIZF is abundantly present in cells and functions as a negative regulator of transcription by binding to MBD2 and recruiting HDAC-containing complexes.	Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Biomol Sci, Fukushima 9601295, Japan; Miyagi Univ, Sch Nursing, Taiwa, Miyagi 9813298, Japan	Fukushima Medical University; Miyagi University	Homma, Y (corresponding author), Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Biomol Sci, Fukushima 9601295, Japan.			Murakami-Sekimata, Akiko/0000-0002-9417-2377				Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bender CM, 1998, CANCER RES, V58, P95; BESTOR TH, 1988, GENE, V74, P9, DOI 10.1016/0378-1119(88)90238-7; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; James P, 1996, GENETICS, V144, P1425; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; NG HH, CELL BIOL, V20, P1394; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tatematsu K, 2000, GENES CELLS, V5, P677, DOI 10.1046/j.1365-2443.2000.00359.x; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; WIDEN SG, 1988, J BIOL CHEM, V263, P16992; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	36	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42632	42638		10.1074/jbc.M107048200	http://dx.doi.org/10.1074/jbc.M107048200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553631	hybrid			2022-12-27	WOS:000172169300002
J	Lockwich, T; Singh, BB; Liu, XB; Ambudkar, IS				Lockwich, T; Singh, BB; Liu, XB; Ambudkar, IS			Stabilization of cortical actin induces internalization of transient receptor potential 3 (Trp3)-associated caveolar Ca2+ signaling complex and loss of Ca2+ influx without disruption of Trp3-inositol trisphosphate receptor association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PROTEIN PHOSPHATASE; POTENTIAL CHANNELS; STORE DEPLETION; ACTIVATION; ORGANIZATION; MEMBRANE; ENTRY; CYTOSKELETAL; DOMAIN	Ca2+ influx via plasma membrane Trp3 channels is proposed to be regulated by a reversible interaction with inositol trisphosphate receptor (IP,R) in the endoplasmic reticulum. Condensation of the cortical actin layer has been suggested to physically disrupt this interaction and inhibit Trp3-mediated Ca2+ influx. This study examines the effect of cytoskeletal reorganization on the localization and function of Trp3 and key Ca2+ signaling proteins. Calyculin-A treatment resulted in formation of condensed actin layer at the plasma membrane; internalization of Trp3, G alpha (q/11), phospholipase C beta, and caveolin-1; and attenuation of 1-oleoyl-2-acetyl-sn-glycerol- and ATP-stimulated Sr2+ influx. Importantly, Trp3 and IP3R-3 remained co-localized inside the cell and were co-immunoprecipitated. Jasplakinolide also induced internalization of Trp3 and caveolin-1. Pretreatment of cells with cytochalasin D or staurosporine did not affect Trp3 but prevented calyculin-A-induced effects. Based on these data, we suggest that Trp3 is assembled in a caveolar Ca2+ signaling complex with IP3R, SERCA, G alpha (q/11), phospholipase C beta, caveolin-1, and ezrin. Furthermore, our data demonstrate that conditions which stabilize cortical actin induce loss of Trp3 activity due to internalization of the Trp3-signaling complex, not disruption of IP3R-Trp3 interaction. This suggests that localization of the Trp3-associated signaling complex, rather than Trp3-IP3R coupling, depends on the status of the actin cytoskeleton.	NIDCR, Secretory Physiol Sect, Gene Therapy & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ambudkar, IS (corresponding author), NIDCR, Secretory Physiol Sect, Gene Therapy & Therapeut Branch, NIH, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.	indu.ambukar@nih.gov		Singh, Brij/0000-0003-0535-5997	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000438] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Bahner M, 2000, J BIOL CHEM, V275, P2901, DOI 10.1074/jbc.275.4.2901; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chorna-Ornan I, 2001, J NEUROSCI, V21, P2622, DOI 10.1523/JNEUROSCI.21-08-02622.2001; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Fujimoto T, 1998, J ELECTRON MICROSC, V47, P451, DOI 10.1093/oxfordjournals.jmicro.a023616; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Isshiki M, 1999, CELL CALCIUM, V26, P201, DOI 10.1054/ceca.1999.0073; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; KREIENBUHL P, 1992, BLOOD, V80, P2911; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liu XB, 1998, J BIOL CHEM, V273, P33295, DOI 10.1074/jbc.273.50.33295; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lockwich T, 1995, J MEMBRANE BIOL, V148, P277; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; Sakai T, 1997, PFLUG ARCH EUR J PHY, V433, P464, DOI 10.1007/s004240050301; Sakai T, 1996, AM J PHYSIOL-CELL PH, V271, pC284, DOI 10.1152/ajpcell.1996.271.1.C284; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; SHINOKI N, 1995, J CELL BIOCHEM, V59, P368, DOI 10.1002/jcb.240590308; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Toivola DM, 1997, J CELL SCI, V110, P23; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wang WC, 1999, AM J PHYSIOL-CELL PH, V276, pC969, DOI 10.1152/ajpcell.1999.276.4.C969; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhu X, 1998, NEWS PHYSIOL SCI, V13, P211; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	42	125	129	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42401	42408		10.1074/jbc.M106956200	http://dx.doi.org/10.1074/jbc.M106956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11524429	hybrid			2022-12-27	WOS:000172450400112
J	Song, CS; Echchgadda, I; Baek, BS; Ahn, SC; Oh, T; Roy, AK; Chatterjee, B				Song, CS; Echchgadda, I; Baek, BS; Ahn, SC; Oh, T; Roy, AK; Chatterjee, B			Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; MOLECULAR-CLONING; STRUCTURAL CHARACTERIZATION; NUCLEAR RECEPTORS; ANDROGEN; PROTEIN; BINDING; IDENTIFICATION; EXPRESSION; PROMOTER	Dehydroepiandrosterone sulfotransferase (STD) is a hydroxysteroid sulfo-conjugating enzyme with preferential substrate specificity for C-19 androgenic steroids and C-24 bile acids. STD is primarily expressed in the liver, intestine and adrenal cortex. Earlier studies have shown that androgens inhibit the rat Std promoter function through a negative androgen response region located between -235 and -310 base pair positions (Song, C. S., Jung, M. H., Kim, S. C., Hassan, T., Roy, A. K., and Chatterjee, B. (1998) J. Biol Chem. 273, 21856-21866). Here we report that the primary bile acid chenodeoxycholic acid (CDCA) also acts as an important regulator of the Std gene promoter. CDCA is a potent inducer of the Std gene, and its inducing effect is mediated through the bile acid-activated farnesoid X receptor (FXR), a recently characterized member of the nuclear receptor superfamily. The ligand-activated FXR acts as a heterodimer with the 9-cis-retinoic acid receptor (RXR) and regulates the Std gene by binding to an upstream region at base pair positions -169 to -193. This specific binding region was initially identified by bile acid responsiveness of the progressively deleted forms of the Std promoter in transfected HepG2 hepatoma and enterocyte-like Caco-2 cells. Subsequently, the precise RXR/FXR binding position was established by protein-DNA interaction using in vitro footprinting and electrophoretic mobility shift analyses. Unlike all other previously characterized FXR target genes, which contain an inverted repeat (IR) of the consensus hexanucleotide half-site (A/G)G(G/T)TCA with a single nucleotide spacer (IR-1), the bile acid response element of the Std promoter does not contain any spacer between the two hexanucleotide repeats (IR-0). A promoter-reporter construct carrying three tandem copies of the IR-0 containing -169/-193 element, linked to a minimal thymidine kinase promoter, can be stimulated more than 70-fold in transfected Caco-2 cells upon CDCA treatment. Autoregulation of the STD gene by its bile acid substrate may provide an important contributing role in the enterohepatic bile acid metabolism and cholesterol homeostasis.	Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chatterjee, B (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.				NIA NIH HHS [AG-10486] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG010486, R37AG010486] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Bahar RJ, 1999, GASTROENTEROL CLIN N, V28, P27, DOI 10.1016/S0889-8553(05)70042-X; BARNES S, 1989, J LIPID RES, V30, P529; Bouly M, 2001, J BIOL CHEM, V276, P25841, DOI 10.1074/jbc.M101160200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTILLOOLIVARE.A, 2000, J BIOL CHEM, V275, P17793; Chan J, 1998, CHEM-BIOL INTERACT, V109, P267, DOI 10.1016/S0009-2797(97)00138-5; CHATTERJEE B, 1994, CHEM-BIOL INTERACT, V92, P273, DOI 10.1016/0009-2797(94)90069-8; Chatterjee B, 1996, P NATL ACAD SCI USA, V93, P728, DOI 10.1073/pnas.93.2.728; CHATTERJEE B, 1987, J BIOL CHEM, V262, P822; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; DAVITT NB, 2001, ENDOCRINOLOGY, V142, P2978; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Freimuth RR, 2000, GENOMICS, V65, P157, DOI 10.1006/geno.2000.6150; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Her C, 1998, GENOMICS, V53, P284, DOI 10.1006/geno.1998.5518; Her C, 1996, DRUG METAB DISPOS, V24, P1328; KRAMER W, 1993, J BIOL CHEM, V268, P18035; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Liu MC, 1999, BIOCHEM BIOPH RES CO, V254, P65, DOI 10.1006/bbrc.1998.9872; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; LUUTHE V, 1995, DNA CELL BIOL, V14, P511, DOI 10.1089/dna.1995.14.511; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mulder G.J., 1990, CONJUGATION REACTION, P107; OGURA K, 1994, CHEM-BIOL INTERACT, V92, P129, DOI 10.1016/0009-2797(94)90059-0; OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R; OTTERNESS DM, 1995, DNA CELL BIOL, V14, P331, DOI 10.1089/dna.1995.14.331; Parker CR, 2000, ENDOCR RES, V26, P517; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; RADOMINSKA A, 1990, BIOCHEM J, V272, P597, DOI 10.1042/bj2720597; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Rikke BA, 1996, BBA-GENE STRUCT EXPR, V1307, P331, DOI 10.1016/0167-4781(96)00065-6; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Song CS, 1998, J BIOL CHEM, V273, P21856, DOI 10.1074/jbc.273.34.21856; SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160	44	166	167	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42549	42556		10.1074/jbc.M107557200	http://dx.doi.org/10.1074/jbc.M107557200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533040	hybrid			2022-12-27	WOS:000172450400130
J	Donovan, JCH; Milic, A; Slingerland, JM				Donovan, JCH; Milic, A; Slingerland, JM			Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR P27; CYCLIN E-CDK2 ACTIVATION; DEPENDENT KINASE; ESTROGEN-RECEPTOR; PROTEIN-KINASE; TAMOXIFEN RESISTANCE; RESTRICTION POINT; ENDOCRINE THERAPY; EPITHELIAL-CELLS; DOWN-REGULATION	Antiestrogens, such as the drug tamoxifen, inhibit breast cancer growth by inducing cell cycle arrest. Antiestrogens require action of the cell cycle inhibitor p27(Kip1) to mediate G(1) arrest in estrogen receptor-positive breast cancer cells. We report that constitutive activation of the mitogen-activated protein kinase (MAPK) pathway alters p27 phosphorylation, reduces p27 protein levels, reduces the cdk2 inhibitory activity of the remaining p27, and contributes to antiestrogen resistance. In two antiestrogen-resistant cell lines that showed increased MAPK activation, inhibition of the MAPK kinase (MEK) by addition of U0126 changed p27 phosphorylation and restored p27 inhibitory function and sensitivity to antiestrogens. Using antisense p27 oligonucleotides, we demonstrated that this restoration of antiestrogen-mediated cell cycle arrest required p27 function. These data suggest that oncogene-mediated MAPK activation, frequently observed in human breast cancers, contributes to antiestrogen resistance through p27 deregulation.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Slingerland, JM (corresponding author), Sunnybrook & Womens Coll, Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.							Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; BRONZERT DA, 1985, ENDOCRINOLOGY, V117, P1409, DOI 10.1210/endo-117-4-1409; BRUNNER N, 1993, CANCER RES, V53, P3229; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Coutts AS, 1998, CANCER RES, V58, P4071; ELASHRY D, 1997, ONCOGENE, V15, P435; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Florenes VA, 1996, ONCOGENE, V13, P2447; FOSTER J, 1996, MOL ENDOCRINOL, P488; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; FUQUA SAW, 1993, J CELL BIOCHEM, V51, P135, DOI 10.1002/jcb.240510204; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hori M, 2000, PATHOL RES PRACT, V196, P817, DOI 10.1016/S0344-0338(00)80081-3; Houston SJ, 1999, BRIT J CANCER, V79, P1220, DOI 10.1038/sj.bjc.6690196; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; JORDAN VC, 1995, BREAST CANCER RES TR, V36, P267, DOI 10.1007/BF00713399; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Kurokawa H, 2000, CANCER RES, V60, P5887; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Maemura M, 1999, ONCOLOGY-BASEL, V57, P37, DOI 10.1159/000055273; Millard SS, 1997, J BIOL CHEM, V272, P7093, DOI 10.1074/jbc.272.11.7093; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Naumann U, 1999, BIOCHEM BIOPH RES CO, V261, P890, DOI 10.1006/bbrc.1999.1126; NICHOLSON S, 1989, LANCET, V1, P182; NICHOLSON S, 1990, J STEROID BIOCHEM, V37, P811, DOI 10.1016/0960-0760(90)90424-J; Novotny L, 2000, NEOPLASMA, V47, P3; OSBORNE CK, 1991, J NATL CANCER I, V83, P1477, DOI 10.1093/jnci/83.20.1477; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PIETENPOL JA, 1995, CANCER RES, V55, P1206; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; PRESS MF, 1993, CANCER RES, V53, P4960; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Robertson JFR, 1996, BRIT J CANCER, V73, P5, DOI 10.1038/bjc.1996.2; Salh B, 1999, ANTICANCER RES, V19, P731; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Takimoto GS, 1999, J STEROID BIOCHEM, V69, P45, DOI 10.1016/S0960-0760(98)00148-4; Takuwa N, 1997, MOL CELL BIOL, V17, P5348, DOI 10.1128/MCB.17.9.5348; Tan P, 1997, CANCER RES, V57, P1259; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WRIGHT C, 1989, CANCER RES, V49, P2087; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200	62	118	126	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40888	40895		10.1074/jbc.M106448200	http://dx.doi.org/10.1074/jbc.M106448200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527971	hybrid			2022-12-27	WOS:000171925600069
J	Johnson, AA; Ray, AS; Hanes, J; Suo, ZC; Colacino, JM; Anderson, KS; Johnson, KA				Johnson, AA; Ray, AS; Hanes, J; Suo, ZC; Colacino, JM; Anderson, KS; Johnson, KA			Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; KINETIC CHARACTERIZATION; NUCLEOTIDE INCORPORATION; FIALURIDINE FIAU; DIDANOSINE DDI; SIV INFECTION; WILD-TYPE; INHIBITION; MECHANISM	To examine the role of the mitochondrial polymerase (Pol gamma) in clinically observed toxicity of nucleoside analogs used to treat AIDS, we examined the kinetics of incorporation catalyzed by Pol gamma for each Food and Drug Administration-approved analog plus 1-(2-deoxy2-fluoro-beta -D-arabinofuranosyl)-5-iodouracil (FIAU), beta -L-(-)-2',3'-dideoxy-3'-thiacytidine (-)3TC, and (R)-9-(2-phosphonylmethoxypropyl) adenine (PMPA). We used recombinant exonuclease-deficient (E200A), reconstituted human Poly holoenzyme in single turnover kinetic studies to measure K-d (K-m) and k(pol) (k(cat)) to estimate the specificity constant (k(cat)/K-m) for each nucleoside analog triphosphate. The specificity constants vary more than 500,000-fold for the series ddC > ddA (ddI) much greater than 2',3'-didehydro-2',3'-dideoxythymidine (d4T) much greater than (+)3TC (-)3TC > PMPA > azidothymidine (AZT) Carbovir (CBV). Abacavir (prodrug of CBV) and PMPA are two new drugs that are expected to be least toxic. Notably, the higher toxicities of d4T, ddC, and ddA arose from their 13-36-fold tighter binding relative to the normal dNTP even though their rates of incorporation were comparable with PMPA and AZT. We also examined the rate of exonuclease removal of each analog after incorporation. The rates varied from 0.06 to 0.0004 s(-1) for the series FIAU > (+)3TC (-)3TC > CBV > AZT > PMPA similar to d4T much greater than ddA (ddI) much greater than ddC. Removal of ddC was too slow to measure (<0.00002 s(-1)). The high toxicity of dideoxy compounds, ddC and ddI (metabolized to ddA), may be a combination of high rates of incorporation and ineffective exonuclease removal. Conversely, the more effective excision of (-)3TC, CBV, and AZT may contribute to lower toxicity. FIAU is readily extended by the next correct base pair (0.13 s(-1)) faster than it is removed (0.06 s(-1)) and, therefore, is stably incorporated and highly mutagenic. We define a toxicity index for chain terminators to account for relative rates of incorporation versus removal. These results provide a method to rapidly screen new analogs for potential toxicity.	Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Eli Lilly & Co, Lilly Res Labs, Infect Dis Res, Indianapolis, IN 46285 USA	University of Texas System; University of Texas Austin; Yale University; Eli Lilly	Johnson, KA (corresponding author), Univ Texas, Inst Mol & Cellular Biol, MBB 3-122,A4800, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu		Ray, Adrian/0000-0002-3508-3008	NIGMS NIH HHS [GM49551, GM44613] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; BALZARINI J, 1994, PHARM WORLD SCI, V16, P113, DOI 10.1007/BF01880662; BALZARINI J, 1991, BIOCHEM BIOPH RES CO, V178, P329, DOI 10.1016/0006-291X(91)91818-W; Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8; Brinkman K, 2000, CURR OPIN INFECT DIS, V13, P5, DOI 10.1097/00001432-200002000-00002; CHANG CN, 1992, J BIOL CHEM, V267, P22414; CHANG CN, 1992, J BIOL CHEM, V267, P13938; CHEN CH, 1989, J BIOL CHEM, V264, P11934; CHEN CH, 1991, MOL PHARMACOL, V39, P625; Colacino JM, 1996, TOXICOL IN VITRO, V10, P297, DOI 10.1016/0887-2333(96)00016-1; CUI LX, 1995, J CLIN INVEST, V95, P555, DOI 10.1172/JCI117698; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Deeks SG, 1998, ANTIMICROB AGENTS CH, V42, P2380, DOI 10.1128/AAC.42.9.2380; EGER BT, 1992, BIOCHEMISTRY-US, V31, P9227, DOI 10.1021/bi00153a016; Einolf HJ, 2000, J BIOL CHEM, V275, P16316, DOI 10.1074/jbc.M001291200; ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929; Feng JY, 2001, J BIOL CHEM, V276, P23832, DOI 10.1074/jbc.M101156200; Feng JY, 1999, BIOCHEMISTRY-US, V38, P55, DOI 10.1021/bi982340r; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Honkoop P, 1997, DRUG SAFETY, V17, P1, DOI 10.2165/00002018-199717010-00001; Horn DM, 1997, ANTIVIR RES, V34, P71, DOI 10.1016/S0166-3542(96)01027-3; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson AA, 2001, J BIOL CHEM, V276, P38090; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Kewn S, 1999, AIDS RES HUM RETROV, V15, P793, DOI 10.1089/088922299310692; Krayevsky AA, 1998, NUCLEOS NUCLEOT, V17, P1153, DOI 10.1080/07328319808004228; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; Kumar A, 2001, VIROLOGY, V279, P97, DOI 10.1006/viro.2000.0710; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Lewis W, 1996, P NATL ACAD SCI USA, V93, P3592, DOI 10.1073/pnas.93.8.3592; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; Nusbaum NJ, 1996, DNA CELL BIOL, V15, P363, DOI 10.1089/dna.1996.15.363; Parker WB, 1997, ANTIVIR RES, V34, P131, DOI 10.1016/S0166-3542(97)01033-4; PARKER WB, 1994, J NIH RES, V6, P57; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Periclou AP, 2000, IN VIVO, V14, P377; Ray AS, 2001, NUCLEOS NUCLEOT NUCL, V20, P1247, DOI 10.1081/NCN-100002528; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SEMIZAROV DG, 1994, FEBS LETT, V354, P187, DOI 10.1016/0014-5793(94)01123-0; SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1; SKOWRON G, 1990, AM J MED, V88, pS20, DOI 10.1016/0002-9343(90)90417-C; Smith MS, 2000, VIROLOGY, V277, P306, DOI 10.1006/viro.2000.0609; STASCHKE KA, 1994, J VIROL, V68, P8265, DOI 10.1128/JVI.68.12.8265-8269.1994; Suo ZC, 1998, J BIOL CHEM, V273, P27250, DOI 10.1074/jbc.273.42.27250; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1997, AIDS RES HUM RETROV, V13, P707, DOI 10.1089/aid.1997.13.707; Vaccaro JA, 2000, ANTIMICROB AGENTS CH, V44, P217, DOI 10.1128/AAC.44.1.217-221.2000; Wang HY, 1996, BBA-MOL BASIS DIS, V1316, P51, DOI 10.1016/0925-4439(96)00015-4; Zhu CY, 2000, J BIOL CHEM, V275, P26727	58	279	297	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40847	40857		10.1074/jbc.M106743200	http://dx.doi.org/10.1074/jbc.M106743200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526116	hybrid			2022-12-27	WOS:000171925600064
J	Mao, C; Zhou, M; Uckun, FM				Mao, C; Zhou, M; Uckun, FM			Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SRC FAMILY; C-SRC; INSULIN-RECEPTOR; SUBSTRATE RECOGNITION; CONSERVED FEATURES; PEPTIDE SUBSTRATE; CATALYTIC SUBUNIT; SIGNALING COMPLEX; BTK	Bruton's tyrosine kinase is intimately involved in signal transduction pathways regulating survival, activation, proliferation, and differentiation of B lineage lymphoid cells. Mutations in the human btk gene are the cause of X-linked agammaglobulinemia, a male immune deficiency disorder characterized by a lack of mature, immunoglobulin-producing B lymphocytes. We have determined the x-ray crystal structure of the Bruton's tyrosine kinase kinase domain in its unphosphorylated state to a 2.1 Angstrom resolution. A comparison with the structures of other tyrosine kinases and a possible mechanism of activation unique to Bruton's tyrosine kinase are provided.	Parker Hughes Canc Ctr, Dept Biol Struct, St Paul, MN 55113 USA; Parker Hughes Canc Ctr, Dept Immunol, St Paul, MN 55113 USA		Mao, C (corresponding author), Parker Hughes Canc Ctr, 2657 Patton Rd, Roseville, MN 55113 USA.	cmao@ih.org; fatih_uckun@ih.org		Uckun, Fatih M./0000-0001-9334-183X				ACCILI D, 1992, J ENDOCRINOL INVEST, V15, P857, DOI 10.1007/BF03348820; Afar DEH, 1996, MOL CELL BIOL, V16, P3465; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRUNGER AT, 1992, XPLOR VERSION 3 1; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; COPLEY RR, 1994, J MOL BIOL, V242, P321; FERRACINI R, 1990, ONCOGENE RES, V5, P205; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hubbard SR, 1999, NAT STRUCT BIOL, V6, P711, DOI 10.1038/11468; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; JONES TA, 1989, CRYSTALLOGRAPHIC COM, P120; JONES TA, 1992, MOL REPLACEMENT, P91; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KLEYWEGT GJ, 1994, FIRST MAP FINAL MODE, P59; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; *MOL SIM INC, 1997, INS VERS 2; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nisitani S, 2000, P NATL ACAD SCI USA, V97, P2737, DOI 10.1073/pnas.050583597; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; Oda A, 2000, BLOOD, V95, P1663; Orlandi P, 2000, Hum Mutat, V15, P117, DOI 10.1002/(SICI)1098-1004(200001)15:1<117::AID-HUMU26>3.0.CO;2-H; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; RAWLINGS DJ, 1994, IMMUNOL REV, V138, P105, DOI 10.1111/j.1600-065X.1994.tb00849.x; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Sack J. S., 1988, J MOL GRAPHICS, V6, P244; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Skamnaki VT, 1999, BIOCHEMISTRY-US, V38, P14718, DOI 10.1021/bi991454f; TSUKADA S, 1994, ADV EXP MED BIOL, V365, P233; Uckun FM, 1998, BIOCHEM PHARMACOL, V56, P683, DOI 10.1016/S0006-2952(98)00122-1; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1995, IMMUNOL TODAY, V16, P460, DOI 10.1016/0167-5699(95)80027-1; Vihinen M, 1998, NUCLEIC ACIDS RES, V26, P242, DOI 10.1093/nar/26.1.242; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	57	89	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41435	41443		10.1074/jbc.M104828200	http://dx.doi.org/10.1074/jbc.M104828200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527964	hybrid			2022-12-27	WOS:000171925600140
J	Dessen, A; Mouz, N; Gordon, E; Hopkins, J; Dideberg, O				Dessen, A; Mouz, N; Gordon, E; Hopkins, J; Dideberg, O			Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate - A mosaic framework containing 83 mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN 2X; BETA-LACTAMASES; BACTERIAL-RESISTANCE; IDENTIFICATION; TRANSPEPTIDASE; ANTIBIOTICS; VARIANTS	Penicillin-binding proteins (PBPs) are the main targets for beta -lactam antibiotics, such as penicillins and cephalosporins, in a wide range of bacterial species. In some Gram-positive strains, the surge of resistance to treatment with beta -lactams is primarily the result of the proliferation of mosaic PBP-encoding genes, which encode novel proteins by recombination. PBP2x is a primary resistance determinant in Streptococcus pneumoniae, and its modification is an essential step in the development of high level beta -lactam resistance. To understand such a resistance mechanism at an atomic level, we have solved the x-ray crystal structure of PBP2x from a highly penicillin-resistant clinical isolate of S. pneumoniae, Sp328, which harbors 83 mutations in the soluble region. In the proximity of the Sp328 PBP2x* active site, the Thr(338)--> Ala mutation weakens the local hydrogen bonding network, thus abrogating the stabilization of a crucial buried water molecule. In addition, the Ser(389)--> Leu and Asn(514)--> His mutations produce a destabilizing effect that generates an "open" active site. It has been suggested that peptidoglycan substrates for beta -lactam-resistant PBPs contain a large amount of abnormal, branched peptides, whereas sensitive strains tend to catalyze cross-linking of linear forms. Thus, in vivo, an "open" active site could facilitate the recognition of distinct, branched physiological substrates.	Inst Biol Struct Jean Pierre Ebel, Lab Cristallog Macromol, CNRS, CEA, F-38027 Grenoble, France; Inst Biol Struct Jean Pierre Ebel, Lab Ingn Macromol, CNRS, CEA, F-38027 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Dessen, A (corresponding author), Inst Biol Struct Jean Pierre Ebel, Lab Cristallog Macromol, CNRS, CEA, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	dessen@ibs.fr		Dessen, Andrea/0000-0001-6487-4020; Gordon, Elspeth Jane/0000-0002-9876-8020				Asahi Y, 1999, ANTIMICROB AGENTS CH, V43, P1252, DOI 10.1128/AAC.43.5.1252; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dessen A., 2001, Current Drug Targets - Infectious Disorders, V1, P63, DOI 10.2174/1568005013343272; Di Guilmi AM, 1998, J BACTERIOL, V180, P5652, DOI 10.1128/JB.180.21.5652-5659.1998; Di Guilmi AM, 1999, J BACTERIOL, V181, P2773, DOI 10.1128/JB.181.9.2773-2781.1999; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; Hakenbeck R, 1999, MICROB DRUG RESIST, V5, P91, DOI 10.1089/mdr.1999.5.91; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kernodle DS, 2000, GRAM-POSITIVE PATHOGENS, P609; LAIBLE G, 1987, MOL MICROBIOL, V1, P355; LAIBLE G, 1991, J BACTERIOL, V173, P6986, DOI 10.1128/jb.173.21.6986-6990.1991; Lu WP, 2001, J BIOL CHEM, V276, P31494, DOI 10.1074/jbc.M102499200; Maveyraud L, 2000, STRUCTURE, V8, P1289, DOI 10.1016/S0969-2126(00)00534-7; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Reichmann P, 1996, MICROB DRUG RESIST, V2, P177, DOI 10.1089/mdr.1996.2.177; Reichmann P, 1997, J INFECT DIS, V176, P1001, DOI 10.1086/516532; Severin A, 1996, J BACTERIOL, V178, P1788, DOI 10.1128/jb.178.7.1788-1792.1996; Severin A, 1996, J BACTERIOL, V178, P168, DOI 10.1128/jb.178.1.168-174.1996; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Zhao GS, 1997, J BACTERIOL, V179, P4901, DOI 10.1128/jb.179.15.4901-4908.1997	33	99	107	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45106	45112		10.1074/jbc.M107608200	http://dx.doi.org/10.1074/jbc.M107608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11553637	hybrid			2022-12-27	WOS:000172406700101
J	Maenaka, K; van der Merwe, PA; Stuart, DI; Jones, EY; Sondermann, P				Maenaka, K; van der Merwe, PA; Stuart, DI; Jones, EY; Sondermann, P			The human low affinity Fc gamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN-PROTEIN INTERACTIONS; T-CELL RECEPTORS; CRYSTAL-STRUCTURE; INHIBITORY RECEPTOR; NATURAL-KILLER; CLASS-I; IMMUNOGLOBULIN SUPERFAMILY; LIGAND-BINDING; SOLUBLE FORM	Fc gamma receptors (Fc gamma Rs) are expressed on all immunologically active cells. They bind the Fe portion of IgG, thereby triggering a range of immunological functions. We have used surface plasmon resonance to analyze the kinetic and thermodynamic properties of the interactions between the ectodomains of human low affinity Fc gamma Rs (Fc gamma RIIa, Fc gamma RIIb, and Fc gamma gamma RIIb-NA2) and IgG1 or the Fc fragment of IgG1. All three receptors bind Fc or IgG with similarly low affinities (K-D similar to0.6-2.5 muM) and fast kinetics, suggesting that Fc gammaR-mediated recognition of aggregated IgG and IgG-coated particles or cells is mechanistically similar to cell-cell recognition. Interestingly, the Fe receptors exhibit distinct thermodynamic properties. Whereas the binding of the Fc gamma RIIa and Fc gamma RIIb to Fe is driven by favorable entropic and enthalpic changes, the binding of Fc gamma RIII is characterized by highly unfavorable entropic changes. Although the structural bases for these differences remain to be determined, they suggest that the molecular events coupled to the binding differ among the low affinity Fc gamma Rs.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Natl Inst Genet, Struct Biol Ctr, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Sch Adv Sci, Kanagawa 2400193, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Oxford Ctr Mol Sci, Oxford OX1 3QT, England	Max Planck Society; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Sondermann, P (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.		Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019; van der Merwe, P. Anton/F-8539-2011	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Stuart, David/0000-0002-3426-4210				Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Dennis G, 2000, P NATL ACAD SCI USA, V97, P13245, DOI 10.1073/pnas.230442897; Edberg JC, 1997, J IMMUNOL, V159, P3849; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; FLEIT HB, 1992, BLOOD, V79, P2721; FRIDMAN WH, 1992, IMMUNOL REV, V125, P49, DOI 10.1111/j.1600-065X.1992.tb00625.x; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; HOMSY J, 1989, SCIENCE, V244, P1357, DOI 10.1126/science.2786647; HUTIN P, 1994, INT ARCH ALLERGY IMM, V103, P23, DOI 10.1159/000236601; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; KHAYAT D, 1990, J INFECT DIS, V161, P430, DOI 10.1093/infdis/161.3.430; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; MATHIOT C, 1993, J CLIN IMMUNOL, V13, P41, DOI 10.1007/BF00920634; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Nishimiya Y, 2000, J BIOL CHEM, V275, P12813, DOI 10.1074/jbc.275.17.12813; Powell MS, 1999, IMMUNOL LETT, V68, P17, DOI 10.1016/S0165-2478(99)00025-5; Ravanel K, 1997, J EXP MED, V186, P269, DOI 10.1084/jem.186.2.269; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 1999, BIOL CHEM, V380, P717, DOI 10.1515/BC.1999.090; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Tominaga Y, 1998, J IMMUNOL, V161, P4016; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Vales-Gomez M, 2000, HUM IMMUNOL, V61, P28, DOI 10.1016/S0198-8859(99)00159-7; Vales-Gomez M, 1998, IMMUNITY, V9, P337, DOI 10.1016/S1074-7613(00)80616-0; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wines BD, 1999, J IMMUNOL, V162, P2146; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; YOO SH, 1995, BIOCHEMISTRY-US, V34, P632, DOI 10.1021/bi00002a030	50	110	173	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44898	44904		10.1074/jbc.M106819200	http://dx.doi.org/10.1074/jbc.M106819200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11544262	hybrid			2022-12-27	WOS:000172406700076
J	Funderburgh, JL; Funderburgh, ML; Mann, MM; Corpuz, L; Roth, MR				Funderburgh, JL; Funderburgh, ML; Mann, MM; Corpuz, L; Roth, MR			Proteoglycan expression during transforming growth factor beta-induced keratocyte-myofibroblast transdifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; PATHOLOGICAL HUMAN CORNEAS; COLLAGEN TYPE-I; EXTRACELLULAR-MATRIX; BOVINE KERATOCYTES; RADIAL KERATOTOMY; BIGLYCAN; LUMICAN; DECORIN; TISSUE	Keratocytes of the corneal stroma secrete a unique population of proteoglycan molecules considered essential for corneal transparency. In healing corneal wounds, keratocytes exhibit a myofibroblastic phenotype in response to transforming growth factor beta (TGF-beta), characterized by expression of a-smooth muscle actin. This study examined proteoglycan and collagen expression by keratocytes in vitro during the TGF-beta induced keratocyte-myofibroblast transition. TGF-beta treated primary bovine keratocytes developed myofibroblastic features, including actin stress fibers anchored to paxillin-containing focal adhesions, cell-associated fibronectin, a, integrin, and a-smooth muscle actin. Collagen I and III protein and mRNA increased in response to TGF-beta. Secretion of [S-35]sulfate-labeled keratan sulfate proteoglycans decreased markedly in response to TGF-beta. Dermatan sulfate proteoglycans, however, increased in size and abundance. Protein and mRNA transcripts for normal stromal proteoglycans (lumican, keratocan, mimecan, and decorin) all decreased in response to TGF-beta, but protein expression and mRNA for biglycan, a proteoglycan present in fibrotic tissue, was markedly up-regulated. These results show that TGF-beta in vitro induces a proteoglycan expression pattern similar to that of corneal scars in vivo. This altered proteoglycan expression occurred coordinately with transdifferentiation. of keratocytes to the myofibroblastic phenotype, implicating these cells as the source of fibrotic tissue in nontransparent corneal scars.	Univ Pittsburgh, Dept Ophthalmol, Eye & Ear Inst 1011, Pittsburgh, PA 15213 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kansas State University	Funderburgh, JL (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Eye & Ear Inst 1011, 203 Lothrop St, Pittsburgh, PA 15213 USA.	jlfunder@pitt.edu			NEI NIH HHS [R01 EY009368, R01 EY000952, EY09368, R01 EY009368-09, P30 EY008098, P30-EY08098, EY00952] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009368, P30EY008098, R01EY000952] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANSETH A, 1969, EXP EYE RES, V8, P302, DOI 10.1016/S0014-4835(69)80043-6; Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; CINTRON C, 1977, DEV BIOL, V61, P346, DOI 10.1016/0012-1606(77)90304-9; CINTRON C, 1990, INVEST OPHTH VIS SCI, V31, P1975; CIONNI RJ, 1986, CURR EYE RES, V5, P549, DOI 10.3109/02713688609015118; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; DELAIGUE O, 1995, GRAEF ARCH CLIN EXP, V233, P331, DOI 10.1007/BF00200481; Dutt JE, 1996, CORNEA, V15, P606; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FUNDERBURGH JL, 1989, INVEST OPHTH VIS SCI, V30, P435; Funderburgh JL, 1996, J BIOL CHEM, V271, P31431, DOI 10.1074/jbc.271.49.31431; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P14226; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Funderburgh JL, 1998, INVEST OPHTH VIS SCI, V39, P1957; GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3705, DOI 10.1073/pnas.77.6.3705; HASSELL JR, 1983, ARCH BIOCHEM BIOPHYS, V222, P362, DOI 10.1016/0003-9861(83)90532-5; Hogemann B, 1997, PATHOL RES PRACT, V193, P747; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; Jester JV, 1996, CORNEA, V15, P505; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809; JOST CJ, 1991, J BIOL CHEM, V266, P13336; Kato T, 2000, JPN J OPHTHALMOL, V44, P334, DOI 10.1016/S0021-5155(00)00168-4; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; Ljubimov AV, 1998, EXP EYE RES, V67, P265, DOI 10.1006/exer.1998.0511; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; Maguen E, 1997, CORNEA, V16, P675; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; MATSUDA H, 1973, EXP EYE RES, V16, P427, DOI 10.1016/0014-4835(73)90100-0; Moller-Pedersen T, 1998, CURR EYE RES, V17, P736, DOI 10.1076/ceyr.17.7.736.5163; Nakazawa K, 1998, ARCH BIOCHEM BIOPHYS, V359, P269, DOI 10.1006/abbi.1998.0897; POWER WJ, 1995, CURR EYE RES, V14, P879, DOI 10.3109/02713689508995127; SAWAGUCHI S, 1991, INVEST OPHTH VIS SCI, V32, P1846; Song QH, 2000, J CELL BIOCHEM, V77, P186, DOI 10.1002/(SICI)1097-4644(20000501)77:2<186::AID-JCB3>3.0.CO;2-M; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; Ungefroren H, 1996, J BIOL CHEM, V271, P15787, DOI 10.1074/jbc.271.26.15787; Venkatesan N, 2000, AM J RESP CRIT CARE, V161, P2066, DOI 10.1164/ajrccm.161.6.9909098; Vesaluoma MH, 1998, J REFRACT SURG, V14, P447; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306	47	140	146	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44173	44178		10.1074/jbc.M107596200	http://dx.doi.org/10.1074/jbc.M107596200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11555658	Green Accepted, hybrid			2022-12-27	WOS:000172297700088
J	Keates, AC; Keates, S; Kwon, JH; Arseneau, KO; Law, DJ; Bai, LC; Merchant, JL; Wang, TC; Kelly, CP				Keates, AC; Keates, S; Kwon, JH; Arseneau, KO; Law, DJ; Bai, LC; Merchant, JL; Wang, TC; Kelly, CP			ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZBP-89; BINDING PROTEIN; DNA-BINDING; ALPHA-GENE; INTERLEUKIN-8 GENE; CHEMOKINE; PROMOTER; ENA-78; CYTOKINE; CLONING	We reported previously that human colonic epithelial cells produce the C-X-C chemokine epithelial neutrophil-activating peptide-78 (ENA-78) and that its expression is up-regulated in ulcerative colitis. The aim of this study was to investigate the transcriptional regulation of ENA-78 gene expression in Caco-2 intestinal epithelial cells. Reporter gene transfection and electrophoretic mobility shift assay studies demonstrated that cooperation between two regions of the ENA-78 promoter were required for maximal gene expression in interleukin-1 beta -stimulated Caco-2 cells. Binding of activated p50/p65 nuclear factor-kappaB to nucleotides -82 to -91 was essential for interleukin-1 beta -dependent gene transcription, whereas binding of constitutively expressed zinc-requiring nuclear factors to nucleotides -125 to -134 (site A) was required for basal gene expression. Scanning mutagenesis of site A demonstrated overlapping binding elements at this locus. One site (CTCCCCC) bound Sp1 and Sp3, and overexpression of Sp1 (but not Sp3) up-regulated basal ENA-78 transcription. Another site (CCCCTCCCCC) was found to bind the zinc finger nuclear factor ZBP-89, and overexpression of this protein significantly repressed ENA-78 reporter gene activity. This study demonstrates that ENA-78 gene expression in Caco-2 intestinal epithelial cells is subject to complex regulation involving the coordinate binding of ZBP-89, Spl, and nuclear factor-kappaB to the ENA-78 promoter.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Massachusetts, Med Ctr, Dept Med, Worcester, MA 01655 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Keates, AC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Dana 501,330 Brookline Ave, Boston, MA 02215 USA.	akeates@caregroup.harvard.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184	NIDDK NIH HHS [DK54920, DK55732, DK58858, DK43551] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054920, R01DK058858, R01DK055732, R56DK055732] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; CHANG MS, 1994, J BIOL CHEM, V269, P25277; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CORBETT MS, 1994, BIOCHEM BIOPH RES CO, V205, P612, DOI 10.1006/bbrc.1994.2709; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; ECKMANN L, 1993, GASTROENTEROLOGY, V105, P1689, DOI 10.1016/0016-5085(93)91064-O; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; HAUCK W, 1995, J BIOL CHEM, V270, P3602, DOI 10.1074/jbc.270.8.3602; Hen BG, 2001, J BIOL CHEM, V276, P7937, DOI 10.1074/jbc.M007470200; Jobin C, 1997, J IMMUNOL, V158, P226; Keates S, 1997, AM J PHYSIOL-GASTR L, V273, pG75, DOI 10.1152/ajpgi.1997.273.1.G75; KELLY CP, 1994, AM J PHYSIOL-GASTR L, V267, pG991, DOI 10.1152/ajpgi.1994.267.6.G991; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Law GL, 1998, J BIOL CHEM, V273, P19955, DOI 10.1074/jbc.273.32.19955; MCCORMICK BA, 1995, J CELL BIOL, V131, P1599, DOI 10.1083/jcb.131.6.1599; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Ping DS, 2000, J BIOL CHEM, V275, P1708, DOI 10.1074/jbc.275.3.1708; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SchnyderCandrian S, 1997, J IMMUNOL, V158, P3888; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Taniuchi T, 1997, BIOCHEM BIOPH RES CO, V233, P154, DOI 10.1006/bbrc.1997.6310; UEDA A, 1994, J IMMUNOL, V153, P2052; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; WALZ A, 1993, ADV EXP MED BIOL, V351, P129; Wang DY, 1997, J BIOL CHEM, V272, P14244, DOI 10.1074/jbc.272.22.14244; Wieczorek E, 2000, J BIOL CHEM, V275, P12879, DOI 10.1074/jbc.275.17.12879; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Wu GD, 1997, J BIOL CHEM, V272, P2396; Ye S, 1999, FEBS LETT, V450, P268, DOI 10.1016/S0014-5793(99)00509-8; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634, DOI 10.1002/jlb.62.5.634; ZGraggen K, 1997, GASTROENTEROLOGY, V113, P808, DOI 10.1016/S0016-5085(97)70175-6	53	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43713	43722		10.1074/jbc.M107838200	http://dx.doi.org/10.1074/jbc.M107838200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559712	hybrid			2022-12-27	WOS:000172297700032
J	Salmon, D; Montero-Lomeli, M; Goldenberg, S				Salmon, D; Montero-Lomeli, M; Goldenberg, S			A DnaJ-Iike protein homologous to the yeast co-chaperone Sis1 (TcJ6p) is involved in initiation of translation in Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; FINGER-LIKE DOMAIN; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSFERRIN-RECEPTOR; MOLECULAR CHAPERONES; RICH REGION; GENE; EXPRESSION; HSP70	In eukaryotes, proteins homologous to the bacterial DnaJ protein are involved in regulation of the Hsp70 molecular chaperones, which are implicated in a variety of protein biogenesis pathways. We report herewith the molecular characterization of a T. cruzi DnaJ gene, termed TcJ6, encoding a protein that displays high sequence homology with the Saccharomyces cerevisiae Sis1 co-chaperone required for the initiation of translation. TcJ6 protein was expressed as a polypeptide of 36.5 kDa at a constant level during parasite differentiation and was associated to the cytoplasmic fraction. We showed that overexpression of TcJ6 complemented a temperature-sensitive yeast sis1 mutant. In addition, sucrose gradient sedimentation analysis of polysomes from T. cruzi and a yeast mutant overexpressing TcJ6p showed that the trypanosomal co-chaperone was closely associated with ribosomal subunits, 80 S monosomes and the smaller polysomes, as observed for Sis1p. Furthermore, in T. cruzi TcJ6p was also found to be preferentially concentrated around the nucleus, giving a speckled staining pattern. This suggests that TcJ6p is associated with the endoplasmic reticulum. Taken together, these data suggest that the trypanosomal DnaJ is involved in initiation of translation.	Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil; IBMP, BR-8135010 Curitiba, Parana, Brazil; Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Goldenberg, S (corresponding author), Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.	sgoldenb@ioc.fiocruz.br	Salmon, Didier/M-5670-2013; GOLDENBERG, SAMUEL/B-4116-2009; Goldenberg, Samuel/ABD-8908-2022; Montero-Lomeli, Monica/D-9885-2013; P, CM/B-1358-2013	GOLDENBERG, SAMUEL/0000-0002-4892-163X; 				ARGAMAN M, 1994, MOL BIOCHEM PARASIT, V64, P95, DOI 10.1016/0166-6851(94)90138-4; Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; BORST P, 1991, TRENDS GENET, V7, P307, DOI 10.1016/0168-9525(91)90406-G; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Bringaud F, 1998, MOL BIOCHEM PARASIT, V94, P249, DOI 10.1016/S0166-6851(98)00080-2; BUKAU B, 1992, TRENDS BIOCHEM SCI, V17, P129; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Carreira MAC, 1998, FEMS MICROBIOL LETT, V166, P141, DOI 10.1111/j.1574-6968.1998.tb13195.x; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; CRAIG E, 1999, MOL CHAPERONES FOLDI, P139; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRAGON EA, 1987, MOL CELL BIOL, V7, P1271, DOI 10.1128/MCB.7.3.1271; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; FRAGOSO SP, 1992, MOL BIOCHEM PARASIT, V55, P127, DOI 10.1016/0166-6851(92)90133-5; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; GOLDENBERG S, 1985, FEBS LETT, V180, P265, DOI 10.1016/0014-5793(85)81083-8; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Henriksson J, 1996, PARASITOL TODAY, V12, P108, DOI 10.1016/0169-4758(96)80670-3; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200; KAISER C, 1994, METHODS YEAST GENETI, P149; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Krumlauf Robb, 1994, Molecular Biotechnology, V2, P227, DOI 10.1007/BF02745879; Kuo MH, 1997, MOL CELL BIOL, V17, P819, DOI 10.1128/MCB.17.2.819; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; Ohba M, 1997, FEBS LETT, V409, P307, DOI 10.1016/S0014-5793(97)00535-8; OLSON CL, 1994, J BIOL CHEM, V269, P3868; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; PAYS E, 1980, NUCLEIC ACIDS RES, V8, P5965, DOI 10.1093/nar/8.24.5965; PAYS E, 1989, EUKARYOTIC GENOME OR, P127; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; STANSFIELD I, 1992, MOL MICROBIOL, V6, P3469, DOI 10.1111/j.1365-2958.1992.tb01782.x; SULLIVAN MA, 1994, MOL BIOCHEM PARASIT, V68, P197, DOI 10.1016/0166-6851(94)90165-1; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; TAKLE GB, 1992, MOL BIOCHEM PARASIT, V56, P117, DOI 10.1016/0166-6851(92)90159-H; TETAUD E, 1994, P NATL ACAD SCI USA, V91, P8278, DOI 10.1073/pnas.91.17.8278; Tibbetts RS, 1998, MOL BIOCHEM PARASIT, V91, P319, DOI 10.1016/S0166-6851(97)00214-4; WICKNER SH, 1990, P NATL ACAD SCI USA, V87, P2690, DOI 10.1073/pnas.87.7.2690; Yan W, 1999, MOL CELL BIOL, V19, P7751; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8; Zhong T, 1996, J BIOL CHEM, V271, P1349, DOI 10.1074/jbc.271.3.1349	54	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43970	43979		10.1074/jbc.M102427200	http://dx.doi.org/10.1074/jbc.M102427200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551903	hybrid			2022-12-27	WOS:000172297700064
J	Steen, IH; Madern, D; Karlstrom, M; Lien, T; Ladenstein, R; Birkeland, NK				Steen, IH; Madern, D; Karlstrom, M; Lien, T; Ladenstein, R; Birkeland, NK			Comparison of isocitrate dehydrogenase from three hyperthermophiles reveals differences in thermostability, cofactor specificity, oligomeric state, and phylogenetic affiliation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP-NOV REPRESENTS; SP STRAIN ABE-1; COENZYME SPECIFICITY; THERMUS-THERMOPHILUS; 3-ISOPROPYLMALATE DEHYDROGENASE; ISOPROPYLMALATE DEHYDROGENASE; CORYNEBACTERIUM-GLUTAMICUM; CALDOCOCCUS-NOBORIBETUS; PSYCHROPHILIC BACTERIUM; SUBSTRATE-SPECIFICITY	With the aim of gaining insight into the molecular and phylogenetic relationships of isocitrate dehydrogenase (IDH) from hyperthermophiles, we carried out a comparative study of putative IDHs identified in the genomes of the eubacterium Thermotoga maritima and the archaea Aeropyrum pernix and Pyrococcus furiosus. An optimum for activity at 90 degreesC or above was found for each IDH. PfIDH and ApIDH were the most thermostable with a melting temperature of 103.7 and 109.9 degreesC, respectively, compared with 98.3 and 98.5 degreesC for TmIDH and AfIDH, respectively. Analytical ultracentrifugation revealed a tetrameric oligomeric state for TmIDH and a homodimeric state for ApIDH and PfIDH. TmIDH and ApIDH were NADP-dependent (K-m(NADP) of 55.2 and 44.4 muM, respectively) whereas PfIDH was NAD-dependent (K-m(NAD) of 68.3 muM). These data document that TmIDH represents a novel tetrameric NADP-dependent form of IDH and that PfIDH is a homodimeric NAD-dependent IDH not previously found among the archaea. The homodimeric NADP-IDH present in A. pernix is the most common form of IDH known so far. The evolutionary relationships of ApIDH, PfIDH, and TmIDH with all of the available amino acid sequences of di- and multimeric IDHs are described and discussed.	Univ Bergen, Dept Microbiol, N-5020 Bergen, Norway; UJF, CNRS, CEA, UMR 5075,Inst Biol Struct,Lab Biophys Mol, F-38027 Grenoble 1, France; Karolinska Inst, Novum, Ctr Struct Biochem, S-14157 Huddinge, Sweden	University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Karolinska Institutet	Birkeland, NK (corresponding author), Univ Bergen, Dept Microbiol, POB 7800,Jahnebakken 5, N-5020 Bergen, Norway.	nils.birkeland@im.uib.no	Steen, Ida Helene/HGD-1549-2022					Aoshima M, 1996, ARCH BIOCHEM BIOPHYS, V336, P77, DOI 10.1006/abbi.1996.0534; Aoshima M, 1997, BBA-PROTEIN STRUCT M, V1340, P227, DOI 10.1016/S0167-4838(97)00046-0; BARNES LD, 1971, BIOCHEMISTRY-US, V10, P3939, DOI 10.1021/bi00797a022; BOLDUC JM, 1995, SCIENCE, V268, P1312, DOI 10.1126/science.7761851; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMACHO ML, 1995, FEMS MICROBIOL LETT, V134, P85; CHEN RD, 1990, PLANT PHYSIOL BIOCH, V28, P411; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; Chen RD, 2000, ARCH BIOCHEM BIOPHYS, V383, P238, DOI 10.1006/abbi.2000.2082; CHUNG AE, 1969, BIOCHEMISTRY-US, V8, P3175, DOI 10.1021/bi00836a007; CUPP JR, 1993, BIOCHEMISTRY-US, V32, P9323, DOI 10.1021/bi00087a010; DANSON MJ, 1984, FEBS LETT, V172, P289, DOI 10.1016/0014-5793(84)81143-6; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; DEAN AM, 1993, BIOCHEMISTRY-US, V32, P9302, DOI 10.1021/bi00087a007; Doyle SA, 2000, BIOCHEMISTRY-US, V39, P14348, DOI 10.1021/bi001458g; Doyle SA, 2001, BIOCHEMISTRY-US, V40, P4234, DOI 10.1021/bi002533q; EGUCHI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P133, DOI 10.1016/S0304-4165(89)80024-8; EIKMANNS BJ, 1995, J BACTERIOL, V177, P774, DOI 10.1128/jb.177.3.774-782.1995; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; FUKUNAGA N, 1992, J BIOCHEM-TOKYO, V112, P849, DOI 10.1093/oxfordjournals.jbchem.a123988; GALVEZ S, 1995, PLANT SCI, V105, P1, DOI 10.1016/0168-9452(94)04041-E; Grodsky NB, 2000, BIOCHEMISTRY-US, V39, P2193, DOI 10.1021/bi9919753; HASELBECK RJ, 1992, BIOCHEMISTRY-US, V31, P6219, DOI 10.1021/bi00142a007; Howell DM, 2000, J BACTERIOL, V182, P5013, DOI 10.1128/JB.182.17.5013-5016.2000; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; HURLEY JH, 1990, J BIOL CHEM, V265, P3599; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; ISHII A, 1987, J BIOCHEM, V102, P1489, DOI 10.1093/oxfordjournals.jbchem.a122196; ISHII A, 1993, J BACTERIOL, V175, P6873, DOI 10.1128/jb.175.21.6873-6880.1993; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lancien M, 1998, PLANT J, V16, P325, DOI 10.1046/j.1365-313x.1998.00305.x; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LEYLAND ML, 1991, EUR J BIOCHEM, V202, P85, DOI 10.1111/j.1432-1033.1991.tb16347.x; LLOYD AJ, 1988, BIOCHEM SOC T, V16, P871, DOI 10.1042/bst0160871; Miyazaki K, 1996, APPL ENVIRON MICROB, V62, P4627, DOI 10.1128/AEM.62.12.4627-4631.1996; MIYAZAKI K, 1993, FEBS LETT, V332, P35, DOI 10.1016/0014-5793(93)80477-C; MUROPASTOR MI, 1994, J BACTERIOL, V176, P2718, DOI 10.1128/JB.176.9.2718-2726.1994; MUROPASTOR MI, 1992, EUR J BIOCHEM, V203, P99, DOI 10.1111/j.1432-1033.1992.tb19833.x; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070, DOI 10.1099/00207713-46-4-1070; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Soundar S, 2000, J BIOL CHEM, V275, P5606, DOI 10.1074/jbc.275.8.5606; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Steen IH, 2001, METHOD ENZYMOL, V331, P13; Steen IH, 1998, FEMS MICROBIOL LETT, V160, P75, DOI 10.1016/S0378-1097(98)00014-7; Steen IH, 1998, FEMS MICROBIOL LETT, V161, P365; Steen IH, 1997, ARCH MICROBIOL, V168, P412, DOI 10.1007/s002030050516; STETTER KO, 1987, SCIENCE, V236, P822, DOI 10.1126/science.236.4803.822; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9317, DOI 10.1021/bi00087a009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIPTON PA, 1994, ARCH BIOCHEM BIOPHYS, V313, P15, DOI 10.1006/abbi.1994.1352; ZHANG T, 1995, PROTEIN SCI, V4, P84	64	57	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43924	43931		10.1074/jbc.M105999200	http://dx.doi.org/10.1074/jbc.M105999200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11533060	hybrid			2022-12-27	WOS:000172297700059
J	Selvapandiyan, A; Duncan, R; Debrabant, A; Bertholet, S; Sreenivas, G; Negi, NS; Salotra, P; Nakhasi, HL				Selvapandiyan, A; Duncan, R; Debrabant, A; Bertholet, S; Sreenivas, G; Negi, NS; Salotra, P; Nakhasi, HL			Expression of a mutant form of Leishmania donovani centrin reduces the growth of the parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE CHAIN-REACTIONS; SPINDLE POLE BODY; MOLECULAR-CLONING; SACCHAROMYCES-CEREVISIAE; CDC31 GENE; PROTEIN; BINDING; IDENTIFICATION; CELLS; YEAST	Leishmania donovani, a protozoan parasite, causes visceral disease in humans. To identify genes that control growth, we have isolated for the first time in the order Kinetoplastida a gene encoding for centrin from L. donovani. Centrin is a calcium-binding cytoskeletal protein essential for centrosome duplication or segregation. Protein sequence similarity and immunoreactivity confirmed that Leishmania centrin is a homolog of human centrin 2. Immunofluorescence analysis localized the protein in the basal body. Calcium binding analysis revealed that its C-terminal Ca2+ binding domain binds 16-fold more calcium than the N-terminal domain. Electrophoretic mobility shift of centrin treated with EGTA and abrogation of the shift in its mutants lacking a Ca2+ binding site suggest that Ca2+ binding to these regions may have a role in the protein conformation. The levels of centrin mRNA and protein were high during the exponential growth of the parasite in culture and declined to a low level in the stationary phase. Expression of N-terminal-deleted centrin in the parasite significantly reduces its growth rate, and it was found that significantly more cells are arrested in the G(2)/M stage than in control cells. These studies indicate that centrin may have a functional role in Leishmania growth.	US FDA, Lab Bacterial Parasit & Unconvent Agents, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; US FDA, Lab Parasit Biol & Biochem, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Safdarjang Hosp, New Delhi 110029, India; Indian Council Med Res, Inst Pathol, New Delhi 110029, India	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP)	Nakhasi, HL (corresponding author), US FDA, Lab Bacterial Parasit & Unconvent Agents, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.		Selvapandiyan, Angamuthu/AAA-8602-2021; Duncan, Robert/I-8168-2015; Selvapandiyan, Angamuthu/AAY-2556-2021	Duncan, Robert/0000-0001-8409-2501; Selvapandiyan, Angamuthu/0000-0002-2194-1534; Gannavaram, Sreenivas/0000-0002-6557-8220; Salotra, Poonam/0000-0002-4057-4872	NIAID NIH HHS [Y3-AI-9319-01] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad S, 2000, INT J SYST EVOL MICR, V50, P1761, DOI 10.1099/00207713-50-5-1761; BARON AT, 1991, CELL MOTIL CYTOSKEL, V18, P1, DOI 10.1002/cm.970180102; Bastin P, 2000, MICROBES INFECT, V2, P1865, DOI 10.1016/S1286-4579(00)01344-7; BHATTACHARYA D, 1993, PLANT MOL BIOL, V23, P1243, DOI 10.1007/BF00042357; Brugerolle G, 2000, J EUKARYOT MICROBIOL, V47, P129, DOI 10.1111/j.1550-7408.2000.tb00022.x; CHANG KP, 1990, ANNU REV MICROBIOL, V44, P499, DOI 10.1146/annurev.mi.44.100190.002435; DEBRABANT A, 1995, MOL BIOCHEM PARASIT, V71, P51, DOI 10.1016/0166-6851(95)00035-Y; Debrabant A, 2000, J BIOL CHEM, V275, P16366, DOI 10.1074/jbc.M908725199; Durussel I, 2000, FEBS LETT, V472, P208, DOI 10.1016/S0014-5793(00)01452-6; Geier BM, 1996, J BIOL CHEM, V271, P28366, DOI 10.1074/jbc.271.45.28366; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; HUANG B, 1988, J CELL BIOL, V107, P133, DOI 10.1083/jcb.107.1.133; Ivanovska I, 2001, GENETICS, V157, P503; Joshi M, 1996, MOL BIOCHEM PARASIT, V81, P53, DOI 10.1016/0166-6851(96)02676-X; JOSHI M, 1995, J EUKARYOT MICROBIOL, V42, P628, DOI 10.1111/j.1550-7408.1995.tb05918.x; JOSHI M, 1993, MOL BIOCHEM PARASIT, V58, P345, DOI 10.1016/0166-6851(93)90057-5; Khalfan W, 2000, GENETICS, V155, P1543; Klink VP, 2001, MOL BIOL CELL, V12, P761, DOI 10.1091/mbc.12.3.761; Laoukili J, 2000, J CELL SCI, V113, P1355; LeDizet M, 1998, AM J PHYSIOL-LUNG C, V275, pL1145, DOI 10.1152/ajplung.1998.275.6.L1145; Levy YY, 1996, CELL MOTIL CYTOSKEL, V33, P298; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Nakhasi HL, 1998, PARASITOL TODAY, V14, P157, DOI 10.1016/S0169-4758(97)01180-0; Paoletti A, 1996, J CELL SCI, V109, P3089; PATI UK, 1992, GENE, V114, P285, DOI 10.1016/0378-1119(92)90589-H; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pogue GP, 1996, MOL BIOCHEM PARASIT, V81, P27, DOI 10.1016/0166-6851(96)02697-7; POGUE GP, 1995, GENE, V165, P31, DOI 10.1016/0378-1119(95)00461-E; POGUE GP, 1995, PARASITOL RES, V81, P282, DOI 10.1007/BF00931531; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; SELVAPANDIYAN A, 1995, FEBS LETT, V374, P253, DOI 10.1016/0014-5793(95)01124-W; SPANG A, 1995, J CELL BIOL, V128, P863, DOI 10.1083/jcb.128.5.863; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALLEN EA, 1994, GENETICS, V137, P407; WEBER C, 1994, J BIOL CHEM, V269, P15795; Wiech H, 1996, J BIOL CHEM, V271, P22453, DOI 10.1074/jbc.271.37.22453; WILSON K, 1991, NUCLEIC ACIDS RES, V19, P5787, DOI 10.1093/nar/19.20.5787; WOLFRUM U, 1995, CELL MOTIL CYTOSKEL, V32, P55, DOI 10.1002/cm.970320107; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	46	62	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43253	43261		10.1074/jbc.M106806200	http://dx.doi.org/10.1074/jbc.M106806200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544261	hybrid			2022-12-27	WOS:000172169300081
J	Sirim, P; Zeitlmann, L; Kellersch, B; Falk, CS; Schendel, DJ; Kolanus, W				Sirim, P; Zeitlmann, L; Kellersch, B; Falk, CS; Schendel, DJ; Kolanus, W			Calcium signaling through the beta(2)-cytoplasmic domain of LFA-1 requires intracellular elements of the T cell receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN CYTOPLASMIC DOMAIN; ZAP-70 TYROSINE KINASE; ANTIGEN-RECEPTOR; IMMUNOLOGICAL SYNAPSE; ADHESION MOLECULE-1; ZETA-CHAIN; ACTIVATION; TRANSDUCTION; PHOSPHORYLATION; COSTIMULATION	The beta (2) integrin LFA-1 is an important cell-cell adhesion receptor of the immune system. Evidence suggests that the molecule also participates in signaling and costimulatory function. We show here that clustering of the intracellular domain of the beta (2) chain but not of the alpha (L)- or beta (1)-cytoplasmic domains, respectively, triggers intracellular Ca2+ mobilization in Jurkat cells. A beta (2)-specific NPXF motif, located in the C-terminal portion of the beta (2) tail, is required for Ca2+ signaling, and we show that this motif is important for the induction of allospecific target cell lysis by cytotoxic T cells in vitro. Significantly, the Ca2+-signaling capacity of the beta (2) integrin is abrogated in T cells that do not express the T cell receptor but may be reconstituted by co-expression of the T cell receptor-zeta chain. Our data suggest a specific function of the cytoplasmic domain of the beta (2) integrin chain in T cell signaling.	Univ Munich, Genzentrum, Mol Biol Lab, D-81377 Munich, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kolanus, W (corresponding author), Univ Munich, Genzentrum, Mol Biol Lab, Feodor Lynen Str 25, D-81377 Munich, Germany.		Zeitlmann, Lutz/AAF-3586-2019; Falk, Christine/Q-4143-2016	Falk, Christine/0000-0003-1376-7318				Abraham C, 1999, J IMMUNOL, V162, P4399; ALCOVER A, 1988, EMBO J, V7, P2077; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Besser M, 1999, J IMMUNOL, V162, P6303; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Farrelly N, 1999, J CELL BIOL, V144, P1337, DOI 10.1083/jcb.144.6.1337; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Retta SF, 1998, MOL BIOL CELL, V9, P715, DOI 10.1091/mbc.9.4.715; ROMEO C, 1992, COLD SPRING HARB SYM, V57, P117, DOI 10.1101/SQB.1992.057.01.015; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; SCHENDEL DJ, 1979, TISSUE ANTIGENS, V13, P112; Sedwick CE, 1999, J IMMUNOL, V162, P1367; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Soede RDM, 1999, J IMMUNOL, V163, P4253; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; SPRINGER TA, 1985, ADV EXP MED BIOL, V184, P311; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Ulivieri C, 1999, EUR J IMMUNOL, V29, P2625; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zuckerman LA, 1998, J IMMUNOL, V160, P3259	66	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42945	42956		10.1074/jbc.M103224200	http://dx.doi.org/10.1074/jbc.M103224200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11559699	hybrid			2022-12-27	WOS:000172169300043
J	Carballo, E; Cao, HP; Lai, WS; Kennington, EA; Campbell, D; Blackshear, PJ				Carballo, E; Cao, HP; Lai, WS; Kennington, EA; Campbell, D; Blackshear, PJ			Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENTS; FINGER TRANSCRIPTION FACTOR; MESSENGER-RNA DEGRADATION; FACTOR-ALPHA; MAP KINASE; TNF-ALPHA; INFLAMMATORY DISEASE; PYRIDINYL IMIDAZOLES	Treatment of macrophages with pyridinyl imidazole inhibitors of p38 protein kinases can inhibit lipopolysaccharide-stimulated tumor necrosis factor a secretion. However, bone marrow-derived macrophages from tristetraprolin (TTP)-deficient mice were less sensitive than normal macrophages to this effect of p38 inhibitors, despite evidence for normal p38 activation in response to lipopolysaccharide. TTP is known to cause decreased stability of tumor necrosis factor a and granulocyte-macrophage colony-stimulating factor mRNAs after binding to an AU-rich element in their 3'-untranslated regions. A recombinant TTP fusion protein could be phosphorylated by a recombinant p38 kinase in cell-free assays and was phosphorylated to the same extent by immunoprecipitated p38 derived from normal and TTP-deficient cells stimulated with lipopolysaccharide; in both cases, the enzyme activity was inhibited by the p38 inhibitors. TTP phosphorylation also was increased in intact macrophages after lipopolysaccharide stimulation, an effect that was blocked by the p38 inhibitors. Finally, TTP in mammalian cell extracts bound less well to an AU-rich element RNA probe than did the same amount of TTP following dephosphorylation. These results suggest that TTP may be a component of the signaling cascade, initiated by inflammatory stimuli and mediated in part by activation of p38, that ultimately leads to enhanced secretion of tumor necrosis factor a.	NIEHS, Off Clin Res, Res Triangle Pk, NC 27709 USA; NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; AstraZeneca Pharmaceut, Macclesfield SK10 4TG, Cheshire, England	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; AstraZeneca	Blackshear, PJ (corresponding author), NIEHS, Off Clin Res, POB 12233, Res Triangle Pk, NC 27709 USA.		Blackshear, Perry J./C-6206-2019; Cao, Heping/AAC-1666-2021	Blackshear, Perry J./0000-0002-9561-8529; Cao, Heping/0000-0002-0958-1468	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090080] Funding Source: NIH RePORTER; NIEHS NIH HHS [Z01 ES090080-08] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Barlaam B, 1999, J MED CHEM, V42, P4890, DOI 10.1021/jm990377j; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHIN J, 1993, J IMMUNOL, V151, P5574; Clerk A, 1998, FEBS LETT, V426, P93, DOI 10.1016/S0014-5793(98)00324-X; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Glaser KB, 1999, BIOCHEM PHARMACOL, V57, P291, DOI 10.1016/S0006-2952(98)00300-1; Hale KK, 1999, J IMMUNOL, V162, P4246; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Paine E, 2000, J BIOL CHEM, V275, P11284, DOI 10.1074/jbc.275.15.11284; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; PRICHETT W, 1995, J INFLAMM, V45, P97; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; van den Blink B, 2001, J IMMUNOL, V166, P582, DOI 10.4049/jimmunol.166.1.582; Wadsworth SA, 1999, J PHARMACOL EXP THER, V291, P680; Wang SW, 1999, INFLAMM RES, V48, P533, DOI 10.1007/s000110050499; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; YOUNG P, 1993, AGENTS ACTIONS, V39, pC67, DOI 10.1007/BF01972723; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	43	163	169	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42580	42587		10.1074/jbc.M104953200	http://dx.doi.org/10.1074/jbc.M104953200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546803	Green Accepted, hybrid			2022-12-27	WOS:000172450400134
J	Gilmore, ES; Stutts, MJ; Milgram, SL				Gilmore, ES; Stutts, MJ; Milgram, SL			Src family kinases mediate epithelial Na+ channel inhibition by endothelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE CELLS; SODIUM-CHANNEL; TYROSINE KINASE; LIDDLE SYNDROME; GROWTH-FACTOR; ENAC CHANNEL; COAT COLOR; ACTIVATION; PHOSPHORYLATION	The epithelial Na+ channel (ENaC) is implicated in the pathogenesis of salt-sensitive hypertension. Recent evidence from animal models suggests that the vasoactive peptide, endothelin (ET-1), may be an important negative regulator of ENaC in vivo. We investigated the signaling pathway involved in endothelin-mediated ENaC inhibition. Experiments were performed in NIH 3T3 cells stably expressing genes for the three (alpha, beta, and gamma) ENaC subunits. In whole cell patch clamp experiments, we found that ET-1 treatment induced a dose-dependent decrease in amiloride-sensitive currents. Using receptor-specific antagonists, we determined that the effects of ET-1 were attributed to activation of the ETB receptor. Moreover, the inhibitory effect of ET-1 on ENaC could be completely blocked when cells were pretreated with the selective Src family kinase inhibitor, PP2. Further studies revealed that basal Src family kinase activity strongly regulates ENaC whole cell currents and single channel gating. These results suggest that Src family kinases lie in a signaling pathway activated by ET-1 and are components of a novel negative regulatory cascade resulting in ENaC inhibition.	Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Cyst Fibrosis Pulm Res & Tratment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Milgram, SL (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, CB 7545, Chapel Hill, NC 27599 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063755] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63755] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BABRY P, 1997, AM J PHYSIOL, V273, pG571; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1992, AM J PHYSIOL, V262, pF454, DOI 10.1152/ajprenal.1992.262.3.F454; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Chigaev A, 2001, AM J PHYSIOL-RENAL, V280, pF1030, DOI 10.1152/ajprenal.2001.280.6.F1030; Chu TS, 1996, J CLIN INVEST, V97, P1454, DOI 10.1172/JCI118567; Chu TS, 1996, AM J PHYSIOL-CELL PH, V271, pC763, DOI 10.1152/ajpcell.1996.271.3.C763; Ciampolillo F, 1996, AM J PHYSIOL-CELL PH, V271, pC1303, DOI 10.1152/ajpcell.1996.271.4.C1303; DAVENPORT AP, 1989, J CARDIOVASC PHAR S5, V13, P166; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DETEJADA IS, 1992, J UROLOGY, V148, P1290, DOI 10.1016/S0022-5347(17)36895-7; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Donowitz M, 2000, ANN NY ACAD SCI, V915, P30; Emala CW, 1999, AM J PHYSIOL-LUNG C, V276, pL564, DOI 10.1152/ajplung.1999.276.4.L564; Gallego MS, 1996, AM J PHYSIOL-RENAL, V271, pF451, DOI 10.1152/ajprenal.1996.271.2.F451; Gariepy CE, 2000, J CLIN INVEST, V105, P925, DOI 10.1172/JCI8609; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Garty H, 2000, KIDNEY INT, V57, P1270, DOI 10.1046/j.1523-1755.2000.00961.x; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; HANEDA M, 1995, J AM SOC NEPHROL, V6, P1504; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Imamura T, 1999, J BIOL CHEM, V274, P33691, DOI 10.1074/jbc.274.47.33691; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Karet FE, 1996, CLIN SCI, V91, P267, DOI 10.1042/cs0910267; KIMURA S, 1989, J CARDIOVASC PHAR S5, V13, P5; Kleyman TR, 1999, SEMIN NEPHROL, V19, P524; Kovacic B, 1998, J BIOL CHEM, V273, P35185; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MacFarlane SN, 2000, J NEUROSCI, V20, P5245, DOI 10.1523/JNEUROSCI.20-14-05245.2000; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; MARUNAKA Y, 1992, AM J PHYSIOL, V263, pF392, DOI 10.1152/ajprenal.1992.263.3.F392; MASAKI T, 1990, JPN CIRC J, V54, P1221, DOI 10.1253/jcj.54.1221; MASUDA Y, 1989, FEBS LETT, V257, P208, DOI 10.1016/0014-5793(89)81535-2; May A, 1997, J AM SOC NEPHROL, V8, P1813; Mizuguchi T, 1997, BRIT J PHARMACOL, V120, P1427, DOI 10.1038/sj.bjp.0701054; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; Robey RB, 2001, AM J PHYSIOL-RENAL, V280, pF844, DOI 10.1152/ajprenal.2001.280.5.F844; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Schieffer B, 1997, AM J PHYSIOL-CELL PH, V272, pC2019, DOI 10.1152/ajpcell.1997.272.6.C2019; Schild L, 1996, NEPHROLOGIE, V17, P395; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SHICHIRI M, 1991, J CLIN INVEST, V87, P1867, DOI 10.1172/JCI115210; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Shraga-Levine Z, 2000, CELL MOL NEUROBIOL, V20, P305, DOI 10.1023/A:1007010125316; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; TAKAYANAGI R, 1996, J CARDIOVASC PHARM, V17, pS127; TAKEMOTO F, 1993, AM J PHYSIOL, V264, pF827, DOI 10.1152/ajprenal.1993.264.5.F827; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yue G, 2000, AM J PHYSIOL-CELL PH, V279, pC81, DOI 10.1152/ajpcell.2000.279.1.C81	56	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42610	42617		10.1074/jbc.M106919200	http://dx.doi.org/10.1074/jbc.M106919200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11560932	hybrid, Green Published			2022-12-27	WOS:000172450400137
J	LaRochelle, O; Gagne, V; Charron, J; Soh, JW; Seguin, C				LaRochelle, O; Gagne, V; Charron, J; Soh, JW; Seguin, C			Phosphorylation is involved in the activation of metal-regulatory transcription factor 1 in response to metal ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; METALLOTHIONEIN GENE-EXPRESSION; FACTOR MTF-1; IN-VIVO; MEDIATED ACTIVATION; POTENT INHIBITORS; OXIDATIVE STRESS; BINDING-PROTEINS; HEME OXYGENASE-1; ZINC FINGERS	We have studied the role of phosphorylation in the activation of metal-regulatory transcription factor-1 (MTF-1) and metallothionein (MT) gene expression. We showed that MTF-1 is phosphorylated in vivo and that zinc stimulates MTF-1 phosphorylation 2-4-fold. Several kinase inhibitors were used to examine the possible involvement of kinase cascades in the activation of MTF-1. Metal-induced MT gene expression was abrogated by protein kinase C (PKC), c-Jun N-terminal kinase (JN-K), phosphoinositide 3-kinase, and tyrosine-specific protein kinases inhibitors, as assayed by Northern analysis and by cotransfection experiments using a metal regulatory element-luciferase reporter plasmid. The extracellular signal-activated protein kinase and the p38 kinase cascades did not appear to be essential for the activation Aff gene transcription by metals. By using dominant-negative mutants of PKC, JNK., mitogen-activated kinase kinase 4 (MKK4), and MKK7, we provide further evidence supporting a role for PKC and JNK in the activation of MTF-1 in response to metals. Notably, increased MTF-1 DNA binding in response to zinc and MTF-1 nuclear localization was not inhibited in cells preincubated with the different kinase inhibitors despite strong inhibition of MTF-1-mediated gene expression. This suggests that phosphorylation is essential for MTF-1 transactivation function. We hypothesize that metal-induced phosphorylation of MTF-1 is one of the primary events leading to increased MTF-1 activity. Thus, metal ions such as cadmium could activate MTF-1 and induce MT gene expression by stimulating one or several kinases in the MTF-1 signal transduction pathway.	Univ Laval, CHUQ, Hotel Dieu, Ctr Rech Canc, Quebec City, PQ G1R 2J6, Canada; Univ Laval, Fac Med, Dept Anat & Physiol, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Fac Med, Dept Med Biol, Quebec City, PQ G1K 7P4, Canada; Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Laval University; Laval University; Laval University; Columbia University	Seguin, C (corresponding author), Univ Laval, CHUQ, Hotel Dieu, Ctr Rech Canc, 11 Cote Palais, Quebec City, PQ G1R 2J6, Canada.	Carl.Seguin@crhdq.ulaval.ca	Charron, Jean/A-9792-2013	Charron, Jean/0000-0002-5133-0056				AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alam J, 2000, J BIOL CHEM, V275, P27694; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; ARIZONO K, 1993, LIFE SCI, V53, P1031, DOI 10.1016/0024-3205(93)90126-N; Bagchi D, 1997, TOXICOL LETT, V91, P31, DOI 10.1016/S0378-4274(97)03868-X; Bellmann K, 2000, J BIOL CHEM, V275, P18172, DOI 10.1074/jbc.M000340200; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Chu WA, 1999, J BIOL CHEM, V274, P5279, DOI 10.1074/jbc.274.9.5279; Cross JV, 1999, J BIOL CHEM, V274, P31150, DOI 10.1074/jbc.274.44.31150; DAFFADA AAI, 1994, BBA-MOL CELL RES, V1222, P234, DOI 10.1016/0167-4889(94)90174-0; DALTON T, 1994, NUCLEIC ACIDS RES, V22, P5016, DOI 10.1093/nar/22.23.5016; Dalton TP, 1997, MOL CELL BIOL, V17, P2781, DOI 10.1128/MCB.17.5.2781; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran N, 1998, ONCOGENE, V17, P1329, DOI 10.1038/sj.onc.1202170; Faraonio R, 2000, EUR J BIOCHEM, V267, P1743, DOI 10.1046/j.1432-1327.2000.01167.x; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Koizumi S, 2000, J CELL PHYSIOL, V185, P464, DOI 10.1002/1097-4652(200012)185:3<464::AID-JCP18>3.0.CO;2-4; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; KOIZUMI S, 1992, EUR J BIOCHEM, V210, P555, DOI 10.1111/j.1432-1033.1992.tb17454.x; Kumahara E, 1999, J BIOL CHEM, V274, P10430, DOI 10.1074/jbc.274.15.10430; LABBE S, 1991, NUCLEIC ACIDS RES, V19, P4225, DOI 10.1093/nar/19.15.4225; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; Maeshima H, 1996, NUCLEIC ACIDS RES, V24, P2959, DOI 10.1093/nar/24.15.2959; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Moffatt P, 1998, DNA CELL BIOL, V17, P501, DOI 10.1089/dna.1998.17.501; Moffatt P, 1997, DRUG METAB REV, V29, P261, DOI 10.3109/03602539709037585; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Murphy BJ, 1999, CANCER RES, V59, P1315; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Otsuka F, 2000, BBA-GENE STRUCT EXPR, V1492, P330, DOI 10.1016/S0167-4781(00)00110-X; Ozes ON, 1999, NATURE, V401, P82; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Park HS, 2000, J BIOL CHEM, V275, P2527, DOI 10.1074/jbc.275.4.2527; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; Pouyssegur J, 2000, SCIENCE, V290, P1515, DOI 10.1126/science.290.5496.1515; PRASAD AS, 1995, NUTRITION, V11, P93; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rajanna B, 1995, TOXICOL LETT, V81, P197, DOI 10.1016/0378-4274(95)03433-1; Ray A, 2000, J BIOL CHEM, V275, P39727, DOI 10.1074/jbc.M007907200; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEFTON BM, 1996, CURRENT PROTOCOLS MO; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Wang Z, 1998, J BIOL CHEM, V273, P73, DOI 10.1074/jbc.273.1.73; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; WHITE C, 1995, DIS EPID MED, V2, P9; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Yoo HY, 1999, MOL GEN GENET, V262, P310, DOI 10.1007/s004380051088; Yu CW, 1997, FEBS LETT, V420, P69, DOI 10.1016/S0014-5793(97)01489-0; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	68	97	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41879	41888		10.1074/jbc.M108313200	http://dx.doi.org/10.1074/jbc.M108313200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551972	hybrid			2022-12-27	WOS:000172450400046
J	Shichiri, M; Hoshikawa, C; Nakamori, S; Takagi, H				Shichiri, M; Hoshikawa, C; Nakamori, S; Takagi, H			A novel acetyltransferase found in Saccharomyces cerevisiae Sigma 1278b that detoxifies a proline analogue, azetidine-2-carboxylic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; SERRATIA-MARCESCENS; HEAT-SHOCK; ESCHERICHIA-COLI; PROBA OPERON; GENE; YEAST; BIOSYNTHESIS; SUPERFAMILY	L-Azetidine-2-carboxylic acid (AZC), a toxic four-membered ring analogue Of L-proline, is transported into the cells via proline transporters. It causes misfolding of the proteins into which it is incorporated competitively with L-proline and thereby inhibits the growth of the cells. We recently have discovered, on the chromosome of Saccharomyces cerevisiae Sigma 1278b, a novel gene MPR1 required for the resistance of Sigma 1278 background strains to toxic AZC. This gene was missing in the particular yeast strain used for the genomic sequence determination. Although the protein sequence was homologous to that of the S. cerevisiae transcriptional regulator, Mpr1p did not affect the expression of genes involved in proline uptake. However, gene expression in Escherichia coli and enzymatic analysis showed that the MPR1 gene encodes a novel AZC acetyltransferase, by which L-proline itself and other L-proline analogues are not acetylated. Mpr1p was considered to be a member of the N-acetyl-transferase superfamily based on the results of an Ala-scan mutagenesis through the highly conserved region involved in binding acetyl-CoA in members of the superfamily. Our findings suggest that Mpr1p detoxifies AZC by acetylating it in the cytoplasm. This enzyme might be utilized as a selective marker in a wide variety of organisms, because the cells expressing the MPR1 gene acquire the AZC-resistant phenotype.	Fukui Prefectural Unit, Dept Biosci, Fukui 9101195, Japan		Takagi, H (corresponding author), Fukui Prefectural Unit, Dept Biosci, 4-1-1 Kenjojima,Matsuokacho, Fukui 9101195, Japan.	hiro@fpu.ac.jp		Takagi, Hiroshi/0000-0002-1786-3174				ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; Bonhivers M, 1998, J BIOL CHEM, V273, P27565, DOI 10.1074/jbc.273.42.27565; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; FOWDEN L, 1963, BIOCHIM BIOPHYS ACTA, V71, P459, DOI 10.1016/0006-3002(63)91104-1; GRENSON M, 1972, BIOCHEM BIOPH RES CO, V48, P749, DOI 10.1016/0006-291X(72)90670-5; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; Inouye S, 1997, GENE, V189, P159, DOI 10.1016/S0378-1119(96)00753-6; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; KELLEY PM, 1978, CELL, V15, P1277, DOI 10.1016/0092-8674(78)90053-3; KLOHS WD, 1985, J NATL CANCER I, V75, P353; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LEETE E, 1964, J AM CHEM SOC, V86, P3162, DOI 10.1021/ja01069a045; LEETE E, 1986, PHYTOCHEMISTRY, V25, P2753, DOI 10.1016/S0031-9422(00)83735-8; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Liu HP, 1996, GENETICS, V144, P967; MINAKATA H, 1985, EXPERIENTIA, V41, P1622, DOI 10.1007/BF01964840; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; NATSOULIS G, 1994, GENETICS, V136, P93; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; OMORI K, 1991, J GEN MICROBIOL, V137, P509, DOI 10.1099/00221287-137-3-509; OMORI K, 1992, J GEN MICROBIOL, V138, P693, DOI 10.1099/00221287-138-4-693; PETERSON PJ, 1963, NATURE, V200, P148, DOI 10.1038/200148a0; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Reese LM, 1996, LETT APPL MICROBIOL, V22, P202, DOI 10.1111/j.1472-765X.1996.tb01143.x; Sambrook J., 2001, MOL CLONING LAB MANU; SMITH CJ, 1984, J BACTERIOL, V157, P545, DOI 10.1128/JB.157.2.545-551.1984; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; SUGIURA M, 1985, APPL MICROBIOL BIOT, V21, P213, DOI 10.1007/BF00295125; Takagi H, 2000, J BACTERIOL, V182, P4249, DOI 10.1128/JB.182.15.4249-4256.2000; Takagi H, 1997, APPL MICROBIOL BIOT, V47, P405, DOI 10.1007/s002530050948; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X; YAMASHITA I, 1993, MOL GEN GENET, V241, P616, DOI 10.1007/BF00279904; Yokota S, 2000, EUR J BIOCHEM, V267, P1658, DOI 10.1046/j.1432-1327.2000.01157.x	40	43	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41998	42002		10.1074/jbc.C100487200	http://dx.doi.org/10.1074/jbc.C100487200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11555637	hybrid			2022-12-27	WOS:000172450400062
J	Kaiya, H; Kojima, M; Hosoda, H; Koda, A; Yamamoto, K; Kitajima, Y; Matsumoto, M; Minamitake, Y; Kikuyama, S; Kangawa, K				Kaiya, H; Kojima, M; Hosoda, H; Koda, A; Yamamoto, K; Kitajima, Y; Matsumoto, M; Minamitake, Y; Kikuyama, S; Kangawa, K			Bullfrog ghrelin is modified by n-octanoic acid at its third threonine residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE RELEASE; CYCLASE-ACTIVATING POLYPEPTIDE; SECRETAGOGUE RECEPTOR; PITUITARY-CELLS; ACYLATED PEPTIDE; GLYCOPROTEIN HORMONES; RANA-CATESBEIANA; RAT PITUITARY; PROLACTIN; SITES	We have identified the amphibian ghrelin from the stomach of the bullfrog. We also examined growth hormone (GH)-releasing activity of this novel peptide in both the rat and bullfrog. The three forms of ghrelin identified, each comprised of 27 or 28 amino acids, possessed 29% sequence identity to the mammalian ghrelins. A unique threonine at amino acid position 3 (Thr(3)) in bullfrog ghrelin differs from the serine present in the mammalian ghrelins; this Thr(3) is acylated by either n-octanoic or n-decanoic acid. The frog ghrelin-28 has a complete structure of GLT (O-n-octanoyl)FLSPADMQKLAERQSQNKLRHGNM; the structure of frog ghrelin-27 was determined to be GLT(O-n-octanoyl)FLSPADMQKLAERQSQNKLRHGN; frog ghelin-27-C10 possessed a structure of GLT(O-n-decanoyl)FLSPADMQKLAERQSQNKLRHGN. Northern blot analysis demonstrated that ghrelin mRNA is predominantly expressed in the stomach. Low levels of gene expression were observed in the heart, lung, small intestine, gall bladder, pancreas, and testes, as revealed by reverse transcription polymerase chain reaction analysis. Bullfrog ghrelin stimulated the secretion of both GH and prolactin in dispersed bullfrog pituitary cells with potency 2-3 orders of magnitude greater than that of rat ghrelin. Bullfrog ghrelin, however, was only minimally effective in elevating plasma GH levels following intravenous injection into rats. These results indicate that although the regulatory mechanism of ghrelin to induce GH secretion is evolutionary conserved, the structural changes in the different ghrelins result in species-specific receptor binding.	Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; Waseda Univ, Sch Educ, Dept Biol, Shinjuku Ku, Tokyo 1698050, Japan; Suntory Inst Med Res & Dev, Gunma 3700503, Japan	National Cerebral & Cardiovascular Center - Japan; Waseda University	Kaiya, H (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Biochem, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.		Kaiya, Hiroyuki/I-9221-2019	Yamamoto, Kazutoshi/0000-0002-7935-7015				Aida T, 1999, GEN COMP ENDOCR, V115, P101, DOI 10.1006/gcen.1999.7289; Alexandre D, 2000, J COMP NEUROL, V421, P234, DOI 10.1002/(SICI)1096-9861(20000529)421:2<234::AID-CNE8>3.0.CO;2-S; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; BERTHERAT J, 1995, EUR J ENDOCRINOL, V132, P12, DOI 10.1530/eje.0.1320012; BLAKE AD, 1991, J ENDOCRINOL, V129, P11, DOI 10.1677/joe.0.1290011; Bodart V, 1999, CIRC RES, V85, P796, DOI 10.1161/01.RES.85.9.796; BOWERS CY, 1984, ENDOCRINOLOGY, V114, P1537, DOI 10.1210/endo-114-5-1537; Bowers CY., 1977, MOL ENDOCRINOL, P287; CHENG K, 1991, ENDOCRINOLOGY, V129, P3337; CHENG K, 1989, ENDOCRINOLOGY, V124, P2791; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Date Y, 2001, BIOCHEM BIOPH RES CO, V280, P904, DOI 10.1006/bbrc.2000.4212; Feighner SD, 1998, MOL ENDOCRINOL, V12, P137, DOI 10.1210/mend.12.1.0051; Geris KL, 1998, GEN COMP ENDOCR, V111, P186, DOI 10.1006/gcen.1998.7102; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hosoda H, 2000, J BIOL CHEM, V275, P21995, DOI 10.1074/jbc.M002784200; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hu ZT, 2000, ENDOCRINOLOGY, V141, P3366, DOI 10.1210/en.141.9.3366; Jeandel L, 1998, J NEUROENDOCRINOL, V10, P187; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KOBAYASHI T, 1991, GEN COMP ENDOCR, V82, P14, DOI 10.1016/0016-6480(91)90291-D; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Montero M, 2000, J MOL ENDOCRINOL, V25, P157, DOI 10.1677/jme.0.0250157; Muccioli G, 2001, J ENDOCRINOL INVEST, V24, pRC7, DOI 10.1007/BF03343831; Muccioli G, 2000, ANN ENDOCRINOL-PARIS, V61, P27; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oguchi A, 1997, GEN COMP ENDOCR, V107, P128, DOI 10.1006/gcen.1997.6904; Oguchi A, 1996, GEN COMP ENDOCR, V102, P141, DOI 10.1006/gcen.1996.0055; Palyha OC, 2000, MOL ENDOCRINOL, V14, P160, DOI 10.1210/me.14.1.160; Shepherd BS, 2000, J ENDOCRINOL, V167, pR7, DOI 10.1677/joe.0.167R007; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUZUKI H, 1997, ADV COMP ENDOCRINOLO, V2, P1033; TANAKA S, 1991, GEN COMP ENDOCR, V84, P318, DOI 10.1016/0016-6480(91)90055-B; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; YAMAMOTO K, 1982, ENDOCRINOL JAPON, V29, P159	39	130	142	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40441	40448		10.1074/jbc.M105212200	http://dx.doi.org/10.1074/jbc.M105212200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546772	hybrid			2022-12-27	WOS:000171925600013
J	Roelofs, J; Loovers, HM; Van Haastert, PJM				Roelofs, J; Loovers, HM; Van Haastert, PJM			GTP gamma S regulation of a 12-transmembrane guanylyl cyclase is retained after mutation to an adenylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; SIGNAL-TRANSDUCTION PATHWAYS; ACTIVATED PROTEIN-KINASE; AMINO-ACID SUBSTITUTIONS; DICTYOSTELIUM-DISCOIDEUM; MULTICELLULAR DEVELOPMENT; CATALYTIC DOMAINS; BINDING PROTEINS; PHOSPHOLIPASE-C; ALPHA-SUBUNIT	DdGCA is a Dictyostelium guanylyl cyclase with a topology typical for mammalian adenylyl cyclases containing 12 transmembrane-spanning regions and two cyclase domain. In Dictyostelium cells heterotrimeric G-proteins are essential for guanylyl cyclase activation by extracellular cAMP. In lysates, guanylyl cyclase activity is strongly stimulated by guanosine 5'-3-O-(thio) triphosphate (GTP gammaS), which is also a substrate of the enzyme. DdGCA was converted to an adenylyl cyclase by introducing three point mutations. Expression of the obtained DdGCA(kqd) in adenylyl cyclase-defective cells restored the phenotype of the mutant. GTP gammaS stimulated the adenylyl cyclase activity of DdGCAkqd with properties similar to those of the wild-type enzyme (decrease of K-m and increase of V-max), demonstrating that GTP gammaS stimulation is independent of substrate specificity. Furthermore, GTP gammaS activation of DdGCAkqd is retained in several null mutants of Ga and G beta proteins, indicating that GTP gammaS activation is not mediated by a heterotrimerie G-protein but possibly by a monomeric G-protein.	Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	Van Haastert, PJM (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.		Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465				Aubry L, 1998, GENE DEV, V12, P1525, DOI 10.1101/gad.12.10.1525; BOMINAAR AA, 1994, BIOCHEM J, V297, P189, DOI 10.1042/bj2970189; BRANDWEIN HJ, 1982, J BIOL CHEM, V257, P1309; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Carucci DJ, 2000, J BIOL CHEM, V275, P22147, DOI 10.1074/jbc.M001021200; Chubb JR, 2001, BBA-GEN SUBJECTS, V1525, P262, DOI 10.1016/S0304-4165(01)00111-8; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; DICOU E, 1980, EUR J BIOCHEM, V109, P507, DOI 10.1111/j.1432-1033.1980.tb04822.x; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Emala CW, 1999, AM J PHYSIOL-LUNG C, V276, pL564, DOI 10.1152/ajplung.1999.276.4.L564; Foster D C, 1999, Rev Physiol Biochem Pharmacol, V135, P1, DOI 10.1007/BFb0033668; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; HADWIGER JA, 1992, GENE DEV, V6, P38, DOI 10.1101/gad.6.1.38; HADWIGER JA, 1994, P NATL ACAD SCI USA, V91, P10566, DOI 10.1073/pnas.91.22.10566; HALL AL, 1993, DEV BIOL, V157, P73, DOI 10.1006/dbio.1993.1113; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Heikoop JC, 1998, EUR J BIOCHEM, V256, P359, DOI 10.1046/j.1432-1327.1998.2560359.x; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; JANSSENS PMW, 1989, J BIOL CHEM, V264, P4329; JANSSENS PMW, 1988, BIOCHEM BIOPH RES CO, V150, P405, DOI 10.1016/0006-291X(88)90535-9; KESBEKE F, 1988, J CELL BIOL, V107, P521, DOI 10.1083/jcb.107.2.521; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; KUMAGAI A, 1991, J BIOL CHEM, V266, P1220; LILLY P, 1993, GENE DEV, V7, P986, DOI 10.1101/gad.7.6.986; Linder JU, 1999, EMBO J, V18, P4222, DOI 10.1093/emboj/18.15.4222; Linder JU, 2000, J BIOL CHEM, V275, P11235, DOI 10.1074/jbc.275.15.11235; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; MANN SKO, 1994, P NATL ACAD SCI USA, V91, P10561, DOI 10.1073/pnas.91.22.10561; Martelli AM, 1996, BIOCHEM BIOPH RES CO, V218, P182, DOI 10.1006/bbrc.1996.0032; OKAICHI K, 1992, MOL BIOL CELL, V3, P735, DOI 10.1091/mbc.3.7.735; OYAMA M, 1991, BIOCHEM BIOPH RES CO, V176, P1245, DOI 10.1016/0006-291X(91)90419-8; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Roelofs J, 2001, BIOCHEM J, V354, P697, DOI 10.1042/0264-6021:3540697; Root PA, 1999, J CELL BIOCHEM, V74, P301, DOI 10.1002/(SICI)1097-4644(19990801)74:2<301::AID-JCB14>3.0.CO;2-9; SCHAAP P, 1995, DEV BIOL, V168, P179, DOI 10.1006/dbio.1995.1070; SCHOEN CD, 1992, THESIS U AMSTERDAM; SCHULKES CCGM, 1992, BIOCHIM BIOPHYS ACTA, V1135, P73, DOI 10.1016/0167-4889(92)90168-B; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; SNAARJAGALSKA BE, 1994, METHOD ENZYMOL, V237, P387; Srinivasan J, 1999, DEV BIOL, V215, P443, DOI 10.1006/dbio.1999.9474; Sucgang R, 1997, DEV BIOL, V192, P181, DOI 10.1006/dbio.1997.8720; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; VALKEMA R, 1992, BIOCHEM BIOPH RES CO, V186, P263, DOI 10.1016/S0006-291X(05)80802-2; VANHAASTERT PJM, 1984, J CELL BIOL, V98, P709, DOI 10.1083/jcb.98.2.709; VANHAASTERT PJM, 1982, FEBS LETT, V147, P149, DOI 10.1016/0014-5793(82)81029-6; Wedel BJ, 2001, ANNU REV PHYSIOL, V63, P215, DOI 10.1146/annurev.physiol.63.1.215; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	62	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40740	40745		10.1074/jbc.M105154200	http://dx.doi.org/10.1074/jbc.M105154200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522784	Green Published, hybrid			2022-12-27	WOS:000171925600050
J	Gage, RM; Kim, KA; Cao, TT; von Zastrow, M				Gage, RM; Kim, KA; Cao, TT; von Zastrow, M			A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; DELTA-OPIOID RECEPTOR; DYNAMIN-DEPENDENT ENDOCYTOSIS; DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; BETA-2-ADRENERGIC RECEPTOR; VASOPRESSIN RECEPTOR; ACTIVATED RECEPTOR-1; THROMBIN RECEPTORS	The beta (2)-adrenergic receptor and delta opioid receptor represent distinct G protein-coupled receptors that undergo agonist-induced endocytosis via clathrin-coated pits but differ significantly in their postendocytic sorting between recycling and degradative membrane pathways, respectively. Previous results indicate that a distal portion of the carboxyl-terminal cytoplasmic domain of the beta (2)-adrenergic receptor, which engages in PDZ domain-mediated protein interaction, is required for efficient recycling of receptors after agonist-induced endocytosis. Here we demonstrate that a four-residue sequence (DSLL) comprising the core of this protein interaction domain functions as a transplantable endocytic sorting signal that is sufficient to re-route endocytosed delta opioid receptor into a rapid recycling pathway, to inhibit proteolytic down-regulation of receptors, and to mediate receptor-autonomous sorting of mutant receptors from the wild type allele when co-expressed in the same cells. These observations define a transplantable signal mediating rapid recycling of a heterologous G protein-coupled receptor, and they suggest that rapid recycling of certain membrane proteins does not occur by bulk membrane flow but is instead mediated by a specific endocytic sorting mechanism.	Univ Calif San Francisco, Dept Psychiat, Grad Program Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gage, RM (corresponding author), Univ Calif San Francisco, Dept Psychiat, Grad Program Pharmaceut Chem, Box 0984, San Francisco, CA 94143 USA.							Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Cvejic S, 1996, J BIOL CHEM, V271, P4073; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; HEIN L, 1994, J BIOL CHEM, V269, P27719; Innamorati G, 1999, J RECEPT SIGNAL TR R, V19, P315, DOI 10.3109/10799899909036654; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Jockers R, 1999, J BIOL CHEM, V274, P28900, DOI 10.1074/jbc.274.41.28900; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Ko JL, 1999, MOL BRAIN RES, V69, P171, DOI 10.1016/S0169-328X(99)00094-7; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; LAW PY, 1984, J BIOL CHEM, V259, P4096; LAW PY, 1982, MOL PHARMACOL, V72, P1; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; VON ZM, 1992, J BIOL CHEM, V267, P3530; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	55	109	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44712	44720		10.1074/jbc.M107417200	http://dx.doi.org/10.1074/jbc.M107417200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11560936	hybrid			2022-12-27	WOS:000172406700051
J	Mograbi, B; Bocciardi, R; Bourget, I; Busca, R; Rochet, N; Farahi-Far, D; Juhel, T; Rossi, B				Mograbi, B; Bocciardi, R; Bourget, I; Busca, R; Rochet, N; Farahi-Far, D; Juhel, T; Rossi, B			Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway - Importance for the rescue of neuroectodermic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MICE LACKING GDNF; RECEPTOR TYROSINE KINASE; ENTERIC NERVOUS-SYSTEM; C-RET PROTOONCOGENE; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; PHOSPHOINOSITIDE 3-KINASE; INDEPENDENT MECHANISMS; RAF-1 KINASE	Glial cell line-derived neurotrophic factor (GDNF) plays a crucial role in rescuing neural crest cells from apoptosis during their migration in the foregut. This survival factor binds to the heterodimer GDNF family receptor alpha1/Ret, inducing the Ret tyrosine kinase activity. ret loss-of-function mutations result in Hirschsprung's disease, a frequent developmental defect of the enteric nervous system. Although critical to enteric nervous system development, the intracellular signaling cascades activated by GDNF and their importance in neuroectodermic cell survival still remain elusive. Using the neuroectodermic SK-N-MC cell line, we found that the Ret tyrosine kinase activity is essential for GDNF to induce phosphatidylinositol 3-kinase (PI3K)/Akt and ERK pathways as well as cell rescue. We demonstrate that activation of PI3K is mandatory for GDNF-induced cell survival. In addition, evidence is provided for a critical up-regulation of the ERK pathway by PI3K at the level of Raf-1. Conversely, Akt inhibits the ERK pathway. Thus, both PI3K and Akt act in concert to finely regulate the level of ERK. We found that Akt activation is indispensable for counteracting the apoptotic signal on mitochondria, whereas ERK is partially involved in precluding procaspase-3 cleavage. Altogether, these findings underscore the importance of the Ret/PI3K/Akt pathway in GDNF-induced neuroectodermic cell survival.	Fac Med Pasteur, INSERM, U364, IFR50, F-06107 Nice 02, France; Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Fac Med Pasteur, INSERM, U385, IFR50, F-06107 Nice 02, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Genoa; IRCCS Istituto Giannina Gaslini; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Mograbi, B (corresponding author), Fac Med Pasteur, INSERM, U364, IFR50, F-06107 Nice 02, France.		Mograbi, Baharia/Q-7953-2019; Mograbi, Baharia/N-5531-2018; ROCHET, Nathalie/N-1819-2018; Bocciardi, Renata/J-8577-2016; ROCHET, Nathalie/S-3027-2019	ROCHET, Nathalie/0000-0002-9995-6699; Bocciardi, Renata/0000-0001-8415-3802; ROCHET, Nathalie/0000-0002-9995-6699; Mograbi, Baharia/0000-0002-1025-3429; BOURGET, Isabelle/0000-0001-6369-8176; Juhel, Thierry/0000-0002-2271-2952				Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bocciardi R, 1997, ONCOGENE, V15, P2257, DOI 10.1038/sj.onc.1201413; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; De Vita G, 2000, CANCER RES, V60, P3727; delPeso L, 1997, SCIENCE, V278, P687; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7886; Durbec PL, 1996, DEVELOPMENT, V122, P349; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Geneste O, 1999, HUM MOL GENET, V8, P1989, DOI 10.1093/hmg/8.11.1989; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Guan KL, 2000, J BIOL CHEM, V275, P27354; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Jarpe MB, 1998, ONCOGENE, V17, P1475, DOI 10.1038/sj.onc.1202183; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Kokaia Z, 1999, EUR J NEUROSCI, V11, P1202, DOI 10.1046/j.1460-9568.1999.00513.x; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Muller G, 1998, EMBO J, V17, P732, DOI 10.1093/emboj/17.3.732; Navarro P, 1998, EXP CELL RES, V243, P213, DOI 10.1006/excr.1998.4168; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pong K, 1998, J NEUROCHEM, V71, P1912; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sawada H, 2000, J NEUROCHEM, V74, P1175; SchmidAntomarchi H, 1996, EUR J IMMUNOL, V26, P717, DOI 10.1002/eji.1830260331; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; Shichiri M, 1998, MOL ENDOCRINOL, V12, P172, DOI 10.1210/me.12.2.172; Soler RM, 1999, J NEUROSCI, V19, P9160; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; vanWeering DHJ, 1997, J BIOL CHEM, V272, P249; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yu T, 1998, J NEUROSCI, V18, P4684; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	80	76	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45307	45319		10.1074/jbc.M101220200	http://dx.doi.org/10.1074/jbc.M101220200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11535584	hybrid			2022-12-27	WOS:000172406700126
J	Allen, DL; Sartorius, CA; Sycuro, LK; Leinwand, LA				Allen, DL; Sartorius, CA; Sycuro, LK; Leinwand, LA			Different pathways regulate expression of the skeletal myosin heavy chain genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBER-TYPE; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; PROMOTER ELEMENTS; BINDING-SITE; MUSCLE-CELLS; E-BOX; MOUSE; STIMULATION; DIVERSITY	Mammalian skeletal muscles are a mosaic of different fiber types largely defined by differential myosin heavy chain (MyHC) expression. Little is known about the molecular mechanisms regulating expression of the MyHC gene family members in different fiber types. In this work, we identified several cis- and trans-elements that regulate expression of the three adult fast MyHC genes. Despite multiple DNA-binding motifs for well characterized muscle transcription factors upstream of all three fast MyHC genes, expression of MyoD/Myf-5, calcineurin, or NFAT3 had different effects on the three promoters. MyoD or Myf-5 overexpression preferentially activated the M promoter, whereas NFAT or activated calcineurin overexpression preferentially activated the IIa promoter. Calcineurin had a 50-100-fold stimulatory effect on the IIa promoter, and the known downstream effectors of calcineurin (myocyte enhancer factor-2 and NFAT) cannot completely account for this activation. Finally, we identified two elements critical for regulating MyHC-IId/x expression: a 130-base pair enhancer element and a CArG-like element that inhibited IId/x promoter activity in vitro. Thus, we have found specific regulatory pathways that are distinct for the three adult fast MyHC genes. These elements are logical candidates for fiber-specific control of skeletal muscle gene expression in vivo.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Campus Box 347, Boulder, CO 80309 USA.			Sycuro, Laura/0000-0002-2011-6305; LEINWAND, LESLIE/0000-0003-1470-4810	NIAMS NIH HHS [F32AR08443] Funding Source: Medline; NIGMS NIH HHS [R01-GM29090] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AcakpoSatchivi LJR, 1997, J CELL BIOL, V139, P1219, DOI 10.1083/jcb.139.5.1219; BOUVAGNET PF, 1987, MOL CELL BIOL, V7, P4377, DOI 10.1128/MCB.7.12.4377; BUTLERBROWNE GS, 1984, DEV BIOL, V102, P324, DOI 10.1016/0012-1606(84)90197-0; BUTTRICK PM, 1992, CIRC RES, V70, P193, DOI 10.1161/01.RES.70.1.193; Calvo S, 1999, MOL CELL BIOL, V19, P515; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Diagana TT, 1997, J MOL BIOL, V265, P480, DOI 10.1006/jmbi.1996.0752; Esser K, 1999, J BIOL CHEM, V274, P12095, DOI 10.1074/jbc.274.17.12095; GULICK J, 1985, J BIOL CHEM, V260, P1413; GUNNING P, 1991, FASEB J, V5, P3064, DOI 10.1096/fasebj.5.15.1835946; GUSTAFSON TA, 1987, P NATL ACAD SCI USA, V84, P3122, DOI 10.1073/pnas.84.10.3122; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; Lakich MM, 1998, J BIOL CHEM, V273, P15217, DOI 10.1074/jbc.273.24.15217; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; MILLER JB, 1989, J BIOL CHEM, V264, P13122; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P19512; Nakayama M, 1996, MOL CELL BIOL, V16, P2408; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RINDT H, 1993, J BIOL CHEM, V268, P5332; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Swoap SJ, 1998, AM J PHYSIOL-CELL PH, V274, pC681, DOI 10.1152/ajpcell.1998.274.3.C681; TAKEDA S, 1995, J BIOL CHEM, V270, P15664, DOI 10.1074/jbc.270.26.15664; TAKEDA S, 1992, J BIOL CHEM, V267, P16957; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Talmadge Robert J., 1993, Current Opinion in Rheumatology, V5, P695; TAYLOR M, 1989, DEVELOPMENT, V106, P67; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; WALSH K, 1988, MOL CELL BIOL, V8, P1800, DOI 10.1128/MCB.8.4.1800; WASSENBERG DR, 1987, J BIOL CHEM, V262, P10741; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Wheeler MT, 1999, AM J PHYSIOL-CELL PH, V276, pC1069, DOI 10.1152/ajpcell.1999.276.5.C1069; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963	39	113	122	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43524	43533		10.1074/jbc.M108017200	http://dx.doi.org/10.1074/jbc.M108017200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551968	hybrid			2022-12-27	WOS:000172297700008
J	Siegmund, D; Hausser, A; Peters, N; Scheurich, P; Wajant, H				Siegmund, D; Hausser, A; Peters, N; Scheurich, P; Wajant, H			Tumor necrosis factor (TNF) and phorbol ester induce TNF-related apoptosis-inducing ligand (TRAIL) under critical involvement of NF-kappa B essential modulator (NEMO)/IKK gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-CELLS; FAS LIGAND; MEDIATED CYTOTOXICITY; DEATH PATHWAY; IN-VITRO; ACTIVATION; GENE; EXPRESSION; IMMATURE; CYTOKINE	We show that tumor necrosis factor (TNF) and phorbol 12-myristate 13-acetate (PMA) induce TNF-related apoptosis-inducing ligand (TRAIL) in T cells. In cells deficient for NF-kappaB essential modulator (NEMO)/IKK gamma, an essential component of the NF-kappaB-inducing I-kappaB kinase (IKK) complex, induction of TRAIL expression was completely abrogated but was recovered in cells restored for IKK gamma expression. In cells deficient for receptor-interacting protein expression TNF, but not PMA-induced TRAIL expression was blocked. Inhibition of protein synthesis with cycloheximide blocked PMA, but not TNF-induced up-regulation of TRAIL. As both TNF and PMA rapidly induce NF-kappaB activation this suggests that NEMO/IKK gamma -dependent activation of the NF-kappaB pathway is necessary but not sufficient for up-regulation of TRAIL in T cells. The capability of the NF-kappaB pathway to induce the potent death ligand TRAIL may explain the reported proapoptotic features of this typically antiapoptotic pathway.	Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	University of Stuttgart	Wajant, H (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.		Hausser, Angelika/AAC-4531-2021; Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949				ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Katsikis PD, 1997, J EXP MED, V186, P1365, DOI 10.1084/jem.186.8.1365; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LIPTON SA, 1997, NAT MED, P320; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Rivera-Walsh I, 2000, J BIOL CHEM, V275, P25222, DOI 10.1074/jbc.M000444200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Thomas WD, 1998, J IMMUNOL, V161, P2195; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Wajant H, 1999, CYTOKINE GROWTH F R, V10, P15, DOI 10.1016/S1359-6101(98)00023-9; Wang QD, 2000, BIOCHEM BIOPH RES CO, V276, P466, DOI 10.1006/bbrc.2000.3512; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	34	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43708	43712		10.1074/jbc.M106421200	http://dx.doi.org/10.1074/jbc.M106421200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557763	hybrid			2022-12-27	WOS:000172297700031
J	Hallgren, J; Spillmann, D; Pejler, G				Hallgren, J; Spillmann, D; Pejler, G			Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6 - Formation of active tryptase monomers in the presence of low molecular weight heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG TRYPTASE; SPONTANEOUS INACTIVATION; TETRAMER; ENZYME; PROTEOGLYCAN; INFLAMMATION; LACTOFERRIN; FIBRONECTIN; BASOPHILS; HISTAMINE	Mast cell tryptase is stored as an active tetramer in complex with heparin in mast cell secretory granules. Previously, we demonstrated the dependence on heparin for the activation/tetramer formation of a recombinant tryptase. Here we have investigated the structural requirements for this activation process. The ability of heparin-related saccharides to activate a recombinant murine tryptase, mouse mast cell protease-6 (mMCP-6), was strongly dependent on anionic charge density and size. The dose-response curve for heparin-induced mMCP-6 activation displayed a bell-shaped appearance, indicating that heparin acts by binding to more than one tryptase monomer simultaneously. The minimal heparin oligosaccharide required for binding to mMCP-6 was 8-10 saccharide units. Gel filtration analyses showed that such short oligosaccharides were unable to generate tryptase tetramers, but instead gave rise to active mMCP-6 monomers. The active monomers were inhibited by bovine pancreatic trypsin inhibitor, whereas the tetramers were resistant. Furthermore, monomeric (but not tetrameric) mMCP-6 degraded fibronectin. Our results suggest a model for tryptase tetramer formation that involves bridging of tryptase monomers by heparin or other highly sulfated polysaccharides of sufficient chain length. Moreover, our results raise the possibility that some of the reported activities of tryptase may be related to active tryptase monomers that may be formed according to the mechanism described here.	Swedish Univ Agr Sci, Ctr Biomed, Dept Vet Med Chem, S-75123 Uppsala, Sweden; Univ Uppsala, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Pejler, G (corresponding author), Swedish Univ Agr Sci, Ctr Biomed, Dept Vet Med Chem, POB 575, S-75123 Uppsala, Sweden.		Hallgren Martinsson, Jenny/AAZ-6356-2021; Hallgren Martinsson, Jenny/AAZ-5937-2021	Hallgren Martinsson, Jenny/0000-0002-3685-5364				Addington AK, 1996, BIOCHEMISTRY-US, V35, P13511, DOI 10.1021/bi960042t; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; Elrod KC, 1997, AM J RESP CRIT CARE, V156, P375, DOI 10.1164/ajrccm.156.2.9607012; Feyzi E, 1997, J BIOL CHEM, V272, P24850, DOI 10.1074/jbc.272.40.24850; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Hallgren J, 2001, BIOCHEMISTRY-US, V40, P7342, DOI 10.1021/bi001988c; He SH, 1997, J IMMUNOL, V159, P6216; He SH, 1997, EUR J PHARMACOL, V328, P89, DOI 10.1016/S0014-2999(97)83033-6; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1998, J CLIN IMMUNOL, V18, P169, DOI 10.1023/A:1020574820797; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; JORDAN RE, 1980, J BIOL CHEM, V255, P81; Kaminska R, 1999, J INVEST DERMATOL, V113, P567, DOI 10.1046/j.1523-1747.1999.00738.x; KIELTY CM, 1993, BIOCHEM BIOPH RES CO, V191, P1230, DOI 10.1006/bbrc.1993.1349; KJELLEN L, 1989, BIOCHEM J, V263, P105, DOI 10.1042/bj2630105; Kozik A, 1998, BBA-PROTEIN STRUCT M, V1385, P139, DOI 10.1016/S0167-4838(98)00053-3; Lindqvist C, 1999, SKANDINAVISTIK, V29, P1; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Molinari JF, 1996, AM J RESP CRIT CARE, V154, P649, DOI 10.1164/ajrccm.154.3.8810600; Pejler G, 1999, BIOCHEMISTRY-US, V38, P12187, DOI 10.1021/bi991046b; Pejler G, 1996, BIOCHEM J, V320, P897, DOI 10.1042/bj3200897; PEJLER G, 1988, J BIOL CHEM, V263, P5197; PEJLER G, 1994, BIOCHEM J, V299, P507, DOI 10.1042/bj2990507; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Sakai K, 1996, J CLIN INVEST, V97, P988, DOI 10.1172/JCI118523; SCHECHTER NM, 1995, BIOCHEMISTRY-US, V34, P10628, DOI 10.1021/bi00033a038; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Sommerhoff CP, 1999, P NATL ACAD SCI USA, V96, P10984, DOI 10.1073/pnas.96.20.10984; Sommerhoff CP, 2000, BBA-PROTEIN STRUCT M, V1477, P75, DOI 10.1016/S0167-4838(99)00265-4; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; STEVENS RL, 1989, IMMUNOL TODAY, V10, P381, DOI 10.1016/0167-5699(89)90272-7; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0	37	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42774	42781		10.1074/jbc.M105531200	http://dx.doi.org/10.1074/jbc.M105531200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11533057	hybrid			2022-12-27	WOS:000172169300020
J	Kennedy, EP				Kennedy, EP			Hitler's gift and the era of biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kennedy, EP (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.							Bernhard K, 1940, J BIOL CHEM, V133, P707; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; BLOCH K, 1987, ANNU REV BIOCHEM, V56, P1; CLARKE HT, 1958, ANNU REV BIOCHEM, V27, P1, DOI 10.1146/annurev.bi.27.070158.000245; Hevesy G, 1923, BIOCHEM J, V17, P439, DOI 10.1042/bj0170439; HEVESY G, 1948, COLD SPRING HARB SYM, V13, P129, DOI 10.1101/SQB.1948.013.01.020; Kohler R. E., 1977, HIST STUD PHYS BIOL, V8, P257, DOI DOI 10.2307/27757372; LANGDON RG, 1952, J BIOL CHEM, V200, P129; Lewis G N, 1934, Science, V79, P151, DOI 10.1126/science.79.2042.151; LIPMANN F, 1946, J BIOL CHEM, V162, P743; LIPMANN F, 1947, J BIOL CHEM, V167, P869; LIPMANN F, 1945, J BIOL CHEM, V160, P173; Lipmann F, 1941, ADV ENZYMOL REL S BI, V1, P99, DOI 10.1002/9780470122464.ch4; LIPMANN F, 1953, ANNU REV BIOCHEM, V54, P1; LIPMANN F, 1971, WANDERINGS BIOCH; LIPMANN F, 1939, NATURE, V144, P33; LYNEN F, 1951, ANGEW CHEM-GER EDIT, V63, P47, DOI 10.1002/ange.19510630207; Medawar J. S., 2001, HITLERS GIFT; PALMER W, 1966, NOBEL LECT CHEM 1922, P333; Rittenberg D, 1937, J BIOL CHEM, V121, P235; Robinson R., 1934, J SOC CHEM IND LOND, V53, P1062; Schoenheimer R, 1939, J BIOL CHEM, V127, P333; Schoenheimer R, 1935, Science, V82, P156, DOI 10.1126/science.82.2120.156; Schoenheimer R, 1949, DYNAMIC STATE BODY C; Sondenhoff R, 1937, LIEBIGS ANN CHEM, V530, P195; TAVORMINA PA, 1956, J AM CHEM SOC, V78, P4498, DOI 10.1021/ja01598a089; TCHEN TT, 1956, J AM CHEM SOC, V78, P1516, DOI 10.1021/ja01588a072; WARBURG O, 1949, WASSERSTOFFUEBERTRAG; WINDAUS HO, 1996, NOBEL LECT CHEM 1922, P105; WOLF DE, 1956, J AM CHEM SOC, V78, P4499, DOI 10.1021/ja01598a090; Young VR, 1999, P NUTR SOC, V58, P15, DOI 10.1079/PNS19990004	31	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42619	42631		10.1074/jbc.R100051200	http://dx.doi.org/10.1074/jbc.R100051200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11559714	hybrid			2022-12-27	WOS:000172169300001
J	Matsuda, T; Yamamoto, T; Muraguchi, A; Saatcioglu, F				Matsuda, T; Yamamoto, T; Muraguchi, A; Saatcioglu, F			Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESANGIAL CELLS; TRANSCRIPTIONAL ACTIVATION; SEX-HORMONES; ER-BETA; MATRIX; GENE; GROWTH-FACTOR-BETA-1; IDENTIFICATION; ONCOPROTEIN	Transforming growth factor-beta (TGF-beta) plays central roles in embryonic development, organogenesis, and physiologic connective tissue remodeling during wound healing and tissue repair as well as in carcinogenesis. Estrogens have key roles in a variety of biological events, such as the development and maintenance of female reproductive organs and bone and lipid metabolism. Previous studies demonstrated that estrogens suppress TGF-beta -induced gene expression, such as type IV collagen in kidney mesangial cells. However, the molecular mechanisms that mediate this antagonistic effect are unknown. To elucidate the mechanisms of cross-talk between TGF-beta and estrogen receptor (ER) signaling pathways, we reconstituted TGF-beta and ER signaling in human kidney carcinoma cells. Here we demonstrate that TGF-beta -induced activation of Sma and MAD-related protein 3 (Smad3) activity, one of the major intracellular transducers of TGF-beta signaling, was suppressed by ER, whereas ER-mediated transcriptional activation was enhanced by TGF-beta signaling. We provide evidence that this two-way cross-talk between the estrogen and TGF-beta signaling pathways was the result of direct physical interactions between Smad3 and ER. These findings have implications for a variety of disease states, such as the pathophysiology of kidney function, atherosclerosis, and breast cancer.	Toyama Med & Pharmaceut Univ, Fac Med, Dept Immunol, Toyama 9300194, Japan; Univ Oslo, Biotechnol Ctr Oslo, N-0349 Oslo, Norway	University of Toyama; University of Oslo	Saatcioglu, F (corresponding author), Toyama Med & Pharmaceut Univ, Fac Med, Dept Immunol, 2630 Sugitani, Toyama 9300194, Japan.		Matsuda, Tadashi/A-3835-2012	Matsuda, Tadashi/0000-0002-3089-3757				Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; BECK LS, 1993, J CLIN INVEST, V92, P2841, DOI 10.1172/JCI116904; Benson JR, 1996, BRIT J CANCER, V74, P993, DOI 10.1038/bjc.1996.475; Bitzer M, 2000, GENE DEV, V14, P187; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BRUIJN JA, 1994, J LAB CLIN MED, V123, P34; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; HANSCH GM, 1995, J CELL PHYSIOL, V163, P451, DOI 10.1002/jcp.1041630304; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayes SA, 2001, CANCER RES, V61, P2112; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kwan G, 1996, KIDNEY INT, V50, P1173, DOI 10.1038/ki.1996.425; LEI J, 1998, AM J PHYSIOL, V274, P252; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuda T, 2000, FEBS LETT, V472, P235, DOI 10.1016/S0014-5793(00)01444-7; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NEUGARTEN J, 1995, AM J KIDNEY DIS, V26, P147, DOI 10.1016/0272-6386(95)90168-X; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PIERCE GF, 1989, P NATL ACAD SCI USA, V86, P2229, DOI 10.1073/pnas.86.7.2229; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; SILBIGER S, 1998, AM J PHYSIOL, V274, P1113; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; SUKOVICH DA, 1994, MOL CELL BIOL, V14, P7134, DOI 10.1128/MCB.14.11.7134; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; SUZUKI S, 1993, EXP NEPHROL, V1, P229; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317	49	198	206	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42908	42914		10.1074/jbc.M105316200	http://dx.doi.org/10.1074/jbc.M105316200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555647	hybrid			2022-12-27	WOS:000172169300038
J	Wiltfang, J; Esselmann, H; Cupers, P; Neumann, M; Kretzschmar, H; Beyermann, M; Schleuder, D; Jahn, H; Ruther, E; Kornhuber, J; Annaert, W; De Strooper, B; Saftig, P				Wiltfang, J; Esselmann, H; Cupers, P; Neumann, M; Kretzschmar, H; Beyermann, M; Schleuder, D; Jahn, H; Ruther, E; Kornhuber, J; Annaert, W; De Strooper, B; Saftig, P			Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; NECROSIS-FACTOR-ALPHA; PRECURSOR PROTEIN; A-BETA; CEREBROSPINAL-FLUID; ELECTROPHORETIC SEPARATION; AMINOPEPTIDASE ACTIVITY; BRAIN PARENCHYMA; CLEAVAGE; PRESENILIN-1	Urea-based beta -amyloid (A beta) SDS-polyacrylamide gel electrophoresis and immunoblots were used to analyze the generation of A beta peptides in conditioned medium from primary mouse neurons and a neuroglioma cell line, as well as in human cerebrospinal fluid. A comparable and highly conserved pattern of A beta peptides, namely, 1-40/42 and carboxyl-terminal-truncated 1-37, 1-38, and 1-39, was found. Besides A beta1-42, we also observed a consistent elevation of amino-terminal-truncated A beta2-42 in a detergent-soluble pool in brains of subjects with Alzheimer's disease. A beta2-42 was also specifically elevated in cerebrospinal fluid samples of Alzheimer's disease patients. To decipher the contribution of potential different gamma -secretases (presenilins (PSs)) in generating the amino-terminal- and carboxyl-terminal-truncated A beta peptides, we overexpressed. beta -amyloid precursor protein (APP)-trafficking mutants in PS1+/+ and PS1-/- neurons. As compared with APP-WT (primary neurons from control or PS1-deficient mice infected with Semliki Forest virus), PS1-/- neurons and PS1+/+ neurons overexpressing APP-Delta ct (a slow-internalizing mutant) show a decrease of all secreted A beta peptide species, as expected, because this mutant is processed mainly by alpha -secretase. This drop is even more pronounced for the APP-KK construct (APP mutant carrying an endoplasmic reticulum retention motif). Surprisingly, A beta2-42 is significantly less affected in PS1-/- neurons and in neurons transfected with the endocytosis-deficient APP-Delta ct construct. Our data confirm that PS1 is closely involved in the production of A beta1-40/42 and the carboxyl-terminal-truncated A beta1-37, A beta1-38, and A beta1-39, but the amino-terminal-truncated and carboxyl-terminal-elongated A beta2-42 seems to be less affected by PS1 deficiency. Moreover, our results indicate that the latter A beta peptide species could be generated by a beta (Asp/Ala)-secretase activity.	Univ Gottingen, Dept Psychiat Mol Neurobiol, D-37073 Gottingen, Germany; Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; Catholic Univ Louvain, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, Neuronal Cell Biol Grp, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Munich, Inst Neuropathol, D-81377 Munich, Germany; Res Inst Mol Pharmacol, D-13125 Berlin, Germany; Univ Munster, Inst Med Phys & Biophys, D-48129 Munster, Germany; Univ Hamburg, Dept Psychiat, D-20246 Hamburg, Germany; Univ Erlangen Nurnberg, Dept Psychiat, D-91054 Erlangen, Germany	University of Gottingen; University of Gottingen; Universite Catholique Louvain; University of Munich; University of Munster; University of Hamburg; University of Erlangen Nuremberg	Wiltfang, J (corresponding author), Univ Gottingen, Dept Psychiat Mol Neurobiol, D-37073 Gottingen, Germany.	jwiltfa@gwdg.de	Kornhuber, Johannes/B-9613-2014; Jahn, Holger/A-9255-2008; Saftig, Paul/A-7966-2010; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Neumann, Manuela/F-6558-2011; Cruz e Silva, Odete/AAH-5595-2020; , eruether@msn.com/K-2369-2019	Kornhuber, Johannes/0000-0002-8096-3987; Jahn, Holger/0000-0003-3607-7651; De Strooper, Bart/0000-0001-5455-5819; Neumann, Manuela/0000-0002-6232-4057; Wiltfang, Jens/0000-0003-1492-5330				Alliot F, 1999, J NEUROSCI RES, V58, P367; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Association, 1994, DIAGN STAT MAN MENT, P139; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cescato R, 2000, J NEUROCHEM, V74, P1131; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; COOPER PN, 1995, ARCH NEUROL-CHICAGO, V52, P1011, DOI 10.1001/archneur.1995.00540340103019; Crawford F, 1997, Ann N Y Acad Sci, V826, P461, DOI 10.1111/j.1749-6632.1997.tb48504.x; Crawford F, 1997, ANN NY ACAD SCI, V826, P35, DOI 10.1111/j.1749-6632.1997.tb48459.x; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; DESTROOPER B, 1995, J BIOL CHEM, V270, P4058, DOI 10.1074/jbc.270.8.4058; Fujiwara H, 1999, ENDOCR J, V46, P11, DOI 10.1507/endocrj.46.11; Geddes JW, 1999, NEUROBIOL AGING, V20, P75; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ikezu T, 1998, J BIOL CHEM, V273, P10485, DOI 10.1074/jbc.273.17.10485; Iribar MC, 1998, DEMENT GERIATR COGN, V9, P44, DOI 10.1159/000017021; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e; Jellinger KA, 1998, BRAIN PATHOL, V8, P367; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kouchi Z, 1998, EUR J BIOCHEM, V258, P291, DOI 10.1046/j.1432-1327.1998.2580291.x; Kuda T, 1997, BIOCHEM BIOPH RES CO, V231, P526, DOI 10.1006/bbrc.1996.5920; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Larner AJ, 1999, NEUROBIOL AGING, V20, P65; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Orpiszewski J, 1999, J MOL BIOL, V289, P413, DOI 10.1006/jmbi.1999.2768; Paik SR, 1998, FEBS LETT, V421, P73, DOI 10.1016/S0014-5793(97)01537-8; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Schleuder D, 1999, ANAL CHEM, V71, P3238, DOI 10.1021/ac9810720; SchraderFischer G, 1997, J NEUROCHEM, V68, P1571; Selkoe DJ, 2000, P NATL ACAD SCI USA, V97, P5690, DOI 10.1073/pnas.97.11.5690; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Szendrei GI, 1996, INT J PEPT PROT RES, V47, P289; Tamaoka A, 1997, J NEUROL SCI, V148, P41, DOI 10.1016/S0022-510X(96)00314-0; URMONEIT B, 1995, J MOL NEUROSCI, V6, P23, DOI 10.1007/BF02736756; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; WILTFANG J, 1991, ELECTROPHORESIS, V12, P352, DOI 10.1002/elps.1150120507; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamazaki T, 1997, BIOCHEMISTRY-US, V36, P8377, DOI 10.1021/bi970209y; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	88	110	116	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42645	42657		10.1074/jbc.M102790200	http://dx.doi.org/10.1074/jbc.M102790200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11526104	hybrid			2022-12-27	WOS:000172169300004
J	de Vet, ECJM; Aguado, B; Campbell, RD				de Vet, ECJM; Aguado, B; Campbell, RD			G6b, a novel immunoglobulin superfamily member encoded in the human major histocompatibility complex, interacts with SHP-1 and SHP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; CLASS-III REGION; PROTEIN-TYROSINE PHOSPHATASE; INHIBITORY RECEPTOR; MOLECULAR-CLONING; NK CELLS; IDENTIFICATION; SUBSTRATE; DOMAINS; RECOGNITION	The G6b gene, located in the class III region of the human major histocompatibility complex, has been suggested to encode a putative receptor of the immunoglobulin superfamily. Genomic sequence information was used as a starting point to clone the corresponding cDNA. Reverse transcriptase polymerase chain reaction showed that expression of the gene is restricted to certain hematopoietic cell lines including K562, Molt 4, and Jurkat. Several splice variants were detected, varying only in their C-terminal parts. One of the potential membrane-bound isoforms contained two immunoreceptor tyrosine-based inhibitory motifs in its cytoplasmic tail. Four of the isoforms were expressed as epitope-tagged proteins in the cell lines K562 and COS-7. The two splice isoforms lacking the hydrophobic transmembrane segment were secreted from the cell. Glycosidase treatment of the four recombinant proteins provided evidence for N- and O-glycosylation. Immunofluorescence studies indicated that the spliced isoforms having a transmembrane segment were directed to the cell membrane. The G6b isoform containing two immunoreceptor tyrosine-based inhibitory motifs in its cytoplasmic tail was found to be phosphorylated on tyrosine residues after pervanadate treatment of cells and, subsequently, interacts with the SH2-containing protein-tyrosine phosphatases SHP-1 and SHP-2. Mutagenesis studies showed that phosphorylation of tyrosine 211 is critical for the interaction of G6b with SHP-1 and SHP-2.	MRC UK HGMP Resource Ctr, Cambridge CB10 1SB, England		Campbell, RD (corresponding author), MRC UK HGMP Resource Ctr, Hinxton, Cambridge CB10 1SB, England.	rcampbel@hgmp.mrc.ac.uk	Aguado, Begoña/R-4496-2019	Aguado, Begona/0000-0003-4043-6944				Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Aguado B, 1999, BIOCHEM J, V341, P679, DOI 10.1042/0264-6021:3410679; AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Binstadt BA, 1998, J BIOL CHEM, V273, P27518, DOI 10.1074/jbc.273.42.27518; Brown MA, 1998, ARTHRITIS RHEUM, V41, P588, DOI 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Milner CM, 1997, J BIOL CHEM, V272, P4549, DOI 10.1074/jbc.272.7.4549; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Ribas G, 1999, J IMMUNOL, V163, P278; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; Schatzle JD, 1999, P NATL ACAD SCI USA, V96, P3870, DOI 10.1073/pnas.96.7.3870; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SIMMONS D, 1988, J IMMUNOL, V141, P2797; Stepp SE, 1999, EUR J IMMUNOL, V29, P2392, DOI 10.1002/(SICI)1521-4141(199908)29:08<2392::AID-IMMU2392>3.3.CO;2-I; Streuli M, 1996, CURR OPIN CELL BIOL, V8, P182, DOI 10.1016/S0955-0674(96)80064-0; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; Taylor L S, 2000, Rev Immunogenet, V2, P204; Todd JA, 1997, PATHOL BIOL, V45, P219; Valiante NM, 1996, J EXP MED, V184, P2243, DOI 10.1084/jem.184.6.2243; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xu MJ, 2000, J BIOL CHEM, V275, P17440, DOI 10.1074/jbc.M001313200; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhao RX, 2000, J BIOL CHEM, V275, P5453, DOI 10.1074/jbc.275.8.5453	36	37	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42070	42076		10.1074/jbc.M103214200	http://dx.doi.org/10.1074/jbc.M103214200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11544253	hybrid			2022-12-27	WOS:000172450400072
J	Hellyer, NJ; Kim, MS; Koland, JG				Hellyer, NJ; Kim, MS; Koland, JG			Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; EPIDERMAL GROWTH-FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; ERBB SIGNALING NETWORK; BREAST-CANCER CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; INSULIN-RECEPTOR; REGULATORY SUBUNIT; SH2 DOMAINS; BINDING	The ErbB2/ErbB3 heregulin co-receptor has been shown to couple to phosphoinositide (PI) 3-kinase in a heregulin-dependent manner. The recruitment and activation of PI 3-kinase by this co-receptor is presumed to occur via its interaction with phosphorylated Tyr-Xaa-Xaa-Met (YXXM) motifs occurring in the ErbB3 C terminus. In this study, mutant ErbB3 receptor proteins expressed in COS7 cells were used to investigate PI 3-kinase-dependent signaling pathways activated by the ErbB2/ErbB3 co-receptor. We observed that a mutant ErbB3 protein with each of its six YXXM motifs containing a Tyr --> Phe substitution was unable to bind either the p85 regulatory or p110 catalytic subunit of PI 3-kinase. However, restoration of a single YXXM motif was sufficient to mediate association with the PI 3-kinase holoenzyme, although at a lower level han wild-type ErbB3. When ErbB3 YXXM motifs were restored in pairs, evidence for cooperativity between two, those incorporating Tyr-1273 and Tyr-1286, was observed. Interestingly, we have shown that an apparent association of PI 3-kinase activity with ErbB2/Neu was due to the residual presence of ErbB3 in ErbB2 immunoprecipitates. The necessity of ErbB3 association with PI 3-kinase for downstream signaling to the effector kinase Akt was also investigated. Here, the heregulin-dependent translocation of Akt to the plasma membrane and its subsequent activation was observed in intact NIH-3T3 fibroblasts. Recruitment of PI 3-kinase to ErbB3 was required for both activities, and it appeared that ErbB2 activation alone was not sufficient to activate PI 3-kinase signaling in these cells.	Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; Chosun Univ, Coll Dent, Dept Pharmacol, Kwangju 501759, South Korea	University of Iowa; Chosun University	Koland, JG (corresponding author), Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA.	john-koland@uiowa.edu		Koland, John/0000-0002-5028-4297; HELLYER, NATHAN/0000-0002-2359-9082	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295, R01DK044684, R29DK044684] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25295, DK44684] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alimandi M, 1997, EMBO J, V16, P5608, DOI 10.1093/emboj/16.18.5608; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; HELLYER NJ, 1995, GENE, V165, P279, DOI 10.1016/0378-1119(95)00436-A; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Juang SH, 1996, ONCOGENE, V12, P1033; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KIM HH, 1994, J BIOL CHEM, V269, P24747; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Liu W, 1999, BIOCHEM BIOPH RES CO, V261, P897, DOI 10.1006/bbrc.1999.1144; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; PELES E, 1992, J BIOL CHEM, V267, P12266; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Ram TG, 1996, CELL GROWTH DIFFER, V7, P551; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; SeppLorenzino L, 1996, ONCOGENE, V12, P1679; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Vijapurkar U, 1998, J BIOL CHEM, V273, P20996, DOI 10.1074/jbc.273.33.20996; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; WHITE MF, 1991, METHOD ENZYMOL, V201, P65; YAMAGUCHI T, 1995, BIOCHEMISTRY-US, V34, P4962, DOI 10.1021/bi00015a007; Yenush L, 1996, MOL CELL BIOL, V16, P2509; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	60	126	133	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42153	42161		10.1074/jbc.M102079200	http://dx.doi.org/10.1074/jbc.M102079200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546794	hybrid			2022-12-27	WOS:000172450400083
J	Lamberti, C; Lin, KM; Yamamoto, Y; Verma, U; Verma, IM; Byers, S; Gaynor, RB				Lamberti, C; Lin, KM; Yamamoto, Y; Verma, U; Verma, IM; Byers, S; Gaynor, RB			Regulation of beta-catenin function by the I kappa B kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTION FACTOR LEF-1; IKK-BETA; XENOPUS EMBRYOS; NEGATIVE REGULATION; LIVER DEGENERATION; COLON-CARCINOMA; MICE LACKING; CYCLIN D1; ACTIVATION	Both the beta -catenin and the nuclear factor kappaB (NF-kappaB) proteins are important regulators of gene expression and cellular proliferation. Two kinases, IKK alpha and IKK beta, are critical activators of the NF-kappaB pathway. Here we present evidence that these kinases are also important in the regulation of beta -catenin function. IKK alpha- and IKK beta -eficient mouse embryo fibroblasts exhibited different patterns of beta -catenin cellular localization. IKK beta decreases beta -catenin-dependent transcriptional activation, while IKK alpha increases beta -catenin-dependent transcriptional activity. IKK alpha and IKK beta interact with and phosphorylate beta -catenin using both in vitro and in vivo assays. Our results suggest that differential interactions of beta -catenin with IKK alpha and IKK beta may in part be responsible for regulating beta -catenin protein levels and cellular localization and integrating signaling events between the NF-kappaB and Wingless pathways.	Univ Texas, SW Med Ctr, Dept Med, Div Hematol Oncol,Harold Simmons Canc Ctr, Dallas, TX 75390 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Georgetown Univ, Sch Med, Lombardi Canc Ctr, Dept Cell Biol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20007 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Salk Institute; Georgetown University; Georgetown University	Gaynor, RB (corresponding author), Univ Texas, SW Med Ctr, Dept Med, Div Hematol Oncol,Harold Simmons Canc Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NCI NIH HHS [CA 74128] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074128] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwak YT, 2000, J BIOL CHEM, V275, P14752, DOI 10.1074/jbc.M001039200; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Li J, 1998, J BIOL CHEM, V273, P30736, DOI 10.1074/jbc.273.46.30736; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li XH, 1999, J BIOL CHEM, V274, P34417, DOI 10.1074/jbc.274.48.34417; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Polakis P, 2000, GENE DEV, V14, P1837; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	61	110	115	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42276	42286		10.1074/jbc.M104227200	http://dx.doi.org/10.1074/jbc.M104227200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527961	hybrid			2022-12-27	WOS:000172450400098
J	Jacquenet, S; Mereau, A; Bilodeau, PS; Damier, L; Stoltzfus, CM; Branlan, C				Jacquenet, S; Mereau, A; Bilodeau, PS; Damier, L; Stoltzfus, CM; Branlan, C			A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; BRANCH SITE SELECTION; U2 SNRNP; IN-VIVO; POLYPYRIMIDINE TRACT; REGULATORY ELEMENTS; KAPOSIS-SARCOMA; TRANSGENIC MICE; FACTOR U2AF(35); GROWTH-FACTOR	An equilibrium between spliced and unspliced primary transcripts is essential for retrovirus multiplication. This equilibrium is maintained by the presence of inefficient splice sites. The A3 3'-splice site of human immunodeficiency virus type I (HIV-1) is required for Tat mRNA production. The infrequent utilization of this splice site has been attributed to the presence of a suboptimal polypyrimidine tract and an exonic splicing silencer (ESS2) in tat exon 2 similar to 60 nucleotides downstream of 3'-splice site A3. Here, using site-directed mutagenesis followed by analysis of splicing in vitro and in HeLa cells, we show that the 5' extremity of tat exon 2 contains a second exonic splicing silencer (ESS2p), which acts to repress splice site A3. The inhibitory property of this exonic silencer was active when inserted downstream of another HIV-1 3'-splice site (A2). Protein hnRNP H binds to this inhibitory element, and two U-to-C substitutions within the ESS2p element cause a decreased hnRNP H affinity with a concomitant increase in splicing efficiency at 3'-splice site A3. This suggests that hnRNP H is directly involved in splicing inhibition. We propose that hnRNP H binds to the HIV-1 ESS2p element and competes with U2AF(35) for binding to the exon sequence flanking 3'-splice site A3. This binding results in the inhibition of splicing at 3'-splice site A3.	Univ Nancy 1, CNRS, Unite Mixte Rech 7567, Lab Maturat Acide Ribo Nucleotid & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Iowa	Branlan, C (corresponding author), Univ Nancy 1, CNRS, Unite Mixte Rech 7567, Lab Maturat Acide Ribo Nucleotid & Enzymol Mol, Blvd Aiguillettes,BP239, F-54506 Vandoeuvre Les Nancy, France.	christiane.branlant@maem.uhpnancy.fr		MEREAU, AGNES/0000-0002-5603-757X; Branlant, Christiane/0000-0003-4728-5499				AMENDT BA, 1994, MOL CELL BIOL, V14, P3960, DOI 10.1128/MCB.14.6.3960; AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Chabot B, 1997, MOL CELL BIOL, V17, P1776, DOI 10.1128/MCB.17.4.1776; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chou MY, 1999, MOL CELL BIOL, V19, P69; Damier L, 1997, BIOCHEM BIOPH RES CO, V237, P182, DOI 10.1006/bbrc.1997.7091; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DelGatto F, 1996, NUCLEIC ACIDS RES, V24, P2017, DOI 10.1093/nar/24.11.2017; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; DYHRMIKKELSEN H, 1995, J BIOL CHEM, V270, P24060, DOI 10.1074/jbc.270.41.24060; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fogel BL, 2000, J BIOL CHEM, V275, P32371, DOI 10.1074/jbc.M005000200; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; Guth S, 1999, MOL CELL BIOL, V19, P8263; Jacquenet S, 2001, NUCLEIC ACIDS RES, V29, P464, DOI 10.1093/nar/29.2.464; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; KUIKEN CL, 1999, HUMAN RETROVIRUSES A; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LOTZ M, 1994, J CELL BIOL, V124, P365, DOI 10.1083/jcb.124.3.365; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NOUR M, 1995, CURR MICROBIOL, V31, P270, DOI 10.1007/BF00314579; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Selvakumar M, 1999, RNA, V5, P378, DOI 10.1017/S1355838299981050; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; Si ZH, 1998, MOL CELL BIOL, V18, P5404, DOI 10.1128/MCB.18.9.5404; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Stark JM, 1998, P NATL ACAD SCI USA, V95, P2163, DOI 10.1073/pnas.95.5.2163; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VOGEL J, 1991, CANCER RES, V51, P6686; VOGEL J, 1988, NATURE, V335, P606, DOI 10.1038/335606a0; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088	66	102	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40464	40475		10.1074/jbc.M104070200	http://dx.doi.org/10.1074/jbc.M104070200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526107	hybrid			2022-12-27	WOS:000171925600016
J	Riddle, TM; Kuhel, DG; Woollett, LA; Fichtenbaum, CJ; Hui, DY				Riddle, TM; Kuhel, DG; Woollett, LA; Fichtenbaum, CJ; Hui, DY			HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; INSULIN-RESISTANCE; PREADIPOCYTE DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; PERIPHERAL LIPODYSTROPHY; CHOLESTEROL-SYNTHESIS; DIABETES-MELLITUS; GENE-EXPRESSION; HYPERLIPIDEMIA; TRANSCRIPTION	The mechanism by which human immunodeficiency virus (HIV) protease inhibitor therapy adversely induces lipodystrophy and hyperlipidemia has not been defined. This study explored the mechanism associated with the adverse effects of the prototype protease inhibitor ritonavir in mice. Ritonavir treatment increased plasma triglyceride and cholesterol levels through increased fatty acid and cholesterol biosynthesis in adipose and liver. Ritonavir treatment also resulted in hepatic steatosis and hepatomegaly. These abnormalities, which were especially pronounced after feeding a Western type high fat diet, were due to ritonavir-induced accumulation of the activated forms of sterol regulatory binding protein (SREBP)-1 and -2 in the nucleus of liver and adipose, resulting in elevated expression of lipid metabolism genes. Interestingly, protease inhibitor treatment did not alter SREBP mRNA levels in these tissues. Thus, the adverse lipid abnormalities associated with protease inhibitor therapy are caused by the constitutive induction of lipid biosynthesis in liver and adipose tissues due to the accumulation of activated SREBP in the nucleus.	Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	huidy@Email.uc.edu		Fichtenbaum, Carl/0000-0002-6778-7253	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065915] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL65915] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andre P, 1998, P NATL ACAD SCI USA, V95, P13120, DOI 10.1073/pnas.95.22.13120; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Dowell P, 2000, J BIOL CHEM, V275, P41325, DOI 10.1074/jbc.M006474200; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Echevarria KL, 1999, ANN PHARMACOTHER, V33, P859, DOI 10.1345/aph.18174; Ericsson J, 1998, J BIOL CHEM, V273, P17865, DOI 10.1074/jbc.273.28.17865; Fatkenheuer G, 1999, AIDS, V13, P1485, DOI 10.1097/00002030-199908200-00007; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; GOULD RG, 1953, J BIOL CHEM, V201, P519; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUANG Y, 1994, BBA-LIPID LIPID MET, V1214, P317; Jackson SM, 1998, J LIPID RES, V39, P767; Kempf DJ, 1998, J MED CHEM, V41, P602, DOI 10.1021/jm970636+; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; KISSEL JA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P227, DOI 10.1016/0005-2760(89)90201-4; Korn BS, 1998, J CLIN INVEST, V102, P2050, DOI 10.1172/JCI5341; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Nguyen AT, 2000, AIDS, V14, P2467, DOI 10.1097/00002030-200011100-00007; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; OSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760; Periard D, 1999, CIRCULATION, V100, P700, DOI 10.1161/01.CIR.100.7.700; Roth VR, 1998, CLIN INFECT DIS, V27, P65, DOI 10.1086/514639; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SATO R, 1994, J BIOL CHEM, V269, P17267; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; SoRelle R, 1998, CIRCULATION, V98, P829, DOI 10.1161/01.CIR.98.9.829; Sullivan AK, 1997, AIDS, V11, P938; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VANSTEENBERGEN W, 1995, INT J OBESITY, V19, pS27; Vittecoq D, 1998, LANCET, V351, P1959, DOI 10.1016/S0140-6736(05)78644-X; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wentworth JM, 2000, J ENDOCRINOL, V164, pR7, DOI 10.1677/joe.0.164R007; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Zhang B, 1999, J CLIN ENDOCR METAB, V84, P4274, DOI 10.1210/jc.84.11.4274	52	156	160	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2001	276	40					37514	37519		10.1074/jbc.M104557200	http://dx.doi.org/10.1074/jbc.M104557200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478YD	11546771	hybrid			2022-12-27	WOS:000171375700086
J	Docagne, F; Colloc'h, N; Bougueret, V; Page, M; Paput, J; Tripier, M; Dutartre, P; MacKenzie, ET; Buisson, A; Komesli, S; Vivien, D				Docagne, F; Colloc'h, N; Bougueret, V; Page, M; Paput, J; Tripier, M; Dutartre, P; MacKenzie, ET; Buisson, A; Komesli, S; Vivien, D			A soluble transforming growth factor-beta (TGF-beta) type I receptor mimics TGF-beta responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRANSGENIC MICE; INFLAMMATORY RESPONSE; EXTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; HALF-LIFE; GENE; BINDING; FACTOR-BETA-1; EXPRESSION	Transforming growth factor-beta (TGF-beta) signaling requires a ligand-dependent interaction of TGF-beta receptors T betaR-I and T betaR-II. It has been previously demonstrated that a soluble TGF-beta type II receptor could be used as a TGF-beta antagonist. Here we have generated and investigated the biochemical and signaling properties of a soluble TGF-beta type I receptor (T beta RIs-Fc). As reported for the wild-type receptor, the soluble T betaR-I does not bind TGF-beta1 on its own. Surprisingly, in the absence of TGF-beta1, the T beta RIs-Fc mimicked TGF-beta1-induced transcriptional and growth responses in mink lung epithelial cells (Mv1Lu). Signaling induced by the soluble TGF-beta type I receptor is mediated via the obligatory presence of both TGF-beta type I and type II receptors at the cell surface since no signal was observed in Mv1Lu-derivated mutants for TGF-beta receptors R-1B and DR-26. The comparison between the structures of TGF-betas and a three-dimensional model of the extracellular domain of T beta RI has shown that five residues of the supposed binding site of TGF-beta1 (Lys(31), His(34), Glu(5), Tyr(91), and Lys(94)) were found with equivalent biochemical properties and similar spatial positions.	Univ Caen, CNRS, UMR 6551, Ctr CYCERON, F-14074 Caen, France; Lab Fournier SA, F-21121 Daix, France	Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie	Vivien, D (corresponding author), Univ Caen, CNRS, UMR 6551, Ctr CYCERON, IFR 47,Bd H Becquerel,BP 5229, F-14074 Caen, France.		Colloc'h, Nathalie/L-1570-2015; Docagne, Fabian/S-8308-2018; buisson, alain/AAI-8218-2020; Mackenzie, Eric Thomson/L-1938-2015	buisson, alain/0000-0002-4281-7911; MacKenzie, Eric T/0000-0003-1057-7033; Docagne, Fabian/0000-0003-1745-0625; VIVIEN, DENIS/0000-0002-7636-2185				Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Burmester JK, 1998, GROWTH FACTORS, V15, P231, DOI 10.3109/08977199809002119; Clark JG, 2000, TRANSPLANTATION, V70, P39; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EVERAERDT B, 1994, J IMMUNOL, V152, P5041; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Jensen RL, 1998, SURG NEUROL, V49, P189, DOI 10.1016/S0090-3019(97)00218-8; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JOKIRANTA TS, 1995, FEBS LETT, V376, P31, DOI 10.1016/0014-5793(95)01239-7; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Komesli S, 1998, EUR J BIOCHEM, V254, P505, DOI 10.1046/j.1432-1327.1998.2540505.x; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Labesse G, 1998, BIOINFORMATICS, V14, P206, DOI 10.1093/bioinformatics/14.2.206; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Letterio JJ, 1996, J LEUKOCYTE BIOL, V59, P769, DOI 10.1002/jlb.59.6.769; LIN F, 1996, NATURE, V381, P620; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Peters M, 1996, J EXP MED, V183, P1399, DOI 10.1084/jem.183.4.1399; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Qian SW, 1996, J BIOL CHEM, V271, P30656, DOI 10.1074/jbc.271.48.30656; Qian SW, 1999, GROWTH FACTORS, V17, P63, DOI 10.3109/08977199909001063; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHIHAB FS, 1995, J AM SOC NEPHROL, V6, P286; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SIGOUNAS G, 1994, J CLIN IMMUNOL, V14, P134, DOI 10.1007/BF01541346; Sime PJ, 1997, CHEST, V111, pS137, DOI 10.1378/chest.111.6_Supplement.137S; VIVIEN D, 1995, EXP CELL RES, V221, P60, DOI 10.1006/excr.1995.1352; Vivien D, 1998, J NEUROCHEM, V70, P2296; Wang D, 2000, CANCER RES, V60, P4507; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yang HK, 1999, ONCOGENE, V18, P2213, DOI 10.1038/sj.onc.1202535	52	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46243	46250		10.1074/jbc.M010915200	http://dx.doi.org/10.1074/jbc.M010915200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11544249	hybrid			2022-12-27	WOS:000172573100103
J	Maeda, S; Akanuma, M; Mitsuno, Y; Hirata, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M				Maeda, S; Akanuma, M; Mitsuno, Y; Hirata, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M			Distinct mechanism of helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAG PATHOGENICITY ISLAND; EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; BACTERIAL LIPOPOLYSACCHARIDE; INTERLEUKIN-8 EXPRESSION; VIRULENCE FACTORS; KINASE CASCADES; IV SECRETION; C-JUN; INFECTION	NF-kappaB is a critical regulator of genes involved in inflammation. Gastric epithelial cells and macrophages are considered the main sources of pro-inflammatory cytokines. We investigated NF-kappaB activation by Helicobacter pylori in MKN45 gastric epithelial cells and THP-1 monocytic cells. Although, cag pathogenicity island (PAI)-positive H. pylori (wild type) activated NF-kappaB in both cells, isogenic mutant of cagE (Delta cagE) activated it only in THP-1 cells. Supernatant from the wild type culture could activate NF-kappaB in THP-1 cells but not in MKN45 cells. High density cDNA array analysis revealed that mRNA expression of NF-kappaB-regulated genes such as interleukin (IL)-8, tumor necrosis factor-alpha (TNF alpha), and IL-1 beta was significantly up-regulated by the wild type in both cells, whereas it was up-regulated by Delta cagE only in THP-1 cells. Experiments using CD14-neutralizing antibody and IL-1 receptor-associated kinase (IRAK) assay showed that both wild type and Delta cagE H. pylori activated NF-kappaB through CD14 and IRAK in THP-1 cells but not in MKN45 cells. Macrophages from C3H/HeJ mice carrying point mutation in the Toll-like receptor 4 (TLR4) gene showed decreased NF-kappaB activation and TNFa secretion compared with C3H/HeN mouse macrophage when treated with H. pylori. In conclusion, H. pylori-induced NF-kappaB activation in epithelial cells is dependent on cag PAI and contact but does not involve CD14 and IRAK, whereas in macrophage/monocytic cells it is independent of cag PAI or contact but involves CD14 and TLR4.	Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo	Maeda, S (corresponding author), Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.							Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BEAUERLE PA, 1996, CELL, V87, P13; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; COVACCI A, 1993, MOL MICROBIOL, V8, P429, DOI 10.1111/j.1365-2958.1993.tb01587.x; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; Crabtree JE, 1996, ALIMENT PHARM THER, V10, P29, DOI 10.1046/j.1365-2036.1996.22164003.x; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; Goto T, 2000, J BIOL CHEM, V275, P37311, DOI 10.1074/jbc.M002947200; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ikenoue T, 2001, CLIN DIAGN LAB IMMUN, V8, P181, DOI 10.1128/CDLI.8.1.181-186.2001; Jenks PJ, 1998, GUT, V43, P752, DOI 10.1136/gut.43.6.752; Karin M, 1998, CANCER J SCI AM, V4, pS92; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Maeda S, 1999, GUT, V44, P336, DOI 10.1136/gut.44.3.336; Maeda S, 2001, BIOCHEM BIOPH RES CO, V284, P443, DOI 10.1006/bbrc.2001.5006; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Medvedev AE, 1998, J IMMUNOL, V160, P4535; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 1998, DIGEST DIS SCI, V43, P2738, DOI 10.1023/A:1026671815512; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 1995, LAB INVEST, V73, P760; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Sharma SA, 1998, J IMMUNOL, V160, P2401; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; ZUPAN JR, 1995, PLANT PHYSIOL, V107, P1041, DOI 10.1104/pp.107.4.1041	52	167	175	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44856	44864		10.1074/jbc.M105381200	http://dx.doi.org/10.1074/jbc.M105381200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11546774	hybrid			2022-12-27	WOS:000172406700071
J	Nishitani, H; Taraviras, S; Lygerou, Z; Nishimoto, T				Nishitani, H; Taraviras, S; Lygerou, Z; Nishimoto, T			The human licensing factor for DNA replication Cdt1 accumulates in G(1) and is destabilized after initiation of S-phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; CELL-CYCLE; FISSION YEAST; MCM PROTEINS; BUDDING YEAST; CHROMATIN ASSOCIATION; CDK PHOSPHORYLATION; NUCLEAR EXPORT; MAMMALIAN CDC6; MITOSIS	S-phase onset is controlled, so that it occurs only once every cell cycle. DNA is licensed for replication after mitosis in Gl, and passage through S-phase removes the license to replicate. In fission yeast, Cdc6/18 and Cdt1, two factors required for licensing, are central to ensuring that replication occurs once per cell cycle. We show that the human Cdt1 homologue (hCdt1), a nuclear protein, is present only during G(1). After S-phase onset, hCdt1 levels decrease, and it is hardly detected in cells in early S-phase or G(2). hCdt1 can associate with the DNA replication inhibitor Geminin, however these two proteins are mostly expressed at different cell cycle stages. hCdt1 mRNA, in contrast to hCdt1 protein, is expressed in S-phase-arrested cells, and its levels do not change dramatically during a cell cycle, suggesting that proteolytic rather than transcriptional controls ensure the timely accumulation of hCdt1. Consistent with this view, proteasome inhibitors stabilize hCdt1 in S-phase. In contrast, hCdc6/18 levels are constant through most of the cell cycle and are only low for a brief period at the end of mitosis. These results suggest that the presence of active hCdt1 may be crucial for determining when licensing is legitimate in human cells.	Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; Univ Patras, Sch Med, GR-26110 Patras, Greece	Kyushu University; University of Patras	Nishitani, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	hideonc@molbiol.med.kyushu-u.ac.jp	Taraviras, Stavros/AAJ-4690-2020	Taraviras, Stavros/0000-0002-7455-647X; Nishitani, Hideo/0000-0001-5907-9380				Adams PD, 1996, MOL CELL BIOL, V16, P6623; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Baum B, 1998, EMBO J, V17, P5689, DOI 10.1093/emboj/17.19.5689; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2000, NATURE, V404, P560, DOI 10.1038/35007187; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Coverley D, 2000, J CELL SCI, V113, P1929; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Johnston L H, 2000, Prog Cell Cycle Res, V4, P61; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lygerou Z, 1999, J CELL SCI, V112, P3703; Lygerou Z, 2000, COLD SPRING HARB SYM, V65, P323, DOI 10.1101/sqb.2000.65.323; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MuziFalconi M, 1996, P NATL ACAD SCI USA, V93, P1566, DOI 10.1073/pnas.93.4.1566; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Pelizon C, 2000, GENE DEV, V14, P2526, DOI 10.1101/gad.176300; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; USUI T, 1991, J CELL BIOL, V115, P1275, DOI 10.1083/jcb.115.5.1275; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Whittaker AJ, 2000, GENE DEV, V14, P1765; Williams RS, 1997, P NATL ACAD SCI USA, V94, P142, DOI 10.1073/pnas.94.1.142; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wuarin J, 1996, CELL, V85, P785, DOI 10.1016/S0092-8674(00)81261-1; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	61	215	216	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44905	44911		10.1074/jbc.M105406200	http://dx.doi.org/10.1074/jbc.M105406200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11555648	hybrid			2022-12-27	WOS:000172406700077
J	Golfman, LS; Bakovic, M; Vance, DE				Golfman, LS; Bakovic, M; Vance, DE			Transcription of the CTP : phosphocholine cytidylyltransferase alpha gene is enhanced during the S phase of the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; RAT-LIVER; PHOSPHORYLCHOLINE CYTIDYLYLTRANSFERASE; PROTEIN; IDENTIFICATION; PHOSPHATIDYLETHANOLAMINE; METABOLISM; EXPRESSION; REQUIREMENT	We have studied the transcription of the CTP:phosphocholine cytidylyltransferase alpha (CT alpha) gene in C3H10T1/2 fibroblasts as a function of the cell cycle. The cells were incubated for 48 h with 0.5% fetal bovine serum. The cells were induced into the Gi phase of the cell cycle by the addition of medium with 10% fetal bovine serum. The cells began the synthesis of DNA after 12 h. At 16 and 20 h there was an increased amount of CT alpha mRNA that coincided with an increase in the expression of CTa proximal promoter-luciferase constructs (-201/+38 and -130/+38). Luciferase constructs with the basal promoter (-52/+38) showed no change in activity during the cell cycle. Incorporation of [H-3]choline into phosphatidylcholine began to increase by 8 h after the addition of serum and peaked at 18 h. The mass of phosphatidylcholine nearly doubled between 8 and 26 h after addition of serum. CT activity increased by 6 h after serum addition and was maintained until 22 h. Thus, the increase of phosphatidylcholine biosynthesis in the G(1) phase of the cell cycle is not due to enhanced transcription of the CT alpha gene. Instead increased transcription of the CT alpha gene occurred during the S phase of the cell cycle in preparation for mitosis.	Univ Alberta, Dept Biochem, Heritage Med Res Ctr 328, Edmonton, AB T6H 5S3, Canada; Univ Alberta, CIHR, Grp Mol & Cell Biol Lipids, Edmonton, AB T6H 5S3, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Heritage Med Res Ctr 328, Edmonton, AB T6H 5S3, Canada.	dennis.vance@ualberta.ca						Agellon LB, 1999, HEPATOLOGY, V30, P725, DOI 10.1002/hep.510300305; Bakovic M, 1999, BBA-MOL CELL BIOL L, V1438, P147, DOI 10.1016/S1388-1981(99)00042-6; Bakovic M, 2000, J LIPID RES, V41, P583; CORNELL R, 1977, EXP CELL RES, V109, P299, DOI 10.1016/0014-4827(77)90009-X; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Cui Z, 1997, BBA-LIPID LIPID MET, V1346, P10, DOI 10.1016/S0005-2760(97)00012-X; DeLong CJ, 2000, J BIOL CHEM, V275, P32325, DOI 10.1074/jbc.M004644200; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; ESKO JD, 1981, J BIOL CHEM, V256, P7388; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FELDMAN DA, 1987, J BIOL CHEM, V262, P9075; GROSS G, 1988, BIOCHIM BIOPHYS ACTA, V962, P220, DOI 10.1016/0005-2760(88)90163-4; HABENICHT AJR, 1985, J BIOL CHEM, V260, P1370; Hogan M, 1996, BIOCHEM J, V314, P799, DOI 10.1042/bj3140799; HOUWELING M, 1991, BIOCHEM J, V278, P347, DOI 10.1042/bj2780347; HOUWELING M, 1993, EUR J BIOCHEM, V214, P927, DOI 10.1111/j.1432-1033.1993.tb17996.x; HOUWELING M, 1997, BIOCHIM BIOPHYS ACTA, V1546, P7; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; Kast HR, 2001, J LIPID RES, V42, P1266; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Lagace TK, 2000, J BIOL CHEM, V275, P14367, DOI 10.1074/jbc.275.19.14367; LYDIDIS A, 1998, J BIOL CHEM, V273, P14022; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Ryan AJ, 2000, J LIPID RES, V41, P1268; Sesca E, 1996, BIOCHEM BIOPH RES CO, V229, P158, DOI 10.1006/bbrc.1996.1773; SLEIGHT R, 1980, J BIOL CHEM, V255, P644; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sugimoto H, 2001, J BIOL CHEM, V276, P12338, DOI 10.1074/jbc.M100090200; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; TERCE F, 1994, J LIPID RES, V35, P2130; TESSNER TG, 1991, J BIOL CHEM, V266, P16261; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; VANCE DE, 1984, TRENDS BIOCHEM SCI, V9, P17, DOI 10.1016/0968-0004(84)90041-0; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P33; VANCE JE, 1985, CAN J BIOCHEM CELL B, V63, P870, DOI 10.1139/o85-108; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; WARDEN CH, 1985, J BIOL CHEM, V260, P6006; WARDEN CH, 1984, BIOCHIM BIOPHYS ACTA, V792, P270, DOI 10.1016/0005-2760(84)90194-2; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; Yang JL, 1997, BIOCHEM J, V325, P29, DOI 10.1042/bj3250029	48	42	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43688	43692		10.1074/jbc.M108170200	http://dx.doi.org/10.1074/jbc.M108170200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557772	hybrid			2022-12-27	WOS:000172297700028
J	Zwaal, RR; Van Baelen, K; Groenen, JTM; van Geel, A; Rottiers, V; Kaletta, T; Dode, L; Raeymaekers, L; Wuytack, F; Bogaert, T				Zwaal, RR; Van Baelen, K; Groenen, JTM; van Geel, A; Rottiers, V; Kaletta, T; Dode, L; Raeymaekers, L; Wuytack, F; Bogaert, T			The sarco-endoplasmic reticulum Ca2+ ATPase is required for development and muscle function in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-VENTRICULAR FUNCTION; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; TUMOR PROMOTER; C-ELEGANS; GENE; PHOSPHOLAMBAN; CA2+-ATPASE; OVEREXPRESSION; THAPSIGARGIN	The sarco-endoplasmic reticulum Ca2+-transport ATPase (SERCA) loads intracellular releasable Ca2+ stores by transporting cytosolic Ca2+ into the endoplasmic (ER) or sarcoplasmic reticulum (SR). We characterized the only SERCA homologue of the nematode Caenorhabditis elegans, which is encoded by the sca-1 gene. The sca-1 transcript is alternatively spliced in a similar mode as the vertebrate SERCA2 transcript, giving rise to two protein variants: CeSERCAa and CeSERCAb. These proteins showed structural and functional conservation to the vertebrate SERCA2a/b proteins. The CeSERCAs were primarily expressed in contractile tissues. Loss of CeSERCA through gene ablation or RNA interference resulted in contractile dysfunctioning and in early larval or embryonic lethality, respectively. Similar defects could be induced pharmacologically using the SERCA-specific inhibitor thapsigargin, which bound CeSERCA at a conserved site. The conservation of SERCA2 homologues in C. elegans will allow genetic and chemical suppressor analyses to identify promising drug targets and lead molecules for treatment of SERCA-related diseases such as heart disease.	Devgen NV, B-9052 Zwijnaarde, Belgium; Katholieke Univ Leuven, Dept Mol Celbiol, Fysiol Lab, B-3000 Louvain, Belgium	KU Leuven	Zwaal, RR (corresponding author), Devgen NV, Technol Pk 9, B-9052 Zwijnaarde, Belgium.	richard.zwaal@devgen.com	Kaletta, Titus/F-5361-2012					Baker DL, 1998, CIRC RES, V83, P1205, DOI 10.1161/01.RES.83.12.1205; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cho JH, 2000, GENE, V261, P211, DOI 10.1016/S0378-1119(00)00536-9; CHRISTENSEN SB, 1992, J CANCER RES CLIN, V118, P344, DOI 10.1007/BF01294438; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Dode L, 1998, J BIOL CHEM, V273, P13982, DOI 10.1074/jbc.273.22.13982; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; HOIT BD, 1995, CIRC RES, V77, P632, DOI 10.1161/01.RES.77.3.632; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Maryon EB, 1998, J CELL SCI, V111, P2885; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Moller JV, 1997, J BIOL CHEM, V272, P29015, DOI 10.1074/jbc.272.46.29015; Myers CD, 1996, J CELL BIOL, V132, P1061, DOI 10.1083/jcb.132.6.1061; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Sakube Y, 1997, J MOL BIOL, V267, P849, DOI 10.1006/jmbi.1997.0910; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; WUYTACK F, 1998, ADV MOL CEL A&B, V23, P205; Yu MH, 1999, ARCH BIOCHEM BIOPHYS, V362, P225, DOI 10.1006/abbi.1998.1049	35	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43557	43563		10.1074/jbc.M104693200	http://dx.doi.org/10.1074/jbc.M104693200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559701	hybrid			2022-12-27	WOS:000172297700012
J	Kopriva, S; Buchert, T; Fritz, G; Suter, M; Weber, M; Benda, R; Schaller, J; Feller, U; Schurmann, P; Schunemann, V; Trautwein, AX; Kroneck, PMH; Brunold, C				Kopriva, S; Buchert, T; Fritz, G; Suter, M; Weber, M; Benda, R; Schaller, J; Feller, U; Schurmann, P; Schunemann, V; Trautwein, AX; Kroneck, PMH; Brunold, C			Plant adenosine 5 '-phospho sulfate reductase is a novel iron-sulfur protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAEROBIC RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; 5'-ADENYLYLSULFATE REDUCTASE; APS-SULFOTRANSFERASE; PAPS-REDUCTASE; MOFE PROTEIN; MOSSBAUER; ASSIMILATION; CLUSTERS; NITROGENASE	Adenosine 5'-phosphosulfate reductase (APR) catalyzes the two-electron reduction of adenosine 5'-phosphosulfate to sulfite and AMP, which represents the key step of sulfate assimilation in higher plants. Recombinant APRs from both Lemna minor and Arabidopsis thaliana were overexpressed in Escherichia coli and isolated as yellow-brown proteins. UV-visible spectra of these recombinant proteins indicated the presence of iron-sulfur centers, whereas flavin was absent. This result was confirmed by quantitative analysis of iron and acid-labile sulfide, suggesting a [4Fe-4S] cluster as the cofactor. EPR spectroscopy of freshly purified enzyme showed, however, only a minor signal at g = 2.01. Therefore, Mossbauer spectra of Fe-57-enriched APR were obtained at 4.2 K in magnetic fields of up to 7 tesla, which were assigned to a diamagnetic [4Fe-4S](2+) cluster. This cluster was unusual because only three of the iron sites exhibited the same Mossbauer parameters. The fourth iron site gave, because of the bistability of the fit, a significantly smaller isomer shift or larger quadrupole splitting than the other three sites. Thus, plant assimilatory APR represents a novel type of adenosine 5'-phosphosulfate reductase with a [4Fe-4S] center as the sole cofactor, which is clearly different from the dissimilatory adenosine 5'-phosphosulfate reductases found in sulfate reducing bacteria.	Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Univ Constance, Fachbereich Biol, D-78457 Constance, Germany; Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; Med Univ Lubeck, Inst Phys, D-23538 Lubeck, Germany; Univ Bern, Dept Chem, CH-3013 Bern, Switzerland; Univ Neuchatel, Biochim Lab, CH-2000 Neuchatel, Switzerland	University of Bern; University of Konstanz; University of Zurich; University of Lubeck; University of Bern; University of Neuchatel	Kopriva, S (corresponding author), Inst Tree Physiol, Georges Kohler Allee 053, D-79085 Freiburg, Germany.		Feller, Urs/A-1807-2008; Fritz, Guenter/E-2933-2013; Kopriva, Stanislav/C-7401-2013; Schünemann, Volker/C-6603-2016	Feller, Urs/0000-0001-7858-5721; Fritz, Guenter/0000-0002-4571-8812; Kopriva, Stanislav/0000-0002-7416-6551; 				Bates DM, 2000, J BIOL CHEM, V275, P6234, DOI 10.1074/jbc.275.9.6234; Bick JA, 1998, P NATL ACAD SCI USA, V95, P8404, DOI 10.1073/pnas.95.14.8404; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNOLD C, 1990, SULFUR NUTRITION AND SULFUR ASSIMILATION IN HIGHER PLANTS, P13; BRUNOLD C, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P61; Brunold C., 1990, METHODS PLANT BIOCH, P339; Buchanan BB, 1971, METHOD ENZYMOL, V23, P413, DOI [10.1016/S0076-6879(71)23115-3, DOI 10.1016/S0076-6879(71)23115-3]; CAMMACK R, 1992, ADV INORG CHEM, V38, P281, DOI 10.1016/S0898-8838(08)60066-5; Coropceanu V, 2000, CHEM PHYS LETT, V323, P14, DOI 10.1016/S0009-2614(00)00502-9; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Fritz G, 2000, FEBS LETT, V473, P63, DOI 10.1016/S0014-5793(00)01500-3; GutierrezMarcos JF, 1996, P NATL ACAD SCI USA, V93, P13377, DOI 10.1073/pnas.93.23.13377; Hawkesford MJ, 2000, ADV BOT RES, V33, P159, DOI 10.1016/S0065-2296(00)33043-9; HOLM RH, 1990, PROG INORG CHEM, V38, P2; HUYNH BH, 1980, BIOCHIM BIOPHYS ACTA, V623, P124, DOI 10.1016/0005-2795(80)90015-X; JONESMOR.MC, 1968, BIOCHEM J, V110, P589, DOI 10.1042/bj1100589; KRAHN E, 2001, IN PRESS J BIOL INOR; Krebs C, 2000, J AM CHEM SOC, V122, P12497, DOI 10.1021/ja003335p; KREDICH NM, 1971, J BIOL CHEM, V246, P3474; KRONE FA, 1991, MOL GEN GENET, V225, P314, DOI 10.1007/BF00269864; Leustek T, 1999, PLANT PHYSIOL, V120, P637, DOI 10.1104/pp.120.3.637; LI JY, 1991, BIOCHEM J, V274, P355, DOI 10.1042/bj2740355; MACDONNELL FM, 1995, INORG CHEM, V34, P1815, DOI 10.1021/ic00111a032; Ollagnier S, 1999, J AM CHEM SOC, V121, P6344, DOI 10.1021/ja990073m; Prior A, 1999, BBA-PROTEIN STRUCT M, V1430, P25, DOI 10.1016/S0167-4838(98)00266-0; RAVI N, 1994, J BIOL CHEM, V269, P20920; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; SCHMIDT A, 1972, ARCH MIKROBIOL, V84, P77, DOI 10.1007/BF00408084; SCHMIDT A, 1975, PLANT SCI LETT, V5, P407, DOI 10.1016/0304-4211(75)90008-5; SCHWENN JD, 1989, Z NATURFORSCH C, V44, P504; Setya A, 1996, P NATL ACAD SCI USA, V93, P13383, DOI 10.1073/pnas.93.23.13383; STIEGER PA, 1994, PLANT SOIL, V166, P173, DOI 10.1007/BF00008330; Suter M, 2000, J BIOL CHEM, V275, P930, DOI 10.1074/jbc.275.2.930; Tamarit J, 2000, J BIOL CHEM, V275, P15669, DOI 10.1074/jbc.275.21.15669; TRAUTWEIN AX, 1991, STRUCT BOND, V78, P1; TSANG MLS, 1981, J BACTERIOL, V146, P1059, DOI 10.1128/JB.146.3.1059-1066.1981; VERHAGEN MFJM, 1994, EUR J BIOCHEM, V221, P831, DOI 10.1111/j.1432-1033.1994.tb18797.x; Weber M, 2000, EUR J BIOCHEM, V267, P3647, DOI 10.1046/j.1432-1327.2000.01394.x; Xia JQ, 1997, J AM CHEM SOC, V119, P8301, DOI 10.1021/ja971025+; Yoo SJ, 2000, J AM CHEM SOC, V122, P4926, DOI 10.1021/ja000254k	41	60	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42881	42886		10.1074/jbc.M107424200	http://dx.doi.org/10.1074/jbc.M107424200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553635	hybrid, Green Submitted			2022-12-27	WOS:000172169300034
J	Panagotopulos, SE; Horace, EM; Maiorano, JN; Davidson, WS				Panagotopulos, SE; Horace, EM; Maiorano, JN; Davidson, WS			Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER-1; MEMBRANE PENETRATION DEPTH; TANGIER-DISEASE; CHOLESTEROL TRANSPORT; INTERSTITIAL FLUID; APOA-I; FLUORESCENCE; MODEL; DEFICIENCY; MUTATIONS	Apolipoprotein A-I (apoA-I) is the major protein associated with high density lipoprotein (HDL), and its plasma levels have been correlated with protection against atherosclerosis. Unfortunately, the structural basis of this phenomenon is not fully understood. Over 25 years of study have produced two general models of apoA-I structure in discoidal HDL complexes. The "belt" model states that the amphipathic helices of apoA-I are aligned perpendicular to the acyl chains of the lipid bilayer, whereas the "picket fence" model argues that the helices are aligned parallel with the acyl chains. To distinguish between the two models, various single tryptophan mutants of apoA-I were analyzed in reconstituted, discoidal HDL particles composed of phospholipids containing nitroxide spin labels at various positions along the acyl chain. We have previously used this technique to show that the orientation of helix 4 of apoA-I is most consistent with the belt model. In this study, we performed additional control experiments on helix 4, and we extended the results by performing the same analysis on the remaining 22-mer helices (helices 1, 2,5,6,7,8, and 10) of human apoA-I. For each helix, two different mutants were produced that each contained a probe Trp occurring two helical turns apart. In the belt model, the two Trp residues in each helix should exhibit maximal quenching at the same nitroxide group position on the lipid acyl chains. For the picket fence model, maximal quenching should occur at two different levels in the bilayer. The results show that the majority of the helices are in an orientation that is consistent with a belt model, because most Trp residues localized to a position about 5 A from the center of the bilayer. This study corroborates a belt hypothesis for the majority of the helices of apoA-I in phospholipid discs.	Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Davidson, WS (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.			Davidson, William/0000-0003-2756-2989	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062542] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL62542] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; BAKER HN, 1975, J BIOL CHEM, V250, P2725; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; DAVIDSON WS, 1995, J BIOL CHEM, V270, P17106, DOI 10.1074/jbc.270.29.17106; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; GLOMSET JA, 1968, J LIPID RES, V9, P155; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Maiorano JN, 2000, J BIOL CHEM, V275, P17374, DOI 10.1074/jbc.M000044200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCLACHLAN AD, 1977, NATURE, V267, P465, DOI 10.1038/267465a0; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; ROHEIM PS, 1990, EUR HEART J, V11, P225, DOI 10.1093/eurheartj/11.suppl_E.225; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHAEFER EJ, 1994, J LIPID RES, V35, P871; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; WALD JH, 1990, J BIOL CHEM, V265, P20044; WONG L, 1992, J CLIN INVEST, V90, P2370, DOI 10.1172/JCI116127	36	68	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42965	42970		10.1074/jbc.M106462200	http://dx.doi.org/10.1074/jbc.M106462200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11557764	hybrid			2022-12-27	WOS:000172169300045
J	Bennett, SE; Sung, JS; Mosbaugh, DW				Bennett, SE; Sung, JS; Mosbaugh, DW			Fidelity of uracil-initiated base excision DNA repair in DNA polymerase beta-proficient and -deficient mouse embryonic fibroblast cell extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLASE INHIBITOR PROTEIN; PURIFIED HUMAN PROTEINS; NUCLEAR ANTIGEN; LIGASE-I; CRYSTAL-STRUCTURES; MAMMALIAN-CELLS; PCNA BINDING; SITE REPAIR; RAT-LIVER; UNG GENE	Uracil-initiated base excision DNA repair was conducted using homozygous mouse embryonic fibroblast DNA polymerase (+/+) and (-/-) cells to determine the error frequency and mutational specificity associated with the completed repair process. Form I DNA substrates were constructed with site-specific uracil residues at U-A, U-G, and U-T targets contained within the lacZ alpha gene of M13mp2 DNA. Efficient repair was observed in both DNA polymerase beta (+/+) and (-/-) cell free extracts. Repair was largely dependent on uracil-DNA glycosylase activity because addition of the PBS-2 uracil-DNA glycosylase inhibitor (Ugi) protein reduced (similar to 88%) the initial rate of repair in both types of cell-free extracts. In each case, the DNA repair patch size was primarily distributed between 1 and 8 nucleotides in length with 1 nucleotide repair patch constituting similar to 20% of the repair events. Addition of p21 peptide or protein to DNA polymerase beta (+/+) cell-free extracts increased the frequency of short-patch (1 nucleotide) repair by similar to2-fold. The base substitution reversion frequency associated with uracil-DNA repair of M13mp2op14 (U-T) DNA was determined to be 5.7-7.2 x 10(-4) when using DNA polymerase P (+/+) and (-/-) cell-free extracts. In these two cases, the error frequency was very similar, but the mutational spectrum was noticeably different. The presence or absence of Ugi did not dramatically influence either the error rate or mutational specificity. In contrast, the combination of Ugi and p21 protein promoted an increase in the mutation frequency associated with repair of M13mp2 (U-G) DNA. Examination of the mutational spectra generated by a forward mutation assay revealed that errors in DNA repair synthesis occurred predominantly at the position of the U-G target and frequently involved a 1-base deletion or incorporation of dTMP.	Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Oregon State Univ, Ctr Environm Hlth Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Mosbaugh, DW (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032823] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [GM32823] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; ARAVIND L, 2000, GENOME BIOL, V1; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Bellacosa A, 2001, J CELL PHYSIOL, V187, P137, DOI 10.1002/jcp.1064; BENNETT SE, 1993, J BIOL CHEM, V268, P26879; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Chen XL, 2000, J BIOL CHEM, V275, P17677, DOI 10.1074/jbc.M910278199; Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811; Dimitriadis EK, 1998, J BIOL CHEM, V273, P20540, DOI 10.1074/jbc.273.32.20540; DOMENA JD, 1985, BIOCHEMISTRY-US, V24, P7320, DOI 10.1021/bi00346a045; DOMENA JD, 1988, BIOCHEMISTRY-US, V27, P6742, DOI 10.1021/bi00418a015; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; INGRAHAM HA, 1986, BIOCHEMISTRY-US, V25, P3223; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; MOSBAUGH DW, 1983, J BIOL CHEM, V258, P108; MOSBAUGH DW, 1984, J BIOL CHEM, V259, P247; NEDDERMANN P, 1994, P NATL ACAD SCI USA, V91, P1642, DOI 10.1073/pnas.91.5.1642; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; OLSEN LC, 1989, EMBO J, V8, P3121, DOI 10.1002/j.1460-2075.1989.tb08464.x; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; Radany EH, 2000, MUTAT RES-DNA REPAIR, V461, P41, DOI 10.1016/S0921-8777(00)00040-9; Sanderson RJ, 1998, J BIOL CHEM, V273, P24822, DOI 10.1074/jbc.273.38.24822; Sanderson RJ, 2001, PROG NUCLEIC ACID RE, V68, P165; SANDERSON RJ, 1998, THESIS OREGON STATE; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Sung JS, 2001, J BIOL CHEM, V276, P2276, DOI 10.1074/jbc.M008147200; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154	70	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42588	42600		10.1074/jbc.M106212200	http://dx.doi.org/10.1074/jbc.M106212200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551933	hybrid			2022-12-27	WOS:000172450400135
J	Chew, LJ; Yuan, XQ; Scherer, SE; Qie, L; Huang, F; Hayes, WP; Gallo, V				Chew, LJ; Yuan, XQ; Scherer, SE; Qie, L; Huang, F; Hayes, WP; Gallo, V			Characterization of the rat GRIK5 kainate receptor subunit gene promoter and its intragenic regions involved in neural cell specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; SODIUM-CHANNEL GENE; GLUTAMATE-RECEPTOR; SYNAPTIC TRANSMISSION; REGULATORY ELEMENTS; MAMMALIAN-CELLS; AMPA RECEPTORS; GROWTH-FACTOR; ION CHANNELS; EXPRESSION	The GRIK5 (glutamate receptor ionotropic kainate-5) gene encodes the kainate-preferring glutamate receptor subunit KA2. The GRIK5 promoter is TATA-less and GC-rich, with multiple consensus initiator sequences. Transgenic mouse lines carrying 4 kilobases of the GRIK5 5'-flanking sequence showed lacZ reporter expression predominantly in the nervous system. Reporter assays in central glial (CG-4) and non-neural cells indicated that a 1200-base pair (bp) 5'-flanking region could sustain neural cell-specific promoter activity. Transcriptional activity was associated with the formation of a transcription factor IID-containing complex on an initiator sequence located 1100 bp upstream of the first intron. In transfection studies, deletion of exonic sequences downstream of the promoter resulted in reporter gene activity that was no longer neural cell-specific. When placed downstream of the GRIK5 promoter, a 77-bp sequence from the deleted fragment completely silenced reporter expression in NIH3T3 fibroblasts while attenuating activity in CG-4 cells. Analysis of the 77-bp sequence revealed a functional SP1-binding site and a sequence resembling a neuron-restrictive silencer element. The latter sequence, however, did not display cell-specific binding of REST-like proteins. Our studies thus provide evidence for intragenic control of GRIK5 promoter activity and suggest that elements contributing to tissue-specific expression are contained within the first exon.	NICHHD, Sect Mol & Cellular Neurobiol, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Catholic University of America	Gallo, V (corresponding author), NICHHD, Sect Mol & Cellular Neurobiol, Lab Cellular & Synapt Neurophysiol, NIH, Bldg 49,Rm 5A-78,49 Convent Dr, Bethesda, MD 20892 USA.							Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BAHN S, 1994, J NEUROSCI, V14, P5525; Bai G, 1998, J BIOL CHEM, V273, P1086, DOI 10.1074/jbc.273.2.1086; BETTLER B, 1990, NEURON, V5, P584; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Bischoff S, 1997, J COMP NEUROL, V379, P541, DOI 10.1002/(SICI)1096-9861(19970324)379:4<541::AID-CNE6>3.0.CO;2-2; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P471; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chew LJ, 1999, J BIOL CHEM, V274, P29366, DOI 10.1074/jbc.274.41.29366; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; Dingledine R, 1999, PHARMACOL REV, V51, P7; Discher DJ, 1998, J BIOL CHEM, V273, P26087, DOI 10.1074/jbc.273.40.26087; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Emami KH, 1998, NUCLEIC ACIDS RES, V26, P839, DOI 10.1093/nar/26.3.839; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; GALLO V, 1992, J NEUROSCI, V12, P1010; GALLO V, 1995, NEUROCHEM RES, V20, P549, DOI 10.1007/BF01694536; GALLO V, 1995, J NEUROSCI, V15, P394; HAYES WP, 1990, DEVELOPMENT, V110, P747; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang F, 1997, J BIOL CHEM, V272, P8618, DOI 10.1074/jbc.272.13.8618; Hyder SM, 2000, CANCER RES, V60, P3183; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KALLUNKI P, 1995, J BIOL CHEM, V270, P21291, DOI 10.1074/jbc.270.36.21291; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kim HS, 1998, J NEUROCHEM, V71, P41; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Myers SJ, 1998, J NEUROSCI, V18, P6723; Myers SJ, 1999, ANNU REV PHARMACOL, V39, P221, DOI 10.1146/annurev.pharmtox.39.1.221; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NIELSEN DA, 1983, P NATL ACAD SCI-BIOL, V80, P5198, DOI 10.1073/pnas.80.17.5198; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Sahara Y, 1997, J NEUROSCI, V17, P6611; SASNER M, 1998, SOC NEUR ABSTR, V24, P10863; Scherer SE, 1998, J NEUROSCI RES, V52, P356, DOI 10.1002/(SICI)1097-4547(19980501)52:3<356::AID-JNR12>3.0.CO;2-4; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shou YP, 1998, J BIOL CHEM, V273, P5716, DOI 10.1074/jbc.273.10.5716; SUCHANEK B, 1995, J BIOL CHEM, V270, P41, DOI 10.1074/jbc.270.1.41; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; SZPIRER C, 1994, P NATL ACAD SCI USA, V91, P11849, DOI 10.1073/pnas.91.25.11849; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332; WERNER P, 1991, NATURE, V351, P741; WISDEN W, 1993, J NEUROSCI, V13, P3582	66	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42162	42171		10.1074/jbc.M101895200	http://dx.doi.org/10.1074/jbc.M101895200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533047	hybrid			2022-12-27	WOS:000172450400084
J	Fung, H; Bennett, RAO; Demple, B				Fung, H; Bennett, RAO; Demple, B			Key role of a downstream specificity protein 1 site in cell cycle-regulated transcription of the AP endonuclease gene APE1/APEX in NIH3T3 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR ENZYME; HUMAN APURINIC ENDONUCLEASE; BASE EXCISION-REPAIR; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; APYRIMIDINIC ENDONUCLEASE; IONIZING-RADIATION; GROWTH-REGULATION; BINDING ACTIVITY; POLYMERASE-BETA; MAMMALIAN-CELLS	Abasic (apurinic/apyrimidinic or AP) sites are a frequent type of DNA damage that threatens genetic stability. The predominant mammalian enzyme initiating repair of AP sites is the Ape1 AP endonuclease (also called Apex or Hap1), which also facilitates DNA binding by several transcription factors (Ref1 activity). We found that expression of the APE1 gene was coordinated with the cell cycle in murine NIH3T3 cells: APE1 mRNA levels rose after the G(1)-S transition and peaked similar to4-fold higher in early to mid-S phase. The increased APE1 mRNA was the result of transcriptional activation rather than increased mRNA stability. Fusions of various APE1 promoter fragments to the chloramphenicol. acetyltransferase CAT reporter gene indicated that APE1 expression depends on two transcription factor Sp1 binding sites within the promoter region. Mutation of these sites or of two CCAAT elements within the APE1 promoter, in conjunction with protein binding studies, demonstrated their specific roles. The Sp1 site upstream of the transcription start, together with an adjacent CCAAT element, establishes a protein-DNA complex required for basal transcription of APE1. The Spl site downstream of the transcription start was required for the response to cell growth. Because Ape I is a dual function enzyme, its cell cycle-dependent expression might affect both DNA repair and the activity of various transcription factors as a function of the cell cycle.	Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Demple, B (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, 665 Huntington Ave,Bldg 1, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040000] Funding Source: NIH RePORTER; NIEHS NIH HHS [T32-ES07155] Funding Source: Medline; NIGMS NIH HHS [GM40000] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Banfalvi G, 1997, DNA CELL BIOL, V16, P1155, DOI 10.1089/dna.1997.16.1155; BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; Bouziane M, 2000, MUTAT RES-DNA REPAIR, V461, P15, DOI 10.1016/S0921-8777(00)00036-7; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fung H, 1998, CANCER RES, V58, P189; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; GENTIL A, 1992, J MOL BIOL, V227, P981, DOI 10.1016/0022-2836(92)90513-J; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; Grosch S, 1998, CANCER RES, V58, P4410; Harrison L, 1997, MUTAT RES-DNA REPAIR, V385, P159, DOI 10.1016/S0921-8777(97)00053-0; Harrison L, 1996, CARCINOGENESIS, V17, P377, DOI 10.1093/carcin/17.2.377; Haug T, 1998, NUCLEIC ACIDS RES, V26, P1449, DOI 10.1093/nar/26.6.1449; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Izumi T, 1996, BIOCHEMISTRY-US, V35, P14679, DOI 10.1021/bi961995u; Izumi T, 2000, CARCINOGENESIS, V21, P1329, DOI 10.1093/carcin/21.7.1329; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; LOMMEL L, 1995, MUTAT RES-DNA REPAIR, V336, P181, DOI 10.1016/0921-8777(94)00055-B; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Marquis JC, 1998, CANCER RES, V58, P3435; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; Nakamura J, 1999, CANCER RES, V59, P2522; Noe V, 1997, EUR J BIOCHEM, V249, P13, DOI 10.1111/j.1432-1033.1997.00013.x; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; ONO Y, 1994, MUTAT RES, V315, P55, DOI 10.1016/0921-8777(94)90028-0; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Robertson KA, 1997, CELL GROWTH DIFFER, V8, P443; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; SEKI S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P287, DOI 10.1016/0167-4781(92)90027-W; Sorensen P, 1999, J BIOL CHEM, V274, P30943, DOI 10.1074/jbc.274.43.30943; Strauss PR, 1998, J BIOL CHEM, V273, P14435, DOI 10.1074/jbc.273.23.14435; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wei SJ, 2000, CANCER RES, V60, P6688; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson DM, 1995, NUCLEIC ACIDS RES, V23, P5027; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; Xu Y, 1997, ANTICANCER RES, V17, P3713; Xu YJ, 1998, J BIOL CHEM, V273, P28837, DOI 10.1074/jbc.273.44.28837; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743	59	36	37	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42011	42017		10.1074/jbc.M106423200	http://dx.doi.org/10.1074/jbc.M106423200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11555653	hybrid			2022-12-27	WOS:000172450400064
J	Giedroc, DP; Chen, XH; Pennella, MA; LiWang, AC				Giedroc, DP; Chen, XH; Pennella, MA; LiWang, AC			Conformational heterogeneity in the C-terminal zinc fingers of human MTF-1 - An NMR and zinc-binding study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; METAL-RESPONSE ELEMENT; METALLOTHIONEIN GENE-EXPRESSION; SEQUENTIAL BACKBONE ASSIGNMENT; DNA-BINDING; METALLOREGULATORY PROTEIN; CHEMICAL-SHIFT; FUNCTIONAL-HETEROGENEITY; DEPENDENT STRUCTURE; ESCHERICHIA-COLI	The human metalloregulatory transcription factor, metal-response element (MRE)-binding transcription factor-1 (MTF-1), contains six TFIIIA-type Cys(2)-His(2) motifs, each of which was projected to form well-structured beta beta alpha domains upon Zn(II) binding. In this report, the structure and backbone dynamics of a fragment containing the unusual C-terminal fingers F4-F6 has been investigated. N-15 heteronuclear single quantum coherence (HSQC) spectra of uniformly N-15-labeled hMTF-zf46 show that Zn(ll) induces the folding of hMTF-zf46. Analysis of the secondary structure of Zn-3 hMTF-zf46 determined by C-13 alpha chemical shift indexing and the magnitude of (3)J(H alpha -HN) clearly reveal that zinc fingers F4 and F6 adopt typical beta beta alpha structures. An analysis of the heteronuclear backbone N-15 relaxation dynamics behavior is consistent with this picture and further reveals independent tumbling of the finger domains in solution. Titration of apo-MTF-zf46 with Zn(H) reveals that the F4 domain binds Zn(II) significantly more tightly than do the other two finger domains. In contrast to fingers F4 and F6, the beta beta alpha fold of finger F5 is unstable and only partially populated at substoichiometric Zn(II); a slight molar excess of zinc results in severe conformational exchange broadening of all F5 NH cross-peaks. Finally, although Cd(II) binds to apo-hMTF-zf46 as revealed by intense S---> Cd(II) absorption, a non-native structure results; addition of stoichiometric Zn(II) to the Cd(Il) complex results in quantitative refolding of the beta beta alpha structure in F4 and F6. The functional implications of these results are discussed.	Texas A&M Univ, Ctr Adv Biomol Res, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Giedroc, DP (corresponding author), Texas A&M Univ, Ctr Adv Biomol Res, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.	giedroc@tamu.edu	LiWang, Andy/AAE-5205-2020; Giedroc, David/A-8608-2018	LiWang, Andy/0000-0003-4741-6946; Giedroc, David/0000-0002-2342-1620	NIGMS NIH HHS [T32 GM08523, GM42569] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042569, R29GM042569, T32GM008523] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; APUY JL, 2001, IN PRESS BIOCHEMISTR, V40; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Busenlehner LS, 2001, BIOCHEMISTRY-US, V40, P4426, DOI 10.1021/bi010006g; Chen XH, 2000, J BIOL INORG CHEM, V5, P93, DOI 10.1007/s007750050012; Chen XH, 1999, BIOCHEMISTRY-US, V38, P12915, DOI 10.1021/bi9913000; Chen XH, 1998, BIOCHEMISTRY-US, V37, P11152, DOI 10.1021/bi980843r; Chu WA, 1999, J BIOL CHEM, V274, P5279, DOI 10.1074/jbc.274.9.5279; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; der Maur Adrian Auf, 1999, Biological Chemistry, V380, P175; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Gao Y, 1998, PROTEIN SCI, V7, P2265, DOI 10.1002/pro.5560071104; GLEDROC DP, 2001, ANTIAXID REDOX SIGNA, V3, P577; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Guo JQ, 1997, BIOCHEMISTRY-US, V36, P730, DOI 10.1021/bi9617769; HENEHAN CJ, 1993, PROTEIN SCI, V2, P1756, DOI 10.1002/pro.5560021019; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Koizumi S, 2000, J CELL PHYSIOL, V185, P464, DOI 10.1002/1097-4652(200012)185:3<464::AID-JCP18>3.0.CO;2-4; KRIZEK BA, 1991, J AM CHEM SOC, V113, P4518, DOI 10.1021/ja00012a021; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; Lichtlen P, 2001, NUCLEIC ACIDS RES, V29, P1514, DOI 10.1093/nar/29.7.1514; MAKOTO K, 1999, MICROBIOL IMMUNOL, V43, P115; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MICHAEL SF, 1992, P NATL ACAD SCI USA, V89, P4796, DOI 10.1073/pnas.89.11.4796; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Murphy BJ, 1999, CANCER RES, V59, P1315; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Parkin G, 2000, CHEM COMMUN, P1971, DOI 10.1039/b004816j; PARRAGA G, 1988, SCIENCE, V241, P1489, DOI 10.1126/science.3047872; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Razmiafshari M, 2001, TOXICOL APPL PHARM, V172, P1, DOI 10.1006/taap.2001.9132; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WANG AC, 1994, J MAGN RESON SER B, V105, P196, DOI 10.1006/jmrb.1994.1123; Wang AC, 1996, J AM CHEM SOC, V118, P2483, DOI 10.1021/ja9535524; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; ZHU G, 1990, J MAGN RESON, V90, P405, DOI 10.1016/0022-2364(90)90150-8	64	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42322	42332		10.1074/jbc.M106517200	http://dx.doi.org/10.1074/jbc.M106517200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11524427	hybrid			2022-12-27	WOS:000172450400103
J	Kumar, PG; Laloraya, M; Wang, CY; Ruan, QG; Davoodi-Semiromi, A; Kao, KJ; She, JX				Kumar, PG; Laloraya, M; Wang, CY; Ruan, QG; Davoodi-Semiromi, A; Kao, KJ; She, JX			The autoimmune regulator (AIRE) is a DNA-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; MUTATIONS; GENE; SPECIFICITY; DISEASE; DOMAIN; RULES	The autoimmune regulator (AIRE) protein is a putative transcription regulator with two plant homeodomain-type zinc fingers, a putative DNA-binding domain (SAND), and four nuclear receptor binding LXXLL motifs. We have shown here that in vitro, recombinant AIRE can form homodimers and homotetramers that were also detected in thymic protein extracts. Recombinant AIRE also oligomerizes spontaneously upon phosphorylation by CAMP dependent protein kinase A or protein kinase C. Similarly, thymic AIRE protein is phosphorylated at the tyrosine and serine/threonine residues. AIRE dimers and tetramers, but not the monomers, can bind to G-doublets with the ATTGGTTA motif and the TTATTA-box. Competition assays revealed that sequences with one TTATTA motif and two tandem repeats of ATTGGTTA had the highest binding affinity. These findings demonstrate that AIRE is an important DNA binding molecule involved in immune regulation.	Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Ctr Mammalian Genet, Gainesville, FL 32610 USA; Univ Florida, Diabet Ctr Excellence, Coll Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	She, JX (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Ctr Mammalian Genet, Box 100275, Gainesville, FL 32610 USA.	she@ufl.edu	Kumar, Pradeep/GQA-7930-2022; Kumar, Pradeep/Y-4242-2019	Kumar, Pradeep/0000-0001-7603-3579; Wang, Cong-Yi/0000-0001-7914-168X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI042288] Funding Source: NIH RePORTER; NIAID NIH HHS [1P01AI-42288] Funding Source: Medline; NICHD NIH HHS [1RO1HD37800] Funding Source: Medline; NIDDK NIH HHS [1R24DK58778] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Bjorses P, 1996, AM J HUM GENET, V59, P879; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; DESJARLAIS JR, 1992, PROTEINS, V12, P101, DOI 10.1002/prot.340120202; DESJARLAIS JR, 1994, P NATL ACAD SCI USA, V91, P11099, DOI 10.1073/pnas.91.23.11099; DESJARLAIS JR, 1993, P NATL ACAD SCI USA, V90, P2256, DOI 10.1073/pnas.90.6.2256; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Heino M, 1999, HUM MUTAT, V13, P69, DOI 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Ishii T, 2000, J CLIN ENDOCR METAB, V85, P2922, DOI 10.1210/jc.85.8.2922; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891	23	119	122	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41357	41364		10.1074/jbc.M104898200	http://dx.doi.org/10.1074/jbc.M104898200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533054	hybrid			2022-12-27	WOS:000171925600130
J	Li, YK; Chin, LS; Weigel, C; Li, L				Li, YK; Chin, LS; Weigel, C; Li, L			Spring, a novel RING finger protein that regulates synaptic vesicle exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; SNARE COMPLEX; NERVE-TERMINALS; KINASE-C; SYNTAXIN; DOCKING; DOMAINS; SNAP-25; PHOSPHORYLATION	The synaptosome-associated protein of 25 kDa (SNAP-25) interacts with syntaxin 1 and vesicle-associated membrane protein 2 (VAMP2) to form a ternary soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor (SNARE) complex that is essential for synaptic vesicle exocytosis. We report a novel RING finger protein, Spring, that specifically interacts with SNAP-25. Spring is exclusively expressed in brain and is concentrated at synapses. The association of Spring with SNAP-25 abolishes the ability of SNAP-25 to interact with syntaxin 1 and VAMP2 and prevents the assembly of the SNARE complex. Overexpression of Spring or its SNAP-25-interacting domain reduces Ca2+-dependent exocytosis from PC12 cells. These results indicate that Spring may act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP-25 for the SNARE complex formation.	Univ N Carolina, Sch Med, Dept Pharmacol & Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Li, L (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 5109 Rollins Res Ctr, Atlanta, GA 30322 USA.			Chin, Lih-Shen/0000-0002-0817-0368; Li, Lian/0000-0003-4700-1134	NINDS NIH HHS [NS37939] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037939] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Betz A, 1997, J BIOL CHEM, V272, P2520; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hao JC, 1997, J NEUROSCI, V17, P1596; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lonart G, 2000, J BIOL CHEM, V275, P27703; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MISHIMA K, 1993, J BIOL CHEM, V268, P8801; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Ossig R, 2000, EMBO J, V19, P6000, DOI 10.1093/emboj/19.22.6000; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sambrook J., 2002, MOL CLONING LAB MANU; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; SCHWEITZER ES, 1985, J CELL BIOL, V101, P667, DOI 10.1083/jcb.101.2.667; Seto MH, 1999, PROTEINS, V35, P235, DOI 10.1002/(SICI)1097-0134(19990501)35:2<235::AID-PROT9>3.3.CO;2-O; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsujimoto S, 2000, J BIOL CHEM, V275, P2938, DOI 10.1074/jbc.275.4.2938; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wang GY, 1997, J CELL SCI, V110, P505; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; WICK PF, 1993, J BIOL CHEM, V268, P10983; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551	61	47	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40824	40833		10.1074/jbc.M106141200	http://dx.doi.org/10.1074/jbc.M106141200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524423	Green Published, hybrid			2022-12-27	WOS:000171925600061
J	Lopez-Boado, YS; Wilson, CL; Parks, WC				Lopez-Boado, YS; Wilson, CL; Parks, WC			Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; DEFENSINS; PATHOGENESIS; ACTIVATION; ALPHA; GENE; LIPOPOLYSACCHARIDE; IDENTIFICATION; INFECTION; PILI	Matrilysin (matrix metalloproteinase-7) is expressed by mucosal epithelia throughout the body and functions in host defense by activating murine intestinal a-defensins. In normal adult human lung, matrilysin is expressed at low levels in the airway epithelium, but is markedly up-regulated in cystic fibrosis (CF). Because CF lungs support a heavy bacterial load, we assessed if relevant CF pathogens regulate matrilysin expression in human lung epithelial cells. Indeed, acute infection with Pseudomonas aeruginosa (but not Staphylococcus aureus, Haemophilus influenzae, or Klebsiella pneumoniae) induced the expression of matrilysin in Calu-3 lung epithelial cells. Increased matrilysin mRNA levels were detectable at 3 h post-infection and peaked at a 25-fold induction between 6 and 8 h. Both P. aeruginosa CF isolates and laboratory strains induced matrilysin expression to similar levels. Flagellin, the monomeric precursor of bacterial flagella, was identified as the inductive factor released by P. aeruginosa that regulated matrilysin expression. In addition, flagellin-null mutants failed to stimulate matrilysin expression in cultured cells or in lungs infected in vivo. These data show that P. aeruginosa (and specifically flagellin) potently stimulates matrilysin expression in lung epithelial cells and may mediate the overexpression of this proteinase in CF lungs.	Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA; Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Parks, WC (corresponding author), Washington Univ, Dept Pediat, Sch Med, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	parks_w@kids.wustl.edu	Parks, William C./AAH-6786-2021		NHLBI NIH HHS [HL29594, HL54619] Funding Source: Medline; NIDCR NIH HHS [DE14040] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014040] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bals R, 1999, J CLIN INVEST, V103, P303, DOI 10.1172/JCI6277; Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797; Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998; BUSIEK DF, 1992, J BIOL CHEM, V267, P9087; Comolli JC, 1999, INFECT IMMUN, V67, P3207, DOI 10.1128/IAI.67.7.3207-3214.1999; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; deBentzmann S, 1996, AM J RESP CRIT CARE, V154, pS155, DOI 10.1164/ajrccm/154.4_Pt_2.S155; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Firth JD, 1997, INFECT IMMUN, V65, P4931, DOI 10.1128/IAI.65.12.4931-4936.1997; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Pier GB, 1996, AM J RESP CRIT CARE, V154, pS175, DOI 10.1164/ajrccm/154.4_Pt_2.S175; PROSSER IW, 1989, AM J PATHOL, V135, P1073; RODGERS WH, 1994, J CLIN INVEST, V94, P946, DOI 10.1172/JCI117461; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SAARIALHOKERE UK, 1995, J INVEST DERMATOL, V105, P190, DOI 10.1111/1523-1747.ep12317104; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Soong LB, 1997, INFLAMM RES, V46, P98, DOI 10.1007/s000110050114; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; WILSON CL, 1995, MOL BIOL CELL, V6, P851, DOI 10.1091/mbc.6.7.851; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WILSON MJ, 1992, BIOL REPROD, V47, P683, DOI 10.1095/biolreprod47.5.683; Zhang H, 2001, AM J PHYSIOL-LUNG C, V280, pL947, DOI 10.1152/ajplung.2001.280.5.L947	39	72	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41417	41423		10.1074/jbc.M107121200	http://dx.doi.org/10.1074/jbc.M107121200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527977	hybrid			2022-12-27	WOS:000171925600138
J	Morton, NM; Holmes, MC; Fievet, C; Staels, B; Tailleux, A; Mullins, JJ; Seckl, JR				Morton, NM; Holmes, MC; Fievet, C; Staels, B; Tailleux, A; Mullins, JJ; Seckl, JR			Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; LIPOGENIC ENZYME GENES; FATTY-ACID OXIDATION; MESSENGER-RNA LEVELS; TRANSGENIC MICE; PPAR-ALPHA; GLUCOCORTICOID RECEPTOR; TISSUE-DISTRIBUTION; METABOLIC SYNDROME; PRIMARY CULTURES	Excess tissue glucocorticoid action may underlie the dyslipidemia, insulin resistance, and impaired glucose tolerance of the metabolic syndrome. 11 beta -Hydroxy-steroid dehydrogenase type 1 (11 beta -HSD-1) catalyzes conversion of circulating inert 11-dehydrocorticosterone into active corticosterone, thus amplifying local intracellular glucocorticoid action, particularly in liver. The importance of 11 beta -HSD-1 in glucose homeostasis is suggested by the resistance of 11 beta -HSD-1(-/-) mice to hyperglycemia upon stress or obesity, due to attenuated gluconeogenic responses. The present study further investigates the metabolic consequences of 11 beta -HSD-1 deficiency, focusing on the lipid and lipoprotein profile. Ad lib fed 11 beta -HSD-1(-/-) mice have markedly lower plasma triglyceride levels. This appears to be driven by increased hepatic expression of enzymes of fat catabolism (carnitine palmitoyltransferase-I, acyl-CoA oxidase, and uncoupling protein-2) and their coordinating transcription factor, peroxisome proliferator-activated receptor-a (PPAR alpha). 11 beta -HSD-1(-/-) mice also have increased HDL cholesterol, with elevated liver mRNA and serum levels of apolipoprotein Al. Conversely, liver A alpha -fibrinogen mRNA levels are decreased. Upon fasting, the normal elevation of peroxisome proliferator-activated receptor-a mRNA is lost in 11 beta -HSD-1(-/-) mice, consistent with attenuated glucocorticoid induction. Despite this, crucial oxidative responses to fasting are maintained; carnitine palmitoyltransferase-I induction and glucose levels are similar to wild type. Refeeding shows exaggerated induction of genes encoding lipogenic enzymes and a more marked suppression of genes for fat catabolism in 11 beta -HSD-1(-/-) mice, implying increased liver insulin sensitivity. Concordant with this, 24-h refed 11 beta -HSD-1(-/-) mice have higher triglyceride but lower glucose levels. Further, 11 beta -HSD-1(-/-) mice have improved glucose tolerance. These data suggest that 11 beta -HSD-1 deficiency produces an improved lipid profile, hepatic insulin sensitization, and a potentially atheroprotective phenotype.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Mol Physiol Lab, Edinburgh EH8 9AG, Midlothian, Scotland; Inst Pasteur, Dept Atherosclerose, U545, INSERM, F-59019 Lille, France; Univ Lille 2, F-59019 Lille, France	University of Edinburgh; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Morton, NM (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Mol Med Ctr, Crewe Rd S, Edinburgh EH4 2XU, Midlothian, Scotland.	nik.morton@ed.ac.uk	TAILLEUX, Anne/R-5530-2018; Seckl, Jonathan R/C-3555-2013; Staels, Bart/N-9497-2016; Morton, NICHOLAS/ABF-3774-2020	TAILLEUX, Anne/0000-0003-1430-2627; Staels, Bart/0000-0002-3784-1503; 				AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Ambrosi B, 2000, EXP CLIN ENDOCR DIAB, V108, P294, DOI 10.1055/s-2000-8000; Andrew R, 1998, J CLIN ENDOCR METAB, V83, P1806, DOI 10.1210/jc.83.5.1806; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; BHATTACHARYA A, 1991, MOL ENDOCRINOL, V5, P587, DOI 10.1210/mend-5-4-587; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; BROWN RW, 1993, ENDOCRINOLOGY, V132, P2614, DOI 10.1210/en.132.6.2614; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Chien D, 2000, AM J PHYSIOL-ENDOC M, V279, pE259, DOI 10.1152/ajpendo.2000.279.2.E259; Cole TJ, 1999, MOL CELL ENDOCRINOL, V154, P29, DOI 10.1016/S0303-7207(99)00105-7; Collett GP, 2000, CLIN CANCER RES, V6, P3241; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; DAMMERMAN M, 1993, P NATL ACAD SCI USA, V90, P4562, DOI 10.1073/pnas.90.10.4562; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; ETTINGER WH, 1987, ATHEROSCLEROSIS, V63, P167, DOI 10.1016/0021-9150(87)90117-1; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; FREEDMAN MR, 1986, AM J PHYSIOL, V250, pR595, DOI 10.1152/ajpregu.1986.250.4.R595; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Hargrove GM, 1999, J MOL ENDOCRINOL, V22, P103, DOI 10.1677/jme.0.0220103; Harris HJ, 2001, ENDOCRINOLOGY, V142, P114, DOI 10.1210/en.142.1.114; Hermanowski-Vosatka A, 2000, BIOCHEM BIOPH RES CO, V279, P330, DOI 10.1006/bbrc.2000.3966; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jamieson PM, 2000, J ENDOCRINOL, V165, P685, DOI 10.1677/joe.0.1650685; JAMIESON PM, 1995, ENDOCRINOLOGY, V136, P4754, DOI 10.1210/en.136.11.4754; Kannel WB, 1997, DRUGS, V54, P32, DOI 10.2165/00003495-199700543-00006; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kockx M, 1999, BLOOD, V93, P2991; KOELEVTSEV Y, P NATL ACAD SCI US, V94, P14924; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Murao K, 1998, J BIOL CHEM, V273, P18959, DOI 10.1074/jbc.273.30.18959; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; Peeke PM, 1995, ANN NY ACAD SCI, V771, P665, DOI 10.1111/j.1749-6632.1995.tb44719.x; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; RAJAN V, 1995, J STEROID BIOCHEM, V52, P141, DOI 10.1016/0960-0760(94)00159-J; Rajan V, 1996, J NEUROSCI, V16, P65; Schultz R, 1999, ENDOCRINOLOGY, V140, P2968, DOI 10.1210/en.140.7.2968; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; STAELS B, 1991, ARTERIOSCLER THROMB, V11, P760, DOI 10.1161/01.ATV.11.3.760; Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022; Tailleux A, 2000, ARTERIOSCL THROM VAS, V20, P2453, DOI 10.1161/01.ATV.20.11.2453; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Tsuboyama-Kasaoka N, 1999, BIOCHEM BIOPH RES CO, V257, P879, DOI 10.1006/bbrc.1999.0555; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; Yau JLW, 2001, P NATL ACAD SCI USA, V98, P4716, DOI 10.1073/pnas.071562698; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901; Zammit VA, 2000, BIOCHEM SOC T, V28, P103, DOI 10.1042/bst0280103	63	366	424	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41293	41300		10.1074/jbc.M103676200	http://dx.doi.org/10.1074/jbc.M103676200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546766	hybrid			2022-12-27	WOS:000171925600122
J	Shin, ME; Ogburn, KD; Varban, OA; Gilbert, PM; Burd, CG				Shin, ME; Ogburn, KD; Varban, OA; Gilbert, PM; Burd, CG			FYVE domain targets Pib1p ubiquitin ligase to endosome and vacuolar membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; YEAST; RING; TRANSPORT; COMPLEX; LOCALIZATION; REGULATOR; FINGER	Signaling by phosphatidylinositol 3-kinases (PI3Ks) is often mediated by proteins which bind PI3K products directly and are localized to intracellular membranes rich in PI3K products. The FYVE finger domain binds with high specificity to PtdIns(3)P and proteins containing this domain have been shown to be important components of diverse PI3K signaling pathways. The genome of the yeast Saccharomyces cerevisiae encodes five proteins containing FIVE domains, including Pib1p, whose function is unknown. In addition to a FYVE finger motif, the primary structure of Pib1p contains a region rich in cysteine and histidine residues that we demonstrate binds 2 mol eq of zinc, consistent with this region containing a RING structural domain. The Pib1p RING domain exhibited E2-dependent ubiquitin ligase activity in vitro, indicating that Pib1p is an E3 RING-type ubiquitin ligase. Fluorescence microscopy was used to demonstrate that a GFP-Pib1p fusion protein localized to endosomal and vacuolar membranes and deletional analysis of Pib1p domains indicated that localization of GFP-Pib1p is mediated solely by the FYVE domain. These results suggest that Pib1p mediates ubiquitination of a subset of cellular proteins localized to endosome and vacuolar membranes, and they expand the repertoire of PI3K-regulated pathways identified in eukaryotic cells.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Burd, CG (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.			Gilbert, Penney/0000-0001-5509-9616; Burd, Christopher/0000-0003-1831-8706	NIGMS NIH HHS [GM61221] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061221] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; GIEDROC DP, 1986, P NATL ACAD SCI USA, V83, P8452, DOI 10.1073/pnas.83.22.8452; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Maniatis T., 1982, MOL CLONING LAB MANU; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sherman F, 1979, METHODS YEAST GENETI; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Webb GC, 1997, MOL BIOL CELL, V8, P871, DOI 10.1091/mbc.8.5.871; Wurmser AE, 1998, EMBO J, V17, P4930, DOI 10.1093/emboj/17.17.4930; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	32	37	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41388	41393		10.1074/jbc.M105665200	http://dx.doi.org/10.1074/jbc.M105665200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526110	hybrid			2022-12-27	WOS:000171925600134
J	Carr, KM; Kaguni, JM				Carr, KM; Kaguni, JM			Stoichiometry of DnaA and DnaB protein in initiation at the Escherichia coli chromosomal origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION ORIGIN; STRANDED-DNA; HELICASE; INVITRO; COMPLEX; BINDING; PRIMASE; SITES; GENE; REVEALS	Initiation of DNA replication at the Escherichia coli chromosomal origin, oriC, occurs through an ordered series of events that depend first on the binding of DnaA protein, the replication initiator, to DnaA box sequences within oriC followed by unwinding of an AT-rich region near the left border. The prepriming complex then forms, involving the binding of DnaB helicase at oriC so that it is properly positioned at each replication fork. We assembled and isolated the prepriming complexes on an oriC plasmid, then determined the stoichiometries of proteins in these complexes by quantitative immunoblot analysis. DnaA protein alone binds to oriC with a stoichiometry of 4-5 monomers per oriC DNA. In the prepriming complex, the stoichiometries are 10 DnaA monomers and 2 DnaB hexamers per oriC plasmid. That only two DnaB hexamers are bound, one for each replication fork, suggests that the binding of additional molecules of DnaA in forming the prepriming complex restricts the loading of additional DnaB hexamers that can bind at oriC.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Kaguni, JM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kaguni@msu.edu		Kaguni, Jon/0000-0002-3096-4447	NIGMS NIH HHS [R01 GM033992, GM33992] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI K, 1981, J BIOL CHEM, V256, P5253; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; BAKER TA, 1987, J BIOL CHEM, V262, P6877; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2000, BIOCHEMISTRY-US, V39, P12959, DOI 10.1021/bi0012484; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; HWANG DS, 1992, J BIOL CHEM, V267, P23083; Kaguni JM, 1997, MOL CELLS, V7, P145; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; Majka J, 2001, J BIOL CHEM, V276, P6243, DOI 10.1074/jbc.M007876200; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; Marszalek J, 1996, J BIOL CHEM, V271, P18535, DOI 10.1074/jbc.271.31.18535; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MARSZALEK J, 1992, J BIOL CHEM, V267, P19334; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; MESSER W, 1996, ESCHERICHIA COLI SAL, V2, P1579; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Sutton MD, 1997, J MOL BIOL, V274, P546, DOI 10.1006/jmbi.1997.1425; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; TOUGU K, 1994, J BIOL CHEM, V269, P4675; VANDERENDE A, 1985, P NATL ACAD SCI USA, V82, P3954; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; WU CA, 1992, J BIOL CHEM, V267, P4074; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	35	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44919	44925		10.1074/jbc.M107463200	http://dx.doi.org/10.1074/jbc.M107463200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11551962	hybrid			2022-12-27	WOS:000172406700079
J	O'Donovan, CN; Tobin, D; Cotter, TG				O'Donovan, CN; Tobin, D; Cotter, TG			Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; CALCIUM-CHANNEL ACTIVITY; OXIDATIVE STRESS; INTRACELLULAR CALCIUM; HYDROGEN-PEROXIDE; AMYLOID PROTEIN; IN-VITRO; BCL-2; DEATH; INHIBITION	The synthetic peptide PrP-(106-126) has previously been shown to be neurotoxic. Here, for the first time, we report that it induces apoptosis in the human neuroblastoma cell line SH-SY5Y. The earliest detectable apoptotic event in this system is the rapid depolarization of mitochondrial membranes, occurring immediately upon treatment of cells with PrP-(106-126). Subsequent to this, cytochrome c release and caspase activation were observed. Caspase inhibitors demonstrated that while the peptide activates caspases they are not an absolute requirement for apoptosis. Parallel to caspase activation, PrP-(106-126) was also observed to trigger a rise in intracellular calcium through release of mitochondrial calcium stores. This leads to the activation of calpains, another family of proteases. A calpain inhibitor demonstrated that while calpains are activated by the peptide they also are not an absolute requirement for apoptosis. Interestingly a combination of caspase and calpain inhibitors significantly inhibited apoptosis. This illustrates alternative pathways leading to apoptosis via caspases and calpains and that blocking both pathways is required to inhibit apoptosis. These results implicate the mitochondrion as a primary site of action of PrP-(106-126).	Natl Univ Ireland Univ Coll Cork, Tumor Biol Lab, Dept Biochem, Cork, Ireland	University College Cork	Cotter, TG (corresponding author), Natl Univ Ireland Univ Coll Cork, Tumor Biol Lab, Dept Biochem, Cork, Ireland.	t.cotter@ucc.ie		Cotter, Thomas/0000-0003-4626-5613				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; Andreyev A, 1999, CELL DEATH DIFFER, V6, P825, DOI 10.1038/sj.cdd.4400565; Baumann MH, 2000, BIOCHEM J, V349, P77, DOI 10.1042/0264-6021:3490077; BEHRENS MM, 1995, CELL GROWTH DIFFER, V6, P1375; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1997, INT J DEV NEUROSCI, V15, P961, DOI 10.1016/S0736-5748(97)00042-7; Bruce-Keller AJ, 1998, J NEUROCHEM, V70, P31; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARMODY RJ, 1998, SEPSIS, V2, P9; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; COSSARIZZA A, 1994, EXP CELL RES, V214, P323, DOI 10.1006/excr.1994.1264; Debiasi RL, 1999, J VIROL, V73, P695, DOI 10.1128/JVI.73.1.695-701.1999; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; FAIRBAIRN DW, 1994, FEMS MICROBIOL LETT, V115, P341, DOI 10.1111/j.1574-6968.1994.tb06661.x; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GIESE A, 1995, BRAIN PATHOL, V5, P213, DOI 10.1111/j.1750-3639.1995.tb00597.x; Gorman AM, 1996, J NEUROL SCI, V139, P45, DOI 10.1016/0022-510X(96)00097-4; Gray F, 1999, J NEUROPATH EXP NEUR, V58, P321, DOI 10.1097/00005072-199904000-00002; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Guentchev M, 2000, NEUROBIOL DIS, V7, P270, DOI 10.1006/nbdi.2000.0290; Gupta PD, 1999, CYTOBIOS, V99, P83; Herms JW, 2000, J NEUROCHEM, V75, P1487, DOI 10.1046/j.1471-4159.2000.0751487.x; Hope J, 1996, NEURODEGENERATION, V5, P1, DOI 10.1006/neur.1996.0001; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Ishihara I, 2000, NEUROSCI LETT, V279, P97, DOI 10.1016/S0304-3940(99)00960-X; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014; Kurschner C, 1996, MOL BRAIN RES, V37, P249, DOI 10.1016/0169-328X(95)00323-K; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Larochette N, 1999, EXP CELL RES, V249, P413, DOI 10.1006/excr.1999.4519; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lin MX, 1997, J BIOL CHEM, V272, P44; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MASTERS CL, 1978, BRAIN, V101, P333, DOI 10.1093/brain/101.2.333; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; McHattie SJ, 1999, J NEUROCYTOL, V28, P149, DOI 10.1023/A:1007028323666; MCKENNA SL, 1999, CELL ENG; Mikol J, 1999, BIOMED PHARMACOTHER, V53, P19, DOI 10.1016/S0753-3322(99)80056-0; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Okuno S, 1998, J BIOL CHEM, V273, P34272, DOI 10.1074/jbc.273.51.34272; Paradis E, 1996, J NEUROSCI, V16, P7533; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Perkins CL, 2000, CANCER RES, V60, P1645; Perovic S, 1997, EXP NEUROL, V147, P518, DOI 10.1006/exnr.1997.6559; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ray SK, 1999, ANN NY ACAD SCI, V890, P261, DOI 10.1111/j.1749-6632.1999.tb08001.x; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Rymer DL, 2000, J NEUROCHEM, V75, P2536, DOI 10.1046/j.1471-4159.2000.0752536.x; Saez-Valero J, 2000, NEUROSCI LETT, V293, P207, DOI 10.1016/S0304-3940(00)01532-9; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Silei V, 1999, BRAIN RES, V818, P168, DOI 10.1016/S0006-8993(98)01272-4; SIMS NR, 1987, BRAIN RES, V436, P30, DOI 10.1016/0006-8993(87)91553-8; SINGER TP, 1987, J NEUROCHEM, V49, P1, DOI 10.1111/j.1471-4159.1987.tb03384.x; Slater AFG, 1996, CELL DEATH DIFFER, V3, P57; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; Tombal B, 2000, PROSTATE, V43, P303; VERHAEGEN S, 1995, BIOCHEM PHARMACOL, V50, P1021, DOI 10.1016/0006-2952(95)00233-P; Wong BS, 2000, BIOCHEM BIOPH RES CO, V275, P249, DOI 10.1006/bbrc.2000.3158; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zamzami N, 1998, ONCOGENE, V16, P1055, DOI 10.1038/sj.onc.1201864	75	120	123	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43516	43523		10.1074/jbc.M103894200	http://dx.doi.org/10.1074/jbc.M103894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11533027	hybrid			2022-12-27	WOS:000172297700007
J	Perreault, N; Katz, JP; Sackett, SD; Kaestner, KH				Perreault, N; Katz, JP; Sackett, SD; Kaestner, KH			Foxl1 controls the Wnt/beta-catenin pathway by modulating the expression of proteoglycans in the gut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; HEPARAN-SULFATE PROTEOGLYCANS; BETA-CATENIN; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; DIFFERENTIATION; MICE; PROLIFERATION; INTESTINE; CANCER	Foxl1 is a winged helix transcription factor expressed in the mesenchyme of the gastrointestinal tract. Foxl1 null mice display severe structural defects in the epithelia of the stomach, duodenum, and jejunum. Here we addressed the molecular mechanisms by which Foxl1 controls gastrointestinal differentiation. First we showed that the abnormalities found in the epithelia of the null mice are the result of an increase in the number of proliferating cells and not a change in the rate of cell migration. Next we investigated the regulatory circuits affected by Foxl1. We focused on the Wnt/beta -catenin signaling pathway as a possible target of Foxl1 as it has been shown to play a central role in gastrointestinal proliferation. We demonstrated that Foxl1 activates the Wnt/beta -catenin pathway by increasing extracellular proteoglycans, which act as co-receptors for Wnt. Thus we establish that Foxl1 is involved in the regulation of the Wnt/beta -catenin pathway, providing a novel link in mesenchymal/epithelial cross-talk in the gut. Moreover, we provide the first example implicating proteoglycans in the regulation of cellular proliferation in the gastrointestinal tract.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK053839, K08DK002809] Funding Source: NIH RePORTER; NIDDK NIH HHS [KO8 DK02809-01, P30DK50306, R01 DK53839] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; BEAULIEU JF, 1991, ANAT EMBRYOL, V183, P363; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Couchman JR, 1996, J CELL BIOCHEM, V61, P578, DOI 10.1002/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C; Cumberledge S, 1997, TRENDS GENET, V13, P421, DOI 10.1016/S0168-9525(97)01275-4; Dale TC, 1998, BIOCHEM J, V329, P209; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Duncan SA, 1997, DEVELOPMENT, V124, P279; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Gumbiner BM, 1998, CURR OPIN GENET DEV, V8, P430, DOI 10.1016/S0959-437X(98)80114-7; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Pabst O, 1999, DEVELOPMENT, V126, P2215; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PIGNATELLI A, 1997, GUT MODEL CELL MOL B; PODOLSKY DK, 1993, AM J PHYSIOL, V264, pG179, DOI 10.1152/ajpgi.1993.264.2.G179; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336	29	65	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43328	43333		10.1074/jbc.M104366200	http://dx.doi.org/10.1074/jbc.M104366200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555641	hybrid			2022-12-27	WOS:000172169300091
J	Ajuh, P; Sleeman, J; Chusainow, J; Lamond, AI				Ajuh, P; Sleeman, J; Chusainow, J; Lamond, AI			A direct interaction between the carboxyl-terminal region of CDC5L, and the WD40 domain of PLRG1 is essential for pre-mRNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP19P-ASSOCIATED COMPLEX; PROTEIN; IDENTIFICATION; COMPONENT; REPEAT; DISSOCIATION; SEPARATION; HOMOLOG; PLANT; PRL1	The human proteins CDC5L (hCDC5) and PLRG1 are both highly conserved components of a multiprotein complex that is a subunit of the spliceosome. The respective homologues in yeast of both proteins are also associated with a sub-spliceosomal multiprotein complex that has been shown to be important for pre-mRNA splicing. We show that these two human proteins are associated in vivo and will interact directly in vitro. The regions containing the interacting domains in both proteins have been identified. Our results indicate that the carboxyl-terminal region of CDC5L, and the WD40 domain of PLRG1 are essential for direct interaction between both proteins. By using a bacterially expressed mutant protein, containing the PLRG1 interacting domain in CDC5L, we show that the CDC5L-PLRG1 interaction in HeLa nuclear extract can be disrupted causing pre-mRNA splicing to be inhibited. Thus, a direct interaction between the CDC5L protein and PLRG1 in the CDC5L, complex is essential for pre-mRNA splicing progression.	Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	a.i.lamond@dundee.ac.uk	/F-4368-2012	/0000-0003-0351-4579; Lamond, Angus/0000-0001-6204-6045; Sleeman, Judith/0000-0003-0345-6508				Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Bernstein HS, 1997, J BIOL CHEM, V272, P5833, DOI 10.1074/jbc.272.9.5833; Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Hirayama T, 1996, P NATL ACAD SCI USA, V93, P13371, DOI 10.1073/pnas.93.23.13371; Janda L, 1996, J BACTERIOL, V178, P1487, DOI 10.1128/jb.178.5.1487-1489.1996; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; KRAMER A, 1995, PREMRNA PROCESSING, P39; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; Lei XH, 2000, J CELL SCI, V113, P4523; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nemeth K, 1998, GENE DEV, V12, P3059, DOI 10.1101/gad.12.19.3059; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Ohi R, 1998, MOL CELL BIOL, V18, P4097, DOI 10.1128/MCB.18.7.4097; OHI R, 1994, EMBO J, V13, P471, DOI 10.1002/j.1460-2075.1994.tb06282.x; PETTERSSON I, 1984, J BIOL CHEM, V259, P5907; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; REED R, 1997, EUKARYOTIC MRNA PROC, P103; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; WILL CL, 1997, EUKARYOTIC MRNA PROC, P130; Xia G, 1996, PLANT J, V10, P761, DOI 10.1046/j.1365-313X.1996.10040761.x	34	47	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42370	42381		10.1074/jbc.M105453200	http://dx.doi.org/10.1074/jbc.M105453200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11544257	hybrid			2022-12-27	WOS:000172450400109
J	Ceccarelli, E; Mann, C				Ceccarelli, E; Mann, C			A Cdc28 mutant uncouples G(1) cyclin phosphorylation and ubiquitination from G(1) cyclin proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP PHOSPHORYLATION; CDK-DEPENDENT PHOSPHORYLATION; MULTIUBIQUITIN-CHAIN-BINDING; XENOPUS SUC1/CKS PROTEIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MUTATIONAL ANALYSIS; ENZYME CDC34; CLN3 CYCLIN; KINASE CAK	Proteolysis of the yeast G, cyclins is triggered by their Cdc28-dependent phosphorylation. Phosphorylated Cln1 and Cln2 are ubiquitinated by the SCF-Grr1 complex and then degraded by the 26 S proteasome. In this study, we identified a cak1 allele in a genetic screen for mutants that stabilize the yeast G(1) cyclins. Further characterization showed that Cln2HA was hypophosphorylated, unable to bind Cdc28, and stabilized in cak1 mutants at the restrictive temperature. Hypophosphorylation of Cln2HA could thus explain its stabilization. To test this possibility, we expressed a Cak1-independent mutant of Cdc28 (Cdc28-43244) in cak1 mutants and found that Cln2HA phosphorylation was restored, but surprisingly, the phospho-Cln2HA was stabilized. When bound to Cdc28-43244, Cln2HA was recognized and polyubiquitinated by SCF-Grr1. The Cdc28-43244 mutant thus reveals an unexpected complexity in the degradation of polyubiquitinated Cln2HA by the proteasome.	CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Mann, C (corresponding author), CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France.			Mann, Carl/0000-0001-7212-1512				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BANERJEE A, 1995, J BIOL CHEM, V270, P26209, DOI 10.1074/jbc.270.44.26209; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Chun KT, 1997, MOL GEN GENET, V256, P365, DOI 10.1007/s004380050580; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Cross FR, 1998, MOL CELL BIOL, V18, P2923, DOI 10.1128/MCB.18.5.2923; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Cross FR, 2000, GENETICS, V154, P1549; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; Egan EA, 1998, MOL CELL BIOL, V18, P3659, DOI 10.1128/MCB.18.7.3659; Espinoza FH, 1996, SCIENCE, V273, P1714, DOI 10.1126/science.273.5282.1714; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; Kaldis P, 1996, CELL, V86, P553, DOI 10.1016/S0092-8674(00)80129-4; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kishi T, 1998, J CELL SCI, V111, P3655; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Lim HH, 1996, MOL CELL BIOL, V16, P4573; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; REED SI, 1992, ANNU REV CELL BIOL, V8, P529, DOI 10.1146/annurev.cb.08.110192.002525; Reynard GJ, 2000, MOL CELL BIOL, V20, P5858, DOI 10.1128/MCB.20.16.5858-5864.2000; Ross KE, 2000, MOL BIOL CELL, V11, P1597, DOI 10.1091/mbc.11.5.1597; Sambrook J., 2002, MOL CLONING LAB MANU; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Thuret JY, 1996, CELL, V86, P565, DOI 10.1016/S0092-8674(00)80130-0; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yaglom JA, 1996, MOL CELL BIOL, V16, P3679	48	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41725	41732		10.1074/jbc.M107087200	http://dx.doi.org/10.1074/jbc.M107087200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527976	hybrid			2022-12-27	WOS:000172450400026
J	Dai, GX; Steede, NK; Landry, SJ				Dai, GX; Steede, NK; Landry, SJ			Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HUMAN CD4(+) CELLS; HEPATITIS-C VIRUS; ANTIGEN PRESENTATION; PEPTIDE BINDING; HIV GP120; EGG LYSOZYME; MOLECULES; PROTEIN; COMPLEX	The specificity and intensity of CD4(+) helper T-cell responses determine the effectiveness of immune effector functions. Promiscuously immunodominant helper T-cell epitopes in the human immunodeficiency virus (HIV) envelope glycoprotein gp120 could be important in the development of broadly protective immunity, but the underlying mechanisms of immunodominance and promiscuity remain poorly defined. In this study, gp120 helper T-cell epitopes were systematically mapped in CBA/J and BALB/c mice by restimulation assays using a set of overlapping peptides spanning the entire sequence of the gp120 encoded by HIV strain 89.6. The results were analyzed in the context of the HIV gp120 structure determined by x-ray crystallography. One major finding was that all of the promiscuously immunodominant gp120 sequences are located in the outer domain. Further analyses indicated that epitope immunogenicity in the outer domain correlates with structural disorder in adjacent N-terminal segments, as indicated by crystallographic D-factors or sequence divergence. In contrast, the correlation was poor when the analysis encompassed the entire gp120 sequence or was restricted to only the inner domain. These findings suggest that local disorder promotes the processing and presentation of adjacent epitopes in the outer domain of gp120 and therefore reveal how three-dimensional structure shapes the profile of helper T-cell epitope immunogenicity.	Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA	Tulane University	Landry, SJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA.		Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543	NIAID NIH HHS [R21-AI42702] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042702] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Bouhdoud L, 2000, J VIROL, V74, P2121, DOI 10.1128/JVI.74.5.2121-2130.2000; BUSCH R, 1990, INT IMMUNOL, V2, P443, DOI 10.1093/intimm/2.5.443; Cardenas-Freytag L, 1999, INFECT IMMUN, V67, P826; Castellino F, 1998, J IMMUNOL, V161, P4048; Chianese-Bullock KA, 1998, J IMMUNOL, V161, P1599; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048; DENG HK, 1993, J EXP MED, V178, P1675, DOI 10.1084/jem.178.5.1675; Diethelm-Okita BM, 2000, J INFECT DIS, V181, P1001, DOI 10.1086/315324; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dormann D, 1998, CLIN EXP ALLERGY, V28, P1374; GAMMON G, 1991, J EXP MED, V173, P609, DOI 10.1084/jem.173.3.609; GAO XM, 1989, J IMMUNOL, V143, P3007; GERETY SJ, 1994, J IMMUNOL, V152, P908; Hagmann M, 2000, SCIENCE, V290, P80, DOI 10.1126/science.290.5489.80; Hale P M, 1989, Int Immunol, V1, P409, DOI 10.1093/intimm/1.4.409; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; Haque MA, 2001, J IMMUNOL, V166, P4543, DOI 10.4049/jimmunol.166.7.4543; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; JANSSEN R, 1994, INT IMMUNOL, V6, P1187, DOI 10.1093/intimm/6.8.1187; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Landry SJ, 1997, IMMUNOL TODAY, V18, P527, DOI 10.1016/S0167-5699(97)01152-3; Landry SJ, 2000, J THEOR BIOL, V203, P189, DOI 10.1006/jtbi.1999.1056; Lindner R, 1996, EMBO J, V15, P6910, DOI 10.1002/j.1460-2075.1996.tb01083.x; Ma CL, 1999, J IMMUNOL, V163, P6413; Manici S, 1999, J EXP MED, V189, P871, DOI 10.1084/jem.189.5.871; MEISTER GE, 1995, VACCINE, V13, P581, DOI 10.1016/0264-410X(94)00014-E; Moudgil KD, 1998, J IMMUNOL, V161, P6046; Moudgil KD, 1996, J EXP MED, V183, P535, DOI 10.1084/jem.183.2.535; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Nakagawa TY, 1999, IMMUNOL REV, V172, P121, DOI 10.1111/j.1600-065X.1999.tb01361.x; Nayak BP, 1999, FEBS LETT, V443, P159, DOI 10.1016/S0014-5793(98)01715-3; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; Niedermann G, 1999, IMMUNOL REV, V172, P29, DOI 10.1111/j.1600-065X.1999.tb01354.x; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Phelps RG, 1998, J BIOL CHEM, V273, P11440, DOI 10.1074/jbc.273.19.11440; Raju R, 1995, EUR J IMMUNOL, V25, P3207, DOI 10.1002/eji.1830251202; Roberts CGP, 1996, AIDS RES HUM RETROV, V12, P593, DOI 10.1089/aid.1996.12.593; RODRIGUEZ GM, 1995, EUR J IMMUNOL, V25, P1823, DOI 10.1002/eji.1830250705; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SCHRIER RD, 1989, J IMMUNOL, V142, P1166; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Shirai M, 1999, J IMMUNOL, V162, P568; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Sjolander S, 1996, VACCINE, V14, P344, DOI 10.1016/0264-410X(95)00163-U; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STEVANOVIC S, 1996, STRUCTURE ANTIGENS, V3, P61; Surman S, 2001, P NATL ACAD SCI USA, V98, P4587, DOI 10.1073/pnas.071063898; Vanegas RA, 1997, VACCINE, V15, P321, DOI 10.1016/S0264-410X(96)00167-3; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; WAHREN B, 1989, J ACQ IMMUN DEF SYND, V2, P448; Wang H, 1999, J IMMUNOL, V162, P4177; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; Zeiler T, 1999, J IMMUNOL, V162, P1415	63	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41913	41920		10.1074/jbc.M106018200	http://dx.doi.org/10.1074/jbc.M106018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551929	hybrid			2022-12-27	WOS:000172450400050
J	Gallagher, PG; Sabatino, DE; Basseres, DS; Nilson, DM; Wong, C; Cline, AP; Garrett, LJ; Bodine, DM				Gallagher, PG; Sabatino, DE; Basseres, DS; Nilson, DM; Wong, C; Cline, AP; Garrett, LJ; Bodine, DM			Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BLOCKING ACTIVITY; BETA-SPECTRIN GENE; TRANSGENIC MICE; GLOBIN GENE; DEFICIENCY; CELLS; DOMINANT; CTCF; METHYLATION; PROTEINS	Ankyrin defects are the most common cause of hereditary spherocytosis (HS). In several kindreds with recessive, ankyrin-deficient HS, mutations have been identified in the ankyrin promoter that have been proposed to decrease ankyrin synthesis. We analyzed the effects of two mutations, - 108T to C and - 108T to C in cis with - 153G to A, on ankyrin expression. No difference between wild type and mutant promoters was demonstrated in transfection or gel shift assays in vitro. Transgenic mice with a wild type ankyrin promoter linked to a human (A)gamma -globin gene expressed gamma -globin in 100% of erythrocytes in a copy number-dependent, position-independent manner. Transgenic mice with the mutant -108 promoter demonstrated variegated gamma -globin expression, but showed copy number-dependent and position-independent expression similar to wild type. Severe effects in ankyrin expression were seen in mice with the linked -108/-153 mutations. Three transgenic lines had undetectable levels of (A)gamma -globin mRNA, indicating position-dependent expression, and four lines expressed significantly lower levels of (A)gamma -globin mRNA than wild type. Two of four expressing lines showed variegated gamma -globin expression, and there was no correlation between transgene copy number and RNA level, indicating copy number-independent expression. These data are the first demonstration of functional defects caused by HS-related, ankyrin gene promoter mutations.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; NGHRI, Genet & Mol Biol Branch, Hematopoiesis Sect, NIH, Bethesda, MD 20892 USA; Univ Estadual Campinas, Hemoctr, BR-13083970 Campinas, SP, Brazil	Yale University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Universidade Estadual de Campinas	Gallagher, PG (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.		Bassères, Daniela S/C-6623-2013	Bassères, Daniela S/0000-0001-7745-3567				AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BECKER PS, 1993, J CLIN INVEST, V92, P612, DOI 10.1172/JCI116628; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BENNETT V, 1992, J BIOL CHEM, V267, P8703; del Giudice EM, 2001, BRIT J HAEMATOL, V112, P42; delGiudice EM, 1996, BRIT J HAEMATOL, V93, P828; Dhermy D, 1998, BLOOD CELL MOL DIS, V24, P251, DOI 10.1006/bcmd.1998.0190; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; EBER SW, 1992, ANN HEMATOL, V64, P88, DOI 10.1007/BF01715351; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Gallagher PG, 2000, BLOOD, V96, P1136, DOI 10.1182/blood.V96.3.1136.015k48_1136_1143; Gallagher PG, 1999, J BIOL CHEM, V274, P6062, DOI 10.1074/jbc.274.10.6062; Gallagher PG, 1998, BLOOD, V92, p300A; GALLAGHER PG, 1999, HEMATOLOGY BASIC PRI, P576; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GODAL HC, 1981, SCAND J HAEMATOL, V27, P30; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HOGAN B, 1986, MANIPULATING MOUSE E; Iolascon A, 1998, HAEMATOLOGICA, V83, P240; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Leite R C, 2000, Hum Mutat, V16, P529, DOI 10.1002/1098-1004(200012)16:6<529::AID-HUMU13>3.0.CO;2-N; MASON P, 1993, GENE TRANSCRIPTION P, P243; Morle L, 1997, AM J HEMATOL, V54, P242, DOI 10.1002/(SICI)1096-8652(199703)54:3<242::AID-AJH11>3.0.CO;2-F; Persons DA, 2001, BLOOD, V97, P3275, DOI 10.1182/blood.V97.10.3275; PETERS LL, 1993, SEMIN HEMATOL, V30, P85; Randon J, 1997, BRIT J HAEMATOL, V96, P500, DOI 10.1046/j.1365-2141.1997.d01-2074.x; SAAD STO, 1994, BRIT J HAEMATOL, V88, P295, DOI 10.1111/j.1365-2141.1994.tb05021.x; Sabatino DE, 1998, MOL CELL BIOL, V18, P6634, DOI 10.1128/MCB.18.11.6634; Sabatino DE, 2000, J BIOL CHEM, V275, P28549, DOI 10.1074/jbc.M004043200; SAVVIDES P, 1993, BLOOD, V82, P2953; THORPE SJ, 1994, BRIT J HAEMATOL, V87, P125, DOI 10.1111/j.1365-2141.1994.tb04881.x; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; WHITFIELD CF, 1991, BLOOD, V78, P3043; Wichterle H, 1996, J CLIN INVEST, V98, P2300, DOI 10.1172/JCI119041; Yawata Y, 2000, INT J HEMATOL, V71, P118	40	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41683	41689		10.1074/jbc.M105844200	http://dx.doi.org/10.1074/jbc.M105844200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527968	hybrid			2022-12-27	WOS:000172450400021
J	Han, JW; Ahn, SH; Kim, YK; Bae, GU; Yoon, JW; Hong, SY; Lee, HY; Lee, YW; Lee, HW				Han, JW; Ahn, SH; Kim, YK; Bae, GU; Yoon, JW; Hong, SY; Lee, HY; Lee, YW; Lee, HW			Activation of p21(WAF1-Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin - Involvement of protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GENE PROMOTER; WAF1/CIP1 GENE; IN-VIVO; P21(WAF1/CIP1); EXPRESSION; CELLS; INDUCTION; CANCER; P53	We previously reported that apicidin, a novel histone deacetylase inhibitor, inhibited the proliferation of tumor cells via induction of p21(WAF1/Cip1). In this study, we determined the molecular mechanisms by which apicidin induced the p21(WAF1/Cip1) gene expression in HeLa cells. Apicidin induced p21(WAF1/Cip1) mRNA independent of the de novo protein synthesis and activated the p21(WAF1/Cip1) promoter through Sp1-3 site located at -82 and -77 relative to the transcription start site. This transcriptional activation appears to be mediated by protein kinase C (PKC), because calphostin C, a PKC inhibitor, significantly attenuated the activation of p21(WAF1/Cip1) promoter via Spl sites, which was accompanied by a marked suppression of p21(WAF1/Cip1) mRNA and protein expression induced by apicidin. Consistent with the transcriptional activation of p21(WAF1/Cip1) promoter by apicidin, apicidin treatment led to the translocation of PKC epsilon from cytosolic to particulate fraction, which was reversed by pretreatment with calphostin C, indicating the involvement of PKC in the transcriptional activation of p21(WAF1/Cip1) via Sp1 sites by apicidin. However, the PKC-mediated transcriptional activation of p21(WAF1/Cip1) by apicidin appears to be independent of the histone hyperacetylation, because apicidin-induced histone hyperacetylation was not affected by calphostin C. Furthermore, a PKC activator, phorbol 12,13-dibutyrate, alone induced the transcriptional activation of p21(WAF1/Cip1) promoter, p21(WAF1/Cip1) mRNA, and protein expression without induction of the histone hyperacetylation, suggesting that the transcriptional activation of p21(WAF1/Cip1) by apicidin might have been mediated by a mechanism other than chromatin remodeling through the histone hyperacetylation. Taken together, these results suggest that the PKC signaling pathway plays a pivotal role in the transcriptional activation of the p21(WAF1/Cip1) gene by apicidin.	Sungkyunkwan Univ, Coll Pharm, Dept Biochem & Mol Biol, Changan Ku, Suwon 440746, Kyunggido, South Korea; Sungkyunkwan Univ, Coll Life Sci & nat Resources, Dept Genet Engn, Changan Ku, Suwon 440746, Kyunggido, South Korea; Konyang Univ, Coll Med, Dept Pharmacol, Nonsan 320711, South Korea; Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Konyang University; Konyang University Hospital; Seoul National University (SNU)	Lee, HY (corresponding author), Sungkyunkwan Univ, Coll Pharm, Dept Biochem & Mol Biol, Changan Ku, 300 Chonchondong, Suwon 440746, Kyunggido, South Korea.	hylee@yurim.skku.ac.kr		Ahn, Seong-Hoon/0000-0002-9174-4966				Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Akashi M, 1999, BIOCHEM J, V337, P607, DOI 10.1042/0264-6021:3370607; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; CHEDID M, 1994, ONCOGENE, V9, P3021; DRAETTA GF, 1994, CURR OPIN CELL BIOL, V6, P842, DOI 10.1016/0955-0674(94)90054-X; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinos E, 1998, MOL BRAIN RES, V56, P118, DOI 10.1016/S0169-328X(98)00036-9; Frey MR, 1997, J BIOL CHEM, V272, P9424; Glick RD, 1999, CANCER RES, V59, P4392; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Han JW, 2000, CANCER RES, V60, P6068; HARPER JW, 1993, CELL, V75, P805; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Kim YB, 1999, ONCOGENE, V18, P2461, DOI 10.1038/sj.onc.1202564; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Lee BI, 2001, CANCER RES, V61, P931; Lee TH, 2000, ONCOGENE, V19, P3766, DOI 10.1038/sj.onc.1203715; LI YJ, 1995, ONCOGENE, V10, P599; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Park JS, 1999, APPL ENVIRON MICROB, V65, P126; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rivero JA, 1998, BIOCHEM BIOPH RES CO, V248, P664, DOI 10.1006/bbrc.1998.9041; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; SCHERR CJ, 1995, GENE DEV, V9, P1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sowa Y, 1999, CANCER RES, V59, P4266; Xiao HY, 1999, J CELL BIOCHEM, V73, P291, DOI 10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5; Xiao HY, 1997, BIOCHEM BIOPH RES CO, V237, P457, DOI 10.1006/bbrc.1997.7158; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	39	84	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42084	42090		10.1074/jbc.M106688200	http://dx.doi.org/10.1074/jbc.M106688200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551946	hybrid			2022-12-27	WOS:000172450400074
J	Ostrom, RS; Gregorian, C; Drenan, RM; Xiang, Y; Regan, JW; Insel, PA				Ostrom, RS; Gregorian, C; Drenan, RM; Xiang, Y; Regan, JW; Insel, PA			Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; NITRIC-OXIDE SYNTHASE; CARDIAC MYOCYTES; BETA(2)-ADRENERGIC RECEPTOR; G-PROTEIN; VENTRICULAR MYOCYTES; TRANSGENIC MICE; PHOSPHORYLATION; CA2+; STIMULATION	Recent evidence suggests that many signaling molecules localize in microdomains of the plasma membrane, particularly caveolae. In this study, overexpression of adenylyl cyclase was used as a functional probe of G protein-coupled receptor (GPCR) compartmentation. We found that three endogenous receptors in neonatal rat cardiomyocytes couple with different levels of efficiency to the activation of adenylyl cyclase type 6 (AC6), which localizes to caveolin-rich membrane fractions. Overexpression of AC6 enhanced the maximal cAMP response to beta (1)-adrenergic receptor (beta (1)AR)-selective activation 3.7-fold, to beta (2)AR-selective activation only 1.6-fold and to prostaglandin E-2 (PGE(2)) not at all. Therefore, the rank order of efficacy in coupling to AC6 is beta (1)AR > beta (2)AR > prostaglandin E-2 receptor (EP2R). beta (2)AR coupling efficiency was greater when we overexpressed the receptor or blocked its desensitization by expressing beta ARKct, an inhibitor of G protein-coupled receptor kinase activation, but was not significantly greater when cells were treated with pertussis toxin. Assessment of receptor and AC expression indicated co-localization of AC5/6,beta (1)AR, and beta (2)AR, but not EP2R, in caveolin-rich membranes and caveolin-3 immunoprecipitates, likely explaining the observed activation of AC6 by beta AR subtypes but lack thereof by PGE(2). When cardiomyocytes were stimulated with a beta AR agonist, beta (2)AR were no longer found in caveolin-3 immunoprecipitates; an effect that was blocked by expression of beta ARKet. Thus, agonist-induced translocation of beta (2)AR out of caveolae causes a sequestration of receptor from effector and likely contributes to the lower efficacy of beta (2)AR coupling to AC6 as compared with beta (1)AR, which do not similarly translocate. Therefore, spatial co-localization is a ey determinant of efficiency of coupling by particular extracellular signals to activation of GPCR-linked effectors.	Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; Stanford University; University of Arizona		pinsel@ucsd.edu	Ostrom, Rennolds/AAG-9694-2019	Ostrom, Rennolds/0000-0002-7204-0357	NHLBI NIH HHS [HL07444, HL63885, HL53773] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773, R01HL063885] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BROOKER G, 1973, SCIENCE, V182, P933, DOI 10.1126/science.182.4115.933; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Drazner MH, 1997, J CLIN INVEST, V99, P288, DOI 10.1172/JCI119157; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KUZNETSOV V, 1995, CIRC RES, V76, P40, DOI 10.1161/01.RES.76.1.40; Lipskaia L, 2000, CIRC RES, V86, P795, DOI 10.1161/01.RES.86.7.795; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; RAPUNDALO ST, 1989, CIRC RES, V64, P104, DOI 10.1161/01.RES.64.1.104; Rybin VO, 1999, CIRC RES, V84, P980, DOI 10.1161/01.RES.84.9.980; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Schwencke C, 1999, J CELL BIOCHEM, V75, P64, DOI 10.1002/(SICI)1097-4644(19991001)75:1<64::AID-JCB7>3.0.CO;2-L; Schwencke C, 1999, MOL ENDOCRINOL, V13, P1061, DOI 10.1210/me.13.7.1061; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Steinberg SF, 1999, CIRC RES, V85, P1101; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Tepe NM, 1999, BIOCHEMISTRY-US, V38, P16706, DOI 10.1021/bi991619k; XIAO RP, 1994, J BIOL CHEM, V269, P19151; Xiao RP, 1999, CIRC RES, V84, P43; XIAO RP, 1993, CIRC RES, V73, P286, DOI 10.1161/01.RES.73.2.286; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Yatani A, 1999, CELL SIGNAL, V11, P337, DOI 10.1016/S0898-6568(98)00050-3	34	206	213	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42063	42069		10.1074/jbc.M105348200	http://dx.doi.org/10.1074/jbc.M105348200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533056	Green Published, hybrid			2022-12-27	WOS:000172450400071
J	Webb, DC; McKenzie, ANJ; Foster, PS				Webb, DC; McKenzie, ANJ; Foster, PS			Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction - Identification of a novel allergy-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; AIRWAYS HYPERREACTIVITY; T-CELLS; BRONCHIAL HYPERREACTIVITY; DEFICIENT MICE; LUNG DAMAGE; BALB/C MICE; TH2 CELLS; INFLAMMATION; ASTHMA	Asthma pathophysiology is intimately regulated by CD4(+) Th2 lymphocytes and the cytokines interleukin (IL)-4 and IL-13. However, the mechanisms by which these cytokines promote disease have not been fully elucidated. In order to identify novel molecular mediators of allergy, a comparison was made of the bronchoalveolar lavage, which demonstrated that the Ym2 protein was abundantly up-regulated in the lung during the development of allergy. Low levels of the Ym1 isomer were also detected. Importantly, neither Ym1 nor Ym2 has been characterized previously in the context of allergic pulmonary inflammation. Western immunoblot showed that enhanced expression of these proteins was dependent on CD4(+) T cells and IL-4 or IL-13 signaling via the IL-4R alpha subunit. In addition, intratracheal instillation of IL-13 into naive mice was sufficient to induce expression. Ym1 is homologous to eosinophil chemotactic factor L. However, only weak eosinophil chemotaxis was observed in response to Ym protein in both in vitro and in vivo assays. By contrast, the homology of Ym1 and Ym2 to proteins associated with tissue remodeling, together with the previous findings that Ym1 is homologous to chitinase and binds heparin sulfate and GlcN oligomers (chitobiose, chitotriose, and chitotetraose), strongly suggests these proteins play an important role in airway wall remodeling in the allergic lung.	Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 2601, Australia; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Australian National University; John Curtin School of Medical Research; MRC Laboratory Molecular Biology	Foster, PS (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 2601, Australia.		Webb, Dianne C/D-8626-2011; Foster, Paul/G-5057-2013	, Paul/0000-0002-0827-8299				BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; DVORAK AM, 1988, BLOOD, V72, P150; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gonzalo JA, 1996, IMMUNITY, V4, P1, DOI 10.1016/S1074-7613(00)80293-9; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Hegele RG, 2000, IMMUNOPHARMACOLOGY, V48, P257, DOI 10.1016/S0162-3109(00)00238-1; Hogan SP, 1997, IMMUNOL CELL BIOL, V75, P284, DOI 10.1038/icb.1997.43; Hogan SP, 1998, J IMMUNOL, V161, P1501; Hogan SP, 1998, AM J RESP CRIT CARE, V157, P210, DOI 10.1164/ajrccm.157.1.9702074; Homer RJ, 2000, CLIN CHEST MED, V21, P331, DOI 10.1016/S0272-5231(05)70270-7; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Murata T, 1998, INT J MOL MED, V1, P551; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Owhashi M, 1998, PARASITOL RES, V84, P136, DOI 10.1007/s004360050370; OWHASHI M, 1987, INT ARCH ALLER A IMM, V84, P185, DOI 10.1159/000234421; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Temann UA, 1997, AM J RESP CELL MOL, V16, P471, DOI 10.1165/ajrcmb.16.4.9115759; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; Webb DC, 2000, J IMMUNOL, V165, P108, DOI 10.4049/jimmunol.165.1.108; WEBB DC, 1999, CURR OPIN ANTIINFLAM, V1, P433; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; YANG M, 2001, IN PRESS AM J RESP C; Zimmermann N, 2000, J IMMUNOL, V165, P5839, DOI 10.4049/jimmunol.165.10.5839	42	132	135	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41969	41976		10.1074/jbc.M106223200	http://dx.doi.org/10.1074/jbc.M106223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553626	hybrid			2022-12-27	WOS:000172450400058
J	Worby, CA; Simonson-Leff, N; Clemens, JC; Kruger, RP; Muda, M; Dixon, JE				Worby, CA; Simonson-Leff, N; Clemens, JC; Kruger, RP; Muda, M; Dixon, JE			The sorting nexin, DSH3PX1, connects the axonal guidance receptor, dscam, to the actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; SYNAPTIC VESICLE ENDOCYTOSIS; ADAPTER PROTEIN; SACCHAROMYCES-CEREVISIAE; MEDIATED ENDOCYTOSIS; ADHESION MOLECULE; ARP2/3 COMPLEX; DROSOPHILA; CLATHRIN; CELLS	Dock, an adaptor protein that functions in Drosophila axonal guidance, consists of three tandem Src homology 3 (SH3) domains preceding an SH2 domain. To develop a better understanding of axonal guidance at the molecular level, we used the SH2 domain of Dock to purify a protein complex from fly S2 cells. Five proteins were obtained in pure form from this protein complex. The largest protein in the complex was identified as Dscam ((D) under bar own (s) under bar yndrome (c) under bar ell (a) under bar dhesion (m) under bar olecule), which was subsequently shown to play a key role in directing neurons of the fly embryo to correct positions within the nervous system (Schmucker, D., Clemens, J. C., Shu, H., Worby, C. A., Xiao, J., Muda, M., Dixon, J. E., and Zipursky, S. L. (2000) Cell 101, 671-684). The smallest protein in this complex (p63) has now been identified. We have named p63 DSH3PXI because it appears to be the Drosophila orthologue of the human protein known as SH3PX1. DSH3PX1 is comprised of an NH2-terminal SH3 domain, an internal PHOX homology (PX) domain, and a carboxyl-terminal coiled-coil region. Because of its PX domain, DSH3PX1 is considered to be a member of a growing family of proteins known collectively as sorting nexins, some of which have been shown to be involved in vesicular trafficking. We demonstrate that DSH3PX1 immunoprecipitates with Dock and Dscam from S2 cell extracts. The domains responsible for the in vitro interaction between DSH3PX1 and Dock were also identified. We further show that DSH3PX1 interacts with the Drosophila orthologue of Wasp, a protein component of actin polymerization machinery, and that DSH3PX1 coimmunoprecipitates with AP-50, the clathrin-coat adapter protein. This evidence places DSH3PX1 in a complex linking cell surface receptors like Dscam to proteins involved in cytoskeletal rearrangements and/or receptor trafficking.	Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dixon, JE (corresponding author), Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA.				PHS HHS [18024] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Barr VA, 2000, TRAFFIC, V1, P904, DOI 10.1034/j.1600-0854.2000.011109.x; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EKENA K, 1995, MOL CELL BIOL, V15, P1671; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; She HY, 1997, MOL BIOL CELL, V8, P1709, DOI 10.1091/mbc.8.9.1709; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; WORBY CA, 1997, CELL BIOL LAB MANUAL, P1; WORBY CA, 2001, SCI STKE; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273; Zhang YQ, 1999, GENE, V233, P171, DOI 10.1016/S0378-1119(99)00142-0; Zigmond SH, 2000, J CELL BIOL, V150, pF117, DOI 10.1083/jcb.150.6.F117	52	59	61	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41782	41789		10.1074/jbc.M107080200	http://dx.doi.org/10.1074/jbc.M107080200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546816	hybrid			2022-12-27	WOS:000172450400033
J	Zhang, Z; Coomans, C; David, G				Zhang, Z; Coomans, C; David, G			Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling - Evidence in support of the "cooperative end structures" model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FGF RECEPTOR DIMERIZATION; HUMAN-LUNG FIBROBLASTS; CELL-SURFACE; CORE PROTEIN; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; LIGAND-BINDING; BFGF BINDING	Fibroblast growth factor 2 (FGF2)-initiated FGF receptor (FGFR)-signaling requires the assistance of heparin/heparan sulfate. Here, we evaluated the effects of different heparan sulfate proteoglycan (HSPG)-expressing cell lines and HSPGs derived from these cells on FGF2-induced FGFR1-phosphorylation in heparan sulfate-negative BaF3 cells. HSPGs supplied in membrane-associated form, by presenting cells, were all effective promotors of FGF2-initiated FGFR1 phosphorylation, independently of their nature (syndecan/glypican) or cellular origin (human lung fibroblasts, transfected Namalwa cells, or transfected K562 cells). A treatment with heparitinase initially stimulated, but finally completely inhibited, the activity of these presenting cells. In comparison, equivalent amounts of soluble HSPGs, obtained by trypsinization of these cells or by immunopurification from cell extracts, did not promote FGF2-induced FGFR1-phosphorylation, yet removal of the less anionic species or a further treatment with heparitinase converted these soluble fractions into potent activators of FGF2/FGFR1 signaling. Extrapolating from current structural models, we suggest that FGFR dimerization and autophosphorylation is supported by cooperative "heparin-like end structures," and that cell surface association and concentration compensate for the relative scarcity of such end structures in native HSPGs. In this model, "proteolytic" shedding of heparan sulfate would act as a diluting, down-regulatory mechanism, while "heparanolytic" shedding might act as an up-regulatory mechanism, by increasing the concentration of these end structures.	Catholic Univ Louvain, Lab Glycobiol & Dev Genet, Dept Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	Universite Catholique Louvain	David, G (corresponding author), Catholic Univ Louvain, Ctr Human Genet, Herestr 49,Campus Gasthuisberg,O&N, B-3000 Louvain, Belgium.							ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; AVIEZER D, 1994, J BIOL CHEM, V269, P114; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; Carey DJ, 1997, BIOCHEM J, V327, P1; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; DAVID G, 1990, J CELL BIOL, V111, P3165, DOI 10.1083/jcb.111.6.3165; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z; Filla MS, 1998, J CELL PHYSIOL, V174, P310, DOI 10.1002/(SICI)1097-4652(199803)174:3<310::AID-JCP5>3.0.CO;2-R; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Forsten KE, 1997, J CELL PHYSIOL, V172, P209, DOI 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S; GALLAGHER JT, 1994, EUR J CLIN CHEM CLIN, V32, P239; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; GRASSEL S, 1995, MOL CELL BIOCHEM, V145, P61, DOI 10.1007/BF00925714; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Jones M, 2000, J BIOL CHEM, V275, P7964, DOI 10.1074/jbc.275.11.7964; KATO M, 1994, J BIOL CHEM, V269, P18881; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Lin XH, 1999, DEVELOPMENT, V126, P3715; LORIES V, 1989, J BIOL CHEM, V264, P7009; LYON M, 1994, J BIOL CHEM, V269, P11208; MALI M, 1990, J BIOL CHEM, V265, P6884; MALI M, 1993, J BIOL CHEM, V268, P24215; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RICHARD C, 1995, J BIOL CHEM, V270, P24188, DOI 10.1074/jbc.270.41.24188; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Uematsu F, 2000, BIOCHEM BIOPH RES CO, V272, P830, DOI 10.1006/bbrc.2000.2872; Venkataraman G, 1996, P NATL ACAD SCI USA, V93, P845, DOI 10.1073/pnas.93.2.845; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; WALKER A, 1994, J BIOL CHEM, V269, P931; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	48	92	97	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41921	41929		10.1074/jbc.M106608200	http://dx.doi.org/10.1074/jbc.M106608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551944	hybrid			2022-12-27	WOS:000172450400051
J	Block, K; Boyer, TG; Yew, PR				Block, K; Boyer, TG; Yew, PR			Phosphorylation of the human ubiquitin-conjugating enzyme, CDC34, by casein kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; CELL-CYCLE GENE; SACCHAROMYCES-CEREVISIAE; F-BOX; DEPENDENT DEGRADATION; SUBSTRATE-SPECIFICITY; MEDIATED PROTEOLYSIS; NEDD8 MODIFICATION; PROTEIN-KINASES; COMPLEX	The ubiquitin-conjugating enzyme, CDC34, has been implicated in the ubiquitination of a number of vertebrate substrates, including p27(Kipl), I kappaB alpha, Weel, and MyoD. We show that mammalian CDC34 is a phosphoprotein that is phosphorylated in proliferating cells. By yeast two-hybrid screening, we identified the regulatory (beta) subunit of human casein kinase 2 (CK2) as a CDC34-interacting protein and show that human CDC34 interacts in vivo with CK2 beta in transfected cells. CDC34 is specifically phosphorylated in vitro by recombinant CK2 and HeLa nuclear extract at five sites within the carboxyl-terminal 36 amino acids of CDC34. Importantly, this phosphorylation is inhibited by heparin, a substrate-specific inhibitor of CK2. We have also identified a kinase activity associated with CDC34 in proliferating cells, and we show that this kinase is sensitive to heparin and can utilize GTP, strongly suggesting it is CK2. Phosphorylation of CDC34 by the associated kinase maps predominantly to residues 203 and 222. Mutation of CDC34 at CK2-targeted residues, Ser-203, Ser-222, Ser-231, Thr-233, and Ser-236, abolishes the phosphorylation of CDC34 observed in vivo and markedly shifts nuclearly localized CDC34 to the cytoplasm. These results suggest a potential role for CK2-mediated phosphorylation in the regulation of CDC34 cell localization and function.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Yew, PR (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	yew@uthscsa.edu						ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DeSalle LM, 2001, FEBS LETT, V490, P179, DOI 10.1016/S0014-5793(01)02121-4; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOEBL MG, 1994, MOL CELL BIOL, V14, P3022, DOI 10.1128/MCB.14.5.3022; Gray N, 1999, CURR MED CHEM, V6, P859; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Mathias N, 1999, MOL CELL BIOL, V19, P1759; MEGGIO F, 1983, FEBS LETT, V160, P203, DOI 10.1016/0014-5793(83)80967-3; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Mitev Vanio, 1994, Journal of Dermatological Science, V8, P45, DOI 10.1016/0923-1811(94)90320-4; MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Pati D, 1999, MOL CELL BIOL, V19, P5001; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; PLON SE, 1993, P NATL ACAD SCI USA, V90, P10484, DOI 10.1073/pnas.90.22.10484; PTAK C, 1994, J BIOL CHEM, V269, P26539; Raymond F, 2000, J CELL SCI, V113, P1687; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Taylor JA, 1999, J MOL BIOL, V290, P839, DOI 10.1006/jmbi.1999.2912; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Yew PR, 1997, SCIENCE, V277, P1672, DOI 10.1126/science.277.5332.1672; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yew PR, 2001, J CELL PHYSIOL, V187, P1, DOI 10.1002/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO;2-O; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	59	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41049	41058		10.1074/jbc.M106453200	http://dx.doi.org/10.1074/jbc.M106453200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546811	hybrid			2022-12-27	WOS:000171925600091
J	Cervoni, N; Szyf, M				Cervoni, N; Szyf, M			Demethylase activity is directed by histone acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; TRANSCRIPTIONAL REGULATION; DEACETYLASE COMPLEX; GENE; CHROMATIN; PROTEIN; ACTIVATION; REPRESSION; INHIBITION; MECHANISM	Mammalian genomes are compartmentalized into dense inactive chromatin that is hypermethylated and active open chromatin that is hypomethylated. It is generally accepted that this bimodal pattern of methylation is established during development and is then faithfully inherited through subsequent cell divisions by a maintenance DNA methyltransferase (DNMT1). The pattern of methylation is believed to direct local histone acetylation states. In contrast to this well accepted consensus, we show here using a transient transfection model that an active demethylase is involved in shaping patterns of methylation in somatic cells. Demethylase activity is directed by the state of histone acetylation, and therefore, the resulting methylation pattern is determined by local histone acetylation states contrary to the accepted model. Our data support a new model suggesting that the pattern of methylation is maintained by a dynamic balance of methylation and demethylation activities and the local state of histone acetylation. This provides a simple mechanism for explaining why active genes are not methylated.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cervoni N, 1999, J BIOL CHEM, V274, P8363, DOI 10.1074/jbc.274.13.8363; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; Hu JF, 2000, ENDOCRINOLOGY, V141, P4428, DOI 10.1210/en.141.12.4428; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MCWHINNEY C, 1990, NUCLEIC ACIDS RES, V18, P1233, DOI 10.1093/nar/18.5.1233; Milutinovic S, 2000, J BIOL CHEM, V275, P6353, DOI 10.1074/jbc.275.9.6353; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nguyen TT, 2000, PROSTATE, V43, P233; NUR I, 1985, J BACTERIOL, V164, P19, DOI 10.1128/JB.164.1.19-24.1985; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; RAMAIN P, 1986, CELL, V45, P545, DOI 10.1016/0092-8674(86)90286-2; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1977, P NATL ACAD SCI USA, V74, P2725, DOI 10.1073/pnas.74.7.2725; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; SHAPIRO GI, 1995, CANCER RES, V55, P6200; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Stunkel W, 2001, J BIOL CHEM, V276, P20743, DOI 10.1074/jbc.M010967200; SUN YL, 1986, EMBO J, V5, P293, DOI 10.1002/j.1460-2075.1986.tb04212.x; SZYF M, 1985, P NATL ACAD SCI USA, V82, P8090, DOI 10.1073/pnas.82.23.8090; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	37	230	247	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40778	40787		10.1074/jbc.M103921200	http://dx.doi.org/10.1074/jbc.M103921200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524416	hybrid			2022-12-27	WOS:000171925600055
J	Knipp, M; Charnock, JM; Garner, CD; Vasak, M				Knipp, M; Charnock, JM; Garner, CD; Vasak, M			Structural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain - Zn(II) release activates DDAH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RAY-ABSORPTION-SPECTROSCOPY; ZINC-BINDING SITES; N-G,N-G-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE; ENDOTHELIAL DYSFUNCTION; MONOCLONAL-ANTIBODY; PROTEIN; METHYLARGININES; INHIBITOR; DISEASE	L-N-omega,N-omega-Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) is a Zn(II)-containing enzyme that, through hydrolysis of side-chain methylated L-arginines, regulates the activity of nitric-oxide synthase. Herein we report the structural and functional properties of the Zn(II)-binding site in DDAH-1 from bovine brain. Activity measurements of the native and metal-free enzyme have revealed that the endogenously bound Zn(II) inhibits the enzyme. Native DDAH-1 could be fully or partially activated using various concentrations of phosphate, imidazole, histidine, and histamine, a process that is paralleled by the release of Zn(II). The slow activation of the enzyme by the bulky complexing agents EDTA and 1,10-phenantroline suggests that the Zn(II)-binding site is partially buried in the protein structure. The apparent Zn(II)-dissociation constant of 4.2 nM, determined by F-19 NMR using the chelator 5F-BAPTA (1,2-bis(2-amino-5-fluorophenoxy)ethane-N,N,N',N'-tetraacetic acid), lies in the range of intracellular free Zn(II) concentrations. These results suggest a regulatory role for the Zn(II)binding site. The coordination environment of the Zn(II) in DDAH-1 has been examined by Zn K-edge x-ray absorption spectroscopy. The extended x-ray absorption fine structure observed is consistent with Zn(II) being coordinated by 2 S and 2 N (or O) atoms. The biological implications of these findings are discussed.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England; Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England	University of Zurich; University of Manchester; University of Nottingham	Vasak, M (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	mvasak@bioc.unizh.ch						Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; AULD DS, 1988, METHOD ENZYMOL, V158, P13, DOI 10.1016/0076-6879(88)58043-6; BINSTED N, 1998, CLRC DARESBURY LAB E; Birdsey GM, 2000, ACTA PHYSIOL SCAND, V168, P73; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Bogumil R, 1998, BIOCHEMISTRY-US, V37, P4791, DOI 10.1021/bi972312t; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Clark-Baldwin K, 1998, J AM CHEM SOC, V120, P8401, DOI 10.1021/ja980580o; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; CREAGER MA, 1992, J CLIN INVEST, V90, P1248, DOI 10.1172/JCI115987; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Dawson TM, 1996, ANNU REV MED, V47, P219, DOI 10.1146/annurev.med.47.1.219; DIAKUN GP, 1986, NATURE, V324, P698, DOI 10.1038/324698a0; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Fickling SA, 1993, ENDOTHELIUM, V1, P137; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; Fundel SM, 1996, FEBS LETT, V395, P33, DOI 10.1016/0014-5793(96)00997-0; GARNER CD, 1991, ADV INORG CHEM, V36, P303, DOI 10.1016/S0898-8838(08)60042-2; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Grover R, 1999, CRIT CARE MED, V27, P913, DOI 10.1097/00003246-199905000-00025; GURMAN SJ, 1984, J PHYS C SOLID STATE, V17, P143, DOI 10.1088/0022-3719/17/1/019; Hasler DW, 2000, BIOCHEMISTRY-US, V39, P14567, DOI 10.1021/bi001569f; Hedin L., 1969, SOLID STATE PHYS, V23, P1, DOI [10.1016/S0081-1947(08)60615-3, DOI 10.1016/S0081-1947(08)60615-3]; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jacquamet L, 1998, BIOCHEMISTRY-US, V37, P2564, DOI 10.1021/bi9721344; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; KIMOTO M, 1993, ARCH BIOCHEM BIOPHYS, V300, P657, DOI 10.1006/abbi.1993.1091; Kimoto M, 1997, BBA-PROTEIN STRUCT M, V1337, P6, DOI 10.1016/S0167-4838(96)00196-3; KIMOTO M, 1995, J BIOCHEM-TOKYO, V117, P237, DOI 10.1093/jb/117.2.237; Kimoto M, 1998, EUR J BIOCHEM, V258, P863, DOI 10.1046/j.1432-1327.1998.2580863.x; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; KOTANI K, 1992, J NEUROCHEM, V58, P1127, DOI 10.1111/j.1471-4159.1992.tb09371.x; KROTKIEWSKA B, 1992, INT J BIOCHEM, V24, P1501, DOI 10.1016/0020-711X(92)90078-F; Lassen LH, 1998, CEPHALALGIA, V18, P27, DOI 10.1046/j.1468-2982.1998.1801027.x; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; LONG GJ, 1994, J BIOL CHEM, V269, P834; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MCDERMOTT JR, 1976, BIOCHEM J, V154, P179, DOI 10.1042/bj1540179; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Murphy MP, 1999, BBA-BIOENERGETICS, V1411, P401, DOI 10.1016/S0005-2728(99)00029-8; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Nakagomi S, 1999, EUR J NEUROSCI, V11, P2160, DOI 10.1046/j.1460-9568.1999.00634.x; OGAWA T, 1989, J BIOL CHEM, V264, P10205; OGAWA T, 1987, BIOCHEM BIOPH RES CO, V148, P671, DOI 10.1016/0006-291X(87)90929-6; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Sayre LM, 1999, CURR OPIN CHEM BIOL, V3, P220, DOI 10.1016/S1367-5931(99)80035-0; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Smith MA, 1998, FREE RADICAL BIO MED, V25, P898, DOI 10.1016/S0891-5849(98)00119-1; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Tsao PS, 1998, J CARDIOVASC PHARM, V32, pS48; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; UENO S, 1992, J NEUROCHEM, V59, P2012; VALLANCE P, 1992, LANCET, V339, P572; VANSOMMEREN APG, 1993, J CHROMATOGR, V639, P23, DOI 10.1016/0021-9673(93)83084-6; Wilcox CS, 1998, CURR OPIN NEPHROL HY, V7, P443; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	64	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40449	40456		10.1074/jbc.M104056200	http://dx.doi.org/10.1074/jbc.M104056200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546769	hybrid			2022-12-27	WOS:000171925600014
J	Moudy, R; Manning, TJ; Beckers, CJ				Moudy, R; Manning, TJ; Beckers, CJ			The loss of cytoplasmic potassium upon host cell breakdown triggers egress of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE; MICRONEME PROTEIN; INVASION; MOBILIZATION; PARASITES; SURFACE; BINDS; EXIT	The ability of intracellular parasites to monitor the viability of their host cells is essential for their survival. The protozoan parasite Toxoplasma gondii actively invades nucleated animal cells and replicates in their cytoplasm. Two to 3 days after infection, the parasite-filled host cell breaks down and the parasites leave to initiate infection of a new cell. Parasite egress from the host cell is triggered by rupture of the host plasma membrane and the ensuing reduction in the concentration of cytoplasmic potassium. The many other changes in host cell composition do not appear be used as triggers. The reduction in the host cell [K+] appears to activate a phospholipase C activity in Toxoplasma that, in turn, causes an increase in cytoplasmic [Ca2+] in the parasite. The latter appears to be necessary and sufficient for inducing egress, as buffering of cytoplasmic Ca2+ blocks egress and calcium ionophores circumvent the need for a reduction of host cell [K+] and parasite phospholipase C activation. The increase in [Ca2+]c brings about egress by the activation of at least two signaling pathways: the protein kinase TgCDPK1 and the calmodulin-dependent protein phosphatase calcineurin.	Univ Alabama, Div Geog Med, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beckers, CJ (corresponding author), Univ Alabama, Div Geog Med, Dept Med, Birmingham, AL 35294 USA.				NIAID NIH HHS [AI41765] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041765, R29AI041765] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Fourmaux MN, 1996, MOL BIOCHEM PARASIT, V83, P201, DOI 10.1016/S0166-6851(96)02773-9; FRENKEL JK, 1988, PARASITOL TODAY, V4, P273, DOI 10.1016/0169-4758(88)90018-X; Garcia-Reguet N, 2000, CELL MICROBIOL, V2, P353, DOI 10.1046/j.1462-5822.2000.00064.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Manning TJ, 1997, GLIA, V20, P163, DOI 10.1002/(SICI)1098-1136(199706)20:2<163::AID-GLIA8>3.0.CO;2-A; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Moreno SNJ, 1998, BIOCHEM J, V330, P853; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Stommel EW, 1997, EXP PARASITOL, V87, P88, DOI 10.1006/expr.1997.4187; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856	21	159	164	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41492	41501		10.1074/jbc.M106154200	http://dx.doi.org/10.1074/jbc.M106154200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526113	hybrid			2022-12-27	WOS:000171925600147
J	Saito, H; Dhanasekaran, P; Baldwin, F; Weisgraber, KH; Lund-Katz, S; Phillips, MC				Saito, H; Dhanasekaran, P; Baldwin, F; Weisgraber, KH; Lund-Katz, S; Phillips, MC			Lipid binding-induced conformational change in human apolipoprotein E - Evidence for two lipid-bound states on spherical particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; TRIGLYCERIDE-RICH LIPOPROTEINS; AMPHIPATHIC HELICAL PEPTIDES; HUMAN PLASMA-LIPOPROTEINS; RECEPTOR-RELATED PROTEIN; N-TERMINAL DOMAIN; CHYLOMICRON REMNANTS; UNILAMELLAR VESICLES; A-I; CHOLESTEROL	Apolipoprotein (apo) E contains two structural domains, a 22-kDa (amino acids 1-191) N-terminal domain and a 10-kDa (amino acids 223-299) C-terminal domain. To better understand apoE-lipid interactions on lipoprotein surfaces, we determined the thermodynamic parameters for binding of apoE4 and its 22- and 10-kDa fragments to triolein-egg phosphatidylcholine emulsions using a centrifugation assay and titration calorimetry. In both large (120 nm) and small (35 nm) emulsion particles, the binding affinities decreased in the order 10-kDa fragment approximate to 34-kDa intact apoE4 > 22-kDa fragment, whereas the maximal binding capacity of intact apoE4 was much larger than those of the 22- and 10-kDa fragments. These results suggest that at maximal binding, the binding behavior of intact apoE4 is different from that of each fragment and that the N-terminal domain of intact apoE4 does not contact lipid. Isothermal titration calorimetry measurements showed that apoE binding to emulsions was an exothermic process. Binding to large particles is enthalpically driven, and binding to small particles is entropically driven. At a low surface concentration of protein, the binding enthalpy of intact apoE4 (-69 kcal/mol) was approximately equal to the sum of the enthalpies for the 22- and 10-kDa fragments, indicating that both the 22- and 10-kDa fragments interact with lipids. In a saturated condition, however, the binding enthalpy of intact apoE4 (-39 kcal/mol) was less exothermic and rather similar to that of each fragment, supporting the hypothesis that only the C-terminal domain of intact apoE4 binds to lipid. We conclude that the N-terminal four-helix bundle can adopt either open or closed conformations, depending upon the surface concentration of emulsion-bound apoE.	Univ Penn, Sch Med, Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Phillips, MC (corresponding author), Univ Penn, Sch Med, Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Abramson Res Bldg,Suite 302,3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.			Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056083, P01HL041633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41633, HL56083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AITO H, 2001, LANGMUIR, V17, P2528; BORENSZTAJN J, 1988, J LIPID RES, V29, P1087; BRASAEMLE DL, 1993, J LIPID RES, V34, P455; DEPAUW M, 1995, BIOCHEMISTRY-US, V34, P1093; Derksen A, 1996, BIOPHYS J, V70, P330, DOI 10.1016/S0006-3495(96)79574-7; DERKSEN A, 1989, BIOCHEMISTRY-US, V28, P900, DOI 10.1021/bi00428a074; Dong LM, 1998, J LIPID RES, V39, P1173; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Fisher CA, 1999, J LIPID RES, V40, P93; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Gazzara JA, 1997, J LIPID RES, V38, P2147; Gazzara JA, 1997, J LIPID RES, V38, P2134; GIANTURCO SH, 1983, J BIOL CHEM, V258, P4526; IBDAH JA, 1988, BIOCHEMISTRY-US, V27, P7155, DOI 10.1021/bi00418a073; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; Kypreos KE, 2001, BIOCHEMISTRY-US, V40, P6027, DOI 10.1021/bi002414a; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Lund-Katz S, 2000, J BIOL CHEM, V275, P34459, DOI 10.1074/jbc.M005265200; Lund-Katz S, 2001, J LIPID RES, V42, P894; LUNDKATZ S, 1993, J BIOL CHEM, V268, P23008; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1995, METABOLIC MOL BASES, P1953; Massey JB, 1998, BIOPHYS J, V74, P869, DOI 10.1016/S0006-3495(98)74010-X; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; Saito H, 1996, J BIOL CHEM, V271, P15515, DOI 10.1074/jbc.271.26.15515; Saito H, 1997, J LIPID RES, V38, P287; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Segelke BW, 2000, PROTEIN SCI, V9, P886, DOI 10.1110/ps.9.5.886; SEHAYEK E, 1991, J CLIN INVEST, V88, P553, DOI 10.1172/JCI115339; TAJIMA S, 1983, J BIOL CHEM, V258, P73; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WEISGRABER KH, 1992, HIGH DENSITY LIPOPRO, V3, P175; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; Wieprecht T, 2000, BIOPHYS CHEM, V85, P187, DOI 10.1016/S0301-4622(00)00120-4; WINDLER E, 1980, J BIOL CHEM, V255, P8303; WINDLER E, 1985, J LIPID RES, V26, P556; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375	49	102	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40949	40954		10.1074/jbc.M106337200	http://dx.doi.org/10.1074/jbc.M106337200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533033	hybrid			2022-12-27	WOS:000171925600077
J	Tong, JF; Killeen, M; Steven, R; Binns, KL; Culotti, J; Pawson, T				Tong, JF; Killeen, M; Steven, R; Binns, KL; Culotti, J; Pawson, T			Netrin stimulates tyrosine phosphorylation of the UNC-5 family of netrin receptors and induces Shp2 binding to the RCM cytodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE GUIDANCE; AXON GUIDANCE; C-ELEGANS; CAENORHABDITIS-ELEGANS; COLORECTAL-CANCER; GENETIC-ANALYSIS; EPH RECEPTOR; SIGNAL-TRANSDUCTION; LIGAND ACTIVATION; DROSOPHILA EMBRYO	Caenorhabditis elegans UNC-5 and its mammalian homologues such as RCM are receptors for the secreted axon guidance cue UNC-6/netrin and are required to mediate the repulsive effects of UNC-6/netrin on growth cones. We find that C. elegans UNC-5 and mouse RCM are phosphorylated on tyrosine in vivo. C. elegans UNC-5 tyrosine phosphorylation is reduced in unc-6 null mutants, and RCM tyrosine phosphorylation is induced by netrin-1 in transfected HEK-293 cells, demonstrating that phosphorylation of UNC-5 proteins is enhanced by UNC-6/netrin stimulation in both worms and mammalian cells. An activated Src tyrosine kinase induces phosphorylation of RCM at multiple cytoplasmic tyrosine residues creating potential binding sites for cytoplasmic signaling proteins. Indeed, the NH2-terminal SH2 domain of the Shp2 tyrosine phosphatase bound specifically to a Tyr(568) RCM phosphopeptide. Furthermore, Shp2 associated with RCM in a netrin-dependent manner in transfected cells, and co-immunoprecipitated with RCM from an embryonic mouse brain lysate. A Y568F mutant RCM receptor failed to bind Shp2 and was more highly phosphorylated on tyrosine than the wild type receptor. These results suggest that netrin-stimulated phosphorylation of RCM Tyr(568) recruits Shp2 to the cell membrane where it can potentially modify RCM phosphorylation and function.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	Pawson@mshri.on.ca	Culotti, Joseph/G-6467-2013; Pawson, Tony J/E-4578-2013; Killeen, Marie/C-1131-2012	Killeen, Marie/0000-0001-9404-4845; Culotti, Joseph/0000-0001-6325-4612				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; BRENNER S, 1974, GENETICS, V77, P71; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Galko MJ, 2000, J BIOL CHEM, V275, P7832, DOI 10.1074/jbc.275.11.7832; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Klein R, 1999, CURR BIOL, V9, pR691, DOI 10.1016/S0960-9822(99)80441-2; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LIU XQ, 1994, RECENT PROG HORM RES, V49, P149; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Pawson T, 2000, GENE DEV, V14, P1027; Saxton TM, 1999, P NATL ACAD SCI USA, V96, P3790, DOI 10.1073/pnas.96.7.3790; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Sun Q, 2000, DEVELOPMENT, V127, P801; Tallquist MD, 2000, GENE DEV, V14, P3179, DOI 10.1101/gad.844700; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Van Vactor D, 1998, CURR OPIN GENET DEV, V8, P112, DOI 10.1016/S0959-437X(98)80070-1; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	58	50	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40917	40925		10.1074/jbc.M103872200	http://dx.doi.org/10.1074/jbc.M103872200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533026	hybrid			2022-12-27	WOS:000171925600073
J	Xi, X; Han, JH; Zhang, JZ				Xi, X; Han, JH; Zhang, JZ			Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; SELECTIVE ACTIVATION; GLUT4 TRANSLOCATION; SIGNAL-TRANSDUCTION; CLONE-9 CELLS; INSULIN	Activation of AMP-activated protein kinase (AMPK) has been recently demonstrated to be associated with 5-aminoimidazole-4-carboxa;de ribonucleoside (AICAR)stimulated glucose transport mediated by both GLUT1 and GLUT4 transporters. However, signaling events upstream and downstream of AMPK are unknown. Here we report that 1) p38 mitogen-activated protein kinase (MAPK) and mitogen-activated protein kinase kinase 3 (MKK3) were activated by AICAR in Clone 9 cells, which express only the GLUT1 transporters, and 2) activation of p38 was required for AICAR-stimulated glucose transport since treatment of the cells with p38 inhibitor SB203580 or overexpression of dominant negative p38 mutant inhibited glucose transport. Moreover, we found that overexpression of the constitutively active form of AMPK mutant also resulted in a significant activation of p38, and inhibition of p38 activity by SB203580 did not affect AICAR-stimulated activation of AMPK. These findings demonstrate that AICAR-stimulated activation of p38 is indeed mediated by AMPK, and the p38 MAPK cascade is downstream of AMPK in the signaling pathway of AICAR-stimulated glucose transport in Clone 9 cells.	Case Western Reserve Univ, Dept Med, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Case Western Reserve University; Scripps Research Institute	Zhang, JZ (corresponding author), Case Western Reserve Univ, Dept Med, Div Clin & Mol Endocrinol, 2109 Adelbert Rd, Cleveland, OH 44106 USA.		Han, J/G-4671-2010					Abbud W, 2000, ARCH BIOCHEM BIOPHYS, V380, P347, DOI 10.1006/abbi.2000.1935; Barros LF, 1997, J PHYSIOL-LONDON, V504, P517, DOI 10.1111/j.1469-7793.1997.517bd.x; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Derave W, 2000, DIABETES, V49, P1281, DOI 10.2337/diabetes.49.8.1281; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fujishiro M, 2001, J BIOL CHEM, V276, P19800, DOI 10.1074/jbc.M101087200; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hansen PA, 1998, J BIOL CHEM, V273, P18173, DOI 10.1074/jbc.273.29.18173; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; ISMAILBEIGI F, 1993, J MEMBRANE BIOL, V135, P1; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Koseoglu MH, 1999, MOL CELL BIOCHEM, V194, P109, DOI 10.1023/A:1006965106331; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Ryder JW, 2000, J BIOL CHEM, V275, P1457, DOI 10.1074/jbc.275.2.1457; Salt IP, 2000, DIABETES, V49, P1649, DOI 10.2337/diabetes.49.10.1649; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SHETTY M, 1992, AM J PHYSIOL, V262, pC527, DOI 10.1152/ajpcell.1992.262.2.C527; SHETTY M, 1993, J BIOL CHEM, V268, P17225; SHI YW, 1995, J BIOL CHEM, V270, P21772, DOI 10.1074/jbc.270.37.21772; Snedecor G W, 1976, STAT METHODS; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Tong HY, 2000, J BIOL CHEM, V275, P11981, DOI 10.1074/jbc.275.16.11981; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Yamamoto Y, 2000, DIABETES, V49, P332, DOI 10.2337/diabetes.49.3.332; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277	49	154	164	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41029	41034		10.1074/jbc.M102824200	http://dx.doi.org/10.1074/jbc.M102824200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546797	hybrid			2022-12-27	WOS:000171925600088
J	Filipe, SR; Severina, E; Tomasz, A				Filipe, SR; Severina, E; Tomasz, A			Functional analysis of Streptococcus pneumoniae MurM reveals the region responsible for its specificity in the synthesis of branched cell wall peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-TRANSFORMATION; PENICILLIN RESISTANCE; PEPTIDOGLYCAN; EXPRESSION; COMPETENCE; VARIANTS; STRAINS; MUREIN; MUTANT; DNA	The recently identified murMN operon of Streptococcus pneumoniae encodes enzymes involved in the synthesis of branched structured muropeptides of the pneumococcal cell wall peptidoglycan. Its inactivation was shown to cause production of a peptidoglycan composed exclusively of linear muropeptides and a virtually complete loss of resistance in penicillin-resistant strains. The studies described in this communication follow up these observations in several directions. The substrate of the MurM-catalyzed reaction (addition of alanine or serine) was identified as the lipid-linked N-acetylglucosamine-muramyl pentapeptide. Different murM alleles from several penicillin-resistant S. pneumoniae strains, each with a characteristic branched peptide pattern, were cloned into pLS578, a pneumococcal plasmid capable of replicating in S. pneumoniae, and transformed into the penicillin-susceptible laboratory strain R36A All transformants remained penicillin-susceptible; however, their cell wall composition changed in directions corresponding to the muropeptide pattern of the strain from which the murM allele was derived. This suggests that the muropeptide composition of the pneumococcal cell walls is determined by the particular murM allele carried by the cells. A 30-amino acid long sequence within the MurM protein was shown to be the main determinant of the specificity of the reaction (addition of alanine versus serine).	Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia; Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Unit, P-2780 Oeiras, Portugal	Rockefeller University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Universidade Nova de Lisboa	Tomasz, A (corresponding author), Rockefeller Univ, Microbiol Lab, 1230 York Ave, New York, NY 10021 USA.		Filipe, Sergio Raposo/B-9167-2008	Filipe, Sergio Raposo/0000-0002-4485-832X; Tomasz, Alexander/0000-0003-1520-1983	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037275] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI37275] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atherton D., 1989, TECHNIQUES PROTEIN C, P273; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; CHEN JD, 1988, GENE, V64, P155, DOI 10.1016/0378-1119(88)90489-1; Corso A, 1998, MICROB DRUG RESIST, V4, P325, DOI 10.1089/mdr.1998.4.325; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; GARCIABUSTOS JF, 1987, J BIOL CHEM, V262, P15400; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; HEDGE SS, 2001, J BIOL CHEM, V276, P6998; KOHLRAUSCH U, 1991, J BACTERIOL, V173, P3425, DOI 10.1128/jb.173.11.3425-3431.1991; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; ORNELASSOARES A, 1994, J BIOL CHEM, V269, P27246; PLAPP R, 1970, J BIOL CHEM, V245, P3675; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Severin A, 1996, J BACTERIOL, V178, P1788, DOI 10.1128/jb.178.7.1788-1792.1996; Severin A, 1996, J BACTERIOL, V178, P168, DOI 10.1128/jb.178.1.168-174.1996; SEVERIN A, 1992, J BACTERIOL, V174, P5152, DOI 10.1128/JB.174.15.5152-5155.1992; ZIGHELBOIM S, 1980, ANTIMICROB AGENTS CH, V17, P434, DOI 10.1128/AAC.17.3.434	26	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39618	39628		10.1074/jbc.M106425200	http://dx.doi.org/10.1074/jbc.M106425200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11522792	hybrid			2022-12-27	WOS:000171789200017
J	Bai, XM; Zhou, DP; Brown, JR; Crawford, BE; Hennet, T; Esko, JD				Bai, XM; Zhou, DP; Brown, JR; Crawford, BE; Hennet, T; Esko, JD			Biosynthesis of the linkage region of glycosaminoglycans - Cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE BIOSYNTHESIS; UDP-GALACTOSE; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; EXPRESSION CLONING; PROTEIN; GENE; IDENTIFICATION; GLYCOPROTEINS; CHONDROITIN	A family of five beta1,3-galactosyltransferases has been characterized that catalyze the formation of Gal beta1, 3GlcNAc beta and Gal beta1,3GalNAc beta linkages present in glycoproteins and glycolipids (beta 3Ga1T1, -2, -3, -4, and -5). We now report a new member of the family (beta 3GalT6), involved in glycosaminoglycan biosynthesis. The human and mouse genes were located on chromosomes 1p36.3 and 4E2, respectively, and homologs are found in Drosophila melanogaster and Caenorhabditis elegans. Unlike other members of the family, beta 3GalT6 showed a broad mRNA expression pattern by Northern blot analysis. Although a high degree of homology across several subdomains exists among other members of the beta3-galactosyltransferase family, recombinant enzyme did not utilize glucosamine- or galactosamine-containing acceptors. Instead, the enzyme transferred galactose from UDP-galactose to acceptors containing a terminal beta -linked galactose residue. This product, Gal beta1,3Gal beta is found in the linkage region of heparan sulfate and chondroitin sulfate (GlcA beta1, 3Gal beta1, 3Gal beta1, 4Xyl beta -O-Ser), indicating that beta 3GalT6 is the so-called galactosyltransferase II involved in glycosaminoglycan biosynthesis. Its identity was confirmed in vivo by siRNA-mediated inhibition of glycosaminoglycan synthesis in HeLa S3 cells. Its localization in the medial Golgi indicates that this is the major site for assembly of the linkage region.	Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	University of California System; University of California San Diego; University of Zurich	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jesko@ucsd.edu	zhou, dapeng/GXG-9715-2022; Zhou, Dapeng/A-6446-2019	Zhou, Dapeng/0000-0003-1347-3811	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal PK, 1999, GLYCOBIOLOGY, V9, P669, DOI 10.1093/glycob/9.7.669; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Brown JR, 2001, BIOORGAN MED CHEM, V9, P815, DOI 10.1016/S0968-0896(00)00300-X; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; HELTING T, 1969, J BIOL CHEM, V244, P2790; Henion TR, 2001, J BIOL CHEM, V276, P30261, DOI 10.1074/jbc.M102979200; Hennet T, 1998, J BIOL CHEM, V273, P58, DOI 10.1074/jbc.273.1.58; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kolbinger F, 1998, J BIOL CHEM, V273, P433, DOI 10.1074/jbc.273.1.433; KRISHNA NR, 1990, J BIOL CHEM, V265, P18256; Krishna NR, 2001, ADV CARBOHYD CHEM BI, V56, P201; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Okajima T, 2000, J BIOL CHEM, V275, P40498, DOI 10.1074/jbc.M006902200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Qian R, 2001, J BIOL CHEM, V276, P28641, DOI 10.1074/jbc.M103664200; Salvini R, 2001, J BIOL CHEM, V276, P3564, DOI 10.1074/jbc.M006662200; Sarkar AK, 2000, CARBOHYD RES, V329, P287, DOI 10.1016/S0008-6215(00)00200-7; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; SIAKOTOS AN, 1965, J AM OIL CHEM SOC, V42, P913, DOI 10.1007/BF02632444; TOYAYACHI A, 2001, J BIOL CHEM, V276, P22032; VANHALBEEK H, 1982, EUR J BIOCHEM, V127, P1; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; Wei G, 1999, J BIOL CHEM, V274, P7857, DOI 10.1074/jbc.274.12.7857; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8; Zhou DP, 2000, P NATL ACAD SCI USA, V97, P11673; Zhou DP, 1999, EUR J BIOCHEM, V263, P571, DOI 10.1046/j.1432-1327.1999.00541.x; Zhou DP, 2000, J BIOL CHEM, V275, P22631, DOI 10.1074/jbc.C000263200	45	129	138	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2001	276	51					48189	48195		10.1074/jbc.M107339200	http://dx.doi.org/10.1074/jbc.M107339200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505QL	11551958	hybrid			2022-12-27	WOS:000172927000061
J	Kanamaru, C; Yasuda, H; Takeda, M; Ueda, N; Suzuki, J; Tsuchida, T; Mashima, H; Ohnishi, H; Fujita, T				Kanamaru, C; Yasuda, H; Takeda, M; Ueda, N; Suzuki, J; Tsuchida, T; Mashima, H; Ohnishi, H; Fujita, T			Smad7 is induced by norepinephrine and protects rat hepatocytes from activin A-induced growth inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TGF-BETA RECEPTOR; LIVER-REGENERATION; DNA-SYNTHESIS; AUTOCRINE INHIBITOR; PARTIAL-HEPATECTOMY; GENE-EXPRESSION; ACTIVATION; CELLS	Activin A induces growth arrest of rat hepatocytes in vitro and in vivo. The alpha (1)-adrenergic agonist, norepinephrine (NE), enhances epidermal growth factor-stimulated DNA synthesis and inhibits activin A-induced growth inhibition, but the mechanisms of these actions are unclear. Smad proteins have recently been identified as intracellular signaling mediators of transforming growth factor-beta family members. In the present study, we explored how NE modulates the Smad signaling pathway in rat cultured hepatocytes. We demonstrate that NE inhibits activin A-induced nuclear accumulation of Smad2/3 and that NE rapidly induces inhibitory Smad7 mRNA expression. Infection of Smad7 adenovirus into rat hepatocytes inhibited activin A-induced nuclear accumulation of Smad2/3, enhanced epidermal growth factor-stimulated DNA synthesis, and abolished the growth inhibitory effect of activin A. We also demonstrated that the induction of Smad7 by NE is dependent on nuclear factor-kappaB (NF-kappaB). The amount of active NF-kappaB complex rapidly increased after NE treatment. Preincubation of the cells with an NF-kappaB pathway inhibitor N-tosyl-L-phenylalanine chloromethyl ketone or infection of the cells with an adenovirus expressing an I kappaB super-repressor (Ad5I kappaB) abolished the NE-induced Smad7 expression. These results indicate a mechanism of transmodulation between the Smad and trimeric G protein signaling pathways in rat hepatocytes.	Univ Tokyo, Sch Med, Dept Med, Tokyo 1138655, Japan	University of Tokyo	Yasuda, H (corresponding author), Univ Tokyo, Sch Med, Dept Med, 7-3-1 Hongo, Tokyo 1138655, Japan.	YASUDA-DIS@h.u-tokyo.ac.jp	Mashima, Hirosato/ABE-6412-2020					BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; Bitzer M, 2000, GENE DEV, V14, P187; BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539; Cowen DS, 1997, MOL PHARMACOL, V52, P221, DOI 10.1124/mol.52.2.221; CRUISE JL, 1985, SCIENCE, V227, P749, DOI 10.1126/science.2982212; CRUISE JL, 1987, HEPATOLOGY, V7, P1189, DOI 10.1002/hep.1840070604; Dajani OF, 1999, J CELL PHYSIOL, V180, P203, DOI 10.1002/(SICI)1097-4652(199908)180:2<203::AID-JCP8>3.3.CO;2-K; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOUCK KA, 1988, J CELL PHYSIOL, V135, P551, DOI 10.1002/jcp.1041350327; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishisaki A, 1998, J BIOL CHEM, V273, P24293, DOI 10.1074/jbc.273.38.24293; KAJIYAMA Y, 1994, BIOCHEM J, V303, P313, DOI 10.1042/bj3030313; Kajiyama Y, 1998, CELL SIGNAL, V10, P241, DOI 10.1016/S0898-6568(97)00122-8; KISO S, 1995, HEPATOLOGY, V22, P1584, DOI 10.1016/0270-9139(95)90168-X; Kogure K, 2000, HEPATOLOGY, V31, P916, DOI 10.1053/he.2000.6100; KOGURE K, 1995, GASTROENTEROLOGY, V108, P1136, DOI 10.1016/0016-5085(95)90212-0; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lieb K, 1997, J IMMUNOL, V159, P4952; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MARI B, 1994, J BIOL CHEM, V269, P8517; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuzaki K, 2000, HEPATOLOGY, V32, P218, DOI 10.1053/jhep.2000.9145; MCNIEL PL, 1985, J CELL BIOL, V101, P372; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Rahman A, 1999, J IMMUNOL, V162, P5466; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; Shahrestanifar M, 1999, J BIOL CHEM, V274, P3828, DOI 10.1074/jbc.274.6.3828; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727; Zhang YQ, 1996, HEPATOLOGY, V23, P288	51	20	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45636	45641		10.1074/jbc.M105302200	http://dx.doi.org/10.1074/jbc.M105302200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551920	hybrid			2022-12-27	WOS:000172573100021
J	Kumar, JK; Kremsdorf, R; Tabor, S; Richardson, CC				Kumar, JK; Kremsdorf, R; Tabor, S; Richardson, CC			A mutation in the gene-encoding bacteriophage T7 DNA polymerase that renders the phage temperature-sensitive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID POLYMERASE; ESCHERICHIA-COLI; EXONUCLEASE ACTIVITY; REPLICATION INVITRO; PROTEIN STABILITY; FOLDING KINETICS; MUTANTS; THIOREDOXIN; COMPLEXES; FRAGMENT	Gene 5 of bacteriophage T7 encodes a DNA polymerase essential for phage replication. A single point mutation in gene 5 confers temperature sensitivity for phage growth. The mutation results in an alanine to valine substitution at residue 73 in the exonuclease domain. Upon infection of Escherichia coli by the temperature-sensitive phage at 42 degreesC, there is no detectable T7 DNA synthesis in vivo. DNA polymerase activity in these phage-infected cell extracts is undetectable at assay temperatures of 30 degreesC or 42 degreesC. Upon infection at 30 degreesC, both DNA synthesis in vivo and DNA polymerase activity in cell extracts assayed at 30 degreesC or 42 degreesC approach levels observed using wild-type T7 phage. The amount of soluble gene 5 protein produced at 42 degreesC is comparable to that produced at 30 degreesC, indicating that the temperature-sensitive phenotype is not due to reduced expression, stability, or solubility. Thus the polymerase induced at elevated temperatures by the temperature-sensitive phage is functionally inactive. Consistent with this observation, biochemical properties and heat inactivation profiles of the genetically altered enzyme over-produced at 30 degreesC closely resemble that of wild-type T7 DNA polymerase. It is likely that the polymerase produced at elevated temperatures is a misfolded intermediate in its folding pathway.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.				NIGMS NIH HHS [GM-54397] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER T, 1989, ANNU REV BIOCHEM, V58, P765, DOI 10.1146/annurev.biochem.58.1.765; Banavar JR, 2001, PROTEINS, V42, P433, DOI 10.1002/1097-0134(20010301)42:4<433::AID-PROT10>3.3.CO;2-J; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; CHEN HF, 1994, VIROLOGY, V205, P364, DOI 10.1006/viro.1994.1654; Chowdhury K, 2000, P NATL ACAD SCI USA, V97, P12469, DOI 10.1073/pnas.230448397; Clarke J, 2001, CURR OPIN STRUC BIOL, V11, P67, DOI 10.1016/S0959-440X(00)00179-2; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GRIPPO P, 1971, J BIOL CHEM, V246, P6867; HERSHFIELD MS, 1972, J BIOL CHEM, V247, P3393; HORI K, 1979, J BIOL CHEM, V254, P1598; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HUBER HE, 1987, J BIOL CHEM, V262, P16224; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kumar JK, 2001, J BIOL CHEM, V276, P34905, DOI 10.1074/jbc.M104151200; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Liu RJ, 2000, J MOL BIOL, V295, P127, DOI 10.1006/jmbi.1999.3300; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; MODRICH P, 1975, J BIOL CHEM, V250, P5508; MOSES RE, 1970, P NATL ACAD SCI USA, V67, P674, DOI 10.1073/pnas.67.2.674; Muir RS, 1997, J MOL BIOL, V274, P722, DOI 10.1006/jmbi.1997.1419; MUZYCZKA N, 1972, J BIOL CHEM, V247, P7116; Nossal NG, 1998, GENETICS, V148, P1535; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Plaxco KW, 2000, J MOL BIOL, V298, P303, DOI 10.1006/jmbi.1999.3663; Ptitsyn OB, 1999, J MOL BIOL, V291, P671, DOI 10.1006/jmbi.1999.2920; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; SAITO H, 1981, J VIROL, V37, P343, DOI 10.1128/JVI.37.1.343-351.1981; SANDKVIST M, 1993, MOL MICROBIOL, V10, P635, DOI 10.1111/j.1365-2958.1993.tb00935.x; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; STUDIER FW, 1969, VIROLOGY, V39, P562, DOI 10.1016/0042-6822(69)90104-4; Sunyaev S, 2001, CURR OPIN STRUC BIOL, V11, P125, DOI 10.1016/S0959-440X(00)00175-5; SWARTZ MN, 1972, VIROLOGY, V47, P338, DOI 10.1016/0042-6822(72)90269-3; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1987, J BIOL CHEM, V262, P15330; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1989, J BIOL CHEM, V264, P6447; TABOR S, 1986, THIOREDOXIN GLUTARED, P285; THORNER J, 1975, VIROLOGY, V68, P338, DOI 10.1016/0042-6822(75)90277-9; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WETZEL R, 1994, FEBS LETT, V350, P245, DOI 10.1016/0014-5793(94)00775-6	52	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46151	46159		10.1074/jbc.M106319200	http://dx.doi.org/10.1074/jbc.M106319200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551938	hybrid, Green Published			2022-12-27	WOS:000172573100090
J	Gheorghiu, I; Deschenes, C; Blais, M; Boudreau, F; Rivard, N; Asselin, C				Gheorghiu, I; Deschenes, C; Blais, M; Boudreau, F; Rivard, N; Asselin, C			Role of specific CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; HAPTOGLOBIN GENE-EXPRESSION; 3 C/EBP ISOFORMS; TRANSCRIPTION FACTORS; C-FOS; ADIPOCYTE DIFFERENTIATION; HEPATOCYTE PROLIFERATION; HORMONAL-REGULATION; MESSENGER-RNA; NEWBORN MICE	Intestinal epithelial cells participate in the acute phase response in response to inflammation. We have shown that acute phase protein genes are induced during intestinal acute phase response, and that the CCAAT/enhancer binding protein family of transcription factors are involved. To address the role of specific C/EBP isoforms, we generated IEC-6 rat intestinal epithelial cell lines expressing different C/EBP isoforms, by retroviral infection. Overexpression of C/EBP alpha p30 and C/EBP delta led to increases in C/EBP beta LAP and C/EBP beta LIP endogenous protein levels, as determined by electrophoretic mobility shift assays and Western blot. Inhibition of C/EBP activity with dominant negative C/EBPs (C/EBP beta LIP, 3hF, 4hF) decreased glucocorticoid-, cAMP- and IL-1 responsiveness of the endogenous haptoglobin gene, while overexpression of each C/EBP isoform increased the responsiveness to these regulators. In contrast, dominant negative C/EBPs or C/EBP isoforms did not alter the expression of alpha -acid glycoprotein in response to dexamethasone and of C/EBP beta and C/EBP delta in response to various regulators as assessed by Northern blot. These data show that the three C/EBP isoforms are involved in the regulation of haptoglobin and that C/EBP beta, C/EBP delta, and alpha -acid glycoprotein expression are not induced by C/EBP isoforms in contrast to other cell types. C/EBP beta LAP-expressing cells showed an inhibition of cell growth characterized by a delay in P27(Kip1) decrease in response to serum and a decrease in cyclin D isoforms and cyclin E protein levels. Finally, C/EBP isoforms interact with the E2F4 transcription factor. Thus, specific C/EBP isoforms are involved in the differential expression of acute phase protein genes in response to hormones and cytokines. Furthermore, C/EBP isoforms may play a role in the control of cell cycle progression.	Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, Grp Rech BiolDev, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Asselin, C (corresponding author), Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, Grp Rech BiolDev, Sherbrooke, PQ J1H 5N4, Canada.							ALAM T, 1992, J BIOL CHEM, V267, P5021; Boudreau F, 1996, EXP CELL RES, V222, P1, DOI 10.1006/excr.1996.0001; Boudreau F, 1998, DNA CELL BIOL, V17, P669, DOI 10.1089/dna.1998.17.669; Boudreau F, 1999, MOL CELL BIOCHEM, V195, P99, DOI 10.1023/A:1006987313013; BOUDREAU F, 1997, GASTROENTEROLOGY, V112; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Burgess-Beusse BL, 1998, MOL CELL BIOL, V18, P7269, DOI 10.1128/MCB.18.12.7269; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHANG CJ, 1995, DNA CELL BIOL, V14, P529, DOI 10.1089/dna.1995.14.529; CHANG EB, 2000, INFLAMM BOWEL DIS, P3; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Deschenes C, 2001, GASTROENTEROLOGY, V120, pA501; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; DESCOMBES P, 1991, CELL, V67, P559; Desilets A, 2000, BIOCHEM BIOPH RES CO, V276, P673, DOI 10.1006/bbrc.2000.3531; Diehl AM, 1998, J BIOL CHEM, V273, P30843, DOI 10.1074/jbc.273.47.30843; DRAETTA GF, 1994, CURR OPIN CELL BIOL, V6, P842, DOI 10.1016/0955-0674(94)90054-X; FEDORAK RN, 2000, INFLAMM BOWEL DIS, P113; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; LEGRAVEREND C, 1993, NUCLEIC ACIDS RES, V21, P1735, DOI 10.1093/nar/21.8.1735; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LEMISCHKA IR, 1981, J MOL BIOL, V151, P101, DOI 10.1016/0022-2836(81)90223-0; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Mackiewicz A, 1997, Int Rev Cytol, V170, P225, DOI 10.1016/S0074-7696(08)61623-X; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; MAYER L, 2000, INFLAMM BOWEL DIS, P280; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Opitz OG, 2000, CANCER RES, V60, P2825; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Pelletier N, 1998, FEBS LETT, V439, P275, DOI 10.1016/S0014-5793(98)01388-X; PODOLSKY DK, 2000, INFLAMM BOWEL DIS, P191; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; SANDERSON AR, 2000, INFLAMM BOWEL DIS, P65; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; SOULEIMANI A, 1993, BIOCHEM BIOPH RES CO, V193, P330, DOI 10.1006/bbrc.1993.1628; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Vietor I, 1996, J BIOL CHEM, V271, P5595, DOI 10.1074/jbc.271.10.5595; Wang H, 2001, BRIT J PHARMACOL, V133, P713, DOI 10.1038/sj.bjp.0704102; Yamada T, 1998, BIOCHEM BIOPH RES CO, V242, P88, DOI 10.1006/bbrc.1997.7915; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yu SJ, 1999, BIOCHEM BIOPH RES CO, V259, P544, DOI 10.1006/bbrc.1999.0808	54	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44331	44337		10.1074/jbc.M107591200	http://dx.doi.org/10.1074/jbc.M107591200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559710	Green Submitted, hybrid			2022-12-27	WOS:000172297700106
J	Kretz-Remy, C; Munsch, B; Arrigo, AP				Kretz-Remy, C; Munsch, B; Arrigo, AP			NF kappa B-dependent transcriptional activation during heat shock recovery - Thermolability of the NF-kappa B center dot I kappa B complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; MESSENGER-RNA EXPRESSION; DNA-BINDING ACTIVITY; INDUCED CELL-DEATH; GENE-EXPRESSION; TNF-ALPHA; NUCLEAR-LOCALIZATION; SIGNAL-TRANSDUCTION; TYPE-1 INFECTION	Heat shock induces the accumulation of misfolded proteins and results in the preferential expression of heat shock proteins, which help the cell to recover from thermal damage. Heat shock is a well known transcriptional activator of the human immunodeficiency virus type 1 long terminal repeat (LTR). We report here that mutations or deletions of the LTR KR sites impaired the LTR transcriptional activation by heat shock. Further analysis revealed that, during heat shock recovery, the NF-kappaB p65 and p50 subunits migrated into the nucleus of HeLa cells, bound to DNA, and induced kappaB-dependent reporter gene expression. This NF-kappaB activation did not depend on new transcriptional and/or translational events and on the pro-oxidant state generated by heat shock. It was not concomitant with I kappaB alpha phosphorylation and was not abolished by the expression of I kappaB kinase or I kappaB alpha dominant-negative mutants. Moreover, NF-KB activation and migration into the nucleus were not concomitant with I kappaB alpha/beta or p105 degradation. However, during heat shock recovery, NF-kappaB was dissociated from its complexing partners, allowing its migration into the nucleus. Hence, we describe here a novel mechanism for activation of NF-kappaB based on the thermolability of the NF-kappaB.I kappaB complex.	Univ Lyon 1, CNRS,UMR 5534, Ctr Genet Mol & Cellulaire, Lab Stress Oxydant Chaperons & Apoptose, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Arrigo, AP (corresponding author), Univ Lyon 1, CNRS,UMR 5534, Ctr Genet Mol & Cellulaire, Lab Stress Oxydant Chaperons & Apoptose, Batiment Gregor Mendel,16 Rue Dubois, F-69622 Villeurbanne, France.		Kretz-Remy, Carole/J-7850-2019	Kretz-Remy, Carole/0000-0002-9553-5598				ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; ARRIGO AP, 1997, FREE RADICALS MOL BI, P183; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAGNARELLI P, 1992, J VIROL, V66, P7328, DOI 10.1128/JVI.66.12.7328-7335.1992; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BECKER J, 1990, EUR J BIOCHEM, V189, P553, DOI 10.1111/j.1432-1033.1990.tb15522.x; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; BROWN FL, 1993, MOL CELL BIOL, V13, P5245, DOI 10.1128/MCB.13.9.5245; BUREL C, 1992, EXPERIENTIA, V48, P629, DOI 10.1007/BF02118307; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chung KC, 2000, J NEUROSCI RES, V59, P117, DOI 10.1002/(SICI)1097-4547(20000101)59:1<117::AID-JNR14>3.0.CO;2-Q; COURGEON AM, 1990, FREE RADICAL RES COM, V9, P147, DOI 10.3109/10715769009148582; Curry HA, 1999, J BIOL CHEM, V274, P23061, DOI 10.1074/jbc.274.33.23061; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; DEJARDIN E, 1995, ONCOGENE, V11, P1835; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724; GARCIA JA, 1994, PROG NUCLEIC ACID RE, V49, P157; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; GENDELMAN HE, 1986, P NATL ACAD SCI USA, V83, P9759, DOI 10.1073/pnas.83.24.9759; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Hashimoto K, 1996, ARCH VIROL, V141, P439, DOI 10.1007/BF01718308; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; ISSELS RD, 1987, CANCER RES, V47, P2268; JAATTELA M, 1993, J IMMUNOL, V151, P4286; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Jornot L, 1997, FEBS LETT, V416, P381, DOI 10.1016/S0014-5793(97)01244-1; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Katschinski DM, 2000, J BIOL CHEM, V275, P21094, DOI 10.1074/jbc.M001629200; Kretz-Remy C, 1998, J BIOL CHEM, V273, P3180, DOI 10.1074/jbc.273.6.3180; KRETZREMY C, 1994, FEBS LETT, V351, P191, DOI 10.1016/S0014-5793(94)80103-7; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; LOVE JD, 1986, J CELL PHYSIOL, V126, P60, DOI 10.1002/jcp.1041260109; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; RE MC, 1989, J VIROL METHODS, V26, P313, DOI 10.1016/0166-0934(89)90113-4; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Rossi A, 1998, J BIOL CHEM, V273, P16446, DOI 10.1074/jbc.273.26.16446; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; SAPPEY C, 1994, AIDS RES HUM RETROV, V10, P1451, DOI 10.1089/aid.1994.10.1451; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Scheidereit C, 1998, NATURE, V395, P225, DOI 10.1038/26121; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; STANLEY SK, 1990, J IMMUNOL, V145, P1120; STEFFY K, 1991, MICROBIOL REV, V55, P193, DOI 10.1128/MMBR.55.2.193-205.1991; STEIN B, 1989, J VIROL, V63, P4540, DOI 10.1128/JVI.63.11.4540-4544.1989; VAN AD, 1996, SCIENCE, V274, P787; Vayssier M, 1998, BIOCHEM BIOPH RES CO, V252, P249, DOI 10.1006/bbrc.1998.9586; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wong HR, 1997, BIOCHEM BIOPH RES CO, V231, P257, DOI 10.1006/bbrc.1997.6076; Wong HR, 1999, CELL STRESS CHAPERON, V4, P1; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; ZABEL U, 1991, J BIOL CHEM, V266, P252; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zou JY, 1998, CELL STRESS CHAPERON, V3, P130, DOI 10.1379/1466-1268(1998)003<0130:CBGOAT>2.3.CO;2	75	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43723	43733		10.1074/jbc.M010821200	http://dx.doi.org/10.1074/jbc.M010821200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559696	hybrid			2022-12-27	WOS:000172297700033
J	Katayama, T; Imaizumi, K; Honda, A; Yoneda, T; Kudo, T; Takeda, M; Mori, K; Rozmahel, R; Fraser, P; St George-Hyslop, P; Tohyama, M				Katayama, T; Imaizumi, K; Honda, A; Yoneda, T; Kudo, T; Takeda, M; Mori, K; Rozmahel, R; Fraser, P; St George-Hyslop, P; Tohyama, M			Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; AMYLOID PRECURSOR PROTEIN; KNOCK-IN MICE; MISSENSE MUTATIONS; SIGNALING PATHWAY; GENE; CHROMOSOME-1; ATF6; IRE1; ACCUMULATION	Recent studies have shown independently that presenifin-1 (PS1) null mutants and familial Alzheimer's disease (FAD)-linked mutants should both down-regulate signaling of the unfolded protein response (UPR). However, it is difficult to accept that both mutants possess the same effects on the UPR. Furthermore, contrary to these observations, neither loss of PS1 and PS2 function nor expression of FAD-linked PS1 mutants were reported to have a discernable impact on the UPR. Therefore, re-examination and detailed analyses are needed to clarify the relationship between PS1 function and UPR signaling. Here, we report that PS1/PS2 null and dominant negative PS1 mutants, which are mutated at aspartate residue 257 or 385, did not affect signaling of the UPR. In contrast, FAD-linked PSI mutants were confirmed to disturb UPR signaling by inhibiting activation of both Ire1 alpha and ATF6, both of which are endoplasmic reticulum (ER) stress transducers in the UPR. Furthermore, PS1 mutants also disturbed activation of PERK (PKR-like ER kinase), which plays a crucial role in inhibiting translation during ER stress. Taken together, these observations suggested that PS1 mutations could affect signaling pathways controlled by each of the respective ER-stress transducers, possibly through a gain-of-function.	Nara Inst Sci & Technol, Div Struct Cell Biol, Nara 6300101, Japan; Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan; Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, Osaka 5320031, Japan; Osaka Univ, Grad Sch Med, Dept Clin Neurosci, Suita, Osaka 5650871, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068304, Japan; Univ Toronto, Dept Med Neurol, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 1A8, Canada; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Nara Institute of Science & Technology; Osaka University; Mitsubishi Tanabe Pharma Corporation; Osaka University; Kyoto University; University of Toronto; Japan Science & Technology Agency (JST)	Imaizumi, K (corresponding author), Nara Inst Sci & Technol, Div Struct Cell Biol, 8916-5 Takayama, Nara 6300101, Japan.		Mori, Kazutoshi/K-6106-2015	St George-Hyslop, Peter/0000-0003-0796-7209				Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Guo Q, 1997, J NEUROSCI, V17, P4212; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Imaizumi K, 2001, NAT CELL BIOL, V3, pE104, DOI 10.1038/35074613; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nakano Y, 1999, EUR J NEUROSCI, V11, P2577, DOI 10.1046/j.1460-9568.1999.00698.x; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	38	150	163	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43446	43454		10.1074/jbc.M104096200	http://dx.doi.org/10.1074/jbc.M104096200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551913	hybrid			2022-12-27	WOS:000172169300105
J	Molik, S; Karnauchov, I; Weidlich, CE; Herrmann, RG; Klosgen, RB				Molik, S; Karnauchov, I; Weidlich, CE; Herrmann, RG; Klosgen, RB			The Rieske Fe/S protein of the cytochrome b(6)/f complex in chloroplasts - Missing link in the evolution of protein transport pathways in chloroplasts?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; DELTA-PH PATHWAY; BLUE NATIVE ELECTROPHORESIS; OXYGEN-EVOLVING COMPLEX; LUMEN-SIDE DOMAIN; THYLAKOID MEMBRANE; SPINACH-CHLOROPLASTS; PRECURSOR PROTEIN; ESCHERICHIA-COLI; PROTON GRADIENT	The Rieske Fe/S protein, a nuclear-encoded subunit of the cytochrome b(6)/f complex in chloroplasts, is retarded in the stromal space after import into the chloroplast and only slowly translocated further into the thylakoid membrane system. As shown by the sensitivity to nigericin and to specific competitor proteins, thylakoid transport takes place by the Delta pH-dependent TAT pathway. The Rieske protein is an untypical TAT substrate, however. It is only the second integral membrane protein shown to utilize this pathway, and it is the first authentic substrate without a cleavable signal peptide. Transport is instead mediated by the NH2-terminal membrane anchor, which lacks, however, the twin-arginine motif indicative of Delta pH/TAT-dependent transport signals. Furthermore, transport is affected by sodium azide as well as by competitor proteins for the See pathway in chloroplasts, demonstrating for the first time some cross-talk of the two pathways. This might take place in the stroma where the Rieske protein accumulates after import in several complexes of high molecular mass, among which the cpn60 complex is the most prominent. These untypical. features suggest that the Rieske protein represents an intermediate or early state in the evolution of the thylakoidal protein transport pathways.	Univ Halle Wittenberg, Inst Pflanzenphysiol, D-06120 Halle Saale, Germany; Univ Munich, Inst Bot, D-80638 Munich, Germany	Martin Luther University Halle Wittenberg; University of Munich	Klosgen, RB (corresponding author), Univ Halle Wittenberg, Inst Pflanzenphysiol, Weinbergweg 10, D-06120 Halle Saale, Germany.							BARTLETT SG, 1982, METHODS CHLOROPLAST, P1081; BARTLING D, 1990, BOT MAG TOKYO, V2, P119; BERGHOFER J, 1995, J BIOL CHEM, V270, P18341, DOI 10.1074/jbc.270.31.18341; Berghofer J, 1999, FEBS LETT, V460, P328, DOI 10.1016/S0014-5793(99)01365-4; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Blaudeck N, 2001, J BACTERIOL, V183, P604, DOI 10.1128/JB.183.2.604-610.2001; BROCK IW, 1993, PLANT MOL BIOL, V23, P717, DOI 10.1007/BF00021527; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; CLAUSMEYER S, 1993, J BIOL CHEM, V268, P13869; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CREIGHTON AM, 1995, J BIOL CHEM, V270, P1663, DOI 10.1074/jbc.270.4.1663; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Halbig D, 1999, FEBS LETT, V447, P95, DOI 10.1016/S0014-5793(99)00269-0; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; HULFORD A, 1994, J BIOL CHEM, V269, P3251; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; KARNAUCHOV I, 1994, J BIOL CHEM, V269, P32871; Karnauchov I, 1997, EUR J BIOCHEM, V249, P497, DOI 10.1111/j.1432-1033.1997.t01-1-00497.x; Karnauchov I, 1997, FEBS LETT, V408, P206, DOI 10.1016/S0014-5793(97)00427-4; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; Klosgen RB, 1997, J PHOTOCH PHOTOBIO B, V38, P1, DOI 10.1016/S1011-1344(96)07408-8; KNOTT TG, 1994, J BIOL CHEM, V269, P7843; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lill R, 1999, BIOL CHEM, V380, P1157, DOI 10.1515/BC.1999.147; LUBBEN TH, 1989, PLANT CELL, V1, P1223, DOI 10.1105/tpc.1.12.1223; MADUENO F, 1993, PLANT CELL, V5, P1865, DOI 10.1105/tpc.5.12.1865; MADUENO F, 1994, J BIOL CHEM, V269, P17458; MADUENO F, 1992, PLANT MOL BIOL, V20, P289, DOI 10.1007/BF00014496; MANT A, 1994, J BIOL CHEM, V269, P27303; MANT A, 1995, J BIOL CHEM, V270, P23275, DOI 10.1074/jbc.270.40.23275; MICHL D, 1994, EMBO J, V13, P1310, DOI 10.1002/j.1460-2075.1994.tb06383.x; Mori H, 1998, J BIOL CHEM, V273, P11405, DOI 10.1074/jbc.273.19.11405; MOULD RM, 1991, J BIOL CHEM, V266, P12189; MUNEYUKI E, 1993, BIOCHIM BIOPHYS ACTA, V1144, P62, DOI 10.1016/0005-2728(93)90031-A; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; REUTER W, 1990, FEBS LETT, V273, P155, DOI 10.1016/0014-5793(90)81073-W; SALTER AH, 1992, PLANT MOL BIOL, V20, P569, DOI 10.1007/BF00040617; Sambrook J., 2002, MOL CLONING LAB MANU; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; STEPPUHN J, 1987, MOL GEN GENET, V210, P171, DOI 10.1007/BF00337775; VACHEREAU A, 1989, ANAL BIOCHEM, V179, P206, DOI 10.1016/0003-2697(89)90227-3; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633; YUAN JG, 1994, J BIOL CHEM, V269, P18463; Zhang JM, 1996, J BIOL CHEM, V271, P31360, DOI 10.1074/jbc.271.49.31360	56	110	113	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42761	42766		10.1074/jbc.M106690200	http://dx.doi.org/10.1074/jbc.M106690200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11526115	hybrid			2022-12-27	WOS:000172169300018
J	Rice, AM; Sartorelli, AC				Rice, AM; Sartorelli, AC			Inhibition of 20 S and 26 S proteasome activity by lithium chloride - Impact on the differentiation of leukemia cells by all-trans-retinoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE COMPLEX; DEPENDENT DEGRADATION; HIGH EXPRESSION; ACTIVATION; INDUCTION; PATHWAY; AGENTS; SYSTEM; ALPHA; P27	Lithium affects several enzymatic activities, however, the molecular mechanisms of lithium actions are not fully understood. We previously showed that LiCl interacts synergistically with all-trans-retinoic acid to promote terminal differentiation of WEHI-3B D+ cells, a phenomenon accompanied by the recovery of the retinoid-induced loss of retinoic acid receptor alpha protein pools. Here, we demonstrate the effects of LiCl on proteasome-dependent degradation of retinoic acid receptor alpha proteins. LiCl alone, or in combination with all-trans-retinoic acid, increased cellular levels of ubiquitinated retinoic acid receptor alpha and markedly reduced chymotryptic-like activity of WEHI-3B D+ 20 S and 26 S proteasome enzymes. Neither KCl nor all-trans-retinoic acid affected enzyme activity, whereas NaCl produced a modest reduction at relatively high concentrations. In addition, LiCl inhibited 20 S proteasome chymotryptic-like activity from rabbits but had no effect on tryptic-like activity of the 26 S proteasome. This effect has significant consequences in stabilizing the retinoic acid receptor alpha protein levels that are necessary to promote continued differentiation of leukemia cells in response to all-trans-retinoic acid. In support of this concept, combination of proteasome inhibitors beta -clastolactacystin or benzyloxycarbonyl-Leu-Leu-Phe with all-trans-retinoic acid increased differentiation of WEHI-3B D+ cells in a manner that was analogous to the combination of LiCl and all-trans-retinoic acid.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ctr Canc, Dev Therapeut Program, New Haven, CT 06520 USA	Yale University; Yale University	Sartorelli, AC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL CANCER INSTITUTE [R01CA002817] Funding Source: NIH RePORTER; NCI NIH HHS [CA-02817] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams J, 1999, CANCER RES, V59, P2615; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BOGGS DR, 1983, SEMIN HEMATOL, V20, P129; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Finch RA, 2000, BLOOD, V96, P2262; Frisan T, 2000, INT J CANCER, V88, P881, DOI 10.1002/1097-0215(20001215)88:6<881::AID-IJC7>3.0.CO;2-D; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Henry L, 1996, CELL PROLIFERAT, V29, P589, DOI 10.1111/j.1365-2184.1996.tb00974.x; Henry L, 1997, ANAL CELL PATHOL, V15, P131, DOI 10.1155/1997/869747; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hideshima T, 2001, CANCER RES, V61, P3071; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KUMATORI A, 1990, P NATL ACAD SCI USA, V87, P7071, DOI 10.1073/pnas.87.18.7071; Lin RJ, 1999, TRENDS GENET, V15, P179, DOI 10.1016/S0168-9525(99)01710-2; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PRICE LH, 1994, NEW ENGL J MED, V331, P591; SHIMBARA N, 1992, J BIOL CHEM, V267, P18100; SOKOLOSKI JA, 1993, LEUKEMIA RES, V17, P403, DOI 10.1016/0145-2126(93)90095-3; Tanaka T, 2001, BIOCHEM PHARMACOL, V61, P1347, DOI 10.1016/S0006-2952(01)00600-1; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	31	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42722	42727		10.1074/jbc.M106583200	http://dx.doi.org/10.1074/jbc.M106583200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555654	hybrid			2022-12-27	WOS:000172169300013
J	Boorstein, RJ; Cummings, A; Marenstein, DR; Chan, MK; Ma, YL; Neubert, TA; Brown, SM; Teebor, GW				Boorstein, RJ; Cummings, A; Marenstein, DR; Chan, MK; Ma, YL; Neubert, TA; Brown, SM; Teebor, GW			Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-(HYDROXYMETHYL) URACIL; CELLS; 8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE; 5-HYDROXYMETHYL-2'-DEOXYURIDINE; PURIFICATION; MAINTENANCE; EXPRESSION; CLONING	Purification from calf thymus of a DNA N-glycosylase activity (HMUDG) that released 5-hydroxymethyluracil (5hmUra) from the DNA of Bacillus subtilis phage SPO1 was undertaken. Analysis of the most purified fraction by SDS-polyacrylamide gel electrophoresis revealed a multiplicity of protein species making it impossible to identify HMUDG by inspection. Therefore, we renatured the enzyme after SDS-polyacrylamide gel electrophoresis and assayed slices of the gel for DNA N-glycosylase activity directed against 5hmUra. Maximum enzymatic activity was identified between molecular mass markers 30 and 34 kDa. Protein was extracted from gel slices and subjected to tryptic digestion and analysis by mass spectrometry. Analysis revealed the presence of 11 peptides that were homologous or identical to the sequence of the recently characterized human single-stranded monofunctional uracil DNA N-glycosylase (hSMUG1). The cDNA of hSMUG1 was isolated and expressed as a recombinant glutathione S-transferase fusion protein that was shown to release 5hmUra with 20X the specific activity of the most purified bovine fraction. We conclude that hSMUG1 and HMUDG are the same protein.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Teebor, GW (corresponding author), NYU, Med Ctr, Dept Pathol, 550 1st Ave, New York, NY 10016 USA.	george.teebor@med.nyu.edu		Teebor, George/0000-0002-7397-2500	NCI NIH HHS [CA 49869, 5T32 CA-09161, CA 16087, CA 16669] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016669, R37CA016669, R01CA049869, T32CA009161, P30CA016087] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BALTZ RH, 1976, P NATL ACAD SCI USA, V73, P1269, DOI 10.1073/pnas.73.4.1269; BOORSTEIN RJ, 1992, MOL CELL BIOL, V12, P5536, DOI 10.1128/MCB.12.12.5536; BOORSTEIN RJ, 1987, MUTAT RES, V183, P257, DOI 10.1016/0167-8817(87)90008-3; BOORSTEIN RJ, 1989, NUCLEIC ACIDS RES, V17, P7653, DOI 10.1093/nar/17.19.7653; CANNONCARLSON SV, 1989, J BIOL CHEM, V264, P13306; CERUTTI PA, 1976, PHOTOCHEM PHOTOBIOL, P375; DJURIC Z, 1991, J NATL CANCER I, V83, P766, DOI 10.1093/jnci/83.11.766; Faure H, 1998, FREE RADICAL RES, V28, P377, DOI 10.3109/10715769809070806; Frenkel K, 1998, CANCER EPIDEM BIOMAR, V7, P49; FRENKEL K, 1985, BIOCHEMISTRY-US, V24, P4527, DOI 10.1021/bi00338a007; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HERZOG M, 1982, EUR J CELL BIOL, V27, P151; Hilbert TP, 1996, BIOCHEMISTRY-US, V35, P2505, DOI 10.1021/bi952516e; HOLLSTEIN MC, 1984, P NATL ACAD SCI-BIOL, V81, P4003, DOI 10.1073/pnas.81.13.4003; KALLEN RG, 1962, J MOL BIOL, V5, P248, DOI 10.1016/S0022-2836(62)80087-4; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Pourcelot S, 1999, FREE RADICAL RES, V30, P173, DOI 10.1080/10715769900300191; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	24	118	123	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41991	41997		10.1074/jbc.M106953200	http://dx.doi.org/10.1074/jbc.M106953200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11526119	hybrid			2022-12-27	WOS:000172450400061
J	Ivanova, L; Barmada, S; Kummer, T; Harris, DA				Ivanova, L; Barmada, S; Kummer, T; Harris, DA			Mutant prion proteins axe partially retained in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; BIOCHEMICAL-PROPERTIES; THERMODYNAMIC STABILITY; CELLS; METABOLISM; MUTATIONS; FORM; DEGRADATION	Familial prion diseases are linked to point and insertional mutations in the prion protein (PrP) gene that are presumed to favor conversion of the cellular isoform of PrP to the infectious isoform. In this report, we have investigated the subcellular localization of PrP molecules carrying pathogenic mutations using immunofluorescence staining, immunogold labeling, and PrP-green fluorescent protein chimeras. To facilitate visualization of the mutant proteins, we have utilized a novel Sindbis viral replicon engineered to produce high protein levels without cytopathology. We demonstrate that several different pathogenic mutations have a common effect on the trafficking of PrP, impairing delivery of the molecules to the cell surface and causing a portion of them to accumulate in the endoplasmic reticulum. These observations suggest that protein quality control in the endoplasmic reticulum. may play an important role in prion diseases, as it does in some other inherited human disorders. Our experiments also show that chimeric PrP molecules with the sequence of green fluorescent protein inserted adjacent to the glycolipidation site are post-translationally modified and localized normally, thus documenting the utility of these constructs in cell biological studies of PrP.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Harris, DA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	dharris@cellbio.wustl.edu		Harris, David/0000-0002-6985-5790; Barmada, Sami/0000-0002-9604-968X	NIGMS NIH HHS [GM07200] Funding Source: Medline; NINDS NIH HHS [R01 NS35496] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035496] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agapov EV, 1998, P NATL ACAD SCI USA, V95, P12989, DOI 10.1073/pnas.95.22.12989; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Capellari S, 2000, AM J PATHOL, V157, P613, DOI 10.1016/S0002-9440(10)64572-5; Chiesa R, 2000, J NEUROCHEM, V75, P72, DOI 10.1046/j.1471-4159.2000.0750072.x; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Frolov I, 1999, J VIROL, V73, P3854, DOI 10.1128/JVI.73.5.3854-3865.1999; Gambetti P, 1999, COLD SPRING HARBOR M, V38, P509; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; Harris DA, 1997, ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, P631; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lehmann S, 2000, J BIOL CHEM, V275, P1520; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; Negro A, 2001, MOL CELL NEUROSCI, V17, P521, DOI 10.1006/mcne.2000.0953; Perlmutter DH, 1999, LAB INVEST, V79, P623; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Priola SA, 1998, J BIOL CHEM, V273, P11980, DOI 10.1074/jbc.273.19.11980; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555; YOIUNG K, 1999, PRIONS MOL CELLULAR, P1039; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	45	95	101	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42409	42421		10.1074/jbc.M106928200	http://dx.doi.org/10.1074/jbc.M106928200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527974	hybrid			2022-12-27	WOS:000172450400113
J	Padmanabhan, S; Elias-Arnanz, M; Carpio, E; Aparicio, P; Murillo, FJ				Padmanabhan, S; Elias-Arnanz, M; Carpio, E; Aparicio, P; Murillo, FJ			Domain architecture of a high mobility group A-type bacterial transcriptional factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INDUCED CAROTENOGENESIS; GROUP CHROMOSOMAL-PROTEINS; NF-KAPPA-B; MYXOCOCCUS-XANTHUS; BINDING-PROPERTIES; ESCHERICHIA-COLI; RNA-POLYMERASE; CARR REGION; AMINO-ACID; DNA	Myxococcus xanthus transcriptional factor CarD participates in carotenogenesis and fruiting body formation. It is the only reported prokaryotic protein having adjacent "AT-hook" DNA-binding and acidic regions characteristic of eukaryotic high mobility group A (HMGA) proteins. The latter are small, unstructured, nonhistone nuclear proteins that function as architectural factors to remodel DNA and chromatin structure and modulate various DNA binding activities. We find CarD to be predominantly dimeric with two stable domains: (a) an N-terminal domain of defined secondary and tertiary structure which is absent in eukaryotic HMGA proteins; (b) a C-terminal domain formed by the acidic and AT-hook segments and lacking defined structure. CarD, like HMGA proteins, binds specifically to the minor-groove of AT-rich DNA present in two appropriately spaced tracts. As in HMGA proteins, casein kinase II can phosphorylate the CarD acidic region, and this dramatically decreases the DNA binding affinity of CarD. The acidic region, in addition to modulating DNA binding, confers structural stability to CarD. We discuss how the structural and functional plasticity arising from domain organization in CarD could be linked to its role as a general transcriptional factor in M. xanthus.	Univ Murcia, Dept Genet & Microbiol, E-30071 Murcia, Spain; Univ Murcia, Area Inmunol, E-30071 Murcia, Spain	University of Murcia; University of Murcia	Murillo, FJ (corresponding author), Univ Murcia, Dept Genet & Microbiol, E-30071 Murcia, Spain.		Elías-Arnanz, Montserrat/H-4707-2015; Padmanabhan, S./E-8943-2017	Elías-Arnanz, Montserrat/0000-0003-1980-3092; Aparicio, Pedro/0000-0001-9162-1563; Padmanabhan, S./0000-0002-8772-0152				Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; AUSUBEL FM, 1995, CURRENT PROTOCOLS S, V13; Ayora S, 1996, J MOL BIOL, V256, P301, DOI 10.1006/jmbi.1996.0087; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; BROWN KC, 1995, BIOCHEMISTRY-US, V34, P4733, DOI 10.1021/bi00014a030; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Carey J, 2000, METHOD ENZYMOL, V328, P499, DOI 10.1016/S0076-6879(00)28415-2; CAYUELA ML, 1999, THESIS U MURCIA SPAI, P86; CLAUS P, 1994, J BIOL CHEM, V269, P33042; Cohen SL, 1997, ANAL BIOCHEM, V247, P257, DOI 10.1006/abio.1997.2072; CORBETT RJT, 1984, BIOCHEMISTRY-US, V23, P1888, DOI 10.1021/bi00303a047; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Elias-Arnanz M, 1999, GENE DEV, V13, P2502, DOI 10.1101/gad.13.19.2502; FERRANTI P, 1992, J BIOL CHEM, V267, P22486; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HANSEN JC, 1994, BIOCHEMISTRY-US, V33, P13155, DOI 10.1021/bi00249a001; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Hodgson D, 1993, MYXOBACTERIA, VII, P157; HODGSON DA, 1993, MOL MICROBIOL, V7, P471, DOI 10.1111/j.1365-2958.1993.tb01138.x; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Jain R, 1998, J BACTERIOL, V180, P6544, DOI 10.1128/JB.180.24.6544-6550.1998; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KAISER D, 1984, MICROBIAL DEV, P197; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; MCGOWAN SJ, 1993, MOL MICROBIOL, V10, P713, DOI 10.1111/j.1365-2958.1993.tb00943.x; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; NICOLAS FJ, 1994, GENE DEV, V8, P2375, DOI 10.1101/gad.8.19.2375; Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881; NOZAKI Y, 1976, BIOCHEMISTRY-US, V15, P3884, DOI 10.1021/bi00662a036; ORTIZ ML, 1992, FEBS LETT, V296, P300, DOI 10.1016/0014-5793(92)80309-5; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALVIMO J, 1989, FEBS LETT, V257, P101, DOI 10.1016/0014-5793(89)81796-X; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; POTSCHKA M, 1987, ANAL BIOCHEM, V162, P47, DOI 10.1016/0003-2697(87)90009-1; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; REEVES R, 1990, J BIOL CHEM, V265, P8573; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; Schwanbeck R, 2001, J BIOL CHEM, V276, P26012, DOI 10.1074/jbc.M011053200; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Serrano L, 2000, ADV PROTEIN CHEM, V53, P49; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; WANG DZ, 1995, J BIOL CHEM, V270, P22924, DOI 10.1074/jbc.270.39.22924; Werner MH, 1997, CELL, V88, P733, DOI 10.1016/S0092-8674(00)81917-0; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; Yie JM, 1997, MOL CELL BIOL, V17, P3649, DOI 10.1128/MCB.17.7.3649; Zhang XM, 1999, J BIOL CHEM, V274, P20235, DOI 10.1074/jbc.274.29.20235	70	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41566	41575		10.1074/jbc.M106352200	http://dx.doi.org/10.1074/jbc.M106352200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533063	hybrid			2022-12-27	WOS:000172450400006
J	Paoli, P; Giannoni, E; Pescitelli, R; Camici, G; Manao, G; Ramponi, G				Paoli, P; Giannoni, E; Pescitelli, R; Camici, G; Manao, G; Ramponi, G			Hydrogen peroxide triggers the formation of a disulfide dimer of muscle acylphosphatase and modifies some functional properties of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING DOMAIN; MUSCULAR ISOENZYME; PROTEIN; PURIFICATION; EXPRESSION; DIFFERENTIATION; NUCLEUS; ASSAY; FORMS	Acylphosphatase is expressed in vertebrates as two molecular forms, the organ common and the muscle types. The former does not contain cysteine residues, whereas the latter contains a single conserved cysteine (Cys-21). We demonstrated that H2O2 at micromolar levels induces, in vitro, the formation of a disulfide dimer of muscle acylphosphatase, which displays properties differing from those of the reduced enzyme. In particular, we observed changes in the kinetic behavior of its intrinsic ATPase activity, whereas the kinetic behavior of its benzoyl phosphatase activity does not change. Moreover, the disulfide dimer is capable of interacting with some polynucleotides such as poly(G), poly(C), and poly(T) but not with poly(A), whereas the reduced enzyme does not bind polynucleotides. Experiments performed with H2O2 in the presence of increasing SDS concentrations demonstrated that disulfide dimer formation is prevented by SDS concentrations higher than 300 mum, suggesting that a non-covalently-linked dimer is present in non-denaturing solvents. Light-induced cross-linking experiments performed on the Cys-21 Ser mutant in the pH range 3.8-9.0 have demonstrated that a non-covalently-linked dimer is in fact present in non-denaturing solutions and that an enzyme group with a pK(a) of 6.4 influences the monomer-dimer equilibrium.	Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy	University of Florence	Camici, G (corresponding author), Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.		Paoli, Paolo/A-2040-2014; Giannoni, Elisa/AAE-2092-2020; Camici, Giovanni/H-1631-2018	Paoli, Paolo/0000-0001-6448-7266; Camici, Giovanni/0000-0002-0523-0695; Giannoni, Elisa/0000-0001-7136-1098				BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; BERTI A, 1992, ARCH BIOCHEM BIOPHYS, V294, P261, DOI 10.1016/0003-9861(92)90166-T; BERTI A, 1987, ITAL J BIOCHEM, V36, P82; BERTI A, 1986, INT J PEPT PROT RES, V28, P15; CAMICI G, 1976, EXPERIENTIA, V32, P535, DOI 10.1007/BF01920843; Chiarugi P, 1996, BIOCHEM MOL BIOL INT, V40, P73; Chiarugi P, 1997, CELL DEATH DIFFER, V4, P334, DOI 10.1038/sj.cdd.4400230; CHIARUGI P, 1995, BIOCHEM J, V311, P567, DOI 10.1042/bj3110567; Chiarugi P, 1997, BIOCHEM BIOPH RES CO, V231, P717, DOI 10.1006/bbrc.1997.6176; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; GHETTI A, 1990, FEBS LETT, V277, P272, DOI 10.1016/0014-5793(90)80863-E; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANAO G, 1983, ARCH BIOCHEM BIOPHYS, V226, P414, DOI 10.1016/0003-9861(83)90310-7; MIZUNO Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P437, DOI 10.1016/0003-9861(90)90282-4; Modesti A, 1995, PROTEIN EXPRES PURIF, V6, P799, DOI 10.1006/prep.1995.0011; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NASSI P, 1991, J BIOL CHEM, V266, P10867; NEDIANI C, 1991, BIOCHEM INT, V24, P959; Paoli P, 2000, BIOCHEM J, V349, P43, DOI 10.1042/0264-6021:3490043; RAMPONI G, 1966, EXPERIENTIA, V22, P705, DOI 10.1007/BF01901326; Raugei G, 1999, BIOCHEM MOL BIOL INT, V47, P127; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SEGEL IH, 1975, ENZYME KINETICS, P64; Steer BA, 1999, BIOCHEM J, V340, P631, DOI 10.1042/0264-6021:3400631; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; Thunnissen MMGM, 1997, STRUCTURE, V5, P69, DOI 10.1016/S0969-2126(97)00167-6	30	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41862	41869		10.1074/jbc.M106886200	http://dx.doi.org/10.1074/jbc.M106886200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551950	hybrid			2022-12-27	WOS:000172450400044
J	Wang, SSS; Rymer, DL; Good, TA				Wang, SSS; Rymer, DL; Good, TA			Reduction in cholesterol and sialic acid content protects cells from the toxic effects of beta-amyloid peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; RADICAL OXIDATIVE STRESS; MTT FORMAZAN EXOCYTOSIS; ALZHEIMERS-DISEASE BRAIN; PRECURSOR PROTEIN; CORTICAL-NEURONS; SPHINGOLIPID DEPLETION; HIPPOCAMPAL-NEURONS; SIGNAL-TRANSDUCTION; APOLIPOPROTEIN-E	beta -Amyloid (A beta) is the primary protein component of senile plaques associated with Alzheimer's disease and has been implicated in the neurotoxicity associated with the disease. A variety of evidence points to the importance of A beta -membrane interactions in the mechanism of A beta neurotoxicity and indicates that cholesterol and gangliosides are particularly important for A beta aggregation and binding to membranes. We investigated the effects of cholesterol and sialic acid depletion on A beta -induced GTPase activity in cells, a step implicated in the mechanism of A beta toxicity, and A beta -induced cell toxicity. Cholesterol reduction and depletion of membrane-associated sialic acid residues both significantly reduced the A beta -induced GTPase activity. In addition, cholesterol and membrane-associated sialic acid residue depletion or inhibition of cholesterol and ganglioside synthesis protected PC12 cells from A beta -induced toxicity. These results indicate the importance of A beta -membrane interactions in the mechanism of A beta toxicity. In addition, these results suggest that control of cellular cholesterol and/or ganglioside content may prove useful in the prevention or treatment of Alzheimer's disease.	Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Good, TA (corresponding author), Texas A&M Univ, Dept Chem Engn, TAMU 3122, College Stn, TX 77843 USA.							Abe K, 1999, BRAIN RES, V830, P146, DOI 10.1016/S0006-8993(99)01421-3; Abe K, 1999, NEUROSCI RES, V35, P165, DOI 10.1016/S0168-0102(99)00048-6; Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; AKTORIES K, 1983, N-S ARCH PHARMACOL, V324, P196, DOI 10.1007/BF00503894; Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; Ariga T, 1999, NEUROCHEM RES, V24, P219, DOI 10.1023/A:1022557920150; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1994, ANN NY ACAD SCI, V747, P256; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; Avdulov NA, 1999, BBA-MOL CELL BIOL L, V1437, P37, DOI 10.1016/S0005-2760(98)00178-7; Brouillet E, 1999, J NEUROSCI, V19, P1717; BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x; Butterfield DA, 1999, METHOD ENZYMOL, V309, P746; Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e; BUTTERFIELD DA, 1994, BIOCHEM BIOPH RES CO, V200, P710, DOI 10.1006/bbrc.1994.1508; CASSEL D, 1976, BIOCHIM BIOPHYS ACTA, V452, P538, DOI 10.1016/0005-2744(76)90206-0; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; CZECH C, 1994, EUR ARCH PSY CLIN N, V243, P291, DOI 10.1007/BF02191587; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; ETCHEBERRIGARAY R, 1994, ANN NY ACAD SCI, V747, P245; Evans RM, 2000, NEUROLOGY, V54, P240, DOI 10.1212/WNL.54.1.240; FERRARIDILEO G, 1995, MOL CHEM NEUROPATHOL, V24, P69, DOI 10.1007/BF03160113; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Good TA, 1996, BIOPHYS J, V70, P296, DOI 10.1016/S0006-3495(96)79570-X; Good TA, 1996, P NATL ACAD SCI USA, V93, P15130, DOI 10.1073/pnas.93.26.15130; GOREVIC PD, 1987, BIOCHEM BIOPH RES CO, V147, P854, DOI 10.1016/0006-291X(87)91008-4; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HEIDER JG, 1978, J LIPID RES, V19, P514; Hertel C, 1997, P NATL ACAD SCI USA, V94, P9412, DOI 10.1073/pnas.94.17.9412; Hirakura Y, 1998, BIOCHEM MOL BIOL INT, V46, P787; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; INOUYE H, 1993, BIOPHYS J, V64, P502, DOI 10.1016/S0006-3495(93)81393-6; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Kanfer JN, 1999, NEUROCHEM RES, V24, P1621, DOI 10.1023/A:1021172620295; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; Klinker JF, 1996, NEUROSCI LETT, V213, P25, DOI 10.1016/0304-3940(96)12816-0; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Liu YB, 1998, J NEUROCHEM, V71, P2322; Liu YB, 1999, PROG NEURO-PSYCHOPH, V23, P377, DOI 10.1016/S0278-5846(99)00003-2; Liu YB, 2001, ANAL BIOCHEM, V289, P130, DOI 10.1006/abio.2000.4928; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; MASON RP, 1993, ANN NY ACAD SCI, V695, P54, DOI 10.1111/j.1749-6632.1993.tb23027.x; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Merrill AH, 1996, ADV EXP MED BIOL, V392, P297; Michikawa M, 1999, J NEUROCHEM, V72, P2278, DOI 10.1046/j.1471-4159.1999.0722278.x; MILLER RG, 1984, CELL BIOL INT REP, V8, P519, DOI 10.1016/0309-1651(84)90050-X; Mizuno T, 1998, BBA-BIOMEMBRANES, V1373, P119, DOI 10.1016/S0005-2736(98)00097-2; Mizuno T, 1999, J BIOL CHEM, V274, P15110, DOI 10.1074/jbc.274.21.15110; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; OFFERMANNS S, 1989, EUR J BIOCHEM, V180, P283, DOI 10.1111/j.1432-1033.1989.tb14645.x; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Rolsma MD, 1998, J VIROL, V72, P9079, DOI 10.1128/JVI.72.11.9079-9091.1998; Rymer DL, 2001, J BIOL CHEM, V276, P2523, DOI 10.1074/jbc.M005800200; SCHNECKO A, 1994, BRAIN RES, V644, P291, DOI 10.1016/0006-8993(94)91692-6; SEIFERT R, 1987, BIOCHEM BIOPH RES CO, V146, P1296, DOI 10.1016/0006-291X(87)90790-X; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SHEN CL, 1994, BIOPHYS J, V67, P1238, DOI 10.1016/S0006-3495(94)80593-4; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soomets U, 1999, BRAIN RES, V850, P179, DOI 10.1016/S0006-8993(99)02142-3; Stevens VL, 1997, J BIOL CHEM, V272, P18020, DOI 10.1074/jbc.272.29.18020; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; WEISS JH, 1994, J NEUROCHEM, V62, P372; WHITSON JS, 1994, BIOCHEM BIOPH RES CO, V199, P163, DOI 10.1006/bbrc.1994.1209; Woo JT, 2000, J BONE MINER RES, V15, P650, DOI 10.1359/jbmr.2000.15.4.650; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yoo HS, 1996, TOXICOL APPL PHARM, V138, P211, DOI 10.1006/taap.1996.0119; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhou Y, 1996, NEUROREPORT, V7, P2487	96	82	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42027	42034		10.1074/jbc.M102834200	http://dx.doi.org/10.1074/jbc.M102834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11557751	hybrid			2022-12-27	WOS:000172450400066
J	Yao, PM; Tabas, I				Yao, PM; Tabas, I			Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; CYTOCHROME-C RELEASE; ACYL-COENZYME-A; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; UP-REGULATION; LOCALIZATION; CELLS; BAX; NECROSIS; DEATH	Macrophage death in advanced atherosclerotic lesions leads to lesional necrosis and possibly plaque rupture and acute vascular occlusion. Among the likely causes of lesional macrophage death is intracellular accumulation of excess free cholesterol (FC), which is known to occur in vivo. We recently showed that FC loading of macrophages causes apoptosis, similar to 50% of which is mediated by activation of cell-surface FasL and triggering of the Fas pathway (Yao, P. M., and Tabas, I. (2000) J. Biol. Chem. 275, 23807-23813). To elucidate other pathways of death in FC-loaded macrophages, we investigated mitochondrial transmembrane potential (Delta psi (m)) and the mitochondrial apoptosis pathway in FC-loaded mouse peritoneal macrophages. Starting between 3 and 6 h of FC loading, Delta psi (m) was markedly decreased in the majority of macrophages and was independent of the Fas pathway. The decrease in Delta psi (m) by FC loading was not prevented by GSH, thus distinguishing it from 7-ketocholesterol-induced mitochondrial dysfunction. Cytochrome c release into the cytosol was noted by 4 h of FC loading, and activation of caspase-9 and effector caspases was observed at 6 h. Finally, we found that both cellular and mitochondrial levels of the pro-apoptotic protein Bax were increased severalfold as early as 4 h after FC loading. Thus, FC loading, perhaps via increased levels of Bax and/or cholesterol overloading of mitochondria, triggers cytochrome c release and activation of caspase-9 and the effector caspases, leading to macrophage apoptosis. These findings and our previous data support a model in which FC loading of macrophages promotes a dual program of caspase-mediated death.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.	iat1@columbia.edu			NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591] Funding Source: NIH RePORTER; NCI NIH HHS [5 P30 CA13696] Funding Source: Medline; NHLBI NIH HHS [HL-54591] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; Bauriedel G, 1997, Z KARDIOL, V86, P902, DOI 10.1007/s003920050130; BERBERIAN PA, 1990, AM J PATHOL, V136, P71; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; CALANNI RF, 1986, FEBS LETT, V198, P353; COLEMAN PS, 1978, BIOCHEM BIOPH RES CO, V84, P202, DOI 10.1016/0006-291X(78)90282-6; Colles SM, 1996, J LIPID RES, V37, P2018; ECHEGOYEN S, 1993, BIOCHEM J, V289, P703, DOI 10.1042/bj2890703; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kolodgie FD, 2000, AM J PATHOL, V157, P1259, DOI 10.1016/S0002-9440(10)64641-X; Komoriya A, 2000, J EXP MED, V191, P1819, DOI 10.1084/jem.191.11.1819; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Lizard G, 2000, FREE RADICAL BIO MED, V28, P743, DOI 10.1016/S0891-5849(00)00163-5; Lizard G, 1998, FASEB J, V12, P1651, DOI 10.1096/fasebj.12.15.1651; LUNDBERG B, 1985, ATHEROSCLEROSIS, V56, P93, DOI 10.1016/0021-9150(85)90087-5; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mitchinson MJ, 1996, CURR OPIN LIPIDOL, V7, P324, DOI 10.1097/00041433-199610000-00011; MIYASHITA T, 1995, CELL, V80, P293; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; RAPP JH, 1983, J LIPID RES, V24, P1329; ROSS AC, 1984, J BIOL CHEM, V259, P815; ROUSLIN W, 1982, AM J PHYSIOL, V242, pH254, DOI 10.1152/ajpheart.1982.242.2.H254; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schlesinger M, 2000, BIOCHEM PHARMACOL, V60, P1693, DOI 10.1016/S0006-2952(00)00484-6; SHIO H, 1979, LAB INVEST, V41, P160; SHIRATORI Y, 1994, J BIOL CHEM, V269, P11337; SMALL DM, 1984, J CLIN INVEST, V73, P1590, DOI 10.1172/JCI111366; Tabas I, 1996, J BIOL CHEM, V271, P22773, DOI 10.1074/jbc.271.37.22773; Tang W, 1999, BBA-MOL CELL BIOL L, V1437, P301, DOI 10.1016/S1388-1981(99)00023-2; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200	46	156	162	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42468	42476		10.1074/jbc.M101419200	http://dx.doi.org/10.1074/jbc.M101419200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533046	hybrid			2022-12-27	WOS:000172450400119
J	Communi, D; Gonzalez, NS; Detheux, M; Brezillon, S; Lannoy, V; Parmentier, M; Boeynaems, JM				Communi, D; Gonzalez, NS; Detheux, M; Brezillon, S; Lannoy, V; Parmentier, M; Boeynaems, JM			Identification of a novel human ADP receptor coupled to G(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE NUCLEOTIDE RECEPTOR; INHIBITS ADENYLYL-CYCLASE; FUNCTIONAL EXPRESSION; PHOSPHOLIPASE-C; MOLECULAR-CLONING; P2Y(1) RECEPTOR; ATP RECEPTOR; G-PROTEINS; CELLS; PURINOCEPTOR	We have cloned and expressed a novel human G-protein-coupled receptor closely related to the human P2Y(12) receptor. It corresponds to the orphan receptor called GPR86. GPR86 proved to be a G; coupled receptor displaying a high affinity for ADP, similar to the P2Y12 receptor and can therefore be tentatively called P2Y(13). In 1321N1 cells, the P2Y13 receptor coupled to the phosphoinositide pathway only when coexpressed with Gals. Inositol trisphosphate formation was stimulated equipotently by nanomolar concentrations of ADP and 2MeSADP, whereas 2MeSATP and ATP were inactive. In CHO-K1 cells expressing the P2Y13 receptor, ADP and 2MeSADP had a biphasic effect on the forskolin-stimulated accumulation of cAMP: inhibition at nanomolar concentrations and potentiation at micromolar levels. In the same cells, ADP and 2MeSADP also stimulated the phosphorylation of Erk1 and Erk2, in a pertussis toxin-sensitive way. The tissue distribution of P2Y13 was investigated by reverse transcriptase-polymerise chain reaction, and the predominant signals were obtained in spleen and brain. Although these can be discriminated by tissue distribution and some pharmacological features, the P2Y12 and P2Y13 receptors form a subgroup of related P2Y subtypes that is structurally different from the other P2Y subtypes but share coupling to Gi and a high affinity for ADP.	Free Univ Brussels, Sch Med, Inst Interdisciplinary Res, B-1070 Brussels, Belgium; Euroscreen, B-1070 Brussels, Belgium; Free Univ Brussels, Dept Med Chem, Erasme Hosp, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Communi, D (corresponding author), Free Univ Brussels, Sch Med, Inst Interdisciplinary Res, 808 Route Lennik, B-1070 Brussels, Belgium.		Gonzalez Cordova, Nadia Lorena/GSN-4164-2022	BREZILLON, stephane/0000-0001-7954-8340; Parmentier, Marc/0000-0001-8081-4685				ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Akbar GKM, 1996, J BIOL CHEM, V271, P18363, DOI 10.1074/jbc.271.31.18363; Bogdanov YD, 1997, J BIOL CHEM, V272, P12583, DOI 10.1074/jbc.272.19.12583; BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140; Boyer JL, 2000, MOL PHARMACOL, V57, P805, DOI 10.1124/mol.57.4.805; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; CHABRE O, 1994, J BIOL CHEM, V269, P5730; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; CHANG KG, 1995, J BIOL CHEM, V270, P26152, DOI 10.1074/jbc.270.44.26152; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; COMMUNI D, 1995, CIRC RES, V76, P191, DOI 10.1161/01.RES.76.2.191; Communi D, 1995, J BIOL CHEM, V270, P30849, DOI 10.1074/jbc.270.52.30849; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; EASON MG, 1992, J BIOL CHEM, V267, P15795; ERB L, 1995, J BIOL CHEM, V270, P4185, DOI 10.1074/jbc.270.9.4185; Fredholm BB, 1997, TRENDS PHARMACOL SCI, V18, P79, DOI 10.1016/S0165-6147(96)01038-3; Gerhardt CC, 1999, MOL PHARMACOL, V55, P255, DOI 10.1124/mol.55.2.255; Hechler B, 1998, MOL PHARMACOL, V53, P727, DOI 10.1124/mol.53.4.727; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Janssens R, 1997, BIOCHEM BIOPH RES CO, V236, P106, DOI 10.1006/bbrc.1997.6895; Leon C, 1997, FEBS LETT, V403, P26, DOI 10.1016/S0014-5793(97)00022-7; Li Q, 1997, BIOCHEM BIOPH RES CO, V236, P455, DOI 10.1006/bbrc.1997.6984; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Nguyen T, 1995, J BIOL CHEM, V270, P30845, DOI 10.1074/jbc.270.52.30845; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Simon J, 2001, BRIT J PHARMACOL, V132, P173, DOI 10.1038/sj.bjp.0703816; Webb TE, 1996, MOL PHARMACOL, V50, P258; Webb TE, 1996, BIOCHEM BIOPH RES CO, V219, P105, DOI 10.1006/bbrc.1996.0189; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	34	262	268	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41479	41485		10.1074/jbc.M105912200	http://dx.doi.org/10.1074/jbc.M105912200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546776	hybrid			2022-12-27	WOS:000171925600145
J	Osawa, M; Tong, KI; Lilliehook, C; Wasco, W; Buxbaum, JD; Cheng, HYM; Penninger, JM; Ikura, M; Ames, JB				Osawa, M; Tong, KI; Lilliehook, C; Wasco, W; Buxbaum, JD; Cheng, HYM; Penninger, JM; Ikura, M; Ames, JB			Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOVERIN; CALSENILIN; CYCLASE; SENSOR	Calsenilin/DREAM/KChIP3, a member of the recoverin branch of the EF-hand superfamily, interacts with presenilins, serves as a calcium-regulated transcriptional repressor, and interacts with A-type potassium channels. Here we report physicochemical characterization of calcium binding, oligomerization, and DNA binding of human calsenilin/DREAM/KChIP3. Equilibrium Ca2+ binding measurements indicate that the protein binds 3 Ca2+ with a dissociation constant of 14 muM and a Hill coefficient of 0.7. Dynamic light scattering and size exclusion chromatography show that the Ca2+-bound protein exists as a dimer at protein concentrations lower than 150 muM and forms a tetramer at concentrations above 200 muM. The Ca2+-free protein is a tetramer in the concentration range 20-450 muM. Isothermal titration calorimetry and dynamic light scattering indicate that the Ca2+-free protein tetramer binds endothermically (DeltaH = +25 kcal/mol) to four molecules of DNA derived from the downstream regulatory element (DRE) of either the prodynorphin or c-fos genes. One DRE molecule binds tightly to the protein with a dissociation constant (K-d) of 75 nM, and the other three bind more weakly (K-d = 640 nM). No significant DNA binding was observed for the Ca2+-bound protein. The N-terminal protein fragment (residues 1-70) binds nonspecifically to DRE in a Ca2+-independent manner, whereas a C-terminal fragment containing the four EF-hands (residues 65-256) binds DRE (K-d = 200 nM) in a Ca2+-regulated and sequence-specific fashion. The C-terminal fragment is a tetramer in the Ca2+-free state and dissociates into dimers at saturating Ca2+ levels.	Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Univ Toronto, Ontario Canc Inst, Div Mol & Struct Biol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; Univ Toronto, Amgen Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Ames, JB (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.		Penninger, Josef M/I-6860-2013; Osawa, Masanori/GRS-5726-2022; Buxbaum, Joseph D/G-6001-2010	Penninger, Josef M/0000-0002-8194-3777; Osawa, Masanori/0000-0002-1285-4316; Buxbaum, Joseph/0000-0001-8898-8313; Ikura, Mitsuhiko/0000-0002-9524-1303	NEI NIH HHS [EY12347] Funding Source: Medline; NIA NIH HHS [AG05138, AG15801] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015801] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FREIFELDER D, 1982, PHYSICAL BIOCH, P537; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; Ledo F, 2000, BBA-MOL CELL RES, V1498, P162, DOI 10.1016/S0167-4889(00)00092-6; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Lundback T, 1996, P NATL ACAD SCI USA, V93, P4754, DOI 10.1073/pnas.93.10.4754; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008; O'Brien R, 1998, J MOL BIOL, V279, P117, DOI 10.1006/jmbi.1998.1743; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; TAKAMATSU K, 1992, BIOCHEM BIOPH RES CO, V183, P245, DOI 10.1016/0006-291X(92)91635-4; TAKEDA Y, 1992, P NATL ACAD SCI USA, V89, P8180, DOI 10.1073/pnas.89.17.8180; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y	29	109	115	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41005	41013		10.1074/jbc.M105842200	http://dx.doi.org/10.1074/jbc.M105842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11535596	hybrid, Green Published			2022-12-27	WOS:000171925600085
J	Regel, RE; Ivleva, NB; Zer, H; Meurer, J; Shestakov, SV; Herrmann, RG; Pakrasi, HB; Ohad, I				Regel, RE; Ivleva, NB; Zer, H; Meurer, J; Shestakov, SV; Herrmann, RG; Pakrasi, HB; Ohad, I			Deregulation of electron flow within photosystem II in the absence of the PsbJ protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; D1 PROTEIN; IN-VIVO; THERMO-LUMINESCENCE; CYTOCHROME B(559); REACTION CENTERS; LOW-LIGHT; MUTANT; DEGRADATION; MECHANISM	The photosystem II (PSII) complex of photosynthetic oxygen evolving membranes comprises a number of small proteins whose functions remain unknown. Here we report that the low molecular weight protein encoded by the psbJ gene is an intrinsic component of the PSII complex. Fluorescence kinetics, oxygen flash yield, and thermoluminescence measurements indicate that inactivation of the psbJ gene in Synechocystis 6803 cells and tobacco chloroplasts lowers PSII-mediated oxygen evolution activity and increases the lifetime of the reduced primary acceptor Q(A)(-) (more than a 100-fold in the tobacco Delta psbJ mutant). The decay of the oxidized S-2,S-3 states of the oxygen-evolving complex is considerably accelerated, and the oscillations of the Q(B)(-)/S-2,S-3 recombination with the number of exciting flashes are damped. Thus, PSII can be assembled in the absence of PsbJ. However, the forward electron flow from Q(A)(-) to plastoquinone and back electron flow to the oxidized Mn cluster of the donor side are deregulated in the absence of PsbJ, thereby affecting the efficiency of PSII electron flow following the charge separation process.	Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; Univ Munich, Inst Bot, D-80638 Munich, Germany; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Moscow MV Lomonosov State Univ, Dept Genet, Moscow 119899, Russia	Hebrew University of Jerusalem; University of Munich; Washington University (WUSTL); Lomonosov Moscow State University	Ohad, I (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel.		Meurer, Jörg/F-8479-2010	Meurer, Jörg/0000-0003-2973-9514	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045797] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 45797] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ANBUDURAI PR, 1993, Z NATURFORSCH C, V48, P267; BARBER J, 1993, P NATL ACAD SCI USA, V90, P10942, DOI 10.1073/pnas.90.23.10942; Barber J, 1998, BBA-BIOENERGETICS, V1365, P269, DOI 10.1016/S0005-2728(98)00079-6; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; CARPENTER SD, 1993, BIOCHIM BIOPHYS ACTA, V1144, P204, DOI 10.1016/0005-2728(93)90174-E; De Santis-Maciossek G, 1999, PLANT J, V18, P477, DOI 10.1046/j.1365-313X.1999.00473.x; Debus RJ, 2000, MET IONS BIOL SYST, V37, P657; DEBUS RJ, 1986, BIOCHEMISTRY-US, V25, P2276, DOI 10.1021/bi00356a064; Hanley J, 1999, BIOCHEMISTRY-US, V38, P8189, DOI 10.1021/bi990633u; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; KEREN N, 1995, J BIOL CHEM, V270, P806, DOI 10.1074/jbc.270.2.806; Koop HU, 1996, PLANTA, V199, P193, DOI 10.1007/BF00196559; Krieger A, 1997, BBA-BIOENERGETICS, V1319, P91, DOI 10.1016/S0005-2728(96)00117-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIND LK, 1993, J BIOL CHEM, V268, P1575; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; Meetam M, 1999, PLANT PHYSIOL, V121, P1267, DOI 10.1104/pp.121.4.1267; Minagawa J, 1999, BIOCHEMISTRY-US, V38, P770, DOI 10.1021/bi981217x; Mizusawa N, 1999, BBA-BIOENERGETICS, V1410, P273, DOI 10.1016/S0005-2728(99)00005-5; MOR TS, 1995, MOL GEN GENET, V246, P600, DOI 10.1007/BF00298966; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Pakrasi HB, 1995, ANNU REV GENET, V29, P755; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; Schreiber U, 1996, FEBS LETT, V397, P131, DOI 10.1016/S0014-5793(96)01176-3; SHUKLA VK, 1992, MOL MICROBIOL, V6, P947, DOI 10.1111/j.1365-2958.1992.tb01544.x; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Tal S, 1999, J PHOTOCH PHOTOBIO B, V48, P120, DOI 10.1016/S1011-1344(99)00040-8; Trtilek M, 1997, J LUMIN, V72-4, P597, DOI 10.1016/S0022-2313(97)00066-5; VASS I, 1981, BIOCHIM BIOPHYS ACTA, V634, P140, DOI 10.1016/0005-2728(81)90134-1; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; Vrettos JS, 1999, J PHYS CHEM B, V103, P6403, DOI 10.1021/jp991464q; Whitmarsh J., 1996, OXYGENIC PHOTOSYNTHE, P249, DOI 10.1007/0-306-48127-8_13; ZER H, 1994, J BIOL CHEM, V269, P17670; Zer H, 1999, P NATL ACAD SCI USA, V96, P8277, DOI 10.1073/pnas.96.14.8277	37	44	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41473	41478		10.1074/jbc.M102007200	http://dx.doi.org/10.1074/jbc.M102007200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546758	hybrid			2022-12-27	WOS:000171925600144
J	Teusink, B; Mensenkamp, AR; van der Boom, H; Kuipers, F; van Dijk, KW; Havekes, LM				Teusink, B; Mensenkamp, AR; van der Boom, H; Kuipers, F; van Dijk, KW; Havekes, LM			Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CONTAINING LIPOPROTEINS; APOE-DEFICIENT MICE; TRANSGENIC MICE; LDL RECEPTOR; GENE-TRANSFER; E EXPRESSION; SECRETION; CLEARANCE; VLDL; TRIGLYCERIDES	Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as yet unknown mechanism. Recently, a working mechanism for apoE was proposed (Twisk, J., Gillian-Daniel, D. L., Tebon, A., Wang, L., Barrett, P. H., and Attie, A. D. (2000) J. Clan. Invest. 105, 521-532) in which apoE prevents the inhibitory action of the low density lipoprotein receptor (LDLr) by binding to it. We have first tested whether this newly described effect of the LDLr on VLDL secretion, obtained in vitro, is also observed in vavo. In LDLr knockout mice (LDLr-/-), the production of VLDL triglycerides and apoB was 30% higher than that in controls. Also the ratio of apoB100:apoB48 secretion was increased in the LDLr-/- mice. The composition of nascent VLDL was similar in both strains. To test whether the action of apoE depends on the presence of the LDLr, VLDL production was measured in LDLr-/- and apoE-/- LDLr-/- mice. Deletion of apoE on a LDLr-/-background still caused a 50% decrease of VLDL triglycerides and apoB production. The composition of nascent VLDL was again similar for both strains. We conclude that the effect of apoE on hepatic VLDL production is independent of the presence of the LDLr.	TNO Prevent & Hlth, Gaubius Lab, NL-2301 CE Leiden, Netherlands; Univ Groningen Hosp, Pediat Lab, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands; Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Internal Med, NL-2300 RA Leiden, Netherlands	Netherlands Organization Applied Science Research; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Teusink, B (corresponding author), TNO Prevent & Hlth, Gaubius Lab, POB 2215, NL-2301 CE Leiden, Netherlands.		van Dijk, Ko Willems/A-1798-2008; Mensenkamp, Arjen/L-4520-2015; van Dijk, Ko Willems/AAT-4681-2021	van Dijk, Ko Willems/0000-0002-2172-7394; Mensenkamp, Arjen/0000-0003-3805-877X; van Dijk, Ko Willems/0000-0002-2172-7394; Teusink, Bas/0000-0003-3929-0423; Kuipers, Folkert/0000-0003-2518-737X				AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Arrol S, 2000, ATHEROSCLEROSIS, V150, P255, DOI 10.1016/S0021-9150(99)00374-3; Brown ML, 2000, P NATL ACAD SCI USA, V97, P7488, DOI 10.1073/pnas.120184097; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; de Beer F, 2000, ARTERIOSCL THROM VAS, V20, P1800, DOI 10.1161/01.ATV.20.7.1800; EGUSA G, 1983, J LIPID RES, V24, P1261; Huang YD, 1999, ARTERIOSCL THROM VAS, V19, P2952, DOI 10.1161/01.ATV.19.12.2952; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jong MC, 1997, BIOCHEM J, V328, P745; Jong MC, 1996, ARTERIOSCL THROM VAS, V16, P934, DOI 10.1161/01.ATV.16.8.934; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Kypreos KE, 2001, FASEB J, V15, P1598, DOI 10.1096/fj.00-0882fje; Kypreos KE, 2001, J BIOL CHEM, V276, P19778, DOI 10.1074/jbc.M100418200; Lewis GF, 1997, CURR OPIN LIPIDOL, V8, P146, DOI 10.1097/00041433-199706000-00004; Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Maugeais C, 2000, J LIPID RES, V41, P1673; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; MENSENKAMP AR, 2001, IN PRESS ARTERIOSCLE, V21; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Packard CJ, 1999, CURR OPIN LIPIDOL, V10, P237, DOI 10.1097/00041433-199906000-00006; Packard CJ, 2000, J LIPID RES, V41, P305; Packard CJ, 1997, ARTERIOSCL THROM VAS, V17, P3542, DOI 10.1161/01.ATV.17.12.3542; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Tacken PJ, 2000, J LIPID RES, V41, P2055; Tsukamoto K, 2000, J LIPID RES, V41, P253; Tsukamoto K, 1997, J CLIN INVEST, V100, P107, DOI 10.1172/JCI119501; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; van Dijk KW, 1999, ARTERIOSCL THROM VAS, V19, P2945, DOI 10.1161/01.ATV.19.12.2945; Veniant MM, 1998, J CLIN INVEST, V102, P1559, DOI 10.1172/JCI4164; Voyiaziakis E, 1999, J LIPID RES, V40, P2004	32	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40693	40697		10.1074/jbc.M106396200	http://dx.doi.org/10.1074/jbc.M106396200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546779	Green Published, hybrid			2022-12-27	WOS:000171925600043
J	Cho, H; Thorvaldsen, JL; Chu, QW; Feng, F; Birnbaum, MJ				Cho, H; Thorvaldsen, JL; Chu, QW; Feng, F; Birnbaum, MJ			Akt1/PKB alpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; INSULIN-RECEPTOR; CELL-SIZE; S6 KINASE; DROSOPHILA; IGF-1; ACTIVATION; DISRUPTION; GENE; ADIPOCYTES	The serine-threonine kinase Akt, also known as protein kinase B (PKB), is an important effector for phosphatidylinositol 3-kinase signaling initiated by numerous growth factors and hormones. Akt2/PKB beta, one of three known mammalian isoforms of Akt/PKB, has been demonstrated recently to be required for at least some of the metabolic actions of insulin (Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., and Birnbaum, M. J. (2001) Science 292,1728-1731). Here we show that mice deficient in another closely related isoform of the kinase, Akt1/PKB alpha, display a conspicuous impairment in organismal growth. Akt1(-/-) mice demonstrated defects in both fetal and postnatal growth, and these persisted into adulthood. However, in striking contrast to Akt2/PKB beta null mice, Akt1/PKB alpha -deficient mice are normal with regard to glucose tolerance and insulin-stimulated disposal of blood glucose. Thus, the characterization of the Akt1 knockout mice and its comparison to the previously reported Akt2 deficiency phenotype reveals the non-redundant functions of Akt1 and Akt2 genes with respect to organismal growth and insulin-regulated glucose metabolism.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.			Birnbaum, Morris/0000-0001-9972-8680	NIDDK NIH HHS [R01 DK56886] Funding Source: Medline; NIGMS NIH HHS [GM07229] Funding Source: Medline; PHS HHS [P30 19525] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coffer PJ, 1998, BIOCHEM J, V335, P1; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Hill MM, 1999, MOL CELL BIOL, V19, P7771; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Murthy SS, 2000, CYTOGENET CELL GENET, V88, P38, DOI 10.1159/000015481; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Park BC, 1999, BIOCHEMISTRY-US, V38, P7517, DOI 10.1021/bi9830718; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631	26	776	815	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 19	2001	276	42					38349	38352		10.1074/jbc.C100462200	http://dx.doi.org/10.1074/jbc.C100462200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	484CT	11533044	hybrid			2022-12-27	WOS:000171673200005
J	Christian, S; Ahorn, H; Novatchkova, M; Garin-Chesa, P; Park, JE; Weber, G; Eisenhaber, F; Rettig, WJ; Lenter, MC				Christian, S; Ahorn, H; Novatchkova, M; Garin-Chesa, P; Park, JE; Weber, G; Eisenhaber, F; Rettig, WJ; Lenter, MC			Molecular cloning and characterization of EndoGlyx-1, an EMILIN-like multisubunit glycoprotein of vascular endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; CDNA SEQUENCE; ORGANIZATION; MULTIMERIN; PROTEINS; IDENTIFICATION; LOCALIZATION; CADHERIN; ELASTIN; PEPTIDE	EndoGlyx-1, the antigen identified with the monoclonal antibody H572, is a pan-endothelial human cell surface glycoprotein complex composed of four different disulfide-bonded protein species with an apparent molecular mass of approximately 500 kDa. Here, we report the purification and peptide analysis of two EndoGlyx-1 subunits, p125 and p140, and the identification of a common, full-length cDNA with an open reading frame of 2847 base pairs. The EndoGlyx-1 cDNA encodes a protein of 949 amino acids with a predicted molecular mass of 105 kDa, found as an entry for an unnamed protein with unknown function in public data bases. A short sequence tag matching the cDNA of this gene was independently discovered by serial analysis of gene expression profiling as a pan-endothelial marker, PEM87. Bioinformatic evaluation classifies EndoGlyx-1 as an EMILIN-like protein composed of a signal sequence, an N-terminal EMI domain, and a C-terminal Clq-like domain, separated from each other by a central coiled-coil-rich region. Biochemical and carbohydrate analysis revealed that p125, p140, and the two additional EndoGlyx-1 subunits, p110 and p200, are exposed on the cell surface. The three smaller subunits show a similar pattern of N-linked and O-linked carbohydrates, as shown by enzyme digestion. Because the two globular domains of EndoGlyx-1 p125/p140 show structural features shared by EMILIN-1 and Multimerin, two oligomerizing glycoproteins implicated in cell-matrix adhesion and hemostasis, it will be of interest to explore similar functions for EndoGlyx-1 in human vascular endothelium.	Boehringer Ingelheim Pharma KG, Dept Oncol Res, D-88397 Biberach, Germany; Boehringer Ingelheim Austria GmbH, Dept Drug Discovery, A-1121 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria	Boehringer Ingelheim; Boehringer Ingelheim; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Lenter, MC (corresponding author), Boehringer Ingelheim Pharma KG, Dept Oncol Res, D-88397 Biberach, Germany.	martin.lenter@bc.boehringer.ingelheim.com						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belien JAM, 1999, J PATHOL, V189, P309; CARLOS TM, 1994, BLOOD, V84, P2068; Christian S, 2001, J BIOL CHEM, V276, P7408, DOI 10.1074/jbc.M009604200; COLOMBATTI A, 1985, COLLAGEN REL RES, V5, P181; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; COLOMBATTI A, 1985, J CELL BIOL, V100, P18, DOI 10.1083/jcb.100.1.18; COLOMBATTI A, 1987, COLLAGEN REL RES, V7, P259; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Hayward CPM, 1999, BLOOD, V94, P1337, DOI 10.1182/blood.V94.4.1337.416k20_1337_1347; HAYWARD CPM, 1993, J CLIN INVEST, V91, P2630, DOI 10.1172/JCI116502; HAYWARD CPM, 1991, BLOOD, V77, P2556; HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; REICHENBERGER E, 1992, FEBS LETT, V311, P305, DOI 10.1016/0014-5793(92)81126-7; REID KBM, 1985, IMMUNOLOGY, V55, P185; SANZMONCASI MP, 1994, LAB INVEST, V71, P366; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; SOBEL M, 1992, J BIOL CHEM, V267, P8857; St Croix B, 2000, SCIENCE, V289, P1197; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	30	48	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2001	276	51					48588	48595		10.1074/jbc.M106152200	http://dx.doi.org/10.1074/jbc.M106152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505QL	11559704	hybrid			2022-12-27	WOS:000172927000114
J	Ganguly, S; Mummaneni, P; Steinbach, PJ; Klein, DC; Coon, SL				Ganguly, S; Mummaneni, P; Steinbach, PJ; Klein, DC; Coon, SL			Characterization of the Saccharomyces cerevisiae homolog of the melatonin rhythm enzyme arylalkylamine N-acetyltransferase (EC 2.3.1.87)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-FORCE FIELD; DROSOPHILA-MELANOGASTER; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; PINEAL-GLAND; MMFF94; PROTEIN; CLONING; GEOMETRIES; DYNAMICS	Arylalkylamine N-acetyltransferase (AANAT, serotonin N-acetyltransferase, EC 2.3.1.87) plays a unique transduction role in vertebrate physiology by converting information about day and night into a hormonal signal: melatonin. Only vertebrate members of the AANAT family have been functionally characterized. Here a putative AANAT from Saccharomyces cerevisiae (scAANAT) was studied to determine whether it possessed the catalytic activity of the vertebrate enzyme. scAANAT is 47% similar to ovine AANAT, but lacks the regulatory N- and C-terminal flanking regions conserved in all vertebrate AANATs. It was found to have enzyme activity generally typical for AANAT family members, although the substrate preference pattern was somewhat broader, the specific activity was lower, and the pH optimum was higher. Deletion of scAANAT reduced arylalkylamine acetylation by S. cerevisiae extracts, indicating that scAANAT contributes significantly to this process. The scAANAT sequence conformed to the three-dimensional structure of ovine AANAT catalytic core; however, an important structural element (loop 1) was found to be shorter and to lack a proline involved in substrate binding. These differences could explain the lower specific activity of scAANAT, because of the importance of loop 1 in catalysis. Data base analysis revealed the presence of putative AANATs in other fungi but not in the nearly complete genomes of Drosophila melanogaster or Caenorhabditis elegans. These studies indicate that the catalytic and kinetic characteristics of fungal and vertebrate enzymes can be considered to be generally similar, although some differences exist that appear to be linked to changes in one structural element. Perhaps the most striking difference is that fungal AANATs lack the regulatory domains of the vertebrate enzyme, which appear to be essential for the regulatory role the enzyme plays in photochemical transduction.	NICHHD, Dev Neurobiol Lab, Sect Neuroendocrinol, NIH, Bethesda, MD 20892 USA; NIH, Ctr Informat Technol, Ctr Mol Modeling, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Klein, DC (corresponding author), NICHHD, Dev Neurobiol Lab, Sect Neuroendocrinol, NIH, 49 Convent Dr,MSC 4480,Bldg 49,Rm 6A-82, Bethesda, MD 20892 USA.	klein@helix.nih.gov		Klein, David/0000-0002-1792-5806; Ganguly, Surajit/0000-0002-1876-9147	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000265, Z01CT000265] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000095, ZIAHD000095] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amherd R, 2000, DNA CELL BIOL, V19, P697, DOI 10.1089/10445490050199081; Benyassi A, 2000, NEUROREPORT, V11, P255, DOI 10.1097/00001756-200002070-00006; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 2001, J BIOL CHEM, V276, P24097, DOI 10.1074/jbc.M011298200; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P553, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<553::AID-JCC3>3.0.CO;2-T; Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO;2-Q; Hardeland R, 1999, REPROD NUTR DEV, V39, P399, DOI 10.1051/rnd:19990311; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hintermann E, 1996, P NATL ACAD SCI USA, V93, P12315, DOI 10.1073/pnas.93.22.12315; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN DC, 1998, HDB BEHAV STATE CONT, V4, P45; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAMBOODIRI MAA, 1987, METHOD ENZYMOL, V142, P583; NAMBOODIRI MAA, 1979, J NEUROCHEM, V33, P807, DOI 10.1111/j.1471-4159.1979.tb05229.x; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; RIODAN JF, 1972, METHODS ENZYMOL B, V25, P494; Sprenger J., 1999, Cytologia (Tokyo), V64, P209; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	36	47	49	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2001	276	50					47239	47247		10.1074/jbc.M107222200	http://dx.doi.org/10.1074/jbc.M107222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	502XR	11559708	hybrid			2022-12-27	WOS:000172768500077
J	Entelis, NS; Kolesnikova, OA; Dogan, S; Martin, RP; Tarassov, IA				Entelis, NS; Kolesnikova, OA; Dogan, S; Martin, RP; Tarassov, IA			5 S rRNA and tRNA import into human mitochondria - Comparison of in vitro requirements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASES; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; PROTEIN IMPORT; DISTINCT MECHANISMS; TRYPANOSOMA-BRUCEI; MAMMALIAN-CELLS; RIBOSOMAL-RNA; DNA; TRNA(LYS)	In vivo, human mitochondria import 5 S rRNA and do not import tRNAs from the cytoplasm. We demonstrated previously that isolated human mitochondria are able to internalize a yeast tRNA(Lys) in the presence of yeast soluble factors. Here, we describe an assay for specific uptake of 5 S rRNA by isolated human mitochondria and compare its requirements with the artificial tRNA import. The efficiency of 5 S rRNA uptake by isolated mitochondria was comparable with that found in vivo. The import was shown to depend on ATP and the transmembrane electrochemical potential and was directed by soluble proteins. Blocking the pre-protein import channel inhibited internalization of both 5 S rRNA and tRNA, which suggests this apparatus be involved in RNA uptake by the mitochondria. We show that human mitochondria can also selectively internalize several in vitro synthesized versions of yeast tRNA(Lys) as well as a transcript of the human mitochondrial tRNA(Lys). Either yeast or human soluble proteins can direct this import, suggesting that human cells possess all factors needed for such an artificial translocation. On the other hand, the efficiency of import directed by yeast or human protein factors varies significantly, depending on the tRNA version. Similarly to the yeast system, tRNA(Lys) import into human mitochondria depended on aminoacylation and on the precursor of the mitochondrial lysyl-tRNA synthetase. 5 S rRNA import was also dependent upon soluble protein(s), which were distinct from the factors providing tRNA internalization.	CNRS Modeles Etud Pathol Humaines, Format Rech Evolut 2375, F-67084 Strasbourg, France; Moscow MV Lomonosov State Univ, Dept Mol Biol, Fac Biol, Moscow 119899, Russia	Centre National de la Recherche Scientifique (CNRS); Lomonosov Moscow State University	Tarassov, IA (corresponding author), CNRS Modeles Etud Pathol Humaines, Format Rech Evolut 2375, 21 Rue Rene Descartes, F-67084 Strasbourg, France.	i.tarassov@ibmc.u-strasbg.fr		Entelis, Nina/0000-0002-7915-5528; Tarassov, Ivan/0000-0001-8763-6703	CSR NIH HHS [RG0349/1999-M] Funding Source: Medline	CSR NIH HHS		Adhya S, 1997, J BIOL CHEM, V272, P21396, DOI 10.1074/jbc.272.34.21396; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; CAHILL A, 1995, ANAL BIOCHEM, V232, P47, DOI 10.1006/abio.1995.9962; CIRAKOGLU B, 1985, FEBS LETT, V183, P185; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Dietrich A, 1996, BIOCHIMIE, V78, P518, DOI 10.1016/0300-9084(96)84758-4; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; Entelis NS, 1996, FEBS LETT, V384, P38, DOI 10.1016/0014-5793(96)00259-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; ENTELIS NS, 1991, ADV DRUG DELIV RES, V49, P199; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; GOULD GW, 1986, BIOCHEM J, V237, P217, DOI 10.1042/bj2370217; Kazakova HA, 1999, FEBS LETT, V442, P193, DOI 10.1016/S0014-5793(98)01653-6; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KERN D, 1977, BIOCHIMIE, V59, P453, DOI 10.1016/S0300-9084(77)80050-3; KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; Kun E, 1979, Methods Enzymol, V55, P115; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lang BF, 1996, J MOL BIOL, V261, P607, DOI 10.1006/jmbi.1996.0486; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; MacCallum RM, 2000, BIOINFORMATICS, V16, P125, DOI 10.1093/bioinformatics/16.2.125; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; MANIATIS T, MOL CLONING LAB MANA; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; MARTIN RP, 1977, NUCLEIC ACIDS RES, V4, P3497, DOI 10.1093/nar/4.10.3497; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; Nabholz CE, 1999, MOL BIOL CELL, V10, P2547, DOI 10.1091/mbc.10.8.2547; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; O'Brien T W, 1996, Methods Enzymol, V264, P237, DOI 10.1016/S0076-6879(96)64024-5; OJALA D, 1972, J MOL BIOL, V65, P273, DOI 10.1016/0022-2836(72)90282-3; Onesti S, 2000, BIOCHEMISTRY-US, V39, P12853, DOI 10.1021/bi001487r; Pfanner N, 1997, CURR BIOL, V7, pR100, DOI 10.1016/S0960-9822(06)00048-0; PICAMATTOCCIA L, 1971, J MOL BIOL, V57, P615, DOI 10.1016/0022-2836(71)90113-6; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; POSAKONY JW, 1975, J CELL SCI, V19, P315; Rose MD., 1990, METHODS YEAST GENETI; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rubio MAT, 2000, RNA, V6, P988, DOI 10.1017/S1355838200991519; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Schneider Andre, 1994, Trends in Cell Biology, V4, P282, DOI 10.1016/0962-8924(94)90218-6; SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10; Shiba K, 1997, J BIOL CHEM, V272, P22809, DOI 10.1074/jbc.272.36.22809; SIKORSKI RS, 1989, GENETICS, V122, P19; SILBERKLANG M, 1977, NUCLEIC ACIDS RES, V4, P4091, DOI 10.1093/nar/4.12.4091; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; Szymanski M, 2000, NUCLEIC ACIDS RES, V28, P166, DOI 10.1093/nar/28.1.166; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; TARASSOV IA, 1992, NUCLEIC ACIDS RES, V20, P1277, DOI 10.1093/nar/20.6.1277; Tarassov IA, 1996, BIOCHIMIE, V78, P502, DOI 10.1016/0300-9084(96)84756-0; TARASSOV IA, 1999, MITOCHONDRIAL DIS MO, P303; Teter SA, 1999, TRENDS CELL BIOL, V9, P428, DOI 10.1016/S0962-8924(99)01652-9; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; TOPPER JN, 1992, CELL, V70, P16, DOI 10.1016/0092-8674(92)90529-L; VESTWEBER D, 1988, J CELL BIOL, V107, P2037, DOI 10.1083/jcb.107.6.2037; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WLODAWER A, 1987, J MOL BIOL, V193, P145, DOI 10.1016/0022-2836(87)90633-4; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253; YOSHIONARI S, 1994, FEBS LETT, V338, P137, DOI 10.1016/0014-5793(94)80351-X	69	86	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45642	45653		10.1074/jbc.M103906200	http://dx.doi.org/10.1074/jbc.M103906200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551911	hybrid			2022-12-27	WOS:000172573100022
J	Karatan, E; Saulmon, MM; Bunn, MW; Ordal, GW				Karatan, E; Saulmon, MM; Bunn, MW; Ordal, GW			Phosphorylation of the response regulator CheV is required for adaptation to attractants during Bacillus subtilis chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; BACTERIAL CHEMOTAXIS; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; PROTEIN METHYLTRANSFERASE; RHIZOBIUM-MELILOTI; METHYLESTERASE; PURIFICATION; RECEPTOR	In the Gram-positive soil bacterium Bacillus subtilis, the chemoreceptors are coupled to the central two-component kinase CheA via two proteins, CheW and CheV. CheV is a two-domain protein with an N-terminal CheW-like domain and a C-terminal two-component receiver domain. In this study, we show that CheV is phosphorylated in vitro on a conserved aspartate in the presence of phosphorylated CheA (CheA-P). This reaction is slower compared with the phospho-transfer reaction between CheA-P and one other response regulator of the system, CheB. CheV-P is also highly stable in comparison with CheB-P. Both of these properties are more pronounced in the full-length protein compared with a truncated form composed only of the receiver domain, that is, deletion of the CheW-like domain results in increase in the rate of the phospho-transfer reaction and decrease in stability of the phosphorylated protein. Phosphorylation of CheV is required for adaptation to the addition of the chemoattractant asparagine. In tethered-cell assays, strains expressing an unphosphorylatable point mutant of cheV or a truncated mutant lacking the entire receiver domain are severely impaired in adaptation to the addition of asparagine. Both of these strains, however, show near normal counterclockwise biases, suggesting that in the absence of the attractant the chemoreceptors are efficiently coupled to CheA kinase by the mutant CheV proteins. Inability of the CheW-like domain of CheV to support complete adaptation to the addition of asparagine also suggests that unlike CheW this domain by itself may lead to the formation of signaling complexes that stay overactive in the presence of the attractant. A possible structural basis for this feature is discussed.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Ordal, GW (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.				NIGMS NIH HHS [GM54365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054365, R01GM054365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLGREN JA, 1983, BIOCHEM J, V213, P759, DOI 10.1042/bj2130759; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAHNDARI P, 1997, J BACTERIOL, V179, P4403; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; BISCHOFF DS, 1993, BIOCHEMISTRY-US, V32, P9256, DOI 10.1021/bi00086a035; BISHOFF DS, 1991, J BIOL CHEM, V266, P12301; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BURGESSCASSLER A, 1982, J BIOL CHEM, V257, P8412; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; DAHL MK, 1992, J BIOL CHEM, V267, P14509; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; FREDRICK KL, 1994, J BACTERIOL, V176, P2727, DOI 10.1128/JB.176.9.2727-2735.1994; FUHRER DK, 1991, J BACTERIOL, V173, P7443, DOI 10.1128/jb.173.23.7443-7448.1991; Garrity LF, 1997, MICROBIOL-UK, V143, P2945, DOI 10.1099/00221287-143-9-2945; Garrity LF, 1998, J BACTERIOL, V180, P4475, DOI 10.1128/JB.180.17.4475-4480.1998; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLDMAN DJ, 1984, BIOCHEMISTRY-US, V23, P675, DOI 10.1021/bi00299a014; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HANLON DW, 1992, J BIOL CHEM, V267, P12055; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; Kirby JR, 1999, J BIOL CHEM, V274, P11092, DOI 10.1074/jbc.274.16.11092; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MCCARTER LL, 1995, J BACTERIOL, V177, P1595, DOI 10.1128/jb.177.6.1595-1609.1995; METTKE I, 1995, J BACTERIOL, V177, P5056, DOI 10.1128/jb.177.17.5056-5061.1995; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; ROSARIO MML, 1995, BIOCHEMISTRY-US, V34, P3823, DOI 10.1021/bi00011a040; ROSARIO MML, 1994, J BACTERIOL, V176, P2736, DOI 10.1128/JB.176.9.2736-2739.1994; SCHON U, 1994, GENE, V147, P91, DOI 10.1016/0378-1119(94)90044-2; SIMMS SA, 1985, J BIOL CHEM, V260, P161; Sourjik V, 1996, MOL MICROBIOL, V22, P427, DOI 10.1046/j.1365-2958.1996.1291489.x; Sourjik V, 1998, BIOCHEMISTRY-US, V37, P2327, DOI 10.1021/bi972330a; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; Stewart RC, 1997, BIOCHEMISTRY-US, V36, P2030, DOI 10.1021/bi962261k; STEWART RC, 1993, J BIOL CHEM, V268, P1921; Stock J, 1999, CELL CALCIUM, V26, P157, DOI 10.1054/ceca.1999.0075; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; Surette MG, 1996, J BIOL CHEM, V271, P17966, DOI 10.1074/jbc.271.30.17966; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takami H, 1999, EXTREMOPHILES, V3, P227, DOI 10.1007/s007920050120; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WEIS RM, 1990, J BIOL CHEM, V265, P6817; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; YONEKAWA H, 1983, J BACTERIOL, V156, P1228, DOI 10.1128/JB.156.3.1228-1235.1983; Zimmer MA, 2000, J BIOL CHEM, V275, P24264, DOI 10.1074/jbc.M004001200	56	65	70	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43618	43626		10.1074/jbc.M104955200	http://dx.doi.org/10.1074/jbc.M104955200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11553614	Green Submitted, hybrid			2022-12-27	WOS:000172297700020
J	Sohn, YC; Kwak, E; Na, YJ; Lee, JW; Lee, SK				Sohn, YC; Kwak, E; Na, YJ; Lee, JW; Lee, SK			Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; BINDING PROTEIN; FACTOR MEF2; KINASE-IV; COACTIVATOR; APOPTOSIS; EXPRESSION; GENE; COREPRESSOR; CELLS	For the orphan nuclear receptor subfamily that includes Nur77 (NGFI-B), Nurr1, and NOR-1, no transcriptional coregulators have been identified thus far. In this report, we found that Ca2+/calmodulin-dependent protein kinase IV enhances Nur77 transactivation in cotransfections either alone or in synergy with AF2-dependent coactivator ASC-2, whereas corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) is repressive. Interestingly, Nur77 interacted with SMRT but did not directly bind ASC-2, and accordingly, the putative AF2 core domain of Nur77 did not affect the Nur77 transactivation. SMRT harbors transferable repression domains that associate with various histone deacetylases. Surprisingly, histone deacetylase inhibitor trichostatin A was unable to block the repressive effect of SMRT while dramatically stimulating the Nur77 transactivation. These results suggest that SMRT and ASC-2 are specific coregulators of Nur77 and that SMRT may dynamically compete with a putative adaptor molecule, which links ASC-2 to Nur77, for the identical binding sites within Nur77 in vivo.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Salk Inst Biol Studies, Gene Express Lab, San Diego, CA 92185 USA	Pohang University of Science & Technology (POSTECH); Salk Institute	Lee, JW (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.			KWAK, EUNYEE/0000-0001-8336-9986				Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Kang HJ, 2000, EXP CELL RES, V256, P545, DOI 10.1006/excr.2000.4832; Kawamura KI, 1996, BIOCHEM PHARMACOL, V52, P1903, DOI 10.1016/S0006-2952(96)00692-2; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Maruyama K, 1998, INT J ONCOL, V12, P1237; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Means AR, 1997, RECENT PROG HORM RES, V52, P389; Moore DD, 1995, GLOB MOB SURV; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; Soderstrom M, 1997, MOL ENDOCRINOL, V11, P682, DOI 10.1210/me.11.6.682; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; YOUNG CYF, 1994, ONCOL RES, V6, P203; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510	37	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43734	43739		10.1074/jbc.M107208200	http://dx.doi.org/10.1074/jbc.M107208200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559707	hybrid			2022-12-27	WOS:000172297700034
J	Niemeyer, MI; Cid, LP; Barros, LF; Sepulveda, FV				Niemeyer, MI; Cid, LP; Barros, LF; Sepulveda, FV			Modulation of the two-pore domain acid-sensitive K+ channel TASK-2 (KCNK5) by changes in cell volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCITES TUMOR-CELLS; POTASSIUM-CHANNEL; CHLORIDE CHANNELS; FLUORESCENT-PROBES; HELA-CELLS; DECREASE; CURRENTS; PH; EXPRESSION; CLONING	The molecular identity of K+ channels involved in Ehrlich cell volume regulation is unknown. A background K+ conductance is activated by cell swelling and is also modulated by extracellular pH. These characteristics are most similar to those of newly emerging TASK (TWIK-related acid-sensitive K+ channels)-type of two pore-domain K+ channels. mTASK-2, but not TASK-1 or -3, is present in Ehrlich cells and mouse kidney tissue from where the full coding sequences were obtained. Heterologous expression of mTASK-2 cDNA in HEK-293 cells generated K+ currents in the absence intracellular Ca2+. Exposure to hypotonicity enhanced mTASK-2 currents and osmotic cell shrinkage led to inhibition. This occurred without altering voltage dependence and with only slight decrease in pK(a) in hypotonicity but no change in hypertonicity. Replacement with other cations yields a permselectivity sequence for mTASK-2 of K+ > Rb+ >> Cs+ > NH4+ > Na+ congruent to Li+, similar to that for the native conductance (I-K,I- vol). Clofflium, a quaternary ammonium blocker of I-K, (vol), blocked the mTASK-2-mediated K+ current with an IC50 of 25 mum. The presence of mTASK-2 in Ehrlich cells, its functional similarities with I-K, (vol), and its modulation by changes in cell volume suggest that this two-pore domain K+ channel participates in the regulatory volume decrease phenomenon.	Ctr Estudios Cient, Valdivia, Chile		Niemeyer, MI (corresponding author), Ctr Estudios Cient, Av Arturo Prat 514,Casilla 1469, Valdivia, Chile.			Cid, Pablo/0000-0003-0394-0498; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598				Altamirano J, 1998, J GEN PHYSIOL, V112, P145, DOI 10.1085/jgp.112.2.145; ALVAREZLEEFMANS FJ, 1995, METH NEUROSCI, V27, P361; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BUSCH AE, 1992, BIOCHEM BIOPH RES CO, V184, P804, DOI 10.1016/0006-291X(92)90661-4; CHRISTENSEN O, 1992, J MEMBRANE BIOL, V129, P13; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; DIAZ M, 1993, PFLUG ARCH EUR J PHY, V422, P347, DOI 10.1007/BF00374290; DIAZ M, 1995, PFLUG ARCH EUR J PHY, V430, P168, DOI 10.1007/BF00374647; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; FOSKETT JK, 1994, J EXP ZOOL, V268, P104, DOI 10.1002/jez.1402680206; Gallardo P, 2001, AM J PHYSIOL-GASTR L, V281, pG856, DOI 10.1152/ajpgi.2001.281.3.G856; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; Hougaard C, 2001, PFLUG ARCH EUR J PHY, V442, P622, DOI 10.1007/s004240100585; Hougaard C, 2000, PFLUG ARCH EUR J PHY, V440, P283, DOI 10.1007/s004240051050; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Jorgensen NK, 1997, J MEMBRANE BIOL, V157, P281, DOI 10.1007/s002329900236; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Kim D, 1998, CIRC RES, V82, P513, DOI 10.1161/01.RES.82.4.513; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; LANG F, 1993, RENAL PHYSIOL BIOCH, V16, P48; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lock H, 2000, J BIOL CHEM, V275, P34849, DOI 10.1074/jbc.C000633200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; MACLEOD RJ, 1991, AM J PHYSIOL, V260, pG405, DOI 10.1152/ajpgi.1991.260.3.G405; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; MONTROSERAFIZADEH C, 1990, ANNU REV PHYSIOL, V52, P761; Niemeyer MI, 2000, J PHYSIOL-LONDON, V524, P757, DOI 10.1111/j.1469-7793.2000.00757.x; Niemeyer MI, 2000, J PHYSIOL-LONDON, V523, p6S; North RA, 2000, TRENDS NEUROSCI, V23, P234, DOI 10.1016/S0166-2236(00)01592-7; OBRIEN JA, 1991, BIOCHIM BIOPHYS ACTA, V1070, P501, DOI 10.1016/0005-2736(91)90093-N; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Riquelme G, 1998, BBA-BIOMEMBRANES, V1371, P101, DOI 10.1016/S0005-2736(98)00006-6; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; VALVERDE MA, 1995, FASEB J, V9, P509, DOI 10.1096/fasebj.9.7.7737459; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Vanoye CG, 1999, P NATL ACAD SCI USA, V96, P6511, DOI 10.1073/pnas.96.11.6511; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; WANGEMANN P, 1995, J MEMBRANE BIOL, V147, P263	48	127	134	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43166	43174		10.1074/jbc.M107192200	http://dx.doi.org/10.1074/jbc.M107192200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11560934	hybrid			2022-12-27	WOS:000172169300070
J	Takei, N; Kawamura, M; Hara, K; Yonezawa, K; Nawa, H				Takei, N; Kawamura, M; Hara, K; Yonezawa, K; Nawa, H			Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes - Comparison with the effects of insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; P70 S6 KINASE; SIGNAL-TRANSDUCTION PATHWAYS; MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; STIMULATED PHOSPHORYLATION; 4E-BP1 PHOSPHORYLATION; GLYCOGEN-SYNTHASE; EIF-4E BP1; PHAS-I	The effects of neurotrophic factors on translational activation were investigated in cortical neurons. Brain-derived neurotrophic factor (BDNF) increased protein synthesis within 30 min, whereas insulin produced a weaker enhancement of protein synthesis. BDNF-triggered protein synthesis was inhibited by LY294002, PD98059, and rapamycin, whereas the effect of insulin was unaffected by PD98059. To explore the mechanisms underlying this effect, the protein phosphorylation cascades that lead to the activation of translation initiation in neurons were examined. BDNF induced the phosphorylation of both eukaryote initiation factor (eIF) 4E and its binding protein (eIF4E-binding protein-1). The former reaction was inhibited by PD98059, whereas the latter was inhibited by LY294002 or rapamycin. In agreement, BDNF induced the phosphorylation of mammalian TOR ((t) under bar arget (o) under barf (r) under bar apamycin) and enhanced its kinase activity toward eIF4E-binding protein-1. In contrast, insulin failed to activate MAPK and did not induce the phosphorylation of eIF4E. Since BDNF and insulin increased the activity of eIF2B and eIF2, the only difference between them was eIF4E phosphorylation. Thus, this may explain the lower activity of insulin in potentiating neuronal protein synthesis. These results suggest strongly that BDNF simultaneously activates multiple signaling cascades consisting of phosphatidylinositol 3-kinase, mammalian TOR and MAPK to enhance translation initiation in neurons.	Niigata Univ, Inst Brain Res, Dept Mol Neurobiol, Niigata 9518585, Japan; Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan	Niigata University; Kobe University	Takei, N (corresponding author), Niigata Univ, Inst Brain Res, Dept Mol Neurobiol, Asahimachi 1, Niigata 9518585, Japan.	nobtak@bri.niigata-u.ac.jp						ALCAZAR A, 1995, J NEUROCHEM, V65, P754; ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Flynn A, 1996, FEBS LETT, V389, P162, DOI 10.1016/0014-5793(96)00564-9; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; HU CB, 1994, P NATL ACAD SCI USA, V91, P3730, DOI 10.1073/pnas.91.9.3730; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; IP NY, 1991, J NEUROSCI, V11, P3124; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nawa H, 1997, CRIT REV NEUROBIOL, V11, P91, DOI 10.1615/CritRevNeurobiol.v11.i1.50; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nishiuma T, 1998, BIOCHEM BIOPH RES CO, V252, P440, DOI 10.1006/bbrc.1998.9671; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Proud CG, 1997, BIOCHEM J, V328, P329; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SONENBERG N, 1996, TRANSLATIONAL CONTRO, P249; Takata M, 1999, J BIOL CHEM, V274, P20611, DOI 10.1074/jbc.274.29.20611; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Takei N, 1998, Hum Cell, V11, P157; Takei N, 1997, J NEUROCHEM, V68, P370; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Welsh GI, 1996, J BIOL CHEM, V271, P11410, DOI 10.1074/jbc.271.19.11410; YAMADA M, 1995, EUR J NEUROSCI, V7, P2130, DOI 10.1111/j.1460-9568.1995.tb00635.x; Yamada M, 2001, J NEUROCHEM, V78, P940, DOI 10.1046/j.1471-4159.2001.00497.x	57	170	174	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42818	42825		10.1074/jbc.M103237200	http://dx.doi.org/10.1074/jbc.M103237200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551908	hybrid			2022-12-27	WOS:000172169300026
J	Wick, MJ; Dong, LQ; Hu, DR; Langlais, P; Liu, F				Wick, MJ; Dong, LQ; Hu, DR; Langlais, P; Liu, F			Insulin receptor-mediated p62(dok) tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; SRC HOMOLOGY 2; DOCKING PROTEIN; GRB-IR; PLECKSTRIN HOMOLOGY; SH2 DOMAIN; KINASE; IDENTIFICATION; SUBSTRATE; MUTAGENESIS	A GTPase-activating protein (GAP)-associated 60-kDa protein has been found to undergo rapid tyrosine phosphorylation in response to insulin stimulation. However, whether this protein is a direct in vivo substrate for the insulin receptor (IR) tyrosine kinase and whether the tyrosine phosphorylation plays a role in insulin signaling remain to be established. Here we show that the insulin-stimulated tyrosine phosphorylation of the GAP-associated protein, now identified as p62(dok), is inhibited by Grb10, an adaptor protein that binds directly to the kinase domain of the IR, both in vitro and in cells. Replacing Tyr(362). and Tyr(398) with phenylalanine greatly decreased the IR-catalyzed p62(dok) tyrosine phosphorylation in vitro, suggesting that these two residues are the major IR-mediated phosphorylation sites. However, mutations at Tyr362 and Tyr398 only partially blocked insulin-stimulated p62(dok) tyrosine phosphorylation in cells, indicating that p62(dok) is also a target for other cellular tyrosine kinase(s) in addition to the IR. Replacing Tyr(362) with phenylalanine abolished the interaction between p62(dok) and Nck. Mutations at Tyr(362/398) of p62(dok) disrupted the interaction between p62(dok) and GAP and decreased the inhibitory effect of p62(dok) on the insulin-stimulated activation of Ras and Akt, but not mitogen-activated protein kinase. Furthermore, the inhibitory effect of p62(dok) on Akt phosphorylation could be blocked by coexpression of a constitutively active Has. Taken together, our findings indicate that p62(dok) is a direct substrate for the IR tyrosine kinase and that phosphorylation at Tyr(362) and Tyr(398) plays an essential role for p62(dok) to interact with its effectors and negatively regulate the insulin signaling pathway.	Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Dong, LQ (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dongq@uthscsa.edu; liuf@uthscsa.edu			NIDDK NIH HHS [DK52933] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052933] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Cong F, 1999, MOL CELL BIOL, V19, P8314; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Dong LQ, 1997, MOL ENDOCRINOL, V11, P1757, DOI 10.1210/me.11.12.1757; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frantz JD, 1997, J BIOL CHEM, V272, P2659, DOI 10.1074/jbc.272.5.2659; He WM, 1998, J BIOL CHEM, V273, P6860, DOI 10.1074/jbc.273.12.6860; HOSOMI Y, 1994, J BIOL CHEM, V269, P11498; Jones N, 1998, ONCOGENE, V17, P1097, DOI 10.1038/sj.onc.1202115; Kashige N, 2000, P NATL ACAD SCI USA, V97, P2093, DOI 10.1073/pnas.040547997; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; KOVACINA KS, 1993, BIOCHEM BIOPH RES CO, V192, P1303, DOI 10.1006/bbrc.1993.1558; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Langlais P, 2000, ONCOGENE, V19, P2895, DOI 10.1038/sj.onc.1203616; Liu F, 1998, MOL CELL BIOCHEM, V182, P73, DOI 10.1023/A:1006899832614; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; LIU F, 1994, BIOCHEM J, V298, P471, DOI 10.1042/bj2980471; Marais R, 1996, CANCER SURV, V27, P101; Nelms K, 1998, IMMUNITY, V9, P13, DOI 10.1016/S1074-7613(00)80584-1; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; OGAWA W, 1994, J BIOL CHEM, V269, P29602; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PORRAS A, 1992, J BIOL CHEM, V267, P21124; RodriguezViciana P, 1996, PHILOS T ROY SOC B, V351, P225, DOI 10.1098/rstb.1996.0020; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Songyang Z, 2001, J BIOL CHEM, V276, P2459, DOI 10.1074/jbc.M005504200; Stein EG, 2001, FEBS LETT, V493, P106, DOI 10.1016/S0014-5793(01)02282-7; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; van Dijk TB, 2000, BLOOD, V96, P3406; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yoshida K, 2000, J BIOL CHEM, V275, P24945, DOI 10.1074/jbc.M909012199; ZHANG B, 1992, J BIOL CHEM, V267, P18320	43	51	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42843	42850		10.1074/jbc.M102116200	http://dx.doi.org/10.1074/jbc.M102116200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551902	hybrid			2022-12-27	WOS:000172169300029
J	Brusca, EM; True, HL; Celander, DW				Brusca, EM; True, HL; Celander, DW			Novel RNA-binding properties of Pop3p support a role for eukaryotic RNase P protein subunits in substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEASE-P; RIBOZYME; MRP; COMPONENT; COMPLEX; ENZYME	Ribonuclease P (RNase P) catalyzes the 5'-end maturation of transfer RNA molecules. Recent evidence suggests that the eukaryotic protein subunits may provide substrate-binding functions (True, H. L., and Celander, D. W. (1998) J. Biol Chem. 273, 7193-7196). We now report that Pop3p, an essential protein subunit of the holoenzyme in Saccharomyces cerevisiae, displays novel RNA-binding properties. A recombinant form of Pop3p (H6Pop3p) displays a 3-fold greater affinity for binding pre-tRNA substrates relative to tRNA products. The recognition sequence for the H6Pop3p-substrate interaction in vitro was mapped to a 39-nucleotide long sequence that extends from position -21 to +18 surrounding the natural processing site in pre-tRNA substrates. H6Pop3p binds a variety of RNA molecules with high affinity (K-d = 16-25 nm) and displays a preference for single-stranded RNAs. Removal or modification of basic C-terminal residues attenuates the RNA-binding properties displayed by the protein specifically for a pre-tRNA substrate. These studies support the model that eukaryotic RNase P proteins bind simultaneously to the RNA subunit and RNA substrate.	Loyola Univ, Dept Chem, Chicago, IL 60626 USA	Loyola University Chicago	Celander, DW (corresponding author), Loyola Univ, Dept Chem, 6525 N Sheridan Rd, Chicago, IL 60626 USA.		True, Heather/D-2979-2012					ALTMAN S, 1993, FASEB J, V7, P7, DOI 10.1096/fasebj.7.1.7916700; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2610, DOI 10.1021/bi00280a003; CARRARA G, 1995, P NATL ACAD SCI USA, V92, P2627, DOI 10.1073/pnas.92.7.2627; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; Dichtl B, 1997, EMBO J, V16, P417, DOI 10.1093/emboj/16.2.417; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HARDT WD, 1993, BIOCHEMISTRY-US, V32, P13046, DOI 10.1021/bi00211a014; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; Mohan A, 2000, J MOL BIOL, V303, P605, DOI 10.1006/jmbi.2000.4162; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; PACE NR, 1995, J BACTERIOL, V177, P1919, DOI 10.1128/jb.177.8.1919-1928.1995; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; RYAN PC, 1989, BIOCHEMISTRY-US, V28, P9949, DOI 10.1021/bi00452a012; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; True HL, 1998, J BIOL CHEM, V273, P7193, DOI 10.1074/jbc.273.13.7193; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Ziehler WA, 2000, BIOCHEMISTRY-US, V39, P9909, DOI 10.1021/bi000603n	22	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42543	42548		10.1074/jbc.M107293200	http://dx.doi.org/10.1074/jbc.M107293200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527978	hybrid			2022-12-27	WOS:000172450400129
J	Lo Bello, M; Nuccetelli, M; Caccuri, AM; Stella, L; Parker, MW; Rossjohn, J; McKinstry, WJ; Mozzi, AF; Federici, G; Polizio, F; Pedersen, JZ; Ricci, G				Lo Bello, M; Nuccetelli, M; Caccuri, AM; Stella, L; Parker, MW; Rossjohn, J; McKinstry, WJ; Mozzi, AF; Federici, G; Polizio, F; Pedersen, JZ; Ricci, G			Human glutathione transferase P1-1 and nitric oxide carriers - New role for an old enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; S-NITROSOGLUTATHIONE; CRYSTAL-STRUCTURE; IRON COMPLEXES; POSITIVE COOPERATIVITY; IN-VIVO; RAT; PROTEIN; IDENTIFICATION; NITROSYLATION	S-Nitrosoglutathione and the dinitrosyl-diglutathionyl iron complex are involved in the storage and transport of NO in biological systems. Their interactions with the human glutathione transferase P1-1 may reveal an additional physiological role for this enzyme. In the absence of GSH, S-nitrosoglutathione causes rapid and stable S-nitrosylation of both the CyS47 and Cys(101) residues. Ion spray ionization-mass spectrometry ruled out the possibility of S-glutathionylation and confirms the occurrence of a poly-S-nitrosylation in GST P1-1. S-Nitrosylation of Cys(47) lowers the affinity 10-fold for GSH, but this negative effect is minimized by a half-site reactivity mechanism that protects one Cys(47)/dimer from nitrosylation. Thus, glutathione transferase P1-1, retaining most of its original activity, may act as a NO carrier protein when GSH depletion occurs in the cell. The dinitrosyl-diglutathionyl iron complex, which is formed by S-nitrosoglutathione decomposition in the presence of physiological concentrations of GSH and traces of ferrous ions, binds with extraordinary affinity to one active site of this dimeric enzyme (K-i < 10(-12) M) and triggers negative cooperativity in the vacant subunit (K-i = 10(-9) m). The complex bound to the enzyme is stable for hours, whereas in the free form and at low concentrations, its life time is only a few minutes. ESR and molecular modeling studies provide a reasonable explanation of this strong interaction, suggesting that Tyr(7) and enzyme-bound GSH could be involved in the coordination of the iron atom. All of the observed findings suggest that glutathione transferase P1-1, by means of an intersubunit communication, may act as a NO carrier under different cellular conditions while maintaining its well known detoxificating activity toward dangerous compounds.	Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Chem, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy; St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; Childrens Hosp, I-00165 Rome, Italy; Ist Ric & Cura Caratters Sci Bambino Gesu, I-00165 Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; St. Vincent's Institute of Medical Research; IRCCS Bambino Gesu	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy.	riccig@uniroma2.it	CACCURI, ANNA MARIA/AFU-2643-2022; McKinstry, William J/D-2612-2013; Rossjohn, Jamie/F-9032-2013; Stella, Lorenzo/A-7996-2010; Parker, Michael W/F-9069-2013	McKinstry, William J/0000-0001-9668-9364; Rossjohn, Jamie/0000-0002-2020-7522; Stella, Lorenzo/0000-0002-5489-7381; Parker, Michael W/0000-0002-3101-1138; Ricci, Giorgio/0000-0002-7108-2846				Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BATTISTONI A, 1995, PROTEIN EXPRES PURIF, V6, P579, DOI 10.1006/prep.1995.1076; Board PG, 1997, BIOCHEM J, V328, P929; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BOESE M, 1985, J BIOL CHEM, V272, P29244; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUETLER TM, 1992, J ENVIRON SCI HEAL C, V10, P181; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; CLARK AG, 1988, BIOCHEM PHARMACOL, V37, P3199, DOI 10.1016/0006-2952(88)90321-8; DELBOCCIO G, 1991, J BIOL CHEM, V266, P13777; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Habig W H, 1981, Methods Enzymol, V77, P398; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Kauser K, 1999, ENDOTHEL CELL RES S, V5, P195; Keese MA, 1997, BIOCHEM PHARMACOL, V54, P1307, DOI 10.1016/S0006-2952(97)00348-1; Kleschyov AL, 2000, AM J PHYSIOL-HEART C, V279, pH2743, DOI 10.1152/ajpheart.2000.279.6.H2743; Kluge I, 1997, J NEUROCHEM, V69, P2599; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; LITWACK G, 1971, NATURE, V234, P466, DOI 10.1038/234466a0; Lo Bello M, 1998, J MOL BIOL, V284, P1717; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1986, CHEM SCRIPTA, V26B, P281; MEY C, 1998, CURR MED RES OPIN, V14, P187; MEYER DJ, 1995, BIOCHEM J, V311, P739, DOI 10.1042/bj3110739; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; Mitchell AE, 1998, BIOCHEMISTRY-US, V37, P6752, DOI 10.1021/bi971846r; MONCADA S, 1994, J HYPERTENS, V12, pS35; MONCADA S, 1991, PHARMACOL REV, V43, P109; MULSCH A, 1991, FEBS LETT, V294, P252, DOI 10.1016/0014-5793(91)81441-A; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; PARK JW, 1988, BIOCHEM BIOPH RES CO, V152, P916, DOI 10.1016/S0006-291X(88)80127-X; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Piredda L, 1999, FASEB J, V13, P355, DOI 10.1096/fasebj.13.2.355; RICCI G, 1991, J BIOL CHEM, V266, P21409; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; RICCI G, 1989, J BIOL CHEM, V264, P5462; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; SIMONS PC, 1977, ANAL BIOCHEM, V82, P334, DOI 10.1016/0003-2697(77)90169-5; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stella L, 1999, PROTEINS, V37, P1; TAMIR S, 1996, BIOCHIM BIOPHYS ACTA, V1288, P31; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; Vanin AF, 1996, BBA-PROTEIN STRUCT M, V1295, P5, DOI 10.1016/0167-4838(95)00247-2; VANIN AF, 1975, STUD BIOPHYS, V49, P13; VEDERNIKOV YP, 1992, EUR J PHARMACOL, V211, P313, DOI 10.1016/0014-2999(92)90386-I; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; WILCE MCJ, 1995, EMBO J, V14, P2133, DOI 10.1002/j.1460-2075.1995.tb07207.x; Wilce MCJ, 1994, BIOCHIM BIOPHYS ACTA, V205, P1	65	81	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42138	42145						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533048				2022-12-27	WOS:000172450400081
J	Yanagita, M; Arai, H; Nakano, T; Ohashi, K; Mizuno, K; Fukatsu, A; Doi, T; Kita, T				Yanagita, M; Arai, H; Nakano, T; Ohashi, K; Mizuno, K; Fukatsu, A; Doi, T; Kita, T			Gas6 induces mesangial cell proliferation via latent transcription factor STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; IN-VIVO; INTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; SUPPRESSES GROWTH; TYROSINE KINASE; GLOMERULONEPHRITIS; INHIBITION; PATHWAY; ACTIVATION	Mesangial cell proliferation is essential for the pathogenesis and progression of glomerular disease. Previously, we showed that Gas6 plays a pivotal role in mesangial cell proliferation in vitro and in vivo. In the present study, we identified downstream targets of Gas6 signaling to examine the role in mesangial cell proliferation in vitro and in vivo. We found that Gas6 tyrosine phosphorylates STAT3 (signal transducers and activators of transcription) with concomitant translocation to the nucleus and induces STAT3-dependent transcriptional activation in cultured mesangial cells. Expressing dominant negative STAT3 inhibited Gas6-mediated transcriptional activation of STAT3 and abolished Gas6-induced mesangial cell proliferation. In a model of mesangial proliferative glomerulonephritis, STAT3 is phosphorylated in mesangial cells, and its phosphorylation peaks at day 8 after the injection of anti-Thy1.1 antibody. Inhibition of Gas6 by warfarin and the extracellular domain of its receptor, AxI, abolished phosphorylation of STAT3 in vivo. Thus, our in vitro and in vivo findings indicate that autocrine growth factor Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. Therefore, STAT3 might be a new therapeutic target for kidney disease induced by mesangial proliferation.	Kyoto Univ, Sch Med, Dept Geriatr Med, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Dept Artificial Kidneys, Kyoto 6068507, Japan; Shionogi & Co Ltd, Discovery Res Lab, Osaka 5530002, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; Univ Tokushima, Dept Lab Med, Tokushima 7708503, Japan	Kyoto University; Kyoto University; Shionogi & Company Limited; Tohoku University; Tokushima University	Arai, H (corresponding author), Kyoto Univ, Sch Med, Dept Geriatr Med, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	harai@kuhp.kyoto-u.ac.jp	Arai, Hidenori/P-9816-2017; FUKATSU, ATSUSHI/R-7941-2019; Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019	Arai, Hidenori/0000-0002-9000-6849; Ohashi, Kazumasa/0000-0001-7617-403X; Yanagita, Motoko/0000-0002-0339-9008				Bartoli M, 2000, J BIOL CHEM, V275, P33189, DOI 10.1074/jbc.C000318200; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bokemeyer D, 2000, J AM SOC NEPHROL, V11, P232, DOI 10.1681/ASN.V112232; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Decker T, 1999, CELL MOL LIFE SCI, V55, P1535, DOI 10.1007/s000180050393; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; FLOEGE J, 1993, J CLIN INVEST, V92, P2952, DOI 10.1172/JCI116918; FLOEGE J, 1991, AM J KIDNEY DIS, V17, P673, DOI 10.1016/S0272-6386(12)80349-0; FLOEGE J, 1993, KIDNEY INT, V43, pS47; FOGO A, 1989, SEMIN NEPHROL, V9, P329; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; JOHNSON RJ, 1993, J AM SOC NEPHROL, V4, P119; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Nagasawa Y, 2000, KIDNEY INT, V57, P717, DOI 10.1046/j.1523-1755.2000.00894.x; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Ni Z, 2000, CANCER RES, V60, P1225; Niu GL, 1999, CANCER RES, V59, P5059; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Pichler RH, 1996, AM J PATHOL, V148, P1153; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; STRIKER LJ, 1991, LAB INVEST, V64, P446; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Ziswiler R, 1998, J AM SOC NEPHROL, V9, P2055; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	34	78	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42364	42369		10.1074/jbc.M107488200	http://dx.doi.org/10.1074/jbc.M107488200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546821	hybrid			2022-12-27	WOS:000172450400108
J	Zhang, M; Chiang, JYL				Zhang, M; Chiang, JYL			Transcriptional regulation of the human sterol 12 alpha-hydroxylase gene (CYP8B1) - Roles of hepatocyte nuclear factor 4 alpha in mediating bile acid repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; LIVER-SPECIFIC EXPRESSION; HEPATITIS-B VIRUS; ALPHA PPAR-ALPHA; ACTIVATED RECEPTOR; CYP7A1 TRANSCRIPTION; RESPONSIVE ELEMENT; P450 CYP8B; RAT-LIVER; IDENTIFICATION	Sterol 12 alpha -hydroxylase catalyzes the synthesis of cholic acid and controls the ratio of cholic acid over chenodeoxycholic acid in the bile. Transcription of CYP8B1 is inhibited by bile acids, cholesterol, and insulin. To study the mechanism of CYP8B1 transcription by bile acids, we have cloned and determined 3389 base pairs of the 5'-upstream nucleotide sequences of the human CYP8B1. Deletion analysis of CYP8B1/luciferase reporter activity in HepG2 cells revealed that the sequences from -57 to +300 were important for basal and liver-specific promoter activities. Hepatocyte nuclear factor 4 alpha (IINF4 alpha) strongly activated human CYP8B1 promoter activities, whereas cholesterol 7 alpha -hydroxylase promoter factor (CPF), an NR5A2 family of nuclear receptors, had much less effect. Electrophoretic mobility shift assay identified an overlapping HNF4 alpha- and CPF-binding site in the +198/+227 region. The human CYP8B1 promoter activities were strongly repressed by bile acids, and the bile acid response element was localized between +137 and +220. Site-directed mutagenesis of the HNF4 alpha -binding site markedly reduced promoter activity and its response to bile acid repression. On the other hand, mutation of the CPF-binding site had little effect on promoter activity and bile acid inhibition. A negative nuclear receptor, small heterodimer partner markedly inhibited transactivation of CYP8B1 by HNF4 alpha. Mammalian two-hybrid assay confirmed that HNF4 alpha interacted with small heterodimer partner. Furthermore, bile acids and farnesoid X receptor reduced the expression of nuclear HNF4 alpha in HepG2 cells and rat livers and its binding to DNA. Bile acids and farnesoid X receptor also inhibited mouse HNF4 alpha gene transcription. In summary, our data revealed the critical roles HNF4 alpha play on CYP8B1 transcription and its repression by bile acids. Bile acids repress human CYP8B1 transcription by reducing the transactivation activity of HNF4 alpha through interaction of HNF4 alpha with SHP and reduction of HNF4 alpha expression in the liver.	NE Ohio Univ, Coll Med, Dept Biochem & Mol Pathol, Rootstown, OH 44272 USA	Northeast Ohio Medical University (NEOMED)	Chiang, JYL (corresponding author), NE Ohio Univ, Coll Med, Dept Biochem & Mol Pathol, POB 95, Rootstown, OH 44272 USA.		Chiang, John Y. L./G-2658-2011	Chiang, John Y. L./0000-0001-9360-7650	NIDDK NIH HHS [R01 DK044442, DK44442, R01 DK058379] Funding Source: Medline; NIGMS NIH HHS [GM31584] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK044442, R01DK058379, R01DK044442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031584] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Andersson U, 1999, BBA-MOL CELL BIOL L, V1438, P167, DOI 10.1016/S1388-1981(99)00036-0; BJORKHEM I, 1983, J LIPID RES, V24, P1451; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen WL, 2001, J LIPID RES, V42, P1402; CHIANG JYL, 1994, J BIOL CHEM, V269, P17502; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; CHIANG JYL, 1998, FRONT BIOSCI, V3, P176; Crestani M, 1998, J LIPID RES, V39, P2192; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Castillo-Olivares A, 2000, J BIOL CHEM, V275, P17793, DOI 10.1074/jbc.M000996200; Eggertsen G, 1996, J BIOL CHEM, V271, P32269, DOI 10.1074/jbc.271.50.32269; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gafvels M, 1999, GENOMICS, V56, P184, DOI 10.1006/geno.1998.5606; Galarneau L, 1998, CYTOGENET CELL GENET, V82, P269, DOI 10.1159/000015116; Gilbert S, 2000, J VIROL, V74, P5032, DOI 10.1128/JVI.74.11.5032-5039.2000; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; ISHIDA H, 1992, J BIOL CHEM, V267, P21319; Ishida H, 1999, J BIOCHEM-TOKYO, V126, P19, DOI 10.1093/oxfordjournals.jbchem.a022422; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li M, 1998, J BIOL CHEM, V273, P29022, DOI 10.1074/jbc.273.44.29022; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Marrapodi M, 2000, J LIPID RES, V41, P514; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; OBRIEN RM, 1996, DIABETES MELLITUS, P234; Pare JF, 2001, J BIOL CHEM, V276, P13136, DOI 10.1074/jbc.M010737200; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; RUSSELL DW, 1992, CARDIOVASC DRUG THER, V6, P103, DOI 10.1007/BF00054556; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stroup D, 2000, J LIPID RES, V41, P1; Stroup D, 1997, AM J PHYSIOL-GASTR L, V273, pG508, DOI 10.1152/ajpgi.1997.273.2.G508; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	48	194	200	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41690	41699		10.1074/jbc.M105117200	http://dx.doi.org/10.1074/jbc.M105117200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535594	hybrid			2022-12-27	WOS:000172450400022
J	Zhu, HM; Duerr, JS; Varoqui, H; McManus, JR; Rand, JB; Erickson, JD				Zhu, HM; Duerr, JS; Varoqui, H; McManus, JR; Rand, JB; Erickson, JD			Analysis of point mutants in the Caenorhabditis elegans vesicular acetylcholine transporter reveals domains involved in substrate translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE TRANSPORTER; RESERPINE BINDING; MUTATIONAL ANALYSIS; LACTOSE PERMEASE; BLOCKING ACTION; GENE; RESIDUES; VESAMICOL; TORPEDO; RELEASE	Cholinergic neurotransmission depends upon the regulated release of acetylcholine. This requires the loading of acetylcholine into synaptic vesicles by the vesicular acetylcholine transporter (VAChT). Here, we identify point mutants in Caenorhabditis elegans that map to highly conserved regions of the VAChT gene of Caenorhabditis elegans (CeVAChT) (unc-17) and exhibit behavioral phenotypes consistent with a reduction in vesicular transport activity and neurosecretion. Several of these mutants express normal amounts of VAChT protein and exhibit appropriate targeting of VAChT to synaptic vesicles. By site-directed mutagenesis, we have replaced the conserved amino acid residues found in human VAChT with the mutated residue in CeVAChT and stably expressed these cDNAs in PC-12 cells. These mutants display selective defects in initial acetylcholine ;transport velocity (K-m), with values ranging from 2- to 8-fold lower than that of the wild-type. One of these mutants has lost its specific interaction with vesamicol, a selective inhibitor of VAChT, and displays vesamicol-insensitive uptake of acetylcholine. The relative order of behavioral severity of the CeVAChT point mutants is identical to the order of reduced affinity of VAChT for acetylcholine in vitro. This indicates that specific structural changes in VAChT translate into specific alterations in the intrinsic parameters of transport and in the storage and synaptic release of acetylcholine in vivo.	Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Oklahoma Medical Research Foundation	Erickson, JD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.	jerick@lsuhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38679, R01 GM038679] Funding Source: Medline; NINDS NIH HHS [NS36936] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; ALFONSO A, 1994, J MOL BIOL, V241, P627, DOI 10.1006/jmbi.1994.1538; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AND JB, 1995, C ELEGANS MODERN BIO, P187; BAHR BA, 1986, J NEUROCHEM, V46, P1214, DOI 10.1111/j.1471-4159.1986.tb00640.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1974, GENETICS, V77, P71; BRITTAIN RT, 1969, EUR J PHARMACOL, V8, P93, DOI 10.1016/0014-2999(69)90133-2; Chen XZ, 1995, BIOPHYS J, V69, P2405, DOI 10.1016/S0006-3495(95)80110-4; DARCHEN F, 1989, BIOCHEMISTRY-US, V28, P1692, DOI 10.1021/bi00430a040; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DIEBLER MF, 1989, J NEUROCHEM, V52, P813, DOI 10.1111/j.1471-4159.1989.tb02526.x; Duerr JS, 2001, AM J PHYSIOL-CELL PH, V280, pC1616, DOI 10.1152/ajpcell.2001.280.6.C1616; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; He MM, 1997, BIOCHEMISTRY-US, V36, P13688, DOI 10.1021/bi9715324; HENRY JP, 1987, ANN NY ACAD SCI, V493, P194, DOI 10.1111/j.1749-6632.1987.tb27201.x; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; HOSONO R, 1989, ZOOL SCI, V6, P697; KANNER BI, 1979, FEBS LETT, V100, P175, DOI 10.1016/0014-5793(79)81158-8; Keller JE, 2000, J NEUROCHEM, V74, P1739, DOI 10.1046/j.1471-4159.2000.0741739.x; Kim MH, 2000, J BIOL CHEM, V275, P6175, DOI 10.1074/jbc.275.9.6175; Kim MH, 1999, J BIOL CHEM, V274, P673, DOI 10.1074/jbc.274.2.673; Kitamoto T, 2000, J NEUROBIOL, V42, P161, DOI 10.1002/(SICI)1097-4695(20000205)42:2<161::AID-NEU1>3.0.CO;2-P; KOSHIMURA K, 1990, J NEUROCHEM, V54, P533, DOI 10.1111/j.1471-4159.1990.tb01904.x; LEE JA, 1989, BIOCHEMISTRY-US, V28, P2540, DOI 10.1021/bi00432a029; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; MARSHALL IG, 1970, BRIT J PHARMACOL, V38, P503, DOI 10.1111/j.1476-5381.1970.tb10592.x; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; Nguyen ML, 1998, BIOCHEMISTRY-US, V37, P13400, DOI 10.1021/bi9802263; PARSONS SM, 1993, INT REV NEUROBIOL, V35, P279, DOI 10.1016/S0074-7742(08)60572-3; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Pothos E, 1996, J NEUROCHEM, V66, P629; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; RAND JB, 1984, GENETICS, V106, P227; RAND JB, 1989, GENETICS, V122, P73; RUDNICK G, 1990, BIOCHEMISTRY-US, V29, P603, DOI 10.1021/bi00455a002; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; SCHULDINER S, 1993, J BIOL CHEM, V268, P29; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SteinerMordoch S, 1996, J BIOL CHEM, V271, P13048, DOI 10.1074/jbc.271.22.13048; ULUS IH, 1989, BRAIN RES, V484, P217, DOI 10.1016/0006-8993(89)90364-8; Varoqui H, 1998, J BIOL CHEM, V273, P9094, DOI 10.1074/jbc.273.15.9094; Varoqui H, 1997, MOL NEUROBIOL, V15, P165, DOI 10.1007/BF02740633; VAROQUI H, 1994, FEBS LETT, V342, P97, DOI 10.1016/0014-5793(94)80592-X; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; Varoqui H, 1998, J PHYSIOLOGY-PARIS, V92, P141, DOI 10.1016/S0928-4257(98)80152-6; Varoqui H, 1998, METHOD ENZYMOL, V296, P84; VIZI ES, 1989, BRIT J PHARMACOL, V98, P898, DOI 10.1111/j.1476-5381.1989.tb14619.x; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; WILLIAMS BD, 1992, GENETICS, V131, P609	58	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41580	41587		10.1074/jbc.M103550200	http://dx.doi.org/10.1074/jbc.M103550200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551909	hybrid			2022-12-27	WOS:000172450400008
J	Han, JW; Liu, SC; Rose, DM; Schlaepfer, DD; McDonald, H; Ginsberg, MH				Han, JW; Liu, SC; Rose, DM; Schlaepfer, DD; McDonald, H; Ginsberg, MH			Phosphorylation of the integrin alpha(4) cytoplasmic domain regulates paxillin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL INTERACTIONS; MIGRATING FIBROBLASTS; ADHESION; TYROSINE; ACTIVATION; MODULATION; RECEPTOR; PROTEINS; SUBUNIT; TAIL	alpha4 integrins are essential for embryogenesis, hematopoiesis, inflammation, and immune response possibly because alpha (4) integrins have distinct signaling properties from other integrins. Specifically, the alpha (4) cytoplasmic domain binds tightly to paxillin, a signaling adaptor protein, leading to increased cell migration and an altered cytoskeletal organization that results in reduced cell spreading. The alpha (4) tail contains potential phosphorylation sites clustered in its core paxillin binding region. We now report that the alpha (4) tail is phosphorylated in vitro and in viva. Furthermore, Ser(988) is a major phosphorylation site. Using antibodies specific for Ser(988)- phosphorylated alpha (4), we found the stoichiometry of a4 phosphorylation varied in different cells. However, > 60% of a4 was phosphorylated in Jurkat T cells. Phosphorylation at Ser(988) blocked paxillin binding to the alpha (4) tail. A phosphorylation-mimicking mutant of alpha (4) (alpha (4)S988D) blocked paxillin binding and reversed the inhibitory effect of alpha (4) on cell spreading. Consequently, alpha (4) phosphorylation is a biochemical mechanism to modulate paxillin binding to alpha (4) integrins with consequent regulation of alpha (4) integrin-dependent cellular functions.	Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ginsberg, MH (corresponding author), Scripps Res Inst, Dept Vasc Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ginsberg@scripps.edu			NCI NIH HHS [CA-75240] Funding Source: Medline; NCRR NIH HHS [RR11823-5] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA075240, R01CA075240] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BUYON JP, 1990, J IMMUNOL, V144, P191; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; HOGERVORST F, 1993, J BIOL CHEM, V268, P18427; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Law DA, 1998, BLOOD, V92, p701A; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; LUO K, 1990, ONCOGENE, V5, P921; Palecek SP, 1996, J CELL SCI, V109, P941; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PARDI R, 1992, J CELL BIOL, V116, P1211, DOI 10.1083/jcb.116.5.1211; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Salgia R, 1999, ONCOGENE, V18, P67, DOI 10.1038/sj.onc.1202273; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; ZENT R, 2001, MOL BASIS BLOOD DIS, P485; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351	33	71	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40903	40909		10.1074/jbc.M102665200	http://dx.doi.org/10.1074/jbc.M102665200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533025	hybrid			2022-12-27	WOS:000171925600071
J	Jain, D; Nair, DT; Swaminathan, GJ; Abraham, EG; Nagaraju, J; Salunke, DM				Jain, D; Nair, DT; Swaminathan, GJ; Abraham, EG; Nagaraju, J; Salunke, DM			Structure of the induced antibacterial protein from tasar silkworm, Antheraea mylitta - Implications to molecular evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT DEFENSIN-A; ANTIFUNGAL PROTEIN; IMMUNE HEMOLYMPH; INNATE IMMUNITY; PURIFICATION; ALIGNMENT; PEPTIDES; GLOVERIN; LARVAE; PUPAE	The crystal structure of an antibacterial protein of immune origin (TSWAB), purified from tasar silkworm (Antheraea mylitta) larvae after induction by Escherichia cola infection, has been determined. This is the first insect lysozyme structure and represents induced lysozymes of innate immunity. The core structure of TSWAB is similar to c-type lysozymes and alpha -lactalbumins. However, TSWAB shows significant differences with respect to the other two proteins in the exposed loop regions. The catalytic residues in TSWAB are conserved with respect to the chicken lysozyme, indicating a common mechanism of action. However, differences in the noncatalytic residues in the substrate binding groove imply subtle differences in the specificity and the level of activity. Thus, conformational differences between TSWAB and chicken lysozyme exist, whereas functional mechanisms appear to be similar. On the other hand, alpha -lactalbumins and c-type lysozymes exhibit drastically different functions with conserved molecular conformation. It is evident that a common molecular scaffold is exploited in the three enzymes for apparently different physiological roles. It can be inferred on the basis of the structure-function comparison of these three proteins having common phylogenetic origin that the conformational changes in a protein are minimal during rapid evolution as compared with those in the normal course of evolution.	Natl Inst Immunol, Struct Biol Unit, New Delhi 110067, India; Seribiotech Res Lab, Bangalore 560086, Karnataka, India; Ctr DNA Fingerprinting & Diagnost, Hyderabad 500076, Andhra Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Salunke, DM (corresponding author), Natl Inst Immunol, Struct Biol Unit, Aruna Asaf Ali Marg, New Delhi 110067, India.		Nair, Deepak T/AAR-5234-2020	Swaminathan, Jawahar/0000-0002-0215-4084; Jain, Deepti/0000-0002-8631-7230; Nair, Deepak/0000-0002-0677-9444				ABRAHAM EG, 1995, J INVERTEBR PATHOL, V65, P17, DOI 10.1006/jipa.1995.1003; Akuffo H, 1998, INT J MOL MED, V1, P77; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARLSSON A, 1991, INFECT IMMUN, V59, P3040, DOI 10.1128/IAI.59.9.3040-3045.1991; CASTEELS P, 1990, RES IMMUNOL, V141, P940, DOI 10.1016/0923-2494(90)90199-9; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; Chung KT, 2000, EUR J BIOCHEM, V267, P677, DOI 10.1046/j.1432-1327.2000.01034.x; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; JOLLES J, 1979, J MOL EVOL, V14, P267, DOI 10.1007/BF01732494; JONES TA, 1994, O MANUAL; Katsutoshi N., 1989, EUR J BIOCHEM, V182, P111; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KH, 1998, FEBS LETT, V439, P41, DOI 10.1016/S0014-5793(98)01333-7; Lee YT, 1999, BIOCHEM MOL BIOL INT, V47, P369; Mackintosh JA, 1998, DEV COMP IMMUNOL, V22, P387, DOI 10.1016/S0145-305X(98)00025-1; MAGETDANA R, 1995, BIOCHIMIE, V77, P240, DOI 10.1016/0300-9084(96)88130-2; Mandard N, 1998, EUR J BIOCHEM, V256, P404, DOI 10.1046/j.1432-1327.1998.2560404.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAGARAJU J, 1992, WILD SILKMOTH 92, P22; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKADA M, 1985, J BIOL CHEM, V260, P7174; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHIPPS DJ, 1994, DEV COMP IMMUNOL, V18, P13, DOI 10.1016/0145-305X(94)90248-8; POWNING RF, 1976, COMP BIOCHEM PHYS B, V55, P221, DOI 10.1016/0305-0491(76)90234-0; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Ulevitch RJ, 2000, IMMUNOL RES, V21, P49, DOI 10.1385/IR:21:2-3:49; Wang CY, 2001, NAT STRUCT BIOL, V8, P47; [No title captured]	39	24	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41377	41382		10.1074/jbc.M104674200	http://dx.doi.org/10.1074/jbc.M104674200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522783	hybrid			2022-12-27	WOS:000171925600132
J	Mitsuzawa, H; Wada, I; Sano, H; Iwaki, D; Murakami, S; Himi, T; Matsushima, N; Kuroki, Y				Mitsuzawa, H; Wada, I; Sano, H; Iwaki, D; Murakami, S; Himi, T; Matsushima, N; Kuroki, Y			Extracellular toll-like receptor 2 region containing Ser(40)-Ile(64) but not Cys(30)-Ser(39) is critical for the recognition of Staphylococcus aureus peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL WALL COMPONENTS; LEUCINE-RICH REPEAT; CUTTING EDGE; LIPOPOLYSACCHARIDE-BINDING; SOLUBLE PEPTIDOGLYCAN; CD14; PROTEINS; GENE; ACTIVATION; MICE	Toll-like receptor 2 (TLR2) and CD14 function as pat tern recognition receptors for bacterial peptidoglycan (PGN). TLRs and CD14 possess repeats of the leucine rich motif. To address the role of the extracellular domain of TLR2 in PGN signaling, we constructed CD14/TLR2 chimeras, in which residues 1-356 or 1-323 of CD14 were substituted for the extracellular domain of TLR2, and five deletion mutants of TLR2, in which the progressively longer regions of extracellular TLR2 regions were deleted. PGN induced NF-kappaB activation in HEK293 cells expressing TLR2 but not in cells expressing CD14/TLR2 chimeras. The cells transfected with a deletion mutant TLR2(Delta Cys30-Ile64) as well as TLR2(Delta Cys30-Asp160) and TLR2 Delta (Cys30-Asp305) failed to respond to PGN, indicating the importance of the TLR2 region Cys(30)-Ile(64). Although TLR2(Delta Cys30-Ser39) conferred cell responsiveness to PGN, the cells expressing TLR2(Delta Ser40-Ile64) failed to induce NF-kappaB activation. In addition, NF-kappaB activity elicited by PGN was significantly attenuated in the presence of synthetic peptide corresponding to the TLR2 region Ser(40)-Ile(64). From these results, we conclude that; 1) CD14 cannot functionally replace the extracellular domain of TLR2 in PGN signaling; 2) the TLR2 region Cys(30)-Ser(39) is not required for PGN recognition; 3) the TLR2 region containing Ser(40)-Ile(64) is critical for PGN recognition.	Sapporo Med Univ, Sch Med, Dept Biochem 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Med, Dept Biochem 2, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Med, Dept Otolaryngol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Hlth Sci, Dept Biochem 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Hlth Sci, Dept Biochem 2, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Hlth Sci, Dept Otolaryngol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Kuroki, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South-1 West-17, Sapporo, Hokkaido 0608556, Japan.			Wada, Ikuo/0000-0001-5668-6994				Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; FERRERO E, 1990, J IMMUNOL, V145, P331; GUPTA D, 1995, J IMMUNOL, V155, P2620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoshino K, 1999, J IMMUNOL, V162, P3749; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; READ MA, 1993, P NATL ACAD SCI USA, V90, P9887, DOI 10.1073/pnas.90.21.9887; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; SIMMONS DL, 1989, BLOOD, V73, P284; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tapping RI, 1997, J BIOL CHEM, V272, P23157, DOI 10.1074/jbc.272.37.23157; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Viriyakosol S, 1996, INFECT IMMUN, V64, P653, DOI 10.1128/IAI.64.2.653-656.1996; Weidemann B, 1997, INFECT IMMUN, V65, P858, DOI 10.1128/IAI.65.3.858-864.1997; Yoshimura A, 1999, J IMMUNOL, V163, P1	36	51	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41350	41356		10.1074/jbc.M104177200	http://dx.doi.org/10.1074/jbc.M104177200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522781	hybrid			2022-12-27	WOS:000171925600129
J	Monroy, MA; Ruhl, DD; Xu, XQ; Granner, DK; Yaciuk, P; Chrivia, JC				Monroy, MA; Ruhl, DD; Xu, XQ; Granner, DK; Yaciuk, P; Chrivia, JC			Regulation of cAMP-responsive element-binding protein-mediated transcription by the SNF2/SWI-related protein, SRCAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RNA-POLYMERASE-II; COACTIVATORS P300; CONSTITUTIVE ACTIVATION; GLUCOCORTICOID RESPONSE; GENE-TRANSCRIPTION; CREB INTERACTS; FACTOR GATA-1; CBP; DOMAIN	SRCAP (SNF2-related CPB activator protein) belongs to the SNF2 family of proteins whose members participate in various aspects of transcriptional regulation, including chromatin remodeling. It was identified by its ability to bind to cAMP-responsive-binding protein (CREB)-binding protein (CBP), and it increases the transactivation function of CBP. The phosphoenolpyruvate carboxykinase (PEPCK) promoter was used as a model system to explore the role of SRCAP in the regulation of transcription mediated by factors that utilize CBP as a coactivator. We show that transcription of a PEPCK chloramphenicol acetyltransferase (CAT) reporter gene activated by protein kinase A (PKA) is enhanced 7-fold by SRCAP. In the absence of PKA this SRCAP-mediated enhancement does not occur, suggesting that SRCAP functions as a coactivator for PKA-activated factors such as CREB. Replacing the PEPCK promoter binding site for CREB with a binding site for Gal4 (Delta CRE (CAMP-responsive element) Gal4 PEPCK-CAT reporter gene) blocks the ability of SRCAP to activate transcription despite the presence of PKA. Expression of a Gal-CREB chimera restores the ability of PKA to regulate transcription of the Delta CRE Gal4 PEPCK gene and restored the ability of SRCAP to stimulate PKA-activated transcription. In addition, SRCAP in the presence of PKA enhances the ability of the Gal-CREB chimera to activate transcription of a Gal-CAT reporter gene that contains only binding sites for Gal4. SRCAP binds to CBP amino acids 280-460, a region that is important for CBP to function as a coactivator for CREB. Overexpression of a SRCAP peptide corresponding to this CBP binding domain acts as a dominant negative inhibitor of CREB-mediated transcription. Structure-function studies were done to explore the mechanism(s) by which SRCAP regulates transcription. These studies indicate that the N-terminal region of SRCAP, which contains five of the seven regions that comprise the ATPase domain, is not needed for activation of CREB-mediated transcription. SRCAP apparently has several domains that participate in the activation of transcription.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Saint Louis University; Saint Louis University; Vanderbilt University	Chrivia, JC (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand, St Louis, MO 63104 USA.	Chrivia@SLU.edu						Alleva DG, 1997, J IMMUNOL, V159, P2941; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Bisotto S, 1996, J BIOL CHEM, V271, P17746, DOI 10.1074/jbc.271.30.17746; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chen CJ, 2001, MOL CELL BIOL, V21, P476, DOI 10.1128/MCB.21.2.476-487.2001; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Felinski EA, 1999, J BIOL CHEM, V274, P11672, DOI 10.1074/jbc.274.17.11672; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hiramoto T, 1999, ONCOGENE, V18, P3422, DOI 10.1038/sj.onc.1202691; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LIU JS, 1991, J BIOL CHEM, V266, P19095; Liu MY, 1998, J BIOL CHEM, V273, P25541, DOI 10.1074/jbc.273.40.25541; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nishikawa J, 1997, P NATL ACAD SCI USA, V94, P85, DOI 10.1073/pnas.94.1.85; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PETERSEN DD, 1988, MOL CELL BIOL, V8, P96, DOI 10.1128/MCB.8.1.96; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; ROESLER WJ, 1995, J BIOL CHEM, V270, P8225, DOI 10.1074/jbc.270.14.8225; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sano Y, 2001, J BIOL CHEM, V276, P3674, DOI 10.1074/jbc.M006896200; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Ugai H, 1999, J MOL MED, V77, P481, DOI 10.1007/s001099900021; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; XING LP, 1995, J BIOL CHEM, V270, P17488, DOI 10.1074/jbc.270.29.17488; XING LP, 1994, J BIOL CHEM, V269, P28732; Xu XQ, 2001, J VIROL, V75, P10033, DOI 10.1128/JVI.75.21.10033-10040.2001; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000	54	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40721	40726		10.1074/jbc.M103615200	http://dx.doi.org/10.1074/jbc.M103615200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522779	hybrid			2022-12-27	WOS:000171925600047
J	Tung, L; Shen, TJ; Abel, MG; Powell, RL; Takimoto, GS; Sartorius, CA; Horwitz, KB				Tung, L; Shen, TJ; Abel, MG; Powell, RL; Takimoto, GS; Sartorius, CA; Horwitz, KB			Mapping the unique activation function 3 in the progesterone B-receptor upstream segment - Two LXXLL motifs and a tryptophan residue are required for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; DNA-BINDING DOMAIN; CARBOXYL-TERMINAL REGIONS; HYDROPHOBIC AMINO-ACIDS; HUMAN-BREAST-CANCER; NUCLEAR RECEPTOR; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; ANDROGEN RECEPTOR; A-FORM	Progesterone receptors (PR) contain three activation functions (AFs) that together define the extent to which they regulate transcription. AF I and AF2 are common to the two isoforms of PR, PR-A and PR-B, whereas AF3 lies within the N-terminal 164 amino acids unique to PR-B, termed the "B-upstream segment" (BUS). To define the BUS regions that contribute to AF3 function, we generated a series of deletion and amino acid substitution mutants and tested them in three backgrounds as follows: BUS alone fused to the PR DNA binding domain (BUS-DBD), the entire PR-B N terminus linked to its DBD (NT-B), and full-length PR-B. Analyses of these mutants identified two regions in BUS whose loss reduces AF3 activity by more than 90%. These are associated with amino acids 54-90 (RI) and 120-154 (R2). RI contains a consensus (LXXLL59)-L-55 motif (LI) identical to ones found in nuclear receptor co-activators. R2 is adjacent to a second nuclear receptor box (L2) at (LXXLL119)-L-115 and contains a conserved tryptophan (Trp-140). Their mutation completely disrupts AF3 activity in a promoter and cell type-independent manner. Critical mutations elicited similar effects on all three B-receptor backgrounds. This underscores the probability that these mutations alter a process linking BUS structure to the function of full-length PR-B in a fundamental way.	Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sartorius, CA (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Box B-151,4200 E 9th Ave, Denver, CO 80262 USA.			Horwitz, Kathryn/0000-0001-7402-6455	NCI NIH HHS [CA 26869] Funding Source: Medline; NIDDK NIH HHS [DK 48238] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA026869, R37CA026869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048238] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMLOF T, 1995, J BIOL CHEM, V270, P17535, DOI 10.1074/jbc.270.29.17535; Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; Almlof T, 1997, MOL CELL BIOL, V17, P934, DOI 10.1128/MCB.17.2.934; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Bain DL, 2001, J BIOL CHEM, V276, P23825, DOI 10.1074/jbc.M102611200; Bamberger AM, 2000, HORM RES, V54, P32; BECK CA, 1993, P NATL ACAD SCI USA, V90, P4441, DOI 10.1073/pnas.90.10.4441; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Chang CY, 1999, MOL CELL BIOL, V19, P8226; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; ESTES PA, 1987, BIOCHEMISTRY-US, V26, P6250, DOI 10.1021/bi00393a045; FOLKERS GE, 1995, J BIOL CHEM, V270, P23552, DOI 10.1074/jbc.270.40.23552; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GRAHAM JD, 1995, CANCER RES, V55, P5063; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hovland AR, 1998, J BIOL CHEM, V273, P5455, DOI 10.1074/jbc.273.10.5455; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; KNOTTES TA, 2000, J BIOL CHEM, V60, P4; Knotts TA, 2001, J BIOL CHEM, V276, P8475, DOI 10.1074/jbc.M009805200; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; LEFSTIN JA, 1994, GENE DEV, V8, P2842, DOI 10.1101/gad.8.23.2842; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lydon JP, 1996, J STEROID BIOCHEM, V56, P67, DOI 10.1016/0960-0760(95)00254-5; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mangal RK, 1997, J STEROID BIOCHEM, V63, P195, DOI 10.1016/S0960-0760(97)00119-2; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MEYER ME, 1992, J BIOL CHEM, V267, P10882; MOHAMED MK, 1994, J STEROID BIOCHEM, V51, P241, DOI 10.1016/0960-0760(94)90036-1; Mote PA, 1999, J CLIN ENDOCR METAB, V84, P2963, DOI 10.1210/jc.84.8.2963; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rowan BG, 2000, STEROIDS, V65, P545, DOI 10.1016/S0039-128X(00)00112-4; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; SARTORIUS CA, 1994, CANCER RES, V54, P3868; SARTORIUS CA, 1993, J BIOL CHEM, V268, P9262; Schaufele F, 2000, MOL ENDOCRINOL, V14, P2024, DOI 10.1210/me.14.12.2024; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Shen F, 1996, J BIOL CHEM, V271, P4827; SHERIDAN PL, 1989, J BIOL CHEM, V264, P6520; Shyamala G, 2000, P NATL ACAD SCI USA, V97, P3044, DOI 10.1073/pnas.97.7.3044; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; SMITH DF, 1988, ENDOCRINOLOGY, V122, P2816, DOI 10.1210/endo-122-6-2816; Solomon C, 2001, J BONE MINER RES, V16, P39, DOI 10.1359/jbmr.2001.16.1.39; Takimoto GS, 1996, J BIOL CHEM, V271, P13308, DOI 10.1074/jbc.271.23.13308; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; ZHANG YX, 1994, J BIOL CHEM, V269, P31034; ZHANG YX, 1995, MOL ENDOCRINOL, V9, P1029, DOI 10.1210/me.9.8.1029	69	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39843	39851		10.1074/jbc.M106843200	http://dx.doi.org/10.1074/jbc.M106843200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546784	hybrid			2022-12-27	WOS:000171789200046
J	Maynes, JT; Bateman, KS; Cherney, MM; Das, AK; Luu, HA; Holmes, CFB; James, MNG				Maynes, JT; Bateman, KS; Cherney, MM; Das, AK; Luu, HA; Holmes, CFB; James, MNG			Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-PRODUCT INHIBITORS; SER-THR PHOSPHATASES; CATALYTIC SUBUNIT; BETA-12-BETA-13 LOOP; BINDING; PP1; CALCINEURIN; MOTUPORIN; MOLSCRIPT; PROGRAM	Protein phosphatase-1 (PP1) plays a key role in dephosphorylation in numerous biological processes such as glycogen metabolism, cell cycle regulation, smooth muscle contract-ion, and protein synthesis. Microorganisms produce a variety of inhibitors of PP1, which include the microcystin class of inhibitors and okadaic acid, the latter being the major cause of diarrhetic shellfish poisoning and a powerful tumor promoter. We have determined the crystal structure of the molecular complex of okadaic acid bound to PPI to a resolution of 1.9 Angstrom. This structure reveals that the acid binds in a hydrophobic groove adjacent to the active site of the protein and interacts with basic residues within the active site. Okadaic acid exhibits a cyclic structure, which is maintained via an intramolecular hydrogen bond. This is reminiscent of other macrocyclic protein phosphatase inhibitors. The inhibitor-bound enzyme shows very little conformational change when compared with two other PPI structures, except in the inhibitor-sensitive beta 12-beta 13 loop region. The selectivity of okadaic acid for protein phosphatases-1 and -2A but not PP-2B (calcineurin) may be reassessed in light of this study.	Univ Alberta, Fac Med, Dept Biochem, Grp Prot Struct & Funct,Canadian Inst Hlth Res, Edmonton, AB T6G 2H7, Canada; Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Institute for Work & Health; University of Alberta; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	James, MNG (corresponding author), Univ Alberta, Fac Med, Dept Biochem, Grp Prot Struct & Funct,Canadian Inst Hlth Res, Edmonton, AB T6G 2H7, Canada.	Michael.James@ualberta.ca	Maynes, Jason/AAE-4344-2020					Bagu JR, 1997, J BIOL CHEM, V272, P5087, DOI 10.1074/jbc.272.8.5087; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Connor JH, 1999, J BIOL CHEM, V274, P22366, DOI 10.1074/jbc.274.32.22366; Craig M, 1996, BIOCHEM CELL BIOL, V74, P569, DOI 10.1139/o96-061; DAWSON JF, 1998, THESIS U ALBERTA EDM; Dawson John F., 1999, Frontiers in Bioscience, V4, pd646, DOI 10.2741/Dawson; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Evans DRH, 2001, FEBS LETT, V498, P110, DOI 10.1016/S0014-5793(01)02448-6; Gauss CM, 1997, BIOORGAN MED CHEM, V5, P1751, DOI 10.1016/S0968-0896(97)00145-4; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gupta V, 1997, J MED CHEM, V40, P3199, DOI 10.1021/jm960873x; HOLMES CFB, 1993, CURR OPIN STRUC BIOL, V3, P934, DOI 10.1016/0959-440X(93)90159-I; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang HB, 1997, P NATL ACAD SCI USA, V94, P3530, DOI 10.1073/pnas.94.8.3530; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE EY, 1999, FRONT BIOSCI, V15, pD270; Lindvall MK, 1997, J BIOL CHEM, V272, P23312, DOI 10.1074/jbc.272.37.23312; MCREE DE, 1993, PRACTICAL PROTEIN CR, P303; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHIWAKI S, 1990, CARCINOGENESIS, V11, P1837, DOI 10.1093/carcin/11.10.1837; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUINN RJ, 1993, BIOORG MED CHEM LETT, V3, P1029, DOI 10.1016/S0960-894X(00)80281-4; Sheppeck JE, 1997, BIOORGAN MED CHEM, V5, P1739, DOI 10.1016/S0968-0896(97)00146-6; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TACHIBANA K, 1981, J AM CHEM SOC, V103, P2469, DOI 10.1021/ja00399a082; TAKAI A, 1992, BIOCHEM J, V284, P539, DOI 10.1042/bj2840539; TAKAI A, 1987, FEBS LETT, V217, P81, DOI 10.1016/0014-5793(87)81247-4; Zhang LF, 1996, BIOCHEMISTRY-US, V35, P1606, DOI 10.1021/bi9521396	36	135	144	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44078	44082		10.1074/jbc.M107656200	http://dx.doi.org/10.1074/jbc.M107656200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11535607	hybrid			2022-12-27	WOS:000172297700077
J	Tomasin, R; Samir, AA; Vaccaro, MI; Pebusque, MJ; Dagorn, JC; Iovanna, JL; Dusetti, NJ				Tomasin, R; Samir, AA; Vaccaro, MI; Pebusque, MJ; Dagorn, JC; Iovanna, JL; Dusetti, NJ			Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing - SIP induced by stress and promotes cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERULEIN-INDUCED PANCREATITIS; ACUTE-PHASE; APOPTOSIS; EXPRESSION; INDUCTION; SEVERITY; SEQUENCES; ACID; MICE	We have used a quantitative fluorescent cDNA microarray hybridization approach to identify pancreatic genes induced by the cellular stress promoted by acute pancreatitis in the mouse. We report the cloning and characterization of one of them that encodes the stress-induced proteins (SIP). The mouse SIP gene is organized into five exons and expands over similar to 20 kilobase pairs. Exon 4 (38 base pairs) is alternatively spliced to generate two transcripts. Northern blot and in situ hybridization showed that both SIP mRNAs are rapidly and strongly induced in acinar cells of the pancreas with acute pancreatitis. They are also constitutively expressed in several other tissues, although with different ratios. They encode proteins of 18 and 27 kDa (SIP18 and SIP27). SIP27 is identical to the thymus-expressed acidic protein (TEAP) protein, formerly described as a thymus-specific protein. Expression of the SIP18 and SIP27/EGFP or V5 fusion proteins showed that both are nuclear factors. We monitored SIP expression in NIH3T3 cells submitted to various stress agents. UV stress, base damaging, mutagenic stress, ethanol, heat shock, and oxidative stress induced the concomitant expression of SIP's and SIP27 mRNAs. Finally, transient transfection of SIP's and SIP27 expression plasmids induced death by apoptosis in COS7 cells as measured by terminal deoxynuelcotidyltransferase-mediated dUTP nick end-labeling staining. In conclusion, the SIP gene is an important element of cellular stress response. It is expressed in many tissues and induced by a variety of stress agents affecting many cellular pathways. SIP generates, by alternative splicing, two nuclear proteins that can promote cell death by apoptosis.	INSERM, EMI 0116, Ctr Rech, F-13276 Marseille, France; Univ Buenos Aires, Dept Fisiol, RA-1121 Buenos Aires, DF, Argentina; INSERM, U119, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm)	Iovanna, JL (corresponding author), INSERM, EMI 0116, Ctr Rech, 163 Av Luminy,BP 172, F-13276 Marseille, France.		tomasini, richard/F-1130-2017; Iovanna, Juan/M-9805-2017; Vaccaro, Maria I./L-8348-2017; Dusetti, Nelson/O-7919-2017	tomasini, richard/0000-0003-0869-0811; Iovanna, Juan/0000-0003-1822-2237; Dusetti, Nelson/0000-0002-6161-8483; Vaccaro, Maria/0000-0002-2456-747X				Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; Carrier A, 1999, IMMUNOGENETICS, V50, P255, DOI 10.1007/s002510050601; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dagorn JC, 1997, DIGESTION, V58, P50, DOI 10.1159/000201526; Dusetti NJ, 2000, BIOCHEM BIOPH RES CO, V277, P660, DOI 10.1006/bbrc.2000.3734; Hahm KB, 1998, PANCREAS, V17, P153, DOI 10.1097/00006676-199808000-00007; He ZJ, 2000, ANN CHIR GYNAECOL FE, V89, P65; IOVANNA JL, 1991, AM J PHYSIOL, V261, pG485, DOI 10.1152/ajpgi.1991.261.3.G485; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Karne S, 1999, SURG CLIN N AM, V79, P699, DOI 10.1016/S0039-6109(05)70036-0; Kimura K, 1998, PANCREAS, V17, P120, DOI 10.1097/00006676-199808000-00002; KOMMINOTH P, 1995, LAB INVEST, V72, P424; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Ortiz EM, 1998, GASTROENTEROLOGY, V114, P808, DOI 10.1016/S0016-5085(98)70595-5; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Saluja A, 1996, BIOCHEM BIOPH RES CO, V220, P875, DOI 10.1006/bbrc.1996.0498; Steer ML, 1997, DIGESTION, V58, P46, DOI 10.1159/000201525; WILSON C, 1991, DRUGS, V41, P358, DOI 10.2165/00003495-199141030-00004	19	67	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44185	44192		10.1074/jbc.M105647200	http://dx.doi.org/10.1074/jbc.M105647200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557757	hybrid			2022-12-27	WOS:000172297700090
J	Cheng, AW; Chan, SL; Milhavet, O; Wang, SQ; Mattson, MP				Cheng, AW; Chan, SL; Milhavet, O; Wang, SQ; Mattson, MP			p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; CENTRAL-NERVOUS-SYSTEM; AMYLOID BETA-PEPTIDE; ADULT HUMAN BRAIN; SIGNAL-TRANSDUCTION; NEURONAL APOPTOSIS; CYTOCHROME-C; NEURODEGENERATIVE DISORDERS; CASPASE ACTIVATION	Neural progenitor cells (NPC) can proliferate, differentiate into neurons or glial cells, or undergo a form of programmed cell death called apoptosis. Although death of NPC occurs during development of the nervous system and in the adult, the underlying mechanisms are unknown. Here we show that nitric oxide (NO) can induce death of C17.2 NPC by a mechanism requiring activation of p38 MAP kinase, poly(ADP-ribose) polymerase, and caspase-3. Nitric oxide causes release of cytochrome c from mitochondria, and Bcl-2 protects the neural progenitor cells against nitric oxide-induced death, consistent with a pivotal role for mitochondrial changes in controlling the cell death process. Inhibition of p38 MAP kinase by SB203580 abolished NO-induced cell death, cytochrome c release, and activation of caspase-3, indicating that p38 activation serves as an upstream mediator in the cell death process. The antiapoptotic protein Bcl-2 protected NPC against nitric oxide-induced apoptosis and suppressed activation of p38 MAP kinase. The ability of nitric oxide to trigger death of NPC by a mechanism involving p38 MAP kinase suggests that this diffusible gas may regulate NPC fate in physiological and pathological settings in which NO is produced.	NIA, Neurosci Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Gerontol Res Ctr, 4F02,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012	Milhavet, Ollivier/0000-0001-6236-0499	NATIONAL INSTITUTE ON AGING [ZIAAG000312, Z01AG000313, ZIAAG000313, Z01AG000312] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABEDOHMAE S, 1993, BIOCHEM BIOPH RES CO, V191, P915, DOI 10.1006/bbrc.1993.1304; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Ayata C, 1997, J NEUROSCI, V17, P6908; Bartsch H, 2000, EUR J CANCER, V36, P1229, DOI 10.1016/S0959-8049(00)00095-2; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Bernier PJ, 2000, NEUROSCI RES, V37, P67, DOI 10.1016/S0168-0102(00)00102-4; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bloodsworth A, 2000, ARTERIOSCL THROM VAS, V20, P1707, DOI 10.1161/01.ATV.20.7.1707; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Bruce-Keller AJ, 1998, J NEUROCHEM, V70, P31; Brune B, 1999, CELL DEATH DIFFER, V6, P969, DOI 10.1038/sj.cdd.4400582; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Calabrese V, 2000, NEUROCHEM RES, V25, P1315, DOI 10.1023/A:1007604414773; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Contestabile A, 2000, BRAIN RES REV, V32, P476, DOI 10.1016/S0165-0173(00)00018-7; D'Sa-Eipper C, 2000, DEV NEUROSCI-BASEL, V22, P116, DOI 10.1159/000017433; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dawson VL, 1998, PROG BRAIN RES, V118, P215; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J NEUROSCI, V16, P2479; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Deschesnes RG, 2001, MOL BIOL CELL, V12, P1569, DOI 10.1091/mbc.12.6.1569; Didier C, 1999, FASEB J, V13, P1817, DOI 10.1096/fasebj.13.13.1817; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Franklin RA, 2000, LEUKEMIA, V14, P2019, DOI 10.1038/sj.leu.2401967; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; GIUILI G, 1994, DEV BRAIN RES, V81, P269, DOI 10.1016/0165-3806(94)90313-1; GRAHAM A, 1993, DEVELOPMENT, V119, P233; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hagedorn L, 2000, DEV BIOL, V228, P57, DOI 10.1006/dbio.2000.9936; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harada J, 1999, JPN J PHARMACOL, V79, P369, DOI 10.1254/jjp.79.369; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Holscher C, 1997, TRENDS NEUROSCI, V20, P298, DOI 10.1016/S0166-2236(97)01065-5; HOMMA S, 1994, J COMP NEUROL, V345, P377, DOI 10.1002/cne.903450305; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jun CD, 1999, J IMMUNOL, V162, P3395; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kikuchi M, 2000, J NEUROSCI, V20, P5037; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KITCHENS DL, 1994, J NEUROBIOL, V25, P797, DOI 10.1002/neu.480250705; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leist M, 1997, MOL MED, V3, P750, DOI 10.1007/BF03401713; Levison SW, 2000, DEV NEUROSCI-BASEL, V22, P106, DOI 10.1159/000017432; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 1998, BRAIN RES, V807, P167, DOI 10.1016/S0006-8993(98)00763-X; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Messmer UK, 1996, FEBS LETT, V384, P162; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Moreno-Lopez B, 2000, BRAIN RES, V869, P244, DOI 10.1016/S0006-8993(00)02474-4; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; OGILVIE P, 1995, FASEB J, V9, P799, DOI 10.1096/fasebj.9.9.7541381; Phung YT, 1999, MOL BRAIN RES, V64, P165, DOI 10.1016/S0169-328X(98)00315-5; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pieper AA, 2000, P NATL ACAD SCI USA, V97, P1845, DOI 10.1073/pnas.97.4.1845; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rakic S, 2000, EUR J NEUROSCI, V12, P2721, DOI 10.1046/j.1460-9568.2000.00153.x; REED DJ, 1990, CHEM RES TOXICOL, V3, P495, DOI 10.1021/tx00018a002; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rialas CM, 2000, EXP CELL RES, V260, P268, DOI 10.1006/excr.2000.5017; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Rosini P, 2000, BIOCHEM BIOPH RES CO, V278, P753, DOI 10.1006/bbrc.2000.3871; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Samama B, 1996, DEV BRAIN RES, V96, P192; Santacana M, 1998, DEV BRAIN RES, V111, P205, DOI 10.1016/S0165-3806(98)00140-0; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; SLACK RS, 1995, J CELL BIOL, V129, P779, DOI 10.1083/jcb.129.3.779; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Tamatani M, 1998, CELL DEATH DIFFER, V5, P911, DOI 10.1038/sj.cdd.4400439; Tamatani M, 1998, J NEUROCHEM, V71, P1588; Uehara T, 1999, J NEUROCHEM, V72, P196, DOI 10.1046/j.1471-4159.1999.0720196.x; Weller M, 1997, J NEURAL TRANSM-SUPP, P115; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	106	134	146	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43320	43327		10.1074/jbc.M107698200	http://dx.doi.org/10.1074/jbc.M107698200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555660	hybrid			2022-12-27	WOS:000172169300090
J	Goldberg, AFX; Fales, LM; Hurley, JB; Khattree, N				Goldberg, AFX; Fales, LM; Hurley, JB; Khattree, N			Folding and subunit assembly of photoreceptor peripherin/rds is mediated by determinants within the extracellular/intradiskal EC2 domain - Implications for heterogeneous molecular pathologies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGENERATION SLOW RDS; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; ROD PHOTORECEPTORS; DISK MEMBRANE; CANDIDATE GENE; MESSENGER-RNA; ROM-1; PROTEIN; CLONING	Peripherin/rds is an integral membrane protein required for the elaboration of rod and cone photoreceptor outer segments in the vertebrate retina; it causes a surprising variety of progressive retinal degenerations in humans and dysmorphic photoreceptors in murine models if defective or absent. (Peripherin/rds is also known as photoreceptor peripherin, peripherin/rds, rds/peripherin, rds, and peripherin-2.) Peripherin/rds appears to act as a structural element in outer segment architecture. However, neither its function at the molecular level nor its role in retinal disease processes are well understood. This report initiates a systematic investigation of protein domain structure and function by examining the molecular and cellular consequences of a series of 14 insertional mutations distributed throughout the polypeptide sequence. Protein expression, disulfide bonding, sedimentation velocity, and subcellular localization of the COS-1 cell-expressed mutant variants were examined to test the hypothesis that protein folding and tetrameric subunit assembly are mediated primarily by EC2, a conserved extracellular/intradiskal domain. Protein folding and tetrameric subunit assembly were not affected by insertion of either an uncharged dipeptide (GA) or a highly charged hendecapeptide (GDYKDDDDKAA) into any one of nine sites residing outside of EC2 as assayed by nonreducing Western blot analysis, sedimentation velocity, and subcellular localization. In contrast, insertions at five positions within the EC2 domain did cause either gross protein misfolding (two sites) or a reduction in protein sedimentation coefficient (two sites) or both (one site). These results indicate that although the vast majority of extramembranous polypeptide sequence makes no measurable contribution to protein folding and tetramerization, discrete regions within the EC2 domain do contain determinants for normal subunit assembly. These findings raise the possibility that multiple classes of structural perturbation are produced by inherited defects in peripherin/rds and contribute to the observed heterogeneity of retinal disease phenotypes..	Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA; Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98195 USA	Oakland University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Goldberg, AFX (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	goldberg@oakland.edu			NATIONAL EYE INSTITUTE [R01EY006641, R01EY013246] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY13246, R01 EY06641, R01 EY013246, R01 EY006641] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2000, BBA-BIOMEMBRANES, V1463, P343, DOI 10.1016/S0005-2736(99)00226-6; BORJIGIN J, 1994, J BIOL CHEM, V269, P14715; Chubet RG, 1996, BIOTECHNIQUES, V20, P136; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; Goldberg AFX, 2000, METHOD ENZYMOL, V316, P671; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; GORIN MB, 1993, MAMM GENOME, V4, P544, DOI 10.1007/BF00364792; Gould DJ, 1997, ANIM GENET, V28, P391, DOI 10.1111/j.1365-2052.1997.00185.x; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; Kedzierski W, 1999, J BIOL CHEM, V274, P29181, DOI 10.1074/jbc.274.41.29181; Kedzierski W, 1996, J CELL SCI, V109, P2551; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kohl S, 1998, ACTA ANAT, V162, P75; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MOGHRABI WN, 1995, EXP EYE RES, V61, P641, DOI 10.1016/S0014-4835(05)80059-4; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; Weng J, 1998, INVEST OPHTH VIS SCI, V39, P440; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	41	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42700	42706		10.1074/jbc.M107511200	http://dx.doi.org/10.1074/jbc.M107511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553636	hybrid, Green Accepted			2022-12-27	WOS:000172169300010
J	Jankova, L; Harrop, SJ; Saunders, DN; Andrews, JL; Bertram, KC; Gould, AR; Baker, MS; Curmi, PMG				Jankova, L; Harrop, SJ; Saunders, DN; Andrews, JL; Bertram, KC; Gould, AR; Baker, MS; Curmi, PMG			Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM STRUCTURE; SERPIN; PROTEIN; MODEL; ALPHA(1)-ANTITRYPSIN; OVALBUMIN; MECHANISM; INSERTION; SIGNAL; ACID	The structure of the serpin, plasminogen activator inhibitor type-2 (PAI-2), in a complex with a peptide mimicking its reactive center loop (RCL) has been determined at 1.6-Angstrom resolution. The structure shows the relaxed state serpin structure with a prominent six-stranded beta -sheet. Clear electron density is seen for all residues in the peptide. The P1 residue of the peptide binds to a well defined pocket at the base of PAI-2 that may be important in determining the specificity of protease inhibition. The stressed-to-relaxed state (S --> R) transition in PAI-2 can be modeled as the relative motion between a quasirigid core domain and a smaller segment comprising helix hF and beta -strands s1A, s2A, and s3A. A comparison of the Ramachandran plots of the stressed and relaxed state PAI-2 structures reveals the location of several hinge regions connecting these two domains. The hinge regions cluster in three locations on the structure, ensuring a cooperative S --> R transition. We hypothesize that the hinge formed by the conserved Gly(206) on P-strand s3A in the breach region of PAI-2 effects the S --> R transition by altering its backbone torsion angles. This torsional change is due to the binding of the P14 threonine of the RCL to the open breach region of PAI-2.	Univ New S Wales, Sch Phys, Initiat Biomol Struct, Sydney, NSW 2052, Australia; Univ Wollongong, Dept Biol Sci, Wollongong, NSW 2522, Australia; St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; Biotech Australia, Roseville, NSW 2069, Australia; Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Gynaecol Canc Res Ctr, Melbourne, Vic 3153, Australia	University of New South Wales Sydney; University of Wollongong; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Melbourne	Curmi, PMG (corresponding author), Univ New S Wales, Sch Phys, Initiat Biomol Struct, Sydney, NSW 2052, Australia.	p.curmi@unsw.edu.au	Curmi, Paul/G-7185-2011; Saunders, Darren/B-7677-2008	Curmi, Paul/0000-0001-5762-7638; Baker, Mark/0000-0001-5858-4035; Saunders, Darren/0000-0003-0924-0513				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUMANN U, 1992, J MOL BIOL, V226, P1207, DOI 10.1016/0022-2836(92)91062-T; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jensen PH, 1996, J BIOL CHEM, V271, P26892, DOI 10.1074/jbc.271.43.26892; JENSEN PH, 1994, J BIOL CHEM, V269, P15394; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; LECANDER I, 1986, BRIT J HAEMATOL, V62, P221, DOI 10.1111/j.1365-2141.1986.tb02925.x; LESLIE A, 1993, CRYSTALLOGRAPHIC COM, V5; Li JP, 1999, STRUCTURE, V7, P103, DOI 10.1016/S0969-2126(99)80013-6; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; MEDCALF RL, 1992, J BIOL CHEM, V267, P12220; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Renatus M, 2000, STRUCT FOLD DES, V8, P789, DOI 10.1016/S0969-2126(00)00165-9; Risse BC, 1998, HISTOCHEM CELL BIOL, V110, P559, DOI 10.1007/s004180050318; Risse BC, 2000, J CELL PHYSIOL, V182, P281, DOI 10.1002/(SICI)1097-4652(200002)182:2<281::AID-JCP17>3.0.CO;2-D; Saunders DN, 1998, J BIOL CHEM, V273, P10965, DOI 10.1074/jbc.273.18.10965; Saunders DN, 2001, J BIOL CHEM, V276, P43383, DOI 10.1074/jbc.M103123200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Skinner R, 1998, J MOL BIOL, V283, P9, DOI 10.1006/jmbi.1998.2083; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; VONHEIJNE G, 1991, J BIOL CHEM, V266, P15240; Whisstock JC, 2000, J MOL BIOL, V296, P685, DOI 10.1006/jmbi.1999.3520; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1	50	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43374	43382		10.1074/jbc.M103021200	http://dx.doi.org/10.1074/jbc.M103021200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11546761	hybrid			2022-12-27	WOS:000172169300096
J	Leland, PA; Staniszewski, KE; Kim, BM; Raines, RT				Leland, PA; Staniszewski, KE; Kim, BM; Raines, RT			Endowing human pancreatic ribonuclease with toxicity for cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL STABILITY; CATALYTIC-ACTIVITY; RANA-CATESBEIANA; GROWTH-FACTOR; CYTOTOXIC RIBONUCLEASES; 3-DIMENSIONAL STRUCTURE; INHIBITOR INTERACTION; ANTITUMOR-ACTIVITY; ENDOTHELIAL-CELLS; HUMAN ANGIOGENIN	Onconase(R) is an amphibian protein that is now in Phase IH clinical trials as a cancer chemotherapeutic. Human pancreatic ribonuclease (RNase 1) is homologous to Onconase(R) but is not cytotoxic. Here, ERDD RNase 1, which is the L86E/N88R/G89D/R91D variant of RNase 1, is shown to have conformational. stability and ribonucleolytic activity similar to that of the wild-type enzyme but >10(3)-fold less affinity for the endogenous cytosolic ribonuclease inhibitor protein. Most significantly, ERDD RNase 1 is toxic to hum an leukemia cells. The addition of a non-native disulfide bond to ERDD RNase I not only increases the conformational stability of the enzyme but also increases its cytotoxicity such that its IC(50) value is only 8-fold greater than that of Onconase(R). Thus, only a few amino acid substitutions are necessary to make a human protein toxic to human cancer cells. This finding has significant implications for human cancer chemotherapy.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	raines@biochem.wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719; Turkow, Kristine/0000-0002-6102-0668	NATIONAL CANCER INSTITUTE [R01CA073808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NCI NIH HHS [CA73808] Funding Source: Medline; NIGMS NIH HHS [T32 GM07215] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blackburn P, 1982, ENZYMES, VXV, P317; Boix E, 1996, J MOL BIOL, V257, P992, DOI 10.1006/jmbi.1996.0218; BRAVO J, 1994, ANAL BIOCHEM, V219, P82, DOI 10.1006/abio.1994.1234; Bretscher LE, 2000, J BIOL CHEM, V275, P9893, DOI 10.1074/jbc.275.14.9893; Canals A, 1999, PROTEIN EXPRES PURIF, V17, P169, DOI 10.1006/prep.1999.1112; DIDONATO A, 1994, J BIOL CHEM, V269, P17394; Futami J, 1999, PROTEIN ENG, V12, P1013, DOI 10.1093/protein/12.11.1013; Futami J, 2000, J BIOCHEM-TOKYO, V128, P245, DOI 10.1093/oxfordjournals.jbchem.a022747; Gaur D, 2001, J BIOL CHEM, V276, P24978, DOI 10.1074/jbc.M102440200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hofsteenge J., 1997, RIBONUCLEASES STRUCT, P621, DOI [10.1016/b978-012588945-2/50020-0, DOI 10.1016/B978-012588945-2/50020-0]; Hu GF, 2000, J CELL BIOCHEM, V76, P452, DOI 10.1002/(SICI)1097-4644(20000301)76:3<452::AID-JCB12>3.0.CO;2-Z; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Irie M, 1998, CELL MOL LIFE SCI, V54, P775, DOI 10.1007/s000180050206; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kim JS, 1995, J BIOL CHEM, V270, P31097, DOI 10.1074/jbc.270.52.31097; KIM JS, 1993, PROTEIN SCI, V2, P348; Klink TA, 2000, J BIOL CHEM, V275, P17463, DOI 10.1074/jbc.M001132200; Klink TA, 2000, EUR J BIOCHEM, V267, P566, DOI 10.1046/j.1432-1327.2000.01037.x; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Leland PA, 1998, P NATL ACAD SCI USA, V95, P10407, DOI 10.1073/pnas.95.18.10407; Leland PA, 2001, CHEM BIOL, V8, P405, DOI 10.1016/S1074-5521(01)00030-8; Leland PA, 2000, FEBS LETT, V477, P203, DOI 10.1016/S0014-5793(00)01804-4; MESSMORE JM, 1995, J AM CHEM SOC, V117, P8057, DOI 10.1021/ja00136a001; MIKULSKI SM, 1995, INT J ONCOL, V6, P889; MIKULSKI SM, 1993, INT J ONCOL, V3, P57; MIKULSKI SM, 1990, CELL TISSUE KINET, V23, P237, DOI 10.1111/j.1365-2184.1990.tb01119.x; MIKULSKI SM, 1992, INT J ONCOL, V1, P779; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MURTHY BS, 1992, BIOCHEM J, V281, P343, DOI 10.1042/bj2810343; NEWTON DL, 1992, J BIOL CHEM, V267, P19572; NITTA K, 1993, GLYCOBIOLOGY, V3, P37, DOI 10.1093/glycob/3.1.37; NITTA K, 1987, CANCER RES, V47, P4877; OKABE Y, 1991, J BIOCHEM-TOKYO, V109, P786, DOI 10.1093/oxfordjournals.jbchem.a123457; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Piccoli R, 1999, P NATL ACAD SCI USA, V96, P7768, DOI 10.1073/pnas.96.14.7768; Pous J, 2000, J MOL BIOL, V303, P49, DOI 10.1006/jmbi.2000.4506; Pous J, 2001, ACTA CRYSTALLOGR D, V57, P498, DOI 10.1107/S0907444901001147; Psarras K, 1998, PROTEIN ENG, V11, P1285, DOI 10.1093/protein/11.12.1285; Raines RT, 1999, BIOM HLTH R, V27, P235; RIBO M, 1994, BIOL CHEM H-S, V375, P357; ROTH JS, 1967, METHOD CANCER RES, V3, P153; RYBAK SM, 1991, J BIOL CHEM, V266, P21202; Rybak SM, 1996, J NATL CANCER I, V88, P747, DOI 10.1093/jnci/88.11.747; SAKAKIBARA F, 1979, CANCER RES, V39, P1347; SAXENA SK, 1991, J BIOL CHEM, V266, P21208; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Suwa T, 1999, ANTICANCER RES, V19, P4161; Suzuki M, 1999, NAT BIOTECHNOL, V17, P265, DOI 10.1038/7010; Teter SA, 1999, TRENDS CELL BIOL, V9, P428, DOI 10.1016/S0962-8924(99)01652-9; TRAUTWEIN K, 1991, FEBS LETT, V281, P275, DOI 10.1016/0014-5793(91)80410-5; Vasandani VM, 1999, CANCER CHEMOTH PHARM, V44, P164, DOI 10.1007/s002800050962; Vasandani VM, 1996, CANCER RES, V56, P4180; WLODAWER A, 1988, BIOCHEMISTRY-US, V27, P2705, DOI 10.1021/bi00408a010; WU YN, 1995, J BIOL CHEM, V270, P17476, DOI 10.1074/jbc.270.29.17476; WU YN, 1993, J BIOL CHEM, V268, P10686; Youle R. J., 1997, RIBONUCLEASES STRUCT, P491	63	78	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43095	43102		10.1074/jbc.M106636200	http://dx.doi.org/10.1074/jbc.M106636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555655	hybrid			2022-12-27	WOS:000172169300062
J	Matsubayashi, Y; Fukuda, M; Nishida, E				Matsubayashi, Y; Fukuda, M; Nishida, E			Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; GROWTH-FACTOR; NUCLEOCYTOPLASMIC TRANSPORT; CYTOPLASMIC LOCALIZATION; IMPORT SUBSTRATE; EXPORT SIGNAL; BETA-CATENIN; PHOSPHORYLATION; IDENTIFICATION	The classical mitogen-activated protein kinase (MAPK, also known as ERK) pathway is widely involved in eukaryotic signal transductions. In response to extracellular stimuli, MAPK becomes activated and translocates from the cytoplasm to the nucleus. At least two pathways for the nuclear import of MAPK are shown to exist; passive diffusion of a monomer and Ran-dependent active transport of a dimer, the detailed molecular mechanism of which is unknown. In this study, we have reconstituted nuclear import of MAPK in vitro by using digitonin-permeabilized cells with GFP-fused MAPK protein (GFP-MAPK), which is too large to pass through the nuclear pore by passive diffusion. GFP-MAPK was able to accumulate in the nucleus irrespective of its phosphorylation state. This import of GFP-MAPK occurred even in the absence of any soluble cytosolic factors or ATP but was inhibited by wheat germ agglutinin or an excess amount of importin-beta or at low temperatures. Moreover, ALAPK directly bound to an FG repeat region of nucleoporin CAN/Nup214 in vitro. Taken together, these results suggest the third pathway for nuclear import of MAPK, in which MAPK passes through the nuclear pore by directly interacting with the nuclear pore complex.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kitashirekawa, Kyoto 6068502, Japan.	L50174@sakura.kudpc.kyoto-u.ac.jp	Matsubayashi, Yutaka/GRR-9659-2022; Fukuda, Makoto/S-9748-2019; Fukuda, Makoto/I-7915-2014; Fukuda, Makoto/C-9745-2009	Fukuda, Makoto/0000-0003-0112-9925; Fukuda, Makoto/0000-0003-0112-9925; Fukuda, Makoto/0000-0003-0112-9925; Matsubayashi, Yutaka/0000-0003-2196-8099				Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; ADAM SA, 1992, METHOD ENZYMOL, V219, P97; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GOTOH Y, 1994, ONCOGENE, V9, P1891; IMAMOTO N, 1995, J BIOL CHEM, V270, P8559, DOI 10.1074/jbc.270.15.8559; Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kosako H, 1996, BIOCHEMISTRY-US, V35, P13212, DOI 10.1021/bi960956f; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LOMBILLO VA, 1993, METHOD CELL BIOL, V39, P149, DOI 10.1016/S0091-679X(08)60168-5; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; MORIGUCHI T, 1995, EUR J BIOCHEM, V234, P32, DOI 10.1111/j.1432-1033.1995.032_c.x; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P2008, DOI 10.1073/pnas.92.6.2008; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	59	130	138	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41755	41760		10.1074/jbc.M106012200	http://dx.doi.org/10.1074/jbc.M106012200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546808	hybrid			2022-12-27	WOS:000172450400030
J	Napper, S; Brokx, SJ; Pally, E; Kindrachuk, J; Delbaere, LTJ; Waygood, EB				Napper, S; Brokx, SJ; Pally, E; Kindrachuk, J; Delbaere, LTJ; Waygood, EB			Substitution of aspartate and glutamate for active center histidines in the Escherichia coli phosphoenolpyruvate : sugar phosphotransferase system maintain phosphotransfer potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCARRIER PROTEIN-IIIGLC; SALMONELLA-TYPHIMURIUM; ENZYME-I; BACTERIAL PHOSPHOENOLPYRUVATE; PHOSPHOGLYCERATE MUTASE; PHOSPHORYL TRANSFER; ENTERIC BACTERIA; TERMINAL DOMAIN; HPR; TRANSPORT	The active center histidines of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system proteins; histidine-containing protein, enzyme I, and enzyme HAG(Glc) were substituted with a series of amino acids (serine, threonine, tyrosine, cysteine, aspartate, and glutamate) with the potential to undergo phosphorylation. The mutants [H189E]enzyme I, [H15D]HPr, and [H90E]enzyme IIA(Glc) retained ability for phosphorylation as indicated by [P-32]phosphoenolpyruvate labeling. As the active center histidines of both enzyme I and enzyme IIA(Glc) undergo phosphorylation of the N-epsilon2 atom, while HPr is phosphorylated at the N-delta1 atom, a pattern of successful substitution of glutamates for N-epsilon2 phosphorylations and aspartates for N-delta1 phosphorylations emerges. Furthermore, phosphotransfer between acyl residues: P-aspartyl to glutamyl and P-glutaxnyl to aspartyl was demonstrated with these mutant proteins and enzymes.	Univ Saskatchewan, Vet Infect Dis Org, Dept Biochem, Saskatoon, SK S7N 5E3, Canada; Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan	Napper, S (corresponding author), Univ Saskatchewan, Vet Infect Dis Org, Dept Biochem, 120 Vet Rd, Saskatoon, SK S7N 5E3, Canada.			Kindrachuk, Jason/0000-0002-3305-7084				ANDERSON B, 1971, J BIOL CHEM, V246, P7023; ANDERSON JW, 1991, BIOCHEMISTRY-US, V30, P9601, DOI 10.1021/bi00104a006; ANDERSON JW, 1993, J BIOL CHEM, V268, P12325; Brokx SJ, 2000, BIOCHEMISTRY-US, V39, P3624, DOI 10.1021/bi991250z; COLOMB MG, 1972, BIOCHEMISTRY-US, V11, P3378, DOI 10.1021/bi00768a010; ERNI B, 1989, J BIOL CHEM, V264, P18733; FOX DK, 1986, J BIOL CHEM, V261, P3487; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; JIA ZC, 1993, J BIOL CHEM, V268, P22490; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LOWE DM, 1985, BIOCHEMISTRY-US, V24, P5106, DOI 10.1021/bi00340a022; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; MATTOO RL, 1984, ANAL BIOCHEM, V139, P1, DOI 10.1016/0003-2697(84)90383-X; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Napper S, 1996, BIOCHEMISTRY-US, V35, P11260, DOI 10.1021/bi9603480; Napper S, 1999, J BIOL CHEM, V274, P21776, DOI 10.1074/jbc.274.31.21776; NAPPER S, 1999, THESIS U SASKATCHEWA; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PAS HH, 1991, J BIOL CHEM, V266, P6690; PELTON JG, 1992, BIOCHEMISTRY-US, V31, P5215, DOI 10.1021/bi00137a017; PILKIS SJ, 1987, J BIOL CHEM, V262, P12672; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POSTMA PW, 1996, ESCHERICHIA COLI SAL; ROBERTSON EF, 1988, J BIOL CHEM, V263, P2477; ROSE ZB, 1982, METHOD ENZYMOL, V87, P42; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SAIER MH, 1993, J CELL BIOCHEM, V51, P62, DOI 10.1002/jcb.240510112; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TITEMEYER F, 1993, J CELL BIOCHEM, V51, P69; Trumbore MW, 1997, J BIOL CHEM, V272, P26394, DOI 10.1074/jbc.272.42.26394; WAYGOOD EB, 1987, J BACTERIOL, V169, P2810, DOI 10.1128/jb.169.6.2810-2818.1987; WAYGOOD EB, 1980, CAN J BIOCHEM CELL B, V58, P40, DOI 10.1139/o80-006; WAYGOOD EB, 1985, BIOCHEMISTRY-US, V24, P6938, DOI 10.1021/bi00345a028; WAYGOOD EB, 1984, J CELL BIOCHEM, V25, P139, DOI 10.1002/jcb.240250304; WAYGOOD EB, 1979, ANAL BIOCHEM, V95, P293, DOI 10.1016/0003-2697(79)90219-7; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; WILLIAMS SP, 1985, BIOCHEMISTRY-US, V24, P5527, DOI 10.1021/bi00341a037; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382	40	6	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41588	41593		10.1074/jbc.M104139200	http://dx.doi.org/10.1074/jbc.M104139200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551914	hybrid			2022-12-27	WOS:000172450400009
J	Schmitt, I; Gerace, L				Schmitt, I; Gerace, L			In vitro analysis of nuclear transport mediated by the C-terminal shuttle domain of tap	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; PORE COMPLEX; LEPTOMYCIN B; POLY(A)(+) RNA; HUMAN HOMOLOG; RAN-GTP; PROTEIN; BINDING; VIRUS; SIGNAL	The Tap protein of higher eukaryotes is implicated in the nuclear export of type D retroviral mRNA and some cellular mRNAs. Here we have developed an in vitro assay to study nuclear export mediated by the C-terminal shuttle domain of Tap involving the rapamycin-induced attachment of this transport domain to a nuclear green fluorescent protein-containing reporter. We found that export by the Tap transport domain does not involve cytosolic transport factors including the GTPase Ran. The transport domain directly binds to several nucleoporins positioned in different regions of the nuclear pore complex. These results argue that a direct interaction of the Tap transport domain with nucleoporins is responsible for its nucleocytoplasmic translocation. We found that the karyopherin beta -related export receptor CRM1 competes with the Tap transport domain for binding to Nup214 but not for binding to Nup62 or Nup153, suggesting that the Tap and CRM1 nuclear export pathways converge at the cytoplasmic periphery of the nuclear pore complex. Because the rates of in vitro nuclear import and export by the Tap transport domain are very similar, the directionality of mRNA export mediated by Tap probably is determined by mechanisms other than simple binding of the Tap transport domain to nucleoporins.	Scripps Res Inst, Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Gerace, L (corresponding author), Scripps Res Inst, Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lgerace@scripps.edu						Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Black BE, 1999, MOL CELL BIOL, V19, P8616; Black BE, 2001, J CELL BIOL, V152, P141, DOI 10.1083/jcb.152.1.141; Bodendorf U, 1999, J VIROL, V73, P7769, DOI 10.1128/JVI.73.9.7769-7779.1999; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Cullen BR, 2000, MOL CELL BIOL, V20, P4181, DOI 10.1128/MCB.20.12.4181-4187.2000; Daneholt B, 1999, CURR BIOL, V9, pR412, DOI 10.1016/S0960-9822(99)80256-5; DUMONT FJ, 1990, J IMMUNOL, V144, P1418; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1996, ONCOGENE, V13, P1801; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; GERACE L, 1978, J CELL BIOL, V79, P546, DOI 10.1083/jcb.79.2.546; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kang YB, 2000, J VIROL, V74, P5863, DOI 10.1128/JVI.74.13.5863-5871.2000; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Klemm JD, 1997, CURR BIOL, V7, P638, DOI 10.1016/S0960-9822(06)00290-9; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Michael WM, 1995, COLD SPRING HARB SYM, V60, P663, DOI 10.1101/SQB.1995.060.01.071; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Noble SM, 1996, GENETICS, V143, P67; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Soliman TM, 2000, J VIROL, V74, P2814, DOI 10.1128/JVI.74.6.2814-2825.2000; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Suyama M, 2000, EMBO REP, V1, P53, DOI 10.1093/embo-reports/kvd009; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	66	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42355	42363		10.1074/jbc.M103916200	http://dx.doi.org/10.1074/jbc.M103916200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551912	hybrid			2022-12-27	WOS:000172450400107
J	Howes, BD; Feis, A; Raimondi, L; Indiani, C; Smulevich, G				Howes, BD; Feis, A; Raimondi, L; Indiani, C; Smulevich, G			The critical role of the proximal calcium ion in the structural properties of horseradish peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTRA; C-TYPE CYTOCHROMES; MANGANESE PEROXIDASE; CRYSTAL-STRUCTURE; SPECTROSCOPIC EVIDENCE; ANGSTROM RESOLUTION; CIRCULAR-DICHROISM; PEANUT PEROXIDASE; LIGNIN PEROXIDASE; HEME CAVITY	The extent to which the structural Ca2+ ions of horseradish peroxidase (HRPC) are a determinant in defining the heme pocket architecture is investigated by electronic absorption and resonance Raman spectroscopy upon removal of one Ca2+ ion. The Fe(III) heme states are modified upon Ca2+ depletion, with an uncommon quantum mechanically mixed spin state becoming the dominant species. Ca2+-depleted HRPC forms complexes with benzohydroxamic acid and CO which display spectra very similar to those of native HRPC, indicating that any changes to the distal cavity structural properties upon Ca2+ depletion are easily reversed. Contrary to the native protein, the Ca2+-depleted ferrous form displays a low-spin bis-histidyl heme state and a small proportion of high-spin heme. Furthermore, the v(Fe-Im) stretching mode downshifts 27 cm(-1) upon Ca2+ depletion revealing a significant structural perturbation of the proximal cavity near the histidine ligand. The specific activity of the Ca2+-depleted enzyme is 50% that of the native form. The effects on enzyme activity and spectral features observed upon Ca2+ depletion are reversible upon reconstitution. Evaluation of the present and previous data firmly favors the proximal Ca2+ ion as that which is lost upon Ca2+ depletion and which likely plays the more critical role in regulating the heme pocket structural and catalytic properties.	Univ Florence, Dipartimento Chim, I-50121 Florence, Italy; Dipartimento Farmacol Preclin & Clin, I-50134 Florence, Italy	University of Florence	Smulevich, G (corresponding author), Univ Florence, Dipartimento Chim, Via G Capponi 9, I-50121 Florence, Italy.	smulev@chim.unifi.it	Feis, Alessandro/J-1724-2014; smulevich, giulietta/A-6510-2008; Raimondi, laura/A-9280-2013	Feis, Alessandro/0000-0003-3469-0647; Raimondi, Laura/0000-0002-8423-0860; Smulevich, Giulietta/0000-0003-3021-8919				BABCOCK GT, 1985, BIOCHEMISTRY-US, V24, P3638, DOI 10.1021/bi00335a036; BARBER KR, 1995, EUR J BIOCHEM, V232, P825, DOI 10.1111/j.1432-1033.1995.tb20879.x; Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; deRopp JS, 1997, J AM CHEM SOC, V119, P4732, DOI 10.1021/ja9642018; Feis A, 1998, J RAMAN SPECTROSC, V29, P933, DOI 10.1002/(SICI)1097-4555(199810/11)29:10/11<933::AID-JRS319>3.0.CO;2-P; Feis A, 1998, BIOCHEMISTRY-US, V37, P13575, DOI 10.1021/bi981399v; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; Fuhrhop J.H., 1975, LAB METHODS PORPHYRI, P757; FUJII S, 1995, BBA-PROTEIN STRUCT M, V1251, P161, DOI 10.1016/0167-4838(95)00092-9; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; George SJ, 1999, BIOCHEM J, V344, P237, DOI 10.1042/0264-6021:3440237; Gilfoyle DJ, 1996, EUR J BIOCHEM, V236, P714, DOI 10.1111/j.1432-1033.1996.00714.x; HASCHKE RH, 1978, BIOCHEM BIOPH RES CO, V80, P1039, DOI 10.1016/0006-291X(78)91350-5; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; Howes BD, 1999, BIOPHYS J, V77, P478, DOI 10.1016/S0006-3495(99)76905-5; Howes BD, 1997, BIOCHEMISTRY-US, V36, P1532, DOI 10.1021/bi962502o; Howes BD, 2001, BIOCHEM J, V353, P181, DOI 10.1042/0264-6021:3530181; Indiani C, 2000, J AM CHEM SOC, V122, P7368, DOI 10.1021/ja000587h; Kishi K, 1997, BIOCHEMISTRY-US, V36, P4268, DOI 10.1021/bi962627t; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kunishima N, 1996, FEBS LETT, V378, P291, DOI 10.1016/0014-5793(95)01458-6; Lukat-Rodgers GS, 2000, BIOCHEMISTRY-US, V39, P9984, DOI 10.1021/bi0006870; MARANON MJR, 1993, BIOCHEM BIOPH RES CO, V194, P326, DOI 10.1006/bbrc.1993.1823; MARKLUND S, 1974, BIOCHIM BIOPHYS ACTA, V350, P304, DOI 10.1016/0005-2744(74)90504-X; Nie GJ, 1997, BIOCHEMISTRY-US, V36, P5113, DOI 10.1021/bi962583o; Nissum M, 1998, BIOSPECTROSCOPY, V4, P355, DOI 10.1002/(SICI)1520-6343(1998)4:6<355::AID-BSPY1>3.0.CO;2-I; OGAWA S, 1979, BIOCHEM BIOPH RES CO, V90, P674, DOI 10.1016/0006-291X(79)91288-9; OTHMAN S, 1994, BIOCHEMISTRY-US, V33, P15437, DOI 10.1021/bi00255a026; Othman S, 1996, BIOCHEMISTRY-US, V35, P9224, DOI 10.1021/bi952818g; OTHMAN S, 1993, BIOCHEMISTRY-US, V32, P9781, DOI 10.1021/bi00088a033; PAPPA HS, 1993, EUR J BIOCHEM, V212, P227, DOI 10.1111/j.1432-1033.1993.tb17654.x; Reading NS, 2001, BIOCHEMISTRY-US, V40, P8161, DOI 10.1021/bi010440i; Schuller DJ, 1996, STRUCTURE, V4, P311, DOI 10.1016/S0969-2126(96)00035-4; SHIRO Y, 1986, J BIOL CHEM, V261, P9382; SITTER AJ, 1988, J BIOL CHEM, V263, P13032; SMITH AT, 1992, EUR J BIOCHEM, V207, P507, DOI 10.1111/j.1432-1033.1992.tb17077.x; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Smulevich G, 1998, BIOSPECTROSCOPY, V4, pS3, DOI 10.1002/(SICI)1520-6343(1998)4:5+<S3::AID-BSPY2>3.0.CO;2-R; Smulevich G, 1999, J BIOL INORG CHEM, V4, P39, DOI 10.1007/s007750050287; SMULEVICH G, 1994, BIOCHEMISTRY-US, V33, P7398, DOI 10.1021/bi00189a046; SMULEVICH G, 1994, BIOCHEMISTRY-US, V33, P15425, DOI 10.1021/bi00255a024; Spiro, 1988, BIOL APPL RAMAN SPEC, P1; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P8567, DOI 10.1021/bi970484k; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P3654, DOI 10.1021/bi962195m; Tanaka M, 1998, BIOCHEMISTRY-US, V37, P2629, DOI 10.1021/bi9725273; TERAOKA J, 1981, J BIOL CHEM, V256, P3969; Tsaprailis G, 1998, BIOCHEMISTRY-US, V37, P2004, DOI 10.1021/bi971032a; Veitch NC, 2001, ADV INORG CHEM, V51, P107; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]	52	65	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40704	40711		10.1074/jbc.M107489200	http://dx.doi.org/10.1074/jbc.M107489200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546788	hybrid			2022-12-27	WOS:000171925600045
J	Misura, KMS; Gonzalez, LC; May, AP; Scheller, RH; Weis, WI				Misura, KMS; Gonzalez, LC; May, AP; Scheller, RH; Weis, WI			Crystal structure and biophysical properties of a complex between the N-terminal SNARE region of SNAP25 and syntaxin 1a.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOSOMAL-ASSOCIATED PROTEIN; SENSITIVE FUSION PROTEIN; MEMBRANE-FUSION; DOMAIN; IDENTIFICATION; EXOCYTOSIS; MECHANISM; TRANSPORT; DOCKING; SNAP-25	SNARE proteins are required for intracellular membrane fusion. In the neuron, the plasma membrane SNARES syntaxin 1a and SNAP25 bind to VAMP2 found on neurotransmitter-containing vesicles. These three proteins contain "SNARE regions" that mediate their association into stable tetrameric coiled-coil structures. Syntaxin la contributes one such region, designated H3, and SNAP25 contributes two SNARE regions to the fusogenic complex with VAMP2. Syntaxin la H3 (synlaH3) and SNAP25 can form a stable assembly, which can then be bound by VAMP2 to form the full SNARE complex. Here we show that syn1aH3 can also form a stable but kinetically trapped complex with the N-terminal SNARE region of SNAP25 (S25N). The crystal structure of this complex reveals an extended parallel four-helix bundle similar to that of the core SNARE and the syn1aH3(.)SNAP25 complexes. The inherent ability of synlaH3 and S25N to associate stably in vitro implies that the intracellular fusion machinery must prevent formation of, or remove, any nonproductive complexes. Comparison with the syn1aH3(.)SNAP25 complex suggests that the linkage of the N- and C-terminal SNAP25 SNARE regions is kinetically advantageous in preventing formation of the non-productive syn1aH3(.)S25N complex. We also demonstrate that the syn1aH3(.)S25N complex can be disassembled by a-SNAP and N-ethylmaleimide-sensitive factor.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011; Gonzalez, Lino/E-4102-2012	Weis, William I/0000-0002-5583-6150; Gonzalez, Lino/0000-0003-3817-6450	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038710, R01MH058570, R37MH038710] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM08294] Funding Source: Medline; NIMH NIH HHS [MH38710, MH58570] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burling FT, 1996, SCIENCE, V271, P72, DOI 10.1126/science.271.5245.72; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Grosse-Kunstleve RW, 1999, ACTA CRYSTALLOGR D, V55, P1568, DOI 10.1107/S0907444999007763; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HESS DT, 1992, J NEUROSCI, V12, P4634; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; PHILLIPS JC, 1980, ACTA CRYSTALLOGR A, V36, P856, DOI 10.1107/S0567739480001817; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Wade N, 2001, J BIOL CHEM, V276, P19820, DOI 10.1074/jbc.M010838200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	51	44	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41301	41309		10.1074/jbc.M106853200	http://dx.doi.org/10.1074/jbc.M106853200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533035	hybrid			2022-12-27	WOS:000171925600123
J	Wang, HZ; Yang, BF; Zhang, YQ; Han, H; Wang, JX; Shi, H; Wang, ZG				Wang, HZ; Yang, BF; Zhang, YQ; Han, H; Wang, JX; Shi, H; Wang, ZG			Different subtypes of alpha(1)-adrenoceptor modulate different K+ currents via different signaling pathways in canine ventricular myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT OUTWARD CURRENT; HUMAN ATRIAL MYOCYTES; PROTEIN-KINASE; PURKINJE-FIBERS; CHANNEL; STIMULATION; MECHANISMS; MYOCARDIUM; AGONISTS; ANTAGONISTS	Multiple subtypes (alpha (1A), alpha (1B), and alpha (1D)) of alpha (1)-adrenoreceptors (alpha (1)ARs) co-exist in the heart and mediate a variety of cellular functions. We studied alpha (1)AR modulation of inward rectifier (I-K1) and transient outward (I-to) K+ currents in canine ventricular myocytes. Phenylephrine at 10 mum depressed only It. without affecting I-K1 and at 100 muM inhibited both I-to and I-K1. The effect of phenylephrine on I-to. was abolished by (+)niguldipine (10 nm) to inhibit alpha (1A)ARs but not by chloroethyclonidine (10 mum) to inactivate alpha (1B)ARs nor by BMY-7378 to antagonize alpha (1D)ARs. In contrast, phenylephrine inhibition of I-K1 was reversed only by BMY-7378 (1 nM). PDD (100 nM, phorbol ester activator of protein kinase C (PKC)) simulates and bisindolylmaleimide (50 nM, PKC inhibitor) weakens phenylephrine modulation of I-to. but not I-K1. Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93 and inhibitor peptides abolished the effects of phenylephrine on I-K1. Enhancement of PKC or CaMKII activities was seen in alpha (1a)AR- or alpha (1d)dAR-transfected HEK293 cells and in myocytes pretreated with 10 or 100 muM phenylephrine, respectively. Our data suggest that different subtypes of alpha 1ARs selectively modulate different cardiac K+ currents via different signal transduction mechanisms; alpha (1A)ARs mediate It. regulation via PKC, and alpha (1D)ARs mediate I-K1 regulation via CaMKII.	Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Harbin Med Coll, Dept Pharmacol, Harbin 150086, Heilongjiang, Peoples R China	Universite de Montreal; Universite de Montreal; Harbin Medical University	Wang, ZG (corresponding author), Montreal Heart Inst, Res Ctr, 500 Belanger E, Montreal, PQ H1T 1C8, Canada.		Wang, Zhiguo/GRS-4339-2022; wang, zhiguo/AAN-4182-2021; Zhang, Yiqiang/D-9613-2012; Han, Ho Jae/M-1476-2016	Wang, Zhiguo/0000-0002-0811-2045; Zhang, Yiqiang/0000-0003-0691-6645; Han, Ho Jae/0000-0002-0657-1766				ANYUKHOVSKY EP, 1991, CIRCULATION, V83, P2076, DOI 10.1161/01.CIR.83.6.2076; APKON M, 1988, P NATL ACAD SCI USA, V85, P8756, DOI 10.1073/pnas.85.22.8756; BEAUMONT J, 1995, AM J PHYSIOL-HEART C, V268, pH1181, DOI 10.1152/ajpheart.1995.268.3.H1181; BILLMAN GE, 1994, J CARDIOVASC PHARM, V24, P394, DOI 10.1097/00005344-199409000-00007; BRAUN AP, 1992, PFLUG ARCH EUR J PHY, V421, P431, DOI 10.1007/BF00370253; BRAUN AP, 1990, J PHYSIOL-LONDON, V431, P689, DOI 10.1113/jphysiol.1990.sp018355; Butta N, 1996, BRIT J PHARMACOL, V118, P1797, DOI 10.1111/j.1476-5381.1996.tb15606.x; Chevalier P, 1998, J PHARMACOL EXP THER, V284, P832; Deng XF, 1996, BRIT J PHARMACOL, V119, P269, DOI 10.1111/j.1476-5381.1996.tb15981.x; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Drouin E, 1996, J CARDIOVASC PHARM, V27, P320, DOI 10.1097/00005344-199603000-00003; Endoh M, 1996, NEUROCHEM RES, V21, P217, DOI 10.1007/BF02529138; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; FEDIDA D, 1993, PHYSIOL REV, V73, P469, DOI 10.1152/physrev.1993.73.2.469; FEDIDA D, 1991, J PHYSIOL-LONDON, V441, P673, DOI 10.1113/jphysiol.1991.sp018772; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Guo WN, 1998, PFLUG ARCH EUR J PHY, V436, P26, DOI 10.1007/s004240050600; HAN C, 1991, MOL PHARMACOL, V40, P531; HAN C, 1987, MOL PHARMACOL, V32, P505; Han C, 1995, EUR J PHARMACOL, V294, P593, DOI 10.1016/0014-2999(95)00607-9; Han H, 2001, J BIOL CHEM, V276, P26357, DOI 10.1074/jbc.M011136200; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Hieble J P, 1996, Prog Drug Res, V47, P81; Koh SD, 1999, J PHYSIOL-LONDON, V517, P75, DOI 10.1111/j.1469-7793.1999.0075z.x; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; MINNEMAN KP, 1994, MOL PHARMACOL, V46, P929; Nakamura TY, 1997, AM J PHYSIOL-HEART C, V273, pH1775, DOI 10.1152/ajpheart.1997.273.4.H1775; Ohmi K, 1999, BRIT J PHARMACOL, V127, P756, DOI 10.1038/sj.bjp.0702588; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Roeper J, 1997, J NEUROSCI, V17, P3379; SATO R, 1995, J MEMBRANE BIOL, V148, P185; Shi H, 2000, AM J PHYSIOL-HEART C, V278, pH295, DOI 10.1152/ajpheart.2000.278.1.H295; Taguchi K, 1998, N-S ARCH PHARMACOL, V357, P100, DOI 10.1007/PL00005143; Tessier S, 1999, CIRC RES, V85, P810, DOI 10.1161/01.RES.85.9.810; VanWagoner DR, 1996, AM J PHYSIOL-HEART C, V271, pH937, DOI 10.1152/ajpheart.1996.271.3.H937; Varma DR, 2000, CAN J PHYSIOL PHARM, V78, P267, DOI 10.1139/cjpp-78-4-267; Wang HZ, 2001, MOL PHARMACOL, V59, P1029, DOI 10.1124/mol.59.5.1029; Wang HZ, 2000, CIRCULATION, V102, P1165, DOI 10.1161/01.CIR.102.10.1165; WANG XL, 1991, J PHARMACOL EXP THER, V259, P783; Wang ZG, 1999, CIRC RES, V84, P551, DOI 10.1161/01.RES.84.5.551; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422; WILLIAMSON AP, 1994, CAN J PHYSIOL PHARM, V72, P1574, DOI 10.1139/y94-226; Yang HT, 1997, BRIT J PHARMACOL, V122, P1541, DOI 10.1038/sj.bjp.0701506; Yue LX, 1999, J PHYSIOL-LONDON, V516, P385, DOI 10.1111/j.1469-7793.1999.0385v.x; Zhong HY, 1999, EUR J PHARMACOL, V375, P261, DOI 10.1016/S0014-2999(99)00222-8	45	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40811	40816		10.1074/jbc.M105572200	http://dx.doi.org/10.1074/jbc.M105572200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524420	hybrid			2022-12-27	WOS:000171925600059
J	Wiens, GD; O'Hare, T; Rittenberg, MB				Wiens, GD; O'Hare, T; Rittenberg, MB			Recovering antibody secretion using a hapten ligand as a chemical chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; COMPLEMENTARITY-DETERMINING REGION-2; NEPHROGENIC DIABETES-INSIPIDUS; AFFINITY CHOLINE TRANSPORTER; KEYHOLE LIMPET HEMOCYANIN; IG LIGHT-CHAINS; ENDOPLASMIC-RETICULUM; BINDING-PROTEIN; ANTIGEN-BINDING; IMMUNOLOGICAL MEMORY	Engineered antibodies have come to the forefront as research reagents and clinical therapeutics. However, reduced stability or expression levels pose a major problem with many engineered antibodies. As a model for understanding functional consequences of variable region mutation, we have studied the assembly and trafficking of anti-phenylphosphocholine antibodies. Previously, we identified severe secretion defects because of mutations in the heavy chain second complementarity determining region, which is involved in antigen binding. Here we demonstrate that immunoglobulin secretion is increased up to 27-fold by incubating stably transfected PCG1-1 cells with cognate hapten p-nitro-phenylphosphocholine. Secretion was unaffected by nonbinding analogs. Radiotracer and metabolic labeling experiments demonstrated specific cellular uptake of p-nitrophenylphosphocholine and increased intracellular heavy and light chain assembly. Brefeldin A inhibited hapten-mediated immunoglobulin secretion but not assembly, indicating that assembly occurs early within the biosynthetic pathway. Recovery of secretion correlated with antigen binding capacity, suggesting that the rescue mechanism involves stabilization of heavy and light chain variable domains. This model system provides the first demonstration that cognate ligands can increase intracellular assembly of functional anti-hapten antibody within mammalian cells and suggests that small molecules of appropriate specificity and affinity acting as chemical chaperones may find application for increasing or regulating immunoglobulin expression.	Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Wiens, GD (corresponding author), Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, L220,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.			Wiens, Gregory/0000-0002-5478-7780	NIAID NIH HHS [AI-26827, AI-14985] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026827, R01AI014985] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTHONY J, 1992, MOL IMMUNOL, V29, P1237, DOI 10.1016/0161-5890(92)90060-B; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; BROWN M, 1992, J IMMUNOL, V148, P339; Brown M, 2000, J EXP MED, V191, P2101, DOI 10.1084/jem.191.12.2101; BRUDERER U, 1989, MOL IMMUNOL, V26, P63, DOI 10.1016/0161-5890(89)90021-7; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; CHEN C, 1994, J EXP MED, V180, P577, DOI 10.1084/jem.180.2.577; CHESEBRO B, 1972, BIOCHEMISTRY-US, V11, P766, DOI 10.1021/bi00755a014; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; Dul JL, 1996, J IMMUNOL, V157, P2969; ELLIOTT T, 1992, EUR J IMMUNOL, V22, P3121, DOI 10.1002/eji.1830221214; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Gavilondo JV, 2000, BIOTECHNIQUES, V29, P128, DOI 10.2144/00291ov01; Glennie MJ, 2000, IMMUNOL TODAY, V21, P403, DOI 10.1016/S0167-5699(00)01669-8; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; HORWITZ AH, 1994, MOL IMMUNOL, V31, P683, DOI 10.1016/0161-5890(94)90178-3; Jager M, 1999, J MOL BIOL, V285, P2005, DOI 10.1006/jmbi.1998.2425; JOST CR, 1994, J BIOL CHEM, V269, P26267; Klein U, 1998, IMMUNOL REV, V162, P261; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Martin TM, 1998, J IMMUNOL, V160, P5963; MELNICK J, 1995, IMMUNOL TODAY, V16, P243, DOI 10.1016/0167-5699(95)80167-7; MORRISON SL, 1978, EUR J IMMUNOL, V8, P194, DOI 10.1002/eji.1830080311; MOULTON HM, 1996, THESIS PORTLAND STAT; O'Hare T, 1999, J IMMUNOL, V163, P11; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Pellequer JL, 1999, J MOL RECOGNIT, V12, P267, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<267::AID-JMR465>3.0.CO;2-9; PILLAI S, 1991, INT REV CYTOL, V130, P1, DOI 10.1016/S0074-7696(08)61500-4; Rajan DP, 2000, J BIOL CHEM, V275, P14331, DOI 10.1074/jbc.275.19.14331; Reddy PS, 1998, BIOESSAYS, V20, P546, DOI 10.1002/(SICI)1521-1878(199807)20:7<546::AID-BIES5>3.0.CO;2-I; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; SAUERS LJ, 1986, J IMMUNOPHARMACOL, V8, P611; SCHARFF MD, 1975, HARVEY LECT, V69, P125; SELIGMANN M, 1979, IMMUNOL REV, V48, P145, DOI 10.1111/j.1600-065X.1979.tb00302.x; Sompuram SR, 1996, J IMMUNOL, V156, P1071; STENZELPOORE MP, 1987, J IMMUNOL, V139, P1698; Stevens FJ, 1999, IMMUNOL TODAY, V20, P451, DOI 10.1016/S0167-5699(99)01502-9; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tamarappoo BK, 1999, J BIOL CHEM, V274, P34825, DOI 10.1074/jbc.274.49.34825; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Wang J, 1999, J BIOL CHEM, V274, P12883, DOI 10.1074/jbc.274.18.12883; Wiens GD, 2001, J IMMUNOL, V167, P2179, DOI 10.4049/jimmunol.167.4.2179; Wiens GD, 1997, J IMMUNOL, V159, P1293; WILSON A, 1993, CURR OPIN STRUC BIOL, V3, P113; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z	55	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40933	40939		10.1074/jbc.M104979200	http://dx.doi.org/10.1074/jbc.M104979200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533029	hybrid			2022-12-27	WOS:000171925600075
J	Aschenbach, WG; Suzuki, Y; Breeden, K; Prats, C; Hirshman, MF; Dufresne, SD; Sakamoto, K; Vilardo, PG; Steele, M; Kim, JH; Jing, SL; Goodyear, LJ; DePaoli-Roach, AA				Aschenbach, WG; Suzuki, Y; Breeden, K; Prats, C; Hirshman, MF; Dufresne, SD; Sakamoto, K; Vilardo, PG; Steele, M; Kim, JH; Jing, SL; Goodyear, LJ; DePaoli-Roach, AA			The muscle-specific protein phosphatase PP1G/R-GL(G(M)) is essential for activation of glycogen synthase by exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; TARGETING SUBUNITS; CONTRACTILE ACTIVITY; MOLECULAR-MECHANISM; PRO-GLYCOGENOLYSIS; INSULIN; KINASE; PHOSPHORYLATION; GLUCOSE-6-PHOSPHATE	In skeletal muscle both insulin and contractile activity are physiological stimuli for glycogen synthesis, which is thought to result in part from the dephosphorylation and activation of glycogen synthase (GS). PP1G/R-GL(G(M)) is a glycogen/sarcoplasmic reticulum-associated type I phosphatase that was originally postulated to mediate insulin control of glycogen metabolism. However, we recently showed (Suzuki, Y., Lanner, C., Kim, J.-H., Vilardo, P. G., Zhang, H., Jie Yang, J., Cooper, L. D., Steele, M., Kennedy, A., Bock, C., Scrimgeour, A., Lawrence, J. C. Jr., L., and DePaoli-Roach, A. A. (2001) Mol. Cell. Biol. 21, 2683-2694) that insulin activates GS in muscle of R-GL(G(M)) knockout (KO) mice similarly to the wild type (WT). To determine whether PP1G is involved in glycogen metabolism during muscle contractions, RGL KO and overexpressors (OE) were subjected to two models of contraction, in vivo treadmill running and in situ electrical stimulation. Both procedures resulted in a 2-fold increase in the GS -/+ glucose-6-P activity ratio in WT mice, but this response was completely absent in the KO mice. The KO mice, which also have a reduced GS activity associated with significantly reduced basal glycogen levels, exhibited impaired maximal exercise capacity, but contraction-induced activation of glucose transport was unaffected. The R-GL OE mice are characterized by enhanced GS activity ratio and an similar to3-4-fold increase in glycogen content in skeletal muscle. These animals were able to tolerate exercise normally. Stimulation of GS and glucose uptake following muscle contraction was not significantly different as compared with WT littermates. These results indicate that although PP1G/R-GL is not necessary for activation of GS by insulin, it is essential for regulation of glycogen metabolism under basal conditions and in response to contractile activity, and may explain the reduced muscle glycogen content in the R-GL KO mice, despite the normal insulin activation of GS.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Joslin Diabet Ctr, Res Div, Boston, MA 02215 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	DePaoli-Roach, AA (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	adepaoli@iupui.edu	sakamoto, kei/C-8806-2019; Prats, Clara/F-5993-2014	sakamoto, kei/0000-0001-8839-5980; Prats, Clara/0000-0001-6465-3068	NIAMS NIH HHS [AR 45670, AR 42238] Funding Source: Medline; NIDDK NIH HHS [DK 59769, DK 36569] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045670, R01AR042238, R29AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036569, F32DK059769] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLQUIST LE, 1992, EUR J APPL PHYSIOL O, V65, P360, DOI 10.1007/BF00868141; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Azpiazu I, 1996, J BIOL CHEM, V271, P5033; Azpiazu I, 2000, AM J PHYSIOL-ENDOC M, V278, pE234, DOI 10.1152/ajpendo.2000.278.2.E234; Bergmeyer H. V., 1974, METHOD ENZYMAT AN, V2, P1196; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BLOCH G, 1994, AM J PHYSIOL, V266, pE85, DOI 10.1152/ajpendo.1994.266.1.E85; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; COHEN P, 1987, BIOCHEM SOC T, V15, P999, DOI 10.1042/bst0150999; Cohen P., 1986, ENZYMES, VXVII, P461; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cushman SW, 1998, ADV EXP MED BIOL, V441, P63; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; Derave W, 1999, AM J PHYSIOL-ENDOC M, V277, pE1103, DOI 10.1152/ajpendo.1999.277.6.E1103; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Franch J, 1999, BIOCHEM J, V344, P231, DOI 10.1042/0264-6021:3440231; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Goodyear L J, 2000, Exerc Sport Sci Rev, V28, P113; Graham TE, 2001, J APPL PHYSIOL, V90, P873, DOI 10.1152/jappl.2001.90.3.873; Hayashi T, 1999, AM J PHYSIOL-CELL PH, V277, pC701, DOI 10.1152/ajpcell.1999.277.4.C701; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hogan B, 1994, MANIPULATING MOUSE E; HUBBARD MJ, 1989, EUR J BIOCHEM, V180, P457, DOI 10.1111/j.1432-1033.1989.tb14668.x; Ivy JL, 1998, ACTA PHYSIOL SCAND, V162, P295, DOI 10.1046/j.1365-201X.1998.0302e.x; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; JUE T, 1989, P NATL ACAD SCI USA, V86, P1439, DOI 10.1073/pnas.86.5.1439; Katz A, 1995, PFLUG ARCH EUR J PHY, V431, P259, DOI 10.1007/BF00410199; Kawanaka K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1311, DOI 10.1152/ajpendo.2000.279.6.E1311; Laurent D, 2000, AM J PHYSIOL-ENDOC M, V278, pE663, DOI 10.1152/ajpendo.2000.278.4.E663; LAWRENCE JC, 1983, J BIOL CHEM, V258, P710; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; LEE AD, 1995, FEBS LETT, V361, P51, DOI 10.1016/0014-5793(95)00147-2; Lerin C, 2000, J BIOL CHEM, V275, P39991, DOI 10.1074/jbc.M006251200; Liu J, 2000, J BIOL CHEM, V275, P15940, DOI 10.1074/jbc.M909303199; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Markuns JF, 1999, J BIOL CHEM, V274, P24896, DOI 10.1074/jbc.274.35.24896; NAKIELNY S, 1991, EUR J BIOCHEM, V199, P713, DOI 10.1111/j.1432-1033.1991.tb16175.x; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; O'Gorman DJ, 2000, J APPL PHYSIOL, V89, P1412, DOI 10.1152/jappl.2000.89.4.1412; Price TB, 1999, P NUTR SOC, V58, P851, DOI 10.1017/S0029665199001159; Price TB, 2000, J APPL PHYSIOL, V88, P698, DOI 10.1152/jappl.2000.88.2.698; PRICE TB, 1994, MED SCI SPORT EXER, V26, P983; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Ragolia L, 2000, J BIOL CHEM, V275, P26102, DOI 10.1074/jbc.M001955200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Roach PJ, 2001, HDB PHYSL 7, VII, P609, DOI DOI 10.1002/CPHY.CP070219; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; Shearer J, 2001, J APPL PHYSIOL, V90, P880, DOI 10.1152/jappl.2001.90.3.880; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; SHERMAN WM, 1995, AM J CLIN NUTR, V62, p228S, DOI 10.1093/ajcn/62.1.228S; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; TANG PM, 1991, J BIOL CHEM, V266, P15782; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; WAGENMAKERS AJM, 1991, AM J PHYSIOL, V260, pE883, DOI 10.1152/ajpendo.1991.260.6.E883; Walker KS, 2000, FEBS LETT, V466, P121, DOI 10.1016/S0014-5793(99)01771-8; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; YEH JI, 1995, J BIOL CHEM, V270, P2107, DOI 10.1074/jbc.270.5.2107	69	87	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39959	39967		10.1074/jbc.M105518200	http://dx.doi.org/10.1074/jbc.M105518200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11522787	hybrid			2022-12-27	WOS:000171789200062
J	Sheluho, D; Ackerman, SH				Sheluho, D; Ackerman, SH			An accessible hydrophobic surface is a key element of the molecular chaperone action of Atp11p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ALPHA-CRYSTALLIN; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL F-1-ATPASE; F1-ATPASE; YEAST; SUBSTRATE; IDENTIFICATION; MECHANISM; BINDING	Atp11p is a soluble protein of mitochondria that binds unassembled beta subunits of the F-1-ATPase and prevents them from aggregating in the matrix. In this report, we show that Atp11p protects the insulin B chain from aggregating in vitro and therefore acts as a molecular chaperone. The chaperone action of Atp11p is mediated by hydrophobic interactions. An accessible hydrophobic surface in Atp11p was identified with the environment-sensitive fluorescent probe 1,1'-bis(4-anilino-5-napth-thalenesulfonic acid (bis-ANS). The spectral changes of bis-ANS in the presence of Atp11p indicate that the probe binds to a nonpolar region of the protein. Furthermore, the dye quenches the fluorescence of Atp11p tryptophan residues in a concentration-dependent manner. Although up to three molecules of bis-ANS can bind cooperatively to Atp11p, the binding of only one dye molecule is sufficient to virtually eliminate the chaperone activity of the protein.	Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Biochem, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University	Ackerman, SH (corresponding author), Wayne State Univ, Sch Med, Dept Surg, 1225 Ellman Bldg,421 E Canfield Ave, Detroit, MI 48201 USA.				NIGMS NIH HHS [GM48157] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ACKERMAN SH, 1992, J BIOL CHEM, V267, P7386; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; FARRIS FJ, 1978, J AM CHEM SOC, V100, P4469, DOI 10.1021/ja00482a026; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HONG S, 1995, J BIOCHEM MOL BIOL, V29, P230; Kumar LVS, 2000, J BIOL CHEM, V275, P22009, DOI 10.1074/jbc.M003307200; Lakowicz J. R, 1999, PRINCIPLES FLUORESCE, P446; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Panse VG, 2000, J BIOL CHEM, V275, P18698, DOI 10.1074/jbc.275.25.18698; SANGER F, 1949, BIOCHEM J, V44, P126, DOI 10.1042/bj0440126; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; SHI L, 1994, BIOCHEMISTRY-US, V33, P7536, DOI 10.1021/bi00190a006; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; TUITE MF, 1990, ANTON LEEUW INT J G, V58, P147, DOI 10.1007/BF00548925; Wang ZG, 2000, EMBO J, V19, P1486, DOI 10.1093/emboj/19.7.1486; Wang ZG, 1999, FEBS LETT, V452, P305, DOI 10.1016/S0014-5793(99)00676-6; Wang ZG, 1996, J BIOL CHEM, V271, P4887; Wang ZG, 2000, J BIOL CHEM, V275, P5767, DOI 10.1074/jbc.275.8.5767; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; WHITE M, 1995, ARCH BIOCHEM BIOPHYS, V319, P299, DOI 10.1006/abbi.1995.1296	28	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39945	39949		10.1074/jbc.M107252200	http://dx.doi.org/10.1074/jbc.M107252200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11522798	hybrid			2022-12-27	WOS:000171789200060
J	Schmidt, SLG; Pautz, AL; Burgers, PMJ				Schmidt, SLG; Pautz, AL; Burgers, PMJ			ATP utilization by yeast replication factor C IV. RFC ATP-binding mutants show defects in DNA replication, DNA repair, and checkpoint regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINT; PROTEIN-KINASE; SMALL-SUBUNIT; P-LOOP; COMPLEX; MUTATIONS; RAD24	Replication factor C is required to load proliferating cell nuclear antigen onto primer-template junctions, using the energy of ATP hydrolysis. Four of the five RFC genes have consensus ATP-binding motifs. To determine the relative importance of these sites for proper DNA metabolism in the cell, the conserved lysine in the Walker A motif of RFC1, RFC2, RFC3, or RFC4 was mutated to either arginine or glutamic acid. Arginine mutations in all RFC genes tested permitted cell growth, although poor growth was observed for rfc2-K71R. A glutamic acid substitution resulted in lethality in RFC2 and RFC3 but not in RFC1 or RFC4. Most double mutants combining mutations in two RFC genes were inviable. Except for the rfc1-K359R and rfc4-K55E mutants, which were phenotypically similar to wild type in every assay, the mutants were sensitive to DNA-damaging agents. The rfc2-K71R and rfc4-K55R mutants show checkpoint defects, most likely in the intra-S phase checkpoint. Regulation of the damage-inducible RNR3 promoter was impaired in these mutants, and phosphorylation of Rad53p in response to DNA damage was specifically defective when cells were in S phase. No dramatic defects in telomere length regulation were detected in the mutants. These data demonstrate that the ATP binding function of RFC2 is important for both DNA replication and checkpoint function and, for the first time, that RFC4 also plays a role in checkpoint regulation.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		NIGMS NIH HHS [GM32431, R01 GM032431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams AK, 1996, MOL CELL BIOL, V16, P4614; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BURGERS PMJ, 1986, J BACTERIOL, V166, P905, DOI 10.1128/jb.166.3.905-913.1986; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; GRIFFITHS DJF, 1995, EMBO J, V14, P5812, DOI 10.1002/j.1460-2075.1995.tb00269.x; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Hishida T, 1999, J BIOL CHEM, V274, P25335, DOI 10.1074/jbc.274.36.25335; HOWELL EA, 1994, MOL CELL BIOL, V14, P255, DOI 10.1128/MCB.14.1.255; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; KONOLA JT, 1994, J MOL BIOL, V237, P20, DOI 10.1006/jmbi.1994.1206; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MCALEAR MA, 1994, MOL CELL BIOL, V14, P4390, DOI 10.1128/MCB.14.7.4390; McAlear MA, 1996, GENETICS, V142, P65; Mizushima T, 2000, GENE DEV, V14, P1631; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; Navas TA, 1996, GENE DEV, V10, P2632, DOI 10.1101/gad.10.20.2632; Neuwald AF, 1999, GENOME RES, V9, P27; Noskov VN, 1998, MOL CELL BIOL, V18, P4914, DOI 10.1128/MCB.18.8.4914; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Reynolds N, 1999, NUCLEIC ACIDS RES, V27, P462, DOI 10.1093/nar/27.2.462; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; SCHUDDEMAT J, 1988, BIOCHIM BIOPHYS ACTA, V937, P81, DOI 10.1016/0005-2736(88)90229-5; Shimada M, 1999, MOL BIOL CELL, V10, P3991, DOI 10.1091/mbc.10.12.3991; Shimomura T, 1998, MOL CELL BIOL, V18, P5485, DOI 10.1128/MCB.18.9.5485; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; Sugimoto K, 1996, P NATL ACAD SCI USA, V93, P7048, DOI 10.1073/pnas.93.14.7048; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang B, 1999, J BIOL CHEM, V274, P8291, DOI 10.1074/jbc.274.12.8291; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Yang G, 1997, BIOCHEMISTRY-US, V36, P4751, DOI 10.1021/bi9631677; ZHOU Z, 1992, GENETICS, V131, P851	47	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34792	34800		10.1074/jbc.M011671200	http://dx.doi.org/10.1074/jbc.M011671200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11549622	hybrid			2022-12-27	WOS:000171024600061
J	Murata, T; Kakinuma, Y; Yamato, I				Murata, T; Kakinuma, Y; Yamato, I			ATP-dependent affinity change of Na+-binding sites of V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-HIRAE; TRANSLOCATING ATPASE; ENERGY TRANSDUCTION; ESCHERICHIA-COLI; F-ATPASE; EVOLUTION; SYNTHASE; ROTATION; MOTOR; POLYPEPTIDE	V-type Na+-ATPase of Enterococcus hirae binds about six (6 +/- 1) Na+ ions/enzyme molecule with a high affinity (Murata, T., Igarashi, K., Kakinuma, Y., and Yamato, 1. (2000) J. Biol. Chem. 275, 13415-13419). After the addition of 5 mM ATP, the binding capacity dropped to about 2 (1.8 +/- 0.3) Na+ ions/enzyme molecule, returning to the initial value concomitant with the decrease of ATP hydrolysis rate. These findings suggest that the affinity of four of six Na+-binding sites of the enzyme changes (lowers) in enzyme reaction. The ATP analogs (adenosine 5'-O-(3-thiotriphosphate) or 5'-adenylylimido-diphosphate), ADP, or aluminum fluoride that is postulated to trap ATPases at their transition state did not inhibit the Na+ binding capacity significantly. Therefore, the affinity decrease of Na+-binding sites was unlikely to be due to ATP binding alone or at the transition state of ATP hydrolysis. In the presence of 5 mM ATP, the ATPase showed strong negative cooperativity (n(H) = 0.16 +/- 0.03) for Na+ stimulation of ATPase activity. The Hill coefficient (n(H)) increased to 1 in parallel to the decrease of ATP concentration in the reaction mixture. Thus, the ATP-dependent affinity change cooperatively occurs in continuous enzyme reaction.	Tokyo Univ Sci, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan; Muroran Inst Technol, Dept Appl Chem, Muroran, Hokkaido 0508585, Japan	Tokyo University of Science; Muroran Institute of Technology	Murata, T (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.	tm@mrc-dunn.cam.ac.uk	Murata, Takeshi/J-6181-2017; Murata, Takeshi/F-6114-2011	Murata, Takeshi/0000-0002-5748-4670; 				ARAI H, 1987, J BIOL CHEM, V262, P11006; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; GLYNN LM, 1985, ENZYMES BIOL MEMBR, P35; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; JENCKS WP, 1989, J BIOL CHEM, V264, P18855; Kaim G, 1998, EMBO J, V17, P5887, DOI 10.1093/emboj/17.20.5887; KAKINUMA Y, 1990, FEBS LETT, V271, P97, DOI 10.1016/0014-5793(90)80381-R; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Murata T, 1996, J BIOL CHEM, V271, P10042, DOI 10.1074/jbc.271.17.10042; Murata T, 1996, J BIOL CHEM, V271, P23661, DOI 10.1074/jbc.271.39.23661; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; NELSON N, 1992, BIOCHIM BIOPHYS ACTA, V1100, P109; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PALI T, 1995, BIOCHEMISTRY-US, V34, P9211, DOI 10.1021/bi00028a034; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SUGINO Y, 1964, BIOCHEM BIOPH RES CO, V16, P362, DOI 10.1016/0006-291X(64)90041-5; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Xu YW, 1997, P NATL ACAD SCI USA, V94, P3579, DOI 10.1073/pnas.94.8.3579; YAMATO I, 1993, P JPN ACAD B-PHYS, V69, P218, DOI 10.2183/pjab.69.218; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	31	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2001	276	51					48337	48340		10.1074/jbc.M106821200	http://dx.doi.org/10.1074/jbc.M106821200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505QL	11557766	hybrid			2022-12-27	WOS:000172927000081
J	Abreu, MT; Arnold, ET; Chow, JYC; Barrett, KE				Abreu, MT; Arnold, ET; Chow, JYC; Barrett, KE			Phosphatidylinositol 3-kinase-dependent pathways oppose Fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells - Implications for inflammatory diarrheal states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BARRIER FUNCTION; TIGHT JUNCTIONS; MOLECULAR PHYSIOLOGY; CROHNS-DISEASE; HT-29 CELLS; EP-CAM; PROTEIN; KINASE; 3-KINASE	The epithelial lining of the intestine serves as a barrier to lumenal bacteria and can be compromised by pathologic Fas-mediated epithelial apoptosis. Phosphatidylinositol (PI)3-kinase signaling has been described to limit apoptosis in other systems. We hypothesized that PI3-kinase-dependent pathways regulate Fas-mediated apoptosis and barrier function in intestiynal epithelial cells (IEC). IEC lines (HT-29 and T84) were exposed to agonist anti-Fas antibody in the presence or absence of chemical inhibitors of PI3-kinase (LY294002 and wortmannin). Apoptosis, barrier function, changes in short circuit current and expression of adhesion molecules were assessed. Inhibition of PI3-kinase strongly sensitized IEC to Fas-mediated apoptosis. Expression of constitutively active Akt, a principal downstream effector of the PI3-kinase pathway, protected against Fas-mediated apoptosis to an extent that was comparable with expression of a genetic caspase inhibitor, p35. PI3-kinase inhibition sensitized to apoptosis by increasing and accelerating Fas-mediated caspase activation. Inhibition of PI3-kinase combined with cross-linking Fas was associated with increased permeability to molecules that were < 400 Da but not those that were > 3,000 Da. Inhibition of PI3-kinase resulted in chloride secretion that was augmented by cross-linking Fas. Confocal analyses revealed polymerization of actin and maintenance of epithelial cell adhesion molecule-mediated interactions in monolayers exposed to anti-Fas antibody in the context of PI3-kinase inhibition. PI3-kinase-dependent pathways, especially Akt, protect IEC against Fas-mediated apoptosis. Inhibition of PI3-kinase in the context of Fas signaling results in increased chloride secretion and barrier dysfunction. These findings suggest that agonists of PI3-kinase such as growth factors may have a dual effect on intestinal inflammation by protecting epithelial cells against immune-mediated apoptosis and limiting chloride secretory diarrhea.	Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA; Univ Calif San Diego, Sch Med, Div Gastroenterol, San Diego, CA 92103 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California San Diego	Abreu, MT (corresponding author), Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, 8631 W 3rd St,Suite 245E, Los Angeles, CA 90048 USA.	Maria.Abreu@cshs.org	Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X; Abreu, Maria T./0000-0002-7294-0574	NCRR NIH HHS [1S10 RR 13717-01] Funding Source: Medline; NIDDK NIH HHS [1R03 DK 59469, K08 DK 02635, DK 28305] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028305, K08DK002635, R03DK059469] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Abreu-Martin MT, 1999, AM J PHYSIOL-GASTR L, V276, pG599, DOI 10.1152/ajpgi.1999.276.3.G599; ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Balzar M, 1998, MOL CELL BIOL, V18, P4833, DOI 10.1128/MCB.18.8.4833; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chi SG, 1998, GASTROENTEROLOGY, V115, P1084, DOI 10.1016/S0016-5085(98)70078-2; Chow JYC, 2000, J BIOL CHEM, V275, P21169, DOI 10.1074/jbc.M002160200; COLGAN SP, 1994, J IMMUNOL, V153, P2122; DAndrea L, 1996, J BIOL CHEM, V271, P28969, DOI 10.1074/jbc.271.46.28969; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DEL PL, 1997, SCIENCE, V278, P687; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; DHARMSATHAPHORN K, 1990, METHOD ENZYMOL, V192, P354; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dufner A, 1999, MOL CELL BIOL, V19, P4525; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Haller DG, 2001, SEMIN ONCOL, V28, P25, DOI 10.1053/sonc.2001.19719; Hausler P, 1998, EUR J IMMUNOL, V28, P57, DOI 10.1002/(SICI)1521-4141(199801)28:01<57::AID-IMMU57>3.0.CO;2-8; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Hilsden RJ, 1999, INFLAMM BOWEL DIS, V5, P85, DOI 10.1097/00054725-199905000-00003; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hrnjez BJ, 1999, AM J PHYSIOL-GASTR L, V277, pG521, DOI 10.1152/ajpgi.1999.277.3.G521; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; Kang JJ, 1999, J BIOL CHEM, V274, P3189, DOI 10.1074/jbc.274.5.3189; Keely SJ, 1999, J BIOL CHEM, V274, P33449, DOI 10.1074/jbc.274.47.33449; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Khurana S, 1996, J BIOL CHEM, V271, P9919, DOI 10.1074/jbc.271.17.9919; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kitada S, 1998, AM J PATHOL, V152, P51; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; MADARA JL, 1987, AM J PHYSIOL, V253, pC854, DOI 10.1152/ajpcell.1987.253.6.C854; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; MARIN ML, 1983, AM J GASTROENTEROL, V78, P537; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; MATTHEWS JB, 1994, J SURG RES, V56, P505, DOI 10.1006/jsre.1994.1081; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Merlin D, 2001, AM J PHYSIOL-CELL PH, V280, pC296, DOI 10.1152/ajpcell.2001.280.2.C296; Miceli R, 1999, J PHARMACOL EXP THER, V290, P464; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; Mullin JM, 1997, J CELL PHYSIOL, V171, P226, DOI 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B; NASH S, 1991, J CLIN INVEST, V87, P1474, DOI 10.1172/JCI115156; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Nusrat A, 1997, GASTROENTEROLOGY, V113, P1489, DOI 10.1053/gast.1997.v113.pm9352851; PASDAR M, 1988, J CELL BIOL, V106, P687, DOI 10.1083/jcb.106.3.687; Pastorino JG, 1999, J BIOL CHEM, V274, P19411, DOI 10.1074/jbc.274.27.19411; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Potten CS, 1997, AM J PHYSIOL-GASTR L, V273, pG253, DOI 10.1152/ajpgi.1997.273.2.G253; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sanders SE, 1995, EPITHELIAL CELL BIOL, V4, P25; Sasaki T, 2000, NATURE, V406, P897, DOI 10.1038/35022585; Sears CL, 2000, AM J PHYSIOL-GASTR L, V279, pG1129, DOI 10.1152/ajpgi.2000.279.6.G1129; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Slonim AE, 2000, NEW ENGL J MED, V342, P1633, DOI 10.1056/NEJM200006013422203; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2000, HEPATOLOGY, V32, P796, DOI 10.1053/jhep.2000.17738; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Taylor CT, 1997, GUT, V40, P634, DOI 10.1136/gut.40.5.634; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; VinkvanWijngaarden T, 1996, EUR J CANCER, V32A, P842, DOI 10.1016/0959-8049(95)00647-8; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Wright K, 1999, J BIOL CHEM, V274, P17193, DOI 10.1074/jbc.274.24.17193; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	97	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2001	276	50					47563	47574		10.1074/jbc.M106226200	http://dx.doi.org/10.1074/jbc.M106226200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	502XR	11551934	hybrid			2022-12-27	WOS:000172768500116
J	Katayama, H; Zhou, H; Li, Q; Tatsuka, M; Sen, S				Katayama, H; Zhou, H; Li, Q; Tatsuka, M; Sen, S			Interaction and feedback regulation between STK15/BTAK/aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCED EXPRESSION; CATALYTIC SUBUNIT; HISTONE H3; PHOSPHORYLATION; GENE; CENTROSOME; SPINDLE; ENCODES; TYPE-1; KINETOCHORES	STK15 is an Aurora/Ipl-1 related serine/threonine kinase that is associated with centrosomes and induces aneuploidy when overexpressed in mammalian cells. It is well known that phosphorylation and dephosphorylation of kinases are important for regulation of their activity. But mechanisms by which STR15 activity is regulated have not been elucidated. We report that STK15 contains two functional binding sites for protein phosphatase type 1 (PPI), and the binding of these proteins is cell cycle-regulated peaking at mitosis. Activated STK15 at mitosis phosphorylates PP1 and inhibits PP1 activity in vitro. In vivo, PP1 activity co-immunoprecipitated with STK15 is also reduced. These data indicate that STK15 inhibits PPI activity during mitosis. Also, PPI is shown to dephosphorylate active STK15 and abolish its activity in vitro. Furthermore, we show that non-binding mutants of STK15 for PP1 are superphosphorylated, but their kinase activities are markedly reduced. Cells transfected with these non-binding mutants manifest aberrant chromosome alignment during mitosis. Our results suggest that a feedback regulation through phosphorylation/dephosphorylation events between STK15 kinase and PP1 phosphatase operates through the cell cycle. Deregulation of this balance may contribute to anomalous segregation of chromosomes during mitotic progression of cancer cells.	Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; Hiroshima Univ, Dept Regulatory Radiobiol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan	University of Texas System; UTMD Anderson Cancer Center; Hiroshima University	Sen, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ssen@mail.mdanderson.org			NATIONAL CANCER INSTITUTE [U01CA085078, P30CA016672, R01CA061979] Funding Source: NIH RePORTER; NCI NIH HHS [U01CA85078, CA 61979, P30 CA 16672-24] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BLACK S, 1995, YEAST, V11, P747, DOI 10.1002/yea.320110806; CHAN CSM, 1993, GENETICS, V135, P677; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Farruggio DC, 1999, P NATL ACAD SCI USA, V96, P7306, DOI 10.1073/pnas.96.13.7306; Giet R, 2000, EXP CELL RES, V258, P145, DOI 10.1006/excr.2000.4903; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nigg EA, 1996, EXP CELL RES, V229, P174, DOI 10.1006/excr.1996.0356; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; Roghi C, 1998, J CELL SCI, V111, P557; SAADAT M, 1994, CANCER DETECT PREV, V18, P115; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SOGAWA K, 1994, RES COMMUN MOL PATH, V85, P359; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; VANDRE DD, 1991, J CELL SCI, V98, P577; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	37	167	177	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46219	46224		10.1074/jbc.M107540200	http://dx.doi.org/10.1074/jbc.M107540200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551964	hybrid			2022-12-27	WOS:000172573100099
J	Martins, BM; Grimm, B; Mock, HP; Huber, R; Messerschmidt, A				Martins, BM; Grimm, B; Mock, HP; Huber, R; Messerschmidt, A			Crystal structure and substrate binding modeling of the uroporphyrinogen-III decarboxylase from Nicotiana tabacum - Implications for the catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAPYRROLE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; PURIFICATION; PORPHOBILINOGEN; RECOGNITION; EXPRESSION; SEQUENCE; TOBACCO; GENE	The enzymatic catalysis of many biological processes of life is supported by the presence of cofactors; and prosthetic groups originating from the common tetrapyrrole precursor uroporphyrinogen-III. Uroporphyrinogen-III decarboxylase catalyzes its conversion into coproporphyrinogen-III, leading in plants to chlorophyll and heme biosynthesis. Here we report the first crystal structure of a plant (Nicotiana tabacum) uroporphyrinogen-M decarboxylase, together with the molecular modeling of substrate binding in tobacco and human enzymes. Its structural comparison with the homologous human protein reveals a similar catalytic cleft with six invariant polar residues, Arg(32), Arg(36), Asp(82), Ser(214) (Thr in Escherichia coli), Tyr(159), and His(329) (tobacco numbering). The functional relationships obtained from the structural and modeling analyses of both enzymes allowed the proposal for a refined catalytic mechanism. Asp(82) and Tyr(159) seem to be the catalytic functional groups, whereas the other residues may serve in substrate recognition and binding, with Arg(32) steering its insertion. The crystallographic dimer appears to represent the protein dimer under physiological conditions. The dimeric arrangement offers a plausible mechanism at least for the first two (out of four) decarboxylation steps.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Humboldt Univ, Lehrstuhl Pflanzenphysiol, D-10099 Berlin, Germany; Inst Pflanzengenet & Kulturpflanzenforsch, Abt Mol Zellbiol, D-06466 Gatersleben, Germany	Max Planck Society; Humboldt University of Berlin; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Martins, BM (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18a, D-82152 Martinsried, Germany.	martins@biochem.mpg.de	Mock, Hans-Peter/C-8202-2019; Messerschmidt, Albrecht/A-8337-2008	Mock, Hans-Peter/0000-0002-3983-3099; 				AKHTAR M, 1994, CIBA F SYMP, V180, P131; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARNARD GF, 1979, J CHEM SOC PERK T 1, P2354, DOI 10.1039/p19790002354; BARNARD GF, 1975, J CHEM SOC CHEM COMM, P494, DOI 10.1039/c39750000494; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Dasgupta S, 1997, PROTEINS, V28, P494, DOI 10.1002/(SICI)1097-0134(199708)28:4<494::AID-PROT4>3.0.CO;2-A; DEVERNEUIL H, 1983, J BIOL CHEM, V258, P2454; Elder GH, 1998, HEPATOLOGY, V27, P289, DOI 10.1002/hep.510270142; ELDER GH, 1995, J BIOENERG BIOMEMBR, V27, P207, DOI 10.1007/BF02110035; Erskine PT, 1999, BIOCHEMISTRY-US, V38, P4266, DOI 10.1021/bi982137w; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FELIX F, 1990, EUR J BIOCHEM, V188, P393, DOI 10.1111/j.1432-1033.1990.tb15416.x; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; GAREY JR, 1992, EUR J BIOCHEM, V205, P1011, DOI 10.1111/j.1432-1033.1992.tb16868.x; Grimm B, 1998, CURR OPIN PLANT BIOL, V1, P245, DOI 10.1016/S1369-5266(98)80112-X; Guex, 1996, PROTEIN DATA BANK Q, V77, P7; Hu GS, 1998, PLANT CELL, V10, P1095, DOI 10.1105/tpc.10.7.1095; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; JACKSON AH, 1976, PHILOS T ROY SOC B, V273, P191, DOI 10.1098/rstb.1976.0009; JACOBS JM, 1993, PLANT PHYSIOL, V101, P1181, DOI 10.1104/pp.101.4.1181; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; KAWANISHI S, 1983, J BIOL CHEM, V258, P4285; LASH TD, 1991, BIOCHEM J, V278, P901, DOI 10.1042/bj2780901; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehmann C, 1997, HELV CHIM ACTA, V80, P1421, DOI 10.1002/hlca.19970800508; LEHNEN LP, 1990, PESTIC BIOCHEM PHYS, V37, P239, DOI 10.1016/0048-3575(90)90130-T; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; LUO J, 1993, BIOCHEM J, V289, P529, DOI 10.1042/bj2890529; Martins BM, 2001, ACTA CRYSTALLOGR D, V57, P1709, DOI 10.1107/S0907444901013361; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; MOCK HP, 1995, PLANT MOL BIOL, V28, P245, DOI 10.1007/BF00020244; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano N, 1999, PROTEIN SCI, V8, P2072, DOI 10.1110/ps.8.10.2072; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shalygo NV, 1997, PHYSIOL PLANTARUM, V99, P160, DOI 10.1034/j.1399-3054.1997.990122.x; STRAKA JG, 1983, BIOCHEMISTRY-US, V22, P4664, DOI 10.1021/bi00289a009; TURK D, 1992, WEITERENTWICKLUNG PR; Whitby FG, 1998, EMBO J, V17, P2463, DOI 10.1093/emboj/17.9.2463; Wyckoff EE, 1996, BBA-PROTEIN STRUCT M, V1298, P294, DOI 10.1016/S0167-4838(96)00148-3	44	37	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44108	44116		10.1074/jbc.M104759200	http://dx.doi.org/10.1074/jbc.M104759200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11524417	hybrid			2022-12-27	WOS:000172297700081
J	Paramio, JM; Segrelles, C; Ruiz, S; Martin-Caballero, J; Page, A; Martinez, J; Serrano, M; Jorcano, JL				Paramio, JM; Segrelles, C; Ruiz, S; Martin-Caballero, J; Page, A; Martinez, J; Serrano, M; Jorcano, JL			The ink4/arf tumor suppressors cooperate with p21(cip1/waf) in the processes of mouse epidermal differentiation, senescence, and carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; RETINOBLASTOMA GENE FAMILY; REPLICATIVE SENESCENCE; CDK INHIBITORS; SKIN CARCINOGENESIS; MICE LACKING; TERMINAL DIFFERENTIATION; MALIGNANT CONVERSION; HUMAN FIBROBLASTS; ONCOGENIC RAS	In mammalian cells, cell cycle withdrawal is a prerequisite for terminal differentiation. Accordingly, in most tissues, including epidermis, the expression of the cyclin-dependent kinase inhibitors increases during differentiation. However, the actual role of cyclin-dependent kinase inhibitors is unclear. Different aspects of epidermal growth and differentiation in ink4a(Delta2,3)-null, p21-null, and ink4a(Delta2,3)/p21-doubly deficient mice were studied. Altered differentiation and decreased age-related senescence were found in the epidermis of ink4a(Delta2,3)/p21-null mice and, to a lesser extent, in ink4a(Delta2,3)- and p21-null mice. inh4a(Delta2,3)/p21-null primary keratinocytes underwent cell cycle arrest upon calcium or transforming growth factor-P treatment, but failed to differentiate. This differentiation deficiency was not observed in p21-or ink4a(Delta2,3) -deficient keratinocytes. Upon infection with a v-Ha-ras-coding retrovirus, wild-type keratinocytes displayed features indicative of premature cell senescence. In p21- or ink4a(Delta2,3)-deficient keratinocytes, only a partial response was observed. ink4a(Delta2,3)/p21-deficient keratinocytes did not display senescent features, but showed increased tumorigenic potential upon injection into nude mice. These results indicate that ink4a/ arf and cip1/waf genes cooperate to allow normal keratinocyte differentiation and that the absence of both favors malignant transformation.	CIEMAT, Cell Mol Biol & Gene Therapy Project, E-28040 Madrid, Spain; Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Paramio, JM (corresponding author), CIEMAT, Cell Mol Biol & Gene Therapy Project, Avenida Complutense 22, E-28040 Madrid, Spain.		Serrano, Manuel/H-2634-2015; Segrelles, Carmen/E-3655-2016; Paramio, Jesus M/M-8482-2014; Ruiz, Sergio/G-1561-2016	Serrano, Manuel/0000-0001-7177-9312; Segrelles, Carmen/0000-0001-9340-2102; Paramio, Jesus M/0000-0001-7520-3177; Ruiz, Sergio/0000-0002-0177-6965; Page, Angustias/0000-0002-0231-8536				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BRISSETTE J, 1992, MOL CARCINOGEN, V7, P21; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Byrne C, 1997, BIOESSAYS, V19, P691, DOI 10.1002/bies.950190809; Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; GUO K, 1995, MOL CELL BIOL, V15, P3823; Hara E, 1996, MOL CELL BIOL, V16, P859; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; Harvat BL, 1998, J CELL SCI, V111, P1185; HARVEY M, 1993, ONCOGENE, V8, P2457; Hauser PJ, 1997, CELL GROWTH DIFFER, V8, P203; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Loughran O, 1996, ONCOGENE, V13, P561; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Paramio JM, 2000, J BIOL CHEM, V275, P41219, DOI 10.1074/jbc.M004973200; Paramio JM, 2000, MOL CARCINOGEN, V29, P251, DOI 10.1002/1098-2744(200012)29:4<251::AID-MC1007>3.0.CO;2-O; Paramio JM, 1998, ONCOGENE, V17, P949, DOI 10.1038/sj.onc.1202031; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Reznikoff CA, 1996, CANCER RES, V56, P2886; Rodriguez-Puebla ML, 1998, ONCOGENE, V17, P2251, DOI 10.1038/sj.onc.1202131; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; Sayama K, 1999, J CELL PHYSIOL, V179, P40, DOI 10.1002/(SICI)1097-4652(199904)179:1<40::AID-JCP5>3.0.CO;2-Z; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Tremain R, 2000, ONCOGENE, V19, P1698, DOI 10.1038/sj.onc.1203471; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weinberg WC, 1997, ONCOGENE, V15, P685, DOI 10.1038/sj.onc.1201230; Weinberg WC, 1999, CANCER RES, V59, P2050; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	59	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44203	44211		10.1074/jbc.M105650200	http://dx.doi.org/10.1074/jbc.M105650200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551927	hybrid			2022-12-27	WOS:000172297700092
J	Cain, K; Langlais, C; Sun, XM; Brown, DG; Cohen, GM				Cain, K; Langlais, C; Sun, XM; Brown, DG; Cohen, GM			Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTINCT CASPASE CASCADES; MEDIATED OLIGOMERIZATION; NEGATIVE REGULATION; APAF-1 APOPTOSOME; ACTIVATION; PROCASPASE-9; PROTEASE; BINDING; COMPLEX; RECEPTOR	In many forms of apoptosis, cytochrome c released from mitochondria induces the oligomerization of Apaf-1 to form a caspase-activating apoptosome complex. Activation of lysates in vitro with dATP and cytochrome c results in the formation of an active caspase-processing similar to 700-kDa apoptosome complex, which predominates in apoptotic cells, and a relatively inactive similar to1.4-MDa complex. We now demonstrate that assembly of the active complex is suppressed by normal intracellular concentrations of K+. Using a defined apoptosome reconstitution system with recombinant Apaf-1 and cytochrome c, K+ also inhibits caspase activation by abrogating Apaf-1 oligomerization and apoptosome assembly. Once assembled, the apoptosome is relatively insensitive to the effects of ionic strength and processes/activates effector caspases. The inhibitory effects of K+ on apoptosome formation are antagonized in a concentration-dependent manner by cytochrome c. These studies support the hypothesis that the normal intracellular concentrations of K+ act to safeguard the cell against inappropriate formation of the apoptosome complex, caused by the inadvertent release of small amounts of cytochrome c. Thus, the assembly and activation of the apoptosome complex in the cell requires the rapid and extensive release of cytochrome c to overcome the inhibitory effects of normal intracellular concentrations of K+.	Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Cain, K (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.		Cohen, Gerald M/A-1687-2008					Almond JB, 2001, LEUKEMIA, V15, P1388, DOI 10.1038/sj.leu.2402201; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Bratton SB, 2001, CELL DEATH DIFFER, V8, P425, DOI 10.1038/sj.cdd.4400834; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hampton MB, 1998, BIOCHEM J, V329, P95; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; Purring C, 1999, J AM CHEM SOC, V121, P7435, DOI 10.1021/ja991235h; Purring-Koch C, 2000, P NATL ACAD SCI USA, V97, P11928, DOI 10.1073/pnas.220416197; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Von Ahsen O, 2000, CELL DEATH DIFFER, V7, P1192, DOI 10.1038/sj.cdd.4400782; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; ZHU HJ, 1995, FEBS LETT, V374, P303, DOI 10.1016/0014-5793(95)01116-V; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	38	156	161	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41985	41990		10.1074/jbc.M107419200	http://dx.doi.org/10.1074/jbc.M107419200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553634	hybrid			2022-12-27	WOS:000172450400060
J	Dodt, G; Warren, D; Becker, E; Rehling, P; Gould, SJ				Dodt, G; Warren, D; Becker, E; Rehling, P; Gould, SJ			Domain mapping of human PEX5 reveals functional and structural similarities to Saccharomyces cerevisiae Pex18p and Pex21p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL; RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; PROTEIN IMPORT; PTS1 RECEPTOR; 3-KETOACYL-COA THIOLASE; CAENORHABDITIS-ELEGANS; MUTATIONAL ANALYSIS; ZELLWEGER-SYNDROME; MATRIX PROTEINS; LONGER ISOFORM	PEX5 functions as an import receptor for proteins with the type-1 peroxisomal targeting signal (PTS1). Although PEX5 is not involved in the import of PTS2-targeted proteins in yeast, it is essential for PTS2 protein import in mammalian cells. Human cells generate two isoforms of PEX5 through alternative splicing, PEX5S and PEX5L, and PEX5L contains an additional insert 37 amino acids long. Only one isoform, PEX5L, is involved in PTS2 protein import, and PEX5L physically interacts with PEX7, the import receptor for PTS2-containing proteins. In this report we map the regions of human PEX5L involved in PTS2 protein import, PEX7 interaction, and targeting to peroxisomes. These studies revealed that amino acids 1-230 of PEX5L are required for PTS2 protein import, amino acids 191-222 are sufficient for PEX7 interaction, and amino acids 1-214 are sufficient for targeting to peroxisomes. We also identified a 21-amino acid-long peptide motif of PEX5L, amino acids 209-229, that overlaps the regions sufficient for fall PTS2 rescue activity and PEX7 interaction and is shared by Saccharomyces cerevisiae Pex18p and Pex21p, two yeast peroxins that act only in PTS2 protein import in yeast. A mutation in PEX5 that changes a conserved serine of this motif abrogates PTS2 protein import in mammalian cells and reduces the interaction of PEX5L and PEX7 in vitro. This peptide motif also lies within regions of Pex18p and Pex21p that interact with yeast PEX7. Based on these and other results, we propose that mammalian PEX5L may have acquired some of the functions that yeast Pex18p and/or Pex21p perform in PTS2 protein import. This hypothesis may explain the essential role of PEX51, in PTS2 protein import in mammalian cells and its lack of importance for PTS2 protein import in yeast.	Ruhr Univ Bochum, Inst Physiol, D-44801 Bochum, Germany; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany	Ruhr University Bochum; Johns Hopkins University; University of Freiburg	Dodt, G (corresponding author), Ruhr Univ Bochum, Inst Physiol, Univ Str 150, D-44801 Bochum, Germany.	gabriele.dodt@ruhr-uni-bochum.de						Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Amery L, 1998, BIOCHEM J, V336, P367, DOI 10.1042/bj3360367; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; BLATTNER J, 1995, FEBS LETT, V360, P310, DOI 10.1016/0014-5793(95)00128-V; BRAVERMAN N, 1995, HUM MOL GENET, V4, P1791, DOI 10.1093/hmg/4.suppl_1.1791; Braverman N, 2000, GENOMICS, V63, P181, DOI 10.1006/geno.1999.6080; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brites P, 1998, J INHERIT METAB DIS, V21, P306, DOI 10.1023/A:1005301112923; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Chang CC, 1999, J CELL SCI, V112, P1579; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; de Walque S, 1999, MOL BIOCHEM PARASIT, V104, P107, DOI 10.1016/S0166-6851(99)00144-9; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1998, J CELL BIOL, V140, P807, DOI 10.1083/jcb.140.4.807; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; FUNG K, 1991, MOL BIOCHEM PARASIT, V45, P261, DOI 10.1016/0166-6851(91)90093-L; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Geisbrecht BV, 1999, J BIOL CHEM, V274, P21797, DOI 10.1074/jbc.274.31.21797; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gould SJ., 2001, METABOLIC MOL BASES, P3181; Gurvitz A, 2000, YEAST, V17, P188, DOI 10.1002/1097-0061(20000930)17:3<188::AID-YEA27>3.0.CO;2-E; HANSEN H, 1992, MOL GEN GENET, V235, P269, DOI 10.1007/BF00279370; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; Jardim A, 2000, J BIOL CHEM, V275, P13637, DOI 10.1074/jbc.275.18.13637; Jones JM, 2000, BIOCHEM BIOPH RES CO, V275, P233, DOI 10.1006/bbrc.2000.3285; Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Luo Y, 1997, BIOTECHNIQUES, V22, P350, DOI 10.2144/97222pf02; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Purdue PE, 1998, J CELL BIOL, V143, P1859; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Shimozawa N, 1999, BIOCHEM BIOPH RES CO, V262, P504, DOI 10.1006/bbrc.1999.1232; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; TOLBERT NE, 1981, ANNU REV BIOCHEM, V50, P133, DOI 10.1146/annurev.bi.50.070181.001025; TSUKAMOTO T, 1994, J BIOL CHEM, V269, P6001; Urquhart AJ, 2000, J BIOL CHEM, V275, P4127, DOI 10.1074/jbc.275.6.4127; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Wanders RJA, 1999, NEUROCHEM RES, V24, P565, DOI 10.1023/A:1022592014988; Warren DS, 2000, HUM MUTAT, V15, P509, DOI 10.1002/1098-1004(200006)15:6<509::AID-HUMU3>3.0.CO;2-#; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Will GK, 1999, MOL CELL BIOL, V19, P2265; Wimmer C, 1998, PLANT J, V16, P453, DOI 10.1046/j.1365-313x.1998.00320.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	89	94	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41769	41781		10.1074/jbc.M106932200	http://dx.doi.org/10.1074/jbc.M106932200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546814	hybrid			2022-12-27	WOS:000172450400032
J	Finlin, BS; Gau, CL; Murphy, GA; Shao, HP; Kimel, T; Seitz, RS; Chiu, YF; Botstein, D; Brown, PO; Tamanoi, F; Andres, DA; Perou, CM				Finlin, BS; Gau, CL; Murphy, GA; Shao, HP; Kimel, T; Seitz, RS; Chiu, YF; Botstein, D; Brown, PO; Tamanoi, F; Andres, DA; Perou, CM			RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION PATTERNS; SMALL GTPASES; G-PROTEIN; CELLS; RIT; FAMILY; TRANSFORMATION; SUPERFAMILY; SEQUENCES; MEMBER	Using microarray analysis, we identified a unique ras superfamily gene, termed RERG (ras-related and estrogen-regulated growth inhibitor), whose expression was decreased or lost in a significant percentage of primary human breast tumors that show a poor clinical prognosis. Importantly, high RERG expression correlated with expression of a set of genes that define a breast tumor subtype that is estrogen receptor-positive and associated with a slow rate of tumor cell proliferation and a favorable prognosis for these cancer patients. RERG mRNA expression was induced rapidly in MCF-7 cells stimulated by beta -estradiol and repressed by tamoxifen treatment. Like Ras, RERG protein exhibited intrinsic GDP/GTP binding and GTP hydrolysis activity. Unlike Ras proteins, RERG lacks a known recognition signal for COOH-terminal prenylation and was localized primarily in the cytoplasm. Expression of RERG protein in MCF-7 breast carcinoma cells resulted in a significant inhibition of both anchorage-dependent and anchorage-independent growth in vitro and inhibited tumor formation in nude mice. These features of RERG are strikingly different from most Ras superfamily GTP-binding proteins and suggest that the loss of RERG expression may contribute to breast tumorigenesis.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biostat, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Res Genet Inc, Huntsville, AL 35801 USA; Appl Genom Inc, Huntsville, AL 35801 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Kentucky; University of California System; University of California Los Angeles; Stanford University; Howard Hughes Medical Institute; Stanford University	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biostat, CB 7295, Chapel Hill, NC 27599 USA.		Chiu, Yen-Feng/E-3847-2010; Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247; Der, Channing/0000-0002-7751-2747; Repasky, Gretchen/0000-0001-6466-6467	NATIONAL CANCER INSTITUTE [R01CA041996, R01CA069577] Funding Source: NIH RePORTER; NCI NIH HHS [CA41996, CA69577] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bilan PJ, 1998, EXP CELL RES, V242, P391, DOI 10.1006/excr.1998.4092; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CAVAILLES V, 1991, BIOCHEM BIOPH RES CO, V174, P816, DOI 10.1016/0006-291X(91)91491-T; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cox AD, 1997, BIOCHIM BIOPHYS ACTA, V1333, P51; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Inadera H, 2000, BIOCHEM BIOPH RES CO, V275, P108, DOI 10.1006/bbrc.2000.3276; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KNIGHT WA, 1977, CANCER RES, V37, P4669; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PEROU CM, 2000, NEW TECHNOLOGIES LIF, P67; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavassoli FA, 1992, PATHOLOGY BREAST, P193; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214	38	129	142	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42259	42267		10.1074/jbc.M105888200	http://dx.doi.org/10.1074/jbc.M105888200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533059	hybrid, Green Published			2022-12-27	WOS:000172450400096
J	Nishi, H; Senoo, M; Nishi, KH; Murphy, B; Rikiyama, T; Matsumura, Y; Habu, S; Johnson, AC				Nishi, H; Senoo, M; Nishi, KH; Murphy, B; Rikiyama, T; Matsumura, Y; Habu, S; Johnson, AC			p53 homologue p63 represses epidermal growth factor receptor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; CELL-LINES; P53-RELATED PROTEIN; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; BINDING FACTOR; RETINOIC ACID; HUMAN CANCERS; TRANSCRIPTION; PROMOTER	Tumor suppressor p53 has been shown to transactivate epidermal growth factor receptor (EGFR) expression through binding to a putative p53 responsive element in the EGFR promoter between nucleotides -265 and -239 (EGFRp53RE). Isotypes of p63 gene products, recently identified as p53 relatives, have a similar function to transactivate several p53 target gene promoters. However, our results indicate that TAp63 gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and e dogenous EGFR expression. Transient transfection a says show that the EGFR promoter region between -348 and -293, containing two Sp1 sites, is crucial for the repression of the EGFR expression by TAp63 gamma. Mutations in these Spl sites in the reporter constructs result in loss of the TAp63 gamma repression effect. We further show that TAp63 gamma directly interacts with Sp1 by immunoprecipitation analysis and that TAp63 gamma impairs Spl binding to the target DNA site in electrophoretic mobility shift assays. These results suggest that TAp63 gamma is involved in the regulation of the EGFR gene expression through interactions with basal transcription factors.	NCI, Mol Biol Lab, CCR, NIH, Bethesda, MD 20892 USA; Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa 25911, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tokai University	Johnson, AC (corresponding author), NCI, Mol Biol Lab, CCR, NIH, Bldg 37,Rm 2D18,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.		nishi, Hiroaki/X-7736-2019	nishi, Hiroaki/0000-0002-6331-2947; Senoo, Makoto/0000-0002-0155-0683	NATIONAL CANCER INSTITUTE [Z01BC008000] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamson ED, 1997, CURR TOP DEV BIOL, V35, P71, DOI 10.1016/S0070-2153(08)60257-4; Augustin M, 1998, MAMM GENOME, V9, P899, DOI 10.1007/s003359900891; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; CHEN LL, 1993, CELL GROWTH DIFFER, V4, P975; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hagiwara K, 1999, CANCER RES, V59, P4165; HERNANDEZSOTOMAYOR SMT, 1992, J MEMBRANE BIOL, V128, P81; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HOU XY, 1994, CELL GROWTH DIFFER, V5, P801; HOU XY, 1994, J BIOL CHEM, V269, P4307; Hudson L G, 1991, Genet Eng (N Y), V13, P137; HUDSON LG, 1990, P NATL ACAD SCI USA, V87, P7536, DOI 10.1073/pnas.87.19.7536; HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Johnson AC, 1996, J BIOL CHEM, V271, P3033; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KAGEYAMA R, 1988, J BIOL CHEM, V263, P6329; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; Kinzler KW, 1996, NATURE, V379, P19, DOI 10.1038/379019a0; Lee LA, 1999, J INVEST DERMATOL, V113, P146, DOI 10.1046/j.1523-1747.1999.00651.x; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LudesMeyers JH, 1996, MOL CELL BIOL, V16, P6009; Merlino G T, 1990, Semin Cancer Biol, V1, P277; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MIYASHITA T, 1995, CELL, V80, P293; Nishi H, 1999, INT J ONCOL, V15, P1149; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Park BJ, 2000, CANCER RES, V60, P3370; PERREM K, 1995, ONCOGENE, V11, P1299; Reed AL, 1998, J BIOL CHEM, V273, P21594, DOI 10.1074/jbc.273.34.21594; Rubinstein YR, 1998, FEBS LETT, V431, P268, DOI 10.1016/S0014-5793(98)00774-1; Salimath B, 2000, ONCOGENE, V19, P3470, DOI 10.1038/sj.onc.1203672; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; Senoo M, 2001, BRIT J CANCER, V84, P1235, DOI 10.1054/bjoc.2000.1735; Sheikh MS, 1997, ONCOGENE, V15, P1095, DOI 10.1038/sj.onc.1201264; Shimada A, 1999, CANCER RES, V59, P2781; SHIVAKUMAR CV, 1995, MOL CELL BIOL, V15, P6785; Sunahara M, 1999, ONCOGENE, V18, P3761, DOI 10.1038/sj.onc.1202972; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; ZHENG ZS, 1992, CELL GROWTH DIFFER, V3, P225	63	62	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41717	41724		10.1074/jbc.M101241200	http://dx.doi.org/10.1074/jbc.M101241200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546792	hybrid			2022-12-27	WOS:000172450400025
J	St Onge, RP; Besley, BDA; Park, M; Casselman, R; Davy, S				St Onge, RP; Besley, BDA; Park, M; Casselman, R; Davy, S			DNA damage-dependent and -independent phosphorylation of the hRad9 checkpoint protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; HUMAN HOMOLOG; FAMILY MEMBERS; SLIDING CLAMP; CONTROL GENE; ATM KINASE; RAD9; COMPLEX	Cell cycle checkpoints are regulatory mechanisms that maintain genomic integrity by preventing cell cycle progression when genetic anomalies are present. The hRad9 protein is the human homologue of Schizosaccharomyces pombe Rad9, a checkpoint protein required for preventing the onset of mitosis if DNA damage is present or if DNA replication is incomplete. Genetic and biochemical analyses indicate that hRad9 is a component of the checkpoint response in humans and has possible roles in regulating the cell cycle, apoptosis, and DNA repair. Previous studies indicate that hRad9 is modified by phosphorylation, both in the absence of exogenous stress and in response to various genotoxins. In this study, we report the mapping of several sites of constitutive phosphorylation of hRad9 to (S/T)PX(R/P) sequences near the C terminus of the protein. We also demonstrate that a serine to alanine mutation at residue 272 abrogates an ionizing radiation (IR)-induced phosphorylation of hRad9 and further show that phosphorylation at (S/T)P sites is not a prerequisite for IR-induced phosphorylation of serine 272. Finally, we report that hRad9 undergoes cell cycle-regulated hyper-phosphorylation in G(2)/M that is enhanced by IR but distinct from that on serine 272. Unlike the IR-induced phosphorylation at serine 272, this event is dependent on serine 277 and threonine 292, two C-terminal (S/T)P sites in hRad9.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Oncol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davy, S (corresponding author), Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada.				PHS HHS [E507940] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Chen JJ, 2000, CANCER RES, V60, P5037; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Hang HY, 2000, GENOMICS, V65, P24, DOI 10.1006/geno.2000.6142; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Kostrub CF, 1998, EMBO J, V17, P2055, DOI 10.1093/emboj/17.7.2055; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lieberman HB, 1996, P NATL ACAD SCI USA, V93, P13890, DOI 10.1073/pnas.93.24.13890; LOEB LA, 1991, CANCER RES, V51, P3075; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Mossi R, 1998, EUR J BIOCHEM, V254, P209, DOI 10.1046/j.1432-1327.1998.254209.x; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Parker AE, 1998, J BIOL CHEM, V273, P18340, DOI 10.1074/jbc.273.29.18340; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Udell CM, 1998, NUCLEIC ACIDS RES, V26, P3971, DOI 10.1093/nar/26.17.3971; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41898	41905		10.1074/jbc.M105152200	http://dx.doi.org/10.1074/jbc.M105152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551919	hybrid			2022-12-27	WOS:000172450400048
J	Zhang, LJ; Beeler, DL; Lawrence, R; Lech, M; Liu, J; Davis, JC; Shriver, Z; Sasisekharan, R; Rosenberg, RD				Zhang, LJ; Beeler, DL; Lawrence, R; Lech, M; Liu, J; Davis, JC; Shriver, Z; Sasisekharan, R; Rosenberg, RD			6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; HAMSTER OVARY CELLS; ANTITHROMBIN-BINDING SEQUENCE; EMBRYONAL CARCINOMA-CELLS; HUMAN CDNAS; PROTEOGLYCANS; MUTANTS; RESIDUES; EXPRESSION; ACID	Using recombinant retroviral transduction, we have introduced the heparin/heparan sulfate (HS) 3-O-sulfotransferase I (3-OST-1) gene into Chinese hamster ovary (CHO) cells. Expression of 3-OST-1 confers upon CHO cells the ability to produce anticoagulantly active HS (HSact). To understand how 6-OST and other proteins regulate HSact biosynthesis, a CHO cell clone with three copies of 3-OST-1 was chemically mutagenized. Resulting mutants that make HS but are defective in generating HSact were single-cell-cloned. One cell mutant makes fewer 6-O-sulfated residues. Modification of HS chains from the mutant with pure 6-OST-1 and 3'-phosphoadenosine 5'-phosphosulfate increased HSact from 7% to 51%. Transfection of this mutant with 6-OST-1 created a CHO cell line that makes HS, 50% of which is HSact. We discovered in this study that M 6-OST-1 is a limiting enzyme in the HSact biosynthetic pathway in vivo when the limiting nature of 3-OST-1 is removed; (ii) HS chains from the mutant cells serve as an excellent substrate for demonstrating that 6-OST-1 is the limiting factor for Hs(act) generation in vitro; (iii) in contradiction to the literature, 6-OST-1 can add 6-O-sulfate to GlcNAc residues, especially the critical 6-O-sulfate in the antithrombin binding motif; (iv) both 3-O- and 6-O-sulfation can be the final step in HSact biosynthesis in contrast to prior publications that concluded 3-O-sulfation is the final step in HSact biosynthesis; (v), in the presence of HS interacting protein peptide, 3-O-sulfate-containing sugars can be degraded into disaccharides by heparitinase digestion as demonstrated by capillary high performance liquid chromatography coupled with mass spectrometry.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Div Bioengn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, BIDMC, Dept Med, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rosenberg, RD (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Bldg 68-480, Cambridge, MA 02139 USA.	rdrrosen@mit.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER; NHLBI NIH HHS [5-P01-HL41484, 5-R01-HL-58479] Funding Source: Medline; NIGMS NIH HHS [GM-50573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; ATHA DH, 1984, P NATL ACAD SCI-BIOL, V81, P1030, DOI 10.1073/pnas.81.4.1030; ATHA DH, 1987, BIOCHEMISTRY-US, V26, P6454, DOI 10.1021/bi00394a024; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Conrad H. E., 1998, HEPARIN BINDING PROT; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1986, J BIOL CHEM, V261, P5725; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1989, METHOD CELL BIOL, V32, P387; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; LINDAHL U, 1983, J BIOL CHEM, V258, P9826; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lindqvist C, 1999, SKANDINAVISTIK, V29, P1; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu SC, 1997, P NATL ACAD SCI USA, V94, P1739, DOI 10.1073/pnas.94.5.1739; LOGANATHAN D, 1990, BIOCHEMISTRY-US, V29, P4362, DOI 10.1021/bi00470a015; MacRae IJ, 1998, J BIOL CHEM, V273, P28583, DOI 10.1074/jbc.273.44.28583; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Rosenberg RD, 1997, J CLIN INVEST, V100, pS67; Rostand KS, 1997, INFECT IMMUN, V65, P1; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Wei G, 2000, J BIOL CHEM, V275, P27733; YAMADA S, 1995, J BIOL CHEM, V270, P8696; YAMADA SH, 1993, J BIOL CHEM, V268, P4780; Zaia J, 2001, ANAL CHEM, V73, P233, DOI 10.1021/ac000777a; Zhang LJ, 2001, J BIOL CHEM, V276, P28806, DOI 10.1074/jbc.M100204200; Zhang LJ, 1999, J BIOL CHEM, V274, P5681, DOI 10.1074/jbc.274.9.5681; Zhang LJ, 1998, J BIOL CHEM, V273, P27998, DOI 10.1074/jbc.273.43.27998	42	62	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42311	42321		10.1074/jbc.M101441200	http://dx.doi.org/10.1074/jbc.M101441200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551899	hybrid			2022-12-27	WOS:000172450400102
J	Brzovic, PS; Meza, JE; King, MC; Klevit, RE				Brzovic, PS; Meza, JE; King, MC; Klevit, RE			BRCA1 RING domain cancer-predisposing mutations - Structural consequences and effects on protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER	Cancer-predisposing missense mutations in the RING domain of BRCA1 primarily target Zn2+-liganding residues. Here we report on the structural consequences of such mutations introduced into the second Zn2+ site (Site II) of the BRCA1 RING domain and their effect on the interaction with the BARD1 RING domain. Each of the BRCA1 Site II mutants still interact and form a stable heterodimer with BARD1. Limited proteolysis of BRCA1/BARD1 complexes, monitored by matrix-assisted laser desorption ionization time-of-flight spectrometry, show that the mutations cause a local structural perturbation that is primarily confined to the second Zn2+ binding loop of the BRCA1 subunit. These findings are consistent with the structure of the BRCA1/BARD1 heterodimer, which shows this region is well removed from the helices required for dimerization with BARD1. Instead, the mutations alter a region of BRCA1 that appears to be required for interaction with ubiquitin-conjugating enzymes.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357742, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [R01 CA79953, R01 CA27632-18S1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079953, R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Brzovic PS, 1998, J BIOL CHEM, V273, P7795, DOI 10.1074/jbc.273.14.7795; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Roehm PC, 1997, BIOCHEMISTRY-US, V36, P10240, DOI 10.1021/bi970863d; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	19	104	108	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41399	41406		10.1074/jbc.M106551200	http://dx.doi.org/10.1074/jbc.M106551200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526114	hybrid			2022-12-27	WOS:000171925600136
J	Jeon, Y; Lee, YS; Han, JS; Kim, JB; Hwang, DS				Jeon, Y; Lee, YS; Han, JS; Kim, JB; Hwang, DS			Multimerization of phosphorylated and non-phosphorylated ArcA is necessary for the response regulator function of the Arc two-component signal transduction system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MEDIATING REPRESSION; 2-COMPONENT SYSTEM; AEROBIC PATHWAYS; DNA-BINDING; IN-VITRO; PROTEIN; ACTIVATION; MODULES; CHEY	To adapt to anaerobic conditions, Escherichia coli operates the Arc two-component signal transduction system, consisting of a sensor kinase, ArcB, and a response regulator, ArcA. ArcA is converted to the active form, phosphorylated ArcA (ArcA-P), by ArcB-mediated phosphorylation. The active ArcA-P binds to the promoter regions of target genes, thereby regulating their transcriptional activities. The phosphoryl group of ArcA-P is unstable with a half-life of 30 min. However, we were able to inhibit the dephosphorylation for more than 12 h by the addition of EDTA; this allowed us to characterize ArcA-P. Gel-filtration and glycerol sedimentation experiments demonstrated that ArcA exists as a homo-dimer. ArcA phosphorylated by either ArcB or carbamyl phosphate multimerizes to form a tetramer of dimers; this multimer binds to the ArcA DNA binding site. Isoelectric focusing gel electrophoresis and nitrocellulose-filter binding analyses indicated that the ArcA multimer is composed of both ArcA-P and ArcA in a ratio, 1:1. The ArcA(D54E) mutant protein was unable to be phosphorylated by ArcB. This defect resulted in the inability of ArcA(D54E) to form a multimer or to bind to the ArcA DNA binding site. These results indicate that phosphorylation of ArcA induces multimerization prior to DNA binding, and the multimerization is a prerequisite for binding. Our results suggest a novel model that phosphorylation of ArcA by ArcB regulates multimerization of ArcA, which in turn functions as a response regulator.	Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Seoul 151742, South Korea	Seoul National University (SNU)	Hwang, DS (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Seoul 151742, South Korea.							Colloms SD, 1998, MOL MICROBIOL, V28, P521, DOI 10.1046/j.1365-2958.1998.00812.x; DRAPAL N, 1995, MOL MICROBIOL, V16, P597, DOI 10.1111/j.1365-2958.1995.tb02422.x; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; HWANG DS, 1992, J BIOL CHEM, V267, P2209; IUCHI S, 1989, J BACTERIOL, V171, P868, DOI 10.1128/jb.171.2.868-873.1989; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; IUCHI S, 1992, J BACTERIOL, V174, P5617, DOI 10.1128/JB.174.17.5617-5623.1992; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Lee YS, 2001, J BIOL CHEM, V276, P9917, DOI 10.1074/jbc.M008629200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; LYNCH AS, 1996, ESCHERICHIA COLI SAL, V1, P1526; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; NAKASHIMA K, 1991, J BIOL CHEM, V266, P10775; NINFA AJ, 1996, ESCHERICHIA COLI SAL, V1, P1246; Parkinson J.S., 1995, 2 COMPONENT SIGNAL T, P9; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PORTER SC, 1993, GENE DEV, V7, P2258, DOI 10.1101/gad.7.11.2258; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; VOLZ K, 1991, J BIOL CHEM, V266, P15511; WEISS V, 1988, P NATL ACAD SCI USA, V85, P8919, DOI 10.1073/pnas.85.23.8919	26	74	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40873	40879		10.1074/jbc.M104855200	http://dx.doi.org/10.1074/jbc.M104855200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527965	hybrid			2022-12-27	WOS:000171925600067
J	Steveson, TC; Zhao, GC; Keutmann, HT; Mains, RE; Eipper, BA				Steveson, TC; Zhao, GC; Keutmann, HT; Mains, RE; Eipper, BA			Access of a membrane protein to secretory granules is facilitated by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; TRANS-GOLGI NETWORK; MANNOSE 6-PHOSPHATE RECEPTOR; PEPTIDE PROCESSING ENZYME; CYTOSOLIC ROUTING DETERMINANTS; PH-DEPENDENT AGGREGATION; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; IN-VITRO; INTRACELLULAR TRAFFICKING	Peptidylglycine a-amidating monooxygenase (PAM), an integral membrane protein essential for the biosynthesis of amidated peptides, was used to assess the role of cytosolic acidic clusters in trafficking to regulated secretory granules. Casein kinase II phosphorylates Ser(949) and Thr(946) of PAM, generating a short, cytosolic acidic cluster. P-CIP2, a protein kinase identified by its ability to interact with several juxtamembrane determinants in the PAM cytosolic domain, also phosphorylates Ser(949). Antibody specific for phospho-Ser(949)-PAM-CD demonstrates that a small fraction of the PAM-1 localized to the perinuclear region bears this modification. Pituitary cell lines expressing PAM-1 mutants that mimic (TS/DD) or prevent (TS/AA) phosphorylation at these sites were studied. PAM-1 TS/AA yields a lumenal monooxygenase domain that enters secretory granules inefficiently and is rapidly degraded. In contrast, PAM-1 TS/DD is routed to regulated secretory granules more efficiently than wild-type PAM-1 and monooxygenase release is more responsive to secretagogue. Furthermore, this acidic cluster affects exit of internalized PAM-antibody complexes from late endosomes; internalized PAM-1 TS/DD accumulates in a late endocytic compartment instead of the trans-Golgi network. The increased ability of solubilized PAM-1 TS/DD to aggregate at neutral pH may play an important role in its altered trafficking.	Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; Georgetown Univ, Georgetown Med Ctr, Washington, DC 20007 USA; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA	University of Connecticut; Georgetown University; Harvard University; Massachusetts General Hospital	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, MC 3401,263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu			NIDDK NIH HHS [DK-09520, DK-32949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009520, R01DK032949, R37DK032949, R56DK032949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Alconada A, 1996, EMBO J, V15, P6096, DOI 10.1002/j.1460-2075.1996.tb00998.x; ARVAN P, 1991, J BIOL CHEM, V266, P14171; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Breuer P, 1997, MOL BIOL CELL, V8, P567, DOI 10.1091/mbc.8.4.567; Caldwell BD, 1999, J BIOL CHEM, V274, P34646, DOI 10.1074/jbc.274.49.34646; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; DISDIER M, 1992, MOL BIOL CELL, V3, P309, DOI 10.1091/mbc.3.3.309; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; EIPPER BA, 1995, BIOCHEMISTRY-US, V34, P2857, DOI 10.1021/bi00009a016; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Eng FJ, 1999, MOL BIOL CELL, V10, P35, DOI 10.1091/mbc.10.1.35; FUTTER CE, 1989, J CELL SCI, V94, P685; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Guerra B, 1999, PHARMACOL THERAPEUT, V82, P303, DOI 10.1016/S0163-7258(98)00064-3; HEMER F, 1993, J BIOL CHEM, V268, P17108; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; HUSTEN EJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P487, DOI 10.1006/abbi.1994.1336; HUSTEN EJ, 1991, J BIOL CHEM, V266, P17004; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; JIN MJ, 1993, J BIOL CHEM, V268, P18390; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; KOEDAM JA, 1992, J CELL BIOL, V116, P617, DOI 10.1083/jcb.116.3.617; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; MALTESE JY, 1993, ENDOCRINOLOGY, V133, P2579, DOI 10.1210/en.133.6.2579; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Milgram SL, 1996, J BIOL CHEM, V271, P17526, DOI 10.1074/jbc.271.29.17526; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Norcott JP, 1996, J CELL BIOL, V134, P1229, DOI 10.1083/jcb.134.5.1229; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; OKAMOTO CT, 1994, J BIOL CHEM, V269, P15676; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Rindler MJ, 1998, J BIOL CHEM, V273, P31180, DOI 10.1074/jbc.273.47.31180; Rohn WM, 2000, J CELL SCI, V113, P2093; ROHRER J, 1995, J CELL BIOL, V130, P1297, DOI 10.1083/jcb.130.6.1297; SAKAI T, 1991, J BIOCHEM-TOKYO, V109, P528, DOI 10.1093/oxfordjournals.jbchem.a123415; SHENNAN KIJ, 1994, J BIOL CHEM, V269, P18646; Simmen T, 1999, MOL CELL BIOL, V19, P3136; SONG LX, 1995, J BIOL CHEM, V270, P7963, DOI 10.1074/jbc.270.14.7963; STEINER DF, 1973, NATURE, V243, P528, DOI 10.1038/243528a0; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; SUBRAMANIAM M, 1993, MOL BIOL CELL, V4, P791, DOI 10.1091/mbc.4.8.791; Suvorova ES, 2001, J BIOL CHEM, V276, P22810, DOI 10.1074/jbc.M011624200; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Tooze SA, 2001, SCIENCE, V292, P1663, DOI 10.1126/science.1062239; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Xu X, 1999, MOL CELL BIOCHEM, V191, P65, DOI 10.1023/A:1006866412652; YOO SH, 1994, J BIOL CHEM, V269, P12001; YOO SH, 1990, J BIOL CHEM, V265, P14414; Yoo SH, 1996, J BIOL CHEM, V271, P1558; Yoo SH, 1997, FEBS LETT, V406, P259, DOI 10.1016/S0014-5793(97)00276-7; YUN HY, 1995, J BIOL CHEM, V270, P30075; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	81	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40326	40337		10.1074/jbc.M011460200	http://dx.doi.org/10.1074/jbc.M011460200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11524414	hybrid			2022-12-27	WOS:000171789200110
J	El-Husseini, AE; Craven, SE; Brock, SC; Bredt, DS				El-Husseini, AE; Craven, SE; Brock, SC; Bredt, DS			Polarized targeting of peripheral membrane proteins in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; COATED PITS; GLUTAMATE RECEPTORS; LIPID COMPLEXES; CELL-MEMBRANES; DOMAINS; PALMITOYLATION; GAP-43	Differential targeting of neuronal proteins to axons and dendrites is essential for directional information flow within the brain, however, little is known about this protein-sorting process. Here, we investigate polarized targeting of lipid-anchored peripheral membrane proteins, postsynaptic density-95 (PSD-95) and growth-associated protein-43 (GAP-43). Whereas the N-terminal palmitoylated motif of PSD-95 is necessary but not sufficient for sorting to dendrites, the palmitoylation motif of GAP-43 is sufficient for axonal targeting and can redirect a PSD-95 chimera to axons. Systematic mutagenesis of the GAP-43 and PSD-95 palmitoylation motifs indicates that the spacing of the palmitoylated cysteines and the presence of nearby basic amino acids determine polarized targeting by these two motifs. Similarly, the axonal protein paralemmin contains a C-terminal palmitoylated domain, which resembles that of GAP-43 and also mediates axonal targeting. These axonally targeted palmitoylation motifs also mediate targeting to detergent-insoluble glycolipid-enriched complexes in heterologous cells, suggesting a possible role for specialized lipid domains in axonal sorting of peripheral membrane proteins.	Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Sch Med, Dept Physiol, 513 Parnassus Ave, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036017] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36017] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; BRETSCHER MS, 1980, P NATL ACAD SCI-BIOL, V77, P4156, DOI 10.1073/pnas.77.7.4156; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Kaech S, 1996, MOL BRAIN RES, V35, P344, DOI 10.1016/0169-328X(95)00238-N; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Kutzleb C, 1998, J CELL BIOL, V143, P795, DOI 10.1083/jcb.143.3.795; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; Lazarovits J, 1996, J CELL BIOL, V134, P339, DOI 10.1083/jcb.134.2.339; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; LIU YC, 1994, J NEUROSCI, V14, P5807; Maekawa S, 1997, BBA-BIOMEMBRANES, V1323, P1, DOI 10.1016/S0005-2736(96)00222-2; MATUS AI, 1979, J NEUROCYTOL, V8, P513, DOI 10.1007/BF01214806; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Perez AS, 1998, NEUROSCI LETT, V258, P121, DOI 10.1016/S0304-3940(98)00846-5; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554	40	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44984	44992		10.1074/jbc.M103049200	http://dx.doi.org/10.1074/jbc.M103049200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11546762	hybrid			2022-12-27	WOS:000172406700087
J	van der Veen, BA; Leemhuis, H; Kralj, S; Uitdehaag, JCM; Dijkstra, BW; Dijkhuizen, L				van der Veen, BA; Leemhuis, H; Kralj, S; Uitdehaag, JCM; Dijkstra, BW; Dijkhuizen, L			Hydrophobic amino acid residues in the acceptor binding site are main determinants for reaction mechanism and specificity of cyclodextrin-glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CIRCULANS STRAIN-251; PRODUCT SPECIFICITY; ANGSTROM RESOLUTION; ACTIVE-CENTER; GLUCANOTRANSFERASE; INHIBITOR	Cyclodextrin-glycosyltransferases (CGTases) (EC 2.4.1.19) preferably catalyze transglycosylation reactions with glucosyl residues as acceptor, whereas the homologous alpha -amylases catalyze hydrolysis reactions using water as acceptor. This difference in reaction specificity is most likely caused by the acceptor binding site. To investigate this in detail we altered the acceptor site residues Lys-232, Phe-183, Phe-259, and Glu-264 of Bacillus circulans strain 251 CGTase using site-directed mutagenesis. Lys-232 is of general importance for catalysis, which appears to result mainly from stabilization of the conformation of the loop containing the catalytic nucleophile Asp-229 and His-233, a residue that has been implied in transition state stabilization. Glu-264 contributes to the disproportionation reaction only, where it is involved in initial binding of the (maltose) acceptor. Phe-183 and Phe-259 play important and distinct roles in the transglycosylation reactions catalyzed by CGTase. Mutation of Phe-183 affects especially the cyclization and coupling reactions, whereas Phe-259 is most important for the cyclization and disproportionation reactions. Moreover, the hydrophobisity of Phe-183 and Phe-259 limits the hydrolyzing activity of the enzyme. Hydrolysis can be enhanced by making these residues more polar, which concomitantly results in a lower transglycosylation activity. A double mutant was constructed that yielded an enzyme preferring hydrolysis over cyclization (15:1), whereas the wild type favors cyclization over hydrolysis (90:1).	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbiol, NL-9751 NN Haren, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, BIOSON Res Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.		Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014; Dijkstra, Bauke W./H-4308-2019	Dijkhuizen, Lubbert/0000-0003-2312-7162; Dijkstra, Bauke W./0000-0001-9731-6586; Kralj, Slavko/0000-0001-7855-4888				Allegre M., 1994, Agro Food Industry hi-tech, V5, P9; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BRON S, 1990, MODERN MICROBIOLOGIC, P146; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; MEISSNER PS, 1987, P NATL ACAD SCI USA, V84, P4171, DOI 10.1073/pnas.84.12.4171; NAKAMURA A, 1993, BIOCHEMISTRY-US, V32, P6624, DOI 10.1021/bi00077a015; NAKAMURA A, 1994, BIOCHEMISTRY-US, V33, P9929, DOI 10.1021/bi00199a015; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; PENNINGA D, 1995, BIOCHEMISTRY-US, V34, P3368, DOI 10.1021/bi00010a028; Sambrook J., 2002, MOL CLONING LAB MANU; SMITH H, 1988, GENE, V70, P351, DOI 10.1016/0378-1119(88)90207-7; Strokopytov B, 1996, BIOCHEMISTRY-US, V35, P4241, DOI 10.1021/bi952339h; SUNDBERG L, 1974, J CHROMATOGR, V90, P87, DOI 10.1016/S0021-9673(01)94777-6; Uitdehaag JCM, 1999, J BIOL CHEM, V274, P34868, DOI 10.1074/jbc.274.49.34868; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Uitdehaag JCM, 2001, PROTEINS, V43, P327, DOI 10.1002/prot.1044; Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x; van der Veen BA, 2000, EUR J BIOCHEM, V267, P658, DOI 10.1046/j.1432-1327.2000.01031.x; VANDERVOSSEN JMBM, 1992, APPL ENVIRON MICROB, V58, P3142, DOI 10.1128/AEM.58.9.3142-3149.1992; Vikmon M., 1982, 1ST P INT S CYCL BUD, P69; VOSS H, 1992, Methods in Molecular and Cellular Biology, V3, P30; Wind RD, 1998, J BIOL CHEM, V273, P5771, DOI 10.1074/jbc.273.10.5771; ZIMMERMANN J, 1990, NUCLEIC ACIDS RES, V18, P1067, DOI 10.1093/nar/18.4.1067	26	84	87	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44557	44562		10.1074/jbc.M107533200	http://dx.doi.org/10.1074/jbc.M107533200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11555657	Green Published, hybrid			2022-12-27	WOS:000172406700030
J	Ito, Y; Zhao, J; Mogharei, A; Shuler, CF; Weinstein, M; Deng, CX; Chai, Y				Ito, Y; Zhao, J; Mogharei, A; Shuler, CF; Weinstein, M; Deng, CX; Chai, Y			Antagonistic effects of Smad2 versus Smad7 are sensitive to their expression level during tooth development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG BRANCHING MORPHOGENESIS; MAD-RELATED PROTEIN; TGF-BETA; TARGETED DISRUPTION; RECEPTOR; LACKING; MICE; DEFECTS; INHIBITION	Members of the transforming growth factor-beta (TGF-beta) superfamily regulate cell proliferation, differentiation, and apoptosis, controlling the development and maintenance of most tissues. TGF-beta signal is transmitted through the phosphorylation of Smad proteins by TGF-beta receptor serine/threonine kinase. During early tooth development, TGF-beta inhibits proliferation of enamel organ epithelial cells but the underlying molecular mechanisms are largely unknown. Here we tested the hypothesis that antagonistic effects between Smad2 and Smad7 regulate TGF-beta signaling during tooth development. Attenuation of Smad2 gene expression resulted in significant advancement of embryonic tooth development with increased proliferation of enamel organ epithelial cells, while attenuation of Smad7 resulted in significant inhibition of embryonic tooth development with increased apoptotic activity within enamel organ epithelium. These findings suggest that different Smads may have differential activities in regulating TGF-beta -mediated cell proliferation and death. Furthermore, functional haplo-insufficiency of Smad2, but not Smad3, altered TGF-beta -mediated tooth development. The results indicate that Smads are critical factors in orchestrating TGF-beta -mediated gene regulation during embryonic tooth development. The effectiveness of TGF-beta signaling is highly sensitive to the level of Smad gene expression.	Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	University of Southern California; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chai, Y (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	ychai@hsc.usc.edu	deng, chuxia/N-6713-2016		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711, P01DE012941] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE12941, DE12711] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Chai Y, 2000, DEVELOPMENT, V127, P1671; CHAI Y, 1994, DEV BIOL, V162, P85, DOI 10.1006/dbio.1994.1069; CHAI Y, 1993, ANAT REC, V235, P303, DOI 10.1002/ar.1092350214; Chai Y, 1999, MECH DEVELOP, V86, P63, DOI 10.1016/S0925-4773(99)00112-4; Chai Y, 1998, DEV DYNAM, V213, P500, DOI 10.1002/(SICI)1097-0177(199812)213:4<500::AID-AJA14>3.0.CO;2-A; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen Y, 1996, P NATL ACAD SCI USA, V93, P12992, DOI 10.1073/pnas.93.23.12992; Dick A, 1998, DEV DYNAM, V211, P293, DOI 10.1002/(SICI)1097-0177(199804)211:4<293::AID-AJA1>3.0.CO;2-C; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; Flanders KC, 2001, DEV DYNAM, V220, P141, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1096>3.0.CO;2-4; HALL BK, 1992, BIOL MECH TOOTH MOVE; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; HEIKINHEIMO K, 1993, J CLIN INVEST, V91, P1019, DOI 10.1172/JCI116258; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; KRONMILLER JE, 1991, DEV BIOL, V147, P485, DOI 10.1016/0012-1606(91)90307-O; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Laurikkala J, 2001, DEV BIOL, V229, P443, DOI 10.1006/dbio.2000.9955; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; MARCUSSEKURA CJ, 1988, TRENDS CELL BIOL, V7, P187; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyazono K, 2000, J CELL SCI, V113, P1101; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yang X, 1999, DEVELOPMENT, V126, P1571; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhao JS, 2000, J BIOL CHEM, V275, P23992, DOI 10.1074/jbc.M002433200; Zhao JS, 1998, MECH DEVELOP, V72, P89, DOI 10.1016/S0925-4773(98)00019-7; Zhao JS, 1996, DEV BIOL, V180, P242, DOI 10.1006/dbio.1996.0298; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	57	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44163	44172		10.1074/jbc.M011424200	http://dx.doi.org/10.1074/jbc.M011424200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557747	hybrid			2022-12-27	WOS:000172297700087
J	Schmidt-Mende, J; Bieck, E; Hugle, T; Penin, F; Rice, CM; Blum, HE; Moradpour, D				Schmidt-Mende, J; Bieck, E; Hugle, T; Penin, F; Rice, CM; Blum, HE; Moradpour, D			Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CELL-LINES; CRYSTAL-STRUCTURE; SUBCELLULAR-LOCALIZATION; BIOCHEMICAL-PROPERTIES; TRANSMEMBRANE HELICES; TARGETING SIGNAL; MAMMALIAN-CELLS; CYTOCHROME B(5); VIRAL-PROTEINS	The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp), represented by nonstructural protein 5B (NS5B), is believed to form a membrane-associated RNA replication complex together with other nonstructural proteins and as yet unidentified host components. However, the determinants for membrane association of this essential viral enzyme have not been defined. By double label immunofluorescence analyses, NS5B was found in the endoplasmic reticulum (ER) or an ER-like modified compartment both when expressed alone or in the context of the entire HCV polyprotein. The carboxyl-terminal 21 amino acid residues were necessary and sufficient to target NS5B or a heterologous protein to the cytosolic side of the ER membrane. This hydrophobic domain is highly conserved among 269 HCV isolates analyzed and predicted to form a transmembrane a-helix. Association of NS5B with the ER membrane occurred by a posttranslational mechanism that was ATP-independent. These features define the HCV RdRp as a new member of the tail-anchored protein family, a class of integral membrane proteins that are membrane-targeted posttranslationally via a carboxyl-terminal insertion sequence. Formation of the HCV replication complex, therefore, involves specific determinants for membrane association that represent potential targets for antiviral intervention.	Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany; CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 07, France; Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Rockefeller University	Moradpour, D (corresponding author), Univ Hosp Freiburg, Dept Med 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	moradpou@ruf.uni-freiburg.de	PENIN, Francois/A-7315-2008; Moradpour, Darius/G-7918-2017	Moradpour, Darius/0000-0003-1977-6792				Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; ANDREWS DW, 1993, MOL CELL BIOL, V13, P4703, DOI 10.1128/MCB.13.8.4703; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; Blanchet C, 2000, BIOINFORMATICS, V16, P286, DOI 10.1093/bioinformatics/16.3.286; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Brideau AD, 1998, J VIROL, V72, P4560, DOI 10.1128/JVI.72.6.4560-4570.1998; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLAROS MG, 1994, COMPUT APPL BIOSCI, V269, P26898; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000; Dubuisson J, 2000, CURR TOP MICROBIOL, V242, P135; Egger D, 2000, J VIROL, V74, P6570, DOI 10.1128/JVI.74.14.6570-6580.2000; Egger D, 1996, J VIROL, V70, P8675, DOI 10.1128/JVI.70.12.8675-8683.1996; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Fauquet C. M., 2000, VIRUS TAXONOMY; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Hagedorn CH, 2000, CURR TOP MICROBIOL, V242, P225; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Hope DA, 1997, J VIROL, V71, P9490, DOI 10.1128/JVI.71.12.9490-9498.1997; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Hwang SB, 1997, VIROLOGY, V227, P439, DOI 10.1006/viro.1996.8357; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kim JE, 1999, ARCH VIROL, V144, P329, DOI 10.1007/s007050050507; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kretzschmar E, 1996, VIROLOGY, V220, P37, DOI 10.1006/viro.1996.0283; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; LI ZM, 1993, J BIOL CHEM, V268, P4584; Lin C, 1997, J VIROL, V71, P6465, DOI 10.1128/JVI.71.9.6465-6471.1997; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; MARKLAND W, 1987, BIOCHIM BIOPHYS ACTA, V907, P299, DOI 10.1016/0304-419X(87)90011-4; MIGLIACCIO G, 1992, J CELL BIOL, V117, P15, DOI 10.1083/jcb.117.1.15; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Moradpour D, 2001, SWISS MED WKLY, V131, P291; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; PRECIOUS B, 1995, J VIROL, V69, P8001, DOI 10.1128/JVI.69.12.8001-8010.1995; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; ROST B, 1995, PROTEIN SCI, V4, P521; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8	76	165	174	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44052	44063		10.1074/jbc.M103358200	http://dx.doi.org/10.1074/jbc.M103358200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557752	hybrid			2022-12-27	WOS:000172297700074
J	Tan, KML; Chan, SL; Tan, KO; Yu, VC				Tan, KML; Chan, SL; Tan, KO; Yu, VC			The Caenorhabditis elegans sex-determining protein FEM-2 and its human homologue, hFEM-2, are Ca (2+)/calmodulin-dependent protein kinase phosphatases that promote apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DETERMINING GENE; SIGNAL-TRANSDUCTION; MEDIATES APOPTOSIS; EVOLUTION; SUBSTRATE; CLONING; CED-3; 2C; CONSERVATION	In Caenorhabditis elegans, fem-1, fem-2, and fem-3 play pivotal roles in sex determination. Recently, a mammalian homologue of the C. elegans sex-determining protein FEM-1, F1A alpha, has been described. Although there is little evidence to link F1A alpha to sex determination, F1A alpha and FEM-1 both promote apoptosis in mammalian cells. Here we report the identification and characterization of a human homologue of the C. elegans sex-determining protein FEM-2, hFEM-2. Similar to FEM-2, hFEM-2 exhibited PP2C phosphatase activity and associated with FEM-3. hFEM-2 shows striking similarity (79% amino acid identity) to rat Ca2+/calmodulin (CaM)-dependent protein kinase phosphatase (rCaMKPase). hFEM-2 and FEM-2, but not PP2C alpha, were demonstrated to dephosphorylate CaM kinase H efficiently in vitro, suggesting that hFEM-2 and FEM-2 are specific phosphatases for CaM kinase. Furthermore, hFEM-2 and FEM-2 associated with F1A alpha and FEM-1 respectively. Overexpression of hFEM-2, FEM-2, or rCaMKPase all mediated apoptosis in mammalian cells. The catalytically active, but not the inactive, forms of hFEM-2 induced caspase-dependent apoptosis, which was blocked by Bcl-XL or a dominant negative mutant of caspase-9. Taken together, our data suggest that hFEM-2 and rCaMKPase are mammalian homologues of FEM-2 and they are evolutionarily conserved CaM kinase phosphatases that may have a role in apoptosis signaling.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Yu, VC (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbyuck@imcb.nus.edu.sg	Chan, S.L./X-4154-2018; Yu, Victor/A-7899-2015	Chan, S.L./0000-0002-3270-0525; Yu, Victor/0000-0003-3270-4734; Tan, Kuan/0000-0002-0947-7337; Tan, Karen/0000-0002-7768-037X				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AHRINGER J, 1992, EMBO J, V11, P2303, DOI 10.1002/j.1460-2075.1992.tb05289.x; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chan SL, 2000, J BIOL CHEM, V275, P17925, DOI 10.1074/jbc.C000146200; Chan SL, 1999, J BIOL CHEM, V274, P32461, DOI 10.1074/jbc.274.45.32461; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; deBono M, 1996, GENETICS, V144, P587; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; Eto K, 1999, J BIOL CHEM, V274, P22556, DOI 10.1074/jbc.274.32.22556; Fujisawa H, 2001, J BIOCHEM-TOKYO, V129, P193, DOI 10.1093/oxfordjournals.jbchem.a002843; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Hansen D, 1999, MECH DEVELOP, V83, P3, DOI 10.1016/S0925-4773(99)00024-6; Hansen D, 1998, GENETICS, V149, P1353; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hengartner MO, 1998, NATURE, V391, P441, DOI 10.1038/35036; Horvitz HR, 1999, CANCER RES, V59, p1701S; Ishida A, 1998, BIOCHEM BIOPH RES CO, V253, P159, DOI 10.1006/bbrc.1998.9771; Ishida A, 1998, J BIOL CHEM, V273, P1904, DOI 10.1074/jbc.273.4.1904; KIMBLE J, 1984, DEV BIOL, V105, P234, DOI 10.1016/0012-1606(84)90279-3; Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022, DOI 10.1093/oxfordjournals.jbchem.a022381; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Kuwabara PE, 1996, GENETICS, V144, P597; MANN DJ, 1992, BIOCHIM BIOPHYS ACTA, V1130, P100, DOI 10.1016/0167-4781(92)90471-B; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Marley AE, 1998, FEBS LETT, V431, P121, DOI 10.1016/S0014-5793(98)00708-X; McGinnis KM, 2001, NEUROSCI LETT, V301, P99, DOI 10.1016/S0304-3940(01)01629-9; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; PILGRIM D, 1995, MOL BIOL CELL, V6, P1159, DOI 10.1091/mbc.6.9.1159; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schafer AJ, 1996, BIOESSAYS, V18, P955, DOI 10.1002/bies.950181205; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; SHACKELFORD DA, 1995, J CEREBR BLOOD F MET, V15, P450, DOI 10.1038/jcbfm.1995.56; Shamloo M, 2000, NEUROSCIENCE, V96, P665, DOI 10.1016/S0306-4522(99)00586-2; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Travis SM, 1997, FEBS LETT, V412, P415, DOI 10.1016/S0014-5793(97)00837-5; TUCKER PK, 1993, NATURE, V364, P715, DOI 10.1038/364715a0; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366	56	45	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44193	44202		10.1074/jbc.M105880200	http://dx.doi.org/10.1074/jbc.M105880200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559703	hybrid			2022-12-27	WOS:000172297700091
J	Tanner, A; Bowater, L; Fairhurst, SA; Bornemann, S				Tanner, A; Bowater, L; Fairhurst, SA; Bornemann, S			Oxalate decarboxylase requires manganese and dioxygen for activity - Overexpression and characterization of Bacillus subtilis YvrK and YoaN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED STORAGE PROTEINS; SUPEROXIDE-DISMUTASE; MICROBIAL RELATIVES; ANGSTROM RESOLUTION; COLLYBIA-VELUTIPES; CRYSTAL-STRUCTURE; GERMIN-LIKE; PURIFICATION; LIPOXYGENASE; SUPERFAMILY	The Bacillus subtilis oxalate decarboxylase (EC 4.1.1.2), YvrK, converts oxalate to formate and CO2. YvrK and the related hypothetical proteins YoaN and YxaG from B. subtilis have been successfully overexpressed in Escherichia coli. Recombinant YvrK and YoaN were found to be soluble enzymes with oxalate decarboxylase activity only when expressed in the presence of manganese salts. No enzyme activity has yet been detected for YxaG, which was expressed as a soluble protein without the requirement for manganese salts. YvrK and YoaN were found to catalyze minor side reactions: oxalate oxidation to produce H2O2; and oxalate-dependent, H2O2-independent dye oxidations. The oxalate decarboxylase activity of purified YvrK was O-2-dependent. YvrK was found to contain between 0.86 and 1.14 atoms of manganese/subunit. EPR spectroscopy showed that the metal ion was predominantly but not exclusively in the Mn(H) oxidation state. The hyperfine coupling constant (A = 9.5 millitesla) of the main g = 2 signal was consistent with oxygen and nitrogen ligands with hexacoordinate geometry. The structure of YvrK was modeled on the basis of homology with oxalate oxidase, canavalin, and phaseolin, and its hexameric oligomerization was predicted by analogy with proglycinin and homogentisate 1,2-dioxygenase. Although YvrK possesses two potential active sites, only one could be fully occupied by manganese. The possibility that the C-terminal domain active site has no manganese bound and is buried in an intersubunit interface within the hexameric enzyme is discussed. A mechanism for oxalate decarboxylation is proposed, in which both Mn(II) and O-2 are cofactors that act together as a two-electron sink during catalysis.	John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bornemann, S (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.		Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Bowater, Laura/0000-0003-3232-8062				Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989; BENSON D, 1976, MONOGRAPH, V10, P204; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; EMILIANI E, 1968, BIOCHIM BIOPHYS ACTA, V167, P414, DOI 10.1016/0005-2744(68)90221-0; EMILIANI E, 1964, ARCH BIOCHEM BIOPHYS, V105, P488, DOI 10.1016/0003-9861(64)90040-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HARA MP, 1977, ARCH BIOCHEM BIOPHYS, V183, P511; HARPEL MR, 1990, J BIOL CHEM, V265, P22187; Hsieh YS, 1998, BIOCHEMISTRY-US, V37, P4731, DOI 10.1021/bi972395d; Iwabuchi T, 1998, J BIOL CHEM, V273, P8332, DOI 10.1074/jbc.273.14.8332; Kathiara M, 2000, MYCOL RES, V104, P345, DOI 10.1017/S095375629900129X; Kesarwani M, 2000, J BIOL CHEM, V275, P7230, DOI 10.1074/jbc.275.10.7230; Khuri S, 2001, MOL BIOL EVOL, V18, P593, DOI 10.1093/oxfordjournals.molbev.a003840; KO TP, 1993, PLANT PHYSIOL, V101, P729, DOI 10.1104/pp.101.3.729; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; LILLEHOJ EB, 1965, ARCH BIOCHEM BIOPHYS, V109, P216, DOI 10.1016/0003-9861(65)90355-3; Mabbs F. E., 1992, STUDIES INORGANIC CH, V16; MAGRO P, 1988, FEMS MICROBIOL LETT, V49, P49, DOI 10.1016/0378-1097(88)90100-0; MEHTA A, 1991, J BIOL CHEM, V266, P23548; MEIROVITCH E, 1978, J PHYS CHEM-US, V82, P1920, DOI 10.1021/j100506a013; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MURTHY MSR, 1981, IRCS MED SCI-BIOCHEM, V9, P683; NOGAMI T, 1975, B CHEM SOC JPN, V48, P3709, DOI 10.1246/bcsj.48.3709; OGASAWARA N, 1966, J BIOL CHEM, V241, P613; Papoutsopoulou SV, 1997, MOL CELL BIOCHEM, V177, P183, DOI 10.1023/A:1006825825681; Que L, 2000, MET IONS BIOL SYST, V37, P505; Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185; Rodriguez-Lopez M, 2001, FEBS LETT, V490, P44, DOI 10.1016/S0014-5793(01)02135-4; Sambrook J., 2002, MOL CLONING LAB MANU; SHIMAZONO H, 1955, J BIOCHEM-TOKYO, V42, P321, DOI 10.1093/oxfordjournals.jbchem.a126533; Su C, 2000, J BIOL CHEM, V275, P18830, DOI 10.1074/jbc.M001408200; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tanner A, 2000, J BACTERIOL, V182, P5271, DOI 10.1128/JB.182.18.5271-5273.2000; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Whiting AK, 1996, BIOCHEMISTRY-US, V35, P160, DOI 10.1021/bi951979h; WHITTAKER JW, 1991, J AM CHEM SOC, V113, P5528, DOI 10.1021/ja00015a003; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479, DOI 10.1093/oxfordjournals.jbchem.a131935; Yamahara T, 1999, J BIOL CHEM, V274, P33274, DOI 10.1074/jbc.274.47.33274	48	112	121	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43627	43634		10.1074/jbc.M107202200	http://dx.doi.org/10.1074/jbc.M107202200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546787	hybrid			2022-12-27	WOS:000172297700021
J	Yang, WN; Lin, Q; Zhao, JH; Guan, JL; Cerione, RA				Yang, WN; Lin, Q; Zhao, JH; Guan, JL; Cerione, RA			The nonreceptor tyrosine kinase ACK2, a specific target for Cdc42 and a negative regulator of cell growth and focal adhesion complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ACTIN; RHO; GTPASES; PHOSPHORYLATION; FILOPODIA; PATHWAYS; BINDING; BRAIN; CYCLE	ACK2 (activated Cdc42-associated tyrosine kinase-2) is a nonreceptor tyrosine kinase that is a specific target/ effector for the GTP-binding protein Cdc42. Thus far the biological function of this tyrosine kinase has not been determined. Using an inducible eukaryotic expression system in fibroblasts, we demonstrate that ACK2 can strongly influence cell shape and growth as well as focal complex formation. ACK2 was found to associate with the focal adhesion complex components talin and vinculin, but not with the focal adhesion kinase (FAK), in a kinase-independent manner. The tyrosine kinase activity of FAK was also inhibited in cells overexpressing both wild-type and kinase-defective ACK2. This may be due to a competition between ACK2 and FAK for Src, which is an essential cofactor for FAK activation, as we have found that ACK2 specifically binds Src in cells. The ACK2-Src interaction appears to be mediated by the SH3 domain of Src, and the phosphorylation of ACK2 is enhanced in cells overexpressing the hyperactivated Src(Y527F) mutant. Overexpression of both wild-type and kinase-defective ACK2 also results in a severe inhibition of cell growth. In addition, ACK2 dissolves actin stress fibers and disassembles focal complexes but in a kinase-dependent manner. These results, taken together with previous studies demonstrating an association of ACK2 with integrin beta1 (Yang, W., Lin, Q., Guan, J.-L., Cerione, R. A (1999) J. Biol. Chem. 274,8524-8530) and clathrin (Yang, W., Lo, C. G., Dispenza, T., and Cerione, R. A. (2001) J. Biol. Chem. 276,17468-17473), suggest that the binding and protein tyrosine kinase activities of ACK2 coordinate changes in cell morphology and growth with the disassembly of focal adhesion sites, perhaps to organize new integrin complexes that are required for endocytosis and/or for cellular differentiation.	Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.				NIGMS NIH HHS [GM47458, GM40654] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R01GM040654] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Jones RJ, 2000, EUR J CANCER, V36, P1595, DOI 10.1016/S0959-8049(00)00153-2; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	22	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43987	43993		10.1074/jbc.M104819200	http://dx.doi.org/10.1074/jbc.M104819200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11535592	hybrid			2022-12-27	WOS:000172297700066
J	Gensure, RC; Carter, PH; Petroni, BD; Juppner, H; Gardella, TJ				Gensure, RC; Carter, PH; Petroni, BD; Juppner, H; Gardella, TJ			Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TERMINAL REGION; WILD-TYPE; BINDING; PTH; ANTAGONISTS; ACTIVATION; MUTAGENESIS; RESIDUES; ANALOGS	We have investigated receptor structural components responsible for ligand-dependent inverse agonism in a constitutively active mutant of the human parathyroid hormone (PTH)/parathyroid hormone-related peptide (PTHrP) receptor type 1 (hP1R). This mutant receptor, hP1R-H223R (hP1R(CAM-HR)), was originally identified in Jansen's chondrodysplasia and is altered in transmembrane domain (TM) 2. We utilized the PTHrP analog, [Bpa(2), Ile(5),Trp(23),Tyr(36)]PTHrP-(1-36)-amide (Bpa(2)-PTHrP- (1-36)), which has valine 2 replaced by p-benzoyl-L-phenylalanine (Bpa); this substitution renders the peptide a photoreactive inverse agonist at hP1R(CAM-HR). This analog cross-linked to hP1R(CAM-HR) at two contiguous receptor regions as follows: the principal cross-link site (site A) was between receptor residues Pro(415)-Met(441), spanning the TM6/extracellular loop three boundary; the second crosslink site (site B) was within the TM4/TM5 region. Within the site A interval, substitution of Met(425) to Leu converted Bpa(2)-PTHrP-(1-36) from an inverse agonist to a weak partial agonist; this conversion was accompanied by a relative shift of cross-linking from site A to site B. The functional effect of the M425L mutation was specific for Bpa(2)-containing analogs, as inverse agonism of Bpa(2)-PTH-(1-34) was similarly eliminated, whereas inverse agonism of [Leu(11), D-Trp(12)]PTHrP-(5-36) was not affected. Overall, our data indicate that interactions between residue 2 of the ligand and the extracellular end of TM6 of the hP1R play an important role in modulating the conversion between active and inactive receptor states.	Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gardella, TJ (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	gardella@helix.mgh.harvard.edu			NIDDK NIH HHS [DK11794, 1F32DK10034-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, F32DK010034] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alewijnse AE, 1998, J NEUROCHEM, V71, P799; Bakker RA, 2000, EUR J PHARMACOL, V387, pR5, DOI 10.1016/S0014-2999(99)00803-1; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; Bowen WP, 1995, TRENDS PHARMACOL SCI, V16, P413, DOI 10.1016/S0165-6147(00)89091-4; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Carter PH, 2001, ENDOCRINOLOGY, V142, P1534, DOI 10.1210/en.142.4.1534; Carter PH, 1999, ENDOCRINOLOGY, V140, P4972, DOI 10.1210/en.140.11.4972; Claeysen S, 2000, MOL PHARMACOL, V58, P136, DOI 10.1124/mol.58.1.136; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; GARDELLA TJ, 1994, ENDOCRINOLOGY, V135, P1186, DOI 10.1210/en.135.3.1186; Gardella TJ, 1996, ENDOCRINOLOGY, V137, P3936, DOI 10.1210/en.137.9.3936; Gardella TJ, 1996, J BIOL CHEM, V271, P12820, DOI 10.1074/jbc.271.22.12820; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Hall DA, 1997, BRIT J PHARMACOL, V121, P731, DOI 10.1038/sj.bjp.0701196; Hoare SRJ, 2001, J BIOL CHEM, V276, P7741, DOI 10.1074/jbc.M009395200; HORIUCHI N, 1983, SCIENCE, V220, P1053, DOI 10.1126/science.6302844; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Juppner H., 2000, ENDOCRINOLOGY, P969; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P301; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lattion AL, 1999, FEBS LETT, V457, P302, DOI 10.1016/S0014-5793(99)01064-9; LEE CW, 1995, MOL ENDOCRINOL, V9, P1269, DOI 10.1210/me.9.10.1269; Nagaraja S, 1999, BRIT J PHARMACOL, V127, P1099, DOI 10.1038/sj.bjp.0702645; NUTT RF, 1990, ENDOCRINOLOGY, V127, P491, DOI 10.1210/endo-127-1-491; Rolz C, 2001, BIOPHYS CHEM, V89, P119, DOI 10.1016/S0301-4622(00)00222-2; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schipani E, 1999, J CLIN ENDOCR METAB, V84, P3052, DOI 10.1210/jc.84.9.3052; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Smit MJ, 1996, P NATL ACAD SCI USA, V93, P6802, DOI 10.1073/pnas.93.13.6802; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; Vilardaga JP, 2001, J BIOL CHEM, V276, P33435, DOI 10.1074/jbc.M011495200	45	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42692	42699		10.1074/jbc.M106215200	http://dx.doi.org/10.1074/jbc.M106215200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553625	hybrid			2022-12-27	WOS:000172169300009
J	Hayashi, M; Otsuka, M; Morimoto, R; Hirota, S; Yatsushiro, S; Takeda, J; Yamamoto, A; Moriyama, Y				Hayashi, M; Otsuka, M; Morimoto, R; Hirota, S; Yatsushiro, S; Takeda, J; Yamamoto, A; Moriyama, Y			Differentiation-associated Na+-dependent inorganic phosphate cotransporter (DNIPI) is a vesicular glutamate transporter in endocrine glutamatergic systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVESICLE-MEDIATED EXOCYTOSIS; SYNAPTIC-LIKE MICROVESICLES; RAT PINEALOCYTES; CHEMICAL TRANSDUCTION; REGIONAL EXPRESSION; PANCREATIC-ISLETS; AMPA SUBTYPE; CELLS; VESICLES; BRAIN	Vesicular glutamate transporter is present in neuronal synaptic vesicles and endocrine synaptic-like microvesicles and is responsible for vesicular storage of L-glutamate. A brain-specific Na+-dependent inorganic phosphate transporter (BNPI) functions as a vesicular glutamate transporter in synaptic vesicles, and the expression of this BNPI defines the glutamatergic phenotype in the central nervous system (Bellocchio, E. E., Reimer, R. J., Fremeau, R.T., Jr., and Edwards, R. H. (2000) Science 289, 957-960; Takamori, S., Rhee, J. S., Rosenmund, C., and Jahn, R. (2000) Nature 407, 189-194). However, since not all glutamatergic neurons contain BNPI, an additional transporter(s) responsible for vesicular glutamate uptake has been postulated. Here we report that differentiation-associated Na+-dependent inorganic phosphate cotransporter (DNPI), an isoform of BNPI (Aihara, Y., Mashima, H., Onda, H., Hisano, S., Kasuya, H., Hori, T., Yamada, S., Tomura, H., Yamada, Y., Inoue, I., Kojima, I., and Takeda, J. (2000) J. Neurochem. 74, 2622-2625), also transports L-glutamate at the expense of an electrochemical gradient of protons established by the vacuolar proton pump when expressed in COS7 cells. Molecular, biological, and immunohistochemical studies have indicated that besides its presence in neuronal cells DNPI is preferentially expressed in mammalian pinealocytes, alpha TC6 cells, clonal pancreatic alpha cells, and alpha cells of Langerhans islets, these cells being proven to secrete L-glutamate through Ca2+-dependent regulated exocytosis followed by its vesicular storage. Pancreatic polypeptide-secreting F cells of Langerhans islets also expressed DNPI. These results constitute evidence that DNPI functions as another vesicular transporter in glutamatergic endocrine cells as well as in neurons.	Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Okayama 7008530, Japan; Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gumma 3718512, Japan; Kansai Med Univ, Dept Physiol, Osaka 5708506, Japan	Okayama University; Gunma University; Kansai Medical University	Moriyama, Y (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.							Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; Hayashi M, 1999, J NEUROCHEM, V73, P2538, DOI 10.1046/j.1471-4159.1999.0732538.x; Hayashi T, 1998, J NEUROCHEM, V71, P356; Hisano S, 2000, MOL BRAIN RES, V83, P34, DOI 10.1016/S0169-328X(00)00194-7; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MORIYAMA Y, 1995, FEBS LETT, V367, P233, DOI 10.1016/0014-5793(95)00559-R; Moriyama Y, 1996, BIOL CHEM H-S, V377, P155; Moriyama Y, 2000, J EXP BIOL, V203, P117; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; NAITO S, 1983, J BIOL CHEM, V258, P696; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; NERLSON N, 1999, PHYSIOL REV, V79, P361; NI BH, 1995, J NEUROSCI, V15, P5789; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Otis TS, 2001, NEURON, V29, P11, DOI 10.1016/S0896-6273(01)00176-3; PAPASOZOMENOS SC, 1983, J NEUROPATH EXP NEUR, V42, P391, DOI 10.1097/00005072-198307000-00003; PEDERSEN EB, 1993, CELL TISSUE RES, V272, P257, DOI 10.1007/BF00302731; REDECKER P, 1993, J NEUROSCI RES, V34, P79, DOI 10.1002/jnr.490340109; Redecker P, 1999, INT REV CYTOL, V191, P201, DOI 10.1016/S0074-7696(08)60160-6; Sakata-Haga H, 2001, BRAIN RES, V902, P143, DOI 10.1016/S0006-8993(01)02290-9; Sambrook J., 2002, MOL CLONING LAB MANU; SCHACHNER M, 1984, CELL TISSUE RES, V237, P245, DOI 10.1007/BF00217142; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Weaver CD, 1998, J BIOL CHEM, V273, P1647, DOI 10.1074/jbc.273.3.1647; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Yamada H, 1996, J PINEAL RES, V21, P175, DOI 10.1111/j.1600-079X.1996.tb00285.x; Yamada H, 1997, J NEUROCHEM, V69, P1491; Yamada H, 1998, J NEUROSCI, V18, P2056; Yamada H, 2001, DIABETES, V50, P1012, DOI 10.2337/diabetes.50.5.1012; Yatsushiro S, 1997, J NEUROCHEM, V69, P340	46	96	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43400	43406		10.1074/jbc.M106244200	http://dx.doi.org/10.1074/jbc.M106244200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551935	hybrid			2022-12-27	WOS:000172169300099
J	Dickson, KS; Thompson, SR; Gray, NK; Wickens, M				Dickson, KS; Thompson, SR; Gray, NK; Wickens, M			Poly(A) polymerase and the regulation of cytoplasmic polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTE MATURATION; B1 MESSENGER-RNA; SPECIFICITY FACTOR; TRANSLATION INITIATION; C-MOS; MUTATIONAL ANALYSIS; BINDING-PROTEIN; FROG OOCYTES; CPEB; CLEAVAGE	Translational activation in oocytes and embryos is often regulated via increases in poly(A) length. Cleavage and polyadenylation specificity factor (CPSF), cytoplasmic polyadenylation element binding protein (CPEB), and poly(A) polymerase (PAP) have each been implicated in cytoplasmic polyadenylation in Xenopus laevis oocytes. Cytoplasmic polyadenylation activity first appears in vertebrate oocytes during meiotic maturation. Data presented here shows that complexes containing both CPSF and CPEB are present in extracts of X. laevis oocytes prepared before or after meiotic maturation. Assessment of a variety of RNA sequences as polyadenylation substrates indicates that the sequence specificity of polyadenylation in egg extracts is comparable to that observed with highly purified mammalian CPSF and recombinant PAP. The two in vitro systems exhibit a sequence specificity that is similar, but not identical, to that observed in vivo, as assessed by injection of the same RNAs into the oocyte. These findings imply that CPSFs intrinsic RNA sequence preferences are sufficient to account for the specificity of cytoplasmic polyadenylation of some mRNAs. We discuss the hypothesis that CPSF is required for all polyadenylation reactions, but that the polyadenylation of some mRNAs may require additional factors such as CPEB. To test the consequences of PAP binding to mRNAs in vivo, PAP was tethered to a reporter mRNA in resting oocytes using MS2 coat protein. Tethered PAP catalyzed polyadenylation and stimulated translation similar to 40-fold; stimulation was exclusively cis-acting, but was independent of a CPE and AAUAAA. Both polyadenylation and translational stimulation required PAPs catalytic core, but did not require the putative CPSF interaction domain of PAP. These results demonstrate that premature recruitment of PAP can cause precocious polyadenylation and translational stimulation in the resting oocyte, and can be interpreted to suggest that the role of other factors is to deliver PAP to the mRNA.	Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA.	wickens@biochen.wisc.edu		gray, nicola/0000-0002-0413-1767; Thompson, Sunnie/0000-0002-7338-8822	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031892] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561111] Funding Source: Medline; NIGMS NIH HHS [R01 GM31892] Funding Source: Medline; MRC [MC_U127561111] Funding Source: UKRI	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BALLANTYNE S, 1995, RNA, V1, P64; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; CONSTABLE A, 1992, P NATL ACAD SCI USA, V89, P4554, DOI 10.1073/pnas.89.10.4554; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; DAVIDSON EH, 1986, GENE ACTIVATION EARL; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; FOX CA, 1992, EMBO J, V11, P5021, DOI 10.1002/j.1460-2075.1992.tb05609.x; GEBAUER F, 1995, MOL CELL BIOL, V15, P1422; Gillian-Daniel DL, 1998, MOL CELL BIOL, V18, P6152, DOI 10.1128/MCB.18.10.6152; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Keiper BD, 1999, DEV BIOL, V206, P1, DOI 10.1006/dbio.1998.9131; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; Martin G, 1999, PROTEIN SCI, V8, P2380; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; RAABE T, 1994, MOL CELL BIOL, V14, P2946, DOI 10.1128/MCB.14.5.2946; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; VARNUM SM, 1990, GENE DEV, V4, P2278, DOI 10.1101/gad.4.12b.2278; Verrotti AC, 1996, P NATL ACAD SCI USA, V93, P9027, DOI 10.1073/pnas.93.17.9027; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wakiyama M, 2000, CURR BIOL, V10, P1147, DOI 10.1016/S0960-9822(00)00701-6; Walker J, 1999, RNA, V5, P14, DOI 10.1017/S1355838299981219; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; WICKENS M, 1992, SEM DEV BIOL, V3, P399; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	54	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41810	41816		10.1074/jbc.M103030200	http://dx.doi.org/10.1074/jbc.M103030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551905	hybrid			2022-12-27	WOS:000172450400037
J	El-Tanani, M; Fernig, DG; Barraclough, R; Green, C; Rudland, P				El-Tanani, M; Fernig, DG; Barraclough, R; Green, C; Rudland, P			Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-INDUCING DNA; OSTEOPONTIN EXPRESSION; ER-ALPHA; GENE; BINDING; IDENTIFICATION; ACTIVATION; MECHANISMS; CLONING; PREGNANCY	Two major signaling pathways, those triggered by estrogen (E-2) and by the Wnt family, interact in the breast to cause growth and differentiation. The estrogen receptors ERalpha and ERbeta are activated by binding E-2 and act as ligand-dependent transcription factors. The effector for the Wnt family is the Tcf family of transcription factors. Both sets of transcription factors recognize discrete but different nucleotide sequences in the promoters of their target genes. By using transient transfections of reporter constructs for the osteopontin and thymidine kinase promoters in rat mammary cells, we show that Tcf-4 antagonizes and Tcf-1 stimulates the effects of activated ER/E-2. For mutants of the former promoter, the stimulatory effects of ERalpha/E-2 can be made to be dependent on Tcf-1, and for the latter promoter the effects of the T cell factors (TCFs) are dependent on ER/E-2. Direct interaction between ERs and Tcfs either at the Tcf/ERalpha-binding site on the DNA or in the absence of DNA is established by gel retardation assays or by coimmuno-precipitation/biosensor methods, respectively. These results show that the two sets of transcription factors can interact directly, the interaction between ERs and Tcf-4 being antagonistic and that between ERs and Tcf-1 being synergistic on the activity of the promoters employed. Since Tcf-4 is the major Tcf family member in the breast, it is suggested that the antagonistic interaction is normally dominant in vivo in this tissue.	Univ Liverpool, Sch Biol Sci, Mol Med Grp, Canc & Polio Res Fund Labs, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Rudland, P (corresponding author), Univ Liverpool, Sch Biol Sci, Mol Med Grp, Canc & Polio Res Fund Labs, POB 147, Liverpool L69 7ZB, Merseyside, England.		Barraclough, Roger/AAH-6516-2020; Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; El-Tanani, Mohamed/0000-0002-4735-5445; Barraclough, Roger/0000-0002-7203-1194				Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; Barker N, 2000, ADV CANCER RES, V77, P1; BARKER PE, 1984, P NATL ACAD SCI-BIOL, V81, P5826, DOI 10.1073/pnas.81.18.5826; Bellahcene A, 1996, LAB INVEST, V75, P203; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; BRADBURY JM, 1995, DEV BIOL, V170, P553, DOI 10.1006/dbio.1995.1236; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; CHANG TC, 1992, MOL ENDOCRINOL, V6, P346, DOI 10.1210/me.6.3.346; Cowley SM, 1999, J STEROID BIOCHEM, V69, P165, DOI 10.1016/S0960-0760(99)00055-2; Curtis SH, 2000, ADV PHARMACOL, V47, P357; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DUNNINGTON DJ, 1983, J NATL CANCER I, V71, P1227; Edwards PAW, 1998, BIOCHEM SOC SYMP, P21; EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522; El-Tanani M, 2001, CANCER RES, V61, P5619; El-Tanani MK, 2001, ONCOGENE, V20, P1793, DOI 10.1038/sj.onc.1204358; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; ElTanani MKK, 1997, J STEROID BIOCHEM, V60, P269, DOI 10.1016/S0960-0760(96)00226-9; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; INCE BA, 1993, J BIOL CHEM, V268, P14026; KERPPOLA T, 1995, NATURE, V373, P199, DOI 10.1038/373199a0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Nemir M, 2000, J BIOL CHEM, V275, P969, DOI 10.1074/jbc.275.2.969; Oates AJ, 1996, ONCOGENE, V13, P97; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; RIDALL AL, 1995, ANN NY ACAD SCI, V760, P59, DOI 10.1111/j.1749-6632.1995.tb44620.x; Rittling SR, 1997, CELL GROWTH DIFFER, V8, P1061; Rudland PS, 1998, BIOCHEM SOC SYMP, P1; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Schilham MW, 1998, SEMIN IMMUNOL, V10, P127, DOI 10.1006/smim.1998.0114; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; TRATNER I, 1992, MOL CELL BIOL, V12, P998, DOI 10.1128/MCB.12.3.998; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Van den Bemd GJCM, 1999, BIOCHEM BIOPH RES CO, V261, P1, DOI 10.1006/bbrc.1999.0864; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794	49	62	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41675	41682		10.1074/jbc.M103966200	http://dx.doi.org/10.1074/jbc.M103966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11522780	hybrid			2022-12-27	WOS:000172450400020
J	Paulhe, F; Racaud-Sultan, C; Ragab, A; Albiges-Rizo, C; Chap, H; Iberg, N; Morand, O; Perret, B				Paulhe, F; Racaud-Sultan, C; Ragab, A; Albiges-Rizo, C; Chap, H; Iberg, N; Morand, O; Perret, B			Differential regulation of phosphoinositide metabolism by alpha(V)beta(3) and alpha(V)beta(5) integrins upon smooth muscle cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE KINASE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 4-KINASE; FACTOR-I; PYK2; ACTIVATION; 3-KINASE; VITRONECTIN; PHOSPHORYLATION	Smooth muscle cell migration is a key step of atherosclerosis and angiogenesis. We demonstrate that alpha (V)beta (3) and alpha (V)beta (5) integrins synergistically regulate smooth muscle cell migration onto vitronectin. Using an original haptotactic cell migration assay, we measured a strong stimulation of phosphoinositide metabolism in migrating vascular smooth muscle cells. Phosphatidic acid production and phosphoinositide 3-kinase IA activation were triggered only upon alpha (V)beta (3) engagement. Blockade of alpha (V)beta (3) engagement or phospholipase C activity resulted in a strong inhibition of smooth muscle cell spreading on vitronectin. By contrast, blockade of alpha (V)beta (5) reinforced elongation and polarization of cell shape. Moreover, Pyk2-associated tyrosine kinase and phosphoinositide 4-kinase activities measured in Pyk2 immunoprecipitates were stimulated upon cell migration. Blockade of either alpha (V)beta (3) or alpha (V)beta (5) function, as well as inhibition of phospholipase C activity, decreased both Pyk2-associated activities. We demonstrated that the Pyk2-associated phosphoinositide 4-kinase corresponded to the beta isoform. Our data point to the metabolism of phosphoinositides as a regulatory pathway for the differential roles played by alpha (V)beta (3) and alpha (V)beta (5) upon cell migration and identify the Pyk2-associated phosphoinositide 4-kinase beta as a common target for both integrins.	Hop Purpan, INSERM, Unite 326, Inst Federat Rech Claude De Preval, F-31059 Toulouse, France; F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Preclin Cardiovasc Res, CH-4002 Basel, Switzerland; Fac Med Grenoble, Inst ALbert Bonniot, UJF, CNRS,UMR 5538,LEDAC, F-38706 La Tronche, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Roche Holding; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Racaud-Sultan, C (corresponding author), Hop Purpan, INSERM, Unite 326, Inst Federat Rech Claude De Preval, F-31059 Toulouse, France.	racaud@purpan.inserm.fr	Albiges-Rizo, Corinne/M-2568-2013	Racaud-Sultan, Claire/0000-0002-6549-1088; ALBIGES-RIZO, Corinne/0000-0002-6333-4150				AnandApte B, 1997, STEM CELLS, V15, P259, DOI 10.1002/stem.150259; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Astier A, 1997, J BIOL CHEM, V272, P228; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Bialkowska K, 2000, J CELL BIOL, V151, P685, DOI 10.1083/jcb.151.3.685; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; COHEN P, 1971, J CLIN INVEST, V50, P762, DOI 10.1172/JCI106547; Corjay MH, 1999, J CELL BIOCHEM, V75, P492, DOI 10.1002/(SICI)1097-4644(19991201)75:3<492::AID-JCB13>3.3.CO;2-Q; DELANNET M, 1994, DEVELOPMENT, V120, P2687; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Dufourcq P, 1998, ARTERIOSCL THROM VAS, V18, P168, DOI 10.1161/01.ATV.18.2.168; Fernandis AZ, 2000, MOL IMMUNOL, V37, P273, DOI 10.1016/S0161-5890(00)00053-5; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Greenwood JA, 1998, J BIOL CHEM, V273, P1755, DOI 10.1074/jbc.273.3.1755; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hatch WC, 1998, BLOOD, V91, P3967, DOI 10.1182/blood.V91.10.3967.3967_3967_3973; Heraud JM, 1998, J BIOL CHEM, V273, P17817, DOI 10.1074/jbc.273.28.17817; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; JOLLES J, 1981, BIOCHIM BIOPHYS ACTA, V666, P90, DOI 10.1016/0005-2760(81)90094-1; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Kumar S, 1999, J BIOL CHEM, V274, P30657, DOI 10.1074/jbc.274.43.30657; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; PASQUALINI R, 1994, J CELL BIOL, V125, P447, DOI 10.1083/jcb.125.2.447; PIGNATARO OP, 1990, J BIOL CHEM, V265, P1718; Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90, DOI 10.1152/ajpcell.2001.280.1.C90; Ronnstrand L, 1999, J BIOL CHEM, V274, P22089, DOI 10.1074/jbc.274.31.22089; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Sayed MR, 2000, J CELL PHYSIOL, V183, P314, DOI 10.1002/(SICI)1097-4652(200006)183:3<314::AID-JCP3>3.0.CO;2-J; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	52	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41832	41840		10.1074/jbc.M105459200	http://dx.doi.org/10.1074/jbc.M105459200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551924	hybrid			2022-12-27	WOS:000172450400040
J	Fukuda, M; Yamamoto, A; Mikoshiba, K				Fukuda, M; Yamamoto, A; Mikoshiba, K			Formation of crystalloid endoplasmic reticulum induced by expression of synaptotagmin lacking the conserved WHXL motif in the C terminus - Structural importance of the WHXL motif in the C2B domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUID GIANT SYNAPSE; HIGH-POLYPHOSPHATE BINDING; PC12 CELLS; NEUROTRANSMITTER RELEASE; FUNCTIONAL DIVERSITY; TRANSMITTER RELEASE; MUTATIONAL ANALYSIS; ANTIBODY INJECTION; NEURITE OUTGROWTH; COS CELLS	Synaptotagmin (Syt) is a family of type I membrane proteins that consists of a single transmembrane domain, a spacer domain, two Ca2+-binding C2 domains, and a short C terminus. We recently showed that deletion of the short C terminus (17 amino acids) of Syt IV prevented the Golgi localization of Syt IV proteins in PC12 cells and induced granular structures of various sizes in the cell body by an unknown mechanism (Fukuda, M., Ibata, K., and Mikoshiba, K. (2001) J. New rochem. 77, 730-740). In this study we showed by electron microscopy that these structures are crystalloid endoplasmic reticulum (ER), analyzed the mechanism of its induction, and demonstrated that: (a) mutation or deletion of the evolutionarily conserved WHXL motif in the C terminus of the synaptotagmin family (Syt DeltaC) destabilizes the C2B domain structure (i.e. causes misfolding of the protein), probably by disrupting the formation of stable anti-parallel beta -sheets between the beta -1 and beta -8 strands of the C2B domain; (b) the resulting malfolded proteins accumulate in the ER rather than being transported to other membrane structures (e.g. the Golgi apparatus), with the malfolded proteins also inducing the expression of BiP (immunoglobulin binding protein), one of the ER stress proteins; and (c) the ERs in which the Syt AC proteins have accumulated associate with each other as a result of oligomerization capacity of the synaptotagmin family, because the Syt IAC mutant, which lacks oligomerization activity, cannot induce crystalloid ER. Our findings indicate that the conserved WHXL motif is important not only for protein interaction site but for proper folding of the C2B domain.	RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Wako, Saitama 3510198, Japan; Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 5708506, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol,Minato Ku, Tokyo 1088639, Japan	RIKEN; Kansai Medical University; University of Tokyo	Fukuda, M (corresponding author), RIKEN, Dev Neurobiol Lab, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mnfukuda@brain.riken.go.jp	Fukuda, MItsunori/I-1511-2015; Mikoshiba, Katsuhiko/N-7943-2015	Fukuda, MItsunori/0000-0002-8620-5853; 				BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Detrait E, 2000, J NEUROBIOL, V44, P382, DOI 10.1002/1097-4695(20000915)44:4<382::AID-NEU2>3.0.CO;2-Q; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2000, NEUROSCI LETT, V295, P33, DOI 10.1016/S0304-3940(00)01585-8; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Fukuda M, 2000, FEBS LETT, V482, P269, DOI 10.1016/S0014-5793(00)02064-0; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; Fukuda M, 2001, J BIOL CHEM, V276, P27670, DOI 10.1074/jbc.M100851200; Fukuda M, 2001, BIOCHEM J, V354, P249, DOI 10.1042/0264-6021:3540249; Fukuda M, 2000, P NATL ACAD SCI USA, V97, P14715, DOI 10.1073/pnas.260491197; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; Fukuda M, 2000, J BIOCHEM, V128, P637, DOI 10.1093/oxfordjournals.jbchem.a022796; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; ISHIHARA N, 1995, J BIOCHEM-TOKYO, V118, P397, DOI 10.1093/oxfordjournals.jbchem.a124920; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kabayama H, 1999, NEUROSCIENCE, V88, P999, DOI 10.1016/S0306-4522(98)00547-8; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Krasnov PA, 2000, J CELL SCI, V113, P1389; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; LENNY N, 1991, J BIOL CHEM, V266, P20532; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mizutani A, 1997, BIOCHEM BIOPH RES CO, V240, P128, DOI 10.1006/bbrc.1997.7578; Mochida S, 1997, NEUROSCIENCE, V77, P937; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OharaImaizumi M, 1997, P NATL ACAD SCI USA, V94, P287, DOI 10.1073/pnas.94.1.287; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; Perin MS, 1996, BIOCHEMISTRY-US, V35, P13808, DOI 10.1021/bi960853x; PERIN MS, 1991, J BIOL CHEM, V266, P623; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; Reist NE, 1998, J NEUROSCI, V18, P7662; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugimori M, 1998, NEUROSCIENCE, V86, P39, DOI 10.1016/S0306-4522(97)00689-1; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Thomas DM, 1998, J NEUROSCI, V18, P3511; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Yamamoto A, 1996, J CELL SCI, V109, P1727	69	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41112	41119		10.1074/jbc.M106209200	http://dx.doi.org/10.1074/jbc.M106209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533032	hybrid			2022-12-27	WOS:000171925600099
J	Schonherr, E; Levkau, B; Schaefer, L; Kresse, H; Walsh, K				Schonherr, E; Levkau, B; Schaefer, L; Kresse, H; Walsh, K			Decorin-mediated signal transduction in endothelial cells - Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; GROWTH-FACTOR RECEPTOR; SULFATE PROTEOGLYCANS; CARCINOMA-CELLS; GENE-EXPRESSION; TUBE FORMATION; SURVIVAL; AKT; ANGIOGENESIS; SUPPRESSION	Endothelial cells undergoing angiogenesis express decorin, a small multifunctional proteoglycan. We have shown that decorin is causally involved in the formation of capillary-like structures and a decrease in apoptosis in endothelial cells cultured in a collagen lattice. Here we investigate signal transduction pathways mediating the effects of decorin. Reverse transcription-polymerase chain reaction demonstrated that p21 and p27, two inhibitors of cyclin-dependent kinases, were up-regulated by decorin induction. Decorin also increased protein levels of p21 and caused its translocation into the nucleus. p21 synthesis started 6 h after decorin addition and reached a plateau after 18 h, while cyclin A, which was also induced, peaked at 12 h and declined below basal levels within 24 h. These effects were mediated by the Akt/protein kinase B pathway. Akt phosphorylation at Thr-308 increased 4-fold and at Ser-473 1.4-fold within 10 min after decorin addition. Overexpression of dominant negative Akt inhibited the decorin-mediated induction of p21 and cyclin A, but had no effect on p27. These results show that decorin is a signaling molecule in sprouting endothelial cells where it acts via different pathways, one of them involving Akt/protein kinase B.	Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; Univ Munster, Inst Arteriosclerosis Res, D-48149 Munster, Germany; Univ Munster, Inst Internal Med, D-48149 Munster, Germany; Univ Hosp Munster, D-48149 Munster, Germany; St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA	University of Munster; University of Munster; University of Munster; University of Munster; St. Elizabeth's Medical Center	Schonherr, E (corresponding author), Univ Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.		Levkau, Bodo/N-9144-2017	Schaefer, Liliana/0000-0002-3318-3005				Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen DH, 2000, ARTERIOSCL THROM VAS, V20, P629, DOI 10.1161/01.ATV.20.3.629; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; GOTTE M, 1995, EUR J CELL BIOL, V66, P226; GREVE H, 1990, BIOCHEM J, V269, P149, DOI 10.1042/bj2690149; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HAUSSER H, 1992, J BIOL CHEM, V267, P11559; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Hocking AM, 1998, MATRIX BIOL, V17, P1; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JARVELAINEN HT, 1992, EXP CELL RES, V203, P395, DOI 10.1016/0014-4827(92)90013-X; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nelimarkka L, 1997, J BIOL CHEM, V272, P12730, DOI 10.1074/jbc.272.19.12730; Nelimarkka L, 2001, AM J PATHOL, V158, P345, DOI 10.1016/S0002-9440(10)63975-2; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rots NY, 1999, BLOOD, V93, P2721, DOI 10.1182/blood.V93.8.2721.408k28_2721_2729; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schonherr E, 1999, EUR J CELL BIOL, V78, P44, DOI 10.1016/S0171-9335(99)80006-5; Schonherr E, 2001, J CELL PHYSIOL, V187, P37, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1048>3.0.CO;2-W; Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969; Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhang PM, 1999, CURR OPIN CELL BIOL, V11, P655, DOI 10.1016/S0955-0674(99)00032-0	39	98	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40687	40692		10.1074/jbc.M105426200	http://dx.doi.org/10.1074/jbc.M105426200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546775	hybrid			2022-12-27	WOS:000171925600042
J	Szaszi, K; Kurashima, K; Kaibuchi, K; Grinstein, S; Orlowski, J				Szaszi, K; Kurashima, K; Kaibuchi, K; Grinstein, S; Orlowski, J			Role of the cytoskeleton in mediating cAMP-dependent protein kinase inhibition of the epithelial Na+/H+ exchanger NHE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; RHO-KINASE; BRUSH-BORDER; CYCLIC-AMP; F-ACTIN; PHOSPHATIDYLINOSITOL 3-KINASE; MORPHOLOGICAL-CHANGES; REGULATORY PROTEIN; MAMMALIAN-CELLS; ATP DEPENDENCE	The Na+/H+ exchanger NHE3 isoform mediates the entry of Na+ into epithelial cells of the kidney and gastrointestinal tract. Hormones and pharmacological agents that activate cAMP-dependent protein kinase A (PKA) are potent inhibitors of native and ectopically expressed NHE3 in epithelial and Chinese hamster ovary AP-1 cells, respectively. Previous studies have shown that acute inhibition is coupled to direct phosphorylation of the exchanger, but this only partly accounts for the observed effects. In this report, we show that inhibition of NHE3 activity by forskolin, an activator of adenylate cyclase, occurs without changes in surface expression of the exchanger but is associated with altered cytoskeletal structure. This effect resembles that obtained with cytochalasin D or latrunculin B, actin disrupting agents that also inhibit NHE3. Such similarities prompted us to further investigate the relationship between PKA-induced inhibition of the exchanger and changes in the actin cytoskeleton. Inhibition of NHE3 by cytochalasin D does not require PKA, because the inhibitory effect is preserved in a mutant NHE3 that is not phosphorylated by PKA and in cells pretreated with the PKA inhibitor H89. In contrast, involvement of actin in the effect of cAMP on the exchanger is supported by the following observations: (i) jasplakinolide, an F-actin stabilizer, prevents the inhibition caused by forskolin, and (ii) constitutively active forms of RhoA and Rho kinase interfere with actin disruption by forskolin and also decrease inhibition of the transporter. These results suggest that reorganization of the cytoskeleton by PKA is involved in mediating inhibition of NHE3.	Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300101, Japan; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Nara Institute of Science & Technology; McGill University	Grinstein, S (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Szaszi, Katalin/J-7522-2012	Szaszi, Katalin/0000-0002-2490-8422; Orlowski, John/0000-0001-7371-175X				Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; BIEMESDERFER D, 1997, AM J PHYSIOL, V273, P289; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cabado AG, 1996, J BIOL CHEM, V271, P3590; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chow CW, 1999, CLIN INVEST MED, V22, P195; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Janecki AJ, 2000, J BIOL CHEM, V275, P8133, DOI 10.1074/jbc.275.11.8133; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; KAPUS A, 1994, J BIOL CHEM, V269, P23544; KREISBERG JI, 1985, AM J PHYSIOL, V249, pF227, DOI 10.1152/ajprenal.1985.249.2.F227; Kreisberg JI, 1997, AM J PHYSIOL-RENAL, V273, pF283, DOI 10.1152/ajprenal.1997.273.2.F283; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; LAMPUGNANI MG, 1990, LAB INVEST, V63, P521; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matthews JB, 1997, AM J PHYSIOL-CELL PH, V272, pC254, DOI 10.1152/ajpcell.1997.272.1.C254; MOE OW, 1995, J CLIN INVEST, V96, P2187, DOI 10.1172/JCI118273; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; PRAT AG, 1995, AM J PHYSIOL-CELL PH, V268, pC1552, DOI 10.1152/ajpcell.1995.268.6.C1552; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; RESHKIN SJ, 1992, AM J PHYSIOL, V262, pF572, DOI 10.1152/ajprenal.1992.262.4.F572; ROGER PP, 1988, FEBS LETT, V232, P409, DOI 10.1016/0014-5793(88)80781-6; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SHAPIRO M, 1991, J CLIN INVEST, V87, P1903, DOI 10.1172/JCI115215; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; SOLEIMANI M, 1994, J BIOL CHEM, V269, P15613; Szaszi K, 2000, J BIOL CHEM, V275, P28599, DOI 10.1074/jbc.M001193200; Szaszi K, 2000, CELL PHYSIOL BIOCHEM, V10, P265, DOI 10.1159/000016358; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; WU MS, 1994, J MEMBRANE BIOL, V142, P323; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978	57	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40761	40768		10.1074/jbc.M106724200	http://dx.doi.org/10.1074/jbc.M106724200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522794	hybrid			2022-12-27	WOS:000171925600053
J	Zheng, XL; Chung, D; Takayama, TK; Majerus, EM; Sadler, JE; Fujikawa, K				Zheng, XL; Chung, D; Takayama, TK; Majerus, EM; Sadler, JE; Fujikawa, K			Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; CYSTEINE SWITCH; GENE FAMILY; CDNA CLONES; PROCOLLAGEN; PROTEINS; IDENTIFICATION; AGGRECANASE-1; PREDICTION; SEQUENCES	Thrombotic thrombocytopenic purpura is associated with acquired or congenital deficiency of a plasma von Willebrand factor-cleaving protease (VWFCP). Based on partial amino acid sequence, VWFCP was identified recently as a new member of the ADAMTS family of metalloproteases and designated ADAMTS13. The 4.6-kilo-base pair cDNA sequence for VWFCP has now been determined. By Northern blotting, full-length VWFCP mRNA was detected only in liver. VWFCP consists of 1427 amino acid residues and has a signal peptide, a short propeptide terminating in the sequence RQRR, a reprolysin-like metalloprotease domain, a disintegrin-like domain, a thrombospondin-1 repeat, a Cys-rich domain, an ADAMTS spacer, seven additional thrombospondin-1 repeats, and two CUB domains. VWFCP apparently is made as a zymogen that requires proteolytic activation, possibly by furin intracellularly. Sites for Zn2+ and Ca2+ ions are conserved in the protease domain. The Cys-rich domain contains an RGDS sequence that could mediate integrin-dependent binding to platelets or other cells. Alternative splicing gives rise to at least seven potential variants that truncate the protein at different positions after the protease domain. Alternative splicing may have functional significance, producing proteins with distinct abilities to interact with cofactors, connective tissue, platelets, and von Wiliebrand factor.	Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Urol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sadler, JE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, 660 S Euclid Ave,Box 8022, St Louis, MO 63110 USA.		Zheng, X. Long/ABD-7362-2021; Sadler, Evan/D-8556-2011	Zheng, X. Long/0000-0003-1680-5295; Sadler, J. Evan/0000-0001-5705-469X; Chung, Dominic/0000-0002-2645-5703	NHLBI NIH HHS [HL16919] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016919] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Adams JC, 2000, DEV DYNAM, V218, P280; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; GOMISRUTH FX, 1994, J MOL BIOL, V239, P513, DOI 10.1006/jmbi.1994.1392; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Kaushal GP, 2000, J CLIN INVEST, V105, P1335, DOI 10.1172/JCI10078; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Moschcowitz E., 1924, P NY PATHOL SOC, V24, P21; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Panetti TS, 1999, J BIOL CHEM, V274, P430, DOI 10.1074/jbc.274.1.430; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Sieron AL, 2000, BIOCHEMISTRY-US, V39, P3231, DOI 10.1021/bi992312o; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STOCKER W, 1995, PROTEIN SCI, V4, P823; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Tang BL, 1999, FEBS LETT, V445, P223, DOI 10.1016/S0014-5793(99)00119-2; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Xu Y, 1997, J COMPUT BIOL, V4, P325, DOI 10.1089/cmb.1997.4.325	49	620	688	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41059	41063		10.1074/jbc.C100515200	http://dx.doi.org/10.1074/jbc.C100515200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11557746	hybrid			2022-12-27	WOS:000171925600092
J	Zamora-Leon, SP; Lee, G; Davies, P; Shafit-Zagardo, B				Zamora-Leon, SP; Lee, G; Davies, P; Shafit-Zagardo, B			Binding of Fyn to MAP-2c through an SH3 binding domain - Regulation of the interaction by ERK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; PROLINE-RICH; TYROSINE KINASE; RAT-BRAIN; ALZHEIMERS-DISEASE; TERMINAL DOMAIN; TAU-PROTEIN; PHOSPHORYLATION; MAP2; LOCALIZATION	Microtubule-associated protein 2 (MAP-2) isoforms are developmentally expressed in the nervous system and contain a number of functional domains. Adjacent to the first repeat of the microtubule-binding domain is an RTPPKSP motif for binding SH3 domains. To identify SH3-containing proteins that interact with MAP-2, transfections, filter overlay assays, glutathione S-transferase (GST)-mediated binding assays, co-immunoprecipitations and enzyme-linked immunosorbent assays were performed. Transfections of MAP-2a, MAP-2b, and MAP-2c constructs into COS7 cells, followed by incubation of the cell lysates with SH3-GST fusion proteins, determined that the strongest interaction was between MAP-2c and the non-receptor tyrosine kinase Fyn; how. ever, MAP-2b and MAP-2c also bound to Grb2. Co-immunoprecipitation of Fyn and MAP-2c from human fetal homogenates confirmed the interaction in vivo. MAP-2 synthetic peptides spanning the RTPPKSP motif bound to Fyn, and the interaction was regulated by phosphorylation. Co-transfections with MAP-2c and the extracellular signal-regulated kinase 2 (ERK2) demonstrated that MAP-2c is theronine/serine-phosphorylated on its R (T) over bar PPK (S) over barP motif and that threonine phosphorylation abolished the MAP-2c/Fyn binding. Kinase assays and co-transfection of MAP-2c and Fyn confirmed that Fyn tyrosine kinase phosphorylates MAP-2c. Thus, the activation of signaling pathways may regulate cytoskeletal dynamics by altering the state of phosphorylation of MAP-2 by both ERK2 and Fyn kinase.	Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	Yeshiva University; Albert Einstein College of Medicine; University of Iowa	Shafit-Zagardo, B (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zagardo@aecom.yu.edu	Lee, Gloria/F-5965-2011; -León, S. Pilar Zamora/AAL-8512-2020	-León, S. Pilar Zamora/0000-0002-4738-9768; Lee, Gloria/0000-0002-8633-1534	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038623, R37MH038623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032100, R01NS038102] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 38623] Funding Source: Medline; NINDS NIH HHS [NS 32100, NS 38102] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AINSZTEIN AM, 1994, J BIOL CHEM, V269, P28465; AKIYAMA T, 1986, J BIOL CHEM, V261, P5648; ALBALA JS, 1995, J NEUROCHEM, V64, P2480; ALBALA JS, 1993, GENE, V136, P377, DOI 10.1016/0378-1119(93)90502-T; BARE DJ, 1993, ONCOGENE, V8, P1429; BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Bhat RV, 1998, J NEUROCHEM, V70, P558; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BIXBY JL, 1993, J NEUROSCI, V13, P3421; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; CARDINE AM, 1995, EUR J IMMUNOL, V25, P3290; Chung WJ, 1996, J NEUROCHEM, V66, P1273; DOLL T, 1993, J CELL SCI, V106, P633; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; GARNER CC, 1988, J NEUROCHEM, V50, P609, DOI 10.1111/j.1471-4159.1988.tb02954.x; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; GREER K, 1989, CELL MOVEMENT, V2, P47; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; GUILLEMINOT J, 1995, CR ACAD SCI III-VIE, V318, P959; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jicha GA, 1997, J NEUROCHEM, V69, P2087; KALCHEVA N, 1995, P NATL ACAD SCI USA, V92, P10894, DOI 10.1073/pnas.92.24.10894; KALCHEVA N, 1994, J NEUROCHEM, V63, P2336; Kalcheva N, 1998, CELL MOTIL CYTOSKEL, V40, P272, DOI 10.1002/(SICI)1097-0169(1998)40:3<272::AID-CM6>3.0.CO;2-F; KALCHEVA N, 1995, J NEUROCHEM, V65, P1472; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee G, 1998, J CELL SCI, V111, P3167; Lim RWL, 2000, J BIOL CHEM, V275, P20578, DOI 10.1074/jbc.M001887200; Lu PJ, 1999, NATURE, V399, P784; Martin CS, 1998, NEUROSCIENCE, V87, P861, DOI 10.1016/S0306-4522(98)00195-X; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Morgan JC, 2000, J NEUROSCI RES, V59, P226, DOI 10.1002/(SICI)1097-4547(20000115)59:2<226::AID-JNR9>3.0.CO;2-J; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Quinlan EM, 1996, J NEUROSCI, V16, P7627; RIEDERER B, 1985, P NATL ACAD SCI USA, V82, P6006, DOI 10.1073/pnas.82.17.6006; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanchez C, 1996, EUR J BIOCHEM, V241, P765, DOI 10.1111/j.1432-1033.1996.00765.x; Scaife RM, 2000, J CELL SCI, V113, P215; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Shafit-Zagardo B, 2000, GLIA, V29, P233, DOI 10.1002/(SICI)1098-1136(20000201)29:3<233::AID-GLIA5>3.0.CO;2-U; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; SILLIMAN CC, 1989, BIOCHEM BIOPH RES CO, V160, P993, DOI 10.1016/S0006-291X(89)80099-3; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; TUCKER RP, 1988, J NEUROSCI, V8, P4503; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; VIERECK C, 1989, J NEUROSCI, V9, P3547; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	61	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39950	39958		10.1074/jbc.M107807200	http://dx.doi.org/10.1074/jbc.M107807200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546790	hybrid			2022-12-27	WOS:000171789200061
J	Ho, CK; Shuman, S				Ho, CK; Shuman, S			Trypanosoma brucei RNA triphosphatase - Antiprotozoal drug target and guide to eukaryotic phylogeny	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPPING APPARATUS; GUANYLYLTRANSFERASE COMPONENT; NUCLEOSIDE TRIPHOSPHATASE; YEAST; MECHANISM; 5'-TRIPHOSPHATASE; ENZYMES	The mRNA capping apparatus of the protozoan parasite Trypanosoma brucei consists of separately encoded RNA triphosphatase and RNA guanylyltransferase enzymes. The triphosphatase ThCet1 is a member of a new family of metal-dependent phosphohydrolases that includes the RNA triphosphatases of fungi and the malaria parasite Plasmodium falciparum. The protozoal/fungal enzymes are structurally and mechanistically unrelated to the RNA triphosphatases of metazoans and plants. These results highlight the potential for discovery of broad spectrum antiprotozoal and antifungal. drugs that selectively block the capping of pathogen-encoded mRNAs. We propose a scheme of eukaryotic phylogeny based on the structure of RNA triphosphatase and its physical linkage to the guanylyltransferase component of the capping apparatus.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org	Ho, KIong/GPP-6051-2022					Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; BANGS JD, 1992, J BIOL CHEM, V267, P9805; Bisaillon M, 2001, J BIOL CHEM, V276, P17261, DOI 10.1074/jbc.M100980200; Cattand P, 2001, TROP MED INT HEALTH, V6, P348, DOI 10.1046/j.1365-3156.2001.00669.x; Changela A, 2001, EMBO J, V20, P2575, DOI 10.1093/emboj/20.10.2575; Docampo R, 2001, CURR PHARM DESIGN, V7, P1157, DOI 10.2174/1381612013397546; Gross CH, 1998, J VIROL, V72, P10020, DOI 10.1128/JVI.72.12.10020-10028.1998; Hausmann S, 2001, J BIOL CHEM, V276, P36116, DOI 10.1074/jbc.M105856200; Ho CK, 2001, P NATL ACAD SCI USA, V98, P3050, DOI 10.1073/pnas.061636198; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 1999, NUCLEIC ACIDS RES, V27, P4671, DOI 10.1093/nar/27.24.4671; Ho CK, 2001, J VIROL, V75, P1744, DOI 10.1128/JVI.75.4.1744-1750.2001; Ho CK, 2000, J VIROL, V74, P5486, DOI 10.1128/JVI.74.12.5486-5494.2000; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; Lehman K, 1999, J BIOL CHEM, V274, P22668, DOI 10.1074/jbc.274.32.22668; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Mair G, 2000, J BIOL CHEM, V275, P28994, DOI 10.1074/jbc.M004193200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pei Y, 2000, NUCLEIC ACIDS RES, V28, P1885, DOI 10.1093/nar/28.9.1885; Pei Y, 1999, J BIOL CHEM, V274, P28865, DOI 10.1074/jbc.274.41.28865; Pei Y, 2001, NUCLEIC ACIDS RES, V29, P387, DOI 10.1093/nar/29.2.387; Rodriguez JB, 2001, CURR PHARM DESIGN, V7, P1105, DOI 10.2174/1381612013397555; Schwer B, 2001, J BIOL CHEM, V276, P1857, DOI 10.1074/jbc.M006072200; Seed JR, 2001, INT J PARASITOL, V31, P434, DOI 10.1016/S0020-7519(01)00142-4; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Silva E, 1998, MOL CELL BIOL, V18, P4612, DOI 10.1128/MCB.18.8.4612; Takase Y, 2000, MOL CELL BIOL, V20, P9307, DOI 10.1128/MCB.20.24.9307-9316.2000; Tiggemann M, 2001, YEAST, V18, P815, DOI 10.1002/yea.728	28	23	23	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46182	46186		10.1074/jbc.M108706200	http://dx.doi.org/10.1074/jbc.M108706200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11553645	hybrid			2022-12-27	WOS:000172573100094
J	Padmanabhan, U; Dasgupta, S; Biswas, BB; Dasgupta, D				Padmanabhan, U; Dasgupta, S; Biswas, BB; Dasgupta, D			High affinity association of myo-inositol trisphosphates with phytase and its effect upon the catalytic potential of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; DOMAIN-PEPTIDE COMPLEX; PROLINE-RICH MOTIF; INOSITOL PHOSPHATES; EVH1 DOMAIN; MUNG BEANS; METABOLISM; PROTEINS; CALCIUM; RAT	A neutral phytase from germinating mung bean (Vigna radiata) seeds dephosphorylates myo-inositol hexakisphosphate sequentially to myo-inositol. The enzyme also binds with higher affinity to myo-inositol trisphosphates (1,4,5), (2,4,5), and (1,3,4) isomers without catalysis. The high affinity complex elicits Ca2+ mobilization in vitro from microsomes/vacuoles via the formation of a ternary complex with the receptor for Ins(1,4,5)P-3. As a sequel to our previous report, we have carried out a detailed characterization of the two sites and examined the mutual interactions between them. Presaturation of the high affinity site leads to an increase in the affinity of the enzyme for phytic acid and its rate of dephosphorylation as well. From the products of limited tryptic cleavage of phytase, two peptides, each with one activity, have been isolated. The larger ;peptide (similar to 66 kDa) contains the catalytic site, and the smaller peptide (similar to5 kDa) has the high affinity myo-inositol trisphosphate-binding site. The interaction between the dual activities of phytase has been observed also at the level of the two peptides. A sequence homology search using N-terminal 12 amino acid residues of the 5-kDa fragment has revealed significant homology with the Homer class of proteins implicated in signaling pathways involving metabotropic glutamate receptor and myo-inositol 1,4,5-trisphosphate receptor. These results indicate a second role of phytase in Ca2+ mobilization during germination of mung been seed via a salvage pathway that involves allosteric activation by myo-inositol trisphosphate.	Saha Inst Nucl Phys, Div Biophys, Kolkata 700037, W Bengal, India; Univ Calcutta, Biophys & Mol Biol Dept, Kolkata 700009, W Bengal, India	Saha Institute of Nuclear Physics; University of Calcutta	Dasgupta, D (corresponding author), Saha Inst Nucl Phys, Div Biophys, 37 Belgachia Rd, Kolkata 700037, W Bengal, India.	dipak@biop.saha.ernet.in						BANIK U, 1990, BIOCHEM J, V266, P611; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Biswas S, 1996, Subcell Biochem, V26, P287; BITAR K, 1972, BIOCHIM BIOPHYS ACTA, V268, P442, DOI 10.1016/0005-2744(72)90340-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTELLAN GW, 1989, PHYSICAL CHEM, P277; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Dasgupta S, 1996, BIOCHEMISTRY-US, V35, P4994, DOI 10.1021/bi9525233; Dasgupta S, 1997, BIOCHEM J, V321, P355, DOI 10.1042/bj3210355; DROBAK BK, 1992, BIOCHEM J, V288, P697, DOI 10.1042/bj2880697; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; FISKE CYRUS H., 1929, JOUR BIOL CHEM, V81, P629; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P258; Lehrer S S, 1978, Methods Enzymol, V49, P222; Lim D, 2000, NAT STRUCT BIOL, V7, P108; LOWRY OH, J BIOL CHEM, V193, P265; MAITRA R, 1988, INDIAN J BIOCHEM BIO, V25, P655; MANDAL NC, 1970, PLANT PHYSIOL, V45, P4, DOI 10.1104/pp.45.1.4; MANDAL NC, 1972, PHYTOCHEMISTRY, V11, P495, DOI 10.1016/0031-9422(72)80003-7; MAZOROW DL, 1990, ANAL BIOCHEM, V186, P28, DOI 10.1016/0003-2697(90)90567-S; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; SAIO K, 1964, PLANT CELL PHYSIOL, V5, P393; SHEARS SB, 1987, BIOCHEM J, V246, P139, DOI 10.1042/bj2460139; Soloviev MM, 2000, J MOL BIOL, V295, P1185; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; WANG JL, 1971, J BIOL CHEM, V246, P1185; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; YANG WJ, 1991, BIOCHIM BIOPHYS ACTA, V1075, P75	36	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43635	43644		10.1074/jbc.M107531200	http://dx.doi.org/10.1074/jbc.M107531200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11527980	hybrid			2022-12-27	WOS:000172297700022
J	Perret, S; Merle, C; Bernocco, S; Berland, P; Garrone, R; Hulmes, DJS; Theisen, M; Ruggiero, F				Perret, S; Merle, C; Bernocco, S; Berland, P; Garrone, R; Hulmes, DJS; Theisen, M; Ruggiero, F			Unhydroxylated triple helical collagen I produced in transgenic plants provides new clues on the role of hydroxyproline in collagen folding and fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR PACKING; CRYSTAL-STRUCTURE; MODEL PEPTIDE; INVITRO; FIBRILLOGENESIS; STABILITY; MONOMERS; CLEAVAGE; BINDING; DRIVEN	Human unhydroxylated homotrimeric triple-helical collagen I produced in transgenic plants was used as an experimental model to provide insights into the role of hydroxyproline in molecular folding and fibril formation. By using chemically cross-linked molecules, we show here that the absence of hydroxyproline residues does not prevent correct folding of the recombinant collagen although it markedly slows down the propagation rate compared with bovine fully hydroxylated homotrimeric collagen 1. Relatively slow cis-trans-isomerization in the absence of hydroxyproline likely represents the rate-limiting factor in the propagation of the unhydroxylated collagen helix. Because of the lack of hydroxylation, recombinant collagen molecules showed increased flexibility as well as a reduced melting temperature compared with native homotrimers and heterotrimers, whereas the distribution of charged amino acids was unchanged. However, unlike with bovine collagen 1, the recombinant collagen did not self-assemble into banded fibrils in physiological ionic strength buffer at 20 degreesC. Striated fibrils were only obtained with low ionic strength buffer. We propose that, under physiological ionic strength conditions, the hydroxyl groups in the native molecule retain water more efficiently thus favoring correct fibril formation. The importance of hydroxyproline in collagen self-assembly suggested by others from the crystal structures of collagen model peptides is thus confirmed experimentally on the entire collagen molecule.	Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 07, France; Meristem Therapeut, F-63100 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ruggiero, F (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, 7 Passage Vercors, F-69367 Lyon 07, France.			RUGGIERO, Florence/0000-0003-2915-5359; Hulmes, David/0000-0002-0651-1317				Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; FIEDLERNAGY C, 1981, ARCH BIOCHEM BIOPHYS, V212, P668, DOI 10.1016/0003-9861(81)90411-2; GEORGE A, 1991, BIOCHEMISTRY-US, V30, P2372, DOI 10.1021/bi00223a011; GUSTAVSON KH, 1955, NATURE, V175, P70, DOI 10.1038/175070a0; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; JIMENEZ SA, 1977, BIOCHEM BIOPH RES CO, V78, P1354, DOI 10.1016/0006-291X(77)91441-3; Kadler KE, 1996, BIOCHEM J, V316, P1; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; MCBRIDE DJ, 1992, MATRIX, V12, P256; Nagarajan V, 1998, J BIOCHEM-TOKYO, V124, P1117, DOI 10.1093/oxfordjournals.jbchem.a022229; Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288; Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200; PAYNE KJ, 1986, BIOPOLYMERS, V25, P1185, DOI 10.1002/bip.360250703; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X; SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5; Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Wess TJ, 1998, J STRUCT BIOL, V122, P92, DOI 10.1006/jsbi.1998.3991	28	68	74	4	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43693	43698		10.1074/jbc.M105507200	http://dx.doi.org/10.1074/jbc.M105507200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557756	hybrid			2022-12-27	WOS:000172297700029
J	Freelove, ACJ; Bolam, DN; White, P; Hazlewood, GP; Gilbert, HJ				Freelove, ACJ; Bolam, DN; White, P; Hazlewood, GP; Gilbert, HJ			A novel carbohydrate-binding protein is a component of the plant cell wall-degrading complex of Piromyces equi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-THERMOCELLUM; CELLULOMONAS-FIMI; ESCHERICHIA-COLI; XYLANASE; DOMAIN; CELLULASES; MODULES; CELLULOSOME; FUNGI; GENE	The recycling of photosynthetically fixed carbon by the action of microbial plant cell wall hydrolases is a fundamental biological process that is integral to one of the major geochemical cycles and, in addition, has considerable industrial potential. Enzyme systems that attack the plant cell wall contain noncatalytic carbohydrate-binding modules (CBMs) that mediate attachment to this composite structure and play a pivotal role in maximizing the hydrolytic process. Anaerobic fungi that colonize herbivores are the most efficient plant cell wall degraders known, and this activity is vested in a high molecular weight complex that binds tightly to the plant cell wall. To investigate whether plant cell wall attachment is mediated by noncatalytic proteins, a CDNA library of the anaerobic fungus Piromyces equi was screened for sequences that encode noncatalytic proteins that are components of the cellulase-hemicellulase complex. A 1.6-kilobase cDNA was isolated encoding a protein of 479 amino acids with a M-r of 52548 designated NCP1. The mature protein had a modular architecture comprising three copies of the noncatalytic dockerin module that targets anaerobic fungal proteins to the cellulase-hemicellulase complex. The two C-terminal modules of NCP1, CBM29-1 and CBM29-2, respectively, exhibit 33% sequence identity with each other but have no homologues in protein data bases. A truncated form of NCP1 comprising CBM29-1 and CBM29-2 (CBM29-1-2) and each of the two individual copies of CBM29 bind primarily to man-nan, cellulose, and glucomannan, displaying the highest affinity for the latter polysaccharide. CBM29-1-2 exhibits 4-45-fold higher affinity than either CBM29-1 or CBM29-2 for the various ligands, indicating that the two modules, when covalently linked, act in synergy to bind to an array of different polysaccharides. This paper provides the first report of a CBM-containing protein from an anaerobic fungal cellulase-hemicellulase complex. The two CBMs constitute a novel CBM family designated CBM29 whose members exhibit unusually wide ligand specificity. We propose, therefore, that NCP1 plays a role in sequestering the fungal enzyme complex onto the plant cell wall.	Newcastle Univ, Dept Biol & Nutr Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Babraham Inst, Lab Mol Enzymol, Cambridge CB2 4AT, England	Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Gilbert, HJ (corresponding author), Newcastle Univ, Dept Biol & Nutr Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	H.J.Gilbert@Newcastle.ac.uk		Bolam, David/0000-0003-0314-3122				Abou Hachem M, 2000, BIOCHEM J, V345, P53, DOI 10.1042/0264-6021:3450053; ALI BRS, 1995, FEMS MICROBIOL LETT, V125, P15, DOI 10.1016/0378-1097(94)00472-4; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; BLUM DL, 1997, APPL ENVIRON MICROB, V65, P3990; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Brett C., 1990, PHYSL BIOCH PLANT CE; Brun E, 2000, BIOCHEMISTRY-US, V39, P2445, DOI 10.1021/bi992079u; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Chen HZ, 1997, J BACTERIOL, V179, P6028, DOI 10.1128/jb.179.19.6028-6034.1997; COUGHLAN MP, 1985, BIOTECHNOL GENET ENG, V3, P39, DOI 10.1080/02648725.1985.10647809; Coutinho PM, 1999, ROY SOC CH, P3; DURRANT AJ, 1991, BIOCHEM J, V273, P289, DOI 10.1042/bj2730289; FANUTTI C, 1995, J BIOL CHEM, V270, P29314, DOI 10.1074/jbc.270.49.29314; Fernandes AC, 1999, BIOCHEM J, V342, P105, DOI 10.1042/0264-6021:3420105; Fillingham IJ, 1999, BIOCHEM J, V343, P215, DOI 10.1042/0264-6021:3430215; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; GILKES NR, 1992, J BIOL CHEM, V267, P6743; Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; KEMP P, 1984, J GEN MICROBIOL, V130, P27; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee SS, 2000, APPL ENVIRON MICROB, V66, P3807, DOI 10.1128/AEM.66.9.3807-3813.2000; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; ORPIN CG, 1981, J GEN MICROBIOL, V123, P287; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Steenbakkers PJM, 2001, J BACTERIOL, V183, P5325, DOI 10.1128/JB.183.18.5325-5333.2001; TAKEO K, 1984, ELECTROPHORESIS, V5, P187, DOI 10.1002/elps.1150050402; TEUNISSEN MJ, 1992, ARCH MICROBIOL, V158, P276, DOI 10.1007/BF00245245; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; ZHOU LQ, 1994, BIOCHEM J, V297, P359, DOI 10.1042/bj2970359	37	57	59	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43010	43017		10.1074/jbc.M107143200	http://dx.doi.org/10.1074/jbc.M107143200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11560933	hybrid			2022-12-27	WOS:000172169300051
J	Hamoen, LW; Haijema, B; Bijlsma, JJ; Venema, G; Lovett, CM				Hamoen, LW; Haijema, B; Bijlsma, JJ; Venema, G; Lovett, CM			The Bacillus subtilis competence transcription factor, ComK, overrides LexA-imposed transcriptional inhibition without physically displacing LexA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECA PROTEIN ANALOG; POLYMERASE ALPHA-SUBUNIT; ESCHERICHIA-COLI LEXA; RNA-POLYMERASE; DNA-DAMAGE; TERMINAL DOMAIN; DINR; INDUCTION; PROMOTER; GENE	During the development of competence in Bacillus subtilis the recA gene is activated by the competence transcription factor, ComK which is presumably required to alleviate the transcriptional repression of recA by LexA. To investigate the mechanism by which ComK activates recA transcription we examined the binding of ComK and LexA to the recA promoter in vitro. Using hydroxyl radical protection analyses to establish the location of ComK dimer-binding sites within the recA promoter, we identified four AT-boxes in a configuration unique for ComK-regulated promoters. Gel mobility shift experiments showed that all four ComK dimer-binding sites were occupied at ComK concentrations in the physiological range. In addition, occupation of all ComK-binding sites did not prevent LexA from binding to the recA promoter, despite the fact that the ComK and LexA recognition motifs partially overlap. Although ComK did not replace LexA from the recA promoter, in vitro transcription analyses indicated that the presence of Com-K is sufficient to alleviate LexA repression of recA.	Univ Groningen, Dept Genet, NL-9751 NN Haren, Netherlands; Univ Utrecht, Inst Virol, NL-3584 CL Utrecht, Netherlands; Vrije Univ Amsterdam, Dept Med Microbiol, Amsterdam, Netherlands; Williams Coll, Dept Chem, Williamstown, MA 01267 USA	University of Groningen; Utrecht University; Vrije Universiteit Amsterdam; Williams College	Hamoen, LW (corresponding author), Univ Groningen, Dept Genet, Kerklaan 30, NL-9751 NN Haren, Netherlands.							Ausubel FM, 1998, CURRENT PROTOCOLS MO; BANNER CDB, 1983, J MOL BIOL, V168, P351, DOI 10.1016/S0022-2836(83)80023-0; CHEO DL, 1993, J BACTERIOL, V175, P5907, DOI 10.1128/JB.175.18.5907-5915.1993; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; DEVOS WM, 1982, MOL GEN GENET, V187, P439, DOI 10.1007/BF00332625; DUBNAU D, 1993, BACILLUS SUBTILIS OT; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Fredrick K, 1997, P NATL ACAD SCI USA, V94, P4982, DOI 10.1073/pnas.94.10.4982; FRISBY D, 1991, J BACTERIOL, V173, P7557, DOI 10.1128/jb.173.23.7557-7564.1991; Hahn J, 1996, MOL MICROBIOL, V21, P763, DOI 10.1046/j.1365-2958.1996.371407.x; HAIJEMA BJ, 1995, MOL MICROBIOL, V15, P203, DOI 10.1111/j.1365-2958.1995.tb02235.x; Haijema BJ, 1996, MOL MICROBIOL, V22, P75, DOI 10.1111/j.1365-2958.1996.tb02657.x; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; LOVE PE, 1985, P NATL ACAD SCI USA, V82, P6201, DOI 10.1073/pnas.82.18.6201; LOVETT CM, 1993, J BACTERIOL, V175, P6842, DOI 10.1128/jb.175.21.6842-6849.1993; LOVETT CM, 1989, J BACTERIOL, V171, P2318, DOI 10.1128/jb.171.5.2318-2322.1989; LOVETT CM, 1988, J BACTERIOL, V170, P1467, DOI 10.1128/jb.170.4.1467-1474.1988; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; LOVETT CM, 1994, J BACTERIOL, V176, P4914, DOI 10.1128/jb.176.16.4914-4923.1994; Miller MC, 1996, J BIOL CHEM, V271, P33502, DOI 10.1074/jbc.271.52.33502; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; Ozoline ON, 2000, J BIOL CHEM, V275, P1119, DOI 10.1074/jbc.275.2.1119; PREDICH M, 1992, J BACTERIOL, V174, P2771, DOI 10.1128/JB.174.9.2771-2778.1992; RAYMONDDENISE A, 1991, J BACTERIOL, V173, P7084, DOI 10.1128/jb.173.22.7084-7091.1991; RAYMONDDENISE A, 1992, J BACTERIOL, V174, P3171, DOI 10.1128/jb.174.10.3171-3176.1992; Sambrook J., 2002, MOL CLONING LAB MANU; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; VENEMA G, 1965, J BACTERIOL, V89, P1250, DOI 10.1128/JB.89.5.1250-1255.1965; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Winterling KW, 1998, J BACTERIOL, V180, P2201, DOI 10.1128/JB.180.8.2201-2211.1998; YASBIN RE, 1992, MOL MICROBIOL, V6, P1263, DOI 10.1111/j.1365-2958.1992.tb00847.x	36	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42901	42907		10.1074/jbc.M104407200	http://dx.doi.org/10.1074/jbc.M104407200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555642	hybrid			2022-12-27	WOS:000172169300037
J	Ingley, E; Chappell, D; Poon, SYK; Sarna, MK; Beaumont, JG; Williams, JH; Stillitano, JP; Tsai, S; Leedman, PJ; Tilbrook, PA; Klinken, SP				Ingley, E; Chappell, D; Poon, SYK; Sarna, MK; Beaumont, JG; Williams, JH; Stillitano, JP; Tsai, S; Leedman, PJ; Tilbrook, PA; Klinken, SP			Thyroid hormone receptor-interacting protein 1 modulates cytokine and nuclear hormone signaling in erythroid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROPOIETIN-INDUCED DIFFERENTIATION; TRANSCRIPTION FACTOR; RETINOIC ACID; BINDING PROTEIN; IN-VITRO; ACTIVATION; LYN; INACTIVATION; KINASE; TARGET	Erythropoietin (Epo) and thyroid hormone (T-3) are key molecules in the development of red blood cells. We have shown previously that the tyrosine kinase Lyn is involved in differentiation signals emanating from an activated erythropoietin receptor. Here we demonstrate that Lyn interacts with thyroid hormone receptor-interacting protein 1 (Trip-1), a transcriptional regulator associated with the T-3 receptor, providing a link between the Epo and T-3 signaling pathways. Trip-1 co-localized with Lyn and the T-3 receptor alpha in the cytoplasm/plasma membrane of erythroid cells but translocated to discrete nuclear foci shortly after Epo-induced differentiation. Our data reveal that T-3 stimulated the proliferation of immature erythroid cells, and inhibited maturation promoted by erythropoietin. Removal of T-3 reduced cell division and enhanced terminal differentiation. This was accompanied by large increases in the cell cycle inhibitor P27(Kip1) and by increasing expression of erythroid transcription factors GATA-1, EKLF, and NF-E2. Strikingly, a truncated Trip-1 inhibited both erythropoietin-induced maturation and T-3-initiated cell division. This mutant Trip-1 acted in a dominant negative fashion by eliminating endogenous Lyn, elevating p27(Kip1), and blocking T-3 response elements. These data demonstrate that Trip-1 can simultaneously modulate responses involving both cytokine and nuclear receptors.	Univ Western Australia, Dept Biochem, Lab Canc Med, Perth, WA 6000, Australia; Royal Perth Hosp, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; CUNY Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, New York, NY 10030 USA	University of Western Australia; Royal Perth Hospital; University of Western Australia; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Klinken, SP (corresponding author), Univ Western Australia, Dept Biochem, Lab Canc Med, Level 6,Med Res Fdn Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	pklinken@cyllene.uwa.edu.au	Sarna, Mohinder/Q-7834-2016; Sarna, Mohinder/AAO-9343-2020; Ingley, Evan/C-2401-2013; Leedman, Peter J/O-4044-2014	Sarna, Mohinder/0000-0002-2448-1588; Sarna, Mohinder/0000-0002-2448-1588; Ingley, Evan/0000-0002-8112-9134; Williams, James/0000-0002-0950-1958				ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Bartunek P, 1998, MOL ENDOCRINOL, V12, P1269, DOI 10.1210/mend.12.9.0173; Bauer A, 1997, ONCOGENE, V15, P701, DOI 10.1038/sj.onc.1201208; Bauer A, 1998, EMBO J, V17, P4291, DOI 10.1093/emboj/17.15.4291; Baur EV, 1996, EMBO J, V15, P110, DOI 10.1002/j.1460-2075.1996.tb00339.x; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; BUSFIELD SJ, 1992, BLOOD, V80, P412; Cheng XB, 1997, MOL CELL BIOL, V17, P1407, DOI 10.1128/MCB.17.3.1407; Chin H, 1998, BLOOD, V91, P3734; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; DAINIAK N, 1978, NATURE, V272, P260, DOI 10.1038/272260a0; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; DeFranceschi L, 1997, J CLIN INVEST, V99, P220, DOI 10.1172/JCI119150; DISELA C, 1991, GENE DEV, V5, P2033, DOI 10.1101/gad.5.11.2033; FEIN HG, 1975, MED CLIN N AM, V59, P1133, DOI 10.1016/S0025-7125(16)31963-0; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Filipe A, 1999, EMBO J, V18, P687, DOI 10.1093/emboj/18.3.687; Fraser RA, 1997, J BIOL CHEM, V272, P7122, DOI 10.1074/jbc.272.11.7122; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; HAWLEY RG, 1994, GENE THER, V1, P136; HENTZEN D, 1987, MOL CELL BIOL, V7, P2416, DOI 10.1128/MCB.7.7.2416; Hsieh FF, 2000, BLOOD, V96, P2746, DOI 10.1182/blood.V96.8.2746.h8002746_2746_2754; Ihle J N, 1993, Semin Immunol, V5, P375, DOI 10.1006/smim.1993.1043; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; KLINKEN SP, 1989, J VIROL, V63, P1489, DOI 10.1128/JVI.63.3.1489-1492.1989; KRANTZ SB, 1991, BLOOD, V77, P419; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; MALGOR LA, 1975, BLOOD, V45, P671; Marcus SL, 1996, J BIOL CHEM, V271, P27197, DOI 10.1074/jbc.271.44.27197; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; PERKINS AC, 1995, NATURE, V375, P318; Perrin MC, 1997, HEMATOL CELL THER, V39, P19, DOI 10.1007/s00282-997-0019-2; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHROEDER C, 1992, ONCOGENE, V7, P217; Singh V, 1998, ENDOCRINOLOGIST, V8, P87, DOI 10.1097/00019616-199803000-00006; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; Tilbrook PA, 1996, J BIOL CHEM, V271, P3453; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Tilbrook PA, 2001, CANCER RES, V61, P2453; TRAINOR CD, 1995, MOL ENDOCRINOL, V9, P1135, DOI 10.1210/me.9.9.1135; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Williams JH, 1999, EMBO J, V18, P5559, DOI 10.1093/emboj/18.20.5559; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Yen PM, 1996, J BIOL CHEM, V271, P10910, DOI 10.1074/jbc.271.18.10910; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	58	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43428	43434		10.1074/jbc.M106645200	http://dx.doi.org/10.1074/jbc.M106645200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544260	Green Published, hybrid			2022-12-27	WOS:000172169300103
J	Trent, MS; Ribeiro, AA; Lin, SH; Cotter, RJ; Raetz, CRH				Trent, MS; Ribeiro, AA; Lin, SH; Cotter, RJ; Raetz, CRH			An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A - Induction in polymyxin-resistant mutants and role of a novel lipid-linked donor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; ACID-DEFICIENT MUTANT; PMRA-MUTANTS; POLYSACCHARIDE SYNTHESIS; PHOSPHATE GROUPS; O-ANTIGEN; TYPHIMURIUM; LIPOPOLYSACCHARIDE; GENE; PHOSPHOETHANOLAMINE	Attachment of the cationic sugar 4-amino-4-deoxy-L-arabinose (L-Ara4N) to lipid A is required for the maintenance of polymyxin resistance in Escherichia coli and Salmonella typhimurium. The enzymes that synthesize L-Ara4N and transfer it to lipid A have not been identified. We now report an inner membrane enzyme, expressed in polymyxin-resistant mutants, that adds one or two L-Ara4N moieties to lipid A or its immediate precursors. No soluble factors are required. A gene located near minute 51 on the S. typhimurium and E. coli chromosomes (previously termed orf5, pmrK, or yfbI) encodes the L-Ara4N transferase. The enzyme, renamed ArnT, consists of 548 amino acid residues in S. typhimurium with 12 possible membrane-spanning regions. ArnT displays distant similarity to yeast protein mannosyltransferases. ArnT adds two L-Ara4N units to lipid A precursors containing a Kdo disaccharide. However, as shown by mass spectrometry and NMR spectroscopy, it transfers only a single L-Ara4N residue to the 1-phosphate moiety of lipid IVA, a precursor lacking Kdo. Proteins with full-length sequence similarity to ArnT are present in genomes of other bacteria thought to synthesize L-Ara4N-modified lipid A, including Pseudomonas aeruginosa and Yersinia pestis. As shown in the following article (Trent, M. S., Ribeiro, A. A., Doerrler, W. T., Lin, S., Cotter, R. J., and Raetz, C. R. H. (2001) J. Biol. Chem. 276, 43132-43144), ArnT utilizes the novel lipid undecaprenyl phosphate-alpha -L-Ara4N as its sugar donor, suggesting that L-Ara4N transfer to lipid A occurs on the periplasmic side of the inner membrane.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke NMR Spect Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Middle Atlantic Mass Spectrometry Lab, Baltimore, MD 21205 USA	Duke University; Duke University; Duke University; Johns Hopkins University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	raetz@biochem.duke.edu			NCI NIH HHS [P30-CA-14236] Funding Source: Medline; NIGMS NIH HHS [GM54882, GM-51310] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, R01GM054882] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Brade H, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P927; BRYN K, 1978, EUR J BIOCHEM, V86, P311, DOI 10.1111/j.1432-1033.1978.tb12312.x; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MICROB PATHOGENESIS, V25, P77, DOI 10.1006/mpat.1998.0217; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; GUYCAFFEY JK, 1992, J BACTERIOL, V174, P2460, DOI 10.1128/jb.174.8.2460-2465.1992; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MUHLRADT PF, 1977, EUR J BIOCHEM, V81, P193, DOI 10.1111/j.1432-1033.1977.tb11941.x; MULFORD CA, 1983, P NATL ACAD SCI-BIOL, V80, P1159, DOI 10.1073/pnas.80.5.1159; NISHIJIMA M, 1977, EUR J BIOCHEM, V73, P115, DOI 10.1111/j.1432-1033.1977.tb11297.x; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; PARK JT, 1987, ESCHERICHIA COLI SAL, V1, P663; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; RAETZ CRH, 1996, ESCHERICHIA COLI SAL, P1035; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Ribeiro AA, 1999, MAGN RESON CHEM, V37, P620, DOI 10.1002/(SICI)1097-458X(199909)37:9<620::AID-MRC517>3.0.CO;2-Q; Rietschel E. T., 1992, BACTERIAL ENDOTOXIC, V1, P3; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; STINAVAGE P, 1989, INFECT IMMUN, V57, P3894, DOI 10.1128/IAI.57.12.3894-3900.1989; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; VAARA M, 1981, FEBS LETT, V129, P145, DOI 10.1016/0014-5793(81)80777-6; VOLK WA, 1970, EUR J BIOCHEM, V17, P223; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	62	238	246	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43122	43131		10.1074/jbc.M106961200	http://dx.doi.org/10.1074/jbc.M106961200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11535604	hybrid			2022-12-27	WOS:000172169300065
J	Yabe, T; Wilson, D; Schwartz, JP				Yabe, T; Wilson, D; Schwartz, JP			NF kappa B activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; GLUTAMATE-INDUCED NEUROTOXICITY; MANGANESE SUPEROXIDE-DISMUTASE; PRIMARY HIPPOCAMPAL-NEURONS; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELL-DEATH; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; FACTOR GENE; SURVIVAL FACTOR	Pigment epithelium-derived factor (PEDF) protects immature cerebellar granule cells (1-3 days in vitro) against induced apoptosis and mature cells (5+ days in vitro) against glutamate toxicity, but its precise mechanism is still unknown. Because the transcription factor NF kappaB blocks cell death, including neuronal apoptosis, we have investigated the ability of PEDF to exert its effects via NF kappaB activation. PEDF induced an increased phosphorylation of I kappaB alpha, decreased levels of I kappaB proteins, and translocation of p65 (RelA) to the nucleus followed by a time-dependent increase of NF kappaB-DNA binding activity in both immature and mature neurons. The protective effects of PEDF against both induced apoptosis and glutamate toxicity were blocked by the addition of either the I kappaB kinase inhibitor BAY 11-7082 which inhibits the phosphorylation of I kappaB, or N-acetyl-Leu-Leu-norleucinal, which blocks. proteosome degradation of I kappaB, demonstrating that NF kappaB is required for the neuroprotective effects of PEDF. Reverse transcription-polymerase chain reaction analysis revealed that up-regulation of the anti-apoptotic genes for Bcl-2, Bcl-x, and manganese superoxide dismutase was observed in PEDF-treated immature but not mature neurons. Up-regulation of nerve growth factor, brain-derived neurotrophic factor, and glial cell-derived neurotrophic factor mRNA was long-lasting in mature neurons. These results suggest that PEDF promotes neuronal survival through activation of NF kappaB, which in turn induces expression of anti-apoptotic and/or neurotrophic factor genes.	NINCDS, NTFS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schwartz, JP (corresponding author), NINCDS, NTFS, NIH, Bldg 36,Rm 4A31, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002752] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; Atabay C, 1996, J NEUROSCI RES, V43, P465; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BALAZS R, 1992, MOL NEUROPHARMACOL, V2, P203; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; BECERRA SP, 1993, J BIOL CHEM, V268, P23148; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1987, J NEUROSCI, V7, P369; Choi JS, 2000, BRAIN RES, V883, P60, DOI 10.1016/S0006-8993(00)02886-9; Courtney MJ, 1997, J NEUROSCI, V17, P4201; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Darville MI, 2000, ENDOCRINOLOGY, V141, P153, DOI 10.1210/en.141.1.153; DeCoster MA, 1999, J NEUROSCI RES, V56, P604; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Glazner GW, 2000, J NEUROCHEM, V75, P101, DOI 10.1046/j.1471-4159.2000.0750101.x; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; Heese K, 1998, GLIA, V22, P401, DOI 10.1002/(SICI)1098-1136(199804)22:4<401::AID-GLIA9>3.0.CO;2-5; Houenou LJ, 1999, J COMP NEUROL, V412, P506; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; JEHAN F, 1993, J NEUROCHEM, V60, P1843, DOI 10.1111/j.1471-4159.1993.tb13411.x; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Kastenbauer S, 1999, INFECT IMMUN, V67, P1553; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Li QT, 2000, GENE DEV, V14, P1729; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Mao XR, 1998, NEUROREPORT, V9, P759, DOI 10.1097/00001756-199803090-00036; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Middleton G, 2000, J CELL BIOL, V148, P325, DOI 10.1083/jcb.148.2.325; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; Pasquini LA, 2000, NEUROCHEM RES, V25, P627, DOI 10.1023/A:1007554902352; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Post A, 1998, J NEUROSCI, V18, P8236; Post A, 2000, EUR J NEUROSCI, V12, P4331, DOI 10.1046/j.0953-816X.2000.01352.x; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Sawada H, 2000, J NEUROCHEM, V74, P1175; Schow SR, 1997, CELL IMMUNOL, V175, P199, DOI 10.1006/cimm.1996.1061; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHIMOHAMA S, 1993, BRAIN RES, V632, P296, DOI 10.1016/0006-8993(93)91164-N; Skaper SD, 1998, J NEUROCHEM, V70, P1859, DOI 10.1046/j.1471-4159.1998.70051859.x; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Tamatani M, 2000, J NEUROCHEM, V75, P683, DOI 10.1046/j.1471-4159.2000.0750683.x; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tanaka M, 2000, BBA-GENE STRUCT EXPR, V1494, P63, DOI 10.1016/S0167-4781(00)00218-9; TANIWAKI T, 1995, J NEUROCHEM, V64, P2509; Taniwaki T, 1997, J NEUROCHEM, V68, P26; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tombran-Tink J, 1996, Mol Vis, V2, P11; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; YAN GM, 1994, BRAIN RES, V656, P43, DOI 10.1016/0006-8993(94)91364-1; Yu ZF, 1999, J NEUROSCI, V19, P8856, DOI 10.1523/JNEUROSCI.19-20-08856.1999	63	113	118	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43313	43319		10.1074/jbc.M107831200	http://dx.doi.org/10.1074/jbc.M107831200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553640	hybrid			2022-12-27	WOS:000172169300089
J	Mark, BL; Vocadlo, DJ; Zhao, DL; Knapp, S; Withers, SG; James, MNG				Mark, BL; Vocadlo, DJ; Zhao, DL; Knapp, S; Withers, SG; James, MNG			Biochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BASED CLASSIFICATION; ALPHA-GLUCOSIDASE INHIBITOR; GLYCOSYL HYDROLASES; SIASTATIN-B; MECHANISM; CATALYSIS; PARTICIPATION; GLYCOSIDASE; CHITOBIASE; ACARBOSE	Azasugar inhibitors of the isofagomine class are potent competitive inhibitors of configuration-retaining beta -glycosidases. This potency results from the formation of a strong electrostatic interaction between a protonated endocyclic nitrogen at the "anomeric" center of the inhibitor and the catalytic nucleophile of the enzyme. Although the majority of retaining beta -glycosidases use a mechanism involving a carboxylate residue as a nucleophile, Streptomyces plicatus beta -N-acetylhexosaminidase (SpHEX) and related family 20 glycosidases lack such a catalytic residue and use instead the carbonyl oxygen of the 2-acetamido group of the substrate as a nucleophile to "attack" the anomeric center. Thus, a strong electrostatic interaction between the inhibitor and enzyme is not expected to occur; nonetheless, the 1-N-azasugar (2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy5-hydroxymethyl-piperidinium hydrochloride (Ga1NAc-isofagomine . HCl), which was synthesized and assayed for its ability to inhibit SpHEX, was found to be a potent competitive inhibitor of the enzyme (K-i = 2.7 mum). A crystallographic complex of Ga1NAc-isofagomine bound to SpHEX was solved and refined to 1.75 Angstrom and revealed that the lack of a strong electrostatic interaction between the "anomeric" center of Ga1NAc-isofagomine and SpHEX is compensated for by a novel 2.8-Angstrom hydrogen bond formed between the equatorial proton of the endocyclic nitrogen of the azasugar ring and the carboxylate of the general acid-base residue Glu-314 of SpHEX. This interaction appears to contribute to the unexpected potency of Ga1NAc-isofagomine toward SpHEX.	Univ Alberta, Dept Biochem, Canadian Inst Hlth Res Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA	University of Alberta; University of British Columbia; Rutgers State University New Brunswick	James, MNG (corresponding author), Univ Alberta, Dept Biochem, Canadian Inst Hlth Res Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada.		Vocadlo, David J/E-5508-2014; Withers, Stephen G/I-7229-2019	Vocadlo, David J/0000-0001-6897-5558; Withers, Stephen G/0000-0002-6722-5701; Mark, Brian/0000-0002-7344-1355				Bols M, 1998, ACCOUNTS CHEM RES, V31, P1, DOI 10.1021/ar970058r; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; GILARDI RD, 1974, ACTA CRYSTALLOGR B, V30, P2931, DOI 10.1107/S0567740874008569; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Heightman TD, 1999, ANGEW CHEM INT EDIT, V38, P750, DOI 10.1002/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Ichikawa Y, 1998, J AM CHEM SOC, V120, P5854, DOI 10.1021/ja985509x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1995, ESF CCP4 NEWSLETT, V31, P45; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Knapp S, 2000, ORG LETT, V2, P4037, DOI 10.1021/ol0066680; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R. J., 1998, GRAFIT VERSION 4 0; Liu HZ, 2001, J AM CHEM SOC, V123, P5116, DOI 10.1021/ja010240u; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Martin AE, 1996, AM J HEALTH-SYST PH, V53, P2277, DOI 10.1093/ajhp/53.19.2277; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MCCARTER JD, 1992, BIOCHEM J, V286, P721, DOI 10.1042/bj2860721; MO F, 1978, ACTA CRYSTALLOGR B, V34, P1562, DOI 10.1107/S0567740878006081; Namchuk MN, 1995, BIOCHEMISTRY-US, V34, P16194, DOI 10.1021/bi00049a035; Nishimura Y, 1996, BIOORGAN MED CHEM, V4, P91, DOI 10.1016/0968-0896(95)00166-2; Notenboom V, 2000, BIOCHEMISTRY-US, V39, P11553, DOI 10.1021/bi0010625; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Welborn TA, 1998, MED J AUSTRALIA, V168, P76, DOI 10.5694/j.1326-5377.1998.tb126718.x; White A, 1996, NAT STRUCT BIOL, V3, P149, DOI 10.1038/nsb0296-149	38	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42131	42137		10.1074/jbc.M107154200	http://dx.doi.org/10.1074/jbc.M107154200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11522797	hybrid			2022-12-27	WOS:000172450400080
J	McGlynn, P; Lloyd, RG				McGlynn, P; Lloyd, RG			Action of RuvAB at replication fork structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION COMPLEX; ESCHERICHIA-COLI; BRANCH MIGRATION; DNA-REPLICATION; IN-VITRO; HOMOLOGOUS RECOMBINATION; CRYSTAL-STRUCTURE; RECG; PROTEIN; PRIA	The replicative apparatus often encounters blocks to its progression that necessitate removal of the block and reloading of the replication machinery. In Escherichia coli, a major pathway of replication restart involves unwinding of the stalled fork to generate a four-stranded Holliday junction, which can then be cleaved by the RuvABC helicase-endonuclease. This fork regression may be catalyzed by RecG but is thought to occur even in its absence. Here we test whether RuvAB helicase can also catalyze the unwinding of forked DNA to form Holliday junctions. We find that fork DNA is unwound in the direction required for Holliday junction formation only if the loading of RuvB is restricted to the parental duplex DNA arm. If the binding of RuvB is unrestricted, then RuvAB preferentially unwinds forks in the opposite direction. This is probably related to the greater efficiency of two opposed RuvB hexamers operating across a junction compared with a single hexamer. These data argue against RuvAB acting directly at damaged replication forks and imply that other mechanisms must operate in vivo to catalyze Holliday junction formation.	Univ Nottingham, Queens Med Ctr, Genet Inst, Nottingham NG7 2UH, England	University of Nottingham	Lloyd, RG (corresponding author), Univ Nottingham, Queens Med Ctr, Genet Inst, Nottingham NG7 2UH, England.			McGlynn, Peter/0000-0001-8629-4713				Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Flores MJ, 2001, EMBO J, V20, P619, DOI 10.1093/emboj/20.3.619; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Hiom K, 1996, GENES CELLS, V1, P443, DOI 10.1046/j.1365-2443.1996.d01-253.x; HIOM K, 1995, CELL, V80, P787, DOI 10.1016/0092-8674(95)90357-7; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kornberg A., 1992, DNA REPLICATION; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; LLOYD RG, 1993, EMBO J, V12, P17, DOI 10.1002/j.1460-2075.1993.tb05627.x; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Lombardo MJ, 2000, J BACTERIOL, V182, P6287, DOI 10.1128/JB.182.22.6287-6291.2000; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; PARSONS CA, 1990, J BIOL CHEM, V265, P9285; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Saveson CJ, 1999, GENETICS, V152, P5; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; Wentzell LM, 2000, J MOL BIOL, V304, P779, DOI 10.1006/jmbi.2000.4266; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zerbib D, 1998, J MOL BIOL, V281, P621, DOI 10.1006/jmbi.1998.1959	40	51	52	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41938	41944		10.1074/jbc.M107945200	http://dx.doi.org/10.1074/jbc.M107945200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551967	hybrid			2022-12-27	WOS:000172450400053
J	Chauvin, C; De Oliveira, F; Ronot, X; Mousseau, M; Leverve, X; Fontaine, E				Chauvin, C; De Oliveira, F; Ronot, X; Mousseau, M; Leverve, X; Fontaine, E			Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CYTOCHROME-C; UBIQUINONE ANALOGS; INDUCED APOPTOSIS; PORE; BUTYLHYDROPEROXIDE; ACTIVATION; INDUCTION; RELEASE	The permeability transition pore (PTP) is a mitochondrial inner membrane Ca2+-sensitive channel that plays a key role in different models of cell death. Because functional links between the PTP and the respiratory chain complex I have been reported, we have investigated the effects of rotenone on PTP regulation in U937 and KB cells. We show that rotenone was more potent than cyclosporin A at inhibiting Ca2+-induced PTP opening in digitonin-permeabilized cells energized with succinate. Consistent with PTP regulation by electron flux through complex I, the effect of rotenone persisted after oxidation of pyridine nucleotides by duroquinone. tert-Butyl hydroperoxide induced PTP opening in intact cells (as shown by mitochondrial permeabilization to calcein and cobalt), as well as cytochrome c release and cell death. All these events were prevented by rotenone or cyclosporin A. These data demonstrate that respiratory chain complex I plays a key role in PTP regulation in vivo and confirm the importance of PTP opening in the commitment to cell death.	Univ Grenoble 1, Lab Bioenerget Fondamentale & Appliquee, F-38041 Grenoble 09, France; Inst Albert Bonniot, Lab Dynam Cellulaire, F-38706 La Tronche, France; Hop Albert Michalon, Med Oncol Serv, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes	Fontaine, E (corresponding author), Univ Grenoble 1, Lab Bioenerget Fondamentale & Appliquee, BP 53X, F-38041 Grenoble 09, France.		Fontaine, Eric/ABA-8853-2020; Mousseau, Mireille/M-5942-2014; RONOT, Xavier/B-8412-2014	Fontaine, Eric/0000-0002-5204-9477; 				Beghetto C, 2000, EUR J BIOCHEM, V267, P5585, DOI 10.1046/j.1432-1327.2000.01625.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Gastman BR, 2000, CANCER RES, V60, P6811; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guidarelli A, 1997, EXP CELL RES, V237, P176, DOI 10.1006/excr.1997.3779; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Hehner SP, 1998, J BIOL CHEM, V273, P18117, DOI 10.1074/jbc.273.29.18117; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Kantrow SP, 1997, BIOCHEM BIOPH RES CO, V232, P669, DOI 10.1006/bbrc.1997.6353; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 1999, BIOPHYS J, V77, P1747, DOI 10.1016/S0006-3495(99)77020-7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Pastorino JG, 2000, HEPATOLOGY, V31, P1141, DOI 10.1053/he.2000.7013; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Scarlett JL, 1997, FEBS LETT, V418, P282, DOI 10.1016/S0014-5793(97)01391-4; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Sestili P, 1999, FEBS LETT, V457, P139, DOI 10.1016/S0014-5793(99)01027-3; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1997, EXP CELL RES, V236, P397, DOI 10.1006/excr.1997.3733; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; VAYSSIERE JL, 1994, P NATL ACAD SCI USA, V91, P11752, DOI 10.1073/pnas.91.24.11752; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549; Zuurendonk P F, 1979, Methods Enzymol, V56, P207	42	111	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41394	41398		10.1074/jbc.M106417200	http://dx.doi.org/10.1074/jbc.M106417200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527970	hybrid			2022-12-27	WOS:000171925600135
J	MacAulay, N; Bendahan, A; Loland, CJ; Zeuthen, T; Kanner, BI; Gether, U				MacAulay, N; Bendahan, A; Loland, CJ; Zeuthen, T; Kanner, BI; Gether, U			Engineered Zn2+ switches in the gamma-aminobutyric acid (GABA) transporter-1 - Differential effects on GABA uptake and currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+CL COTRANSPORT FUNCTION; HUMAN DOPAMINE TRANSPORTER; OOCYTE MEMBRANE PATCHES; XENOPUS-OOCYTES; NEUROTRANSMITTER TRANSPORTERS; ELECTROGENIC PROPERTIES; GLUTAMATE TRANSPORTER; GLUCOSE COTRANSPORTER; CHLORIDE CHANNEL; RAT-BRAIN	Two high affinity Zn2+ binding sites were engineered in the otherwise Zn2+-insensitive rat gamma -aminobutyric acid (GABA) transporter-1 (rGAT-1) based on structural information derived from Zn2+ binding sites engineered previously in the homologous dopamine transporter. Introduction of a histidine (T349H) at the extracellular end of transmembrane segment (TM) 7 together with a histidine (E370H) or a cysteine (Q374C) at the extracellular end of TM 8 resulted in potent inhibition of [H-3]GABA uptake by Zn2+ (IC50 = 35 and 44 muM, respectively). Upon expression in Xenopus laevis oocytes it was similarly observed that Zn2+ was a potent inhibitor of the GABA-induced current (IC50 = 21 muM for T349H/E370H and 51 muM for T349H/Q374C), albeit maximum inhibition was only similar to 40% in T349H/E370H versus similar to 90% in T349H/Q374C. In the wild type, Zn2+ did not affect the Na+-dependent transient currents elicited by voltage jumps and thought to reflect capacitive charge movements associated with Na+ binding. However, in both mutants Zn2+ caused a reduction of the inward transient currents upon jumping to hyperpolarized potentials as reflected in rightward-shifted Q/V relationships. This suggests that Zn2+ is inhibiting transporter function by stabilizing the outward-facing Na+-bound state. Translocation of lithium by the transporter does not require GAGA binding and analysis of this uncoupled Li+ conductance revealed a potent inhibition by Zn2+ in T349H/E370H, whereas surprisingly the T349H/Q374C leak was unaffected. This differential effect supports that the leak conductance represents a unique operational mode of the transporter involving conformational changes different from those of the substrate translocation process. Altogether our results support both an evolutionary conserved structural organization of the TM 7/8 domain and a key role of this domain in GABA-dependent and -independent conformational changes of the transporter.	Univ Copenhagen, Panum Inst, Dept Med Physiol 12 5 22, Div Cellular & Mel Physiol, DK-2200 Copenhagen N, Denmark; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	University of Copenhagen; Hebrew University of Jerusalem	Gether, U (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Physiol 12 5 22, Div Cellular & Mel Physiol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@mfi.ku.dk	Loland, Claus/E-5975-2014; MacAulay, Nanna/AER-7709-2022	Loland, Claus/0000-0002-1773-1446; MacAulay, Nanna/0000-0002-7800-6600; Gether, Ulrik/0000-0002-0020-3807	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408, R37DA005477] Funding Source: NIH RePORTER; NIDA NIH HHS [R37 DA05477, P01 DA 12408] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Barker EL, 1998, METHOD ENZYMOL, V296, P475; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Cammack JN, 1996, P NATL ACAD SCI USA, V93, P723, DOI 10.1073/pnas.93.2.723; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Galli A, 1997, J NEUROSCI, V17, P3401; GETHER U, 1992, FEBS LETT, V296, P241, DOI 10.1016/0014-5793(92)80295-R; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANNER BI, 1994, J EXP BIOL, V196, P237; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; MABJEESH NJ, 1993, BIOCHEMISTRY-US, V32, P8540, DOI 10.1021/bi00084a021; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; MILLER JW, 1997, NEUROTRANSMITTER TRA, P101; Nelson N, 1998, J NEUROCHEM, V71, P1785; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; Risso S, 1996, J PHYSIOL-LONDON, V490, P691, DOI 10.1113/jphysiol.1996.sp021178; Rudnick G, 1997, NEUROTRANSMITTER TRA, P73; Sonders MS, 1997, J NEUROSCI, V17, P960; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; UMBACH JA, 1990, BIOPHYS J, V57, P1217, DOI 10.1016/S0006-3495(90)82640-0; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0	43	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40476	40485		10.1074/jbc.M105578200	http://dx.doi.org/10.1074/jbc.M105578200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527967	hybrid			2022-12-27	WOS:000171925600017
J	Masuda, M; Suzuki, T; Friesen, MD; Ravanat, JL; Cadet, J; Pignatelli, B; Nishino, H; Ohshima, H				Masuda, M; Suzuki, T; Friesen, MD; Ravanat, JL; Cadet, J; Pignatelli, B; Nishino, H; Ohshima, H			Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils - Catalysis by nicotine and trimethylamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER RISK; CALF THYMUS DNA; NITRIC-OXIDE; HYDROXYL RADICALS; MASS-SPECTROMETRY; CELLULAR DNA; OXIDATION; MECHANISM; CHLORIDE; MARKER	Activated human neutrophils secrete myeloperoxidase, which generates HOCl from H2O2 and Cl-. We have found that various (2'-deoxy)nucleosides react with HOCl to form chlorinated (2'-deoxy)nucleosides, including novel 8-chloro(2'-deoxy)guanosine, 5-chloro(2'-deoxy)cytidine, and 8-chloro(2'-deoxy)adenosine formed in yields of 1.6, 1.6, and 0.2%, respectively, when 0.5 mM nucleoside reacted with 0.5 mM HOCl at pH 7.4. The relative chlorination, oxidation, and nitration activities of HOCl, myeloperoxidase, and activated human neutrophils in the presence and absence of nitrite were studied by analyzing 8-chloro-, 8-oxo-7,8-dihydro-, and 8-nitro-guanosine, respectively, using guanosine as a probe. 8-Chloroguanosine was always more easily formed than 8-oxo-7,8-dihydro- or 8-nitro-guanosine. Using electrospray ionization tandem mass spectrometry, we show that several chlorinated nucleosides including 8-chloro(2'-deoxy)guanosine are formed following exposure of isolated DNA or RNA to HOCl. Micromolar concentrations of tertiary amines such as nicotine and trimethylamine dramatically enhanced chlorination of free (2'-deoxy)nucleosides and nucleosides in RNA by HOCl. As the G-463A polymorphism of the MPO gene, which strongly reduces myeloproxidase mRNA expression, is associated with a reduced risk of lung cancer, chlorination damage of DNA/RNA and nucleosides by myeloperoxidase and its enhancement by nicotine may be important in the pathophysiology of human diseases associated with tobacco habits.	Int Agcy Res Canc, Unit Endogenous Canc Risk Factors, F-69372 Lyon 8, France; Int Agcy Res Canc, Unit Nutr & Canc, Lyon, France; CEA, Dept Rech Fondamentale Mat Condensee, Serv Chim Inorgan & Biol, Lab Les Acides Nucl,UMR 5046, F-38054 Grenoble, France; Kyoto Prefectural Univ Med, Dept Biochem, Kyoto 6028566, Japan	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); CEA; Kyoto Prefectural University of Medicine	Ohshima, H (corresponding author), Int Agcy Res Canc, Unit Endogenous Canc Risk Factors, 150 Cours Albert Thomas, F-69372 Lyon 8, France.		Ravanat, Jean-Luc/E-3452-2018; Cadet, Jean/M-2971-2018; Friesen, Marlin D/D-7328-2012; Ohshima, Hiroshi/E-8044-2010	Ravanat, Jean-Luc/0000-0002-7123-6358; Cadet, Jean/0000-0003-2594-9485; 				AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; ARNHOLD J, 1995, CHEM PHYS LIPIDS, V78, P55, DOI 10.1016/0009-3084(95)02484-Z; Brezonik P.L., 1994, CHEM KINETICS PROCES; Byun J, 1999, BIOCHEMISTRY-US, V38, P2590, DOI 10.1021/bi9822980; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Cascorbi I, 2000, CANCER RES, V60, P644; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 1996, J BIOL CHEM, V271, P19199, DOI 10.1074/jbc.271.32.19199; ELLIS AJ, 1954, J CHEM SOC, P1750, DOI 10.1039/jr9540001750; Frelon S, 2000, CHEM RES TOXICOL, V13, P1002, DOI 10.1021/tx000085h; GOULD JP, 1984, WATER RES, V18, P991, DOI 10.1016/0043-1354(84)90250-1; Guengerich FP, 1999, CHEM RES TOXICOL, V12, P906, DOI 10.1021/tx990094u; HAYATSU H, 1971, CHEM PHARM BULL, V19, P2189; Hazen SL, 1999, METHOD ENZYMOL, V300, P88; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Henderson JP, 1999, J BIOL CHEM, V274, P33440, DOI 10.1074/jbc.274.47.33440; HIGUCHI T, 1969, J CHEM SOC B, P626, DOI 10.1039/j29690000626; HUMPHREYS WG, 1992, P NATL ACAD SCI USA, V89, P8278, DOI 10.1073/pnas.89.17.8278; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1986, IARC MON EV CARC RIS, V38; IARC Working group on the Evaluation of Carcinogenic Risks to Humans, 1993, IARC MON EV CARC RIS, V56; Jiang Q, 1997, J BIOL CHEM, V272, P32767, DOI 10.1074/jbc.272.52.32767; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; KHAN AU, 1994, P NATL ACAD SCI USA, V91, P12362, DOI 10.1073/pnas.91.26.12362; Koethe SM, 2000, AM J PATHOL, V157, P1735, DOI 10.1016/S0002-9440(10)64810-9; KOPPENOL WH, 1994, FEBS LETT, V347, P5, DOI 10.1016/0014-5793(94)00494-3; Le Marchand L, 2000, CANCER EPIDEM BIOMAR, V9, P181; London SJ, 1997, CANCER RES, V57, P5001; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; Niles JC, 1999, P NATL ACAD SCI USA, V96, P11729, DOI 10.1073/pnas.96.21.11729; Ohshima H, 1999, NITRIC OXIDE-BIOL CH, V3, P132, DOI 10.1006/niox.1999.0216; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; OHSHIMA H, 2000, FREE RADICALS CHEM B, P92; PATTON W, 1972, BIOCHEM BIOPH RES CO, V48, P880, DOI 10.1016/0006-291X(72)90690-0; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Prutz WA, 1998, ARCH BIOCHEM BIOPHYS, V357, P265, DOI 10.1006/abbi.1998.0822; Ravanat JL, 2000, ARCH BIOCHEM BIOPHYS, V374, P118, DOI 10.1006/abbi.1999.1610; RYU EK, 1981, J ORG CHEM, V46, P2819, DOI 10.1021/jo00326a053; Saran M, 1999, FREE RADICAL BIO MED, V26, P482, DOI 10.1016/S0891-5849(98)00187-7; SAYO H, 1990, XENOBIOTICA, V20, P957, DOI 10.3109/00498259009046911; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Suzuki T, 2001, CHEM RES TOXICOL, V14, P1163, DOI 10.1021/tx010024z; Tanigawa T, 2000, JPN J CANCER RES, V91, P769, DOI 10.1111/j.1349-7006.2000.tb01011.x; TOTTI N, 1984, SCIENCE, V223, P169, DOI 10.1126/science.6318317; Vialas C, 1998, J AM CHEM SOC, V120, P11548, DOI 10.1021/ja981597+; Whiteman M, 1997, CHEM RES TOXICOL, V10, P1240, DOI 10.1021/tx970086i; Whiteman M, 1999, BIOMARKERS, V4, P303, DOI 10.1080/135475099230831; YERMILOV V, 1995, FEBS LETT, V376, P207, DOI 10.1016/0014-5793(95)01281-6; ZEISEL SH, 1986, CANCER RES, V46, P6136	50	114	115	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40486	40496		10.1074/jbc.M102700200	http://dx.doi.org/10.1074/jbc.M102700200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533049	Green Published, hybrid			2022-12-27	WOS:000171925600018
J	Zhao, XH; Varnai, P; Tuymetova, G; Balla, A; Toth, ZE; Oker-Blom, C; Roder, J; Jeromin, A; Balla, T				Zhao, XH; Varnai, P; Tuymetova, G; Balla, A; Toth, ZE; Oker-Blom, C; Roder, J; Jeromin, A; Balla, T			Interaction of neuronal calcium sensor-1 (NCS-1) with phosphatidylinositol 4-kinase beta stimulates lipid kinase activity and affects membrane trafficking in COS-7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE KINASES; FREQUENIN; METABOLISM; PROTEIN; PHOSPHORYLATION; PTDINS(4,5)P-2; SECRETION; HOMOLOG; STT4P; GOLGI	Phosphatidylinositol 4-kinases (PI4K) catalyze the first step in the synthesis of phosphatidylinositol 4,5-bisphosphate, an important lipid regulator of several cellular functions. Here we show that the Ca2+-binding protein, neuronal calcium sensor-1 (NCS-1), can physically associate with the type III P14K beta with functional consequences affecting the kinase. Recombinant P14K beta, but not its glutathione S-transferase-fused form, showed enhanced PI kinase activity when incubated with recombinant NCS-1, but only if the latter was myristoylated. Similarly, in vitro translated NCS-1, but not its myristoylation-defective mutant, was found associated with recombinant- or in vitro translated PI4K beta in PI4K beta -immunoprecipitates. When expressed in COS-7 cells, PI4K beta and NCS-1 formed a complex that could be immunoprecipitated with antibodies against either proteins, and PI 4-kinase activity was present in anti-NCS-1 immunoprecipitates. Expressed NCS-1-YFP showed colocalization with endogenous PI4K beta primarily in the Golgi, but it was also present in the walls of numerous large perinuclear vesicles. Co-expression of a catalytically inactive PI4K beta inhibited the development of this vesicular phenotype. Transfection of PI4K beta and NCS-1 had no effect on basal PIP synthesis in permeabilized COS-7 cells, but it increased the wortmannin-sensitive [P-32]phosphate incorporation into phosphatidylinositol 4-phosphate during Ca2+-induced phospholipase C activation. These results together indicate that NCS-1 is able to interact with PI4K beta also in mammalian cells and may play a role in the regulation of this enzyme in specific cellular compartments affecting vesicular trafficking.	NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA; Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40351 Jyvaskyla, Finland; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Jyvaskyla; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Balla, T (corresponding author), NICHHD, Endocrinol & Reprod Res Branch, NIH, Bldg 49,Rm 6A35,49 Convent Dr, Bethesda, MD 20892 USA.		Toth, Zsuzsanna/U-2579-2019; Roder, John/G-6468-2013	Balla, Andras/0000-0002-6450-2793; Balla, Tamas/0000-0002-9077-3335	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; BALLA T, 1988, J BIOL CHEM, V263, P4083; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Fisher JR, 2000, PROTEIN EXPRES PURIF, V20, P66, DOI 10.1006/prep.2000.1298; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; Martin TFJ, 1997, BIOCHEM SOC T, V25, P1137, DOI 10.1042/bst0251137; Martone ME, 1999, CELL TISSUE RES, V295, P395, DOI 10.1007/s004410051246; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NEF S, 1995, J RECEPT SIGNAL TR R, V15, P365, DOI 10.3109/10799899509045227; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Trotter PJ, 1998, J BIOL CHEM, V273, P13189, DOI 10.1074/jbc.273.21.13189; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Weisz OA, 2000, J BIOL CHEM, V275, P24341, DOI 10.1074/jbc.M000671200; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Zhao XH, 2000, J BIOL CHEM, V275, P14642, DOI 10.1074/jbc.275.19.14642	32	122	129	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40183	40189		10.1074/jbc.M104048200	http://dx.doi.org/10.1074/jbc.M104048200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11526106	hybrid			2022-12-27	WOS:000171789200090
J	Dunn, SE; Simard, AR; Bassel-Duby, R; Williams, RS; Michel, RN				Dunn, SE; Simard, AR; Bassel-Duby, R; Williams, RS; Michel, RN			Nerve activity-dependent modulation of calcineurin signaling in adult fast and slow skeletal muscle fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEF2 TRANSCRIPTION FACTOR; HEAVY-CHAIN EXPRESSION; FUNCTIONAL-SIGNIFICANCE; GENE-EXPRESSION; STIMULATED FAST; RAT MUSCLES; IN-VIVO; HYPERTROPHY; ACTIVATION; PATHWAY	This study tested the hypothesis that calcineurin signaling is modulated in skeletal muscle cells by fluctuations in nerve-mediated activity. We show that dephosphorylation of NFATc1, MEF2A, and MEF2D transcription factors by calcineurin in all muscle types is dependent on nerve activity and positively correlated with muscle usage under normal weightbearing conditions. With increased nerve-mediated activity, calcineurin dephosphorylation of these targets was found to be potentiated in a way that paralleled the higher muscle activation profiles associated with functional overload or nerve electrical stimulation conditions. We also establish that muscle activity must be sustained above native levels for calcineurin-dependent dephosphorylation of MEF2A and MEF2D to be transduced into an increase in MEF2 transcriptional function, suggesting that calcineurin cooperates with other activity-linked events to signal via these proteins. Finally, examination of individual fiber responses to overload and nerve electrical stimulation revealed that calcineurin-MEF2 signaling occurs in all fiber types but most readily in fibers that are normally least active (i.e. those expressing IIx and IIb myosin heavy chain (MHC)), suggesting that signaling via this phosphatase is also dependent upon the activation history of the muscle cell.	Laurentian Univ, Dept Chem & Biochem, Neuromuscular Res Lab, Sudbury, ON P3E 2C6, Canada; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Western Ontario, Fac Hlth Sci, London, ON N6A 3K7, Canada	Laurentian University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Western University (University of Western Ontario)	Michel, RN (corresponding author), Laurentian Univ, Dept Chem & Biochem, Neuromuscular Res Lab, Sudbury, ON P3E 2C6, Canada.	rnmichel@nickel.laurentian.ca	Simard, Alain/E-1493-2013	Simard, Alain/0000-0002-3499-6235				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Adams GR, 1996, J APPL PHYSIOL, V81, P2509, DOI 10.1152/jappl.1996.81.6.2509; AUSONI S, 1990, J NEUROSCI, V10, P153; BENNETT MR, 1974, J PHYSIOL-LONDON, V238, P79, DOI 10.1113/jphysiol.1974.sp010511; Bigard X, 2000, J BIOL CHEM, V275, P19653, DOI 10.1074/jbc.M000430200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Carroll S, 1999, AM J PHYSIOL-CELL PH, V277, pC1122, DOI 10.1152/ajpcell.1999.277.6.C1122; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CHIN ER, 1996, PHYSIOLOGIST, V39, pA75; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; Dunn SE, 1999, PFLUG ARCH EUR J PHY, V437, P432, DOI 10.1007/s004240050798; EKEN T, 1988, J PHYSIOL-LONDON, V402, P651, DOI 10.1113/jphysiol.1988.sp017227; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Garcia-Rodriguez C, 2000, EUR J IMMUNOL, V30, P2432, DOI 10.1002/1521-4141(2000)30:8<2432::AID-IMMU2432>3.0.CO;2-F; GARDINER P, 1986, BRAIN RES, V380, P114, DOI 10.1016/0006-8993(86)91435-6; Haddad F, 1998, J APPL PHYSIOL, V84, P2036, DOI 10.1152/jappl.1998.84.6.2036; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HENNEMAN E, 1985, J EXP BIOL, V115, P105; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Kubis HP, 1997, P NATL ACAD SCI USA, V94, P4205, DOI 10.1073/pnas.94.8.4205; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Meissner JD, 2001, J PHYSIOL-LONDON, V533, P215, DOI 10.1111/j.1469-7793.2001.0215b.x; MIDRIO M, 1988, EXP NEUROL, V100, P216, DOI 10.1016/0014-4886(88)90214-2; MINAMIKAWA T, 1995, CELL CALCIUM, V17, P165, DOI 10.1016/0143-4160(95)90031-4; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; PETTE D, 1992, REV PHYSIOL BIOCH P, V120, P115, DOI 10.1007/BFb0036123; PIEROTTI DJ, 1989, BRAIN RES, V481, P57, DOI 10.1016/0006-8993(89)90485-X; Prilutsky BI, 1996, J EXP BIOL, V199, P801; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Swoap SJ, 2000, AM J PHYSIOL-CELL PH, V279, pC915, DOI 10.1152/ajpcell.2000.279.4.C915; WAN KK, 1980, EXP NEUROL, V70, P475, DOI 10.1016/0014-4886(80)90174-0; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Zhao M, 1999, MOL CELL BIOL, V19, P21	47	75	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45243	45254		10.1074/jbc.M105445200	http://dx.doi.org/10.1074/jbc.M105445200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11555650	hybrid			2022-12-27	WOS:000172406700118
J	Uversky, VN; Li, J; Fink, AL				Uversky, VN; Li, J; Fink, AL			Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein - A possible molecular link between Parkinson's disease and heavy metal exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-PROTEIN; IN-VITRO; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; MOLTEN-GLOBULE; TRANSITION-METALS; BASAL GANGLIA; LEWY BODIES; IRON; ALUMINUM	Parkinson's disease involves the aggregation of alpha -synuclein to form fibrils, which are the major constituent of intracellular protein inclusions (Lewy bodies and Lewy neurites) in dopaminergic neurons of the substantia nigra. Occupational exposure to specific metals, especially manganese, copper, lead, iron, mercury, zinc, aluminum, appears to be a risk factor for Parkinson's disease based on epidemiological studies. Elevated levels of several of these metals have also been reported in the substantia nigra of Parkinson's disease subjects. We examined the effect of various metals on the kinetics of fibrillation of recombinant alpha -synuclein and in inducing conformational changes, as monitored by biophysical techniques. Several di- and trivalent metal ions caused significant accelerations in the rate of alpha -synuclein fibril format-ion. Aluminum was the most effective, along with copper(H), iron(III), cobalt(III), and manganese(II). The effectiveness correlated with increasing ion charge density. A correlation was noted between efficiency in stimulating fibrillation and inducing a conformational change, ascribed to formation of a partially folded intermediate. The potential for ligand bridging by polyvalent metal ions is proposed to be an important factor in the metal-induced conformational changes of a-synuclein. The results indicate that low concentrations of some metals can directly induce alpha -synuclein fibril formation.	Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	University of California System; University of California Santa Cruz; Russian Academy of Sciences	Fink, AL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	enzyme@cats.ucsc.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857				Altschuler E, 1999, MED HYPOTHESES, V53, P22, DOI 10.1054/mehy.1997.0701; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; DEYOUNG LR, 1993, ACCOUNTS CHEM RES, V26, P614, DOI 10.1021/ar00036a002; DUFFY PE, 1965, J NEUROPATH EXP NEUR, V24, P398, DOI 10.1097/00005072-196507000-00003; DUVOISIN RC, 1992, NEUROL CLIN, V10, P301, DOI 10.1016/S0733-8619(18)30211-1; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Esler WP, 1996, BIOCHEMISTRY-US, V35, P13914, DOI 10.1021/bi961302+; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FINK AL, 1995, ANNU REV BIOPH BIOM, V24, P495, DOI 10.1146/annurev.bb.24.060195.002431; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; FINK AL, 1999, ENCY MOL BIOL, P140; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Goedert M, 1997, NATURE, V388, P232, DOI 10.1038/40767; GOOD PF, 1992, BRAIN RES, V593, P343, DOI 10.1016/0006-8993(92)91334-B; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; GOURIEDEVI M, 1991, J ROY SOC MED, V84, P491, DOI 10.1177/014107689108400814; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; HERTZMAN C, 1994, MOVEMENT DISORD, V9, P69, DOI 10.1002/mds.870090111; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Kienzl E, 1995, J NEUROL SCI, V134, P69, DOI 10.1016/0022-510X(95)00210-S; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuznetsova IM, 1999, BIOPHYS J, V77, P2788, DOI 10.1016/S0006-3495(99)77111-0; Le Couteur DG, 1999, BIOMED PHARMACOTHER, V53, P122, DOI 10.1016/S0753-3322(99)80077-8; Lewy F., 1912, HDB NEUROLOGIE; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MONTGOMERY EB, 1995, TOXICOLOGY, V97, P3, DOI 10.1016/0300-483X(94)02962-T; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1996, LAB INVEST, V74, P374; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; OESTREICHER E, 1994, BRAIN RES, V660, P8, DOI 10.1016/0006-8993(94)90833-8; OKAZAKI H, 1961, J NEUROPATHOL EXP NE, V21, P422; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; RODIONOVA NA, 1989, MOL BIOL+, V23, P528; RYBICKI BA, 1993, MOVEMENT DISORD, V8, P87, DOI 10.1002/mds.870080116; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; TANNER CM, 1989, TRENDS NEUROSCI, V12, P49, DOI 10.1016/0166-2236(89)90135-5; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 1998, P NATL ACAD SCI USA, V95, P5480, DOI 10.1073/pnas.95.10.5480; Uversky VN, 1999, PROTEIN SCI, V8, P161; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wetzel R, 1996, CELL, V86, P699, DOI 10.1016/S0092-8674(00)80143-9; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; YASUI M, 1992, NEUROTOXICOLOGY, V13, P593; YOUDIM MBH, 1991, EUR NEUROL, V31, P34, DOI 10.1159/000116719; ZAYED J, 1990, CAN J NEUROL SCI, V17, P286, DOI 10.1017/S0317167100030584	79	849	862	6	151	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44284	44296		10.1074/jbc.M105343200	http://dx.doi.org/10.1074/jbc.M105343200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11553618	hybrid			2022-12-27	WOS:000172297700101
J	van Kats, JP; Methot, D; Paradis, P; Silversides, DW; Reudelhuber, TL				van Kats, JP; Methot, D; Paradis, P; Silversides, DW; Reudelhuber, TL			Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice - Direct and indirect effects of angiotensin II on the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESSURE-OVERLOAD HYPERTROPHY; RAT CARDIAC FIBROBLASTS; IN-VIVO; INTERSTITIAL FLUID; RECEPTOR SUBTYPES; BLOOD-PRESSURE; RENIN; FIBROSIS; SYSTEM; MYOCYTES	Angiotensin II is a peptide hormone regulator of blood pressure and fluid balance in mammals. Evidence obtained largely in vitro has also suggested that angiotensin II has growth-promoting effects and that it might thereby contribute to such pathological phenomena as cardiac hypertrophy, a major risk factor for cardiovascular mortality. It has been difficult to test for the direct growth-promoting effects of angiotensin II in vivo, however, because of the generalized effects of the peptide on hemodynamics. To overcome this limitation and to test for cardiac-specific functions of angiotensin II, we generated transgenic mice expressing an angiotensin II-producing fusion protein exclusively in cardiac myocytes. Our findings are the first to distinguish between local and systemic effects of angiotensin II on the heart and introduce a novel technique for studying tissue-specific peptide function.	Clin Res Inst Montreal, Lab Mol Biochem Hypertens, Montreal, PQ H2W 1R7, Canada; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Washington; University of Washington Seattle; Universite de Montreal	Reudelhuber, TL (corresponding author), Clin Res Inst Montreal, Lab Mol Biochem Hypertens, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	reudelt@ircm.qc.ca	van Kats, Jorge/A-8284-2008					Ammarguellat F, 2001, CIRCULATION, V103, P319; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; BRILLA CG, 1994, J MOL CELL CARDIOL, V26, P809, DOI 10.1006/jmcc.1994.1098; BRUCKSCHLEGEL G, 1995, HYPERTENSION, V25, P250, DOI 10.1161/01.HYP.25.2.250; deLannoy LM, 1997, HYPERTENSION, V29, P1240, DOI 10.1161/01.HYP.29.6.1240; DESCHEPPER CF, 1986, ENDOCRINOLOGY, V119, P36, DOI 10.1210/endo-119-1-36; Dostal DE, 1999, CIRC RES, V85, P643, DOI 10.1161/01.RES.85.7.643; DZAU VJ, 1994, J HYPERTENS       S4, V12, P3; Fareh J, 1996, CIRC RES, V78, P302, DOI 10.1161/01.RES.78.2.302; GOMEZSANCHEZ EP, 1995, STEROIDS, V60, P69; GUARDA E, 1993, CARDIOVASC RES, V27, P2130, DOI 10.1093/cvr/27.12.2130; Hamawaki M, 1998, AM J PHYSIOL-HEART C, V274, pH868, DOI 10.1152/ajpheart.1998.274.3.H868; Harada K, 1999, CIRCULATION, V100, P2093, DOI 10.1161/01.CIR.100.20.2093; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Hogan B, 1994, MANIPULATING MOUSE E; Kaddoura S, 1996, CIRCULATION, V93, P2068, DOI 10.1161/01.CIR.93.11.2068; KHOSLA MC, 1981, J MED CHEM, V24, P885, DOI 10.1021/jm00139a023; KIM SK, 1995, HYPERTENSION, V25, P1252, DOI 10.1161/01.HYP.25.6.1252; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; LEE AA, 1995, J MOL CELL CARDIOL, V27, P2347, DOI 10.1016/S0022-2828(95)91983-X; LEE MA, 1993, CIRCULATION, V87, P7; LINZ W, 1989, CLIN EXP HYPERTENS A, V11, P1325, DOI 10.3109/10641968909038172; Liu Y, 1998, CIRC RES, V82, P1145, DOI 10.1161/01.RES.82.11.1145; MATSUBARA H, 1994, J CLIN INVEST, V93, P1592, DOI 10.1172/JCI117139; Matsusaka T, 1999, J CLIN INVEST, V103, P1451, DOI 10.1172/JCI5056; Mazzolai L, 1998, HYPERTENSION, V31, P1324, DOI 10.1161/01.HYP.31.6.1324; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; MENTLEIN R, 1988, FEBS LETT, V234, P251, DOI 10.1016/0014-5793(88)80092-9; METHOT D, 1995, NUCLEIC ACIDS RES, V23, P4551, DOI 10.1093/nar/23.22.4551; Methot D, 2001, AM J HYPERTENS, V14, p38S, DOI 10.1016/S0895-7061(01)02068-4; Methot D, 1997, J BIOL CHEM, V272, P12994, DOI 10.1074/jbc.272.20.12994; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Prescott G, 2000, PHYSIOL GENOMICS, V4, P67, DOI 10.1152/physiolgenomics.2000.4.1.67; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schuijt MP, 1999, J HYPERTENS, V17, P1885, DOI 10.1097/00004872-199917121-00017; Silvestre JS, 1998, J BIOL CHEM, V273, P4883, DOI 10.1074/jbc.273.9.4883; STASCH JP, 1995, AM J HYPERTENS, V8, P1128, DOI 10.1016/0895-7061(95)00224-D; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; YOUNG M, 1995, AM J PHYSIOL-ENDOC M, V269, pE657, DOI 10.1152/ajpendo.1995.269.4.E657	45	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44012	44017		10.1074/jbc.M106132200	http://dx.doi.org/10.1074/jbc.M106132200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11551931	hybrid			2022-12-27	WOS:000172297700069
J	Basran, J; Sutcliffe, MJ; Scrutton, NS				Basran, J; Sutcliffe, MJ; Scrutton, NS			Optimizing the Michaelis complex of trimethylamine dehydrogenase - Identification of interactions that perturb the ionization of substrate and facilitate catalysis with trimethylamine base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON TRANSFERRING FLAVOPROTEIN; MONOAMINE-OXIDASE; ENZYME-SUBSTRATE; C30A MUTANT; WILD-TYPE; OXIDATION; MECHANISM; BENZYLAMINE; BACTERIUM; W(3)A(1)	Recent evidence from isotope studies supports the view that catalysis by trimethylamine dehydrogenase (TMADH) proceeds from a Michaelis complex involving trimethylamine base and not, as thought previously, trimethylammonium cation. In native TMADH reduction of the flavin by substrate (perdeuterated trimethylamine) is influenced by two ionizations in the Michaelis complex with pK(a) values of 6.5 and 8.4; maximal activity is realized in the alkaline region. The latter ionization has been attributed to residue His-172 and, more recently, the former to the ionization of substrate itself. In the Michaelis complex, the ionization of substrate (pK(a) similar to 6.5 for perdeuterated substrate) is perturbed by similar to -3.3 to -3.6 pH units compared with that of free trimethylamine (pK(a) = 9.8) and free perdeuterated trimethylamine (pK(a) = 10.1), respectively, thus stabilizing trimethylamine base by similar to2 kJ mol(-1). We show, by targeted mutagenesis and stopped-flow studies that this reduction of the pK(a) is a consequence of electronic interaction with residues Tyr-60 and His-172, thus these two residues are key for optimizing catalysis in the physiological pH range. We also show that residue Tyr-174, the remaining ionizable group in the active site that we have not targeted previously by mutagenesis, is not implicated in the pH dependence of flavin reduction. Formation of a Michaelis complex with trimethylamine base is consistent with a mechanism of amine oxidation that we advanced in our previous computational and kinetic studies which involves nucleophilic attack by the substrate nitrogen atom on the electrophilic C4a atom of the flavin isoalloxazine ring. Stabilization of trimethylamine base in the Michaelis complex over that in free solution is key to optimizing catalysis at physiological pH in TMADH, and may be of general importance in the mechanism of other amine dehydrogenases that require the unprotonated form of the substrate for catalysis.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.			Sutcliffe, Mike/0000-0003-0414-1700				Basran J, 1999, J BIOL CHEM, V274, P13155, DOI 10.1074/jbc.274.19.13155; Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Basran J, 1999, BIOCHEM J, V341, P307, DOI 10.1042/0264-6021:3410307; Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; BELLAMY HD, 1989, J BIOL CHEM, V264, P11887; DAVIDSON V, 2000, ENZYME CATALYZED ELE, V35, P119; DIXON HBF, 1973, BIOCHEM J, V131, P149, DOI 10.1042/bj1310149; EDMONDSON DE, 1995, XENOBIOTICA, V25, P735, DOI 10.3109/00498259509061889; GRANT KL, 1989, BIOCHEMISTRY-US, V28, P6597, DOI 10.1021/bi00442a010; Harris RJ, 2000, BIOCHEMISTRY-US, V39, P1189, DOI 10.1021/bi991941v; HUANG LX, 1995, J BIOL CHEM, V270, P23958, DOI 10.1074/jbc.270.41.23958; Jang MH, 1999, J BIOL CHEM, V274, P13147, DOI 10.1074/jbc.274.19.13147; KIM JM, 1993, J AM CHEM SOC, V115, P10591, DOI 10.1021/ja00076a017; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LIM LW, 1986, J BIOL CHEM, V261, P5140; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mewies M, 1997, BIOCHEMISTRY-US, V36, P7162, DOI 10.1021/bi970621d; Miller JR, 1999, BIOCHEMISTRY-US, V38, P13670, DOI 10.1021/bi990920y; Miura R, 1997, J BIOCHEM-TOKYO, V122, P825; Mullis K B, 1991, PCR Methods Appl, V1, P1; NAGY J, 1979, J BIOL CHEM, V254, P2684; ROHLFS RJ, 1994, J BIOL CHEM, V269, P30869; Scrutton, 2000, ENZYME CATALYZED ELE, V35, P183; SCRUTTON NS, 1994, J BIOL CHEM, V269, P13942; SCRUTTON NS, 2000, ENZYME CATALYZED ELE, V35, P145; SILVERMAN RB, 1995, ACCOUNTS CHEM RES, V28, P335, DOI 10.1021/ar00056a003; SINGER TP, 1980, FLAVINS FLAVOPROTEIN, P277; STEENKAMP DJ, 1982, BIOCHEM J, V207, P241, DOI 10.1042/bj2070241; STEENKAMP DJ, 1978, BIOCHEM J, V169, P361, DOI 10.1042/bj1690361; STEENKAMP DJ, 1976, BIOCHIM BIOPHYS ACTA, V429, P705, DOI 10.1016/0005-2744(76)90319-3; STEENKAMP DJ, 1978, MECHANISMS OXIDIZING, P127; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Trickey P, 2000, BIOCHEMISTRY-US, V39, P7678, DOI 10.1021/bi9927181; WILSON EK, 1995, BIOCHEMISTRY-US, V34, P2584, DOI 10.1021/bi00008a024	37	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42887	42892		10.1074/jbc.M108296200	http://dx.doi.org/10.1074/jbc.M108296200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553643	hybrid			2022-12-27	WOS:000172169300035
J	Berkovich, E; Ginsberg, D				Berkovich, E; Ginsberg, D			Ras induces elevation of E2F-1 mRNA levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE MACHINERY; S-PHASE ENTRY; UBIQUITIN-PROTEASOME PATHWAY; TRANSCRIPTION FACTOR E2F-1; MYC PROTEIN STABILITY; DEREGULATED EXPRESSION; FAMILY MEMBERS; MESSENGER-RNA; SUBCELLULAR-LOCALIZATION; RETINOBLASTOMA PROTEIN	Both E2F-1 and Ras play pivotal roles in the regulation of cell proliferation, and in some biological settings, they collaborate in cell transformation. We show here that activated Ras induces an increase in E2F-1 mRNA and protein levels. This Ras-induced increase in E2F-1 levels is dependent on both MEK and PKB, and it is retinoblastoma-independent. The effect of Ras on the up-regulation of E2F-1 mRNA is at the level of mRNA stability. Our data describe a novel functional link between Ras and the retinoblastoma/E2F pathway. Furthermore, we suggest that one of the molecular mechanisms underlying the collaboration between Ras and E2F-1 involves a Ras-induced elevation of transcriptionally active E2F-1 levels.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ginsberg, D (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.			ginsberg, doron/0000-0002-1257-4920				Aklilu F, 2000, CANCER RES, V60, P1753; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; CHANDLER LA, 1994, MOL CELL BIOL, V14, P3085, DOI 10.1128/MCB.14.5.3085; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; Geng Y, 1996, ONCOGENE, V12, P1173; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; HOLTTA E, 1988, J BIOL CHEM, V263, P4500; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Missero C, 2000, MOL CELL BIOL, V20, P2783, DOI 10.1128/MCB.20.8.2783-2793.2000; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; NEBL G, 1994, J BIOL CHEM, V269, P7371; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Terada K, 2000, BIOCHEM BIOPH RES CO, V267, P449, DOI 10.1006/bbrc.1999.1955; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; White FC, 1997, GROWTH FACTORS, V14, P199, DOI 10.3109/08977199709021520; Winston JT, 1996, ONCOGENE, V12, P127; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420	57	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42851	42856		10.1074/jbc.M103596200	http://dx.doi.org/10.1074/jbc.M103596200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551910	hybrid			2022-12-27	WOS:000172169300030
J	Zhou, ZM; Ribeiro, AA; Lin, SH; Cotter, RJ; Miller, SI; Raetz, CRH				Zhou, ZM; Ribeiro, AA; Lin, SH; Cotter, RJ; Miller, SI; Raetz, CRH			Lipid A modifications in polymyxin-resistant Salmonella typhimurium - PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE RESISTANCE; ACID-DEFICIENT MUTANT; ESCHERICHIA-COLI; PHOSPHATE GROUPS; A PRECURSORS; PHOP-PHOQ; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; ENDOTOXINS; VIRULENCE	Lipid A of Salmonella typhimurium can be resolved into multiple molecular species. Many of these substances are more polar than the predominant hexa-acylated lipid A 1,4'-bisphosphate of Escherichia coli K-12. By using new isolation methods, we have purified six lipid A subtypes (St1 to St6) from wild type S. typhimurium. We demonstrate that these lipid A variants are covalently modified with one or two 4-amino-4-deoxy-L-arabinose (L-Ara4N) moieties. Each lipid A species with a defined set of polar modifications can be further derivatized with a palmitoyl moiety and/or a 2-hydroxymyristoyl residue in place of the secondary myristoyl chain at position 3'. The unexpected finding that St5 and St6 contain two L-Ara4N residues accounts for the anomalous structures of lipid A precursors seen in S. typhimurium mutants defective in 3-deoxy-D-manno-octulosonic, acid biosynthesis in which only the 1-phosphate group is modified with the L-Ara4N moiety (Strain, S. M., Armitage, I. M., Anderson, L., Takayama, K., Quershi, N., and Raetz, C. R. H. (1985) J. Biol. Chem. 260, 16089-16098). Phosphoethanolamine (pEtN)-modified lipid A species are much less abundant than L-Ara4N containing forms in wild type S. typhimurium grown in broth but accumulate to high levels when L-Ara4N synthesis is blocked in pmrA(C)pmrE(-) and pmrA(C)pmrF(-) mutants. Purification and analysis of selected compounds demonstrate that one or two pEtN moieties may be present. Our findings show that S. typhimurium contains versatile enzymes capable of modifying both the 1- and 4'-phosphates of lipid A with L-Ara4N and/or pEtN groups. PmrA null mutants of S. typhimurium produce lipid A species without any pEtN or L-Ara4N substituents. However, PmrA is not needed for the incorporation of 2-hydroxymyristate or palmitate.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke NMR Spect Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Middle Atlantic Mass Spectrometry Lab, Baltimore, MD 21205 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	Duke University; Duke University; Duke University; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, R01GM054882] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30479] Funding Source: Medline; NIGMS NIH HHS [GM54882, GM-51310] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROZEK KA, 1987, J BIOL CHEM, V262, P5170; BRYN K, 1978, EUR J BIOCHEM, V86, P311, DOI 10.1111/j.1432-1033.1978.tb12312.x; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Miller J.H., 1972, EXPT MOL GENETICS; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MUHLRADT PF, 1977, EUR J BIOCHEM, V81, P193, DOI 10.1111/j.1432-1033.1977.tb11941.x; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Odegaard TJ, 1997, J BIOL CHEM, V272, P19688, DOI 10.1074/jbc.272.32.19688; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; QURESHI N, 1985, J BIOL CHEM, V260, P5271; Raetz C. R. H., 1996, ESCHERICHIA COLI SAL, V1, P1035; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; Ribeiro AA, 1999, MAGN RESON CHEM, V37, P620, DOI 10.1002/(SICI)1097-458X(199909)37:9<620::AID-MRC517>3.0.CO;2-Q; ROSNER MR, 1979, J BIOL CHEM, V254, P5906; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; VOLK WA, 1970, EUR J BIOCHEM, V17, P223; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Wyckoff TJO, 1998, J BIOL CHEM, V273, P32369, DOI 10.1074/jbc.273.49.32369; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	38	177	181	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43111	43121		10.1074/jbc.M106960200	http://dx.doi.org/10.1074/jbc.M106960200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11535603	hybrid			2022-12-27	WOS:000172169300064
J	Fogg, VC; Azpiazu, I; Linder, ME; Smrcka, A; Scarlata, S; Gautam, N				Fogg, VC; Azpiazu, I; Linder, ME; Smrcka, A; Scarlata, S; Gautam, N			Role of the gamma subunit prenyl moiety in G protein beta gamma complex interaction with phospholipase C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SF9 CELLS; ALPHA-SUBUNIT; GTP-BINDING; ACTIVATION; PURIFICATION; ISOZYMES; REQUIRES; DOMAIN	The G protein beta gamma complex regulates a wide range of effectors, including the phospholipase C beta isozymes (PLC betas). Prenyl modification of the gamma subunit is necessary for this activity. Evidence presented here supports a direct interaction between the G protein gamma subunit prenyl group and PLC isozymes. A geranylgeranylated peptide corresponding to the C-terminal region of the gamma subunit type, gamma2, strongly inhibits stimulation of PLC beta2 and PLC beta3 activity by the beta gamma complex. This effect is specific because the same peptide has no effect on stimulation of PLC beta by an a subunit type, alphaq. Prenylation of the gamma peptide is required for its inhibitory effect. W interaction of prenylated gamma subunit peptide to fluophore-tagged PLC beta2 was examined by fluorescence spectroscopy, prenylated but not unprenylated peptide increased PLC beta2 fluorescence emission energy, indic ting direct binding of the prenyl moiety to PLC. In addition, fluorescence resonance energy transfer was detected between fluorophore tagged PLC beta and wild type Py complex but not an unprenylated mutant beta gamma complex. We conclude that a major function of the gamma subunit prenyl group is to facilitate direct protein-protein interaction between the beta gamma complex and an effector, phospholipase C beta.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; SUNY Stony Brook, Dept Phys & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Rochester	Gautam, N (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Box 8054, St Louis, MO 63110 USA.		Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, R01GM053132] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51466, GM53536, GM46963, R01 GM053536, GM53132, R01 GM046963, R01 GM051466] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azpiazu I, 1999, J BIOL CHEM, V274, P35305, DOI 10.1074/jbc.274.50.35305; AZPIAZU I, 2001, IN PRESS METHODS ENZ; BLANK JL, 1993, J BIOL CHEM, V268, P25184; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dietrich A, 1996, BIOCHEMISTRY-US, V35, P15174, DOI 10.1021/bi960305j; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hou YM, 2001, J BIOL CHEM, V276, P19982, DOI 10.1074/jbc.M010424200; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KISSELEV O, 1995, J BIOL CHEM, V270, P25356, DOI 10.1074/jbc.270.43.25356; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LEE SB, 1993, J BIOL CHEM, V268, P25952; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868	30	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41797	41802		10.1074/jbc.M107661200	http://dx.doi.org/10.1074/jbc.M107661200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546822	hybrid			2022-12-27	WOS:000172450400035
J	He, B; Bowen, NT; Minges, JT; Wilson, EM				He, B; Bowen, NT; Minges, JT; Wilson, EM			Androgen-induced NH2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIGAND-BINDING DOMAIN; PROTEASOME-MEDIATED DEGRADATION; VITAMIN-D-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; INTERDOMAIN COMMUNICATION; AF2 DOMAINS; SPECIFICITY; SEQUENCES; REGIONS	The androgen receptor undergoes an androgen-specific NH2- and COOH-terminal interaction between NH2- terminal motif FXXLF and activation function 2 in the ligand binding domain. We demonstrated previously that activation function 2 forms overlapping binding sites for the androgen receptor FXXLF motif and the LXXLL motifs of p160 coactivators. Here we investigate the influence of the NH2- and COOH-terminal interaction on androgen receptor function. Specificity and relative potency of the motif interactions were evaluated by ligand dissociation rate and the stability of chimeras of transcriptional intermediary factor 2 with full-length and truncated androgen or glucocorticoid receptor. The results indicate that the androgen receptor activation function 2 interacts specifically and with greater avidity with the single FXXLF motif than with the LXXLL motif region of p160 coactivators, whereas this region of the glucocorticoid receptor interacts preferentially with the LXXLL motifs. Expression of the LXXLL motifs as a fusion protein with the glucocorticoid receptor resulted in loss of agonist-induced receptor destabilization and increased half-time of ligand dissociation. The NH2- and COOH-terminal interaction inhibited binding and activation by transcriptional intermediary factor 2. We conclude that the androgen receptor NH2- and COOH-terminal interaction reduces the dissociation rate of bound androgen, stabilizes the receptor, and inhibits p160 coactivator recruitment by activation function 2.	Univ N Carolina, Reprod Biol Lab, Dept Biochem, Chapel Hill, NC 27599 USA; Univ N Carolina, Reprod Biol Lab, Dept Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Reprod Biol Lab, Dept Biochem, CB 7500,Rm 374,Med Sci Res Bldg, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910, U54HD035041] Funding Source: NIH RePORTER; NICHD NIH HHS [HD16910, U54-HD35041] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Alen P, 1999, MOL CELL BIOL, V19, P6085; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ARBOUR NC, 1993, MOL ENDOCRINOL, V7, P1307, DOI 10.1210/me.7.10.1307; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gregory CW, 2001, CANCER RES, V61, P4315; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; HOECK W, 1989, J BIOL CHEM, V264, P14396; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Li XY, 1999, MOL ENDOCRINOL, V13, P1686, DOI 10.1210/me.13.10.1686; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McInerney EM, 1996, P NATL ACAD SCI USA, V93, P10069, DOI 10.1073/pnas.93.19.10069; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; NARDULLI AM, 1988, ENDOCRINOLOGY, V122, P1532, DOI 10.1210/endo-122-4-1532; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; ONATE SA, 1995, SCIENCE, V270, P1354; Osburn DL, 2001, MOL CELL BIOL, V21, P4909, DOI 10.1128/MCB.21.15.4909-4918.2001; PAKDEL F, 1993, J STEROID BIOCHEM, V46, P663, DOI 10.1016/0960-0760(93)90307-I; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SANTISOMERE D, 1993, MOL ENDOCRINOL, V7, P833, DOI 10.1210/me.7.7.833; Scheller A, 1998, J BIOL CHEM, V273, P24216, DOI 10.1074/jbc.273.37.24216; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SPANJAARD RA, 1993, MOL ENDOCRINOL, V7, P12, DOI 10.1210/me.7.1.12; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; Tetel MJ, 1997, MOL ENDOCRINOL, V11, P1114, DOI 10.1210/me.11.8.1114; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang Q, 2001, J BIOL CHEM, V276, P7493, DOI 10.1074/jbc.M009916200; ZEGERS ND, 1991, BIOCHIM BIOPHYS ACTA, V1073, P23, DOI 10.1016/0304-4165(91)90178-J; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	56	109	110	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42293	42301		10.1074/jbc.M107492200	http://dx.doi.org/10.1074/jbc.M107492200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551963	Green Published, hybrid			2022-12-27	WOS:000172450400100
J	Kimura, T; Tani, S; Matsumoto, Y; Takeda, T				Kimura, T; Tani, S; Matsumoto, Y; Takeda, T			Serum amyloid P component is the shiga toxin 2-neutralizing factor in human blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; VERO TOXIN; BINDING; PROTEIN; INFECTIONS; VT2; PURIFICATION; ASSOCIATION; ANTIBODIES	It has been suggested that some factor present in human plasma binds to Shiga toxin 2 (Stx2) and neutralizes it in vitro (Bitzan, M., Klemt, M., Steffens, R., and Muller-Wiefel, D. E. (1993) Infection 21, 140-145). This factor does not exist in other species (Caprioli, A., Luzzi, I., Seganti, L., Marchetti, M., Karmali, M., Clarke, I., and Boyd, B. (1994) Recent Ada. VTEC Infect. 353-356). Because analysis of this factor is important to understanding the pathology induced by Shiga toxin-producing Escherichia coli, we purified this factor from human plasma and identified it. Purification was carried out by serially subjecting human plasma to Con A-Sepharose, DEAF-Sepharose, hydroxyapatite, and gel-filtration high performance liquid chromatography (HPLC), using Stx2-neutralizing activity as the indicator. The gel-filtration HPLC fraction yielded a single band on SDS-polyacrylamide gel electrophoresis. Twenty N-terminal amino acid residues of this fraction were analyzed and found to correspond perfectly to human serum amyloid P component (HuSAP). Because commercially available HuSAP also showed Stx2 binding and neutralizing activity, we identified this factor as HuSAP.	Teijin Ltd, Teijin Inst Biomed Res, Hino, Tokyo 1918512, Japan; Teijin Ltd, Pharmaceut Dev Dept 1, Chiyoda Ku, Tokyo 1008585, Japan; Natl Childrens Med Res Ctr, Dept Infect Dis Res, Setagaya Ku, Tokyo 1548509, Japan	Teijin Limited; Teijin Limited; National Center for Child Health & Development - Japan	Kimura, T (corresponding author), Teijin Ltd, Teijin Inst Biomed Res, 4-3-2 Asahigaoka, Hino, Tokyo 1918512, Japan.	t.kimura@teijin.co.jp						ASHKENAZI S, 1988, J PEDIATR-US, V113, P1008, DOI 10.1016/S0022-3476(88)80572-9; Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e12; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; BITZAN M, 1993, INFECTION, V21, P140, DOI 10.1007/BF01710530; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; BREATHNACH SM, 1981, NATURE, V293, P652, DOI 10.1038/293652a0; BUTLER PJG, 1990, J EXP MED, V172, P13, DOI 10.1084/jem.172.1.13; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; CAPRIOLI A, 1994, INT CONGR SER, V1072, P353; CORIA F, 1988, LAB INVEST, V58, P454; DEBEER FC, 1981, J EXP MED, V154, P1134, DOI 10.1084/jem.154.4.1134; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; KURAZONO H, 1987, FEMS MICROBIOL LETT, V44, P23, DOI 10.1016/0378-1097(87)90193-5; Kurioka T, 1998, INFECT IMMUN, V66, P1726, DOI 10.1128/IAI.66.4.1726-1734.1998; LI XA, 1994, BBA-GEN SUBJECTS, V1201, P143, DOI 10.1016/0304-4165(94)90034-5; LINDGREN SW, 1993, INFECT IMMUN, V61, P3832, DOI 10.1128/IAI.61.9.3832-3842.1993; Melton-Chelsa A.R., 1998, ESCHERICHIA COLI O15, P121; Morooka T, 1996, ACTA PAEDIATR JAPON, V38, P294; NODA M, 1987, MICROB PATHOGENESIS, V2, P339, DOI 10.1016/0882-4010(87)90076-3; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; PEPYS MB, 1982, ANN NY ACAD SCI, V389, P286, DOI 10.1111/j.1749-6632.1982.tb22144.x; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21749; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; SKINNER M, 1988, METHOD ENZYMOL, V163, P523; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; TARR PI, 1995, CLIN INFECT DIS, V20, P1, DOI 10.1093/clinids/20.1.1; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P3959, DOI 10.1128/IAI.58.12.3959-3965.1990; YUTSUDO T, 1987, MICROB PATHOGENESIS, V3, P21, DOI 10.1016/0882-4010(87)90034-9; YUTSUDO T, 1987, FEMS MICROBIOL LETT, V48, P273, DOI 10.1016/0378-1097(87)90175-3; Zahedi K, 1996, J BIOL CHEM, V271, P14897, DOI 10.1074/jbc.271.25.14897; Zahedi K, 1997, J BIOL CHEM, V272, P2143	36	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41576	41579		10.1074/jbc.M107819200	http://dx.doi.org/10.1074/jbc.M107819200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11533067	hybrid			2022-12-27	WOS:000172450400007
J	Unniraman, S; Prakash, R; Nagaraja, V				Unniraman, S; Prakash, R; Nagaraja, V			Alternate paradigm for intrinsic transcription termination in eubacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RNA; MYCOBACTERIUM-SMEGMATIS; ATTENUATOR TEMPLATES; LOOP STRUCTURE; DNA GYRASE; POLYMERASE; RHO; ELONGATION; MECHANISM; GENE	Intrinsic transcription terminators are functionally defined as sites that bring about termination in vitro with purified RNA polymerase alone. Based on studies in Escherichia coli, intrinsic termination requires a palindromic stretch followed by a trail of T (or U) residues in the coding strand. We have developed a highly efficient algorithm to identify hairpin potential sequences in bacterial genomes in order to build a general model for intrinsic transcription termination. The algorithm was applied to analyze the Mycobacterium tuberculosis genome. We find that hairpin potential sequences are concentrated in the immediate downstream of stop codons. However, most of these structures either lack the U trail entirely or have a mixed A/U trail reflecting an evolutionarily relaxed requirement for the U trail in the mycobacterial genome. Predicted atypical structures were shown to work efficiently as terminators both inside the mycobacterial cell and in vitro with purified RNA polymerase. The results are discussed in light of the kinetic competition models for transcription termination. The algorithm identifies > 90% of experimentally tested terminators in bacteria and is an invaluable tool in identifying transcription units in whole genomes.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in						Abe H, 1996, BIOCHIMIE, V78, P1035, DOI 10.1016/S0300-9084(97)86727-2; ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; BRENDEL V, 1986, J BIOMOL STRUCT DYN, V3, P705, DOI 10.1080/07391102.1986.10508457; BRENDEL V, 1984, NUCLEIC ACIDS RES, V12, P4411, DOI 10.1093/nar/12.10.4411; CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546; DAS A, 1993, ANNU REV BIOCHEM, V62, P893; DASGUPTA SK, 1993, J BACTERIOL, V175, P5186, DOI 10.1128/JB.175.16.5186-5192.1993; DORVAL BC, 1991, J MOL BIOL, V221, P837, DOI 10.1016/0022-2836(91)80179-X; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; FISHER R, 1983, J BIOL CHEM, V258, P9208; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; HARTMANN RK, 1991, NUCLEIC ACIDS RES, V19, P5957, DOI 10.1093/nar/19.21.5957; INGHAM CJ, 1995, NUCLEIC ACIDS RES, V23, P370, DOI 10.1093/nar/23.3.370; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; LYNN SP, 1988, J BIOL CHEM, V263, P472; Madhusudan K, 1995, MICROBIOL-SGM, V141, P3029, DOI 10.1099/13500872-141-12-3029; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; NAGARAJA V, 1980, ARCH MICROBIOL, V124, P249, DOI 10.1007/BF00427734; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; POSTLE K, 1985, CELL, V41, P577, DOI 10.1016/S0092-8674(85)80030-1; PREDICH M, 1995, MOL MICROBIOL, V15, P355, DOI 10.1111/j.1365-2958.1995.tb02249.x; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; RYAN T, 1983, J BIOL CHEM, V258, P4690; STEINER K, 1995, MOL GEN GENET, V246, P374, DOI 10.1007/BF00288611; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Unniraman S, 1999, GENES CELLS, V4, P697, DOI 10.1046/j.1365-2443.1999.00296.x; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; VONHIPPEL PH, 1991, P NATL ACAD SCI USA, V88, P2307, DOI 10.1073/pnas.88.6.2307; Wang DG, 1997, P NATL ACAD SCI USA, V94, P8433, DOI 10.1073/pnas.94.16.8433; Washio T, 1998, NUCLEIC ACIDS RES, V26, P5456, DOI 10.1093/nar/26.23.5456; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; YANG MT, 1989, J BIOL CHEM, V264, P2634; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124	41	42	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41850	41855		10.1074/jbc.M106252200	http://dx.doi.org/10.1074/jbc.M106252200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551936	hybrid, Green Published			2022-12-27	WOS:000172450400042
J	Andersson, J; Bodevin, S; Westman, M; Sahlin, M; Sjoberg, BM				Andersson, J; Bodevin, S; Westman, M; Sahlin, M; Sjoberg, BM			Two active site asparagines are essential for the reaction mechanism of the class III anaerobic ribonucleotide reductase from bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; THIOREDOXIN-LIKE ACTIVITY; ESCHERICHIA-COLI; PROTEIN R1; DIPHOSPHATE REDUCTASE; ALLOSTERIC REGULATION; PHENOTYPIC SELECTION; RADICAL INTERMEDIATE; CATALYTIC MECHANISM; CYSTEINE RESIDUES	Class III ribonucleotide reductase is an anaerobic enzyme that uses a glycyl radical to catalyze the reduction of ribonucleotides to deoxyribonucleotides and formate as ultimate reductant. The reaction mechanism of class III ribonucleotide reductases requires two cysteines within the active site, Cys-79 and Cys-290 in bacteriophage T4 NrdD numbering. Cys-290 is believed to form a transient thiyl radical that initiates the reaction with substrate and Cys-79 to take part as a transient thiyl radical in later steps of the reductive reaction. The recently solved three-dimensional structure of class III ribonucleotide reductase (RNR) from bacteriophage T4 shows that two highly conserved asparagines, Asn-78 and Asn-311, are positioned close to the essential Cys-79. We have investigated the function of Asn-78 and Asn-311 by site-directed mutagenesis and measured enzyme activity and glycyl radical formation in five single (N78(A/C/D) and N311(A/C)) and one double (N78A/N311A) mutant proteins. Our results suggest that both asparagines are important for the catalytic mechanism of class III RNR and that one asparagine can partially compensate for the lack of the other functional group in the single Asn --> Ala mutant proteins. A plausible role for these two asparagines could be in positioning formate in the active site to orient it toward the proposed thiyl radical of Cys-79. This would also control the highly reactive carbon dioxide radical anion form of formate within the active site before it is released as carbon dioxide. A detailed reaction scheme including the function of the two asparagines and two formate molecules is proposed for class III RNRs.	Univ Stockholm, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Stockholm University	Sjoberg, BM (corresponding author), Univ Stockholm, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden.	bitte@molbio.su.se		Sjoberg, Britt-Marie/0000-0001-5953-3360				ABERG A, 1989, J BIOL CHEM, V264, P12249; Andersson J, 2000, J BIOL CHEM, V275, P19443, DOI 10.1074/jbc.M001490200; Andersson J, 2000, J BIOL CHEM, V275, P19449, DOI 10.1074/jbc.M001278200; ANDERSSON J, 2000, THESIS STOCKHOLM U S; Becker A, 1999, NAT STRUCT BIOL, V6, P969; BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Cho KB, 2001, J PHYS CHEM B, V105, P6445, DOI 10.1021/jp0107614; Eklund H, 1999, STRUCT FOLD DES, V7, pR257, DOI 10.1016/S0969-2126(00)80019-2; ELIASSON R, 1994, J BIOL CHEM, V269, P26052; ELIASSON R, 1994, J BIOL CHEM, V269, P26116; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; FinerMoore JS, 1996, BIOCHEMISTRY-US, V35, P5125, DOI 10.1021/bi952751x; FREY M, 1994, J BIOL CHEM, V269, P12432; Gray TE, 1996, BIOCHEMISTRY-US, V35, P15640, DOI 10.1021/bi961942c; Hesslinger C, 1998, MOL MICROBIOL, V27, P477, DOI 10.1046/j.1365-2958.1998.00696.x; Himo F, 1998, J AM CHEM SOC, V120, P11449, DOI 10.1021/ja9820947; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Hulsmeyer M, 1998, PROTEIN SCI, V7, P1286; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; Leuthner B, 1998, MOL MICROBIOL, V28, P615, DOI 10.1046/j.1365-2958.1998.00826.x; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9752, DOI 10.1021/bi00155a031; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; Persson AL, 1998, J BIOL CHEM, V273, P31016, DOI 10.1074/jbc.273.47.31016; Persson AL, 1997, J BIOL CHEM, V272, P31533, DOI 10.1074/jbc.272.50.31533; Sahlin M, 2000, Subcell Biochem, V35, P405; Schiott B, 1998, J AM CHEM SOC, V120, P7192, DOI 10.1021/ja9807338; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; Stubbe J, 1998, P NATL ACAD SCI USA, V95, P2723, DOI 10.1073/pnas.95.6.2723; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Uhlin U, 1996, J MOL BIOL, V262, P358, DOI 10.1006/jmbi.1996.0519; UNKRIG V, 1989, EUR J BIOCHEM, V184, P723, DOI 10.1111/j.1432-1033.1989.tb15072.x; VANDERDONK WA, 1995, J AM CHEM SOC, V117, P8908, DOI 10.1021/ja00140a003; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Young P, 1996, J BIOL CHEM, V271, P20770, DOI 10.1074/jbc.271.34.20770	48	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40457	40463		10.1074/jbc.M106863200	http://dx.doi.org/10.1074/jbc.M106863200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526118	hybrid			2022-12-27	WOS:000171925600015
J	Hou, ZJ; Narindrasorasak, S; Bhushan, B; Sarkar, B; Mitra, B				Hou, ZJ; Narindrasorasak, S; Bhushan, B; Sarkar, B; Mitra, B			Functional analysis of chimeric proteins of the Wilson Cu(I)-ATPase (ATP7B) and ZntA, a Pb(II)/Zn(II)/Cd(II)-ATPase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; COPPER-TRANSPORTING ATPASE; N-TERMINAL DOMAIN; MENKES DISEASE; CANDIDATE GENE; SACCHAROMYCES-CEREVISIAE; ENCODES; EXPRESSION; ASSAY	ATP7B, the Wilson disease-associated Cu(I)-transporter, and ZntA from Escherichia coli are soft metal P1-type ATPases with mutually exclusive metal ion substrates. P1-type ATPases have a distinctive amino-terminal domain containing the conserved metal-binding motif GXXCXXC. ZntA has one copy of this motif while ATP7B has six copies. The effect of interchanging the amino-terminal domains of ATP7B and ZntA was investigated. Chimeric proteins were constructed in which either the entire amino-terminal domain of ATP7B or only its sixth metal-binding motif replaced the aminoterminal domain of ZntA. Both chimeras conferred resistance to lead, zinc, and cadmium salts but not to copper salts. The purified chimeras displayed activity with lead, cadmium, zinc, and mercury, which are substrates of ZntA. There was no activity with copper or silver, which are substrates of ATP7B. The chimeras were 2-3-fold less active than ZntA. Thus, the amino-terminal domain of P1-type ATPases cannot alter the metal specificity determined by the transmembrane segment. Also, these results suggest that this domain interacts with the rest of the transporter in a metal ion-specific manner; the amino-terminal domain of ATP7B cannot replace that of ZntA in restoring full catalytic activity.	Hosp Sick Children, Dept Struct Biol & Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wayne State University	Sarkar, B (corresponding author), Hosp Sick Children, Dept Struct Biol & Biochem, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061689] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-61689] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Gatti D, 2000, J BIOL CHEM, V275, P34009, DOI 10.1074/jbc.R000012200; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Mitra B, 2001, BIOCHEMISTRY-US, V40, P7694, DOI 10.1021/bi010576g; Morrison J F, 1979, Methods Enzymol, V63, P257; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1998, J BIOL CHEM, V273, P32614, DOI 10.1074/jbc.273.49.32614; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; SIGEL H, 1987, EUR J BIOCHEM, V165, P65, DOI 10.1111/j.1432-1033.1987.tb11194.x; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Steele RA, 1997, BIOCHEMISTRY-US, V36, P6885, DOI 10.1021/bi9631632; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7	33	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40858	40863		10.1074/jbc.M107455200	http://dx.doi.org/10.1074/jbc.M107455200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527979	hybrid			2022-12-27	WOS:000171925600065
J	Kimberly, WT; Zheng, JB; Guenette, SY; Selkoe, DJ				Kimberly, WT; Zheng, JB; Guenette, SY; Selkoe, DJ			The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notch-like manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SECRETASE CLEAVAGE; C-TERMINAL FRAGMENTS; DISINTEGRIN-METALLOPROTEASE; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; GAMMA-SECRETASE; BINDING; RELEASE; NEURONS; GENE	The beta -amyloid precursor protein (APP) is a ubiquitous receptor-like molecule without a known function. However, the recent recognition that APP and Notch undergo highly similar proteolytic processing has suggested a potential signaling function for APP. After ligand binding, Notch is cleaved by the ADAM-17 metalloprotease followed by an intramembrane cleavage mediated by gamma -secretase. The gamma -secretase cut releases the Notch intracellular domain (NICD), which enters the nucleus and modulates transcription. Because APP is processed similarly by ADAM-17 and gamma -secretase, we reasoned that the APP intracellular domain (AICD) has a role analogous to the NICD. We therefore generated a plasmid encoding the AICD sequence and studied the subcellular localization of the expressed protein (C60). Our results demonstrate that the cytoplasmic domain of APP is a highly labile fragment that is stabilized by forming complexes with Fe65 and can then enter the nucleus in neurons and non-neural cells. These findings strongly support the hypothesis that APP signals in the nucleus in a manner analogous to the function of Notch.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Selkoe, DJ (corresponding author), Harvard Inst Med, Ctr Neurol Dis, 730,77 Ave Louis Pasteur, Boston, MA 02115 USA.				NIA NIH HHS [AG 06173] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006173, R37AG006173] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Murai S, 2000, ENANTIOMER, V5, P197; Perez RG, 1997, J NEUROSCI, V17, P9407; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SIMEONE A, 1994, DEV NEUROSCI-BASEL, V16, P53, DOI 10.1159/000112088; Thomas JE, 1996, J BIOL CHEM, V271, P28630, DOI 10.1074/jbc.271.45.28630; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399	33	373	386	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40288	40292		10.1074/jbc.C100447200	http://dx.doi.org/10.1074/jbc.C100447200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11544248	hybrid			2022-12-27	WOS:000171789200104
J	Zhao, XX; Murata, T; Ohno, S; Day, N; Song, J; Nomura, N; Nakahara, T; Yokoyama, KK				Zhao, XX; Murata, T; Ohno, S; Day, N; Song, J; Nomura, N; Nakahara, T; Yokoyama, KK			Protein kinase C alpha plays a critical role in mannosylerythritol lipid-induced differentiation of melanoma B16 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIC-CELLS; RETINOIC ACID; ERYTHROID DIFFERENTIATION; HEMOGLOBIN SYNTHESIS; CELLULAR-REGULATION; DIMETHYL-SULFOXIDE; GROWTH-INHIBITION; POTENT INDUCER; BUTYRIC-ACID; IN-VITRO	Mannosylerythritol lipid (MEL), a novel extracellular glycolipid from yeast, was found to inhibit the proliferation of mouse melanoma B16 cells in a dose-dependent manner and to induce the apoptosis of B16 cells at concentrations higher than 10 mum (Zhao, X., Wakamatsu, Y., Shibahara, M., Nomura, N., Geltinger, C., Nakahara, T., Murata, T., and Yokoyama, K. K. (1999) Cancer Res. 59, 482-486). We show here that exposure of B16 cells to MEL (5 mum) for 2 days resulted in an increase of the levels of differentiation-associated markers of melanoma cells such as melanogenesis and tyrosinase activity, which were accompanied by morphological changes. The MEL-induced differentiation of B16 cells at this concentration was closely associated with arrest of the cell cycle at G, phase, but no significant population of apoptotic cells was identified. Expression of protein kinase C alpha (PKC alpha) was enhanced after exposure of B16 cells to MEL for 48 h. Antisense oligodeoxynucleotides against the mouse gene for PKC alpha prevented MEL-induced melanogenesis in B16 cells. Conversely, the effects of the expression of a constitutively active form of PKCa mimicked the effects of MEL on B16 cells. These data suggest that MEL, a yeast-derived glycolipid, triggers the differentiation of B16 melanoma cells through a signaling pathway that involves PKC alpha.	RIKEN, Tsukuba Inst, Tsukuba, Ibaraki 3050074, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3050006, Japan; Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	RIKEN; University of Tsukuba; Yokohama City University	Yokoyama, KK (corresponding author), RIKEN, Tsukuba Inst, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	kazu@rtc.riken.go.jp	Ohno, Shigeo/B-1768-2010	Ohno, Shigeo/0000-0002-1294-5269; Nomura, Nobuhiko/0000-0003-1103-9157				Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; BLUMBERG PM, 1991, MOL CARCINOGEN, V4, P339, DOI 10.1002/mc.2940040502; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; Dean N, 1996, CANCER RES, V56, P3499; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; HAKOMORI S, 1985, CANCER RES, V45, P2405; HAKOMORI SI, 1993, ADV LIPID RES, V25, P147; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HUBERMAN E, 1979, CANCER RES, V39, P2618; Isoda H, 1997, LIPIDS, V32, P263, DOI 10.1007/s11745-997-0033-0; JOHNSTON D, 1992, EXP CELL RES, V201, P91, DOI 10.1016/0014-4827(92)90351-8; KAWAI S, 1995, ANTICANCER RES, V15, P427; Kim DG, 1998, PIGM CELL RES, V11, P143, DOI 10.1111/j.1600-0749.1998.tb00724.x; KIMHI Y, 1976, P NATL ACAD SCI USA, V73, P462, DOI 10.1073/pnas.73.2.462; KINDREGAN HC, 1994, J BIOL CHEM, V269, P27756; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P31, DOI 10.1080/00021369.1990.10869918; KOBAYASHI T, 1993, CANCER RES, V53, P2484; KOH HK, 1991, NEW ENGL J MED, V325, P171, DOI 10.1056/NEJM199107183250306; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; LOTAN R, 1983, CANCER RES, V43, P2868; Mahalingam H, 1996, J CELL PHYSIOL, V168, P549, DOI 10.1002/(SICI)1097-4652(199609)168:3<549::AID-JCP7>3.0.CO;2-P; MARKS PA, 1984, CANCER, V11, P2766; NILES RM, 1987, IN VITRO CELL DEV B, V23, P803, DOI 10.1007/BF02620957; NILES RM, 1978, J NATL CANCER I, V61, P523; NILES RM, 1989, CANCER RES, V49, P4483; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NORDENBERG J, 1986, EXP CELL RES, V162, P77, DOI 10.1016/0014-4827(86)90427-1; NOVOGRODSKY A, 1983, CANCER-AM CANCER SOC, V51, P9, DOI 10.1002/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO;2-4; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; PARK HY, 1993, J BIOL CHEM, V268, P11742; Park HY, 1996, EXP CELL RES, V227, P70, DOI 10.1006/excr.1996.0251; ROSEN JM, 1992, J REHABIL RES DEV, V29, P1, DOI 10.1682/JRRD.1992.04.0001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHER W, 1973, J CELL PHYSIOL, V81, P63, DOI 10.1002/jcp.1040810108; Shibahara M, 2000, CYTOTECHNOLOGY, V33, P247, DOI 10.1023/A:1008155111024; SPREMULLI EN, 1984, J CLIN ONCOL, V2, P227, DOI 10.1200/JCO.1984.2.3.227; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wakamatsu Y, 2001, EUR J BIOCHEM, V268, P374, DOI 10.1046/j.1432-1033.2001.01887.x; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamamura S, 1997, BIOCHEM BIOPH RES CO, V236, P218, DOI 10.1006/bbrc.1997.6933; Zhao XX, 1999, CANCER RES, V59, P482; Zhao XX, 2000, CYTOTECHNOLOGY, V33, P123, DOI 10.1023/A:1008129616127	48	53	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39903	39910		10.1074/jbc.M010281200	http://dx.doi.org/10.1074/jbc.M010281200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546757	hybrid			2022-12-27	WOS:000171789200055
J	Bulteau, AL; Verbeke, P; Petropoulos, I; Chaffotte, AF; Friguet, B				Bulteau, AL; Verbeke, P; Petropoulos, I; Chaffotte, AF; Friguet, B			Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED MAILLARD REACTION; COLI GLUTAMINE-SYNTHETASE; METAL-CATALYZED OXIDATION; OXIDIZED PROTEINS; END-PRODUCT; RAT-LIVER; PROTEOLYTIC ACTIVITIES; STRESS; AGE; PENTOSIDINE	Glycation and glycoxidation protein products are formed upon binding of sugars to NH2 groups of lysine and arginine residues and have been shown to accumulate during aging and in pathologies such as Alzheimer's disease and diabetes. Because the proteasome is the major intracellular proteolytic system involved in the removal of altered proteins, the effect of intracellular glycation on proteasome function has been analyzed in human dermal fibroblasts subjected to treatment with glyoxal that promotes the formation of N epsilon -carboxymethyl-lysine adducts on proteins. The three proteasome peptidase activities were decreased in glyoxal-treated cells as compared with control cells, and glyoxal was also found to inhibit these peptidase activities in vitro. In addition, the activity of glucose-6-phosphate dehydrogenase, a crucial enzyme for the regulation of the intracellular redox status, was dramatically reduced in glyoxal-treated cells. Further analysis was performed to determine whether glycated proteins are substrates for proteasome degradation. In contrast to the oxidized glucose-6-phosphate dehydrogenase, both N epsilon -carboxymethyl-lysine- and fluorescent-glycated enzymes were resistant to degradation by the 20 S proteasome in vitro, and this resistance was correlated with an increased conformational stability of the glycated proteins. These results provide one explanation for why glycated proteins build up both as a function of disease and aging. Finally, N epsilon -carboxymethyl-lysine-modified proteins were found to be ubiquitinated in glyoxal-treated cells suggesting a potential mechanism by which these modified proteins may be marked for degradation.	Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75251 Paris 05, France; Univ Aarhus, Dept Biol Mol & Struct, Lab Cellular Ageing, DK-8000 Aarhus, Denmark; Inst Pasteur, CNRS, URA 1129, Unite Biochim Cellulaire, F-75724 Paris 15, France	UDICE-French Research Universities; Universite Paris Cite; Aarhus University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, 2 Pl Jussieu,CC 7128, F-75251 Paris 05, France.	bfriguet@paris7.jussieu.fr	bulteau, anne-laure/AAN-4004-2020	Friguet, Bertrand/0000-0001-8085-1961; Petropoulos, Isabelle/0000-0001-9205-7458				Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8; ARAKI N, 1992, J BIOL CHEM, V267, P10211; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4; Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6; Ciechanover A, 2000, J CELL BIOCHEM, P40; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DEUTSCH J, 1983, METHOD ENZYMAT AN, V3, P190; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; FISHER MT, 1992, J BIOL CHEM, V267, P1872; FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222; Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8; FRIGUET B, 1994, J BIOL CHEM, V269, P21639; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6; Ho HY, 2000, FREE RADICAL BIO MED, V29, P156, DOI 10.1016/S0891-5849(00)00331-2; Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944; Kasper M, 1999, BIOCHEM BIOPH RES CO, V261, P175, DOI 10.1006/bbrc.1999.0902; Kimura T, 1998, PATHOL INT, V48, P575, DOI 10.1111/j.1440-1827.1998.tb03953.x; Kroll M, 1999, CHEM BIOL, V6, P689, DOI 10.1016/S1074-5521(00)80016-2; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; Lenk SE, 1999, J CELL PHYSIOL, V178, P17, DOI 10.1002/(SICI)1097-4652(199901)178:1<17::AID-JCP3>3.0.CO;2-R; Miyata S, 1997, J BIOL CHEM, V272, P4037, DOI 10.1074/jbc.272.7.4037; Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x; Monnier VM, 1996, NEPHROL DIAL TRANSPL, V11, P20; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Niwa H, 1998, BIOCHEM BIOPH RES CO, V248, P93, DOI 10.1006/bbrc.1998.8899; ODETTI P, 1992, DIABETES, V41, P153, DOI 10.2337/diabetes.41.2.153; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Ponnappan U, 1999, CELL IMMUNOL, V192, P167, DOI 10.1006/cimm.1998.1418; Portero-Otin M, 1999, DIABETES, V48, P2215, DOI 10.2337/diabetes.48.11.2215; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; RIVETT AJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P26, DOI 10.1016/0003-9861(90)90226-O; RIVETT AJ, 1985, J BIOL CHEM, V260, P300; Sell DR, 1998, MECH AGEING DEV, V105, P221, DOI 10.1016/S0047-6374(98)00090-6; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; SUAREZ G, 1995, ARCH BIOCHEM BIOPHYS, V321, P209, DOI 10.1006/abbi.1995.1387; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Ullrich O, 1999, FREE RADICAL BIO MED, V27, P487, DOI 10.1016/S0891-5849(99)00060-X; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; Verbeke P, 2000, EXP GERONTOL, V35, P787, DOI 10.1016/S0531-5565(00)00143-1; VLASSARA H, 1994, LAB INVEST, V70, P138	59	104	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45662	45668		10.1074/jbc.M105374200	http://dx.doi.org/10.1074/jbc.M105374200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11559702	hybrid			2022-12-27	WOS:000172573100024
J	Hail, N; Lotan, R				Hail, N; Lotan, R			Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CERVICAL-CARCINOMA CELLS; CYTOCHROME-C; OXYGEN; DEATH; INDUCTION; COMPLEX; CHAIN; RETINAMIDE; INCREASE	The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) is being examined in both chemoprevention and therapy clinical trials. Yet, its mechanism(s) of action is still not fully elucidated. In previous studies, an increase in mitochondrial reactive oxygen species has been proposed as one mechanism through which 4HPR could exert its proapoptotic effects. This study explored whether mitochondrial respiration is required for 4HPR action using human cutaneous squamous cell carcinoma cells and respiration-deficient clones. In parental cells, 4HPR rapidly promoted hydroperoxide production followed by mitochondrial permeability transition, caspase activity, and DNA fragmentation. Short term exposure to 4HPR also inhibited oxygen consumption in parental cells. This activity was reversed by the antioxidant vitamin C indicating the prooxidant effect of 4HPR directly impaired mitochondrial function. In respiration-deficient clones, the proapoptotic qualities of 4HPR were conspicuously diminished illustrating a central role for mitochondrial respiration in 4HPR-induced cell death. In parental cells, various mitochondrial inhibitors were examined to determine potential sites associated with the prooxidant activity of 4HPR. Inhibitors of Complex II as well as center i inhibitors of Complex III enhanced 4HPR-induced hydroperoxide production. Complex I inhibitors, center o inhibitors of Complex III, cyanide, oligomycin A, and coenzyme Q analogues decreased 4HPR-induced hydroperoxide production. The coenzyme Q analogues were very effective in this respect, and they also blocked the enhanced by droperoxide production obtained when center i inhibitors were combined with 4HPR. These results suggest the prooxidant property of 4HPR is associated with redox metabolism via an enzymatic process occurring at a quinone-binding site in Complex I and/or center o of Complex III.	Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lotan, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Box 432,1515 Holcombe Blvd, Houston, TX 77030 USA.	rlotan@mdanderson.org			NCI NIH HHS [P01 CA68233, R25 CA57780] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA068233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brand K, 1997, J BIOENERG BIOMEMBR, V29, P355, DOI 10.1023/A:1022498714522; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Buxser SE, 1999, METHOD ENZYMOL, V300, P256; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042; Dallaporta B, 1999, J IMMUNOL, V162, P6534; Delia D, 1997, CARCINOGENESIS, V18, P943, DOI 10.1093/carcin/18.5.943; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; ESPOSTI MD, 1994, BIOCHEM SOC T, V22, P209, DOI 10.1042/bst0220209; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Formelli F, 1996, FASEB J, V10, P1014, DOI 10.1096/fasebj.10.9.8801162; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hail N, 2000, CANCER EPIDEM BIOMAR, V9, P1293; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; Kelloff G J, 1994, J Cell Biochem Suppl, V20, P176; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0; LI X, 1995, CYTOMETRY, V20, P172, DOI 10.1002/cyto.990200210; Marchetti P, 1999, CANCER RES, V59, P6257; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; MODICANAPOLITANO JS, 1989, CANCER RES, V49, P3369; MOORE GE, 1975, CANCER RES, V35, P2684; Oridate N, 1997, J NATL CANCER I, V89, P1191, DOI 10.1093/jnci/89.16.1191; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Reed JC, 1999, J NATL CANCER I, V91, P1099, DOI 10.1093/jnci/91.13.1099; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Sun SY, 1999, MOL PHARMACOL, V55, P403; Suzuki S, 1999, ONCOGENE, V18, P6380, DOI 10.1038/sj.onc.1203024; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Waliszewski P, 1999, J PHOTOCH PHOTOBIO B, V52, P137, DOI 10.1016/S1011-1344(99)90000-3; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Wei YH, 1996, ANN NY ACAD SCI, V786, P24, DOI 10.1111/j.1749-6632.1996.tb39049.x; YAGUZHINSKY LS, 1973, J BIOENERG, V5, P163, DOI 10.1007/BF01648987; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	43	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45614	45621		10.1074/jbc.M106559200	http://dx.doi.org/10.1074/jbc.M106559200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11546781	hybrid			2022-12-27	WOS:000172573100018
J	Wilkens, S; Forgac, M				Wilkens, S; Forgac, M			Three-dimensional structure of the vacuolar ATPase proton channel by electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; SUBUNIT VPH1P; SYNTHASE; PROTEIN; TOPOGRAPHY; RESOLUTION; 100-KDA; PUMP	Vacuolar ATPases are ATP hydrolysis-driven proton pumps found in the endomembrane system of eucaryotic cells where they are involved in pH regulation. We have determined the three-dimensional structure of the proton channel domain of the vacuolar ATPase from bovine brain clathrin-coated vesicles by electron microscopy at 21 Angstrom resolution. The model shows an asymmetric protein ring with two small openings on the luminal side and one large opening on the cytoplasmic side. The central hole on the luminal side is covered by a globular protein, while the cytoplasmic opening is covered by two elongated proteins arranged in a collar-like fashion.	Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	University of California System; University of California Riverside; Tufts University	Wilkens, S (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	stephan.wilkens@ucr.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600, R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58600, R01 GM034478, GM34478, R37 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARAI H, 1988, J BIOL CHEM, V263, P8796; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Graham LA, 2000, J EXP BIOL, V203, P61; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; PALI T, 1995, BIOCHEMISTRY-US, V34, P9211, DOI 10.1021/bi00028a034; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; SCHATZ M, 1995, J STRUCT BIOL, V114, P28, DOI 10.1006/jsbi.1995.1003; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SUPEK F, 1994, J BIOL CHEM, V269, P24102; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	32	79	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44064	44068		10.1074/jbc.M106579200	http://dx.doi.org/10.1074/jbc.M106579200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11533034	hybrid			2022-12-27	WOS:000172297700075
J	Li, RX; Liu, YH; Ladisch, S				Li, RX; Liu, YH; Ladisch, S			Enhancement of epidermal growth factor signaling and activation of src kinase by gangliosides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; LIPID RAFTS; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; MEDIATED MODULATION; CAVEOLAE MEMBRANE; DOMAIN; TRANSDUCTION; MICRODOMAINS; PATHWAY	In a recent study, inhibition of cellular ganglioside synthesis blocked growth factor-induced fibroblast proliferation. Conversely, enrichment of cell membrane gangliosides by ganglioside preincubation enhanced growth factor-elicited cell proliferation. In the absence of serum and growth factors, NeuNAc alpha2-3Gal beta1-3GalNAc beta1-4(NeuNAc alpha2-3)Gal beta1-4Glc beta1-1Cer (G(D1a)) acted like a growth factor when cells were pretreated with the ganglioside, stimulating proliferation of normal human dermal fibroblasts and Swiss 3T3 fibroblasts. In contrast, growth inhibition was observed when high concentrations of gangliosides were continuously present in the culture medium during incubation of fibroblasts with growth factors (Li, R., Manela, J., Kong, Y., and Ladisch, S. (2000) J. Biol. Chem. 275,34213-34223). Here, we investigated the mechanisms whereby gangliosides elicit proliferation-coupled signaling in normal human dermal fibroblasts. Incubation of the fibroblasts with G(D1a) enhanced epidermal growth factor (EGF) receptor autophosphorylation and Ras and MAPK activation in a dose-dependent manner. Exposure of the cells to G(D1a) also enhanced the phosphorylation of Elk-1 by the activated MAPK. Brief pretreatment of the cells with PD98059 blocked the enhancing effect of gangliosides on EGF-induced MAPK activation. In the absence of serum and growth factors, G(D1a) incubation induced phosphorylation of Src kinase, Ras activation, and phosphorylation of MAPK and Elk-1 in a dose-dependent manner. The activation of Src kinase was confirmed by enhanced Src kinase activity. Brief treatment of the cells with PPI blocked the activation of Src kinase and MAPK. Again, PD98059 treatment inhibited ganglioside-elicited MAPK phosphorylation. Among the gangliosides tested, G(D1a), was the most active molecule, whereas lactosylceramide was the least active one, indicating relative structural specificity of the ganglioside action. In conclusion, gangliosides promote fibroblast proliferation through enhancement of growth factor signaling and activation of Src kinase.	Childrens Res Inst, Ctr Canc & Transplantat Biol, Glycobiol Program, Washington, DC 20010 USA; George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; George Washington Univ, Sch Med, Dept Biochem Mol Biol, Washington, DC 20052 USA	George Washington University; George Washington University	Li, RX (corresponding author), Childrens Res Inst, Ctr Canc & Transplantat Biol, Glycobiol Program, 111 Michigan Ave NW, Washington, DC 20010 USA.	ruixiangli@msn.com			NCI NIH HHS [CA61010] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061010] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Cary LA, 2000, NATURE, V404, P945, DOI 10.1038/35010257; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Chigorno V, 2000, EUR J BIOCHEM, V267, P4187, DOI 10.1046/j.1432-1327.2000.01454.x; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Hakomori SI, 1998, ANN NY ACAD SCI, V845, P1, DOI 10.1111/j.1749-6632.1998.tb09657.x; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Ladisch S, 2000, METHOD ENZYMOL, V312, P135; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meuillet EJ, 1999, CANCER RES, V59, P234; Olshefski R, 1996, FEBS LETT, V386, P11, DOI 10.1016/0014-5793(96)00392-4; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; Rebbaa A, 1996, GLYCOBIOLOGY, V6, P399, DOI 10.1093/glycob/6.4.399; SAQR HE, 1993, J NEUROCHEM, V61, P395; SAQR HE, 1995, J NEUROSCI RES, V41, P491, DOI 10.1002/jnr.490410408; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sorice M, 1997, J LIPID RES, V38, P969; VANBROCKLYN J, 1993, J NEUROCHEM, V61, P371; Whitmarsh AJ, 2000, NATURE, V403, P255, DOI 10.1038/35002220; YATES AJ, 1993, EXP CELL RES, V204, P38, DOI 10.1006/excr.1993.1006; YATES AJ, 1995, J NEURO-ONCOL, V24, P65, DOI 10.1007/BF01052661; ZHOU QG, 1994, J BIOL CHEM, V269, P1959	43	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42782	42792		10.1074/jbc.M101481200	http://dx.doi.org/10.1074/jbc.M101481200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11535585	hybrid			2022-12-27	WOS:000172169300021
J	Toshima, JY; Toshima, J; Mizuno, K				Toshima, JY; Toshima, J; Mizuno, K			Binding of 14-3-3 beta regulates the kinase activity and subcellular localization of testicular protein kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTIS-SPECIFIC PROTEIN-KINASE-1; ACTIN CYTOSKELETAL DYNAMICS; LIM-KINASE; COFILIN PHOSPHORYLATION; SIGNALING PATHWAYS; STRUCTURAL BASIS; ACTIVATION LOOP; T-CELLS; 14-3-3-PROTEINS; IDENTIFICATION	Testicular protein kinase 1 (TESK1) is a serine/threonine kinase that phosphorylates cofilin and induces actin cytoskeletal reorganization. The kinase activity of TESK1 is stimulated by integrin-mediated signaling pathways, but the mechanism of regulation has remained unknown. By using the yeast two-hybrid system, we identified 14-3-3 beta to be the binding protein of TESK1. Specific interaction between TESK1 and 14-3-3 beta became evident in in vitro and in vivo co-precipitation assays. 14-3-3 beta interacts with TESK1 through the C-terminal region of TESK1 and in a manner dependent on the phosphorylation of Ser-439 within an RXXSXP motif. Binding of 14-3-3 beta inhibited the kinase activity of TESK1. During cell spreading on fibronectin, the TESK1/14-3-3 beta interaction significantly decreased, in a time course that inversely correlated with increase in TESK1 kinase activity. Thus, the dissociation of 14-3-3 beta from a TESK1/14-3-3 beta complex is likely to be involved in the integrin-mediated TESK1 activation. In HeLa cells, TESK1, together with 14-3-3 beta, accumulated at the cell periphery when cells were plated on fibronectin, whereas they were diffusely distributed in the cytoplasm in the case of non-stimulated cells. We propose that 14-3-3 beta plays important roles in regulating the kinase activity of TESK1 and localizing TESK1 to cell adhesion sites following integrin stimulation.	Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.		Mizuno, Kensaku/G-8631-2015; 純子, 十島 Y/GRS-7321-2022					Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; BAX B, 1995, CURR BIOL, V5, P1119, DOI 10.1016/S0960-9822(95)00226-0; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chernoff J, 1999, NAT CELL BIOL, V1, pE115, DOI 10.1038/12942; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Garcia-Guzman M, 1999, J BIOL CHEM, V274, P5762, DOI 10.1074/jbc.274.9.5762; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Han DC, 2001, ONCOGENE, V20, P346, DOI 10.1038/sj.onc.1204068; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MIZUNO K, 1994, ONCOGENE, V9, P1605; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nagata K, 1999, BIOCHEM J, V343, P99, DOI 10.1042/0264-6021:3430099; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; PESO LD, 1997, SCIENCE, V278, P687; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Rosok O, 1999, GENOMICS, V61, P44, DOI 10.1006/geno.1999.5922; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Toshima J, 1998, BIOCHEM BIOPH RES CO, V249, P107, DOI 10.1006/bbrc.1998.9099; Toshima J, 1995, J BIOL CHEM, V270, P31331, DOI 10.1074/jbc.270.52.31331; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YAN Z, 1998, NATURE, V395, P507; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	43	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43471	43481		10.1074/jbc.M104620200	http://dx.doi.org/10.1074/jbc.M104620200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555644	hybrid			2022-12-27	WOS:000172169300108
J	Trent, MS; Ribeiro, AA; Doerrler, WT; Lin, SH; Cotter, RJ; Raetz, CRH				Trent, MS; Ribeiro, AA; Doerrler, WT; Lin, SH; Cotter, RJ; Raetz, CRH			Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli - Structural characterization and transfer to lipid A in the periplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; ENTEROBACTERIAL COMMON ANTIGEN; ACID-DEFICIENT MUTANT; CHEMICAL-STRUCTURE; NMR-SPECTROSCOPY; LIPOTEICHOIC ACIDS; PMRA MUTANTS; 4-AMINO-4-DEOXY-L-ARABINOSE; BIOSYNTHESIS; LIPOPOLYSACCHARIDE	Polymyxin-resistant mutants of Escherichia coli and Salmonella typhimurium accumulate a novel minor lipid that can donate 4-amino-4-deoxy-L-arabinose units (L-Ara4N) to lipid A. We now report the purification of this lipid from a pss(-) pmrA(C) mutant of E. coli and assign its structure as undecaprenyl phosphate-alpha -L-Ara4N. Approximately 0.2 mg of homogeneous material was isolated from an 8-liter culture by solvent extraction, followed by chromatography on DEAE-cellulose, C18 reverse phase resin, and silicic acid. Matrix-assisted laser desorption ionization/time of flight mass spectrometry in the negative mode yielded a single species [M - H]- at m/z 977.5, consistent with undecaprenyl phosphate-alpha -L-Ara4N (M-r = 978.41). P-31 NMR spectroscopy showed a single phosphorus atom at -0.44 ppm characteristic of a phosphodiester linkage. Selective inverse decoupling difference spectroscopy demonstrated that the undecaprenyl phosphate group is attached to the anomeric carbon of the L-Ara4N unit. One- and two-dimensional H-1 NMR studies confirmed the presence of a polyisoprene chain and a sugar moiety with chemical shifts and coupling constants expected for an equatorially substituted arabinopyranoside. Heteronuclear multiple-quantum coherence spectroscopy analysis demonstrated that a nitrogen atom is attached to C-4 of the sugar residue. The purified donor supports in vitro conversion of lipid IVA to lipid IIA, which is substituted with a single L-Ara4N moiety. The identification of undecaprenyl phosphate-alpha -L-Ara4N implies that L-Ara4N transfer to lipid A occurs in the periplasm of polymyxin-resistant strains, and establishes a new enzymatic pathway by which Gram-negative bacteria acquire antibiotic resistance.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke NMR Spect Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Middle Atlantic Mass Spectrometry Lab, Baltimore, MD 21205 USA	Duke University; Duke University; Duke University; Johns Hopkins University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	raetz@biochem.duke.edu			NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054882, R01GM051310] Funding Source: NIH RePORTER; NCI NIH HHS [P30-CA-14236] Funding Source: Medline; NIAID NIH HHS [1 F32 AI1056-02] Funding Source: Medline; NIGMS NIH HHS [GM-51310, GM54882] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; BARR K, 1987, J BIOL CHEM, V262, P7142; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLL M, 1994, FEMS IMMUNOL MED MIC, V8, P329; BUGG TDH, 1994, FEMS MICROBIOL LETT, V119, P255; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; DAME JB, 1979, J BACTERIOL, V137, P1043, DOI 10.1128/JB.137.2.1043-1047.1979; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; DOTSON SB, 1995, ARCH BIOCHEM BIOPHYS, V316, P773, DOI 10.1006/abbi.1995.1103; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GALANOS C, 1977, INT REV BIOCH BIOCH, V14, P239; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MICROB PATHOGENESIS, V25, P77, DOI 10.1006/mpat.1998.0217; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HASE S, 1977, EUR J BIOCHEM, V75, P23, DOI 10.1111/j.1432-1033.1977.tb11500.x; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; Koyama T, 1999, BIOSCI BIOTECH BIOCH, V63, P1671, DOI 10.1271/bbb.63.1671; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee RE, 1998, BIOORG MED CHEM LETT, V8, P951, DOI 10.1016/S0960-894X(98)00147-4; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; NALEWAY JJ, 1988, CARBOHYD RES, V179, P199, DOI 10.1016/0008-6215(88)84118-1; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Odegaard TJ, 1997, J BIOL CHEM, V272, P19688, DOI 10.1074/jbc.272.32.19688; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; ORLEAN P, 1992, BIOCHEM CELL BIOL, V70, P438, DOI 10.1139/o92-067; PARK JT, 1987, ESCHERICHIA COLI SAL, V1, P663; Que NLS, 2000, J BIOL CHEM, V275, P28017; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; RAETZ CRH, 1996, ESCHERICHIA COLI SAL, P1035; RAHMAN A, 1992, 13C NMR NATURAL PROD, V2; Rahman A.U., 1992, 13C NMR NATURAL PROD, V1; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Ribeiro AA, 1999, MAGN RESON CHEM, V37, P620, DOI 10.1002/(SICI)1097-458X(199909)37:9<620::AID-MRC517>3.0.CO;2-Q; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; SHIMADA A, 1988, EUR J BIOCHEM, V176, P559, DOI 10.1111/j.1432-1033.1988.tb14314.x; SHIMADA A, 1989, J BACTERIOL, V171, P2835, DOI 10.1128/jb.171.5.2835-2841.1989; SIDORCZYK Z, 1983, EUR J BIOCHEM, V137, P15, DOI 10.1111/j.1432-1033.1983.tb07789.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STANELONI RJ, 1982, CRC CR REV BIOCH MOL, V12, P289, DOI 10.1080/10409238209104422; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; VOLK WA, 1970, EUR J BIOCHEM, V17, P223; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; WOLUCKA BA, 1995, J BIOL CHEM, V270, P20151, DOI 10.1074/jbc.270.34.20151; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; WRIGHT A, 1967, P NATL ACAD SCI USA, V57, P1798, DOI 10.1073/pnas.57.6.1798; YOKOYAMA K, 1988, EUR J BIOCHEM, V173, P453, DOI 10.1111/j.1432-1033.1988.tb14020.x; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	72	103	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43132	43144		10.1074/jbc.M106962200	http://dx.doi.org/10.1074/jbc.M106962200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11535605	hybrid			2022-12-27	WOS:000172169300066
J	Igal, RA; Wang, SL; Gonzalez-Baro, M; Coleman, RA				Igal, RA; Wang, SL; Gonzalez-Baro, M; Coleman, RA			Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; ACYL-COA; SELECTIVE CHANGES; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; 3T3-L1 PREADIPOCYTES; MICROSOMAL-ENZYMES; BINDING PROTEIN; OBESE RATS; LIVER; DIFFERENTIATION	The mitochondrial isoform of glycerol-3-phosphate acyltransferase (GPAT), the first step in glycerolipid synthesis, is up-regulated by insulin and by high carbohydrate feeding via SREBP-1c, suggesting that it plays a role in triacylglycerol synthesis. To test this hypothesis, we overexpressed mitochondrial GPAT in Chinese hamster ovary (CHO) cells. When GPAT was overexpressed 3.8-fold, triacylglycerol mass was 2.7-fold higher than in control cells. After incubation with trace [C-14]oleate (similar to3 mum), control cells incorporated 4.7-fold more label into phospholipid than triacylglycerol, but GPAT-overexpressing cells incorporated equal amounts of label into phospholipid and triacylglycerol. In GPAT-overexpressing cells, the incorporation of label into phospholipid, particularly phosphatidylcholine, decreased 30%, despite normal growth rate and phospholipid content, suggesting that exogenous oleate was directed primarily toward triacylglycerol synthesis. Transiently transfected HEK293 cells that expressed a 4.4-fold increase in GPAT activity incorporated 9.7-fold more [C-14]oleate into triacylglycerol compared with control cells, showing that the effect of GPAT overexpression was similar in two different cell types that had been transfected by different methods. When the stable, GPAT-overexpressing CHO cells were incubated with 100 mum oleate to stimulate triacylglycerol synthesis, they incorporated 1.9-fold more fatty acid into triacylglycerol than did the control cells. Confocal microscopy of CHO and HEK293 cells transfected with the GPAT-FLAG construct showed that GPAT was located correctly in mitochondria and was not present elsewhere in the cell. These studies indicate that overexpressed mitochondrial GPAT directs incorporation of exogenous fatty acid into triacylglycerol rather than phospholipid and imply that (a) mitochondrial GPAT and lysophosphatidic acid acyltransferase produce a separate pool of lysophosphatidic acid and phosphatidic acid that must be transported to the endoplasmic reticulum where the terminal enzymes of triacylglycerol synthesis are located, and W this pool remains relatively separate from the pool of lysophosphatidic acid and phosphatidic acid that contributes to the synthesis of the major phospholipid species.	Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Nutr, Chapel Hill, NC 27599 USA; Natl Univ La Plata, Fac Ciencias Med, Inst Invest Bioquim, RA-1900 La Plata, Argentina	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National University of La Plata	Coleman, RA (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Nutr, CB 7400, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Ariel, Pablo/AGJ-4118-2022		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598] Funding Source: NIH RePORTER; FIC NIH HHS [TW00891] Funding Source: Medline; NIDDK NIH HHS [DK56598] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANIS RJ, 1976, ANAL BIOCHEM, V73, P1, DOI 10.1016/0003-2697(76)90135-4; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bhat BG, 1999, BBA-MOL CELL BIOL L, V1439, P415, DOI 10.1016/S1388-1981(99)00103-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; COLEMAN RA, 1980, J BIOL CHEM, V255, P7681; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; COLEMAN RA, 1983, J BIOL CHEM, V258, P450; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; HOMAN R, 1991, J LIPID RES, V32, P231; Igal RA, 2001, J LIPID RES, V42, P88; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; JERKINS AA, 1995, J BIOL CHEM, V270, P1416, DOI 10.1074/jbc.270.38.22135; Lee Y, 1997, DIABETES, V46, P408, DOI 10.2337/diabetes.46.3.408; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Massey JB, 1997, BIOPHYS J, V72, P1732, DOI 10.1016/S0006-3495(97)78819-2; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Muoio DM, 2000, AM J PHYSIOL-ENDOC M, V279, pE1366, DOI 10.1152/ajpendo.2000.279.6.E1366; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; ROSENTHAL MD, 1981, LIPIDS, V16, P173, DOI 10.1007/BF02535435; ROSENTHAL MD, 1980, LIPIDS, V15, P838, DOI 10.1007/BF02534374; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; VANCURA A, 1992, J BIOL CHEM, V267, P14353; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; [No title captured]	33	77	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42205	42212		10.1074/jbc.M103386200	http://dx.doi.org/10.1074/jbc.M103386200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546763	Green Published, hybrid			2022-12-27	WOS:000172450400089
J	Westwood, M; Aplin, JD; Collinge, IA; Gill, A; White, A; Gibson, JM				Westwood, M; Aplin, JD; Collinge, IA; Gill, A; White, A; Gibson, JM			alpha(2)-macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR (IGF)-BINDING PROTEIN-1; HUMAN AMNIOTIC-FLUID; IGF-I; ALPHA-2-MACROGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTOR; NORMAL PLASMA; FACTOR-XIII; FORMS; CELLS; IGFBP-1	Insulin-like growth factors (IGFs) are crucial for many aspects of development, growth, and metabolism yet control of their activity by IGF-binding proteins (IGFBPs) remains controversial. The effect of IGFBP-1 depends on its phosphorylation status; phosphorylated IGFBP-1 inhibits IGF actions whereas the nonphosphorylated isoform is stimulatory. In order to understand this phenomenon, we purified phosphorylated IGFBP-1 from normal human plasma by immunoaffinity chromatography. Unexpectedly, the resulting preparation enhanced IGF-stimulated 3T3-L1 fibroblast proliferation, due to the presence of a co-purified protein of approximate to 700 kDa. Matrix-assisted laser desorption ionization-mass spectrometry and Western immunoblotting analysis identified this copurified protein as alpha (2)-macroglobulin (alpha M-2). Anti-alpha M-2 antibodies co-immunoprecipitated IGFBP-1 from human plasma and from I-125-IGFBP-1(.)alpha M-2 complexes formed in vitro. The I-125-IGFBP-1/alpha M-2 association could be inhibited with excess unlabeled IGFBP-1. Surface plasmon resonance analysis indicated that alpha M-2 preferentially associates with the phosphorylated isoform of IGFBP-1 and that when complexed to alpha M-2, IGFBP-1 can still bind IGF-I. These findings have functional significance since alpha M-2 protects IGFBP-1 from proteolysis and abrogates the inhibitory effect of phosphorylated. IGFBP-1 on IGF-I stimulated 3T3-L1 cell proliferation. We conclude that alpha M-2 is a binding protein of IGFBP-1 which modifies IGF-I/IG-FBP-1 actions resulting in enhanced IGF effects. In line with its role in regulating the clearance and activity of other growth factors, we predict that alpha M-2 has a novel and important role in controlling the transport and biological activity of IGFs.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, St Marys Hosp, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England; Hope Hosp, Dept Endocrinol & Diabet, Salford M6 8HD, Lancs, England	University of Manchester; University of Manchester	Westwood, M (corresponding author), Univ Manchester, Sch Biol Sci, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.		Westwood, Melissa/G-5954-2015; White, Anne/C-3753-2011; White, Anne/G-7717-2015; Aplin, John/AET-4363-2022	Westwood, Melissa/0000-0001-9725-7010; White, Anne/0000-0002-7686-2884; gibson, martin/0000-0002-1331-1524; Aplin, John/0000-0001-8777-9261				BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BAUMRUCKER CR, 1999, 81 ANN M END SOC JUN, P404; BONNER JC, 1990, J CELL PHYSIOL, V145, P1, DOI 10.1002/jcp.1041450102; BURCH WM, 1990, J CLIN ENDOCR METAB, V70, P173, DOI 10.1210/jcem-70-1-173; BUSBY WH, 1988, J BIOL CHEM, V263, P14203; BUSBY WH, 1989, ENDOCRINOLOGY, V125, P773, DOI 10.1210/endo-125-2-773; CLEMMONS DR, 1990, J CELL PHYSIOL, V145, P129, DOI 10.1002/jcp.1041450118; CROOKSTON KP, 1993, BIOCHEM J, V293, P443, DOI 10.1042/bj2930443; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; FRAUMAN AG, 1989, ENDOCRINOLOGY, V124, P2289, DOI 10.1210/endo-124-5-2289; Frost RA, 1999, ENDOCRINOLOGY, V140, P3962, DOI 10.1210/en.140.9.3962; FROST RA, 1993, BIOL REPROD, V49, P104, DOI 10.1095/biolreprod49.1.104; GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P7916, DOI 10.1021/bi00082a012; Gibson JM, 2001, MOL HUM REPROD, V7, P79, DOI 10.1093/molehr/7.1.79; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Haugh JM, 1999, J BIOL CHEM, V274, P8958, DOI 10.1074/jbc.274.13.8958; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HUANG JS, 1984, P NATL ACAD SCI-BIOL, V81, P342, DOI 10.1073/pnas.81.2.342; Irwin JC, 1998, GROWTH HORM IGF RES, V8, P21, DOI 10.1016/S1096-6374(98)80318-3; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; JONES JI, 1991, P NATL ACAD SCI USA, V88, P7481, DOI 10.1073/pnas.88.17.7481; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAMARRE J, 1991, J CLIN INVEST, V87, P39, DOI 10.1172/JCI114998; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; LIU B, 1999, 81 ANN M END SOC SAN, P405; LIU L, 1991, BIOCHEM BIOPH RES CO, V174, P673, DOI 10.1016/0006-291X(91)91470-W; Martina NA, 1997, J CLIN ENDOCR METAB, V82, P1894, DOI 10.1210/jc.82.6.1894; Misra UK, 1998, CELL SIGNAL, V10, P441, DOI 10.1016/S0898-6568(97)00171-X; Misra UK, 1998, J BIOL CHEM, V273, P13399, DOI 10.1074/jbc.273.22.13399; MISRA UK, 1994, J BIOL CHEM, V269, P12541; PHILIP A, 1991, J BIOL CHEM, V266, P22290; Sakai K, 2001, J BIOL CHEM, V276, P8740, DOI 10.1074/jbc.M008359200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SOKER S, 1993, J BIOL CHEM, V268, P7685; SOTTRUPJENSEN L, 1983, ANN NY ACAD SCI, V421, P41, DOI 10.1111/j.1749-6632.1983.tb18091.x; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9016; VAUGHAN JM, 1993, ENDOCRINOLOGY, V132, P2038, DOI 10.1210/en.132.5.2038; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; WEINZIMER SA, 1999, 81 ANN M END SOC SAN, P83; WESTWOOD M, 1994, J CLIN ENDOCR METAB, V79, P1735, DOI 10.1210/jc.79.6.1735; Westwood M, 1997, ENDOCRINOLOGY, V138, P1130, DOI 10.1210/en.138.3.1130; WRIGHT JF, 1982, J IMMUNOL METHODS, V48, P311, DOI 10.1016/0022-1759(82)90332-5; Yu J, 1998, GROWTH HORM IGF RES, V8, P65, DOI 10.1016/S1096-6374(98)80323-7	48	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41668	41674		10.1074/jbc.M102793200	http://dx.doi.org/10.1074/jbc.M102793200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546760	hybrid			2022-12-27	WOS:000172450400019
J	Wu, Y; Egerton, G; Underwood, AP; Sakuda, S; Bianco, AE				Wu, Y; Egerton, G; Underwood, AP; Sakuda, S; Bianco, AE			Expression and secretion of a larval-specific chitinase (family 18 glycosyl hydrolase) by the infective stages of the parasitic nematode, Onchocerca volvulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; INHIBITION; SEQUENCE; CLASSIFICATION; MICROFILARIAE; PROTEINS; HEVAMINE; ANTIGENS; CLONING	A recently reported chitinase gene, expressed in the infective, third-stage (L3) larvae of the human filarial parasite Onchocerca volvulus, belongs to the family 18 glycosyl hydrolases and has been designated Ov-chi-1. The gene product of Ov-chi-1 is chitinolytic. Allosamidin ablates activity of the native enzyme in a dose-dependent manner but did not significantly inhibit the moulting of L3 larvae. Mono-specific antibodies were used to characterize Ov-CHI-1 as a 60-kDa protein expressed almost exclusively in L3 stages. Immunoelectron microscopy showed that Ov-CHI-1 expression is initiated in late L2 larvae and increases markedly in infective, L3 larvae. It is synthesized exclusively in the glandular esophagus and stored within discrete secretory granules. Secretion occurs through de-granulation during post-infective development, and the primary route of transport appears to be via the pseudo-coelom. An orthologue of Ov-chi-1 was detected in Caenorhabditis elegans by BLAST analysis. It is constitutively expressed at a low level and is overexpressed in dauer larvae and embryonated eggs. It is chitinolytic. We conclude that Ov-CHI-1 is a highly stage-specific enzyme that may have a role in infectivity of the parasite, aiding escape from the vector or participating in early post-infective migration and/or development. The identification of an orthologue in C. elegans opens the way for further studies into the biological function(s) of this intriguing parasite product.	Univ Liverpool, Liverpool Sch Trop Med, Div Mol Biol & Immunol, Liverpool L3 5QA, Merseyside, England; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 113, Japan	Liverpool School of Tropical Medicine; University of Liverpool; University of Tokyo	Wu, Y (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Div Mol Biol & Immunol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	ywu@liverpool.ac.uk		Sakuda, Shohei/0000-0001-7966-1167; Underwood, Anthony/0000-0002-8547-4277				Adam R, 1996, J BIOL CHEM, V271, P1441, DOI 10.1074/jbc.271.3.1441; Blaxter ML, 1997, PARASITOL TODAY, V13, P416, DOI 10.1016/S0169-4758(97)01140-X; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; BRENNER S, 1974, GENETICS, V77, P71; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; CONNOR DH, 1985, REV INFECT DIS, V7, P809; FLACH J, 1992, EXPERIENTIA, V48, P701, DOI 10.1007/BF02124285; FRANZ M, 1983, TROPENMED PARASITOL, V34, P155; FUHRMAN JA, 1992, P NATL ACAD SCI USA, V89, P1548, DOI 10.1073/pnas.89.5.1548; GOODAY GW, 1988, MOL BIOCHEM PARASIT, V29, P223, DOI 10.1016/0166-6851(88)90077-1; Harrison RA, 1999, VACCINE, V18, P647, DOI 10.1016/S0264-410X(99)00274-1; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; IBRAHIM MS, 1992, MOL BIOCHEM PARASIT, V52, P97, DOI 10.1016/0166-6851(92)90039-M; Jenkins RE, 1996, PARASITE IMMUNOL, V18, P29, DOI 10.1046/j.1365-3024.1996.d01-10.x; KING TP, 1987, HISTOCHEM J, V19, P281, DOI 10.1007/BF01675688; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEDINADELAGARZA CE, 1987, TROP MED PARASITOL, V38, P53; MILEWSKI S, 1992, J GEN MICROBIOL, V138, P2545, DOI 10.1099/00221287-138-12-2545; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; ROBBINS PW, 1988, J BIOL CHEM, V263, P443; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; Sakuda S, 1998, BIOORG MED CHEM LETT, V8, P2987, DOI 10.1016/S0960-894X(98)00542-3; SCHLEIN Y, 1991, P ROY SOC B-BIOL SCI, V245, P121, DOI 10.1098/rspb.1991.0097; SCHLEIN Y, 1992, PARASITOL TODAY, V8, P367, DOI 10.1016/0169-4758(92)90169-3; Shahabuddin M, 1996, INFECT IMMUN, V64, P739, DOI 10.1128/IAI.64.3.739-743.1996; SHAHABUDDIN M, 1993, PARASITOL TODAY, V9, P252, DOI 10.1016/0169-4758(93)90069-R; SHAHABUDDIN M, 1993, P NATL ACAD SCI USA, V90, P4266, DOI 10.1073/pnas.90.9.4266; SOMERS PJB, 1987, J ANTIBIOT, V40, P1751, DOI 10.7164/antibiotics.40.1751; STROTE G, 1991, PARASITOL RES, V77, P526, DOI 10.1007/BF00928422; STROTE G, 1987, TROP MED PARASITOL, V38, P211; THYLEFORS B, 1978, B WORLD HEALTH ORGAN, V56, P63; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUDEL J, 1989, ANAL BIOCHEM, V178, P362, DOI 10.1016/0003-2697(89)90653-2; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Wang SH, 1997, AM J TROP MED HYG, V56, P474, DOI 10.4269/ajtmh.1997.56.474; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Wood WB, 1988, NEMATODE CAENORHABDI, P587; Wu Y, 1996, MOL BIOCHEM PARASIT, V75, P207, DOI 10.1016/0166-6851(95)02529-4; Yamage M, 1999, MOL BIOL CELL, V10, p183A	45	52	53	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42557	42564		10.1074/jbc.M103479200	http://dx.doi.org/10.1074/jbc.M103479200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535590	hybrid			2022-12-27	WOS:000172450400131
J	Fu, XY; Kassim, SY; Parks, WC; Heinecke, JW				Fu, XY; Kassim, SY; Parks, WC; Heinecke, JW			Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HYDROGEN-PEROXIDE; OXIDATION; COLLAGENASE; NITROGEN; INACTIVATION; REACTIVITIES; PATHOGENESIS; CHLORAMINES; THIOCYANATE	Myeloperoxidase uses hydrogen peroxide (H2O2) to generate hypochlorous acid (HOCl), a potent cytotoxic oxidant. We demonstrate that HOCl regulates the activity of matrix metalloproteinase-7 (MMP-7, matrilysin) in vitro, suggesting that this oxidant activates MMPs in the artery wall. Indeed, both MMP-7 and myeloperoxidase were colocalized to lipid-laden macrophages in human atherosclerotic lesions. A highly conserved domain called the cysteine switch has been proposed to regulate MMP activity. When we exposed a synthetic peptide that mimicked the cysteine switch to HOCl, HPLC analysis showed that the thiol residue reacted rapidly, generating a near-quantitative yield of products. Tandem mass spectrometric analysis identified the products as sulfinic acid, sulfonic acid, and a dimer containing a disulfide bridge. In contrast, the peptide reacted slowly with H2O2, and the only product was the disulfide. Moreover, HOCl markedly activated pro-MMP-7, an MMP expressed at high levels in lipid-laden macrophages in vivo. Tandem mass spectrometric analysis of trypsin digests revealed that the thiol residue of the enzyme's cysteine switch domain had been converted to sulfinic acid. Thiol oxidation was associated with autolytic cleavage of pro-MMP-7, strongly suggesting that oxygenation activates the latent enzyme. In contrast, H2O2 failed to oxidize the thiol residue of the protein or activate the enzyme. Thus, HOCl activates pro-MMP-7 by converting the thiol residue of the cysteine switch to sulfinic acid. This activation mechanism is distinct from the well-studied proteolytic cleavage of MMP pro-enzymes. Our observations raise the possibility that HOCl generated by myeloperoxidase contributes to MMP activation, and therefore to plaque rupture, in the artery wall. HOCl and other oxidants might regulate MMP activity by the same mechanism in a variety of inflammatory conditions.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Zhejiang Univ, Dept Chem, Hangzhou 310027, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Zhejiang University	Heinecke, JW (corresponding author), Div Atherosclerosis Nutr & Lipid Res, Campus Box 8046,660 S Euclid Ave, St Louis, MO 63110 USA.	heinecke@im.wustl.edu	Parks, William C./AAH-6786-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL064344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015013] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00954] Funding Source: Medline; NHLBI NIH HHS [HL29594, HL64344, HL54619] Funding Source: Medline; NIA NIH HHS [AG15013] Funding Source: Medline; NIDDK NIH HHS [DK56341] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Campbell EJ, 1999, J CLIN INVEST, V104, P337, DOI 10.1172/JCI6092; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Carr AC, 2001, FREE RADICAL BIO MED, V30, P526, DOI 10.1016/S0891-5849(00)00495-0; CHEN LC, 1993, BIOCHEMISTRY-US, V32, P10289, DOI 10.1021/bi00090a003; CRABBE T, 1992, BIOCHEMISTRY-US, V31, P8500, DOI 10.1021/bi00151a017; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Dunford H. B., 1999, HEME PEROXIDASES; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; George SJ, 1998, CURR OPIN LIPIDOL, V9, P413, DOI 10.1097/00041433-199810000-00005; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; Heller JI, 2000, J BIOL CHEM, V275, P9957, DOI 10.1074/jbc.275.14.9957; Henderson JP, 2001, J BIOL CHEM, V276, P7867, DOI 10.1074/jbc.M005379200; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; HOLZ RC, 1992, J AM CHEM SOC, V114, P9611, DOI 10.1021/ja00050a048; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; HURST JK, 1989, CRIT REV BIOCHEM MOL, V24, P271, DOI 10.3109/10409238909082555; KLEBANOFF SJ, 1978, NEUTROPHIL FUNCTIONA; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; Libby P, 2000, AM J CARDIOL, V86, p3J; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; MICHAELIS J, 1992, ARCH BIOCHEM BIOPHYS, V292, P555, DOI 10.1016/0003-9861(92)90030-Z; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; NEWBY AC, 1994, BASIC RES CARDIOL, V89, P59; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Okamoto T, 1997, ARCH BIOCHEM BIOPHYS, V342, P261, DOI 10.1006/abbi.1997.0127; Owens MW, 1997, AM J PHYSIOL-LUNG C, V273, pL445, DOI 10.1152/ajplung.1997.273.2.L445; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; PEPPIN GJ, 1986, P NATL ACAD SCI USA, V83, P4322, DOI 10.1073/pnas.83.12.4322; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Woessner J.F., 2000, PROTEIN PROFILE SER; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P485; Yates JR, 1998, J MASS SPECTROM, V33, P1	56	376	392	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41279	41287		10.1074/jbc.M106958200	http://dx.doi.org/10.1074/jbc.M106958200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533038	hybrid			2022-12-27	WOS:000171925600120
J	Gorgoni, B; Caivano, M; Arizmendi, C; Poli, V				Gorgoni, B; Caivano, M; Arizmendi, C; Poli, V			The transcription factor C/EBP beta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE SYNTHASE-2 GENE; ACTIVATED PROTEIN-KINASE; FACTOR KAPPA-B; RESPONSE ELEMENT; NUCLEAR FACTOR; PROSTAGLANDIN SYNTHASE-2; CYCLOOXYGENASE-2 GENE; GRANULOSA-CELLS; PHORBOL ESTER; PROMOTER	Cyclooxygenase-2 (COX-2) is the rate-limiting enzyme for the inducible synthesis of prostaglandins, and its up-regulated activity is thought to play a pathological role in diseases such as inflammatory bowel disease, rheumatoid arthritis, and cancer. Regulation of COX-2 expression is complex and appears to involve diversified mechanisms in different cell types and conditions. Here we make use of immortalized macrophages and fibroblasts that we have generated from C/EBP beta -deficient mice to directly test and compare the specific role played by this factor in inducible COX-2 expression in these two cell types. We could demonstrate that COX-2 mRNA induction and promoter activity were profoundly impaired in C/EBP beta (-/-) macrophages and could be rescued by expression of C/EBP beta. The obligatory role of C/EBP beta in COX-2 expression appeared to be mediated exclusively by the C/EBP element located at positions -138/-130 of the murine cox-2 promoter; and did not involve altered activity at the level of the other promoter elements described previously (the -402/-392 NF-kappaB site, the -59/-48 CRE/E box element, and a potential second C/EBP site located at positions -93/-85). In contrast, COX-2 induction was completely normal in C/EBP beta -deficient fibroblasts, thus highlighting the diversity of cell-specific molecular mechanisms in determining inducible COX-2 expression and prostaglandins production.	Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Dundee DD1 5EH, Scotland; Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Univ Salamanca, Sch Med, Dept Biochem & Mol Biol, E-37007 Salamanca, Spain	University of Dundee; University of Dundee; University of Salamanca	Poli, V (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.		Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966				Blanco JCG, 2000, J EXP MED, V191, P2131, DOI 10.1084/jem.191.12.2131; CAREY M, 2000, TRANSCRIPTIONAL REGU, P65; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; DOYLE AG, 1996, WEIRS HDB EXPT IMMUN, V4; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Everts B, 2000, CLIN RHEUMATOL, V19, P331, DOI 10.1007/s100670070024; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; HERSCHMAN HR, 1994, CANCER METAST REV, V13, P241, DOI 10.1007/BF00666095; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Hla T, 1999, INT J BIOCHEM CELL B, V31, P551, DOI 10.1016/S1357-2725(98)00152-6; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Inoue H, 1998, BIOCHEM BIOPH RES CO, V244, P143, DOI 10.1006/bbrc.1998.8222; INOUE H, 1994, FEBS LETT, V350, P51, DOI 10.1016/0014-5793(94)00731-4; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Liu JM, 1999, J BIOL CHEM, V274, P35037, DOI 10.1074/jbc.274.49.35037; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Morris JK, 1996, J BIOL CHEM, V271, P16633, DOI 10.1074/jbc.271.28.16633; Nishioka K, 2000, ARTHRITIS RHEUM-US, V43, P1591, DOI 10.1002/1529-0131(200007)43:7<1591::AID-ANR24>3.0.CO;2-9; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; Potter S, 2000, MOL HUM REPROD, V6, P771, DOI 10.1093/molehr/6.9.771; Prescott SM, 2000, J CLIN INVEST, V105, P1511, DOI 10.1172/JCI10241; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Thomas B, 2000, EUR J BIOCHEM, V267, P6798, DOI 10.1046/j.1432-1327.2000.01778.x; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	41	98	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40769	40777		10.1074/jbc.M106865200	http://dx.doi.org/10.1074/jbc.M106865200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522796	hybrid			2022-12-27	WOS:000171925600054
J	Jung, K; Hamann, K; Revermann, A				Jung, K; Hamann, K; Revermann, A			K+ stimulates specifically the autokinase activity of purified and reconstituted EnvZ of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SIGNAL-TRANSDUCTION; PHOSPHATASE-ACTIVITY; PHOSPHORYLATED OMPR; PERIPLASMIC DOMAIN; TURGOR SENSOR; PROTEIN; OSMOREGULATION; KINASE; OSMOSENSOR; MUTATIONS	The histidine kinase/response regulator system EnvZ/ OmpR of Escherichia coli regulates transcription of the genes ompF and ompC, encoding two porins of the outer membrane. Although the total amount of OmpF and OmpC remains constant, the relative levels of the two proteins fluctuate in a reciprocal manner depending on medium osmolality. The membrane-anchored sensor EnvZ somehow monitors changes in environmental osmolality. To characterize the nature of the stimulus perceived by EnvZ, this protein was overproduced, purified, and reconstituted into proteoliposomes. Autokinase activity of purified and reconstituted EnvZ was stimulated by an increase of the K+ concentration. Rb+, Na+, and NH4+ also stimulated the activity but to a smaller extent, whereas an osmotic upshift imposed by various sugars or increasing concentrations of glycine betaine, proline, or Tris/MES were without influence. Neither the transfer of the phosphoryl group from EnvZ similar toP to OmpR nor the EnvZ-mediated OmpR similar toP dephosphorylation were affected by one of the tested solutes. Experiments with the reconstructed signal transduction cascade including DNA fragments demonstrated a substantial increase of the amount of phosphorylated OmpR in the presence of K+ and to a lower extent in the presence of Na+, Rb+, and NH4+. Various K+ salts were tested indicating that the determined effects were K+-specific and not dependent on the anion. In a further in vitro test system, which utilizes right-side-out membrane vesicles, the K+-specific activation of EnvZ autokinase from the luminal side was confirmed. These results clearly indicate a regulation of EnvZ autokinase activity by monovalent ions, specifically K+. Whether K+ accumulation, which is one of the first responses of E. coli after an osmotic upshift, is related to the stimulation of the EnvZ autokinase activity in vivo is discussed.	Univ Osnabruck, Fachbereich Biol Chem, Abt Mikrobiol, D-49069 Osnabruck, Germany	University Osnabruck	Jung, K (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Abt Mikrobiol, D-49069 Osnabruck, Germany.	jung_k@biologie.uni-osnabrueck.de						Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; BARRON A, 1986, J BACTERIOL, V167, P433, DOI 10.1128/jb.167.2.433-438.1986; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Dutta R, 1996, J BIOL CHEM, V271, P1424, DOI 10.1074/jbc.271.3.1424; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; FORST S, 1987, J BIOL CHEM, V262, P16433; FORST SA, 1989, J BACTERIOL, V171, P2949, DOI 10.1128/jb.171.6.2949-2955.1989; HALL MN, 1981, J MOL BIOL, V151, P1, DOI 10.1016/0022-2836(81)90218-7; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849, DOI 10.1074/jbc.270.45.26849; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; HUANG KJ, 1994, J BACTERIOL, V176, P1309, DOI 10.1128/jb.176.5.1309-1315.1994; IGO MM, 1988, J BACTERIOL, V170, P5971, DOI 10.1128/jb.170.12.5971-5973.1988; Jung K, 1997, J BIOL CHEM, V272, P10847; Jung K, 2001, J BACTERIOL, V183, P3800, DOI 10.1128/JB.183.12.3800-3803.2001; Jung K, 2000, J BIOL CHEM, V275, P40142, DOI 10.1074/jbc.M008917200; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AI, 1999, J BACTERIOL, V181, P5309, DOI 10.1128/JB.181.17.5309-5316.1999; Leonardo MR, 1996, MOL MICROBIOL, V22, P405, DOI 10.1046/j.1365-2958.1996.1271487.x; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; MILNER JL, 1988, J BIOL CHEM, V263, P14900; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Park H, 1997, J BACTERIOL, V179, P4382, DOI 10.1128/jb.179.13.4382-4390.1997; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; Qin L, 2000, MOL MICROBIOL, V36, P24, DOI 10.1046/j.1365-2958.2000.01837.x; Qin L, 2001, P NATL ACAD SCI USA, V98, P908, DOI 10.1073/pnas.031383098; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; RHOADS DB, 1978, J GEN PHYSIOL, V72, P283, DOI 10.1085/jgp.72.3.283; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Roessler M, 2001, FEBS LETT, V489, P125, DOI 10.1016/S0014-5793(01)02099-3; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; SIEBERS A, 1988, EUR J BIOCHEM, V178, P131, DOI 10.1111/j.1432-1033.1988.tb14438.x; SLAUCH JM, 1991, J BACTERIOL, V173, P7501, DOI 10.1128/jb.173.23.7501-7510.1991; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; TOKISHITA S, 1990, J BIOCHEM-TOKYO, V108, P488, DOI 10.1093/oxfordjournals.jbchem.a123226; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Waukau J, 1999, J BACTERIOL, V181, P5534, DOI 10.1128/JB.181.17.5534-5538.1999; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	50	35	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40896	40902		10.1074/jbc.M107871200	http://dx.doi.org/10.1074/jbc.M107871200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533042	hybrid			2022-12-27	WOS:000171925600070
J	Soutourina, J; Blanquet, S; Plateau, P				Soutourina, J; Blanquet, S; Plateau, P			Role of D-cysteine desulfhydrase in the adaptation of Escherichia coli to D-cysteine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; INHIBITION; STARVATION; SEQUENCE; PROTEIN; GENES; PEPTIDES; TAURINE; ENZYME; OPERON	D-Cysteine, a powerful inhibitor of Escherichia coli growth, is decomposed in vitro into pyruvate, H2S, and NH3 by D-cysteine desulfhydrase. To assess the role of this reaction in the adaptation of the bacterium to growth on D-cysteine, the gene of the desulfhydrase was cloned. It corresponds to the open reading frame yedO at 43.03 min on the genetic map of E. coli. The amino acid sequence deduced from this gene is homologous to those of several 1-aminocyclopropane-carboxylate deaminases. However, the E. coli desulfhydrase does not use 1-aminocyclopropane-1-carboxylate as substrate. Various mutants in which the yedO gene was inactivated or overexpressed were constructed. They exhibited hypersensitivity or resistance, respectively, to the presence of D-cysteine in the culture medium. Growth protection against D-cysteine in minimal medium was conferred by the simultaneous addition of isoleucine, leucine, and valine. In agreement with this behavior, D-cysteine inhibited the activity of threonine deaminase, a key enzyme of the isoleucine, leucine, and valine pathway. Finally, in the presence of the intact yedO gene, E. coli growth was improved by addition of D-cysteine as the sole sulfur source. In agreement with a role of the desulfhydrase in sulfur metabolism, yedO expression was induced under conditions of sulfate limitation.	CNRS, Ecole Polytech, Unite Mixte Rech 7654, Biochim Lab, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Plateau, P (corresponding author), CNRS, Ecole Polytech, Unite Mixte Rech 7654, Biochim Lab, F-91198 Gif Sur Yvette, France.		Soutourina, Julie/F-8305-2014	Soutourina, Julie/0000-0001-5218-2350				Berlyn MKB, 1998, MICROBIOL MOL BIOL R, V62, P814, DOI 10.1128/MMBR.62.3.814-984.1998; BODANSZK.M, 1974, P NATL ACAD SCI USA, V71, P2791, DOI 10.1073/pnas.71.7.2791; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; BURNELL JN, 1977, BIOCHIM BIOPHYS ACTA, V481, P246, DOI 10.1016/0005-2744(77)90157-7; BUTLER JD, 1993, LIFE SCI, V52, P1209, DOI 10.1016/0024-3205(93)90103-A; Campbell BG, 1996, FEMS MICROBIOL LETT, V138, P207, DOI 10.1016/0378-1097(96)00108-5; CLAESSON R, 1990, ORAL MICROBIOL IMMUN, V5, P137, DOI 10.1111/j.1399-302X.1990.tb00411.x; CORRIGAN JJ, 1969, SCIENCE, V164, P142, DOI 10.1126/science.164.3876.142; DATTA P, 1971, METHOD ENZYMOL, V17, P566; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; ESAKI N, 1988, J BACTERIOL, V170, P751, DOI 10.1128/jb.170.2.751-756.1988; Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u; HAMA H, 1991, J BIOCHEM-TOKYO, V109, P604, DOI 10.1093/oxfordjournals.jbchem.a123427; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HARRIS CL, 1981, J BACTERIOL, V145, P1031, DOI 10.1128/JB.145.2.1031-1035.1981; HIREL PH, 1988, BIOCHIMIE, V70, P773, DOI 10.1016/0300-9084(88)90107-1; Ikebe T, 1999, MICROBIOL-SGM, V145, P1389, DOI 10.1099/13500872-145-6-1389; Jack RW, 1998, CHIMIA, V52, P48; Jia YJ, 2000, BIOSCI BIOTECH BIOCH, V64, P299, DOI 10.1271/bbb.64.299; KANZAKI H, 1987, EUR J BIOCHEM, V163, P105, DOI 10.1111/j.1432-1033.1987.tb10742.x; LEONCINI R, 1989, BIOCHIM BIOPHYS ACTA, V994, P52, DOI 10.1016/0167-4838(89)90061-7; MCFALL E, 1987, CELL MOL BIOL, P1520; MCIVER CJ, 1993, J CLIN MICROBIOL, V31, P2790, DOI 10.1128/JCM.31.10.2790-2793.1993; MILLER HI, 1980, CELL, V20, P711, DOI 10.1016/0092-8674(80)90317-7; MOR A, 1992, TRENDS BIOCHEM SCI, V17, P481, DOI 10.1016/0968-0004(92)90333-5; Mytelka DS, 1996, J BACTERIOL, V178, P24, DOI 10.1128/jb.178.1.24-34.1996; NAGASAWA T, 1982, J BIOL CHEM, V257, P13749; NAGASAWA T, 1985, EUR J BIOCHEM, V153, P541, DOI 10.1111/j.1432-1033.1985.tb09335.x; NAGASAWA T, 1988, ARCH MICROBIOL, V149, P413, DOI 10.1007/BF00425580; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PHILLIPS A. T., 1964, BIOCHEM BIOPHYS RES COMMUN, V15, P530, DOI 10.1016/0006-291X(64)90499-1; Quadroni M, 1996, EUR J BIOCHEM, V239, P773, DOI 10.1111/j.1432-1033.1996.0773u.x; Salgado H, 2000, NUCLEIC ACIDS RES, V28, P65, DOI 10.1093/nar/28.1.65; SCHMIDT A, 1987, METHOD ENZYMOL, V143, P449; SCHMIDT A, 1983, Z NATURFORSCH C, V38, P428; SELIGER HH, 1961, P NATL ACAD SCI USA, V47, P1129, DOI 10.1073/pnas.47.8.1129; Shah S, 1998, CAN J MICROBIOL, V44, P833, DOI 10.1139/cjm-44-9-833; SHEEHY RE, 1991, J BACTERIOL, V173, P5260, DOI 10.1128/jb.173.17.5260-5265.1991; SMITH IK, 1971, BIOCHIM BIOPHYS ACTA, V227, P288, DOI 10.1016/0005-2744(71)90061-1; SORENSEN MA, 1991, J BACTERIOL, V173, P5244, DOI 10.1128/jb.173.16.5244-5246.1991; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 1999, J BIOL CHEM, V274, P19109, DOI 10.1074/jbc.274.27.19109; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; vanderPloeg JR, 1996, J BACTERIOL, V178, P5438, DOI 10.1128/jb.178.18.5438-5446.1996; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILD J, 1981, MOL GEN GENET, V181, P373, DOI 10.1007/BF00425614; YEGGY JP, 1980, CAN J MICROBIOL, V26, P1386, DOI 10.1139/m80-231	48	61	69	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40864	40872		10.1074/jbc.M102375200	http://dx.doi.org/10.1074/jbc.M102375200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527960	hybrid			2022-12-27	WOS:000171925600066
J	Umebayashi, K; Fukuda, R; Hirata, A; Horiuchi, H; Nakano, A; Ohta, A; Takagi, M				Umebayashi, K; Fukuda, R; Hirata, A; Horiuchi, H; Nakano, A; Ohta, A; Takagi, M			Activation of the Ras-cAMP signal transduction pathway inhibits the proteasome-independent degradation of misfolded protein aggregates in the endoplasmic reticulum lumen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIVEUS ASPARTIC PROTEINASE; CYCLIC AMP PATHWAY; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; RHIZOPUS-NIVEUS; STRESS-RESPONSE; ER DEGRADATION; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; TRANSMEMBRANE PROTEIN; MOLECULAR CHAPERONES	Many kinds of misfolded secretory proteins are known to be degraded in the endoplasmic reticulum (ER). Dislocation of misfolded proteins from the ER to the cytosol and subsequent degradation by the proteasome have been demonstrated. Using the yeast Saccharomyces cerevisiae, we have been studying the secretion of a heterologous protein, Rhizopus niveus aspartic proteinase-I (RNAP-I). Previously, we found that the pro sequence of RNAP-I is important for the folding and secretion, and that Delta pro, a mutated derivative of RNAP-I in which the entire region of the pro sequence is deleted, forms gross aggregates in the yeast ER. In this study, we show that the degradation of Delta pro occurs independently of the proteasome. Its degradation was not inhibited either by a potent proteasome inhibitor or in a proteasome mutant. We also show that neither the export from the ER nor the vacuolar proteinase is required for the degradation of Delta pro. These results raise the possibility that the Delta pro aggregates are degraded in the ER lumen. We have isolated a yeast mutant in which the degradation of Delta pro is delayed. We show that the mutated gene is IRA2, which encodes a GTPase-activating protein for Ras. Because Ira2 protein is a negative regulator of the Ras-cAMP pathway, this result suggests that hyperactivation of the Ras-cAMP pathway inhibits the degradation of Delta pro. Consistently, down-regulation of the Ras-CAMP pathway in the ira2 mutant suppressed the defect of the degradation of Delta pro. Thus, the Ras-cAMP signal transduction pathway seems to control the proteasome-independent degradation of the ER misfolded protein aggregates.	RIKEN, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138657, Japan	RIKEN; University of Tokyo; University of Tokyo	Umebayashi, K (corresponding author), RIKEN, Mol Membrane Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kyohei@postman.riken.go.jp	Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/C-6185-2009	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; 				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; BOLENDER RP, 1973, J CELL BIOL, V56, P746, DOI 10.1083/jcb.56.3.746; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; CANNON JF, 1994, GENETICS, V136, P485; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fukuda R, 1996, J BIOL CHEM, V271, P14252, DOI 10.1074/jbc.271.24.14252; FUKUDA R, 1994, J BIOL CHEM, V269, P9556; GARDNER AM, 1993, J BIOL CHEM, V268, P25940; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hanninen AL, 1999, MOL BIOL CELL, V10, P3623, DOI 10.1091/mbc.10.11.3623; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; Heinemann FS, 1998, MOL BIOL CELL, V9, P3445, DOI 10.1091/mbc.9.12.3445; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Holkeri H, 1998, FEBS LETT, V429, P162, DOI 10.1016/S0014-5793(98)00586-9; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; HORIUCHI H, 1988, J BACTERIOL, V170, P272, DOI 10.1128/jb.170.1.272-278.1988; HORIUCHI H, 1990, AGR BIOL CHEM TOKYO, V54, P1771, DOI 10.1080/00021369.1990.10870223; HUAN GLJ, 1999, J CELL BIOL, V145, P951; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; INOUE S, 1992, J BIOL CHEM, V267, P9080; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; LUM PY, 1995, J CELL BIOL, V131, P81, DOI 10.1083/jcb.131.1.81; MATSUURA A, 1993, MOL GEN GENET, V238, P6, DOI 10.1007/BF00279524; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MORI K, 1993, CELL, V74, P743; MORISHITA T, 1995, SCIENCE, V270, P1213, DOI 10.1126/science.270.5239.1213; Moriyama T, 1998, J BIOL CHEM, V273, P22037, DOI 10.1074/jbc.273.34.22037; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; MULLINS C, 1995, J BIOL CHEM, V270, P17139, DOI 10.1074/jbc.270.29.17139; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Ozols J, 1997, MOL BIOL CELL, V8, P2281, DOI 10.1091/mbc.8.11.2281; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Reynolds TB, 1998, J CELL BIOL, V143, P935, DOI 10.1083/jcb.143.4.935; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; ROITELMAN J, 1991, J BIOL CHEM, V266, P16085; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; SUN GH, 1992, J CELL BIOL, V119, P1625, DOI 10.1083/jcb.119.6.1625; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; Umebayashi K, 1999, EUR J CELL BIOL, V78, P726, DOI 10.1016/S0171-9335(99)80041-7; Umebayashi K, 1997, YEAST, V13, P1009; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101; YOUNG J, 1993, J BIOL CHEM, V268, P19810; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	85	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41444	41454		10.1074/jbc.M105829200	http://dx.doi.org/10.1074/jbc.M105829200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526112	hybrid			2022-12-27	WOS:000171925600141
J	Angata, T; Varki, NM; Varki, A				Angata, T; Varki, NM; Varki, A			A second uniquely human mutation affecting sialic acid biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; IMMUNOGLOBULIN SUPERFAMILY; HUMAN GENOME; SIALOADHESIN; PROTEIN; DOMAIN; CD22; PURIFICATION; RECOGNITION; PHYLOGENY	Siglecs are immunoglobulin superfamily member lectins that selectively recognize different types and linkages of sialic acids, which are major components of cell surface and secreted glycoconjugates. We report here a human Siglec-like molecule (Siglec-L1) that lacks a conserved arginine residue known to be essential for optimal sialic acid recognition by previously known Siglecs. Loss of the arginine from an ancestral molecule was caused by a single nucleotide substitution that occurred after the common ancestor of humans with the great apes but before the origin of modern humans. The chimpanzee Siglec-L1 ortholog remains fully functional and preferentially recognizes N-glycolylneuraminic acid, which is a common sialic acid in great apes and other mammals. Reintroducing the ancestral arginine into the human molecule regenerates the same properties. Thus, the single base pair mutation that replaced the arginine on human Siglec-L1 is likely to be evolutionarily related to the previously reported loss of N-glycolylneuraminic acid expression in the human lineage. Siglec-L1 and its chimpanzee Siglec ortholog also have a different expression pattern from previously reported Siglecs because they are found on the lumenal edge of epithelial cell surfaces. Notably, the human genome contains several Siglec-like pseudogenes that have independent mutations that would have replaced the arginine residue required for optimal sialic acid recognition. Thus, additional changes in the biology of sialic acids may have taken place during human evolution.	Univ Calif San Diego, Sch Med, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Sch Med, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr,MC0687, La Jolla, CA 92093 USA.	avarki@ucsd.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01-HL57345] Funding Source: Medline; NIGMS NIH HHS [R01-GM323373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Angata T, 2000, GLYCOBIOLOGY, V10, P431, DOI 10.1093/glycob/10.4.431; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Crocker PR, 1998, GLYCOBIOLOGY, V8; Darwin C., 1871, P475; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Karlsson KA, 1998, MOL MICROBIOL, V29, P1, DOI 10.1046/j.1365-2958.1998.00854.x; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAW CL, 1995, J IMMUNOL, V155, P3368; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; NATH D, 1995, J BIOL CHEM, V270, P26184, DOI 10.1074/jbc.270.44.26184; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schachner M, 2000, GLIA, V29, P154, DOI 10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3; Schauer R., 1982, CELL BIOL MONOGRAPHS, V10; SIBLEY CG, 1990, J MOL EVOL, V30, P202, DOI 10.1007/BF02099992; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Tullius MV, 1996, J BIOL CHEM, V271, P15373, DOI 10.1074/jbc.271.26.15373; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Yu ZB, 2001, J BIOL CHEM, V276, P23816, DOI 10.1074/jbc.M102394200	39	65	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40282	40287		10.1074/jbc.M105926200	http://dx.doi.org/10.1074/jbc.M105926200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546777	hybrid			2022-12-27	WOS:000171789200103
J	Wang, XH; Connor, M; Wilson, D; Wilson, HI; Nicholson, GM; Smith, R; Shaw, D; Mackay, JP; Alewood, PF; Christie, MJ; King, GF				Wang, XH; Connor, M; Wilson, D; Wilson, HI; Nicholson, GM; Smith, R; Shaw, D; Mackay, JP; Alewood, PF; Christie, MJ; King, GF			Discovery and structure of a potent and highly specific blocker of insect calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER; NEUROTOXINS; ANTAGONIST; PEPTIDES; CURRENTS; PROGRAM; TOXINS	We have isolated a novel family of insect-selective neurotoxins that appear to be the most potent blockers of insect voltage-gated calcium channels reported to date. These toxins display exceptional phylogenetic specificity, with at least a 10,000-fold preference for insect versus vertebrate calcium channels. The structure of one of the toxins reveals a highly structured, disulfide-rich core and a structurally disordered C-terminal extension that is essential for channel blocking activity. Weak structural/functional homology with omega -agatoxin-IVA/B, the prototypic inhibitor of vertebrate P-type calcium channels, suggests that these two toxin families might share a similar mechanism of action despite their vastly different phylogenetic specificities.	Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA; Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; Univ Queensland, Dept Biochem, Brisbane, Qld 4072, Australia; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Technol Sydney, Dept Hlth Sci, Sydney, NSW 2007, Australia; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	University of Connecticut; University of Sydney; University of Sydney; University of Queensland; University of Queensland; University of Technology Sydney; Australian National University; John Curtin School of Medical Research	King, GF (corresponding author), Univ Connecticut, Ctr Hlth, Dept Biochem, MC3305,263 Farmington Ave, Farmington, CT 06032 USA.	glenn@psel.uchc.edu	Wilson, David/Q-9865-2019; Connor, Mark/A-4197-2008; Nicholson, Graham M/E-8136-2010; King, Glenn F/J-5059-2012; Mackay, Joel/D-6834-2011	Wilson, David/0000-0001-5047-0711; Connor, Mark/0000-0003-2538-2001; Nicholson, Graham M/0000-0002-4277-4296; King, Glenn F/0000-0002-2308-2200; Christie, MacDonald/0000-0002-0622-609X; Mackay, Joel/0000-0001-7508-8033				BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Benquet P, 1999, J NEUROPHYSIOL, V82, P2284, DOI 10.1152/jn.1999.82.5.2284; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bonning BC, 1996, ANNU REV ENTOMOL, V41, P191, DOI 10.1146/annurev.en.41.010196.001203; BOUGIS PE, 1989, J BIOL CHEM, V264, P19259; BRANTON WD, 1993, NATURE, V365, P496, DOI 10.1038/365496a0; BRUNGER AT, 1992, XPLOR VERSION 3 1; CORY JS, 1994, NATURE, V370, P138, DOI 10.1038/370138a0; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; DINIZ MRV, 1993, J BIOL CHEM, V268, P15340; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Fletcher JI, 1997, STRUCTURE, V5, P1525, DOI 10.1016/S0969-2126(97)00301-8; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Fletcher JI, 1999, EUR J BIOCHEM, V264, P525, DOI 10.1046/j.1432-1327.1999.00659.x; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KIM JI, 1995, J MOL BIOL, V250, P659, DOI 10.1006/jmbi.1995.0406; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leisy DJ, 1996, INSECT BIOCHEM MOLEC, V26, P411, DOI 10.1016/0965-1748(95)00070-4; LENGUYEN D, 1993, PROTEIN SCI, V2, P165; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; LUDVIGSEN S, 1992, J BIOMOL NMR, V2, P227, DOI 10.1007/BF01875318; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9; Olivera BM, 2001, TOXICON, V39, P7, DOI 10.1016/S0041-0101(00)00157-4; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Szeto TH, 2000, TOXICON, V38, P429, DOI 10.1016/S0041-0101(99)00174-9; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YU HT, 1993, BIOCHEMISTRY-US, V32, P13123, DOI 10.1021/bi00211a022	36	73	83	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					40306	40312		10.1074/jbc.M105206200	http://dx.doi.org/10.1074/jbc.M105206200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11522785	hybrid, Green Submitted			2022-12-27	WOS:000171789200107
J	Harrop, SJ; DeMaere, MZ; Fairlie, WD; Reztsova, T; Valenzuela, SM; Mazzanti, M; Tonini, R; Qiu, MR; Jankova, L; Warton, K; Bauskin, AR; Wu, WM; Pankhurst, S; Campbell, TJ; Breit, SN; Curmi, PMG				Harrop, SJ; DeMaere, MZ; Fairlie, WD; Reztsova, T; Valenzuela, SM; Mazzanti, M; Tonini, R; Qiu, MR; Jankova, L; Warton, K; Bauskin, AR; Wu, WM; Pankhurst, S; Campbell, TJ; Breit, SN; Curmi, PMG			Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; MOLECULAR-CLONING; SUBCELLULAR-DISTRIBUTION; CL-CHANNEL; PROTEIN; P64; EXPRESSION; FAMILY; KIDNEY; IDENTIFICATION	CLIC1 (NCC27) is a member of the highly conserved class of chloride ion channels that exists in both soluble and integral membrane forms. Purified CLIC1 can integrate into synthetic lipid bilayers forming a chloride channel with similar properties to those observed in vivo. The structure of the soluble form of CLIC1 has been determined at 1.4-Angstrom resolution. The protein is monomeric and structurally homologous to the glutathione S-transferase superfamily, and it has a redox-active site resembling glutaredoxin. The structure of the complex of CLIC1 with glutathione shows that glutathione occupies the redox-active site, which is adjacent to an open, elongated slot lined by basic residues. Integration of CLIC1 into the membrane is likely to require a major structural rearrangement, probably of the N-domain (residues 1-90), with the putative transmembrane helix arising from residues in the vicinity of the redox-active site. The structure indicates that CLIC1 is likely to be controlled by redox-dependent processes.	Univ New S Wales, Sch Phys, Initiat Biomol Struct, Sydney, NSW 2052, Australia; Univ New S Wales, Dept Med, Sydney, NSW 2052, Australia; St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia; Univ New S Wales, Sydney, NSW 2010, Australia; Univ Roma La Sapienza, Dipartimento Biol Cellulare & Sviluppo, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Fisiol Umana & Farmacol, I-00185 Rome, Italy	University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Sapienza University Rome; Sapienza University Rome	Curmi, PMG (corresponding author), Univ New S Wales, Sch Phys, Initiat Biomol Struct, Sydney, NSW 2052, Australia.	p.curmi@unsw.edu.au	Valenzuela, Stella/R-6387-2019; Mazzanti, Michele/A-8941-2011; DeMaere, Matthew Zachariah/D-9002-2012; Curmi, Paul/G-7185-2011; Fairlie, Walter/M-8401-2015	Valenzuela, Stella/0000-0001-5934-6047; DeMaere, Matthew Zachariah/0000-0002-7601-5108; Curmi, Paul/0000-0001-5762-7638; Fairlie, Walter/0000-0002-2498-1160; Mazzanti, Michele/0000-0002-1819-3811; TONINI, Raffaella/0000-0003-1652-4709				ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; ALAWQATI Q, 1995, SCIENCE, V269, P805, DOI 10.1126/science.7543697; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bunik V, 1999, PROTEIN SCI, V8, P65; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chuang JZ, 1999, J NEUROSCI, V19, P2919; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Edwards JC, 2000, J BIOL CHEM, V275, P31826, DOI 10.1074/jbc.M005275200; Edwards JC, 1998, J MEMBRANE BIOL, V163, P119; Edwards JC, 1999, AM J PHYSIOL-RENAL, V276, pF398, DOI 10.1152/ajprenal.1999.276.3.F398; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Jentsch TJ, 1997, BIOESSAYS, V19, P117, DOI 10.1002/bies.950190206; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LANDRY D, 1993, J BIOL CHEM, V268, P14948; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; LANDRY DW, 1987, J GEN PHYSIOL, V90, P779, DOI 10.1085/jgp.90.6.779; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuefeind T, 1997, J MOL BIOL, V274, P446, DOI 10.1006/jmbi.1997.1402; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Redhead C, 1997, MOL BIOL CELL, V8, P691, DOI 10.1091/mbc.8.4.691; REDHEAD CR, 1992, P NATL ACAD SCI USA, V89, P3716, DOI 10.1073/pnas.89.9.3716; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; Sakai H, 1998, J BIOCHEM, V124, P1051, DOI 10.1093/oxfordjournals.jbchem.a022199; Schlesinger PH, 1997, J BIOL CHEM, V272, P18636, DOI 10.1074/jbc.272.30.18636; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; SUAREZISLA BA, 1983, BIOCHEMISTRY-US, V22, P2319, DOI 10.1021/bi00279a003; Tonini R, 2000, FASEB J, V14, P1171, DOI 10.1096/fasebj.14.9.1171; Tulk BM, 2000, J BIOL CHEM, V275, P26986; Tulk BM, 1998, AM J PHYSIOL-RENAL, V274, pF1140, DOI 10.1152/ajprenal.1998.274.6.F1140; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Wells W W, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P149; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8	54	159	163	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44993	45000		10.1074/jbc.M107804200	http://dx.doi.org/10.1074/jbc.M107804200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11551966	hybrid			2022-12-27	WOS:000172406700088
J	Chen, W; Sun, Y; Welch, C; Gorelik, A; Leventhal, AR; Tabas, I; Tall, AR				Chen, W; Sun, Y; Welch, C; Gorelik, A; Leventhal, AR; Tabas, I; Tall, AR			Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; NIEMANN-PICK-DISEASE; TANGIER-DISEASE; INTRACELLULAR TRAFFICKING; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; C1 PROTEIN; CELLS; ABC1; FIBROBLASTS	Recently, ATP-binding cassette transporter Al (ABCA1), the defective molecule in Tangier disease, has been shown to stimulate phospholipid and cholesterol efflux to apolipoprotein A-I (apoA-I); however, little is known concerning the cellular cholesterol pools that act as the source of cholesterol for ABCA1-mediated efflux. We observed a higher level of isotopic and mass cholesterol efflux from mouse peritoneal macrophages labeled with [H-3]cholesterol/acetyl low density lipoprotein (where cholesterol accumulates in late endosomes and lysosomes) compared with cells labeled with [H-3]cholesterol with 10% fetal bovine serum, suggesting that late endosomes/lysosomes act as a preferential source of cholesterol for ABCA1-mediated efflux. Consistent with this idea, macrophages from Niemann-Pick C1 mice that have an inability to exit cholesterol from late endosomes/lysosomes showed a profound defect in cholesterol efflux to apoA-I. In contrast, phospholipid efflux to apoA-I was normal in Niemann-Pick C1 macrophages, as was cholesterol efflux following plasma membrane cholesterol labeling. These results suggest that cholesterol deposited in late endosomes/lysosomes preferentially acts as a source of cholesterol for ABCA1-mediated cholesterol efflux.	Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA	Columbia University	Tall, AR (corresponding author), Columbia Univ, Dept Med, Div Mol Med, 603 W 168th St, New York, NY 10032 USA.		Tall, Alan/AAT-8528-2021		NHLBI NIH HHS [HL-56984] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056984] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Assmann G., 2001, METABOLIC MOL BASIS; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BUTLER JD, 1992, J BIOL CHEM, V267, P23797; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen WG, 2000, J BIOL CHEM, V275, P30794, DOI 10.1074/jbc.M004552200; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; Costet P, 2000, J BIOL CHEM, V275, P28240; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Cruz JC, 2000, J BIOL CHEM, V275, P41309, DOI 10.1074/jbc.M008272200; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kojima K, 2001, BBA-MOL CELL BIOL L, V1532, P173, DOI 10.1016/S1388-1981(01)00124-X; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; LEVENTHAL AR, 2001, IN PRESS J BIOL CHEM; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mukherjee S, 1999, NAT CELL BIOL, V1, pE37, DOI 10.1038/10030; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Patterson M., 2001, METABOLIC MOL BASIS; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Remaley AT, 1999, P NATL ACAD SCI USA, V96, P12685, DOI 10.1073/pnas.96.22.12685; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHMITZ G, 1985, P NATL ACAD SCI USA, V82, P6305, DOI 10.1073/pnas.82.18.6305; Shamburek RD, 1997, J LIPID RES, V38, P2422; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; TALL AR, 2001, METABOLIC MOL BASIS; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Xie CL, 2000, J LIPID RES, V41, P1278	51	141	148	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43564	43569		10.1074/jbc.M107938200	http://dx.doi.org/10.1074/jbc.M107938200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11559713	hybrid			2022-12-27	WOS:000172297700013
J	Cunningham, CC; Vegner, R; Bucki, R; Funaki, M; Korde, N; Hartwig, JH; Stossel, TP; Janmey, PA				Cunningham, CC; Vegner, R; Bucki, R; Funaki, M; Korde, N; Hartwig, JH; Stossel, TP; Janmey, PA			Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HUMAN PLATELETS; CANALICULAR MEMBRANE; HUMAN-NEUTROPHILS; PLASMA-MEMBRANE; GELSOLIN; DOMAIN; RECEPTOR; PROTEIN; SITE	Polyphosphoinositides (PPIs) affect the localization and activities of many cellular constituents, including actin-modulating proteins. Several classes of polypeptide sequences, including pleckstrin homology domains, FYVE domains, and short linear sequences containing predominantly hydrophobic and cationic residues account for phosphoinositide binding by most such proteins. We report that a ten-residue peptide derived from the phosphatidylinositol 4,5-bisphosphate (PIP2) binding region in segment 2 of gelsolin, when coupled to rhodamine B has potent PIP2 binding activity in vitro; crosses the cell membrane of fibroblasts, platelets, melanoma cells, and neutrophils by a process not involving endocytosis; and blocks cell motility. This peptide derivative transiently disassembles actin filament structures in GFP-actin-expressing NIH3T3 fibroblasts and prevents thrombin- or chemotactic peptide-stimulated actin assembly in platelets and neutrophils, respectively, but does not block the initial [Ca2+] increase caused by these agonists. The blockage of actin assembly and motility is transient, and cells recover motility within an hour after their immobilization by 5-20 muM peptide. This class of reagents confirms the critical relation between inositol lipids and cytoskeletal structure and may be useful to probe the location and function of polyphosphoinositides in vivo.	Univ Penn, Inst Med & Engn, Dept Physiol, Vagelos Labs 1010, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Hematol Div, Boston, MA 02115 USA; Latvian Organ Synth Inst, LV-1006 Riga, Latvia	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Latvian Institute of Organic Synthesis	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Dept Physiol, Vagelos Labs 1010, 3340 Smith Walk, Philadelphia, PA 19104 USA.			Bucki, Robert/0000-0001-7664-9226	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038910, R29AR038910] Funding Source: NIH RePORTER; FIC NIH HHS [TW00100] Funding Source: Medline; NIAMS NIH HHS [AR38910] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABSOLOM D, 1986, PHAGOCYTOSIS CELL ME, P95; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; CUNNINGHAM CC, 1998, PEPTIDES 1996, P317; DUCLOHIER H, 1994, TOXICOLOGY, V87, P175, DOI 10.1016/0300-483X(94)90160-0; FLANAGAN L, 1999, BIOL PHOSPHOINOSITID, P166; Foster WJ, 2001, BIOPHYS CHEM, V91, P211, DOI 10.1016/S0301-4622(01)00171-5; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Hubner S, 1998, EUR J BIOCHEM, V258, P846, DOI 10.1046/j.1432-1327.1998.2580846.x; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Isenberg G, 1998, INT REV CYTOL, V178, P73; Isenberg G, 1996, FEBS LETT, V397, P316, DOI 10.1016/S0014-5793(96)01203-3; JAMNEY PA, 1992, J BIOL CHEM, V267, P11818; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; KAJI T, 1991, TOXICOLOGY, V68, P11; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Ma L, 1998, J CELL BIOL, V140, P1125; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; Medina OP, 2001, CANCER RES, V61, P3978; Meerschaert K, 1998, EMBO J, V17, P5923, DOI 10.1093/emboj/17.20.5923; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rogers KL, 2000, EUR J PHARM SCI, V9, P355, DOI 10.1016/S0928-0987(99)00074-3; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sai Y, 1999, J CELL SCI, V112, P4535; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Sechi AS, 2000, J CELL SCI, V113, P3685; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; SIMOES AP, 1995, FEBS LETT, V365, P155; SIMOES AP, 1993, FEBS LETT, V331, P248, DOI 10.1016/0014-5793(93)80346-V; Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; VonSteyern FV, 1996, J HISTOCHEM CYTOCHEM, V44, P267, DOI 10.1177/44.3.8648087; WANG SS, 1973, J AM CHEM SOC, V95, P1328, DOI 10.1021/ja00785a602; Xian WJ, 1995, BIOPHYS J, V69, P2695, DOI 10.1016/S0006-3495(95)80140-2; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; YU FX, 1992, J BIOL CHEM, V267, P14616	47	97	104	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43390	43399		10.1074/jbc.M105289200	http://dx.doi.org/10.1074/jbc.M105289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11533030	hybrid			2022-12-27	WOS:000172169300098
J	Tahbaz, N; Carmichael, JB; Hobman, TC				Tahbaz, N; Carmichael, JB; Hobman, TC			GERp95 belongs to a family of signal-transducing proteins and requires Hsp90 activity for stability and Golgi localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIFFERENTIATION; C-ELEGANS; GENE; INTERACTS; COMPLEX; PIWI; P23; IDENTIFICATION; IMMUNOPHILINS; EXPRESSION	GERp95 (Golgi-endoplasmic reticulum protein 95 kDa) is part of a large family of highly conserved proteins found in all metazoans and the fission yeast Schizosaccharomyces pombe. Genetic studies suggest that homologs of GERp95 are components of signaling pathways that regulate cellular differentiation, development, and RNA interference. However, the precise molecular functions of these proteins remain unknown. Genetic analysis of GERp95 homologs has been complicated by the presence of multiple genes with overlapping functions in most organisms. Binding partners for members of this protein family have not been identified. The purpose of this study was to identify proteins that associate with GERp95. Glutathione S-transferase-GERp95 fusions were expressed in transfected cells, and proteins that bound to GERp95 were co-purified using glutathione-agarose beads. The amino-terminal region of GERp95 was found to interact with the specialized chaperone Hsp90 and a number of its cognate binding proteins. Inhibition of Hsp90 activity with geldanamycin or radicicol resulted in rapid degradation of newly synthesized GERp95. The membrane-associated pool of GERp95 was not bound to Hsp90, although activity of this chaperone was required for stable association of GERp95 with the Golgi in normal rat kidney cells. These results indicate that GERp95 engages an Hsp90 chaperone complex prior to association with intracellular membranes.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.							Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Goes FS, 2001, EUR J BIOCHEM, V268, P2281, DOI 10.1046/j.1432-1327.2001.02105.x; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HUTCHISON KA, 1992, J BIOL CHEM, V267, P2902; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Lynn K, 1999, DEVELOPMENT, V126, P469; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Miyata Y, 2001, J BIOL CHEM, V276, P21841, DOI 10.1074/jbc.M010944200; Mizuno K, 2001, BIOCHEM BIOPH RES CO, V281, P663, DOI 10.1006/bbrc.2001.4405; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Munoz MJ, 1999, GENETICS, V153, P1561; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P7325, DOI 10.1021/bi00147a017; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	36	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43294	43299		10.1074/jbc.M107808200	http://dx.doi.org/10.1074/jbc.M107808200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11553639	hybrid			2022-12-27	WOS:000172169300086
J	Whitworth, TL; Quick, MW				Whitworth, TL; Quick, MW			Substrate-induced regulation of gamma-aminobutyric acid transporter trafficking requires tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NOREPINEPHRINE TRANSPORTER; PLASMA-MEMBRANE TRANSPORTERS; GLUTAMATE TRANSPORTERS; SEROTONIN TRANSPORTERS; GABA; RECEPTORS; EXPRESSION; RELEASE; COCAINE; INTERNALIZATION	Neurotransmitter transporters regulate synaptic transmitter levels and are themselves functionally regulated by a number of different signal transduction cascades. A common theme in transporter regulation is redistribution of transporter protein between intracellular stores and the plasma membrane. The triggers and mechanisms underlying this regulation are important in the control of extracellular transmitter concentrations and hence synaptic signaling. Previously, we demonstrated that the alpha -aminobutyric acid transporter GAT1 is regulated by direct tyrosine phosphorylation, resulting in an up-regulation of transporter expression on the plasma membrane. In the present report, we show that two tyrosine residues on GAT1 contribute to the phosphorylation and transporter redistribution. Tyrosine phosphorylation is concomitant with a decrease in the rate of transporter internalization from the plasma membrane. A decrease in GAT internalization rates also occurs in the presence of GAT1 substrates, suggesting the hypothesis that tyrosine phosphorylation is required for the substrate-induced up-regulation of GAT1 surface expression. In support of this hypothesis, incubation of GAT1-expressing cells with transporter ligands alters the amount of GAT1 tyrosine phosphorylation, and substrate-induced surface expression is unchanged in a GAT1 mutant lacking tyrosine phosphorylation sites. These data suggest a model in which substrates permit the phosphorylation of GAT1 on tyrosine residues and that the phosphorylated state of the transporter is refractory for internalization.	Univ Alabama Birmingham, Dept Neurobiol, CIRC 446, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Quick, MW (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, CIRC 446, 1719 6th Ave S, Birmingham, AL 35294 USA.	quick@nrc.uab.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010509, R29DA010509] Funding Source: NIH RePORTER; NICHD NIH HHS [HD38985] Funding Source: Medline; NIDA NIH HHS [DA10509] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Bauman AL, 2000, J NEUROSCI, V20, P7571; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; Bernstein EM, 1999, J BIOL CHEM, V274, P889, DOI 10.1074/jbc.274.2.889; CASADO M, 1993, J BIOL CHEM, V268, P27313; Conradt M, 1997, J NEUROCHEM, V68, P1244, DOI 10.1046/j.1471-4159.1997.68031244.x; COREY JL, 1994, J BIOL CHEM, V269, P14759; Davis KE, 1998, J NEUROSCI, V18, P2475; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Diamond JS, 1997, J NEUROSCI, V17, P4672; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Gaspary HL, 1998, J NEUROPHYSIOL, V80, P270, DOI 10.1152/jn.1998.80.1.270; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Huff RA, 1997, J NEUROCHEM, V68, P225; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; IVERSEN LL, 1975, HDB PSYCHOPHARMACOLO, P381; Jankowski M, 1999, PFLUG ARCH EUR J PHY, V438, P689, DOI 10.1007/s004240051094; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Mennerick S, 1999, J NEUROSCI, V19, P9242; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SHARMA N, 1993, J CELL BIOL, V123, P1835, DOI 10.1083/jcb.123.6.1835; SOLIS JM, 1992, J NEUROSCI, V12, P3466; THOMSEN C, 1995, EPILEPSY RES, V21, P79, DOI 10.1016/0920-1211(95)00010-8; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Zhu MY, 2000, J PHARMACOL EXP THER, V295, P951; Zhu MY, 1998, J NEUROCHEM, V70, P1547	39	56	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42932	42937		10.1074/jbc.M107638200	http://dx.doi.org/10.1074/jbc.M107638200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555659	hybrid			2022-12-27	WOS:000172169300041
J	Zhou, NM; Luo, ZW; Luo, JS; Liut, DX; Hall, JW; Pomerantz, RJ; Huang, ZW				Zhou, NM; Luo, ZW; Luo, JS; Liut, DX; Hall, JW; Pomerantz, RJ; Huang, ZW			Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS CORECEPTOR; PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; 2ND EXTRACELLULAR LOOP; VMIP-II; CHARGED RESIDUES; MEMBRANE-FUSION; TYPE-1 ENTRY; INTERNALIZATION; LIGAND	The human CXC chemokine receptor 4 (CXCR4) is a receptor for the chemokine stromal cell-derived factor (SDF-1 alpha) and a co-receptor for the entry of specific strains of human immunodeficiency virus type I (HIV-1). CXCR4 is also recognized by an antagonistic chemokine, the viral macrophage inflammatory protein II (vMIP-II) encoded by human herpesvirus type VIII. SDF-1 alpha or vMIP-II binding to CXCR4 can inhibit HIV-1 entry via this co-receptor. An approach combining protein structural modeling and site-directed mutagenesis was used to probe the structure-function relationship of CXCR4, and interactions with its ligands SDF-1 alpha and vMIP-II and HIV-1 envelope protein gp120. Hypothetical three-dimensional structures were proposed by molecular modeling studies of the CXCR4-SDF-1 alpha complex, which rationalize extensive biological information on the role of CXCR4 in its interactions with HIV-1 envelope protein gp120. With site-directed mutagenesis, we have identified that the amino acid residues Asp (D20A) and Tyr (Y21A) in the N-terminal domain and the residue Glu (E268A) in extracellular loop 3 (ECL3) are involved in ligand binding, whereas the mutation Y190A in extracellular loop 2 (ECL2) impairs the signaling mediated by SDF-1 alpha. As an HIV-1 co-receptor, we found that the N-terminal domain, ECL2, and ECL3 of CXCR4 are involved in HIV-1 entry. These structural and mutational studies provide valuable information regarding the structural basis for CXCR4 activity in chemokine binding and HIV-1 viral entry, and could guide the design of novel targeted inhibitors.	Univ Illinois, Sch Mol & Cellular Biol, Dept Biochem, Urbana, IL 61801 USA; Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Div Infect Dis, Ctr Human Virol,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA	University of Illinois System; University of Illinois Urbana-Champaign; Jefferson University; Jefferson University	Huang, ZW (corresponding author), Univ Illinois, Sch Mol & Cellular Biol, Dept Biochem, 302 Burrill Hall,MC-119,407 S Goodwin Ave, Urbana, IL 61801 USA.				NIAID NIH HHS [AI45414] Funding Source: Medline; NIGMS NIH HHS [GM57761] Funding Source: Medline; NINDS NIH HHS [NS27405] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI045414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS027405, P01NS027405] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Brelot A, 1997, J VIROL, V71, P4744, DOI 10.1128/JVI.71.6.4744-4751.1997; Chabot DJ, 2000, J BIOL CHEM, V275, P23774, DOI 10.1074/jbc.M003438200; Chabot DJ, 1999, J VIROL, V73, P6598, DOI 10.1128/JVI.73.8.6598-6609.1999; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Crump MP, 2001, FEBS LETT, V489, P171, DOI 10.1016/S0014-5793(00)02393-0; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fernandez EJ, 2000, BIOCHEMISTRY-US, V39, P12837, DOI 10.1021/bi001166f; Forster R, 1998, J IMMUNOL, V160, P1522; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HERTEL C, 1990, J BIOL CHEM, V265, P17988; Heveker N, 1998, CURR BIOL, V8, P369, DOI 10.1016/S0960-9822(98)70155-1; Kajumo F, 2000, VIROLOGY, V271, P240, DOI 10.1006/viro.2000.0308; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Liwang AC, 1999, PROTEIN SCI, V8, P2270; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luo JS, 1999, BIOCHEM BIOPH RES CO, V264, P42, DOI 10.1006/bbrc.1999.1476; Luo ZW, 1997, PROTEIN ENG, V10, P1039, DOI 10.1093/protein/10.9.1039; Luo ZW, 2000, BIOCHEMISTRY-US, V39, P13545, DOI 10.1021/bi000633q; Luo ZW, 1999, BIOCHEM BIOPH RES CO, V263, P691, DOI 10.1006/bbrc.1999.1441; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Pelchen-Matthews A, 1999, IMMUNOL REV, V168, P33, DOI 10.1111/j.1600-065X.1999.tb01281.x; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; Rucker J, 1997, METHOD ENZYMOL, V288, P118; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; Wang ZX, 1998, J BIOL CHEM, V273, P15007, DOI 10.1074/jbc.273.24.15007; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zhou NM, 2000, EUR J IMMUNOL, V30, P164, DOI 10.1002/1521-4141(200001)30:1<164::AID-IMMU164>3.0.CO;2-X; Zhou NM, 2000, BIOCHEMISTRY-US, V39, P3782, DOI 10.1021/bi992750v; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	60	116	125	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42826	42833		10.1074/jbc.M106582200	http://dx.doi.org/10.1074/jbc.M106582200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551942	hybrid			2022-12-27	WOS:000172169300027
J	Amor, JC; Horton, JR; Zhu, XJ; Wang, Y; Sullards, C; Ringe, D; Cheng, XD; Kahn, RA				Amor, JC; Horton, JR; Zhu, XJ; Wang, Y; Sullards, C; Ringe, D; Cheng, XD; Kahn, RA			Structures of yeast ARF2 and ARL1 - Distinct roles for the N terminus in the structure and function of ARF family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION-FACTOR; GUANINE-NUCLEOTIDE EXCHANGE; ELECTRON-DENSITY MAPS; GTP-BINDING-PROTEIN; DROSOPHILA; ACTIVATION; COATOMER; COMPLEX; GDP	Structures were determined by x-ray crystallography for two members of the ADP-ribosylation factor (ARF) family of regulatory GTPases, yeast ARF1 and ARL1, and were compared with previously determined structures of human ARF1 and ARF6. These analyses revealed an overall conserved fold but differences in primary sequence and length, particularly in an N-terminal loop, lead to differences in nucleotide and divalent metal binding. Packing of hydrophobic residues is central to the interplay between the N-terminal a-helix, switch I, and the interswitch region, which along with differences in surface electrostatics provide explanations for the different biophysical and biochemical properties of ARF and ARF-like proteins.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Brandeis Univ, Rosenstiel Basic Med Res Ctr, Dept Biochem & Chem, Waltham, MA 02454 USA	Emory University; Brandeis University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Hu, Ruogu/B-2203-2008; Horton, John/F-2375-2010; Kahn, Richard/ABD-2666-2020; Horton, John R/ABB-4770-2020	Kahn, Richard/0000-0002-0259-0601; Horton, John/0000-0001-9749-8068	NIAID NIH HHS [AI43996] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043996] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Beraud-Dufour S, 2001, METHOD ENZYMOL, V329, P245; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Hillig RC, 2000, STRUCTURE, V8, P1239, DOI 10.1016/S0969-2126(00)00531-1; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAHN RA, 1988, J BIOL CHEM, V263, P8282; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 1996, J LIPID MEDIAT CELL, V14, P209, DOI 10.1016/0929-7855(96)00527-5; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; Lacal JC, 1993, RAS SUPERFAMILY GTPA; MARTIN ACR, 1998, PROFIT VERSION 1 8 S; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renault L, 2001, ACTA CRYSTALLOGR D, V57, P1167, DOI 10.1107/S0907444901009556; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhu XJ, 2000, J BIOL CHEM, V275, P13465, DOI 10.1074/jbc.275.18.13465	29	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42477	42484		10.1074/jbc.M106660200	http://dx.doi.org/10.1074/jbc.M106660200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11535602	hybrid			2022-12-27	WOS:000172450400120
J	Zheng, ZF; Zou, JT				Zheng, ZF; Zou, JT			The initial step of the glycerolipid pathway - Identification of glycerol 3-phosphate/dihydroxyacetone phosphate dual substrate acyltransferases in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PHOSPHOLIPID-SYNTHESIS; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DIHYDROXYACETONE PHOSPHATE; CHOLINE-TRANSPORT; ESCHERICHIA-COLI; LIPID PARTICLES; GENE; BIOSYNTHESIS; ACID	The initial step of phospholipid biosynthesis in yeast is carried out through the acylation of glycerol 3-phosphate (G-3-P) and dihydroxyacetone phosphate by stereospecific sn-1 acyltransferases. Here we report the identification of two key fatty acyltransferases of the glycerolipid biosynthesis pathway in Saccharomyces cerevisiae. Disruption of the open reading frame YBLO11w, corresponding to a gene previously identified as a choline transporter suppressor (SCT1), resulted in a substantial decrease of total cellular G-3-P acyltransferase activity. A yeast strain disrupted at the open reading frame YKR067w, which encodes a protein closely related to Sct1p, also exhibited a dramatic reduction in G-3-P acyltransferase activity. Molecular characterizations of the genes revealed that a missense mutation in YKR067w accounted for a defect in the activities of the G-3-P acyltransferase in the yeast mutant strain TTA1. Heterologous expression of YKR067w in Escherichia coli further confirmed its enzyme activity. These results indicate that YKR067w and YBLO11w, designated herein as GAT1 and GAT2(SCT1), respectively, are yeast G-3-P acyltransferase genes. Furthermore, biochemical results are presented to show that both Gat1p and Gat2p(Sct1p) are G-3-P/dihydroxyacetone phosphate dual substrate-specific sn-1 acyltransferases. The fatty acyl specificity of Gat1p is similar to that of the mammalian microsomal G-3-P acyltransferase, as it can effectively utilize a broad range of fatty acids as acyl donors. In contrast, Gat2p(Sct1p) displayed preference toward 16-carbon fatty acids. The most notable of the altered phospholipid compositions of the gat1 Delta and gat2(sct1)Delta strains are a decreased phosphatidic acid pool and an increased phosphatidylserine/phosphatidyl-inositol ratio. This did not appear to affect the mutants as no growth defect was found. However, null mutations of both GAT1 and GAT2(SCT1) are synthetically lethal to yeast.	Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada	National Research Council Canada	Zou, JT (corresponding author), Natl Res Council Canada, Inst Plant Biotechnol, 110 Gymnasium Rd, Saskatoon, SK S7N 0W9, Canada.							Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Athenstaedt K, 2000, J BIOL CHEM, V275, P235, DOI 10.1074/jbc.275.1.235; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BATES EJ, 1979, BIOCHEM J, V182, P751, DOI 10.1042/bj1820751; BELL RM, 1974, J BACTERIOL, V117, P1065, DOI 10.1128/JB.117.3.1065-1076.1974; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CHRISTIANSEN K, 1978, BIOCHIM BIOPHYS ACTA, V530, P78, DOI 10.1016/0005-2760(78)90128-5; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; HAJRA AK, 1978, J NEUROCHEM, V31, P125, DOI 10.1111/j.1471-4159.1978.tb12440.x; Heath RJ, 1999, J BACTERIOL, V181, P1944, DOI 10.1128/JB.181.6.1944-1946.1999; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; LIGHTNER VA, 1980, J BIOL CHEM, V255, P9413; MATSUSHITA M, 1995, J BIOCHEM-TOKYO, V117, P447, DOI 10.1093/jb/117.2.447; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; MORASH SC, 1994, J BIOL CHEM, V269, P28769; Murata N, 1997, BBA-LIPID LIPID MET, V1348, P10, DOI 10.1016/S0005-2760(97)00115-X; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; TILLMAN TS, 1986, J BIOL CHEM, V261, P9144; Wilkison WO, 1997, BBA-LIPID LIPID MET, V1348, P3, DOI 10.1016/S0005-2760(97)00099-4; YAMASHITA S, 1980, EUR J BIOCHEM, V104, P611, DOI 10.1111/j.1432-1033.1980.tb04465.x	27	113	127	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41710	41716		10.1074/jbc.M104749200	http://dx.doi.org/10.1074/jbc.M104749200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11544256	hybrid			2022-12-27	WOS:000172450400024
J	Uchiyama, T; Katouno, F; Nikaidou, N; Nonaka, T; Sugiyama, J; Watanabe, T				Uchiyama, T; Katouno, F; Nikaidou, N; Nonaka, T; Sugiyama, J; Watanabe, T			Roles of the exposed aromatic residues in crystalline chitin hydrolysis by chitinase a from Serratia marcescens 2170	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CIRCULANS WL-12; VALONIA CELLULOSE MICROCRYSTALS; ACID-SEQUENCE SIMILARITIES; BINDING DOMAIN; GLYCOSYL HYDROLASES; TRICHODERMA-REESEI; RESOLUTION; LYSOZYME; SERRATIA-MARCESCENS-2170; DEGRADATION	Four exposed aromatic residues, two in the N-terminal domain (Trp-69 and Trp-33) and two in the catalytic domain (Trp-245 and Phe-232) of Serratia marcescens chitinase A, are linearly aligned with the deep catalytic cleft. To investigate the importance of these residues in the binding activity and hydrolyzing activity against insoluble chitin, site-directed mutagenesis to alanine was carried out. The substitution of Trp-69, Trp-33, or Trp-245 significantly reduced the binding activity to both highly crystalline beta -chitin and colloidal chitin. The substitution of Phe-232, which is located closest to the catalytic cleft, did not affect the binding activity. On the other hand, the hydrolyzing activity against beta -chitin microfibrils was significantly reduced by the substitution of any one of the four aromatic residues including Phe-232. None of the mutations reduced the hydrolyzing activity against soluble substrates. These results clearly demonstrate that the four exposed aromatic residues are essential determinants for crystalline chitin hydrolysis. Three of them, two in the N-terminal domain and one in the catalytic domain, play vital roles in the chitin binding. Phe-232 appeared to be important for guiding the chitin chain into the catalytic cleft. Based on these observations, a model for processive hydrolysis of crystalline chitin by chitinase A is proposed.	Niigata Univ, Fac Agr, Dept Appl Biol Chem, Niigata 9502181, Japan; Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; Kyoto Univ, Wood Res Inst, Kyoto 6110011, Japan	Niigata University; Nagaoka University of Technology; Kyoto University	Watanabe, T (corresponding author), Niigata Univ, Fac Agr, Dept Appl Biol Chem, 8050 Ikarashi 2, Niigata 9502181, Japan.	wata@agr.niigata-u.ac.jp	Sugiyama, Junji/G-2879-2019; Sugiyama, Junji/ABD-5589-2020	Sugiyama, Junji/0000-0002-5388-4925; Sugiyama, Junji/0000-0002-5388-4925				Bray MR, 1996, PROTEIN SCI, V5, P2311, DOI 10.1002/pro.5560051117; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; HART PJ, 1995, J MOL BIOL, V248, P402, DOI 10.1006/jmbi.1995.0230; Hashimoto M, 2000, J BACTERIOL, V182, P3045, DOI 10.1128/JB.182.11.3045-3054.2000; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Jeuniaux C., 1966, METHOD ENZYMOL, V8, P644, DOI [DOI 10.1016/0076-6879(66)08117-5, 10.1016/0076-6879(66)08117-5]; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Koivula A, 1999, FEBS LETT, V447, P334, DOI 10.1016/S0014-5793(99)00213-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsumoto T, 1999, P JPN ACAD B-PHYS, V75, P269, DOI 10.2183/pjab.75.269; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; Ohno T, 1996, J BACTERIOL, V178, P5065, DOI 10.1128/jb.178.17.5065-5070.1996; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Perrakis A, 1997, FOLD DES, V2, P291, DOI 10.1016/S1359-0278(97)00040-0; Simpson HD, 1999, J BACTERIOL, V181, P4611, DOI 10.1128/JB.181.15.4611-4616.1999; Sugiyama J, 1999, J MOL BIOL, V286, P247, DOI 10.1006/jmbi.1998.2458; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Watanabe T, 2001, FEBS LETT, V494, P74, DOI 10.1016/S0014-5793(01)02317-1; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; YAMADA H, 1981, CARBOHYD RES, V92, P160, DOI 10.1016/S0008-6215(00)85993-5; YANASE Y, 1987, ARCH BIOCHEM BIOPHYS, V253, P168, DOI 10.1016/0003-9861(87)90649-7	35	152	156	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41343	41349		10.1074/jbc.M103610200	http://dx.doi.org/10.1074/jbc.M103610200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522778	hybrid			2022-12-27	WOS:000171925600128
J	Wilson, MP; Sun, Y; Cao, L; Majerus, PW				Wilson, MP; Sun, Y; Cao, L; Majerus, PW			Inositol 1,3,4-trisphosphate 5/6-kinase is a protein kinase that phosphorylates the transcription factors c-Jun and ATF-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL GLOMERULOSA CELLS; SIGNAL-TRANSDUCTION; COP9 COMPLEX; ENTAMOEBA-HISTOLYTICA; LIGHT CONTROL; LIPID KINASE; IN-VITRO; POLYPHOSPHATES; ARABIDOPSIS; INHIBITION	Phosphorylation of inositol 1,3,4-trisphosphate by inositol 1,3,4-trisphosphate 5/6-kinase is the first committed step in the formation of higher phosphorylated forms of inositol. We have shown that the eight proteins called the COP9 signalosome complex copurify with calf brain 5/6-kinase. Because the complex has been shown to phosphorylate c-Jun an vitro, we tested both the complex and 5/6-kinase and found that both are able to phosphorylate c-Jun and ATF-2 on serine/threonine residues. These findings establish a link between two major signal transduction systems: the inositol phosphates and the stress response system.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Majerus, PW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672, R01HL016634, R37HL016634] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 55672, HL 16634] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALLA T, 1987, J BIOL CHEM, V262, P9952; BALLA T, 1987, BIOCHEM BIOPH RES CO, V148, P199, DOI 10.1016/0006-291X(87)91095-3; BECK KA, 1991, J BIOL CHEM, V266, P4442; Bondev A, 1999, BIOL CHEM, V380, P1337, DOI 10.1515/BC.1999.171; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Feng YC, 2001, P NATL ACAD SCI USA, V98, P875, DOI 10.1073/pnas.021558098; Field J, 2000, MOL BIOCHEM PARASIT, V108, P119, DOI 10.1016/S0166-6851(00)00197-3; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; HUGHES PJ, 1994, BBA-MOL CELL RES, V1223, P57, DOI 10.1016/0167-4889(94)90073-6; HUGHES PJ, 1989, J BIOL CHEM, V264, P19871; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Itoh T, 2000, J BIOL CHEM, V275, P19389, DOI 10.1074/jbc.M000426200; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; KING WG, 1990, BIOCHEM J, V270, P125, DOI 10.1042/bj2700125; LAM K, 1994, J BIOL CHEM, V269, P20648; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Martin JB, 2000, J BIOL CHEM, V275, P10134, DOI 10.1074/jbc.275.14.10134; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Safrany ST, 1999, BIOL CHEM, V380, P945, DOI 10.1515/BC.1999.117; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; SHEARS SB, 1990, SYM SOC EXP BIOL, V44, P181; SHEARS SB, 1987, BIOCHEM J, V246, P139, DOI 10.1042/bj2460139; SHEARS SB, 1991, PHARMACOL THERAPEUT, V49, P79, DOI 10.1016/0163-7258(91)90023-F; Spain BH, 1996, MOL CELL BIOL, V16, P6698; TOKER A, 1994, J BIOL CHEM, V269, P33258; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wilson MP, 1996, J BIOL CHEM, V271, P11904, DOI 10.1074/jbc.271.20.11904; Wilson MP, 1997, BIOCHEM BIOPH RES CO, V232, P678, DOI 10.1006/bbrc.1997.6355; Yang XN, 2000, BIOCHEM J, V351, P551, DOI 10.1042/0264-6021:3510551; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zhao XH, 2000, J BIOL CHEM, V275, P14642, DOI 10.1074/jbc.275.19.14642	49	56	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40998	41004		10.1074/jbc.M106605200	http://dx.doi.org/10.1074/jbc.M106605200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11533064	hybrid			2022-12-27	WOS:000171925600084
J	Yang, YH; Cheng, P; Zhi, G; Liu, Y				Yang, YH; Cheng, P; Zhi, G; Liu, Y			Identification of a calcium/calmodulin-dependent protein kinase that phosphorylates the Neurospora circadian clock protein FREQUENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOD PROTEIN; DOUBLE-TIME; CALMODULIN; CRASSA; LIGHT; GENE; PHASE; TRANSCRIPTION; CALCIUM; CLONING	Phosphorylation of circadian clock proteins represents a major regulatory step that controls circadian clocks. In Neurospora, the circadian clock protein FREQUENCY (FRQ) is progressively phosphorylated over time, and its level decreases when it is hyperphosphorylated. In this study, we showed that most of the kinase activity phosphorylating FRQ in vitro was calcium/ calmodulin-dependent, and the endogenous FRQ in the Neurospora extracts was phosphorylated by a Ca/ CaM-dependent kinase-like activity. From Neurospora cell extracts, an similar to 50-kDa Ca/CaM-dependent kinase (CAMK-1) that can specifically phosphorylate FRQ was purified. In vitro, this kinase accounts for near half of the FRQ kinase activity, and it can phosphorylate the FRQ region that contains the three known functionally important phosphorylation sites. To understand the function of camk-1 in vivo, it was disrupted in Neurospora by gene replacement. After germination from ascospores, the camk-1 null strains grew slowly, indicating that CAMK-1 plays an important role in growth and development of Neurospora. This phenotype was transient however, revealing redundancy in the system. Analysis of the camk-1 null strain revealed that the deletion of camk-1 affected phase, period, and light-induced phase shifting of the circadian conidiation rhythm. Taken together, our results suggest that multiple kinases may phosphorylate FRQ in vivo.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Yang, Yuhong/A-6033-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062591] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 62591] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; DHARMANANDA S, 1980, STUDIES CIRCADIAN CL; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EBBOLE D, 1990, FUNGAL GENET NEWSL, V37, P15; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; ICHIISHI A, 1995, JPN J GENET, V70, P273, DOI 10.1266/jjg.70.273; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; MCMAHON DG, 1987, J COMP PHYSIOL A, V161, P335, DOI 10.1007/BF00603959; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NAKASHIMA H, 1986, Journal of Biological Rhythms, V1, P163, DOI 10.1177/074873048600100207; Nelson MA, 1997, FUNGAL GENET BIOL, V21, P348, DOI 10.1006/fgbi.1997.0986; Numata O, 2000, J BIOCHEM, V127, P51, DOI 10.1093/oxfordjournals.jbchem.a022583; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rasmussen C, 1999, BIOCHEM CELL BIOL, V77, P421, DOI 10.1139/bcb-77-5-421; Sadakane Y, 1996, J BIOL RHYTHM, V11, P234, DOI 10.1177/074873049601100305; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1994, J BIOL RHYTHM, V9, P27, DOI 10.1177/074873049400900103; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; SUSUKI S, 1996, GENETICS, V143, P1175; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; TECHEL D, 1990, J COMP PHYSIOL B, V159, P695, DOI 10.1007/BF00691715; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Young MW, 1999, RECENT PROG HORM RES, V54, P87	47	93	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41064	41072		10.1074/jbc.M106905200	http://dx.doi.org/10.1074/jbc.M106905200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11551951	hybrid			2022-12-27	WOS:000171925600093
J	Zhao, F; Satoda, M; Licht, JD; Hayashizaki, Y; Gelb, BD				Zhao, F; Satoda, M; Licht, JD; Hayashizaki, Y; Gelb, BD			Cloning and characterization of a novel mouse AP-2 transcription factor, Ap-2 gamma, with unique DNA binding and transactivation properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; EPITHELIAL-CELLS; FAMILY; EMBRYOGENESIS; AP-2-ALPHA; AP-2-BETA; PROTEINS; PROMOTER; MEMBERS; CANCER	AP-2 transcription factors are sequence-specific DNA-binding proteins expressed in neural crest and other tissues during mammalian development. Three mammalian genes, AP-2 alpha, AP-2 beta, and AP-2 gamma, have been reported previously. A partial predicted AP-2 gene was identified in tandem with AP-2 beta on human chromosome 6p12p21.1. The orthologous mouse gene, which we named Ap-2 delta, was identified from a fetal mouse head cDNA library. Northern analysis revealed two transcripts in embryonic and newborn mouse brain, with markedly higher steady-state levels in the former. The predicted Ap-2 delta protein comprised 452 amino acids and was highly similar to other AP-2 proteins across the DNA-binding and dimerization domains. Ap-2 delta formed homodimers and heterodimers in vitro, bound an optimized AP-2 consensus DNA sequence, and transactivated gene expression in eukaryotic cells. Ap-2 delta dimers bound poorly to an AP-2 binding sequence from the human metallothionein IIa promoter in vitro, revealing a sequence specificity not previously observed among other AP-2 proteins. The PY motif and critical residues in the transactivation domain, which are highly conserved in the AP-2 family and believed necessary for transactivation, were divergent in Ap-2 delta. The unique protein sequence and functional features of Ap-2 delta suggest mechanisms, besides tissue-specific AP-2 gene expression, for specific control of target gene activation.	Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; Mt Sinai Sch Med, Derald H Ruttenberg Ctr, New York, NY USA; RIKEN, Genome Sci Lab, Yokohama, Kanagawa 2300045, Japan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; RIKEN	Gelb, BD (corresponding author), Mt Sinai Sch Med, Dept Pediat, 1 Gustave Levy Pl,Box 1498, New York, NY 10029 USA.	gelbb01@doc.mssm.edu	Licht, Jonathan/L-4239-2019; Hayashizaki, Yoshihide/N-6590-2015	Licht, Jonathan/0000-0002-3942-1369; Satoda, Masahiko/0000-0003-0804-860X	NICHD NIH HHS [HD38018] Funding Source: Medline; PHS HHS [A59998] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038018] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anttila MA, 2000, BRIT J CANCER, V82, P1974; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Bisgrove DA, 1997, MOL CELL BIOL, V17, P5935, DOI 10.1128/MCB.17.10.5935; Bosher JM, 1996, ONCOGENE, V13, P1701; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; Doerksen LF, 1996, NUCLEIC ACIDS RES, V24, P2849, DOI 10.1093/nar/24.14.2849; Ebert SN, 1998, J NEUROCHEM, V70, P2286; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; Kannan F, 1999, MOL CELL BIOL, V19, P899; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Maconochie M, 1999, DEVELOPMENT, V126, P1483; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; MOSER M, 1995, DEVELOPMENT, V121, P2779; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SNAPE AM, 1991, DEVELOPMENT, V113, P283; Turner BC, 1998, CANCER RES, V58, P5466; Wankhade S, 2000, J BIOL CHEM, V275, P29701, DOI 10.1074/jbc.M000931200; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	29	123	127	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40755	40760		10.1074/jbc.M106284200	http://dx.doi.org/10.1074/jbc.M106284200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522791	hybrid			2022-12-27	WOS:000171925600052
J	Kozaki, AK; Mayumi, K; Sasaki, Y				Kozaki, AK; Mayumi, K; Sasaki, Y			Thiol-disulfide exchange between nuclear-encoded and chloroplast-encoded subunits of pea acetyl-CoA carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; REDOX; LIGHT; IDENTIFICATION; MUTAGENESIS; ACTIVATION; PLANTS; FORMS	Fatty acid synthesis in pea chloroplasts is regulated by light/dark. The regulatory enzyme acetyl-CoA carboxylase is modulated by light/dark, presumably under redox regulation. Acetyl-CoA carboxylase is a multienzyme complex composed of biotin carboxylase and carboxyltransferase (CT). To demonstrate the redox regulation of CT, composed of the nuclear-encoded a and the chloroplast-encoded beta subunits, we identified the cysteine residues involved in such regulation. We expressed the recombinant CT in Escherichia coli and found that the partly deleted CT was, like the full-length CT, sensitive to a redox state. Site-directed mutagenesis of the deleted CT showed that replacement by alanine of the cysteine residue 267 in the a polypeptide or 442 in the beta polypeptide resulted in redox-insensitive CT and broke the intermolecular disulfide bond between the a and beta polypeptides. Similar results were confirmed in the full-length CT. These results indicate that the two cysteines in recombinant CT are involved in redox regulation by intermolecular disulfide-dithiol exchange between the alpha and beta subunits. Immunoblots of extract from plants incubated in the light or dark supported that such a disulfide-dithiol exchange is relevant in vivo. A covalent bond between a nuclear-encoded polypeptide and a chloroplast-encoded polypeptide probably regulates the enzyme activity in response to light.	Nagoya Univ, Grad Sch Agr Sci, Lab Plant Mol Biol, Nagoya, Aichi 4648601, Japan	Nagoya University	Sasaki, Y (corresponding author), Nagoya Univ, Grad Sch Agr Sci, Lab Plant Mol Biol, Nagoya, Aichi 4648601, Japan.	sasaki@agr.nagoya-u.ac.jp						Anderson LE, 1996, PLANT J, V10, P553, DOI 10.1046/j.1365-313X.1996.10030553.x; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Hunter SC, 1998, ARCH BIOCHEM BIOPHYS, V359, P170, DOI 10.1006/abbi.1998.0900; INAKA K, 1991, J BIOL CHEM, V266, P12599; ISSAKIDIS E, 1994, J BIOL CHEM, V269, P3511; ISSAKIDIS E, 1992, J BIOL CHEM, V267, P21577; Jacquot JP, 1997, FEBS LETT, V401, P143, DOI 10.1016/S0014-5793(96)01459-7; JACQUOT JP, 1995, EUR J BIOCHEM, V229, P675, DOI 10.1111/j.1432-1033.1995.tb20513.x; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KONISHI T, 1994, P NATL ACAD SCI USA, V91, P3598, DOI 10.1073/pnas.91.9.3598; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Kozaki A, 1999, BIOCHEM J, V339, P541, DOI 10.1042/0264-6021:3390541; Kozaki A, 2000, J BIOL CHEM, V275, P10702, DOI 10.1074/jbc.275.14.10702; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; SASAKI Y, 1993, J BIOL CHEM, V268, P25118; Sasaki Y, 1997, P NATL ACAD SCI USA, V94, P11096, DOI 10.1073/pnas.94.20.11096; Sasaki Y, 2001, J BIOL CHEM, V276, P3937, DOI 10.1074/jbc.M008166200; SAUER A, 1984, Z NATURFORSCH C, V39, P268; Schurmann P, 2000, ANNU REV PLANT PHYS, V51, P371, DOI 10.1146/annurev.arplant.51.1.371; STALEY JP, 1992, P NATL ACAD SCI USA, V89, P1519, DOI 10.1073/pnas.89.5.1519	23	41	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39919	39925		10.1074/jbc.M103525200	http://dx.doi.org/10.1074/jbc.M103525200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546765	hybrid			2022-12-27	WOS:000171789200057
J	Martins, A; Shuman, S				Martins, A; Shuman, S			Mutational analysis of baculovirus capping enzyme lef4 delineates an autonomous triphosphatase domain and structural determinants of divalent cation specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-TRIPHOSPHATASE; GUANYLYLTRANSFERASE ACTIVITIES; NUCLEOSIDE TRIPHOSPHATASE; COMPONENT; YEAST; EXPRESSION; 5'-TRIPHOSPHATASE; MECHANISM; APPARATUS; SUBUNIT	The 464-amino acid baculovirus Left protein is a bifunctional mRNA capping enzyme with triphosphatase and guanylyltransferase activities. The hydrolysis of 5'-triphosphate RNA and free NTPs by Lef4 is dependent on a divalent cation cofactor. RNA triphosphatase activity is optimal at pH 7.5 with either magnesium or manganese, yet NTP hydrolysis at neutral pH is activated only by manganese or cobalt. Here we show that Lef4 possesses an intrinsic magnesium-dependent ATPase with a distinctive alkaline pH optimum and a high K-m for ATP (4 mm). Lef4 contains two conserved sequences, motif A ((IEKEISY14)-I-8) and motif C ((LEYEF184)-L-180), which define the fungal/viral/protozoal family of metal-dependent RNA triphosphatases. We find by mutational analysis that Glu(9), Glu(11), Glu(181), and Glu(183) are essential for phosphohydrolase chemistry and likely comprise the metal-binding site of Lef4. Conservative mutations E9D and E183D abrogate the magnesium-dependent triphosphatase activities of Lef4 and transform it into a strictly manganese-dependent RNA triphosphatase. Limited proteolysis of Lef4 and ensuing COOH-terminal deletion analysis revealed that the NH2-terminal 236-amino acid segment of Lef4 constitutes an autonomous triphosphatase catalytic domain.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org	Martins, Alexandra/J-9592-2013	Martins, Alexandra/0000-0003-4322-8497	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042498] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CONG PJ, 1995, MOL CELL BIOL, V15, P6222; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Gross CH, 1998, J VIROL, V72, P10020, DOI 10.1128/JVI.72.12.10020-10028.1998; Guarino LA, 1998, J VIROL, V72, P10003, DOI 10.1128/JVI.72.12.10003-10010.1998; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 2001, P NATL ACAD SCI USA, V98, P3050, DOI 10.1073/pnas.061636198; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 1996, J VIROL, V70, P6658, DOI 10.1128/JVI.70.10.6658-6664.1996; Ho CK, 2001, J VIROL, V75, P1744, DOI 10.1128/JVI.75.4.1744-1750.2001; Ho CK, 2000, J VIROL, V74, P5486, DOI 10.1128/JVI.74.12.5486-5494.2000; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myette JR, 1996, J BIOL CHEM, V271, P11936, DOI 10.1074/jbc.271.20.11936; Pei Y, 2000, NUCLEIC ACIDS RES, V28, P1885, DOI 10.1093/nar/28.9.1885; Pei Y, 1999, J BIOL CHEM, V274, P28865, DOI 10.1074/jbc.274.41.28865; Pei Y, 2001, NUCLEIC ACIDS RES, V29, P387, DOI 10.1093/nar/29.2.387; Sekiguchi J, 1997, NUCLEIC ACIDS RES, V25, P727, DOI 10.1093/nar/25.4.727; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; Tiggemann M, 2001, YEAST, V18, P815, DOI 10.1002/yea.728; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573; Yu L, 1996, J VIROL, V70, P6162, DOI 10.1128/JVI.70.9.6162-6168.1996; Yu L, 1997, J VIROL, V71, P9837, DOI 10.1128/JVI.71.12.9837-9843.1997	24	18	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45522	45529		10.1074/jbc.M107615200	http://dx.doi.org/10.1074/jbc.M107615200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11553638	hybrid			2022-12-27	WOS:000172573100007
J	Sturgeon, BE; Glover, RE; Chen, YR; Burka, LT; Mason, RP				Sturgeon, BE; Glover, RE; Chen, YR; Burka, LT; Mason, RP			Tyrosine iminoxyl radical formation from tyrosyl radical/nitric oxide and nitrosotyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; PHOTOSYSTEM-II; RIBONUCLEOTIDE REDUCTASE; NITRIC-OXIDE; ESCHERICHIA-COLI; HORSERADISH-PEROXIDASE; ANACYSTIS-NIDULANS; MODEL COMPOUNDS; DNA PHOTOLYASE; OXYGEN	The quenching of the Y-D tyrosyl radical in photosystem II by nitric oxide was reported to result from the formation of a weak tyrosyl radical-nitric oxide complex (Petrouleas, V., and Diner, B. A (1990) Biochim. Biophys. Acta 1015, 131-140). This radical/radical reaction is expected to generate an electron spin resonance (ESR)silent 3-nitrosocyclohexadienone species that can reversibly regenerate the tyrosyl radical and nitric oxide or undergo rearrangement to form 3-nitrosotyrosine. It has been proposed that 3-nitrosotyrosine can be oxidized by one electron to form the tyrosine iminoxyl radical (>C=N-O). This proposal was put forth as a result of ESR detection of the iminoxyl radical intermediate when photosystem II was exposed to nitric oxide (Sanakis, Y., Goussias, C., Mason, R. P., and Petrouleas, V. (1997) Biochemistry 36, 1411-1417). A similar iminoxyl radical was detected in prostaglandin H synthase-2 (Gunther, M. R., Hsi, L. C., Curtis, J. F., Gierse, J. K., Marnett. L. J., Eling, T. E., and Mason, R. P. (1997) J. Biol. Chem., 272, 17086-17090). Although the iminoxyl radicals detected in the photosystem II and prostaglandin H synthase-2 systems strongly suggest a mechanism involving 3-nitrosotyrosine, the iminoxyl radical ESR spectrum was not unequivocally identified as originating from tyrosine. We report here the detection of the non-protein L-tyrosine iminoxyl radical generated by two methods: 1) peroxidase oxidation of synthetic 3-nitroso-N-acetyl-L-tyrosine and 2) peroxidase oxidation of free L-tyrosine in the presence of nitric oxide. A newly developed ESR technique that uses immobilized enzyme was used to perform the ESR experiments. Analysis of the high resolution ESR spectrum of the tyrosine iminoxyl radical generated from free tyrosine and nitric oxide reveals a 28.4-G isotropic nitrogen hyperfine coupling and a 2.2-G proton hyperfine coupling assigned to the proton originally ortho to the phenoxyl oxygen.	NIEHS, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sturgeon, BE (corresponding author), NC Sch Sci & Math, 1219 Broad St, Durham, NC 27705 USA.		Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050139, ZIAES050139] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aubert C, 1999, J AM CHEM SOC, V121, P8659, DOI 10.1021/ja991938z; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; BABCOCK GT, 1992, J AM CHEM SOC, V114, P3727, DOI 10.1021/ja00036a023; BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; BARRY BA, 1990, J BIOL CHEM, V265, P20139; Beckman JS, 1996, METHODS NITRIC OXIDE, P61; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; Berho F, 1998, J PHYS CHEM A, V102, P1, DOI 10.1021/jp972576p; Dole F, 1997, J AM CHEM SOC, V119, P11540, DOI 10.1021/ja9717727; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; EISERICH JP, 1995, BIOCHEM J, V310, P745, DOI 10.1042/bj3100745; Glover RE, 1999, NITRIC OXIDE-BIOL CH, V3, P439, DOI 10.1006/niox.1999.0256; Goldstein S, 2000, J BIOL CHEM, V275, P3031, DOI 10.1074/jbc.275.5.3031; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; GREEN RG, 1975, J CHEM SOC PERK T 2, P1380, DOI 10.1039/p29750001380; Gunther MR, 1997, J BIOL CHEM, V272, P17086, DOI 10.1074/jbc.272.27.17086; HOGANSON CW, 1992, BIOCHEMISTRY-US, V31, P11874, DOI 10.1021/bi00162a028; HUNTER EPL, 1989, FREE RADICAL BIO MED, V6, P581, DOI 10.1016/0891-5849(89)90064-6; Ivancich A, 1996, J AM CHEM SOC, V118, P12852, DOI 10.1021/ja9628361; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; LEPOIVRE M, 1990, J BIOL CHEM, V265, P14143; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; LEPOIVRE M, 1994, J BIOL CHEM, V269, P21891; MacMillan F, 1999, BIOCHEMISTRY-US, V38, P9179, DOI 10.1021/bi9911987; MARUYAMA K, 1967, J ORG CHEM, V32, P2516, DOI 10.1021/jo01283a033; MASON RP, 1984, METHOD ENZYMOL, V105, P416; PETROULEAS V, 1990, BIOCHIM BIOPHYS ACTA, V1015, P131, DOI 10.1016/0005-2728(90)90224-R; RAO DNR, 1990, J BIOL CHEM, V265, P844; RIGBY SEJ, 1994, BIOCHEMISTRY-US, V33, P1734, DOI 10.1021/bi00173a016; ROMAN R, 1973, CAN J CHEM, V51, P588, DOI 10.1139/v73-089; Sanakis Y, 1997, BIOCHEMISTRY-US, V36, P1411, DOI 10.1021/bi9622074; SCHONBAUM GR, 1972, J BIOL CHEM, V247, P3353; SEALY RC, 1985, J AM CHEM SOC, V107, P3401, DOI 10.1021/ja00298a001; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; Stanbro WD, 1999, J THEOR BIOL, V197, P557, DOI 10.1006/jtbi.1998.0895; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sturgeon BE, 1998, J BIOL CHEM, V273, P30116, DOI 10.1074/jbc.273.46.30116; Szalai VA, 1996, BIOCHEMISTRY-US, V35, P15080, DOI 10.1021/bi961117w; THOMAS JR, 1964, J AM CHEM SOC, V86, P1446, DOI 10.1021/ja01061a043; TOMMOS C, 1995, J AM CHEM SOC, V117, P10325, DOI 10.1021/ja00146a017; WARNCKE K, 1994, J AM CHEM SOC, V116, P7332, DOI 10.1021/ja00095a042; WHITTAKER MM, 1990, J BIOL CHEM, V265, P9610; YAMAZAKI I, 1961, BIOCHIM BIOPHYS ACTA, V50, P62, DOI 10.1016/0006-3002(61)91060-5; YAMAZAKI I, 1977, FREE RADICALS BIOL, V3, P183; YU T, 1995, J PHYS ORG CHEM, V8, P47, DOI 10.1002/poc.610080110	46	32	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					45516	45521		10.1074/jbc.M106835200	http://dx.doi.org/10.1074/jbc.M106835200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11551949	hybrid			2022-12-27	WOS:000172573100006
J	de Seny, D; Heinz, U; Wommer, S; Kiefer, M; Meyer-Klaucke, W; Galleni, M; Frere, JM; Bauer, R; Adolph, HW				de Seny, D; Heinz, U; Wommer, S; Kiefer, M; Meyer-Klaucke, W; Galleni, M; Frere, JM; Bauer, R; Adolph, HW			Metal ion binding and coordination geometry for wild type and mutants of metallo-beta-lactamase from Bacillus cereus 569/H/9 (BcII) - A combined thermodynamic, kinetic, and spectroscopic approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTURBED-ANGULAR-CORRELATION; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ANGSTROM RESOLUTION; MECHANISM; MONONUCLEAR; CYSTEINE	One high affinity (nm) and one low affinity (IM) macroscopic dissociation constant for the binding of metal ions were found for the wild-type metallo-beta -lactamase from Bacillus cereus as well as six single-site mutants in which all ligands in the two metal binding sites were altered. Surprisingly, the mutations did not cause a specific alteration of the affinity of metal ions for the sole modified binding site as determined by extended x-ray absorption fine structure (EXAFS) and perturbed angular correlation of gamma -rays spectroscopy, respectively. Also UV-visible absorption spectra for the mono-cobalt enzymes clearly contain contributions from both metal sites. The observations of the very similar microscopic dissociation constants of both binding sites in contrast to the significantly differing macroscopic dissociation constants inevitably led to the conclusion that binding to the two metal sites exhibits negative cooperativity. The slow association rates for forming the binuclear enzyme determined by stopped-flow fluorescence measurements suggested that fast metal exchange between the two sites for the mononuclear enzyme hinders the binding of a second metal ion. EXAFS spectroscopy of the mono- and di-zinc wild type enzymes and two di-zinc mutants provide a definition of the metal ion environments, which is compared with the available x-ray crystallographic data.	Univ Saarland, FR Biochem 8 8, D-66041 Saarbrucken, Germany; Univ Liege, Inst Chim B6, Ctr Ingn Prot, B-4000 Liege, Belgium; DESY, European Mol Biol Lab, Outstn Hamburg, D-22603 Hamburg, Germany; Royal Vet & Agr Univ, Dept Math & Phys, DK-1871 Frederiksberg C, Denmark	Saarland University; University of Liege; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Copenhagen	Adolph, HW (corresponding author), Univ Saarland, FR Biochem 8 8, D-66041 Saarbrucken, Germany.	hwadolph@mx.uni-saarland.de	Adolph, Hans W/A-2104-2008; Meyer-Klaucke, Wolfram/G-1148-2010					Bauer R, 1997, BIOCHEMISTRY-US, V36, P11514, DOI 10.1021/bi970936t; BAUER R, 1985, Q REV BIOPHYS, V18, P1, DOI 10.1017/S0033583500004972; BICKNELL R, 1985, BIOCHEMISTRY-US, V24, P6876, DOI 10.1021/bi00345a021; Bounaga S, 1998, BIOCHEM J, V331, P703, DOI 10.1042/bj3310703; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P47, DOI 10.1107/S090744499700927X; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Chantalat L, 2000, PROTEIN SCI, V9, P1402, DOI 10.1110/ps.9.7.1402; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Hedin L., 1969, SOLID STATE PHYS, V23, P1, DOI [10.1016/S0081-1947(08)60615-3, DOI 10.1016/S0081-1947(08)60615-3]; Hemmingsen L, 1996, EUR J BIOCHEM, V241, P546, DOI 10.1111/j.1432-1033.1996.00546.x; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; JOYNER RW, 1987, J PHYS C SOLID STATE, V20, P4005, DOI 10.1088/0022-3719/20/25/028; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; Meneghini C, 1998, BIOPHYS J, V75, P1953, DOI 10.1016/S0006-3495(98)77636-2; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Paul-Soto R, 1999, BIOCHEMISTRY-US, V38, P16500, DOI 10.1021/bi9911381; Paul-Soto R, 1998, FEBS LETT, V438, P137, DOI 10.1016/S0014-5793(98)01289-7; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Teo, 1986, EXAFS BASIC PRINCIPL; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Valladares MH, 2000, FEBS LETT, V467, P221, DOI 10.1016/S0014-5793(00)01102-9; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4	28	107	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45065	45078		10.1074/jbc.M106447200	http://dx.doi.org/10.1074/jbc.M106447200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11551939	Green Published, hybrid			2022-12-27	WOS:000172406700097
J	Iwata, A; Maruyama, M; Kanazawa, I; Nukina, N				Iwata, A; Maruyama, M; Kanazawa, I; Nukina, N			alpha-Synuclein affects the MAPK pathway and accelerates cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MULTIPLE SYSTEM ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; C-JUN; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE-D; LEWY BODIES; IN-VITRO	Insoluble alpha -synuclein accumulates in Parkinson's disease, diffuse Levy body disease, and multiple system atrophy. However, the relationship between its accumulation and pathogenesis is still unclear. Recently, we reported that overexpression of a-synuclein affects Elk-1 phosphorylation in cultured cells, which is mainly performed by mitogen-activated protein kinases (MAPKs). We further examined the relationship between MAPK signaling and the effects of a-synuclein expression on ecdysone-inducible neuro2a cell lines and found that cells expressing a-synuclein had less phosphorylated MAPKs. Moreover, they showed significant cell death when the concentration of serum in the culture medium was reduced. Under normal serum conditions, the addition of the MAPK inhibitor U0126 also caused cell death in alpha -synuclein-expressing cells. Transfection of constitutively active MEK-1 resulted in MAPK phosphorylation in a-synuclein-expressing cells and improved cell viability even under reduced serum conditions. Thus, we conclude that a-synuclein regulates the MAPK pathway by reducing the amount of available active MAPK. Our findings suggest a mechanism for pathogenesis and thus offer therapeutic insight into synucleinopathies.	RIKEN, Brain Sci Inst, Mol Neuropathol Grp, Lab CAG Repeat dis, Wako, Saitama 3510198, Japan; Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan	RIKEN; University of Tokyo	Nukina, N (corresponding author), RIKEN, Brain Sci Inst, Mol Neuropathol Grp, Lab CAG Repeat dis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013; Nukina, Nobuyuki/GPP-6265-2022	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314; 				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baba M, 1998, AM J PATHOL, V152, P879; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; BLACKSHEAR PJ, 1987, J BIOL CHEM, V262, P7774; Bloch-Shilderman E, 2001, J PHARMACOL EXP THER, V296, P704; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Clerk A, 1998, J BIOL CHEM, V273, P7228, DOI 10.1074/jbc.273.13.7228; Cox ME, 1997, J NEUROCHEM, V69, P1119; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Dickson DW, 1999, BRAIN PATHOL, V9, P721; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; GOULD GW, 1995, BIOCHEM J, V311, P735, DOI 10.1042/bj3110735; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; ISHIZAWA M, 1991, NUCLEIC ACIDS RES, V19, P5792, DOI 10.1093/nar/19.20.5792; Ito Y, 1998, J NEUROCHEM, V71, P2278; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura S, 1998, J NEUROPATH EXP NEUR, V57, P690, DOI 10.1097/00005072-199807000-00006; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V280, P1085, DOI 10.1006/bbrc.2000.4253; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHIEMANN WP, 1994, J BIOL CHEM, V269, P6376; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tian JM, 1999, J BIOL CHEM, V274, P15173, DOI 10.1074/jbc.274.21.15173; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wilkie N, 1996, J BIOL CHEM, V271, P32447, DOI 10.1074/jbc.271.50.32447	66	125	127	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45320	45329		10.1074/jbc.M103736200	http://dx.doi.org/10.1074/jbc.M103736200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11560921	hybrid			2022-12-27	WOS:000172406700127
J	Latif, R; Graves, P; Davies, TF				Latif, R; Graves, P; Davies, TF			Oligomerization of the human thyrotropin receptor - Fluorescent protein-tagged hTSHR reveals post-translational complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING HORMONE-RECEPTOR; TSH RECEPTOR; EXTRACELLULAR DOMAIN; DISULFIDE-ISOMERASE; GRAVES-DISEASE; LIVING CELLS; CLEAVAGE; INTERNALIZATION; IDENTIFICATION; AUTOANTIBODIES	To examine thyrotropin (TSH) receptor homophilic interactions we fused the human TSH receptor (hTSHR) carboxyl terminus to green fluorescent protein (GFP) and the corresponding chimeric cDNA was expressed in Chinese hamster ovary cells. Fluorescent TSH receptors on the plasma membrane were functional as assessed by TSH-induced cAMP synthesis. The binding of TSH, as well as TSHR autoantibodies, induced time- and dose-dependent receptor capping. Fluorescence resonance energy transfer between receptors differentially tagged with GFP variants (RFP and YFP) provided evidence for the close proximity of individual receptor molecules. This was consistent with previous studies demonstrating the presence of TSHR dimers and oligomers in thyroid tissue. Co-immunoprecipitation of GFP-tagged and Myc-tagged receptor complexes was performed using doubly transfected cells with Myc antibody. Western blotting of the immunoprecipitated complex revealed the absence of noncleaved TSH holoreceptors. This further suggested that cleavage of the holoreceptor into its two-subunit structure, comprising disulfide-linked TSHR-alpha and TSHR-beta subunits, was required for the formation of TSHR dimers and higher order complexes.	CUNY Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Latif, R (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, Box 1055,1Gustave L Levy Pl, New York, NY 10029 USA.	rauf.latif@mssm.edu	Latif, Rauf/ABH-4394-2020; latif, rauf/AAR-1634-2020	Latif, Rauf/0000-0002-4226-3728; 	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045011, R01DK052464, R01DK035764] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10RR9145-01] Funding Source: Medline; NIDDK NIH HHS [DK45011, DK52464, DK35764] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKAGI S, 1988, J HISTOCHEM CYTOCHEM, V36, P1533, DOI 10.1177/36.12.3192937; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; AVIVI A, 1982, MOL CELL ENDOCRINOL, V25, P55, DOI 10.1016/0303-7207(82)90169-1; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Baratti-Elbaz C, 1999, MOL ENDOCRINOL, V13, P1751, DOI 10.1210/me.13.10.1751; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; Devi LA, 2000, TRENDS PHARMACOL SCI, V21, P324, DOI 10.1016/S0165-6147(00)01519-4; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Graves P, 1999, J CLIN ENDOCR METAB, V84, P2177, DOI 10.1210/jc.84.6.2177; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; GRAVES PN, 1995, ENDOCRINOLOGY, V136, P521, DOI 10.1210/en.136.2.521; Graves PN, 2000, ENDOCRIN METAB CLIN, V29, P267, DOI 10.1016/S0889-8529(05)70131-6; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; HAVERSTICK DM, 1992, AM J PHYSIOL, V262, pC916, DOI 10.1152/ajpcell.1992.262.4.C916; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HOOVER RL, 1983, J CELL BIOL, V97, P73, DOI 10.1083/jcb.97.1.73; Horvat RD, 1999, BIOCHEM BIOPH RES CO, V255, P382, DOI 10.1006/bbrc.1999.0185; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; Kakinuma A, 1997, J BIOL CHEM, V272, P28296, DOI 10.1074/jbc.272.45.28296; Kita M, 1999, ENDOCRINOLOGY, V140, P1392, DOI 10.1210/en.140.3.1392; Kwiatkowska K, 1999, CELL MOTIL CYTOSKEL, V42, P298, DOI 10.1002/(SICI)1097-0169(1999)42:4<298::AID-CM4>3.0.CO;2-Q; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latif R, 2000, THYROID, V10, P407, DOI 10.1089/thy.2000.10.407; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; MARTIN A, 1988, MOL CELL ENDOCRINOL, V60, P233, DOI 10.1016/0303-7207(88)90183-9; MISRAHI M, 1994, EUR J BIOCHEM, V222, P711, DOI 10.1111/j.1432-1033.1994.tb18916.x; Misrahi M, 1997, EUR J ENDOCRINOL, V137, P599, DOI 10.1530/eje.0.1370599; NAGAYAMA Y, 1990, BIOCHEM BIOPH RES CO, V173, P1150, DOI 10.1016/S0006-291X(05)80906-4; Oda Y, 2000, THYROID, V10, P1051, DOI 10.1089/thy.2000.10.1051; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PODESTA EJ, 1983, P NATL ACAD SCI-BIOL, V80, P3986, DOI 10.1073/pnas.80.13.3986; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; RUSSO D, 1992, ENDOCRINOLOGY, V130, P2135, DOI 10.1210/en.130.4.2135; Sanders J, 1997, BAILLIERE CLIN ENDOC, V11, P451, DOI 10.1016/S0950-351X(97)80693-3; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; Tanaka K, 2000, ENDOCRINOLOGY, V141, P3573, DOI 10.1210/en.141.10.3573; Tanaka K, 1999, J BIOL CHEM, V274, P2093, DOI 10.1074/jbc.274.4.2093; Tarasova NI, 1997, CELL TISSUE RES, V287, P325, DOI 10.1007/s004410050757; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	48	94	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					45217	45224		10.1074/jbc.M103727200	http://dx.doi.org/10.1074/jbc.M103727200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11535591	hybrid			2022-12-27	WOS:000172406700115
J	Cahan, R; Axelrad, I; Safrin, M; Ohman, DE; Kessler, E				Cahan, R; Axelrad, I; Safrin, M; Ohman, DE; Kessler, E			A secreted aminopeptidase of Pseudomonas aeruginosa - Identification, primary structure, and relationship to other aminopeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-GRISEUS AMINOPEPTIDASE; AEROMONAS-CAVIAE T-64; INTRAMOLECULAR CHAPERONE; VIBRIO-PROTEOLYTICUS; MOLECULAR-CLONING; ELASTASE ACTIVITY; SENSITIVE METHOD; GENE; PURIFICATION; LASA	Using leucine-p-nitroanilide (Leu-pNA) as a substrate, we demonstrated aminopeptidase activity in the culture filtrates of several Pseudomonas aeruginosa strains. The aminopeptidase was partially purified by DEAE-cellulose chromatography and found to be heat stable. The apparent molecular mass of the enzyme was similar to 56 kDa; hence, it was designated AP(56). Heating (70 degreesC) of the partially purified aminopeptidase preparations led to the conversion of AP56 to a similar to 28-kDa protein (AP(28)) that retained enzyme activity, a reaction that depended on elastase (LasB). The pH optimum for Leu-pNA hydrolysis by AP(28) was 8.5. This activity was inhibited by Zn chelators but not by inhibitors of serine- or thiol-proteases, suggesting that AP(28) is a Zn-dependent enzyme. Of several amino acid p-nitroanilide derivatives examined, Leu-pNA was the preferred substrate. The sequences of the first 20 residues of AP(56), and AP(28) were determined. A search of the P. aeruginosa genomic data base revealed a perfect match of these sequences with positions 39-58 and 273-291, respectively, in a 536-amino acid residue open reading frame predicted to encode an aminopeptidase. A search for sequence similarities with other proteins revealed 52% identity with Streptomyces griseus aminopeptidase, similar to 35% identity with Saccharomyces cerevisiae aminopeptidase Y and a hypothetical aminopeptidase from Bacillus subtilis, and 29-32% with Aeromonas caviae, Vibrio proteolyticus, and Vibrio cholerae aminopeptidases. The residues potentially involved in zinc coordination were conserved in all these proteins. Thus, P. aeruginosa aminopeptidase may belong to the same family (M28) of metalloproteases.	Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Maurice & Gabriela Goldschleger Eye Res Inst, IL-52621 Tel Hashomer, Israel; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; McGuire Dept Vet Affairs Med Ctr, Richmond, VA 23249 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Kessler, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Maurice & Gabriela Goldschleger Eye Res Inst, IL-52621 Tel Hashomer, Israel.			Cahan, Rivka/0000-0001-9783-4033	NIAID NIH HHS [AI 26187] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026187] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AWAD WM, 1998, HDB PROTEOLYTIC ENZY, P1431; BENMEIR D, 1993, EUR J BIOCHEM, V212, P107, DOI 10.1111/j.1432-1033.1993.tb17639.x; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun P, 1998, J BACTERIOL, V180, P3467, DOI 10.1128/JB.180.13.3467-3469.1998; Caballero AR, 2001, ANAL BIOCHEM, V290, P330, DOI 10.1006/abio.2001.4999; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; CHEVRIER B, 1998, HDB PROTEOLYTIC ENZY, P1433; ELLIOTT BW, 1986, J BIOL CHEM, V261, P1259; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; GOLDBERG JB, 1987, J BACTERIOL, V169, P4532, DOI 10.1128/jb.169.10.4532-4539.1987; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; GUENET C, 1992, J BIOL CHEM, V267, P8390; Homma J. Y., 1985, BACTERIAL ENZYMES VI, P41; Izawa N, 1996, J FERMENT BIOENG, V82, P544, DOI 10.1016/S0922-338X(97)81249-4; Izawa N, 1997, J AGR FOOD CHEM, V45, P4897, DOI 10.1021/jf970453w; KANAYAMA N, 1995, J LEUKOCYTE BIOL, V57, P129, DOI 10.1002/jlb.57.1.129; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kessler E, 1997, J BIOL CHEM, V272, P9884; KESSLER E, 1988, J BACTERIOL, V170, P1215, DOI 10.1128/jb.170.3.1215-1219.1988; Kessler E, 1998, HDB PROTEOLYTIC ENZY, P1476; Kessler E., 1998, HDB PROTEOLYTIC ENZY, P1058; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAEDA H, 1995, METHOD ENZYMOL, V248, P395; Maeda H, 1996, BIOL CHEM H-S, V377, P217; Maras B, 1996, EUR J BIOCHEM, V236, P843, DOI 10.1111/j.1432-1033.1996.00843.x; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MORIHARA K, 1995, METHOD ENZYMOL, V248, P242; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; MORIHARA K, 1998, HDB PROTEOLYTIC ENZY, P1150; Nirasawa S, 1999, BBA-PROTEIN STRUCT M, V1433, P335, DOI 10.1016/S0167-4838(99)00158-2; Nirasawa S, 1999, BIOCHEM J, V341, P25, DOI 10.1042/0264-6021:3410025; NISHIZAWA M, 1994, J BIOL CHEM, V269, P13651; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; PARK S, 1995, MOL MICROBIOL, V16, P263, DOI 10.1111/j.1365-2958.1995.tb02298.x; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; PETERS JE, 1992, MOL MICROBIOL, V6, P1155, DOI 10.1111/j.1365-2958.1992.tb01554.x; Pollack M, 1998, INFECT DIS, P1824; Prescott J M, 1976, Methods Enzymol, V45, P530; PRESCOTT JM, 1966, ARCH BIOCHEM BIOPHYS, V117, P328, DOI 10.1016/0003-9861(66)90420-6; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; RAWLINGS ND, 1998, HDB PROTEOLYTIC ENZY, P1412; SPUNGIN A, 1989, EUR J BIOCHEM, V183, P471, DOI 10.1111/j.1432-1033.1989.tb14952.x; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Toma C, 1996, INFECT IMMUN, V64, P4495, DOI 10.1128/IAI.64.11.4495-4500.1996; Van Delden C, 1998, INFECT IMMUN, V66, P4499; VANHEEKE G, 1992, BIOCHIM BIOPHYS ACTA, V1131, P337, DOI 10.1016/0167-4781(92)90037-Z; Vessillier S, 2001, EUR J BIOCHEM, V268, P1049, DOI 10.1046/j.1432-1327.2001.01967.x; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WAGNER FW, 1972, J BIOL CHEM, V247, P1208; Zhang ZZ, 2000, BIOCHEM J, V350, P671, DOI 10.1042/0264-6021:3500671; Zhang ZZ, 2001, BIOSCI BIOTECH BIOCH, V65, P420, DOI 10.1271/bbb.65.420	57	52	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43645	43652		10.1074/jbc.M106950200	http://dx.doi.org/10.1074/jbc.M106950200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11533066	hybrid			2022-12-27	WOS:000172297700023
J	Reis, M; Farage, M; de Souza, ACL; de Meis, L				Reis, M; Farage, M; de Souza, ACL; de Meis, L			Correlation between uncoupled ATP hydrolysis and heat production by the sarcoplasmic reticulum Ca2+-ATPase - Coupling effect of fluoride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; TIGHT-BINDING; ENERGY INTERCONVERSION; FUNCTIONAL-STATES; REACTION CYCLE; TRANSPORT; CA2+; MAGNESIUM; PHOSPHORYLATION; THERMOGENESIS	The sarcoplasmic reticulum Ca2+-ATPase transports Ca2+ using the chemical energy derived from ATP hydrolysis. Part of the chemical energy is used to translocate Ca2+ through the membrane (work) and part is dissipated as heat. The amount of heat produced during catalysis increases after formation of the Ca2+ gradient across the vesicle membrane. In the absence of gradient (leaky vesicles) the amount of heat produced/mol of ATP cleaved is half of that measured in the presence of the gradient. After formation of the gradient, part of the ATPase activity is not coupled to Ca2+ transport. We now show that NaF can impair the uncoupled ATPase activity with discrete effect on the ATPase activity coupled to Ca2+ transport. For the control vesicles not treated with NaF, after formation of the gradient only 20% of the ATP cleaved is coupled to Ca2+ transport, and the caloric yield of the total ATPase activity (coupled plus uncoupled) is 22.8 kcal released/mol of ATP cleaved. In contrast, the vesicles treated with NaF consume only the ATP needed to maintain the gradient, and the caloric yield of ATP hydrolysis is 3.1 kcal/mol of ATP. The slow ATPase activity measured in vesicles treated with NaF has the same Ca2+ dependence as the control vesicles. This demonstrates unambiguously that the uncoupled activity is an actual pathway of the Ca2+-ATPase rather than a contaminating phosphatase. We conclude that when ATP hydrolysis occurs without coupled biological work most of the chemical energy is dissipated as heat. Thus, uncoupled ATPase activity appears to be the mechanistic feature underlying the ability of the Ca2+ ATPase to modulated heat production.	Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	de Meis, L (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.	demeis@biqmed.ufrj.br	Reis, Marcelo Martins/H-9370-2012	Reis, Marcelo Martins/0000-0002-4706-1041				CHIESI M, 1979, J BIOL CHEM, V254, P370; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; COLL RJ, 1992, J BIOL CHEM, V267, P21584; DAGLORIA M, 1976, J BIOL CHEM, V251, P3629; DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018; De Meis L, 1998, AM J PHYSIOL-CELL PH, V274, pC1738, DOI 10.1152/ajpcell.1998.274.6.C1738; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 1974, Biochemistry, V13, P5032, DOI 10.1021/bi00721a026; de Meis L, 1998, BIOCHEM BIOPH RES CO, V243, P598, DOI 10.1006/bbrc.1997.8028; De Meis L, 2000, AN ACAD BRAS CIENC, V72, P365, DOI 10.1590/S0001-37652000000300010; de Meis L, 2000, BIOCHEM BIOPH RES CO, V276, P35, DOI 10.1006/bbrc.2000.3418; deMeis L, 1996, BBA-BIOENERGETICS, V1275, P105, DOI 10.1016/0005-2728(96)00058-8; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; deMeis L, 1997, FEBS LETT, V406, P201, DOI 10.1016/S0014-5793(97)00244-5; DEMEIS L, 1991, J BIOL CHEM, V266, P5736; DEMEIS L, 1988, METHOD ENZYMOL, V157, P190; DEMEIS L, 1981, SARCOPLASMIC RETICUL, V2; DUCHAMP C, 1993, AM J PHYSIOL, V265, pR1076, DOI 10.1152/ajpregu.1993.265.5.R1076; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fortea MI, 2000, J BIOL CHEM, V275, P12521, DOI 10.1074/jbc.275.17.12521; GOULD GW, 1987, J BIOL CHEM, V262, P7676; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HASSELBACH W, 1978, BIOCHIM BIOPHYS ACTA, V515, P23, DOI 10.1016/0304-4157(78)90007-2; HASSELBACH W, 1964, PROGR BIOPHYS MOL BI, V14, P169; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; INESI G, 1976, BIOCHEMISTRY-US, V15, P5293, DOI 10.1021/bi00669a015; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 1978, Ann N Y Acad Sci, V307, P224, DOI 10.1111/j.1749-6632.1978.tb41947.x; JANSKY L, 1995, PHYSIOL REV, V75, P237, DOI 10.1152/physrev.1995.75.2.237; KUBOTA T, 1993, BIOCHIM BIOPHYS ACTA, V1163, P131, DOI 10.1016/0167-4838(93)90174-P; MAKINOSE M, 1965, BIOCHEM Z, V343, P360; MAKINOSE M, 1971, FEBS LETT, V12, P271, DOI 10.1016/0014-5793(71)80196-5; MAKINOSE M, 1973, FEBS LETT, V37, P140, DOI 10.1016/0014-5793(73)80443-0; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitidieri F, 1999, J BIOL CHEM, V274, P28344, DOI 10.1074/jbc.274.40.28344; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; MURPHY AJ, 1992, J BIOL CHEM, V267, P16990; SCWARTZENBACH G, 1957, HELVETIA CHIMICA ACT, V40, P1886; SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128; TANFORD C, 1984, CRC CR REV BIOCH MOL, V17, P123, DOI 10.3109/10409238409113603; TANFORD C, 1984, FEBS LETT, V166, P1, DOI 10.1016/0014-5793(84)80033-2; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; WALTER H, 1973, EUR J BIOCHEM, V36, P110, DOI 10.1111/j.1432-1033.1973.tb02890.x; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	49	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42793	42800		10.1074/jbc.M107625200	http://dx.doi.org/10.1074/jbc.M107625200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544263	hybrid			2022-12-27	WOS:000172169300022
J	Vandenberghe, I; Kim, JK; Devreese, B; Hacisalihoglu, A; Iwabuki, H; Okajima, T; Kuroda, S; Adachi, O; Jongejan, JA; Duine, JA; Tanizawa, K; Van Beeumen, J				Vandenberghe, I; Kim, JK; Devreese, B; Hacisalihoglu, A; Iwabuki, H; Okajima, T; Kuroda, S; Adachi, O; Jongejan, JA; Duine, JA; Tanizawa, K; Van Beeumen, J			The covalent structure of the small subunit from Pseudomonas putida amine dehydrogenase reveals the presence of three novel types of internal cross-linkages, all involving cysteine in a thioether bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN-TRYPTOPHYLQUINONE; COFACTOR; OXIDASE; SEQUENCE; ENZYMES	Pseudomonas putida contains an amine dehydrogenase that is called a quinohemoprotein as it contains a quinone and two hemes c as redox active groups. Amino acid sequence analysis of the smallest (8.5 kDa), quinone-cofactor-bearing subunit of this heterotrimeric enzyme encountered difficulties in the interpretation of the results at several sites of the polypeptide chain. As this suggested posttranslational modifications of the subunit, the structural genes for this enzyme were determined and mass spectrometric de novo sequencing was applied to several peptides obtained by chemical or enzymatic cleavage. In agreement with the interpretation of the X-ray electronic densities in the diffraction data for the holoenzyme, our results show that the polypeptide of the small subunit contains four intrachain cross-linkages in which the sulfur atom of a cysteine residue is involved. Two of these cross-linkages occur with the beta -carbon atom of an aspartic acid, one with the gamma -carbon atom of a glutamic acid and the fourth with a tryptophanquinone residue, this adduct constituting the enzyme's quinone cofactor, CTQ. The thioether type bond in all four of these adducts has never been found in other proteins. CTQ is a novel cofactor in the series of the recently discovered quinone cofactors.	Lab Eiwitbiochem & Eiwitengn, B-9000 Ghent, Belgium; Osaka Univ, Inst Sci & Ind Res, Dept Struct Mol Biol, Osaka 5670047, Japan; Delft Univ Technol, Dept Microbiol & Enzymol, NL-2628 BC Delft, Netherlands; Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan	Osaka University; Delft University of Technology; Yamaguchi University	Van Beeumen, J (corresponding author), Lab Eiwitbiochem & Eiwitengn, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	jozef.vanbeeumen@rug.ac.be	Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Okajima, Toshihide/0000-0003-1733-9580				Adachi O, 1998, BIOSCI BIOTECH BIOCH, V62, P469, DOI 10.1271/bbb.62.469; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Devreese B, 2001, RAPID COMMUN MASS SP, V15, P50, DOI 10.1002/1097-0231(20010115)15:1<50::AID-RCM191>3.0.CO;2-V; DUINE JA, 1997, NATO ASI SER, P149; Gielens C, 1997, EUR J BIOCHEM, V248, P879, DOI 10.1111/j.1432-1033.1997.00879.x; Hacisalihoglu A, 1997, MICROBIOL-UK, V143, P505, DOI 10.1099/00221287-143-2-505; HACISALIHOGLU A, 2000, THESIS DELFT U TECHN; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; Jiang W, 1998, ANAL BIOCHEM, V255, P47, DOI 10.1006/abio.1997.2395; JUE RA, 1994, TECHNIQUES IN PROTEIN CHEMISTRY V, P179; KOZAK M, 1983, MICROBIOL REV, V47, P1; LERCH K, 1982, J BIOL CHEM, V257, P6414; MATSUZAKI R, 1994, FEBS LETT, V351, P360, DOI 10.1016/0014-5793(94)00884-1; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; PAGE MD, 1993, EUR J BIOCHEM, V218, P711, DOI 10.1111/j.1432-1033.1993.tb18425.x; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; VANDERPALEN CJNM, 1995, EUR J BIOCHEM, V230, P860; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078	21	30	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42923	42931		10.1074/jbc.M107164200	http://dx.doi.org/10.1074/jbc.M107164200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11555656	hybrid			2022-12-27	WOS:000172169300040
J	Elrouby, N; Bureau, TE				Elrouby, N; Bureau, TE			A novel hybrid open reading frame formed by multiple cellular gene transductions by a plant long terminal repeat retroelement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-LIKE PARTICLES; SARCOMA-VIRUS; (1->4)-BETA-XYLAN ENDOHYDROLASES; MOLECULAR CHARACTERIZATION; REVERSE-TRANSCRIPTASE; L1 RETROTRANSPOSITION; ARABIDOPSIS-THALIANA; NUCLEOTIDE-SEQUENCE; MAIZE; RETROVIRUSES	The discovery that vertebrate retroviruses could transduce cellular sequences was central to cancer etiology and research. Although not well documented, transduction of cellular sequences by retroelements has been suggested to modify cellular functions. The maize Bs1 transposon was the first non-vertebrate retroelement reported to have transduced a portion of a cellular gene (c-pma). We show that Bs1 has, in addition, transduced portions of at least two more maize cellular genes, namely for 1,3-beta -glucanase (c-bg) and 1,4-beta -xylan endohydrolase (c-xe). We also show that Bs1 has maintained a truncated gag domain with similarity to the magellan gypsy-like long terminal repeat retrotransposon and a region that may correspond to an env-like domain. Our findings suggest that, like oncogenic retroviruses, the three transduced gene fragments and the Bs1 gag domain encode a fusion protein that has the potential to be expressed. We suggest that transduction by retroelements may facilitate the formation of novel hybrid genes in plants.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Bureau, TE (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.							Abe H, 1998, GENES GENET SYST, V73, P353, DOI 10.1266/ggs.73.353; Al-Khayat HA, 1999, J MOL BIOL, V292, P65, DOI 10.1006/jmbi.1999.3055; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Banik M, 1997, MOL GEN GENET, V253, P599, DOI 10.1007/s004380050362; BATTINI JL, 1992, J VIROL, V66, P1468, DOI 10.1128/JVI.66.3.1468-1475.1992; Boeke J. D., 1997, P343; BOVA CA, 1988, J VIROL, V62, P75, DOI 10.1128/JVI.62.1.75-83.1988; BRITTEN RJ, 1995, P NATL ACAD SCI USA, V92, P599, DOI 10.1073/pnas.92.2.599; BUREAU TE, 1994, CELL, V77, P479, DOI 10.1016/0092-8674(94)90210-0; CARRINGTON JC, 1989, VIROLOGY, V170, P219, DOI 10.1016/0042-6822(89)90369-3; Chang PFL, 1996, PHYSIOL PLANTARUM, V98, P505, DOI 10.1111/j.1399-3054.1996.tb05705.x; Cooper G.M., 1995, ONCOGENES, P21; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; DELLAPORTA SL, 1985, MOL BIOL PLANTS, P36; DORNER AJ, 1986, CELL, V45, P365, DOI 10.1016/0092-8674(86)90322-3; Eickbush Thomas H., 1994, P121; ELLIS RW, 1980, J VIROL, V36, P408, DOI 10.1128/JVI.36.2.408-420.1980; Elrouby N, 2000, PLANT PHYSIOL, V124, P369, DOI 10.1104/pp.124.1.369; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; FINNEGAN DJ, 1983, NATURE, V302, P105, DOI 10.1038/302105a0; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; HERMAN SA, 1987, SCIENCE, V236, P845, DOI 10.1126/science.3033828; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; JIN YK, 1994, PLANT CELL, V6, P1177, DOI 10.1105/tpc.6.8.1177; JIN YK, 1989, P NATL ACAD SCI USA, V86, P6235, DOI 10.1073/pnas.86.16.6235; JOHNS MA, 1985, EMBO J, V4, P1093, DOI 10.1002/j.1460-2075.1985.tb03745.x; JOHNS MA, 1989, PLANT MOL BIOL, V12, P633, DOI 10.1007/BF00044154; Jordan IK, 1999, P NATL ACAD SCI USA, V96, P12621, DOI 10.1073/pnas.96.22.12621; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KIM A, 1994, P NATL ACAD SCI USA, V91, P1285, DOI 10.1073/pnas.91.4.1285; Laten HM, 1998, P NATL ACAD SCI USA, V95, P6897, DOI 10.1073/pnas.95.12.6897; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Marillonnet S, 1998, GENETICS, V150, P1245; MELLOR J, 1985, NATURE, V313, P243, DOI 10.1038/313243a0; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; MOTTINGER JP, 1984, MOL GEN GENET, V195, P367, DOI 10.1007/BF00332775; NAHARRO G, 1984, SCIENCE, V223, P63, DOI 10.1126/science.6318314; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; OMER CA, 1983, J VIROL, V47, P380, DOI 10.1128/JVI.47.2.380-382.1983; PALMGREN MG, 1994, PLANT MOL BIOL, V25, P137, DOI 10.1007/BF00023232; PURUGGANAN MD, 1994, P NATL ACAD SCI USA, V91, P11674, DOI 10.1073/pnas.91.24.11674; Sidhu P. K., 1999, Plant Physiology, V121, P685, DOI 10.1104/pp.121.2.685; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; SRINIVASAN A, 1987, GENE, V52, P71, DOI 10.1016/0378-1119(87)90396-9; SWAIN A, 1992, SCIENCE, V255, P841, DOI 10.1126/science.1371365; SWANSTROM R, 1983, P NATL ACAD SCI-BIOL, V80, P2519, DOI 10.1073/pnas.80.9.2519; TEMIN HM, 1980, CELL, V21, P599, DOI 10.1016/0092-8674(80)90420-1; Wright DA, 1998, GENETICS, V149, P703; WU SC, 1994, PLANT PHYSIOL, V106, P1709, DOI 10.1104/pp.106.4.1709; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; ZHANG JY, 1993, SCIENCE, V259, P234, DOI 10.1126/science.8421784	58	27	28	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					41963	41968		10.1074/jbc.M105850200	http://dx.doi.org/10.1074/jbc.M105850200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11553621	hybrid			2022-12-27	WOS:000172450400057
J	Buhman, KK; Chen, HC; Farese, RV				Buhman, KK; Chen, HC; Farese, RV			The enzymes of neutral lipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYL-COENZYME-A; COA-CHOLESTEROL ACYLTRANSFERASE; MESSENGER-RNA LEVELS; DIACYLGLYCEROL ACYLTRANSFERASE; ACAT INHIBITOR; ATHEROSCLEROTIC LESIONS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; ANTIATHEROSCLEROTIC AGENTS; TRIACYLGLYCEROL SYNTHESIS		Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Farese, RV (corresponding author), Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.		Buhman, Kimberly/AAV-3111-2021	Buhman, Kimberly/0000-0002-3784-1028; Chen, Hubert/0000-0002-7599-7218				Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; ARNESEN K, 1955, ACTA ENDOCRINOL-COP, V18, P396, DOI 10.1530/acta.0.0180396; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BILLHEIMER JT, 1990, ADV CHOLESTEROL RES, P7; BOCAN TMA, 1991, ARTERIOSCLER THROMB, V11, P1830, DOI 10.1161/01.ATV.11.6.1830; Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Brewer HB, 2000, J CLIN INVEST, V105, P703, DOI 10.1172/JCI9664; Brindley D. N, 1991, BIOCH LIPIDS LIPOPRO, P171; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; Buhman KF, 2000, BBA-MOL CELL BIOL L, V1529, P142, DOI 10.1016/S1388-1981(00)00144-X; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Burnett JR, 1999, CLIN CHIM ACTA, V286, P231, DOI 10.1016/S0009-8981(99)00104-7; Cao GQ, 1996, J BIOL CHEM, V271, P14642, DOI 10.1074/jbc.271.24.14642; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHANG CCY, 1994, SOMAT CELL MOLEC GEN, V20, P71, DOI 10.1007/BF02257489; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; DIXON JL, 1993, J LIPID RES, V34, P167; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; GOODMAN DS, 1964, J BIOL CHEM, V239, P1335; HAAGSMAN HP, 1982, J BIOL CHEM, V257, P593; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Khelef N, 2000, ARTERIOSCL THROM VAS, V20, P1769; Krause B.R., 1995, INFLAMMATION MEDIATO, P173; KUSUNOKI J, 1995, JPN J PHARMACOL, V69, P53, DOI 10.1254/jjp.69.53; Kusunoki J, 2001, CIRCULATION, V103, P2604; Lau TE, 1996, LIPIDS, V31, P277, DOI 10.1007/BF02529874; Lee O, 1998, J LIPID RES, V39, P1722; Lee RG, 2000, J LIPID RES, V41, P1991; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Matsuda H, 1996, BBA-LIPID LIPID MET, V1301, P76, DOI 10.1016/0005-2760(96)00020-3; Matsuo M, 1995, BBA-LIPID LIPID MET, V1259, P254, DOI 10.1016/0005-2760(95)00178-6; Maung KK, 2001, J LIPID RES, V42, P181; Meiner V, 1997, J LIPID RES, V38, P1928; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Meiner VL, 1998, J BIOL CHEM, V273, P1064, DOI 10.1074/jbc.273.2.1064; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; Nicolosi RJ, 1998, ATHEROSCLEROSIS, V137, P77, DOI 10.1016/S0021-9150(97)00279-7; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; PAPE ME, 1995, J LIPID RES, V36, P823; Perrey S, 2001, ATHEROSCLEROSIS, V155, P359, DOI 10.1016/S0021-9150(00)00599-2; Rea TJ, 1996, BBA-LIPID LIPID MET, V1299, P67, DOI 10.1016/0005-2760(95)00190-5; Roth BD, 1998, DRUG DISCOV TODAY, V3, P19, DOI 10.1016/S1359-6446(97)01123-9; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; SLISKOVIC DR, 1991, TRENDS PHARMACOL SCI, V12, P194, DOI 10.1016/0165-6147(91)90546-5; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Spady DK, 2000, J BIOL CHEM, V275, P27005; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; SUCKLING KE, 1985, J LIPID RES, V26, P647; Tabata N, 1997, PHYTOCHEMISTRY, V46, P683, DOI 10.1016/S0031-9422(97)00157-X; Tomoda H, 1999, J ANTIBIOT, V52, P689, DOI 10.7164/antibiotics.52.689; TOMODA H, 1995, J ANTIBIOT, V48, P942, DOI 10.7164/antibiotics.48.942; UELMEN PJ, 1995, J BIOL CHEM, V270, P26192, DOI 10.1074/jbc.270.44.26192; Vaccaro W, 1996, J MED CHEM, V39, P1704, DOI 10.1021/jm950833d; Wang HX, 1996, ARTERIOSCL THROM VAS, V16, P809, DOI 10.1161/01.ATV.16.6.809; WEISS SB, 1960, J BIOL CHEM, V235, P40; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang HY, 1997, J BIOL CHEM, V272, P3980, DOI 10.1074/jbc.272.7.3980; Yu CJ, 1996, J BIOL CHEM, V271, P24157, DOI 10.1074/jbc.271.39.24157; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	76	129	137	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40369	40372		10.1074/jbc.R100050200	http://dx.doi.org/10.1074/jbc.R100050200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11544264	hybrid			2022-12-27	WOS:000171925600001
J	Quellhorst, GJ; Allen, CM; Wessling-Resnick, M				Quellhorst, GJ; Allen, CM; Wessling-Resnick, M			Modification of Rab5 with a photoactivatable analog of geranylgeranyl diphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; FARNESYL-PROTEIN TRANSFERASE; SMALL GTPASE RAB5; MEMBRANE ASSOCIATION; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; GDP/GTP EXCHANGE; ENDOSOME FUSION; HIGH-AFFINITY; BOVINE BRAIN	A photoprobe analog of geranylgeranyl diphosphate (2-diazo-3,3,3-trifluoropropionyloxy-farnesyl diphosphate or DATFP-FPP) inhibits mevalonate-dependent prenylation of in vitro translated Rab5 in rabbit reticulocyte lysate, suggesting that it competes for lipid binding to the Rab geranylgeranyl transferase. Modification of Rab5 with DATFP-FPP, demonstrated by gel mobility shift and Triton X-114 phase separation experiments, confirms that the enzyme uses the analog as a substrate. The sedimentation of DATFP-modified Rab5 as a larger mass complex on sucrose density gradients indicates that it binds to other factors in rabbit reticulocyte lysate. Most importantly, DATFP-Rab5 cross-links to these soluble factors upon exposure to UV light. Immunoprecipitation with antibodies raised against proteins known to interact with Rab5 reveals that the crosslinked complexes contain Rab escort protein and GDI-1. DATFP-Rab5 also associates with membranes in a guanosine-5'-O-(3-thiotriphosphate)-stimulated manner. However, although prenylated Rab5 can be crosslinked to two unknown membrane-associated factors by the chemical cross-linker disuccinimidyl suberate, these proteins fail to be W cross-linked to membrane-bound DATFP-Rab5. These results strongly suggest that membrane-associated factors bind Rab5 through protein-protein interactions rather than protein-prenyl interactions. The modification of Rab5 with DATFP-FPP establishes a novel photoaffinity technique for the characterization of prenyl-binding sites.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Univ Florida, J Hillis Miller Hlth Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; University of Florida	Quellhorst, GJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.				NIGMS NIH HHS [F32 GM19894] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019894] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMSTRONG J, 2000, INT J BIOCHEM CELL B, V32, P303; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUKHTIYAROV YE, 1995, J BIOL CHEM, V270, P19035, DOI 10.1074/jbc.270.32.19035; BURTON J, 1993, NATURE, V361, P464, DOI 10.1038/361464a0; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Edelstein RL, 1997, BIOCHEM BIOPH RES CO, V235, P377, DOI 10.1006/bbrc.1997.6792; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; GARRETT MD, 1993, FEBS LETT, V331, P233, DOI 10.1016/0014-5793(93)80343-S; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048, DOI 10.1074/jbc.270.10.5048; HORI Y, 1991, ONCOGENE, V6, P515; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Jones AT, 1999, J CELL SCI, V112, P3477; Kilic F, 1997, J BIOL CHEM, V272, P5298, DOI 10.1074/jbc.272.8.5298; LI GP, 1993, J BIOL CHEM, V268, P24475; Luan P, 1999, J BIOL CHEM, V274, P14806, DOI 10.1074/jbc.274.21.14806; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; OMER CA, 1993, BIOCHEMISTRY-US, V32, P5167, DOI 10.1021/bi00070a028; Parish CA, 1996, BIOCHEMISTRY-US, V35, P8473, DOI 10.1021/bi960603g; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SANFORD JC, 1995, J BIOL CHEM, V270, P26904, DOI 10.1074/jbc.270.45.26904; SANFORD JC, 1993, J BIOL CHEM, V268, P23773; SANFORD JC, 1995, ANAL BIOCHEM, V224, P547, DOI 10.1006/abio.1995.1086; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; SHAPIRO AD, 1995, J BIOL CHEM, V270, P11085, DOI 10.1074/jbc.270.19.11085; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; Siddiqui AA, 1998, J BIOL CHEM, V273, P3712, DOI 10.1074/jbc.273.6.3712; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Strickland CL, 1998, BIOCHEMISTRY-US, V37, P16601, DOI 10.1021/bi981197z; THISSEN JA, 1993, J BIOL CHEM, V268, P13780; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; YOKOYAMA K, 1995, BIOCHEMISTRY-US, V34, P1344, DOI 10.1021/bi00004a029; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7	45	11	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40727	40733		10.1074/jbc.M104398200	http://dx.doi.org/10.1074/jbc.M104398200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11522782	hybrid			2022-12-27	WOS:000171925600048
J	Rossi, V; Cseh, S; Bally, I; Thielens, NM; Jensenius, JC; Arlaud, GJ				Rossi, V; Cseh, S; Bally, I; Thielens, NM; Jensenius, JC; Arlaud, GJ			Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; COMPLEMENT-SYSTEM; CATALYTIC REGION; SUB-COMPONENTS; PROTEIN; PURIFICATION; ACTIVATION; C1S; PATHWAY; C1BARS	Mannan-binding lectin (MBL)-associated serine proteases-1 and 2 (MASP-1 and MASP-2) are homologous modular proteases that each interact with MBL, an oligomeric serum lectin involved in innate immunity. To precisely determine their substrate specificity, human MASP-1 and MASP-2, and fragments from their catalytic regions were expressed using a baculovirus/insect cells system. Recombinant MASP-2 displayed a rather wide, Cls-like esterolytic activity, and specifically cleaved complement proteins C2 and C4, with relative efficiencies 3- and 23-fold higher, respectively, than human Cls. MASP-2 also showed very weak C3 cleaving activity. Recombinant MASP-1 had a lower and more restricted esterolytic activity. It showed marginal activity toward C2 and C3, and no activity on C4. The enzymic activity of both MASP-1 and MASP-2 was specifically titrated by C1 inhibitor, and abolished at a 1:1 C1 inhibitor:protease ratio. Taken together with previous findings, these and other data strongly support the hypothesis that MASP-2 is the protease that, in association with MBL, triggers complement activation via the AML pathway, through combined self-activation and proteolytic properties devoted to C1r and Cls in the C1 complex. In view of the very low activity of MASP-1 on C3 and C2, our data raise questions about the implication of this protease in complement activation.	CEA, CNRS, Inst Biol Struct Jean Pierre Ebel, Lab Enzymol Mol, F-38027 Grenoble 1, France; Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Aarhus University	Arlaud, GJ (corresponding author), CEA, CNRS, Inst Biol Struct Jean Pierre Ebel, Lab Enzymol Mol, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.		Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302				ALSALIHI A, 1982, FEBS LETT, V150, P238, DOI 10.1016/0014-5793(82)81342-2; ARLAUD GJ, 1993, METHOD ENZYMOL, V223, P61; Arlaud GJ, 1998, ADV IMMUNOL, V69, P249, DOI 10.1016/S0065-2776(08)60609-4; ARLAUD GJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P151, DOI 10.1016/0005-2795(79)90494-X; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BORK P, 1995, TRENDS BIOCH SCI S, V20, pC3; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Endo Y, 1998, J IMMUNOL, V161, P4924; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; ISENMAN DE, 2000, COMPLEMENT FACTSBOOK, P95; Ji X, 1997, P NATL ACAD SCI USA, V94, P6340, DOI 10.1073/pnas.94.12.6340; KING LA, 1992, BACULOVIRUS EXPRESSI, P111; Lacroix M, 1997, BIOCHEMISTRY-US, V36, P6270, DOI 10.1021/bi962719i; LACROIX MB, 1989, BIOCHEM J, V257, P885, DOI 10.1042/bj2570885; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; MATSUSHITA M, 1995, IMMUNOBIOLOGY, V194, P443, DOI 10.1016/S0171-2985(11)80110-5; Matsushita M, 1998, IMMUNOBIOLOGY, V199, P340, DOI 10.1016/S0171-2985(98)80038-7; MCRAE BJ, 1981, J BIOL CHEM, V256, P2362; Petersen SV, 1998, MOL IMMUNOL, V35, P409, DOI 10.1016/S0161-5890(98)90848-3; PETILLOT Y, 1995, FEBS LETT, V358, P323, DOI 10.1016/0014-5793(94)01429-5; REBOUL A, 1977, FEBS LETT, V79, P45, DOI 10.1016/0014-5793(77)80347-5; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; ROSSI V, 1995, BIOCHEMISTRY-US, V34, P7311, DOI 10.1021/bi00022a004; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; SATO T, 1994, INT IMMUNOL, V6, P665, DOI 10.1093/intimm/6.4.665; SIM RB, 1979, BIOCHEM J, V179, P449, DOI 10.1042/bj1790449a; Stover CM, 1999, J IMMUNOL, V162, P3481; TAKADA F, 1993, BIOCHEM BIOPH RES CO, V196, P1003, DOI 10.1006/bbrc.1993.2349; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; TERAI I, 1995, INT IMMUNOL, V7, P1579, DOI 10.1093/intimm/7.10.1579; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; THIELENS NM, 1982, FEBS LETT, V141, P19, DOI 10.1016/0014-5793(82)80006-9; THIELENS NM, 1990, J BIOL CHEM, V265, P14469; Turner M W, 2000, Rev Immunogenet, V2, P305; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; VORUPJENSEN T, 2000, THESIS U AARHUS; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Wong NKH, 1999, MOL IMMUNOL, V36, P853, DOI 10.1016/S0161-5890(99)00106-6; Xu Y., 2000, COMPLEMENT FACTSBOOK, P73; Zhang Y, 1998, MOL IMMUNOL, V35, P390, DOI 10.1016/S0161-5890(98)90771-4	49	127	145	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40880	40887		10.1074/jbc.M105934200	http://dx.doi.org/10.1074/jbc.M105934200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527969	hybrid			2022-12-27	WOS:000171925600068
J	Wright, CF; Oswald, BW; Dellis, S				Wright, CF; Oswald, BW; Dellis, S			Vaccinia virus late transcription is activated in vitro by cellular heterogeneous nuclear ribonucleoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LATE PROMOTER; INTERMEDIATE GENE; RNA-SYNTHESIS; LUNG-CANCER; IN-VITRO; PROTEIN; BINDING; SPERMATOGENESIS; OVEREXPRESSION	Vaccinia virus gene expression is temporally regulated, and three gene classes have been identified: early, intermediate, and late. Several virus-encoded proteins and an activity designated VLTF-X are required for maximum transcription in vitro of a template containing a late promoter. VLTF-X is present in both cytoplasmic and nuclear extracts prepared from uninfected mammalian cells and co-purifies with a late promoter DNA-binding activity. Here, extensive purification of VLTF-X has revealed that heterogeneous nuclear ribonucleoproteins A2/B1 and RBM3 co-purified with in vitro late transcription stimulation. Overexpression and purification of these proteins from Escherichia coli demonstrated that they both complemented for VLTF-X activity in in vitro transcription reactions. These studies identify two host cell factors potentially contributing to poxvirus replication in vivo.	Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; Coll Charleston, Dept Biol, Charleston, SC 29424 USA	Medical University of South Carolina; College of Charleston	Wright, CF (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, POB 250908, Charleston, SC 29425 USA.			Wright, Cynthia/0000-0003-0442-1665	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043329] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43329] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABMAYR SM, 1996, CURRENT PROTOCOLS MO; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERTHOLET C, 1986, EMBO J, V5, P1951, DOI 10.1002/j.1460-2075.1986.tb04449.x; BIAMONTI G, 1994, NUCLEIC ACIDS RES, V22, P1996, DOI 10.1093/nar/22.11.1996; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; Delbridge ML, 1999, NAT GENET, V22, P223, DOI 10.1038/10279; DERRY JMJ, 1995, HUM MOL GENET, V4, P2307, DOI 10.1093/hmg/4.12.2307; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fielding P, 1999, CLIN CANCER RES, V5, P4048; Gunasinghe SK, 1998, J BIOL CHEM, V273, P27524, DOI 10.1074/jbc.273.42.27524; Hubbs AE, 1996, J VIROL, V70, P327, DOI 10.1128/JVI.70.1.327-331.1996; Kamma H, 1999, EXP CELL RES, V246, P399, DOI 10.1006/excr.1998.4323; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; KECK JG, 1993, J VIROL, V67, P5740, DOI 10.1128/JVI.67.10.5740-5748.1993; KECK JG, 1993, J VIROL, V67, P5749, DOI 10.1128/JVI.67.10.5749-5753.1993; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; MORRISON DK, 1986, CELL, V44, P587, DOI 10.1016/0092-8674(86)90268-0; Passarelli AL, 1996, J VIROL, V70, P4444, DOI 10.1128/JVI.70.7.4444-4450.1996; PEDLEY S, 1984, J GEN VIROL, V65, P1687, DOI 10.1099/0022-1317-65-10-1687; PIOOLROMA S, 1992, NATURE, V355, P730; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; Shen XL, 2001, P NATL ACAD SCI USA, V98, P2717, DOI 10.1073/pnas.031424298; Shi ST, 2000, EMBO J, V19, P4701, DOI 10.1093/emboj/19.17.4701; Sueoka E, 1999, CANCER RES, V59, P1404; Swamynathan SK, 1998, FASEB J, V12, P515, DOI 10.1096/fasebj.12.7.515; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tockman MS, 1997, CLIN CANCER RES, V3, P2237; WEIR JP, 1987, J VIROL, V61, P75, DOI 10.1128/JVI.61.1.75-80.1987; Wolffe AP, 1996, INT J BIOCHEM CELL B, V28, P247, DOI 10.1016/1357-2725(95)00141-7; Wright CF, 1998, J VIROL, V72, P1446, DOI 10.1128/JVI.72.2.1446-1451.1998; WRIGHT CF, 1989, J VIROL, V63, P4224, DOI 10.1128/JVI.63.10.4224-4233.1989; WRIGHT CF, 1993, J VIROL, V67, P7264, DOI 10.1128/JVI.67.12.7264-7270.1993; WRIGHT CF, 1991, J VIROL, V65, P3715, DOI 10.1128/JVI.65.7.3715-3720.1991	39	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40680	40686		10.1074/jbc.M102399200	http://dx.doi.org/10.1074/jbc.M102399200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11546759	hybrid			2022-12-27	WOS:000171925600041
J	Xiao, XL; Tang, YS; Mackins, JY; Sun, XL; Jayaram, HN; Hansen, DK; Antony, AC				Xiao, XL; Tang, YS; Mackins, JY; Sun, XL; Jayaram, HN; Hansen, DK; Antony, AC			Isolation and characterization of a folate receptor mRNA-binding trans-factor from human placenta - Evidence favoring identity with heterogeneous nuclear ribonucleoprotein E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL-TUBE DEFECTS; KH-DOMAIN PROTEINS; MESSENGER-RNA; MOLECULAR-CLONING; GENE-EXPRESSION; IDENTIFICATION; REGION; INVITRO; COMPLEX; TRANSLATION	The interaction of an 18-base cis-element in the 5'-untranslated region of human folate receptor (FR)-alpha mRNA with a cytosolic trans-factor protein is critical for the translation of FR (Sun, X.-L., and Antony, A. C. (1996) J. Biol. Chem. 271, 25539-25547). This trans-factor was isolated to apparent homogeneity as a 43- and 38-kDa doublet from human placenta using poly(U)-Sepharose, followed by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electro-elution as major purification steps. Amino acid microsequencing of two cyanogen bromide-generated peptide fragments of the 43-kDa trans-factor revealed complete identity with 43-kDa heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1). Purified specific rabbit anti-hnRNP E1 peptide antibodies (generated against a synthetic oligopeptide that was not represented in microsequenced peptides of the trans-factor) also recognized the purified trans-factor on Western blots. Conversely, the 18-base FR RNA cis-element also bound hnRNP E1 protein on Northwestern blots. Moreover, a 19-base RNA cis-element in the 3'-untranslated region of 15-lipoxygenase mRNA that is known to bind hnRNP E1 also interacted with placental 43-kDa trans-factor. In addition, several murine tissues containing a hnRNP E1-related protein (also known as alpha CP-1) readily interacted with the 18-base FR RNA cis-element. Finally, anti-hnRNP El antibodies specifically inhibited translation of FR in vitro in a dose-dependent manner, and the antibody effect could be reversed in a dose-dependent manner by either purified trans-factor or hnRNP E1. Collectively, the data favor identity of the FR mRNA-binding trans-factor and hnRNP E1, confirm its critical role in the translation of FR, and highlight yet another role of multifunctional hnRNP E1 in eukaryotic mRNA regulation.	Indiana Univ, Sch Med, Indiana Canc Res Inst, Dept Med,Div Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; US FDA, Natl Ctr Toxicol Res, Div Genet & Reprod Toxicol, Jefferson, AR 72079 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; US Food & Drug Administration (FDA)	Antony, AC (corresponding author), Indiana Univ, Sch Med, Indiana Canc Res Inst, Dept Med,Div Hematol Oncol, R4-266,1044 W Walnut St, Indianapolis, IN 46202 USA.				NCI NIH HHS [R01CA58919] Funding Source: Medline; NICHD NIH HHS [R01 HD39295] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039295] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA058919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antony A.C., 2000, HEMATOLOGY BASIC PRI, P446; ANTONY AC, 1992, BLOOD, V79, P2807; ANTONY AC, 1987, J CLIN INVEST, V80, P711, DOI 10.1172/JCI113126; Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; ANTONY AC, 1987, J CLIN INVEST, V80, P1618, DOI 10.1172/JCI113249; ANTONY AC, 1989, J BIOL CHEM, V264, P1911; ANTONY AC, 1981, J BIOL CHEM, V256, P9684; Antony AC, 2000, TERATOLOGY, V62, P42, DOI 10.1002/1096-9926(200007)62:1&lt;42::AID-TERA9&gt;3.0.CO;2-U; ANTONY AC, 2000, P 19 ANN CONV IND AS; Barber RC, 1998, AM J MED GENET, V76, P310, DOI 10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-T; Cusack Stephen, 1999, Current Opinion in Structural Biology, V9, P66; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; Funke B, 1996, NUCLEIC ACIDS RES, V24, P3821, DOI 10.1093/nar/24.19.3821; Gamarnik AV, 1997, RNA, V3, P882; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hansen D. K., 2001, Teratology, V63, P292; Hansen D. K., 1999, Teratology, V59, P385; Heil SG, 1999, EUR J HUM GENET, V7, P393, DOI 10.1038/sj.ejhg.5200305; HENDERSON GI, 1995, J LAB CLIN MED, V126, P184; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; KANE MA, 1988, J CLIN INVEST, V81, P1398, DOI 10.1172/JCI113469; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; MCCARTHY JEG, 1995, TRENDS BIOCHEM SCI, V20, P191, DOI 10.1016/S0968-0004(00)89006-4; McCarthy JEG, 1998, MICROBIOL MOL BIOL R, V62, P1492, DOI 10.1128/MMBR.62.4.1492-1553.1998; NESBITT SA, 1992, ANAL BIOCHEM, V206, P267, DOI 10.1016/0003-2697(92)90365-E; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Sun XL, 1996, J BIOL CHEM, V271, P25539; VERMA RS, 1992, J BIOL CHEM, V267, P4119; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; Yang XY, 1996, J BIOL CHEM, V271, P11493, DOI 10.1074/jbc.271.19.11493	40	35	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41510	41517		10.1074/jbc.M106824200	http://dx.doi.org/10.1074/jbc.M106824200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527973	hybrid			2022-12-27	WOS:000171925600149
J	Tobe, K; Suzuki, R; Aoyama, M; Yamauchi, T; Kamon, J; Kubota, N; Terauchi, Y; Matsui, J; Akanuma, Y; Kimura, S; Tanaka, J; Abe, M; Ohsumi, J; Nagai, R; Kadowaki, T				Tobe, K; Suzuki, R; Aoyama, M; Yamauchi, T; Kamon, J; Kubota, N; Terauchi, Y; Matsui, J; Akanuma, Y; Kimura, S; Tanaka, J; Abe, M; Ohsumi, J; Nagai, R; Kadowaki, T			Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE PROTEIN; TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; DIABETES-MELLITUS; TRANSGENIC MICE; CULTURED-CELLS; RESISTANCE; IRS-2; DISRUPTION; REPRODUCTION	Insulin receptor substrate (IRS)-2(-/-) mice develop diabetes because of insulin resistance in the liver and failure to undergo beta -cell hyperplasia. Here we show by DNA chip microarray analysis that expression of the sterol regulatory element-binding protein (SREBP)-1 gene, a downstream target of insulin, was paradoxically increased in 16-week-old IRS-2(-/-) mouse liver, where insulin-mediated intracellular signaling events were substantially attenuated. The expression of SREBP-1 downstream genes, such as the spot 14, ATP citrate-lyase, and fatty acid synthase genes, was also increased. Increased liver triglyceride content in IRS-2(-/-) mice assures the physiological importance of SREBP-1 gene induction. IRS-2(-/-) mice showed leptin resistance; low dose leptin administration, enough to reduce food intake and body weight in wild-type mice, failed to do so in IRS-2(-/-) mice. Interestingly, high dose leptin administration reduced SREBP-1 expression in IRS-2(-/-) mouse liver. Thus, IRS-2 gene disruption results in leptin resistance, causing an SREBP-1 gene induction, obesity, fatty liver, and diabetes.	Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 1000005, Japan; Sankyo Corp Ltd, Biomed Res Labs, Tokyo 1408710, Japan	University of Tokyo; Asahi Life Foundation	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Ohsumi, Jun/L-3095-2017; Terauchi, Yasuo/AAO-4347-2020; Suzuki, Ryo/AAA-2736-2019; Kubota, Naoto/N-7892-2015	Suzuki, Ryo/0000-0002-2965-6906; 				ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Keller Susanne R., 1994, Trends in Cell Biology, V4, P115, DOI 10.1016/0962-8924(94)90065-5; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Liu SCH, 1999, J BIOL CHEM, V274, P18093, DOI 10.1074/jbc.274.25.18093; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; TOBE K, 1995, J BIOL CHEM, V270, P5698, DOI 10.1074/jbc.270.11.5698; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	41	107	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 19	2001	276	42					38337	38340		10.1074/jbc.C100160200	http://dx.doi.org/10.1074/jbc.C100160200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	484CT	11546755	hybrid			2022-12-27	WOS:000171673200002
J	Klemm, DJ; Watson, PA; Frid, MG; Dempsey, EC; Schaack, J; Colton, LA; Nesterova, A; Stenmark, KR; Reusch, JEB				Klemm, DJ; Watson, PA; Frid, MG; Dempsey, EC; Schaack, J; Colton, LA; Nesterova, A; Stenmark, KR; Reusch, JEB			cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-HYPERTENSION; TRANSCRIPTION FACTOR; GROWTH; CREB; DIFFERENTIATION; ACTIVATION; PHOSPHORYLATION; EXPRESSION; PATHWAY	We hypothesized that cAMP response element-binding protein (CREB) could function as a molecular determinant of smooth muscle cell fate. In arterial sections from the systemic and pulmonary circulation, CREB content was high in proliferation-resistant medial subpopulations of smooth muscle cells and low in proliferation-prone regions. In vessels from neonatal calves exposed to chronic hypoxia, CREB content was depleted and smooth muscle cell (SMC) proliferation was accelerated. Induction of quiescence by serum deprivation in culture led to increased CREB content. Highly proliferative SMC in culture were observed to have low CREB content. Exposure to proliferative stimuli such as hypoxia or platelet-derived growth factor decreased SMC CREB content. Assessment of CREB gene transcription by nuclear run-on analysis and transcription from a CREB promoter-luciferase construct indicate that CREB levels in SMC are in part controlled at the level of transcription. Overexpression of wild type or constitutively active CREB in primary cultures of SMC arrested cell cycle progression. Additionally, expression of constitutively active CREB decreased both proliferation and chemokinesis. Consistent with these functional properties, active CREB decreased the expression of multiple cell cycle regulatory genes, as well as genes encoding growth factors, growth factor receptors, and cytokines. Our data suggest a unique mode of cellular phenotype determination at the level of the nuclear content of CREB.	Vet Affairs Med Ctr, Endocrinol Sect, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Metab & Diabet, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm & Crit Care, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pediat Crit Care & Dev Lung Biol, Denver, CO 80220 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Reusch, JEB (corresponding author), Vet Affairs Med Ctr, Endocrinol Sect, 111H,1055 Clermont St, Denver, CO 80220 USA.	jane.reusch@uchsc.edu	stenmark, kurt/AAH-3124-2022; stenmark, kurt/AFI-6776-2022	Reusch, Jane/0000-0001-8620-1003	NHLBI NIH HHS [HL56481, HL14985] Funding Source: Medline; NIDDK NIH HHS [DK53969, K08 DK02351] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002351, R01DK053969] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOTT KL, 2001, MOL CELL CARDIOL, V32, P391; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; DURMOWICZ AG, 1993, AM J PHYSIOL-HEART C, V34, pH2175; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Frid MG, 1999, ARTERIOSCL THROM VAS, V19, P2884, DOI 10.1161/01.ATV.19.12.2884; Frid MG, 1997, ARTERIOSCL THROM VAS, V17, P1203, DOI 10.1161/01.ATV.17.7.1203; FRID MG, 1994, CIRC RES, V75, P669, DOI 10.1161/01.RES.75.4.669; Frid MG, 1997, CIRC RES, V81, P940; HEASLEY LE, 1991, CELL REGUL, V2, P479, DOI 10.1091/mbc.2.6.479; Hoshiya M, 1998, HYPERTENSION, V31, P665, DOI 10.1161/01.HYP.31.2.665; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; IVENGAR R, 1996, SCIENCE, V271, P461; Keller JN, 1998, NEUROREPORT, V9, P3731, DOI 10.1097/00001756-199811160-00029; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Kreisberg JI, 1996, KIDNEY INT, V50, P805, DOI 10.1038/ki.1996.379; Li Y, 1997, NEUROPEPTIDES, V31, P503, DOI 10.1016/S0143-4179(97)90046-9; Mann MJ, 2000, J CLIN INVEST, V106, P1071, DOI 10.1172/JCI11459; Musa NL, 1999, AM J RESP CELL MOL, V20, P352, DOI 10.1165/ajrcmb.20.2.3160; OIKE Y, 1999, AM SOC HEMATOL, V9, P2771; Owens GK, 1996, J HYPERTENS, V14, pS55; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Pugazhenthi S, 1999, J BIOL CHEM, V274, P2829, DOI 10.1074/jbc.274.5.2829; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Shimomura A, 1998, J NEUROCHEM, V70, P1029; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; STENMARK KR, 1994, J CLIN INVEST, V93, P1234, DOI 10.1172/JCI117077; STENMARK KR, 1987, J APPL PHYSIOL, V62, P821, DOI 10.1152/jappl.1987.62.2.821; STENMARK KR, 1991, AM J PHYSIOL, V261, P97, DOI 10.1152/ajplung.1991.261.4.L97; Tabernero A, 1998, MOL CELL NEUROSCI, V10, P309, DOI 10.1006/mcne.1998.0662; Tintut Y, 1998, J BIOL CHEM, V273, P7547, DOI 10.1074/jbc.273.13.7547; Vadiveloo PK, 1997, ATHEROSCLEROSIS, V133, P61, DOI 10.1016/S0021-9150(97)00116-0; WHEAT WH, 1994, MOL CELL BIOL, V14, P5881, DOI 10.1128/MCB.14.9.5881; Yang XJ, 1996, J PHARMACOL EXP THER, V278, P338	38	119	120	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2001	276	49					46132	46141		10.1074/jbc.M104769200	http://dx.doi.org/10.1074/jbc.M104769200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499LR	11560924	hybrid			2022-12-27	WOS:000172573100088
J	Chang, WH; Pratt, S; Chen, TH; Bourguignon, L; Shoback, D				Chang, WH; Pratt, S; Chen, TH; Bourguignon, L; Shoback, D			Amino acids in the cytoplasmic C terminus of the parathyroid Ca2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTORS; XENOPUS-LAEVIS OOCYTES; CHAIN BINDING-PROTEIN; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; CLONING; HYPERCALCEMIA; AGONISTS; DOMAIN; TAIL	The C-terminal tail of the calcium receptor (CaR) regulates the affinity of the receptor for ligand, desensitization, and membrane localization. To determine the role of specific amino acids in the bovine parathyroid CaR in mediating signal transduction and cell-surface expression, we transfected truncated and mutated Call cDNAs into HEK-293 cells. The ability of high extracellular [Ca2+] ([Ca2+](o)) to increase total inositol phosphate (InsP) production, an index of phospholipase C (PLC) activation, was determined. Receptor expression was assessed by immunoblotting and immunocytochemistry. In cells transiently or stably expressing receptors with the C-terminal tail truncated after residue 895 (CaR-(1-895)) or 929 (CaR-(1-929)), raising [Ca2+](o) increased InsPs to levels comparable with those of cells expressing wild-type Calls. There were no PLC responses to high [Ca2+](o) (up to 30 mM) in cells expressing CaRs with C-terminal tails of only 3 residues (CaR-(1-866)), even though these receptors were expressed in the membrane. We scanned the residues between Ser(866) and Val(895) using tandem-Ala and single-site mutagenesis. Two point mutants (His(880) --> Ala and Phe(882) --> Ala CaR) showed 50-70% reductions in high [Ca2+](o)-induced InsP production. The levels of expression and glycosylation of these mutants were comparable with wild-type Calls, but both receptors were profoundly retained in intracellular organelles and co-localized with the endoplasmic reticulum marker BiP. This suggested that the signaling defects of these receptors were likely because of defective trafficking of receptors to the cell surface. Modeling of the C-terminal domain of the CaR indicated that His(880) and Phe(882) are situated in a putative alpha -helical structure of 15 amino acids between residues 877 and 891 in the C-terminal tail. Our studies support the idea that specific amino acids, and possibly a unique secondary structure in the C-terminal tail, are required for the efficient targeting of the CaR to the cell surface required for PLC activation.	Univ Calif San Francisco, Dept Med, Dept Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94121 USA	University of California System; University of California San Francisco	Shoback, D (corresponding author), Univ Calif San Francisco, Dept Med, Dept Vet Affairs Med Ctr, Endocrine Res Unit, 111N,4150 Clement St, San Francisco, CA 94121 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055846] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43400, DK55846] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai M, 1997, J CLIN INVEST, V99, P1917, DOI 10.1172/JCI119359; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; BOURGUIGNON LYW, 1993, J IMMUNOL, V151, P6634; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1998, METABOLIC BONE DIS, P479; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Carling T, 2000, J CLIN ENDOCR METAB, V85, P2042, DOI 10.1210/jc.85.5.2042; Chang W, 1999, MOL CELL ENDOCRINOL, V158, P13, DOI 10.1016/S0303-7207(99)00189-6; Chang WH, 1999, ENDOCRINOLOGY, V140, P1911, DOI 10.1210/en.140.4.1911; Chang WH, 1998, AM J PHYSIOL-ENDOC M, V275, pE213, DOI 10.1152/ajpendo.1998.275.2.E213; Chang WH, 2000, J BIOL CHEM, V275, P19955, DOI 10.1074/jbc.M909613199; Chang WH, 1998, J BONE MINER RES, V13, P570, DOI 10.1359/jbmr.1998.13.4.570; Chang YH, 1999, ENDOCRINOLOGY, V140, P5883, DOI 10.1210/en.140.12.5883; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Flor PJ, 1996, J NEUROCHEM, V67, P58; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; KASSENBROCK CK, 1988, NATURE, V333, P90, DOI 10.1038/333090a0; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LAUFFER L, 1985, NATURE, V318, P334, DOI 10.1038/318334a0; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SHOBACK DM, 1988, ENDOCRINOLOGY, V122, P2833, DOI 10.1210/endo-122-6-2833; Ye CP, 1996, BIOCHEM BIOPH RES CO, V224, P271, DOI 10.1006/bbrc.1996.1019	31	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					44129	44136		10.1074/jbc.M104834200	http://dx.doi.org/10.1074/jbc.M104834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11535593	hybrid			2022-12-27	WOS:000172297700083
J	Ching, TT; Lin, HP; Yang, CC; Oliveira, M; Lu, PJ; Chen, CS				Ching, TT; Lin, HP; Yang, CC; Oliveira, M; Lu, PJ; Chen, CS			Specific binding of the c-terminal src homology 2 domain of the p85 alpha subunit of phosphoinositide 3-kinase to phosphatidylinositol 3,4,5-trisphosphate - Localization and engineering of the phosphoinositide-binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; PH DOMAIN; PHOSPHOLIPASE-C; LIPID PRODUCTS; HIGH-AFFINITY; HUMAN PROFILIN; SH2 DOMAIN; 4,5-BISPHOSPHATE; IDENTIFICATION; ACTIVATION	Phosphoinositide second messengers, generated from the action of phosphoinositide 3-kinase (PI3K) mediate an array of signaling pathways through the membrane recruitment and activation of downstream effector proteins. Although pleckstrin domains of many target proteins have been shown to bind phosphatidylinositol 3,4,5-trisphosphate (PIP3) and/or phosphatidylinositol 3,4-bisphosphate (PI(3,4)P-2) with high affinity, published data concerning the phosphoinositide binding specificity of Src homology 2 (SH2) domains remain conflicting. Using three independent assays, we demonstrated that the C-terminal (CT-)SH2 domain, but not the N-terminal SH2 domain, on the PI3K p85 alpha subunit displayed discriminative affinity for PIP3. However, the binding affinity diminished precipitously when the acyl chain of PEP, was shortened. In addition, evidence suggests that the charge density on the phosphoinositol ring represents a key factor in determining the phosphoinositide binding specificity of the CT-SH2 domain. In light of the largely shared structural features between PIP3 and PI(4,5)P-2, we hypothesized that the PIP3-binding site on the CT-SH2 domain encompassed a sequence that recognized PI(4,5)P-2. Based on a consensus PI(4,5)P-2-binding sequence (KXXXXXKXKK; K denotes Arg, Lys, and His), we proposed the sequence (18)RNKAENLLRGKR(29) as the PIP3-binding site. This binding motif was verified by using a synthetic peptide and site-directed mutagenesis. More importantly, neutral substitution of flanking Arg(18) and Arg(29) resulted in a switch of ligand specificity of the CT-SH2 domain to PI(4,5)P-2 and PI(3,4)P-2, respectively. Together with computer modeling, these mutagenesis data suggest a pseudosymmetrical relationship in the recognition of the phosphoinositol head group at the binding motif.	Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA; Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan	Ohio State University; University of Kentucky; National Sun Yat Sen University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Pks Hall,Rm 336,500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu		Ching, Tsui-Ting/0000-0001-7650-1766	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053448] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53448] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lin KM, 1997, J BIOL CHEM, V272, P20443, DOI 10.1074/jbc.272.33.20443; Lo Surdo P, 1999, J BIOL CHEM, V274, P15678, DOI 10.1074/jbc.274.22.15678; Lu PJ, 1997, J BIOL CHEM, V272, P466; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; PANAYOTOU G, 1993, BIOESSAYS, V15, P171, DOI 10.1002/bies.950150305; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; SCHAFFHAUSEN B, 1995, BBA-REV CANCER, V1242, P61, DOI 10.1016/0304-419X(95)00004-Y; Siegal G, 1998, J MOL BIOL, V276, P461, DOI 10.1006/jmbi.1997.1562; SIMOES AP, 1995, BIOCHEMISTRY-US, V34, P5113, DOI 10.1021/bi00015a023; SOHN RH, 1995, J BIOL CHEM, V270, P21114, DOI 10.1074/jbc.270.36.21114; Steffen P, 2000, CELL MOTIL CYTOSKEL, V45, P58; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Van Troys M, 2000, BIOCHEMISTRY-US, V39, P12181, DOI 10.1021/bi000816c; Wang DS, 1998, J ORG CHEM, V63, P5430, DOI 10.1021/jo980356h; Wang DS, 1996, J ORG CHEM, V61, P5905, DOI 10.1021/jo960602u; YONEZAWA N, 1991, J BIOL CHEM, V266, P17218; YU FX, 1992, J BIOL CHEM, V267, P14616; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	38	16	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43932	43938		10.1074/jbc.M105159200	http://dx.doi.org/10.1074/jbc.M105159200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11555646	hybrid			2022-12-27	WOS:000172297700060
J	Whitney, KD; Watson, MA; Goodwin, B; Galardi, CM; Maglich, JM; Wilson, JG; Willson, TM; Collins, JL; Kliewer, SA				Whitney, KD; Watson, MA; Goodwin, B; Galardi, CM; Maglich, JM; Wilson, JG; Willson, TM; Collins, JL; Kliewer, SA			Liver X receptor (LXR) regulation of the LMR alpha gene in human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER-1; BILE-ACID BIOSYNTHESIS; TANGIER-DISEASE; NUCLEAR RECEPTOR; CHOLESTEROL EFFLUX; RESPONSE PATHWAY; PLASMA-MEMBRANE; ABC1 GENE; APOA-I; ACTIVATION	The nuclear oxysterol receptors LXR alpha (NR1H3) and LXR beta (NR1H2) coordinately regulate the expression of genes involved in the transport and catabolism of cholesterol. In macrophages, LXR stimulates the transcription of genes encoding transporters involved in cholesterol efflux, which may limit the transformation of these cells into foam cells in response to lipid loading. Here, we report that natural and synthetic LXR ligands induce the expression of the LXRa gene in primary human macrophages and differentiated THP-1 macrophages. This regulation was not observed in primary human adipocytes or hepatocytes, a human intestinal cell line, or in any mouse tissue or cell line examined. The human LXRa gene was isolated, and the transcription initiation site delineated. Analysis of the LXR alpha promoter revealed a functional LXR/RXR binding site similar to2.9 kb upstream of the transcription initiation site. We conclude that LXRa regulates its own expression in human macrophages and that this response is likely to amplify the effects of oxysterols on reverse cholesterol transport. These findings underscore the importance of LXR as a potential therapeutic target for the treatment of atherosclerosis.	GlaxoSmithKline, Res & Dev, Res Triangle Pk, NC USA	GlaxoSmithKline	Kliewer, SA (corresponding author), GlaxoSmithKline, Res & Dev, 5 Moore Dr, Res Triangle Pk, NC USA.		feinstein, doug/M-9414-2019					Alberti S, 2000, GENE, V243, P93, DOI 10.1016/S0378-1119(99)00555-7; Aouizerat BE, 1999, AM J HUM GENET, V65, P397, DOI 10.1086/302490; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CHIANG JYL, 1998, FRONT BIOSCI, V3, P176; Costet P, 2000, J BIOL CHEM, V275, P28240; Fayard E, 2001, CURR OPIN LIPIDOL, V12, P113, DOI 10.1097/00041433-200104000-00004; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Remaley AT, 1999, P NATL ACAD SCI USA, V96, P12685, DOI 10.1073/pnas.96.22.12685; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schachter M, 1997, INT J CARDIOL, V62, pS3, DOI 10.1016/S0167-5273(97)00235-0; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289	40	132	141	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43509	43515		10.1074/jbc.M106155200	http://dx.doi.org/10.1074/jbc.M106155200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11546778	hybrid			2022-12-27	WOS:000172297700006
J	Yague, J; Marina, A; Vazquez, J; de Castro, JAL				Yague, J; Marina, A; Vazquez, J; de Castro, JAL			Major histocompatibility complex class I molecules bind natural peptide ligands lacking the amino-terminal binding residue in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; VIRAL PEPTIDES; MHC; SPECIFICITY; STABILITY; HLA-B27; HLA; IMMUNOGENICITY; NOMENCLATURE; DISSOCIATION	Major histocompatibility complex (MHC) class I-peptide complexes are stabilized by multiple interactions, including those of the peptidic NH2-terminal group in the A pocket of the MHC molecule. In this study, the characterization of four natural HLA-1339 ligands lacking the amino-terminal binding residue is reported. These peptides were found in the endogenous peptide pool of one or more of the B*3901, B*3905, and B*3909 allotypes and sequenced by nanoelectrospray mass spectrometry. Control experiments ruled out that they resulted from exopeptidase trimming of their NH.-terminally extended counterparts: NAc-SHVAVENAL, EHGPNPIL, IHEPEPHIL, and EHAGVISVL, also present in the same peptide pools, during purification. HAGVISVL and HVAVENAL behaved similarly to the corresponding NH2-terminally extended peptides in their binding to B*3901 and B*3909 at the cell surface in vitro, and in cell surface stabilization of B*3901. This is, to our knowledge, the first demonstration that peptides lacking the amino-terminal binding residue bind in vivo to classical MHC class I molecules. The results indicate that canonical MHC-peptide interactions in the A pocket are not always necessary for endogenous peptide presentation.	Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cientificas, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cientificas, E-28049 Madrid, Spain.		Ramírez, Anabel Marina/ABG-7125-2021; Vazquez, Jesus/B-7697-2015	Ramírez, Anabel Marina/0000-0003-2927-6396; Vazquez, Jesus/0000-0003-1461-5092				Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BURSHTYN DN, 1993, J IMMUNOL, V151, P3082; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; FAHNESTOCK ML, 1994, BIOCHEMISTRY-US, V33, P8149, DOI 10.1021/bi00192a020; FALK K, 1995, IMMUNOGENETICS, V41, P162, DOI 10.1007/BF00182332; Galocha B, 1996, TISSUE ANTIGENS, V48, P509, DOI 10.1111/j.1399-0039.1996.tb02664.x; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Levitsky V, 1996, J EXP MED, V183, P915, DOI 10.1084/jem.183.3.915; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Marina A, 1999, J MASS SPECTROM, V34, P17, DOI 10.1002/(SICI)1096-9888(199901)34:1<17::AID-JMS746>3.3.CO;2-Y; Mitta M, 1996, DNA Res, V3, P31, DOI 10.1093/dnares/3.1.31; OJCIUS DM, 1993, J IMMUNOL, V151, P6020; Paradela A, 2000, J IMMUNOL, V164, P329, DOI 10.4049/jimmunol.164.1.329; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Scaloni A, 1999, J PROTEIN CHEM, V18, P349, DOI 10.1023/A:1021047730831; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TSUNASAWA S, 1975, J BIOCHEM, V77, P89; UTZ U, 1992, J IMMUNOL, V149, P214; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Yague J, 2000, TISSUE ANTIGENS, V56, P385, DOI 10.1034/j.1399-0039.2000.560501.x; Yague J, 2000, J EXP MED, V191, P2083, DOI 10.1084/jem.191.12.2083; Yague J, 1999, TISSUE ANTIGENS, V53, P227, DOI 10.1034/j.1399-0039.1999.530302.x; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	36	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2001	276	47					43699	43707		10.1074/jbc.M105981200	http://dx.doi.org/10.1074/jbc.M105981200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	494QQ	11557759	hybrid			2022-12-27	WOS:000172297700030
J	Jiang, YL; Kwon, K; Stivers, JT				Jiang, YL; Kwon, K; Stivers, JT			Turning on uracil-DNA glycosylase using a pyrene nucleotide switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BASE EXCISION; CATALYSIS; MECHANISM; 2-AMINOPURINE; PROCESSIVITY; FLUORESCENCE; REPLICATION; PYRIMIDINE; CYTOSINE	Base flipping is a highly conserved process by which enzymes swivel an entire nucleotide from the DNA base stack into their active site pockets. Uracil DNA glycosylase (UDG) is a paradigm enzyme that uses a base flipping mechanism to catalyze the hydrolysis of the N-glycosidic bond of 2'-deoxyuridine (2'-dUrd) in DNA as the first step in uracil base excision repair. Flipping of 2'-dUrd by UDG has been proposed to follow a "pushing" mechanism in which a completely conserved leucine side chain (Leu-191) is inserted into the DNA minor groove to expel the uracil. Here we report a novel implementation of the "chemical rescue" approach to show that the weak binding affinity and low catalytic activity of L191A or L191G can be completely or partially restored by substitution of a pyrene (Y) nucleotide wedge on the DNA strand opposite to the uracil base (U/A to U/Y). These results indicate that pyrene acts both as a wedge to push the uracil from the base stack in the free DNA and as a "plug" to hinder its reinsertion after base flipping. Pyrene rescue should serve as a useful and novel tool to diagnose the functional roles of other amino acid side chains involved in base flipping.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Stivers, JT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056834, GM46835] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT SE, 1995, BIOCHEMISTRY-US, V34, P6109, DOI 10.1021/bi00018a014; Cheng XD, 1996, STRUCTURE, V4, P639, DOI 10.1016/S0969-2126(96)00068-8; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Fasman G.D, 1975, HDB BIOCH MOL BIOL N, V1; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; HIGLEY M, 1993, MUTAT RES, V294, P109, DOI 10.1016/0921-8777(93)90019-D; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Jiang YL, 2001, BIOCHEMISTRY-US, V40, P7710, DOI 10.1021/bi010622c; JONES AS, 1963, J CHEM SOC, P3554, DOI 10.1039/jr9630003554; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Kool ET, 2000, ANGEW CHEM INT EDIT, V39, P990, DOI 10.1002/(SICI)1521-3773(20000317)39:6<990::AID-ANIE990>3.0.CO;2-0; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Law SM, 1996, BIOCHEMISTRY-US, V35, P12329, DOI 10.1021/bi9614545; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Matray TJ, 1998, J AM CHEM SOC, V120, P6191, DOI 10.1021/ja9803310; Matray TJ, 1999, NATURE, V399, P704, DOI 10.1038/21453; Morales JC, 1998, NAT STRUCT BIOL, V5, P950, DOI 10.1038/2925; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Ren RXF, 1996, J AM CHEM SOC, V118, P7671, DOI 10.1021/ja9612763; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SCHWEITZER BA, 1994, J ORG CHEM, V59, P7238, DOI 10.1021/jo00103a013; Stivers JT, 1998, NUCLEIC ACIDS RES, V26, P3837, DOI 10.1093/nar/26.16.3837; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Xiao GY, 1999, PROTEINS, V35, P13	32	63	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42347	42354		10.1074/jbc.M106594200	http://dx.doi.org/10.1074/jbc.M106594200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11551943	hybrid			2022-12-27	WOS:000172450400106
J	Kang, JS; Kim, SH; Hwang, MS; Han, SJ; Lee, YC; Kim, YJ				Kang, JS; Kim, SH; Hwang, MS; Han, SJ; Lee, YC; Kim, YJ			The structural and functional organization of the yeast mediator complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; REPEAT DOMAIN; HOLOENZYME; SIN4; BINDING; REQUIREMENT; REPRESSION; PROTEINS	The Mediator complex of Saccharomyces cerevisiae is required for diverse aspects of transcription by RNA polymerase II (pol II). Mediator is composed of two functionally distinct subcomplexes, Rgr1 and Srb4. To identify the structures and functions of each subcomplex, we expressed recombinant proteins for each subunit and assayed their interactions with each other and with basal transcription proteins. The Rgr1 subcomplex is composed of the Gal11 module, which binds activators, and the Med9/10 module. The Med9/10 module is required for both transcriptional activation and repression, and these activities appear to be carried out by two submodules. Proteins in the Med9 submodule interact physically and genetically with Srb10/11, suggesting that the Med9 submodule mediates the repression of pol II. Purified recombinant Srb4 subcomplex stimulated basal transcription of pol II but had little effect on activated transcription and phosphorylation of the C-terminal domain of the Rpb1 subunit of pol II. Both subcomplexes of Mediator interacted with a distinct set of basal transcription factors and pol II. The modular organization of Mediator and the associated functions suggest that the Mediator complex may recruit and/or stabilize the preinitiation complex through several points of contact with transcriptional regulators and basal transcription factors.	Yonsei Univ, Dept Biochem, Natl Creat Res Ctr Genome Regulat, Seodaemoon Ku, Seoul 120749, South Korea	Yonsei University	Kim, SH (corresponding author), Yonsei Univ, Dept Biochem, Natl Creat Res Ctr Genome Regulat, Seodaemoon Ku, 134 Shinchondong, Seoul 120749, South Korea.							Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Balciunas D, 1999, P NATL ACAD SCI USA, V96, P376, DOI 10.1073/pnas.96.2.376; Bjorklund S, 1996, TRENDS BIOCHEM SCI, V21, P335, DOI 10.1016/0968-0004(96)10051-7; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; COVITZ PA, 1994, GENETICS, V138, P577; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Han SJ, 1999, MOL CELL BIOL, V19, P979; Han SJ, 2001, J BIOL CHEM, V276, P37020, DOI 10.1074/jbc.M105596200; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; JIANG YW, 1992, MOL CELL BIOL, V12, P4503, DOI 10.1128/MCB.12.10.4503; JIANG YW, 1995, GENETICS, V140, P47; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Lee YC, 1997, MOL CELL BIOL, V17, P4622, DOI 10.1128/MCB.17.8.4622; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NONET ML, 1989, GENETICS, V123, P715; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Song WJ, 1996, MOL CELL BIOL, V16, P115; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zaman Z, 2001, P NATL ACAD SCI USA, V98, P2550, DOI 10.1073/pnas.041611198	37	116	134	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42003	42010		10.1074/jbc.M105961200	http://dx.doi.org/10.1074/jbc.M105961200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11555651	hybrid			2022-12-27	WOS:000172450400063
J	Nittis, T; George, GN; Winge, DR				Nittis, T; George, GN; Winge, DR			Yeast Sco1, a protein essential for cytochrome c oxidase function is a Cu(I)-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; COPPER-METABOLISM; GENE; PURIFICATION; EXPRESSION; IDENTIFICATION; COORDINATION; ACCUMULATION; DEFICIENCY; CRYSTAL	Sco1 is a conserved essential protein, which has been implicated in the delivery of copper to cytochrome c oxidase, the last enzyme of the electron transport chain. In this study, we show for the first time that the purified C-terminal domain of yeast Sco1 binds one Cu(I)/monomer. X-ray absorption spectroscopy suggests that the Cu(I) is ligated via three ligands, and we show that two cysteines, present in a conserved motif CXXXC, and a conserved histidine are involved in Cu(I) ligation. The mutation of any one of the conserved residues in Sco1 expressed in yeast abrogates the function of Sco1 resulting in a non-functional cytochrome c oxidase complex. Thus, the function of Sco1 correlates with Cu(I) binding. Data obtained from size-exclusion chromatography experiments with mitochondrial lysates suggest that full-length Sco1 may be oligomeric in vivo.	Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Winge, Dennis/G-3611-2010; George, Graham N/E-3290-2013	George, Graham/0000-0002-0420-7493	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES 03817] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bonnefoy N, 2000, MOL GEN GENET, V262, P1036, DOI 10.1007/PL00008646; Brachmann CB, 1998, YEAST, V14, P115; BUCHWALD P, 1991, MOL GEN GENET, V229, P413, DOI 10.1007/BF00267464; CAMERON VL, 1989, J BIOL CHEM, V264, P13391; DANCE IG, 1983, POLYHEDRON, V2, P1031, DOI 10.1016/S0277-5387(00)81450-3; GarciaVasquez JA, 1997, INORG CHIM ACTA, V260, P221, DOI 10.1016/S0020-1693(96)05555-7; GEIER BM, 1995, EUR J BIOCHEM, V227, P296, DOI 10.1111/j.1432-1033.1995.tb20388.x; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; Iwata S, 1998, J BIOCHEM-TOKYO, V123, P369; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; KOCH SA, 1984, INORG CHEM, V23, P121, DOI 10.1021/ic00170a001; KRUMMECK G, 1990, CURR GENET, V18, P13, DOI 10.1007/BF00321109; Lode A, 2000, FEBS LETT, V485, P19, DOI 10.1016/S0014-5793(00)02176-1; MAIRE ML, 2000, BIOCHIM BIOPHYS ACTA, V1509, P86; Mattatall NR, 2000, J BIOL CHEM, V275, P28802, DOI 10.1074/jbc.M002741200; Musatov A, 2000, BIOCHEMISTRY-US, V39, P12996, DOI 10.1021/bi000884z; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NITTIS T, 2001, MICROBIAL TRANSPORT, P419; Papadopoulou LC, 1999, NAT GENET, V23, P333; Paret C, 1999, FEBS LETT, V447, P65, DOI 10.1016/S0014-5793(99)00266-5; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Poyton RO, 1995, METHOD ENZYMOL, V260, P97, DOI 10.1016/0076-6879(95)60133-3; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; RAMAPRABHU S, 1994, Z NATURFORSCH A, V49, P193; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; Rentzsch A, 1999, CURR GENET, V35, P103, DOI 10.1007/s002940050438; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHULZE M, 1988, MOL GEN GENET, V211, P492, DOI 10.1007/BF00425706; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SPENO H, 1995, J BIOL CHEM, V270, P25363, DOI 10.1074/jbc.270.43.25363; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Valnot I, 2000, AM J HUM GENET, V67, P1104; [No title captured]	45	155	157	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42520	42526		10.1074/jbc.M107077200	http://dx.doi.org/10.1074/jbc.M107077200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546815	hybrid			2022-12-27	WOS:000172450400126
J	Li, SL; Jedrzejas, MJ				Li, SL; Jedrzejas, MJ			Hyaluronan binding and degradation by Streptococcus agalactiae hyaluronate lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; ACTION PATTERN; PNEUMONIAE; RESOLUTION; EXPRESSION; GENE; SPECIFICITY; ASSOCIATION; INFECTIONS; VIRULENCE	Streptococcus agalactiae hyaluronate lyase is a virulence factor that helps this pathogen to break through the biophysical barrier of the host tissues by the enzymatic degradation of hyaluronan and certain chondroitin sulfates at beta -1,4 glycosidic linkages. Crystal structures of the native enzyme and the enzyme-product complex were determined at 2.1- and 2.2-Angstrom resolutions, respectively. An elongated cleft transversing the middle of the molecule has been identified as the substrate-binding place. Two product molecules of hyaluronan degradation were observed bound to the cleft. The enzyme catalytic site was identified to comprise three residues: His(479), Tyr(488), and Asn(429). The highly positively charged cleft facilitates the binding of the negatively charged polymeric substrate chain. The matching between the aromatic patch of the enzyme and the hydrophobic patch of the substrate chain anchors the substrate chain into degradation position. A pair of proton exchanges between the enzyme and the substrate results in the cleavage of the beta -1,4 glycosidic linkage of the substrate chain and the unsaturation of the product. Phe(423) likely determines the size of the product at the product release side of the catalytic region. Hyaluronan chain is processively degraded from the reducing end toward the nonreducing end. The unsulfated or 6-sulfated regions of chondroitin sulfate can also be degraded in the same manner as hyaluronan.	Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Jedrzejas, MJ (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	mjedrzejas@chori.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044079] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 44079] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAKER CJ, 1988, ANN NY ACAD SCI, V549, P193, DOI 10.1111/j.1749-6632.1988.tb23972.x; Baker JR, 2000, BIOCHEM J, V348, P465, DOI 10.1042/0264-6021:3480465; Baker JR, 1997, BIOCHEM J, V327, P65, DOI 10.1042/bj3270065; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BLANCHET C, 1998, MULTIPLE PROTEIN SEQ; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DILLON HC, 1987, J PEDIATR-US, V110, P31, DOI 10.1016/S0022-3476(87)80283-4; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Jedrzejas MJ, 1998, PROTEIN EXPRES PURIF, V13, P83, DOI 10.1006/prep.1997.0864; Jedrzejas MJ, 2000, ACTA CRYSTALLOGR D, V56, P460, DOI 10.1107/S0907444900000706; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurent T. C. E., 1998, CHEM BIOL MED APPL H; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P15125, DOI 10.1074/jbc.M011102200; LIN B, 1994, J BIOL CHEM, V269, P30113; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; LINKER A, 1956, J BIOL CHEM, V219, P13; MARKOVITZ A, 1959, J BIOL CHEM, V234, P2343; McCourt PAG, 1999, MATRIX BIOL, V18, P427, DOI 10.1016/S0945-053X(99)00045-1; MILLIGAN TW, 1978, INFECT IMMUN, V21, P738, DOI 10.1128/IAI.21.3.738-746.1978; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park Y, 1997, BBA-PROTEIN STRUCT M, V1337, P217, DOI 10.1016/S0167-4838(96)00167-7; Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817; PRICHARD DG, 2000, PROTEINS, V40, P126; QUIOCHO FA, 1999, BIOORGANIC CHEM CARB, P441; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; Ruijssenaars HJ, 1999, APPL ENVIRON MICROB, V65, P2446; Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850; SHIMADA E, 1980, J BIOCHEM-TOKYO, V88, P1015, DOI 10.1093/oxfordjournals.jbchem.a133052; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	43	76	80	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41407	41416		10.1074/jbc.M106634200	http://dx.doi.org/10.1074/jbc.M106634200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11527972	hybrid			2022-12-27	WOS:000171925600137
J	Prowse, CN; Deal, MS; Lew, J				Prowse, CN; Deal, MS; Lew, J			The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; STRUCTURAL BASIS; PHOSPHORYLATION; SUBSTRATE; MECHANISM; BINDING	The mitogen-activated protein (MAP) kinase ERK2 is an essential signal transduction molecule that mediates extracellular signaling by all polypeptide growth factors. Full activation of ERK2 requires phosphorylation at both a threonine residue (Thr(183)) conserved in most protein kinases as well as a tyrosine residue (Tyr(185)) unique to members of the mitogen-activated protein kinase family. We have characterized the kinetic role of phosphorylation at each site with respect to the overall activation mechanism, providing a complete picture of the reaction steps involved. Phosphorylation at Tyr(185) serves to configure the ATP binding site, while phosphorylation at both residues is required to stabilize binding of the protein substrate, myelin basic protein. Similar control mechanisms are employed to stabilize ATP and myelin basic protein in the phosphoryl group transfer reaction, accounting for the enormous increase in turnover rate. The mechanism of ERK2 activation is kinetically similar to that of the cell cycle control protein, cdk2/cyclinA. Phosphorylation of Tyr(185) in ERK2 and association of cyclinA with cdk2 both serve to stabilize ATP binding. Subsequent phosphorylation of both enzymes on threonine serves to stabilize binding of the phosphoacceptor substrate.	Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Program Biomed Sci & Engn, Santa Barbara, CA 93106 USA	University of California System; University of California San Diego; University of California System; University of California Santa Barbara	Lew, J (corresponding author), Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA.	lew@lifesci.ucsb.edu						BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P683; BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Fersht A., 1999, STRUCTURE MECH PROTE, P349; Hagopian JC, 2001, J BIOL CHEM, V276, P275, DOI 10.1074/jbc.M007337200; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lew J, 1997, J BIOL CHEM, V272, P1507, DOI 10.1074/jbc.272.3.1507; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; NAKATANI H, 1979, J PHYS CHEM-US, V83, P2662, DOI 10.1021/j100483a023; Prowse CN, 2000, BIOCHEMISTRY-US, V39, P6258, DOI 10.1021/bi000277b; Prowse CN, 2001, J BIOL CHEM, V276, P99, DOI 10.1074/jbc.M008137200; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; TAYLOR SS, 1990, PEPT PROT PHOSPH, P1; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	26	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40817	40823		10.1074/jbc.M105860200	http://dx.doi.org/10.1074/jbc.M105860200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11524422	hybrid			2022-12-27	WOS:000171925600060
J	Rivera-Walsh, I; Waterfield, M; Xiao, GT; Fong, A; Sun, SC				Rivera-Walsh, I; Waterfield, M; Xiao, GT; Fong, A; Sun, SC			NF-kappa B signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I tax-induced T-cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I; ACTIVATION; LIGAND; APOPTOSIS; KINASE; LYMPHOCYTES; RETROVIRUS; IMMORTALIZATION; INVOLVEMENT; INDUCTION	The Tax oncoprotein encoded by human T-cell leukemia virus induces both T-cell activation and apoptosis. The mechanism by which Tax induces apoptosis has remained unclear. Using genetically manipulated T-cell lines, we demonstrate that Tax-induced T-cell death is dependent on NF-kappaB signaling. Tax fails to induce apoptosis in T cells lacking I kappaB kinase gamma (IKK gamma), an essential component of the NF-kappaB signaling pathway. This defect was rescued when the mutant cells were reconstituted with exogenous IKK gamma. We further demonstrate that the Tax-induced T-cell death is mediated by TNF (tumor necrosis factor)-related apoptosis-inducing ligand (TRAIL), because this event can be effectively inhibited by a TRAIL-blocking antibody. Consistent with this functional aspect, Tax stimulates the expression of TRAIL mRNA. Finally, we provide genetic evidence demonstrating that the NF-kappaB signaling pathway is essential for TRAIL gene induction by both Tax and T-cell activation signals. These studies reveal a novel function of the NF-kappaB signaling pathway and suggest a key mechanism by which Tax induces T-cell death.	Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sun, SC (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, 500 Univ Dr, Hershey, PA 17033 USA.	sxs70@psu.edu			NATIONAL CANCER INSTITUTE [R01CA068471] Funding Source: NIH RePORTER; NCI NIH HHS [2 R01 CA68471] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551; Chen XL, 1997, J GEN VIROL, V78, P3277, DOI 10.1099/0022-1317-78-12-3277; Chlichlia K, 1997, ONCOGENE, V14, P2265, DOI 10.1038/sj.onc.1201070; CHLICHLIA K, 1995, ONCOGENE, V10, P269; FEUER G, 1992, BIOCHIM BIOPHYS ACTA, V1114, P223, DOI 10.1016/0304-419X(92)90017-S; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Gilmore TD, 1996, ONCOGENE, V13, P1367; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GRILLI M, 1993, INT REV CYTOL, V143, P1; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Los M, 1998, J IMMUNOL, V161, P3050; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Orlinick JR, 1998, CELL SIGNAL, V10, P543, DOI 10.1016/S0898-6568(98)00018-7; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Ressler S, 1996, FEMS MICROBIOL LETT, V140, P99, DOI 10.1016/0378-1097(96)00166-8; Rivera I, 1998, J BIOL CHEM, V273, P22382, DOI 10.1074/jbc.273.35.22382; Rivera-Walsh I, 2000, J BIOL CHEM, V275, P25222, DOI 10.1074/jbc.M000444200; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rudolph D, 2000, GENE DEV, V14, P854; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; Sharma S, 1996, P NATL ACAD SCI USA, V93, P11842, DOI 10.1073/pnas.93.21.11842; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; STENNICKE HR, 2000, BIOCHIM BIOPHYS ACTA, V477, P299; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	36	79	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					40385	40388		10.1074/jbc.C100501200	http://dx.doi.org/10.1074/jbc.C100501200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11553609	hybrid			2022-12-27	WOS:000171925600005
J	Wang, CW; Liao, JC				Wang, CW; Liao, JC			Alteration of product specificity of Rhodobacter sphaeroides phytoene desaturase by directed evolution.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS GENE-CLUSTER; ESCHERICHIA-COLI; CAROTENOID BIOSYNTHESIS; MOLECULAR EVOLUTION; FUNCTIONAL-ANALYSIS; PATHWAY; PROTEIN; LEVEL	Phytoene desaturases occurring in nature convert phytoene to either neurosporene or lycopene in most eubacteria. Approximately 10% of known phytoene desaturases, as in Rhodobacter, produce neurosporene, whereas the rest produce lycopene. These two types of enzymes, although similar in function, have relatively low similarity (below 60%) in terms of nucleotide or amino acid sequence. The mechanism controlling the product specificity of these enzymes is unclear. Here we used directed evolution to change the product of Rhodobacter sphaeroides phytoene desaturase (crtI gene product), a neurosporene-producing enzyme, to lycopene. Two generations of random mutagenesis were performed, from which three positive mutants were isolated and sequenced. We then used site-directed mutagenesis to determine the effect of each amino acid change. Gathering information from random mutagenesis, we further recombined the beneficial mutations by site-directed mutagenesis and increased the percent of lycopene production to 90%.	Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem Engn, 5531 Boelter Hall, Los Angeles, CA 90095 USA.			Liao, James/0000-0002-4580-7276				Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Garcia-Asua G, 1998, TRENDS PLANT SCI, V3, P445, DOI 10.1016/S1360-1385(98)01329-6; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767; LANG HP, 1994, J BACTERIOL, V176, P3859, DOI 10.1128/JB.176.13.3859-3869.1994; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; May O, 2000, NAT BIOTECHNOL, V18, P317, DOI 10.1038/73773; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Patten PA, 1997, CURR OPIN BIOTECH, V8, P724, DOI 10.1016/S0958-1669(97)80127-9; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Wang CW, 2000, BIOTECHNOL PROGR, V16, P922, DOI 10.1021/bp000124f; Wang CW, 1999, BIOTECHNOL BIOENG, V62, P235, DOI 10.1002/(SICI)1097-0290(19990120)62:2<235::AID-BIT14>3.0.CO;2-U	20	31	43	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41161	41164		10.1074/jbc.M105786200	http://dx.doi.org/10.1074/jbc.M105786200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11526111	hybrid			2022-12-27	WOS:000171925600105
J	Leduc, J; Thorsteinsson, MV; Gaal, T; Roberts, GP				Leduc, J; Thorsteinsson, MV; Gaal, T; Roberts, GP			Mapping CooA center dot RNA polymerase interactions - Identification of activating regions 2 and 3 in CooA, the co-sensing transcriptional activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; AMP RECEPTOR PROTEIN; IRON-SULFUR PROTEIN; RHODOSPIRILLUM-RUBRUM; TERMINAL DOMAIN; CONTACT SITE; HISTIDINE 77; HEME; FNR; HYDROGENASE	CooA is a CO-sensing protein that activates the transcription of genes encoding the CO-oxidation (coo) regulon, whose polypeptide products are required for utilizing CO as an energy source in Rhodospirillum rubrum. CooA binds to a position overlapping the -35 element of the P-cooF promoter, similar to the arrangement of class II CRP (cAMP receptor protein)- and FNR (fumarate and nitrate reductase activator protein)-dependent promoters when expressed in Escherichia coli. Gain-of-function CooA variants were isolated in E. coli following mutagenesis of the portion of cooA encoding the effector-binding domain. Some of the mutations affect regions of CooA that are homologous to the activating regions (AR2 and AR3) previously identified in CRP and FNR, whereas others affect residues that lie in a region of CooA between AR2 and ARS. These CooA variants are comparable to wild-type (WT) CooA in DNA binding affinity in response to CO but differ in transcription activation, presumably because of altered interactions with E. coli RNA polymerase. Based on predictions of similarity to CRP and FNR, loss-of-function CooA variants were obtained in the AR2 and AR3 regions that have minimal transcriptional activity, yet have WT-like DNA binding affinities in response to CO. This study demonstrates that WT CooA contains AR2- and AR3-like surfaces that are required for optimal transcription activation.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Roberts, GP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	groberts@bact.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053228] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 53228] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aono S, 1999, COORDIN CHEM REV, V190, P267, DOI 10.1016/S0010-8545(99)00070-3; Ausubel F. M., 1995, SHORT PROTOCOLS MOL, P21; BELL A, 1994, MOL MICROBIOL, V11, P383, DOI 10.1111/j.1365-2958.1994.tb00318.x; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BONAM D, 1987, J BIOL CHEM, V262, P2980; BONAM D, 1989, J BACTERIOL, V171, P3102, DOI 10.1128/jb.171.6.3102-3107.1989; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; DEDUVE C, 1948, ACTA CHEM SCAND, V2, P264, DOI 10.3891/acta.chem.scand.02-0264; ENSIGN SA, 1991, J BIOL CHEM, V266, P18395; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; He YP, 1999, J BIOL CHEM, V274, P10840, DOI 10.1074/jbc.274.16.10840; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Lamberg KE, 2000, MOL MICROBIOL, V38, P817, DOI 10.1046/j.1365-2958.2000.02172.x; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Li B, 1998, NUCLEIC ACIDS RES, V26, P2075, DOI 10.1093/nar/26.9.2075; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Rhodius VA, 2000, J MOL BIOL, V299, P295, DOI 10.1006/jmbi.2000.3736; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; SPIRO S, 1994, ANTON LEEUW INT J G, V66, P23, DOI 10.1007/BF00871630; Thorsteinsson MV, 2000, BIOCHEMISTRY-US, V39, P8284, DOI 10.1021/bi000327c; Thorsteinsson MV, 2000, J BIOL CHEM, V275, P39332, DOI 10.1074/jbc.M007691200; Uchida T, 2000, BIOCHEMISTRY-US, V39, P12747, DOI 10.1021/bi0011476; VOGEL AM, 1994, MOL MICROBIOL, V12, P811, DOI 10.1111/j.1365-2958.1994.tb01067.x; WILLIAMS R, 1991, NUCLEIC ACIDS RES, V19, P6705, DOI 10.1093/nar/19.24.6705; Williams SM, 1997, NUCLEIC ACIDS RES, V25, P4028, DOI 10.1093/nar/25.20.4028	33	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39968	39973		10.1074/jbc.M105758200	http://dx.doi.org/10.1074/jbc.M105758200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11522788	hybrid			2022-12-27	WOS:000171789200063
J	Xing, BD; Jedsadayanmata, A; Lam, SCT				Xing, BD; Jedsadayanmata, A; Lam, SCT			Localization of an integrin binding site to the C terminus of talin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; PLATELET CYTOSKELETON; CELL-ADHESION; MONOCLONAL-ANTIBODIES; BETA(3) SUBUNIT; LIGAND-BINDING; ALPHA-ACTININ; GPIIB-IIIA; PROTEIN; MEMBRANE	Talin, consisting of a 47-kDa N-terminal head domain (residues 1-433) and a 190-kDa C-terminal rod domain (residues 434-2541), links integrins to the actin cytoskeleton. We previously reported that the binding stoichiometry of integrin alpha (IIb)beta (3):talin is similar to2:1. More recently, an integrin binding site has been localized to the talin head domain. In the present study, we identified another integrin binding site at the C-terminal region of the talin rod domain. In a solid phase binding assay, RGD affinity-purified alpha (IIb)beta (3) bound in a dose-dependent manner to microtiter wells coated with the isolated 190-kDa proteolytic fragment of the talin rod domain. Additionally, alpha (IIb)beta (3) also bound to the talin rod domain captured by 8d4, an anti-talin monoclonal antibody. Polyclonal antibodies raised against a recombinant protein fragment corresponding to the entire talin rod domain (anti-talin-R) inhibited alpha (IIb)beta (3) binding to intact talin by similar to 50% but completely blocked alpha (IIb)beta (3) binding to the talin rod domain. To localize the integrin binding site, we examined alpha (IIb)beta (3) binding to recombinant polypeptide fragments corresponding to partial sequences of the talin rod domain. Whereas alpha (IIb)beta (3) bound effectively to talin(1075-2541.) and talin-(1984-2541), it failed to bind to talin-(434-1076) and talin-(434-1975). Furthermore, the binding of alpha (IIb)beta (3) to talin-(1984-2541) was inhibited by anti-talin-R. These results indicate that an integrin binding site is located within residues 1984-2541 of the talin rod domain. Thus, talin contains two integrin binding sites, one in the homologous FERM (band (f) under bar our-point-one, (e) under bar zrin, (r) under bar adixin, (m) under bar oesin) domain and another near its C terminus. Because talin exists as an anti-parallel homodimer in focal adhesions, the two integrin binding sites in the adjacent talin molecules would be in close proximity with each other.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lam, SCT (corresponding author), Univ Illinois, Dept Pharmacol M C 868, 835 S Wolcott Ave, Chicago, IL 60612 USA.		Jedsadayanmata, Arom/AAR-9251-2021	Jedsadayanmata, Arom/0000-0002-5776-1439	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL041793, R01HL041793] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41793] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301; Bolton SJ, 1997, CELL MOTIL CYTOSKEL, V36, P363; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; COLLIER NC, 1982, J BIOL CHEM, V257, P6937; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; GOLDMANN WH, 1994, J STRUCT BIOL, V112, P3, DOI 10.1006/jsbi.1994.1002; Goldmann WH, 2000, BIOCHEM BIOPH RES CO, V271, P553, DOI 10.1006/bbrc.2000.2653; Hemmings L, 1996, J CELL SCI, V109, P2715; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ISENBERG WM, 1987, J CELL BIOL, V104, P1655, DOI 10.1083/jcb.104.6.1655; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MOLONY L, 1987, J BIOL CHEM, V262, P7790; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; NEWMAN PJ, 1985, BLOOD, V65, P227; NUCKOLLS GH, 1992, J CELL SCI, V102, P753; NUCKOLLS GH, 1990, J CELL BIOL, V110, P1635, DOI 10.1083/jcb.110.5.1635; OTEY C, 1990, HYBRIDOMA, V9, P57, DOI 10.1089/hyb.1990.9.57; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Reddy KB, 1998, J BIOL CHEM, V273, P35039, DOI 10.1074/jbc.273.52.35039; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; TAPLEY P, 1989, ONCOGENE, V4, P325; TURNER CE, 1989, EUR J CELL BIOL, V49, P202; TUSZYNSKI GP, 1984, J BIOL CHEM, V259, P5247; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; YLANNE J, 1995, J BIOL CHEM, V270, P9550	46	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 30	2001	276	48					44373	44378		10.1074/jbc.M108587200	http://dx.doi.org/10.1074/jbc.M108587200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496QD	11555663	hybrid			2022-12-27	WOS:000172406700004
J	Buttner, C; Sadtler, S; Leyendecker, A; Laube, B; Griffon, N; Betz, H; Schmalzing, G				Buttner, C; Sadtler, S; Leyendecker, A; Laube, B; Griffon, N; Betz, H; Schmalzing, G			Ubiquitination precedes internalization and proteolytic cleavage of plasma membrane-bound glycine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; GATED ION CHANNELS; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; SPINAL-CORD; NEUROTRANSMITTER RECEPTORS; POSTSYNAPTIC CHANGES; SYNAPTIC PLASTICITY; AMPA RECEPTORS; BETA-SUBUNIT	The inhibitory glycine receptor (GlyR) in developing spinal neurones is internalized efficiently upon antagonist inhibition. Here we used surface labeling combined with affinity purification to show that homopentameric alpha1 GlyRs generated in Xenopus oocytes are proteolytically nicked into fragments of 35 and 13 kDa upon prolonged incubation. Nicked GlyRs do not exist at the cell surface, indicating that proteolysis occurs exclusively in the endocytotic pathway. Consistent with this interpretation, elevation of the lysosomal pH, but not the proteasome inhibitor lactacystin, prevents GlyR cleavage. Prior to internalization, al GlyRs are conjugated extensively with ubiquitin in the plasma membrane. Our results are consistent with ubiquitination regulating the endocytosis and subsequent proteolysis of GlyRs residing in the plasma membrane. Ubiquitin-conjugating enzymes thus may have a crucial role in synaptic plasticity by determining postsynaptic receptor numbers.	Univ Frankfurt, Bioctr, Dept Pharmacol, D-60439 Frankfurt, Germany; Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society	Schmalzing, G (corresponding author), Rhein Westfal TH Aachen, Dept Mol Pharmacol, Wendlingweg 2, D-52074 Aachen, Germany.							Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; AKAGI H, 1991, FEBS LETT, V281, P160, DOI 10.1016/0014-5793(91)80383-E; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; de Stefano ME, 1998, J NEUROPATH EXP NEUR, V57, P1000, DOI 10.1097/00005072-199811000-00002; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Hackam AS, 1997, NEUROREPORT, V8, P1425, DOI 10.1097/00001756-199704140-00020; Harvey RJ, 2000, HANDB EXP PHARM, V147, P479; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HUGANIR RL, 1980, J SUPRAMOL STR CELL, V14, P13, DOI 10.1002/jss.400140103; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Levi S, 1998, J CELL SCI, V111, P335; LINDSTROM J, 1980, BIOCHEMISTRY-US, V19, P4791, DOI 10.1021/bi00562a012; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Missias AC, 1997, DEVELOPMENT, V124, P5075; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; PUMPLIN DW, 1982, ANNU REV PHYSIOL, V44, P319, DOI 10.1146/annurev.ph.44.030182.001535; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMALZING G, 1991, BIOCHEM J, V279, P829; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SEGLEN PO, 1980, MOL PHARMACOL, V18, P468; SERDAROGLU P, 1992, NEUROPATH APPL NEURO, V18, P232, DOI 10.1111/j.1365-2990.1992.tb00785.x; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Strous GJ, 1999, J CELL SCI, V112, P1417; Strous GJ, 1997, J BIOL CHEM, V272, P40; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; WOO JT, 1992, EUR J BIOCHEM, V207, P383, DOI 10.1111/j.1432-1033.1992.tb17061.x; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xu RF, 1999, J CELL PHYSIOL, V181, P107, DOI 10.1002/(SICI)1097-4652(199910)181:1<107::AID-JCP11>3.3.CO;2-0; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	65	72	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42978	42985		10.1074/jbc.M102121200	http://dx.doi.org/10.1074/jbc.M102121200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11560918	hybrid			2022-12-27	WOS:000172169300047
J	Jiang, JH; Ballinger, CA; Wu, YX; Dai, Q; Cyr, DM; Hohfeld, J; Patterson, C				Jiang, JH; Ballinger, CA; Wu, YX; Dai, Q; Cyr, DM; Hohfeld, J; Patterson, C			CHIP is a U-box-dependent E3 ubiquitin ligase - Identification of Hsc70 as a target for ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; PROTEIN; DEGRADATION; MUTANT; HSP70; LINK	Proper folding of proteins (either newly synthesized or damaged in response to a stressful event) occurs in a highly regulated fashion. Cytosolic chaperones such as Hsc/Hsp70 are assisted by cofactors that modulate the folding machinery in a positive or negative manner. CHIP (carboxyl terminus of Hsc70-interacting protein) is such a cofactor that interacts with Hsc70 and, in general, attenuates its most well characterized functions. In addition, CHIP accelerates ubiquitin-dependent degradation of chaperone substrates. Using an in vitro ubiquitylation assay with recombinant proteins, we demonstrate that CHIP possesses intrinsic E3 ubiquitin ligase activity an promotes ubiquitylation. This activity is dependent on the carboxyl-terminal U-box. CHIP interacts functionally and physically with the stress-responsive ubiquitin-conjugating enzyme family UBCH5. Surprisingly, a major target of the ubiquitin ligase activity of CHIP is Hsc70 itself. CHIP ubiquitylates Hsc70, primarily with short, noncanonical multiubiquitin chains but has no appreciable effect on steady-state levels or half-life of this protein. This effect may have heretofore unanticipated consequences with regard to the chaperoning activities of Hsc70 or its ability to deliver substrates to the proteasome. These studies demonstrate that CHIP is a bona fide ubiquitin ligase and indicate that U-box-containing proteins may comprise a new family of E3s.	Univ N Carolina, Div Cardiol, Program Mol Cardiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Sealy Ctr Mol Cardiol, Galveston, TX 77550 USA; Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Bonn	Patterson, C (corresponding author), Univ N Carolina, Div Cardiol, Program Mol Cardiol, 324 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.	epatters@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065619, K08HL003658, R01HL065619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM061728] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL03658, HL65619] Funding Source: Medline; NIGMS NIH HHS [GM56981, GM61728, R01 GM056981] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; PICKART CM, 1988, J BIOL CHEM, V263, P12028; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Pukatzki S, 1998, J BIOL CHEM, V273, P24131, DOI 10.1074/jbc.273.37.24131; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Smith DF, 1998, PHARMACOL REV, V50, P493; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	38	453	477	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42938	42944		10.1074/jbc.M101968200	http://dx.doi.org/10.1074/jbc.M101968200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11557750	hybrid			2022-12-27	WOS:000172169300042
J	Miller, KA; Eklund, EA; Peddinghaus, ML; Cao, ZJ; Fernandes, N; Turk, PW; Thimmapaya, B; Weitzman, SA				Miller, KA; Eklund, EA; Peddinghaus, ML; Cao, ZJ; Fernandes, N; Turk, PW; Thimmapaya, B; Weitzman, SA			Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; BOX-BINDING PROTEIN; PROMOTER ACTIVITY; ERYTHROID-CELLS; FACTOR GENE; IDENTIFICATION; BREAST; GROWTH; CDNA; TRANSCRIPTION	Laminin-5, the major extracellular matrix protein produced by mammary epithelial cells, is composed of three chains (designated alpha 3A, beta3, and gamma2), each encoded by a separate gene. Laminin-5 is markedly down-regulated in breast cancer cells. Little is known about the regulation of laminin gene transcription in normal breast cells, nor about the mechanism underlying the down-regulation seen in cancer. In the present study, we cloned the promoter of the gene for the human laminin alpha 3A chain (LAMA3A) and investigated its regulation in functionally normal MCF10A breast epithelial cells and several breast cancer cell lines. Using site-directed mutagenesis of promoter-reporter constructs in transient transfection assays in MCF10A cells, we find that two binding sites for Kruppel-like factor 4 (KLF4/GKLF/EZF) are required for expression driven by the LAMA3A promoter. Electrophoretic mobility shift assays reveal absence of KLF4 binding activity in extracts from T47D, MDA-MB 231, ZR75-1, MDA-MB 436, and MCF7 breast cancer cells. Transient transfection of a plasmid expressing KLF4 activates transcription from the LAMA3A promoter in breast cancer cells. A reporter vector containing duplicate KLF4-binding sites in its promoter is expressed at high levels in MCF10A cells but at negligible levels in breast cancer cells. Thus, KLF4 is required for LAMA3A expression and absence of laminin alpha 3A in breast cancer cells appears, at least in part, attributable to the lack of KLF4 activity.	Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Lurie Canc Ctr, Dept Microbiol & Immunol, Chicago, IL 60611 USA; Vet Affairs Lakeside Med Ctr, Dept Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Weitzman, SA (corresponding author), Olson 8276,303 E Chicago Ave, Chicago, IL 60611 USA.				NATIONAL CANCER INSTITUTE [T32CA009560, R01CA074403] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA09560, CA74403] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Henning K, 1999, HISTOPATHOLOGY, V34, P305; Jenkins TD, 1998, J BIOL CHEM, V273, P10747, DOI 10.1074/jbc.273.17.10747; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; Martin KJ, 1998, MOL MED, V4, P602, DOI 10.1007/BF03401760; Matsumoto N, 1998, J BIOL CHEM, V273, P28229, DOI 10.1074/jbc.273.43.28229; Miller KA, 2000, J BIOL CHEM, V275, P8176, DOI 10.1074/jbc.275.11.8176; Pulkkinen L, 1998, LAB INVEST, V78, P1067; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Stahl S, 1997, J CELL SCI, V110, P55; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; Virolle T, 2000, EMBO REP, V1, P328, DOI 10.1093/embo-reports/kvd066; Virolle T, 1998, J BIOL CHEM, V273, P17318, DOI 10.1074/jbc.273.28.17318; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917	27	41	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42863	42868		10.1074/jbc.M108130200	http://dx.doi.org/10.1074/jbc.M108130200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11551969	hybrid			2022-12-27	WOS:000172169300032
J	Mitchell, DC; Niu, SL; Litman, BJ				Mitchell, DC; Niu, SL; Litman, BJ			Optimization of receptor-G protein coupling by bilayer lipid composition I - Kinetics of rhodopsin-transducin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METARHODOPSIN-II; PHOTORECEPTOR-MEMBRANES; LATERAL DIFFUSION; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; MOLECULAR ORDER; DISK MEMBRANES; CHOLESTEROL; PHOSPHOLIPIDS; LUMIRHODOPSIN	The role of membrane composition in modulating the rate of G protein-receptor complex formation was examined using rhodopsin and transducin (G(t)) as a model system. Metarhodopsin II (MII) and MII-G(t) complex formation rates were measured, in the absence of GTP, via flash photolysis for rhodopsin reconstituted in 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (18:0,18:1PC) and 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine (18:0,22:6PC) bilayers, with and without 30 mol% cholesterol. Variation in bilayer lipid composition altered the lifetime of MII-G(t) formation to a greater extent than the lifetime of MII. MII-G(t) formation was fastest in 18:0,22:6PC and slowest in 18:0,18:1PC/30 mol% cholesterol. At 37 degreesC and a G(t) to photolyzed rhodopsin ratio of 1:1 in 18:0,22: 6PC bilayers, MII-G(t) formed with a lifetime of 0.6 +/-0.06 ms, which was not significantly different from the lifetime for MII formation. Incorporation of 30 mol% cholesterol slowed the rate of MII-G(t) complex formation by about 400% in 18:0,18:1PC, but by less than 25% in 18:0,22:6PC bilayers. In 18:0,22:6PC, with or without cholesterol, MII-G(t) formed rapidly after MII formed. In contrast, cholesterol in 18:0,18:IPC induced a considerable lag time in MII-G(t) formation after MII formed. These results demonstrate that membrane composition is a critical factor in determining the temporal response of a G protein-coupled signaling system.	NIAAA, Sect Fluorescence Studies, Lab Membrane Biochem & Biophys, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Litman, BJ (corresponding author), NIAAA, Sect Fluorescence Studies, Lab Membrane Biochem & Biophys, Pk 5,Rm 158,12420 Parklawn Dr, Rockville, MD 20852 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000080, ZIAAA000080, Z01AA000105, Z01AA000072] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; BARTLETT GR, 1959, J BIOL CHEM, V234, P596; BENNETT N, 1982, EUR J BIOCHEM, V127, P97, DOI 10.1111/j.1432-1033.1982.tb06842.x; BIRCH DG, 1992, INVEST OPHTH VIS SCI, V33, P2365; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; Borst JW, 2000, BBA-MOL CELL BIOL L, V1487, P61, DOI 10.1016/S1388-1981(00)00084-6; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Dickopf S, 1998, BIOCHEMISTRY-US, V37, P16888, DOI 10.1021/bi981879m; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; HARGRAVE PA, 1993, BIOESSAYS, V15, P43, DOI 10.1002/bies.950150107; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; JACKSON ML, 1985, BIOCHIM BIOPHYS ACTA, V812, P369, DOI 10.1016/0005-2736(85)90311-6; Jager S, 1998, BIOCHEMISTRY-US, V37, P6998, DOI 10.1021/bi9728194; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Ladha S, 1996, BIOPHYS J, V71, P1364, DOI 10.1016/S0006-3495(96)79339-6; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LEWIS JW, 1981, PHOTOCHEM PHOTOBIOL, V34, P375, DOI 10.1111/j.1751-1097.1981.tb09012.x; LITMAN BJ, 1982, METHOD ENZYMOL, V81, P150; LITMAN BJ, 1996, LIPIDS S, V31, P193; MATHEWS RG, 1963, J GEN PHYSIOL, V47, P215; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MCDOWELL JH, 1977, BIOCHEMISTRY-US, V16, P4054, DOI 10.1021/bi00637a018; MILLER JL, 1987, BIOCHIM BIOPHYS ACTA, V898, P81, DOI 10.1016/0005-2736(87)90111-8; Mitchell DC, 1998, BIOPHYS J, V74, P879, DOI 10.1016/S0006-3495(98)74011-1; Mitchell DC, 1998, BIOPHYS J, V75, P896, DOI 10.1016/S0006-3495(98)77578-2; MITCHELL DC, 1992, BIOCHEMISTRY-US, V31, P662, DOI 10.1021/bi00118a005; MITCHELL DC, 1990, BIOCHEMISTRY-US, V29, P9143, DOI 10.1021/bi00491a007; Neuringer M, 2000, AM J CLIN NUTR, V71, p256S, DOI 10.1093/ajcn/71.1.256S; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; Niu SL, 2001, J BIOL CHEM, V276, P42807, DOI 10.1074/jbc.M105778200; OBRIEN DF, 1977, BIOCHEMISTRY-US, V16, P1295, DOI 10.1021/bi00626a009; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; STINSON AM, 1991, EXP EYE RES, V52, P218; STRAUME M, 1990, BIOCHEMISTRY-US, V29, P9135, DOI 10.1021/bi00491a006; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; THORGEIRSSON TE, 1993, BIOCHEMISTRY-US, V32, P13861, DOI 10.1021/bi00213a015	45	97	100	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					42801	42806		10.1074/jbc.M105772200	http://dx.doi.org/10.1074/jbc.M105772200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544258	hybrid			2022-12-27	WOS:000172169300023
J	Reymond, N; Fabre, S; Lecocq, E; Adelaide, J; Dubreuil, P; Lopez, M				Reymond, N; Fabre, S; Lecocq, E; Adelaide, J; Dubreuil, P; Lopez, M			Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with Nectin1/PRR1 through V domain interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX VIRUS TYPE-1; POLIOVIRUS RECEPTOR GENE; CELL-CELL JUNCTIONS; ADHERENS JUNCTIONS; ADHESION MOLECULE; BINDING PROTEIN; AF-6 INTERACTS; MURINE HOMOLOG; GLYCOPROTEIN-D; ENTRY	Nectins are adhesion molecules that participate in the organization of epithelial and endothelial junctions and serve as receptors for herpes simplex virus entry. They belong to the immunoglobulin superfamily, are homologues of the poliovirus receptor (PVR/CD155), and were also named poliovirus receptor-related (PRR) proteins. We identify a new member of the nectin family named nectin4. Peptide sequences of human and murine nectin4 share 92% identity, and as for other members, the ectodomain is made of three immunoglobulin-like domains of V, C, C types. In contrast to other nectin molecules, detection of nectin4 transcripts is mainly restricted to placenta in human tissues. Expression is broader in mouse, and interestingly nectin4 is detected at days 11, 15, and 17 during murine embryogenesis. Nectin4 interacts with afadin, a F-actin-associated molecule, via its carboxyl-terminal cytoplasmic sequence. Both molecules co-localize at cadherin-based adherens junctions in the MDCKII epithelial cell line. Nectins are homophilic adhesion molecules, and recently heterophilic interactions have been described between nectin3/nectin1 and nectin3/nectin2. We confirmed these trans-interactions and also described nectin3 as the PVR/CD155 ligand. By means of several approaches, we report on the identification of nectin4 as a new ligand for nectin1. First, a soluble chimeric recombinant nectin4 ectodomain (nectin4-Fc) trans-interacts with cells expressing nectin1 but not with cells expressing nectin2, nectin3, or PVR/CD155. Conversely, nectin1-Fc binds to cells expressing nectin4. Second, nectin1-Fc precipitates nectin4 expressed in COS cells. Third, reciprocal in vitro physical interactions were detected between nectin4-Fc and nectin1-Fc. The nectin4-Fc/nectin4-Fc interaction was detected suggesting that nectin4 exhibits both homophilic and heterophilic properties. Using the same approaches we demonstrate, for the first time, that the V domain of nectin1 acts as a major functional region involved in trans-heterointeraction with nectin4 and also nectin3.	INSERM, U119, Inst Cancerol & Immunol Marseille, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Lopez, M (corresponding author), INSERM, U119, Inst Cancerol & Immunol Marseille, 27 Bd Lei Roure, F-13009 Marseille, France.		Dubreuil, Patrice/V-4816-2019; dubreuil, patrice/F-5346-2011; ADELAIDE, José JA/O-4390-2017	Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150; ADELAIDE, José JA/0000-0003-4364-9857				Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cocchi F, 1998, P NATL ACAD SCI USA, V95, P15700, DOI 10.1073/pnas.95.26.15700; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; Cocchi F, 2000, J VIROL, V74, P3909, DOI 10.1128/JVI.74.8.3909-3917.2000; Cocchi F, 2001, J VIROL, V75, P7987, DOI 10.1128/JVI.75.17.7987-7994.2001; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Lopez M, 2000, J VIROL, V74, P1267, DOI 10.1128/JVI.74.3.1267-1274.2000; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; Lopez M, 2001, J VIROL, V75, P5684, DOI 10.1128/JVI.75.12.5684-5691.2001; LOPEZ M, 1997, LEUKOCYTE TYPING, V6, P1081; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Menotti L, 2000, P NATL ACAD SCI USA, V97, P4867, DOI 10.1073/pnas.97.9.4867; MORRISON ME, 1992, J VIROL, V66, P2807, DOI 10.1128/JVI.66.5.2807-2813.1992; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Ollendorff V, 1998, INT J ONCOL, V13, P1159; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Watari Y, 1998, GENE, V224, P53, DOI 10.1016/S0378-1119(98)00527-7; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	35	226	240	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43205	43215		10.1074/jbc.M103810200	http://dx.doi.org/10.1074/jbc.M103810200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11544254	hybrid			2022-12-27	WOS:000172169300075
J	Valasek, L; Hasek, J; Nielsen, KH; Hinnebusch, AG				Valasek, L; Hasek, J; Nielsen, KH; Hinnebusch, AG			Dual function of eIF3j/Hcr1p in processing 20 S pre-rRNA and translation initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE HOMOLOG; P40/LAMININ RECEPTOR PRECURSOR; TRANS-ACTING FACTORS; ESCHERICHIA-COLI; 3 EIF3; PROTEIN; COMPLEX; SUBUNITS; GENES; PURIFICATION	eIF3j/Hcr1p, a protein associated with eIF3, was shown to bind to, and stabilize, the multifactor complex containing eIFs 1, 2, 3, and 5 and Met-tRNA(i)(Met), whose formation is required for an optimal rate of translation initiation. Here we present evidence that eIF3j/Hcr1p is an RNA binding protein that enhances a late step in 40 S ribosome maturation involving cleavage of the 20 S precursor of 18 S rRNA in the cytoplasm. Immunofluorescence staining shows that eIF3j/Hcr1p is localized predominantly in the cytoplasm. The herl A mutant exhibits a decreased amount of 40 S subunits, hypersensitivity to paromomycin, and increased levels of 20 S pre-rRNA. Combining the hcr1 Delta mutation with drs2 Delta or rps0a Delta, deletions of two other genes involved in the same step of 40 S subunit biogenesis, produced a synthetic growth defect. p35, the human ortholog of eIF3j/Hcr1p, partially complemented the slow growth phenotype conferred by hcr1 Delta when overexpressed in yeast. heIF3j/p35 was found physically associated with yeast eIF3 and 43 S initiation complexes in vitro and in vivo. Because it did not complement the 40 S biogenesis defect of hcr1 Delta, it appears that heIF3j can substitute for eIF3j/Hcr1p only in translation initiation. We conclude that eIF3j/Hcr1p is required for rapid processing of 20 S to IS S rRNA besides its role in translation initiation, providing an intriguing link between ribosome biogenesis and translation.	NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Hinnebusch, AG (corresponding author), NICHHD, Lab Gene Regulat & Dev, NIH, 6 Ctr Dr,Bldg 6A-B1A-13, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov	Hasek, Jiri/H-2427-2014; Valášek, Leoš Shivaya/I-5743-2014	Hasek, Jiri/0000-0001-6634-2386; Valášek, Leoš Shivaya/0000-0001-8123-8667	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001004] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALASEK L, 2001, EMBO J, V20, P891; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Block KL, 1998, J BIOL CHEM, V273, P31901, DOI 10.1074/jbc.273.48.31901; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; FOLLEY LS, 1994, GENETICS, V137, P369; Ford CL, 1999, CANCER RES, V59, P704; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hasek J, 2000, CELL MOTIL CYTOSKEL, V45, P235, DOI 10.1002/(SICI)1097-0169(200003)45:3<235::AID-CM6>3.0.CO;2-I; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; KLOOTWIJK J, 1989, METHOD ENZYMOL, V180, P96; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; LEE WC, 1992, MOL CELL BIOL, V12, P3865, DOI 10.1128/MCB.12.9.3865; Linder P, 1999, YEAST, V15, P865; Methot N, 1997, J BIOL CHEM, V272, P1110, DOI 10.1074/jbc.272.2.1110; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; RIPMASTER TL, 1993, MOL CELL BIOL, V13, P7901, DOI 10.1128/MCB.13.12.7901; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sherman F., 1974, METHODS YEAST GENETI; Si K, 1999, MOL CELL BIOL, V19, P1416; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; Tollervey D, 1996, EXP CELL RES, V229, P226, DOI 10.1006/excr.1996.0364; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Valasek L, 1998, J BIOL CHEM, V273, P21253, DOI 10.1074/jbc.273.33.21253; Valasek L, 1999, J BIOL CHEM, V274, P27567, DOI 10.1074/jbc.274.39.27567; VALASEK L, 1998, THESIS U VIENNA AUST; Zabetakis D, 2000, YEAST, V16, P1147, DOI 10.1002/1097-0061(20000915)16:12<1147::AID-YEA610>3.0.CO;2-M	35	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2001	276	46					43351	43360		10.1074/jbc.M106887200	http://dx.doi.org/10.1074/jbc.M106887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	492LF	11560931	hybrid			2022-12-27	WOS:000172169300094
J	Gao, XL; Satoh, T; Liao, YH; Song, CH; Hu, CD; Kariya, K; Kataoka, T				Gao, XL; Satoh, T; Liao, YH; Song, CH; Hu, CD; Kariya, K; Kataoka, T			Identification and characterization of RA-GEF-2, a Rap guanine nucleotide exchange factor that serves as a downstream target of M-Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; DEPENDENT ACTIVATION; KINASE ACTIVATION; ADENYLYL-CYCLASE; MAP KINASE; HA-RAS; FAMILY; INTERACTS; PROTEINS; DOMAIN	The Ras family small GTPase Rap is regulated by an array of specific guanine nucleotide exchange factors (GEFs) in response to upstream stimuli. RA-GEF-1 was identified as a novel Rap GEF, which possesses a Ras/Rap1-associating (RA) domain. Here we report a protein closely related to RA-GEF-1, named RA-GEF-2. Like RA-GEF-1, a putative cyclic nucleotide monophosphate-binding domain, a Ras exchanger motif, a PSD-95/D1gA/ZO-1 domain, and an RA domain in addition to the GEF catalytic domain are found in RA-GEF-2. However, RA-GEF-2 displays a different tissue distribution profile from that of RA-GEF-1. RA-GEF-2 stimulates guanine nucleotide exchange of both Rap1 and Rap2, but not Ha-Ras. The RA domain of RA-GEF-2 binds to M-Ras in a GTP-dependent manner, but not to other Ras family GTPases tested, including Ha-Ras, N-Ras, Rap1A, Rap2A, R-Ras, Ra1A, Rin, Rit, and Rheb, in contrast to the RA domain of RA-GEF-1, which specifically binds to Rap1. In accordance with this, RA-GEF-2 colocalizes with activated M-Ras in the plasma membrane in COS-7 cells, suggesting a role of RA-GEF-2 in the regulation of Rap1 and Rap2, particularly in the plasma membrane. In fact, an increase in the level of the GTP-bound form of plasma membrane-located Rap1 was observed when coexpressed with RA-GEF-2 and activated M-Ras. Thus, RA-GEF-2 acts as a GEF for Rap1 and Rap2 downstream of M-Ras in the plasma membrane, whereas RA-GEF-1 exerts Rap GEF function in perinuclear compartments including the Golgi apparatus.	Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Mol Biol,CHuo Ku, Kobe, Hyogo 6500017, Japan; Univ Ryukyus, Sch Med, Dept Biochem 2, Nishihara, Okinawa 9030215, Japan	Kobe University; University of the Ryukyus	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Mol Biol,CHuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	kataoka@kobe-u.ac.jp	Satoh, Takaya/K-2628-2014; song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; song, chunhua/0000-0002-4081-2543				BERANGER F, 1991, P NATL ACAD SCI USA, V88, P1606, DOI 10.1073/pnas.88.5.1606; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; Ichiba T, 1999, FEBS LETT, V457, P85, DOI 10.1016/S0014-5793(99)01012-1; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kimmelman A, 1997, ONCOGENE, V15, P2675, DOI 10.1038/sj.onc.1201674; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Okada T, 1999, MOL CELL BIOL, V19, P6057; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Shima F, 2000, MOL CELL BIOL, V20, P26, DOI 10.1128/MCB.20.1.26-33.2000; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wienecke R, 1996, ONCOGENE, V13, P913; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	37	79	83	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42219	42225		10.1074/jbc.M105760200	http://dx.doi.org/10.1074/jbc.M105760200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11524421	hybrid			2022-12-27	WOS:000172450400091
J	Grahammer, F; Warth, R; Barhanin, J; Bleich, M; Hug, MJ				Grahammer, F; Warth, R; Barhanin, J; Bleich, M; Hug, MJ			The small conductance K+ channel, KCNQ1 - Expression, function, and subunit composition in murine trachea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CL SECRETION; POTASSIUM CHANNEL; EPITHELIAL-CELLS; AIRWAY EPITHELIA; MEMBRANE-PROTEIN; APICAL MEMBRANE; ION-TRANSPORT; RABBIT COLON; RAT; CALCIUM	The gene KCNQ1 encodes a K+ channel a-subunit important for cardiac repolarization, formerly known as K,LQT1. In large and small intestine a channel complex consisting of KCNQ1 and the beta -subunit KCNE3 (MiRP2) is known to mediate the cAMP-activated basolateral K+ current, which is essential for luminal Cl- secretion. Northern blot experiments revealed an expression of both subunits in lung tissue. However, previous reports suggested a role of KCNE1 (minK, Isk) but not KCNE3 in airway epithelial cells. Here we give evidence that KCNE1 is not detected in murine tracheal epithelial cells and that Cl- secretion by these cells is not reduced by the knock-out of the KCNE1 gene. In contrast we show that a complex consisting of KCNQ1 and KCNE3 probably forms a basolateral K+ channel in murine tracheal epithelial cells. As described for colonic epithelium, the current through KCNQ1 complexes in murine trachea is specifically inhibited by the chromanol 293B. A 293B-sensitive current was present after stimulation with forskolin and agonists that increase Ca2+ as well as after administration of the pharmacological K+ channel activator, 1-EBIO. A 293B-inhibitable current was already present under control conditions and reduced after administration of amiloride indicating a role of this K+ channel not only for Cl- secretion but also for Na+ reabsorption. We conclude that at least in mice a KCNQ1 channel complex seems to be the dominant basolateral K+ conductance in tracheal epithelial cells.	Univ Munster, Abt Vegetat Physiol, Inst Physiol, D-48149 Munster, Germany; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Aventis Pharma Deutsch GmbH, D-65926 Frankfurt, Germany	University of Munster; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Sanofi-Aventis	Hug, MJ (corresponding author), Univ Munster, Abt Vegetat Physiol, Inst Physiol, Robert Koch Str 27A, D-48149 Munster, Germany.	hugma@uni-muenster.de	Warth, Richard/N-7119-2014; Bleich, Markus/A-2812-2010; Grahammer, Florian/ABB-7775-2021	Warth, Richard/0000-0001-6084-0659; Bleich, Markus/0000-0002-1745-2295; 				Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Adeagbo ASO, 1999, EUR J PHARMACOL, V379, P151, DOI 10.1016/S0014-2999(99)00489-6; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Arrighi I, 2001, P NATL ACAD SCI USA, V98, P8792, DOI 10.1073/pnas.141233398; Bleich M, 2000, PFLUG ARCH EUR J PHY, V440, P202, DOI 10.1007/s004240000257; Bleich M, 1997, PFLUG ARCH EUR J PHY, V434, P499, DOI 10.1007/s004240050427; Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL785, DOI 10.1152/ajplung.1996.271.5.L785; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; ECKE D, 1995, CELL PHYSIOL BIOCHEM, V5, P204, DOI 10.1159/000154755; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Greger R, 1996, PFLUG ARCH EUR J PHY, V432, P579, DOI 10.1007/s004240050173; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; GREGER R, 1983, B MT DESERT ISL BIOL, V23, P8; Grubb BR, 2001, AM J PHYSIOL-CELL PH, V281, pC615, DOI 10.1152/ajpcell.2001.281.2.C615; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Hwang TH, 1996, AM J PHYSIOL-CELL PH, V270, pC1611, DOI 10.1152/ajpcell.1996.270.6.C1611; Hwang TH, 1996, J MEMBRANE BIOL, V154, P251, DOI 10.1007/s002329900149; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; JORIS L, 1989, PFLUG ARCH EUR J PHY, V415, P118, DOI 10.1007/BF00373149; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; LESAGE F, 1993, RECEPTOR CHANNEL, V1, P143; LI DC, 2000, AM J PHYSIOL, V279, pL14; Lock H, 2000, J BIOL CHEM, V275, P34849, DOI 10.1074/jbc.C000633200; LOHRMANN E, 1995, PFLUG ARCH EUR J PHY, V429, P517, DOI 10.1007/BF00704157; MacVinish LJ, 1998, J PHYSIOL-LONDON, V510, P237, DOI 10.1111/j.1469-7793.1998.237bz.x; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; MCCANN JD, 1990, AM J PHYSIOL, V258, pL334, DOI 10.1152/ajplung.1990.258.6.L334; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Suessbrich H, 1999, Rev Physiol Biochem Pharmacol, V137, P191; SUGIMOTO T, 1990, J MEMBRANE BIOL, V113, P39, DOI 10.1007/BF01869604; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Vallon V, 2001, J AM SOC NEPHROL, V12, P2003, DOI 10.1681/ASN.V12102003; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Warth R, 1996, PFLUG ARCH EUR J PHY, V432, P81, DOI 10.1007/s004240050108; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017	44	59	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42268	42275		10.1074/jbc.M105014200	http://dx.doi.org/10.1074/jbc.M105014200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11527966	hybrid			2022-12-27	WOS:000172450400097
J	Morimura, N; Tezuka, Y; Watanabe, N; Yasuda, M; Miyatani, S; Hozumi, N; Tezuka, K				Morimura, N; Tezuka, Y; Watanabe, N; Yasuda, M; Miyatani, S; Hozumi, N; Tezuka, K			Molecular cloning of POEM - A novel adhesion molecule that interacts with alpha(8)beta(1) integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; EGF-REPEAT; PROTEIN; RECEPTOR; BINDING; ALPHA-8-BETA-1; IDENTIFICATION; GENE; DIFFERENTIATION; OSTEOPONTIN	Cell adhesion molecules are involved in a number of biological functions, such as cell survival, cell differentiation, tissue repair, and development. A novel molecule, POEM (preosteoblast epidermal growth factor-like repeat protein with meprin, A5 protein, and receptor protein-tyrosine phosphatase mu domain), was isolated by reverse transcription-polymerase chain reaction using a set of degenerate primers designed after other known epidermal growth factor (EGF)-like motifs. From its structure, POEM was suggested to be a novel adhesion molecule with five EGF-like domains, an Arg-GlyAsp (RGD) cell binding motif, and a meprin, A5 protein, and receptor protein-tyrosine phosphatase mu (MAM) domain. By in situ hybridization using embryonic day 16.5 (E16.5) mouse embryos, strong expression of POEM mRNA was observed in developing kidney renal tubules, parathyroid and thyroid glands, developing bone, tooth germ, and endocrine organs of the brain. The inner ear, skeletal muscle, smooth muscle (except for the vascular system), and skin were also positive for POEM expression. Bacterial recombinant POEM protein containing the RGD sequence and MAM domain showed strong cell adhesion, spreading, and survival-promoting activities. By mutating the RGD sequence to RGE, the cell spreading and survival activities were significantly decreased, but the MAM domain was shown to contribute only to cell adhesion and not to cell. spreading and survival-promoting activities. The distribution of POEM in several tissues was close to that of alpha (8)beta (1) integrin. Therefore, we conducted cell adhesion assays using KA8 cells, a K562 leukemia clone stably expressing alpha (8) integrin. Parental K562 cells, which expressed alpha (5)beta (1) integrin, bound to fibronectin but not to POEM. On the other hand, KA8 cells showed strong binding and spreading on both fibronectin and POEM. These results suggest that POEM is a novel ligand for alpha (8)beta (1) integrin and that POEM may be involved in the development and function of various tissues, such as kidney, bone, muscles, and endocrine organs.	Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	Tokyo University of Science; RIKEN	Tezuka, K (corresponding author), Tokyo Univ Sci, Res Inst Biol Sci, Yamazaki 2669, Noda, Chiba 2780022, Japan.	tezuka@rs.noda.sut.ac.jp	Tezuka, Ken-ichi/B-3836-2012					ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ausubel FM, 1995, CURRENT PROTOCOLS MO, V1; BOSSY B, 1991, EMBO J, V10, P2375, DOI 10.1002/j.1460-2075.1991.tb07776.x; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Buchner G, 2000, MECH DEVELOP, V98, P179, DOI 10.1016/S0925-4773(00)00462-7; Buchner G, 2000, GENOMICS, V65, P16, DOI 10.1006/geno.2000.6146; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Damsky CH, 1997, KIDNEY INT, V51, P1427, DOI 10.1038/ki.1997.195; Denda S, 1998, BIOCHEMISTRY-US, V37, P5464, DOI 10.1021/bi9727489; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9; Horton M. A., 1996, P217; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kuriyama S, 2000, MECH DEVELOP, V93, P233, DOI 10.1016/S0925-4773(00)00280-X; Liaw L, 1998, J CLIN INVEST, V101, P1468; Marchand P, 1996, J BIOL CHEM, V271, P24236, DOI 10.1074/jbc.271.39.24236; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Moursi AM, 1997, J CELL SCI, V110, P2187; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; MULLER U, 1995, MOL BIOL CELL, V6, P433; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; SCHNAPP LM, 1995, J CELL SCI, V108, P537; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Stein Gary S., 1996, P69; TEZUKA K, 1994, J BIOL CHEM, V269, P1106; TEZUKA K, 1990, BIOCHEM BIOPH RES CO, V173, P246, DOI 10.1016/S0006-291X(05)81048-4; VARNUMFINNEY B, 1995, NEURON, V14, P1213, DOI 10.1016/0896-6273(95)90268-6; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	42	55	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2001	276	45					42172	42181		10.1074/jbc.M103216200	http://dx.doi.org/10.1074/jbc.M103216200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497HY	11546798	hybrid			2022-12-27	WOS:000172450400085
J	Chou, TT; Trojanowski, JQ; Lee, VMY				Chou, TT; Trojanowski, JQ; Lee, VMY			p38 mitogen-activated protein kinase-independent induction of gadd45 expression in nerve growth factor-induced apoptosis in medulloblastomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELLS; DNA-DAMAGE; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTORS; TRANSCRIPTION FACTOR; HUMAN FIBROBLASTS; ENERGY-BALANCE; RECEPTOR TRKC; GENE; BRCA1	We describe a novel nerve growth factor (NGF)signaling pathway leading to gadd45 induction that is independent of JNK and p38 MAPK. We used cDNA arrays representing 588 genes to investigate the role of differential gene expression in NGF-mediated pleiotropic responses. We compared the gene expression profiles obtained from MED283-TrkA cells undergoing NGF-induced apoptosis to PC12 cells undergoing NGF-induced differentiation. An early and specific transcriptional target of NGF in MED283-TrkA cells was the DNA-damage-inducible gene gadd45. Its magnitude of induction directly correlated with the magnitude of apoptosis in MED283 clones transfected with mutant TrkA receptors. Although gadd45 has been implicated in stress response signaling, in vitro kinase assays indicated that NGF neither activated c-Jun NH(2)-terminal kinase (JNK) nor p38 mitogen-activated protein kinase (MAPK). Furthermore, the p38 MAPK inhibitor SB203580 (20 muM) failed to prevent NGF-induced apoptosis and NGF-induced gadd45 expression. These results suggest that differential regulation of gadd45 expression possibly through BRCA1 may be a potential mechanism whereby NGF regulates pleiotropic responses.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, 3rd Floor,Maloney Bldg,36th & Spruce Sts, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu						Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BIGNER SH, 1990, CANCER RES, V50, P2347; BONGARZONE I, 1989, ONCOGENE, V4, P1457; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Chou TT, 2000, J BIOL CHEM, V275, P565, DOI 10.1074/jbc.275.1.565; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Dibenedetto AJ, 1996, PERSPECT DEV NEUROBI, V3, P111; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erhardt JA, 1998, ONCOGENE, V16, P443, DOI 10.1038/sj.onc.1201577; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fong WF, 2001, BBA-GENE STRUCT EXPR, V1517, P250, DOI 10.1016/S0167-4781(00)00287-6; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; HARA E, 1994, J BIOL CHEM, V269, P2139; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jin SQ, 2000, ONCOGENE, V19, P4050, DOI 10.1038/sj.onc.1203759; Joseph R, 1996, BRAIN RES, V738, P32, DOI 10.1016/0006-8993(96)00768-8; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kim JYH, 1999, CANCER RES, V59, P711; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVIMONTALCINI R, 1995, J NEUROL SCI, V130, P119, DOI 10.1016/0022-510X(95)00007-O; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; Matsuda S, 1996, ONCOGENE, V12, P705; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MITRA G, 1987, P NATL ACAD SCI USA, V84, P6707, DOI 10.1073/pnas.84.19.6707; Muragaki Y, 1997, J NEUROSCI, V17, P530; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; NUR E, 2000, INT J ONCOL, V16, P1043; Peterson DA, 1997, SCIENCE, V277, P837, DOI 10.1126/science.277.5327.837; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Shayakul C, 1996, J CLIN INVEST, V98, P2580, DOI 10.1172/JCI119077; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shu TZ, 2000, J COMP NEUROL, V416, P201, DOI 10.1002/(SICI)1096-9861(20000110)416:2<201::AID-CNE6>3.0.CO;2-Z; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; vanGrunsven LA, 1996, ONCOGENE, V12, P1347; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yan GZ, 1997, J NEUROSCI, V17, P6122	60	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41120	41127		10.1074/jbc.M102832200	http://dx.doi.org/10.1074/jbc.M102832200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11544251	hybrid			2022-12-27	WOS:000171925600100
J	Ackermann, M; Padmanabhan, R				Ackermann, M; Padmanabhan, R			De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEPATITIS-C VIRUS; STEM-LOOP STRUCTURE; YELLOW-FEVER VIRUS; PUTATIVE METHYLTRANSFERASE DOMAIN; RIBONUCLEIC-ACID POLYMERASE; FLAVIVIRUS GENOMIC RNA; PROTEIN 5B POLYMERASE; IN-VITRO; POLIOVIRUS RNA; SECONDARY STRUCTURE	Replication of positive strand flaviviruses is mediated by the viral RNA-dependent RNA polymerases (RdRP). To study replication of dengue virus (DEN), a flavivirus family member, an in vitro RdRP assay was established using cytoplasmic extracts of DEN-infected mosquito cells and viral subgenomic RNA templates containing 5'-and 3'-terminal regions (TRs). Evidence supported that an interaction between the TRs containing conserved stem-loop, cyclization motifs, and pseudoknot structural elements is required for RNA synthesis. Two RNA products, a template size and a hairpin, twice that of the template, were formed. To isolate the function of the viral RdRP (NS5) from that of other host or viral factors present in the cytoplasmic extracts, the NS5 protein was expressed and purified from Escherichia coli. In this study, we show that the purified NS5 alone is sufficient for the synthesis of the two products and that the template-length RNA is the product of de novo initiation. Furthermore, the incubation temperature during initiation, but not elongation phase of RNA synthesis modulates the relative amounts of the hairpin and de novo RNA products. A model is proposed that a specific conformation of the viral polymerase and/or structure at the 3' end of the template RNA is required for de novo initiation.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Padmanabhan, R (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	rpadmana@kumc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032078, R21AI032078, R01AI045623] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45623, AI-32078] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; BANERJEE AR, 1993, BIOCHEMISTRY-US, V32, P153, DOI 10.1021/bi00052a021; BARTHOLOMEUSZ AI, 1993, ARCH VIROL, V128, P111, DOI 10.1007/BF01309792; BARTON DJ, 1995, J VIROL, V69, P5516, DOI 10.1128/JVI.69.9.5516-5527.1995; BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; BLUMENTHAL T, 1980, J BIOL CHEM, V255, P1713; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; BROYLES SS, 1991, J BIOL CHEM, V266, P15545; CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991; CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHU PWG, 1987, VIROLOGY, V157, P330, DOI 10.1016/0042-6822(87)90275-3; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5; CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Diaz GA, 1996, BIOCHEMISTRY-US, V35, P10837, DOI 10.1021/bi960488+; DREHER TW, 1988, J MOL BIOL, V201, P31, DOI 10.1016/0022-2836(88)90436-6; DYNAN WS, 1979, BIOCHEMISTRY-US, V18, P4581, DOI 10.1021/bi00588a019; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; GLUICK TC, 1994, J MOL BIOL, V241, P246, DOI 10.1006/jmbi.1994.1493; Gluick TC, 1997, BIOCHEMISTRY-US, V36, P16173, DOI 10.1021/bi971362v; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889; GRUN JB, 1986, J VIROL, V60, P1113, DOI 10.1128/JVI.60.3.1113-1124.1986; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6; HAGLER J, 1992, J VIROL, V66, P2982, DOI 10.1128/JVI.66.5.2982-2989.1992; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HAYES RJ, 1990, CELL, V63, P363, DOI 10.1016/0092-8674(90)90169-F; HEY TD, 1987, J VIROL, V61, P802, DOI 10.1128/JVI.61.3.802-811.1987; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Hsue B, 1998, ADV EXP MED BIOL, V440, P297; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Johnson RB, 2000, ARCH BIOCHEM BIOPHYS, V377, P129, DOI 10.1006/abbi.2000.1749; Kadare G, 1997, J VIROL, V71, P2583; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kautner I, 1997, J PEDIATR-US, V131, P516, DOI 10.1016/S0022-3476(97)70054-4; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lohmann V, 1998, VIROLOGY, V249, P108, DOI 10.1006/viro.1998.9311; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; LUBINSKI JM, 1987, J VIROL, V61, P2997, DOI 10.1128/JVI.61.10.2997-3003.1987; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MARKOFF L, 1989, J VIROL, V63, P3345, DOI 10.1128/JVI.63.8.3345-3352.1989; McKnight KL, 1998, RNA, V4, P1569, DOI 10.1017/S1355838298981006; MOHAN PM, 1991, GENE, V108, P185, DOI 10.1016/0378-1119(91)90433-C; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Murthy HMK, 1999, J BIOL CHEM, V274, P5573, DOI 10.1074/jbc.274.9.5573; Murthy HMK, 2000, J MOL BIOL, V301, P759, DOI 10.1006/jmbi.2000.3924; NAKHASI HL, 1991, J VIROL, V65, P5961, DOI 10.1128/JVI.65.11.5961-5967.1991; NEUFELD KL, 1991, J BIOL CHEM, V266, P24212; NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Osman TAM, 1996, J VIROL, V70, P6227, DOI 10.1128/JVI.70.9.6227-6234.1996; PARDIGON N, 1992, J VIROL, V66, P1007, DOI 10.1128/JVI.66.2.1007-1015.1992; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PLOTCH SJ, 1989, J VIROL, V63, P216, DOI 10.1128/JVI.63.1.216-225.1989; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; POGUE GP, 1992, J VIROL, V66, P674, DOI 10.1128/JVI.66.2.674-684.1992; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; QUADT R, 1993, P NATL ACAD SCI USA, V90, P1498, DOI 10.1073/pnas.90.4.1498; QUADT R, 1990, VIROLOGY, V178, P189, DOI 10.1016/0042-6822(90)90393-6; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; ROHLL JB, 1994, J VIROL, V68, P4384, DOI 10.1128/JVI.68.7.4384-4391.1994; ROHLL JB, 1995, J VIROL, V69, P7835, DOI 10.1128/JVI.69.12.7835-7844.1995; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; SANKAR S, 1991, J VIROL, V65, P2993, DOI 10.1128/JVI.65.6.2993-3000.1991; Schuppli D, 1998, J MOL BIOL, V283, P585, DOI 10.1006/jmbi.1998.2123; Shi PY, 1996, BIOCHEMISTRY-US, V35, P4222, DOI 10.1021/bi952398v; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; SONG CZ, 1994, P NATL ACAD SCI USA, V91, P8792, DOI 10.1073/pnas.91.19.8792; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; Steffens S, 1999, J GEN VIROL, V80, P2583, DOI 10.1099/0022-1317-80-10-2583; Stewart SR, 1998, NUCLEIC ACIDS RES, V26, P5318, DOI 10.1093/nar/26.23.5318; Sun JH, 1997, VIROLOGY, V233, P63, DOI 10.1006/viro.1997.8583; Sun JH, 1996, VIROLOGY, V226, P1, DOI 10.1006/viro.1996.0622; SVITKIN YV, 1984, VIROLOGY, V135, P536, DOI 10.1016/0042-6822(84)90207-1; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573; WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; WU SX, 1991, VIROLOGY, V183, P392, DOI 10.1016/0042-6822(91)90153-3; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998; ZHANG L, 1993, GENE, V129, P197, DOI 10.1016/0378-1119(93)90269-9; ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000; ZUKER M, 1991, NUCLEIC ACIDS RES, V19, P2707, DOI 10.1093/nar/19.10.2707	112	245	257	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39926	39937		10.1074/jbc.M104248200	http://dx.doi.org/10.1074/jbc.M104248200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546770	hybrid			2022-12-27	WOS:000171789200058
J	Oram, JF; Vaughan, AM; Stocker, R				Oram, JF; Vaughan, AM; Stocker, R			ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tecopherol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOCOPHEROL TRANSFER PROTEIN; TANGIER-DISEASE; DENSITY-LIPOPROTEIN; VITAMIN-E; CHOLESTEROL EFFLUX; II PNEUMOCYTES; CELLS; MACROPHAGES; MUTATIONS; RECEPTOR	Alpha -Tocopherol (alpha -TOH) is associated with plasma lipoproteins and accumulates in cell membranes throughout the body, suggesting that lipoproteins play a role in transporting alpha -TOH between tissues. Here we show that secretion of alpha -TOH from cultured cells is mediated in part by ABCA1, an ATP-binding cassette protein that transports cellular cholesterol and phospholipids to lipid-poor high density lipoprotein (HDL) apolipoproteins such as apoA-i. Treatment of human fibroblasts and murine RAW264 macrophages with cholesterol and/or 8-bromo-cyclic AMP, which induces ABCA1 expression, enhanced apoA-1-mediated alpha -TOH efflux. ApoA-I lacked the ability to remove alpha -TOH from Tangier disease fibroblasts that have a nonfunctional ABCA1 BHK cells that lack an active ABCA1 pathway markedly increased secretion of alpha -TOH to apoA-1 when forced to express ABCA1 ABCA1 also mediated a fraction of the alpha -TOH efflux promoted by lipid-containing HDL particles, indicating that HDL promotes alpha -TOH efflux by both ABCA1-dependent and -independent processes. Exposing apoA-1 to ABCA1-expressing cells did not enhance its ability to remove alpha -TOH from cells lacking ABCA1, consistent with this transporter participating directly in the translocation of alpha -TOH to apolipoproteins. These studies provide evidence that ABCA1 mediates secretion of cellular alpha -TOH into the HDL metabolic pathway, a process that may facilitate vitamin transport between tissues and influence lipid oxidation.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Heart Res Inst, Biochem Grp, Sydney, NSW 2050, Australia	University of Washington; University of Washington Seattle; University of Sydney; Heart Research Institute	Oram, JF (corresponding author), Univ Washington, Dept Med, Box 356426, Seattle, WA 98195 USA.		Stocker, Roland/AAV-4489-2021		NHLBI NIH HHS [HL 18645, HL 55362] Funding Source: Medline; NIDDK NIH HHS [DK 02456] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL055362] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Asmis R, 2000, ARTERIOSCL THROM VAS, V20, P2078, DOI 10.1161/01.ATV.20.9.2078; ASSMANN G, 1995, METABOLIC MOL BASES, P2053; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; CATIGNANI GL, 1977, BIOCHIM BIOPHYS ACTA, V497, P349, DOI 10.1016/0304-4165(77)90192-1; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goti D, 1998, BIOCHEM J, V332, P57, DOI 10.1042/bj3320057; Guthmann F, 1997, EUR J CELL BIOL, V74, P197; KAYDEN HJ, 1993, J LIPID RES, V34, P343; Kolleck I, 1999, FREE RADICAL BIO MED, V27, P882, DOI 10.1016/S0891-5849(99)00139-2; KOSTNER GM, 1995, BIOCHEM J, V305, P659, DOI 10.1042/bj3050659; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Mendez AJ, 1997, BBA-LIPID LIPID MET, V1346, P285, DOI 10.1016/S0005-2760(97)00031-3; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Nakamura T, 1998, LIPIDS, V33, P1001, DOI 10.1007/s11745-998-0298-3; Niu XW, 1999, ARTERIOSCL THROM VAS, V19, P1708, DOI 10.1161/01.ATV.19.7.1708; Oram J F, 1986, Methods Enzymol, V129, P645; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 1999, J LIPID RES, V40, P1769; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Panzenbock U, 2000, J BIOL CHEM, V275, P19536, DOI 10.1074/jbc.M000458200; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Smith JD, 1996, J BIOL CHEM, V271, P30647, DOI 10.1074/jbc.271.48.30647; Witt W, 2000, J LIPID RES, V41, P2009	32	146	149	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2001	276	43					39898	39902		10.1074/jbc.M106984200	http://dx.doi.org/10.1074/jbc.M106984200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485XR	11546785	hybrid			2022-12-27	WOS:000171789200054
